title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2037576/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-01-10 22:45:21,"Pfizer (PFE) closed at $47.62 in the latest trading session, marking a -1.59% move from the prior day.",PFE,0.655281,0.308774,Somewhat-Bullish
Halozyme Provides 2023 Financial Guidance and Outlook,https://www.prnewswire.com/news-releases/halozyme-provides-2023-financial-guidance-and-outlook-301717757.html,2023-01-10 22:15:00,2023 Total Revenue Guidance of $815 to $845 Million Representing >20% Growth Over Expected 2022 Revenue 2023 Recurring Revenues from Royalties Projected to Grow by >20% to $445 to $455 Million 2023 EBITDA Projected to Grow by >30% Year-Over-Year to $415 to $440 Million,PFE,0.05333,0.124,Neutral
"If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now - Inovio Pharmaceuticals  ( NASDAQ:INO ) ",https://www.benzinga.com/news/23/01/30315163/if-you-invested-1-000-in-inovio-stock-at-its-covid-19-pandemic-low-heres-how-much-youd-have-now,2023-01-10 17:48:18,Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two and a half years. But there was no question some big-name stocks performed better than others since the pandemic bottom.,PFE,0.129866,0.0,Neutral
Sen. Bernie Sanders urges Moderna not to hike price of Covid-19 vaccines,https://www.cnbc.com/2023/01/10/bernie-sanders-urges-moderna-not-to-hike-covid-19-vaccine-price.html,2023-01-10 17:38:05,"Sanders, the incoming chair of the Senate health committee, called the price increase ""outrageous"" in a letter to Moderna CEO Stephane Bancel.",PFE,0.057767,0.120979,Neutral
China takes first steps to punish countries that imposed testing mandates for Chinese travelers,https://www.marketwatch.com/story/china-takes-first-steps-to-punish-countries-that-imposed-testing-mandates-for-chinese-travelers-11673363816,2023-01-10 16:43:00,China suspended visas for South Koreans on Tuesday in a tit-for-tat response to that country's COVID testing requirement for Chinese tourists.,PFE,0.145583,0.09214,Neutral
"Novavax  ( NVAX )  Names John Jacobs as New CEO, Shares Rise",https://www.zacks.com/stock/news/2037465/novavax-nvax-names-john-jacobs-as-new-ceo-shares-rise,2023-01-10 16:24:00,"Novavax (NVAX) appoints John C. Jacobs as its new president and chief executive officer, effective Jan 23, 2023.",PFE,0.45634,-0.083981,Neutral
3 Passive Income Stocks That Are Screaming Buys in January,https://www.fool.com/investing/2023/01/10/3-passive-income-stocks-are-screaming-buys-january/,2023-01-10 14:45:00,All three could make investors a little bit richer every quarter.,PFE,0.098862,0.023654,Neutral
Is Former CStone Chairman the Medicine Ailing Hengrui Needs? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/23/01/30354269/is-former-cstone-chairman-the-medicine-ailing-hengrui-needs,2023-01-10 14:43:46,"Hengrui Pharma has named the former top executive of the smaller CStone as its new chief strategy officer, hoping he can help to reverse its recent decline The company has lost four vice general managers since last year, and its stock is down nearly 60% from its high at the end of 2020.",PFE,0.072435,0.131973,Neutral
"Top Stories Tuesday, Jan. 10 - Bitcoin  ( BTC/USD ) , Ethereum  ( ETH/USD ) ",https://www.benzinga.com/general/biotech/23/01/30351188/coinbase-discloses-restructuring-plan-amid-macro-headwinds-pfizer-rebuts-generic-version-of-covid,2023-01-10 13:17:16,"Coinbase Global, Inc COIN disclosed a restructuring plan letting go of 950 employees, helping it reduce its operating expenses by 25% amid the crypto meltdown.",PFE,0.077593,0.0,Neutral
"Pfizer Rebuts Generic Version Of COVID-19 Oral Treatment In China, Says It's Not A Poor Country - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/markets/asia/23/01/30350072/pfizer-rebuts-generic-version-of-covid-19-oral-treatment-in-china-says-its-not-a-poor-country,2023-01-10 13:08:16,"Pfizer Inc PFE CEO Albert Bourla rebuffed reports saying the company is in talks with Chinese authorities to license a generic version of its Covid-19 treatment Paxlovid. Bourla speaking at JPMorgan's healthcare conference, said, ""We are not in discussions.",PFE,0.491878,0.149928,Neutral
"Stock Market Live: Stocks Slide On Hawkish Fed Signals, Powell Speech In Focus",https://www.thestreet.com/markets/stock-market-live-stocks-slide-on-hawkish-fed-powell-in-focus,2023-01-10 13:07:00,Fed Chair Jerome Powell is set to address a central banking conference in Stockholm prior to the start of trading.,PFE,0.159922,0.005619,Neutral
Could This Drug News Be a Catalyst for This Big Pharma Stock?,https://www.fool.com/investing/2023/01/10/could-this-drug-news-be-a-catalyst-for-this-stock/,2023-01-10 13:00:00,Pfizer's immunology drug candidate could be approved to treat a type of inflammatory bowel disease.,PFE,0.118064,0.145037,Neutral
"Bed Bath & Beyond Posts Steeper Q3 Loss, 'Exploring Multiple Paths', As Bankruptcy Risk Looms",https://www.thestreet.com/markets/bed-bath-beyond-posts-steeper-q3-loss-as-bankruptcy-risk-looms,2023-01-10 12:52:00,"""We continue to work with advisors as we consider all strategic alternatives to accomplish our near- and long-term goals,"" said CEO Sue Gove.",PFE,0.074001,-0.004047,Neutral
"BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development",https://www.globenewswire.com/news-release/2023/01/10/2586013/0/en/BioNTech-to-Acquire-InstaDeep-to-Strengthen-Pioneering-Position-in-the-Field-of-AI-powered-Drug-Discovery-Design-and-Development.html,2023-01-10 12:15:00,"MAINZ, Germany, and LONDON, United Kingdom, January 10, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" ) and InstaDeep Ltd. ( ""InstaDeep"" ) today announced that they have entered into an agreement under which BioNTech will acquire InstaDeep, a leading global technology company in the field of ...",PFE,0.022161,0.023174,Neutral
Oak Street Health Stock Soars On $10 Billion CVS Takeover Report,https://www.thestreet.com/markets/oak-street-health-stock-soars-on-10-billion-cvs-takeover-report,2023-01-10 11:06:00,CVS is reportedly looking to expand its heath care sector footprint with a $10 billion purchase of primary care center operator Oak Street Health.,PFE,0.107016,-0.027754,Neutral
"Broadcom Stock Slips On Report Apple Planning To Dump WiFi, Bluetooth Chips",https://www.thestreet.com/markets/broadcom-stock-slips-on-report-apple-to-dump-wifi-bluetooth-chips,2023-01-10 10:48:00,Apple accounts for around 20% of Broadcom's overall chip sales.,PFE,0.128135,-0.09552,Neutral
"Stocks Slip Lower, Powell Speech, Pfizer Oak Street, Microsoft - Five Things To Know",https://www.thestreet.com/markets/stocks-dip-powell-pfizer-oak-street-microsoft-5-things-to-know,2023-01-10 10:17:00,Stock futures slip lower on hawkish Fed signals. Powell speech in focus as rate bets test tightening path. Pfizer may sell Covid treatment in China through local partner. Oak Street Health soars on $10 billion CVS takeover report and Microsoft said to eye $10 billion OpenAI investment.,PFE,0.204647,-0.00488,Neutral
Top Asian News 5:51 a.m. GMT,https://apnews.com/article/asia-7952d4ca3343285b8303889df875e1ea,2023-01-10 05:17:21,Top Asian News 5:21 a.m. GMT The Associated Press - en ...,PFE,0.032121,-0.000965,Neutral
Pfizer CEO rules out talk with China on generic Covid drug Paxlovid license,https://www.business-standard.com/article/international/pfizer-ceo-rules-out-talk-with-china-on-generic-covid-drug-paxlovid-license-123011000199_1.html,2023-01-10 04:18:00,Pfizer CEO rules out talk with China on generic Covid drug Paxlovid ... Business Standard ...,PFE,0.533481,-0.112487,Neutral
Mainland Chinese citizens are eager to travel - for the West's mRNA Covid vaccines,https://www.cnbc.com/2023/01/10/chinese-travelers-ready-to-flock-overseas-for-western-mrna-vaccines.html,2023-01-10 02:02:03,"Mainland China has reopened its borders, and citizens eager to travel are booking not just flight tickets, but also vaccination appointments.",PFE,0.060848,0.0,Neutral
Morning Bid: Knocking on CPI's door,https://www.reuters.com/markets/asia/global-markets-view-asia-graphic-pix-2023-01-09/,2023-01-09 21:59:00,"Jan 10 ( Reuters ) - A look at the day ahead in Asian markets from Stephen Culp. Asian markets could be in for a bumpy ride on Tuesday after a rocky U.S. session for stocks, as a lack of market moving catalysts and remarks from a Fed official helped take the air out of earlier gains.",PFE,0.093653,0.024893,Neutral
US Stocks End Mixed As Markets Ponder 'Soft Landing' Odds,https://www.barrons.com/news/us-stocks-end-mixed-as-markets-ponder-soft-landing-odds-01673299508,2023-01-09 21:28:03,"Wall Street stocks ended mixed on Monday despite a strong start, with markets looking ahead to critical inflation data and bank earnings later in the week. Major indices looked poised for another solid run after Friday's rally, which came on the back of jobs data that raised hopes for a ""soft ...",PFE,0.143415,-0.160968,Somewhat-Bearish
"Moderna's Interim Earnings Beat Modestly, Uncertainty Looms Over 2023 - Moderna  ( NASDAQ:MRNA ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30337646/modernas-interim-earnings-beat-modestly-uncertainty-looms-over-2023,2023-01-09 19:57:54,"Moderna Inc MRNA reported interim FY22 COVID-19 vaccine sales of $18.4 billion against $18-19 billion forecasted in the Q3 earnings release and the consensus of $17.8 billion. The company reiterates 2023 expected minimum COVID-19 vaccine sales of approximately $5 billion, with more contracts ...",PFE,0.31282,-0.18284,Somewhat-Bearish
Moderna considers pricing COVID vaccine at $110-$130 - WSJ,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-considers-pricing-covid-vaccine-110-130-wsj-2023-01-09/,2023-01-09 18:57:00,Moderna considers pricing COVID vaccine at ...,PFE,0.21686,0.034029,Neutral
News Exclusive | Moderna Considers Price of $110-$130 for Covid-19 Vaccine,https://www.wsj.com/articles/moderna-considers-price-of-110-130-for-covid-19-vaccine-11673289609,2023-01-09 18:40:00,The commercial price for the shot is similar to Pfizer's plans for after government contracting ends.,PFE,0.682689,0.0,Neutral
"Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly - Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/01/30337360/israel-based-study-shows-omicron-adapted-vaccine-shots-cut-hospitalization-rates-in-elderly,2023-01-09 17:50:06,Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc PFE and BioNTech SE BNTX reduced hospitalizations among older patients. The study has not yet been peer-reviewed.,PFE,0.670742,0.275468,Somewhat-Bullish
FDA Accepts Pfizer's  ( PFE )  sBLA Filing for Pneumococcal Jab,https://www.zacks.com/stock/news/2036832/fda-accepts-pfizers-pfe-sbla-filing-for-pneumococcal-jab,2023-01-09 15:37:00,The FDA grants priority review to Pfizer's (PFE) filing seeking label expansion of its pneumococcal 20-valent conjugate vaccine in infants and children. A decision is expected by this April.,PFE,0.420608,0.105951,Neutral
Dietary Supplements Market is Expected to Present the Potential Growth Opportunities in Coming Years with the Revenue of $220.8 billion by 2027,https://www.benzinga.com/pressreleases/23/01/g30333577/dietary-supplements-market-is-expected-to-present-the-potential-growth-opportunities-in-coming-yea,2023-01-09 14:30:00,"Chicago, Jan. 09, 2023 ( GLOBE NEWSWIRE ) -- According to the MarketsandMarkets, Dietary Supplements Market is estimated at USD 155.2 billion in 2022; it is projected to grow at a CAGR of 7.3% to reach USD 220.8 billion by 2027.",PFE,0.043264,0.068344,Neutral
Novavax Names John C. Jacobs as New President & Chief Executive Officer,https://www.prnewswire.com/news-releases/novavax-names-john-c-jacobs-as-new-president--chief-executive-officer-301716117.html,2023-01-09 14:00:00,Novavax Names John C. Jacobs as New President & Chief ... PR ...,PFE,0.03468,0.045394,Neutral
"Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results - Codex DNA, Inc. - Common Stock  ( NASDAQ:DNAY ) , Telesis Bio  ( NASDAQ:TBIO ) ",https://www.benzinga.com/pressreleases/23/01/g30332674/telesis-bio-pre-announces-preliminary-fourth-quarter-financial-results,2023-01-09 14:00:00,"-- Record revenue of $9M in 4QFY22; Increase of 191% over 4QFY21 -- BioXp® Revenue increased by 131% to $3M, in 4QFY22 over 4QFY21 -- Successful achievement of first technical milestone with Pfizer leveraging Telesis Bio's SOLA platform for enzymatic DNA synthesis technology",PFE,0.138863,0.143472,Neutral
"Top Stories Monday, Jan. 09 - Apple  ( NASDAQ:AAPL ) , AstraZeneca  ( NASDAQ:AZN ) ",https://www.benzinga.com/general/biotech/23/01/30332093/teslas-delivery-wait-times-go-up-china-wants-to-secure-license-for-generic-version-of-pfizers-pax,2023-01-09 13:44:27,Apple Inc AAPL exported more than $2.5 billion worth of iPhones from India between April and December as the company diversified production amid supply disruptions in China. The total export of the Cupertino-based tech giant in the first nine months of the fiscal year ending March 2023 was almost ...,PFE,0.067064,0.085176,Neutral
Why Pfizer  ( PFE )  Shares Are Trading Lower Premarket Today - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/01/30330240/china-in-talks-to-secure-license-for-generic-version-of-pfizers-covid-19-oral-drug,2023-01-09 13:29:55,"China is reportedly in talks with Pfizer Inc PFE to secure a license allowing domestic drugmakers to manufacture and distribute a generic version of its COVID-19 antiviral Paxlovid. Beijing is keen to finalize licensing deal terms before the Lunar New Year, which begins on January 22.",PFE,0.530253,0.46844,Bullish
"General Motors And These 2 Healthcare Majors On CNBC's 'Final Trades' - General Motors  ( NYSE:GM ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/news/23/01/30328216/general-motors-and-these-2-healthcare-majors-on-cnbcs-final-trades,2023-01-09 13:17:19,"On CNBC's ""Halftime Report Final Trades,"" Bryn Talkington of Requisite Capital Management named Pfizer Inc. PFE, saying that it offers ""growth at a reasonable price."" Benzinga's analyst ratings data shows a consensus Equal-Weight rating for Pfizer stock.",PFE,0.751437,0.431067,Bullish
Relmada Therapeutics Appoints CNS Therapeutic Expert Cedric O'Gorman MD as Chief Medical Officer,https://www.prnewswire.com/news-releases/relmada-therapeutics-appoints-cns-therapeutic-expert-cedric-ogorman-md-as-chief-medical-officer-301716208.html,2023-01-09 13:00:00,Relmada Therapeutics Appoints CNS Therapeutic Expert Cedric O ... PR ...,PFE,0.046816,-0.055742,Neutral
Ocugen-Bharat Biotech Covid vaccine meets main goals in US trial: Report,https://www.business-standard.com/article/current-affairs/ocugen-bharat-biotech-covid-vaccine-meets-main-goals-in-us-trial-report-123010900807_1.html,2023-01-09 12:08:00,Ocugen-Bharat Biotech Covid vaccine meets main goals in US trial ... Business Standard ...,PFE,0.303175,0.222748,Somewhat-Bullish
KemPharm Announces Board and Leadership Changes to Support its Transformation into a Leading Rare Disease Company,https://www.globenewswire.com/news-release/2023/01/09/2584962/16626/en/KemPharm-Announces-Board-and-Leadership-Changes-to-Support-its-Transformation-into-a-Leading-Rare-Disease-Company.html,2023-01-09 11:30:00,"Matthew R. Plooster named Chairman of the Board of DirectorsRichard W. Pascoe appointed Chief Executive OfficerTravis C. Mickle, Ph.D. transitions to PresidentJoshua Schafer appointed Chief Commercial Officer and Executive Vice President of Business Development ...",PFE,0.024749,0.025211,Neutral
KemPharm Announces Board and Leadership Changes to Support its Transformation into a Leading Rare Disease Company - KemPharm  ( NASDAQ:KMPH ) ,https://www.benzinga.com/pressreleases/23/01/g30328772/kempharm-announces-board-and-leadership-changes-to-support-its-transformation-into-a-leading-rare-,2023-01-09 11:30:00,"Matthew R. Plooster named Chairman of the Board of DirectorsRichard W. Pascoe appointed Chief Executive OfficerTravis C. Mickle, Ph.D. transitions to PresidentJoshua Schafer appointed Chief Commercial Officer and Executive Vice President of Business Development",PFE,0.024396,0.023337,Neutral
"Sensex spurts 847 pts on positive global cues, Nifty ends above 18,100; IT shares advance",https://www.business-standard.com/article/news-cm/sensex-spurts-847-pts-on-positive-global-cues-nifty-ends-above-18-100-it-shares-advance-123010900802_1.html,2023-01-09 11:21:00,"Sensex spurts 847 pts on positive global cues, Nifty ends above ... Business Standard ...",PFE,0.037446,0.066096,Neutral
Israeli study finds Omicron COVID booster cuts hospitalization in 65+,https://www.reuters.com/business/healthcare-pharmaceuticals/israeli-study-finds-omicron-covid-booster-cuts-hospitalization-65-2023-01-09/,2023-01-09 11:20:00,Israeli study finds Omicron COVID booster cuts hospitalization in ...,PFE,0.149656,0.0,Neutral
Private equity acquires a taste for drug development,https://www.reuters.com/business/healthcare-pharmaceuticals/private-equity-acquires-taste-drug-development-2023-01-09/,2023-01-09 11:10:00,"Jan 9 ( Reuters ) - Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in the sector, raising dedicated funds and coming up with deals that compensate them for the uncertainty involved.",PFE,0.043499,0.093027,Neutral
Pfizer not in talks on licensing generic COVID pill in China,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-not-talks-licensing-generic-covid-pill-china-2023-01-10/,2023-01-09 11:03:45,"[1/2] Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease ( COVID-19 ) , is displayed in this picture illustration taken October 7, 2022. A morning and an evening does consists of one white 100-milligram tablet of Ritonavir and two pink 150-milligram tablets of PF-07321332.",PFE,0.443626,-0.187734,Somewhat-Bearish
This Stock Could Be a Surprise Growth Pick for 2023,https://www.fool.com/investing/2023/01/09/this-stock-may-be-a-surprise-growth-pick-for-2023/,2023-01-09 10:30:00,Pfizer is about to enter a whole new era of growth.,PFE,0.733479,0.195189,Somewhat-Bullish
Sickle Cell Disease Treatment Market Size to Surpass Around USD 8.75 Billion by 2029 | Research Report by Fortune Business Insights,https://www.benzinga.com/pressreleases/23/01/g30327950/sickle-cell-disease-treatment-market-size-to-surpass-around-usd-8-75-billion-by-2029-research-repo,2023-01-09 10:18:21,"Pune, India, Jan. 09, 2023 ( GLOBE NEWSWIRE ) -- The global sickle cell disease treatment market size was valued at USD 1.73 billion in 2021. The market is projected to grow from USD 2.25 billion in 2022 to USD 8.75 billion by 2029, exhibiting a CAGR of 21.4% during the forecast period.",PFE,0.048327,0.0,Neutral
"Market snaps 3-day losing run, Sensex surges 847 pts, Nifty reclaims 18,100 level",https://www.business-standard.com/article/news-cm/market-snaps-3-day-losing-run-sensex-surges-847-pts-nifty-reclaims-18-100-level-123010900694_1.html,2023-01-09 10:16:00,"Market snaps 3-day losing run, Sensex surges 847 pts, Nifty ... Business Standard ...",PFE,0.043186,0.0671,Neutral
"Sensex spurts 790 pts, Nifty reclaims 18,000, IT stocks rally",https://www.business-standard.com/article/news-cm/sensex-spurts-790-pts-nifty-reclaims-18-000-it-stocks-rally-123010900246_1.html,2023-01-09 05:03:00,"The domestic equity barometers marched higher and hit the day's high in morning trade. The Nifty regained the key 18,000 level. IT stocks witnessed bargain hunting after falling in the past three trading sessions. At 10:30 IST, the barometer index, the S&P BSE Sensex, was up 790.23 points or ...",PFE,0.100729,0.073368,Neutral
"TCS, Titan Company, Tata Steel, HCL Tech in focus",https://www.business-standard.com/article/news-cm/tcs-titan-company-tata-steel-hcl-tech-in-focus-123010900122_1.html,2023-01-09 03:24:00,TCS: The IT major will be in focus as the it announces its December quarter ( Q3FY23 ) earnings today. Titan Company: Titan Company in its quarterly update for Q3FY23 said that the healthy consumer demand spurred by a vibrant festive season resulted in about 12% growth in combined sales YoY ...,PFE,0.155451,0.125792,Neutral
Ocugen-Bharat Biotech COVID vaccine meets main goals in U.S. trial,https://www.reuters.com/business/healthcare-pharmaceuticals/ocugen-bharat-biotech-covid-vaccine-meets-main-goal-trial-2023-01-09/,2023-01-09 02:26:15,Ocugen-Bharat Biotech COVID vaccine meets main goal in trial ...,PFE,0.288893,0.214526,Somewhat-Bullish
"TCS, JK Cement, Bandhan Bank, Tata Steel, IDBI Bank, HCL Technologies, NFL, SBI Cards stocks in focus | The Financial Express",https://www.financialexpress.com/market/stocks-to-watch-tcs-jk-cement-bandhan-bank-tata-steel-idbi-bank-hcl-technologies-nfl-sbi-cards-stocks-in-focus/2940531/,2023-01-09 01:44:14,"TCS, JK Cement, Bandhan Bank, Tata Steel, IDBI Bank, HCL Technologies, NFL, SBI Cards stocks in focus The Financial Express ...",PFE,0.043499,0.064456,Neutral
Soft landings and re-openings,https://www.reuters.com/markets/global-markets-view-asia-graphic-pix-2023-01-08/,2023-01-08 21:56:21,Soft landings and ...,PFE,0.083251,0.057672,Neutral
3 Dividend Stocks You Can Invest Confidently in Right Now,https://www.fool.com/investing/2023/01/08/3-dividend-stocks-you-can-invest-confidently-in-ri/,2023-01-08 12:12:00,"These stocks offer the hallmarks of confident investing: healthy earnings, stable outlooks, and superior credit ratings.",PFE,0.036926,0.263242,Somewhat-Bullish
China says talks to include Paxlovid in state health insurance fail,https://www.reuters.com/business/healthcare-pharmaceuticals/china-says-talks-include-paxlovid-state-health-insurance-fail-2023-01-08/,2023-01-08 10:39:00,"BEIJING, Jan 8 ( Reuters ) - China's Health Security Administration said on Sunday that talks to include Pfizer's Paxlovid in the latest drug list for basic state health insurance did not succeed. The talks fell through was due to Pfizer's high quotation for Paxlovid.",PFE,0.47672,-0.36287,Bearish
My Top Value Stock to Buy In 2023,https://www.fool.com/investing/2023/01/07/my-top-value-stock-to-buy-in-2023/,2023-01-07 14:15:00,"This company isn't just a ""pandemic stock."" ...",PFE,0.512596,0.34097,Somewhat-Bullish
"Wall St rallies as jobs, services data calm rate hike worries",https://www.moneycontrol.com/news/business/markets/wall-st-rallies-as-jobs-services-data-calm-rate-hike-worries-9824601.html,2023-01-07 02:58:14,"The Dow Jones Industrial Average rose 700.53 points, or 2.13%, to 33,630.61. the SP 500 gained 86.98 points, or 2.28%, at 3,895.08. and the Nasdaq Composite added 264.05 points, or 2.56%, at 10,569.29.",PFE,0.05234,0.209662,Somewhat-Bullish
"Intergalactic Therapeutics Appoints Theresa G.H. Heah, M.D., M.B.A., as Chief Executive Officer",https://www.prnewswire.com/news-releases/intergalactic-therapeutics-appoints-theresa-gh-heah-md-mba-as-chief-executive-officer-301715778.html,2023-01-06 22:00:00,"Intergalactic Therapeutics Appoints Theresa G.H. Heah, M.D., M.B.A. ... PR ...",PFE,0.047278,0.023588,Neutral
A Highly Contagious Covid-19 Variant Is Spreading in the U.S. What to Know.,https://www.barrons.com/amp/articles/covid-19-omicron-variant-xbb15-kraken-51673026221,2023-01-06 20:46:00,"'Kraken,' a Highly Contagious Covid-19 Variant, Is Spreading. What to Know. ...",PFE,0.12546,-0.031404,Neutral
World 50 I&D Impact Awards 2023 Shortlist Announced,https://www.prnewswire.com/news-releases/world-50-id-impact-awards-2023-shortlist-announced-301715652.html,2023-01-06 18:08:00,"ATLANTA, Jan. 6, 2023 /PRNewswire/ -- World 50, the global community of business leaders from the most respected and influential companies, is delighted to for the inaugural 2023 World 50 I&D Impact Awards.",PFE,0.09989,0.123359,Neutral
"XBB.1.5, which makes up 28% of new COVID cases in the U.S., fuels worries about a winter wave",https://www.marketwatch.com/story/xbb-1-5-which-makes-up-28-of-new-covid-cases-in-the-u-s-fuels-worries-about-a-winter-wave-11673027050,2023-01-06 17:44:00,The highly transmissible subvariant of omicron has rapidly become one of the most dominant strains of the virus in the U.S.,PFE,0.09186,0.131587,Neutral
Ophthalmic Drugs Market was valued USD 34 billion in 2022 & it will grow at a CAGR of 8% till 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30313696/ophthalmic-drugs-market-was-valued-usd-34-billion-in-2022-it-will-grow-at-a-cagr-of-8-till-2030-gr,2023-01-06 17:00:00,"Pune India, Jan. 06, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the ophthalmic drugs market is operating and is ...",PFE,0.05084,0.227469,Somewhat-Bullish
Exclusive: China in talks with Pfizer for generic COVID drug,https://www.reuters.com/business/healthcare-pharmaceuticals/china-talks-with-pfizer-generic-covid-drug-sources-2023-01-06/,2023-01-06 16:37:00,"HONG KONG/BEIJING, Jan 6 ( Reuters ) - China is in talks with Pfizer Inc ( PFE.N ) to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.",PFE,0.345674,0.22141,Somewhat-Bullish
China's latest COVID challenge: Lunar New Year holiday travel surge,https://www.marketwatch.com/story/chinas-latest-covid-challenge-lunar-new-year-holiday-travel-surge-11673020378,2023-01-06 15:52:00,China is hoping to avoid an acceleration in the pace of new COVID cases during the Lunar New Year holiday.,PFE,0.141171,-0.072699,Neutral
USFDA gives final nod to Alembic Pharmaceuticals' tablets for overactive bladder | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/usfda-gives-final-nod-to-alembic-pharmaceuticals-tablets-for-overactive-bladder/2939370/,2023-01-06 14:08:14,USFDA gives final nod to Alembic Pharmaceuticals' tablets for overactive bladder The Financial Express ...,PFE,0.366061,0.124232,Neutral
"Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors",https://www.prnewswire.com/news-releases/blueprint-medicines-appoints-john-tsai-md-to-its-board-of-directors-301715456.html,2023-01-06 14:00:00,"CAMBRIDGE, Mass., Jan. 6, 2023 /PRNewswire/ -- Blueprint Medicines Corporation ( NASDAQ: BPMC ) today announced the appointment of John Tsai, M.D., to its board of directors.",PFE,0.029399,0.038889,Neutral
Injectable Nanomedicines Market will surpass USD 1257.7 million by 2030 at a CAGR of 7.6% till 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30310044/injectable-nanomedicines-market-will-surpass-usd-1257-7-million-by-2030-at-a-cagr-of-7-6-till-2030,2023-01-06 14:00:00,"Pune India, Jan. 06, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the injectable nanomedicines market is operating ...",PFE,0.02607,0.09518,Neutral
"Top Stories Friday, Jan. 06 - Bed Bath & Beyond  ( NASDAQ:BBBY ) , Salesforce  ( NYSE:CRM ) ",https://www.benzinga.com/general/biotech/23/01/30309715/twitter-hackers-stole-more-than-200m-emails-delta-air-lines-to-offer-free-wi-fi-bed-bath-beyonds-,2023-01-06 13:43:26,"Twitter suffered a data breach in which hackers stole over 200 million email addresses and posted them on an online hacking forum, according to a security researcher. Details of the hacking were shared by Alon Gal, co-founder and CTO of Israeli cybersecurity monitoring firm Hudson Rock in a ...",PFE,0.089295,0.0,Neutral
Cancer Vaccine Trials-Using Same mRNA Tech Behind Covid Shots-Could Launch In U.K. This September,https://www.forbes.com/sites/roberthart/2023/01/06/cancer-vaccine-trials-using-same-mrna-tech-behind-covid-shots-could-launch-in-uk-this-september/,2023-01-06 13:40:25,"BioNTech, which worked with Pfizer to build an mRNA Covid vaccine, has partnered with the U.K. to turn the technology towards cancer and plans to treat 10,000 people by 2030.",PFE,0.182967,0.036432,Neutral
BioNTech says it will start cancer vaccine trials in the UK from September,https://www.cnbc.com/2023/01/06/biontech-says-it-will-start-cancer-vaccine-trials-in-the-uk-from-september.html,2023-01-06 13:27:43,"The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.",PFE,0.065327,0.0,Neutral
Pfizer Mulls Strategic Options For Some Early-Stage Rare Disease Candidates - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/01/30308872/pfizer-mulls-strategic-options-for-some-early-stage-rare-disease-candidates,2023-01-06 13:06:55,"Pfizer Inc PFE is reportedly exploring options for some early-stage candidates for rare diseases, including developing new viral-based gene therapies. Financial newspaper Barron's first reported on Thursday.",PFE,0.796885,-0.003963,Neutral
JNJ: 1 Dividend Stock to Buy Now and Retire on Later,https://stocknews.com/news/jnj-nvo-pfe-bmy-1-dividend-stock-to-buy-now-and-retire-on-later/,2023-01-06 13:03:07,"Record-high inflation, the Fed's hawkish stance, geopolitical turbulence, and growing recession fears kept the stock market highly volatile last year. However, Johnson & Johnson ( JNJ ) has been able to survive the market turmoil due to the defensive nature of its business and solid fundamentals.",PFE,0.105604,0.085233,Neutral
"CRISPR, Genetics And AI - Why 2023 Could Be Biotech's Year",https://www.investors.com/news/technology/biotech-stocks-how-crispr-genetics-and-ai-could-drive-a-2023-inflection/,2023-01-06 13:00:00,"Biotech Stocks: How CRISPR, Genetics And AI Could Drive A 2023 ... Investor's Business Daily ...",PFE,0.028155,-0.042845,Neutral
BiondVax's Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study,https://www.globenewswire.com/news-release/2023/01/06/2584350/0/en/BiondVax-s-Innovative-Inhaled-COVID-19-Therapy-Virtually-Eliminated-SARS-COV-2-Virus-in-Preclinical-In-Vivo-Study.html,2023-01-06 12:15:00,"JERUSALEM, Jan. 06, 2023 ( GLOBE NEWSWIRE ) -- via InvestorWire - BiondVax Pharmaceuticals Ltd. ( Nasdaq: BVXV ) , a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune ...",PFE,0.047324,0.038981,Neutral
BiondVax's Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study - BiondVax Pharmaceuticals  ( NASDAQ:BVXV ) ,https://www.benzinga.com/pressreleases/23/01/g30308389/biondvaxs-innovative-inhaled-covid-19-therapy-virtually-eliminated-sars-cov-2-virus-in-preclinical,2023-01-06 12:15:00,Hamsters infected with SARS-COV-2 and then treated with BiondVax's inhaled anti-COVID-19 nanosized antibodies ( NanoAbs ) had over 30-times lower lung viral titer on average compared to those treated with inhaled placebo,PFE,0.045962,0.025977,Neutral
Buy These 3 Market Neutral Funds to Dodge Volatility,https://www.zacks.com/stock/news/2036073/buy-these-3-market-neutral-funds-to-dodge-volatility,2023-01-06 12:00:00,"Below, we share with you three top-ranked market neutral funds. Each has a Zacks Mutual Fund Rank #1 (Strong Buy).",PFE,0.15697,0.03535,Neutral
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer's 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children,https://investingnews.com/u-s-fda-accepts-for-priority-review-the-supplemental-biologics-license-application-for-pfizer-s-20-valent-pneumococcal-conjugate-vaccine-in-infants-and-children/,2023-01-06 11:52:16,"If approved, the vaccine w ould provide the broadest serotype coverage of any pneumococcal conjugate vaccine in infants and children, and have the potential to help protect against more of the clinically significant remaining burden of disease Pfizer Inc. ( NYSE:PFE ) today announced that the U.S.",PFE,0.211191,0.217339,Somewhat-Bullish
Germany's BioNTech Plans UK Trial Of MRNA Cancer Therapy,https://www.barrons.com/news/germany-s-biontech-plans-uk-trial-of-mrna-cancer-therapy-01673001609,2023-01-06 10:42:29,"German pharmaceutical company BioNTech, which developed a trailblazing Covid-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.",PFE,0.130217,0.110437,Neutral
2 Top Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/01/06/2-top-biotech-stocks-to-buy-right-now/,2023-01-06 10:40:00,These two pharmaceutical companies pay market-beating dividends to shareholders.,PFE,0.349575,-0.063822,Neutral
Many Investors Wouldn't Touch This Stock With a 10-Foot Pole Last Year. Here's Why It's a Buy in 2023.,https://www.fool.com/investing/2023/01/06/investors-wouldnt-touch-this-stock-now-a-buy/,2023-01-06 10:30:00,Moderna's vaccine earnings are helping it prepare for the future.,PFE,0.059935,0.0,Neutral
BioNTech signs deal with UK for personalised cancer therapies,https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-signs-deal-with-uk-personalised-cancer-therapies-2023-01-06/,2023-01-06 08:50:00,"Jan 6 ( Reuters ) - BioNTech SE ( 22UAy.DE ) , has signed a deal with the UK government to enrol up to 10,000 patients in clinical trials by the end of 2030 for personalised cancer therapies, the German drug maker said.",PFE,0.245339,0.0,Neutral
Alembic Pharma gets USFDA nod for generic medication,https://www.moneycontrol.com/news/business/alembic-pharma-gets-usfda-nod-for-generic-medication-9821081.html,2023-01-06 06:58:26,"The company has received final approval from the US Food Drug Administration ( USFDA ) for its abbreviated new drug application ( ANDA ) for Fesoterodine Fumarate extended-release tablets in strength of 4 mg and 8 mg, the drug firm said in a statement.",PFE,0.258351,0.374944,Bullish
Alembic receives USFDA approval for Fesoterodine Fumarate ER Tablets,https://www.business-standard.com/article/news-cm/alembic-receives-usfda-approval-for-fesoterodine-fumarate-er-tablets-123010600311_1.html,2023-01-06 05:33:00,Alembic receives USFDA approval for Fesoterodine Fumarate ER ... Business Standard ...,PFE,0.355588,0.244157,Somewhat-Bullish
Pfizer to scale down early-stage rare disease research,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-plans-pull-back-early-stage-rare-disease-research-barrons-2023-01-06/,2023-01-06 02:22:20,"Jan 5 ( Reuters ) - U.S. pharma giant Pfizer Inc ( PFE.N ) said on Thursday it is planning to realign its early-stage research into treatments for rare diseases and oncology, to focus on areas like rare and benign hematology.",PFE,0.641573,0.112945,Neutral
"Pfizer could sell some assets, convert others into new companies amid broader refocus",https://www.marketwatch.com/story/pfizer-could-sell-some-assets-convert-others-into-new-companies-amid-broader-refocus-11672964946,2023-01-06 00:29:00,Drug maker Pfizer Inc. could part with or otherwise distance itself from some of its research programs.,PFE,0.751437,-0.0157,Neutral
"BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030",https://www.globenewswire.com/news-release/2023/01/06/2584176/0/en/BioNTech-Announces-Strategic-Partnership-with-UK-Government-to-Provide-up-to-10-000-Patients-with-Personalized-mRNA-Cancer-Immunotherapies-by-2030.html,2023-01-06 00:01:00,"MAINZ, Germany, January 6, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"", ""the Company"" ) today announced that the Company signed a Memorandum of Understanding ( ""MoU"" ) with the Government of the United Kingdom ( ""UK"" ) to benefit patients by accelerating clinical trials for personalized mRNA ...",PFE,0.091626,0.076141,Neutral
Pfizer to Pull Back on Rare Disease Research,https://www.barrons.com/articles/pfizer-rare-disease-gene-therapy-51672870246,2023-01-05 21:37:00,"Pfizer to Pull Back on Research Into Rare Disease, Gene Therapy ...",PFE,0.414559,0.0,Neutral
eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin and General Corporate Update - eFFECTOR Therapeutics  ( NASDAQ:EFTR ) ,https://www.benzinga.com/pressreleases/23/01/g30301431/effector-therapeutics-provides-positive-clinical-data-update-for-zotatifin-and-general-corporate-u,2023-01-05 21:01:00,"Zotatifin continues to show favorable activity profile, including two confirmed partial responses ( PR ) among seven heavily pretreated subjects who received zotatifin, fulvestrant and abemaciclib ( ECBF+A ) , with good tolerability",PFE,0.019699,0.003627,Neutral
PFE: Investing Champion Leif Soreide Notes Biotech Stocks May Be Countercyclical,https://stocknews.com/news/mrna-investing-champion-leif-soreide-notes-biotech-stocks-may-be-countercyclical/,2023-01-05 16:42:14,PFE: Investing Champion Leif Soreide Notes Biotech Stocks May Be ... ...,PFE,0.468029,0.172483,Somewhat-Bullish
The bad business of developing new antibiotics,https://www.axios.com/2023/01/05/the-bad-business-of-developing-new-antibiotics,2023-01-05 15:17:28,"Everyone agrees that the world needs new antibiotics, as the number of drug-resistant infections continues to soar. But there's little agreement on how to finance their development, and the situation is deteriorating.",PFE,0.091162,-0.055129,Neutral
Johnson & Johnson sets up mega-IPO for consumer health unit,https://www.axios.com/2023/01/05/johnson-and-johnson-ipo-consumer-health-tylenol-band-aid,2023-01-05 15:11:41,"Johnson & Johnson on Wednesday IPO registration papers for its consumer health products business, which is being spun out under the name Kenvue. Why it matters: This could be the largest U.S. IPO since Rivian went public in late 2021, with Renaissance Capital estimating that Kenvue could raise up ...",PFE,0.269776,0.0,Neutral
Choice Hotels  ( CHH )  Boosts New England Presence With New Hotel,https://www.zacks.com/stock/news/2035729/choice-hotels-chh-boosts-new-england-presence-with-new-hotel,2023-01-05 14:54:00,Choice Hotels (CHH) boosts upscale brand presence in New England with the Cambria Hotel New Haven University Area opening.,PFE,0.065506,0.173749,Somewhat-Bullish
Novocure Skyrockets After Pulling Off A Once-In-Six-Years Feat,https://www.investors.com/news/technology/nvcr-stock-skyrockets-after-novocure-pulls-off-a-once-in-six-years-feat/,2023-01-05 14:41:00,"Adding Novocure's ( NVCR ) medical device to standard drugs improved survival for late-stage lung cancer patients, leading NVCR stock to skyrocket Thursday. The company sells a device that uses electrical fields at specific frequencies to interrupt the rapid division of cancer cells.",PFE,0.16171,0.3638,Bullish
China's CanSino: 'positive' interim data on COVID mRNA vaccine booster trial,https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cansino-positive-interim-data-covid-mrna-vaccine-booster-trial-2023-01-05/,2023-01-05 14:21:00,China's CanSino: 'positive' interim data on COVID mRNA vaccine ... ...,PFE,0.218817,0.112669,Neutral
Pfizer Inc.  ( PFE )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2035623/pfizer-inc-pfe-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-01-05 14:00:12,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.531716,0.141922,Neutral
3D Systems Announces Appointment of Bert Bruce to Medical Advisory Board,https://www.globenewswire.com/news-release/2023/01/05/2583729/8852/en/3D-Systems-Announces-Appointment-of-Bert-Bruce-to-Medical-Advisory-Board.html,2023-01-05 13:30:00,"ROCK HILL, S.C., Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- 3D Systems ( NYSE:DDD ) today announced the appointment of Mr. Bert Bruce to the company's Medical Advisory Board. Mr. Bruce will join the five other members of the advisory board who have been named since the Board's establishment in May ...",PFE,0.155051,0.162344,Somewhat-Bullish
"As COVID vaccine and Paxlovid sales decline, analysts want to know what's next for Pfizer",https://www.marketwatch.com/story/as-covid-vaccine-and-paxlovid-sales-decline-analysts-want-to-know-whats-next-for-pfizer-11672859101,2023-01-05 12:40:00,Bank of America analysts downgraded the stock to neutral from buy.,PFE,0.387374,0.190295,Somewhat-Bullish
"Continued pricing pressures in US, European markets to affect Indian pharma firms' profit margins' | The Financial Express",https://www.financialexpress.com/healthcare/pharma-healthcare/continued-pricing-pressures-in-us-european-markets-to-affect-indian-pharma-firms-profit-marginsnbsp/2937823/,2023-01-05 11:31:42,"Continued pricing pressures in US, European markets to affect Indian pharma firms' profit margins' The Financial Express ...",PFE,0.072876,-0.009195,Neutral
German expats in China receive first foreign COVID vaccines,https://www.reuters.com/business/healthcare-pharmaceuticals/german-expats-china-receive-first-foreign-covid-vaccines-2023-01-05/,2023-01-05 08:05:00,"[1/2] A nurse vaccinates a German woman as the German embassy begins its roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas Peter",PFE,0.095517,0.090262,Neutral
Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders,https://www.globenewswire.com/news-release/2023/01/05/2583369/0/en/Sosei-Heptares-Notes-its-Partner-Tempero-Bio-has-Received-FDA-Clearance-to-Advance-Clinical-Development-of-TMP-301-for-Treatment-of-Alcohol-and-Substance-Use-Disorders.html,2023-01-05 07:37:00,"TOKYO and CAMBRIDGE, United Kingdom, Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , the world leader in G protein-coupled receptor ( GPCR ) focused structure-based drug design ( SBDD ) and development, notes its partner Tempero Bio has announced FDA ...",PFE,0.046273,0.04222,Neutral
Chinese Take Risks On Black Market Drugs As Covid Surges,https://www.barrons.com/news/chinese-take-risks-on-black-market-drugs-as-covid-surges-01672896010,2023-01-05 05:21:39,"Desperate families searching for critical Covid-19 medication in China, faced with bare pharmacy shelves and an explosion of cases, are being driven into murky online marketplaces rife with price gouging and fraud.",PFE,0.04882,0.0,Neutral
Chinese Take Risks On Black Market Drugs As Covid Surges,https://www.barrons.com/amp/news/chinese-take-risks-on-black-market-drugs-as-covid-surges-01672896010,2023-01-05 05:21:39,"Desperate families searching for critical Covid-19 medication in China, faced with bare pharmacy shelves and an explosion of cases, are being driven into murky online marketplaces rife with price gouging and fraud.",PFE,0.04882,0.0,Neutral
"Analyst Upgrades Merck To Buy, Downgrades Pfizer To Neutral - Merck & Co  ( NYSE:MRK ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30278987/merck-vs-pfizer-why-analyst-upgrades-one-pharmaceutical-stock-while-downgrading-ano,2023-01-04 18:22:33,"The health care sector held up relatively well in a difficult year for stocks in 2022. On Wednesday, one analyst adjusted his coverage of two large cap pharmaceutical stocks heading into what could be a volatile 2023.",PFE,0.63188,0.227112,Somewhat-Bullish
"Stocks making the biggest moves midday: Wynn Resorts, Microsoft, Honeywell, Salesforce and more",https://www.cnbc.com/2023/01/04/stocks-making-the-biggest-moves-midday-wynn-resorts-microsoft-honeywell-salesforce-and-more.html,2023-01-04 17:28:54,These are the stocks posting the largest moves midday.,PFE,0.051003,-0.227009,Somewhat-Bearish
Deciphera  ( DCPH )  Issues Strategic & Corporate Outlook for 2023,https://www.zacks.com/stock/news/2035281/deciphera-dcph-issues-strategic-corporate-outlook-for-2023,2023-01-04 17:16:00,Deciphera (DCPH) provides a strategic outlook and planned corporate milestones for 2023. The company also posts preliminary fourth-quarter and 2022 revenues.,PFE,0.226301,0.120275,Neutral
Why Pfizer  ( PFE )  Could Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2035284/why-pfizer-pfe-could-beat-earnings-estimates-again,2023-01-04 17:10:12,Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,PFE,0.414559,0.506958,Bullish
How 'Covid Darling' Pfizer Became A 'Show Me' Story For 2023,https://www.investors.com/news/technology/pfizer-stock-how-this-covid-darling-became-a-show-me-story-in-2023/,2023-01-04 17:01:00,"Pfizer ( PFE ) stock tumbled Wednesday after an analyst downgraded it, saying the ""Covid darling"" is now a ""show me"" story as Comirnaty and Paxlovid sales crumble. The pharmaceutical giant raked in more than $43.5 billion in worldwide sales of the Covid vaccine and antiviral pill over the first ...",PFE,0.488777,0.019216,Neutral
China Proves You Can't Hide Forever From Covid,https://www.forbes.com/sites/kenrapoza/2023/01/04/china-proves-you-cant-hide-forever-from-covid/,2023-01-04 15:50:10,"China will likely start hoarding medication and PPE. But this isn't the winter of 2020 in Shanghai, WHO says.",PFE,0.052455,0.172014,Somewhat-Bullish
"As EU works to coordinate response to China's COVID wave, Beijing and airlines are unhappy",https://www.marketwatch.com/story/as-eu-works-to-coordinate-response-to-chinas-covid-wave-beijing-and-airlines-are-unhappy-11672846821,2023-01-04 15:40:00,EU officials are working to coordinate a response to China's current wave of COVID cases and are likely to mandate tests for travelers.,PFE,0.083107,-0.033281,Neutral
Will Investors Notice Exciting Sign On Pfizer's Chart? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/23/01/30274704/will-investors-notice-exciting-sign-on-pfizers-chart,2023-01-04 14:47:19,"If history is any guide, there may be good fortune ahead for shares of Pfizer PFE. A so-called ""golden cross"" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions.",PFE,0.567144,0.561872,Bullish
Worried About 2023? Here's a Safer Way to Invest in Stocks This Year,https://www.fool.com/investing/2023/01/04/worried-about-2023-heres-a-safer-way-to-invest/,2023-01-04 14:37:00,"By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk.",PFE,0.066784,0.003016,Neutral
Why Roivant Sciences  ( ROIV )  Shares Are Trading Higher Today - Roivant Sciences  ( NASDAQ:ROIV ) ,https://www.benzinga.com/general/biotech/23/01/30274148/roivant-touts-encouraging-early-data-from-ulcerative-colitis-candidate,2023-01-04 14:21:34,"Roivant Sciences ROIV announced results from the induction period of the TUSCANY-2 Phase 2b study of RVT-3101 ( previously PF-06480605 ) , a once-monthly anti-TL1A antibody for ulcerative colitis. The data exhibited statistically significant and clinically meaningful efficacy results at each ...",PFE,0.674691,0.400821,Bullish
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar,https://www.zacks.com/stock/news/2035069/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar,2023-01-04 13:50:07,The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.,PFE,0.386875,0.460984,Bullish
Deciphera's Stomach Cancer Treatment Shows Clinical Benefit In Subgroup Of Patients - Deciphera Pharmaceuticals  ( NASDAQ:DCPH ) ,https://www.benzinga.com/general/biotech/23/01/30272768/decipheras-stomach-cancer-treatment-shows-clinical-benefit-in-subgroup-of-patients,2023-01-04 13:47:12,Deciphera Pharmaceuticals Inc DCPH announced an exploratory analysis of data from the INTRIGUE Phase 3 study of Qinlock using circulating tumor DNA ( ctDNA ) . The data comes from a subgroup of patients with gastrointestinal stromal tumors ( GIST ) previously treated with imatinib who harbor ...,PFE,0.303175,0.33927,Somewhat-Bullish
"Stocks making the biggest moves premarket: General Electric, Salesforce, Alibaba and more",https://www.cnbc.com/2023/01/04/stocks-making-the-biggest-moves-premarket-general-electric-salesforce-alibaba-and-more.html,2023-01-04 12:46:59,These are the stocks posting the largest moves in early morning trading.,PFE,0.081276,-0.07109,Neutral
"Over-the-Counter  ( OTC )  Analgesics Market Size to Worth Around USD 38.45 Billion by 2029, Says Brandessence Market Research",https://www.prnewswire.com/news-releases/over-the-counter-otc-analgesics-market-size-to-worth-around-usd-38-45-billion-by-2029--says-brandessence-market-research-301713314.html,2023-01-04 12:40:00,Over-the-Counter ( OTC ) Analgesics Market Size to Worth Around ... PR ...,PFE,0.032871,0.10793,Neutral
"Roivant Announces Statistically Significant and Clinically Meaningful Results from the Induction Period of TUSCANY-2, a Large Global Phase 2b Study of Subcutaneous RVT-3101 for the Treatment of Ulcerative Colitis in Both the Overall and the Biomarker Positive Patient Populations",https://www.globenewswire.com/news-release/2023/01/04/2582711/34323/en/Roivant-Announces-Statistically-Significant-and-Clinically-Meaningful-Results-from-the-Induction-Period-of-TUSCANY-2-a-Large-Global-Phase-2b-Study-of-Subcutaneous-RVT-3101-for-the-.html,2023-01-04 11:05:00,"BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Jan. 04, 2023 ( GLOBE NEWSWIRE ) -- Roivant Sciences ( Nasdaq: ROIV ) today announced positive results from the induction period of the TUSCANY-2 Phase 2b study of RVT-3101 ( previously PF-06480605 ) , a once monthly subcutaneously ...",PFE,0.033942,0.060295,Neutral
Pfizer  ( PFE )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2034830/pfizer-pfe-gains-as-market-dips-what-you-should-know,2023-01-03 22:45:19,"In the latest trading session, Pfizer (PFE) closed at $51.26, marking a +0.04% move from the previous day.",PFE,0.526707,0.12739,Neutral
This Pneumococcal Vaccine Player Is The Top Pick For 2023 For This Analyst - Vaxcyte  ( NASDAQ:PCVX ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30260907/this-pneumococcal-vaccine-player-is-the-top-pick-for-2023-for-this-analyst,2023-01-03 17:34:45,Vaxcyte Inc PCVX is Needham's top pick for 2023 and has been added to the Needham Conviction list and raised the price target to $58 from $52.,PFE,0.391923,0.498297,Bullish
Novavax  ( NVAX )  Starts A New Study on COVID-Flu Combo Jab,https://www.zacks.com/stock/news/2034734/novavax-nvax-starts-a-new-study-on-covid-flu-combo-jab,2023-01-03 17:01:00,Novavax (NVAX) initiates a mid-stage study evaluating its COVID-19-Influenza combination and standalone influenza vaccines in adults aged 50 through 80 years.,PFE,0.377142,0.053677,Neutral
Anti-Cancer Drug Market is expected to grow from USD 150.6 billion in 2022 to USD 266.5 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30259586/anti-cancer-drug-market-is-expected-to-grow-from-usd-150-6-billion-in-2022-to-usd-266-5-billion-by,2023-01-03 16:00:00,"Pune India, Jan. 03, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the Anti-Cancer drug market is operating and is ...",PFE,0.023838,0.040191,Neutral
"Cambria Hotels Celebrates New England Expansion with Grand Opening in New Haven, Connecticut",https://www.prnewswire.com/news-releases/cambria-hotels-celebrates-new-england-expansion-with-grand-opening-in-new-haven-connecticut-301712436.html,2023-01-03 15:26:00,Cambria Hotels Celebrates New England Expansion with Grand ... PR ...,PFE,0.029292,0.116497,Neutral
DocuSign and Ford Motor have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2034582/docusign-and-ford-motor-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-01-03 14:16:00,"Chicago, IL - January 3, 2023 - Zacks Equity Research shares DocuSign ( DOCU Quick QuoteDOCU - ) as the Bull of the Day and Ford Motor Co. ( F Quick QuoteF - ) as the Bear of the Day.",PFE,0.069094,0.017116,Neutral
PFE: 1 Stock That Would Be an Excellent Addition to Your Portfolio for Years to Come,https://stocknews.com/news/pfe-jnj-nvo-bmy-1-stock-that-would-be-an-excellent-addition-to-your/,2023-01-03 13:56:39,PFE: 1 Stock That Would Be an Excellent Addition to Your Portfolio ... ...,PFE,0.787908,0.355978,Bullish
EU 'Offer Stands' To Send Covid Jabs To China,https://www.barrons.com/news/eu-offer-stands-to-send-covid-jabs-to-china-01672750810,2023-01-03 13:00:55,"The EU said Tuesday it is prepared to send Covid vaccines to China as it grapples with a surge in coronavirus infections after lifting its ""zero-Covid"" policy. A European Commission spokeswoman, Dana Spinant, said the bloc months ago proposed giving vaccines and Covid expertise to Beijing and ...",PFE,0.120431,0.015227,Neutral
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023,https://www.zacks.com/stock/news/2034451/gsks-new-drugs-and-pipeline-hold-the-key-to-growth-in-2023,2023-01-03 12:21:00,"GSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive sales, making up for the lower sales of established drugs due to generic erosion.",PFE,0.048327,0.001979,Neutral
Protalix BioTherapeutics Issues 2023 Letter to Stockholders,https://www.prnewswire.com/news-releases/protalix-biotherapeutics-issues-2023-letter-to-stockholders-301712260.html,2023-01-03 11:50:00,"CARMIEL, Israel, Jan. 3, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. ( NYSE American: PLX ) ( TASE: PLX ) , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell based ...",PFE,0.021738,0.05184,Neutral
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study - Valneva  ( NASDAQ:VALN ) ,https://www.benzinga.com/general/biotech/23/01/30253521/valneva-touts-additional-positive-heterologous-booster-data-from-covid-19-vaccine-study,2023-01-03 11:41:38,"Valneva SE VALN reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 vaccine, VLA2001. The data show that a booster dose of VLA2001 was well tolerated in previously vaccinated participants with either Pfizer Inc PFE and BioNTech SE BNTX ...",PFE,0.345674,0.178631,Somewhat-Bullish
Should WisdomTree U.S. High Dividend ETF  ( DHS )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2034420/should-wisdomtree-us-high-dividend-etf-dhs-be-on-your-investing-radar,2023-01-03 11:20:07,Style Box ETF report for ...,PFE,0.124486,0.068857,Neutral
The Year of the Tripledemic,https://investingnews.com/the-year-of-the-tripledemic/,2023-01-03 10:24:27,"COVID-19 may have lost its daily news headline status, but the disease rages on with 2700 weekly deaths in the U.S. and millions of Americans chronically disabled from long-COVID, 4 million of which are being kept from work.",PFE,0.250902,0.154143,Somewhat-Bullish
7 Sensational Stocks That Can Double Your Money in 2023,https://www.fool.com/investing/2023/01/03/7-sensational-stocks-can-double-your-money-in-2023/,2023-01-03 10:06:00,Triple-digit returns could be just a click away from the buy button.,PFE,0.034958,-0.03003,Neutral
Volumes soar at Suven Pharmaceuticals Ltd counter,https://www.business-standard.com/article/news-cm/volumes-soar-at-suven-pharmaceuticals-ltd-counter-123010300309_1.html,2023-01-03 05:30:00,"Suven Pharmaceuticals Ltd recorded volume of 8.47 lakh shares by 10:45 IST on BSE, a 29.51 times surge over two-week average daily volume of 28705 shares Power Finance Corporation Ltd, Pfizer Ltd, CSB Bank Ltd, HDFC Life Insurance Company Ltd are among the other stocks to see a surge in volumes ...",PFE,0.301315,0.192326,Somewhat-Bullish
Where to invest your money in 2023 after rough year-end in the markets,https://www.foxbusiness.com/lifestyle/where-invest-money-2023-rough-year-end-markets,2023-01-02 19:45:26,"Wall Street just wrapped up its worst year since 2008. Major indexes in 2022 experienced intense declines as the Nasdaq dropped more than 30% and the S&P 500 was down almost 20%. With the markets looking grim, investors might be feeling iffy about where to put their money in the New Year of 2023.",PFE,0.140076,0.0,Neutral
2 Relatively Safe Dividend Stocks to Buy Today and Hold Forever,https://www.fool.com/investing/2023/01/02/2-relatively-safe-dividend-stocks-to-buy-and-hold/,2023-01-02 16:00:00,"They already have extensive track records of success, and there's even more on the way.",PFE,0.176717,0.295019,Somewhat-Bullish
Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?,https://www.zacks.com/stock/news/2034286/should-you-invest-in-the-vanguard-health-care-etf-vht,2023-01-02 11:20:07,Sector ETF report for ...,PFE,0.134968,0.071604,Neutral
Is WisdomTree U.S. High Dividend ETF  ( DHS )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2034287/is-wisdomtree-us-high-dividend-etf-dhs-a-strong-etf-right-now,2023-01-02 11:20:07,Smart Beta ETF report for ...,PFE,0.119532,0.067655,Neutral
Indices trade with modest gains; pharma stocks decline,https://www.business-standard.com/article/news-cm/indices-trade-with-modest-gains-pharma-stocks-decline-123010200529_1.html,2023-01-02 09:02:00,Indices trade with modest gains. pharma stocks decline Business Standard ...,PFE,0.098255,-0.045344,Neutral
"Macao eases COVID rules, but tourism, casinos yet to rebound",https://apnews.com/article/health-china-pandemics-business-f97afa00bc06d12ebe3ed6a386fb9769,2023-01-02 01:26:32,"Casino Lisboa, right, is seen in Macao on Dec. 28, 2022. Gambling haven Macao's relaxation of border restrictions after China rolled back its ""zero-COVID"" strategy is widely expected to boost its tourism-driven economy.",PFE,0.046907,-0.028487,Neutral
Study reveals booster dose increases resilience of Covid antibody response,https://www.business-standard.com/article/current-affairs/study-reveals-booster-dose-increases-resilience-of-covid-antibody-response-123010100759_1.html,2023-01-01 18:32:00,Study reveals booster dose increases resilience of Covid antibody ... Business Standard ...,PFE,0.200134,0.046479,Neutral
Why Voyager Therapeutics Stock Is Sinking This Week,https://www.fool.com/investing/2023/01/20/why-voyager-therapeutics-stock-sank-this-week/,2023-01-20 17:08:38,Investors are taking profits on this red-hot stock this week.,PFE,0.160633,0.291132,Somewhat-Bullish
Could Alphabet Cuts Spell a Potentially Tough Year Ahead for Tech?,https://www.benzinga.com/markets/23/01/30504478/could-alphabet-cuts-spell-a-potentially-tough-year-ahead-for-tech,2023-01-20 15:36:03,"( Friday Market Open ) The weekend probably can't come soon enough for the info tech world with Friday's latest round of layoffs. This time, it's Alphabet GOOGL announcing 12,000 job cuts. That follows Microsoft MSFT earlier this week and other major mega-cap tech companies slicing their ...",PFE,0.036228,0.100597,Neutral
"Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20",https://www.benzinga.com/general/biotech/23/01/30502994/google-layoffs-12k-employees-netflixs-q4-earnings-and-ceo-steps-down-fda-rejects-eli-lillys-alzhe,2023-01-20 15:21:39,"Here's a round-up of stories from around the globe and from various media outlets. Alphabet Inc.'s GOOG GOOGL Google prepared to cut 12,000 jobs globally. CEO Sundar Pichai said the eliminations reflected a rigorous review across product areas and functions",PFE,0.089462,0.0,Neutral
"Pharma Stock Roundup: LLY's Donanemab Gets FDA's CRL, MRNA RSV Jab Study Succeeds",https://www.zacks.com/stock/news/2041935/pharma-stock-roundup-llys-donanemab-gets-fdas-crl-mrna-rsv-jab-study-succeeds,2023-01-20 14:23:00,"FDA gives CRL to Lilly's (LLY) Alzheimer's candidate, donanemab. Moderna's (MRNA) phase III study on its mRNA-based RSV vaccine candidate in older adults meets primary efficacy endpoints ...",PFE,0.136113,-0.019731,Neutral
2 Healthcare Stocks You Can Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/01/20/2-healthcare-stocks-you-can-buy-for-next-decade/,2023-01-20 14:15:00,The healthcare industry isn't going anywhere.,PFE,0.3,0.277768,Somewhat-Bullish
Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots,https://www.benzinga.com/general/biotech/23/01/30499929/israel-says-no-stroke-risk-associated-with-pfizerbiontech-updated-covid-19-shots,2023-01-20 14:06:59,Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc PFE and BioNTech SE BNTX.,PFE,0.47379,0.128635,Neutral
2 Nasdaq 100 Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague,https://www.fool.com/investing/2023/01/20/2-nasdaq-100-stocks-buy-and-1-to-avoid-like-plague/,2023-01-20 10:21:00,"The growth-driven Nasdaq 100 is home to two incredible deals in the new year, as well as one previous highflier that can be actively avoided.",PFE,0.029802,0.09641,Neutral
"At CAGR of 4.9%, Radiopharmaceutical Market Size Worth USD 8832.7 Mn by 2028 Reported by Brandessence Market Research",https://www.prnewswire.com/news-releases/at-cagr-of-4-9-radiopharmaceutical-market-size-worth-usd-8832-7-mn-by-2028-reported-by-brandessence-market-research-301726636.html,2023-01-20 08:22:00,"At CAGR of 4.9%, Radiopharmaceutical Market Size Worth USD ... PR ...",PFE,0.030918,0.087565,Neutral
Sun Pharma acquires Concert for $576 million | The Financial Express,https://www.financialexpress.com/industry/sun-pharma-acquires-concert-for-576-million/2954280/,2023-01-20 00:15:00,Sun Pharma acquires Concert for $576 million The Financial Express ...,PFE,0.066047,0.0,Neutral
Pfizer  ( PFE )  Stock Moves -0.09%: What You Should Know,https://www.zacks.com/stock/news/2041620/pfizer-pfe-stock-moves--009-what-you-should-know,2023-01-19 22:45:22,"In the latest trading session, Pfizer (PFE) closed at $44.96, marking a -0.09% move from the previous day.",PFE,0.591634,0.17977,Somewhat-Bullish
Why Shares of Vaxxinity Jumped This Week,https://www.fool.com/investing/2023/01/19/why-shares-of-vaxxinity-jumped-this-week/,2023-01-19 19:04:28,Investors are hoping the company's COVID-19 vaccine will turn the company from a clinical-stage biotech to a commercial one.,PFE,0.126119,0.089001,Neutral
4 Big Pharma Stocks Could Soon Deliver An RSV Vaccine,https://www.investors.com/news/technology/4-pharmaceutical-stocks-are-close-to-cracking-multibillion-dollar-rsv-vaccine-market/,2023-01-19 18:41:00,4 Pharmaceutical Stocks Are Close To Cracking Multibillion-Dollar ... Investor's Business Daily ...,PFE,0.214665,0.028974,Neutral
"Coalition sets 100-day goal for faster, equitable pandemic response",https://www.business-standard.com/article/current-affairs/coalition-sets-100-day-goal-for-faster-equitable-pandemic-response-123011901577_1.html,2023-01-19 18:12:00,"Nearly three years after COVID-19 broke out in China, leading members of the Coalition for Epidemic Preparedness and Innovations ( CEPI ) and world leaders on Thursday set a new 100-day goal for a faster and equitable pandemic response.",PFE,0.116914,0.037482,Neutral
Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide,https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30487796/analyst-views-novo-nordisks-upcoming-obesity-drug-data-to-lay-grounds-for-eli-lilly,2023-01-19 17:19:18,"Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's NVO SELECT CV outcomes study, which is guided to complete in ~mid-2023. In large-cap land, there two two obesity leaders - Eli Lilly And Co LLY and Novo Nordisk.",PFE,0.31282,0.0,Neutral
"Trace Labs, the core development company of OriginTrail, joins Sustainable Medicines Partnership to help make medicines more accessible and sustainable",https://www.benzinga.com/pressreleases/23/01/n30487347/trace-labs-the-core-development-company-of-origintrail-joins-sustainable-medicines-partnership-to-,2023-01-19 16:38:00,"LJUBLJANA, Slovenia, Jan. 19, 2023 /PRNewswire/ -- Trace Labs, the core development company of OriginTrail, is excited to announce that they have joined the Sustainable Medicines Partnership ( SMP ) , a not-for-profit, multi-stakeholder, action collaborative of 48 organizations.",PFE,0.053629,0.199993,Somewhat-Bullish
This Medical Stock Round-Tripped Its Breakout In 9 Days,https://www.investors.com/news/technology/nvcr-stock-tumbles-again-after-unexpected-c-suite-changes/,2023-01-19 16:12:00,NVCR Stock Tumbles Again After Unexpected C-Suite Changes ... Investor's Business Daily ...,PFE,0.116914,0.097396,Neutral
Novavax  ( NVAX )  Gets Nod for COVID-19 Booster Jab in South Korea,https://www.zacks.com/stock/news/2041415/novavax-nvax-gets-nod-for-covid-19-booster-jab-in-south-korea,2023-01-19 15:17:00,Novavax's (NVAX) COVID-19 vaccine gets approval in South Korea as a booster dose in adults 18 years and older.,PFE,0.373751,0.147915,Neutral
CRISPR Therapeutics Stock: Bull vs. Bear,https://www.fool.com/investing/2023/01/19/crispr-therapeutics-stock-bull-vs-bear/,2023-01-19 15:07:00,Should investors buy this risky biotech stock as the company moves toward bringing its first major treatment to market?,PFE,0.048133,-0.050954,Neutral
"The Zacks Analyst Blog Highlights Pfizer, Abbott Laboratories, Union Pacific Corporation, Citigroup and Intuitive Surgical.",https://www.zacks.com/stock/news/2041223/the-zacks-analyst-blog-highlights-pfizer-abbott-laboratories-union-pacific-corporation-citigroup-and-intuitive-surgical,2023-01-19 13:45:00,"Pfizer, Abbott Laboratories, Union Pacific Corporation, Citigroup and Intuitive Surgical are part of the Zacks top Analyst Blog.",PFE,0.724687,0.0,Neutral
Israel says has not found a link between Pfizer COVID shot and stroke,https://www.reuters.com/business/healthcare-pharmaceuticals/israel-says-has-not-found-link-between-pfizer-covid-shot-stroke-2023-01-19/,2023-01-19 13:09:00,"JERUSALEM, Jan 19 ( Reuters ) - Israel has not identified any evidence linking strokes to an updated coronavirus vaccine made by U.S. drugmaker Pfizer ( PFE.N ) and its German partner BioNTech SE , according to a health ministry official. On Friday, the U.S.",PFE,0.462395,-0.114909,Neutral
J&J  ( JNJ )  Discontinues HIV Vaccine Phase III Mosaico Study,https://www.zacks.com/stock/news/2041151/jj-jnj-discontinues-hiv-vaccine-phase-iii-mosaico-study,2023-01-19 12:41:00,"J&J (JNJ) discontinues phase III study on its investigational HIV vaccine regimen, which shows that the candidate lacks efficacy in preventing HIV.",PFE,0.281153,0.121701,Neutral
"Top Analyst Reports for Pfizer, Abbott Laboratories & Union Pacific",https://www.zacks.com/research-daily/2040709/top-analyst-reports-for-pfizer-abbott-laboratories-union-pacific,2023-01-18 20:59:00,"Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Abbott Laboratories (ABT) and Union Pacific Corporation (UNP).",PFE,0.429671,0.241865,Somewhat-Bullish
EU drug regulator has not seen signal of possible Pfizer COVID shot stroke link,https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-has-not-seen-signal-possible-pfizer-covid-shot-stroke-link-2023-01-18/,2023-01-18 18:22:22,EU drug regulator has not seen signal of possible Pfizer COVID shot ... ...,PFE,0.43852,-0.169982,Somewhat-Bearish
IBD Stock Of The Day Vertex Stacks Up Billions In Sales Potential,https://www.investors.com/research/ibd-stock-of-the-day/vrtx-stock-finds-support-as-billions-in-potential-sales-stack-up/,2023-01-18 17:50:00,VRTX Stock Finds Support As Billions In Potential Sales Stack Up Investor's Business Daily ...,PFE,0.104228,0.097848,Neutral
Moderna is the latest company to produce a promising RSV vaccine,https://www.marketwatch.com/story/moderna-is-the-latest-company-to-produce-a-promising-rsv-vaccine-11674062616,2023-01-18 17:23:00,The experimental respiratory syncytial virus vaccine prevented most infections in older adults in a Phase 3 clinical trial ...,PFE,0.255641,0.003845,Neutral
JNJ: 3 Stocks to Buy Right Now if You Want to Retire Early,https://stocknews.com/news/jnj-pfe-bmy-3-stocks-to-buy-right-now-if-you-want-to/,2023-01-18 17:01:25,"The U.S. inflation eased in December, supporting a moderation in the Fed's rate hikes for the upcoming months. Buoyed by the December jobs report and signs of a slowdown in inflation, investors are eyeing a 25-basis-point hike at the Fed's next policy meeting.",PFE,0.202851,0.131139,Neutral
Moderna  ( MRNA )  Up on Upbeat Data From Phase III Study on RSV Jab,https://www.zacks.com/stock/news/2040820/moderna-mrna-up-on-upbeat-data-from-phase-iii-study-on-rsv-jab,2023-01-18 15:38:00,Data from a late-stage study showed that Moderna's (MRNA) RSV vaccine was 83.7% effective at preventing at least two symptoms in adults aged 60 and older.,PFE,0.209365,0.084779,Neutral
Twitter's Money Problems Deepen: Revenues Reportedly Plummet As Major Advertisers Jump Ship After Musk's Takeover,https://www.forbes.com/sites/roberthart/2023/01/18/twitters-money-problems-deepen-revenues-reportedly-plummet-as-major-advertisers-jump-ship-after-musks-takeover/,2023-01-18 15:11:11,Ads accounted for around 90% of Twitter's revenue in recent financial filings but many companies turned away from the platform after Musk took over.,PFE,0.089129,-0.077181,Neutral
Covid Isn't Going Away. New Drugs Are Coming.,https://www.barrons.com/articles/covid-drugs-51673989162,2023-01-18 14:00:00,"A Covid-19 vaccine that comes as a pill. A better version of Pfizer 's Paxlovid. A monoclonal antibody that can survive the virus's mutations. Drug company pipelines remain occupied with Covid-19, even as even masks fall away and the pandemic fades into the background.",PFE,0.895116,-0.024893,Neutral
Davos 2023 | Tata Group's capex commitment in India for next 5 years is $90 billion: N Chandrasekaran,https://www.moneycontrol.com/news/business/davos-2023-tata-groups-capex-commitment-in-india-for-next-5-years-is-90-billion-n-chandrasekaran-9888991.html,2023-01-18 13:42:58,"There is a ""huge opportunity"" in India, the Tata Group chairman said, adding that the fear of private sector not coming to India is unfounded.",PFE,0.08183,0.031539,Neutral
Jim Cramer Says This Stock Up 23% In A Month Is 'A Great Speculative Buy',https://www.benzinga.com/trading-ideas/long-ideas/23/01/30455566/jim-cramer-says-this-stock-up-23-in-a-month-is-a-great-speculative-buy,2023-01-18 13:32:57,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Biohaven Ltd BHVN is a ""great speculative buy."" Analysts agree, Benzinga data shows a consensus Overweight rating on BHVN. When asked about Boston Properties Inc BXP, he said, ""They are disciplined, they've got a good yield.""",PFE,0.570165,0.50077,Bullish
"Futures Rise; Tesla, Moderna Lead Early Movers",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-pauses-tesla-jumps/,2023-01-18 13:19:00,Dow Jones Futures Rise On Bank Of Japan Surprise. Tesla ... Investor's Business Daily ...,PFE,0.046139,0.125628,Neutral
MSFT: These Are the 3 Best Stocks on Wall Street to Buy and Watch Now,https://stocknews.com/news/msft-pfe-t-these-are-the-3-best-stocks-on-wall-street-to/,2023-01-18 13:04:41,MSFT: These Are the 3 Best Stocks on Wall Street to Buy and Watch ... ...,PFE,0.224124,0.142496,Neutral
Moderna Sees Success in RSV Vaccine Trial,https://www.barrons.com/articles/moderna-stock-price-today-rsv-vaccine-51673987032,2023-01-18 13:02:00,"Moderna RSV Vaccine Trial a Success, Stock Soars ...",PFE,0.428632,-0.107391,Neutral
Deloitte's CFO Program Names Frank D'Amelio as CFO-in-Residence,https://www.prnewswire.com/news-releases/deloittes-cfo-program-names-frank-damelio-as-cfo-in-residence-301724411.html,2023-01-18 13:02:00,"NEW YORK, Jan. 18, 2023 /PRNewswire/ -- Deloitte announced today that Frank D'Amelio, former executive vice president and chief financial officer at Pfizer Inc., has been appointed independent senior advisor, U.S.",PFE,0.243864,0.156743,Somewhat-Bullish
Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer,https://www.globenewswire.com/news-release/2023/01/18/2590810/0/en/Reunion-Neuroscience-Appoints-Robert-Alexander-as-Chief-Medical-Officer.html,2023-01-18 12:30:00,"Company Adds Former Executive at Takeda, Pfizer, AstraZeneca, GSK and Merck to Leadership Team Company Adds Former Executive at Takeda, Pfizer, AstraZeneca, GSK and Merck to Leadership Team ...",PFE,0.045396,-0.06577,Neutral
Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer,https://www.benzinga.com/pressreleases/23/01/g30458881/reunion-neuroscience-appoints-robert-alexander-as-chief-medical-officer,2023-01-18 12:30:00,"TORONTO, Jan. 18, 2023 ( GLOBE NEWSWIRE ) -- Reunion Neuroscience Inc. REUNREUN ( ""Reunion"" or ""the Company"" ) , a biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions, announced today that it has appointed Robert ...",PFE,0.043186,-0.064399,Neutral
"The daily business briefing: January 18, 2023",https://theweek.com/briefing/business-briefing/1020160/the-daily-business-briefing-january-18-2023,2023-01-18 12:21:14,"Goldman Sachs on Tuesday reported fourth-quarter profit of $1.3 billion, a 66 percent drop from the same period a year earlier as deal-making slowed on Wall Street. The profit came to $3.32 per share, well below the $5.56 analysts polled by FactSet had expected.",PFE,0.066414,0.02637,Neutral
Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today,https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30456278/moderna-gets-a-booster-shot-why-stock-is-up-nearly-7-today,2023-01-18 11:34:06,"Moderna, Inc. MRNA shares were solidly higher in premarket trading on Wednesday. What Happened: The upside in Moderna's shares comes in reaction to a clinical readout announced late Tuesday, which showed that the Cambridge, Massachusetts-based company's mRNA vaccine targeting the respiratory ...",PFE,0.254307,0.12463,Neutral
"Nykaa, Indus Towers, ICDS among 29 NSE stocks to hit 52-week low, 30 rises to 52-week high | The Financial Express",https://www.financialexpress.com/market/nykaa-indus-towers-icds-among-29-nse-stocks-to-hit-52-week-low-30-rises-to-52-week-high/2952097/,2023-01-18 07:56:19,"Nykaa, Indus Towers, ICDS among 29 NSE stocks to hit 52-week low, 30 rises to 52-week high The Financial Express ...",PFE,0.073098,0.015126,Neutral
Covid Isn't Going Away. New Drugs Are Coming.,https://www.barrons.com/articles/covid-new-drugs-51673989162,2023-01-18 07:48:00,"A Covid-19 vaccine that comes as a pill. A better version of Pfizer 's Paxlovid. A monoclonal antibody that can survive the virus's mutations. Drug company pipelines remain occupied with Covid-19, even as even masks fall away and the pandemic fades into the background.",PFE,0.895116,-0.024893,Neutral
Moderna Sees Success in RSV Vaccine Trial,https://www.barrons.com/articles/moderna-rsv-vaccine-51673987032,2023-01-18 00:42:00,"Moderna RSV Vaccine Trial a Success, Stock Soars. ...",PFE,0.428632,-0.107391,Neutral
Cramer's lightning round: I think Boeing is good,https://www.cnbc.com/2023/01/17/cramers-lightning-round-i-think-boeing-is-good.html,2023-01-18 00:18:53,"""Mad Money"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.",PFE,0.282234,0.55091,Bullish
Market Rally Pauses As Tesla Jumps; 3 Stocks Rising Late,https://www.investors.com/market-trend/stock-market-today/market-rally-pauses-tesla-keeps-rebounding-united-airlines-moderna-microsoft-in-focus/,2023-01-17 22:48:00,"Market Rally Pauses, Tesla Keeps Rebounding. United Airlines ... Investor's Business Daily ...",PFE,0.051111,0.120976,Neutral
"Moderna Comes Swinging For Pfizer, GSK In Scorching RSV Battle",https://www.investors.com/news/technology/moderna-stock-surges-as-it-swings-for-pfizer-gsk-with-new-rsv-vaccine-results/,2023-01-17 22:03:00,"Moderna Stock Surges As It Swings For Pfizer, GSK With New RSV ... Investor's Business Daily ...",PFE,0.246999,0.048799,Neutral
Moderna says RSV vaccine 84% effective at preventing symptoms in older adults,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-says-rsv-vaccine-84-effective-preventing-symptoms-older-adults-2023-01-17/,2023-01-17 21:10:00,Moderna says RSV vaccine 84% effective at preventing symptoms in ... ...,PFE,0.274834,0.033761,Neutral
Moderna says RSV vaccine is 84% effective at preventing disease in older adults,https://www.cnbc.com/2023/01/17/moderna-says-rsv-vaccine-is-84percent-effective-at-preventing-disease-in-older-adults.html,2023-01-17 21:05:05,"RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC.",PFE,0.085629,-0.261284,Somewhat-Bearish
Moderna Sees Success in RSV Vaccine Trial,https://www.barrons.com/articles/moderna-stock-rsv-vaccine-trial-pfizer-gsk-51673987032,2023-01-17 21:05:00,"Moderna on Tuesday announced strong results from a large trial of its respiratory syncytial virus vaccine, adding new drama to what's shaping up to be a clash of the biopharmaceutical titans, as both Pfizer and GSK prepare to launch competing jabs.",PFE,0.428632,-0.107391,Neutral
CDC to investigate 'safety signal' for Pfizer's updated COVID booster,https://www.marketwatch.com/story/cdc-to-investigate-safety-signal-for-pfizers-updated-covid-booster-11673981788,2023-01-17 18:56:00,Federal health agencies are investigating whether there is a link between BioNTech and Pfizer's bivalent COVID-19 booster and stroke in seniors.,PFE,0.377142,0.007859,Neutral
"Costco, Microsoft Are Stocks Fit for Recession: Goldman Sachs",https://www.thestreet.com/investing/stocks/costco-microsoft-recession-stocks-goldman,2023-01-17 18:27:00,"If the economy has a hard landing, Goldman strategists expect the S&P 500 to drop 21% to 3,150.",PFE,0.083833,0.184781,Somewhat-Bullish
"Stocks making the biggest moves midday: Goldman Sachs, Morgan Stanley, Roblox, Alibaba and more",https://www.cnbc.com/2023/01/17/stocks-making-the-biggest-moves-midday-goldman-sachs-morgan-stanley-roblox-alibaba-and-more.html,2023-01-17 17:28:06,These are the stocks posting the largest moves in midday trading.,PFE,0.127119,0.089329,Neutral
The Bear Debate That Drove Novocure's Fall From Grace,https://www.investors.com/news/technology/nvcr-stock-the-bear-debate-that-drove-its-fall-from-grace/,2023-01-17 17:12:00,"Novocure ( NVCR ) will win a paltry 10% of its targeted lung cancer market, an analyst predicted Tuesday as he examined NVCR stock's double-digit drop over seven days. The company tested a device that uses electrical fields at specific frequencies to interrupt the rampant division of cancer ...",PFE,0.065506,0.167364,Somewhat-Bullish
Recession Could Tank The S&P Another 22%-But Tesla And These Other Stocks Could Withstand The Downturn,https://www.forbes.com/sites/dereksaul/2023/01/17/recession-could-tank-the-sp-another-22-but-tesla-and-these-other-stocks-could-withstand-the-downturn/,2023-01-17 15:58:18,"Tesla, which shed 65% of its share value in 2022, is among Goldman Sachs' top stock picks in a mild recession scenario.",PFE,0.057352,-0.043083,Neutral
WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating,https://www.marketwatch.com/story/who-calls-on-china-to-release-more-information-on-its-covid-case-surge-to-learn-more-about-which-variants-are-circulating-11673969670,2023-01-17 15:34:00,"China said Saturday that 60,000 of its citizens have succumbed to the virus since early December ...",PFE,0.153797,-0.03035,Neutral
Can A 'Covid Reset' Save Pfizer's Dwindling Stock Price?,https://www.investors.com/news/technology/pfizer-stock-needs-a-covid-reset-according-to-one-analyst-shares-dive/,2023-01-17 15:24:00,"Pfizer Stock Needs A 'Covid Reset,' According To One Analyst ... Investor's Business Daily ...",PFE,0.840852,0.298796,Somewhat-Bullish
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2040093/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-01-17 14:10:03,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",PFE,0.20279,0.115561,Neutral
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2040035/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2023-01-17 14:00:13,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.529767,0.116317,Neutral
"Jim Cramer's top 10 things to watch in the market Tuesday: Morgan Stanley beat, Goldman Sachs miss, Estee Lauder boost",https://www.cnbc.com/2023/01/17/cramers-top-10-things-tuesday-morgan-stanley-goldman-sachs-estee-lauder.html,2023-01-17 13:48:48,Bond yields are up so the stock market is down.,PFE,0.187705,0.04044,Neutral
Pfizer Offers Up Entire Drug And Vaccine Portfolio To World's Poorest Countries At Non-Profit Prices,https://www.forbes.com/sites/roberthart/2023/01/17/pfizer-offers-up-entire-drug-and-vaccine-portfolio-to-worlds-poorest-countries-at-non-profit-prices/,2023-01-17 13:26:22,The announcement will cover some 1.2 billion people living in 45 low-income countries.,PFE,0.468029,0.065272,Neutral
"Stocks making the biggest moves premarket: Goldman, Pfizer, Cheesecake Factory, Alibaba and more",https://www.cnbc.com/2023/01/17/stocks-making-the-biggest-moves-premarket-goldman-pfizer-cheesecake-factory-alibaba-and-more.html,2023-01-17 12:55:42,These are the stocks posting the largest moves premarket.,PFE,0.158519,0.061597,Neutral
World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday,https://www.benzinga.com/news/23/01/30437749/world-wrestling-entertainment-to-rally-around-12-here-are-10-other-analyst-forecasts-for-tuesday,2023-01-17 12:52:24,Goldman Sachs boosted the price target for The Wendy's Company WEN from $22 to $25. Goldman Sachs analyst Jared Garber maintained a Neutral rating on the stock. Wendy's shares fell 1.4% to $22.75 in pre-market trading. Raymond James raised the price target for First Republic Bank FRC from $142 to ...,PFE,0.268786,-0.29314,Somewhat-Bearish
Pfizer to sell all its drugs in low-income countries at non-profit price,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-sell-all-its-drugs-low-income-countries-non-profit-price-2023-01-17/,2023-01-17 12:02:00,"Jan 17 ( Reuters ) - U.S. drugmaker Pfizer Inc ( PFE.N ) said on Tuesday it will offer its full portfolio of drugs, including off-patent medicines such as chemotherapies and oral cancer treatments, on a not-for-profit basis to 45 low-income countries in the world.",PFE,0.651499,-0.209446,Somewhat-Bearish
Pfizer Expands 'An Accord for a Healthier World' Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries,https://investingnews.com/pfizer-expands-an-accord-for-a-healthier-world-product-offering-to-include-full-portfolio-for-greater-benefit-to-1-2-billion-people-in-45-lower-income-countries/,2023-01-17 11:50:32,Pfizer Inc. ( NYSE: PFE ) today announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to enable greater health for 1.2 billion people living in ...,PFE,0.432752,0.436938,Bullish
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF  ( PJP ) ?,https://www.zacks.com/stock/news/2039886/should-you-invest-in-the-invesco-dynamic-pharmaceuticals-etf-pjp,2023-01-17 11:20:08,Sector ETF report for ...,PFE,0.130926,0.063433,Neutral
Is Invesco Dynamic Large Cap Value ETF  ( PWV )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2039893/is-invesco-dynamic-large-cap-value-etf-pwv-a-strong-etf-right-now,2023-01-17 11:20:06,Smart Beta ETF report for ...,PFE,0.114682,0.054303,Neutral
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People,https://www.benzinga.com/general/biotech/23/01/30430540/us-health-agencies-investigate-preliminary-covid-19-vaccine-safety-signal-in-older-people,2023-01-16 18:45:47,"The U.S. Food and Drug Administration ( FDA ) and the Centers for Disease Control and Prevention ( CDC ) are investigating a ""preliminary signal"" of the likelihood of a stroke among elderly people who received a Covid-19 vaccine booster manufactured by Pfizer Inc PFE and BioNTech SE BNTX.",PFE,0.390904,0.185264,Somewhat-Bullish
Valneva  ( VALN )  Stock Down 61.5% in the Past Year: Here's Why,https://www.zacks.com/stock/news/2039703/valneva-valn-stock-down-615-in-the-past-year-heres-why,2023-01-16 15:25:00,"Valneva's (VALN) COVID-19 vaccine looks promising, but the European Commission's revised advance purchase agreement jeopardizes its COVID-19 vaccine program.",PFE,0.2589,0.037906,Neutral
"China should set aside politics and look at Covid jab imports, world's largest vaccine maker says",https://www.cnbc.com/2023/01/16/china-should-set-aside-political-issues-on-vaccine-imports-ceo-says.html,2023-01-16 14:14:00,"Adar Poonawalla, chief executive of the world's largest vaccine manufacturer, said China needs to ""open... up to healthcare and vaccines from the West."" ...",PFE,0.097062,0.145793,Neutral
3 Biopharma Stocks That Could Help Make You a Fortune,https://www.fool.com/investing/2023/01/16/3-biopharma-stocks-could-help-make-you-a-fortune/,2023-01-16 13:30:00,"All three are protected by sales of in-demand products, with more on the way.",PFE,0.095707,0.068179,Neutral
ABBV: The #1 Pharma Stock to Buy in January 2023,https://stocknews.com/news/abbv-jnj-pfe-bmy-the-no-1-pharma-stock-to-buy-in-january-2023/,2023-01-16 13:20:02,ABBV: The No. 1 Pharma Stock to Buy in January ...,PFE,0.099271,0.168077,Somewhat-Bullish
Degenerative Disc Disease Treatment Market Worth USD 45.92 Billion by 2029 | Report by Fortune Business Insights,https://www.benzinga.com/pressreleases/23/01/g30427361/degenerative-disc-disease-treatment-market-worth-usd-45-92-billion-by-2029-report-by-fortune-busin,2023-01-16 12:44:58,"Pune, India, Jan. 16, 2023 ( GLOBE NEWSWIRE ) -- The global degenerative disc disease treatment market size was USD 26.05 billion in 2021. The market is projected to grow from USD 27.87 billion in 2022 to USD 45.92 billion by 2029, exhibiting a CAGR of 7.4% during the forecast period.",PFE,0.115232,0.034372,Neutral
"Nifty settles below 17,900; Sensex down 168 pts; VIX jumps 3.89%",https://www.business-standard.com/article/news-cm/nifty-settles-below-17-900-sensex-down-168-pts-vix-jumps-3-89-123011600636_1.html,2023-01-16 10:11:00,Nifty settles below 17900. Sensex down 168 pts. VIX jumps 3.89%s Business Standard ...,PFE,0.043342,-0.219349,Somewhat-Bearish
Dr.Reddy's Lab acquires trademark rights of breast cancer drug from Pfizer,https://www.business-standard.com/article/news-cm/dr-reddy-s-lab-acquires-trademark-rights-of-breast-cancer-drug-from-pfizer-123011600252_1.html,2023-01-16 04:59:00,Dr.Reddys Lab acquires trademark rights of breast cancer drug from ... Business Standard ...,PFE,0.218817,-0.265266,Somewhat-Bearish
"Stocks in News: HDFC Bank, Wipro, Vodafone Idea, DMart, Angel One, Delhivery, Dr Reddy's, Just Dial stocks in focus | The Financial Express",https://www.financialexpress.com/market/stocks-to-watch-hdfc-bank-wipro-vodafone-idea-dmart-angel-one-delhivery-dr-reddys-just-dial-stocks-in-focus/2949149/,2023-01-16 01:49:58,"HDFC Bank, Wipro, Vodafone Idea, DMart, Angel One, Delhivery, Dr Reddy's, Just Dial stocks in focus The Financial Express ...",PFE,0.101797,-0.08322,Neutral
"Buzzing Stocks | Wipro, HDFC Bank, Tata Motors, and others in news today",https://www.moneycontrol.com/news/photos/business/stocks/buzzing-stocks-wipro-hdfc-bank-tata-motors-and-others-in-news-today-9862661.html,2023-01-16 01:32:33,Stocks to Watch: Check out the companies making headlines before the opening bell.,PFE,0.119235,-0.087971,Neutral
Bipolar Disorder Market will worth USD 7.6 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30422354/bipolar-disorder-market-will-worth-usd-7-6-billion-by-2030-greyviews,2023-01-14 19:00:00,"Pune India, Jan. 14, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the bipolar disorder market is operating and is ...",PFE,0.025734,-0.024026,Neutral
3 Dirt Cheap Stocks to Buy in January,https://www.fool.com/investing/2023/01/14/3-dirt-cheap-stocks-to-buy-in-january/,2023-01-14 11:15:00,Bargains can easily be found as the new year gets underway.,PFE,0.296313,0.121828,Neutral
How Ireland's buoyant jobs market offers plentiful employment opportunities for varied sectors | The Financial Express,https://www.financialexpress.com/education-2/ireland-jobs-market-job-opportunities-employment-job-abroad-visa-european-union/2947655/,2023-01-14 08:15:00,How Ireland's buoyant jobs market offers plentiful employment opportunities for varied sectors The Financial Express ...,PFE,0.072876,0.038221,Neutral
CDC says it's 'very unlikely' Pfizer booster carries stroke risk for seniors after launching review,https://www.cnbc.com/2023/01/13/pfizer-covid-booster-likely-doesnt-carry-stroke-risk-for-seniors-cdc-says.html,2023-01-13 23:07:57,The CDC said one of its monitoring systems detected a preliminary safety signal for stroke in people ages 65 and older who received the Pfizer omicron booster.,PFE,0.497869,-0.156688,Somewhat-Bearish
CDC Exploring Possible But Unlikely Link Between Covid-19 Bivalent Booster And Strokes,https://www.forbes.com/sites/marisadellatto/2023/01/13/cdc-exploring-possible-but-unlikely-link-between-covid-19-bivalent-booster-and-strokes/,2023-01-13 22:51:48,"There is no recommended change to vaccine practice, and the CDC said it's ""very unlikely"" this signal represents ""a true clinical risk."" ...",PFE,0.301933,-0.139888,Neutral
U.S. says Pfizer's bivalent COVID shot may be linked to stroke in older adults,https://www.reuters.com/business/healthcare-pharmaceuticals/us-says-pfizers-bivalent-covid-shot-may-be-linked-stroke-older-adults-2023-01-13/,2023-01-13 21:26:00,U.S. says Pfizer's bivalent COVID shot may be linked to stroke in ... ...,PFE,0.701875,0.018821,Neutral
"Prostate Cancer Therapeutics Market will worth to USD 19,619 million by 2030 : GreyViews",https://www.benzinga.com/pressreleases/23/01/g30416679/prostate-cancer-therapeutics-market-will-worth-to-usd-19-619-million-by-2030-greyviews,2023-01-13 20:00:00,"Pune India, Jan. 13, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa.",PFE,0.024273,-0.007536,Neutral
J&J slashes production of its unpopular COVID-19 shot,https://www.foxbusiness.com/healthcare/jj-slashes-production-unpopular-covid-19-shot,2023-01-13 18:39:18,"After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand.",PFE,0.093897,-0.013769,Neutral
"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/01/30414942/johnson-johnson-cuts-production-ends-contracts-for-not-so-successful-covid-19-shot,2023-01-13 18:22:37,Johnson & Johnson JNJ has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand. The FDA approved the single-dose shot in February 2021 as it carried fewer cold-chain storage requirements than other shots. J&J's initial supply was small.,PFE,0.33628,0.170321,Somewhat-Bullish
Psychedelic Drugs Market will worth USD 6703.3 million by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30414631/psychedelic-drugs-market-will-worth-usd-6703-3-million-by-2030-greyviews,2023-01-13 18:00:00,"Pune India, Jan. 13, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the psychedelic drugs market is operating and is ...",PFE,0.023487,0.091492,Neutral
Pharmaceutical Packaging Equipment Market is expected to grow from USD 8.5 billion in 2022 to USD 15.7 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30413385/pharmaceutical-packaging-equipment-market-is-expected-to-grow-from-usd-8-5-billion-in-2022-to-usd-,2023-01-13 17:00:00,"Pune India, Jan. 13, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa.",PFE,0.024597,0.135793,Neutral
Dr Reddy's acquires trademark rights for Pfizer breast cancer drug,https://www.business-standard.com/article/companies/dr-reddy-s-acquires-trademark-rights-for-pfizer-breast-cancer-drug-123011301119_1.html,2023-01-13 16:51:00,Dr Reddys acquires trademark rights for Pfizer breast cancer drugs Business Standard ...,PFE,0.334008,-0.090229,Neutral
"Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns",https://www.marketwatch.com/story/drug-companies-plan-to-raise-prices-on-vital-medicines-to-fund-r-d-but-they-already-spend-more-on-shareholder-returns-11673626340,2023-01-13 16:12:00,Drug companies say they need to raise prices on cancer drugs and other treatments to fund research. But they already spend more on stock buybacks and dividends.,PFE,0.25142,0.189368,Somewhat-Bullish
Novo Nordisk's Home Field Diabetes Advantage Just Deepened,https://www.investors.com/news/technology/nvo-stock-jumps-after-novo-nordisk-expands-diabetes-lead-over-pfizer-eli-lilly/,2023-01-13 15:58:00,NVO Stock Jumps After Novo Nordisk Expands Diabetes Lead Over ... Investor's Business Daily ...,PFE,0.271777,0.25441,Somewhat-Bullish
"New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC says",https://www.marketwatch.com/story/new-covid-subvariant-is-now-dominant-across-the-u-s-accounting-for-43-of-all-new-cases-in-latest-week-cdc-says-11673624990,2023-01-13 15:49:00,XBB.1.5 has been dominant in the Northeast for several weeks and is now dominant in the U.S. as a whole.,PFE,0.082963,0.061976,Neutral
Deciphera  ( DCPH )  Rises 70% in the Past 6 Months: Here's Why,https://www.zacks.com/stock/news/2039095/deciphera-dcph-rises-70-in-the-past-6-months-heres-why,2023-01-13 15:15:00,"Deciphera's (DCPH) Qinlock, approved for treating advanced gastrointestinal stromal tumors, has seen strong uptake since its approval. The recent restructuring initiative is saving costs.",PFE,0.212425,0.114461,Neutral
Pick Either Merck Stock Or Its Peer - Both May Offer Similar Returns,https://www.forbes.com/sites/greatspeculations/2023/01/13/pick-either-merck-stock-or-its-peer--both-may-offer-similar-returns/,2023-01-13 13:00:19,We believe that pharmaceutical giants Merck stock (NYSE: MRK) and Pfizer stock (NYSE: PFE) will likely offer similar returns over the next three years.,PFE,0.710888,0.251607,Somewhat-Bullish
Dr. Reddy's acquires trademark rights of Pfizer's breast cancer drug | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/dr-reddys-acquires-trademark-rights-of-pfizers-breast-cancer-drug/2947569/,2023-01-13 12:30:31,Dr. Reddy's acquires trademark rights of Pfizer's breast cancer drug The Financial Express ...,PFE,0.329551,-0.086938,Neutral
Should Schwab U.S. Dividend Equity ETF  ( SCHD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2038864/should-schwab-us-dividend-equity-etf-schd-be-on-your-investing-radar,2023-01-13 11:20:08,Style Box ETF report for ...,PFE,0.121959,0.068236,Neutral
"Autoimmune Patient Perspective on the Corporate Reputation of Pharma Companies, 2021-2022: The Views of 293 Patient Groups - Pfizer Ranked 1st, AbbVie Ranked 2nd, Novartis Ranked 3rd",https://www.prnewswire.com/news-releases/autoimmune-patient-perspective-on-the-corporate-reputation-of-pharma-companies-2021-2022-the-views-of-293-patient-groups---pfizer-ranked-1st-abbvie-ranked-2nd-novartis-ranked-3rd-301721006.html,2023-01-13 11:15:00,Autoimmune Patient Perspective on the Corporate Reputation of ... PR ...,PFE,0.124325,0.167157,Somewhat-Bullish
"Frustration is rising over Covid drug shortages in China, and there are no easy answers",https://www.cnn.com/2023/01/13/china/china-covid-antiviral-drug-shortage-intl-hnk-mic/index.html,2023-01-13 07:38:00,"Editor's Note: Editor's Note: A version of this story appeared in CNN's Meanwhile in China newsletter, a three-times-a-week update exploring what you need to know about the country's rise and how it impacts the world. Sign up here.",PFE,0.200273,-0.032857,Neutral
How Novavax Could Shake Up the Market for Covid-19 Vaccines,https://www.barrons.com/articles/novavax-covid-vaccine-pricing-51673558808,2023-01-13 06:30:00,"As Moderna and Pfizer prepare to sell their mRNA-based Covid-19 vaccines on the commercial market this year, one big wild card remains: What is Novavax going to charge for its alternative Covid-19 vaccine?",PFE,0.9545,-0.223387,Somewhat-Bearish
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/japans-daiichi-sankyo-applies-approval-mrna-covid-vaccine-2023-01-13/,2023-01-13 06:00:05,"TOKYO, Jan 13 ( Reuters ) - Daiichi Sankyo Co ( 4568.T ) said on Friday it submitted its mRNA-based COVID-19 vaccine for regulatory approval in Japan. Approval would give Japan a home-grown mRNA vaccine of the type that have made up the bulk of its COVID inoculations so far.",PFE,0.272788,0.0,Neutral
Human Insulin Market will surpass USD 83.29 billion by 2030 at a CAGR of 8% till 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30397066/human-insulin-market-will-surpass-usd-83-29-billion-by-2030-at-a-cagr-of-8-till-2030-greyviews,2023-01-12 19:00:00,"Pune India, Jan. 12, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the human insulin market is operating and is ...",PFE,0.023372,0.07467,Neutral
PFE: 3 Stocks Investors Should Pour Their Money Into in 2023,https://stocknews.com/news/pfe-hmc-jbl-3-stocks-investors-should-pour-their-money-into-in-2023/,2023-01-12 15:03:58,PFE: 3 Stocks Investors Should Pour Their Money Into in ...,PFE,0.343063,0.176461,Somewhat-Bullish
Don't Blame the Bear Market for This Growth Stock's Jaw-Dropping Sell-Off,https://www.fool.com/investing/2023/01/12/dont-blame-the-bear-market-for-this-growth-stocks/,2023-01-12 15:00:00,Novavax stock would likely have fallen in 2022 even in a bull market.,PFE,0.060085,0.215407,Somewhat-Bullish
Elon Musk Amplifies Bernie Sanders's Outrage Against Moderna,https://www.thestreet.com/technology/elon-musk-amplifies-bernie-sanderss-outrage-against-moderna,2023-01-12 14:03:00,The pharmaceutical company is mulling a move that has enraged both Musk and one of his ideological opposites.,PFE,0.1172,0.141582,Neutral
"After Ditching Promising Drug, Everest Medicines Bets on mRNA - Gilead Sciences  ( NASDAQ:GILD ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/23/01/30388310/after-ditching-promising-drug-everest-medicines-bets-on-mrna,2023-01-12 13:21:20,"Everest Medicines is staking its future on mRNA vaccines, which it will produce in a new $130 facility that recently began operations in Zhejiang province The company will have to compete with many other domestic drug makers shelling out big bucks to develop mRNA vaccines with strong support from ...",PFE,0.082251,-0.049231,Neutral
"Ventyx Biosciences Appoints Allison J. Hulme, Ph.D. and Onaiza Cadoret-Manier to its Board of Directors - Ventyx Biosciences  ( NASDAQ:VTYX ) ",https://www.benzinga.com/pressreleases/23/01/g30387407/ventyx-biosciences-appoints-allison-j-hulme-ph-d-and-onaiza-cadoret-manier-to-its-board-of-directo,2023-01-12 13:00:00,"ENCINITAS, Calif., Jan. 12, 2023 ( GLOBE NEWSWIRE ) -- Ventyx Biosciences, Inc. VTYX ( ""Ventyx"" ) , a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced the ...",PFE,0.028695,-0.051322,Neutral
Psychedelic Drugs Market to Reach USD 11.82 Billion by 2029 | Brandessence Market Research,https://www.prnewswire.com/news-releases/psychedelic-drugs-market-to-reach-usd-11-82-billion-by-2029--brandessence-market-research-301720168.html,2023-01-12 10:12:00,Psychedelic Drugs Market to Reach USD 11.82 Billion by 2029 ... PR ...,PFE,0.030446,0.10391,Neutral
Pfizer Ltd drops for fifth straight session,https://www.business-standard.com/article/news-cm/pfizer-ltd-drops-for-fifth-straight-session-123011200575_1.html,2023-01-12 08:05:00,"Pfizer Ltd is quoting at Rs 4279, down 0.15% on the day as on 13:19 IST on the NSE. The stock jumped 52.47% in last one year as compared to a 2.36% slide in NIFTY and a 10.16% spurt in the Nifty Metal index. Pfizer Ltd is down for a fifth straight session today.",PFE,0.727604,0.484001,Bullish
Chinese hospital says half of its staff got Covid,https://www.cnbc.com/2023/01/12/chinese-hospital-says-half-of-its-staff-got-covid-.html,2023-01-12 08:00:19,"About half of the nearly 2,000 workers at the Beijing Hospital of Traditional Chinese Medicine got Covid-19, director Liu Qingquan said Wednesday.",PFE,0.092569,0.035782,Neutral
"SGS & Co welcomes industry expert Robert Sanders as President, Chief Commercial Officer",https://www.newswire.ca/news-releases/sgs-amp-co-welcomes-industry-expert-robert-sanders-as-president-chief-commercial-officer-836111439.html,2023-01-11 19:54:00,SGS & Co welcomes industry expert Robert Sanders as President ... Canada ...,PFE,0.107978,0.078357,Neutral
Bernie Sanders Begs Moderna Not to Follow in Pfizer's Footsteps,https://www.thestreet.com/biotech/bernie-sanders-begs-moderna-not-to-follow-in-pfizers-footsteps-vaccine-prices,2023-01-11 19:52:00,Big pharma has money to make and the covid vaccine is fertile ground for revenue. But at least one U.S. politician is urging caution.,PFE,0.28387,0.238423,Somewhat-Bullish
Hemp Stock News - Global Hemp Group  ( CSE: GHG )  Announces Execution of Binding LOI with Apollon Formularies PLC,https://www.investorideas.com/news/2023/cannabis/01111CSE-GHG.asp,2023-01-11 16:47:42,Hemp Stock News - Global Hemp Group ( CSE: GHG ) Announces ... ...,PFE,0.01282,0.0,Neutral
BMY: The No. 1 Stock to Keep an Eye on in 2023,https://stocknews.com/news/bmy-nvo-pfe-rdy-the-no-1-stock-to-keep-an-eye-on-in/,2023-01-11 16:23:11,BMY: The No. 1 Stock to Keep an Eye on in ...,PFE,0.075161,0.083378,Neutral
"Top Stories Wednesday, Jan. 11 - Bayer  ( OTC:BAYRY ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/general/biotech/23/01/30371862/faa-technology-glitch-hits-us-flights-operations-coca-cola-pepsico-under-ftc-probe-rivian-hit-by-,2023-01-11 14:23:13,"Standard Chartered PLC SCBFY eyed strategic options for its $3.7 billion aviation unit, including a sale. The aviation finance business represents around 2% of the total Group income and 1% of Group RWA.",PFE,0.082251,-0.127696,Neutral
"Merck, Pfizer Rebuts China's Request For Further Price Cuts For COVID-19 Drugs - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/01/30371064/merck-pfizer-rebuts-chinas-request-for-further-price-cuts-for-covid-19-drugs,2023-01-11 14:06:22,Merck & Co Inc MRK and Pfizer Inc PFE have reportedly signaled that they have not agreed to a request by the Chinese authorities for deeper price cuts for COVID-19 treatments.,PFE,0.595343,0.133061,Neutral
"Arvinas, Inc.  ( ARVN )  Soars 10.3%: Is Further Upside Left in the Stock?",https://www.zacks.com/stock/news/2037806/arvinas-inc-arvn-soars-103-is-further-upside-left-in-the-stock,2023-01-11 13:35:00,"Arvinas, Inc. (ARVN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.",PFE,0.116348,-0.016184,Neutral
"HALOZYME THERAPEUTICS, INC. ANNOUNCES REDEMPTION OF 1.25% CONVERTIBLE SENIOR NOTES DUE 2024",https://www.prnewswire.com/news-releases/halozyme-therapeutics-inc-announces-redemption-of-1-25-convertible-senior-notes-due-2024--301718785.html,2023-01-11 13:30:00,"HALOZYME THERAPEUTICS, INC. ANNOUNCES REDEMPTION ... PR ...",PFE,0.110209,0.139045,Neutral
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off,https://www.fool.com/investing/2023/01/11/3-supercharged-dividend-stocks-to-buy-if-theres-a/,2023-01-11 12:50:00,"These three healthcare stocks all deliver dependable dividends, with yields of 3% or more.",PFE,0.204072,0.136544,Neutral
PFE: The 4 Most Attractive Long-Term Stock Picks,https://stocknews.com/news/pfe-jnj-syy-osg-the-4-most-attractive-long-term-stock-picks/,2023-01-11 12:41:37,The stock market witnessed heightened volatility last year due to lingering macroeconomic and geopolitical headwinds.,PFE,0.295867,0.15664,Somewhat-Bullish
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,https://www.zacks.com/stock/news/2037716/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv,2023-01-11 11:20:07,Sector ETF report for ...,PFE,0.128478,0.069872,Neutral
Xi Jinping's Mouthpiece Slams US For Maximizing Interests During COVID: 'For Them…Profit Always Comes First' - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/23/01/30366375/xi-jinpings-mouthpiece-slams-us-for-maximizing-interests-during-covid-for-them-profit-always-comes-f,2023-01-11 08:36:58,"Amid the COVID-19 chaos in China, President Xi Jinping's official mouthpiece slammed the U.S. ""capital forces"" for profiteering from the pandemic.",PFE,0.524949,-0.41057,Bearish
Pentagon drops Covid-19 vaccine mandate for troops; new memo for deployment,https://www.business-standard.com/article/current-affairs/pentagon-drops-covid-19-vaccine-mandate-for-troops-new-memo-for-deployment-123011100115_1.html,2023-01-11 03:33:00,Pentagon drops Covid-19 vaccine mandate for troops. new memo ... Business Standard ...,PFE,0.049526,0.025001,Neutral
Moderna considers charging $110-$130 for COVID vaccine dose,https://www.axios.com/2023/01/11/moderna-covid-vaccine-price,2023-01-11 00:12:18,"Moderna is considering charging $110 to $130 per dose of its COVID-19 vaccine in the U.S. after it's contract with the government expires, Moderna CEO Stéphane Bancel told the Wall Street Journal.",PFE,0.113597,-0.081854,Neutral
"Markets Close at Session Lows Ahead of Massive Data, Fed",https://www.zacks.com/stock/news/2046587/markets-close-at-session-lows-ahead-of-massive-data-fed,2023-01-30 22:50:00,"The Dow dropped -260 points, -0.77%, and it was the outperformer. The S&P 500 was -1.30% on the day, while the Nasdaq sank -227 points, -1.96%.",PFE,0.140896,0.026503,Neutral
Fasten your seatbelts,https://www.reuters.com/markets/us/global-markets-view-usa-pix-2023-01-30/,2023-01-30 21:47:00,Fasten your ...,PFE,0.094762,0.0,Neutral
Johnson And Johnson Stock Slips After Missing The Mark For Earnings,https://www.forbes.com/sites/qai/2023/01/30/johnson-and-johnson-stock-slips-after-missing-the-mark-for-earnings/,2023-01-30 21:26:19,"Johnson and Johnson's stock took a tumble before its Q4 2022 earnings call, and the numbers reported didn't help it bounce back. Here's what happened.",PFE,0.083833,-0.033417,Neutral
"Down 14.5%, Is Pfizer Stock a Screaming Buy?",https://www.fool.com/investing/2023/01/30/down-145-is-pfizer-stock-a-screaming-buy/,2023-01-30 21:00:00,Pfizer's declining COVID-19 franchise and upcoming patent expirations have weighed heavily on its stock.,PFE,0.541766,-0.040492,Neutral
Volatility Test: VIX Makes an Early Move Higher as Stocks Slide Ahead of Manic Market Week,https://www.benzinga.com/markets/23/01/30628478/volatility-test-vix-makes-an-early-move-higher-as-stocks-slide-ahead-of-manic-market-week,2023-01-30 19:37:45,"( Monday Market Open ) For those who like market news, this week has no shortage. There's something for everyone with central bank meetings, earnings, and a jobs report all straight ahead. Monday kicked off with heavy selling before the open.",PFE,0.080121,0.044666,Neutral
Dow Jones Falls; Warren Buffett's Berkshire Near Buy Point; McDonald's Posts Earnings Tuesday,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-warren-buffetts-berkshire-near-buy-point-mcdonalds-posts-earnings-tuesday/,2023-01-30 18:57:00,Dow Jones Falls. Warren Buffett's Berkshire Near Buy Point ... Investor's Business Daily ...,PFE,0.228073,0.0,Neutral
J&J Dives After Court Denies Bankruptcy For Baby Powder Unit,https://www.investors.com/news/technology/jnj-stock-dives-after-court-says-it-cannot-use-bankruptcy-to-resolve-baby-powder-lawsuits/,2023-01-30 18:40:00,JNJ Stock Dives After Court Says It Can't Use Bankruptcy To ... Investor's Business Daily ...,PFE,0.088472,0.07184,Neutral
What Pfizer's Earnings Will Say About Covid-19 Vaccine Sales,https://www.barrons.com/articles/pfizer-earnings-stock-price-covid-vaccine-51675093548,2023-01-30 18:27:00,Pfizer Reports Earnings Tuesday. What to Expect. ...,PFE,0.980909,0.170994,Somewhat-Bullish
Bipolar Disorder Treatment Market will achieve USD 5.7 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30626924/bipolar-disorder-treatment-market-will-achieve-usd-5-7-billion-by-2030-greyviews,2023-01-30 18:00:00,"Pune India, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa.",PFE,0.02351,-0.019887,Neutral
"Stocks making the biggest moves midday: Carvana, Colgate-Palmolive, Tesla and more",https://www.cnbc.com/2023/01/30/stocks-making-the-biggest-moves-midday-carvana-amd-and-more.html,2023-01-30 17:28:44,These are the stocks posting the biggest moves during midday trading.,PFE,0.090474,-0.03585,Neutral
What Pfizer's Earnings and Guidance Will Say About Covid-19 Vaccine Sales,https://www.barrons.com/articles/pfizer-earnings-stock-covid-vaccine-51675093548,2023-01-30 16:06:00,Pfizer Reports Earnings Tuesday. What to Expect. ...,PFE,0.980909,0.170994,Somewhat-Bullish
"$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns",https://www.benzinga.com/general/biotech/23/01/30622252/1-000-invested-in-4-of-the-5-vaccine-developers-back-when-who-declared-covid-19-an-emergency-yiel,2023-01-30 15:28:16,"The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths. The urgency and the severity of COVID-19 forced biopharma companies to expeditiously develop a vaccine to counter the threat. Moderna, ...",PFE,0.262052,-0.15972,Somewhat-Bearish
The RSV Vaccine Battle Wages On With Moderna Scoring A Win,https://www.investors.com/news/technology/moderna-stock-the-rsv-vaccine-battle-wages-on-with-this-fda-move/,2023-01-30 14:56:00,"The Food and Drug Administration granted Moderna's ( MRNA ) experimental RSV vaccine an expedited review, but Moderna stock dipped Monday. The breakthrough designation allows for a speedier development and review period when a drug could treat a serious condition or demonstrate improvement over ...",PFE,0.47147,-0.009286,Neutral
"Global Pharmaceutical Drug Delivery Market worth $2,206.5 billion by 2026 - Exclusive Report by MarketsandMarkets™",https://www.benzinga.com/pressreleases/23/01/g30622827/global-pharmaceutical-drug-delivery-market-worth-2-206-5-billion-by-2026-exclusive-report-by-marke,2023-01-30 14:30:00,"Chicago, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- According to the new market research report ""Pharmaceutical Drug Delivery Market Size, Growth by Route of Administration ( Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets, Syringes ) , Application ( Cancer, Diabetes ) , ...",PFE,0.087503,0.021576,Neutral
Third Covid vaccine booster linked with 90% reduction in deaths : Study,https://www.business-standard.com/article/current-affairs/third-covid-vaccine-booster-linked-with-90-reduction-in-deaths-study-123013000919_1.html,2023-01-30 14:00:00,Third Covid vaccine booster linked with 90% reduction in deaths ... Business Standard ...,PFE,0.283323,0.085759,Neutral
"Apple and Amazon Earnings, a Fed Decision, Jobs Data, and More to Watch This Week",https://www.barrons.com/articles/stocks-to-watch-this-week-apple-amazon-federal-reserve-jobs-data-51675022417,2023-01-30 13:43:00,"It will be another major week of fourth-quarter earnings, with about 100 S&P 500 companies scheduled to report. There will also be a highly anticipated Federal Reserve interest-rate decision on Wednesday and the latest job-market data on Thursday and Friday.",PFE,0.495015,0.0,Neutral
"Wall Street points lower ahead of tech earnings, Fed call",https://apnews.com/article/financial-market-roundup-jan-30-48aa6003bf396027b3894d3a7f0365ac,2023-01-30 13:41:47,Wall Street was poised to open with lower Monday as attention turns to this week's decision by the Federal Reserve on interest rates and a week heavy with big tech earnings. Futures for the Dow Jones industrials slipped 0.6% and the S&P 500 fell 0.8% before the opening bell.,PFE,0.062434,0.052006,Neutral
eFFECTOR Therapeutics to Present at 2023 BIO CEO & Investor Conference,https://www.globenewswire.com/news-release/2023/01/30/2597479/0/en/eFFECTOR-Therapeutics-to-Present-at-2023-BIO-CEO-Investor-Conference.html,2023-01-30 13:00:00,"SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- eFFECTOR Therapeutics, Inc. ( NASDAQ: EFTR ) , a leader in the development of selective translation regulator inhibitors ( ""STRIs"" ) for the treatment of cancer, announced that the Company will present and host ...",PFE,0.098659,-0.013073,Neutral
Paxlovid sales forecasts may change with Pfizer view on China,https://www.reuters.com/business/healthcare-pharmaceuticals/paxlovid-sales-forecasts-may-change-with-pfizer-view-china-2023-01-30/,2023-01-30 12:41:00,"[1/2] Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease ( COVID-19 ) , is displayed in this picture illustration taken October 7, 2022. REUTERS/Wolfgang Rattay/Illustration/File Photo",PFE,0.465901,-0.030495,Neutral
"5 things to know before the stock market opens Monday, January 30",https://www.cnbc.com/2023/01/30/5-things-to-know-before-the-stock-market-opens-monday-january-30.html,2023-01-30 11:47:07,Here are the most important news items that investors need to start their trading day.,PFE,0.065685,0.0,Neutral
"Longevity Startup VitaDAO Raises $4.1m, Backed By Pfizer, Balaji Srinivasan",https://www.forbes.com/sites/johncumbers/2023/01/30/longevity-startup-vitadao-raises-41m-backed-by-pfizer-balaji-srinivasan/,2023-01-30 11:00:03,"The web transformed life as we know it, allowing new ways of working, solving problems, and distributing currency.",PFE,0.211191,0.052593,Neutral
"The Zacks Analyst Blog Highlights Pfizer/BioNTech, Moderna and Novavax",https://www.zacks.com/stock/news/2046017/the-zacks-analyst-blog-highlights-pfizerbiontech-moderna-and-novavax,2023-01-30 10:00:00,"Pfizer/BioNTech, Moderna and Novavax are included in this Analyst Blog.",PFE,0.456884,0.131736,Neutral
Under-funded WHO seeks 'reinforced' role in global health at key meeting,https://www.reuters.com/business/healthcare-pharmaceuticals/under-funded-who-seeks-reinforced-role-global-health-key-meeting-2023-01-30/,2023-01-30 05:05:00,Under-funded WHO seeks 'reinforced' role in global health at key ... ...,PFE,0.070725,0.0,Neutral
"Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch",https://www.benzinga.com/news/earnings/23/01/30616031/can-market-sustain-upward-momentum-in-tech-heavy-earnings-week-apple-amazon-amd-alphabet-ford-among,2023-01-29 22:25:32,"With a full week of earnings behind us, it's time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed. Some of the big tech names that fell short are Intel Corp. INTC and Texas Instruments, Inc.",PFE,0.081092,0.229106,Somewhat-Bullish
"Apple, Amazon earnings, jobs data and Fed decision top week ahead",https://www.foxbusiness.com/markets/apple-amazon-earnings-jobs-data-fed-decision-top-week-ahead,2023-01-29 21:12:17,Mega Cap earnings and Fed decision top week ahead Fox Business ...,PFE,0.04912,0.0,Neutral
"Could Big Tech layoffs keep growing? Apple, Amazon, Facebook and Google may give hints in biggest week of earnings",https://www.marketwatch.com/story/could-big-tech-layoffs-keep-growing-apple-amazon-facebook-and-google-may-give-hints-in-biggest-week-of-earnings-11675022463,2023-01-29 20:01:00,Quarterly earnings from 2022's top five market-value losers will continue what will the earnings season's most hectic week.,PFE,0.046318,-0.066508,Neutral
"Apple and Amazon Earnings, a Federal Reserve Decision, January Jobs Data, and More for Investors to Watch This Week",https://www.barrons.com/articles/apple-and-amazon-earnings-a-federal-reserve-decision-january-jobs-data-and-more-for-investors-to-watch-this-week-51675022417,2023-01-29 20:00:00,"It will be another major week of fourth-quarter earnings, with about 100 S&P 500 companies scheduled to report. There will also be a highly anticipated Federal Reserve interest-rate decision on Wednesday and the latest job-market data on Thursday and Friday.",PFE,0.495015,0.0,Neutral
Could This Vaccine Become Sanofi's Latest Blockbuster?,https://www.fool.com/investing/2023/01/29/could-this-vaccine-become-sanofis-next-blockbuster/,2023-01-29 13:45:00,This vaccine candidate could be approved in newborns and infants later this year.,PFE,0.074001,-0.016304,Neutral
Jobs report to give further clues about where economy is headed | Business,https://www.cnn.com/2023/01/29/investing/stocks-week-ahead,2023-01-29 12:17:00,Jobs report to give further clues about where economy is headed ...,PFE,0.057907,0.045965,Neutral
Jobs report to give further clues about where economy is headed | Business,https://www.cnn.com/2023/01/29/investing/stocks-week-ahead/index.html,2023-01-29 12:17:00,Jobs report to give further clues about where economy is headed ...,PFE,0.057907,0.045965,Neutral
4 Top Stocks With High Dividend Growth to Buy in 2023 and Hold Forever,https://www.fool.com/investing/2023/01/28/4-stocks-with-high-dividend-growth-to-buy-in-2023/,2023-01-28 15:15:00,"These businesses offer powerful passive income potential, growing their dividends between 178% and 481% over the last five years.",PFE,0.036476,0.030335,Neutral
"Investing Action Plan - January Wrap: Apple, OPEC, Exxon And The Fed",https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-january-wrap-apple-opec-exxon-and-the-fed/,2023-01-27 23:20:00,"Investing Action Plan - January Wrap: Apple, OPEC, Exxon And ... Investor's Business Daily ...",PFE,0.049356,-0.001997,Neutral
"Novavax  ( NVAX )  COVID Jab Aids Growth, Overdependence a Challenge  ( revised ) ",https://www.zacks.com/stock/news/2045677/novavax-nvax-covid-jab-aids-growth-overdependence-a-challenge-revised,2023-01-27 21:41:00,"Despite being one of the few authorized COVID-19 vaccine makers in the United States, Novavax's (NVAX) vaccine struggles for market share.",PFE,0.444919,0.317119,Somewhat-Bullish
"Stocks making the biggest moves midday: American Express, Intel, Silvergate Capital and more",https://www.cnbc.com/2023/01/27/stocks-making-the-biggest-moves-midday-american-express-intel-silvergate-capital-and-more.html,2023-01-27 17:24:50,These are the stocks posting the largest moves in midday trading.,PFE,0.084127,0.008413,Neutral
Consumer Health in Focus After Data Shows Spending Pullback Last Month,https://www.benzinga.com/markets/23/01/30605862/consumer-health-in-focus-after-data-shows-spending-pullback-last-month,2023-01-27 16:52:09,"( Friday Market Open ) The S&P 500® is up 2% this week and more than 5% so far in January, but the market's ""wall of worries"" hasn't disappeared. The latest concern, fresh off the presses this morning, is all about the consumer.",PFE,0.071838,0.044219,Neutral
Bristol-Myers  ( BMY )  to Report Q4 Earnings: What's in Store?,https://www.zacks.com/stock/news/2045584/bristol-myers-bmy-to-report-q4-earnings-whats-in-store,2023-01-27 16:28:00,"Investors are likely to focus on the demand for Eliquis and Opdivo, along with an incremental contribution from newer drugs, when Bristol-Myers (BMY) reports Q4 results.",PFE,0.140896,0.073268,Neutral
"FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases",https://www.marketwatch.com/story/fda-panel-backs-plan-for-annual-covid-19-booster-as-new-omicron-subvariant-continues-to-dominate-in-new-cases-11674836338,2023-01-27 16:18:00,An FDA panel endorsed the agency's plan for a once-a-year COVID-19 booster. And CDC data shows that XBB.1.5 continues to lead other variants in the U.S.,PFE,0.091162,0.08357,Neutral
Novavax Leads Vaccine Stocks On Pledge To Update Covid Shot,https://www.investors.com/news/technology/nvax-stock-outperforms-vaccine-stock-rivals-on-pledge-to-update-covid-vaccine/,2023-01-27 15:24:00,NVAX Stock Outperforms Vaccine Stock Rivals On Pledge To ... Investor's Business Daily ...,PFE,0.252987,0.042714,Neutral
2 Large Cap Stocks To Watch In The Stock Market Today,https://stockmarket.com/featured/2-large-cap-stocks-to-watch-in-the-stock-market-today-2023-01-27,2023-01-27 14:37:38,"To begin, large-cap stocks are shares of companies with a market capitalization of over $10 billion. These are typically well-established companies that have been around for a while and have a proven track record of success.",PFE,0.497733,0.200545,Somewhat-Bullish
3 Great Growth Stocks Down 20% or More to Buy Now,https://www.fool.com/investing/2023/01/27/3-great-growth-stocks-down-20-or-more-to-buy-now/,2023-01-27 14:37:00,These beaten-down stocks could be poised for major rebounds.,PFE,0.044551,0.042027,Neutral
FDA Panel Endorses Simplification of COVID-19 Vaccine Strategy,https://www.zacks.com/stock/news/2045442/fda-panel-endorses-simplification-of-covid-19-vaccine-strategy,2023-01-27 14:13:00,An FDA advisory committee unanimously votes in favor of using the same COVID-19 vaccine strain composition for primary series and booster doses.,PFE,0.428632,0.159601,Somewhat-Bullish
"Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends",https://www.zacks.com/stock/news/2045345/pharma-stock-roundup-jnj-q4-results-mixed-mrk-keytruda-prostate-cancer-study-ends,2023-01-27 13:14:00,J&J (JNJ) reports mixed fourth-quarter results. Merck (MRK) discontinues an advanced prostate cancer study on blockbuster drug Keytruda for futility.,PFE,0.091509,-0.070621,Neutral
Exclusive: EU may pay more for Pfizer COVID shots in return for lower volume,https://www.reuters.com/business/healthcare-pharmaceuticals/eu-may-pay-more-pfizer-covid-shots-return-lower-volume-2023-01-27/,2023-01-27 12:57:00,Exclusive: EU may pay more for Pfizer COVID shots in return for ... ...,PFE,0.371523,0.088591,Neutral
PFE: The Best Healthcare Stock on Wall Street to Buy Now,https://stocknews.com/news/pfe-nvo-alpmy-nbix-the-best-healthcare-stock-on-wall-street-to-buy-now/,2023-01-27 12:50:51,"Global pharmaceutical major Pfizer Inc. ( PFE ) surpassed Wall Street's EPS and revenue estimates in the third quarter. The company's revenue beat the consensus estimate by 7.3%, while its EPS was 27% higher than the estimate.",PFE,0.678909,0.295179,Somewhat-Bullish
FDA's advisers back plan to simplify COVID-19 vaccinations,https://apnews.com/article/health-immunizations-us-food-and-drug-administration-business-covid-6fe66fb4b7c9ac6568fb055544b13e20,2023-01-27 12:19:21,"Syringes with vaccines are prepared at the L.A. Care and Blue Shield of California Promise Health Plans' Community Resource Center where they were offering members and the public free flu and COVID-19 vaccines Friday, Oct. 28, 2022, in Lynwood, Calif.",PFE,0.084127,-0.007226,Neutral
What To Expect From Pfizer's Q4?,https://www.forbes.com/sites/greatspeculations/2023/01/27/what-to-expect-from-pfizers-q4/,2023-01-27 12:00:29,"Its Covid-19 vaccine and the antiviral pill will likely contribute a little over $12 billion to its top line, aligning with prior-year quarter's sales.",PFE,0.608634,-0.068326,Neutral
"This Week In XR: $18 Million For Gemba VR Training, Dreamscape Learn Spins Off With $20 Million",https://www.forbes.com/sites/charliefink/2023/01/27/this-week-in-xr-18-million-for-gemba-vr-training-dreamscape-learn-spins-off-with-20-million/,2023-01-27 05:17:12,"Education, Enterprise focused companies raised money this week.",PFE,0.044634,0.046405,Neutral
"Tesla, Intel, Pfizer, Visa, Northrop: Top 5 Trending Stocks",https://www.benzinga.com/news/earnings/23/01/30597200/tesla-intel-pfizer-visa-northrop-grumman-why-these-5-stocks-are-drawing-investors-attention-today,2023-01-27 01:10:49,"U.S. markets surged on Thursday, following the release of fourth-quarter GDP data that came in better than expected. The U.S. economy grew by an estimated 2.9% in the last quarter of 2022 against economist expectations of 2.6% growth. The Nasdaq Composite and the S&P 500 rose over 1%, while the ...",PFE,0.439786,-0.258447,Somewhat-Bearish
Why This Pfizer Analyst Is No Longer Bullish On The COVID Stock,https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30593668/why-this-pfizer-analyst-is-no-longer-bullish-on-the-covid-stock,2023-01-26 21:44:12,"Pfizer Inc. PFE could see headwinds in 2023 due to declining COVID-19 cases, according to a UBS analyst. The Pfizer Analyst: Colin Bristow downgraded Pfizer from Buy to Neutral and lowered the price target from $55 to $47.",PFE,0.835692,-0.536762,Bearish
FDA advisors recommend replacing original Covid vaccine with bivalent omicron shots for all doses,https://www.cnbc.com/2023/01/26/fda-advisors-recommend-using-covid-omicron-shots-for-all-doses.html,2023-01-26 21:41:59,The Food and Drug Administration's independent advisory committee on Thursday recommended replacing Pfizer and Moderna's original Covid vaccine used in the U.S. for everyone's first two immunizations with the new bivalent omicron shots.,PFE,0.080188,0.119072,Neutral
Novavax needs 6 months to produce annual COVID shots that match new variants,https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-needs-6-months-produce-annual-covid-shots-that-match-new-variants-2023-01-26/,2023-01-26 19:31:04,Novavax needs 6 months to produce annual COVID shots that ... ...,PFE,0.156461,0.060453,Neutral
U.S. CDC still looking at potential stroke risk from Pfizer bivalent COVID shot,https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-still-looking-potential-stroke-risk-pfizer-bivalent-covid-shot-2023-01-26/,2023-01-26 18:25:00,U.S. CDC still looking at potential stroke risk from Pfizer bivalent ... ...,PFE,0.118064,-0.153285,Somewhat-Bearish
"Stocks making the biggest moves midday: Chevron, Tesla, Seagate Technology, United Rentals and more",https://www.cnbc.com/2023/01/26/stocks-making-the-biggest-moves-midday-chevron-tesla-seagate-technology-united-rentals-and-more.html,2023-01-26 18:21:57,These are the stocks posting the largest moves in midday trading.,PFE,0.090474,0.075654,Neutral
FDA has not observed stroke risk among seniors who received Pfizer booster after extensive review,https://www.cnbc.com/2023/01/26/covid-fda-has-not-found-stroke-risk-for-seniors-who-received-pfizer-booster.html,2023-01-26 17:27:21,Preliminary CDC data indicated a possible stroke risk following simultaneous administration of the Pfizer Covid booster and the flu vaccine.,PFE,0.196212,-0.124519,Neutral
Strong GDP Number Doesn't Faze Investors Ahead of Next Week's Fed Decision,https://www.benzinga.com/federal-reserve/23/01/30590053/strong-gdp-number-doesnt-faze-investors-ahead-of-next-weeks-fed-decision,2023-01-26 17:03:42,"( Thursday Market Open ) The Federal Reserve's struggles to harness a galloping economy continue, judging from today's Q4 Gross Domestic Product ( GDP ) data and the latest weekly read on initial jobless claims.",PFE,0.035635,0.088736,Neutral
The recent rise in corporate rebranding,https://www.axios.com/2023/01/26/the-rise-of-corporate-rebranding,2023-01-26 16:58:51,The recent rise in corporate ...,PFE,0.059935,0.168293,Somewhat-Bullish
Is a Beat on the Cards for Novo Nordisk  ( NVO )  in Q4 Earnings?,https://www.zacks.com/stock/news/2044871/is-a-beat-on-the-cards-for-novo-nordisk-nvo-in-q4-earnings,2023-01-26 15:20:00,Novo Nordisk's (NVO) top line is likely to have been driven by sales of its Diabetes and Obesity Care products in the fourth quarter of 2022.,PFE,0.187705,0.085393,Neutral
Merck  ( MRK )  Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release,https://www.zacks.com/stock/news/2044820/merck-mrk-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q4-release,2023-01-26 15:01:11,Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PFE,0.17618,0.049139,Neutral
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2044650/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings,2023-01-26 13:50:08,Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.,PFE,0.380012,0.363069,Bullish
"Stocks making the biggest moves premarket: Southwest, Tesla, Las Vegas Sands and more",https://www.cnbc.com/2023/01/26/stocks-making-the-biggest-moves-premarket-southwest-tesla-las-vegas-sands.html,2023-01-26 13:11:00,These are the stocks posting the largest moves in premarket trading.,PFE,0.15347,0.0,Neutral
Can Pfizer  ( PFE )  Beat Expectations This Earnings Season?,https://www.zacks.com/stock/news/2044597/can-pfizer-pfe-beat-expectations-this-earnings-season,2023-01-26 12:53:00,"Higher alliance revenues from Eliquis, higher sales of Prevnar vaccines and drugs like Vyndaqel/Vyndamax are likely to have contributed to Pfizer's (PFE) sales growth in Q4.",PFE,0.326643,0.170122,Somewhat-Bullish
NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday,https://www.benzinga.com/news/23/01/30583092/nike-to-rally-over-23-here-are-10-other-analyst-forecasts-for-thursday,2023-01-26 12:48:11,"Keybanc raised the price target for D.R. Horton, Inc. DHI from $97 to $109. Keybanc analyst Kenneth Zener maintained an Overweight rating. D.R. Horton shares fell 1.6% to close at $95.48 on Wednesday. Raymond James boosted the price target for Intuitive Surgical, Inc. ISRG from $255 to $270.",PFE,0.28442,0.006377,Neutral
"Novavax  ( NVAX )  COVID Jab Aids Growth, Overdependence A Woe",https://www.zacks.com/stock/news/2044587/novavax-nvax-covid-jab-aids-growth-overdependence-a-woe,2023-01-26 12:31:00,"Despite being one of the few authorized COVID-19 vaccine makers in the United States, Novavax's (NVAX) vaccine struggles for market share.",PFE,0.468029,0.327097,Somewhat-Bullish
"China faces challenge due to flawed Covid policies, vaccines: Report",https://www.business-standard.com/article/international/china-faces-challenge-due-to-flawed-covid-policies-vaccines-report-123012600540_1.html,2023-01-26 10:44:00,"China is facing a significant challenge in the form of COVID-19, due to the Chinese Communist Party's ( CCP ) ""flawed and regressive containment policies and ineffective domestically produced vaccines,"" GeoPolitica.info reported.",PFE,0.077094,-0.082707,Neutral
3 of the Fastest-Growing Stocks on the Planet in 2023,https://www.fool.com/investing/2023/01/26/3-of-the-fastest-growing-stocks-on-planet-in-2023/,2023-01-26 10:21:00,"These hypergrowth stocks are expected to deliver up to 1,075% sales growth this year.",PFE,0.070621,0.042723,Neutral
China's Covid wave drives up consumer interest in insurance after health system shortfalls,https://www.cnbc.com/2023/01/26/chinese-to-buy-insurance-after-covid-reveals-health-system-shortfalls.html,2023-01-26 01:39:53,"More than 60% of non-policyholders now plan to buy health insurance, according to an Oliver Wyman survey of Chinese consumers in December.",PFE,0.024775,-0.237737,Somewhat-Bearish
Pfizer  ( PFE )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2044360/pfizer-pfe-gains-as-market-dips-what-you-should-know,2023-01-25 22:45:19,"In the latest trading session, Pfizer (PFE) closed at $45.07, marking a +0.81% move from the previous day.",PFE,0.509589,0.187773,Somewhat-Bullish
How A 'Thanks Pfizer' Covid Misinformation Meme Went Viral,https://www.forbes.com/sites/conormurray/2023/01/25/how-a-thanks-pfizer-covid-misinformation-meme-went-viral/,2023-01-25 22:14:37,Viral videos falsely claiming the Covid-19 vaccine causes convulsions have inspired widespread mockery and internet jokes.,PFE,0.228717,0.112467,Neutral
"Omicron booster shots provide some protection against mild illness from Covid XBB subvariants, CDC says",https://www.cnbc.com/2023/01/25/covid-omicron-boosters-offer-some-protection-against-xbb-variant.html,2023-01-25 18:03:00,"Pfizer's and Moderna's omicron booster shots reduced the risk of mild illness from the XBB family of subvariants by about 48% compared to people who did not receive the vaccine, according to a study from the Centers for Disease Control and Prevention.",PFE,0.058615,-0.253049,Somewhat-Bearish
Updated COVID vaccines prevented illness from latest variants -CDC,https://www.reuters.com/business/healthcare-pharmaceuticals/updated-covid-vaccines-prevented-illness-latest-variants-cdc-2023-01-25/,2023-01-25 18:03:00,Updated COVID vaccines prevented illness from latest variants ...,PFE,0.232439,0.003562,Neutral
PFE: 3 Top Pharma Stocks to Buy for the Long Haul,https://stocknews.com/news/pfe-abbv-jnj-3-top-pharma-stocks-to-buy-for-the-long-haul/,2023-01-25 17:52:16,"The pharmaceutical sector played a critical role during the pandemic. Moreover, the industry is predicted to grow with an ageing population and the rise of chronic diseases. According to Statista, global pharmaceutical revenue is expected to expand at a 5.4% CAGR to $1.44 trillion by 2027.",PFE,0.345193,0.152745,Somewhat-Bullish
What's So Bad About Feeling Good? Why 2022 Was Better Than You Think.,https://www.forbes.com/sites/andrewtisch/2023/01/25/whats-so-bad-about-feeling-good-why-2022-was-better-than-you-think/,2023-01-25 16:47:33,"As depressing as things often seemed last year, there were many developments that bode well for the future of our society, our country, and the world. Here are 10 of Andrew Tisch's favorite positive developments from 2022.",PFE,0.041828,-0.006967,Neutral
"Abortion pill manufacturer GenBioPro sues West Virginia, argues FDA rules pre-empt state ban",https://www.cnbc.com/2023/01/25/abortion-pill-genbiopro-sues-west-virginia-argues-fda-pre-empts-state-ban.html,2023-01-25 16:23:49,GenBioPro argues that FDA regulations on the abortion pill pre-empt West Virginia's state law that basically bans the medication.,PFE,0.054983,-0.252968,Somewhat-Bearish
"Microsoft's Gloomy Guidance, Boeing's Surprise Q4 Loss Pulls Market Lower",https://www.benzinga.com/markets/23/01/30570358/microsofts-gloomy-guidance-boeings-surprise-q4-loss-pulls-market-lower,2023-01-25 15:50:04,( Wednesday Market Open ) The market gives and the market takes away. That's the lesson Microsoft MSFT shareholders learned since Tuesday's closing bell.,PFE,0.033632,0.088008,Neutral
Could This RSV News Make Moderna a Hot Buy Again?,https://www.fool.com/investing/2023/01/25/could-this-rsv-news-make-moderna-a-hot-buy-again/,2023-01-25 15:00:00,The company could soon have a new vaccine bringing in revenue.,PFE,0.066598,-0.045376,Neutral
"2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies",https://www.benzinga.com/general/biotech/23/01/30566249/2022-was-a-year-of-growth-funding-and-positive-results-for-biorestorative-therapies,2023-01-25 13:13:05,"BioRestorative Therapies Inc. BRTX ( ""BioRestorative"" ) may have had a successful year of novel drug development.",PFE,0.142989,0.187794,Somewhat-Bullish
Merck ends Keytruda trial in prostate cancer patients after dismal interim data,https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-keytruda-extends-survival-bile-duct-cancer-patients-2023-01-25/,2023-01-25 12:26:00,Merck ends Keytruda trial in prostate cancer patients after dismal ... ...,PFE,0.231332,-0.321409,Somewhat-Bearish
Should Invesco Dynamic Large Cap Value ETF  ( PWV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2043783/should-invesco-dynamic-large-cap-value-etf-pwv-be-on-your-investing-radar,2023-01-25 11:20:07,Style Box ETF report for ...,PFE,0.124164,0.061872,Neutral
VR Workforce Training Leader Gemba Secures $18m to Become the Go-To Learning Platform of the Enterprise Metaverse,https://www.benzinga.com/pressreleases/23/01/g30562493/vr-workforce-training-leader-gemba-secures-18m-to-become-the-go-to-learning-platform-of-the-enterp,2023-01-25 09:00:00,"Pioneers in executive education offer a unique multiplayer, collaborative, VR training experience that delivers a powerful ROI for global companies going through digital transformation.",PFE,0.114682,0.120149,Neutral
Sosei Heptares Webinar Presentation for FY2022 Financial Results,https://www.globenewswire.com/news-release/2023/01/25/2594847/0/en/Sosei-Heptares-Webinar-Presentation-for-FY2022-Financial-Results.html,2023-01-25 06:30:00,"TOKYO and CAMBRIDGE, United Kingdom, Jan. 25, 2023 ( GLOBE NEWSWIRE ) -- Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , the world leader in G protein-coupled receptor ( GPCR ) focused structure-based drug design ( SBDD ) and development, will announce its earnings results and present ...",PFE,0.072655,0.043246,Neutral
Pharma Market Forecast: 3 Top Trends That Will Affect Pharma in 2023,https://investingnews.com/pharma-forecast/,2023-01-24 21:15:00,"Pharma investments have disappointed investors in the recent past, but some experts believe the market will regain confidence from investors in 2023. Read on to learn about the trends that will drive the industry.",PFE,0.056808,0.0,Neutral
FDA proposes new lead limits for baby food to reduce potential risks to children's health,https://www.cnbc.com/2023/01/24/fda-proposes-new-lead-limits-for-baby-food.html,2023-01-24 20:25:29,"Lead exposure can impair brain development and the nervous system, resulting in learning disabilities, lower IQ and behavioral difficulties.",PFE,0.067919,-0.254346,Somewhat-Bearish
Start of Earnings Traffic Jam Delivers Mixed Results as Market Waits for Microsoft,https://www.benzinga.com/news/earnings/23/01/30555728/start-of-earnings-traffic-jam-delivers-mixed-results-as-market-waits-for-microsoft,2023-01-24 19:08:26,"The fun starts today after the closing bell with Microsoft MSFT and Texas Instruments TXN. Then get ready for IBM IBM after tomorrow's close and Intel INTC the day after. There's a little concern about what MSFT might report, and that could be one factor pushing stock index futures lower this ...",PFE,0.034136,0.088196,Neutral
Gilead  ( GILD )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2043538/gilead-gild-to-report-q4-earnings-whats-in-the-cards,2023-01-24 18:53:00,Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports its fourth-quarter 2022 results.,PFE,0.127682,0.067334,Neutral
Johnson & Johnson fourth-quarter earnings down 25%,https://www.foxbusiness.com/healthcare/johnson-johnson-fourth-quarter-earnings-down-25-percent,2023-01-24 17:21:17,"Johnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a cautious forecast for sales growth as the company undergoes a big transformation.",PFE,0.062761,-0.102143,Neutral
Depression Treatment Market will manager to achieve USD 15.0 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30552058/depression-treatment-market-will-manager-to-achieve-usd-15-0-billion-by-2030-greyviews,2023-01-24 16:30:00,"Pune India, Jan. 24, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the depression treatment market is operating and ...",PFE,0.023743,-0.014126,Neutral
4 Cancer Stocks to Consider in 2023,https://www.fool.com/investing/stock-market/market-sectors/healthcare/cancer-stocks/,2023-01-24 16:14:16,"Despite significant progress, cancer continues to be a big problem. Over 1.9 million new cases of cancer are likely to be diagnosed in the U.S. alone this year. More than 600,000 deaths are expected from cancer in 2022.There's also a huge financial cost that's growing rapidly.",PFE,0.138863,0.041736,Neutral
"Ex-Dividend Reminder: Pfizer, Unum Group And Signature Bank",https://www.forbes.com/sites/dividendchannel/2023/01/24/ex-dividend-reminder-pfizer-unum-group-and-signature-bank/,2023-01-24 15:15:15,"On 1/26/23, Pfizer, Unum Group, and Signature Bank will all trade ex-dividend for their respective upcoming dividends. Pfizer Inc will pay its quarterly dividend of $0.41 on 3/3/23, Unum Group will pay its quarterly dividend of $0.33 on 2/17/23, and Signature Bank will pay ...",PFE,0.821747,0.291999,Somewhat-Bullish
Pfizer  ( PFE )  Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release,https://www.zacks.com/stock/news/2043367/pfizer-pfe-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q4-release,2023-01-24 15:00:32,Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PFE,0.301933,0.180529,Somewhat-Bullish
The FDA's power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from U.S. market,https://www.cnbc.com/2023/01/24/abortion-pill-fda-challenged-in-lawsuit-seeking-to-pull-mifepristone-from-us.html,2023-01-24 13:36:05,"If the lawsuit prevails, women across the U.S. would lose access to the most common abortion method. The FDA's powers to approve drugs would also be weakened.",PFE,0.022707,-0.23569,Somewhat-Bearish
Johnson & Johnson  ( JNJ )  Q4 Earnings Top Estimates,https://www.zacks.com/stock/news/2043105/johnson-johnson-jnj-q4-earnings-top-estimates,2023-01-24 12:45:05,"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.86% and 0.22%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.136499,0.0,Neutral
"Job Cuts Today, What Tomorrow? Big Tech Faces Some Big Tests.",https://www.barrons.com/amp/articles/what-to-know-today-51674547396,2023-01-24 11:31:00,"Tech stocks are having an impressive start to 2023 but several potential pitfalls are lying in wait. The tech-heavy Nasdaq Composite notched its second consecutive gain of 2% or more Monday, and is now close to 9% up so far in 2023.",PFE,0.064507,0.069557,Neutral
2 Superb Dividend Stocks to Buy Today and Hold Forever,https://www.fool.com/investing/2023/01/24/superb-dividend-stocks-buy-today-hold-forever/,2023-01-24 10:36:00,These two companies have long runways for growth and decent yields today.,PFE,0.060541,0.054052,Neutral
Exclusive: Chinese pharma firm uses AI to find new industrial materials,https://www.scmp.com/business/china-business/article/3207587/xtalpi-rides-ai-expand-materials-science-tencent-backed-pharma-firm-plans-expansion-shanghai-hong,2023-01-24 07:00:16,"Shenzhen-based unicorn's expanded focus to materials science aligns with a key strategic priority for China, as the industry is expected to reach 10 trillion yuan (US$1.48 trillion) by 2025.",PFE,0.051999,0.138524,Neutral
US health officials propose once-a-year Covid shots for most Americans,https://www.business-standard.com/article/international/us-health-officials-propose-once-a-year-covid-shots-for-most-americans-123012400117_1.html,2023-01-24 03:46:00,US health officials propose once-a-year Covid shots for most ... Business Standard ...,PFE,0.081552,-0.141893,Neutral
"An Annual Covid Booster Could Be Coming. What It Means for Pfizer, Moderna.",https://www.barrons.com/amp/articles/fda-annual-covid-vaccine-booster-moderna-pfizer-51674506238,2023-01-23 20:40:00,An Annual Covid Booster May Be Coming. What It Means for Pfizer and Moderna. ...,PFE,0.455525,0.175009,Somewhat-Bullish
FDA Signals Shift Toward Annual Covid-19 Booster,https://www.barrons.com/articles/fda-annual-covid-vaccine-booster-moderna-pfizer-51674506238,2023-01-23 20:40:00,"The Food and Drug Administration on Monday signaled a shift toward an annual Covid-19 vaccine booster, a policy that would enable a long tail of Covid-19 vaccine revenues for companies such as Moderna and Pfizer",PFE,0.436009,0.0,Neutral
"Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk",https://www.benzinga.com/markets/23/01/30530192/stocks-make-a-quiet-move-upward-ahead-of-thursdays-gdp-pause-talk,2023-01-23 18:36:00,"( Monday Market Open ) This week and next could go a long way toward determining how the current quarter plays out on Wall Street. Between now and February 4, we'll receive earnings reports from close to half of S&P 500® companies, including 90 this seek.",PFE,0.034755,0.088423,Neutral
"Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk",https://www.benzinga.com/markets/23/01/30530187/stocks-make-a-quiet-move-upward-ahead-of-thursdays-gdp-pause-talk,2023-01-23 18:35:46,"( Monday Market Open ) This week and next could go a long way toward determining how the current quarter plays out on Wall Street. Between now and February 4, we'll receive earnings reports from close to half of S&P 500® companies, including 90 this seek.",PFE,0.034755,0.088423,Neutral
JNJ: 1 Stable Stock to Put on Your Buy List Now,https://stocknews.com/news/jnj-mrk-abbv-pfe-1-stable-stock-to-put-on-your-buy-list-now/,2023-01-23 17:11:26,The market's promising start to the year is at the risk of fizzling out amid underwhelming earnings releases and other indicators of an economy weighed down by increased borrowing costs due to the Federal Reserve's perpetual interest rate hikes.,PFE,0.104228,0.082727,Neutral
FDA says Covid vaccines will probably get an annual update but most people will only need one shot,https://www.cnbc.com/2023/01/23/covid-fda-says-most-people-probably-only-need-shot-moving-forward.html,2023-01-23 16:52:58,"The agency said the shots will probably get an annual update, but most people will only need one shot moving forward.",PFE,0.065685,-0.253878,Somewhat-Bearish
"mRNA Covid Shots Safe And Effective In Children Ages 5-11, Large Study Finds-Though Vaccine Uptake Remains Low",https://www.forbes.com/sites/roberthart/2023/01/23/mrna-covid-shots-safe-and-effective-in-children-ages-5-11-large-study-finds-though-vaccine-uptake-remains-low/,2023-01-23 16:34:14,"One doctor said the study presents data showing parents that ""the decision to vaccinate their children should be an easy one"" and that the risk of serious side effects like myocarditis is ""miniscule."" ...",PFE,0.187221,-0.017278,Neutral
"COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today",https://www.benzinga.com/general/biotech/23/01/30522388/covid-19-vaccine-strategy-might-follow-the-influenza-shot-way-fda-to-decide-today,2023-01-23 16:27:03,"The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19. Citing an undisclosed federal official, NPR wrote the agency might look at an approach similar to that used for the flu vaccine, with annual updates to match whatever ...",PFE,0.421485,-0.019722,Neutral
Concert  ( CNCE )  Stock Up 17% Last Week on Sun Pharma Buyout Offer,https://www.zacks.com/stock/news/2042653/concert-cnce-stock-up-17-last-week-on-sun-pharma-buyout-offer,2023-01-23 14:38:00,Concert Pharmaceuticals (CNCE) enters into a definitive agreement to be acquired by India-based Sun Pharmaceutical for $576 million. Stock up 17% in the previous week.,PFE,0.193852,0.086378,Neutral
"Global Obesity Drugs Market valued at $2.3 billion  ( 2022 ) , is Projected to Witness a Significant Growth Rate of 25% by 2027",https://www.benzinga.com/pressreleases/23/01/g30524086/global-obesity-drugs-market-valued-at-2-3-billion-2022-is-projected-to-witness-a-significant-growt,2023-01-23 14:30:00,"BRUSSELS, BELGIUM, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- Obesity and overweight are defined as accumulation of excessive or abnormal fat leading to increased risk to health, which can be measured by using body mass index ( BMI ) as a baseline. A BMI of over 30 is considered obese and over 25 is ...",PFE,0.051003,0.0,Neutral
How companies and organizations can gain an analytics edge in 2023 and beyond,https://www.prnewswire.com/news-releases/how-companies-and-organizations-can-gain-an-analytics-edge-in-2023-and-beyond-301727686.html,2023-01-23 13:05:00,How companies and organizations can gain an analytics edge in ... PR ...,PFE,0.049526,0.167117,Somewhat-Bullish
BiondVax's Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study,https://www.benzinga.com/pressreleases/23/01/g30518972/biondvaxs-innovative-inhaled-anti-sars-cov-2-nanoab-virtually-prevented-illness-when-administered-,2023-01-23 11:25:38,COVID-19 illness was virtually prevented in hamsters administered BiondVax's inhaled NanoAb and infected three hours later with SARS-CoV-2 Data further strengthens value proposition of BiondVax's COVID-19 NanoAb as prophylactic and therapeutic drug.,PFE,0.044885,0.02496,Neutral
BiondVax's Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study,https://www.globenewswire.com/news-release/2023/01/23/2593017/0/en/BiondVax-s-Innovative-Inhaled-Anti-SARS-CoV-2-NanoAb-Virtually-Prevented-Illness-When-Administered-Prophylactically-in-Preclinical-In-Vivo-Study.html,2023-01-23 11:25:00,"JERUSALEM, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- via InvestorWire - BiondVax Pharmaceuticals Ltd. ( Nasdaq: BVXV ) , a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune ...",PFE,0.046543,0.038966,Neutral
"3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street",https://www.fool.com/investing/2023/01/23/3-under-the-radar-stocks-590-to-772-upside-in-2023/,2023-01-23 10:21:00,Select analysts expect these small-caps stocks to catapult higher in the new year.,PFE,0.059935,0.046198,Neutral
"Sorbitol Market to Reach USD 1,928.3 Million by 2026 | Exhibiting a CAGR of 5.54%",https://www.benzinga.com/pressreleases/23/01/g30517267/sorbitol-market-to-reach-usd-1-928-3-million-by-2026-exhibiting-a-cagr-of-5-54,2023-01-23 06:12:44,"Pune, India, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- The global sorbitol market is likely to gain impetus from a rise in demand for digestive and low-calorie products. The global sorbitol industry was valued at USD 1,244.5 Million in 2018.",PFE,0.041828,0.100481,Neutral
Sun Pharma: Speciality pipeline gets a boost | The Financial Express,https://www.financialexpress.com/market/sun-pharma-speciality-pipeline-gets-a-boost/2956734/,2023-01-22 21:00:00,Sun Pharma: Speciality pipeline gets a boost The Financial Express ...,PFE,0.072655,0.065892,Neutral
"Elon Musk felt like he 'was dying' after 2nd COVID booster shot, cousin in 'peak health' suffered myocarditis",https://www.foxbusiness.com/business-leaders/elon-musk-felt-like-he-was-dying-2nd-covid-booster-shot-cousin-peak-health-suffered-myocarditis,2023-01-21 11:40:43,"Elon Musk took to Twitter late Friday evening to share his personal experience with the second COVID booster shot, explaining he ran into ""major side effects.""",PFE,0.066784,0.0,Neutral
"COVID, Shmovid: This Could Be the Next Big Growth Story for Moderna Stock",https://www.fool.com/investing/2023/01/21/next-big-growth-story-for-moderna-stock/,2023-01-21 11:04:00,Moderna could follow closely behind Pfizer and GSK in entering the lucrative RSV vaccine market.,PFE,0.274628,0.344743,Somewhat-Bullish
Caliber President and CEO Mark Sanders retiring after 36 years in the collision repair industry,https://www.prnewswire.com/news-releases/caliber-president-and-ceo-mark-sanders-retiring-after-36-years-in-the-collision-repair-industry-301743638.html,2023-02-09 23:40:00,Caliber President and CEO Mark Sanders retiring after 36 years in ... PR ...,PFE,0.064797,0.142213,Neutral
The Covid emergency in the U.S. ends May 11. HHS officials say here's what to expect,https://www.cnbc.com/2023/02/09/the-covid-emergency-in-the-us-ends-may-11-hhs-officials-say-heres-what-to-expect.html,2023-02-09 23:19:13,HHS officials in call with reporters laid out what the the public can expect when the emergency ends.,PFE,0.110462,-0.11629,Neutral
AbbVie  ( ABBV )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/09/abbvie-abbv-q4-2022-earnings-call-transcript/,2023-02-09 23:00:27,"ABBV earnings call for the period ending December 31, 2022.",PFE,0.002846,0.074254,Neutral
How to Build a Lottery Winning Stock Portfolio,https://www.zacks.com/stock/news/2052419/how-to-build-a-lottery-winning-stock-portfolio,2023-02-09 20:42:00,Didn't win the Powerball? Here's how to bet on yourself instead.,PFE,0.307731,0.141674,Neutral
"AbbVie  ( ABBV )  Beats Q4 Earnings Estimates, Misses on Sales",https://www.zacks.com/stock/news/2052457/abbvie-abbv-beats-q4-earnings-estimates-misses-on-sales,2023-02-09 16:37:00,"AbbVie's Q4 earnings (ABBV) beat estimates, while sales miss the same. Full-year 2023 EPS falls short of estimates.",PFE,0.04111,0.038882,Neutral
Hot to Build a Lottery Winning Stock Portfolio,https://www.zacks.com/stock/news/2052419/hot-to-build-a-lottery-winning-stock-portfolio,2023-02-09 15:30:00,Didn't win the Powerball? Here's how to bet on yourself instead.,PFE,0.307731,0.141674,Neutral
2 Excellent Stocks to Buy in 2023 and Never Sell,https://www.fool.com/investing/2023/02/09/2-excellent-stocks-to-buy-in-2023-and-never-sell/,2023-02-09 15:00:00,"If your favorite investment period is ""forever,"" check out these two stocks.",PFE,0.474958,0.312259,Somewhat-Bullish
2 Top Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/02/09/2-top-biotech-stocks-to-buy-right-now/,2023-02-09 14:37:00,These two companies each pay market-beating dividends to shareholders.,PFE,0.068502,0.091281,Neutral
Biden proposal to cap all insulin prices at $35 a month has little chance of passing Congress,https://www.cnbc.com/2023/02/09/biden-proposal-to-cap-all-insulin-prices-at-35-a-month-has-little-chance-of-passing-congress.html,2023-02-09 14:26:12,Senate Republicans killed a proposal last year to cap out-of-pocket costs at $35 for people with private insurance.,PFE,0.036643,-0.170451,Somewhat-Bearish
Pfizer Limited appoints Meenakshi Nevatia as Managing Director and Additional Director | The Financial Express,https://www.financialexpress.com/healthcare/news-healthcare/pfizer-limited-appoints-meenakshi-nevatia-as-managing-director-and-additional-director/2976987/,2023-02-09 14:19:00,Pfizer Limited appoints Meenakshi Nevatia as Managing Director ... The Financial Express ...,PFE,0.483434,0.348757,Somewhat-Bullish
Voyager Therapeutics to Participate in Upcoming Investor Conferences - Voyager Therapeutics  ( NASDAQ:VYGR ) ,https://www.benzinga.com/pressreleases/23/02/g30830125/voyager-therapeutics-to-participate-in-upcoming-investor-conferences,2023-02-09 12:00:00,"CAMBRIDGE, Mass., Feb. 09, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. VYGR, a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that management will participate in the following investor conferences:",PFE,0.126119,0.04498,Neutral
3 Healthcare Stocks That Are Too Cheap to Ignore,https://www.fool.com/investing/2023/02/09/3-healthcare-stocks-that-are-too-cheap-to-ignore/,2023-02-09 10:52:00,Pay attention when stocks have these kinds of low valuations.,PFE,0.592978,0.236662,Somewhat-Bullish
Heparin Market Size to Surpass USD 12.63 Billion by 2029 | With 4.1% CAGR,https://www.benzinga.com/pressreleases/23/02/g30828903/heparin-market-size-to-surpass-usd-12-63-billion-by-2029-with-4-1-cagr,2023-02-09 10:43:05,"Pune, India, Feb. 09, 2023 ( GLOBE NEWSWIRE ) -- The heparin market size was valued at USD 9.41 billion in 2021 and is projected to reach a valuation of USD 9.53 billion in 2022. The market is expected to reach USD 12.63 billion by 2029 with a CAGR of 4.1% during the forecast period.",PFE,0.039614,0.081347,Neutral
"Benchmarks trade sideways; Nifty below 17,900",https://www.business-standard.com/article/news-cm/benchmarks-trade-sideways-nifty-below-17-900-123020900423_1.html,2023-02-09 05:03:00,"Benchmarks trade sideways. Nifty below 17,900 Business Standard ...",PFE,0.087824,0.042189,Neutral
Nifty to surpass 17900 or bears to stage a comeback? 7 things to know before share market opens today | The Financial Express,https://www.financialexpress.com/market/nifty-to-surpass-17900-or-bears-to-stage-a-comeback-7-things-to-know-before-share-market-opens-today/2975990/,2023-02-09 02:21:49,Nifty to surpass 17900 or bears to stage a comeback? 7 things to ... The Financial Express ...,PFE,0.05257,0.090616,Neutral
"Adani Power, TCS, Adani Total Gas, LIC, Zomato, L&T, Cummins, HAL, Page Industries, IRCTC stocks in focus | The Financial Express",https://www.financialexpress.com/market/stocks-to-watch-adani-power-tcs-adani-total-gas-lic-zomato-lt-cummins-hal-page-industries-irctc-stocks-in-focus/2975972/,2023-02-09 01:54:06,"Adani Power, TCS, Adani Total Gas, LIC, Zomato, L&T, Cummins ... The Financial Express ...",PFE,0.05339,0.090697,Neutral
"Buzzing Stocks: Adani Power, Cummins India, Hindalco Industries, and others in news today",https://www.moneycontrol.com/news/photos/business/stocks/buzzing-stocks-adani-power-cummins-india-hindalco-industries-and-others-in-news-today-10035171.html,2023-02-09 01:18:18,Stocks to Watch: Check out the companies making headlines before the opening bell today.,PFE,0.049526,0.092224,Neutral
"Physicians' Education Resource Announces 40th Annual Miami Breast Cancer Conference Scheduled for March 2-5, 2023",https://www.benzinga.com/pressreleases/23/02/g30818618/physicians-education-resource-announces-40th-annual-miami-breast-cancer-conference-scheduled-for-m,2023-02-08 17:27:34,"CRANBURY, N.J., Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Physicians' Education Resource®, LLC ( PER® ) , a top educational resource for health care professionals across all specialties to advance patient care, today announced it will host its 40th Annual Miami Breast Cancer Conference® at the ...",PFE,0.072876,0.155301,Somewhat-Bullish
A Look at Pharma ETFs Post Q4 Earnings,https://www.zacks.com/stock/news/2051723/a-look-at-pharma-etfs-post-q4-earnings,2023-02-08 15:05:00,"Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.",PFE,0.115787,0.027812,Neutral
"Deciphera's  ( DCPH )  Q4 Earnings Miss, Qinlock Drives Revenues",https://www.zacks.com/stock/news/2051494/decipheras-dcph-q4-earnings-miss-qinlock-drives-revenues,2023-02-08 13:43:00,"Deciphera (DCPH) reports a wider-than-expected loss per share for the fourth quarter of 2022, while revenues driven by Qinlock sales, beat estimates.",PFE,0.201105,0.053676,Neutral
3D Systems Announces Appointment of Dr. Rebekah Gee as Member of its Medical Advisory Board,https://www.globenewswire.com/news-release/2023/02/08/2603963/0/en/3D-Systems-Announces-Appointment-of-Dr-Rebekah-Gee-as-Member-of-its-Medical-Advisory-Board.html,2023-02-08 13:30:00,"ROCK HILL, S.C., Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Today, 3D Systems ( NYSE:DDD ) announced the appointment of Dr. Rebekah Gee to the 3D Systems Medical Advisory Board, effective March 1, 2023. Dr. Gee is a recognized expert on public health policy and was elected to the National Academy of ...",PFE,0.03072,0.071669,Neutral
Pfizer India launches brand film to celebrate cancer survivors | The Financial Express,https://www.financialexpress.com/brandwagon/pfizer-india-launches-brand-film-to-celebrate-cancer-survivors/2975579/,2023-02-08 12:01:28,Pfizer India launches brand film to celebrate cancer survivors The Financial Express ...,PFE,0.443626,0.260014,Somewhat-Bullish
"Elon Musk mocked Sam Smith's much-discussed Grammys performance, tweeting, 'If that's satan, we have nothing to worry about'",https://africa.businessinsider.com/entertainment/elon-musk-mocked-sam-smiths-much-discussed-grammys-performance-tweeting-if-thats/8vx5plc,2023-02-08 11:58:06,Elon Musk mocked Sam Smith's much-discussed Grammys ... - Business Insider Africa ...,PFE,0.277433,-0.291206,Somewhat-Bearish
"Elon Musk mocked Sam Smith's much-discussed Grammys performance, tweeting, 'If that's satan, we have nothing to worry about'",https://www.businessinsider.com/elon-musk-sam-smiths-grammys-insulted-performance-2023-2,2023-02-08 11:58:06,Elon Musk Mocked Sam Smith's Much-Discussed Satan Costume at ... - Business Insider ...,PFE,0.195814,-0.223768,Somewhat-Bearish
Is Invesco Dynamic Pharmaceuticals ETF  ( PJP )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2051397/is-invesco-dynamic-pharmaceuticals-etf-pjp-a-strong-etf-right-now,2023-02-08 11:20:08,Smart Beta ETF report for ...,PFE,0.11894,0.055094,Neutral
"Barometers turn rangebound; Nifty hovers above 17,850",https://www.business-standard.com/article/news-cm/barometers-turn-rangebound-nifty-hovers-above-17-850-123020800957_1.html,2023-02-08 11:05:19,"Barometers turn rangebound. Nifty hovers above 17,850 Business Standard ...",PFE,0.061631,0.037195,Neutral
"Baromters turn rangebound; Nifty hovers above 17,850",https://www.business-standard.com/article/news-cm/baromters-turn-rangebound-nifty-hovers-above-17-850-123020800957_1.html,2023-02-08 09:10:00,"Baromters turn rangebound. Nifty hovers above 17,850 Business Standard ...",PFE,0.061631,0.037195,Neutral
"VC Roundup: ZK proofs, DeFi protocol and longevity DAO attract investment",https://cointelegraph.com/news/vc-roundup-zk-proofs-defi-protocol-and-longevity-dao-attract-investment,2023-02-07 21:49:44,"Venture capital deals slowed in the second half of 2022 amid the bear market. However, behind the scenes, blockchain startups continue to build.",PFE,0.052455,0.141586,Neutral
Wall Street bullish on Ron DeSantis presidential prospects in 2024,https://www.foxbusiness.com/politics/wall-street-bullish-ron-desantis-presidential-prospects-2024,2023-02-07 19:05:45,"Wall Street is starting to love Florida Gov. Ron DeSantis's prospects in the 2024 presidential election so much that it is already eyeing stocks that will benefit, as well as those that could tank, if he wins the White House.",PFE,0.029581,-0.055958,Neutral
2 Healthcare Companies That Could Be Acquired Within 5 Years,https://www.fool.com/investing/2023/02/07/2-healthcare-companies-that-could-be-acquired-with/,2023-02-07 15:15:00,These stocks are also cheap buys that are down more than 60% from their highs.,PFE,0.112269,0.148099,Neutral
Pfizer Inc.  ( PFE )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2050898/pfizer-inc-pfe-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-02-07 14:00:12,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.527831,0.084284,Neutral
"Global Acne Medication Market to generate USD 14.26 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting",https://www.benzinga.com/pressreleases/23/02/g30763059/global-acne-medication-market-to-generate-usd-14-26-billion-by-2030-outlines-a-new-report-by-next-,2023-02-07 14:00:00,"New York, Feb. 07, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Next Move Strategy Consulting, the Acne Medication Market generated USD 10.08 billion in 2021, and is projected to generate USD 14.26 billion by 2030, witnessing a CAGR of 3.02% from 2021 to 2030.",PFE,0.044386,-0.03947,Neutral
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response - Precigen  ( NASDAQ:PGEN ) ,https://www.benzinga.com/general/biotech/23/02/30760256/precigen-is-pioneering-a-nonsurgical-treatment-for-a-debilitating-respiratory-disease-positive-da,2023-02-07 13:00:04,"New hope may be on the horizon for sufferers of Recurrent Respiratory Papillomatosis, or RRP, a rare and debilitating disease that typically requires patients to undergo multiple surgeries each year to remove benign tumors called papillomas, that grow in the respiratory tract. Precigen, Inc.",PFE,0.087824,0.157461,Somewhat-Bullish
"MTG, Tucker Carlson, and Donald Trump Jr are stoking a moral panic over Sam Smith dressing as Satan at the Grammys",https://africa.businessinsider.com/politics/mtg-tucker-carlson-and-donald-trump-jr-are-stoking-a-moral-panic-over-sam-smith/fxsckr8,2023-02-07 12:59:06,"MTG, Tucker Carlson, and Donald Trump Jr are stoking a moral ... - Business Insider Africa ...",PFE,0.269776,-0.097975,Neutral
"MTG, Tucker Carlson, and Donald Trump Jr are stoking a moral panic over Sam Smith dressing as Satan at the Grammys",https://africa.businessinsider.com/news/mtg-tucker-carlson-and-donald-trump-jr-are-stoking-a-moral-panic-over-sam-smith/13mcpr6,2023-02-07 12:59:06,"MTG, Tucker Carlson, and Donald Trump Jr are stoking a moral ... - Business Insider Africa ...",PFE,0.269776,-0.097975,Neutral
"MTG, Tucker Carlson, and Donald Trump Jr are stoking a moral panic over Sam Smith dressing as Satan at the Grammys",https://www.businessinsider.com/conservatives-kim-petras-sam-smith-satan-unholy-grammy-devil-2023-2,2023-02-07 12:59:06,Conservatives Rail Against Sam Smith Satan-Themed Grammy ... - Business Insider ...,PFE,0.258351,-0.163418,Somewhat-Bearish
This Healthcare Giant Expects Revenue to Crash More Than 30% This Year,https://www.fool.com/investing/2023/02/07/this-healthcare-giant-expects-revenue-to-crash-mor/,2023-02-07 11:30:00,Could Pfizer be a cheap contrarian stock to buy?,PFE,0.554365,0.207499,Somewhat-Bullish
Continued strong Cresemba®  ( isavuconazole )  sales performance in Asia Pacific and China triggers second sales milestone payment to Basilea from Pfizer,https://www.globenewswire.com/news-release/2023/02/07/2602601/0/en/Continued-strong-Cresemba-isavuconazole-sales-performance-in-Asia-Pacific-and-China-triggers-second-sales-milestone-payment-to-Basilea-from-Pfizer.html,2023-02-07 06:29:00,"Basel/Allschwil, Switzerland, February ...",PFE,0.217346,0.149391,Neutral
Medexus Welcomes Two New Board Members,https://www.benzinga.com/pressreleases/23/02/g30744226/medexus-welcomes-two-new-board-members,2023-02-06 22:00:00,"TORONTO and CHICAGO, Feb. 06, 2023 ( GLOBE NEWSWIRE ) -- Medexus Pharmaceuticals ( Medexus ) MDP MEDXF is pleased to welcome Harmony P. Garges MD MPH, Chief Medical Officer of ViiV Healthcare, and Menassie Taddese MBA, former executive at Pfizer and Viatris, to the Medexus board of directors.",PFE,0.03792,0.153288,Somewhat-Bullish
Medexus Welcomes Two New Board Members,https://www.globenewswire.com/news-release/2023/02/06/2602543/0/en/Medexus-Welcomes-Two-New-Board-Members.html,2023-02-06 22:00:00,Harmony P. Garges MD MPH and Menassie Taddese MBA appointed to Medexus's board of directors ...,PFE,0.03786,0.158201,Somewhat-Bullish
"Hispanic dialysis patients face 40% higher risk of staph infection than whites, CDC says",https://www.cnbc.com/2023/02/06/hispanic-dialysis-patients-face-40percent-higher-risk-of-staph-infection-than-whites-cdc-says.html,2023-02-06 18:00:01,"People of color on dialysis have a higher risk of staph bloodstream infections than white people, according to the CDC.",PFE,0.073098,-0.177625,Somewhat-Bearish
PFE: The Active Stocks to Buy on Wall Street This Week,https://stocknews.com/news/pfe-vz-t-the-active-stocks-to-buy-on-wall-street-this-week/,2023-02-06 16:13:05,"Non-farm payrolls in the United States increased by 517,000 in January, surpassing December's gain of 260,000 and crushing the Dow Jones estimate of 187,000.",PFE,0.289156,0.121451,Neutral
The Pulmonary Edema Therapeutics market is expected to display a steady growth of 3% due to the increase in road accidents leading to severe injury to the chest | UnivDatos Market Insights,https://www.prnewswire.com/news-releases/the-pulmonary-edema-therapeutics-market-is-expected-to-display-a-steady-growth-of-3-due-to-the-increase-in-road-accidents-leading-to-severe-injury-to-the-chest--univdatos-market-insights-301739192.html,2023-02-06 14:30:00,The Pulmonary Edema Therapeutics market is expected to display a ... PR ...,PFE,0.038717,0.0,Neutral
Viridian Appoints Scott Myers as President and Chief Executive Officer,https://www.globenewswire.com/news-release/2023/02/06/2601926/0/en/Viridian-Appoints-Scott-Myers-as-President-and-Chief-Executive-Officer.html,2023-02-06 12:00:00,Transition highlights Viridian's progression towards becoming a fully-integrated biopharmaceutical company Transition highlights Viridian's progression towards becoming a fully-integrated biopharmaceutical company ...,PFE,0.035714,0.0,Neutral
Viridian Appoints Scott Myers as President and Chief Executive Officer - Viridian Therapeutics  ( NASDAQ:VRDN ) ,https://www.benzinga.com/pressreleases/23/02/g30725677/viridian-appoints-scott-myers-as-president-and-chief-executive-officer,2023-02-06 12:00:00,"WALTHAM, Mass., Feb. 06, 2023 ( GLOBE NEWSWIRE ) -- Viridian Therapeutics, Inc.",PFE,0.03463,0.0,Neutral
5 Stocks That Moved the Market in January,https://www.fool.com/investing/2023/02/06/5-stocks-that-moved-the-market-in-january/,2023-02-06 11:20:00,These stocks illustrate the most important trends in the stock market right now.,PFE,0.140348,-0.072416,Neutral
Drug companies face COVID cliff in 2023 as sales set to plummet,https://www.reuters.com/business/healthcare-pharmaceuticals/drug-companies-face-covid-cliff-2023-sales-set-plummet-2023-02-06/,2023-02-06 11:08:02,"[1/3] Empty vials of Pfizer-BioNTech coronavirus disease ( COVID-19 ) children's vaccines are pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., May 19, 2022. REUTERS/Hannah Beier/File Photo",PFE,0.255641,0.017139,Neutral
Is Gilead Sciences a Good Stock to Buy Now?,https://www.fool.com/investing/2023/02/06/is-gilead-sciences-a-good-stock-to-buy-now/,2023-02-06 10:41:00,"Gilead Sciences' breast cancer drug, Trodelvy, just took a big step forward.",PFE,0.060694,-0.055,Neutral
"Barron's Top Weekend Stock Picks: Apple, Disney, Pfizer And Tesla's Price Cuts Are Leading To Growth - Apple  ( NASDAQ:AAPL ) , Activision Blizzard  ( NASDAQ:ATVI ) ",https://www.benzinga.com/news/large-cap/23/02/30719966/barrons-top-weekend-stock-picks-apple-disney-pfizer-and-teslas-price-cuts-are-leading-to-growth,2023-02-04 21:30:10,"Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read. ""Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy,"" by Andrew Bary, looks at the many reasons Pfizer Inc PFE remains an attractive investment moving beyond Covid, including the ...",PFE,0.388879,0.330965,Somewhat-Bullish
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?,https://www.fool.com/investing/2023/02/04/will-these-3-potential-blockbuster-drugs-lift-bris/,2023-02-04 14:26:00,Bristol Myers Squibb has solid replacements for its blockbusters that are facing a patent cliff.,PFE,0.052455,0.048975,Neutral
U.S. plans to stop buying Covid shots for the public this fall. Here's what that means,https://www.cnbc.com/2023/02/04/us-plans-to-stop-buying-covid-shots-in-the-fall-what-that-means.html,2023-02-04 14:00:01,"Under the Affordable Care Act, most Americans would still get their Covid shots for free once the vaccine program goes commercial.",PFE,0.231332,-0.075432,Neutral
Better Buy: Novavax or BioNTech Stock?,https://www.fool.com/investing/2023/02/04/better-buy-novavax-or-biontech-stock/,2023-02-04 13:00:00,"The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.",PFE,0.142284,0.04781,Neutral
HC directs firm to pay Rs 2 crore damages to Pfizer for contempt of court,https://www.business-standard.com/article/companies/hc-directs-firm-to-pay-rs-2-crore-damages-to-pfizer-for-contempt-of-court-123020400909_1.html,2023-02-04 12:22:00,"The Delhi High Court has directed a firm to pay Rs 2 crore as damages to pharma giant Pfizer Inc for committing wilful"" and ""contumacious contempt of court by disobeying its order. The court said if the director of the firm, Triveni Interchem Pvt Ltd, fails to pay the amount in two weeks, he ...",PFE,0.462395,-0.223741,Somewhat-Bearish
Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.,https://www.barrons.com/articles/buy-pfizer-stock-price-pick-covid-51675469303,2023-02-04 00:12:00,"Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped a financial windfall from its twin Covid-19 franchise-the top-selling vaccine and the leading treatment, Paxlovid. The world, however, has stopped worrying about Covid-and Pfizer ( ticker: ...",PFE,0.944494,-0.224039,Somewhat-Bearish
Sanofi  ( SNY )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/03/sanofi-sny-q4-2022-earnings-call-transcript/,2023-02-03 23:30:21,"SNY earnings call for the period ending December 31, 2022.",PFE,0.003527,0.065839,Neutral
4 Biotech Stocks Set to Outpace Q4 Earnings Estimates,https://www.zacks.com/stock/news/2049779/4-biotech-stocks-set-to-outpace-q4-earnings-estimates,2023-02-03 19:43:00,"Let us look at some biotech stocks, ALLO, EDIT, NTLA and SGEN that are poised to beat on fourth-quarter earnings.",PFE,0.058472,0.053179,Neutral
Retirees: Don't fall for a popularity contest when it comes to your investments,https://www.marketwatch.com/story/retirees-dont-fall-for-a-popularity-contest-when-it-comes-to-your-investments-11675443402,2023-02-03 19:15:00,Fortune magazine is out with its latest ranking of the most admired companies ...,PFE,0.13459,-0.162802,Somewhat-Bearish
"Market Rally Powers Higher On Tame Fed, Meta: Weekly Review",https://www.investors.com/news/market-rally-powers-higher-on-tame-fed-meta-earnings-apple-google-amazon/,2023-02-03 18:43:00,"The stock market rally marched higher as the Fed took a slightly more dovish stance, even though it said rate hikes will continue. Friday's superhot jobs report failed to derail the uptrend. Big earnings or guidance continued to be mixed, but Meta Platforms ( META ) skyrocketed on cost cuts, ...",PFE,0.020439,-0.02026,Neutral
"Top 5 Health Care Stocks That May Rally - AstraZeneca  ( NASDAQ:AZN ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/02/30711755/top-5-health-care-stocks-that-may-rally,2023-02-03 18:35:21,"The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.",PFE,0.369685,-0.045047,Neutral
PFE: The Safest Stock to Buy on Wall Street Right Now,https://stocknews.com/news/pfe-jnj-abbv-bmy-the-safest-stock-to-buy-on-wall-street-right-now/,2023-02-03 16:59:24,"While a 25-bps interest-rate hike announced on Wednesday by the Federal Reserve Chair Jerome Powell hardly came as a surprise, market participants seem to have gone overboard over a simple acknowledgment that inflation ""has eased somewhat"" and ""the disinflationary process"" had started.",PFE,0.579393,0.330004,Somewhat-Bullish
PFE: 3 Stocks to Buy if You're Building a Portfolio From Scratch,https://stocknews.com/news/pfe-cnc-k-3-stocks-to-buy-if-youre-building-a-portfolio-from/,2023-02-03 16:45:45,"""Rule number one: never lose money. Rule number two: never forget rule number one."" This is how the fabled investor Warren Buffett, fondly known as the Oracle of Omaha, summed up the simple, although not necessarily easy, the art of investing.",PFE,0.291537,0.142585,Neutral
"China's CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots",https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cansino-confident-its-mrna-covid-vaccine-good-moderna-pfizer-shots-2023-02-03/,2023-02-03 15:56:19,China's CanSino confident its mRNA COVID vaccine as good as ... ...,PFE,0.344074,0.266298,Somewhat-Bullish
High Adoption Rate Of A New Treatment Against Cancer is likely to proliferate the Neuroendocrine Tumor Treatment CAGR: 10%|UnivDatos Market Insights,https://www.prnewswire.com/news-releases/high-adoption-rate-of-a-new-treatment-against-cancer-is-likely-to-proliferate-the-neuroendocrine-tumor-treatment-cagr-10univdatos-market-insights-301738150.html,2023-02-03 14:30:00,High Adoption Rate Of A New Treatment Against Cancer is likely to ... PR ...,PFE,0.039878,0.15811,Somewhat-Bullish
Is It Time to Buy the S&P 500's 3 Worst-Performing January Stocks?,https://www.fool.com/investing/2023/02/03/is-it-time-to-buy-the-sp-500s-3-worst-performing-j/,2023-02-03 14:19:40,It's safe to go bargain-hunting again. Just make sure the bargain is a stock you actually want to own for the long haul.,PFE,0.134339,0.085616,Neutral
"Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits",https://www.zacks.com/stock/news/2049538/pharma-stock-roundup-mrk-lly-pfe-q4-results-jjs-loss-in-talc-lawsuits,2023-02-03 14:19:00,"Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and others report fourth-quarter results. An appeals court dismisses J&J's (JNJ) bankruptcy filing related to its talc lawsuits.",PFE,0.218161,-0.106216,Neutral
Alphabet and Other Stocks That Are Solid Bets in a Wild Market,https://www.barrons.com/articles/southwest-wells-fargo-alphabet-stock-market-51675382150,2023-02-03 13:22:00,"Markets have surged to start 2023, and leadership has shifted. Growth is outperforming value, risky stocks are trouncing defensive ones, and shares of Meta Platforms and Nvidia are leaving those of Northrop Grumman and Pfizer in their dust.",PFE,0.310843,0.324511,Somewhat-Bullish
Value Stocks Are Still Beating Growth - Analysts Like These 5 Best,https://www.investors.com/etfs-and-funds/sectors/sp500-value-stocks-are-still-beating-growth-analysts-like-these-best/,2023-02-03 13:00:00,Some speculative S&P 500 stocks may be getting some lift this year. But make no mistake - value stocks are still in control. And that's why analysts are still spotting big opportunities in value stocks.,PFE,0.119532,0.126646,Neutral
What the end of the COVID-19 emergency declaration will mean for your health coverage - and medical expenses,https://www.marketwatch.com/story/what-the-end-of-the-covid-19-emergency-declaration-will-mean-for-your-health-coverage-and-medical-expenses-11675379175,2023-02-03 11:05:00,"Up to 18 million people could lose Medicaid coverage when the COVID-19 national emergency ends, according to one recent analysis.",PFE,0.028903,0.031025,Neutral
Alphabet and Other Stocks That Are Solid Bets in a Wild Market,https://www.barrons.com/articles/alphabet-and-other-stocks-that-are-solid-bets-in-a-wild-market-51675408502,2023-02-03 07:15:00,"Markets have surged to start 2023, and leadership has shifted. Growth is outperforming value, risky stocks are trouncing defensive ones, and shares of Meta Platforms and Nvidia are leaving those of Northrop Grumman and Pfizer in their dust.",PFE,0.310843,0.324511,Somewhat-Bullish
"Gilead's Unexpectedly Bullish Outlook - Cancer, HIV Remain Key",https://www.investors.com/news/technology/gild-stock-gilead-earnings-q4-2022/,2023-02-02 21:00:00,GILD Stock: Gilead Issues Unexpectedly Bullish Outlook After ... Investor's Business Daily ...,PFE,0.075161,0.0,Neutral
"Bristol-Myers  ( BMY )  Q4 Earnings Top, Revlimid Generic Impact Sales",https://www.zacks.com/stock/news/2049110/bristol-myers-bmy-q4-earnings-top-revlimid-generic-impact-sales,2023-02-02 19:59:00,"Bristol-Myers' (BMY) fourth-quarter 2022 earnings beat estimates, while sales declined year over year due to generic erosion for oncology drug Revlimid.",PFE,0.157483,0.070694,Neutral
Bristol-Myers Squibb  ( BMY )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/02/bristol-myers-squibb-bmy-q4-2022-earnings-call-tra/,2023-02-02 19:00:21,"BMY earnings call for the period ending December 31, 2022.",PFE,0.013865,0.12078,Neutral
Biohaven Nabbed A Nearly $12 Billion Buyout - What's Next?,https://www.investors.com/news/technology/bhvn-stock-what-is-next-for-biohaven-after-a-buyout/,2023-02-02 17:52:00,BHVN Stock: What's Next For Biohaven After A $12 Billion Buyout ... Investor's Business Daily ...,PFE,0.169081,0.029435,Neutral
"Revlimid Generic Competition Hurts Bristol Myers' Q4 Earnings, Issues Annual Outlook Within Expected Range",https://www.benzinga.com/general/biotech/23/02/30687807/revlimid-generic-competition-hurts-bristol-myers-q4-earnings-issues-annual-outlook-within-expecte,2023-02-02 14:05:33,"Bristol Myers Squibb & Co BMY said that its Q4 sales of $11.41 billion fell 5% Y/Y as generic competition impacted sales of its blockbuster cancer drug Revlimid in the U.S. and foreign exchange impacts, partially offset by in-line products ( primarily Opdivo ) and new product portfolio ( ...",PFE,0.16171,-0.210345,Somewhat-Bearish
Merck's Profit Guidance Widely Missed; Shares Slide,https://www.investors.com/news/technology/merck-stock-merck-earnings-q4-2022/,2023-02-02 14:01:00,Merck Stock Slides After Profit Guidance Widely Misses Expectations Investor's Business Daily ...,PFE,0.179788,-0.413643,Bearish
"GOP attorneys general warn CVS, Walgreens against mailing abortion pill in their states",https://www.cnbc.com/2023/02/02/gop-attorneys-general-warn-cvs-walgreens-against-mailing-abortion-pill-in-their-states.html,2023-02-02 13:40:17,CVS and Walgreens last month said they would dispense mifepristone but only in states where the law allows it.,PFE,0.049221,-0.175059,Somewhat-Bearish
"Merck Beats On Q4 earnings, Anticipates Almost 80% Decline In COVID-19 Treatment Sales In 2023",https://www.benzinga.com/general/biotech/23/02/30686289/merck-beats-on-q4-earnings-anticipates-almost-80-decline-in-covid-19-treatment-sales-in-2023,2023-02-02 13:34:43,"Merck & Co Inc's MRK Q4 sales reached $13.8 billion, +2% Y/Y, beating the consensus of $13.67 billion. Excluding the foreign exchange impact, revenues were up 8%. Pharmaceutical sales increased by 1% to $12.2 billion.",PFE,0.165031,-0.209066,Somewhat-Bearish
Budget 2023: No major announcements on health front; Allocations increase by meagre 12 per cent | The Financial Express,https://www.financialexpress.com/budget/budget-2023-no-major-announcements-on-health-front-allocations-increase-by-meagre-12-per-cent-2969712/,2023-02-02 12:55:58,Budget 2023: No major announcements on health front. Allocations ... The Financial Express ...,PFE,0.013808,0.254687,Somewhat-Bullish
"Got $1,000? 3 Cheap Stocks To Buy Right Now",https://www.fool.com/investing/2023/02/02/got-1000-3-cheap-stocks-to-buy-right-now/,2023-02-02 12:54:57,"We may be entering a period of prolonged leadership from undervalued stocks, with these tickers poised to lead the charge.",PFE,0.212674,-0.010183,Neutral
"Drugmakers Raise Prices on Nearly 1,000 Medicines but Show Restraint",https://www.wsj.com/articles/drugmakers-raise-prices-on-nearly-1-000-medicines-but-show-restraint-11675313960,2023-02-02 12:00:00,List prices have climbed by 5.6% on average as a new federal law aims to lower drug costs.,PFE,0.407844,0.0,Neutral
BioNTech to invest $43 mln in German facility for mRNA vaccine building block,https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-invest-43-mln-german-facility-mrna-vaccine-building-block-2023-02-02/,2023-02-02 11:52:01,BioNTech to invest $43 mln in German facility for mRNA vaccine ... ...,PFE,0.140076,-0.159467,Somewhat-Bearish
BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility,https://www.globenewswire.com/news-release/2023/02/02/2600288/0/en/BioNTech-Strengthens-Manufacturing-Capabilities-with-First-In-House-Plasmid-DNA-Manufacturing-Facility.html,2023-02-02 11:45:00,"MAINZ, Germany, February 2, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) today announced construction completion of the Company's first proprietary plasmid DNA manufacturing facility in Marburg, Germany.",PFE,0.053992,0.043999,Neutral
Merck fourth quarter tops expectations on strong COVID pill sales,https://www.reuters.com/business/healthcare-pharmaceuticals/merck-fourth-quarter-tops-expectations-strong-covid-pill-sales-2023-02-02/,2023-02-02 11:31:00,"Feb 2 ( Reuters ) - Merck & Co ( MRK.N ) on Thursday reported higher-than-expected fourth-quarter earnings on strong sales of its COVID-19 antiviral pill molnupiravir in Asia. The U.S. drugmaker said its sales in the quarter were $13.83 billion, up from $13.52 billion a year earlier.",PFE,0.117486,-0.073928,Neutral
"This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years",https://www.fool.com/investing/2023/02/02/this-low-risk-etf-can-turn-39000-into-1-million-in/,2023-02-02 11:10:00,Funneling money into this fund can drastically simplify your investing strategy.,PFE,0.069697,0.173953,Somewhat-Bullish
Pfizer's Sales Could Sink 33% in 2023. Here's Why to Buy the Stock Anyway.,https://www.fool.com/investing/2023/02/02/pfizers-sales-sink-2023-buy-stock-anyway/,2023-02-02 10:50:00,There's a bigger story for Pfizer than its declining COVID-19 revenue.,PFE,0.770897,0.351395,Bullish
"Pfizer  ( NYSE:PFE )  Lowered to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/02/02/pfizer-nysepfe-lowered-to-buy-at-stocknews-com.html,2023-02-02 09:46:41,StockNews.com downgraded shares of Pfizer ( NYSE:PFE - Get Rating ) from a strong-buy rating to a buy rating in a research note issued to investors on Wednesday morning. PFE has been the topic of several other research reports.,PFE,0.915317,0.34186,Somewhat-Bullish
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products,https://www.globenewswire.com/news-release/2023/02/02/2600132/0/en/Ad-hoc-announcement-pursuant-to-Art-53-LR-Roche-reports-good-results-for-2022-despite-decline-in-demand-for-COVID-19-products.html,2023-02-02 06:00:00,"Basel, 2 February ...",PFE,0.009296,0.254272,Somewhat-Bullish
Merck Earnings Are Coming. What to Watch For.,https://www.barrons.com/articles/merck-earnings-stock-price-guidance-51675286601,2023-02-01 21:24:00,Merck Reports Earnings Thursday. What to Expect. ...,PFE,0.615462,0.086483,Neutral
"Powell Talk: It's All About the Fed Chair's Comments Today, as 0.25% Rate Hike Baked In",https://www.benzinga.com/news/23/02/30675086/powell-talk-its-all-about-the-fed-chairs-comments-today-as-0-25-rate-hike-baked-in,2023-02-01 19:52:59,"( Wednesday Market Open ) Today's Federal Reserve rate decision comes just ahead of Groundhog Day. If the groundhog sees its shadow, it means another six weeks of winter, tradition tells us. If the Fed sees an inflation shadow still overhanging the economy, it could mean many, many more weeks of ...",PFE,0.044746,0.087375,Neutral
Analysis: GSK gives few clues on plans to replenish medicine cabinet,https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-gives-few-clues-plans-replenish-medicine-cabinet-2023-02-01/,2023-02-01 18:42:22,"LONDON, Feb 1 ( Reuters ) - GSK ( GSK.L ) chief executive Emma Walmsley on Wednesday made replenishing the drugmaker's pipeline of vaccines and therapies her number-one priority. But analysts were disappointed she did not give more details on how she and her management team plan to find the ...",PFE,0.116348,0.0,Neutral
The Top IBD 50 Stock Is Taking On 'Prestige' Medical Aesthetics,https://www.investors.com/research/the-new-america/rvnc-stock-how-ibd-50-leader-is-taking-on-prestige-medical-aesthetics/,2023-02-01 18:39:00,Revance Therapeutics ( RVNC ) and RVNC stock are all smiles after the Food and Drug Administration approved the company's new treatment for frown lines. The injection called Daxxify is the newest botulinum toxin to hit doctor's offices in the U.S.,PFE,0.073659,0.118007,Neutral
"U.S. FDA removes COVID test requirements for Pfizer, Merck pills",https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-removes-covid-test-requirements-pfizer-merck-pills-2023-02-01/,2023-02-01 18:32:41,"[1/2] Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration Feb 1 ( Reuters ) - The U.S. Food and Drug Administration ( FDA ) on Wednesday removed the need for a positive test for COVID-19 treatments from Pfizer Inc ( PFE.N ) and Merck & Co Inc ( MRK.N ) .",PFE,0.504646,0.2342,Somewhat-Bullish
What the end of the government's COVID emergency could cost you,https://www.marketwatch.com/story/what-the-end-of-the-governments-covid-emergency-could-cost-you-11675275771,2023-02-01 18:22:00,What might happen now that Uncle Sam is poised to trim assistance for the neediest among us?,PFE,0.050359,0.052527,Neutral
An Increase In Investments In The R&D Of Autoimmune Disease Drugs Is Expected To Drive The Autoimmune Treatment Market As Per The Business Research Company's Autoimmune Treatment Global Market Report 2023,https://www.benzinga.com/pressreleases/23/02/g30671480/an-increase-in-investments-in-the-r-d-of-autoimmune-disease-drugs-is-expected-to-drive-the-autoimm,2023-02-01 16:30:00,"LONDON, Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the ""Autoimmune Treatment Market"" forecasts the global autoimmune treatment market size to grow from $6 billion in 2022 to $6.8 billion in 2023 at a compound annual growth rate ( CAGR ) of more than 12%.",PFE,0.050572,-0.049564,Neutral
"Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others",https://www.zacks.com/stock/news/2047789/drugbiotech-stocks-q4-earnings-due-on-feb-2-gild-mrk-others,2023-02-01 15:44:00,Let's look at the four biotech/pharma companies slated to release quarterly results on Feb 2.,PFE,0.086713,-0.138191,Neutral
"MSNBC Host Vossoughian Suffers Myocarditis After Common Cold, Yet Covid-19 Vaccine Claims Spread",https://www.forbes.com/sites/brucelee/2023/02/01/msnbc-host-vossoughian-suffers-myocarditis-after-common-cold-anti-vaxxers-spread-unfounded-claims/,2023-02-01 15:16:33,NBC's Yasmin Vossoughian told viewers why she hasn't been on air for a few weeks and described what had happened.,PFE,0.038717,-0.036528,Neutral
One in five S&P500 CEOs worked for P&G or GE early in their career,https://www.prnewswire.com/news-releases/one-in-five-sp500-ceos-worked-for-pg-or-ge-early-in-their-career-301736211.html,2023-02-01 14:45:00,"Altrata expands Executive Leadership Series with new report which examines the experience, characteristics, and priorities of global CEOs NEW YORK, Jan. 31, 2023 /PRNewswire/ -- Today Altrata released The Role of the CEO 2023 which examines CEOs of public and private companies across 20 major ...",PFE,0.053035,0.037888,Neutral
A Bullish Outlook Helped This Medical Giant To Surge,https://www.investors.com/news/technology/tmo-stock-bsx-stock-q4-2022-earnings/,2023-02-01 14:28:00,TMO Pops On Its Bullish Outlook As BSX Stock Rises On In-Line ... Investor's Business Daily ...,PFE,0.124809,-0.340275,Somewhat-Bearish
"Company News for Feb 1, 2023",https://www.zacks.com/stock/news/2047619/company-news-for-feb-1-2023,2023-02-01 14:20:00,"Companies in The News Are: XOM, PFE, GM, CAT.",PFE,0.595343,0.451143,Bullish
3 Pharma Giants Reported - But A Mixed Bag Sent 1 Diving,https://www.investors.com/news/technology/gsk-stock-novartis-stock-nvo-stock-q4-2022-earnings/,2023-02-01 14:16:00,"GSK Stock, NVO Stock Inch Higher On Wide Beat, But Novartis ... Investor's Business Daily ...",PFE,0.109455,-0.323633,Somewhat-Bearish
AMD To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Wednesday,https://www.benzinga.com/news/23/02/30665430/amd-to-rally-over-26-here-are-10-other-analyst-forecasts-for-wednesday,2023-02-01 13:10:47,"Credit Suisse boosted the price target for Mondelez International, Inc. MDLZ from $70 to $76. Credit Suisse analyst Robert Moskow maintained an Outperform rating. Mondelez shares rose 1.8% to $66.61 in pre-market trading. Oppenheimer raised the price target for Amdocs Limited DOX from $94 to $99.",PFE,0.287762,-0.18235,Somewhat-Bearish
"S&P 500 Jumps 1.5%, Market Volatility Decreases",https://www.benzinga.com/news/earnings/23/02/30662443/s-p-500-jumps-1-5-market-volatility-decreases,2023-02-01 11:11:51,US stocks closed higher on Tuesday following the release of several earnings reports. Caterpillar Inc. CAT shares fell 3.5% on Tuesday after the company reported worse-than-expected Q4 adjusted EPS results. Pfizer Inc.,PFE,0.366061,0.334554,Somewhat-Bullish
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell,https://www.fool.com/investing/2023/02/01/1-reason-to-buy-novavax-in-2023-2-reasons-to-sell/,2023-02-01 11:00:00,Novavax shares sank 93% last year.,PFE,0.052685,0.056012,Neutral
Pfizer  ( PFE )  Reports Q4 Earnings: What Key Metrics Have to Say,https://www.zacks.com/stock/news/2047351/pfizer-pfe-reports-q4-earnings-what-key-metrics-have-to-say,2023-02-01 08:54:00,"The headline numbers for Pfizer (PFE) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",PFE,0.310843,0.109973,Neutral
Novartis continues to grow with further core margin expansion and achieves important innovation milestones,https://www.globenewswire.com/news-release/2023/02/01/2599088/0/en/Novartis-continues-to-grow-with-further-core-margin-expansion-and-achieves-important-innovation-milestones.html,2023-02-01 06:00:00,Ad hoc announcement pursuant to Art. 53 LR ...,PFE,0.011046,0.090228,Neutral
Pfizer  ( PFE )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/01/31/pfizer-pfe-q4-2022-earnings-call-transcript/,2023-02-01 00:00:18,"PFE earnings call for the period ending December 31, 2022.",PFE,0.053637,0.150887,Somewhat-Bullish
Pfizer CEO Says Covid Cases Will Rise. So Will Sales.,https://www.barrons.com/articles/pfizer-vaccine-sales-covid-infections-51675202609,2023-01-31 23:08:00,Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales. ...,PFE,0.535653,0.381584,Bullish
"Markets Close Well into the Green; AMD, SNAP Report Q4",https://www.zacks.com/stock/news/2047296/markets-close-well-into-the-green-amd-snap-report-q4,2023-01-31 23:04:00,"The Dow gained +356 points, +1.06%. the S&P 500 reached +1.48%. and the tech-heavy Nasdaq rose +191 points, +1.68% for the session.",PFE,0.140076,0.100659,Neutral
Edwards Narrowly Tops Fourth-Quarter Views; Shares Pop,https://www.investors.com/news/technology/ew-stock-edwards-lifesciences-earnings-q4-2022/,2023-01-31 21:20:00,EW Stock Pops After Medical Devices Giant Beats Quarterly Views Investor's Business Daily ...,PFE,0.227007,-0.480668,Bearish
The Key Element Missing From Amgen's 2023 Outlook,https://www.investors.com/amgen-stock-amgen-earning-q4-2022/,2023-01-31 21:15:00,"Amgen Stock Dips On Mixed Quarterly Report, Light Guidance ... Investor's Business Daily ...",PFE,0.071784,-0.297026,Somewhat-Bearish
"Amgen Sinks On Mixed Earnings, Light Outlook",https://www.investors.com/news/technology/amgen-stock-amgen-earning-q4-2022/,2023-01-31 21:15:00,"Amgen Stock Dips On Mixed Quarterly Report, Light Guidance Investor's Business Daily ...",PFE,0.214937,-0.463803,Bearish
What Happens This Week Will Lead the Market for 2023,https://www.zacks.com/stock/news/2047236/what-happens-this-week-will-lead-the-market-for-2023,2023-01-31 19:41:00,"From big tech earnings to employment data and interest rate decisions, this is an extremely significant week for Wall Street ...",PFE,0.137083,0.074607,Neutral
Dow Surges Over 200 Points; Pfizer Issues Weak Forecast,https://www.benzinga.com/news/earnings/23/01/30650770/dow-surges-over-200-points-pfizer-issues-weak-forecast,2023-01-31 19:36:33,"U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.63% to 33,931.13 while the NASDAQ rose 1.20% to 11,529.99. The S&P 500 also rose, gaining, 0.93% to 4,055.00. Materials shares rose by 1.7% on Tuesday.",PFE,0.155786,0.019232,Neutral
The end of the Covid health emergency won't slow FDA clearance of shots and treatments,https://www.cnbc.com/2023/01/31/covid-fda-clearance-of-covid-shots-and-treatments-wont-slow-with-end-of-public-health-emergency.html,2023-01-31 18:32:32,"The FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines.",PFE,0.155954,-0.130232,Neutral
Pfizer's COVID revenues have dropped off along with attention to the pandemic,https://www.marketwatch.com/story/pfizers-covid-revenues-have-dropped-off-along-with-attention-to-the-pandemic-11675188980,2023-01-31 18:16:00,Wall Street urged Pfizer to lower its COVID revenue estimates. The company did - but it's still betting on higher demand for its vaccine and antiviral by 2025.,PFE,0.944494,-0.175575,Somewhat-Bearish
PFE: 3 Stocks That Could Help You Beat the Market in 2023,https://stocknews.com/news/pfe-rio-lmt-3-stocks-that-could-help-you-beat-the-market-in/,2023-01-31 18:03:38,PFE: 3 Stocks That Could Help You Beat the Market in ...,PFE,0.249531,0.171492,Somewhat-Bullish
"AbbVIe's Two-Decade Humira Monopoly Ends; So, What's Next?",https://www.investors.com/news/technology/abbvie-stock-the-20-year-humira-monopoly-ends-so-what-is-next/,2023-01-31 17:12:00,"AbbVie Stock: The 20-Year Humira Monopoly Ends. So, What's Next ... Investor's Business Daily ...",PFE,0.217508,-0.047492,Neutral
Stock Market Eyes Fear Gauge Ahead Of Fed; This Biotech Nears Major Breakout: AMD Could Sink Chips,https://www.investors.com/market-trend/stock-market-today/stock-market-firm-but-fear-gauge-rises-amd-could-sink-chips-mcdonalds-caterpillar-sell-off/,2023-01-31 16:57:00,Stock Market Eyes Fear Gauge Ahead Of Fed. This Biotech Nears ... Investor's Business Daily ...,PFE,0.087185,0.001057,Neutral
"Waiting for Powell: As Fed Meeting Starts, Investors Parse Mixed Q4 Earnings and Consider What's Next for Rates",https://www.benzinga.com/news/earnings/23/01/30647013/waiting-for-powell-as-fed-meeting-starts-investors-parse-mixed-q4-earnings-and-consider-whats-next-,2023-01-31 16:33:28,"( Tuesday Market Open ) With three major central banks releasing rate decisions starting tomorrow, investors might be wise to expect subdued trading Tuesday following a sell-off to start the week.",PFE,0.03319,0.015717,Neutral
Pfizer Bids Adieu to Covid Boom Years,https://www.wsj.com/articles/pfizer-bids-adieu-to-covid-boom-years-11675182828,2023-01-31 16:33:00,"The drug company's financial bonanza from Covid-19 is fading, putting pressure on management to deliver new avenues of growth.",PFE,0.760593,-0.45922,Bearish
Employment Cost Index Comes in Lowest Since Q4 2021,https://www.zacks.com/stock/news/2047106/employment-cost-index-comes-in-lowest-since-q4-2021,2023-01-31 16:06:00,"Pre-market futures have fought back from triple-digit deficits on some better-than-expected earnings results ahead of the bell and another inflation metric ticking down favorably. At this hour, the Dow is +35 points, the S&P 500 is +7 and the Nasdaq +10 points.",PFE,0.193465,0.07295,Neutral
Earnings Season In Full Swing,https://www.benzinga.com/markets/asia/23/01/30646358/earnings-season-in-full-swing,2023-01-31 16:01:06,"ChatGPT creator OpenAI has quietly hired hundreds of international contractors to train its AI tech. Paving the way to replace some software engineers. Since the Trump days, sales have been limited needing government approval Internal demand strong and external demand weak",PFE,0.301315,-0.376762,Bearish
"Top Stories Tuesday, Jan. 31",https://www.benzinga.com/general/biotech/23/01/30644231/sony-scales-back-playstation-vr2-output-sam-bankman-fried-attempted-to-regain-control-of-ftx-whit,2023-01-31 16:00:37,"Sony Group Corp SONY has reportedly slashed its forecast for shipments of the PlayStation VR2 scheduled to go on sale on Feb. 22. Sony has reduced the production of its much-hyped PlayStation VR2, given its pre-orders were much lower than anticipated.",PFE,0.121856,0.05452,Neutral
"Pfizer  ( PFE )  Q4 Earnings Top, 2023 View Disappoints, Stock Down",https://www.zacks.com/stock/news/2047097/pfizer-pfe-q4-earnings-top-2023-view-disappoints-stock-down,2023-01-31 15:49:00,Pfizer (PFE) beats estimates for Q4 earnings and sales. Its 2023 financial outlook falls short of expectations. Stock down in pre-market trading.,PFE,0.43852,0.183746,Somewhat-Bullish
The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion,https://www.cnbc.com/2023/01/31/the-covid-pandemic-drives-pfizers-2022-revenue-to-a-record-100-billion.html,2023-01-31 15:41:45,Sales of Paxlovid surged to $18.9 billion in 2022 which was the first full-year that the antiviral pill was available.,PFE,0.307924,0.027345,Neutral
The Covid sales boom is over for Pfizer | Business,https://edition.cnn.com/2023/01/31/investing/pfizer-earnings-covid-vaccine-paxlovid/index.html,2023-01-31 15:41:00,The Covid sales boom is over for Pfizer CNN International ...,PFE,0.930468,0.253579,Somewhat-Bullish
The Covid sales boom is over for Pfizer | Business,https://www.cnn.com/2023/01/31/investing/pfizer-earnings-covid-vaccine-paxlovid/index.html,2023-01-31 15:41:00,The Covid sales boom is over for ...,PFE,0.930468,0.253579,Somewhat-Bullish
"Best January in 4 Years Heads for Its Close; XOM, CAT, GM & More Report",https://www.zacks.com/stock/news/2047090/best-january-in-4-years-heads-for-its-close-xom-cat-gm-more-report,2023-01-31 15:37:00,"The Q4 Employment Cost Index reported +1.0% on headline, dow 10 bps from the +1.1% expected and the +1.2% we saw the previous quarter.",PFE,0.175859,0.107882,Neutral
US Stocks Rise As Markets Digest Company Earnings,https://www.barrons.com/amp/news/us-stocks-rise-as-markets-digest-company-earnings-01675178108,2023-01-31 15:16:53,"Wall Street stocks ticked up Tuesday as investors took in major earnings reports and girded for central bank interest rate decisions this week. Construction equipment manufacturer Caterpillar released mixed fourth quarter results before the opening bell, highlighting that rising transport and ...",PFE,0.136888,-0.025178,Neutral
Pfizer Expects Covid Vaccine And Pill Revenues Will Fall 60% In 2023,https://www.forbes.com/sites/dereksaul/2023/01/31/pfizer-expects-covid-vaccine-and-pill-revenues-will-fall-60-in-2023/,2023-01-31 14:44:58,Shares of the pharmaceutical giant fell Tuesday as investors respond to lower projected sales for Pfizer's core products combatting Covid-19.,PFE,0.895969,-0.38588,Bearish
Why BioNTech And Moderna Shares Are Falling After Pfizer News,https://www.benzinga.com/news/23/01/30643922/why-biontech-and-moderna-shares-are-falling-after-pfizer-news,2023-01-31 14:30:29,"BioNTech SE - ADR BNTX and Moderna Inc MRNA shares are trading lower Tuesday morning in sympathy with Pfizer Inc. PFE after the company issued FY23 guidance below estimates. Also, the Biden Administration said it plans to end COVID-19 emergency declarations on May 11.",PFE,0.83383,-0.008312,Neutral
Most Important Week Of Earnings Season Is Here - Will S&P 500 Companies Continue Beating Wall Street Estimates?,https://www.benzinga.com/news/earnings/23/01/30640585/most-important-week-of-earnings-season-is-here-will-s-p-500-companies-continue-beating-wall-street-,2023-01-31 14:13:54,"Earnings season is in full swing, with 35% of companies in the S&P 500 reporting this week. Company performance through the fourth quarter of 2022 will lend a clearer view into the general state of the U.S. economy after an almost full year of Fed interest rate hikes.",PFE,0.188193,0.0,Neutral
"Global Cytotoxic Drugs Market Predicted to Generate a Revenue of $14,885.2 Million and Grow at a CAGR of 1.2% during the Analysis Timeframe from 2021 to 2028 [202-Pages] | Issued by Research Dive",https://www.benzinga.com/pressreleases/23/01/g30643164/global-cytotoxic-drugs-market-predicted-to-generate-a-revenue-of-14-885-2-million-and-grow-at-a-ca,2023-01-31 14:02:00,"New York, USA, Jan. 31, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Research Dive, the global cytotoxic drugs market is anticipated to generate a revenue of $14,885.2 million and rise at a CAGR of 1.2% over the estimated timeframe from 2021 to 2028.",PFE,0.059341,0.009022,Neutral
Futures Fall Ahead Of Fed Meeting; 9 Key Earnings Movers,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-fed-meeting-caterpillar-exxon-pfizer-mcdonalds-report-earnings/,2023-01-31 13:55:00,Dow Jones Futures Reverse Ahead Of Fed Meeting. Caterpillar ... Investor's Business Daily ...,PFE,0.074537,-0.070496,Neutral
Pfizer's Covid Cliff Is Here - What To Expect For 2023,https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q4-2022/,2023-01-31 13:52:00,Pfizer stock dropped on Tuesday after the pharma giant said it expects earnings and sales to plunge by double digits due to a dropoff in Covid-related revenue. The drug giant reported adjusted earnings of $1.14 per share on $24.29 billion in sales.,PFE,0.970877,0.222892,Somewhat-Bullish
Biggest Earnings Week of the Season: Key Stocks to Watch,https://www.zacks.com/commentary/2046491/biggest-earnings-week-of-the-season-key-stocks-to-watch,2023-01-31 13:50:00,"This week is undoubtedly the most important week of earnings season. Andrew Rocco highlights key industries to watch including big tech, biotech, and energy.",PFE,0.137278,0.023538,Neutral
Pfizer predicts bigger-than-expected sales drop for two key products,https://www.business-standard.com/article/companies/pfizer-predicts-bigger-than-expected-sales-drop-for-two-key-products-123013101407_1.html,2023-01-31 13:32:00,"Pfizer surprised Wall Street with a prediction for a bigger-than-expected sales drop this year for two key products: its COVID-19 vaccine and treatment. The drugmaker also released an earnings forecast that is below analyst expectations, sending shares lower before the opening bell Tuesday.",PFE,0.798255,-0.06023,Neutral
Biden Administration Plans To End COVID-19 Public Health Emergency In May,https://www.benzinga.com/general/biotech/23/01/30636173/biden-administration-plans-to-end-covid-19-public-health-emergency-in-may,2023-01-31 13:26:37,"The Biden administration will allow the ongoing Covid-19 emergency declarations to end on May 11, the White House announced on Monday, as the U.S. shifts away from responding to the pandemic as a national crisis and instead manage the virus more like a seasonal respiratory disease.",PFE,0.299478,0.0,Neutral
Why Pfizer  ( PFE )  Shares Are Trading Lower Premarket Today,https://www.benzinga.com/general/biotech/23/01/30639700/pfizer-beats-q4-earnings-issues-underwhelming-2023-guidance,2023-01-31 13:24:11,"Pfizer Inc PFE has reported a Q4 adjusted EPS of $1.14, up 45% Y/Y, well ahead of the consensus of $1.05. The company achieved revenues of $24.29 billion, up 2% and 13% on an operational basis, marginally missing the Wall Street estimate of $24.32 billion.",PFE,0.87799,0.094403,Neutral
Pfizer  ( PFE )  Q4 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2046833/pfizer-pfe-q4-earnings-and-revenues-beat-estimates,2023-01-31 13:15:09,"Pfizer (PFE) delivered earnings and revenue surprises of 10.68% and 0.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.404563,0.146695,Neutral
Stock Market Today: Stocks Navigate Earnings Wave With Fed In Focus; IMF Boots Global Growth Forecast,https://www.thestreet.com/markets/stock-market-today-stocks-navigate-earnings-wave-fed-in-focus,2023-01-31 13:15:00,Wall Street is set to open modestly lower Tuesday as investors sort through a wave of corporate earnings ahead of tomorrow's crucial Fed rate decision.,PFE,0.164468,0.353821,Bullish
"Stocks making the biggest moves premarket: McDonald's, UPS, General Motors and more",https://www.cnbc.com/2023/01/31/stocks-making-the-biggest-moves-premarket-mcdonalds-ups-and-more.html,2023-01-31 13:10:12,These are the stocks posting the largest moves before the bell.,PFE,0.137278,0.031537,Neutral
Pfizer expects 2023 sales to decline by as much as 33% compared with record-breaking 2022,https://www.cnbc.com/2023/01/31/pfizer-pfe-q4-earnings-2022.html,2023-01-31 13:02:05,"The pharmaceutical company booked $100.3 billion for full-year 2022, an all-time high.",PFE,0.29234,0.02429,Neutral
4 Discounted Dividend Stocks To Buy In February 2023,https://www.fool.com/investing/2023/01/31/4-discounted-dividend-stocks-to-buy-in-february-20/,2023-01-31 13:02:00,All four of these Dividend stocks pay a safe and growing dividend ...,PFE,0.751437,0.691078,Bullish
"Futures drop as earnings roll in, Fed rate decision in focus",https://www.reuters.com/markets/us/futures-drop-earnings-roll-fed-rate-decision-focus-2023-01-31/,2023-01-31 12:52:14,"Jan 31 ( Reuters ) - U.S. stock index futures fell on Tuesday as disappointing earnings and forecasts from bellwethers including Caterpillar, McDonald's and Pfizer set the tone for the busiest earnings week this season, ahead of the outcome of the Federal Reserve's rate-setting meeting.",PFE,0.215894,-0.227263,Somewhat-Bearish
Pfizer Stock Slides As Soft Covid Vaccine Sales Outlook Mars Q4 Earnings Beat,https://www.thestreet.com/markets/pfizer-stock-slides-as-soft-covid-vaccine-outlook-mars-profit-beat,2023-01-31 12:50:00,"""As we turn to 2023, we expect to once again set records, with potentially the largest number of new product and indication launches that we've ever had in such a short period of time,"" said CEO Albert Bourla.",PFE,0.651499,0.237699,Somewhat-Bullish
Pfizer Expects Drop in Revenue as Vaccine Demand Wanes,https://www.wsj.com/articles/pfizer-pfe-4q-earnings-report-2023-11675168771,2023-01-31 12:40:00,The drugmaker said revenue from Covid-19 products is slated to reach a low point this year due to a significant government stockpile on hand.,PFE,0.95919,-0.288986,Somewhat-Bearish
Global Precision Medicine Market Competitive Landscape and Trends - By The Business Research Company,https://www.prnewswire.com/news-releases/global-precision-medicine-market-competitive-landscape-and-trends--by-the-business-research-company-301734691.html,2023-01-31 12:37:00,Global Precision Medicine Market Competitive Landscape and ... PR ...,PFE,0.05749,0.040957,Neutral
"Pfizer tops 4Q expectations, starts low with 2023 forecast",https://apnews.com/article/pfizer-inc-earnings-covid-business-782a97d75a95022dec08e933d926bd93,2023-01-31 12:12:24,COVID-19 vaccine booster shots and treatments for the virus helped push Pfizer to a better-than-expected final quarter of 2022. The drugmaker also debuted on Tuesday a 2023 forecast that starts off well below Wall Street forecasts.,PFE,0.841981,0.207986,Somewhat-Bullish
Drugmaker Pfizer starts low with 2023 earnings forecast,https://apnews.com/article/pfizer-inc-earnings-covid-business-782a97d75a95022dec08e933d926bd93,2023-01-31 12:12:24,"Pfizer surprised Wall Street by predicting a bigger-than-expected sales drop this year for two key products: its COVID-19 vaccine and treatment. The drugmaker also released an earnings forecast that starts off below analyst expectations, sending shares lower after markets opened Tuesday.",PFE,0.792512,-0.06043,Neutral
Drugmaker Pfizer starts low with 2023 earnings forecast,https://apnews.com/article/pfizer-inc-earnings-covid-business-782a97d75a95022dec08e933d926bd93,2023-01-31 12:12:24,Pfizer surprised Wall Street by predicting a bigger-than-expected sales drop this year for two key products: its COVID-19 vaccine and treatment. The drugmaker also released on Tuesday an earnings forecast that starts off below analyst expectations as Pfizer begins what company leaders call a ...,PFE,0.66878,-0.14024,Neutral
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE,https://investingnews.com/pfizer-reports-record-full-year-2022-results-and-provides-full-year-2023-financial-guidance/,2023-01-31 11:56:04,Pfizer Inc. ( NYSE: PFE ) reported exceptional financial results for fourth-quarter and full-year 2022 and provided 2023 financial guidance ( 4 ) . The fourth-quarter 2022 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to Pfizer's ...,PFE,0.264061,0.187127,Somewhat-Bullish
This newsletter editor has been recommending stocks and bonds this year and says the rally has room to run,https://www.marketwatch.com/story/this-newsletter-editor-has-been-recommending-stocks-and-bonds-this-year-and-says-the-rally-has-room-to-run-11675165998,2023-01-31 11:53:00,"Our contrarian call of the day from founder and editor-in-chief of The Kobeissi Letter, Adam Kobeissi is not buying any of the market angst on Wall Street right now.",PFE,0.087503,-0.065551,Neutral
Pfizer forecasts 2023 sales of COVID products below estimates,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-forecasts-2023-sales-covid-products-below-estimates-2023-01-31/,2023-01-31 11:51:00,"Jan 31 ( Reuters ) - Pfizer Inc ( PFE.N ) on Tuesday forecast 2023 sales of its COVID-19 products of $21.5 billion that fell short of Wall Street expectations, hit by lower demand in international markets and slower uptake of booster vaccines.",PFE,0.247838,-0.373834,Bearish
These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts,https://www.benzinga.com/news/23/01/30638598/these-3-healthcare-stocks-with-over-3-dividend-yields-are-recommended-by-benzingas-most-accurate-ana,2023-01-31 11:47:05,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",PFE,0.109956,0.0,Neutral
"Nasdaq, S&P Futures Lower As Powell & Team Kick Off 2-Day Fed Meeting: Analyst Says Positive January Harbinger Of Good Times",https://www.benzinga.com/news/earnings/23/01/30636919/nasdaq-s-p-futures-lower-as-powell-team-kick-off-2-day-fed-meeting-analyst-says-positive-january-ha,2023-01-31 11:37:36,Trading in the major U.S. index futures suggests stocks may extend their losses for a second straight session. Caution will likely be the watchword as Fed Chairman Jerome Powell and his team kickstart a two-day monetary policy meeting on Tuesday.,PFE,0.10607,0.0,Neutral
"Stocks Edge Lower, Samsung, Medicare, Exxon and AMD In Focus - Five Things To Know",https://www.thestreet.com/markets/stocks-edge-lower-samsung-medicare-exxon-amd-5-things-to-know,2023-01-31 10:12:00,"Stock futures lower as Fed decision looms, earnings in focus. Samsung confirms weakest quarterly profit in eight years, maintains capex plans. UnitedHealth, Humana slide as Medicare plans overpayment clawback. Exxon earnings on deck after Chevron miss and AMD earnings in focus as chip sector ...",PFE,0.058976,0.0,Neutral
"General Motors, McDonald's And 3 Stocks To Watch Heading Into Tuesday",https://www.benzinga.com/news/earnings/23/01/30636013/general-motors-mcdonalds-and-3-stocks-to-watch-heading-into-tuesday,2023-01-31 09:01:16,"With US stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects General Motors Company GM to post quarterly earnings at $1.69 per share on revenue of $40.65 billion before the opening bell.",PFE,0.518022,0.41038,Bullish
Biden Administration Will End Covid-19 Emergency Declarations On May 11,https://www.forbes.com/sites/siladityaray/2023/01/31/biden-administration-will-end-covid-19-emergency-declarations-on-may-11/,2023-01-31 08:07:48,The end of the Covid-19 emergency is likely to end wide access to free vaccines and tests.,PFE,0.117486,-0.121299,Neutral
Investor Optimism Declines Ahead Of Fed's Rate Decision,https://www.benzinga.com/news/earnings/23/01/30635788/investor-optimism-declines-ahead-of-feds-rate-decision,2023-01-31 08:02:45,"The CNN Money Fear and Greed index showed some decline in overall sentiment among US investors. US stocks settled lower on Monday, as investors awaited big corporate earnings results and interest-rate decision from the Federal Reserve this week.",PFE,0.371523,0.0,Neutral
Exclusive: Marketing tech firm Constellation raises $15 million,https://www.axios.com/pro/media-deals/2023/02/01/constellation-newlight-partners,2023-01-31 08:00:00,Constellation raises $15 million to grow marketing tech platform ...,PFE,0.138464,-0.034763,Neutral
Prez Biden to end Covid-19 twin national emergencies in US on May 11,https://www.business-standard.com/article/international/prez-biden-to-end-covid-19-twin-national-emergencies-in-us-on-may-11-123013100080_1.html,2023-01-31 01:39:00,Prez Biden to end Covid-19 twin national emergencies in US on ... Business Standard ...,PFE,0.054983,0.005002,Neutral
President Biden to end COVID-19 emergencies on May 11,https://apnews.com/article/biden-united-states-government-district-of-columbia-covid-public-health-2a80b547f6d55706a6986debc343b9fe,2023-01-31 00:22:29,"President Joe Biden talks with reporters on the South Lawn of the White House in Washington, Monday, Jan. 30, 2023, after returning from an event in Baltimore on infrastructure. ( AP Photo/Susan Walsh )",PFE,0.036869,0.004892,Neutral
President Biden to end COVID-19 emergencies on May 11,https://apnews.com/article/biden-united-states-government-district-of-columbia-covid-public-health-2a80b547f6d55706a6986debc343b9fe,2023-01-31 00:02:21,"President Joe Biden talks with reporters on the South Lawn of the White House in Washington, Monday, Jan. 30, 2023, after returning from an event in Baltimore on infrastructure. ( AP Photo/Susan Walsh )",PFE,0.041466,0.004947,Neutral
'Our two-year stay-back visa helps start careers' | The Financial Express,https://www.financialexpress.com/industry/our-two-year-stay-back-visa-helps-start-careers/2986170/,2023-02-19 22:05:00,'Our two-year stay-back visa helps start careers' The Financial Express ...,PFE,0.087824,0.129095,Neutral
"BioNTech sees UK trials on cancer vaccines starting this year, paper says",https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-sees-uk-trials-cancer-vaccines-starting-this-year-paper-2023-02-19/,2023-02-19 13:16:00,"BioNTech sees UK trials on cancer vaccines starting this year, paper ... ...",PFE,0.214937,-0.253171,Somewhat-Bearish
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later,https://www.fool.com/investing/2023/02/18/3-dirt-cheap-stocks-to-buy-sooner-rather-than-late/,2023-02-18 13:14:00,These pharmaceutical stocks probably won't stay so attractively valued for too much longer.,PFE,0.451494,-0.118052,Neutral
"Insider traders have cooked up a new way to leverage secrets, investing at least $3 billion. It's not illegal - but it's probably not making them much money, either.",https://africa.businessinsider.com/markets/insider-traders-have-cooked-up-a-new-way-to-leverage-secrets-investing-at-least/xc4t83m,2023-02-18 10:00:00,Insider traders have cooked up a new way to leverage secrets ... - Business Insider Africa ...,PFE,0.092213,-0.014069,Neutral
The Commercialization of Covid Vaccines Is Coming. Here's What It Means.,https://www.barrons.com/articles/commercialization-of-covid-vaccines-pandemic-emergency-moderna-pfizer-5b8f8046,2023-02-18 06:00:00,The Covid Public Health Emergency Is Ending. What It Means for Vaccine Prices. ...,PFE,0.039614,-0.016289,Neutral
Bladder Cancer Drugs Global Market Report 2023,https://www.prnewswire.com/news-releases/bladder-cancer-drugs-global-market-report-2023-301749125.html,2023-02-17 16:50:00,"NEW YORK, Feb. 17, 2023 /PRNewswire/ --Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, Hoffmann-La Roche, Novartis International and Johnson & Johnson.",PFE,0.031529,-0.124665,Neutral
Shockwave Med Obliterates Earnings Views With 991% Growth,https://www.investors.com/news/technology/swav-stock-earnings-skyrocket-blowing-away-projections/,2023-02-17 16:32:00,"SWAV Stock: Earnings Skyrocket 991%, Blowing Away Projections Investor's Business Daily ...",PFE,0.130217,-0.058294,Neutral
Pfizer Shuts Trial Sites for Lyme Disease Jab After Standards Breaches,https://www.barrons.com/articles/pfizer-lyme-disease-trial-closed-shut-vaccine-valneva-38a8b108,2023-02-17 15:24:00,Pfizer Shuts Trial Sites for Lyme Disease Jab After Standards ... ...,PFE,0.608634,-0.007175,Neutral
"Pfizer, Valneva Hit An Ethics Roadblock In Lyme Disease Test",https://www.investors.com/news/technology/valneva-stock-plummets-as-pfizer-partnered-lyme-disease-study-hits-a-roadblock/,2023-02-17 15:20:00,Valneva Stock Plummets As Pfizer-Partnered Lyme Disease Study ... Investor's Business Daily ...,PFE,0.744851,0.102482,Neutral
"Pfizer, Alphabet And This ETF: CNBC's 'Final Trades' - Alphabet  ( NASDAQ:GOOGL ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/02/30956098/pfizer-alphabet-and-this-etf-cnbcs-final-trades,2023-02-17 13:34:09,"On CNBC's ""Halftime Report Final Trades,"" Jenny Harrington of Gilman Hill Asset Management said Pfizer Inc. PFE has a 3.8% yield and is trading at 12 times earnings. Joshua Brown of Ritholtz Wealth Management said Vanguard Real Estate Index Fund ETF VNQ has 3.5% yield ""with upside.""",PFE,0.582526,0.185366,Somewhat-Bullish
"Pharma Stock Roundup: FDA Nod to PFE Cibinqo for Adolescents, Updates From NVO, RHHBY",https://www.zacks.com/stock/news/2055787/pharma-stock-roundup-fda-nod-to-pfe-cibinqo-for-adolescents-updates-from-nvo-rhhby,2023-02-17 13:33:00,FDA approves Pfizer's (PFE) Cibinqo for adolescent patients. Roche (RHHBY) announces new positive data from phase III studies on Vabysmo for vision loss associated with retinal vein occlusion.,PFE,0.202932,0.047959,Neutral
10 dividend stocks with yields as high as 6.5% from a value manager with a strong track record,https://www.marketwatch.com/story/10-dividend-stocks-with-yields-as-high-as-6-5-from-a-value-manager-with-a-strong-track-record-c85ee360,2023-02-17 13:24:00,"John Buckingham of The Prudent Speculator offers stock picks for investors who share his ""passion for value investing."" ...",PFE,0.103331,0.12143,Neutral
Jasper Therapeutics Appoints Industry Veteran Vishal Kapoor to its Board of Directors,https://www.globenewswire.com/news-release/2023/02/17/2610657/0/en/Jasper-Therapeutics-Appoints-Industry-Veteran-Vishal-Kapoor-to-its-Board-of-Directors.html,2023-02-17 13:20:00,"REDWOOD CITY, Calif., Feb. 17, 2023 ( GLOBE NEWSWIRE ) -- Jasper Therapeutics, Inc. ( Nasdaq: JSPR ) ( Jasper ) , a biotechnology company focused on developing novel antibody therapies targeting c-Kit ( CD117 ) to address diseases such as chronic spontaneous urticaria and lower to intermediate ...",PFE,0.037563,0.08106,Neutral
Jasper Therapeutics Appoints Industry Veteran Vishal Kapoor to its Board of Directors - Jasper Therapeutics  ( NASDAQ:JSPR ) ,https://www.benzinga.com/pressreleases/23/02/g30959154/jasper-therapeutics-appoints-industry-veteran-vishal-kapoor-to-its-board-of-directors,2023-02-17 13:20:00,"REDWOOD CITY, Calif., Feb. 17, 2023 ( GLOBE NEWSWIRE ) -- Jasper Therapeutics, Inc.",PFE,0.03642,0.079756,Neutral
"Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/02/30959062/pfizerbiontech-get-ready-for-london-court-battle-with-moderna-over-covid-19-vaccine-patents,2023-02-17 13:17:26,"A High Court battle between Pfizer Inc PFE, its partner BioNTech SE BNTX locked in a dispute with the rival COVID-19 vaccine maker Moderna Inc MRNA over patents for vaccine technology is set to be heard in London next year. In August, Moderna filed patent infringement lawsuits against ...",PFE,0.906257,-0.375728,Bearish
The Patent Cliff Is Coming For Bristol Myers - Here's What It's Planning For 2023,https://www.investors.com/news/technology/bmy-stock-can-its-new-products-fill-the-looming-patent-cliff-gap/,2023-02-17 13:00:00,BMY Stock: Can Its New Products Fill The Looming Patent-Cliff Gap? Investor's Business Daily ...,PFE,0.081691,-0.156708,Somewhat-Bearish
JNJ: The 3 Best Stocks to Buy Now for Long-Term Investors,https://stocknews.com/news/jnj-pfe-wmt-the-3-best-stocks-to-buy-now-for-long-term-investors/,2023-02-17 11:51:16,"Inflation for January 2023 increased 6.4% year-over-year, higher than the consensus estimate of 6.2%. Stubbornly high prices have increased the odds of continued rate hikes this year. Goldman Sachs expects the U.S. Federal Reserve to raise interest rates three more times in 2023 by 25 bps each.",PFE,0.240886,0.174228,Somewhat-Bullish
"Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate - Valneva  ( NASDAQ:VALN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/02/30956391/pfizer-valneva-discontinue-certain-trial-sites-for-phase-3-study-of-lyme-disease-vaccine-candidat,2023-02-17 10:47:56,"Pfizer Inc PFE and Valneva SE VALN announce that Pfizer, as the study sponsor, will discontinue a significant percentage of participants in the U.S. who had been enrolled in the VALOR Phase 3 study of a Lyme disease vaccine candidate, VLA15.",PFE,0.805127,0.431593,Bullish
Natural infection lowers risk of hospitalisation or death by 88 per cent for at least 10 months: Lancet study | The Financial Express,https://www.financialexpress.com/lifestyle/health/natural-infection-lowers-risk-of-hospitalisation-or-death-by-88-per-cent-for-at-least-10-months-lancet-study/2984641/,2023-02-17 10:17:54,Natural infection lowers risk of hospitalisation or death by 88 per ... The Financial Express ...,PFE,0.053629,-0.110215,Neutral
Pfizer and Valneva discontinue some trials on vaccine against Lyme disease,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-valneva-discontinue-some-trials-vaccine-against-lyme-disease-2023-02-17/,2023-02-17 06:21:16,Pfizer and Valneva discontinue some trials on vaccine against Lyme ... ...,PFE,0.795061,0.203256,Somewhat-Bullish
Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15,https://www.globenewswire.com/news-release/2023/02/17/2610346/0/en/Pfizer-and-Valneva-Issue-Update-on-Phase-3-Clinical-Trial-Evaluating-Lyme-Disease-Vaccine-Candidate-VLA15.html,2023-02-17 06:00:00,"New York & Saint-Herblain ( France ) , February 17, 2023 - Pfizer Inc. ( NYSE: PFE ) and Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) today announce that Pfizer, as the study sponsor, has decided to discontinue a significant percentage of participants in the U.S. who had been enrolled in the ...",PFE,0.53638,0.315872,Somewhat-Bullish
Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15,https://www.benzinga.com/pressreleases/23/02/g30955851/pfizer-and-valneva-issue-update-on-phase-3-clinical-trial-evaluating-lyme-disease-vaccine-candidat,2023-02-17 06:00:00,"New York & Saint-Herblain ( France ) , February 17, 2023 - Pfizer Inc. PFE and Valneva SE VALNVLA today announce that Pfizer, as the study sponsor, has decided to discontinue a significant percentage of participants in the U.S. who had been enrolled in the Vaccine Against Lyme for Outdoor ...",PFE,0.376509,0.285479,Somewhat-Bullish
Covid Infection Gives Similar Immunity To Vaccination: Study,https://www.barrons.com/news/covid-infection-gives-similar-immunity-to-vaccination-study-36641960,2023-02-16 23:36:22,"The protection against Covid-19 from being previously infected lasts at least as long as that offered by vaccination, one of the largest studies conducted on the subject said on Friday.",PFE,0.116348,0.203213,Somewhat-Bullish
"Black Professionals Working In Public Cannabis Companies To Create A More Equitable Industry - Acreage Holdings  ( OTC:ACRDF ) , Ayr Wellness  ( OTC:AYRWF ) ",https://www.benzinga.com/markets/cannabis/23/02/30953002/black-professionals-working-in-public-cannabis-companies-to-create-a-more-equitable-industry,2023-02-16 22:29:11,Troy Datcher is CEO & chairman of The Parent Company GRAMF who made history in August 2021 when he became the first Black CEO to lead a major publicly traded U.S. cannabis organization.,PFE,0.130217,0.0,Neutral
"Pfizer Releases Interim Update On PARP Inhibitor Combo Therapy For Prostate Cancer, Secures FDA Priority Review - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/02/30948190/pfizer-releases-interim-update-on-parp-inhibitor-combo-therapy-for-prostate-cancer-secures-fda-pr,2023-02-16 18:10:20,"Pfizer Inc PFE announced results from the Phase 3 TALAPRO-2 study of Talzenna ( talazoparib ) in combination with Xtandi ( enzalutamide ) in 1,106 patients with metastatic castration-resistant prostate cancer ( mCRPC ) .",PFE,0.800175,-0.168016,Somewhat-Bearish
Here's Why You Should Retain OPKO Health  ( OPK )  Stock for Now,https://www.zacks.com/stock/news/2055549/heres-why-you-should-retain-opko-health-opk-stock-for-now,2023-02-16 17:17:00,Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in RAYALDEE.,PFE,0.054857,0.217925,Somewhat-Bullish
PFE: 3 Cash-Rich Dividend Stocks to Add to Your Portfolio Today,https://stocknews.com/news/pfe-bhp-capl-3-cash-rich-dividend-stocks-to-add-to-your-portfolio-today/,2023-02-16 16:55:25,Inflation eased for the seventh consecutive month in January on an annualized basis. The Consumer Price Index rose 0.5% over the month and 6.4% year-over-year. The sequential rise in inflation follows the hotter-than-expected jobs data in January.,PFE,0.217416,0.072616,Neutral
"New Migraine Drug Offers Sufferers Hope Of 'Fast-Acting Relief' Via Nasal Spray, Pfizer Says",https://www.forbes.com/sites/roberthart/2023/02/16/new-migraine-drug-offers-sufferers-hope-of-fast-acting-relief-via-nasal-spray-pfizer-says/,2023-02-16 16:22:13,The FDA is expected to finish its review of the drug by the end of March.,PFE,0.439786,0.132985,Neutral
"Pfizer/BioNTech, Moderna gear up for 2024 London trial over COVID vaccine patents",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizerbiontech-moderna-gear-up-2024-london-trial-over-covid-vaccine-patents-2023-02-16/,2023-02-16 16:15:00,"Pfizer/BioNTech, Moderna gear up for 2024 London trial over ... ...",PFE,0.810649,-0.208539,Somewhat-Bearish
Eli Lilly recruits Black patients for Alzheimer trial as drugmakers seek more diversity in clinical studies,https://www.cnbc.com/2023/02/16/eli-lilly-recruits-black-patients-for-alzheimer-trial-as-drugmakers-seek-diversity-in-clinical-studies.html,2023-02-16 16:02:23,"Retailers CVS Health, Walgreens and Kroger have announced new initiatives to provide clinical trial enrollment and follow-up services in their pharmacy clinics.",PFE,0.046184,0.170303,Somewhat-Bullish
Moderna's COVID vaccine will remain free for all Americans in coup for Bernie Sanders,https://www.marketwatch.com/story/modernas-covid-vaccine-will-remain-free-for-all-americans-in-coup-for-bernie-sanders-703abbff,2023-02-16 15:41:00,Moderna Inc. will keep its COVID-19 vaccine available and free of charge for all people in the U.S. even after the public-health emergency ends.,PFE,0.111488,0.0,Neutral
Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2 Study - Investing News Network,https://investingnews.com/pfizer-announces-positive-talzenna-r-and-xtandi-r-combination-data-from-phase-3-talapro-2-study/,2023-02-16 15:39:50,Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2 Study Investing News Network ...,PFE,0.121762,0.084262,Neutral
PFE: The No. 1 Pharma Stock to Buy for the Long Haul,https://stocknews.com/news/pfe-nvo-nvs-alpmy-the-no-1-pharma-stock-to-buy-for-the-long/,2023-02-16 14:55:09,"Pharma giant Pfizer Inc. ( PFE ) has paid dividends for 12 consecutive years. Its dividend payouts have increased at a 5.5% CAGR over the past five years. Its current dividend yield is 3.79%, while its four-year average yield is 3.63%.",PFE,0.592978,0.226388,Somewhat-Bullish
Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation and its Symptoms,https://investingnews.com/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-and-its-symptoms/,2023-02-16 12:28:36,"Approximately 9.5 million people in the U.S. are projected to have AFib in 2023, with the number expected to rise to approximately 12.1 million by 2030; many ignore their symptoms, not realizing that AFib increases their risk of stroke by about five times",PFE,0.435385,0.244486,Somewhat-Bullish
Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the Acute Treatment of Migraine in Adults,https://investingnews.com/pfizer-announces-the-lancet-neurology-has-published-phase-3-data-for-zavegepant-for-the-acute-treatment-of-migraine-in-adults/,2023-02-16 12:08:43,"Pfizer Inc. ( NYSE: PFE ) today announced publication of results in The Lancet Neurology from the Phase 3 pivotal clinical trial of zavegepant, an investigational calcitonin gene-related peptide ( CGRP ) receptor antagonist nasal spray for the acute treatment of migraine.",PFE,0.240489,0.268085,Somewhat-Bullish
FDA advisors recommend over-the-counter use of life-saving opioid overdose treatment Narcan,https://www.cnbc.com/2023/02/15/opioid-overdose-treatment-narcan-recommended-by-fda-advisors-for-over-the-counter-use-.html,2023-02-15 21:02:27,"If the life-saving nasal spray Narcan is approved for over-the-counter use, people could buy it in supermarkets, convenience stores or even vending machines.",PFE,0.029802,-0.16635,Somewhat-Bearish
Moderna CEO Stephane Bancel will testify before Senate next month on Covid vaccine price hike,https://www.cnbc.com/2023/02/15/moderna-ceo-bancel-will-testify-before-senate-on-covid-vaccine-price-hike.html,2023-02-15 19:48:59,Moderna CEO Stephane Bancel will testify before the Senate health committee in March over the company's plans to hike the price of its Covid-19 vaccine. Sen.,PFE,0.073773,-0.177772,Somewhat-Bearish
"After IPO, Bausch + Lomb turns to an industry favorite to run the company",https://www.marketwatch.com/story/after-ipo-bausch-lomb-turns-to-an-industry-favorite-to-run-the-company-773e6a4f,2023-02-15 19:03:00,Bausch + Lomb's decision to bring back Brent Saunders as CEO hints at the company's broader ambitions in the global eye-care market.,PFE,0.16171,0.008283,Neutral
"EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue - Bayer  ( OTC:BAYRY ) , Curaleaf Holdings  ( OTC:CURLF ) ",https://www.benzinga.com/general/biotech/23/02/30915385/exclusive-how-to-lower-the-cost-of-cannabis-quality-and-save-30-of-your-top-line-revenue,2023-02-15 17:50:06,"Cannabis companies of all sizes are struggling to increase their profit margins and to make that happen, they're implementing different strategies. Lowering prices and premiumizing products are among the alternatives to create value.",PFE,0.06419,0.0,Neutral
Number of Americans with medical debt fell 18% between 2020 and 2022,https://www.marketwatch.com/story/number-of-americans-with-medical-debt-fell-18-between-2020-and-2022-thanks-to-covid-relief-funds-and-expanded-obamacare-report-finds-1426bd3d,2023-02-15 15:46:00,"The number of Americans with medical debt on their credit reports fell by 8.2 million, or about 18%, between 2020 and 2022.",PFE,0.056011,-0.106998,Neutral
These Are 3 of the Nasdaq's Cheapest Dividend Stocks,https://www.fool.com/investing/2023/02/15/these-are-3-of-the-nasdaqs-cheapest-dividend-stock/,2023-02-15 15:23:00,These stocks can be good options whether you value dividends or growth.,PFE,0.061003,0.0,Neutral
"Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul",https://www.fool.com/investing/2023/02/15/got-10000-buy-these-2-market-beating-etfs-for-the/,2023-02-15 14:37:00,These exchange-traded funds have soundly beaten the S&P 500 over the past 10 years.,PFE,0.063258,0.139111,Neutral
Armstrong World Industries Names Monica Maheshwari Senior Vice President of Human Resources,https://www.globenewswire.com/news-release/2023/02/15/2608777/0/en/Armstrong-World-Industries-Names-Monica-Maheshwari-Senior-Vice-President-of-Human-Resources.html,2023-02-15 14:00:00,"LANCASTER, Pa., Feb. 15, 2023 ( GLOBE NEWSWIRE ) -- Armstrong World Industries, Inc. ( NYSE:AWI ) , a leader in the design, innovation and manufacture of ceiling and wall solutions, today announced that Monica Maheshwari has been named senior vice president, Human Resources and a member of the ...",PFE,0.126119,-0.018741,Neutral
"Cellectar Biosciences Hires Dr. Andrei Shustov as New Senior Vice President, Medical",https://www.globenewswire.com/news-release/2023/02/15/2608712/0/en/Cellectar-Biosciences-Hires-Dr-Andrei-Shustov-as-New-Senior-Vice-President-Medical.html,2023-02-15 13:30:00,"FLORHAM PARK, N.J., Feb. 15, 2023 ( GLOBE NEWSWIRE ) -- Cellectar Biosciences, Inc. ( NASDAQ: CLRB ) , a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that it has hired Andrei ...",PFE,0.042346,-0.021395,Neutral
4 Healthcare Mutual Funds to Buy in the Post-Pandemic Period,https://www.zacks.com/stock/news/2054428/4-healthcare-mutual-funds-to-buy-in-the-post-pandemic-period,2023-02-15 10:34:00,"FBTIX, PHSYX, JNGLX and VGHCX are four healthcare mutual funds that can lend solidity to one's portfolio today and provide big returns in the foreseeable future.",PFE,0.050572,0.064481,Neutral
Talking carveouts and disruption with TPG's Jeff Rhodes,https://www.axios.com/pro/health-tech-deals/2023/02/14/jeff-rhodes-tpg-carveouts-disruption,2023-02-14 17:06:56,Talking carveouts with TPG's Jeff Rhodes ...,PFE,0.112532,0.153797,Somewhat-Bullish
Health Tech: MDI snags $20M,https://www.axios.com/pro/health-tech-deals/newsletters/2023/02/14/health-tech-mdi-snags-20m,2023-02-14 17:02:45,Health Tech: MDI snags ...,PFE,0.112008,0.153532,Somewhat-Bullish
House GOP asks Fauci and dozens of health officials to testify in investigation into Covid origins,https://www.cnbc.com/2023/02/14/gop-asks-fauci-to-testify-in-investigation-into-covid-pandemic-origins.html,2023-02-14 16:15:53,Fauci said in November that he would cooperate with any oversight hearing in the Republican-led House.,PFE,0.044801,-0.17388,Somewhat-Bearish
2 High-Yielding Dividend Stocks Trading Near 52-Week Lows,https://www.fool.com/investing/2023/02/14/2-high-yielding-dividend-stocks-trading-near-lows/,2023-02-14 16:14:22,These stocks both yield more than 3% right now.,PFE,0.600602,0.007141,Neutral
Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results,https://www.globenewswire.com/news-release/2023/02/14/2607501/0/en/Reunion-Neuroscience-Provides-Business-Update-and-Reports-Fiscal-Third-Quarter-2023-Financial-Results.html,2023-02-14 12:30:00,"Company Completed Phase 1 Interim Data Analysis for Lead Asset, RE104, Which Showed Strong Safety and Tolerability with Differentiated Profile. Final Data Anticipated in ...",PFE,0.017048,0.0,Neutral
Is This the Telltale Sign to Sell Novavax Stock?,https://www.fool.com/investing/2023/02/14/is-this-the-tell-tale-sign-to-sell-novavax-stock/,2023-02-14 10:55:00,You won't find Novavax's latest bad news trumpeted in a press release.,PFE,0.164656,0.149429,Neutral
Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2022,https://www.globenewswire.com/news-release/2023/02/14/2607240/0/en/Sosei-Heptares-Operational-Highlights-and-Consolidated-Results-for-12-Months-ended-31-December-2022.html,2023-02-14 06:30:00,"Tokyo, Japan and Cambridge, UK, 14 February 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , the world leader in G protein-coupled receptor ( GPCR ) focused structure-based drug design ( SBDD ) and development, provides an update on operational activities and reports its consolidated ...",PFE,0.061949,0.102151,Neutral
Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2022,https://www.benzinga.com/pressreleases/23/02/g30892512/sosei-heptares-operational-highlights-and-consolidated-results-for-12-months-ended-31-december-202,2023-02-14 06:30:00,"Tokyo, Japan and Cambridge, UK, 14 February 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , the world leader in G protein-coupled receptor ( GPCR ) focused structure-based drug design ( SBDD ) and development, provides an update on operational activities and reports its consolidated ...",PFE,0.061263,0.018,Neutral
Pfizer  ( PFE )  Eczema Drug Cibinqo Gets FDA Nod for Adolescents,https://www.zacks.com/stock/news/2053320/pfizer-pfe-eczema-drug-cibinqo-gets-fda-nod-for-adolescents,2023-02-13 13:35:00,"The FDA approval for Pfizer's (PFE) Cibinqo to treat moderate-to-severe atopic dermatitis in adolescents was based on data from the phase III study, JADE TEEN.",PFE,0.262052,0.047787,Neutral
Is This Dividend Stock a No-Brainer Buy?,https://www.fool.com/investing/2023/02/13/is-this-dividend-stock-a-no-brainer-buy/,2023-02-13 13:15:00,This company led the battle against COVID-19.,PFE,0.48182,0.151257,Somewhat-Bullish
"PFE: The Best Stock to Invest $1,000 in Right Now",https://stocknews.com/news/pfe-nvo-nvs-snphy-the-best-stock-to-invest-1000-in-right-now/,2023-02-13 12:51:02,"The stock market provides wealth creation opportunities regularly. The market started the year positively on the back of improving macroeconomic data. However, many wealth-creation opportunities still exist as several high-quality stocks are available at a discount after a difficult 2022.",PFE,0.492398,0.222637,Somewhat-Bullish
"Global Outlook for Antacids Market | Growth rate at 4.5 percent during the forecast period, Regional Insights and Key Players",https://www.benzinga.com/pressreleases/23/02/g30872081/global-outlook-for-antacids-market-growth-rate-at-4-5-percent-during-the-forecast-period-regional-,2023-02-13 09:57:44,"NEW YORK, Feb. 13, 2023 ( GLOBE NEWSWIRE ) -- Maximize Market research, a global Healthcare market research firm, has published a competitive intelligence and market research report on the ""Antacids Market"".",PFE,0.03319,-0.009406,Neutral
These Cheap Growth Stocks Could Supercharge Your Portfolio,https://www.fool.com/investing/2023/02/12/these-cheap-growth-stocks-could-boost-portfolio/,2023-02-12 10:30:00,All of these players are cheap today considering their growth potential.,PFE,0.04912,0.098831,Neutral
Gambling on Biotechs-and Pfizer,https://www.barrons.com/articles/gambling-on-biotechsand-pfizer-e64e7d80,2023-02-10 23:30:00,Gambling on ...,PFE,0.890401,0.389011,Bullish
Sam Smith's Grammys Performance Criticized By Conservatives And Satanists,https://www.forbes.com/sites/danidiplacido/2023/02/10/sam-smiths-grammys-performance-criticized-by-conservatives-and-satanists/,2023-02-10 21:10:00,Sam Smith and Kim Petras' performance of 'Unholy' provoked a range of negative reactions and conspiracy theories.,PFE,0.204072,-0.055801,Neutral
22 attorneys general say pulling abortion pill from U.S. would have 'devastating consequences',https://www.cnbc.com/2023/02/10/abortion-pill-states-says-pulling-medication-would-have-devastating-consequences.html,2023-02-10 19:26:32,"The 22 attorneys general argued the attempt to pull the abortion pill from the U.S. market would have ""devastating consequences"" for women.",PFE,0.052226,-0.175589,Somewhat-Bearish
Antifungal Drugs Market Report will Surpass USD 25.04 Billion by 2030 at a CAGR of 4.2% Till 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/02/g30860017/antifungal-drugs-market-report-will-surpass-usd-25-04-billion-by-2030-at-a-cagr-of-4-2-till-2030-g,2023-02-10 19:00:00,"Pune India, Feb. 10, 2023 ( GLOBE NEWSWIRE ) -- Antifungal Drugs Market Size By Drug Class ( Allylamines, Azoles, Polyenes, Echinocandins, and Others ) , By Route of Administration ( Parenteral, Oral and Topical ) , By Indication ( Candidiasis, Dermatophytosis, Aspergillosis and Others ) , ...",PFE,0.032251,0.125042,Neutral
FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® - Investing News Network,https://investingnews.com/fda-approves-pfizer-s-supplemental-new-drug-application-for-cibinqo-r/,2023-02-10 17:24:14,FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® Investing News Network ...,PFE,0.136028,0.174636,Somewhat-Bullish
TSM: 3 Cream-of-the-Crop Stocks to Buy Today,https://stocknews.com/news/tsm-wmt-pfe-3-cream-of-the-crop-stocks-to-buy-today/,2023-02-10 17:11:23,"Today, Russia announced its plans to cut its crude production by 5% in response to oil price caps and embargoes imposed by the West. Further constrained supply of energy, ergo higher price, threatens to throw a spanner in the works of Jerome Powell's narrative of the beginning of the ...",PFE,0.241444,0.14979,Neutral
Judge extends deadline in lawsuit seeking to pull abortion pill mifepristone from U.S. until Feb. 24,https://www.cnbc.com/2023/02/10/abortion-pill-judge-extends-deadline-in-lawsuit-seeking-to-pull-medication-from-us.html,2023-02-10 15:21:48,"The abortion rights group NARAL Pro-Choice America, in an analysis published Friday, said 40 million women could lose access to the abortion pill.",PFE,0.051003,-0.1754,Somewhat-Bearish
PET Radiotracer Market is expected to display a steady growth of 8% due to the rise in demand for the effective diagnostic system | UnivDatos Market Insights,https://www.prnewswire.com/news-releases/pet-radiotracer-market-is-expected-to-display-a-steady-growth-of-8-due-to-the-rise-in-demand-for-the-effective-diagnostic-system--univdatos-market-insights-301743907.html,2023-02-10 15:01:00,PET Radiotracer Market is expected to display a steady growth of 8 ... PR ...,PFE,0.037098,0.050549,Neutral
"Pharma Stock Roundup: AZN, ABBV Mixed Q4 Results, BAYRY's New CEO",https://www.zacks.com/stock/news/2052858/pharma-stock-roundup-azn-abbv-mixed-q4-results-bayrys-new-ceo,2023-02-10 14:05:00,AstraZeneca (AZN) and AbbVie (ABBV) report fourth-quarter results. Roche (RHHBY) and J&J (JNJ) announce positive data from studies on pipeline candidates for rare diseases.,PFE,0.091162,-0.160431,Somewhat-Bearish
"BioRestorative Therapies Inc  ( NASDAQ: BRTX )  Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes - Eli Lilly  ( NYSE:LLY ) , BioRestorative Therapies  ( NASDAQ:BRTX ) ",https://www.benzinga.com/general/biotech/23/02/30853303/biorestorative-therapies-inc-nasdaq-brtx-announces-european-patentability-of-thermostem-program-w,2023-02-10 13:00:18,"BioRestorative Therapies BRTX, a clinical-stage biotechnology company focused on stem cell-based therapies, announced on the 8th of February that the European Patent Office had issued a notice of allowance for a patent application related to its metabolic ThermoStem® program.",PFE,0.15347,0.157127,Somewhat-Bullish
PFE: 2 Dividend Stocks to Buy in 2023 for a Stable Income Stream,https://stocknews.com/news/pfe-sire-2-dividend-stocks-to-buy-in-2023-for-a-stable/,2023-02-10 11:32:15,"The Federal Reserve raised its benchmark interest rate by a quarter percentage point recently, which indicated that it is seeing progress in its battle with inflation. This came after a series of outsized rate increases over the last year. While inflation is cooling, it is still far from the ...",PFE,0.416614,0.064891,Neutral
Is Novavax Stock a Buy With the New Normal for COVID?,https://www.fool.com/investing/2023/02/10/is-novavax-stock-a-buy-with-new-normal-for-covid/,2023-02-10 10:50:00,The landscape has shifted dramatically in the COVID-19 vaccine market.,PFE,0.425428,0.248334,Somewhat-Bullish
"Zacks Market Edge Highlights: Pfizer, Exxon Mobil, Citigroup, Enterprise Products Partners and Intel",https://www.zacks.com/stock/news/2052699/zacks-market-edge-highlights-pfizer-exxon-mobil-citigroup-enterprise-products-partners-and-intel,2023-02-10 10:00:00,"Pfizer, Exxon Mobil, Citigroup, Enterprise Products Partners and Intel have been highlighted in this Market Edge article.",PFE,0.286864,0.133958,Neutral
"Sensex slips 224 pts, Nifty below 17,850 mark",https://www.business-standard.com/article/news-cm/sensex-slips-224-pts-nifty-below-17-850-mark-123021000738_1.html,2023-02-10 08:03:00,"The headline equity indices traded with modest losses in afternoon trade. The Nifty traded below the 17,850 mark. PSU bank, media and realty stocks advanced while metal, oil & gas and FMCG shares corrected. At 13:27 IST, the barometer index, the S&P BSE Sensex, was down 224.41 points or 0.37% to ...",PFE,0.055621,0.188939,Somewhat-Bullish
Sensex down 102 pts; oil & gas shares decline,https://www.business-standard.com/article/news-cm/sensex-down-102-pts-oil-gas-shares-decline-123021000541_1.html,2023-02-10 06:03:00,Sensex down 102 pts. oil & gas shares decline Business Standard ...,PFE,0.088799,0.131447,Neutral
Pfizer Q3 PAT up 5% YoY; board appoints Meenakshi Nevatia as MD,https://www.business-standard.com/article/news-cm/pfizer-q3-pat-up-5-yoy-board-appoints-meenakshi-nevatia-as-md-123021000468_1.html,2023-02-10 04:18:45,Pfizer Q3 PAT up 5% YoY. board appoints Meenakshi Nevatia as MDs Business Standard ...,PFE,0.502207,0.360123,Bullish
"Buzzing Stocks: Mahindra & Mahindra, Life Insurance Corporation, Zomato, and others in news today",https://www.moneycontrol.com/news/photos/business/stocks/buzzing-stocks-mahindra-mahindra-life-insurance-corporation-zomato-and-others-in-news-today-10045321.html,2023-02-10 01:21:10,Stocks to Watch: Check out the companies making headlines before the opening bell today.,PFE,0.056011,0.044002,Neutral
United in the Fight Against Colorectal Cancer,https://www.benzinga.com/pressreleases/23/03/g31145199/united-in-the-fight-against-colorectal-cancer,2023-03-01 22:42:36,"Springfield, Mo., March 01, 2023 ( GLOBE NEWSWIRE ) -- On the heels of the White House declaring March as Colorectal Cancer Awareness Month, urging the public to get screened, national advocacy organization Fight Colorectal Cancer ( Fight CRC ) is bringing awareness to D.C. and beyond through ...",PFE,0.070935,-0.003072,Neutral
"FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks",https://www.cnbc.com/2023/03/01/fda-advisors-recommend-gsks-rsv-vaccine-for-older-adults-but-flag-potential-safety-risks.html,2023-03-01 19:32:47,"A majority of the FDA panel said GSK's vaccine safety data was adequate, and the advisors were unanimous that the shot's efficacy was good.",PFE,0.08666,0.164452,Somewhat-Bullish
"Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional' - Novavax  ( NASDAQ:NVAX ) ",https://www.benzinga.com/general/biotech/23/03/31134429/jim-cramer-says-hes-known-novavax-is-worthless-for-very-long-time-trashes-company-for-being-too-p,2023-03-01 18:21:42,"Novavax Inc NVAX shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue. ""I've been saying the thing is, not phony, but worthless for a very long time,"" Cramer said Wednesday on CNBC's ""Squawk On The Street.""",PFE,0.268294,0.225314,Somewhat-Bullish
Why Novavax Stock Is Crashing Today,https://www.fool.com/investing/2023/03/01/why-novavax-stock-is-crashing-today/,2023-03-01 16:06:29,The vaccine maker gave a warning that no investor wants to hear.,PFE,0.135347,0.0,Neutral
FDA AdComm Gives Thumbs Up To Pfizer's RSV Vaccine Candidate For Elderly People - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/03/31125554/fda-adcomm-gives-thumbs-up-to-pfizers-rsv-vaccine-candidate-for-elderly-people,2023-03-01 15:36:40,The FDA's Vaccines and Related Biological Products Advisory Committee ( VRBPAC ) voted in favor of Pfizer Inc's PFE available data is adequate to support the safety and effectiveness of its respiratory syncytial virus ( RSV ) bivalent vaccine candidate PF-06928316 or RSVpreF.,PFE,0.863608,0.576435,Bullish
Pfizer/BioNTech seeks U.S. nod for updated COVID vaccine as booster in kids under 5,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizerbiontech-seeks-us-nod-updated-covid-vaccine-booster-kids-under-5-2023-03-01/,2023-03-01 15:36:00,Pfizer/BioNTech seeks U.S. nod for updated COVID vaccine as ... ...,PFE,0.327366,0.076476,Neutral
Covid vaccine maker Novavax says it may not survive | Business,https://www.cnn.com/2023/03/01/investing/novavax-covid-vaccine-going-concern/index.html,2023-03-01 15:25:00,Covid vaccine maker Novavax says it may not survive ...,PFE,0.190417,-0.085835,Neutral
"The Consortium for Top-Down Proteomics Announces the 2nd International Top-Down Proteomics Symposium, October 3-5, 2023, in Chicago, IL",https://www.benzinga.com/pressreleases/23/03/g31127450/the-consortium-for-top-down-proteomics-announces-the-2nd-international-top-down-proteomics-symposi,2023-03-01 15:17:00,"CAMBRIDGE, Mass., March 01, 2023 ( GLOBE NEWSWIRE ) -- The Consortium for Top-Down Proteomics today announced the 2nd International Top-Down Proteomics Symposium, which will be held in Chicago, IL October 3-5, 2023. The Symposium is being hosted by Northwestern University's Chemistry of Life ...",PFE,0.101154,0.178663,Somewhat-Bullish
"Seagen, Delta Air Lines And 2 Other Stocks Insiders Are Selling - Entergy  ( NYSE:ETR ) , Delta Air Lines  ( NYSE:DAL ) ",https://www.benzinga.com/news/23/03/31124074/seagen-delta-air-lines-and-2-other-stocks-insiders-are-selling,2023-03-01 14:05:13,"The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on ...",PFE,0.085629,0.047141,Neutral
3 Value Stocks You'll Regret Not Buying on the Dip,https://www.fool.com/investing/2023/03/01/3-value-stocks-youll-regret-not-buying-on-the-dip/,2023-03-01 13:45:00,These three undervalued healthcare stocks are solid picks for patient investors.,PFE,0.249361,-0.087871,Neutral
"Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance",https://www.cnbc.com/2023/03/01/lilly-cuts-insulin-prices-70percent-cap-prices-at-35-per-month-for-private-insurance.html,2023-03-01 13:30:04,The announcement comes amid growing federal pressure to lower the cost of insulin prices.,PFE,0.123526,0.363983,Bullish
BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel,https://www.globenewswire.com/news-release/2023/03/01/2618110/0/en/BioNTech-Announces-Establishment-of-Interdisciplinary-mRNA-Excellence-Center-to-Conduct-Research-Jointly-with-Scientists-from-Weizmann-Institute-of-Science-in-Israel.html,2023-03-01 13:00:00,"JERUSALEM, Israel, March 1, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"", ""the Company"" ) announced that the Company and the Weizmann Institute of Science ( ""Weizmann Institute"" ) signed a Memorandum of Understanding ( MoU ) . As part of this MoU, scientists from a variety of disciplines from ...",PFE,0.042876,0.024859,Neutral
EU silence over Pfizer COVID contract talks is problem that won't go away -watchdog,https://www.reuters.com/business/healthcare-pharmaceuticals/eu-silence-over-pfizer-covid-contract-talks-is-problem-that-wont-go-away-2023-03-01/,2023-03-01 12:13:00,EU silence over Pfizer COVID contract talks is problem that won't go ... ...,PFE,0.368773,-0.092798,Neutral
Novavax shares sink premarket as going concern worries weigh,https://www.reuters.com/business/healthcare-pharmaceuticals/vaccine-maker-novavaxs-frankfurt-shares-plunge-26-2023-03-01/,2023-03-01 08:21:35,"LONDON March 1 ( Reuters ) - Novavax Inc's shares ( NVAX.O ) plunged more than 24% in U.S. premarket trading on Wednesday, a day after the COVID-19 vaccine maker raised doubts about its ability to remain in business. The stock dropped 24.3% to $7.01 by 4:28 a.m.",PFE,0.229149,-0.140706,Neutral
Novavax Stock Plunges 25% As Vaccine Maker Has 'Substantial Doubt' About Staying In Business,https://www.forbes.com/sites/nicholasreimann/2023/02/28/novavax-stock-plunges-25-as-vaccine-maker-has-substantial-doubt-about-staying-in-business/,2023-03-01 00:21:49,Shares of the pharmaceutical company have slipped below $7 after trading well above $300 at points in 2021.,PFE,0.264897,0.184046,Somewhat-Bullish
Business Highlights: Biden loan plan; New labor secretary,https://apnews.com/article/business-highlights-4ec77ecb3cd288dbdac454d37cd254ed,2023-02-28 22:44:29,Business Highlights: Biden loan plan. New labor secretary The Associated Press - en ...,PFE,0.081138,0.057853,Neutral
Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older Adults,https://investingnews.com/pfizer-receives-positive-fda-advisory-committee-votes-supporting-potential-approval-for-vaccine-candidate-to-help-combat-rsv-in-older-adults/,2023-02-28 22:10:13,Pfizer Inc. ( NYSE: PFE ) announced today that the U.S. Food and Drug Administration's ( FDA ) Vaccines and Related Biological Products Advisory Committee ( VRBPAC ) voted that available data is adequate to support the safety and effectiveness of its respiratory syncytial virus ( RSV ) bivalent ...,PFE,0.306416,0.224952,Somewhat-Bullish
"FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risks",https://www.cnbc.com/2023/02/28/rsv-vaccine-fda-committee-votes-on-pfizer-shot-for-older-adults.html,2023-02-28 21:30:40,"The Food and Drug Administration's independent advisors on Tuesday recommended Pfizer's RSV vaccine for adults ages 60 and older, despite safety concerns after two people who received the shot developed a rare neurological disorder.",PFE,0.250386,0.060803,Neutral
U.S. FDA panel votes for Pfizer's RSV vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-pfizers-rsv-vaccine-2023-02-28/,2023-02-28 21:15:00,"Feb 28 ( Reuters ) - A panel of outside advisers to the U.S. Food and Drug Administration ( FDA ) on Tuesday recommended Pfizer Inc's ( PFE.N ) respiratory syncytial virus ( RSV ) vaccine, paving the way for one of the first approved RSV shots in the United States for older adults.",PFE,0.331765,0.200023,Somewhat-Bullish
Novavax raises doubts about its ability to remain in business,https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-raises-doubts-about-its-ability-remain-business-2023-02-28/,2023-02-28 21:08:53,"NEW YORK, Feb 28 ( Reuters ) - COVID-19 vaccine maker Novavax Inc ( NVAX.O ) on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign.",PFE,0.065866,-0.02912,Neutral
"February's Stock Winners And Losers: Tesla And Nvidia Lead Charge, Moderna Lags Behind",https://www.forbes.com/sites/dereksaul/2023/02/28/februarys-stock-winners-and-losers-tesla-and-nvidia-lead-charge-moderna-lags-behind/,2023-02-28 21:08:23,"Bulls piled into the nation's largest chipmaker and most valuable car company this month, with shares of each company surging about 20%.",PFE,0.160633,-0.07,Neutral
Business Highlights: Biden loan plan; New labor secretary,https://apnews.com/article/business-highlights-biden-loan-plan-new-labor-secretary-4ec77ecb3cd288dbdac454d37cd254ed,2023-02-28 20:37:30,Business Highlights: Biden loan plan. New labor secretary The Associated Press - en ...,PFE,0.081138,0.057853,Neutral
"Analysts Sees Over 50% Upside Opportunity For This Newly Listed Obesity Player Stock, Participating In Big Pharma Race - Structure Therapeutics  ( NASDAQ:GPCR ) ",https://www.benzinga.com/general/biotech/23/02/31098964/analysts-sees-over-50-upside-opportunity-for-this-newly-listed-obesity-player-stock-participating,2023-02-28 19:27:26,Guggenheim Partners initiated coverage on Structure Therapeutics Inc GPCR with a Buy rating and a price target of $50 based on the multi-billion-dollar potential of oral small GLP1R agonist GSBR-1290.,PFE,0.285526,0.0,Neutral
"Dow Jones Stalls: Chips Act Goes Live, Small Chip Stocks Soar; Tesla's Investor Day On Deck",https://www.investors.com/market-trend/stock-market-today/dow-jones-stalls-chip-stocks-soar-as-chips-act-goes-live-teslas-investor-day-on-deck/,2023-02-28 18:46:00,"Dow Jones Stalls: CHIPS Act Goes Live, Small Chip Stocks Soar ... Investor's Business Daily ...",PFE,0.129866,-0.064357,Neutral
PFE: 2 COVID-19 Stocks That are Still Darlings in 2023,https://stocknews.com/news/pfe-gild-2-covid-19-stocks-that-are-still-darlings-in-2023/,2023-02-28 17:31:18,PFE: 2 COVID-19 Stocks That are Still Darlings in ...,PFE,0.405378,0.227315,Somewhat-Bullish
The Good News For Novavax Ahead Of Its Quarterly Report,https://www.investors.com/news/technology/nvax-stock-novavax-earnings-q4-2022/,2023-02-28 17:10:00,NVAX Stock: Here's What To Expect When Covid Shot-Maker ... Investor's Business Daily ...,PFE,0.234684,0.105236,Neutral
It's Crunch Time for RSV Vaccines as FDA Advisers Prepare to Vote,https://www.barrons.com/articles/pfizer-gsk-rsv-fda-approval-20cfd9cf,2023-02-28 16:32:00,It's Crunch Time for Pfizer and GSK's RSV Vaccines as FDA Advisers Vote ...,PFE,0.933751,0.118755,Neutral
Pfizer Unusual Options Activity For February 28 - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/02/31095211/pfizer-unusual-options-activity-for-february-28,2023-02-28 16:30:16,"Someone with a lot of money to spend has taken a bullish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.891493,0.366004,Bullish
"February's Stock Winners And Losers: Tesla, Nvidia Lead Charge As Moderna Plunges",https://www.forbes.com/sites/dereksaul/2023/02/28/februarys-stock-winners-and-losers-tesla-nvidia-lead-charge-as-moderna-plunges/,2023-02-28 16:16:38,"Bulls piled into the nation's largest chipmaker and most valuable car company this month, with shares of each company surging about 20%.",PFE,0.170878,-0.091098,Neutral
"Company News for Feb 28, 2023",https://www.zacks.com/stock/news/2059806/company-news-for-feb-28-2023,2023-02-28 14:34:00,"Companies in The News Are: UNP, ...",PFE,0.674691,0.262471,Somewhat-Bullish
Pulmonary Arterial Hypertension Market Worth  ( $10.88 Billion by 2028 )  Lead by Asia Pacific Region  ( 6.5% CAGR )  - Global Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/02/g31091255/pulmonary-arterial-hypertension-market-worth-10-88-billion-by-2028-lead-by-asia-pacific-region-6-5,2023-02-28 14:03:29,"New York, Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Pulmonary Arterial Hypertension Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Drugs [Endothelin Receptor Antagonists ( ERAs ) , Prostacyclin and ...",PFE,0.021087,0.076814,Neutral
"Henlius Swallows Bitter Pill In Watered-Down Licensing Deal - Abbott Laboratories  ( NYSE:ABT ) , Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/news/small-cap/23/02/31090323/henlius-swallows-bitter-pill-in-watered-down-licensing-deal,2023-02-28 13:41:25,"Henlius Biotech will receive up to $11 million less than originally agreed under a licensing agreement due to higher-than-expected R&D costs Such alterations aren't uncommon to licensing deals, but can still undermine investor confidence in a company and slow its overseas expansion",PFE,0.110293,-0.005581,Neutral
"Top 5 Health Care Stocks That You May Want To Dump In Q1 2023 - Genelux  ( NASDAQ:GNLX ) , Ambrx Biopharma  ( NYSE:AMAM ) ",https://www.benzinga.com/news/23/02/31090297/top-5-health-care-stocks-that-you-may-want-to-dump-in-q1-2023,2023-02-28 13:40:06,"The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.",PFE,0.126119,0.042638,Neutral
Merck's scraps another prostate cancer study as Keytruda therapy disappoints,https://www.reuters.com/business/healthcare-pharmaceuticals/merck-discontinue-keytruda-combination-study-prostate-cancer-2023-02-28/,2023-02-28 12:50:00,Merck's scraps another prostate cancer study as Keytruda therapy ... ...,PFE,0.141726,-0.04752,Neutral
"Pfizer, GSK face FDA panel review in race for RSV vaccines",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-gsk-face-fda-panel-review-race-rsv-vaccines-2023-02-28/,2023-02-28 12:03:00,Feb 28 ( Reuters ) - The frontrunners in a crowded race to develop the first respiratory syncytial virus ( RSV ) vaccine - Pfizer Inc ( PFE.N ) and GSK ( GSK.L ) - will face scrutiny from a panel of experts to the U.S. Food and Drug Administration this week.,PFE,0.222838,-0.046746,Neutral
Voyager Therapeutics Announces Fourth Quarter and Full Year 2022 Conference Call and Webcast,https://www.globenewswire.com/news-release/2023/02/28/2616860/36461/en/Voyager-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2022-Conference-Call-and-Webcast.html,2023-02-28 12:00:00,"CAMBRIDGE, Mass., Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( Nasdaq: VYGR ) a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced it will report fourth quarter and full year 2023 financial and operating results before ...",PFE,0.118647,0.044933,Neutral
"US Stocks Recover After Recording Worst Week Of 2023, Market Volatility Declines - Apple  ( NASDAQ:AAPL ) , Seagen  ( NASDAQ:SGEN ) ",https://www.benzinga.com/news/earnings/23/02/31084183/us-stocks-recover-after-recording-worst-week-of-2023-market-volatility-declines,2023-02-28 10:28:33,"US stocks settled slightly higher on Monday, after Wall Street's major benchmarks recorded the biggest percentage declines of the year during the last week. On the economic data front, durable goods orders in the US dropped 4.5% month-over-month in January, the most since April 2020.",PFE,0.181137,0.156643,Somewhat-Bullish
Indices hit fresh day's low; pharma stocks decline,https://www.business-standard.com/article/news-cm/indices-hit-fresh-day-s-low-pharma-stocks-decline-123022800582_1.html,2023-02-28 09:06:00,Indices hit fresh day's low. pharma stocks decline Business Standard ...,PFE,0.111488,-0.076878,Neutral
US Stocks rebound on bargain buying,https://www.business-standard.com/article/news-cm/us-stocks-rebound-on-bargain-buying-123022800125_1.html,2023-02-28 02:49:00,"At the close of trade, the Dow Jones Industrial Average index advanced 72.17 points, or 0.22%, to 32,889.09. The S&P500 index was up 12.20 points, or 0.31%, to 3,982.24. The tech-heavy Nasdaq Composite Index increased 72.04 points, or 0.63%, to 11,466.98.",PFE,0.246582,0.262395,Somewhat-Bullish
US stocks close slightly up after prior week's selloff,https://www.moneycontrol.com/news/business/markets/us-stocks-close-slightly-up-after-prior-weeks-selloff-10171321.html,2023-02-28 00:29:31,"All three main stock indexes climbed more than 1% shortly after the opening bell, in part due to an easing in Treasury yields, and all three closed well off their session highs.",PFE,0.062434,0.087021,Neutral
"Seagen, Union Pacific rise; Range Resources, Tegna fall",https://apnews.com/article/union-pacific-corp-tegna-inc-range-resources-business-fd9421e6add90e02b4320dfeafa8602f,2023-02-27 21:16:31,"Seagen, Union Pacific rise. Range Resources, Tegna fall The Associated Press - en ...",PFE,0.306963,0.459015,Bullish
Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger - Adamis Pharmaceuticals  ( NASDAQ:ADMP ) ,https://www.benzinga.com/pressreleases/23/02/g31077100/adamis-pharmaceuticals-and-dmk-pharmaceuticals-announce-agreement-and-plan-of-merger,2023-02-27 21:05:00,"Combined company will have commercial products and a library of development candidates, two of which are clinical stage Will be under the leadership of DMK CEO, Dr. Ebrahim ( Eboo ) Versi MD, PhD Lead development program will be a clinical stage therapeutic under development for the ...",PFE,0.017664,0.048153,Neutral
Why Seagen Stock Perked Up Today,https://www.fool.com/investing/2023/02/27/why-seagen-stock-perked-up-today/,2023-02-27 21:02:18,Rumors of another buyout are pushing the drugmaker's shares higher today.,PFE,0.636698,-0.10285,Neutral
Axsome Therapeutics  ( AXSM )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/27/axsome-therapeutics-axsm-q4-2022-earnings-call-tra/,2023-02-27 21:00:21,"AXSM earnings call for the period ending December 31, 2022.",PFE,0.005603,0.180106,Somewhat-Bullish
Dow Jones Up As Stocks Dig In; 3 Warren Buffett Stocks Eye Entries,https://www.investors.com/market-trend/stock-market-today/dow-jones-up-as-stocks-dig-in-3-warren-buffett-stocks-eye-entries-tesla-stock-pops-on-report-elon-musk/,2023-02-27 20:14:00,Dow Jones Gains. 3 Warren Buffett Stocks Eye Entries. Tesla Stock ... Investor's Business Daily ...,PFE,0.084722,0.171654,Somewhat-Bullish
IBD 50 Growth Stock: Diabetes Breakthrough Lifts Denmark Drugmaker,https://www.investors.com/research/growth-stock-novo-nordisk-drug-stock-rises-after-fda-approval-of-diabetes-drug-breakthrough/,2023-02-27 19:43:00,IBD 50 Growth Stock: Diabetes Breakthrough Lifts Novo Nordisk ... Investor's Business Daily ...,PFE,0.154951,0.382543,Bullish
This Top 3% Biotech Is In Limbo Amid An FDA Shakeup,https://www.investors.com/news/technology/reta-stock-plummets-will-officials-fda-exit-shake-up-reata-review/,2023-02-27 17:47:00,RETA Stock Plummets. Will Official's FDA Exit Shake Up Reata's ... Investor's Business Daily ...,PFE,0.099476,0.0,Neutral
"Analyst Cautions Investors On Overreacting To 'Early-Stage' Pfizer/Seagen Discussions - Seagen  ( NASDAQ:SGEN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/02/31072006/analyst-cautions-investors-on-overreacting-to-early-stage-pfizerseagen-discussions,2023-02-27 17:43:08,"In a news article by the Wall Street Journal, Pfizer Inc PFE is reportedly in early-stage talks to acquire Seagen Inc SGEN for over $30 billion. In June last year, the Wall Street Journal reported that Merck & Co Inc MRK showed interest in buying Seagen.",PFE,0.433523,0.093171,Neutral
"Shionogi's COVID-19 Pill, Based On Similar Action Like Pfizer's, Sees Around $2B In Annual Sales - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/02/31067269/shionogis-covid-19-pill-based-on-similar-action-like-pfizers-sees-around-2b-in-annual-sales,2023-02-27 17:34:45,"Japanese pharmaceutical company Shionogi & Co Ltd's CEO believes its COVID-19, Xocova, pill can generate $2 billion in annual sales if it secures FDA approval. The company expects U.S. approval by late 2024. The treatment is a protease inhibitor, just like Paxlovid, the COVID-19 treatment made ...",PFE,0.369685,0.074705,Neutral
Seagen's stock surges almost 11% after a report that Pfizer is in talks to buy the cancer-focused biotech,https://africa.businessinsider.com/markets/seagens-stock-surges-almost-11-after-a-report-that-pfizer-is-in-talks-to-buy-the/k0fk1gk,2023-02-27 17:33:33,Seagen's stock surges almost 11% after a report that Pfizer is in talks ... - Business Insider Africa ...,PFE,0.702434,0.042276,Neutral
"Getting Back Up: Stock Futures Edge Higher as Investors Gauge the Fed, Data and Yields This Week",https://www.benzinga.com/markets/23/02/31073447/getting-back-up-stock-futures-edge-higher-as-investors-gauge-the-fed-data-and-yields-this-week,2023-02-27 17:20:24,"( Monday market open ) With major indexes down three weeks in a row as investors plug in expectations for higher interest rates and watch the dollar climb, will this week break the streak? It may depend on a heavy load of company reports and data as we hit the tail end of a disappointing Q4 ...",PFE,0.036393,-0.087129,Neutral
Pfizer in talks to acquire Seagen in deal likely valued at more than $30B,https://www.foxbusiness.com/markets/pfizer-talks-acquire-seagen-deal-valued-more-than-30-billion,2023-02-27 17:15:58,"Pfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targeted cancer therapies. The talks are at an early stage, and there is no guarantee there will be a deal, ...",PFE,0.601928,0.060531,Neutral
"Stocks making the biggest moves midday: Union Pacific, Fisker, Tesla, Zillow and more",https://www.cnbc.com/2023/02/27/stocks-making-the-biggest-moves-midday-unp-fsr-tsla-z-and-more.html,2023-02-27 17:11:29,Union Pacific soared on news of a leadership change.,PFE,0.068502,-0.030472,Neutral
Durable Goods Orders Come in Nearly at a Three-Year Low,https://www.zacks.com/stock/news/2059377/durable-goods-orders-come-in-nearly-at-a-three-year-low,2023-02-27 15:58:00,"A fresh economic report is out this morning, though this one more likely would help bolster quarterly Gross Domestic Product ( GDP ) than interest rate levels: Durable Goods Orders for January came in at their lowest tally since the depth of the Covid market in April 2020: -4.5%.",PFE,0.163354,0.064659,Neutral
Stock Market Starts Anew After A Rough Week; Oil Tankers Sail To Highs,https://www.investors.com/market-trend/stock-market-today/stock-market-bulls-back-after-a-rough-week-oil-tankers-sail-to-highs/,2023-02-27 15:54:00,Stock Market Starts Anew After A Rough Week. Oil Tankers Sail To ... Investor's Business Daily ...,PFE,0.119235,-0.003507,Neutral
"Durables Goods Sink -4.5%, but Higher on Business Spending",https://www.zacks.com/stock/news/2059365/durables-goods-sink--45-but-higher-on-business-spending,2023-02-27 15:39:00,"These Durable Goods figures are preliminary, and subject to future revisions.",PFE,0.231332,0.01459,Neutral
"Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday - Altisource Asset Mgmt  ( AMEX:AAMC ) , Acrivon Therapeutics  ( NASDAQ:ACRV ) ",https://www.benzinga.com/news/23/02/31070786/union-pacific-kosmos-energy-fisker-and-other-big-stocks-moving-higher-on-monday,2023-02-27 15:21:58,"U.S. stocks traded higher, with the Dow Jones gaining more than 300 points on Monday. Here are some big stocks recording gains in today's session. Moolec Science SA MLEC jumped 25.3% to $5.14. Fisker Inc. FSR shares gained 24% to $6.95 after the company reported Q4 financial results.",PFE,0.265859,0.052321,Neutral
'Here We Go Again': Seagen Soars On Rumored Pfizer Buyout Talks,https://www.investors.com/news/technology/sgen-stock-rockets-as-yet-another-big-pharma-reportedly-considers-a-takeover/,2023-02-27 14:52:00,SGEN Stock Rockets As Yet Another Big Pharma Reportedly ... Investor's Business Daily ...,PFE,0.551009,-0.118851,Neutral
"Overview Of Value Stocks In The Healthcare Sector - Sunshine Biopharma  ( NASDAQ:SBFM ) , Celularity  ( NASDAQ:CELU ) , Aptevo Therapeutics  ( NASDAQ:APVO ) , Assertio Holdings  ( NASDAQ:ASRT ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/02/31069746/overview-of-value-stocks-in-the-healthcare-sector,2023-02-27 14:43:49,A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.,PFE,0.222838,0.255855,Somewhat-Bullish
US stocks climb as investors try to recover from the worst trading week of the year,https://markets.businessinsider.com/news/stocks/stock-market-news-today-recession-fed-durable-goods-orders-inflation-2023-2,2023-02-27 14:31:10,Stock Market News Today: Indexes Jump After Worst Trading Week ... - Markets Insider ...,PFE,0.109455,-0.111957,Neutral
Seagen Stock Soars On Pfizer Takeover Talks: What's Going On? - Seagen  ( NASDAQ:SGEN ) ,https://www.benzinga.com/m-a/23/02/31068947/seagen-stock-soars-on-pfizer-takeover-talks-whats-going-on,2023-02-27 14:19:49,"Seagen Inc SGEN shares are trading higher Monday following reports indicating pharmaceutical giant Pfizer Inc PFE is considering acquiring the biotech company. What To Know: According to a Wall Street Journal report citing people familiar with the matter, Pfizer is in early stage talks to acquire ...",PFE,0.636698,0.187154,Somewhat-Bullish
"Jim Cramer's top 10 things to watch in the stock market Monday: Bouncing stocks, Club earnings ahead, inflation signs",https://www.cnbc.com/2023/02/27/cramers-top-10-things-to-watch-monday-stocks-earnings-inflation.html,2023-02-27 14:18:13,"The Dow, the S&P 500 and the Nasdaq look to bounce Monday after their worst week of 2023.",PFE,0.182967,-0.078452,Neutral
PFE: 1 High-Value Stock to Keep in Your Portfolio Forever,https://stocknews.com/news/pfe-bmy-tak-alpmy-1-high-value-stock-to-keep-in-your-portfolio-forever/,2023-02-27 14:05:03,"With value investing gaining traction amid volatile market conditions, investors could consider adding attractively valued shares of fundamentally strong, profitable businesses. At the current price level, I think Pfizer Inc. ( PFE ) is one of the best value stocks for reasons explained ...",PFE,0.6338,0.342774,Somewhat-Bullish
Seagen's stock surges almost 11% after a report that Pfizer is in talks to buy the cancer-focused biotech,https://markets.businessinsider.com/news/stocks/seagen-stock-price-pfizer-talks-acquire-cancer-biotech-drugmaker-wsj-2023-2,2023-02-27 13:53:12,Seagen Stock Price Surges Near 11% After Report of Pfizer Buyout ... - Markets Insider ...,PFE,0.733479,0.062529,Neutral
Seagen  ( SGEN )  Likely to be Acquired by Pfizer Claims WSJ,https://www.zacks.com/stock/news/2059219/seagen-sgen-likely-to-be-acquired-by-pfizer-claims-wsj,2023-02-27 13:46:00,"Seagen (SGEN) may be acquired by the large-cap pharma company Pfizer at a valuation of more than $30 billion, according to a Wall Street Journal article. Seagen's stock is up 17% in pre-market hours in response to the news.",PFE,0.330286,0.113056,Neutral
"Li Auto Powers Up, but Another Stock Is Really Stepping on the Gas",https://www.fool.com/investing/2023/02/27/li-auto-powers-up-but-another-stock-is-really-step/,2023-02-27 13:44:33,The stock market looked poised to climb on Monday morning.,PFE,0.33628,0.16966,Somewhat-Bullish
Pfizer in Talks to Buy Seagen for $30 Billion or More,https://www.barrons.com/articles/pfizer-merck-seagen-pharma-stock-price-c7161fc2,2023-02-27 13:25:00,"Multinational pharmaceutical company Pfizer is in discussions to acquire biotech firm Seagen in a deal that could be worth more than $30 billion, The Wall Street Journal reported. Seagen ( ticker: SGEN ) is currently valued at about $30 billion and a buyout would likely require a premium to that.",PFE,0.504646,0.0,Neutral
2 Dividend Stocks to Buy at a Discounted Price In 2023,https://www.fool.com/investing/2023/02/27/2-dividend-stocks-to-buy-at-a-discounted-price-in/,2023-02-27 13:00:00,Their shares are ripe for getting while the getting is good.,PFE,0.181137,-0.043051,Neutral
"Stocks making the biggest moves premarket: Best Buy, Seagen, Union Pacific and more",https://www.cnbc.com/2023/02/27/stocks-making-the-biggest-moves-premarket-bby-sgen-unp.html,2023-02-27 12:58:13,Shares of Union Pacific rose 9.5% after the company said CEO Lance Fritz would have a successor named this year.,PFE,0.139265,0.00784,Neutral
"Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket - AERWINS Technologies  ( NASDAQ:AWIN ) , Bed Bath & Beyond  ( NASDAQ:BBBY ) ",https://www.benzinga.com/news/23/02/31067122/why-lucira-health-shares-are-trading-higher-by-over-228-here-are-20-stocks-moving-premarket,2023-02-27 12:45:37,"Lucira Health, Inc. LHDX rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses. ObsEva SA OBSV rose 60.3% to $0.1331 in pre-market trading.",PFE,0.072435,0.079495,Neutral
Biosimilars Market Size Worth  ( $136+ Billion by 2028 )  Lead by Intravenous Segment  ( 36% CAGR )  - Exclusive Research Study by The Insight Partners,https://www.benzinga.com/pressreleases/23/02/g31066933/biosimilars-market-size-worth-136-billion-by-2028-lead-by-intravenous-segment-36-cagr-exclusive-re,2023-02-27 12:39:55,"New York, Feb. 27, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Biosimilars Market Size, Share, Growth, Strategy & Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication ( Cancer, Diabetes, Autoimmune Diseases, and Other Diseases ) , Drug Class ( ...",PFE,0.022181,0.139643,Neutral
Bristol Myers Squibb to Present Data Supporting its Cardiovascular Portfolio at the American College of Cardiology Annual Scientific Session Together With World Congress of Cardiology,https://investingnews.com/bristol-myers-squibb-to-present-data-supporting-its-cardiovascular-portfolio-at-the-american-college-of-cardiology-annual-scientific-session-together-with-world-congress-of-cardiology/,2023-02-27 12:26:58,"Bristol Myers Squibb ( NYSE: BMY ) today announced the presentation of research supporting the company's cardiovascular franchise at the American College of Cardiology ( ACC ) Annual Scientific Session & Expo together with the World Congress of Cardiology ( WCC ) , taking place in-person and ...",PFE,0.061737,0.024,Neutral
"Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/02/31065503/nasdaq-s-p-500-futures-rebound-in-new-trading-week-but-rising-bond-yields-remain-a-risk,2023-02-27 11:47:05,"US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could trigger bargain-hunting-related buying.",PFE,0.116914,0.087269,Neutral
"This is what Warren Buffett, a self-described 'so-so investor,' says is his 'secret sauce'",https://www.marketwatch.com/story/this-is-what-warren-buffett-a-self-described-so-so-investor-says-is-his-secret-sauce-f90b41e,2023-02-27 11:44:00,It's all about dividends and the long game for storied investor Warren Buffett who dished out a few bits of wisdom over the weekend.,PFE,0.079261,-0.157701,Somewhat-Bearish
Protalix BioTherapeutics Reports Fiscal Year 2022 Financial and Business Results,https://www.prnewswire.com/news-releases/protalix-biotherapeutics-reports-fiscal-year-2022-financial-and-business-results-301756357.html,2023-02-27 11:30:00,Protalix BioTherapeutics Reports Fiscal Year 2022 Financial and ... PR ...,PFE,0.030739,0.09341,Neutral
Protalix BioTherapeutics Reports Fiscal Year 2022 Financial and Business Results,https://www.prnewswire.com/il/news-releases/protalix-biotherapeutics-reports-fiscal-year-2022-financial-and-business-results-301756357.html,2023-02-27 11:30:00,Protalix BioTherapeutics Reports Fiscal Year 2022 Financial and ... PR ...,PFE,0.030739,0.09341,Neutral
Futures rise after Wall Street's worst weekly rout of 2023,https://www.reuters.com/markets/us/futures-rise-after-wall-streets-worst-weekly-rout-2023-2023-02-27/,2023-02-27 11:11:42,Futures rise after Wall Street's worst weekly rout of ...,PFE,0.115787,0.097024,Neutral
3 Crucial Things to Know About Moderna Right Now,https://www.fool.com/investing/2023/02/27/3-crucial-things-to-know-about-moderna-right-now/,2023-02-27 10:30:00,This vaccine leader is preparing for a post-pandemic world.,PFE,0.136888,0.096049,Neutral
Pfizer in Talks to Buy Seagen for $30 Billion or More,https://www.barrons.com/articles/pfizer-buy-seagen-30-billion-stock-pharma-c7161fc2,2023-02-27 09:17:00,"Multinational pharmaceutical company Pfizer is in discussions to acquire biotech firm Seagen in a deal that could be worth more than $30 billion, The Wall Street Journal reported. Seagen ( ticker: SGEN ) is currently valued at about $30 billion and a buyout would likely require a premium to that.",PFE,0.504646,0.0,Neutral
"Seagen, Occidental Petroleum And 3 Stocks To Watch Heading Into Monday - Li Auto  ( NASDAQ:LI ) , Kosmos Energy  ( NYSE:KOS ) ",https://www.benzinga.com/news/earnings/23/02/31064178/seagen-occidental-petroleum-and-3-stocks-to-watch-heading-into-monday,2023-02-27 08:44:22,"With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Occidental Petroleum Corporation OXY to post quarterly earnings at $1.8 per share on revenue of $8.66 billion after the closing bell.",PFE,0.345674,0.119368,Neutral
'Clinical trial participation should be offered as a care option by physicians in India' | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/clinical-trial-participation-should-be-offered-as-a-care-option-by-physicians-in-india/2993921/,2023-02-27 08:30:00,'Clinical trial participation should be offered as a care option by ... The Financial Express ...,PFE,0.015054,-0.070105,Neutral
Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval,https://www.reuters.com/business/healthcare-pharmaceuticals/shionogi-sees-covid-pill-reaping-2-billion-annual-sales-upon-us-approval-2023-02-27/,2023-02-27 05:52:00,Shionogi sees COVID pill reaping $2 billion in annual sales upon ... ...,PFE,0.069094,0.029512,Neutral
Pfizer in talks to buy Seagen for likely for more than $30 bln - WSJ,https://www.reuters.com/markets/deals/pfizer-talks-buy-seagen-likely-more-than-30-bln-wsj-2023-02-27/,2023-02-27 03:34:55,Pfizer in talks to buy Seagen for likely for more than ...,PFE,0.530253,-0.126467,Neutral
"Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion",https://www.marketwatch.com/story/pfizer-eyes-takeover-of-biotech-seagen-at-value-of-more-than-30-billion-d9d87363,2023-02-27 03:26:00,"Pfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targeted cancer therapies.",PFE,0.690822,-0.057618,Neutral
"Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ - Seagen  ( NASDAQ:SGEN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/02/31063159/pfizer-in-early-talks-to-buy-cancer-focused-seagen-wsj,2023-02-27 03:14:53,"Pfizer Inc PFE is in early discussions to purchase biotechnology company Seagen Inc SGEN, The Wall Street Journal reported late on Sunday, citing people familiar with the matter. The deal would reportedly be valued at more than $30 billion and will help Pfizer bolster its cancer treatments lineup.",PFE,0.769861,0.072053,Neutral
News Exclusive | Pfizer in Early-Stage Talks to Acquire Seagen,https://www.wsj.com/articles/pfizer-in-early-stage-talks-to-acquire-seagen-3f53309e,2023-02-27 02:51:00,"Pfizer Inc. is in talks to acquire biotech Seagen Inc, according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targeted cancer therapies.",PFE,0.582526,-0.116332,Neutral
This Big Pharma Stock Is a Clear Buy,https://www.fool.com/investing/2023/02/26/this-big-pharma-stock-is-a-clear-buy/,2023-02-26 12:40:00,This drugmaker is one of the most well-known in the world.,PFE,0.064623,0.135181,Neutral
Pharma companies team up with DeSci to accelerate scientific research,https://cointelegraph.com/news/pharma-companies-team-up-with-desci-to-accelerate-scientific-research,2023-02-25 18:00:00,Pfizer is now the first big pharma to participate in a decentralized autonomous organization ( DAO ) .,PFE,0.327366,0.225142,Somewhat-Bullish
StockNews.com Downgrades Glaukos  ( NYSE:GKOS )  to Sell,https://www.defenseworld.net/2023/02/25/stocknews-com-downgrades-glaukos-nysegkos-to-sell.html,2023-02-25 09:34:43,"Glaukos ( NYSE:GKOS - Get Rating ) was downgraded by stock analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a research report issued on Thursday.",PFE,0.069697,0.113876,Neutral
Rockwell Medical  ( NASDAQ:RMTI )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/02/25/rockwell-medical-nasdaqrmti-research-coverage-started-at-stocknews-com.html,2023-02-25 09:12:42,Rockwell Medical ( NASDAQ:RMTI ) Research Coverage Started at ... Defense World ...,PFE,0.088147,0.097751,Neutral
TESSCO Technologies  ( NASDAQ:TESS )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/tessco-technologies-nasdaqtess-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 09:12:42,TESSCO Technologies ( NASDAQ:TESS ) Coverage Initiated by ... Defense World ...,PFE,0.104228,0.163016,Somewhat-Bullish
Sypris Solutions  ( NASDAQ:SYPR )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/sypris-solutions-nasdaqsypr-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-02-25 09:12:41,Sypris Solutions ( NASDAQ:SYPR ) Receives New Coverage from ... Defense World ...,PFE,0.085324,0.06809,Neutral
Streamline Health Solutions  ( NASDAQ:STRM )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/streamline-health-solutions-nasdaqstrm-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 09:12:41,Streamline Health Solutions ( NASDAQ:STRM ) Now Covered by ... Defense World ...,PFE,0.083833,0.188136,Somewhat-Bullish
Riverview Bancorp  ( NASDAQ:RVSB )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/riverview-bancorp-nasdaqrvsb-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 09:12:41,Riverview Bancorp ( NASDAQ:RVSB ) Now Covered by Analysts at ... Defense World ...,PFE,0.071357,0.10425,Neutral
UTStarcom  ( NASDAQ:UTSI )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/utstarcom-nasdaqutsi-now-covered-by-stocknews-com.html,2023-02-25 09:12:41,"Investment analysts at StockNews.com initiated coverage on shares of UTStarcom ( NASDAQ:UTSI - Get Rating ) in a research note issued on Saturday. The firm set a ""sell"" rating on the Wireless communications provider's stock. UTSI opened at $4.41 on Friday.",PFE,0.133841,0.080912,Neutral
Xinyuan Real Estate  ( NYSE:XIN )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/xinyuan-real-estate-nysexin-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 09:12:41,Xinyuan Real Estate ( NYSE:XIN ) Coverage Initiated by Analysts at ... Defense World ...,PFE,0.118647,0.129142,Neutral
Flowserve  ( NYSE:FLS )  Rating Increased to Buy at StockNews.com,https://www.etfdailynews.com/2023/02/25/flowserve-nysefls-rating-increased-to-buy-at-stocknews-com/,2023-02-25 09:06:41,"Flowserve ( NYSE:FLS - Get Rating ) was upgraded by StockNews.com from a ""hold"" rating to a ""buy"" rating in a research report issued on Thursday. A number of other equities research analysts also recently commented on the stock. Robert W.",PFE,0.059935,0.104052,Neutral
Nymox Pharmaceutical  ( NASDAQ:NYMX )  Coverage Initiated by Analysts at StockNews.com,https://www.etfdailynews.com/2023/02/25/nymox-pharmaceutical-nasdaqnymx-coverage-initiated-by-analysts-at-stocknews-com-2/,2023-02-25 09:04:41,Nymox Pharmaceutical ( NASDAQ:NYMX ) Coverage Initiated by ... ETF Daily News ...,PFE,0.127456,0.079702,Neutral
Nymox Pharmaceutical  ( NASDAQ:NYMX )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/nymox-pharmaceutical-nasdaqnymx-now-covered-by-analysts-at-stocknews-com-2.html,2023-02-25 09:04:41,Nymox Pharmaceutical ( NASDAQ:NYMX ) Now Covered by Analysts ... Defense World ...,PFE,0.123526,0.078476,Neutral
Materion  ( NYSE:MTRN )  Lowered to Hold at StockNews.com,https://reporter.am/2023/02/25/materion-nysemtrn-lowered-to-hold-at-stocknews-com.html,2023-02-25 08:58:41,"Materion ( NYSE:MTRN - Get Rating ) was downgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a report released on Saturday. Separately, KeyCorp raised their price objective on Materion from $92.00 to $130.00 and gave the stock an ""overweight"" rating in a ...",PFE,0.080458,0.109366,Neutral
StockNews.com Initiates Coverage on Reading International  ( NASDAQ:RDI ) ,https://www.etfdailynews.com/2023/02/25/stocknews-com-initiates-coverage-on-reading-international-nasdaqrdi/,2023-02-25 08:40:44,StockNews.com Initiates Coverage on Reading International ... ETF Daily News ...,PFE,0.097457,0.157105,Somewhat-Bullish
Telephone and Data Systems  ( NYSE:TDS )  Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/02/25/telephone-and-data-systems-nysetds-lowered-to-sell-at-stocknews-com.html,2023-02-25 08:40:44,Telephone and Data Systems ( NYSE:TDS ) Lowered to Sell at ... Defense World ...,PFE,0.062926,0.112225,Neutral
Atlassian  ( NASDAQ:TEAM )  Rating Increased to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/atlassian-nasdaqteam-rating-increased-to-hold-at-stocknews-com.html,2023-02-25 08:40:44,Atlassian ( NASDAQ:TEAM ) Rating Increased to Hold at StockNews ... Defense World ...,PFE,0.050572,0.141702,Neutral
Cantaloupe  ( NASDAQ:USAT )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/cantaloupe-nasdaqusat-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:40:44,Cantaloupe ( NASDAQ:USAT ) Now Covered by Analysts at ... Defense World ...,PFE,0.18967,0.090103,Neutral
Meridian Bioscience  ( NASDAQ:VIVO )  Receives New Coverage from Analysts at StockNews.com,https://www.etfdailynews.com/2023/02/25/meridian-bioscience-nasdaqvivo-receives-new-coverage-from-analysts-at-stocknews-com/,2023-02-25 08:40:43,Meridian Bioscience ( NASDAQ:VIVO ) Receives New Coverage from ... ETF Daily News ...,PFE,0.088472,0.080017,Neutral
Sotherly Hotels  ( NASDAQ:SOHO )  Now Covered by StockNews.com,https://www.etfdailynews.com/2023/02/25/sotherly-hotels-nasdaqsoho-now-covered-by-stocknews-com/,2023-02-25 08:40:43,"Investment analysts at StockNews.com started coverage on shares of Sotherly Hotels ( NASDAQ:SOHO - Get Rating ) in a report released on Saturday. The firm set a ""hold"" rating on the real estate investment trust's stock. Shares of SOHO stock opened at $2.13 on Friday.",PFE,0.087185,0.135222,Neutral
SeaChange International  ( NASDAQ:SEAC )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/seachange-international-nasdaqseac-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-02-25 08:40:43,SeaChange International ( NASDAQ:SEAC ) Earns Hold Rating from ... Defense World ...,PFE,0.079656,0.149412,Neutral
United Security Bancshares  ( NASDAQ:UBFO )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/united-security-bancshares-nasdaqubfo-now-covered-by-stocknews-com.html,2023-02-25 08:40:43,United Security Bancshares ( NASDAQ:UBFO ) Now Covered by ... Defense World ...,PFE,0.074692,0.121754,Neutral
United States Cellular  ( NYSE:USM )  Downgraded to Sell at StockNews.com,https://www.defenseworld.net/2023/02/25/united-states-cellular-nyseusm-downgraded-to-sell-at-stocknews-com.html,2023-02-25 08:40:42,United States Cellular ( NYSE:USM ) Downgraded to Sell at ... Defense World ...,PFE,0.053035,0.08891,Neutral
Rocky Mountain Chocolate Factory  ( NASDAQ:RMCF )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/rocky-mountain-chocolate-factory-nasdaqrmcf-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 08:40:42,Rocky Mountain Chocolate Factory ( NASDAQ:RMCF ) Coverage ... Defense World ...,PFE,0.128135,0.165884,Somewhat-Bullish
RiceBran Technologies  ( NASDAQ:RIBT )  Receives New Coverage from Analysts at StockNews.com,https://www.etfdailynews.com/2023/02/25/ricebran-technologies-nasdaqribt-receives-new-coverage-from-analysts-at-stocknews-com/,2023-02-25 08:40:42,RiceBran Technologies ( NASDAQ:RIBT ) Receives New Coverage ... ETF Daily News ...,PFE,0.107016,0.105381,Neutral
Xcel Brands  ( NASDAQ:XELB )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/02/25/xcel-brands-nasdaqxelb-research-coverage-started-at-stocknews-com.html,2023-02-25 08:40:42,Xcel Brands ( NASDAQ:XELB ) Research Coverage Started at ... Defense World ...,PFE,0.10607,0.101811,Neutral
StockNews.com Initiates Coverage on Sotherly Hotels  ( NASDAQ:SOHO ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-initiates-coverage-on-sotherly-hotels-nasdaqsoho-2.html,2023-02-25 08:40:42,StockNews.com Initiates Coverage on Sotherly Hotels ( NASDAQ ... Defense World ...,PFE,0.104683,0.141968,Neutral
StockNews.com Begins Coverage on SB Financial Group  ( NASDAQ:SBFG ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-begins-coverage-on-sb-financial-group-nasdaqsbfg.html,2023-02-25 08:40:41,StockNews.com Begins Coverage on SB Financial Group ( NASDAQ ... Defense World ...,PFE,0.069294,0.19771,Somewhat-Bullish
Siebert Financial  ( NASDAQ:SIEB )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/siebert-financial-nasdaqsieb-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-02-25 08:40:41,Siebert Financial ( NASDAQ:SIEB ) Receives New Coverage from ... Defense World ...,PFE,0.148731,0.095027,Neutral
Tantech  ( NASDAQ:TANH )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/tantech-nasdaqtanh-earns-sell-rating-from-analysts-at-stocknews-com-2.html,2023-02-25 08:40:41,Tantech ( NASDAQ:TANH ) Earns Sell Rating from Analysts at ... Defense World ...,PFE,0.140076,0.103979,Neutral
Polar Power  ( NASDAQ:POLA )  Coverage Initiated by Analysts at StockNews.com,https://reporter.am/2023/02/25/polar-power-nasdaqpola-coverage-initiated-by-analysts-at-stocknews-com-2.html,2023-02-25 08:34:44,Polar Power ( NASDAQ:POLA ) Coverage Initiated by Analysts at ... Armenian Reporter ...,PFE,0.093653,0.090658,Neutral
Pingtan Marine Enterprise  ( NASDAQ:PME )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/pingtan-marine-enterprise-nasdaqpme-now-covered-by-stocknews-com.html,2023-02-25 08:34:43,Pingtan Marine Enterprise ( NASDAQ:PME ) Now Covered by ... Defense World ...,PFE,0.101154,0.068309,Neutral
Pro-Dex  ( NASDAQ:PDEX )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/02/25/pro-dex-nasdaqpdex-coverage-initiated-at-stocknews-com.html,2023-02-25 08:32:52,"Investment analysts at StockNews.com initiated coverage on shares of Pro-Dex ( NASDAQ:PDEX - Get Rating ) in a research note issued to investors on Saturday. The firm set a ""buy"" rating on the medical instruments supplier's stock. Shares of PDEX stock opened at $15.32 on Friday.",PFE,0.076847,0.087445,Neutral
Marchex  ( NASDAQ:MCHX )  Coverage Initiated at StockNews.com,https://reporter.am/2023/02/25/marchex-nasdaqmchx-coverage-initiated-at-stocknews-com.html,2023-02-25 08:32:50,"Research analysts at StockNews.com initiated coverage on shares of Marchex ( NASDAQ:MCHX - Get Rating ) in a report released on Saturday. The brokerage set a ""hold"" rating on the technology company's stock. Shares of NASDAQ:MCHX opened at $2.07 on Friday.",PFE,0.097457,0.127833,Neutral
IRIDEX  ( NASDAQ:IRIX )  Now Covered by Analysts at StockNews.com,https://reporter.am/2023/02/25/iridex-nasdaqirix-now-covered-by-analysts-at-stocknews-com-2.html,2023-02-25 08:32:50,"Investment analysts at StockNews.com started coverage on shares of IRIDEX ( NASDAQ:IRIX - Get Rating ) in a research report issued to clients and investors on Saturday. The brokerage set a ""buy"" rating on the medical equipment provider's stock. Shares of NASDAQ IRIX opened at $2.14 on Friday.",PFE,0.085324,0.095129,Neutral
NantHealth  ( NASDAQ:NH )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/02/25/nanthealth-nasdaqnh-research-coverage-started-at-stocknews-com.html,2023-02-25 08:32:50,NantHealth ( NASDAQ:NH ) Research Coverage Started at ... Defense World ...,PFE,0.118647,0.202996,Somewhat-Bullish
Coffee  ( NASDAQ:JVA )  Coverage Initiated at StockNews.com,https://reporter.am/2023/02/25/coffee-nasdaqjva-coverage-initiated-at-stocknews-com.html,2023-02-25 08:32:50,"Research analysts at StockNews.com initiated coverage on shares of Coffee ( NASDAQ:JVA - Get Rating ) in a research note issued to investors on Saturday. The firm set a ""hold"" rating on the stock. NASDAQ:JVA opened at $1.90 on Friday. Coffee has a 12-month low of $1.73 and a 12-month high of ...",PFE,0.114682,0.071881,Neutral
StockNews.com Begins Coverage on NetSol Technologies  ( NASDAQ:NTWK ) ,https://www.etfdailynews.com/2023/02/25/stocknews-com-begins-coverage-on-netsol-technologies-nasdaqntwk/,2023-02-25 08:32:49,StockNews.com Begins Coverage on NetSol Technologies ... ETF Daily News ...,PFE,0.166169,0.045605,Neutral
Good Times Restaurants  ( NASDAQ:GTIM )  Now Covered by StockNews.com,https://reporter.am/2023/02/25/good-times-restaurants-nasdaqgtim-now-covered-by-stocknews-com-2.html,2023-02-25 08:32:49,Good Times Restaurants ( NASDAQ:GTIM ) Now Covered by ... Armenian Reporter ...,PFE,0.132368,0.019281,Neutral
OptimumBank  ( NASDAQ:OPHC )  Coverage Initiated at StockNews.com,https://www.etfdailynews.com/2023/02/25/optimumbank-nasdaqophc-coverage-initiated-at-stocknews-com/,2023-02-25 08:32:49,"Equities researchers at StockNews.com began coverage on shares of OptimumBank ( NASDAQ:OPHC - Get Rating ) in a report released on Saturday. The firm set a ""hold"" rating on the bank's stock. Shares of OPHC opened at $3.85 on Friday.",PFE,0.128822,0.139115,Neutral
NantHealth  ( NASDAQ:NH )  Research Coverage Started at StockNews.com,https://www.etfdailynews.com/2023/02/25/nanthealth-nasdaqnh-research-coverage-started-at-stocknews-com/,2023-02-25 08:32:49,NantHealth ( NASDAQ:NH ) Research Coverage Started at ... ETF Daily News ...,PFE,0.119235,0.203462,Somewhat-Bullish
NeoGenomics  ( NASDAQ:NEO )  Upgraded at StockNews.com,https://www.etfdailynews.com/2023/02/25/neogenomics-nasdaqneo-upgraded-at-stocknews-com/,2023-02-25 08:32:48,"NeoGenomics ( NASDAQ:NEO - Get Rating ) was upgraded by equities research analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a research report issued to clients and investors on Saturday. A number of other equities analysts have also recently weighed in on the company.",PFE,0.068502,-0.005095,Neutral
StockNews.com Initiates Coverage on Natural Alternatives International  ( NASDAQ:NAII ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-initiates-coverage-on-natural-alternatives-international-nasdaqnaii.html,2023-02-25 08:32:48,StockNews.com Initiates Coverage on Natural Alternatives ... Defense World ...,PFE,0.113062,0.17316,Somewhat-Bullish
Marchex  ( NASDAQ:MCHX )  Coverage Initiated at StockNews.com,https://www.etfdailynews.com/2023/02/25/marchex-nasdaqmchx-coverage-initiated-at-stocknews-com/,2023-02-25 08:32:47,"Equities researchers at StockNews.com assumed coverage on shares of Marchex ( NASDAQ:MCHX - Get Rating ) in a note issued to investors on Saturday. The firm set a ""hold"" rating on the technology company's stock. MCHX opened at $2.07 on Friday.",PFE,0.097854,0.127976,Neutral
Mannatech  ( NASDAQ:MTEX )  Coverage Initiated at StockNews.com,https://www.etfdailynews.com/2023/02/25/mannatech-nasdaqmtex-coverage-initiated-at-stocknews-com/,2023-02-25 08:32:47,"StockNews.com started coverage on shares of Mannatech ( NASDAQ:MTEX - Get Rating ) in a research note issued to investors on Saturday. The firm set a ""buy"" rating on the stock. Mannatech stock opened at $17.20 on Friday. Mannatech has a 52-week low of $15.49 and a 52-week high of $38.30.",PFE,0.095138,0.25008,Somewhat-Bullish
Mannatech  ( NASDAQ:MTEX )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/02/25/mannatech-nasdaqmtex-coverage-initiated-at-stocknews-com.html,2023-02-25 08:32:47,"StockNews.com initiated coverage on shares of Mannatech ( NASDAQ:MTEX - Get Rating ) in a research report issued to clients and investors on Saturday. The firm set a ""buy"" rating on the stock. NASDAQ MTEX opened at $17.20 on Friday.",PFE,0.09439,0.249571,Somewhat-Bullish
Landmark Bancorp  ( NASDAQ:LARK )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/02/25/landmark-bancorp-nasdaqlark-coverage-initiated-at-stocknews-com.html,2023-02-25 08:32:47,Landmark Bancorp ( NASDAQ:LARK ) Coverage Initiated at ... Defense World ...,PFE,0.076847,0.110921,Neutral
National CineMedia  ( NASDAQ:NCMI )  Coverage Initiated at StockNews.com,https://www.etfdailynews.com/2023/02/25/national-cinemedia-nasdaqncmi-coverage-initiated-at-stocknews-com/,2023-02-25 08:32:47,National CineMedia ( NASDAQ:NCMI ) Coverage Initiated at ... ETF Daily News ...,PFE,0.074001,0.112484,Neutral
Eltek  ( NASDAQ:ELTK )  Coverage Initiated at StockNews.com,https://reporter.am/2023/02/25/eltek-nasdaqeltk-coverage-initiated-at-stocknews-com-2.html,2023-02-25 08:32:47,"Stock analysts at StockNews.com began coverage on shares of Eltek ( NASDAQ:ELTK - Get Rating ) in a research report issued to clients and investors on Saturday. The firm set a ""hold"" rating on the technology company's stock.",PFE,0.156461,0.098747,Neutral
First United  ( NASDAQ:FUNC )  Receives New Coverage from Analysts at StockNews.com,https://reporter.am/2023/02/25/first-united-nasdaqfunc-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-02-25 08:32:47,First United ( NASDAQ:FUNC ) Receives New Coverage from ... Armenian Reporter ...,PFE,0.101154,0.170687,Somewhat-Bullish
Key Tronic  ( NASDAQ:KTCC )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/key-tronic-nasdaqktcc-now-covered-by-stocknews-com.html,2023-02-25 08:32:46,"StockNews.com started coverage on shares of Key Tronic ( NASDAQ:KTCC - Get Rating ) in a research note issued on Saturday. The firm set a ""hold"" rating on the technology company's stock. Shares of KTCC stock opened at $6.77 on Friday.",PFE,0.08687,0.10178,Neutral
IRIDEX  ( NASDAQ:IRIX )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/iridex-nasdaqirix-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:32:46,"Investment analysts at StockNews.com started coverage on shares of IRIDEX ( NASDAQ:IRIX - Get Rating ) in a research report issued to clients and investors on Saturday. The brokerage set a ""buy"" rating on the medical equipment provider's stock. Shares of NASDAQ IRIX opened at $2.14 on Friday.",PFE,0.085324,0.095129,Neutral
StockNews.com Begins Coverage on Hawthorn Bancshares  ( NASDAQ:HWBK ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-begins-coverage-on-hawthorn-bancshares-nasdaqhwbk.html,2023-02-25 08:32:46,StockNews.com Begins Coverage on Hawthorn Bancshares ... Defense World ...,PFE,0.084722,0.17178,Somewhat-Bullish
StockNews.com Begins Coverage on Landmark Bancorp  ( NASDAQ:LARK ) ,https://www.etfdailynews.com/2023/02/25/stocknews-com-begins-coverage-on-landmark-bancorp-nasdaqlark/,2023-02-25 08:32:46,StockNews.com Begins Coverage on Landmark Bancorp ( NASDAQ ... ETF Daily News ...,PFE,0.076115,0.11079,Neutral
Coffee  ( NASDAQ:JVA )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/02/25/coffee-nasdaqjva-coverage-initiated-at-stocknews-com.html,2023-02-25 08:32:46,"Research analysts at StockNews.com initiated coverage on shares of Coffee ( NASDAQ:JVA - Get Rating ) in a research note issued to investors on Saturday. The firm set a ""hold"" rating on the stock. NASDAQ:JVA opened at $1.90 on Friday. Coffee has a 12-month low of $1.73 and a 12-month high of ...",PFE,0.114682,0.071881,Neutral
Coffee  ( NASDAQ:JVA )  Coverage Initiated at StockNews.com,https://www.etfdailynews.com/2023/02/25/coffee-nasdaqjva-coverage-initiated-at-stocknews-com/,2023-02-25 08:32:46,"Equities research analysts at StockNews.com began coverage on shares of Coffee ( NASDAQ:JVA - Get Rating ) in a research report issued on Saturday. The brokerage set a ""hold"" rating on the stock. Shares of NASDAQ JVA opened at $1.90 on Friday.",PFE,0.113062,0.071479,Neutral
Hallmark Financial Services  ( NASDAQ:HALL )  Now Covered by StockNews.com,https://www.etfdailynews.com/2023/02/25/hallmark-financial-services-nasdaqhall-now-covered-by-stocknews-com/,2023-02-25 08:32:45,Hallmark Financial Services ( NASDAQ:HALL ) Now Covered by ... ETF Daily News ...,PFE,0.089462,0.032851,Neutral
Good Times Restaurants  ( NASDAQ:GTIM )  Now Covered by StockNews.com,https://www.etfdailynews.com/2023/02/25/good-times-restaurants-nasdaqgtim-now-covered-by-stocknews-com-2/,2023-02-25 08:32:44,Good Times Restaurants ( NASDAQ:GTIM ) Now Covered by ... ETF Daily News ...,PFE,0.140076,0.019925,Neutral
First United  ( NASDAQ:FUNC )  Now Covered by StockNews.com,https://www.etfdailynews.com/2023/02/25/first-united-nasdaqfunc-now-covered-by-stocknews-com/,2023-02-25 08:32:43,"Equities researchers at StockNews.com began coverage on shares of First United ( NASDAQ:FUNC - Get Rating ) in a note issued to investors on Saturday. The firm set a ""buy"" rating on the bank's stock. Shares of First United stock opened at $19.67 on Friday.",PFE,0.092213,0.166442,Somewhat-Bullish
First Capital  ( NASDAQ:FCAP )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/first-capital-nasdaqfcap-now-covered-by-stocknews-com.html,2023-02-25 08:32:43,"Stock analysts at StockNews.com initiated coverage on shares of First Capital ( NASDAQ:FCAP - Get Rating ) in a report issued on Saturday. The firm set a ""hold"" rating on the savings and loans company's stock. First Capital stock opened at $26.80 on Friday.",PFE,0.076115,0.082221,Neutral
First Community  ( NASDAQ:FCCO )  Now Covered by Analysts at StockNews.com,https://www.etfdailynews.com/2023/02/25/first-community-nasdaqfcco-now-covered-by-analysts-at-stocknews-com/,2023-02-25 08:32:43,First Community ( NASDAQ:FCCO ) Now Covered by Analysts at ... ETF Daily News ...,PFE,0.07446,0.097345,Neutral
GigaMedia  ( NASDAQ:GIGM )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/gigamedia-nasdaqgigm-now-covered-by-stocknews-com-2.html,2023-02-25 08:32:43,"Investment analysts at StockNews.com began coverage on shares of GigaMedia ( NASDAQ:GIGM - Get Rating ) in a research note issued on Saturday. The brokerage set a ""sell"" rating on the technology company's stock. Shares of GIGM opened at $1.40 on Friday.",PFE,0.130217,0.166043,Somewhat-Bullish
GSI Technology  ( NASDAQ:GSIT )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/02/25/gsi-technology-nasdaqgsit-research-coverage-started-at-stocknews-com.html,2023-02-25 08:32:41,GSI Technology ( NASDAQ:GSIT ) Research Coverage Started at ... Defense World ...,PFE,0.097854,0.068712,Neutral
Ekso Bionics  ( NASDAQ:EKSO )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/ekso-bionics-nasdaqekso-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 08:32:41,Ekso Bionics ( NASDAQ:EKSO ) Coverage Initiated by Analysts at ... Defense World ...,PFE,0.097062,0.093649,Neutral
Educational Development  ( NASDAQ:EDUC )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/02/25/educational-development-nasdaqeduc-coverage-initiated-at-stocknews-com.html,2023-02-25 08:32:41,Educational Development ( NASDAQ:EDUC ) Coverage Initiated at ... Defense World ...,PFE,0.092569,0.107217,Neutral
Symbolic Logic  ( NASDAQ:EVOL )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/02/25/symbolic-logic-nasdaqevol-coverage-initiated-at-stocknews-com.html,2023-02-25 08:32:41,Symbolic Logic ( NASDAQ:EVOL ) Coverage Initiated at StockNews ... Defense World ...,PFE,0.199037,0.114854,Neutral
Energy Focus  ( NASDAQ:EFOI )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/energy-focus-nasdaqefoi-earns-sell-rating-from-analysts-at-stocknews-com.html,2023-02-25 08:32:41,Energy Focus ( NASDAQ:EFOI ) Earns Sell Rating from Analysts at ... Defense World ...,PFE,0.11983,0.148301,Neutral
Five9  ( NASDAQ:FIVN )  Rating Increased to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/five9-nasdaqfivn-rating-increased-to-hold-at-stocknews-com.html,2023-02-25 08:30:48,"Five9 ( NASDAQ:FIVN - Get Rating ) was upgraded by equities research analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a report issued on Thursday.",PFE,0.050786,0.074955,Neutral
Baidu  ( NASDAQ:BIDU )  Stock Rating Upgraded by StockNews.com,https://www.defenseworld.net/2023/02/25/baidu-nasdaqbidu-stock-rating-upgraded-by-stocknews-com.html,2023-02-25 08:30:47,"Baidu ( NASDAQ:BIDU - Get Rating ) was upgraded by equities research analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a report issued on Thursday. Other research analysts have also issued research reports about the stock.",PFE,0.061631,0.098102,Neutral
Flowserve  ( NYSE:FLS )  Rating Increased to Buy at StockNews.com,https://www.defenseworld.net/2023/02/25/flowserve-nysefls-rating-increased-to-buy-at-stocknews-com.html,2023-02-25 08:30:47,"Flowserve ( NYSE:FLS - Get Rating ) was upgraded by StockNews.com from a ""hold"" rating to a ""buy"" rating in a research report issued on Thursday. Other equities research analysts have also issued reports about the company. TheStreet upgraded Flowserve from a ""c"" rating to a ""b"" rating in a ...",PFE,0.061473,0.10411,Neutral
Globus Medical  ( NYSE:GMED )  Rating Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/globus-medical-nysegmed-rating-lowered-to-hold-at-stocknews-com.html,2023-02-25 08:30:47,Globus Medical ( NYSE:GMED ) Rating Lowered to Hold at ... Defense World ...,PFE,0.053992,0.158016,Somewhat-Bullish
"Charles & Colvard, Ltd.  ( NASDAQ:CTHR )  Receives New Coverage from Analysts at StockNews.com",https://www.defenseworld.net/2023/02/25/charles-colvard-ltd-nasdaqcthr-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-02-25 08:28:42,"Charles & Colvard, Ltd. ( NASDAQ:CTHR ) Receives New Coverage ... Defense World ...",PFE,0.097854,0.11737,Neutral
StockNews.com Begins Coverage on Cyclacel Pharmaceuticals  ( NASDAQ:CYCC ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-begins-coverage-on-cyclacel-pharmaceuticals-nasdaqcycc.html,2023-02-25 08:28:42,StockNews.com Begins Coverage on Cyclacel Pharmaceuticals ... Defense World ...,PFE,0.096671,0.037159,Neutral
The Dixie Group  ( NASDAQ:DXYN )  Coverage Initiated by Analysts at StockNews.com,https://reporter.am/2023/02/25/the-dixie-group-nasdaqdxyn-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 08:28:42,The Dixie Group ( NASDAQ:DXYN ) Coverage Initiated by Analysts at ... Armenian Reporter ...,PFE,0.101582,0.099291,Neutral
Smart Powerr  ( NASDAQ:CREG )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/smart-powerr-nasdaqcreg-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-02-25 08:28:41,Smart Powerr ( NASDAQ:CREG ) Receives New Coverage from ... Defense World ...,PFE,0.123526,0.229001,Somewhat-Bullish
Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/02/25/cumberland-pharmaceuticals-nasdaqcpix-research-coverage-started-at-stocknews-com.html,2023-02-25 08:26:48,Cumberland Pharmaceuticals ( NASDAQ:CPIX ) Research Coverage ... Defense World ...,PFE,0.104683,0.096929,Neutral
StockNews.com Begins Coverage on Creative Media & Community Trust Co.  ( NASDAQ:CMCT ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-begins-coverage-on-creative-media-community-trust-co-nasdaqcmct.html,2023-02-25 08:26:47,StockNews.com Begins Coverage on Creative Media & Community ... Defense World ...,PFE,0.073773,0.249913,Somewhat-Bullish
ZW Data Action Technologies  ( NASDAQ:CNET )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/zw-data-action-technologies-nasdaqcnet-now-covered-by-stocknews-com.html,2023-02-25 08:26:47,ZW Data Action Technologies ( NASDAQ:CNET ) Now Covered by ... Defense World ...,PFE,0.108958,0.083453,Neutral
Cellectar Biosciences  ( NASDAQ:CLRB )  Coverage Initiated at StockNews.com,https://www.etfdailynews.com/2023/02/25/cellectar-biosciences-nasdaqclrb-coverage-initiated-at-stocknews-com/,2023-02-25 08:26:46,Cellectar Biosciences ( NASDAQ:CLRB ) Coverage Initiated at ... ETF Daily News ...,PFE,0.074692,0.009301,Neutral
StockNews.com Begins Coverage on Cancer Genetics  ( NASDAQ:CGIX ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-begins-coverage-on-cancer-genetics-nasdaqcgix-2.html,2023-02-25 08:26:46,StockNews.com Begins Coverage on Cancer Genetics ( NASDAQ ... Defense World ...,PFE,0.166169,-0.028676,Neutral
Chembio Diagnostics  ( NASDAQ:CEMI )  Now Covered by StockNews.com,https://www.etfdailynews.com/2023/02/25/chembio-diagnostics-nasdaqcemi-now-covered-by-stocknews-com/,2023-02-25 08:26:45,Chembio Diagnostics ( NASDAQ:CEMI ) Now Covered by StockNews ... ETF Daily News ...,PFE,0.098255,0.098317,Neutral
CB Financial Services  ( NASDAQ:CBFV )  Coverage Initiated by Analysts at StockNews.com,https://www.etfdailynews.com/2023/02/25/cb-financial-services-nasdaqcbfv-coverage-initiated-by-analysts-at-stocknews-com/,2023-02-25 08:26:45,CB Financial Services ( NASDAQ:CBFV ) Coverage Initiated by ... ETF Daily News ...,PFE,0.081001,0.139489,Neutral
StockNews.com Initiates Coverage on BIOLASE  ( NASDAQ:BIOL ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-initiates-coverage-on-biolase-nasdaqbiol.html,2023-02-25 08:26:45,"Investment analysts at StockNews.com assumed coverage on shares of BIOLASE ( NASDAQ:BIOL - Get Rating ) in a report released on Saturday. The brokerage set a ""sell"" rating on the medical technology company's stock. Other equities research analysts have also recently issued research reports ...",PFE,0.074926,0.084525,Neutral
Euro Tech  ( NASDAQ:CLWT )  Earns Sell Rating from Analysts at StockNews.com,https://reporter.am/2023/02/25/euro-tech-nasdaqclwt-earns-sell-rating-from-analysts-at-stocknews-com.html,2023-02-25 08:26:45,Euro Tech ( NASDAQ:CLWT ) Earns Sell Rating from Analysts at ... Armenian Reporter ...,PFE,0.133841,0.121095,Neutral
ZW Data Action Technologies  ( NASDAQ:CNET )  Now Covered by StockNews.com,https://reporter.am/2023/02/25/zw-data-action-technologies-nasdaqcnet-now-covered-by-stocknews-com.html,2023-02-25 08:26:45,ZW Data Action Technologies ( NASDAQ:CNET ) Now Covered by ... Armenian Reporter ...,PFE,0.108958,0.083453,Neutral
Chembio Diagnostics  ( NASDAQ:CEMI )  Now Covered by StockNews.com,https://reporter.am/2023/02/25/chembio-diagnostics-nasdaqcemi-now-covered-by-stocknews-com-2.html,2023-02-25 08:26:44,Chembio Diagnostics ( NASDAQ:CEMI ) Now Covered by StockNews ... Armenian Reporter ...,PFE,0.095899,0.097619,Neutral
BancFirst  ( NASDAQ:BANF )  Stock Rating Lowered by StockNews.com,https://www.etfdailynews.com/2023/02/25/bancfirst-nasdaqbanf-stock-rating-lowered-by-stocknews-com/,2023-02-25 08:26:44,"BancFirst ( NASDAQ:BANF - Get Rating ) was downgraded by equities research analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a report issued on Saturday.",PFE,0.089797,0.099204,Neutral
ClearSign Technologies  ( NASDAQ:CLIR )  Coverage Initiated by Analysts at StockNews.com,https://reporter.am/2023/02/25/clearsign-technologies-nasdaqclir-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 08:26:44,ClearSign Technologies ( NASDAQ:CLIR ) Coverage Initiated by ... Armenian Reporter ...,PFE,0.138464,0.175288,Somewhat-Bullish
StockNews.com Begins Coverage on Comstock Holding Companies  ( NASDAQ:CHCI ) ,https://reporter.am/2023/02/25/stocknews-com-begins-coverage-on-comstock-holding-companies-nasdaqchci-2.html,2023-02-25 08:26:44,StockNews.com Begins Coverage on Comstock Holding Companies ... Armenian Reporter ...,PFE,0.109956,0.135046,Neutral
BancFirst  ( NASDAQ:BANF )  Stock Rating Lowered by StockNews.com,https://reporter.am/2023/02/25/bancfirst-nasdaqbanf-stock-rating-lowered-by-stocknews-com.html,2023-02-25 08:26:43,"BancFirst ( NASDAQ:BANF - Get Rating ) was downgraded by equities research analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a research report issued on Saturday.",PFE,0.096283,0.100897,Neutral
StockNews.com Initiates Coverage on Beasley Broadcast Group  ( NASDAQ:BBGI ) ,https://reporter.am/2023/02/25/stocknews-com-initiates-coverage-on-beasley-broadcast-group-nasdaqbbgi.html,2023-02-25 08:26:43,StockNews.com Initiates Coverage on Beasley Broadcast Group ... Armenian Reporter ...,PFE,0.09186,0.106107,Neutral
StockNews.com Begins Coverage on Safeguard Scientifics  ( NYSE:SFE ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-begins-coverage-on-safeguard-scientifics-nysesfe-2.html,2023-02-25 08:26:43,StockNews.com Begins Coverage on Safeguard Scientifics ( NYSE ... Defense World ...,PFE,0.090474,0.131094,Neutral
StockNews.com Begins Coverage on Bellerophon Therapeutics  ( NASDAQ:BLPH ) ,https://reporter.am/2023/02/25/stocknews-com-begins-coverage-on-bellerophon-therapeutics-nasdaqblph.html,2023-02-25 08:26:43,StockNews.com Begins Coverage on Bellerophon Therapeutics ... Armenian Reporter ...,PFE,0.128135,0.126676,Neutral
Art's-Way Manufacturing  ( NASDAQ:ARTW )  Coverage Initiated at StockNews.com,https://reporter.am/2023/02/25/arts-way-manufacturing-nasdaqartw-coverage-initiated-at-stocknews-com.html,2023-02-25 08:26:43,Art's-Way Manufacturing ( NASDAQ:ARTW ) Coverage Initiated at ... Armenian Reporter ...,PFE,0.112532,0.076016,Neutral
ADDvantage Technologies Group  ( NASDAQ:AEY )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/addvantage-technologies-group-nasdaqaey-earns-sell-rating-from-analysts-at-stocknews-com-2.html,2023-02-25 08:26:42,ADDvantage Technologies Group ( NASDAQ:AEY ) Earns Sell Rating ... Defense World ...,PFE,0.087503,0.099582,Neutral
AstroNova  ( NASDAQ:ALOT )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/astronova-nasdaqalot-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:26:42,AstroNova ( NASDAQ:ALOT ) Now Covered by Analysts at ... Defense World ...,PFE,0.072655,0.069883,Neutral
"OGE Energy  ( NYSE:OGE )  Downgraded to ""Hold"" at StockNews.com",https://www.etfdailynews.com/2023/02/25/oge-energy-nyseoge-downgraded-to-hold-at-stocknews-com/,2023-02-25 08:26:42,"OGE Energy ( NYSE:OGE - Get Rating ) was downgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a report released on Saturday.",PFE,0.068896,0.11235,Neutral
Nabors Industries  ( NYSE:NBR )  Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/nabors-industries-nysenbr-lowered-to-hold-at-stocknews-com.html,2023-02-25 08:26:42,"Nabors Industries ( NYSE:NBR - Get Rating ) was downgraded by investment analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a report issued on Saturday. A number of other analysts have also recently commented on NBR. Benchmark began coverage on Nabors Industries in a research ...",PFE,0.062597,0.13948,Neutral
Advaxis  ( NASDAQ:ADXS )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/advaxis-nasdaqadxs-coverage-initiated-by-analysts-at-stocknews-com-2.html,2023-02-25 08:26:42,Advaxis ( NASDAQ:ADXS ) Coverage Initiated by Analysts at ... Defense World ...,PFE,0.218817,-0.008804,Neutral
StockNews.com Initiates Coverage on Natuzzi  ( NYSE:NTZ ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-initiates-coverage-on-natuzzi-nysentz.html,2023-02-25 08:26:42,"Stock analysts at StockNews.com started coverage on shares of Natuzzi ( NYSE:NTZ - Get Rating ) in a note issued to investors on Saturday. The brokerage set a ""hold"" rating on the stock. NYSE NTZ opened at $6.23 on Friday. Natuzzi has a 1 year low of $4.40 and a 1 year high of $14.00.",PFE,0.169676,0.128604,Neutral
ATA Creativity Global  ( NASDAQ:AACG )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/ata-creativity-global-nasdaqaacg-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:26:42,ATA Creativity Global ( NASDAQ:AACG ) Now Covered by Analysts at ... Defense World ...,PFE,0.1331,0.146077,Neutral
AstroNova  ( NASDAQ:ALOT )  Now Covered by Analysts at StockNews.com,https://reporter.am/2023/02/25/astronova-nasdaqalot-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:26:41,AstroNova ( NASDAQ:ALOT ) Now Covered by Analysts at ... Armenian Reporter ...,PFE,0.072655,0.069883,Neutral
Everest Re Group  ( NYSE:RE )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/02/25/everest-re-group-nysere-stock-rating-lowered-by-stocknews-com.html,2023-02-25 08:26:41,Everest Re Group ( NYSE:RE ) Stock Rating Lowered by StockNews ... Defense World ...,PFE,0.056275,0.049052,Neutral
Startek  ( NYSE:SRT )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/startek-nysesrt-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 08:26:41,"Analysts at StockNews.com assumed coverage on shares of Startek ( NYSE:SRT - Get Rating ) in a research report issued on Saturday. The firm set a ""buy"" rating on the business services provider's stock. Separately, B. Riley reaffirmed a ""buy"" rating on shares of Startek in a research report on ...",PFE,0.158519,0.229646,Somewhat-Bullish
StockNews.com Begins Coverage on Akari Therapeutics  ( NASDAQ:AKTX ) ,https://reporter.am/2023/02/25/stocknews-com-begins-coverage-on-akari-therapeutics-nasdaqaktx-2.html,2023-02-25 08:26:41,StockNews.com Begins Coverage on Akari Therapeutics ( NASDAQ ... Armenian Reporter ...,PFE,0.138464,0.140668,Neutral
StockNews.com Lowers Aptevo Therapeutics  ( NASDAQ:APVO )  to Sell,https://reporter.am/2023/02/25/stocknews-com-lowers-aptevo-therapeutics-nasdaqapvo-to-sell.html,2023-02-25 08:26:41,"Aptevo Therapeutics ( NASDAQ:APVO - Get Rating ) was downgraded by research analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a research note issued to investors on Saturday. Shares of APVO stock opened at $2.01 on Friday.",PFE,0.10607,0.049057,Neutral
Materion  ( NYSE:MTRN )  Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/materion-nysemtrn-lowered-to-hold-at-stocknews-com.html,2023-02-25 08:18:49,"Materion ( NYSE:MTRN - Get Rating ) was downgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a report released on Saturday. Separately, KeyCorp raised their price objective on Materion from $92.00 to $130.00 and gave the stock an ""overweight"" rating in a ...",PFE,0.080458,0.109366,Neutral
Leju  ( NYSE:LEJU )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/leju-nyseleju-now-covered-by-stocknews-com.html,2023-02-25 08:18:49,"Analysts at StockNews.com started coverage on shares of Leju ( NYSE:LEJU - Get Rating ) in a note issued to investors on Saturday. The firm set a ""buy"" rating on the financial services provider's stock. LEJU stock opened at $1.20 on Friday.",PFE,0.204072,0.079722,Neutral
China Life Insurance  ( NYSE:LFCHY )  Now Covered by Analysts at StockNews.com,https://www.etfdailynews.com/2023/02/25/china-life-insurance-nyselfchy-now-covered-by-analysts-at-stocknews-com/,2023-02-25 08:18:48,China Life Insurance ( NYSE:LFCHY ) Now Covered by Analysts at ... ETF Daily News ...,PFE,0.158519,0.045569,Neutral
Cheetah Mobile  ( NYSE:CMCM )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/cheetah-mobile-nysecmcm-now-covered-by-stocknews-com.html,2023-02-25 08:18:48,"Equities research analysts at StockNews.com assumed coverage on shares of Cheetah Mobile ( NYSE:CMCM - Get Rating ) in a research report issued on Saturday. The brokerage set a ""hold"" rating on the software maker's stock. Cheetah Mobile stock opened at $2.59 on Friday.",PFE,0.124809,0.211101,Somewhat-Bullish
Badger Meter  ( NYSE:BMI )  Cut to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/badger-meter-nysebmi-cut-to-hold-at-stocknews-com.html,2023-02-25 08:18:47,"Badger Meter ( NYSE:BMI - Get Rating ) was downgraded by StockNews.com from a ""buy"" rating to a ""hold"" rating in a research note issued on Saturday. NYSE BMI opened at $117.39 on Friday. Badger Meter has a fifty-two week low of $73.20 and a fifty-two week high of $123.59.",PFE,0.07446,0.103379,Neutral
WidePoint  ( NYSE:WYY )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/02/25/widepoint-nysewyy-research-coverage-started-at-stocknews-com.html,2023-02-25 08:18:47,WidePoint ( NYSE:WYY ) Research Coverage Started at StockNews ... Defense World ...,PFE,0.185306,0.060048,Neutral
International Tower Hill Mines  ( NYSE:THM )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/international-tower-hill-mines-nysethm-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:18:47,International Tower Hill Mines ( NYSE:THM ) Now Covered by ... Defense World ...,PFE,0.174587,0.078957,Neutral
China Green Agriculture  ( NYSE:CGA )  Now Covered by Analysts at StockNews.com,https://www.etfdailynews.com/2023/02/25/china-green-agriculture-nysecga-now-covered-by-analysts-at-stocknews-com/,2023-02-25 08:18:47,China Green Agriculture ( NYSE:CGA ) Now Covered by Analysts at ... ETF Daily News ...,PFE,0.137671,0.115554,Neutral
Leju  ( NYSE:LEJU )  Now Covered by StockNews.com,https://reporter.am/2023/02/25/leju-nyseleju-now-covered-by-stocknews-com.html,2023-02-25 08:18:46,"Analysts at StockNews.com started coverage on shares of Leju ( NYSE:LEJU - Get Rating ) in a note issued to investors on Saturday. The firm set a ""buy"" rating on the financial services provider's stock. LEJU stock opened at $1.20 on Friday.",PFE,0.204072,0.079722,Neutral
Cheetah Mobile  ( NYSE:CMCM )  Now Covered by StockNews.com,https://reporter.am/2023/02/25/cheetah-mobile-nysecmcm-now-covered-by-stocknews-com.html,2023-02-25 08:18:46,"Equities research analysts at StockNews.com assumed coverage on shares of Cheetah Mobile ( NYSE:CMCM - Get Rating ) in a research report issued on Saturday. The brokerage set a ""hold"" rating on the software maker's stock. Cheetah Mobile stock opened at $2.59 on Friday.",PFE,0.124809,0.211101,Somewhat-Bullish
Badger Meter  ( NYSE:BMI )  Cut to Hold at StockNews.com,https://reporter.am/2023/02/25/badger-meter-nysebmi-cut-to-hold-at-stocknews-com.html,2023-02-25 08:18:45,"Badger Meter ( NYSE:BMI - Get Rating ) was downgraded by StockNews.com from a ""buy"" rating to a ""hold"" rating in a research note issued on Saturday. NYSE BMI opened at $117.39 on Friday. Badger Meter has a fifty-two week low of $73.20 and a fifty-two week high of $123.59.",PFE,0.07446,0.103379,Neutral
Navidea Biopharmaceuticals  ( NYSE:NAVB )  Research Coverage Started at StockNews.com,https://www.etfdailynews.com/2023/02/25/navidea-biopharmaceuticals-nysenavb-research-coverage-started-at-stocknews-com/,2023-02-25 08:18:45,Navidea Biopharmaceuticals ( NYSE:NAVB ) Research Coverage ... ETF Daily News ...,PFE,0.195814,0.05936,Neutral
WidePoint  ( NYSE:WYY )  Research Coverage Started at StockNews.com,https://reporter.am/2023/02/25/widepoint-nysewyy-research-coverage-started-at-stocknews-com-2.html,2023-02-25 08:18:45,WidePoint ( NYSE:WYY ) Research Coverage Started at StockNews ... Armenian Reporter ...,PFE,0.185306,0.060048,Neutral
Evolve Transition Infrastructure  ( NYSE:SNMP )  Coverage Initiated at StockNews.com,https://reporter.am/2023/02/25/evolve-transition-infrastructure-nysesnmp-coverage-initiated-at-stocknews-com.html,2023-02-25 08:18:45,Evolve Transition Infrastructure ( NYSE:SNMP ) Coverage Initiated at ... Armenian Reporter ...,PFE,0.183895,0.097335,Neutral
Oragenics  ( NYSE:OGEN )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/oragenics-nyseogen-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 08:18:45,Oragenics ( NYSE:OGEN ) Coverage Initiated by Analysts at ... Defense World ...,PFE,0.181137,0.059075,Neutral
International Tower Hill Mines  ( NYSE:THM )  Now Covered by Analysts at StockNews.com,https://reporter.am/2023/02/25/international-tower-hill-mines-nysethm-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:18:45,International Tower Hill Mines ( NYSE:THM ) Now Covered by ... Armenian Reporter ...,PFE,0.174587,0.078957,Neutral
Emerson Radio  ( NYSE:MSN )  Receives New Coverage from Analysts at StockNews.com,https://www.etfdailynews.com/2023/02/25/emerson-radio-nysemsn-receives-new-coverage-from-analysts-at-stocknews-com/,2023-02-25 08:18:44,Emerson Radio ( NYSE:MSN ) Receives New Coverage from ... ETF Daily News ...,PFE,0.188193,0.105327,Neutral
Oragenics  ( NYSE:OGEN )  Coverage Initiated by Analysts at StockNews.com,https://reporter.am/2023/02/25/oragenics-nyseogen-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 08:18:44,Oragenics ( NYSE:OGEN ) Coverage Initiated by Analysts at ... Armenian Reporter ...,PFE,0.181137,0.059075,Neutral
Inuvo  ( NYSE:INUV )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/02/25/inuvo-nyseinuv-research-coverage-started-at-stocknews-com.html,2023-02-25 08:18:43,"Analysts at StockNews.com began coverage on shares of Inuvo ( NYSE:INUV - Get Rating ) in a report released on Saturday. The firm set a ""sell"" rating on the stock. Shares of NYSE:INUV opened at $0.38 on Friday. The stock has a market cap of $45.41 million, a price-to-earnings ratio of -4.20 and ...",PFE,0.199037,0.095108,Neutral
Bluerock Residential Growth REIT  ( NYSE:BRG )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/bluerock-residential-growth-reit-nysebrg-coverage-initiated-by-analysts-at-stocknews-com.html,2023-02-25 08:18:43,Bluerock Residential Growth REIT ( NYSE:BRG ) Coverage Initiated ... Defense World ...,PFE,0.181137,0.140896,Neutral
Emerson Radio  ( NYSE:MSN )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/emerson-radio-nysemsn-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-02-25 08:18:43,Emerson Radio ( NYSE:MSN ) Receives New Coverage from ... Defense World ...,PFE,0.181137,0.069798,Neutral
StockNews.com Initiates Coverage on Avalon  ( NYSE:AWX ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-initiates-coverage-on-avalon-nyseawx.html,2023-02-25 08:18:43,"Equities researchers at StockNews.com assumed coverage on shares of Avalon ( NYSE:AWX - Get Rating ) in a research note issued to investors on Saturday. The brokerage set a ""hold"" rating on the stock. Shares of NYSE AWX opened at $2.90 on Friday.",PFE,0.166169,0.067752,Neutral
StockNews.com Initiates Coverage on Isoray  ( NYSE:ISR ) ,https://www.defenseworld.net/2023/02/25/stocknews-com-initiates-coverage-on-isoray-nyseisr.html,2023-02-25 08:18:42,"Analysts at StockNews.com began coverage on shares of Isoray ( NYSE:ISR - Get Rating ) in a research note issued on Saturday. The firm set a ""sell"" rating on the stock. Isoray has a 12-month low of $0.19 and a 12-month high of $0.45.",PFE,0.224903,0.096924,Neutral
Milestone Scientific  ( NYSE:MLSS )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/milestone-scientific-nysemlss-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:18:42,Milestone Scientific ( NYSE:MLSS ) Now Covered by Analysts at ... Defense World ...,PFE,0.169676,0.052057,Neutral
Impac Mortgage  ( NYSE:IMH )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/02/25/impac-mortgage-nyseimh-research-coverage-started-at-stocknews-com.html,2023-02-25 08:18:42,Impac Mortgage ( NYSE:IMH ) Research Coverage Started at ... Defense World ...,PFE,0.16171,0.063751,Neutral
StockNews.com Initiates Coverage on Isoray  ( NYSE:ISR ) ,https://reporter.am/2023/02/25/stocknews-com-initiates-coverage-on-isoray-nyseisr.html,2023-02-25 08:18:41,"Analysts at StockNews.com began coverage on shares of Isoray ( NYSE:ISR - Get Rating ) in a research note issued on Saturday. The firm set a ""sell"" rating on the stock. Isoray has a 12-month low of $0.19 and a 12-month high of $0.45.",PFE,0.224903,0.096924,Neutral
CoreCard  ( NYSE:INS )  Earns Hold Rating from Analysts at StockNews.com,https://reporter.am/2023/02/25/corecard-nyseins-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-02-25 08:18:41,CoreCard ( NYSE:INS ) Earns Hold Rating from Analysts at ... Armenian Reporter ...,PFE,0.202366,0.10976,Neutral
StockNews.com Begins Coverage on InnSuites Hospitality Trust  ( NYSE:IHT ) ,https://reporter.am/2023/02/25/stocknews-com-begins-coverage-on-innsuites-hospitality-trust-nyseiht.html,2023-02-25 08:18:41,StockNews.com Begins Coverage on InnSuites Hospitality Trust ... Armenian Reporter ...,PFE,0.175859,0.118079,Neutral
Golden Star Resources  ( NYSE:GSS )  Now Covered by Analysts at StockNews.com,https://reporter.am/2023/02/25/golden-star-resources-nysegss-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:18:41,Golden Star Resources ( NYSE:GSS ) Now Covered by Analysts at ... Armenian Reporter ...,PFE,0.169676,0.148566,Neutral
Golden Star Resources  ( NYSE:GSS )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/02/25/golden-star-resources-nysegss-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:18:41,Golden Star Resources ( NYSE:GSS ) Now Covered by Analysts at ... Defense World ...,PFE,0.169676,0.148566,Neutral
Ballantyne Strong  ( NYSE:BTN )  Now Covered by Analysts at StockNews.com,https://reporter.am/2023/02/25/ballantyne-strong-nysebtn-now-covered-by-analysts-at-stocknews-com.html,2023-02-25 08:18:41,Ballantyne Strong ( NYSE:BTN ) Now Covered by Analysts at ... Armenian Reporter ...,PFE,0.16849,0.118945,Neutral
Impac Mortgage  ( NYSE:IMH )  Research Coverage Started at StockNews.com,https://reporter.am/2023/02/25/impac-mortgage-nyseimh-research-coverage-started-at-stocknews-com.html,2023-02-25 08:18:41,Impac Mortgage ( NYSE:IMH ) Research Coverage Started at ... Armenian Reporter ...,PFE,0.16171,0.063751,Neutral
Contango Oil & Gas  ( NYSE:MCF )  Research Coverage Started at StockNews.com,https://reporter.am/2023/02/25/contango-oil-gas-nysemcf-research-coverage-started-at-stocknews-com.html,2023-02-25 08:18:41,Contango Oil & Gas ( NYSE:MCF ) Research Coverage Started at ... Armenian Reporter ...,PFE,0.158519,0.090654,Neutral
NVIDIA  ( NASDAQ:NVDA )  Stock Rating Upgraded by StockNews.com,https://www.defenseworld.net/2023/02/25/nvidia-nasdaqnvda-stock-rating-upgraded-by-stocknews-com.html,2023-02-25 08:02:43,"NVIDIA ( NASDAQ:NVDA - Get Rating ) was upgraded by stock analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a report released on Thursday. Other equities research analysts also recently issued reports about the company.",PFE,0.047654,0.073423,Neutral
"NVIDIA  ( NASDAQ:NVDA )  Lifted to ""Hold"" at StockNews.com",https://www.etfdailynews.com/2023/02/25/nvidia-nasdaqnvda-lifted-to-hold-at-stocknews-com/,2023-02-25 08:02:41,"NVIDIA ( NASDAQ:NVDA - Get Rating ) was upgraded by investment analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a research report issued on Thursday.",PFE,0.045482,0.073139,Neutral
StockNews.com Downgrades Brinker International  ( NYSE:EAT )  to Hold,https://www.defenseworld.net/2023/02/25/stocknews-com-downgrades-brinker-international-nyseeat-to-hold.html,2023-02-25 07:58:46,StockNews.com Downgrades Brinker International ( NYSE:EAT ) to ... Defense World ...,PFE,0.053271,0.095936,Neutral
American Superconductor  ( NASDAQ:AMSC )  Stock Rating Upgraded by StockNews.com,https://www.defenseworld.net/2023/02/25/american-superconductor-nasdaqamsc-stock-rating-upgraded-by-stocknews-com.html,2023-02-25 07:58:45,American Superconductor ( NASDAQ:AMSC ) Stock Rating ... Defense World ...,PFE,0.076847,0.130915,Neutral
Invesco Mortgage Capital  ( NYSE:IVR )  Rating Increased to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/invesco-mortgage-capital-nyseivr-rating-increased-to-hold-at-stocknews-com.html,2023-02-25 07:58:45,Invesco Mortgage Capital ( NYSE:IVR ) Rating Increased to Hold at ... Defense World ...,PFE,0.076602,0.128309,Neutral
Allegion  ( NYSE:ALLE )  Stock Rating Upgraded by StockNews.com,https://reporter.am/2023/02/25/allegion-nysealle-stock-rating-upgraded-by-stocknews-com.html,2023-02-25 07:58:45,"Allegion ( NYSE:ALLE - Get Rating ) was upgraded by equities research analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research report issued on Thursday. A number of other equities analysts have also weighed in on the stock.",PFE,0.07031,0.163417,Somewhat-Bullish
StockNews.com Downgrades Kaiser Aluminum  ( NASDAQ:KALU )  to Sell,https://www.defenseworld.net/2023/02/25/stocknews-com-downgrades-kaiser-aluminum-nasdaqkalu-to-sell.html,2023-02-25 07:58:45,StockNews.com Downgrades Kaiser Aluminum ( NASDAQ:KALU ) to ... Defense World ...,PFE,0.067919,0.092839,Neutral
Physicians Realty Trust  ( NYSE:DOC )  Rating Increased to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/physicians-realty-trust-nysedoc-rating-increased-to-hold-at-stocknews-com.html,2023-02-25 07:58:45,Physicians Realty Trust ( NYSE:DOC ) Rating Increased to Hold at ... Defense World ...,PFE,0.066414,0.201193,Somewhat-Bullish
StockNews.com Upgrades Stantec  ( NYSE:STN )  to Strong-Buy,https://reporter.am/2023/02/25/stocknews-com-upgrades-stantec-nysestn-to-strong-buy.html,2023-02-25 07:58:44,"Stantec ( NYSE:STN - Get Rating ) ( TSE:STN ) was upgraded by equities researchers at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a report issued on Thursday.",PFE,0.07423,0.130793,Neutral
Masonite International  ( NYSE:DOOR )  Rating Lowered to Buy at StockNews.com,https://www.defenseworld.net/2023/02/25/masonite-international-nysedoor-rating-lowered-to-buy-at-stocknews-com.html,2023-02-25 07:58:44,Masonite International ( NYSE:DOOR ) Rating Lowered to Buy at ... Defense World ...,PFE,0.067727,0.065487,Neutral
"Big Lots  ( NYSE:BIG )  Downgraded to ""Sell"" at StockNews.com",https://reporter.am/2023/02/25/big-lots-nysebig-downgraded-to-sell-at-stocknews-com.html,2023-02-25 07:58:44,"Big Lots ( NYSE:BIG - Get Rating ) was downgraded by analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a note issued to investors on Thursday. A number of other equities analysts have also recently commented on BIG. Credit Suisse Group began coverage on shares of Big Lots in ...",PFE,0.062597,0.090225,Neutral
StockNews.com Downgrades Civista Bancshares  ( NASDAQ:CIVB )  to Hold,https://www.defenseworld.net/2023/02/25/stocknews-com-downgrades-civista-bancshares-nasdaqcivb-to-hold.html,2023-02-25 07:58:44,StockNews.com Downgrades Civista Bancshares ( NASDAQ:CIVB ... Defense World ...,PFE,0.061315,0.112106,Neutral
Rio Tinto Group  ( NYSE:RIO )  Rating Increased to Strong-Buy at StockNews.com,https://www.defenseworld.net/2023/02/25/rio-tinto-group-nyserio-rating-increased-to-strong-buy-at-stocknews-com.html,2023-02-25 07:58:44,Rio Tinto Group ( NYSE:RIO ) Rating Increased to Strong-Buy at ... Defense World ...,PFE,0.060388,0.123096,Neutral
"StockNews.com Upgrades Kroger  ( NYSE:KR )  to ""Strong-Buy""",https://reporter.am/2023/02/25/stocknews-com-upgrades-kroger-nysekr-to-strong-buy.html,2023-02-25 07:58:44,"Kroger ( NYSE:KR - Get Rating ) was upgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research report issued on Thursday. KR has been the topic of a number of other reports.",PFE,0.054236,0.138983,Neutral
OLO  ( NYSE:OLO )  Rating Increased to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/olo-nyseolo-rating-increased-to-hold-at-stocknews-com.html,2023-02-25 07:58:44,"OLO ( NYSE:OLO - Get Rating ) was upgraded by StockNews.com from a ""sell"" rating to a ""hold"" rating in a research note issued on Thursday. OLO has been the topic of several other research reports. Piper Sandler reissued a ""neutral"" rating and set a $9.00 price target on shares of OLO in a ...",PFE,0.049732,0.142596,Neutral
Wolverine World Wide  ( NYSE:WWW )  Rating Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/02/25/wolverine-world-wide-nysewww-rating-lowered-to-sell-at-stocknews-com.html,2023-02-25 07:58:44,Wolverine World Wide ( NYSE:WWW ) Rating Lowered to Sell at ... Defense World ...,PFE,0.045396,0.162837,Somewhat-Bullish
GEE Group  ( NYSE:JOB )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/gee-group-nysejob-now-covered-by-stocknews-com.html,2023-02-25 07:58:44,"StockNews.com started coverage on shares of GEE Group ( NYSE:JOB - Get Rating ) in a report released on Thursday. The brokerage set a ""buy"" rating on the stock. Shares of JOB opened at $0.40 on Thursday.",PFE,0.188193,0.084936,Neutral
GEE Group  ( NYSE:JOB )  Now Covered by StockNews.com,https://reporter.am/2023/02/25/gee-group-nysejob-now-covered-by-stocknews-com.html,2023-02-25 07:58:44,"StockNews.com started coverage on shares of GEE Group ( NYSE:JOB - Get Rating ) in a report released on Thursday. The brokerage set a ""buy"" rating on the stock. Shares of JOB opened at $0.40 on Thursday.",PFE,0.188193,0.084936,Neutral
Amkor Technology  ( NASDAQ:AMKR )  Stock Rating Upgraded by StockNews.com,https://www.defenseworld.net/2023/02/25/amkor-technology-nasdaqamkr-stock-rating-upgraded-by-stocknews-com.html,2023-02-25 07:58:43,Amkor Technology ( NASDAQ:AMKR ) Stock Rating Upgraded by ... Defense World ...,PFE,0.060694,0.074133,Neutral
StockNews.com Downgrades WESCO International  ( NYSE:WCC )  to Hold,https://www.defenseworld.net/2023/02/25/stocknews-com-downgrades-wesco-international-nysewcc-to-hold.html,2023-02-25 07:58:43,StockNews.com Downgrades WESCO International ( NYSE:WCC ) to ... Defense World ...,PFE,0.045569,0.120912,Neutral
KNOT Offshore Partners  ( NYSE:KNOP )  Rating Lowered to Hold at StockNews.com,https://reporter.am/2023/02/25/knot-offshore-partners-nyseknop-rating-lowered-to-hold-at-stocknews-com.html,2023-02-25 07:58:42,KNOT Offshore Partners ( NYSE:KNOP ) Rating Lowered to Hold at ... Armenian Reporter ...,PFE,0.084722,0.059511,Neutral
StockNews.com Upgrades Stantec  ( NYSE:STN )  to Strong-Buy,https://www.defenseworld.net/2023/02/25/stocknews-com-upgrades-stantec-nysestn-to-strong-buy.html,2023-02-25 07:58:42,"Stantec ( NYSE:STN - Get Rating ) ( TSE:STN ) was upgraded by equities researchers at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a report issued on Thursday.",PFE,0.07423,0.130793,Neutral
StockNews.com Downgrades Constellium  ( NYSE:CSTM )  to Hold,https://www.defenseworld.net/2023/02/25/stocknews-com-downgrades-constellium-nysecstm-to-hold.html,2023-02-25 07:58:42,"Constellium ( NYSE:CSTM - Get Rating ) was downgraded by investment analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research report issued to clients and investors on Thursday. Other analysts have also recently issued reports about the stock.",PFE,0.071784,0.093886,Neutral
StockNews.com Downgrades Unisys  ( NYSE:UIS )  to Sell,https://www.defenseworld.net/2023/02/25/stocknews-com-downgrades-unisys-nyseuis-to-sell.html,2023-02-25 07:58:42,"Unisys ( NYSE:UIS - Get Rating ) was downgraded by analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a research note issued on Thursday. UIS has been the subject of several other research reports.",PFE,0.059194,0.153705,Somewhat-Bullish
Wolverine World Wide  ( NYSE:WWW )  Rating Lowered to Sell at StockNews.com,https://reporter.am/2023/02/25/wolverine-world-wide-nysewww-rating-lowered-to-sell-at-stocknews-com.html,2023-02-25 07:58:42,Wolverine World Wide ( NYSE:WWW ) Rating Lowered to Sell at ... Armenian Reporter ...,PFE,0.045396,0.162837,Somewhat-Bullish
BlueLinx  ( NYSE:BXC )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/02/25/bluelinx-nysebxc-stock-rating-lowered-by-stocknews-com.html,2023-02-25 07:58:41,"BlueLinx ( NYSE:BXC - Get Rating ) was downgraded by equities research analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research report issued on Thursday. Separately, Benchmark boosted their target price on BlueLinx from $95.00 to $105.00 and gave the stock a ""buy"" rating ...",PFE,0.097457,0.098878,Neutral
Nautilus  ( NYSE:NLS )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/02/25/nautilus-nysenls-stock-rating-lowered-by-stocknews-com.html,2023-02-25 07:58:41,"Nautilus ( NYSE:NLS - Get Rating ) was downgraded by StockNews.com from a ""hold"" rating to a ""sell"" rating in a research report issued on Thursday. Separately, William Blair lowered shares of Nautilus from an ""outperform"" rating to a ""market perform"" rating in a report on Friday, February 10th.",PFE,0.085022,0.143714,Neutral
StockNews.com Downgrades Canon  ( NYSE:CAJ )  to Buy,https://www.defenseworld.net/2023/02/25/stocknews-com-downgrades-canon-nysecaj-to-buy.html,2023-02-25 07:58:41,"Canon ( NYSE:CAJ - Get Rating ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued to investors on Thursday.",PFE,0.082111,0.082049,Neutral
StockNews.com Upgrades Innospec  ( NASDAQ:IOSP )  to Strong-Buy,https://reporter.am/2023/02/25/stocknews-com-upgrades-innospec-nasdaqiosp-to-strong-buy.html,2023-02-25 07:58:41,"Innospec ( NASDAQ:IOSP - Get Rating ) was upgraded by research analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research report issued on Thursday. NASDAQ:IOSP opened at $109.42 on Thursday. Innospec has a one year low of $83.13 and a one year high of $116.00.",PFE,0.07887,0.093842,Neutral
StockNews.com Downgrades Comfort Systems USA  ( NYSE:FIX )  to Hold,https://reporter.am/2023/02/25/stocknews-com-downgrades-comfort-systems-usa-nysefix-to-hold.html,2023-02-25 07:58:41,StockNews.com Downgrades Comfort Systems USA ( NYSE:FIX ) to ... Armenian Reporter ...,PFE,0.076602,0.090026,Neutral
TJX Companies  ( NYSE:TJX )  Rating Increased to Buy at StockNews.com,https://reporter.am/2023/02/25/tjx-companies-nysetjx-rating-increased-to-buy-at-stocknews-com.html,2023-02-25 07:58:41,TJX Companies ( NYSE:TJX ) Rating Increased to Buy at StockNews ... Armenian Reporter ...,PFE,0.069697,0.102684,Neutral
Edwards Lifesciences  ( NYSE:EW )  Rating Increased to Buy at StockNews.com,https://www.defenseworld.net/2023/02/25/edwards-lifesciences-nyseew-rating-increased-to-buy-at-stocknews-com.html,2023-02-25 07:58:41,Edwards Lifesciences ( NYSE:EW ) Rating Increased to Buy at ... Defense World ...,PFE,0.047465,0.159974,Somewhat-Bullish
StockNews.com Downgrades Farmland Partners  ( NYSE:FPI )  to Sell,https://reporter.am/2023/02/25/stocknews-com-downgrades-farmland-partners-nysefpi-to-sell.html,2023-02-25 07:58:41,"Farmland Partners ( NYSE:FPI - Get Rating ) was downgraded by StockNews.com from a ""hold"" rating to a ""sell"" rating in a note issued to investors on Thursday. Separately, Janney Montgomery Scott raised Farmland Partners from a ""neutral"" rating to a ""buy"" rating and set a $16.00 price target for ...",PFE,0.154455,0.102144,Neutral
"OneMain  ( NYSE:OMF )  Upgraded to ""Buy"" at StockNews.com",https://www.etfdailynews.com/2023/02/25/onemain-nyseomf-upgraded-to-buy-at-stocknews-com/,2023-02-25 07:30:43,"OneMain ( NYSE:OMF - Get Rating ) was upgraded by stock analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a report issued on Thursday.",PFE,0.06697,0.07953,Neutral
StockNews.com Lowers First Hawaiian  ( NASDAQ:FHB )  to Sell,https://www.etfdailynews.com/2023/02/25/stocknews-com-lowers-first-hawaiian-nasdaqfhb-to-sell/,2023-02-25 07:30:42,"First Hawaiian ( NASDAQ:FHB - Get Rating ) was downgraded by stock analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a report issued on Thursday. A number of other research analysts have also recently commented on the company.",PFE,0.079656,0.172071,Somewhat-Bullish
"Strategic Education  ( NASDAQ:STRA )  Cut to ""Hold"" at StockNews.com",https://www.etfdailynews.com/2023/02/25/strategic-education-nasdaqstra-cut-to-hold-at-stocknews-com/,2023-02-25 07:30:42,"Strategic Education ( NASDAQ:STRA - Get Rating ) was downgraded by equities research analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a note issued to investors on Thursday. Other research analysts have also recently issued reports about the company.",PFE,0.075397,0.089292,Neutral
Repligen  ( NASDAQ:RGEN )  Rating Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/02/25/repligen-nasdaqrgen-rating-lowered-to-sell-at-stocknews-com.html,2023-02-25 07:30:42,"Repligen ( NASDAQ:RGEN - Get Rating ) was downgraded by analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a research note issued on Thursday.",PFE,0.063933,0.085191,Neutral
SP Plus  ( NASDAQ:SP )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/02/25/sp-plus-nasdaqsp-stock-rating-lowered-by-stocknews-com.html,2023-02-25 07:30:41,"SP Plus ( NASDAQ:SP - Get Rating ) was downgraded by equities researchers at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a report released on Thursday. Shares of SP stock opened at $34.43 on Thursday. The company's fifty day simple moving average is $36.20 and its 200-day ...",PFE,0.076115,0.06904,Neutral
StockNews.com Upgrades Gladstone Land  ( NASDAQ:LAND )  to Hold,https://www.defenseworld.net/2023/02/25/stocknews-com-upgrades-gladstone-land-nasdaqland-to-hold.html,2023-02-25 07:28:42,"Gladstone Land ( NASDAQ:LAND - Get Rating ) was upgraded by analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a report released on Thursday. A number of other equities research analysts have also commented on the company.",PFE,0.124164,0.1329,Neutral
PGT Innovations  ( NYSE:PGTI )  Rating Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/pgt-innovations-nysepgti-rating-lowered-to-hold-at-stocknews-com.html,2023-02-25 07:28:41,PGT Innovations ( NYSE:PGTI ) Rating Lowered to Hold at ... Defense World ...,PFE,0.058759,0.08201,Neutral
"Nordson  ( NASDAQ:NDSN )  Lowered to ""Hold"" at StockNews.com",https://www.etfdailynews.com/2023/02/25/nordson-nasdaqndsn-lowered-to-hold-at-stocknews-com/,2023-02-25 07:28:41,"Nordson ( NASDAQ:NDSN - Get Rating ) was downgraded by research analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research report issued to clients and investors on Thursday. Several other equities research analysts also recently issued reports on the stock. Robert W.",PFE,0.050044,0.144846,Neutral
Spok  ( NASDAQ:SPOK )  Stock Rating Upgraded by StockNews.com,https://www.defenseworld.net/2023/02/25/spok-nasdaqspok-stock-rating-upgraded-by-stocknews-com.html,2023-02-25 06:58:47,"Spok ( NASDAQ:SPOK - Get Rating ) was upgraded by StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a report issued on Thursday. Separately, Lake Street Capital reiterated a ""buy"" rating and issued a $15.00 price target on shares of Spok in a report on Monday, December 19th.",PFE,0.089462,0.182257,Somewhat-Bullish
StockNews.com Downgrades United Therapeutics  ( NASDAQ:UTHR )  to Buy,https://www.defenseworld.net/2023/02/25/stocknews-com-downgrades-united-therapeutics-nasdaquthr-to-buy.html,2023-02-25 06:58:47,StockNews.com Downgrades United Therapeutics ( NASDAQ:UTHR ... Defense World ...,PFE,0.04872,0.091983,Neutral
Ulta Beauty  ( NASDAQ:ULTA )  Rating Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/02/25/ulta-beauty-nasdaqulta-rating-lowered-to-hold-at-stocknews-com.html,2023-02-25 06:58:46,Ulta Beauty ( NASDAQ:ULTA ) Rating Lowered to Hold at StockNews ... Defense World ...,PFE,0.064973,0.149556,Neutral
StockNews.com Initiates Coverage on Taylor Devices  ( NASDAQ:TAYD ) ,https://www.etfdailynews.com/2023/02/25/stocknews-com-initiates-coverage-on-taylor-devices-nasdaqtayd/,2023-02-25 06:58:44,StockNews.com Initiates Coverage on Taylor Devices ( NASDAQ ... ETF Daily News ...,PFE,0.090474,-0.014052,Neutral
"Spok  ( NASDAQ:SPOK )  Lifted to ""Strong-Buy"" at StockNews.com",https://www.etfdailynews.com/2023/02/25/spok-nasdaqspok-lifted-to-strong-buy-at-stocknews-com/,2023-02-25 06:58:44,"Spok ( NASDAQ:SPOK - Get Rating ) was upgraded by investment analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research report issued on Thursday. Separately, Lake Street Capital reaffirmed a ""buy"" rating and set a $15.00 price objective on shares of Spok in a report ...",PFE,0.085936,0.180732,Somewhat-Bullish
First Hawaiian  ( NASDAQ:FHB )  Rating Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/02/25/first-hawaiian-nasdaqfhb-rating-lowered-to-sell-at-stocknews-com.html,2023-02-25 06:58:44,First Hawaiian ( NASDAQ:FHB ) Rating Lowered to Sell at StockNews ... Defense World ...,PFE,0.074926,0.17068,Somewhat-Bullish
"StockNews.com Upgrades OneMain  ( NYSE:OMF )  to ""Buy""",https://www.defenseworld.net/2023/02/25/stocknews-com-upgrades-onemain-nyseomf-to-buy.html,2023-02-25 06:58:44,"OneMain ( NYSE:OMF - Get Rating ) was upgraded by StockNews.com from a ""hold"" rating to a ""buy"" rating in a note issued to investors on Thursday.",PFE,0.063091,0.079254,Neutral
"StockNews.com Upgrades OneMain  ( NYSE:OMF )  to ""Buy""",https://reporter.am/2023/02/25/stocknews-com-upgrades-onemain-nyseomf-to-buy.html,2023-02-25 06:58:42,"OneMain ( NYSE:OMF - Get Rating ) was upgraded by StockNews.com from a ""hold"" rating to a ""buy"" rating in a note issued to investors on Thursday.",PFE,0.063091,0.079254,Neutral
FreightCar America  ( NASDAQ:RAIL )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/02/25/freightcar-america-nasdaqrail-now-covered-by-stocknews-com.html,2023-02-25 06:56:48,"Investment analysts at StockNews.com assumed coverage on shares of FreightCar America ( NASDAQ:RAIL - Get Rating ) in a research note issued to investors on Thursday. The firm set a ""sell"" rating on the transportation company's stock. Shares of NASDAQ:RAIL opened at $3.68 on Thursday.",PFE,0.084722,0.09082,Neutral
StockNews.com Downgrades Peoples Bancorp of North Carolina  ( NASDAQ:PEBK )  to Hold,https://www.etfdailynews.com/2023/02/25/stocknews-com-downgrades-peoples-bancorp-of-north-carolina-nasdaqpebk-to-hold/,2023-02-25 06:56:47,StockNews.com Downgrades Peoples Bancorp of North Carolina ... ETF Daily News ...,PFE,0.076115,0.140392,Neutral
FreightCar America  ( NASDAQ:RAIL )  Now Covered by StockNews.com,https://reporter.am/2023/02/25/freightcar-america-nasdaqrail-now-covered-by-stocknews-com.html,2023-02-25 06:56:46,"Investment analysts at StockNews.com assumed coverage on shares of FreightCar America ( NASDAQ:RAIL - Get Rating ) in a research note issued to investors on Thursday. The firm set a ""sell"" rating on the transportation company's stock. Shares of NASDAQ:RAIL opened at $3.68 on Thursday.",PFE,0.084722,0.09082,Neutral
StockNews.com Downgrades Overstock.com  ( NASDAQ:OSTK )  to Sell,https://reporter.am/2023/02/25/stocknews-com-downgrades-overstock-com-nasdaqostk-to-sell.html,2023-02-25 06:56:45,"Overstock.com ( NASDAQ:OSTK - Get Rating ) was downgraded by research analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a research report issued to clients and investors on Thursday.",PFE,0.064797,0.107323,Neutral
StockNews.com Downgrades Overstock.com  ( NASDAQ:OSTK )  to Sell,https://www.etfdailynews.com/2023/02/25/stocknews-com-downgrades-overstock-com-nasdaqostk-to-sell/,2023-02-25 06:56:45,"Overstock.com ( NASDAQ:OSTK - Get Rating ) was downgraded by stock analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a note issued to investors on Thursday.",PFE,0.061003,0.107097,Neutral
Lam Research  ( NASDAQ:LRCX )  Rating Increased to Buy at StockNews.com,https://www.defenseworld.net/2023/02/25/lam-research-nasdaqlrcx-rating-increased-to-buy-at-stocknews-com.html,2023-02-25 06:56:45,Lam Research ( NASDAQ:LRCX ) Rating Increased to Buy at ... Defense World ...,PFE,0.051551,0.120829,Neutral
StockNews.com Initiates Coverage on InVivo Therapeutics  ( NASDAQ:NVIV ) ,https://reporter.am/2023/02/25/stocknews-com-initiates-coverage-on-invivo-therapeutics-nasdaqnviv.html,2023-02-25 06:56:45,StockNews.com Initiates Coverage on InVivo Therapeutics ... Armenian Reporter ...,PFE,0.106541,0.057489,Neutral
StockNews.com Upgrades Magic Software Enterprises  ( NASDAQ:MGIC )  to Strong-Buy,https://www.defenseworld.net/2023/02/25/stocknews-com-upgrades-magic-software-enterprises-nasdaqmgic-to-strong-buy.html,2023-02-25 06:56:44,StockNews.com Upgrades Magic Software Enterprises ( NASDAQ ... Defense World ...,PFE,0.091509,0.099553,Neutral
NVE  ( NASDAQ:NVEC )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/02/25/nve-nasdaqnvec-stock-rating-lowered-by-stocknews-com.html,2023-02-25 06:56:44,"NVE ( NASDAQ:NVEC - Get Rating ) was downgraded by equities research analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research note issued to investors on Thursday. NVE stock opened at $75.11 on Thursday.",PFE,0.100308,0.073349,Neutral
Democratic attorneys general sue FDA to drop all remaining restrictions on abortion pill,https://www.cnbc.com/2023/02/24/democratic-ags-sue-fda-over-abortion-pill-restrictions.html,2023-02-24 19:50:16,The lawsuit adds to an escalating series of legal battles over access to the abortion pill in the U.S.,PFE,0.082677,0.361262,Bullish
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults,https://www.cnbc.com/2023/02/24/fda-says-guillain-barre-syndrome-is-possible-risk-of-pfizer-rsv-vaccine.html,2023-02-24 19:15:30,"The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.",PFE,0.14497,0.099651,Neutral
Get Ready For The Holy Grail In Cancer Treatment,https://www.investors.com/news/technology/moderna-stock-may-usher-in-new-cancer-vaccines-whats-in-it-for-biotech-stocks/,2023-02-24 16:57:00,Moderna Stock May Usher In A New Generation Of Cancer Vaccines ... Investor's Business Daily ...,PFE,0.032056,-0.030046,Neutral
"OPKO Health  ( OPK )  Q4 Earnings Match Estimates, Revenues Top",https://www.zacks.com/stock/news/2058816/opko-health-opk-q4-earnings-match-estimates-revenues-top,2023-02-24 15:43:00,"Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in Pharmaceuticals segment, its overall fourth-quarter results reflect soft performances.",PFE,0.074576,0.225843,Somewhat-Bullish
"Pharma Stock Roundup: FDA Updates for SNY, PFE & Others, EU Nod to AZN Cancer Combo",https://www.zacks.com/stock/news/2058812/pharma-stock-roundup-fda-updates-for-sny-pfe-others-eu-nod-to-azn-cancer-combo,2023-02-24 15:30:00,FDA approves Sanofi's (SNY) Altuviiio and grants a priority tag to Pfizer's (PFE) regulatory applications for pipeline candidates.,PFE,0.185022,0.02448,Neutral
"Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination - Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/02/31047821/pfizerbiontech-seek-expanded-approval-for-its-updated-covid-19-shot-as-primary-series-vaccination,2023-02-24 15:03:48,Pfizer Inc PFE and BioNTech SE BNTX have submitted an FDA supplemental marketing application for approval of omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as a primary series and booster dose ( s ) for 12 years and older.,PFE,0.504646,0.29145,Somewhat-Bullish
Pfizer/BioNTech apply for full approval of updated COVID vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizerbiontech-apply-full-approval-updated-covid-vaccine-2023-02-24/,2023-02-24 14:22:00,Feb 24 ( Reuters ) - Pfizer Inc ( PFE.N ) and BioNTech SE ( 22UAy.DE ) said on Friday they filed an application to the U.S Food and Drug Administration for a full approval of their Omicron-adapated COVID-19 vaccine.,PFE,0.524949,0.302726,Somewhat-Bullish
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for Pegunigalsidase Alfa for Treatment of Fabry Disease,https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-and-protalix-biotherapeutics-receive-positive-chmp-opinion-for-pegunigalsidase-alfa-for-treatment-of-fabry-disease-301755440.html,2023-02-24 14:15:00,Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive ... PR ...,PFE,0.020249,0.051307,Neutral
'Ukraine is open for business': Western companies urged to be part of Ukrainian recovery,https://www.marketwatch.com/story/ukraine-is-open-for-business-western-companies-urged-to-be-part-of-ukrainian-recovery-81ea2a42,2023-02-24 13:18:00,"Ukraine's GDP fell by 30.4% in 2022, according to the country's Ministry of Economy.",PFE,0.098054,0.0,Neutral
PFE: 3 Stocks You Can Buy Now and Hold Onto for the Next Decade,https://stocknews.com/news/pfe-hsy-bvh-3-stocks-you-can-buy-now-and-hold-onto-for/,2023-02-24 13:04:29,"Recessionary concerns have surged amid the Fed's hawkish statements, crushing investor sentiments. With the likelihood soaring of an impending downturn, we look into some quality stocks for the long term, Pfizer Inc. ( PFE ) , The Hershey Company ( HSY ) , and Bluegreen Vacations Holding ...",PFE,0.303463,0.112455,Neutral
"Indices trade with minor gains, pharma stocks in demand",https://www.business-standard.com/article/news-cm/indices-trade-with-minor-gains-pharma-stocks-in-demand-123022400434_1.html,2023-02-24 06:02:00,"The headline equity indices traded with small gains in mid-morning trade. The Nifty traded above the 17,500 level. Pharma stocks witnessed bargain buying after declining in the past five trading sessions. At 11:30 IST, the barometer index, the S&P BSE Sensex, was up 79.19 points or 0.13% to ...",PFE,0.055236,-0.027912,Neutral
Opko Health  ( OPK )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/24/opko-health-opk-q4-2022-earnings-call-transcript/,2023-02-24 06:00:43,"OPK earnings call for the period ending December 31, 2022.",PFE,0.111821,0.114501,Neutral
First Zantac cancer risk trial in Calif. postponed by months,https://www.reuters.com/business/healthcare-pharmaceuticals/first-zantac-cancer-risk-trial-calif-postponed-by-months-2023-02-23/,2023-02-23 23:23:00,"Feb 23 ( Reuters ) - The first scheduled trial over claims that GSK Plc's ( GSK.L ) heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed, likely by several months.",PFE,0.111488,-0.189755,Somewhat-Bearish
Moderna  ( MRNA )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/23/moderna-mrna-q4-2022-earnings-call-transcript/,2023-02-23 19:30:39,"MRNA earnings call for the period ending December 31, 2022.",PFE,0.003972,-0.049363,Neutral
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi,https://www.cnbc.com/2023/02/23/medicare-rejects-alzheimer-association-request-on-coverage-for-treatments-like-leqembi.html,2023-02-23 15:47:23,"The Alzheimer's Association, in a statement Wednesday, said it was ""appalled"" by CMS' decision.",PFE,0.037155,0.345858,Somewhat-Bullish
PFE: 3 Bargain Stocks to Buy Before the Crowd Catches On,https://stocknews.com/news/pfe-mcd-umc-3-bargain-stocks-to-buy-before-the-crowd-catches-on/,2023-02-23 14:31:02,"The stock market has witnessed significant volatility of late on concerns over the prospect of progressive rate hikes and other macro uncertainties. However, this has led several fundamentally strong stocks to trade at affordable prices.",PFE,0.346046,0.131866,Neutral
"Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop",https://www.fool.com/investing/2023/02/23/pharma-giant-pfizer-looks-strong-for-investors-des/,2023-02-23 14:15:00,The company is doubling down on its vaccine success.,PFE,0.506917,0.100756,Neutral
"Cameo Names Meta Veteran Matty de Castro as GM Enterprise Sales, Cameo for Business",https://www.prnewswire.com/news-releases/cameo-names-meta-veteran-matty-de-castro-as-gm-enterprise-sales-cameo-for-business-301754162.html,2023-02-23 14:00:00,Cameo Names Meta Veteran Matty de Castro as GM Enterprise ... PR ...,PFE,0.06211,0.102025,Neutral
"Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields - AbbVie  ( NYSE:ABBV ) , GSK  ( NYSE:GSK ) ",https://www.benzinga.com/news/23/02/31027525/wall-streets-most-accurate-analysts-say-hold-these-3-healthcare-stocks-delivering-high-dividend-yiel,2023-02-23 13:49:45,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",PFE,0.109455,0.124722,Neutral
International Myeloma Foundation  ( IMF )  Launches #MYelomaSTORY Campaign for Myeloma Action Month in March 2023,https://www.benzinga.com/pressreleases/23/02/g31027448/international-myeloma-foundation-imf-launches-myelomastory-campaign-for-myeloma-action-month-in-ma,2023-02-23 13:45:00,"STUDIO CITY, Calif., Feb. 23, 2023 ( GLOBE NEWSWIRE ) -- With the International Myeloma Foundation ( IMF ) at the forefront, Myeloma Action Month is held every year for the whole month of March to encourage individuals and groups to take actions that positively impact the myeloma community.",PFE,0.034332,0.225632,Somewhat-Bullish
GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With Gilead's: Study Shows - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/large-cap/23/02/31022960/gskpfizer-backed-viiv-healthcares-hiv-treatment-at-par-with-gileads-study-shows,2023-02-23 13:43:36,"ViiV Healthcare, majority-owned by GSK Plc GSK, Pfizer Inc PFE, and Shionogi Limited, announced 12-month findings from the SOLAR Phase 3b study of the long-acting injectable regimen Cabenuva ( cabotegravir, rilpivirine [CAB+RPV LA] ) compared against complete daily oral regimen Biktarvy ( ...",PFE,0.443626,0.014539,Neutral
Why Moderna  ( MRNA )  Shares Are Diving Today - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/general/biotech/23/02/31026525/modernas-q4-earnings-fall-68-on-sliding-covid-19-vaccine-revenues-miss-earnings-expectations,2023-02-23 13:35:32,"Moderna Inc MRNA reported Thursday, a Q4 FY22 EPS of $3.61, compared to the $11.29 posted a year ago, missing the consensus of $4.68. Revenue was $5.08 billion compared to $7.21 billion a year ago, slightly above the consensus of $5.02, mainly due to a decline in COVID-19 vaccine sales.",PFE,0.141726,-0.008008,Neutral
"Moderna misses on earnings as costs rise from surplus production capacity, lower Covid shot demand",https://www.cnbc.com/2023/02/23/moderna-mrna-q4-earnings-2022.html,2023-02-23 13:10:40,"Moderna reported quarterly earnings of $3.61 per share, a 68% decrease from the same period in 2021 when it booked $11.29 per share.",PFE,0.06697,0.353137,Bullish
"Sliding vaccine sales, new costs, shrink Moderna 4Q profit",https://apnews.com/article/business-moderna-inc-covid-d663855b2a1ddb65d56a495dba2c331c,2023-02-23 12:46:50,Moderna's fourth-quarter profit tumbled 70% as COVID-19 vaccine sales fell and the drugmaker caught up on a royalty payment. Moderna said Thursday that its cost of sales jumped nearly a billion dollars to $1.9 billion in the final quarter of 2022.,PFE,0.143415,-0.002514,Neutral
Arvinas Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update,https://www.globenewswire.com/news-release/2023/02/23/2614100/0/en/Arvinas-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html,2023-02-23 12:00:00,"- Initiated multiple trials with ARV-471, including a 2L+ Phase 3 trial for patients with metastatic breast cancer ...",PFE,0.168255,0.128929,Neutral
3 Supercharged Growth Stocks Down 89% to 97% That Billionaires Can't Stop Buying,https://www.fool.com/investing/2023/02/23/3-growth-stocks-down-89-to-97-billionaires-buying/,2023-02-23 10:06:00,Beaten-down growth stocks were popular buys during the fourth quarter for some of the brightest billionaire money managers.,PFE,0.067347,0.073574,Neutral
Maravai LifeSciences  ( MRVI )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/23/maravai-lifesciences-mrvi-q4-2022-earnings-call-tr/,2023-02-23 06:00:19,"MRVI earnings call for the period ending December 31, 2022.",PFE,0.004887,-0.017272,Neutral
West Virginia asks judge to dismiss lawsuit seeking to overturn state restrictions on abortion pill,https://www.cnbc.com/2023/02/22/west-virginia-seeks-to-dismiss-lawsuit-over-abortion-pill-access.html,2023-02-22 21:38:19,The case is one in a series of ongoing legal battles in federal courts around the U.S. over the FDA's two-decade-old approval of mifepristone.,PFE,0.057215,0.351114,Bullish
CDC advisors recommend mpox vaccine for at-risk adults in future outbreaks,https://www.cnbc.com/2023/02/22/mpox-cdc-advisors-recommend-vaccine-for-at-risk-adults-in-future-outbreaks.html,2023-02-22 19:19:27,"Once limited to Africa, mpox has spread widely around the world and has caused more than 30,000 cases and 32 deaths in the U.S. since May.",PFE,0.038717,0.346759,Somewhat-Bullish
"Flu vaccine was 68% effective at preventing hospitalization in children, but less protective for seniors this season",https://www.cnbc.com/2023/02/22/flu-vaccine-cdc-releases-effectiveness-data-for-children-and-seniors.html,2023-02-22 19:16:16,The effectiveness of flu vaccines can vary widely season to season depending on how well the strains included in the shots are matched to circulating viruses.,PFE,0.107016,0.261955,Somewhat-Bullish
"After 2022 Slowdown, WuXi Biologics Gets Growth Medicine From Big New Order - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/23/02/31010395/after-2022-slowdown-wuxi-biologics-gets-growth-medicine-from-big-new-order,2023-02-22 16:23:54,"WuXi Biologics revenue growth slowed sharply to 48.4% last year, but it got a jumpstart with its signing of a major new order last month The company's major shareholder recently sold 56 million shares, the latest in a steady series of such sales since its listing in 2017",PFE,0.068797,0.070208,Neutral
GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill,https://www.reuters.com/business/healthcare-pharmaceuticals/gsks-viiv-says-study-shows-its-long-acting-hiv-shot-effective-gileads-daily-pill-2023-02-22/,2023-02-22 16:08:00,GSK's ViiV says study shows its long-acting HIV shot as effective as ... ...,PFE,0.100729,0.0,Neutral
National AIDS Memorial Announces Recipients of the Mary Bowman Arts in Activism Award - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/pressreleases/23/02/g31010079/national-aids-memorial-announces-recipients-of-the-mary-bowman-arts-in-activism-award,2023-02-22 16:07:13,"SAN FRANCISCO, CA, Feb. 22, 2023 ( GLOBE NEWSWIRE ) -- The National AIDS Memorial announces that Bobbi-Angelica Morris, currently at Gallaudet University in Washington, D.C., and Joseph Taylor, at Maryland Institute College of Art in Baltimore, are the most recent recipients of the Mary Bowman ...",PFE,0.076724,0.139396,Neutral
Moderna Hopes To Build On mRNA Tech Used In Its Covid Shots-By Targeting Genetic Diseases,https://www.forbes.com/sites/roberthart/2023/02/22/moderna-hopes-to-build-on-mrna-tech-used-in-its-covid-shots-by-targeting-genetic-diseases/,2023-02-22 15:28:50,"Moderna announced a partnership with Life Edit Therapeutics to tackle ""some of the most challenging genetic diseases"" using its mRNA technology.",PFE,0.096671,0.344049,Somewhat-Bullish
Innovation At A Reasonable Price  ( IRP )  Investing Is Always In Favor - Cisco Systems  ( NASDAQ:CSCO ) ,https://www.benzinga.com/23/02/31008925/innovation-at-a-reasonable-price-irp-investing-is-always-in-favor,2023-02-22 15:19:45,Since the decade long bull market stumbled in January of 2022 the debate among market participants has centered around whether the stock market has ushered in durable new leadership in investment style and sector performance.,PFE,0.058903,0.130021,Neutral
"Cramer Says Avoid This Stock, But His Dog May Disagree: 'It Is At $10...Something's Wrong' - Pfizer  ( NYSE:PFE ) , AST SpaceMobile  ( NASDAQ:ASTS ) ",https://www.benzinga.com/news/23/02/31001624/cramer-says-avoid-this-stock-but-his-dog-may-disagree-it-is-at-10-somethings-wrong,2023-02-22 13:56:46,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Impinj Inc. PI is a ""great company. Problem is it's not a great stock."" He added, ""You've got to wait for it to come down before you buy any Impinj."" Analysts disagree, Benzinga data shows a consensus Buy rating on PI stock.",PFE,0.656549,0.228302,Somewhat-Bullish
Want More Reliable Dividend Income? Buy This Dividend King.,https://www.fool.com/investing/2023/02/22/want-more-reliable-dividend-income-buy-abbv-stock/,2023-02-22 12:30:00,This big pharma company possesses a deep drug portfolio and pipeline.,PFE,0.057628,0.070008,Neutral
This Recession-Proof Company Has a Best-in-Class Dividend,https://www.fool.com/investing/2023/02/22/this-recession-proof-company-has-a-best-in-class-d/,2023-02-22 12:30:00,"Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.",PFE,0.339046,0.229493,Somewhat-Bullish
Pfizer's Elranatamab Receives FDA and EMA Filing Acceptance - Investing News Network,https://investingnews.com/pfizer-s-elranatamab-receives-fda-and-ema-filing-acceptance/,2023-02-22 11:58:39,Pfizer's Elranatamab Receives FDA and EMA Filing Acceptance Investing News Network ...,PFE,0.223866,0.250772,Somewhat-Bullish
Better Buy: Beam Therapeutics or Intellia Therapeutics?,https://www.fool.com/investing/2023/02/22/better-buy-beam-therapeutics-or-intellia-therapeut/,2023-02-22 11:00:00,The two clinical-stage gene-editing companies have good long-term prospects.,PFE,0.051663,0.09479,Neutral
Press release Biocartis Group NV: Biocartis announces change in Board composition,https://www.globenewswire.com/news-release/2023/02/22/2612818/0/en/Press-release-Biocartis-Group-NV-Biocartis-announces-change-in-Board-composition.html,2023-02-22 06:00:00,PRESS RELEASE ...,PFE,0.036643,0.061114,Neutral
Exact Sciences  ( EXAS )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/21/exact-sciences-exas-q4-2022-earnings-call-transcri/,2023-02-22 03:30:43,"EXAS earnings call for the period ending December 31, 2022.",PFE,0.004932,0.154806,Somewhat-Bullish
HALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL AND OPERATING RESULTS,https://www.prnewswire.com/news-releases/halozyme-reports-fourth-quarter-and-full-year-2022-financial-and-operating-results-301752201.html,2023-02-21 21:01:00,HALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2022 ... PR ...,PFE,0.027876,0.117778,Neutral
Where Will Moderna Be in 5 Years?,https://www.fool.com/investing/2023/02/21/where-will-moderna-be-in-5-years/,2023-02-21 19:00:00,Moderna shares have what it takes to gain over time.,PFE,0.054483,0.133801,Neutral
Pfizer RSV vaccine that protects infants could receive FDA approval this summer,https://www.cnbc.com/2023/02/21/pfizer-rsv-vaccine-for-infants-could-receive-fda-approval-this-summer.html,2023-02-21 18:37:02,The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.,PFE,0.112269,0.104362,Neutral
My 3 Biggest Stock Market Predictions for March,https://www.fool.com/investing/2023/02/21/my-3-biggest-stock-market-predictions-for-march/,2023-02-21 15:15:00,These three trends will likely drive revenue and share prices.,PFE,0.08398,0.0,Neutral
First RSV Vaccine For Kids-Given To Pregnant Moms-Could Arrive Months Early As FDA Fast-Tracks Review,https://www.forbes.com/sites/roberthart/2023/02/21/first-rsv-vaccine-for-kids-given-to-pregnant-moms-could-arrive-months-early-as-fda-fast-tracks-review/,2023-02-21 14:30:40,"If approved, Pfizer's RSV shot for pregnant people could be the first on the market and protect infants from complications from birth through six months.",PFE,0.357293,0.115673,Neutral
Med Giant Tightens Outlook After Earnings Beat,https://www.investors.com/news/technology/mdt-stock-medtronic-earnings-q3-2023/,2023-02-21 13:46:00,MDT Stock: Medtronic Tightens 2023 Profit Outlook After Earnings ... Investor's Business Daily ...,PFE,0.207571,-0.07987,Neutral
U.S. FDA Accepts Biologics License Application for Pfizer's Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review,https://investingnews.com/u-s-fda-accepts-biologics-license-application-for-pfizer-s-respiratory-syncytial-virus-maternal-vaccine-candidate-for-priority-review/,2023-02-21 12:10:45,Pfizer Inc. ( NYSE:PFE ) today announced that the U.S.,PFE,0.191834,0.141891,Neutral
Merck's COVID pill fails to prevent infection in household members,https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-covid-pill-fails-reduce-infection-risk-household-contacts-2023-02-21/,2023-02-21 12:04:00,Feb 21 ( Reuters ) - Merck & Co Inc ( MRK.N ) said on Tuesday its COVID-19 pill was ineffective in reducing the risk of infection in people exposed to an infected individual in the same household.,PFE,0.263942,-0.101032,Neutral
3 Dividend Stocks to Buy on Sale,https://www.fool.com/investing/2023/02/21/3-dividend-stocks-to-buy-on-sale/,2023-02-21 10:35:00,"Whether an investor or a consumer, everybody appreciates a good deal. And good deals, these three stocks appear to be.",PFE,0.221819,0.172673,Somewhat-Bullish
Pfizer pins hopes on record pipeline to recover from post-Covid hangover,https://www.ft.com/content/ba2cba41-0a13-4251-bbd7-2abeff90433f,2023-02-21 05:00:07,Pharma group is launching 19 drugs over the next 18 months to counteract a sharp fall in sales from pandemic highs ...,PFE,0.451494,0.098341,Neutral
These Are The Best  ( And Worst )  Performing Stocks Of 2023,https://www.forbes.com/sites/dereksaul/2023/02/20/these-are-the-best-and-worst-performing-stocks-of-2023/,2023-02-20 16:24:32,Tesla's 69% surge leads the charge.,PFE,0.150592,0.027577,Neutral
PFE: 4 Pharma Stocks to Buy Now for the Long Haul,https://stocknews.com/news/pfe-azn-bmy-zts-4-pharma-stocks-to-buy-now-for-the-long-haul/,2023-02-20 14:53:40,"The pharmaceutical sector has thrived in recent years and is anticipated to reach $1.5 trillion this year. The integration of innovative technologies has opened a new world of possibilities for the industry. Moreover, customized medicine should potentially bolster the healthcare sector, ...",PFE,0.257805,0.211841,Somewhat-Bullish
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2056309/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2023-02-20 14:00:10,"Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",PFE,0.53074,0.074831,Neutral
9 promising blockchain use cases in healthcare industry,https://cointelegraph.com/news/9-promising-blockchain-use-cases-in-healthcare-industry,2023-02-20 14:00:00,"Blockchain enables healthcare record management, clinical trial transparency, efficient supply chain management and more.",PFE,0.062926,0.113057,Neutral
Pancreatic Cancer Treatment Market Exhibits 15.7% CAGR to Hit USD 6.85 Billion by 2029,https://www.benzinga.com/pressreleases/23/02/g30975762/pancreatic-cancer-treatment-market-exhibits-15-7-cagr-to-hit-usd-6-85-billion-by-2029,2023-02-20 12:04:21,"Pune, India, Feb. 20, 2023 ( GLOBE NEWSWIRE ) -- The global pancreatic cancer treatment market size was worth USD 2.15 billion in 2021 and is slated to rise from USD 2.48 billion in 2022 to USD 6.85 billion by 2029, at 15.7% CAGR during forecast period.",PFE,0.062843,-0.016022,Neutral
PFE: 3 Stocks You Won't Have Regrets About Buying in 2023,https://stocknews.com/news/pfe-cvs-ulh-3-stocks-you-wont-have-regrets-about-buying-in-2023/,2023-02-20 11:57:53,PFE: 3 Stocks You Won't Have Regrets About Buying in ...,PFE,0.337951,0.235549,Somewhat-Bullish
"Buy these 16 dividend stocks to collect consistent cash payments while inflation stays high, according to a fund manager who outperformed 95% of his peers last year",https://www.businessinsider.com/investing-dividend-stocks-to-buy-inflation-outlook-federal-reserve-rates-2023-2,2023-02-20 10:30:00,16 Dividend Stocks to Buy As Inflation Persists: Top 5% Fund Manager - Business Insider ...,PFE,0.040553,0.048535,Neutral
"Barometers trade with minor gains, pharma stocks decline",https://www.business-standard.com/article/news-cm/barometers-trade-with-minor-gains-pharma-stocks-decline-123022000284_1.html,2023-02-20 05:03:00,"The key equity indices traded with small gains in morning trade. The Nifty hovered around the 17,950 mark. IT, FMCG and auto stocks advanced while pharma, healthcare and oil & gas shares slipped. At 10:29 IST, the barometer index, the S&P BSE Sensex, was up 109 points or 0.18% to 61,111.57.",PFE,0.100308,-0.034969,Neutral
A new migraine medication is coming this summer - and it promises relief in just 15 minutes,https://www.businessinsider.com/fda-approves-migraine-medication-nasal-spray-pfizer-relief-15-minutes-2023-3,2023-03-11 17:50:29,New Migraine Medication Promises Relief in 15 Minutes - Business Insider ...,PFE,0.337811,0.379227,Bullish
A new migraine medication is coming this summer - and it promises relief in just 15 minutes,https://africa.businessinsider.com/retail/a-new-migraine-medication-is-coming-this-summer-and-it-promises-relief-in-just-15/0dff0wb,2023-03-11 17:50:29,A new migraine medication is coming this summer - and it ... - Business Insider Africa ...,PFE,0.282234,0.304562,Somewhat-Bullish
3 No-Brainer Dividend Stocks to Buy in March,https://www.fool.com/investing/2023/03/11/3-no-brainer-dividend-stocks-to-buy-in-march/,2023-03-11 11:14:00,Going with these great dividend stocks is an easy choice.,PFE,0.381625,0.366564,Bullish
Novavax Stock: Bear vs. Bull,https://www.fool.com/investing/2023/03/10/novavax-stock-bear-vs-bull/,2023-03-10 19:00:00,The stock has brought investors eye-popping gains and losses over the past few years.,PFE,0.107016,0.078087,Neutral
North Carolina lawmakers intervene to defend abortion pill restrictions in case testing FDA power,https://www.cnbc.com/2023/03/10/abortion-pill-north-carolina-lawmakers-intervene-to-defend-restrictions.html,2023-03-10 18:46:54,A North Carolina physician sued the state in January to block its restrictions on mifepristone because they go beyond FDA regulations.,PFE,0.045918,0.280446,Somewhat-Bullish
JNJ: 2 Stocks That'll Help You Keep Money in Your Pockets,https://stocknews.com/news/jnj-pfe-bac-2-stocks-thatll-help-you-keep-money-in-your-pockets/,2023-03-10 16:34:07,The early-year market rally lost its steam gradually owing to the inpouring of hotter-than-anticipated macroeconomic data. The Fed's hawkish comments further aggravated the already existing investor anxieties.,PFE,0.334624,0.291787,Somewhat-Bullish
US FDA Approves Nasal Spray For Migraines,https://www.barrons.com/news/us-fda-approves-nasal-spray-for-migraines-8fa37a73,2023-03-10 15:41:19,"The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday. Pfizer said it expected the drug, marketed under the name Zavzpret, to be available in pharmacies in July 2023.",PFE,0.642555,0.085264,Neutral
"House votes unanimously to declassify intelligence on origins of Covid pandemic, sending bill to Biden",https://www.cnbc.com/2023/03/10/covid-house-votes-to-declassify-intelligence-on-possible-wuhan-lab-leak.html,2023-03-10 15:41:06,"The effort by Congress to declassify intel comes after the Energy Department concluded with ""low confidence"" the the virus most likely escaped from a lab.",PFE,0.036812,0.276208,Somewhat-Bullish
BioNTech  ( BNTX )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2064231/biontech-bntx-to-report-q4-earnings-whats-in-the-cards,2023-03-10 15:29:00,BioNTech's (BNTX) fourth-quarter COVID-19 vaccine sales are likely to have declined with the pandemic largely in control. Updates on the company's booster dose authorization status and pipeline will be in focus.,PFE,0.224383,0.121402,Neutral
BioNTech  ( BNTX )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2064231/biontech-bntx-to-report-q4-earnings-whats-in-the-cards,2023-03-10 14:29:00,BioNTech's (BNTX) fourth-quarter COVID-19 vaccine sales are likely to have declined with the pandemic largely in control. Updates on the company's booster dose authorization status and pipeline will be in focus.,PFE,0.224383,0.121402,Neutral
FDA Approves Pfizer's Fast Acting Migraine Drug Acquired Via $11B Biohaven Acquisition - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/03/31295140/fda-approves-pfizers-fast-acting-migraine-drug-acquired-via-11b-biohaven-acquisition,2023-03-10 13:52:56,"The FDA has approved Pfizer Inc PFE acquired Biohaven's Zavzpret ( zavegepant ) , the first and only calcitonin gene-related peptide ( CGRP ) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in adults.",PFE,0.663719,0.210858,Somewhat-Bullish
"Pharma Stock Roundup: LLY's Alzheimer's Study Setback, FDA Updates for SNY, MRK",https://www.zacks.com/stock/news/2064066/pharma-stock-roundup-llys-alzheimers-study-setback-fda-updates-for-sny-mrk,2023-03-10 13:23:00,FDA accepts Sanofi's (SNY) Dupixent sBLA. Lilly's (LLY) solanezumab fails to prevent Alzheimer's in a study.,PFE,0.112269,-0.162572,Somewhat-Bearish
Wall Street Thinks These 2 Undervalued Stocks Have Exceptional Growth Potential,https://www.fool.com/investing/2023/03/10/wall-street-thinks-these-2-undervalued-stocks-have/,2023-03-10 13:00:00,"They're both facing the same fierce headwind, and it won't be going away soon.",PFE,0.051663,0.045991,Neutral
"Pharma Stock Roundup: LLY's Alzheimer's Study Setback, FDA Updates for SNY, MRK",https://www.zacks.com/stock/news/2064066/pharma-stock-roundup-llys-alzheimers-study-setback-fda-updates-for-sny-mrk,2023-03-10 12:23:00,FDA accepts Sanofi's (SNY) Dupixent sBLA. Lilly's (LLY) solanezumab fails to prevent Alzheimer's in a study.,PFE,0.112269,-0.162572,Somewhat-Bearish
Pfizer's ZAVZPRET Migraine Nasal Spray Receives FDA Approval - Investing News Network,https://investingnews.com/pfizer-s-zavzpret-migraine-nasal-spray-receives-fda-approval/,2023-03-10 12:06:58,Pfizer's ZAVZPRET Migraine Nasal Spray Receives FDA Approval Investing News Network ...,PFE,0.28861,0.333947,Somewhat-Bullish
U.S. FDA approves Pfizer's nasal spray for migraine,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-nasal-spray-migraine-2023-03-10/,2023-03-10 11:59:00,"March 10 ( Reuters ) - The U.S. Food and Drug Administration ( FDA ) on Friday approved Pfizer Inc's ( PFE.N ) nasal spray for migraine, giving patients access to a potentially fast-acting option to treat their headaches.",PFE,0.550532,0.54211,Bullish
New 'Fast-Acting' Migraine Drug Approved By FDA,https://www.forbes.com/sites/roberthart/2023/03/10/new-fast-acting-migraine-drug-approved-by-fda/,2023-03-10 11:55:41,"Pfizer's nasal spray drug can provide migraine pain relief in as little as 15 minutes, clinical trials suggest.",PFE,0.327366,-0.009695,Neutral
3 Market-Neutral Funds to Counter Market Volatility,https://www.zacks.com/stock/news/2063937/3-market-neutral-funds-to-counter-market-volatility,2023-03-10 11:28:00,"Below, we share with you three top-ranked market-neutral funds. Each has a Zacks Mutual Fund Rank #1 (Strong Buy).",PFE,0.160099,0.035812,Neutral
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results,https://www.globenewswire.com/news-release/2023/03/09/2624614/25359/en/CytoSorbents-Reports-Fourth-Quarter-and-Full-Year-2022-Results.html,2023-03-09 21:15:00,"Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales momentum from Q4 2022 continues in Q1 2023 to date, with expectation of sales growth in ...",PFE,0.00737,0.103265,Neutral
Moderna Stock: Bear vs. Bull,https://www.fool.com/investing/2023/03/09/moderna-stock-bear-vs-bull/,2023-03-09 19:00:00,Moderna stock has soared about 300% over three years.,PFE,0.109705,0.183337,Somewhat-Bullish
California will not renew $54 million contract with Walgreens over abortion pill policy,https://www.cnbc.com/2023/03/09/california-will-not-renew-walgreens-contract-over-abortion-pill-move.html,2023-03-09 15:36:57,"Gov. Gavin Newsom said California will ""leverage our market power to defend the right to choose"" as the state chose not to renew the contract with Walgreens.",PFE,0.060085,0.282208,Somewhat-Bullish
Eli Lilly's Decade-Long Effort In Alzheimer's Disease Just Failed,https://www.investors.com/news/technology/eli-lilly-stock-decade-long-effort-in-alzheimers-treatment-fails/,2023-03-09 14:37:00,Eli Lilly Stock: Decade-Long Effort In Alzheimer's Treatment Fails ... Investor's Business Daily ...,PFE,0.07446,-0.144445,Neutral
Pfizer Is Targeting an Acquisition That Could Be a Game Changer for Its Business,https://www.fool.com/investing/2023/03/09/pfizer-is-targeting-an-acquisition-that-could-be-a/,2023-03-09 14:37:00,The company is rumored to be interested in buying Seagen.,PFE,0.464393,0.251044,Somewhat-Bullish
"Global Gene Synthesis Market Predicted to Generate a Revenue of $5,984,016.7 Thousand, Rising at a CAGR of 18.4% throughout the Analysis Timeframe 2022-2031 [250-Pages] | Declared by Research Dive",https://www.benzinga.com/pressreleases/23/03/g31277038/global-gene-synthesis-market-predicted-to-generate-a-revenue-of-5-984-016-7-thousand-rising-at-a-c,2023-03-09 14:05:00,"New York, USA, March 09, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Research Dive, the global gene synthesis market is anticipated to generate a revenue of $5,984,016.7 thousand and rise at a stunning CAGR of 18.4% over the estimated timeframe from 2022 to 2031.",PFE,0.06211,0.144067,Neutral
Predictive Oncology Issues Letter to Shareholders,https://www.globenewswire.com/news-release/2023/03/09/2624127/37244/en/Predictive-Oncology-Issues-Letter-to-Shareholders.html,2023-03-09 13:30:00,"EAGAN, Minn., March 09, 2023 ( GLOBE NEWSWIRE ) -- Predictive Oncology ( Nasdaq: POAI ) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities to accelerate oncologic drug discovery and enable drug development, today issued the following ...",PFE,0.013732,0.112612,Neutral
"Vitamin B12 Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast",https://www.benzinga.com/pressreleases/23/03/g31274725/vitamin-b12-market-size-2023-2030-industry-share-revenue-key-players-cagr-demand-and-forecast,2023-03-09 12:44:41,"Pune, India, March 09, 2023 ( GLOBE NEWSWIRE ) -- The global vitamin B12 market size is expected to gain momentum owing to the rising prevalence of vitamin deficiency during the projected period. This information is published by Fortune Business Insights™ in an upcoming report, titled, ""Vitamin ...",PFE,0.048133,0.0,Neutral
"Thin Film Drugs Market Size Expected to Reach USD 16.27 Billion in 2028, at a CAGR of 10.5%.",https://www.benzinga.com/pressreleases/23/03/g31274383/thin-film-drugs-market-size-expected-to-reach-usd-16-27-billion-in-2028-at-a-cagr-of-10-5,2023-03-09 12:30:18,"Pune, India, March 09, 2023 ( GLOBE NEWSWIRE ) -- The global thin film drugs market size was valued at USD 7.35 billion in 2020. The market is projected to grow from USD 8.16 billion in 2021 to USD 16.27 Billion in 2028, exhibiting a CAGR of 10.5% during the forecast period.",PFE,0.078354,0.023486,Neutral
Is WisdomTree U.S. High Dividend ETF  ( DHS )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2063350/is-wisdomtree-us-high-dividend-etf-dhs-a-strong-etf-right-now,2023-03-09 11:20:07,Smart Beta ETF report for ...,PFE,0.115787,0.066792,Neutral
"Pfizer ready to launch RSV vaccines for older adults, pregnant women in US, Europe",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ready-launch-rsv-vaccines-older-adults-pregnant-women-us-europe-2023-03-09/,2023-03-09 11:15:00,"Pfizer ready to launch RSV vaccines for older adults, pregnant ... ...",PFE,0.333257,0.252346,Somewhat-Bullish
GSK set for US launch of RSV vaccine with no supply issues,https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-set-us-launch-rsv-vaccine-with-no-supply-issues-2023-03-09/,2023-03-09 08:06:00,"LONDON, March 9 ( Reuters ) - GSK ( GSK.L ) is prepared to launch its respiratory syncytial virus ( RSV ) vaccine in the U.S. this year without supply constraints and sees China as a major future market for the shot, the company's head of vaccines research & development told Reuters.",PFE,0.241284,-0.015601,Neutral
Pfizer Ltd slips for fifth straight session,https://www.business-standard.com/article/news-cm/pfizer-ltd-slips-for-fifth-straight-session-123030900510_1.html,2023-03-09 08:05:00,"Pfizer Ltd is quoting at Rs 3733, down 0.2% on the day as on 13:19 IST on the NSE. The stock tumbled 14.45% in last one year as compared to a 6.41% rally in NIFTY and a 10.41% spurt in the Nifty Metal index. Pfizer Ltd dropped for a fifth straight session today.",PFE,0.727604,0.428504,Bullish
Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression,https://www.cnbc.com/2023/03/09/alzheimers-eli-lilly-treatment-solanezumab-failed-to-slow-disease.html,2023-03-09 04:34:19,Solanezumab's failure is a blow to efforts to treat Alzheimer's in people who have not yet shown clinical symptoms.,PFE,0.053629,0.281925,Somewhat-Bullish
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2063177/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-03-08 22:45:24,"Pfizer (PFE) closed the most recent trading day at $40.12, moving -0.55% from the previous trading session.",PFE,0.670305,0.137241,Neutral
"Antifungal Drugs Market Worth  ( $13.99 Billion by 2028 )  at 3.3% CAGR - Global Analysis by Therapeutic Indication  ( Aspergillosis, Dermatophytosis, Candidiasis ) ",https://www.benzinga.com/pressreleases/23/03/g31257180/antifungal-drugs-market-worth-13-99-billion-by-2028-at-3-3-cagr-global-analysis-by-therapeutic-ind,2023-03-08 13:59:36,"New York, March 08, 2023 ( GLOBE NEWSWIRE ) -- Latest Research Report by The Insight Partners, ""Antifungal Drugs Market Size, Share, Growth, Value and Global Forecast to 2028 - Global Analysis by Infection Type ( Superficial Fungal Infection and Systemic Fungal Infection ) , Drug Type ( ...",PFE,0.033098,0.098384,Neutral
PHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ADVISORY BOARD,https://www.newswire.ca/news-releases/pharmaceutical-industry-veteran-joins-netramark-advisory-board-805620045.html,2023-03-08 13:30:00,PHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ... Canada ...,PFE,0.047185,0.0,Neutral
There's Another Contender In The RSV Battle Vs. Pfizer,https://www.investors.com/news/technology/sanofi-stock-pharma-tees-up-to-rival-to-pfizer-in-rsv-vaccine-battle/,2023-03-08 13:15:00,Sanofi Stock: Pharma Tees Up To Rival Pfizer In RSV Vaccine Battle ... Investor's Business Daily ...,PFE,0.24289,0.193855,Somewhat-Bullish
Six Flags and Equinox Gold have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2062830/six-flags-and-equinox-gold-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-03-08 13:13:00,"Chicago, IL - March 8, 2023 - Zacks Equity Research shares Six Flags ( SIX Quick QuoteSIX - ) as the Bull of the Day and Equinox Gold ( EQX Quick QuoteEQX - ) as the Bear of the Day.",PFE,0.20698,0.114878,Neutral
Xeriant partners with TMF Corporation for NEXBOARD™ test production,https://www.globenewswire.com/news-release/2023/03/08/2622993/0/en/Xeriant-partners-with-TMF-Corporation-for-NEXBOARD-test-production.html,2023-03-08 13:05:00,Established U.S. manufacturer of plastic industrial products to contribute material integration expertise Established U.S. manufacturer of plastic industrial products to contribute material integration expertise ...,PFE,0.051886,0.160798,Somewhat-Bullish
Xeriant partners with TMF Corporation for NEXBOARD™ test production - Xeriant  ( OTC:XERI ) ,https://www.benzinga.com/pressreleases/23/03/g31255891/xeriant-partners-with-tmf-corporation-for-nexboard-test-production,2023-03-08 13:05:00,"BOCA RATON, Fla., March 08, 2023 ( GLOBE NEWSWIRE ) -- Xeriant, Inc.",PFE,0.050679,0.160666,Somewhat-Bullish
"BRTX's ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome - Eli Lilly  ( NYSE:LLY ) , BioRestorative Therapies  ( NASDAQ:BRTX ) ",https://www.benzinga.com/general/biotech/23/03/31255521/brtxs-thermostem-a-new-weapon-in-the-fight-against-metabolic-syndrome,2023-03-08 12:57:41,"Metabolism is the chemical process whereby the body produces energy from food. By breaking down carbohydrates and fats into sugars, the cells access fuel that can be used or stored via the liver or body fat. A metabolic disorder can occur when the body's chemical reactions become abnormal.",PFE,0.109206,0.001147,Neutral
Big Companies Seeing Tax Benefits From Law Change Some of Them Fought,https://www.wsj.com/articles/big-companies-seeing-tax-benefits-from-law-change-some-of-them-fought-d836535d,2023-03-08 10:30:00,Some large technology and pharmaceutical companies are telling investors that a new tax-law change is reducing their tax rates. It's the same tax-law change corporate executives at many companies have been urging Congress to reverse.,PFE,0.039614,0.185213,Somewhat-Bullish
Sosei Heptares Receives Approval for Change of Market Listing Segment to the Tokyo Stock Exchange Prime Market,https://www.globenewswire.com/news-release/2023/03/08/2622696/0/en/Sosei-Heptares-Receives-Approval-for-Change-of-Market-Listing-Segment-to-the-Tokyo-Stock-Exchange-Prime-Market.html,2023-03-08 08:00:00,"Tokyo, Japan and Cambridge, UK, 8 March 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , the world leader in G protein-coupled receptor ( GPCR ) focused structure-based drug design ( SBDD ) and development, is pleased to announce it has received approval from the Tokyo Stock ...",PFE,0.067347,0.043074,Neutral
Sosei Heptares Receives Approval for Change of Market Listing Segment to the Tokyo Stock Exchange Prime Market,https://www.benzinga.com/pressreleases/23/03/g31252344/sosei-heptares-receives-approval-for-change-of-market-listing-segment-to-the-tokyo-stock-exchange-,2023-03-08 08:00:00,"Tokyo, Japan and Cambridge, UK, 8 March 2023 - Sosei Group Corporation ( ""the Company"".",PFE,0.064104,0.040016,Neutral
Alembic Pharmaceuticals receives USFDA approval for Prazosin Hydrochloride Capsules,https://www.business-standard.com/article/news-cm/alembic-pharmaceuticals-receives-usfda-approval-for-prazosin-hydrochloride-capsules-123030800168_1.html,2023-03-08 03:44:00,Alembic Pharmaceuticals receives USFDA approval for Prazosin ... Business Standard ...,PFE,0.608634,-0.124591,Neutral
Florida state lawmakers introduce bill that would ban abortion after six weeks,https://www.cnbc.com/2023/03/07/florida-state-lawmakers-introduce-bill-that-would-ban-abortion-after-six-weeks.html,2023-03-07 20:22:19,The legislation would make performing an abortion after six weeks a third-degree felony punishable by up to five years in prison.,PFE,0.0864,0.327438,Somewhat-Bullish
"FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report -  ( LHDX ) , Novavax  ( NASDAQ:NVAX ) ",https://www.benzinga.com/general/biotech/23/03/31242301/fdas-regulatory-delay-is-the-reason-for-novavax-lucira-healths-failure-wsj-report,2023-03-07 18:29:57,"Failures of Covid vaccine maker Novavax Inc NVAX and diagnostic start-up Lucira Health Inc LHDX show that companies often succeed or fail, owing to the whims of the government. Last week, while reporting Q4 earnings, Novavax raised doubts about its ability to remain in business and announced ...",PFE,0.291182,0.144557,Neutral
Republican states say the FDA doesn't have the authority to override state abortion pill bans,https://www.cnbc.com/2023/03/07/fda-powers-dont-override-state-abortion-pill-bans-republican-attorneys-general-argue-in-west-virginia-lawsuit.html,2023-03-07 17:55:10,The Republicans argued that FDA approval of a drug does not give the manufacturer an unconditional right to the sell the medication at all times.,PFE,0.082251,0.32472,Somewhat-Bullish
Lilly's  ( LLY )  Verzenio Gets FDA Nod for Expanded Breast Cancer,https://www.zacks.com/stock/news/2062620/lillys-lly-verzenio-gets-fda-nod-for-expanded-breast-cancer,2023-03-07 16:00:00,"Eli Lilly (LLY) announces FDA approval of label expansion of Verzenio (abemaciclib), in combination with endocrine therapy, for treating HR+, HER2-, node-positive and high-risk early breast cancer.",PFE,0.197951,0.026885,Neutral
Pfizer  ( PFE )  or GSK: Who Will Get the First FDA Nod for RSV Jab?,https://www.zacks.com/stock/news/2062612/pfizer-pfe-or-gsk-who-will-get-the-first-fda-nod-for-rsv-jab,2023-03-07 15:33:00,"An FDA advisory committee recommended approving Pfizer's (PFE) and GSK's respective RSV vaccines for older adults. Currently, there are no RSV vaccines anywhere in the world.",PFE,0.445179,0.190506,Somewhat-Bullish
PFE: 4 Stocks to Buy in Any Market Climate,https://stocknews.com/news/pfe-bmy-amgn-elv-jnj-azn-4-stocks-to-buy-in-any-market-climate/,2023-03-07 12:18:04,"The stock market remains volatile ahead of Fed chair Jerome Powell's Semiannual Monetary Policy Report delivery to Congress. Moreover, as recessionary fears are high, quality healthcare stocks Pfizer Inc. ( PFE ) , Bristol-Myers Squibb Company ( BMY ) , Amgen Inc. ( AMGN ) , and Elevance Health ...",PFE,0.26061,0.110042,Neutral
Voyager Therapeutics Reports Fourth Quarter and Full Year 2022 Financial and Operating Results,https://www.globenewswire.com/news-release/2023/03/07/2621867/36461/en/Voyager-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-and-Operating-Results.html,2023-03-07 12:00:00,- Transformational progress in 2022 marked by reprioritization of high-value neurology pipeline and validation of TRACER™ novel capsid platform through transactions with Pfizer and ...,PFE,0.131483,0.086199,Neutral
Should WisdomTree U.S. High Dividend ETF  ( DHS )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2062446/should-wisdomtree-us-high-dividend-etf-dhs-be-on-your-investing-radar,2023-03-07 11:20:07,Style Box ETF report for ...,PFE,0.122581,0.068387,Neutral
"IDEAYA Biosciences, Inc. Reports 2022 Financial Results and Provides Business Update",https://www.prnewswire.com/news-releases/ideaya-biosciences-inc-reports-2022-financial-results-and-provides-business-update-301763946.html,2023-03-07 11:00:00,"IDEAYA Biosciences, Inc. Reports 2022 Financial Results and ... PR ...",PFE,0.010078,0.076663,Neutral
California governor says state won't do business with Walgreens over position on abortion pill,https://www.cnbc.com/2023/03/06/abortion-pill-california-governor-newsom-says-state-wont-do-business-with-walgreens.html,2023-03-06 21:55:58,Newsom's statement comes after Walgreens said it would not sell the abortion pill in 21 states due to legal restrictions.,PFE,0.108466,0.346855,Somewhat-Bullish
Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from 2022 to 2027: Growth opportunities led by Abbott Laboratories and Alvogen Iceland ehf among others- Technavio,https://www.prnewswire.com/news-releases/osteoarthritis-therapeutics-market-to-grow-at-a-cagr-of-8-97-from-2022-to-2027-growth-opportunities-led-by-abbott-laboratories-and-alvogen-iceland-ehf-among-others--technavio-301761982.html,2023-03-06 19:30:00,Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from ... PR ...,PFE,0.03878,0.017745,Neutral
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July,https://www.cnbc.com/2023/03/06/alzheimers-fda-will-review-eisais-and-biogens-treatment-leqembi-with-decision-expected-in-july.html,2023-03-06 14:19:29,Medicare has agreed to provide broader coverage once Leqembi receives full FDA approval.,PFE,0.086245,0.327331,Somewhat-Bullish
ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS,https://www.prnewswire.com/news-releases/endo-reports-fourth-quarter-2022-financial-results-301762972.html,2023-03-06 13:50:00,"DUBLIN, March 6, 2023 /PRNewswire/ -- Endo International plc ( OTC: ENDPQ ) today reported financial results for the fourth-quarter ended December 31, 2022. Adjusted Income from Continuing Operations ( 2 ) ( 3 ) Adjusted Diluted Weighted Average Shares ( 1 ) ( 2 )",PFE,0.021115,0.014405,Neutral
ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS,https://www.newswire.ca/news-releases/endo-reports-fourth-quarter-2022-financial-results-829432463.html,2023-03-06 13:50:00,"DUBLIN, March 6, 2023 /CNW/ -- Endo International plc ( OTC: ENDPQ ) today reported financial results for the fourth-quarter ended December 31, 2022. Total revenues were $556 million in fourth-quarter 2022, a decrease of 30% compared to $789 million in fourth-quarter 2021.",PFE,0.016271,0.0,Neutral
International Superstar and Business Mogul Flo Rida Embarks Upon a New Journey with his new company JettSet1 Enterprises,https://www.prnewswire.com/news-releases/international-superstar-and-business-mogul-flo-rida-embarks-upon-a-new-journey-with-his-new-company-jettset1-enterprises-301762918.html,2023-03-06 13:00:00,International Superstar and Business Mogul Flo Rida Embarks Upon ... PR ...,PFE,0.099066,0.181908,Somewhat-Bullish
"Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA",https://www.prnewswire.com/news-releases/corbus-pharmaceuticals-expands-board-of-directors-with-appointment-of-yong-ben-md-mba-301762805.html,2023-03-06 13:00:00,Corbus Pharmaceuticals Expands Board of Directors with ... PR ...,PFE,0.047278,0.044789,Neutral
Why Big Drugmakers Want to Buy Cancer Biotech Seagen,https://www.wsj.com/articles/why-big-drugmakers-want-to-buy-cancer-biotech-seagen-3adb9c4f,2023-03-06 13:00:00,The unprofitable biotech that pioneered a relatively new kind of cancer therapy has caught the attention of the world's largest drugmakers.,PFE,0.345674,0.547307,Bullish
Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets,https://investingnews.com/voyager-therapeutics-to-receive-25-million-payment-for-license-of-next-generation-aav-capsids-for-multiple-neurologic-disease-targets/,2023-03-06 12:20:48,"Options exercised on two targets; Voyager eligible to receive associated development, regulatory, and commercial milestones, plus tiered royalties With option exercise, potential to expand agreement to include capsids for up to two additional targets extends for next 18 months",PFE,0.073098,0.071912,Neutral
"Smart Life Sciences Manufacturing Market Worth $78.97 Billion, Globally, by 2033 - Rising Adoption of Pharma 4.0 | Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/03/g31213997/smart-life-sciences-manufacturing-market-worth-78-97-billion-globally-by-2033-rising-adoption-of-p,2023-03-06 12:05:48,"New York, March 06, 2023 ( GLOBE NEWSWIRE ) -- The Insight Partners published latest research study on ""Smart Life Sciences Manufacturing Market Size, Share, Growth, Trends and Global Forecast to 2033 - COVID-19 Impact and Global Analysis by Component ( Solutions and Services ) , Technology ...",PFE,0.027103,0.166386,Somewhat-Bullish
"Avanos Medical, Inc. Appoints Dr. Lisa Egbuonu-Davis to Board of Directors",https://www.prnewswire.com/news-releases/avanos-medical-inc-appoints-dr-lisa-egbuonu-davis-to-board-of-directors-301762853.html,2023-03-06 12:00:00,"Avanos Medical, Inc. Appoints Dr. Lisa Egbuonu-Davis to Board of ... PR ...",PFE,0.07423,0.213433,Somewhat-Bullish
Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets,https://www.globenewswire.com/news-release/2023/03/06/2620904/36461/en/Voyager-Therapeutics-to-Receive-25-Million-Payment-for-License-of-Next-Generation-AAV-Capsids-for-Multiple-Neurologic-Disease-Targets.html,2023-03-06 12:00:00,"Options exercised on two targets. Voyager eligible to receive associated development, regulatory, and commercial milestones, plus tiered royalties ...",PFE,0.061869,0.072125,Neutral
"Global Lyme Disease Treatment Market Expected to Garner $1,636.6 Million by 2031, Growing at 8.4% CAGR from 2022-2031 [200-Pages] | Commended by Research Dive",https://www.prnewswire.com/news-releases/global-lyme-disease-treatment-market-expected-to-garner-1-636-6-million-by-2031--growing-at-8-4-cagr-from-2022-2031-200-pages--commended-by-research-dive-301763053.html,2023-03-06 11:59:00,Global Lyme Disease Treatment Market Expected to Garner ... PR ...,PFE,0.038969,0.110392,Neutral
"US Stocks Could Consolidate As S&P 500, Nasdaq Futures Tick Up Ahead Of Fed Chair Powell's Congressional Testimony - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/03/31213132/us-stocks-could-consolidate-as-s-p-500-nasdaq-futures-tick-up-ahead-of-fed-chair-powells-congressio,2023-03-06 11:36:50,"Stocks could pause on Monday after returning to winning ways in the past week, as the focus shifts to Fed Chair Jerome Powell's two-day Congressional testimony this week. U.S. stocks advanced in the week ended March 3, with the S&P 500 Index snapping a three-week losing streak.",PFE,0.127119,0.0,Neutral
"2 Reasons to Buy Moderna Stock, and 1 Reason to Sell",https://www.fool.com/investing/2023/03/06/2-reasons-to-buy-moderna-stock-1-reason-to-sell/,2023-03-06 10:31:00,"2023 and 2024 will be difficult, but after that, its fortunes should improve again.",PFE,0.067536,0.185712,Somewhat-Bullish
Better Generics Pharmaceutical Stock: Teva or Viatris?,https://www.fool.com/investing/2023/03/05/better-generics-pharmaceutical-stock-teva-or-viatr/,2023-03-05 16:28:00,Both have plans to return to growth.,PFE,0.04823,0.025817,Neutral
"What Are Cannabinoids, Their Types, And Effects?",https://www.benzinga.com/markets/cannabis/23/03/31197289/what-are-cannabinoids-their-types-and-effects,2023-03-05 14:00:02,"This article was originally published on Askgrowers and appears here with permission. Marijuana lovers already know that cannabis contains THC and CBD. The percentage of these cannabinoids decides the weed characteristics. But in fact, there are many more cannabinoids definitions than just two.",PFE,0.018965,-0.003468,Neutral
Could This Be the Next Blockbuster Vaccine for This Big Pharma Stock?,https://www.fool.com/investing/2023/03/05/could-this-be-the-next-blockbuster-vaccine-for-gsk/,2023-03-05 13:30:00,This vaccine candidate could help tackle the respiratory syncytial virus.,PFE,0.063933,0.112094,Neutral
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?,https://www.fool.com/investing/2023/03/05/time-to-buy-sp-500s-worst-performing-stocks-2023/,2023-03-05 12:38:00,"Can Lumen Technologies, Moderna, Baxter International, and Pfizer recover this year?",PFE,0.203215,-0.094054,Neutral
Should You Give Up on Novavax?,https://www.fool.com/investing/2023/03/03/should-you-give-up-on-novavax/,2023-03-03 19:00:00,"After a spectacular 2020 performance, Novavax's shares have plummeted.",PFE,0.114409,-0.053766,Neutral
"How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/03/31194439/how-much-did-us-government-spend-on-mrna-vaccine-technology-before-and-during-the-pandemic-the-nu,2023-03-03 16:22:06,"The U.S. government invested at least $31.9 billion to develop, produce, and purchase mRNA COVID-19 vaccines, including sizeable investments in the three decades before the pandemic through March 2022, according to a new BMJ study. That includes at least $337 million was invested pre-pandemic.",PFE,0.468029,-0.080292,Neutral
Jim Cramer's stock picks: Investors can now bet on or against them through two new funds | The Financial Express,https://www.financialexpress.com/investing-abroad/featured-stories/jim-cramers-stock-picks-investors-can-now-bet-on-or-against-them-through-two-new-funds/2999013/,2023-03-03 14:31:00,Jim Cramer's stock picks: Investors can now bet on or against them ... The Financial Express ...,PFE,0.102013,0.0,Neutral
Investors Heavily Search Pfizer Inc.  ( PFE ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2061503/investors-heavily-search-pfizer-inc-pfe-here-is-what-you-need-to-know,2023-03-03 14:00:17,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.529767,0.077997,Neutral
Is Moderna Stock a Buy Now?,https://www.fool.com/investing/2023/03/03/is-moderna-stock-a-buy-now/,2023-03-03 12:30:00,"The company is looking to transition beyond its COVID-19 vaccine, and that could mean a bumpy ride for investors.",PFE,0.059488,0.100548,Neutral
Grey Group appoints Gabriel Schmitt as Global Chief Creative Officer,https://www.prnewswire.com/news-releases/grey-group-appoints-gabriel-schmitt-as-global-chief-creative-officer-301761744.html,2023-03-03 11:10:00,"NEW YORK, March 3, 2023 /PRNewswire/ -- Today Grey Group announces the latest addition to its global leadership team: Gabriel Schmitt joins as Global Chief Creative Officer. He will report to Global CEO Laura Maness.",PFE,0.076115,0.148825,Neutral
China is rolling out the red carpet to attract foreign executives,https://www.cnbc.com/2023/03/03/china-is-rolling-out-the-red-carpet-to-attract-foreign-executives.html,2023-03-03 01:02:17,China is pulling out all the stops to keep multinationals like Apple and its supplier Foxconn in the country.,PFE,0.088147,-0.040154,Neutral
Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update,https://www.prnewswire.com/news-releases/cardiff-oncology-reports-fourth-quarter-and-full-year-2022-results-and-provides-business-update-301760531.html,2023-03-02 21:10:00,Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results ... PR ...,PFE,0.024826,0.011144,Neutral
Latina Podcasters Network Welcomes Chicklet + Maleni Show to Its Lineup; Real-life relationship podcast becomes part of growing Latino Pods Subsidiary,https://www.benzinga.com/pressreleases/23/03/n31181169/latina-podcasters-network-welcomes-chicklet-maleni-show-to-its-lineup-real-life-relationship-podca,2023-03-02 21:00:00,"HOUSTON, March 2, 2023 /PRNewswire-PRWeb/ -- Latina Podcasters Network, a Latina and certified minority-owned and operated podcast network group, announces the addition of the ""Chicklet + Maleni: That's Your Reality"" program under its Latino Pods subsidiary.",PFE,0.05833,0.141997,Neutral
"Bears control the stock market for now, but these takeover plays can keep the bulls satisfied",https://www.marketwatch.com/story/bears-control-the-stock-market-for-now-but-these-takeover-plays-can-keep-the-bulls-satisfied-3daffd54,2023-03-02 19:33:00,"S&P 500 has been under pressure since early February's false breakout, writes Lawrence McMillan.",PFE,0.062352,0.100414,Neutral
"European Commission Keeps Mum On Talks Regarding Pfizer COVID-19 Vaccine Contract: Report - Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/03/31170243/european-commission-keeps-mum-on-talks-regarding-pfizer-covid-19-vaccine-contract-report,2023-03-02 19:03:43,European Commission President Ursula von der Leyen remains silent on her dealings with Pfizer Inc PFE regarding the EU's COVID-19 vaccine contract is hurting public trust.,PFE,0.682689,0.219821,Somewhat-Bullish
Moderna May Be Just Getting Started in This Big Market,https://www.fool.com/investing/2023/03/02/moderna-just-getting-started-in-this-big-market/,2023-03-02 19:00:00,We still may be able to count on Moderna for blockbuster revenue -- and over the long term.,PFE,0.12645,0.085387,Neutral
FDA Advisers Had Questions on Pfizer's RSV Vaccine. GSK Could Be First to Market.,https://www.barrons.com/articles/rsv-vaccine-pfizer-gsk-fda-b66510b2,2023-03-02 17:09:00,Some FDA Advisers Doubt Pfizer's RSV Vaccine. GSK Could Be First to Market. ...,PFE,0.699089,0.05367,Neutral
Why Is Pfizer  ( PFE )  Down 8.6% Since Last Earnings Report?,https://www.zacks.com/stock/news/2061131/why-is-pfizer-pfe-down-86-since-last-earnings-report,2023-03-02 16:30:59,Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PFE,0.363768,0.03635,Neutral
European chemicals firms downbeat on 2023 prospects,https://www.reuters.com/markets/europe/european-chemicals-firms-downbeat-2023-prospects-2023-03-02/,2023-03-02 15:11:09,"[1/3] The logo of German specialty chemical company Evonik Industries AG is pictured at their plant in Bitterfeld, Germany, February 29, 2016. REUTERS/Fabrizio Bensch//File Photo",PFE,0.0699,0.034495,Neutral
Is Pfizer Stock a Buy Now?,https://www.fool.com/investing/2023/03/02/is-pfizer-stock-a-buy-now/,2023-03-02 14:30:00,"Is this drug company just a ""pandemic stock""?",PFE,0.417501,0.147321,Neutral
Plot To Kill Jewish Michigan Officials Targeted Attorney General,https://www.forbes.com/sites/tylerroush/2023/03/02/michigan-attorney-general-targeted-in-plot-to-kill-jewish-state-officials/,2023-03-02 14:08:06,The FBI arrested a former University of Michigan employee in connection with the threats.,PFE,0.117486,-0.181523,Somewhat-Bearish
Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential,https://www.fool.com/investing/2023/03/02/dont-miss-out-on-2-undervalued-stocks-with-huge/,2023-03-02 13:45:00,There isn't much that's stopping them from penetrating their markets globally.,PFE,0.059488,0.045992,Neutral
Lessons from Novo Nordisk on the stampede for obesity drugs,https://www.economist.com/business/2023/03/02/lessons-from-novo-nordisk-on-the-stampede-for-obesity-drugs,2023-03-02 12:04:36,Dos and don'ts on how to handle a gold rush ...,PFE,0.036756,0.086185,Neutral
FDA Fuels Respiratory Syncytial Virus Vaccine Race While Backing GSK's Candidate Soon After Pfizer's - GSK  ( NYSE:GSK ) ,https://www.benzinga.com/general/biotech/23/03/31160955/fda-fuels-respiratory-syncytial-virus-vaccine-race-while-backing-gsks-candidate-soon-after-pfizer,2023-03-02 11:15:23,The FDA's Vaccines and Related Biological Products Advisory Committee voted that GSK plc's GSK available data support the safety and effectiveness of its respiratory syncytial virus ( RSV ) candidate to prevent lower respiratory tract disease in adults aged 60 years and older.,PFE,0.263942,0.15211,Somewhat-Bullish
GSK spinoff Haleon forecasts 4-6% revenue growth in 2023,https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-spinoff-haleon-forecasts-4-6-revenue-growth-2023-2023-03-02/,2023-03-02 07:27:00,GSK spinoff Haleon forecasts 4-6% revenue growth in ...,PFE,0.200688,0.285089,Somewhat-Bullish
Merck KGaA expects 2023 profit to slip as COVID demand wanes,https://www.reuters.com/markets/europe/merck-kgaa-expects-2023-profit-slip-covid-demand-wanes-2023-03-02/,2023-03-02 06:04:00,"FRANKFURT, March 2 ( Reuters ) - Germany's Merck KGaA ( MRCG.DE ) on Thursday predicted 2023 earnings would slip, warning of a decline at its electronic chemicals unit and citing a drop in COVID-related demand for its lab supplies from drug and vaccine makers.",PFE,0.151539,0.0,Neutral
argenx Announces Planned Transition of Chief Operating Officer - argenx  ( NASDAQ:ARGX ) ,https://www.benzinga.com/pressreleases/23/03/g31154896/argenx-announces-planned-transition-of-chief-operating-officer,2023-03-02 06:00:00,"Karen Massey appointed as Chief Operating Officer, effective March 13, 2023 Keith Woods to retire and serve as Advisor on argenx Board of Directors",PFE,0.042346,0.028511,Neutral
Evonik sees lower 2023 core profit,https://www.reuters.com/markets/commodities/evonik-sees-lower-2023-core-profit-2023-03-02/,2023-03-02 05:48:49,"March 2 ( Reuters ) - German chemicals group Evonik Industries ( EVKn.DE ) on Thursday forecast 2023 core profit below last year's level, as animal nutrition prices decline and negative effects of high inflation, fluctuating energy prices and the war in Ukraine persist.",PFE,0.299478,0.149248,Neutral
FDA advisors recommend 2 RSV vaccines for older adults,https://www.axios.com/2023/03/02/fda-advisors-rsv-vaccine-older-adults-gsk-pfizer,2023-03-02 02:02:14,"A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Photo: Sarah Silbiger/Getty Images A Food and Drug Administration advisory panel recommended Wednesday the second vaccine in two days against the respiratory syncytial virus, ...",PFE,0.133841,0.098848,Neutral
US declines to force lower price on cancer drug Xtandi,https://www.reuters.com/business/healthcare-pharmaceuticals/us-declines-force-lower-price-cancer-drug-xtandi-2023-03-21/,2023-03-21 23:39:00,US declines to force lower price on cancer drug ...,PFE,0.209365,-0.202146,Somewhat-Bearish
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance,https://www.globenewswire.com/news-release/2023/03/21/2631825/0/en/Telesis-Bio-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-2023-Guidance.html,2023-03-21 20:05:00,-- Record revenue of $9.5M in 4QFY22. Increase of 208% over ...,PFE,0.109455,0.173249,Somewhat-Bullish
"Potentially deadly fungus Candida auris is spreading at an 'alarming rate,' CDC says",https://www.cnbc.com/2023/03/21/candida-auris-fungus-resistant-to-drugs-spreading-rapidly-cdc-says.html,2023-03-21 18:57:55,"Candida auris was limited to New York City and Chicago, but has since been detected in more than half of U.S. states and has become endemic in some areas.",PFE,0.093836,0.051766,Neutral
"Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/news/large-cap/23/03/31444127/additional-covid-19-booster-shots-officials-anticipate-fda-authorization-within-few-weeks,2023-03-21 18:43:14,"The U.S. Food and Drug Administration is reportedly moving toward authorizing a second round of omicron-targeted COVID-19 booster shots for the elderly and other people at high risk. FDA officials could decide within a few weeks and could change their mind, Wall Street Journal reported citing the ...",PFE,0.316846,0.281501,Somewhat-Bullish
PFE: Adding These 2 Stocks to Your Portfolio Could End up Being a Genius Move,https://stocknews.com/news/pfe-hmc-sgen-adding-these-2-stocks-to-your-portfolio-could-end-up/,2023-03-21 17:25:08,PFE: Adding These 2 Stocks to Your Portfolio Could End up Being a ... ...,PFE,0.486415,0.193134,Somewhat-Bullish
4 Biotech Stocks to Consider for Your Portfolio in 2023,https://www.zacks.com/commentary/2068484/4-biotech-stocks-to-consider-for-your-portfolio-in-2023,2023-03-21 15:32:00,"New drug approvals and pipeline progress should maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and a solid pipeline progress position CRSP, LGND, THRX and KALA well amid volatility.",PFE,0.02689,0.098044,Neutral
Moderna's Stephane Bancel Faces Off With Bernie Sanders,https://www.investors.com/news/technology/moderna-stock-stephane-bancel-faces-off-with-bernie-sanders/,2023-03-21 15:31:23,Moderna Stock: Stephane Bancel Faces Off With Bernie Sanders ... Investor's Business Daily ...,PFE,0.379435,-0.013425,Neutral
U.S. FDA to soon decide on second round of Omicron-tailored boosters - WSJ,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-soon-decide-second-round-omicron-tailored-boosters-wsj-2023-03-21/,2023-03-21 15:22:00,U.S. FDA to soon decide on second round of Omicron-tailored ... ...,PFE,0.252987,0.247832,Somewhat-Bullish
JNJ: Want to Retire a Millionaire? 2 Stocks to Buy Now,https://stocknews.com/news/jnj-pfe-abmd-want-to-retire-a-millionaire-2-stocks-to-buy-now/,2023-03-21 14:44:29,"Concerns over the Fed's tighter monetary policy and the banking crisis will likely tip the economy into a recession. However, that should not deter investors from investing in quality stocks Johnson & Johnson ( JNJ ) and Pfizer Inc. ( PFE ) , which could help retire a millionaire.",PFE,0.304585,0.095147,Neutral
Texas judge could invoke 1873 Comstock Act to roll back mail delivery of abortion pill mifepristone,https://www.cnbc.com/2023/03/21/abortion-pill-texas-judge-could-invoke-comstock-act-to-roll-back-mail-delivery.html,2023-03-21 14:43:17,U.S. Judge Matthew Kacsmaryk raised the Comstock Act repeatedly in last week's hearing for the case challenging FDA approval of mifepristone.,PFE,0.056943,0.048108,Neutral
"Pfizer Has Another Blockbuster on the Horizon, but That's Not All",https://www.fool.com/investing/2023/03/21/pfizer-has-another-blockbuster-on-the-horizon-but/,2023-03-21 14:00:00,The drugmaker continues to grab headlines for the right reasons.,PFE,0.754857,0.420903,Bullish
Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/general/biotech/23/03/31435256/moderna-wants-to-charge-about-130-per-covid-19-vaccine-dose,2023-03-21 13:12:12,"From now on, Moderna Inc MRNA expects to charge $130 per dose for its COVID-19 vaccine as purchases move from the government to the private sector.",PFE,0.29234,0.0,Neutral
"What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years? - BioRestorative Therapies  ( NASDAQ:BRTX ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/23/03/31438097/what-is-autologous-cell-based-therapy-the-treatment-revolutionizing-regenerative-medicine-that-co,2023-03-21 13:07:08,Autologous cell based therapies are personalized therapies using your own cells to target a disease or disorder. Personalized therapies targeting cancer such CAR-T cell therapies have generated impressive clinical results with complete remission rates in B-acute lymphoblastic leukemia in over ...,PFE,0.09989,0.203818,Somewhat-Bullish
CD47 Inhibitors Drugs Cancer Therapy Clinical Trials Market Size Companies Insight,https://www.benzinga.com/pressreleases/23/03/g31435842/cd47-inhibitors-drugs-cancer-therapy-clinical-trials-market-size-companies-insight,2023-03-21 11:49:18,"Delhi, March 21, 2023 ( GLOBE NEWSWIRE ) -- Global CD47 Inhibitor Drug Clinical Trials Insight 2028 Report Highlights: CD47 Inhibitor Drug Market Trends & Future Prospects Insight On More Than 50 CD47 Inhibitors Drugs In Clinical Trials Orphan, Fast Track, Breakthrough Therapy Designation ...",PFE,0.049732,0.006996,Neutral
Buyer Beware: 3 Risks to Watch for With Biotech Stocks in 2023,https://www.fool.com/investing/2023/03/21/buyer-beware-3-risks-to-watch-for-with-biotech-sto/,2023-03-21 11:25:00,"It's still a decent time to invest, but you'll need to be more careful than usual.",PFE,0.055109,0.03302,Neutral
Vigil Neuroscience Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update,https://www.globenewswire.com/news-release/2023/03/21/2631116/0/en/Vigil-Neuroscience-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Business-Update.html,2023-03-21 11:00:00,- Dosed first patient in IGNITE Phase 2 clinical trial to evaluate VGL101 in patients with ...,PFE,0.018699,0.065724,Neutral
Moderna expects to price its COVID vaccine at about $130 in the US,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-expects-price-its-covid-vaccine-about-130-us-2023-03-20/,2023-03-20 22:13:00,"[1/3] A vial of the Moderna coronavirus disease ( COVID-19 ) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier",PFE,0.148731,0.021939,Neutral
Biden signs legislation to declassify certain intelligence on Covid pandemic origins,https://www.cnbc.com/2023/03/20/covid-origins-biden-signs-bill-to-declassify-intelligence-on-wuhan-lab.html,2023-03-20 21:48:06,Biden signed legislation requiring the declassification of information on any possible links between a lab in China and the origins of the Covid-19 pandemic.,PFE,0.238913,-0.065765,Neutral
Pfizer  ( PFE )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2068184/pfizer-pfe-outpaces-stock-market-gains-what-you-should-know,2023-03-20 21:45:20,"In the latest trading session, Pfizer (PFE) closed at $40.81, marking a +1.77% move from the previous day.",PFE,0.606946,0.199478,Somewhat-Bullish
"Insiders Selling Pfizer And 2 Other Stocks - Kulicke & Soffa Indus  ( NASDAQ:KLIC ) , Jacobs Solutions  ( NYSE:J ) ",https://www.benzinga.com/news/23/03/31427222/insiders-selling-pfizer-and-2-other-stocks,2023-03-20 19:42:03,"The Nasdaq Composite traded slightly higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go ...",PFE,0.47147,-0.152616,Somewhat-Bearish
Rating: add; ITC - Good progress across businesses | The Financial Express,https://www.financialexpress.com/market/rating-add-itc-good-progress-across-businesses/3016805/,2023-03-20 18:40:00,Rating: add. ITC - Good progress across businesses The Financial Express ...,PFE,0.045054,-0.099329,Neutral
"A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats - Merck & Co  ( NYSE:MRK ) , Gilead Sciences  ( NASDAQ:GILD ) ",https://www.benzinga.com/general/biotech/23/03/31420230/a-company-with-solutions-against-emerging-covid-variants-and-other-viral-infections-to-combat-fut,2023-03-20 13:15:48,"With the COVID pandemic still ongoing, having claimed more than 6.8 million lives from about 758 million cases and crippling the global economy, there are several reasons why drug research and development related to the COVID virus remains highly relevant and necessary.",PFE,0.192694,-0.04682,Neutral
2 Undervalued Stocks to Buy Today to Prepare for the Next Bull Market,https://www.fool.com/investing/2023/03/20/2-undervalued-stocks-to-buy-today-to-prepare-for/,2023-03-20 12:30:00,"Both have some headwinds coming up, but their long-term outlook still looks great.",PFE,0.329551,0.206783,Somewhat-Bullish
BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications,https://www.globenewswire.com/news-release/2023/03/20/2630166/0/en/BioNTech-and-OncoC4-Announce-Strategic-Collaboration-to-Co-Develop-and-Commercialize-Novel-Checkpoint-Antibody-in-Multiple-Solid-Tumor-Indications.html,2023-03-20 11:45:00,"MAINZ, Germany and ROCKVILLE, Maryland, USA, March 20, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" ) and OncoC4, Inc. ( ""OncoC4"" ) , a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel biologicals for cancer treatment, today announced that they have ...",PFE,0.030799,-0.006725,Neutral
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF  ( PJP ) ?,https://www.zacks.com/stock/news/2067783/should-you-invest-in-the-invesco-dynamic-pharmaceuticals-etf-pjp,2023-03-20 10:20:07,Sector ETF report for ...,PFE,0.133841,0.064137,Neutral
Is Invesco Dynamic Large Cap Value ETF  ( PWV )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2067787/is-invesco-dynamic-large-cap-value-etf-pwv-a-strong-etf-right-now,2023-03-20 10:20:06,Smart Beta ETF report for ...,PFE,0.116348,0.055726,Neutral
"Reliance Industries, Pfizer among 245 NSE stocks to touch 52-week lows; 26 hit 52-week highs | The Financial Express",https://www.financialexpress.com/market/reliance-industries-pfizer-among-245-nse-stocks-to-touch-52-week-lows-26-hit-52-week-highs/3015825/,2023-03-20 07:42:29,"Reliance Industries, Pfizer among 245 NSE stocks to touch 52-week ... The Financial Express ...",PFE,0.076602,0.055755,Neutral
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, ADAP, PRVB, XM - Provention Bio  ( NASDAQ:PRVB ) , Adaptimmune Therapeutics  ( NASDAQ:ADAP ) ",https://www.benzinga.com/pressreleases/23/03/g31412276/shareholder-investigation-halper-sadeh-llc-investigates-sgen-adap-prvb-xm,2023-03-19 14:16:02,"NEW YORK, March 19, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Seagen Inc.",PFE,0.133841,0.092806,Neutral
1 Top Healthcare Stock That Could Make You Richer in the Next Decade,https://www.fool.com/investing/2023/03/19/1-top-healthcare-stock-that-could-make-you-richer/,2023-03-19 13:15:00,The Pfizer of tomorrow will be larger and even more lucrative to hold than it is now.,PFE,0.33433,0.251455,Somewhat-Bullish
"Lifshitz Law PLLC Announces Investigations of SGEN, PRVB, KBAL, and ADAP - Kimball International  ( NASDAQ:KBAL ) , Adaptimmune Therapeutics  ( NASDAQ:ADAP ) ",https://www.benzinga.com/pressreleases/23/03/g31410546/lifshitz-law-pllc-announces-investigations-of-sgen-prvb-kbal-and-adap,2023-03-19 00:11:00,"NEW YORK, March 18, 2023 ( GLOBE NEWSWIRE ) -- Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SGEN to Pfizer Inc. for $229.00 per share in cash.",PFE,0.112008,-0.029596,Neutral
"Stock Market Diverges Amid Bank Woes, Growth Gains",https://www.investors.com/news/stock-market-diverges-amid-bank-woes-growth-gains-first-republic-credit-suisse-meta-in-focus/,2023-03-17 17:22:48,"The stock market showed volatile split action, amid efforts to avoid a wider bank crisis following the SVB Financial and Signature Bank shutdowns in the prior week. Credit Suisse ( CS ) borrowed up to $54 billion from the Swiss National Bank after the long-ailing giant tumbled to a record low.",PFE,0.064973,-0.059472,Neutral
Pfizer's  ( PFE )  COVID-19 Drug Paxlovid Gets FDA Panel Vote,https://www.zacks.com/stock/news/2067467/pfizers-pfe-covid-19-drug-paxlovid-gets-fda-panel-vote,2023-03-17 16:19:00,FDA's Antimicrobial Drugs Advisory Committee (AMDAC) votes 16 to 1 for Pfizer's Paxlovid for the treatment of mild-to-moderate COVID-19 in adult patients at high risk of hospitalization or death.,PFE,0.377712,0.064121,Neutral
WHO expects to declare end to pandemic sometime in 2023 as virus becomes more like seasonal flu,https://www.marketwatch.com/story/who-expects-to-declare-end-to-pandemic-sometime-in-2023-as-virus-becomes-more-like-seasonal-flu-2bc4b80c,2023-03-17 15:18:00,The World Health Organization said Friday that it expects to declare an end to the COVID-19 pandemic sometime in 2023.,PFE,0.092927,0.03179,Neutral
Two Biotech Stocks Hit In Medicare Negotiation Crossfire,https://www.investors.com/research/ibd-industry-themes/regn-stock-halo-stock-tumble-on-cms-negotiation-confusion/,2023-03-17 14:50:45,"REGN Stock, HALO Stock Tumble On CMS Negotiation Confusion ... Investor's Business Daily ...",PFE,0.127795,0.0,Neutral
"Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug - Astellas Pharma  ( OTC:ALPMY ) , Astellas Pharma  ( OTC:ALPMF ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/03/31397615/pfizer-astellas-tout-positive-xtandi-data-to-potentially-expand-label-for-the-prostate-cancer-dru,2023-03-17 14:17:10,Pfizer Inc PFE and Astellas Pharma Inc ALPMY released topline results from the Phase 3 EMBARK trial evaluating Xtandi ( enzalutamide ) in non-metastatic hormone-sensitive prostate cancer.,PFE,0.399204,-0.139327,Neutral
"Pharma Stock Roundup: M&A Boom in Drug Industry With PFE & SNY Deals, Other Updates",https://www.zacks.com/stock/news/2067324/pharma-stock-roundup-ma-boom-in-drug-industry-with-pfe-sny-deals-other-updates,2023-03-17 14:08:00,Pfizer (PFE) is set to buy Seagen (SGEN) for $43 billion while Sanofi (SNY) is acquiring Provention Bio. Novo Nordisk (NVO) and Sanofi are looking to cut insulin prices.,PFE,0.31282,0.00234,Neutral
U.S. judge in Texas will soon rule on the abortion pill mifepristone. Here's what could happen,https://www.cnbc.com/2023/03/17/abortion-pill-texas-judge-will-soon-rule-on-mifepristone-heres-what-could-happen.html,2023-03-17 13:25:27,The judge could order the FDA to withdraw mifepristone. He could also stop short of blocking sales and impose tougher restrictions on distribution instead.,PFE,0.082582,-0.036517,Neutral
"Top Stories Friday, Mar. 17",https://www.benzinga.com/news/large-cap/23/03/31396809/svb-financial-officially-files-for-bankruptcy-yellen-powell-dimon-behind-first-republic-banks-30b-,2023-03-17 13:11:11,"SVB Financial Group SIVB has filed a voluntary petition for a court-supervised reorganization under Chapter 11 in the United States Bankruptcy Court for the Southern District of New York to preserve value. SVB Securities, SVB Capital's funds, and general partner entities are not included in the ...",PFE,0.06623,-0.120242,Neutral
FDA Advisory Committee Votes Favoring Pfizer's COVID-19 Pill Paxlovid - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/03/31396668/fda-advisory-committee-votes-favoring-pfizers-covid-19-pill-paxlovid,2023-03-17 13:04:41,The FDA's Antimicrobial Drugs Advisory Committee voted 16-1 that available data support the safety and effectiveness of Pfizer Inc's PFE Paxlovid for mild-to-moderate COVID-19 in adult patients who are at high risk for progression to severe illness.,PFE,0.726435,0.326471,Somewhat-Bullish
Is Pfizer Stock Undervalued At $40?,https://www.forbes.com/sites/greatspeculations/2023/03/17/is-pfizer-stock-undervalued-at-40/,2023-03-17 13:00:00,"Pfizer stock (NYSE: PFE) has seen a fall of 21% this year, compared with 2% returns for the broader S&P500 index.",PFE,0.765213,-0.083816,Neutral
"Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?",https://www.fool.com/investing/2023/03/17/better-rsv-vaccine-stock-pfizer-gsk-or-moderna/,2023-03-17 12:45:00,An approved RSV vaccine could be the next big thing for these companies.,PFE,0.267804,0.136586,Neutral
"Pfizer Working To Develop New Packaging For Migraine Drug Over Child Safety, Poisoning Concerns - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/03/31395434/pfizer-working-to-develop-new-packaging-for-migraine-drug-over-child-safety-poisoning-concerns,2023-03-17 12:11:18,"Pfizer Inc PFE recalled prescription migraine drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child-resistant blister card packaged in a carton containing the product's name, dosage strength, NDC number, and ...",PFE,0.567144,0.061409,Neutral
"SpaceX, Netflix, Boeing to join ""biggest-ever"" US business mission to Vietnam",https://www.reuters.com/business/spacex-netflix-boeing-join-biggest-ever-us-business-mission-vietnam-2023-03-17/,2023-03-17 04:42:56,"SpaceX, Netflix, Boeing to join ""biggest-ever"" US business mission ... ...",PFE,0.070105,-0.007058,Neutral
Phase 3 Study Shows XTANDI® plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer,https://investingnews.com/phase-3-study-shows-xtandi-r-plus-leuprolide-significantly-improves-metastasis-free-survival-in-men-with-non-metastatic-prostate-cancer/,2023-03-17 00:05:48,Pfizer and Astellas announce positive topline results from Phase 3 EMBARK trial,PFE,0.152258,0.046132,Neutral
Senators re-launch bill seeking to force Supreme Court to televise sessions,https://www.cnbc.com/2023/03/16/senators-bill-would-force-supreme-court-to-televise-sessions.html,2023-03-16 20:26:47,The Supreme Court has resisted calls to televise sessions. A senator cited recent rulings on abortion and gun control in pushing for more transparency.,PFE,0.044551,-0.181787,Somewhat-Bearish
FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's PAXLOVID,https://investingnews.com/fda-advisory-committee-votes-in-support-of-favorable-benefit-risk-profile-for-pfizer-s-paxlovid/,2023-03-16 20:03:05,Pfizer Inc. ( NYSE: PFE ) announced today that the U.S.,PFE,0.131532,0.073307,Neutral
Pediatric hospital beds are in high demand for ailing children. Here's why,https://www.cnn.com/2023/03/16/health/pediatric-hospital-bed-shortage-ctrp,2023-03-16 20:02:00,Pediatric hospital beds are in high demand for ailing children. Here's ... ...,PFE,0.013188,0.134746,Neutral
Pediatric hospital beds are in high demand for ailing children. Here's why,https://www.cnn.com/2023/03/16/health/pediatric-hospital-bed-shortage-ctrp/index.html,2023-03-16 20:02:00,Pediatric hospital beds are in high demand for ailing children. Here's ... ...,PFE,0.013188,0.134746,Neutral
FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk people,https://www.cnbc.com/2023/03/16/fda-advisors-recommend-full-approval-of-pfizer-covid-drug-paxlovid.html,2023-03-16 19:25:43,Paxlovid is recommended for people over 50 or those with medical conditions like high blood pressure or diabetes that place them at a greater risk of Covid.,PFE,0.114956,0.011449,Neutral
Pfizer recalls 4.2M prescription drug packages due to risk of child poisonings,https://www.foxbusiness.com/lifestyle/pfizer-recalls-prescription-drug-packages-risk-child-posioning,2023-03-16 18:30:35,"Pharmaceutical giant Pfizer is recalling 4.2 million prescription drug packages for failing to meet child-resistant requirements, according to federal safety regulators.",PFE,0.277433,0.121547,Neutral
Stifel Is Bullish On This 'Competitive Late-Comer' In Gastric Cancer Space - Theseus Pharmaceuticals  ( NASDAQ:THRX ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/03/31384940/stifel-is-bullish-on-this-competitive-late-comer-in-gastric-cancer-space,2023-03-16 17:47:49,Stifel has initiated coverage on Theseus Pharmaceuticals Inc THRX with a Buy rating and a $24 price target. The company's Predictive Resistance Assay was validated by Deciphera Pharmaceuticals Inc's DCPH INTRIGUE subgroup data published recently in January.,PFE,0.366061,0.232562,Somewhat-Bullish
Two Biotech Stocks Hit In Medicare Negotiation Crossfire,https://www.investors.com/news/technology/regn-stock-halo-stock-tumble-on-cms-negotiation-confusion/,2023-03-16 16:05:45,"REGN Stock, HALO Stock Tumble On CMS Negotiation Confusion Investor's Business Daily ...",PFE,0.1331,0.0,Neutral
Pfizer Unusual Options Activity For March 16 - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/03/31383457/pfizer-unusual-options-activity-for-march-16,2023-03-16 15:45:47,"Someone with a lot of money to spend has taken a bullish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.701476,0.345631,Somewhat-Bullish
"Biotech Stock Roundup: ACAD's Drug Approval, SGEN to be Acquired by PFE & More",https://www.zacks.com/stock/news/2066904/biotech-stock-roundup-acads-drug-approval-sgen-to-be-acquired-by-pfe-more,2023-03-16 15:20:00,"Acadia's (ACAD) pipeline and regulatory updates, and Seagen's (SGEN) acquisition news are the key highlights from the biotech sector during the past week.",PFE,0.186378,0.14961,Neutral
"Yellen says U.S. banking system is 'stable' and deposits 'remain safe' following failure of SVB, Signature",https://www.cnbc.com/2023/03/16/svb-signature-bank-failures-yellen-says-us-banking-system-is-stable-and-deposits-remain-safe.html,2023-03-16 15:00:30,Treasury Secretary Janet Yellen sought to reassure markets and lawmakers that the government will protect U.S. bank deposits amid a rash of bank failures.,PFE,0.086556,-0.189954,Somewhat-Bearish
Shareholders have high hopes for Bayer's new boss,https://www.economist.com/business/2023/03/16/shareholders-have-high-hopes-for-bayers-new-boss,2023-03-16 14:49:28,Bill Anderson has two qualifications for the job. He knows pharma. And he is American ...,PFE,0.052801,0.167975,Somewhat-Bullish
TSM: 4 Robinhood Stocks to Buy Right Now,https://stocknews.com/news/tsm-pfe-gm-nok-hood-sgen-gfs-kd-4-robinhood-stocks-to-buy-right-now/,2023-03-16 14:02:05,"Robinhood is a financial services company that offers commission-free stock, options, ETF, and cryptocurrency trades, making it extremely attractive to Gen Z and millennial investors.",PFE,0.208285,0.157866,Somewhat-Bullish
Pfizer recalls migraine drug over packaging issues - CPSC,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-recalls-migraine-drug-over-packaging-issues-cpsc-2023-03-16/,2023-03-16 13:57:00,Pfizer recalls migraine drug over packaging issues ...,PFE,0.7887,-0.150221,Somewhat-Bearish
This Must-Buy Dividend Growth Stock Could Pay You for Life,https://www.fool.com/investing/2023/03/16/must-buy-dividend-growth-stock-pay-you-pfizer/,2023-03-16 13:53:59,"It might not regularly beat the market, but it won't have any trouble padding your wallet.",PFE,0.458593,0.345456,Somewhat-Bullish
Ex-fugitive in fraud scheme tied to $100 million NJ deli willing to pay millions for bail,https://www.cnbc.com/2023/03/16/nj-deli-fugitive-detained-bail.html,2023-03-16 13:25:29,Peter Coker Jr. is charged with his father and another man over alleged stock fraud involving a small town New Jersey deli.,PFE,0.036037,-0.17804,Somewhat-Bearish
"Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial of PYX-201, a Novel ADC for Solid Tumors",https://www.globenewswire.com/news-release/2023/03/16/2628535/0/en/Pyxis-Oncology-Announces-Dosing-of-First-Subject-in-Phase-1-Trial-of-PYX-201-a-Novel-ADC-for-Solid-Tumors.html,2023-03-16 11:30:00,Milestone marks transition of Pyxis Oncology to a clinical-stage company ...,PFE,0.06515,0.160302,Somewhat-Bullish
Nuvalent Highlights Pipeline and Business Progress and Reports Fourth Quarter and Full Year 2022 Financial Results,https://www.prnewswire.com/news-releases/nuvalent-highlights-pipeline-and-business-progress-and-reports-fourth-quarter-and-full-year-2022-financial-results-301773623.html,2023-03-16 10:30:00,Nuvalent Highlights Pipeline and Business Progress and Reports ... PR ...,PFE,0.024446,0.059599,Neutral
Should Schwab U.S. Dividend Equity ETF  ( SCHD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2066515/should-schwab-us-dividend-equity-etf-schd-be-on-your-investing-radar,2023-03-16 10:20:08,Style Box ETF report for ...,PFE,0.121037,0.068013,Neutral
Here's Why Pfizer Stock Is Looking Increasingly Attractive,https://www.fool.com/investing/2023/03/16/heres-why-pfizer-stock-is-looking-increasingly-att/,2023-03-16 09:52:00,Many investors appear to be writing off Pfizer. That could prove to be a mistake.,PFE,0.834516,0.341592,Somewhat-Bullish
UiPath  ( PATH )  Q4 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/03/15/uipath-path-q4-2023-earnings-call-transcript/,2023-03-16 01:00:20,"PATH earnings call for the period ending December 31, 2022.",PFE,0.005099,0.101776,Neutral
U.S. issues initial Medicare drug price negotiation guidance,https://www.reuters.com/business/healthcare-pharmaceuticals/us-issues-initial-medicare-drug-price-negotiation-guidance-2023-03-15/,2023-03-15 21:07:00,"WASHINGTON, March 15 ( Reuters ) - The U.S. government will select the Medicare program's 10 costliest prescription medicines based on gross spending for negotiating price cuts that will go into effect in 2026, the U.S. Centers for Medicare and Medicaid Services ( CMS ) said on Wednesday",PFE,0.083833,0.067467,Neutral
"STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger - MLVF, XM, PRVB, SGEN",https://www.benzinga.com/pressreleases/23/03/g31370576/stockholder-alert-the-m-a-class-action-firm-continues-its-investigation-of-the-merger-mlvf-xm-prvb,2023-03-15 20:49:52,"NEW YORK, March 15, 2023 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and ...",PFE,0.070105,0.121321,Neutral
Pfizer  ( PFE )  Gets FDA Nod for Bivalent COVID Jab in Infants,https://www.zacks.com/stock/news/2066329/pfizer-pfe-gets-fda-nod-for-bivalent-covid-jab-in-infants,2023-03-15 18:38:00,Pfizer (PFE) and partner BioNTech receive FDA label expansion to use their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as a single booster dose in young children under five years.,PFE,0.7503,0.10044,Neutral
Pfizer Unusual Options Activity For March 15 - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/03/31364592/pfizer-unusual-options-activity-for-march-15,2023-03-15 15:45:43,"A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 16 strange trades. If we consider the specifics of each trade, it is accurate to state that 75% of the investors opened trades with bullish expectations and ...",PFE,0.713164,0.305755,Somewhat-Bullish
"DOJ charges Chinese businessman Guo Wengui, associate of Steve Bannon, in $1 billion fraud",https://www.cnbc.com/2023/03/15/doj-charges-guo-wengui-steve-bannon-associate-in-1-billion-fraud.html,2023-03-15 14:58:27,"Prosecutors accused Guo Wengui, an associate of former Trump White House advisor Steve Bannon, of a large conspiracy that duped his online followers.",PFE,0.076602,-0.186604,Somewhat-Bearish
Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs,https://www.cnbc.com/2023/03/15/pfizer-to-pay-medicare-rebates-for-five-drugs-under-biden-plan-to-lower-rx-costs.html,2023-03-15 14:04:39,Five of Pfizer's drugs will cost less for Medicare recipients starting next month as part of President Joe Biden's plan to lower prescription drug cost.,PFE,0.110462,-0.067206,Neutral
"Company News for Mar 15, 2023",https://www.zacks.com/stock/news/2066026/company-news-for-mar-15-2023,2023-03-15 13:19:00,"Companies In The News Are: META, BG, SBNY, PFE, UAL.",PFE,0.622414,0.525544,Bullish
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines - AbbVie  ( NYSE:ABBV ) ,https://www.benzinga.com/general/biotech/23/03/31357344/drug-companies-raising-prices-greater-than-inflation-us-government-mulling-imposing-fines,2023-03-15 12:30:10,"Under Joe Biden's signature Inflation Reduction Act, drugmakers for twenty-seven drugs will be penalized for charging prices that rise faster than inflation for people with disabilities or the elderly on the government's Medicare health program.",PFE,0.147818,0.221919,Somewhat-Bullish
"FDA Approves Pfizer/BioNTech's Bivalent COVID-19 Vaccine For Youngest Kids - Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/03/31355830/fda-approves-pfizerbiontechs-bivalent-covid-19-vaccine-for-youngest-kids,2023-03-15 12:21:19,The FDA has expanded the emergency use authorization ( EUA ) of Pfizer Inc PFE / BioNTech SE's BNTX bivalent COVID-19 vaccine as a single booster dose in children under five years of age.,PFE,0.795061,0.116277,Neutral
Why a nasal vaccine could reduce the risk of COVID infections and new variants,https://www.marketwatch.com/story/why-a-nasal-vaccine-could-reduce-the-risk-of-covid-infections-and-new-variants-e68a284b,2023-03-15 12:15:00,"Three years into the pandemic, the World Health Organization's Joachim Hombach talks about the future of vaccines with MarketWatch.",PFE,0.779232,0.282374,Somewhat-Bullish
PFE: The Smartest Stock to Buy for Under $50 Now,https://stocknews.com/news/pfe-nvo-bmy-nvs-sgen-the-smartest-stock-to-buy-for-under-50-now/,2023-03-15 12:12:45,"Stronger-than-expected macroeconomic data combined with the Fed's hawkish comments have increased investor anxiety. However, the pharma sector tends to be more resilient to economic downturns compared to others, as the demand for pharmaceutical products is generally not affected by macroeconomic ...",PFE,0.564501,0.30167,Somewhat-Bullish
Royalty Pharma Raises Full Year 2023 Guidance - Royalty Pharma  ( NASDAQ:RPRX ) ,https://www.benzinga.com/pressreleases/23/03/g31358101/royalty-pharma-raises-full-year-2023-guidance,2023-03-15 12:00:00,"Royalty Pharma now expects 2023 Adjusted Cash Receipts ( 1 ) ( non-GAAP ) to be between $2,850 million and $2,950 million, excluding contributions from future transactions",PFE,0.033006,0.018903,Neutral
Strength Seen in Mirati  ( MRTX ) : Can Its 13.5% Jump Turn into More Strength?,https://www.zacks.com/stock/news/2065889/strength-seen-in-mirati-mrtx-can-its-135-jump-turn-into-more-strength,2023-03-15 09:56:00,Mirati (MRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.,PFE,0.114137,0.056425,Neutral
"Reliance Industries, HDFC AMC, Pfizer among 103 NSE stocks to touch 52-week lows; 22 hit 52-week highs | The Financial Express",https://www.financialexpress.com/market/reliance-industries-hdfc-amc-pfizer-among-103-nse-stocks-to-touch-52-week-lows-22-hit-52-week-highs/3010135/,2023-03-15 07:39:57,"Reliance Industries, HDFC AMC, Pfizer among 103 NSE stocks to ... The Financial Express ...",PFE,0.091509,0.106961,Neutral
Indian companies need to reduce corporate flying emissions: Report,https://www.business-standard.com/article/companies/indian-companies-need-to-reduce-corporate-flying-emissions-report-123031500095_1.html,2023-03-15 07:25:00,"Globally, only 50 companies out of 322 have set targets to reduce business travel, with technology company Wipro paving the way in India ...",PFE,0.055492,0.0,Neutral
How GSK plans to replenish its depleted medicine cabinet,https://www.reuters.com/business/healthcare-pharmaceuticals/how-gsk-plans-replenish-its-depleted-medicine-cabinet-2023-03-15/,2023-03-15 06:12:00,"STEVENAGE, England, March 15 ( Reuters ) - GSK's ( GSK.L ) chief scientist says an overhaul of the drugmaker's R&D unit has begun delivering results - citing an RSV vaccine and promising hepatitis B and asthma treatments - and pledged a tighter focus than his predecessor on infectious disease ...",PFE,0.042346,0.130718,Neutral
Sosei Heptares Announces Change of Market Listing Segment to the Tokyo Stock Exchange Prime Market,https://www.globenewswire.com/news-release/2023/03/15/2627310/0/en/Sosei-Heptares-Announces-Change-of-Market-Listing-Segment-to-the-Tokyo-Stock-Exchange-Prime-Market.html,2023-03-15 00:05:00,"Tokyo, Japan and Cambridge, UK, 15 March 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , the world leader in G protein-coupled receptor ( GPCR ) focused structure-based drug design ( SBDD ) and development, today announces it has changed the market on which the Company's shares are ...",PFE,0.048621,0.04245,Neutral
U.S. FDA expands authorization of Pfizer bivalent COVID-19 shots in kids,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-expands-authorization-pfizer-bivalent-covid-19-shots-kids-2023-03-14/,2023-03-14 23:03:00,U.S. FDA expands authorization of Pfizer bivalent COVID-19 shots in ... ...,PFE,0.47672,-0.003081,Neutral
FDA authorizes Pfizer's Covid omicron booster as fourth shot for kids under 5,https://www.cnbc.com/2023/03/14/fda-authorizes-pfizers-covid-omicron-booster-as-fourth-shot-for-kids-under-5.html,2023-03-14 22:07:02,The FDA authorized Pfizer's omicron booster shot for kids younger than five who were previously vaccinated with three doses of the company's original shot.,PFE,0.30569,0.178486,Somewhat-Bullish
Pfizer  ( PFE )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2065710/pfizer-pfe-gains-but-lags-market-what-you-should-know,2023-03-14 21:45:24,"Pfizer (PFE) closed the most recent trading day at $39.90, moving +0.1% from the previous trading session.",PFE,0.686288,0.150368,Somewhat-Bullish
"Senate Democrats urge Walmart, Costco, Albertsons and Kroger to sell abortion pill mifepristone",https://www.cnbc.com/2023/03/14/abortion-pill-democrats-tell-walmart-costco-albertsons-kroger-to-sell-mifepristone.html,2023-03-14 19:54:40,The senators urged the companies to get certified with the FDA to sell the abortion pill mifepristone and provide access that is as broad as possible.,PFE,0.069596,-0.00204,Neutral
"""The Buzz"" Show: Pfizer  ( NYSE: PFE )  to Acquire Seagen Inc. for USD 43 Billion | Financial Buzz",https://www.financialbuzz.com/the-buzz-show-pfizer-nyse-pfe-to-acquire-seagen-inc-for-usd-43-billion/,2023-03-14 19:34:12,"FinancialBuzz.com's latest The Buzz Show: Featuring Our Corporate News Recap on ""Pfizer Invests USD 43 Billion to Battle Cancer"" Pfizer Inc. ( NYSE: PFE ) and Seagen Inc. ( NASDAQ: SGEN ) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire ...",PFE,0.767202,0.411739,Bullish
Pfizer agrees to revise EU COVID vaccine contract -FT,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-agrees-revise-eu-covid-vaccine-contract-ft-2023-03-14/,2023-03-14 19:19:59,Pfizer agrees to revise EU COVID vaccine contract - FT ...,PFE,0.645887,-0.10637,Neutral
Should Investors Consider Pfizer  ( PFE )  or Seagen  ( SGEN )  Stock After Acquisition,https://www.zacks.com/stock/news/2065682/should-investors-consider-pfizer-pfe-or-seagen-sgen-stock-after-acquisition,2023-03-14 19:14:00,Shares of Seagen (SGEN) popped 14% yesterday on news that Pfizer (PFE) would acquire the company for $43 billion. The deal values Seagen shares at $229 and 15% above current levels.,PFE,0.663719,0.137813,Neutral
FDA staff report says data shows Pfizer's Covid treatment Paxlovid is effective in high-risk adults,https://www.cnbc.com/2023/03/14/fda-staff-report-says-data-shows-pfizers-covid-treatment-paxlovid-is-effective-in-high-risk-adults.html,2023-03-14 19:04:36,FDA staff said Pfizer's clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.,PFE,0.184598,-0.003024,Neutral
Data For Pfizer's COVID-19 Drug Shows No Possible Association With Infection Rebound - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/03/31347048/data-for-pfizers-covid-19-drug-shows-no-possible-association-with-infection-rebound,2023-03-14 18:48:14,The FDA dropped in briefing document as the agency's external advisors meet on Thursday ( March 16 ) to discuss complete approval for Pfizer Inc's PFE Covid-19 treatment drug Paxlovid. Data from the drug's trials support its use in adults at high risk of progressing to severe disease.,PFE,0.657566,0.204127,Somewhat-Bullish
Does This Billion-Dollar Deal Solve Pfizer's Biggest Problem?,https://www.fool.com/investing/2023/03/14/does-billion-dollar-deal-solve-pfizers-big-problem/,2023-03-14 18:00:00,Pfizer's planned acquisition of Seagen could be a very important move.,PFE,0.819113,-0.101949,Neutral
"Citing 'death threats,' Texas judge asked attorneys to keep news of hearing on legality of abortion pill quiet",https://www.cnbc.com/2023/03/14/abortion-pill-texas-judge-told-attorneys-to-keep-date-of-a-key-hearing-quiet.html,2023-03-14 17:29:27,Federal Judge Matthew Kacsmaryk asked attorneys in a pivotal case over the abortion pill mifepristone to not disclose a key hearing set for Wednesday.,PFE,0.064276,-0.002023,Neutral
OPKO Health  ( OPK )  to Develop EBV Vaccine With Latest Tie-Up,https://www.zacks.com/stock/news/2065588/opko-health-opk-to-develop-ebv-vaccine-with-latest-tie-up,2023-03-14 16:08:00,OPKO Health's (OPK) entry into a worldwide license and collaboration agreement with Merck is expected to aid in developing a vaccine against EBV.,PFE,0.123209,0.218526,Somewhat-Bullish
Is Pfizer Stock a Screaming Buy After Its $43 Billion Seagen Acquisition?,https://www.fool.com/investing/2023/03/14/if-pfizer-stock-a-screaming-buy-after-its-43-billi/,2023-03-14 15:45:00,Pfizer's $43 billion Seagen acquisition is a long-term value-creation strategy.,PFE,0.559416,0.242402,Somewhat-Bullish
"Moore Kuehn Encourages XM, OSH, SGEN, and PRVB Investors to Contact Law Firm - Oak Street Health  ( NYSE:OSH ) , Provention Bio  ( NASDAQ:PRVB ) ",https://www.benzinga.com/pressreleases/23/03/g31342808/moore-kuehn-encourages-xm-osh-sgen-and-prvb-investors-to-contact-law-firm,2023-03-14 14:28:37,"NEW YORK, March 14, 2023 ( GLOBE NEWSWIRE ) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.",PFE,0.110462,0.212618,Somewhat-Bullish
"Pfizer  ( PFE )  to Buy Seagen for $43B, Boost Cancer Portfolio",https://www.zacks.com/stock/news/2065457/pfizer-pfe-to-buy-seagen-for-43b-boost-cancer-portfolio,2023-03-14 14:24:00,Pfizer (PFE) is set to buy Seagen (SGEN) in a $43 billion deal. Seagen's key products focus on cancer treatment.,PFE,0.672533,-0.081975,Neutral
Pfizer's COVID drug data supports use in high-risk patients - FDA staff,https://www.reuters.com/business/healthcare-pharmaceuticals/trial-data-supports-pfizers-covid-drug-high-risk-adults-fda-staff-2023-03-14/,2023-03-14 13:39:00,"March 14 ( Reuters ) - The U.S. Food and Drug Administration's staff reviewers said on Tuesday that data from Pfizer Inc's ( PFE.N ) trials of its COVID-19 drug supports its use in adults at high-risk of the disease, ahead of a meeting of the agency's experts to discuss full approval of the pill.",PFE,0.742397,0.143597,Neutral
"Company News for Mar 14, 2023",https://www.zacks.com/stock/news/2065310/company-news-for-mar-14-2023,2023-03-14 13:24:00,"Companies In The News Are: SGEN, PFE, PODD, SIVB, ILMN, PNC.",PFE,0.535653,0.211446,Somewhat-Bullish
"These Analysts Boost Price Targets On Seagen Following Acquisition News - Seagen  ( NASDAQ:SGEN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/m-a/23/03/31339606/these-analysts-boost-price-targets-on-seagen-following-acquisition-news,2023-03-14 13:06:37,Pfizer Inc PFE agreed to acquire Seagen Inc SGEN for $229 in cash per Seagen share for a total enterprise value of $43 billion. Seagen shares jumped 14.5% to close at $197.65 on Monday. These analysts made changes to their price targets on Seagen following the release of results.,PFE,0.432291,0.651437,Bullish
Pediatric Asthma Treatment Market Size to Reach US$ 14.4 Bn by 2031 with CAGR of 2.9% - According to the Global Report by TMR,https://www.benzinga.com/pressreleases/23/03/g31339601/pediatric-asthma-treatment-market-size-to-reach-us-14-4-bn-by-2031-with-cagr-of-2-9-according-to-t,2023-03-14 13:06:11,"Wilmington, Delaware, United States, March 14, 2023 ( GLOBE NEWSWIRE ) -- According to a Transparency Market Research study, the global pediatric asthma treatment market was valued at US$ 11.2 Bn in 2022 and is anticipated to grow at a compound annual growth rate of 2.9% during the forecast ...",PFE,0.04531,0.109307,Neutral
"Seagen  ( SGEN )  Set to be Acquired by Pfizer for $43 B, Stock Up",https://www.zacks.com/stock/news/2065490/seagen-sgen-set-to-be-acquired-by-pfizer-for-43-b-stock-up,2023-03-14 13:06:00,"Seagen is set to be acquired by the large-cap pharma company, Pfizer, at a valuation of $43 billion. The stock is up about 15% in response to the news.",PFE,0.247208,0.248037,Somewhat-Bullish
Pfizer Inc.  ( PFE )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2065278/pfizer-inc-pfe-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-03-14 13:00:12,"Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",PFE,0.526867,0.074503,Neutral
"SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates PRVB, SGEN, XM - Provention Bio  ( NASDAQ:PRVB ) , Seagen  ( NASDAQ:SGEN ) ",https://www.benzinga.com/pressreleases/23/03/g31338788/shareholder-notice-halper-sadeh-llc-investigates-prvb-sgen-xm,2023-03-14 12:43:27,"NEW YORK, March 14, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Provention Bio, Inc.",PFE,0.165031,0.105018,Neutral
V: 3 Best Stocks to Buy and Hold for a Lifetime,https://stocknews.com/news/v-pfe-moh-sgen-3-best-stocks-to-buy-and-hold-for-a-lifetime/,2023-03-14 11:31:04,"Last year, the stock market witnessed extreme volatility as geopolitical issues, high inflation, and interest rate hikes weighed on investors' sentiments.",PFE,0.374312,0.146959,Neutral
Biogen Appoints Chuck Triano as Head of Investor Relations,https://www.globenewswire.com/news-release/2023/03/14/2626506/0/en/Biogen-Appoints-Chuck-Triano-as-Head-of-Investor-Relations.html,2023-03-14 11:30:00,"CAMBRIDGE, Mass., March 14, 2023 ( GLOBE NEWSWIRE ) -- Biogen Inc. ( NASDAQ: BIIB ) today announced the appointment of Chuck Triano as Senior Vice President, Head of Investor Relations effective 10 April 2023. Mr. Triano will report to Michael McDonnell, Executive Vice President and Chief ...",PFE,0.043186,0.013847,Neutral
Biogen Appoints Chuck Triano as Head of Investor Relations - Biogen  ( NASDAQ:BIIB ) ,https://www.benzinga.com/pressreleases/23/03/g31336884/biogen-appoints-chuck-triano-as-head-of-investor-relations,2023-03-14 11:30:00,"CAMBRIDGE, Mass., March 14, 2023 ( GLOBE NEWSWIRE ) -- Biogen Inc. BIIB today announced the appointment of Chuck Triano as Senior Vice President, Head of Investor Relations effective 10 April 2023. Mr. Triano will report to Michael McDonnell, Executive Vice President and Chief Financial Officer.",PFE,0.042571,0.013829,Neutral
Biotech deals provide a split-screen moment for battered sector,https://www.axios.com/2023/03/14/biotech-deals-split-screen-moment-sector,2023-03-14 09:56:56,A pair of big biotech deals is stirring some hope for a segment that's been in a deep funk and just starting to size up the aftereffects of Silicon Valley Bank's demise.,PFE,0.185781,-0.022997,Neutral
"Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines? - Merck & Co  ( NYSE:MRK ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/03/31334008/did-elon-musk-just-put-his-skepticism-behind-and-warm-up-to-mrna-tech-that-powers-most-covid-19-v,2023-03-14 09:41:32,"Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr. Anthony Fauci, who in his previous capacity as the director of the National Institute of Allergy And Infectious Diseases, spearheaded the vaccine drive against the pandemic.",PFE,0.387374,0.077425,Neutral
Strength Seen in Seattle Genetics  ( SGEN ) : Can Its 14.5% Jump Turn into More Strength?,https://www.zacks.com/stock/news/2065130/strength-seen-in-seattle-genetics-sgen-can-its-145-jump-turn-into-more-strength,2023-03-14 08:53:00,Seattle Genetics (SGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.,PFE,0.204072,0.134974,Neutral
Glenmark receives USFDA approval for Clindamycin Hydrochloride Capsules,https://www.business-standard.com/article/news-cm/glenmark-receives-usfda-approval-for-clindamycin-hydrochloride-capsules-123031400487_1.html,2023-03-14 07:24:00,Glenmark receives USFDA approval for Clindamycin Hydrochloride ... Business Standard ...,PFE,0.622414,0.0,Neutral
USFDA approves Glenmark Pharmaceuticals' bacterial infection capsules | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/usfda-approves-glenmark-pharmaceuticals-bacterial-infection-capsules/3008636/,2023-03-14 07:17:00,USFDA approves Glenmark Pharmaceuticals' bacterial infection ... The Financial Express ...,PFE,0.275867,0.148959,Neutral
FDA: Paxlovid not associated with COVID rebound,https://www.axios.com/2023/03/14/fda-paxlovid-not-associated-with-covid-rebound,2023-03-14 03:16:23,"Paxlovid isn't associated with COVID rebound, in which patients test positive or have symptoms days after a course of the drug is completed, Food and Drug Administration staff said in briefing documents released Tuesday.",PFE,0.141726,-0.081243,Neutral
Astellas Announces Phase 3 China ARCHES Study of XTANDI® Meets Primary Endpoint - Investing News Network,https://investingnews.com/astellas-announces-phase-3-china-arches-study-of-xtandi-r-meets-primary-endpoint/,2023-03-13 23:52:02,Astellas Announces Phase 3 China ARCHES Study of XTANDI® Meets Primary Endpoint Investing News Network ...,PFE,0.059415,0.147003,Neutral
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners,https://www.fool.com/investing/2023/03/13/monday-merger-mania-just-made-these-2-biotech-stoc/,2023-03-13 23:15:00,"On a volatile market day, companies are still looking for smart combinations.",PFE,0.341857,-0.062937,Neutral
"Precision Medicine Group Appoints John Hubbard, PhD, as Board of Directors Chair",https://www.prnewswire.com/news-releases/precision-medicine-group-appoints-john-hubbard-phd-as-board-of-directors-chair-301770773.html,2023-03-13 22:37:00,"Precision Medicine Group Appoints John Hubbard, PhD, as Board of ... PR ...",PFE,0.07446,0.030382,Neutral
"Business Highlights: Banking system aid, Alaska oil project",https://apnews.com/article/business-economy-news-highlights-de83150a459e33f2e52f76af618ccc36,2023-03-13 21:35:18,"Government races to reassure US that banking system is safe NEW YORK ( AP ) - Depositors withdrew savings, and investors broadly sold off bank shares as the federal government raced to reassure Americans that the banking system is secure following two bank failures.",PFE,0.085476,-0.059962,Neutral
Judge shares date of abortion pill hearing after media outlets criticize him for secrecy,https://www.cnbc.com/2023/03/13/abortion-pill-mifepristone-lawsuit-judge-sets-hearing-for-wednesday.html,2023-03-13 21:18:19,A coalition of physicians of who oppose abortion asked Kacsmaryk in November to order the FDA to withdraw its approval of the abortion pill mifepristone.,PFE,0.118064,-0.002369,Neutral
"Moderna shares pop 7% after Cowen upgrades stock, saying it 'will be a leader' in RSV vaccines",https://www.cnbc.com/2023/03/13/moderna-shares-pop-7percent-after-cowen-upgrades-stock-saying-it-will-be-a-leader-in-rsv-vaccines.html,2023-03-13 20:53:18,"Moderna shares closed nearly 7% after TD Cowen upgraded the stock, saying the company will ""be a leader"" in the RSV vaccine market.",PFE,0.227007,-0.019184,Neutral
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients,https://www.cnbc.com/2023/03/13/veterans-health-will-cover-alzheimers-treatment-leqembi-for-some-patients.html,2023-03-13 20:48:37,"Veterans with early Alzheimer's who meet certain VHA criteria can get the treatment covered, according to Eisai.",PFE,0.123209,-0.002418,Neutral
"KeyCorp, Philips 66 fall; Seagen, Insulet rise",https://apnews.com/article/financial-markets-stocks-wall-street-10d555a5804b140f08ae8e2b565cb60d,2023-03-13 20:26:27,"KeyCorp, Philips 66 fall. Seagen, Insulet rise The Associated Press - en ...",PFE,0.340915,0.448933,Bullish
"Week Ahead: Banking Crisis, Inflation Reports, and Big Pharma Acquisitions",https://www.zacks.com/stock/news/2064983/week-ahead-banking-crisis-inflation-reports-and-big-pharma-acquisitions,2023-03-13 20:08:00,Last week ended on a hectic note...,PFE,0.153145,0.159928,Somewhat-Bullish
The Pfizer-Seagen deal has a hidden $1 billion warning for workers,https://www.businessinsider.com/pfizer-seagen-deal-cost-efficiencies-reductions-jobs-warning-workers-2023-3,2023-03-13 18:41:30,Pfizer-Seagen Deal Has $1 Billion of Cost Cuts - Business Insider ...,PFE,0.823417,0.115146,Neutral
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qualtrics  ( Nasdaq - XM ) , Seagen Inc.  ( Nasdaq - SGEN ) , Provention Bio Inc.  ( Nasdaq - PRVB ) , Kimball International, Inc.  ( Nasdaq - KBAL ) ",https://www.benzinga.com/pressreleases/23/03/g31326657/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-qualtrics-nas,2023-03-13 17:58:27,"BALA CYNWYD, Pa., March 13, 2023 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",PFE,0.331765,0.104638,Neutral
Stock Market Feels Some Relief As Rate Hikes Look Smaller,https://www.investors.com/market-trend/stock-market-today/stock-market-feels-some-relief-as-rate-hikes-look-smaller/,2023-03-13 17:55:40,"The stock market's major indexes continued turbulent action, off session highs in afternoon trading Monday. Investors felt some comfort that the Fed likely won't raise rates as quickly as anticipated, as the banking meltdown continued. Three banks have failed in the past few days.",PFE,0.172097,-0.231497,Somewhat-Bearish
Pfizer CEO says it will be able to deliver Seagen's cancer therapy at a scale not seen before with $43 billion deal,https://www.cnbc.com/2023/03/13/pfizer-will-bring-seagens-cancer-drugs-to-the-world-at-a-scale-not-seen-before-ceo-says.html,2023-03-13 17:48:20,Pfizer CEO Albert Bourla said it will deliver Seagen's cancer therapy to the world at a scale that hasn't been seen before with its $43 billion acquisition.,PFE,0.382925,0.118707,Neutral
Pfizer's $43 billion bid for Seagen aims to broaden company's cancer portfolio,https://www.marketwatch.com/story/pfizer-to-purchase-seagen-in-43-billion-all-cash-deal-cancer-biotechs-stock-pops-20-1792912e,2023-03-13 17:36:00,"Pfizer plans to pay $229 per share in cash for Seagen, whose stock soared more than 15% in trading on Monday afternoon. Pfizer's shares gained about 1.7%.",PFE,0.885652,0.241041,Somewhat-Bullish
"Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation - Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/23/03/31324057/best-selling-drugs-by-bristol-myers-pfizer-abbvie-likely-candidates-for-us-price-negotiation,2023-03-13 17:18:58,"Bristol Myers Squibb & Co's BMY Eliquis, Pfizer Inc's PFE Ibrance, and AbbVie Inc's ABBV Imbruvica are expected to be among the ten top-selling drugs subject to U.S. price negotiations for 2026.",PFE,0.428632,0.106399,Neutral
"Dow Jones Rises With Gold, Bitcoin Amid Bank Sell-Off; Analysts See Rate Freeze In March",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-gold-bitcoin-rise-amidst-bank-run-fears-analysts-see-rate-hike-pause-as-banks-crater/,2023-03-13 17:10:31,"Dow Jones Rises With Gold, Bitcoin Amid Bank Sell-Off. Analysts ... Investor's Business Daily ...",PFE,0.109705,-0.202145,Somewhat-Bearish
"Stocks making the biggest moves midday: First Republic Bank, Moderna, Newmont, Illumina and more",https://www.cnbc.com/2023/03/13/stocks-moving-big-midday-frc-mrna-nem-prvb.html,2023-03-13 16:56:32,These are the stocks posting the largest moves midday.,PFE,0.067727,-0.062617,Neutral
Factbox: Pfizer snaps up Seagen for $43 bln as drugmaker extends buying spree,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-snaps-up-seagen-43-bln-drugmaker-extends-buying-spree-2023-03-13/,2023-03-13 16:20:00,Factbox: Pfizer snaps up Seagen for $43 bln as drugmaker extends ... ...,PFE,0.842959,0.211064,Somewhat-Bullish
Why Seagen Stock Is Soaring Today,https://www.fool.com/investing/2023/03/13/why-seagen-stock-is-soaring-today/,2023-03-13 15:48:27,Investors are cheering Pfizer's planned acquisition of Seagen.,PFE,0.871234,0.181077,Somewhat-Bullish
Pfizer  ( PFE )  Gets FDA Nod for Migraine Nasal Spray Zavzpret,https://www.zacks.com/stock/news/2064840/pfizer-pfe-gets-fda-nod-for-migraine-nasal-spray-zavzpret,2023-03-13 15:39:00,Zavzpret (zavegepant) is now part of Pfizer's (PFE) migraine drugs portfolio with the 2022 acquisition of Biohaven. Zavzpret provides migraine patients access to a fast-acting pain-relief option.,PFE,0.382925,0.018447,Neutral
"Illumina, Seagen And Other Big Stocks Moving Higher On Monday - Agenus  ( NASDAQ:AGEN ) , First Majestic Silver  ( NYSE:AG ) ",https://www.benzinga.com/news/23/03/31322709/illumina-seagen-and-other-big-stocks-moving-higher-on-monday,2023-03-13 14:55:50,"U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today's session. Provention Bio, Inc. PRVB shares gained 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.",PFE,0.08183,0.106086,Neutral
Wall Street falls as SVB collapse fuels bank contagion fears; S&P down 1%,https://www.business-standard.com/article/international/wall-street-falls-as-svb-collapse-fuels-bank-contagion-fears-s-p-down-1-123031301123_1.html,2023-03-13 14:49:00,"Trading in shares of SVB's peer Signature Bank, which was shut down by regulators on Sunday, was halted ...",PFE,0.071784,0.0,Neutral
"Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio",https://www.marketwatch.com/story/regional-banks-pace-decliners-as-biotech-deals-lift-seagen-and-provention-bio-78a5d161,2023-03-13 14:32:00,Here are some of the biggest movers on Monday with banks in focus after federal regulators stepped into protect deposits at fallen bank SVB.,PFE,0.485711,0.178968,Somewhat-Bullish
Pfizer just made a $43 billion bet on a precise new way of attacking cancer,https://africa.businessinsider.com/news/pfizer-just-made-a-dollar43-billion-bet-on-a-precise-new-way-of-attacking-cancer/mzgblm2,2023-03-13 13:41:24,Pfizer just made a $43 billion bet on a precise new way of attacking ... - Business Insider Africa ...,PFE,0.512093,0.04578,Neutral
Why Pfizer just made a $43 billion bet on a precise new way of attacking cancer,https://africa.businessinsider.com/news/why-pfizer-just-made-a-dollar43-billion-bet-on-a-precise-new-way-of-attacking-cancer/mzgblm2,2023-03-13 13:41:24,Why Pfizer just made a $43 billion bet on a precise new way of ... - Business Insider Africa ...,PFE,0.512093,0.04578,Neutral
Why Pfizer just made a $43 billion bet on a precise new way of attacking cancer,https://www.businessinsider.com/pfizer-acquire-seagen-stock-cancer-treatment-oncology-deal-2023-3,2023-03-13 13:41:24,Pfizer to Acquire Seagen in $43 Billion Bet on Cancer Treatments - Business Insider ...,PFE,0.445569,0.041959,Neutral
Pfizer Buys Biotech Firm Seagen For $43 Billion,https://www.barrons.com/news/pfizer-buys-biotech-firm-seagen-for-43-billion-d63f8cbe,2023-03-13 13:26:13,"US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion. Pfizer is offering $229 per share in cash, and the companies expect to complete the transaction later this year or in early 2024, ...",PFE,0.737428,0.007902,Neutral
"Seagen, Provention Bio Soar After Nabbing Takeover Deals",https://www.investors.com/news/technology/sgen-stock-prvb-stock-rocket-after-nabbing-takeover-deals/,2023-03-13 13:17:57,"SGEN Stock, PRVB Stock Rocket After Nabbing Takeover Deals Investor's Business Daily ...",PFE,0.651499,-0.014836,Neutral
Selects: Top stories this evening,https://www.moneycontrol.com/news/business/moneycontrol-selects-top-stories-this-evening-306-10243071.html,2023-03-13 13:15:50,Our specially curated package of the most interesting articles to help you stay at the top of your game.,PFE,0.204072,-0.175792,Somewhat-Bearish
"Seagen's $43B Deal To Double Pfizer's Early-Stage Oncology Pipeline, Seagen Says Is Right Step - Seagen  ( NASDAQ:SGEN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/03/31319372/seagens-43b-deal-to-double-pfizers-early-stage-oncology-pipeline-seagen-says-is-right-step,2023-03-13 13:09:57,"Pfizer Inc PFE has agreed to acquire Seagen Inc SGEN for $229 in cash per Seagen share for a total enterprise value of $43 billion. ""Pfizer is deploying its financial resources to advance the battle against cancer, a leading cause of death worldwide with a significant impact on public health,"" ...",PFE,0.83383,0.199682,Somewhat-Bullish
2 Top Biotech Stocks to Buy In March and Hold Forever,https://www.fool.com/investing/2023/03/13/2-biotech-stocks-to-buy-in-march-and-hold-forever/,2023-03-13 12:45:00,"Their price is right, and their future is bright.",PFE,0.055364,0.037895,Neutral
Pfizer Is Sending Seagen Stock Soaring Monday: What's Going On? - Seagen  ( NASDAQ:SGEN ) ,https://www.benzinga.com/general/biotech/23/03/31318312/pfizer-is-sending-seagen-stock-soaring-monday-whats-going-on,2023-03-13 12:29:29,"Seagen Inc SGEN shares are trading higher Monday after Pfizer Inc PFE announced plans to acquire the global biotech company. What Happened: Seagen and Pfizer entered into a definitive merger agreement under which Pfizer will acquire Seagen for $229 in cash, representing a total enterprise value ...",PFE,0.904419,0.524432,Bullish
Futures Mixed After SVB Plan; First Republic Crashes On Bank Fears,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-after-svb-rescue-plan-first-republic-crashes-65-on-bank-fears/,2023-03-13 12:27:19,Futures Mixed After SVB Plan. First Republic Crashes On Bank Fears Investor's Business Daily ...,PFE,0.099202,0.138489,Neutral
"Stocks making the biggest moves premarket: Illumina, First Republic, Seagen and more",https://www.cnbc.com/2023/03/13/stocks-making-the-biggest-moves-premarket-ilmn-frc-sgen-more.html,2023-03-13 12:14:00,"Bank lenders saw major losses in early morning trading, stinging from the closure of Silicon Valley Bank and Signature Bank.",PFE,0.160633,0.034091,Neutral
Pfizer to buy cancer drugmaker Seagen for $43 billion,https://www.axios.com/2023/03/13/pfizer-seagen-deal-cancer-drugs,2023-03-13 12:05:32,"Pfizer on Monday said it has agreed to buy cancer drugmaker Seagen for $43 billion in cash. Why it matters: This is the largest merger announcement so far in 2023, and the largest pharma deal since Abbvie bought Allergan in 2020. • It also reflects how Pfizer is using its COVID vaccine fortune to ...",PFE,0.672055,0.279079,Somewhat-Bullish
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qualtrics , Seagen Inc. , Provention Bio Inc. , Kimball International, Inc.",https://investingnews.com/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-qualtrics-seagen-inc-provention-bio-inc-kimball-international-inc/,2023-03-13 12:00:00,"Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847. There is no cost or financial obligation to you.",PFE,0.349329,0.108743,Neutral
Pfizer to acquire Seagen for $43 bn to deepen reach into treating cancer,https://www.business-standard.com/article/companies/pfizer-to-acquire-seagen-for-43-bn-to-deepen-reach-into-treating-cancer-123031300826_1.html,2023-03-13 11:53:00,Pfizer to acquire Seagen for $43 bn to deepen reach into treating ... Business Standard ...,PFE,0.429671,0.140714,Neutral
"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023",https://www.globenewswire.com/news-release/2023/03/13/2625621/0/en/BioNTech-to-Report-Full-Year-and-Fourth-Quarter-2022-Financial-Results-and-Operational-Update-on-March-27-2023.html,2023-03-13 11:45:00,"MAINZ, Germany, March 13, 2023 ( GLOBE NEWSWIRE ) - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) will announce its financial results for the full year and fourth quarter 2022 on Monday, March 27th, 2023. BioNTech invites investors and the general public to join a conference call and ...",PFE,0.122894,0.01074,Neutral
Pfizer to Buy Cancer Biotech Seagen for $43 Billion,https://www.barrons.com/articles/pfizer-buying-seagen-7e76af73,2023-03-13 11:23:22,Pfizer announced Monday that it would pay $229 a share in cash for Seagen in a deal that values the biotech company at $43 billion. Seagen ( ticker: SGEN ) shares closed at $172.61 on Friday. The stock soared in late February after The Wall Street Journal reported that Pfizer ( ticker: PFE ) was ...,PFE,0.993614,0.394831,Bullish
Pfizer Agrees to Buy Seagen for $43 Billion,https://www.wsj.com/articles/pfizer-agrees-to-buy-seagen-for-43-billion-180a9117,2023-03-13 11:22:00,The New York drugmaker would pay $229 a share in cash for the biotech company and its pioneering cancer treatments.,PFE,0.978984,-0.182252,Somewhat-Bearish
"Pfizer buys Seagen for $43B, boosts access to cancer drugs",https://apnews.com/article/pfizer-seagen-acquisition-cancer-05b11f085125df5941f64a2ecbb5abba,2023-03-13 11:09:10,"Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 in cash for each Seagen share. Bothell, Washington-based Seagen Inc. is a biotech drug developer that specializes in antibody-drug conjugate, or ADC, ...",PFE,0.508878,0.022534,Neutral
Pfizer Invests $43 Billion to Battle Cancer - Investing News Network,https://investingnews.com/pfizer-invests-43-billion-to-battle-cancer/,2023-03-13 11:06:45,Pfizer Invests $43 Billion to Battle Cancer Investing News Network ...,PFE,0.393405,0.263799,Somewhat-Bullish
This Logistics Company Appears To Be A Better Pick Over Pfizer Stock,https://www.forbes.com/sites/greatspeculations/2023/03/13/this-logistics-company-appears-to-be-a-better-pick-over-pfizer-stock/,2023-03-13 11:00:14,"We believe that FedEx stock (NYSE: FDX) is a better pick than the pharmaceutical giant Pfizer stock (NYSE: PFE), given its better prospects.",PFE,0.653884,0.114944,Neutral
Pfizer to buy Seagen for about $43 billion,https://www.reuters.com/markets/deals/pfizer-buy-seagen-deal-valued-43-billion-2023-03-13/,2023-03-13 10:54:00,"March 13 ( Reuters ) - Pfizer Inc ( PFE.N ) said on Monday it would buy Seagen Inc ( SGEN.O ) for about $43 billion to expand its portfolio of cancer treatments. Pfizer will pay $229 in cash per Seagen share, a 32.7% premium to Friday's closing price. Shares of Seagen were up 23% before ...",PFE,0.798255,-0.118256,Neutral
"Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation",https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-pfizer-abbvie-drugs-likely-face-us-price-negotiation-2023-03-13/,2023-03-13 10:09:00,"[1/3] A pharmacist holds a bottle of the drug Eliquis, made by Bristol Myers Squibb and Pfizer, at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey",PFE,0.176825,-0.037457,Neutral
This Growth Stock Is Down 90%. Is It Time to Sell or Buy?,https://www.fool.com/investing/2023/03/12/this-growth-stock-is-down-90-time-to-sell-or-buy/,2023-03-12 12:45:00,"Think twice about picking up shares of Novavax, even if you're brave.",PFE,0.05833,0.220751,Somewhat-Bullish
Millions will start losing Medicaid coverage as Covid safety net is dismantled,https://www.cnbc.com/2023/03/31/medicaid-millions-to-lose-coverage-as-covid-safety-net-dismantled.html,2023-03-31 20:10:03,As many as 15 million people stand to lose Medicaid coverage as safety net expansions implemented during the Covid pandemic are dismantled.,PFE,0.043658,-0.09603,Neutral
Sleep Disorders Treatment Global Market Report 2023: Growing Demand for Home Sleep Tests Presents Opportunities,https://www.prnewswire.com/news-releases/sleep-disorders-treatment-global-market-report-2023-growing-demand-for-home-sleep-tests-presents-opportunities-301786962.html,2023-03-31 18:45:00,Sleep Disorders Treatment Global Market Report 2023: Growing ... PR ...,PFE,0.051441,-0.016975,Neutral
Biden administration appeals Texas court decision striking down free Obamacare coverage of preventive care,https://www.cnbc.com/2023/03/31/obamacare-biden-appeals-ruling-striking-down-free-preventive-care.html,2023-03-31 18:01:13,The types of preventive services covered under Obamacare can range from screenings for certain types of cancers to HIV prevention drugs.,PFE,0.082393,-0.100042,Neutral
"Texas Judge Obstructs Affordable Act Coverage Mandate For Some Cancer Screenings, Prophylaxis - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/03/31609651/texas-judge-obstructs-affordable-act-coverage-mandate-for-some-cancer-screenings-prophylaxis,2023-03-31 14:47:01,"A Texas federal judge reportedly blocked Obamacare's mandate that health insurance plans cover preventive care, including screenings for certain cancers and pre-exposure prophylaxis against HIV ( PrEP ) , at no cost to patients.",PFE,0.294093,0.055333,Neutral
"COVID Remains A Global Threat - NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All - AstraZeneca  ( NASDAQ:AZN ) , Gilead Sciences  ( NASDAQ:GILD ) ",https://www.benzinga.com/general/biotech/23/03/31608814/covid-remains-a-global-threat-nanoviricides-set-to-begin-clinical-trials-for-pan-coronavirus-drug,2023-03-31 13:29:55,"Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates of hospitalizations and COVID remains many times more deadly than influenza.",PFE,0.183895,-0.103546,Neutral
"J&J Drops Out Of A Key Race With Pfizer, GSK, Moderna",https://www.investors.com/research/ibd-industry-themes/jnj-stock-johnson-johnson-drops-out-of-rsv-vaccine-race-pfizer-gsk-moderna-duke-it-out/,2023-03-31 12:48:00,JNJ Stock: Johnson & Johnson Drops Out Of RSV Vaccine Race ... Investor's Business Daily ...,PFE,0.462395,0.175833,Somewhat-Bullish
Which Is the Better Dividend Stock: Viatris or Apple?,https://www.fool.com/investing/2023/03/31/which-is-the-better-dividend-stock-viatris-or-appl/,2023-03-31 12:00:00,"One has a higher dividend yield, but there's more to the story.",PFE,0.046724,-0.054113,Neutral
"Virgin Orbit Holdings' stock sinks on job axes, Rumble and Digital World Acquisition shares rise on Donald Trump indictment",https://www.marketwatch.com/story/virgin-orbit-holdings-stock-sinks-on-job-axes-rumble-and-digital-world-acquisition-shares-rise-on-donald-trump-indictment-c4041f10,2023-03-31 11:58:00,Chicken Soup for the Soul Entertainment slumps and Nikola's stock sinks ...,PFE,0.272788,0.12666,Neutral
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board,https://www.globenewswire.com/news-release/2023/03/31/2638509/29446/en/BioCryst-Appoints-Dr-Nancy-Hutson-as-Chair-of-the-Board.html,2023-03-31 11:00:00,"RESEARCH TRIANGLE PARK, N.C., March 31, 2023 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq: BCRX ) today announced the appointment of Dr. Nancy Hutson as chair of its board of directors, effective immediately.",PFE,0.10607,0.010895,Neutral
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board - BioCryst Pharma  ( NASDAQ:BCRX ) ,https://www.benzinga.com/pressreleases/23/03/g31605158/biocryst-appoints-dr-nancy-hutson-as-chair-of-the-board,2023-03-31 11:00:00,"RESEARCH TRIANGLE PARK, N.C., March 31, 2023 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. BCRX today announced the appointment of Dr. Nancy Hutson as chair of its board of directors, effective immediately. ""I am honored to succeed Bob Ingram. He was a model of effective board ...",PFE,0.102013,0.011833,Neutral
Global dealmaking sinks to lowest level in over a decade,https://www.reuters.com/markets/deals/global-dealmaking-sinks-lowest-level-over-decade-2023-03-31/,2023-03-31 08:03:26,"NEW YORK/LONDON, March 31 ( Reuters ) - Global mergers and acquisitions ( M&A ) activity shrank to its lowest level in more than a decade in the first quarter of 2023, as rising interest rates, high inflation and fears of a recession soured the appetite of companies for dealmaking.",PFE,0.048327,-0.026967,Neutral
Investment Bank Centerview Jumps Ahead in Deal Rankings,https://www.fool.com/investing/2023/03/30/investment-bank-centerview-jumps-ahead-in-deal-ran/,2023-03-31 00:00:29,"A Wall Street David has upstaged the Goliaths. So far this year, boutique investment bank Centerview Partners handled nearly 20 deals with a total...",PFE,0.131643,0.038386,Neutral
"Judge strikes down Obamacare coverage of preventive care for cancers, diabetes, HIV and other conditions",https://www.cnbc.com/2023/03/30/obamacare-judge-overturns-coverage-of-some-preventive-care.html,2023-03-30 16:52:40,Christian businesses sued the government arguing the Obamacare mandate violates their religious freedom because it covers of drugs that prevent HIV infection.,PFE,0.06623,-0.098172,Neutral
"Texas judge blocks Obamacare coverage mandate for PrEP, cancer screening",https://www.reuters.com/business/healthcare-pharmaceuticals/texas-judge-blocks-obamacare-coverage-mandate-prep-cancer-screening-2023-03-30/,2023-03-30 14:40:00,"Texas judge blocks Obamacare coverage mandate for PrEP, cancer ... ...",PFE,0.174587,0.130925,Neutral
Amyotrophic Lateral Sclerosis Treatment Market Size to Hit USD 436.17 Million by 2027 at 5.52% CAGR Reported by Brandessence Market Research,https://www.prnewswire.com/news-releases/amyotrophic-lateral-sclerosis-treatment-market-size-to-hit-usd-436-17-million-by-2027-at-5-52-cagr-reported-by-brandessence-market-research-301785993.html,2023-03-30 14:20:00,Amyotrophic Lateral Sclerosis Treatment Market Size to Hit USD ... PR ...,PFE,0.030759,0.160638,Somewhat-Bullish
Biotech Stock Crashes After A 'Rarer Than Rare' Event,https://www.investors.com/news/technology/rna-stock-crashes-after-a-rarer-than-rare-event-sidelines-its-key-study/,2023-03-30 14:06:00,"A key study from Avidity Biosciences ( RNA ) remains on hold after a patient using its test-phase treatment experienced a ""rarer than rare"" side effect, leading RNA stock to plummet Thursday. Avidity is testing its experimental drug in patients with myotonic dystrophy 1, an inherited disorder ...",PFE,0.087185,0.0,Neutral
Viatris Among Three Companies Licensed To Make GSK/Pfizer-Backed Long Acting HIV Prevention Drug - Viatris  ( NASDAQ:VTRS ) ,https://www.benzinga.com/general/biotech/23/03/31578765/viatris-among-three-companies-licensed-to-make-gskpfizer-backed-long-acting-hiv-prevention-drug,2023-03-30 12:16:00,"ViiV Healthcare and Medicines Patent Pool ( MPP ) have signed sublicence agreements with Aurobindo Pharma, Cipla Limited, and Viatris Inc VTRS - through its subsidiary Mylan - to manufacture generic versions of cabotegravir long-acting ( LA ) for HIV pre-exposure prophylaxis ( PrEP ) .",PFE,0.130217,0.0,Neutral
"BioRestorative Therapies  ( NASDAQ: BRTX )  Is Targeting The Global Obesity Epidemic With Its Recent IP Portfolio Expansion - Altimmune  ( NASDAQ:ALT ) , BioRestorative Therapies  ( NASDAQ:BRTX ) ",https://www.benzinga.com/general/biotech/23/03/31577969/biorestorative-therapies-nasdaq-brtx-is-targeting-the-global-obesity-epidemic-with-its-recent-ip-,2023-03-30 11:00:25,"BioRestorative Therapies Inc BRTX is expanding its ThermoStem® intellectual property portfolio for treatments targeting obesity, diabetes and other indications related to metabolic syndrome with another patent notice of allowance from the United States Patent Office, adding to its already 19 ...",PFE,0.089629,0.057938,Neutral
"If You Invested $25,000 in Pfizer in 2020, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/03/30/if-invested-25k-pfizer-2020-how-much-today/,2023-03-30 09:40:00,"The company's COVID-19 vaccine led to a surge in sales, but not a surge in the stock price.",PFE,0.290607,0.300955,Somewhat-Bullish
COVID-19 continues to surge in India but Paxlovid is only a minor player,https://www.moneycontrol.com/news/trends/covid-19-continues-to-surge-in-india-but-paxlovid-is-only-a-minor-player-10335201.html,2023-03-30 05:40:48,"Apart from reducing hospitalisation for the most vulnerable group and its efficacy against Omicron variants, Paxlovid has also shown to decrease the chances of long COVID-19.",PFE,0.067727,-0.150401,Somewhat-Bearish
Pfizer Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/03/31560219/pfizer-unusual-options-activity,2023-03-29 20:00:50,"A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and ...",PFE,0.748842,0.261463,Somewhat-Bullish
Is It Time to Buy These Ultra-Cheap Dividend Stocks?,https://www.fool.com/investing/2023/03/29/is-it-time-to-buy-these-ultra-cheap-dividend-stock/,2023-03-29 20:00:00,"These two biopharma stocks aren't exciting growth plays, but they are reliable income vehicles.",PFE,0.320557,0.007002,Neutral
What Are Synthetic Cannabinoids And Synthetic Marijuana,https://www.benzinga.com/markets/cannabis/23/03/31281410/what-are-synthetic-cannabinoids-and-synthetic-marijuana,2023-03-29 19:26:26,"This article was originally published on Askgrowers and appears here with permission. You've probably heard the term ""synthetic marijuana"" and have seen news stories about people becoming extremely sick after consuming it. You may also have questions about what it is, how harmful it can be and if ...",PFE,0.028903,0.032473,Neutral
Dueling court cases in Washington state and Texas could determine legality of abortion pill,https://www.cnbc.com/2023/03/29/abortion-pill-dueling-court-cases-could-determine-legality-of-mifepristone.html,2023-03-29 18:42:35,A hearing in Spokane place took place Tuesday as a judge in Texas is expected to rule in another case that threatens to pull the abortion pill from the market.,PFE,0.030524,-0.091531,Neutral
"Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/03/31556135/johnson-johnson-pulls-plug-on-large-late-stage-study-of-rsv-vaccine-candidate-gsk-pfizer-shots-ar,2023-03-29 18:41:37,"After reviewing its portfolio to prioritize and assessing the respiratory syncytial virus ( RSV ) vaccine landscape, Janssen, a unit of Johnson & Johnson JNJ, will exit its investigational RSV adult vaccine program and discontinue its Phase 3 EVERGREEN study.",PFE,0.514619,0.0,Neutral
The Government Move That Could Further Stoke Obesity Drugs,https://www.investors.com/news/technology/eli-lilly-stock-the-government-move-that-could-drive-obesity-treatments-to-the-forefront/,2023-03-29 16:51:00,Eli Lilly Stock: The Government Move That Could Drive Obesity ... Investor's Business Daily ...,PFE,0.081276,0.0,Neutral
J&J backs out of RSV vaccine race with rivals Pfizer and GSK,https://www.cnbc.com/2023/03/29/jj-backs-out-of-rsv-vaccine-race-with-rivals-pfizer-and-gsk-.html,2023-03-29 16:28:06,"J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month.",PFE,0.160099,-0.129643,Neutral
What the WHO's New Covid-19 Vaccine Guidance Means for Pfizer and Moderna,https://www.barrons.com/articles/world-health-organization-covid-vaccine-pfizer-moderna-8ce4be0c,2023-03-29 16:08:00,What the WHO's New Covid-19 Vaccine Guidance Means for Pfizer and ...,PFE,0.33628,0.058931,Neutral
"J&J Drops Out Of A Key Race With Pfizer, GSK, Moderna",https://www.investors.com/news/technology/jnj-stock-johnson-johnson-drops-out-of-rsv-vaccine-race-pfizer-gsk-moderna-duke-it-out/,2023-03-29 15:05:00,JNJ Stock: Johnson & Johnson Drops Out Of RSV Vaccine Race ... Investor's Business Daily ...,PFE,0.461006,0.154745,Somewhat-Bullish
Exclusive: ICU Medical to compete against GE Healthcare for Medtronic units -sources,https://www.reuters.com/markets/deals/icu-medical-compete-against-ge-healthcare-medtronic-units-sources-2023-03-29/,2023-03-29 13:47:00,Exclusive: ICU Medical to compete against GE Healthcare for ... ...,PFE,0.094762,0.067095,Neutral
Zoetis Stock Could Rise 30% as People Spend More on Pets,https://www.barrons.com/articles/buy-zoetis-stock-price-pick-ae1b526e,2023-03-29 13:36:00,Buy Zoetis Stock. Shares Could Rise 30% as People Spend More on Pets. ...,PFE,0.760593,0.303436,Somewhat-Bullish
J&J bows out of RSV vaccine race after scrapping trial,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-bows-out-rsv-vaccine-race-after-scrapping-trial-2023-03-29/,2023-03-29 13:09:00,"March 29 ( Reuters ) - Johnson & Johnson ( JNJ.N ) said it will discontinue the late-stage study of its experimental respiratory syncytial virus ( RSV ) adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against the virus.",PFE,0.421485,0.226998,Somewhat-Bullish
"CSPC Pharma Wins China's mRNA Vaccine Race, But Just Not Fast Enough - Moderna  ( NASDAQ:MRNA ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/23/03/31547727/cspc-pharma-wins-chinas-mrna-vaccine-race-but-just-not-fast-enough,2023-03-29 13:06:42,"News of marketing approval for China's first mRNA vaccine falls flat with investors, who worry the drug is being rushed to market before Phase 3 trials are complete As the pandemic abates, the market for the vaccine is shrinking rapidly",PFE,0.111315,-0.028163,Neutral
David Charpie Named Co-CEO and Chief People Officer of Mach49,https://www.prnewswire.com/news-releases/david-charpie-named-co-ceo-and-chief-people-officer-of-mach49-301784331.html,2023-03-29 13:00:00,"Industry veteran, successful serial entrepreneur, and CEO builds upon Mach49's success helping the Global 1000 drive meaningful growth",PFE,0.046999,-0.017986,Neutral
"Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run",https://www.fool.com/investing/2023/03/29/up-463-this-sizzling-growth-stock-could-have-a-lot/,2023-03-29 11:45:00,Viking Therapeutics stock might in the midst of a historic run.,PFE,0.09439,0.054225,Neutral
Better Growth Stock: AbbVie vs. Pfizer,https://www.fool.com/investing/2023/03/29/better-growth-stock-abbvie-vs-pfizer/,2023-03-29 11:30:00,One of the pair will have trouble challenging its recent heights.,PFE,0.491878,0.237881,Somewhat-Bullish
The Trend Toward Pet Pampering Makes Zoetis Stock Look Fetching,https://www.barrons.com/articles/zoetis-stock-pick-pets-livestock-healthcare-ae1b526e,2023-03-29 05:00:00,Zoetis Stock Could Rise 30% as People Spend More on Pets ...,PFE,0.760593,0.303436,Somewhat-Bullish
BioCina Awarded Grant to Develop Enabling Technologies for Manufacturing Precision mRNA Vaccines,https://www.benzinga.com/pressreleases/23/03/n31536741/biocina-awarded-grant-to-develop-enabling-technologies-for-manufacturing-precision-mrna-vaccines,2023-03-28 18:32:00,"SAN DIEGO and ADELAIDE, Australia, March 28, 2023 /PRNewswire/ -- BioCina, a leading contract development and manufacturing organization ( CDMO ) , has been awarded a $5 million AUD grant under the Federal Government's Medical Research Future Fund ( MRFF ) Grants scheme to fund work with its ...",PFE,0.056275,0.121919,Neutral
2 Dividend Stocks Down 11% to 22% to Buy and Hold Forever,https://www.fool.com/investing/2023/03/28/2-dividend-stocks-down-11-to-22-to-buy-and-hold/,2023-03-28 13:53:00,Investors should buy the dips on these healthcare giants.,PFE,0.498479,0.34683,Somewhat-Bullish
Wynn Resorts and BioNTech have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2071215/wynn-resorts-and-biontech-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-03-28 12:55:00,"Chicago, IL - March 28, 2023 - Zacks Equity Research shares Wynn Resorts ( WYNN Quick QuoteWYNN - ) as the Bull of the Day and BioNTech ( BNTX Quick QuoteBNTX - ) as the Bear of the Day.",PFE,0.05183,-0.10751,Neutral
eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences,https://www.globenewswire.com/news-release/2023/03/28/2635678/0/en/eFFECTOR-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html,2023-03-28 12:30:00,"SOLANA BEACH, Calif. and REDWOOD CITY, Calif., March 28, 2023 ( GLOBE NEWSWIRE ) -- eFFECTOR Therapeutics, Inc. ( NASDAQ: EFTR ) , a leader in the development of selective translation regulator inhibitors ( ""STRIs"" ) for the treatment of cancer, today announced that the management team will ...",PFE,0.115232,-0.061808,Neutral
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results,https://www.globenewswire.com/news-release/2023/03/28/2635546/0/en/Vera-Therapeutics-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results.html,2023-03-28 11:30:00,"BRISBANE, Calif., March 28, 2023 ( GLOBE NEWSWIRE ) -- Vera Therapeutics, Inc. ( Nasdaq: VERA ) , a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its business ...",PFE,0.029691,-0.08293,Neutral
Voyager Therapeutics Presents New Data Supporting Tau Antibody Program for Alzheimer's Disease and GBA1 Gene Therapy Program for Parkinson's Disease at the AD/PD™ Conference - Voyager Therapeutics  ( NASDAQ:VYGR ) ,https://www.benzinga.com/pressreleases/23/03/g31525763/voyager-therapeutics-presents-new-data-supporting-tau-antibody-program-for-alzheimers-disease-and-,2023-03-28 11:00:00,"CAMBRIDGE, Mass., March 28, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc.",PFE,0.035821,0.036779,Neutral
Voyager Therapeutics Presents New Data Supporting Tau Antibody Program for Alzheimer's Disease and GBA1 Gene Therapy Program for Parkinson's Disease at the AD/PD™ Conference,https://www.globenewswire.com/news-release/2023/03/28/2635513/36461/en/Voyager-Therapeutics-Presents-New-Data-Supporting-Tau-Antibody-Program-for-Alzheimer-s-Disease-and-GBA1-Gene-Therapy-Program-for-Parkinson-s-Disease-at-the-AD-PD-Conference.html,2023-03-28 11:00:00,"CAMBRIDGE, Mass., March 28, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( Nasdaq: VYGR ) , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today presented new data from its anti-tau antibody program for Alzheimer's disease ( AD ) and from ...",PFE,0.032736,0.037363,Neutral
BioNTech Announces New ADS Repurchase Program,https://www.globenewswire.com/news-release/2023/03/28/2635491/0/en/BioNTech-Announces-New-ADS-Repurchase-Program.html,2023-03-28 10:45:00,"MAINZ, Germany, March 28, 2023 ( GLOBE NEWSWIRE ) -- BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or the ""Company"" ) today announced that it has entered into a new share repurchase program ( the ""Program"" ) , pursuant to which the Company may purchase American Depositary Shares, each representing one ...",PFE,0.071784,0.010188,Neutral
Should Invesco Dynamic Large Cap Value ETF  ( PWV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2071143/should-invesco-dynamic-large-cap-value-etf-pwv-be-on-your-investing-radar,2023-03-28 10:20:10,Style Box ETF report for ...,PFE,0.122581,0.061521,Neutral
How Pfizer's Sally Susman commands the communications hot seat,https://www.axios.com/2023/03/28/sally-susman-breaking-through-book,2023-03-28 10:00:00,Sally Susman book: Commanding the communications hot seat ...,PFE,0.213048,0.278582,Somewhat-Bullish
Bear of the Day: BioNTech  ( BNTX ) ,https://www.zacks.com/commentary/2071086/bear-of-the-day-biontech-bntx,2023-03-28 08:00:00,"BNTX is ranked a lowly 5 for a reason. Earnings have peaked, COVID hysteria has subsided, and the technical picture is lagging.",PFE,0.380978,-0.241794,Somewhat-Bearish
China's new premier rolls out the welcome wagon for foreign companies | Business,https://www.cnn.com/2023/03/28/economy/china-development-forum-foreign-companies-welcome-intl-hnk/index.html,2023-03-28 07:07:05,China's new premier rolls out the welcome wagon for foreign companies ...,PFE,0.052918,0.0,Neutral
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2071001/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-03-27 21:45:24,"In the latest trading session, Pfizer (PFE) closed at $40.22, marking a -0.42% move from the previous day.",PFE,0.549988,0.224108,Somewhat-Bullish
Why Shares of BioNTech Slumped Monday,https://www.fool.com/investing/2023/03/27/why-shares-of-biontech-slumped-monday/,2023-03-27 19:06:59,The company released fourth-quarter earnings.,PFE,0.137671,0.011282,Neutral
"Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer - Pfizer  ( NYSE:PFE ) , Merck  ( OTC:MKKGY ) ",https://www.benzinga.com/general/biotech/23/03/31516552/merck-germany-regains-exclusive-global-rights-to-cancer-drug-from-pfizer,2023-03-27 17:23:19,"Germany's Merck KGaA MKGAF MKKGY has regained exclusive worldwide rights to develop, manufacture, and commercialize its checkpoint blocker Bavencio ( avelumab ) from Pfizer Inc PFE. The news comes just a few weeks after Pfizer announced plans to buy antibody-drug conjugate ( ADC ) company ...",PFE,0.927326,0.359354,Bullish
Alibaba's Jack Ma returns as China tries to allay private sector fears,https://www.business-standard.com/world-news/alibaba-s-jack-ma-returns-as-china-tries-to-allay-private-sector-fears-123032701087_1.html,2023-03-27 16:16:00,"Ma's re-emergence in public offers support for the government's softening tone toward the private sector as leaders try to shore up an economy battered by three years of Covid-19 curbs. Alibaba founder Jack Ma has returned to China, ending a stay overseas of more than a year.",PFE,0.100308,0.093551,Neutral
"Winners And Losers Reveal The Market's Flavor This Year: Nvidia Is Up, Pfizer Is Down",https://www.forbes.com/sites/johndorfman/2023/03/27/pfizer-tesla-nvidia-winners-losers-reveal-markets-flavor/,2023-03-27 14:50:23,"Among the 167 stocks with a market value of $100 billion or more, the best performers this year are Nvidia, Meta Platforms and Tesla. Pfizer is down the most. Which stocks should investors buy?",PFE,0.22595,0.065943,Neutral
Tencent's Cash Dividend Weighs On Meituan,https://www.forbes.com/sites/brendanahern/2023/03/27/tencents-cash-dividend-weighs-on-meituan/,2023-03-27 14:36:16,Asian equity markets were mixed overnight on light volumes as investors worried about financial contagion.,PFE,0.057767,0.050009,Neutral
2 Rock Solid Dividend Stocks to Buy on the Dip,https://www.fool.com/investing/2023/03/27/2-rock-solid-dividend-stocks-to-buy-on-the-dip/,2023-03-27 13:56:41,The decline in the share prices for these two stocks is likely to be short-lived.,PFE,0.165409,0.186842,Somewhat-Bullish
Titan Partners Group Announces Addition of Dr. David Sans as Head of Healthcare,https://www.benzinga.com/pressreleases/23/03/g31512013/titan-partners-group-announces-addition-of-dr-david-sans-as-head-of-healthcare,2023-03-27 13:30:00,"NEW YORK, March 27, 2023 ( GLOBE NEWSWIRE ) -- via InvestorWire -- Titan Partners Group LLC, a division of American Capital Partners, LLC ( ""Titan Partners"" ) , announces today that Dr. David Sans has joined the firm as head of healthcare.",PFE,0.065327,0.007032,Neutral
BioNTech Careens Lower After 2023 Outlook Misses By Almost $3 Billion,https://www.investors.com/news/technology/bntx-stock-crumbles-after-2023-guide-misses-by-almost-3-billion/,2023-03-27 13:28:00,BNTX Stock Crumbles After 2023 Guide Misses By Almost $3 Billion ... Investor's Business Daily ...,PFE,0.325924,0.0,Neutral
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2070715/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2023-03-27 13:00:12,"Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",PFE,0.529767,0.113281,Neutral
LianBio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update,https://www.globenewswire.com/news-release/2023/03/27/2634766/0/en/LianBio-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html,2023-03-27 12:36:00,"Phase 3 trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy ( oHCM ) ongoing, with data expected ...",PFE,0.232885,0.103947,Neutral
Deere and Pfizer have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2070669/deere-and-pfizer-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-03-27 12:26:00,"Chicago, IL - March 27, 2023 - Zacks Equity Research shares Deere & Company ( DE Quick QuoteDE - ) as the Bull of the Day and Pfizer ( PFE Quick QuotePFE - ) as the Bear of the Day.",PFE,0.194938,0.0,Neutral
"Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors",https://www.prnewswire.com/news-releases/aadi-bioscience-appoints-mohammad-hirmand-md-to-board-of-directors-301781997.html,2023-03-27 12:00:00,"Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of ... PR ...",PFE,0.043579,0.0,Neutral
Pneumonia testing market size is set to grow by USD 709 million from 2022 to 2027; The rising number of M and A and new product launches are a key trend - Technavio,https://www.prnewswire.com/news-releases/pneumonia-testing-market-size-is-set-to-grow-by-usd-709-million-from-2022-to-2027-the-rising-number-of-m-and-a-and-new-product-launches-are-a-key-trend---technavio-301781432.html,2023-03-27 10:56:00,Pneumonia testing market size is set to grow by USD 709 million ... PR ...,PFE,0.029728,0.003889,Neutral
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update,https://www.globenewswire.com/news-release/2023/03/27/2634587/0/en/BioNTech-Announces-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Corporate-Update.html,2023-03-27 10:45:00,Conference call and webcast scheduled for March 27 at 8:00 am ET ( 2:00 pm ...,PFE,0.14212,0.113005,Neutral
Could CRISPR Therapeutics Become the Next Moderna?,https://www.fool.com/investing/2023/03/27/could-crispr-therapeutics-become-the-next-moderna/,2023-03-27 10:00:00,Both companies use cutting-edge technology.,PFE,0.055621,0.076016,Neutral
Bear of the Day: Pfizer Inc.  ( PFE ) ,https://www.zacks.com/commentary/2070374/bear-of-the-day-pfizer-inc-pfe,2023-03-27 09:00:00,"Pfizer shares haven't been very healthy in 2023, down more than 20% year-to-date and widely lagging behind the general market.",PFE,0.757528,-0.032091,Neutral
Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in broad population of patients with early breast cancer,https://www.prnewswire.com/news-releases/novartis-kisqali-phase-iii-natalee-trial-meets-primary-endpoint-at-interim-analysis-demonstrating-clinically-meaningful-benefit-in-broad-population-of-patients-with-early-breast-cancer-301781616.html,2023-03-27 05:20:00,Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at ... PR ...,PFE,0.015168,0.0,Neutral
Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in broad population of patients with early breast cancer,https://www.globenewswire.com/news-release/2023/03/27/2634440/0/en/Novartis-Kisqali-Phase-III-NATALEE-trial-meets-primary-endpoint-at-interim-analysis-demonstrating-clinically-meaningful-benefit-in-broad-population-of-patients-with-early-breast-ca.html,2023-03-27 05:15:00,Ad hoc announcement pursuant to Art. 53 LR ...,PFE,0.015304,0.0,Neutral
Pfizer signs agreement with China on improving health coverage in the country,https://www.cnbc.com/2023/03/27/pfizer-signs-agreement-with-china-on-improving-health-coverage-in-the-country.html,2023-03-27 02:47:42,"U.S. pharma giant Pfizer has signed an agreement with China to cooperate on improving the country's health coverage, according to the company.",PFE,0.585687,0.402196,Bullish
"Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio",https://www.fool.com/investing/2023/03/26/got-1500-you-can-confidently-add-these-3-stocks-to/,2023-03-26 15:11:00,These companies sport strong performance histories and plenty of promise.,PFE,0.228073,0.099035,Neutral
"3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential",https://www.fool.com/investing/2023/03/26/3-healthcare-spinoffs-worth-a-look-but-1-has-the-b/,2023-03-26 12:45:00,These three spinoffs are already profitable.,PFE,0.134339,0.072385,Neutral
More than 900 members of American Chamber of Commerce in China no longer regard China as a top-three investment priority,https://www.moneycontrol.com/news/business/markets/china-no-longer-among-top-3-investment-priority-for-us-companies-survey-10313491.html,2023-03-26 10:06:23,"The percentage of companies which see the ""uncertainty of bilateral relations"" as their leading challenge in China has risen to 66 percent. At the same time, the number of companies which think that China has become less welcoming to foreign companies has grown to 49 percent, the survey found.",PFE,0.056011,0.17895,Somewhat-Bullish
This Cancer Drug Candidate Could Be a Hit for Pfizer,https://www.fool.com/investing/2023/03/25/cancer-drug-candidate-could-be-a-hit-for-pfizer/,2023-03-25 14:15:00,The FDA recently accepted the drugmaker's regulatory filing for review of a potential drug to treat a type of blood cancer.,PFE,0.2306,0.073738,Neutral
Can This New Drug Boost Pfizer's Stock?,https://www.fool.com/investing/2023/03/25/can-this-new-drug-boost-pfizers-stock/,2023-03-25 13:45:00,A first-of-its-kind medicine was recently approved by the FDA to treat a common condition.,PFE,0.392362,0.311113,Somewhat-Bullish
I Own 12 High-Yield Dividend Stocks. Here's the Best of the Bunch.,https://www.fool.com/investing/2023/03/25/i-own-12-high-yield-dividend-stocks-heres-the-best/,2023-03-25 09:52:00,It isn't an easy decision to choose the best among this group of dividend stocks.,PFE,0.056143,0.207082,Somewhat-Bullish
"Apple CEO praises China's innovation, history of cooperation during visit",https://www.business-standard.com/article/international/apple-ceo-praises-china-s-innovation-history-of-cooperation-during-visit-123032500448_1.html,2023-03-25 09:39:00,"Cook is in Beijing to attend the China Development Forum, a government-organised event being held again in full force after the country ended its Covid controls late last year ...",PFE,0.135347,0.108992,Neutral
Check Out What Whales Are Doing With PFE - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/03/31497644/check-out-what-whales-are-doing-with-pfe,2023-03-24 20:00:48,"A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer PFE we detected 19 strange trades. If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened trades with bullish expectations and ...",PFE,0.748842,0.046793,Neutral
V: 2 Robinhood Stocks to Buy and Hold Forever,https://stocknews.com/news/v-pfe-hood-sgen-2-robinhood-stocks-to-buy-and-hold-forever/,2023-03-24 18:29:56,"With its no-fee structure and easy-to-use trading experience, the financial services platform Robinhood has garnered massive popularity among millennial and Gen Z investors. Quality Robinhood stocks Visa Inc. ( V ) and Pfizer Inc. ( PFE ) present promising long-term investment opportunities for ...",PFE,0.417419,0.279857,Somewhat-Bullish
Apple CEO Tim Cook one of few US execs expected to attend China investment conference amid tensions,https://www.foxbusiness.com/technology/apple-ceo-tim-cook-one-of-few-us-execs-attend-china-investment-conference-tensions,2023-03-24 17:32:26,"Apple CEO Tim Cook is attending a Chinese business forum in Beijing this weekend, one of the few U.S. business leaders slated to make an appearance. Cook will be attending the China Development Forum - an annual conference sponsored by the Chinese Communist Party, according to China Daily and ...",PFE,0.16171,0.120976,Neutral
AbbVie  ( ABBV )  Provides Clinical Updates on Inflammatory Drugs,https://www.zacks.com/stock/news/2070329/abbvie-abbv-provides-clinical-updates-on-inflammatory-drugs,2023-03-24 16:56:00,AbbVie???s (ABBV) two studies evaluating Skyrizi in ulcerative colitis and Rinvoq in systemic lupus erythematosus meet their primary endpoints.,PFE,0.056808,0.102935,Neutral
4 Healthcare Mutual Funds to Act as a Hedge Against Volatility,https://www.zacks.com/stock/news/2070104/4-healthcare-mutual-funds-to-act-as-a-hedge-against-volatility,2023-03-24 13:19:00,"Invest in healthcare funds like FSHCX, PCHSX, SWHFX, and VGHCX to diversify your portfolio against uncertain market conditions.",PFE,0.043579,0.043866,Neutral
Dr. Reddy's focuses on differentiated portfolio in key therapy areas as part of India growth strategy: GlobalData | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/dr-reddys-focuses-on-differentiated-portfolio-in-key-therapy-areas-as-part-of-india-growth-strategy-globaldata/3020758/,2023-03-24 06:23:00,Dr. Reddy's focuses on differentiated portfolio in key therapy areas ... The Financial Express ...,PFE,0.099066,0.028505,Neutral
"China authorities raid US due diligence firm, detain staff",https://www.aljazeera.com/economy/2023/3/24/us-law-firms-beijing-office-raided-by-authorities,2023-03-24 03:33:45,"US due diligence firm's Beijing office raided, staff detained Al Jazeera English ...",PFE,0.166169,0.0,Neutral
Biohaven Reports Fourth Quarter and Full Year 2022 Financial Results and Reports Recent Business Developments,https://www.prnewswire.com/news-releases/biohaven-reports-fourth-quarter-and-full-year-2022-financial-results-and-reports-recent-business-developments-301780341.html,2023-03-23 20:05:00,Biohaven Reports Fourth Quarter and Full Year 2022 Financial ... PR ...,PFE,0.06954,0.084485,Neutral
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Oak Street Health , Seagen Inc. , Provention Bio Inc. , Kimball International, Inc.",https://investingnews.com/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-oak-street-health-seagen-inc-provention-bio-inc-kimball-international-inc/,2023-03-23 14:24:50,"Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847. There is no cost or financial obligation to you.",PFE,0.350564,0.109026,Neutral
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Oak Street Health  ( NYSE - OSH ) , Seagen Inc.  ( Nasdaq - SGEN ) , Provention Bio Inc.  ( Nasdaq - PRVB ) , Kimball International, Inc.  ( Nasdaq - KBAL ) ",https://www.benzinga.com/pressreleases/23/03/g31475683/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-oak-street-he,2023-03-23 14:08:30,"BALA CYNWYD, Pa., March 23, 2023 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",PFE,0.332883,0.104903,Neutral
"Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval - Incyte  ( NASDAQ:INCY ) ",https://www.benzinga.com/general/biotech/23/03/31471634/incyte-would-now-compete-with-merck-pfizer-as-its-skin-cancer-treatment-scores-fda-accelerated-ap,2023-03-23 11:39:19,The FDA granted accelerated approval to Incyte Corporation's INCY Zynyz ( retifanlimab-dlwr ) for adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma ( MCC ) .,PFE,0.271274,0.383112,Bullish
Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ,https://www.benzinga.com/pressreleases/23/03/g31471796/monte-rosa-therapeutics-appoints-dr-jan-skvarka-to-board-of-directors,2023-03-23 11:30:00,"BOSTON, March 23, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Jan Skvarka, Ph.D., MBA to its Board of Directors.",PFE,0.072655,0.07548,Neutral
Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors,https://www.globenewswire.com/news-release/2023/03/23/2633019/0/en/Monte-Rosa-Therapeutics-Appoints-Dr-Jan-Skvarka-to-Board-of-Directors.html,2023-03-23 11:30:00,"BOSTON, March 23, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Jan Skvarka, Ph.D., MBA to its Board of Directors.",PFE,0.04794,0.074087,Neutral
Phase 3 Study Shows XTANDI®  ( enzalutamide )  plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Nonmetastatic Prostate Cancer,https://www.newswire.ca/news-releases/phase-3-study-shows-xtandi-r-enzalutamide-plus-leuprolide-significantly-improves-metastasis-free-survival-in-men-with-nonmetastatic-prostate-cancer-872614795.html,2023-03-23 11:00:00,Phase 3 Study Shows XTANDI® ( enzalutamide ) plus Leuprolide ... Canada ...,PFE,0.090474,0.148166,Neutral
Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders' Meeting,https://www.globenewswire.com/news-release/2023/03/23/2632841/0/en/Sosei-Heptares-Confirms-Changes-to-its-Board-and-Executive-Management-Team-at-Annual-Shareholders-Meeting.html,2023-03-23 07:00:00,"Tokyo, Japan and Cambridge, UK, 23 March 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , the world leader in G protein-coupled receptor ( GPCR ) focused structure-based drug design ( SBDD ) and development, announces the election of Ms. Eiko Tomita to the Board of Directors as an ...",PFE,0.077845,-0.009127,Neutral
Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders' Meeting,https://www.benzinga.com/pressreleases/23/03/g31469178/sosei-heptares-confirms-changes-to-its-board-and-executive-management-team-at-annual-shareholders-,2023-03-23 07:00:00,"Eiko Tomita, Vice President, Global Regulatory Affairs at Bristol Myers Squibb, elected to the Company's Board of Directors Candelle Chong promoted to Executive Vice President and Chief of Staff, previously Senior Vice President, Corporate Strategy",PFE,0.075161,-0.008082,Neutral
Valneva Reports Full Year 2022 Results and Provides Corporate Updates,https://www.globenewswire.com/news-release/2023/03/23/2632827/0/en/Valneva-Reports-Full-Year-2022-Results-and-Provides-Corporate-Updates.html,2023-03-23 06:00:00,Total revenues of €361.3 million in 2022 compared to €348.1 million in ...,PFE,0.164398,0.115771,Neutral
It Will Cost More Than $100 to Get a Moderna Covid Vaccine,https://www.fool.com/investing/2023/03/22/it-will-cost-more-than-100-to-get-a-moderna-covid/,2023-03-23 00:00:23,"Remember when they used to be free? As the US government winds down its pandemic emergency spending, health giant Moderna is preparing to shift its...",PFE,0.113062,0.080077,Neutral
Moderna CEO Stephane Bancel defends fivefold price hike of Covid vaccine during Senate grilling,https://www.cnbc.com/2023/03/22/moderna-ceo-stephane-bancel-defends-fivefold-price-hike-of-covid-vaccine-during-senate-grilling.html,2023-03-22 18:09:14,Bernie Sanders pressed Stephane Bancel during the Senate hearing to make a commitment that Moderna will not increase the vaccine's list price to $130.,PFE,0.095517,0.052039,Neutral
Nutricosmetics Market Size Worth USD 6.51 billion by 2030 at 6.45% CAGR - Report by Market Research Future  ( MRFR ) ,https://www.benzinga.com/pressreleases/23/03/g31459540/nutricosmetics-market-size-worth-usd-6-51-billion-by-2030-at-6-45-cagr-report-by-market-research-f,2023-03-22 15:36:00,"New York, US, March 22, 2023 ( GLOBE NEWSWIRE ) -- Nutricosmetics Market Overview:",PFE,0.032425,0.104175,Neutral
Why Pfizer Likely Isn't Done With M&A After the Seagen Deal,https://www.fool.com/investing/2023/03/22/why-pfizer-likely-isnt-done-with-ma-after-seagen/,2023-03-22 14:45:00,"Pfizer's stock remains down despite its latest dealmaking, but it may only be a matter of time before it starts to rally.",PFE,0.629492,0.152489,Somewhat-Bullish
Moderna CEO faces Senate panel as company prepares to quadruple price of COVID-19 vaccine - .com,https://www.upi.com/Top_News/US/2023/03/22/senate-committee-hearing-to-grill-Moderna-over-COVID-19-vaccine-price/1821679488170/,2023-03-22 14:20:30,Moderna CEO faces Senate panel as price of COVID-19 vaccine set to quadruple UPI News ...,PFE,0.077593,0.0,Neutral
Watch live: Moderna CEO Stephane Bancel testifies before Senate on Covid vaccine price hike,https://www.cnbc.com/2023/03/22/watch-live-moderna-ceo-stephane-bancel-testifies-before-senate-on-covid-vaccine-price-hike.html,2023-03-22 14:18:30,The Boston biotech company plans to charge $130 per dose once the vaccination program moves to the private market as early as this fall.,PFE,0.184598,0.074065,Neutral
China's First mRNA Vaccine: Drugmaker CSPC Wins China's Approval For COVID-19 Vaccine - CSPC Pharma Gr  ( OTC:CSPCY ) ,https://www.benzinga.com/government/23/03/31452647/chinas-first-mrna-vaccine-drugmaker-cspc-wins-chinas-approval-for-covid-19-vaccine,2023-03-22 13:33:35,"Chinese health authorities approved CSPC Pharmaceuticals Group Ltd's CSPCY messenger RNA ( mRNA ) COVID-19 vaccine for emergency use authorization. CSPC's mRNA became China's first domestically developed mRNA shot as COVID cases decline across the country after a resurgence, Reuters reports.",PFE,0.272788,-0.014733,Neutral
Benign Prostatic Hyperplasia Treatment Market is Expected to Reach $14.1 billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/03/g31456711/benign-prostatic-hyperplasia-treatment-market-is-expected-to-reach-14-1-billion-marketsandmarkets,2023-03-22 13:30:00,"Chicago, March 22, 2023 ( GLOBE NEWSWIRE ) -- In the near future, the Benign Prostatic Hyperplasia ( BPH ) treatment industry is likely to see further developments and advancements in treatment options.",PFE,0.03878,0.017192,Neutral
PRGN Expands Global Presence with Addition of Pan-African and Indian Agencies,https://www.benzinga.com/pressreleases/23/03/g31455038/prgn-expands-global-presence-with-addition-of-pan-african-and-indian-agencies,2023-03-22 12:33:05,"NEW YORK and LONDON, March 22, 2023 ( GLOBE NEWSWIRE ) -- The Public Relations Global Network ( PRGN ) announced today it has added two new agencies in the emerging markets of Africa and India as full members, enhancing its ability to seamlessly serve clients throughout the world.",PFE,0.03448,0.166319,Somewhat-Bullish
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine  ( ISICEM )  - CytoSorbents  ( NASDAQ:CTSO ) ,https://www.benzinga.com/pressreleases/23/03/g31454432/cytosorbents-highlights-new-clinical-data-from-current-studies-at-the-live-42nd-international-symp,2023-03-22 12:09:06,"PRINCETON, N.J., March 22, 2023 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation CTSO, a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced its scientific program for the 42nd International Symposium on ...",PFE,0.026591,0.121806,Neutral
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine  ( ISICEM ) ,https://www.globenewswire.com/news-release/2023/03/22/2632168/25359/en/CytoSorbents-Highlights-New-Clinical-Data-from-Current-Studies-at-the-Live-42nd-International-Symposium-on-Intensive-Care-Emergency-Medicine-ISICEM.html,2023-03-22 12:09:00,"PRINCETON, N.J., March 22, 2023 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation ( NASDAQ: CTSO ) , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced its scientific program for the 42nd International ...",PFE,0.027892,0.124466,Neutral
"Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals",https://www.zacks.com/stock/news/2068930/zacks-industry-outlook-highlights-crispr-therapeutics-ligand-pharmaceuticals-theseus-pharmaceuticals-and-kala-pharmaceuticals,2023-03-22 11:37:00,"CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals are part of the Zacks Industry Outlook article.",PFE,0.026013,0.017488,Neutral
"$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying - Bird Glb  ( NYSE:BRDS ) , Champions Oncology  ( NASDAQ:CSBR ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/03/31453546/5m-bet-on-pyxis-oncology-check-out-these-4-penny-stocks-insiders-are-buying,2023-03-22 11:21:13,"The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...",PFE,0.096283,0.13807,Neutral
EvolveImmune Therapeutics Presents New Preclinical Data Demonstrating Improved Anti-Tumor Potential of Novel Costimulatory T Cell Engager Platform at Festival of Biologics Immunotherapy World Congress,https://www.benzinga.com/pressreleases/23/03/g31453145/evolveimmune-therapeutics-presents-new-preclinical-data-demonstrating-improved-anti-tumor-potentia,2023-03-22 11:00:40,"Company Unveils EVOLVE-105 Program, A Best-in-Class CD20xCD3 Multispecific Antibody Designed to Concurrently Drive CD2 Costimulation to Improve the Treatment of B cell Malignancies",PFE,0.03443,0.052828,Neutral
3 Signs That It's Time to Sell Your Favorite Biotech Stock,https://www.fool.com/investing/2023/03/22/signs-its-time-to-sell-favorite-biotech-stock/,2023-03-22 09:31:00,It's in your interest to know when things aren't going to go your way with a stock.,PFE,0.051441,-0.041678,Neutral
"China approves its first mRNA vaccine, from domestic drugmaker CSPC",https://www.reuters.com/business/healthcare-pharmaceuticals/china-approves-its-first-mrna-vaccine-domestic-drugmaker-cspc-2023-03-22/,2023-03-22 07:36:00,"China approves its first mRNA vaccine, from domestic drugmaker ... ...",PFE,0.162802,0.084068,Neutral
China Approves First Domestic MRNA Vaccine For Covid-19,https://www.barrons.com/news/china-approves-first-domestic-mrna-vaccine-for-covid-19-69b6f5eb,2023-03-22 07:27:01,China Approves First Domestic MRNA Vaccine For ...,PFE,0.156461,-0.070664,Neutral
Four Elements Of Healthcare Industry Leadership: China Summit,https://www.forbes.com/sites/forbeschina/2023/03/22/four-elements-of-healthcare-industry-leadership-forbes-china-summit/,2023-03-22 04:56:00,"""Healthcare can often be a very conservative industry because it's an industry that deals with very long timetables. However, playing it too safe and too careful can leave you behind competitors,"" Forbes Senior Editor Alex Knapp believes.",PFE,0.085629,0.116594,Neutral
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Index™",https://www.globenewswire.com/news-release/2023/04/11/2644010/0/en/Hywin-Holdings-Leonteq-AG-and-ARTA-TechFin-jointly-launch-principal-protected-note-linked-to-FactSet-Hywin-Global-Health-Care-Index.html,2023-04-11 00:00:00,"HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) ( NASDAQ: HYW ) , a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured ...",PFE,0.036869,0.079891,Neutral
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Index™ - Hywin Holdings  ( NASDAQ:HYW ) ",https://www.benzinga.com/pressreleases/23/04/g31736283/hywin-holdings-leonteq-ag-and-arta-techfin-jointly-launch-principal-protected-note-linked-to-facts,2023-04-11 00:00:00,"HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) HYW, a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured investment solutions, ...",PFE,0.036091,0.079702,Neutral
It's crucial you understand why this jobs report is so important,https://moneymorning.com/investing/its-crucial-you-understand-why-this-jobs-report-is-so-important/,2023-04-10 22:41:20,"The market spent all weekend frothing at the mouth after seeing Friday's jobs report. The numbers weren't great, and today marked the first opportunity for traders to react. However, it's less about the present impact and more what it says about the future.",PFE,0.170878,0.066038,Neutral
Pharma CEOs Say US Abortion Pill Ruling Threatens Drug Development,https://www.barrons.com/news/pharma-ceos-say-us-abortion-pill-ruling-threatens-drug-development-2b33898c,2023-04-10 20:05:35,"Hundreds of pharmaceutical executives on Monday condemned a US judicial ruling outlawing a leading abortion pill, saying it threatens the development of needed medications in the United States.",PFE,0.115232,-0.104932,Neutral
DOJ asks judge to clarify legality of abortion pill mifepristone after dueling court rulings,https://www.cnbc.com/2023/04/10/mifepristone-abortion-pill-doj-asks-judge-to-clarify-court-rulings.html,2023-04-10 19:55:42,Dueling court rulings out of Washington state and Texas have created confusion about the abortion pill mifepristone's legal status in the U.S.,PFE,0.072655,0.296334,Somewhat-Bullish
"Drug companies blast Texas judge for abortion drug decision, call for reversal",https://www.foxbusiness.com/politics/drug-companies-blast-texas-judge-ban-abortion-drug-reversing-decision,2023-04-10 19:52:30,"Hundreds of pharmaceutical and biotech company executives signed an open letter Monday condemning a federal judge in Texas for halting the U.S. Food and Drug Administration's approval of abortion drug mifepristone, and called for the decision to be reversed. Trump-appointed U.S.",PFE,0.107495,0.155825,Somewhat-Bullish
"Canadian Cancer Diagnostic Company BioMark Working On Early Lung Detection Assay - AstraZeneca  ( NASDAQ:AZN ) , AstraZeneca  ( OTC:AZNCF ) ",https://www.benzinga.com/news/23/04/31730953/canadian-cancer-diagnostic-company-biomark-working-on-early-lung-detection-assay,2023-04-10 18:25:19,"In March, BioMark Diagnostics Inc BMKDF, a Canada-based liquid biopsy company, released data suggesting that Pulmonary Neuroendocrine Tumors ( NETs ) are reprogramming their metabolism as reflected by the presence of a panel of distinct metabolic biomarkers.",PFE,0.301315,0.0,Neutral
Justice Department asks appeals court to keep abortion pill mifepristone on market as litigation plays out,https://www.cnbc.com/2023/04/10/abortion-pill-us-asks-appeals-court-to-keep-mifepristone-on-market.html,2023-04-10 18:08:30,Danco Laboratories will likely ask the Supreme Court to intervene if the 5th Circuit does not at least temporarily block Kacsmaryk's decision.,PFE,0.11894,0.116399,Neutral
US drugmakers call for reversing Texas abortion pill ruling,https://www.reuters.com/business/healthcare-pharmaceuticals/us-drugmakers-call-reversing-texas-abortion-pill-ruling-2023-04-10/,2023-04-10 15:50:00,"[1/2] A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration",PFE,0.240489,-0.105433,Neutral
Pfizer CEO signs letter in support of FDA after federal judge suspends approval of abortion pill,https://www.cnbc.com/2023/04/10/abortion-pill-ruling-pfizer-ceo-signs-letter-in-support-of-fda.html,2023-04-10 15:34:02,Pfizer's CEO was among the more than 200 pharmaceutical company executives who signed the letter after a federal judge's controversial ruling on mifepristone.,PFE,0.155451,0.0,Neutral
Citric Acid Market to Capture a CAGR of 5.78% Between 2023 and 2030 While Touching Approximately USD 6.22 Billion by 2030-End - Report by Market Research Future  ( MRFR ) ,https://www.benzinga.com/pressreleases/23/04/g31728956/citric-acid-market-to-capture-a-cagr-of-5-78-between-2023-and-2030-while-touching-approximately-us,2023-04-10 15:33:00,"New York, US, April 10, 2023 ( GLOBE NEWSWIRE ) -- Citric Acid Market Overview According to a Comprehensive Research Report by Market Research Future ( MRFR ) , Citric Acid Market Information by Form, Application, Function, and Region - Forecast till 2030"", Citric Acid Market could thrive at ...",PFE,0.031529,0.113973,Neutral
"Moderna  ( MRNA ) , Merck's Cancer Jab Gets EMA's PRIME Tag",https://www.zacks.com/stock/news/2076370/moderna-mrna-mercks-cancer-jab-gets-emas-prime-tag,2023-04-10 15:12:00,The EMA grants PRIME designation to Moderna's (MRNA) personalized cancer vaccine candidate combined with Merck's Keytruda for treating certain types of melanoma.,PFE,0.050465,0.161923,Somewhat-Bullish
3 Sector ETFs to Play as Recession Fears Are on the Rise,https://www.zacks.com/stock/news/2076344/3-sector-etfs-to-play-as-recession-fears-are-on-the-rise,2023-04-10 14:41:00,"With recession fears on the rise, look into some sectors that can shield from market volatility.",PFE,0.116914,-0.021983,Neutral
"The Zacks Analyst Blog Highlights J&J, AstraZeneca, Merck, Seagen and Pfizer",https://www.zacks.com/stock/news/2076295/the-zacks-analyst-blog-highlights-jj-astrazeneca-merck-seagen-and-pfizer,2023-04-10 12:55:00,"J&J, AstraZeneca, Merck, Seagen and Pfizer are part of the Zacks Top Analyst Blog.",PFE,0.095517,0.0,Neutral
"Zacks Investment Ideas feature highlights: Nvidia, United Healthcare, Merck, Pfizer and Intuitive Surgical",https://www.zacks.com/stock/news/2076198/zacks-investment-ideas-feature-highlights-nvidia-united-healthcare-merck-pfizer-and-intuitive-surgical,2023-04-10 12:17:00,"Nvidia, United Healthcare, Merck, Pfizer and Intuitive Surgical are part of the Zacks Investment Ideas article.",PFE,0.254751,0.130995,Neutral
3 Things About Novo Nordisk That Smart Investors Know,https://www.fool.com/investing/2023/04/10/3-things-about-novo-nordisk-smart-investors-know/,2023-04-10 12:00:00,"The outlook for its diabetes and weight-loss drug is very promising, but there's more to the stock's story.",PFE,0.054483,0.061035,Neutral
Is Invesco Dynamic Pharmaceuticals ETF  ( PJP )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2076050/is-invesco-dynamic-pharmaceuticals-etf-pjp-a-strong-etf-right-now,2023-04-10 10:20:09,Smart Beta ETF report for ...,PFE,0.11894,0.060738,Neutral
5 High-Yield Dividend Stocks in Warren Buffett's Secret Portfolio You Can Buy Right Now,https://www.fool.com/investing/2023/04/10/high-yield-dividend-stocks-warren-buffett-buy-now/,2023-04-10 09:52:00,The dividend yields for these Buffett stocks range from 3.7% to 10.6%.,PFE,0.239895,0.19158,Somewhat-Bullish
Here's Why Pfizer Will Bounce Back This Year,https://www.fool.com/investing/2023/04/08/heres-why-pfizer-will-bounce-back-this-year/,2023-04-08 13:23:00,The company has used its COVID-19 therapy and vaccine profits to beef up its pipeline.,PFE,0.510952,0.067535,Neutral
2 Top Stocks to Buy in April and Hold Forever,https://www.fool.com/investing/2023/04/08/2-top-stocks-to-buy-in-april-and-hold-forever/,2023-04-08 11:39:00,The need for healthcare goods and/or services is here to stay.,PFE,0.062597,-0.0756,Neutral
3 No-Brainer Stocks to Buy in a New Bull Market,https://www.fool.com/investing/2023/04/08/3-no-brainer-stocks-to-buy-in-a-new-bull-market/,2023-04-08 10:11:00,These stocks have what it takes to soar if and when a new bull market begins.,PFE,0.367865,0.270826,Somewhat-Bullish
"Federal judge stays FDA abortion pill approval, gives Biden administration time to appeal",https://www.cnbc.com/2023/04/07/federal-judge-stays-fda-abortion-pill-approval-gives-time-to-appeal.html,2023-04-07 22:58:27,"A federal judge in Texas on Friday stayed the FDA's appwroval of the abortion pill mifepristone, but delayed the ruling taking effect for a week, giving time to appeal.",PFE,0.050148,-0.122247,Neutral
"Renal Anemia Therapeutics Market size to grow by USD 1.97 billion from 2021 to 2026, Driven by the presence of a large pool of CKD patients - Technavio",https://www.prnewswire.com/news-releases/renal-anemia-therapeutics-market-size-to-grow-by-usd-1-97-billion-from-2021-to-2026--driven-by-the-presence-of-a-large-pool-of-ckd-patients---technavio-301790685.html,2023-04-07 13:00:00,Renal Anemia Therapeutics Market size to grow by USD 1.97 billion ... PR ...,PFE,0.026299,-0.013399,Neutral
2 Top Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/04/07/2-top-biotech-stocks-to-buy-right-now/,2023-04-07 09:20:00,These two companies pay market-beating dividends to shareholders.,PFE,0.449219,0.063021,Neutral
"AnaptysBio Announces Appointment of Rita Jain, M.D., to Board of Directors",https://www.globenewswire.com/news-release/2023/04/06/2642996/0/en/AnaptysBio-Announces-Appointment-of-Rita-Jain-M-D-to-Board-of-Directors.html,2023-04-06 20:15:00,"SAN DIEGO, April 06, 2023 ( GLOBE NEWSWIRE ) -- AnaptysBio, Inc. ( Nasdaq: ANAB ) , a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced the appointment of Rita Jain, M.D., to the company's Board of Directors, effective immediately.",PFE,0.040484,-0.085299,Neutral
"AnaptysBio Announces Appointment of Rita Jain, M.D., to Board of Directors - AnaptysBio  ( NASDAQ:ANAB ) ",https://www.benzinga.com/pressreleases/23/04/g31705743/anaptysbio-announces-appointment-of-rita-jain-m-d-to-board-of-directors,2023-04-06 20:15:00,"SAN DIEGO, April 06, 2023 ( GLOBE NEWSWIRE ) -- AnaptysBio, Inc. ANAB, a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced the appointment of Rita Jain, M.D., to the company's Board of Directors, effective immediately.",PFE,0.039353,-0.085043,Neutral
"Pfizer RSV vaccine for older adults should be monitored for nervous system condition Guillain-Barre, scientists say",https://www.cnbc.com/2023/04/06/rsv-adult-vaccine-pfizer-shot-monitored-for-guillain-barre.html,2023-04-06 19:58:55,"Scientists said Pfizer's RSV vaccine for older adults should be monitored for Guillain-Barre, in an article published in the New England Journal of Medicine.",PFE,0.248851,0.071587,Neutral
Bear Market Blues? Listen to These Words From Warren Buffett.,https://www.fool.com/investing/2023/04/06/bear-market-blues-listen-to-these-words-from-warre/,2023-04-06 18:00:00,Buffett's strategy has led Berkshire Hathaway to market-beating performance over the years.,PFE,0.207571,0.093613,Neutral
PFE: 3 Low P/E Stocks Gearing Up to Rebound This Year,https://stocknews.com/news/pfe-cvx-t-3-low-p-e-stocks-gearing-up-to-rebound-this-year/,2023-04-06 15:01:44,"Investor sentiment has been significantly affected due to the Fed's monetary tightening and the recent bank collapses. However, a down market provides attractive opportunities to invest in undervalued stocks, whose prices tend to trend back upward in the near future.",PFE,0.24267,0.067855,Neutral
GeoVax Announces Presentation of Preliminary Data from Clinical Trial of Next-Generation COVID-19 Vaccine Candidate,https://www.globenewswire.com/news-release/2023/04/06/2642736/0/en/GeoVax-Announces-Presentation-of-Preliminary-Data-from-Clinical-Trial-of-Next-Generation-COVID-19-Vaccine-Candidate.html,2023-04-06 14:00:00,Analysis of Open-Label Portion of Ongoing Phase 2 Trial of ...,PFE,0.056407,0.136936,Neutral
"Top Stories Thursday, Apr. 06: Biden Admin Finalizes Rule To Crack Down Deceptive Medicare Advantage Advertising, Weekly Jobless Claims Higher Than Expected, US Big Techs Face Difficulty Downsizing In Europe - Amazon.com  ( NASDAQ:AMZN ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/general/biotech/23/04/31697997/weekly-jobless-claims-higher-than-expected-us-big-techs-face-difficulty-downsizing-in-europe-bide,2023-04-06 13:45:00,"Weekly Initial Jobless Claims were 228,000, a decrease of 18,000 from the previous week's revised level, according to data the Labor Department released on Thursday. The number is above the average economist estimates of 201,000 but lower than the previous week's revised level.",PFE,0.076236,0.0,Neutral
"Pfizer's RSV Candidate Shines with 82% Efficacy, Despite Competition in Crowded Field - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/04/31697198/pfizers-rsv-candidate-shines-with-82-efficacy-despite-competition-in-crowded-field,2023-04-06 13:16:54,"On Wednesday, Pfizer Inc PFE detailed late-stage study results for its RSV vaccine in the New England Journal of Medicine detailing late-stage study results for its RSV vaccine. Pfizer in November released initial trial results on the vaccine currently under review by health regulators in the ...",PFE,0.492659,0.189233,Somewhat-Bullish
3 Reasons to Buy Healthcare Stocks in the Current Market Environment,https://www.zacks.com/commentary/2075389/3-reasons-to-buy-healthcare-stocks-in-the-current-market-environment,2023-04-06 12:59:00,"Healthcare stocks are currently providing investors with an attractive way to counterbalance a portfolio overexposed to tech. In general, healthcare stocks have lower betas, are more defensive, and have cleaner balance sheets.",PFE,0.156461,0.074795,Neutral
Air pollution linked to lower antibody response to Covid vaccine: Study,https://www.business-standard.com/india-news/air-pollution-linked-to-lower-antibody-response-to-covid-vaccine-study-123040600686_1.html,2023-04-06 11:07:00,"People exposed to higher levels of air pollution before the pandemic had lower antibody responses to COVID-19 vaccines, according to a study.",PFE,0.081552,0.0,Neutral
"Air pollution can affect your Covid-19 vaccine efficacy, says study",https://www.business-standard.com/health/air-pollution-can-affect-your-covid-19-vaccine-efficacy-says-study-123040600381_1.html,2023-04-06 07:55:00,"People exposed to higher levels of air pollution before the pandemic are likely to have lower antibody responses to Covid-19 vaccines, suggests a study.",PFE,0.08183,0.0,Neutral
"Pfizer RSV vaccine 82% effective vs severe infection in infants, final data shows",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-rsv-vaccine-82-effective-vs-severe-infection-infants-final-data-shows-2023-04-05/,2023-04-05 21:12:00,"Pfizer RSV vaccine 82% effective vs severe infection in infants, final ... ...",PFE,0.298264,-0.210701,Somewhat-Bearish
Pfizer  ( PFE )  Gets FDA Acceptance for Braftovi + Mektovi sNDAs,https://www.zacks.com/stock/news/2074907/pfizer-pfe-gets-fda-acceptance-for-braftovi-mektovi-sndas,2023-04-05 14:05:00,FDA accepts Pfizer's (PFE) sNDAs seeking approval of Braftovi + Mektovi for BRAF V600E-mutant non-small cell lung cancer.,PFE,0.504646,-0.167217,Somewhat-Bearish
3 Cheap Dividend Stocks to Buy In April,https://www.fool.com/investing/2023/04/05/3-cheap-dividend-stocks-to-buy-in-april/,2023-04-05 13:15:00,Buy these stocks this month and hang on to them for years.,PFE,0.256314,0.1445,Neutral
How the market's biggest companies manage their cash and investments,https://www.cnbc.com/2023/04/05/how-markets-biggest-companies-manage-cash-and-investments.html,2023-04-05 11:29:56,"A bank run doesn't touch most corporate cash, but big companies from Apple to Microsoft and Tesla are sitting on a lot of money, with potential for losses.",PFE,0.034332,0.0,Neutral
US is going to hell: Donald Trump in first post-indictment address,https://www.business-standard.com/world-news/us-is-going-to-hell-donald-trump-in-first-post-indictment-address-123040500109_1.html,2023-04-05 03:28:00,"The United States is going to hell, said former President Donald Trump in a jibe at Joe Biden's administration while addressing a public gathering on Tuesday night.",PFE,0.078611,-0.251318,Somewhat-Bearish
"Gilead details promising early COVID antiviral data, setting up larger studies",https://www.reuters.com/business/healthcare-pharmaceuticals/gilead-details-promising-early-covid-antiviral-data-setting-up-larger-studies-2023-04-04/,2023-04-04 22:34:00,"Gilead details promising early COVID antiviral data, setting up larger ... ...",PFE,0.081552,0.0,Neutral
Pfizer  ( PFE )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2074526/pfizer-pfe-dips-more-than-broader-markets-what-you-should-know,2023-04-04 21:45:20,"In the latest trading session, Pfizer (PFE) closed at $40.90, marking a -1.09% move from the previous day.",PFE,0.603594,0.092076,Neutral
Ozempic Is About to Be Old News,https://www.theatlantic.com/health/archive/2023/04/ozempic-wegovy-mounjaro-weight-loss-drug-development-access/673627/,2023-04-04 21:31:00,"All of a sudden, Ozempic is everywhere. The weight-loss drug that it contains, semaglutide, is a potent treatment for obesity, and Hollywood and TikTok celebrities have turned it into a sensation.",PFE,0.050306,0.041906,Neutral
Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots,https://markets.businessinsider.com/news/stocks/pfizer-slapped-with-additional-patent-infringement-lawsuit-over-its-famed-covid-19-shots-1032214756,2023-04-04 18:08:19,"Arbutus Biopharma Corporation ( NASDAQ:ABUS ) and its licensee Genevant Sciences have sued Pfizer Inc ( NYSE:PFE ) and its partner BioNTech SE ( NASDAQ:BNTX ) in the U.S. District Court for the District of New Jersey, seeking damages for infringement of five U.S. patents.",PFE,0.722944,-0.481735,Bearish
"Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots - Arbutus Biopharma  ( NASDAQ:ABUS ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/04/31663427/pfizer-slapped-with-additional-patent-infringement-lawsuit-over-its-famed-covid-19-shots,2023-04-04 18:08:18,"Arbutus Biopharma Corporation ABUS and its licensee Genevant Sciences have sued Pfizer Inc PFE and its partner BioNTech SE BNTX in the U.S. District Court for the District of New Jersey, seeking damages for infringement of five U.S. patents.",PFE,0.779232,-0.503603,Bearish
Overactive Bladder Treatment Market Is Expected to Generate $3.5 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/04/g31659799/overactive-bladder-treatment-market-is-expected-to-generate-3-5-billion-by-2031-allied-market-rese,2023-04-04 15:09:40,"Portland, OR, April 04, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global Overactive Bladder Treatment Market garnered $2.4 billion in 2021, and is estimated to generate $3.5 billion by 2031, manifesting a CAGR of 3.6% from 2022 to 2031.",PFE,0.034087,-0.042407,Neutral
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/04/31658328/this-is-what-whales-are-betting-on-pfizer,2023-04-04 14:16:13,"A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer PFE we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish expectations and ...",PFE,0.759278,0.047062,Neutral
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Univar Solutions Inc. , Oak Street Health , Seagen Inc. , U.S. Xpress Enterprises, Inc.",https://investingnews.com/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-univar-solutions-inc-oak-street-health-seagen-inc-u-s-xpress-enterprises-inc/,2023-04-04 14:06:12,"Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847. There is no cost or financial obligation to you.",PFE,0.343279,0.107344,Neutral
"Top Stories Tuesday, Apr. 04: Russia Warns As Finland Joins NATO, Spotify Highlights Struggle With Live Audio, Anticompetitive Charges Against Activision Blizzard: Today's Top Stories - Activision Blizzard  ( NASDAQ:ATVI ) , Allianz  ( OTC:ALIZY ) ",https://www.benzinga.com/general/biotech/23/04/31657231/russia-warns-as-finland-joins-nato-spotify-highlights-struggle-with-live-audio-anticompetitive-ch,2023-04-04 13:52:14,"The Finland foreign minister signed the accession document, and Finland has become the 31st member of the North Atlantic Treaty Organization ( NATO ) security alliance.",PFE,0.115232,-0.035153,Neutral
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Univar Solutions Inc.  ( NYSE - UNVR ) , Oak Street Health  ( NYSE - OSH ) , Seagen Inc.  ( Nasdaq - SGEN ) , U.S. Xpress Enterprises, Inc.  ( NYSE - USX ) ",https://www.benzinga.com/pressreleases/23/04/g31657034/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-univar-soluti,2023-04-04 13:33:41,"BALA CYNWYD, Pa., April 04, 2023 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",PFE,0.327366,0.103589,Neutral
"After Denying Earlier, Pfizer & Merck Marginally Cut Prices For COVID-19 Treatments In China - Merck & Co  ( NYSE:MRK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/04/31654558/after-denying-earlier-pfizer-merck-marginally-cut-prices-for-covid-19-treatments-in-china,2023-04-04 13:06:58,Pfizer Inc PFE and Merck & Co Inc MRK have reportedly lowered the prices of their respective COVID-19 treatments in China.,PFE,0.716023,0.003822,Neutral
"Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Pfizer/BioNTech - Arbutus Biopharma  ( NASDAQ:ABUS ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/23/04/g31652249/arbutus-biopharma-and-genevant-sciences-file-patent-infringement-lawsuit-against-pfizerbiontech,2023-04-04 11:52:33,"WARMINSTER, Pa., April 04, 2023 ( GLOBE NEWSWIRE ) -- Arbutus Biopharma Corporation ABUS ( ""Arbutus"" ) , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, and Genevant Sciences ( Genevant ) ...",PFE,0.210579,-0.046635,Neutral
Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Pfizer/BioNTech,https://www.globenewswire.com/news-release/2023/04/04/2640556/14025/en/Arbutus-Biopharma-and-Genevant-Sciences-File-Patent-Infringement-Lawsuit-Against-Pfizer-BioNTech.html,2023-04-04 11:52:00,Companies seek compensation for Pfizer's and BioNTech's unlicensed use of patented technologies in COVID-19 mRNA-LNP vaccines ...,PFE,0.210274,-0.048304,Neutral
1 Stock to Buy and 1 to Avoid Before the Next Bull Market,https://www.fool.com/investing/2023/04/04/1-stock-to-buy-and-1-to-avoid-before-the-next-bull/,2023-04-04 11:07:00,These stocks could move in opposite directions come the next bull market.,PFE,0.050465,0.018951,Neutral
Entrada Therapeutics Appoints Dr. Bernhardt Zeiher to its Board of Directors,https://www.globenewswire.com/news-release/2023/04/04/2640446/0/en/Entrada-Therapeutics-Appoints-Dr-Bernhardt-Zeiher-to-its-Board-of-Directors.html,2023-04-04 11:00:00,"BOSTON, April 04, 2023 ( GLOBE NEWSWIRE ) -- Entrada Therapeutics, Inc. ( Nasdaq: TRDA ) , a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle ( EEV™ ) -therapeutics as a new class of medicines, today announced the ...",PFE,0.068502,-0.08187,Neutral
Entrada Therapeutics Appoints Dr. Bernhardt Zeiher to its Board of Directors - Entrada Therapeutics  ( NASDAQ:TRDA ) ,https://www.benzinga.com/pressreleases/23/04/g31650776/entrada-therapeutics-appoints-dr-bernhardt-zeiher-to-its-board-of-directors,2023-04-04 11:00:00,"BOSTON, April 04, 2023 ( GLOBE NEWSWIRE ) -- Entrada Therapeutics, Inc. TRDA, a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle ( EEV™ ) -therapeutics as a new class of medicines, today announced the appointment of Dr. ...",PFE,0.064797,-0.081514,Neutral
FDA Accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI - Investing News Network,https://investingnews.com/fda-accepts-pfizer-s-supplemental-new-drug-applications-for-braftovi-mektovi/,2023-04-04 10:57:24,FDA Accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI Investing News Network ...,PFE,0.174817,0.133811,Neutral
"Pfizer, Merck trim prices in China for Paxlovid, molnupiravir - reports",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-merck-trim-prices-china-paxlovid-molnupiravir-reports-2023-04-04/,2023-04-04 09:45:00,"SHANGHAI, April 4 ( Reuters ) - Pfizer ( PFE.N ) and Merck ( MRK.N ) have slightly lowered the prices of their respective Paxlovid and molnupiravir COVID-19 treatments in China, local media reported on Tuesday citing pricing information published by the province of Jiangsu.",PFE,0.507107,-0.107992,Neutral
2 Top Biotech Stocks to Buy in April,https://www.fool.com/investing/2023/04/04/2-top-biotech-stocks-to-buy-in-april/,2023-04-04 09:30:00,Right now you can pick up these stocks on the dip.,PFE,0.062597,0.0,Neutral
"IoT In Healthcare Market Size Growing at 19.20 % CAGR, Set to Reach USD 388.18 Billion by 2027 says Brandessence Market Research",https://www.prnewswire.com/news-releases/iot-in-healthcare-market-size-growing-at-19-20--cagr-set-to-reach-usd-388-18-billion-by-2027-says-brandessence-market-research-301789350.html,2023-04-04 08:46:00,"IoT In Healthcare Market Size Growing at 19.20 % CAGR, Set to ... PR ...",PFE,0.058472,0.148017,Neutral
Around 1 mn children above 5 years deprived of Covid vaccines in Nepal,https://www.business-standard.com/world-news/around-1-mn-children-above-5-years-deprived-of-covid-vaccines-in-nepal-123040400090_1.html,2023-04-04 03:38:00,Around 1 mn children above 5 years deprived of Covid vaccines in ... Business Standard ...,PFE,0.089797,0.074503,Neutral
Advantage Solutions Names Jim Kilts Chairman of the Board of Directors,https://www.globenewswire.com/news-release/2023/04/03/2640186/0/en/Advantage-Solutions-Names-Jim-Kilts-Chairman-of-the-Board-of-Directors.html,2023-04-03 20:35:00,"IRVINE, Calif., April 03, 2023 ( GLOBE NEWSWIRE ) -- The board of directors of Advantage Solutions Inc. ( NASDAQ: ADV ) , a leading provider of outsourced sales and marketing services to consumer goods manufacturers and retailers, last week unanimously voted to appoint Jim Kilts to the role of ...",PFE,0.03786,0.106076,Neutral
Advantage Solutions Names Jim Kilts Chairman of the Board of Directors - Advantage Solutions  ( NASDAQ:ADV ) ,https://www.benzinga.com/pressreleases/23/04/g31644029/advantage-solutions-names-jim-kilts-chairman-of-the-board-of-directors,2023-04-03 20:35:00,"IRVINE, Calif., April 03, 2023 ( GLOBE NEWSWIRE ) -- The board of directors of Advantage Solutions Inc. ADV, a leading provider of outsourced sales and marketing services to consumer goods manufacturers and retailers, last week unanimously voted to appoint Jim Kilts to the role of chairman of the ...",PFE,0.037098,0.105796,Neutral
Sensible Biotechnologies And Ginkgo Bioworks Announce Partnership To Make In Vivo RNA To Unlock The Promise Of RNA Therapeutics,https://www.forbes.com/sites/johncumbers/2023/04/03/sensible-biotechnologies-and-ginkgo-bioworks-announce-partnership-to-make-in-vivo-rna-to-unlock-the-promise-of-rna-therapeutics/,2023-04-03 18:27:50,Coaxing cells to produce mRNA for therapeutic applications has been an unsuccessful endeavor so far. Miroslav Gasparek is on a mission to use synbio to change that. His company Sensible Biotechnologies is partnering with Ginkgo Bioworks to develop the next generation of mRNA therapeutics.,PFE,0.033562,0.006604,Neutral
"5 Value Stocks To Watch In The Healthcare Sector - Fulgent Genetics  ( NASDAQ:FLGT ) , Maravai LifeSciences  ( NASDAQ:MRVI ) , Zymeworks  ( NASDAQ:ZYME ) , Pfizer  ( NYSE:PFE ) , ProPhase Labs  ( NASDAQ:PRPH ) ",https://www.benzinga.com/news/23/04/31635573/5-value-stocks-to-watch-in-the-healthcare-sector,2023-04-03 14:43:16,A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.,PFE,0.213048,0.090823,Neutral
Beamr Teams Up with Wochit as Design Partner to Bring Video Optimization Technology to Its Platform,https://www.globenewswire.com/news-release/2023/04/03/2639696/0/en/Beamr-Teams-Up-with-Wochit-as-Design-Partner-to-Bring-Video-Optimization-Technology-to-Its-Platform.html,2023-04-03 13:04:00,"Herzeliya, Israel, April 03, 2023 ( GLOBE NEWSWIRE ) -- Beamr Imaging Ltd. ( Nasdaq: BMR ) announced today that it has teamed up with Wochit as a design partner for its upcoming SaaS offering.",PFE,0.057907,0.313349,Somewhat-Bullish
2 High-Yield Dividend Stocks to Buy Near Their 52-Week Lows,https://www.fool.com/investing/2023/04/03/2-high-yield-dividend-stocks-to-buy-near-their-52/,2023-04-03 12:25:00,"The market isn't favoring these two stocks now, but the long-term opportunities remain intact.",PFE,0.331129,0.150495,Somewhat-Bullish
"Arvinas Appoints Kelly Page as Senior Vice President, Global Head of Oncology Strategy and Program Leadership",https://www.globenewswire.com/news-release/2023/04/03/2639394/0/en/Arvinas-Appoints-Kelly-Page-as-Senior-Vice-President-Global-Head-of-Oncology-Strategy-and-Program-Leadership.html,2023-04-03 11:00:00,"NEW HAVEN, Conn., April 03, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ( Nasdaq: ARVN ) , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Kelly Page has joined the company as Senior Vice President, Global Head of ...",PFE,0.054732,0.058989,Neutral
BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors,https://www.globenewswire.com/news-release/2023/04/03/2639380/0/en/BioNTech-and-DualityBio-Form-Global-Strategic-Partnership-to-Accelerate-Development-of-Differentiated-Antibody-Drug-Conjugate-Therapeutics-for-Solid-Tumors.html,2023-04-03 10:45:00,"MAINZ, Germany and SHANGHAI, China, April 3, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" ) and Duality Biologics ( Suzhou ) Co. Ltd. ( ""DualityBio"" ) , a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate ( ""ADC"" ) therapeutics ...",PFE,0.029728,-0.006696,Neutral
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, KBAL, BGRY, TCFC - Kimball International  ( NASDAQ:KBAL ) , Berkshire Grey  ( NASDAQ:BGRY ) ",https://www.benzinga.com/pressreleases/23/04/g31623940/shareholder-investigation-halper-sadeh-llc-investigates-sgen-kbal-bgry-tcfc,2023-04-02 13:42:47,"NEW YORK, April 02, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Seagen Inc.",PFE,0.13459,0.093072,Neutral
Could This Move by Johnson & Johnson Equal Billions for Moderna?,https://www.fool.com/investing/2023/04/02/could-this-j-and-j-move-equal-billions-for-moderna/,2023-04-02 09:30:00,An RSV vaccine could be a driver of blockbuster revenue.,PFE,0.238133,0.211911,Somewhat-Bullish
3 Surprisingly Underrated Stocks to Buy in April,https://www.fool.com/investing/2023/04/01/3-surprisingly-underrated-stocks-to-buy-in-april/,2023-04-01 10:14:00,These drugmakers could deliver greater gains than many investors expect.,PFE,0.339046,0.11804,Neutral
Drug Development For Neglected Tropical Diseases Is Finally Getting A Tool That Can Get The Job Done,https://www.forbes.com/sites/johncumbers/2023/04/01/drug-development-for-neglected-tropical-diseases-is-finally-getting-a-tool-that-can-get-the-job-done/,2023-04-01 09:35:32,The neglected tropical diseases impact millions of the world's poorest each year. Now researchers in Africa can advance their drug discovery efforts through Collaborative Drug Discovery.,PFE,0.029149,0.027163,Neutral
Why Shares of Roivant Sciences Jumped This Week,https://www.fool.com/investing/2023/04/20/why-shares-of-roivant-sciences-jumped-this-week/,2023-04-20 20:29:19,The company's stock benefited from another company's buyout.,PFE,0.137671,0.051259,Neutral
'Technology and industrials could be vulnerable to a 20% to 40% correction.' Why this veteran trader likes oil and retail stocks now.,https://www.marketwatch.com/story/technology-and-industrials-could-be-vulnerable-to-a-20-to-40-correction-why-this-veteran-trader-likes-oil-and-retail-stocks-now-f83192f2,2023-04-20 20:02:00,Jeffrey Bierman expects high inflation to continue and hit the market with stiff headwinds.,PFE,0.089129,-0.033342,Neutral
Check Out What Whales Are Doing With PFE - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/04/31921984/check-out-what-whales-are-doing-with-pfe,2023-04-20 18:16:29,"A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and ...",PFE,0.866386,0.338765,Somewhat-Bullish
Moat ETFs Are Beating S&P 500: Here's Why,https://www.zacks.com/stock/news/2082362/moat-etfs-are-beating-sp-500-heres-why,2023-04-20 16:35:00,"""Moat stocks"" refer to companies that possess strong competitive advantages. The term was popularized by legendary investor Warren Buffett who said that he seeks ""economic castles protected by unbreachable moats."" ...",PFE,0.063425,0.29451,Somewhat-Bullish
Novavax Dives On Downgrade; Is It The Covid Engine That Couldn't?,https://www.investors.com/news/technology/nvax-stock-plummets-on-downgrade-is-it-the-covid-engine-that-could-not/,2023-04-20 16:33:00,Novavax Dives On Downgrade. Is It The Covid Engine That Couldn't? Investor's Business Daily ...,PFE,0.238133,0.055613,Neutral
These 2 Growth Stocks Might Be Incredibly Undervalued Right Now,https://www.fool.com/investing/2023/04/20/these-2-growth-stocks-might-be-incredibly-underval/,2023-04-20 15:45:00,These two biopharma stocks could be poised for a major growth spurt.,PFE,0.063258,0.011028,Neutral
Former Pfizer Legal Counsel Discusses Gene Therapy with CancerVAX CEO Ryan Davies,https://www.benzinga.com/pressreleases/23/04/g31918296/former-pfizer-legal-counsel-discusses-gene-therapy-with-cancervax-ceo-ryan-davies,2023-04-20 15:37:17,"LEHI, Utah, April 20, 2023 ( GLOBE NEWSWIRE ) -- CancerVAX, developer of a breakthrough universal cancer vaccine that will use the body's immune system to fight cancer, reported that the Company's CEO, Ryan Davies, recently discussed gene therapy's role in the treatment of chronic diseases with ...",PFE,0.12165,0.027361,Neutral
Big pharma's patent cliff is fast approaching,https://www.economist.com/business/2023/04/20/big-pharmas-patent-cliff-is-fast-approaching,2023-04-20 15:11:14,A flurry of deals suggests that drug firms favour buying their way out of trouble ...,PFE,0.146025,-0.027698,Neutral
Moderna Partners With IBM Hoping AI Can Help Develop More mRNA Medicine,https://www.forbes.com/sites/roberthart/2023/04/20/moderna-partners-with-ibm-hoping-ai-can-help-develop-more-mrna-medicine/,2023-04-20 14:35:50,"Moderna's CEO said the partnership will allow the company to advance and accelerate its mRNA research and help it build a ""quantum-ready workforce."" ...",PFE,0.079392,0.100664,Neutral
"Guggenheim lures Greenhill's dealmakers to expand into Europe, sources say",https://www.reuters.com/business/finance/guggenheim-lures-greenhills-dealmakers-expand-into-europe-sources-say-2023-04-20/,2023-04-20 12:59:00,Guggenheim lures Greenhill's dealmakers to expand into Europe ... ...,PFE,0.158519,0.0,Neutral
Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2081855/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,2023-04-20 12:50:06,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,PFE,0.317254,0.307696,Somewhat-Bullish
"Actinium Announces Positive Phase 3 Trial Results, NCI CRADA For AML Drug Candidates - Could They Become New Standards Of Care For This Deadly Disease? - Syndax Pharmaceuticals  ( NASDAQ:SNDX ) , Novartis  ( NYSE:NVS ) ",https://www.benzinga.com/general/biotech/23/04/31912028/actinium-announces-positive-phase-3-trial-results-nci-crada-for-aml-drug-candidates-could-they-be,2023-04-20 12:24:01,"Patients with relapsed or refractory ( r/r ) acute myeloid leukemia ( AML ) have a poor prognosis, and treatment remains challenging. It is a devastating disease that still represents a major unmet medical need, and for the majority of r/r patients, allogeneic hematopoietic stem cell ...",PFE,0.057698,0.179999,Somewhat-Bullish
WHO Hails Africa's First MRNA Vaccine Hub,https://www.barrons.com/news/who-hails-africa-s-first-mrna-vaccine-hub-8e72238b,2023-04-20 10:26:25,"Africa's first mRNA vaccine hub was ceremonially launched on Thursday to acclaim from the UN's global health chief, who hailed it as a historic shift to help poor countries gain access to life-saving jabs.",PFE,0.094762,0.17194,Somewhat-Bullish
3 Things About Pfizer That Smart Investors Know,https://www.fool.com/investing/2023/04/20/3-things-about-pfizer-that-smart-investors-know/,2023-04-20 09:30:00,"Pfizer has stood out in recent times, thanks to its coronavirus vaccine and treatment.",PFE,0.713572,-0.042409,Neutral
WHO officially launches mRNA vaccine hub in Cape Town,https://www.reuters.com/business/healthcare-pharmaceuticals/who-officially-launches-mrna-vaccine-hub-cape-town-2023-04-20/,2023-04-20 06:04:00,"CAPE TOWN, April 20 ( Reuters ) - The World Health Organization ( WHO ) on Thursday officially launched its mRNA vaccine technology hub in Cape Town, a facility established during the COVID-19 pandemic to help poorer countries struggling to access life-saving medication.",PFE,0.118064,-0.052884,Neutral
US CDC signs off on second Omicron-updated COVID booster for older adults,https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-signs-off-second-omicron-updated-covid-booster-older-adults-2023-04-19/,2023-04-19 22:16:00,US CDC signs off on second Omicron-updated COVID booster for ... ...,PFE,0.152499,0.071584,Neutral
"Twitter scraps ban against misgendering, deadnaming transgender people",https://www.foxbusiness.com/technology/twitter-scraps-ban-misgendering-deadnaming-transgender-people,2023-04-19 22:11:10,"Twitter no longer considers deadnaming or misgendering transgender people to be ""hateful conduct"" under its polices.",PFE,0.104683,-0.454525,Bearish
CDC greenlights another round of COVID booster shots,https://www.axios.com/2023/04/19/cdc-greenlights-another-round-of-covid-booster-shots,2023-04-19 19:45:45,The Centers for Disease Control and Prevention on Wednesday moved to make a second omicron booster available for adults 65 and older and immunocompromised people as soon as late this week.,PFE,0.169081,-0.134947,Neutral
Supreme Court delays ruling on abortion pill mifepristone restrictions until at least Friday,https://www.cnbc.com/2023/04/19/supreme-court-rules-on-abortion-pill-mifepristone.html,2023-04-19 19:17:15,Supreme Court Justice Samuel Alito on Wednesday issued an order allowing the abortion pill mifepristone to remain on the market without restrictions until at least Friday. Alito's decision punts a ruling by the high court on how the legal battle over mifepristone should proceed.,PFE,0.045743,0.080802,Neutral
Moderna Stock: Bear vs. Bull,https://www.fool.com/investing/2023/04/19/moderna-stock-bear-vs-bull/,2023-04-19 18:00:00,Moderna shares have delivered big for early investors.,PFE,0.058903,0.078116,Neutral
"Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales",https://www.cnbc.com/2023/04/19/abbott-labs-shares-pop-as-revenue-earnings-defy-drop-in-covid-sales.html,2023-04-19 17:57:22,Abbott Laboratories said Covid-related headwinds may actually be easing.,PFE,0.099476,0.067809,Neutral
Here's Why You Should Add Allogene  ( ALLO )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2081565/heres-why-you-should-add-allogene-allo-stock-to-your-portfolio,2023-04-19 17:53:00,"Allogene Therapeutics (ALLO), a top-ranked stock, is currently focused on developing allogenic CAR T therapies for treating cancer.",PFE,0.17715,0.211967,Somewhat-Bullish
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/earnings/23/04/31874517/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-04-19 15:59:10,"In the latest trading session, Pfizer PFE closed at $40.55, marking a -1.53% move from the previous day. This change lagged the S&P 500's 0.09% gain on the day. Meanwhile, the Dow lost 0.03%, and the Nasdaq, a tech-heavy index, lost 2.51%. Coming into today, shares of the drugmaker had gained ...",PFE,0.56415,0.175203,Somewhat-Bullish
3 Vanguard Mutual Funds to Buy in a Dull Investment Landscape,https://www.zacks.com/stock/news/2081527/3-vanguard-mutual-funds-to-buy-in-a-dull-investment-landscape,2023-04-19 15:37:00,"Amid topsy-turvy market conditions, it's prudent for investors to place their bets on low-cost Vanguard funds like VASVX, VGHCX and VWELX.",PFE,0.04406,0.043928,Neutral
"The Zacks Analyst Blog Highlights Pfizer, Accenture, Wells Fargo, Starbucks and Chubb",https://www.zacks.com/stock/news/2081371/the-zacks-analyst-blog-highlights-pfizer-accenture-wells-fargo-starbucks-and-chubb,2023-04-19 13:26:00,"Pfizer, Accenture, Wells Fargo, Starbucks and Chubb are part of the Zacks top Analyst Blog.",PFE,0.369946,0.3537,Bullish
Could This Rare-Disease Drug Candidate Become a Blockbuster?,https://www.fool.com/investing/2023/04/19/could-rare-disease-drug-candidate-be-blockbuster/,2023-04-19 13:15:00,This drug candidate could be a great treatment option for patients with a potentially deadly disease.,PFE,0.058903,0.17722,Somewhat-Bullish
"Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability",https://www.prnewswire.com/news-releases/crystal-pharmatechs-cdmo-business-unit---crystal-formulation-services-received-china-drug-product-manufacturing-license-achieving-the-important-milestone-in-formulation-capability-301801366.html,2023-04-19 13:00:00,Crystal Pharmatech's CDMO Business Unit - Crystal Formulation ... PR ...,PFE,0.068306,0.209015,Somewhat-Bullish
Here's How Much a $1000 Investment in Ligand Pharmaceuticals Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2080898/heres-how-much-a-1000-investment-in-ligand-pharmaceuticals-made-10-years-ago-would-be-worth-today,2023-04-19 12:30:04,Holding on to popular or trending stocks for the long-term can make your portfolio a winner.,PFE,0.059636,0.064017,Neutral
FDA Gives Nod for Using Bivalent Jab for All COVID Vaccinations,https://www.zacks.com/stock/news/2080973/fda-gives-nod-for-using-bivalent-jab-for-all-covid-vaccinations,2023-04-19 12:19:00,"To simplify the COVID-19 vaccination schedule for all individuals, the FDA authorizes using bivalent COVID-19 vaccines for all doses administered to individuals aged six years and older.",PFE,0.436009,-0.017301,Neutral
NRG Therapeutics Appoints Vad Lazari Ph.D. as Vice President of Biology to Advance its Mitochondrial Therapeutics for Neurodegenerative Disorders,https://www.benzinga.com/pressreleases/23/04/g31882949/nrg-therapeutics-appoints-vad-lazari-ph-d-as-vice-president-of-biology-to-advance-its-mitochondria,2023-04-19 08:00:00,"Vad Lazari Ph.D., appointed to the newly created position of VP of Biology, based in Stevenage, UK Joins from Charles River and brings two decades of drug discovery experience including at Pfizer and BioFocus DPI",PFE,0.199447,0.149606,Neutral
FDA clears extra Covid-19 booster dose for some high-risk Americans,https://www.business-standard.com/world-news/fda-clears-extra-covid-19-booster-dose-for-some-high-risk-americans-123041900017_1.html,2023-04-19 03:35:11,US regulators on Tuesday cleared another booster dose of the Pfizer or Moderna COVID-19 vaccines for older Americans and people with weak immune systems.,PFE,0.43082,0.0,Neutral
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2080717/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-04-18 21:45:20,"Pfizer (PFE) closed the most recent trading day at $40.55, moving -1.53% from the previous trading session.",PFE,0.645887,0.18777,Somewhat-Bullish
"Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat",https://www.cnbc.com/2023/04/18/jj-q1-earnings-covid-vaccine-sales-fueled-beat-but-no-sales-ahead.html,2023-04-18 20:27:39,"J&J's unpopular Covid vaccine appeared to bear its last fruit during the first quarter, contributing $747 million in sales.",PFE,0.081001,-0.11602,Neutral
Anti-abortion group asks Supreme Court to keep mifepristone restrictions,https://www.cnbc.com/2023/04/18/anti-abortion-group-supreme-court-mifepristone-restrictions.html,2023-04-18 18:02:30,Supreme Court Justice Samuel Alito on Friday temporarily blocked abortion pill restrictions until 11:59 p.m. Wednesday.,PFE,0.050465,-0.17,Somewhat-Bearish
"Finance Sector Scorecard and Analyst Reports for Pfizer, Accenture & Wells Fargo",https://www.zacks.com/research-daily/2080482/finance-sector-scorecard-and-analyst-reports-for-pfizer-accenture-wells-fargo,2023-04-18 17:09:00,"Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Accenture plc (ACN) and Wells Fargo & Company (WFC).",PFE,0.33433,0.322732,Somewhat-Bullish
Vaxcyte  ( PCVX )  Up on Pneumococcal Conjugate Vaccine Data,https://www.zacks.com/stock/news/2080633/vaxcyte-pcvx-up-on-pneumococcal-conjugate-vaccine-data,2023-04-18 16:56:00,"Vaxcyte (PCVX) announces positive results from the mid-stage study of its 24-Valent pneumococcal conjugate vaccine candidate, VAX-24, in adults aged 65 and older.",PFE,0.136113,0.080148,Neutral
FDA Expands AbbVie's  ( ABBV )  Qulipta Label in Chronic Migraine,https://www.zacks.com/stock/news/2080652/fda-expands-abbvies-abbv-qulipta-label-in-chronic-migraine,2023-04-18 16:12:00,"Following FDA's label-expansion approval, AbbVie's (ABBV) Qulipta is the first and the only oral CGRP receptor antagonist approved to prevent episodic and chronic migraines.",PFE,0.171282,0.057369,Neutral
Why Pfizer  ( PFE )  is Poised to Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2080566/why-pfizer-pfe-is-poised-to-beat-earnings-estimates-again,2023-04-18 16:10:11,Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,PFE,0.425746,0.470211,Bullish
Top Stocks To Buy Now? 3 Healthcare Stocks To Know,https://stockmarket.com/featured/top-stocks-to-buy-now-3-healthcare-stocks-to-know-2023-04-18,2023-04-18 16:04:15,"The healthcare industry, which is responsible for the development, manufacture, and distribution of medical products and services, is a critical sector of the economy. Healthcare stocks are the shares of businesses that produce pharmaceuticals, medical equipment, healthcare services, and ...",PFE,0.365166,0.206468,Somewhat-Bullish
"FDA Gives Green Signal To Second Omicron-Adapted Booster Shots For People At High Risk From Covid - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/04/31858107/fda-gives-green-signal-to-second-omicron-adapted-booster-shots-for-people-at-high-risk-from-covid,2023-04-18 15:53:06,"On Tuesday, the FDA amended the emergency use authorizations ( EUAs ) of Moderna Inc MRNA and Pfizer Inc PFE, and BioNTech SE's BNTX COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule.",PFE,0.685386,-0.081632,Neutral
FDA authorizes additional omicron Covid shots for seniors and people with weak immune systems,https://www.cnbc.com/2023/04/18/covid-seniors-immunocompromised-can-receive-additional-omicron-shots.html,2023-04-18 15:52:31,"Although the burden of the pandemic has eased substantially, the CDC says Covid continues to kill more than 1,300 people per week.",PFE,0.274834,-0.053242,Neutral
FDA approves 2nd omicron booster for high-risk people,https://www.axios.com/2023/04/18/fda-second-booster-omicron-high-risk-vaccine,2023-04-18 14:21:27,The Food and Drug Administration on Tuesday approved a second omicron booster from Moderna and Pfizer for people over the age of 65 and immunocompromised individuals.,PFE,0.216215,0.086205,Neutral
China Turns on the Charm but Economist Stephen Roach Isn't Buying It.,https://www.barrons.com/articles/china-turns-on-the-charm-but-economist-stephen-roach-isnt-buying-it-f835dc5a,2023-04-18 13:55:00,"Following his first visit to Beijing in 3½ years, Stephen Roach, the economist and former chairman of Morgan Stanley Asia, is sounding the alarm on what he considers a dangerous path for U.S.-China relations.",PFE,0.485711,-0.075185,Neutral
FDA authorizes second bivalent COVID booster for older adults,https://www.reuters.com/business/healthcare-pharmaceuticals/fda-withdraws-authorization-older-covid-vaccines-by-moderna-pfizer-2023-04-18/,2023-04-18 13:42:00,"[1/2] Syringes ready to be administrated to residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots of the coronavirus disease ( COVID-19 ) vaccines are seen in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin",PFE,0.195814,0.05455,Neutral
These 10 Crummy Stocks Already Cost Investors $300 Billion,https://www.investors.com/etfs-and-funds/sectors/sp500-these-crummy-stocks-already-cost-investors-billions/,2023-04-18 12:00:00,S&P 500: These 10 Crummy Stocks Already Cost Investors $300 ... Investor's Business Daily ...,PFE,0.255641,0.002059,Neutral
Johnson & Johnson  ( JNJ )  Q1 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2080100/johnson-johnson-jnj-q1-earnings-and-revenues-top-estimates,2023-04-18 11:45:02,"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 6.77% and 5.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.137278,0.0,Neutral
Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?,https://www.fool.com/investing/2023/04/18/modernas-flu-vaccine-struggles-is-novavax-stock-no/,2023-04-18 09:50:00,Moderna's pain translates to Novavax's gain.,PFE,0.157827,0.05547,Neutral
The Top Healthcare Stocks to Buy With $100,https://www.fool.com/investing/2023/04/18/the-top-healthcare-stocks-to-buy-with-100/,2023-04-18 09:30:00,A small investment now may bring big results over time.,PFE,0.405963,0.030781,Neutral
GSK Inks $2 Billion For Cough Medicine Biotech To Bolster Drug Pipeline,https://www.forbes.com/sites/roberthart/2023/04/18/gsk-inks-2-billion-for-cough-medicine-biotech-to-bolster-drug-pipeline/,2023-04-18 09:22:23,"GSK said Bellus' experimental cough medicine could help treat millions of people with untreatable chronic coughs and had ""significant sales potential"" if approved.",PFE,0.076847,0.017484,Neutral
3 Robinhood Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/04/18/3-robinhood-stocks-to-buy-and-hold-forever/,2023-04-18 09:19:00,There are solid reasons for the trio's popularity with retail investors.,PFE,0.211191,0.150778,Somewhat-Bullish
"With 13.87% CAGR, Atopic Dermatitis Market Size to Surpass USD 16.23 Billion by 2028 Says Brandessence Market Research",https://www.prnewswire.com/news-releases/with-13-87-cagr-atopic-dermatitis-market-size-to-surpass-usd-16-23-billion-by-2028-says-brandessence-market-research-301799955.html,2023-04-18 07:07:00,"With 13.87% CAGR, Atopic Dermatitis Market Size to Surpass USD ... PR ...",PFE,0.059268,0.115019,Neutral
"J&J's Earnings Are Tuesday. Watch for News on Spinoff, Talc Litigation.",https://www.barrons.com/articles/jnj-earnings-stock-price-a9883ad9,2023-04-17 21:00:00,Johnson & Johnson Reports Earnings Tuesday. Here's What to Watch. ...,PFE,0.699089,0.030353,Neutral
Merck's takeover of Prometheus gives it a foothold in immunology,https://www.marketwatch.com/story/mercks-10-8-billion-takeover-of-prometheus-is-a-good-strategic-move-that-gives-it-a-foothold-in-immunology-2f922a41,2023-04-17 16:19:00,Merck's acquisition of Prometheus Biosciences will help the drug company diversify and reduce the risk of overreliance on its cancer drug Keytruda.,PFE,0.118064,0.0,Neutral
"Moderna  ( MRNA ) , Merck's Cancer Jab Delays Melanoma Recurrence",https://www.zacks.com/stock/news/2079768/moderna-mrna-mercks-cancer-jab-delays-melanoma-recurrence,2023-04-17 15:29:00,Detailed data from a mid-stage study shows that Moderna (MRNA)/Merck's personalized cancer vaccine candidate reduces the risk of recurrence/death.,PFE,0.052685,0.161998,Somewhat-Bullish
Merck inks $11 billion deal to buy Prometheus Biosciences,https://www.axios.com/2023/04/17/merck-inks-11-billion-deal-to-buy-prometheus-biosciences,2023-04-17 14:22:06,"Merck has agreed to buy Prometheus Biosciences, a San Diego-based immunology biotech with an ulcerative colitis candidate, for around $10.8 billion in cash.",PFE,0.245339,0.215328,Somewhat-Bullish
Merck Snags $10.8 Billion Buyout As Keytruda Declines Loom,https://www.investors.com/news/technology/rxdx-stock-merck-nabs-deal-as-keytruda-patent-expiration-looms/,2023-04-17 14:21:00,RXDX Stock: Merck Nabs $10.8 Billion Deal As Keytruda Patent ... Investor's Business Daily ...,PFE,0.338582,0.203509,Somewhat-Bullish
CRH: 3 Quality and Inexpensive Stocks Above the 100-Day Moving Average,https://stocknews.com/news/crh-egiey-hyw-3-quality-and-inexpensive-stocks-above-the-100-day-moving-average/,2023-04-17 14:20:40,CRH: 3 Quality and Inexpensive Stocks Above the 100-Day Moving ... ...,PFE,0.051221,0.025954,Neutral
Consider This Undervalued Pharma Giant Before Its Blockbuster Deal Closes,https://www.fool.com/investing/2023/04/17/consider-undervalued-pharma-giant-before-deal/,2023-04-17 13:13:35,Wall Street isn't showing one of pharma's most prominent players any love.,PFE,0.616612,0.530741,Bullish
HLS Therapeutics Announces CEO Transition,https://www.newswire.ca/news-releases/hls-therapeutics-announces-ceo-transition-846646495.html,2023-04-17 11:00:00,"• Craig Millian to replace retiring CEO, Gilbert Godin, on May 1, 2023",PFE,0.037329,0.094634,Neutral
"Got $1,000? 3 Stocks to Buy Now While They're on Sale.",https://www.fool.com/investing/2023/04/15/got-1000-3-stocks-to-buy-now-while-theyre-on-sale/,2023-04-15 14:30:00,These names have been upended for only temporary reasons. Here's your chance to act on longer-lived tailwinds.,PFE,0.199365,-0.031837,Neutral
"1 ""Safe"" Stock to Avoid and 1 to Consider Buying in April",https://www.fool.com/investing/2023/04/15/1-safe-stock-to-avoid-and-1-to-consider-buying-in/,2023-04-15 12:56:00,There's more to the concept of safety than having a business model that looks safe.,PFE,0.05387,0.0,Neutral
Novo Nordisk Charges Higher And Could Be Just Getting Started - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/general/biotech/23/04/31806254/novo-nordisk-charges-higher-and-could-be-just-getting-started,2023-04-14 21:20:03,"Shares of Novo Nordisk A/S NVO are up over 3.6% on April 12. The immediate catalyst is the announcement of a $2.6 billion collaboration with Aspect Biosystems. But for investors who have been watching the stock, this is just the continuation of a larger trend for the Danish pharmaceutical company.",PFE,0.152983,0.305678,Somewhat-Bullish
Generative AI can deliver life-changing disease treatments,https://cointelegraph.com/news/generative-ai-can-deliver-life-changing-disease-treatments,2023-04-14 18:23:00,"Scientists are using the same AI foundations to make drug discovery faster, safer and more effective.",PFE,0.03804,-0.099297,Neutral
NOT REAL NEWS: A look at what didn't happen this week,https://apnews.com/article/fact-check-misinformation-federal-reserve-vaccines-lgbtq-5f38c57913075f0450ac9aa3dcfd8da7,2023-04-14 15:33:53,"A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts:",PFE,0.023013,-0.019973,Neutral
StockNews.com Issues Imperative Report on Heska Corporation's Healthcare Stock,https://beststocks.com/stocknews-com-issues-imperative-report-on-heska-co/,2023-04-14 15:14:47,StockNews.com Issues Imperative Report on Heska Corporation's ... Best Stocks ...,PFE,0.118647,0.132212,Neutral
"Got $1,000? 2 Stocks that Smart Investors Should Be Buying Hand Over Fist Right Now",https://www.fool.com/investing/2023/04/14/got-1000-2-stocks-smart-investors-should-be-buying/,2023-04-14 13:37:00,The fluctuating market is giving investors plenty of opportunities to buy some wonderful stocks.,PFE,0.282234,0.132964,Neutral
FDA Strikes Down Eli Lilly's Application Seeking Approval For Ulcerative Colitis Drug - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/23/04/31803789/fda-strikes-down-eli-lillys-application-seeking-approval-for-ulcerative-colitis-drug,2023-04-14 13:33:50,"The FDA has issued a complete response letter for Eli Lilly And Co's LLY mirikizumab biologic license application ( BLA ) for ulcerative colitis ( UC ) . In the letter, the FDA cited issues related to the proposed manufacturing of mirikizumab, with no concerns about the clinical data ...",PFE,0.277433,0.0,Neutral
"Pharma Stock Roundup: FDA Rejects LLY's Mirikizumab, NVO Ups 2023 Sales & Profit View",https://www.zacks.com/stock/news/2078816/pharma-stock-roundup-fda-rejects-llys-mirikizumab-nvo-ups-2023-sales-profit-view,2023-04-14 13:05:00,FDA issues CRL to Eli Lilly's (LLY) BLA seeking approval of mirikizumab for ulcerative colitis (UC). Novo Nordisk (NVO) ups sales and profit outlook for 2023.,PFE,0.045482,0.0,Neutral
How The Texas Abortion Ruling Could Destroy Biotech Stocks,https://www.investors.com/news/technology/biotech-stocks-how-the-texas-abortion-ruling-could-be-their-undoing/,2023-04-14 12:15:00,"A federal judge's decision in Texas to outlaw a decades-old abortion drug undermines the foundation of all biotech stocks, warns a group of nearly 600 health care executives and experts. Chiefs of big medical names like Pfizer ( PFE ) , Biogen ( BIIB ) and Incyte ( INCY ) are uniting to oppose ...",PFE,0.074926,0.020285,Neutral
Is It Too Late to Buy Pfizer Stock?,https://www.fool.com/investing/2023/04/14/is-it-too-late-to-buy-pfizer-stock/,2023-04-14 09:30:00,"In spite of near-term challenges, a new phase of growth may be just ahead.",PFE,0.896596,0.27475,Somewhat-Bullish
Pfizer bivalent vaccine reduces Covid-related death risk by 68 per cent in older people: Study | The Financial Express,https://www.financialexpress.com/healthcare/covid-19/pfizer-bivalent-vaccine-reduces-covid-related-death-risk-by-68-per-cent-in-older-people-study/3046912/,2023-04-14 08:18:57,Pfizer bivalent vaccine reduces Covid-related death risk by 68 per ... The Financial Express ...,PFE,0.226301,-0.173817,Somewhat-Bearish
"Vitamins Market Size to Reach $8.9 billion by 2028, Exhibiting a CAGR of 6.0%",https://www.benzinga.com/pressreleases/23/04/g31801693/vitamins-market-size-to-reach-8-9-billion-by-2028-exhibiting-a-cagr-of-6-0,2023-04-14 08:00:00,"Chicago, April 14, 2023 ( GLOBE NEWSWIRE ) -- The global vitamins market size was valued at USD 6.7 billion in 2023. The market is estimated to expand 8.9 billion in 2028, exhibiting a CAGR of 6.0% over the projected period.",PFE,0.050679,0.086405,Neutral
"Arvinas, Inc.  ( ARVN )  Surges 7.6%: Is This an Indication of Further Gains?",https://www.zacks.com/stock/news/2078653/arvinas-inc-arvn-surges-76-is-this-an-indication-of-further-gains,2023-04-14 07:32:00,"Arvinas, Inc. (ARVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",PFE,0.107495,0.009135,Neutral
Pfizer's new bivalent mRNA Covid booster vax highly effective: Lancet,https://www.business-standard.com/world-news/pfizer-s-new-bivalent-mrna-covid-booster-vax-highly-effective-lancet-123041400328_1.html,2023-04-14 07:22:43,"US pharma giant Pfizer's new bivalent mRNA-based Covid booster vaccine has shown to be highly effective in reducing hospitalisation and deaths, particularly in vulnerable patients aged 65 years and above, according to a study published in The Lancet Infectious Diseases.",PFE,0.08183,-0.096875,Neutral
NFL's Aaron Rodgers' Hail Mary For 2024 Presidential Election: Fellow Anti-Vaxxer Robert Kennedy Jr.,https://www.benzinga.com/markets/cryptocurrency/23/04/31798585/nfls-aaron-rodgers-hail-mary-for-2024-presidential-election-fellow-anti-vaxxer-robert-kenn,2023-04-13 23:01:49,A leading National Football League player has shown early support for a presidential candidate ahead of the 2024 election. Here's who quarterback Aaron Rodgers is supporting and how one important platform plays into the potential support.,PFE,0.053629,-0.094716,Neutral
"Blocking FDA approval of abortion pill could stifle innovation in the biopharma industry, experts say",https://www.cnbc.com/2023/04/13/abortion-pill-blocking-fda-approval-could-harm-biopharma-innovation.html,2023-04-13 19:37:18,"A complicated legal fight over abortion pill mifepristone could reduce innovation in the biopharma industry, companies and experts in law and economics said.",PFE,0.08197,0.113326,Neutral
Pfizer Invites Shareholders to Attend Virtual-Only 2023 Annual Meeting of Shareholders on April 27,https://investingnews.com/pfizer-invites-shareholders-to-attend-virtual-only-2023-annual-meeting-of-shareholders-on-april-27/,2023-04-13 14:58:52,"Pfizer Inc. ( NYSE: PFE ) announced today that its shareholders and the general public are invited to access its virtual-only 2023 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 27, 2023.",PFE,0.430251,0.451433,Bullish
PFE: 2 of the Best Biotech Stocks to Buy This Month,https://stocknews.com/news/pfe-azn-2-of-the-best-biotech-stocks-to-buy-this-month/,2023-04-13 13:32:24,"Despite market volatility, the biotech sector has performed relatively well as a result of breakthrough achievements, advancements in biopharma, and inelastic demand for healthcare products and services.",PFE,0.423606,0.130873,Neutral
Pfizer Inc.  ( PFE )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2078094/pfizer-inc-pfe-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-04-13 13:00:12,"Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",PFE,0.53074,0.160513,Somewhat-Bullish
Pfizer signs strategic cooperation pact with China's Sinopharm,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-signs-strategic-cooperation-pact-with-chinas-sinopharm-2023-04-13/,2023-04-13 12:51:00,Pfizer signs strategic cooperation pact with China's ...,PFE,0.742397,0.451092,Bullish
Ozempic and other new weight-loss drugs could save lives. Too bad millions of Americans are being denied access to them.,https://www.businessinsider.com/ozempic-wegovy-weight-loss-drugs-doctors-patients-broken-healthcare-system-2023-4,2023-04-13 10:02:00,"People Can't Get Ozempic, New Weight-Loss Drugs Because of ... - Business Insider ...",PFE,0.01769,0.08488,Neutral
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?,https://www.fool.com/investing/2023/04/13/can-pfizer-beat-gsk-and-moderna-in-this-10-billion/,2023-04-13 09:52:00,There's such a big need in preventing RSV that multiple companies should be big winners.,PFE,0.585975,-0.003544,Neutral
"The Glioblastoma Multiforme  ( GBM )  Treatment Market Overview: Market Size, Expected CAGR, Growth Driver And Major Players",https://www.prnewswire.com/news-releases/the-glioblastoma-multiforme-gbm-treatment-market-overview-market-size-expected-cagr-growth-driver-and-major-players-301796434.html,2023-04-13 09:31:00,The Glioblastoma Multiforme ( GBM ) Treatment Market Overview ... PR ...,PFE,0.056275,-0.067905,Neutral
"No, farmers aren't required to vaccinate livestock with mRNA vaccines",https://apnews.com/article/fact-check-mrna-vaccine-livestock-mandate-covid-564035224253,2023-04-12 21:53:16,"CLAIM: Farmers and ranchers are required to inject livestock with mRNA vaccines. AP'S ASSESSMENT: False. There is no mandate in the U.S. that livestock receive certain vaccines and there are no COVID-19 mRNA vaccines licensed for animals, as some online have suggested.",PFE,0.055881,0.047019,Neutral
"US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma - Arbutus Biopharma  ( NASDAQ:ABUS ) , Moderna  ( NASDAQ:MRNA ) ",https://www.benzinga.com/general/biotech/23/04/31769282/us-court-favors-moderna-in-covid-19-vaccine-patent-infringement-case-with-arbutus-biopharma,2023-04-12 14:37:01,A U.S. appeals court affirmed a decision to cancel an Arbutus Biopharma Corporation ABUS patent related to a legal fight over Moderna Inc's MRNA COVID-19 vaccines. The U.S. Court of Appeals for the Federal Circuit upheld a U.S.,PFE,0.338582,-0.528077,Bearish
2 Unstoppable Growth Stocks to Buy While Share Prices Are Low,https://www.fool.com/investing/2023/04/12/2-unstoppable-growth-stocks-to-buy-share-prices/,2023-04-12 10:07:00,These could be ideal stocks to load up on for the long haul.,PFE,0.344987,0.08692,Neutral
Fidelity eyes array of product launches in China after equity debut this quarter,https://www.scmp.com/business/banking-finance/article/3216464/fidelity-plans-china-fixed-income-product-launch-after-targeting-market-debut-equity-fund-float,2023-04-12 00:30:19,Fidelity believes the time is ripe to launch fund products in China as Beijing's market friendly policies and the country's positive economic outlook improve investment environment.,PFE,0.054483,0.004998,Neutral
Pfizer  ( PFE )  Stock Moves 0.14%: What You Should Know,https://www.zacks.com/stock/news/2077160/pfizer-pfe-stock-moves-014-what-you-should-know,2023-04-11 21:45:23,"Pfizer (PFE) closed the most recent trading day at $41.79, moving +0.14% from the previous trading session.",PFE,0.6809,0.23538,Somewhat-Bullish
Anti-Vaccine Groups See Hope in Abortion-Pill Ruling. What It Means for Pharma.,https://www.barrons.com/articles/abortion-pill-ruling-fda-effects-pharma-5036f02e,2023-04-11 19:51:00,Antivaccine advocates say a federal judge's injunction reversing the Food and Drug Administration's approval of the abortion pill mifepristone is a good sign for their own legal efforts. Their response is just one indication of how judges being able to roll back drug approvals could radically ...,PFE,0.146618,0.132548,Neutral
"Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: ""Devastating Risks"" Ahead - VanEck Biotech ETF  ( NASDAQ:BBH ) , Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/general/biotech/23/04/31752497/attorney-generals-of-over-20-states-sound-alarm-over-suspension-of-abortion-med-approval-devastat,2023-04-11 18:28:28,"In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone ""presents devastating risks to millions of people,"" including those in states where abortion remains legal.",PFE,0.136888,0.177593,Somewhat-Bullish
"AstraZeneca  ( AZN ) , Sanofi Simply RSV Antibody Agreement Terms",https://www.zacks.com/stock/news/2077127/astrazeneca-azn-sanofi-simply-rsv-antibody-agreement-terms,2023-04-11 17:13:00,AstraZeneca (AZN) and Sanofi (SNY) revise the contractual terms of the agreement for Beyfortus. Sanofi will have full commercial control of Beyfortus in the United States.,PFE,0.233556,0.174348,Somewhat-Bullish
Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-fends-off-arbutus-appeal-covid-19-vaccine-patent-fight-2023-04-11/,2023-04-11 17:01:44,"April 11 ( Reuters ) - A U.S. appeals court handed Moderna Inc ( MRNA.O ) a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp ( ABUS.O ) patent related to the companies' legal fight over Moderna's blockbuster COVID-19 vaccines. The U.S.",PFE,0.138464,-0.313697,Somewhat-Bearish
States where abortion is legal warn appeals court about Texas mifepristone ruling,https://www.cnbc.com/2023/04/11/abortion-texas-mifepristone-ruling-order-threatens-access.html,2023-04-11 16:36:05,A Texas federal judges says the FDA's approval of the abortion pill mifepristone is invalid. A group of states asked an appeals court to block his ruling.,PFE,0.055492,0.293,Somewhat-Bullish
Celebrating Canada's Global Leadership in Access to Biosimilars,https://www.newswire.ca/news-releases/celebrating-canada-s-global-leadership-in-access-to-biosimilars-882616997.html,2023-04-11 16:23:00,"TORONTO, April 11, 2023 /CNW/ - With Ontario, Newfoundland & Labrador and the Yukon each implementing new policies over the past few days, nearly 96% of Canadians now live in jurisdictions with expanded access to biosimilars.",PFE,0.126784,0.175953,Somewhat-Bullish
"Top Stories Tuesday, Apr. 11: Twitter Inc Is Officially Defunct, Alibaba Plans to Integrate ChatGPT Like Chatbot Across Products - Alibaba Group Holding  ( NYSE:BABA ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/general/biotech/23/04/31742441/twitter-inc-is-officially-defunct-alibaba-plans-to-integrate-chatgpt-like-chatbot-across-products,2023-04-11 13:16:37,"Twitter Inc, the parent company of the namesake social media platform, has ceased to exist, and it has now been merged into X Corp., court filings show. 'Chief Twit' Elon Musk also appeared to acknowledge the change early on Tuesday by tweeting out ""X.""",PFE,0.076358,0.068808,Neutral
"Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension - Ovid Therapeutics  ( NASDAQ:OVID ) , Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/general/biotech/23/04/31739346/drugmakers-stand-up-for-reproductive-rights-pfizer-and-biogen-among-300-condemning-abortion-pill-,2023-04-11 11:48:20,"Last week Friday, a U.S. judge suspended the FDA's approval of mifepristone, effectively banning sales. Executives from over 300 companies, including Pfizer Inc PFE and Biogen Inc BIIB, signed an open letter calling to reverse a federal judge's decision. The abortion pill has been available since ...",PFE,0.362505,0.101557,Neutral
2 Forever Stocks to Buy No Matter What the Market Is Doing,https://www.fool.com/investing/2023/04/11/2-forever-stocks-to-buy-no-matter-what-the-market/,2023-04-11 09:30:00,These two top stocks are trading at very reasonable prices right now.,PFE,0.470174,0.006167,Neutral
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Index™",https://www.globenewswire.com/news-release/2023/04/11/2644010/0/en/Hywin-Holdings-Leonteq-AG-and-ARTA-TechFin-jointly-launch-principal-protected-note-linked-to-FactSet-Hywin-Global-Health-Care-Index.html,2023-04-11 00:00:00,"HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) ( NASDAQ: HYW ) , a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured ...",PFE,0.036869,0.079891,Neutral
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Index™ - Hywin Holdings  ( NASDAQ:HYW ) ",https://www.benzinga.com/pressreleases/23/04/g31736283/hywin-holdings-leonteq-ag-and-arta-techfin-jointly-launch-principal-protected-note-linked-to-facts,2023-04-11 00:00:00,"HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) HYW, a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured investment solutions, ...",PFE,0.036091,0.079702,Neutral
"First Republic fate, Apple earnings, jobs data and Fed decision top week ahead",https://www.foxbusiness.com/markets/first-republic-fate-apple-earnings-jobs-data-fed-decision-top-week-ahead,2023-04-30 17:26:13,"It's another busy week for investors with a plethora of blue chip and entertainment earnings on tap, as well as the Federal Reserve's decision on rates and the future of First Republic Bank.",PFE,0.052112,0.0,Neutral
Wall Street wants clarity from Fed meeting and jobs data | Business,https://www.cnn.com/2023/04/30/business/stocks-week-ahead/index.html,2023-04-30 11:57:00,Wall Street wants clarity from Fed meeting and jobs data ...,PFE,0.092927,0.0,Neutral
5 Women-Led Businesses Absolutely Crushing the Stock Market Right Now,https://www.fool.com/retirement/2023/04/30/5-women-led-businesses-absolutely-crushing-the-sto/,2023-04-30 09:09:00,"The number of businesses led by women is growing every year. And as the results show, investors should embrace -- and invest in -- women-led companies.",PFE,0.078226,0.056712,Neutral
"Pfizer, BioNTech propose EU pays half for each cancelled COVID dose - FT",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-biontech-propose-eu-pays-half-each-cancelled-covid-dose-ft-2023-04-30/,2023-04-30 07:43:00,"Pfizer, BioNTech propose EU pays half for each cancelled COVID ... ...",PFE,0.456884,0.090319,Neutral
XTANDI® plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide,https://investingnews.com/xtandi-r-plus-leuprolide-reduced-the-risk-of-metastasis-by-58-in-non-metastatic-hormone-sensitive-prostate-cancer-versus-placebo-plus-leuprolide/,2023-04-29 15:22:02,"Data from Phase 3 EMBARK trial to be presented as a plenary session during the 2023 American Urological Association Annual Meeting Results show the potential for XTANDI to add to the standard of care in prostate cancer, if approved",PFE,0.127591,-0.016922,Neutral
XTANDI®  ( enzalutamide )  plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide,https://www.prnewswire.com/news-releases/xtandi-enzalutamide-plus-leuprolide-reduced-the-risk-of-metastasis-by-58-in-non-metastatic-hormone-sensitive-prostate-cancer-versus-placebo-plus-leuprolide-301811445.html,2023-04-29 14:45:00,XTANDI® ( enzalutamide ) plus Leuprolide Reduced the Risk of ... PR ...,PFE,0.086378,-0.027265,Neutral
3 Biotech Buyout Targets to Watch,https://www.fool.com/investing/2023/04/29/3-biotech-buyout-targets-to-watch/,2023-04-29 12:25:00,The trio all have late-stage therapies with blockbuster potential.,PFE,0.045918,0.0,Neutral
3 Unstoppable Stocks to Buy Right Now,https://moneymorning.com/investing/3-unstoppable-stocks-to-buy-right-now/,2023-04-29 10:14:00,"The laws of physics apply in some ways to investing. For example, some stocks have inertia -- they just can't break out of their rut. Others, though, either have momentum or the likelihood of gaining it in the future. Those are the kinds of stocks that are hard to keep down.",PFE,0.384102,-0.05374,Neutral
3 Unstoppable Stocks to Buy Right Now,https://www.fool.com/investing/2023/04/29/3-unstoppable-stocks-to-buy-right-now/,2023-04-29 10:14:00,Don't let the temporary headwinds for two of these stocks fool you.,PFE,0.29234,-0.00217,Neutral
"The class of 2023 wants jobs that match their personal values and interests, even if it means less money",https://www.businessinsider.com/gen-z-employment-job-trends-college-grads-pay-values-interests-2023-4,2023-04-29 10:00:00,"Class of 2023 Employment Trends: Values, Interests More Important ... - Business Insider ...",PFE,0.034984,0.126208,Neutral
Worried About a Recession? 2 Resilient Stocks to Buy Now,https://moneymorning.com/investing/worried-about-a-recession-2-resilient-stocks-to-buy-now/,2023-04-29 09:30:00,"High inflation and general economic woes may have been preoccupying you for a while -- and now, fears of a recession look even more likely to become a reality. The Federal Reserve recently predicted that the United States is heading for a mild one later this year.",PFE,0.454174,0.428188,Bullish
Worried About a Recession? 2 Resilient Stocks to Buy Now,https://www.fool.com/investing/2023/04/29/worried-about-recession-2-resilient-stocks-to-buy/,2023-04-29 09:30:00,The healthcare industry is a great place to find stocks that can perform well under any economic conditions.,PFE,0.383905,0.386823,Bullish
"Sports Medicine Devices Market to Witness 5.6% CAGR during 2021 - 2028, Reaching USD 13.85 Bn: TMR Study",https://www.benzinga.com/pressreleases/23/04/g32092403/sports-medicine-devices-market-to-witness-5-6-cagr-during-2021-2028-reaching-usd-13-85-bn-tmr-stud,2023-04-28 19:30:00,"Wilmington, Delaware, United States, April 29, 2023 ( GLOBE NEWSWIRE ) -- Increase in preference for minimally invasive surgeries and surge in adoption of arthroscopic surgery for the treatment of common sports injuries are propelling market growth.",PFE,0.038592,0.071758,Neutral
The DeSci Movement: Will Crypto Really Solve Science's Biggest Problems?,https://www.forbes.com/sites/johncumbers/2023/04/28/the-desci-movement-will-crypto-really-solve-sciences-biggest-problems/,2023-04-28 18:50:44,"The DeSci movement is about giving ""scientists more freedom to express their visions for the future and the ability to tackle them."" Check out my new Forbes article that looks at the current DeSci landscape.",PFE,0.076602,0.093061,Neutral
"Stock Charts Strategy May 1-5: Fed Policy, April Payrolls, Apple Earnings",https://www.investors.com/all-categories/stock-charts-action-plan-may-1-5-fed-policy-april-payrolls-apple-earnings/,2023-04-28 17:12:00,"Stock Charts Strategy May 1-5: Fed Policy, April Payrolls, Apple ... Investor's Business Daily ...",PFE,0.047371,-0.073673,Neutral
"Pharma Stock Roundup: MRK & Others Post Q1 Results, LLY Drug Shines in Obesity Study",https://www.zacks.com/stock/news/2087081/pharma-stock-roundup-mrk-others-post-q1-results-lly-drug-shines-in-obesity-study,2023-04-28 16:47:00,"Merck (MRK), Eli Lilly (LLY), AstraZeneca (AZN) and others report first-quarter results. J&J (JNJ) provides an update on the IPO of its Consumer Health segment, Kenvue.",PFE,0.070414,-0.070296,Neutral
Remember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction Bid - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/04/32086821/remember-lucira-healths-30-minute-home-test-kit-pfizer-just-bought-the-bankrupt-company-via-winni,2023-04-28 16:27:48,"Lucira Health Inc LHDXQ has been acquired by Pfizer Inc PFE for $36.4 million through a bankruptcy auction. According to the SEC document, the asset sale closed on April 20.",PFE,0.576289,0.267652,Somewhat-Bullish
Seagen's  ( SGEN )  Q1 Earnings and Revenues Miss Expectations,https://www.zacks.com/stock/news/2086948/seagens-sgen-q1-earnings-and-revenues-miss-expectations,2023-04-28 14:18:00,"Seagen (SGEN) reports worse-than-expected results in the first quarter of 2023, missing both earnings and sales estimates.",PFE,0.210274,0.174353,Somewhat-Bullish
"Top Stories Friday, Apr. 28: Microsoft Strikes Nware Deal to Woo European Officials Over Activision Acquisition, Lyft Lay-offs Over 1K Employees, Big Oil Earnings - Alibaba Group Holding  ( NYSE:BABA ) , Activision Blizzard  ( NASDAQ:ATVI ) ",https://www.benzinga.com/news/earnings/23/04/32084110/microsoft-strikes-nware-deal-to-woo-european-officials-over-activision-acquisition-lyft-lay-offs-ov,2023-04-28 14:06:25,"Microsoft Corp MSFT President Brad Smith tweeted that European cloud gaming platform Nware inked a 10-year agreement to stream PC games built by Xbox on Nware's platform. After the acquisition closes, the deal also includes rights to stream Activision Blizzard, Inc's ATVI titles on Nware's ...",PFE,0.089797,0.260326,Somewhat-Bullish
19 recent scientific breakthroughs,https://theweek.com/health-and-science/1019386/recent-scientific-breakthroughs,2023-04-28 13:18:53,Scientific discoveries: Recent breakthroughs that could change the world The Week ...,PFE,0.012952,-0.019339,Neutral
Equitable Vaccine Distribution: Pfizer's RSV Vaccine Might Face Some Delivery Challenges for Low Income Countries - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/04/32081495/equitable-vaccine-distribution-pfizers-rsv-vaccine-might-face-some-delivery-challenges-for-low-in,2023-04-28 13:04:28,"Pfizer Inc PFE committed to better equitable access after being criticized for prioritizing wealthy nations for the COVID-19 vaccine early in the pandemic. The company, in a Reuters report, said it wants to shorten a timeline in which poorer countries often get vaccines many years after they are ...",PFE,0.379051,0.277481,Somewhat-Bullish
Government Drug Price Curbs Could Sound A Death Knell For Industry,https://www.investors.com/news/technology/biotech-stocks-brace-for-the-worst-as-government-drug-price-negotiations-loom/,2023-04-28 12:00:00,Biotech Stocks Brace For The Worst As Government Drug Price ... Investor's Business Daily ...,PFE,0.08123,-0.011317,Neutral
Pfizer pledge for more equal access to RSV shot faces hurdles,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-pledge-more-equal-access-rsv-shot-faces-hurdles-2023-04-28/,2023-04-28 10:04:00,"[1/2] Vials with a sticker reading, ""COVID-19 / Coronavirus vaccine / Injection only"" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/File Photo",PFE,0.28987,0.121653,Neutral
3 High-Growth Stocks That Could Be Worth $1 Trillion in 10 Years -- or Sooner,https://www.fool.com/investing/2023/04/28/3-high-growth-stocks-that-could-be-worth-1-trillio/,2023-04-28 09:24:00,It may not be all that unlikely to see $1 trillion valuations for these three businesses within the next 10 years.,PFE,0.040212,0.294186,Somewhat-Bullish
5 Brand-Name Safe Stocks I Wouldn't Touch With a 10-Foot Pole Right Now,https://moneymorning.com/investing/5-brand-name-safe-stocks-i-wouldnt-touch-with-a-10-foot-pole-right-now/,2023-04-28 09:21:00,"There's no two ways about it, the last 16 months have been challenging for investors. All three major U.S. stock indexes entered a bear market in 2022, with growth stocks getting hit especially hard. But the volatility equities experienced last year may be about to ramp up once again.",PFE,0.083735,-0.067109,Neutral
5 Brand-Name Safe Stocks I Wouldn't Touch With a 10-Foot Pole Right Now,https://www.fool.com/investing/2023/04/28/5-safe-stocks-i-wouldnt-touch-with-a-10-foot-pole/,2023-04-28 09:21:00,"These well-known, time-tested businesses are exceptionally pricey given the current economic outlook.",PFE,0.061315,0.176076,Somewhat-Bullish
US FDA approves Pfizer's next-generation pneumococcal vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-next-generation-pneumococcal-vaccine-2023-04-28/,2023-04-28 08:03:45,"April 28 ( Reuters ) - The U.S. Food and Drug Administration ( FDA ) has approved Pfizer Inc's ( PFE.N ) next-generation vaccine to prevent pneumococcal disease in children aged six weeks to 17 years, the company said late on Thursday.",PFE,0.207571,0.163751,Somewhat-Bullish
Moderna tries to show it's not a 'one trick pony',https://www.ft.com/content/5fc71e17-541c-4fe8-a2cb-ae7d17917366,2023-04-28 04:00:02,Covid vaccine maker is sitting on $18bn and embarking on a host of ambitious projects ...,PFE,0.0699,0.032155,Neutral
"U.S. FDA Approves PREVNAR 20®, Pfizer's 20-valent Pneumococcal Conjugate Vaccine for Infants and Children",https://investingnews.com/u-s-fda-approves-prevnar-20-r-pfizer-s-20-valent-pneumococcal-conjugate-vaccine-for-infants-and-children/,2023-04-27 20:23:28,Pfizer Inc. ( NYSE: PFE ) announced today that the U.S.,PFE,0.291707,0.310107,Somewhat-Bullish
Pharmaceutical Company Sets Gold Standard for New Drugs,https://www.investorideas.com/news/2023/biotech/04271Pharmaceutical-Drug-Standard.asp,2023-04-27 19:20:04,"April 27, 2023 ( Investorideas.com Newswire ) Algernon Pharmaceuticals Inc. has received a U.S. patent for a ground-breaking new Non-Alcoholic Steatohepatitis ( NASH ) drug under investigation, and is developing another for refractory chronic cough ( RCC ) .",PFE,0.026098,0.077548,Neutral
"AbbVie  ( ABBV )  Q1 Earnings Beat, Skyrizi Sales Underperform",https://www.zacks.com/stock/news/2086355/abbvie-abbv-q1-earnings-beat-skyrizi-sales-underperform,2023-04-27 16:33:00,"AbbVie's (ABBV) first-quarter 2023 earnings and sales beat estimates. However, share price dives as some key drugs miss sales estimates.",PFE,0.042421,0.055312,Neutral
"Bristol-Myers  ( BMY )  Q1 Earnings Beat, Revlimid Generics Hurt Sales",https://www.zacks.com/stock/news/2086348/bristol-myers-bmy-q1-earnings-beat-revlimid-generics-hurt-sales,2023-04-27 16:16:00,"Bristol-Myers' (BMY) first-quarter 2023 earnings top estimates, while sales missed the same and declined year over year due to generic erosion for the oncology drug Revlimid.",PFE,0.138997,0.182134,Somewhat-Bullish
Merck Makes a Bold Move That Could Transform Its Business,https://www.fool.com/investing/2023/04/27/merck-makes-a-bold-move-that-could-transform-its/,2023-04-27 13:15:00,"It's a risky deal for Merck, but it could pay off significantly.",PFE,0.061949,-0.07516,Neutral
Merck Makes a Bold Move That Could Transform Its Business,https://moneymorning.com/investing/merck-makes-a-bold-move-that-could-transform-its-business/,2023-04-27 13:15:00,"There's nothing quite like a big acquisition to turn a business around. Consider how CVS Health acquired health insurer Aetna to broaden its operations. AbbVie acquired Botox-maker Allergan, which also helped diversify its business. and most recently, Pfizer announced plans to buy cancer company ...",PFE,0.106541,-0.225007,Somewhat-Bearish
This 'No-Brainer' Way Of Making Money On Stocks Stopped Working,https://www.investors.com/etfs-and-funds/etfs/sp500-no-brainer-way-of-making-money-on-stocks-stopped-working/,2023-04-27 12:00:00,Dividends used to calm the nerves of investors rattled by the S&P 500. But dividend ETFs aren't working anymore.,PFE,0.121343,0.338127,Somewhat-Bullish
Merck  ( MRK )  Surpasses Q1 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2085673/merck-mrk-surpasses-q1-earnings-and-revenue-estimates,2023-04-27 11:45:10,"Merck (MRK) delivered earnings and revenue surprises of 4.48% and 4.65%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.140076,0.0,Neutral
AstraZeneca increases bets on China as COVID vaccine sales fade,https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-increases-bets-china-covid-vaccine-sales-fade-2023-04-27/,2023-04-27 11:44:00,"LONDON, April 27 ( Reuters ) - AstraZeneca plans to spend about $450 million building a factory in China making inhalers to treat ""smoker's lung"", doubling down on the world's No.2 pharmaceuticals market as the drugmaker predicts only ""minimal"" sales of its COVID vaccine this year.",PFE,0.076847,-0.034795,Neutral
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment,https://www.cnbc.com/2023/04/27/merck-mrk-q1-earnings-report-2023.html,2023-04-27 10:33:20,"Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for Q1 2023 beat Wall Street's expectations.",PFE,0.076358,0.095058,Neutral
EU Watchdog Backs GSK's RSV Vaccine For Over 60s,https://www.barrons.com/news/eu-watchdog-backs-gsk-s-rsv-vaccine-for-over-60s-d0d15147,2023-04-27 10:11:08,EU Watchdog Backs GSK's RSV Vaccine For Over ...,PFE,0.231332,-0.103915,Neutral
Better Buy: Pfizer vs. Gilead,https://moneymorning.com/investing/better-buy-pfizer-vs-gilead/,2023-04-27 09:30:00,"You may not immediately think of growth when you think of big-pharma companies. Smaller biotech players often steal the show when they introduce a first product or report positive clinical-trial news. But bigger, more established companies actually can bring you a fair share of growth -- and ...",PFE,0.582526,0.256661,Somewhat-Bullish
Better Buy: Pfizer vs. Gilead,https://www.fool.com/investing/2023/04/27/better-buy-pfizer-vs-gilead/,2023-04-27 09:30:00,Pfizer and Gilead look cheap right now.,PFE,0.565145,0.26186,Somewhat-Bullish
Lawyer Up: Class-Action Suits Are Thriving in New York,https://www.nytimes.com/2023/04/27/nyregion/class-action-lawsuits-nyc.html,2023-04-27 09:00:23,New York State Bill Could Give Class-Action Lawsuits a Boost The New York Times ...,PFE,0.033894,-0.015714,Neutral
AstraZeneca beats estimates on strong emerging market sales as COVID wanes,https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-first-quarter-profit-revenue-beat-expectations-2023-04-27/,2023-04-27 07:59:00,AstraZeneca beats estimates on strong emerging market sales as ... ...,PFE,0.095899,0.0,Neutral
Virios Therapeutics Up 75% On Fibromyalgia Phase 3 Proposal - Virios Therapeutics  ( NASDAQ:VIRI ) ,https://www.benzinga.com/general/biotech/23/04/32015096/virios-therapeutics-up-75-on-fibromyalgia-phase-3-proposal,2023-04-26 21:45:04,Virios Therapeutics Inc. VIRI is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromyalgia and other abnormal immune response-triggered maladies. The company went public in December 2020.,PFE,0.099271,0.025896,Neutral
Pfizer Declares Second-Quarter 2023 Dividend - Investing News Network,https://investingnews.com/pfizer-declares-second-quarter-2023-dividend/,2023-04-26 20:53:27,Pfizer Declares Second-Quarter 2023 Dividend Investing News Network ...,PFE,0.911269,0.648539,Bullish
Better Buy: Pfizer vs. Moderna,https://moneymorning.com/investing/better-buy-pfizer-vs-moderna/,2023-04-26 18:10:50,"Pfizer ( NYSE: PFE ) and Moderna ( NASDAQ: MRNA ) have one big thing in common. Both companies have dominated the coronavirus vaccine market -- and aim to continue generating blockbuster revenue from their vaccines in a post-pandemic world. Besides that program, though, the companies are very ...",PFE,0.63188,0.101877,Neutral
Better Buy: Pfizer vs. Moderna,https://www.fool.com/investing/2023/04/26/better-buy-pfizer-vs-moderna/,2023-04-26 18:00:00,Pfizer and Moderna each have lost more than 20% since the start of the year.,PFE,0.591019,0.238029,Somewhat-Bullish
GSK's RSV vaccine first to get EU regulator's nod,https://www.reuters.com/business/healthcare-pharmaceuticals/gsks-rsv-vaccine-first-get-eu-regulators-nod-2023-04-26/,2023-04-26 17:36:00,"April 26 ( Reuters ) - The European Medicines Agency ( EMA ) on Wednesday recommended authorization of GSK's ( GSK.L ) Arexvy vaccine for respiratory syncytial virus ( RSV ) in adults aged 60 and older, putting Europe on track to approve the world's first such vaccine.",PFE,0.205807,0.278391,Somewhat-Bullish
"May Outlook: Tone Could Be Set In First Week As Apple Reports, Fed Meets, And Jobs Report Looms",https://www.benzinga.com/markets/23/04/32016824/may-outlook-tone-could-be-set-in-first-week-as-apple-reports-fed-meets-and-jobs-report-looms,2023-04-26 17:12:45,"One phrase you're likely to hear this time of year is, ""Sell in May and go away."" If you paid no heed the last few years, you're probably better off. Why? Because today's market doesn't care about old myths. The S&P 500® index ( SPX ) rose 4.5% in May 2020, 0.5% in May 2021, and was flat in May ...",PFE,0.045396,-0.045075,Neutral
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/04/32016600/this-is-what-whales-are-betting-on-pfizer,2023-04-26 17:01:17,"Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.811755,0.108063,Neutral
"Microsoft's Strong Quarter Lifts Tech, But Banking Worries Keep Market Mainly On Defensive - Alphabet  ( NASDAQ:GOOGL ) , Chipotle Mexican Grill  ( NYSE:CMG ) ",https://www.benzinga.com/markets/23/04/32014643/microsofts-strong-quarter-lifts-tech-but-banking-worries-keep-market-mainly-on-defensive,2023-04-26 15:42:38,"( Wednesday market open ) When it's earnings season, the trading day seldom ends with the closing bell. If you shut down your screens at 4 p.m. ET yesterday, you might have felt gloomy after the S&P 500® index ( SPX ) posted its lowest close since March 30.",PFE,0.03777,0.0,Neutral
3 Biotechs That Might Get Bought Out in 2023,https://www.fool.com/investing/2023/04/26/3-biotechs-that-might-get-bought-out-in-2023/,2023-04-26 15:30:00,Biotech is expected to be a hotbed of mergers and acquisitions this year.,PFE,0.069495,-0.129582,Neutral
"Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from azenosertib at the 2023 ASCO Annual Meeting - Zentalis Pharma  ( NASDAQ:ZNTL ) ",https://www.benzinga.com/pressreleases/23/04/g32011594/zentalis-to-present-positive-clinical-data-in-ovarian-cancer-combining-azenosertib-and-chemotherap,2023-04-26 14:00:11,Builds on recent preclinical data presented at AACR supporting the use of CCNE1 amplification and / or Cyclin E1 expression as a potential marker for the enrichment of patient populations for treatment with azenosertib,PFE,0.024102,-0.018496,Neutral
"Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from azenosertib at the 2023 ASCO Annual Meeting",https://www.globenewswire.com/news-release/2023/04/26/2655296/0/en/Zentalis-to-present-positive-clinical-data-in-ovarian-cancer-combining-azenosertib-and-chemotherapy-including-clinical-support-for-Cyclin-E1-expression-as-predictive-marker-for-cli.html,2023-04-26 14:00:00,Builds on recent preclinical data presented at AACR supporting the use of CCNE1 amplification and / or Cyclin E1 expression as a potential marker for the enrichment of patient populations for treatment with ...,PFE,0.024421,-0.0195,Neutral
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2084822/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2023-04-26 13:00:13,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.528798,0.141451,Neutral
Precision Medicine Group Welcomes New General Counsel and Chief Compliance Officer and Chief People Officer,https://www.prnewswire.com/news-releases/precision-medicine-group-welcomes-new-general-counsel-and-chief-compliance-officer-and-chief-people-officer-301807519.html,2023-04-26 12:00:00,Precision Medicine Group Welcomes New General Counsel and ... PR ...,PFE,0.052801,-0.016965,Neutral
Medicare is prohibited from covering weight-loss drugs - Ozempic could change that,https://africa.businessinsider.com/news/medicare-is-prohibited-from-covering-weight-loss-drugs-ozempic-could-change-that/3sfqhql,2023-04-26 06:46:44,Medicare is prohibited from covering weight-loss drugs - Ozempic ... - Business Insider Africa ...,PFE,0.090816,-0.105933,Neutral
Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit,https://www.prnewswire.com/news-releases/bridgewest-perth-pharma-to-commercialize-sterile-injectable-drugs-under-lumacina-business-unit-301806221.html,2023-04-26 00:41:00,Bridgewest Perth Pharma to commercialize Sterile Injectable drugs ... PR ...,PFE,0.318074,0.315185,Somewhat-Bullish
The Fed Predicts a Recession: Should You Still Buy Stocks Now?,https://www.fool.com/investing/2023/04/25/the-fed-predicts-recession-should-you-invest/,2023-04-25 18:00:00,"The Fed expects a ""mild"" downturn.",PFE,0.12165,0.033083,Neutral
"Risk-Off Rerun: Banking Concerns, Nerves Ahead of Microsoft, Alphabet Earnings Bring Pressure - First Republic Bank  ( NYSE:FRC ) , General Electric  ( NYSE:GE ) ",https://www.benzinga.com/markets/23/04/31993957/risk-off-rerun-banking-concerns-nerves-ahead-of-microsoft-alphabet-earnings-bring-pressure,2023-04-25 16:25:43,( Tuesday market open ) The rubber hits the road for info tech earnings starting later today when Microsoft MSFT and Alphabet GOOGL open their quarterly books.,PFE,0.037416,0.0,Neutral
"Moore Kuehn Encourages SGEN, TA, MNTV, and UNVR Investors to Contact Law Firm - Momentive Glb  ( NASDAQ:MNTV ) , Seagen  ( NASDAQ:SGEN ) ",https://www.benzinga.com/pressreleases/23/04/g31991296/moore-kuehn-encourages-sgen-ta-mntv-and-unvr-investors-to-contact-law-firm,2023-04-25 14:56:18,"NEW YORK, April 25, 2023 ( GLOBE NEWSWIRE ) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.",PFE,0.109455,0.211938,Somewhat-Bullish
Pfizer  ( PFE )  Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release,https://www.zacks.com/stock/news/2084240/pfizer-pfe-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release,2023-04-25 14:01:15,Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PFE,0.263467,0.147624,Neutral
This Supercharged Dividend King Stock Might Soon Run Out of Steam,https://www.fool.com/investing/2023/04/25/this-supercharged-dividend-king-stock-may-soon-run/,2023-04-25 13:45:00,"Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker's growth trajectory post-2025.",PFE,0.038223,0.056664,Neutral
Is Moderna Setting Expectations Too High?,https://www.fool.com/investing/2023/04/25/is-moderna-setting-expectations-too-high/,2023-04-25 12:33:00,The company may be overly optimistic when it comes to its outlook.,PFE,0.069697,0.130634,Neutral
2 Excellent Dividend Stocks to Buy for Less Than $100,https://www.fool.com/investing/2023/04/25/2-excellent-dividend-stocks-to-buy-for-less-than-1/,2023-04-25 11:45:00,Both companies are steals at current levels.,PFE,0.217834,0.213638,Somewhat-Bullish
Medicare is prohibited from covering weight-loss drugs - Ozempic could change that,https://www.businessinsider.com/medicare-coverage-could-change-weight-loss-medication-ozempic-2023-4,2023-04-25 09:30:00,Medicare Coverage Could Change With Weight Loss Medication ... - Business Insider ...,PFE,0.060694,-0.102004,Neutral
"ImmunOs Therapeutics Appoints Michael A. Curran, PhD, as Chairman of its Scientific Advisory Board",https://www.benzinga.com/pressreleases/23/04/g31981931/immunos-therapeutics-appoints-michael-a-curran-phd-as-chairman-of-its-scientific-advisory-board,2023-04-25 08:00:00,"Schlieren ( Zurich Area ) , Switzerland, and Gaithersburg, MD, USA - April 25, 2023 - ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its HLA-based technology platform to develop first-in-class therapeutics for the treatment of cancer and autoimmune diseases, today announced that ...",PFE,0.072435,0.05044,Neutral
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2083689/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-04-24 21:45:18,"In the latest trading session, Pfizer (PFE) closed at $39.91, marking a -0.75% move from the previous day.",PFE,0.558244,0.205737,Somewhat-Bullish
Opinion: The unnecessary price of Covid-19,https://www.cnn.com/2023/04/24/opinions/covid-unnecessary-price-bergen/index.html,2023-04-24 18:24:00,Opinion: The unnecessary price of ...,PFE,0.050858,0.049588,Neutral
"As Countries Bolster Defense, Opportunities Emerge",https://www.investorideas.com/news/2023/defense/04241Opportunities.asp,2023-04-24 16:54:47,"April 24, 2023 ( Investorideas.com Newswire ) Defense stocks are uniquely positioned to enjoy considerable, reliable funding from government contracts. This stability, and the ensuing profitability, increases during times of international political instability.",PFE,0.048004,0.073777,Neutral
Scientists Develop Mobile Printer For MRNA Vaccine Patches,https://www.barrons.com/news/scientists-develop-mobile-printer-for-mrna-vaccine-patches-3db71999,2023-04-24 15:06:13,"Scientists said Monday they have developed the first mobile printer that can produce thumbnail-sized patches able to deliver mRNA Covid vaccines, hoping the tabletop device will help immunise people in remote regions.",PFE,0.119532,-0.034387,Neutral
2 Fairly Safe Stocks You'll Regret Not Buying on the Dip,https://www.fool.com/investing/2023/04/24/2-fairly-safe-stocks-youll-regret-not-buying-on-th/,2023-04-24 14:10:00,They both have the potential to bounce back and grow for years and years.,PFE,0.254042,-0.001973,Neutral
2 Popular Stocks to Avoid in April and Beyond,https://www.fool.com/investing/2023/04/24/2-popular-stocks-to-avoid-in-april-and-beyond/,2023-04-24 13:45:00,"These two ""pandemic stocks"" aren't worth investing in.",PFE,0.055109,0.00701,Neutral
"Horizon Media Names Nicky Lorenzo SVP, Executive Creative Director of 305 Worldwide",https://www.prnewswire.com/news-releases/horizon-media-names-nicky-lorenzo-svp-executive-creative-director-of-305-worldwide-301804745.html,2023-04-24 12:00:00,"Horizon Media Names Nicky Lorenzo SVP, Executive Creative ... PR ...",PFE,0.074926,0.19837,Somewhat-Bullish
"BrainStorm Cell Therapeutics Strengthens Leadership Team with Appointment of Kirk Taylor, M.D., as Executive Vice President and Chief Medical Officer",https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-strengthens-leadership-team-with-appointment-of-kirk-taylor-md-as-executive-vice-president-and-chief-medical-officer-301805136.html,2023-04-24 11:00:00,BrainStorm Cell Therapeutics Strengthens Leadership Team with ... PR ...,PFE,0.033375,-0.001903,Neutral
"BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023",https://www.globenewswire.com/news-release/2023/04/24/2652515/0/en/BioNTech-to-Report-First-Quarter-2023-Financial-Results-and-Operational-Update-on-May-8-2023.html,2023-04-24 10:45:00,"MAINZ, Germany, April 24, 2023 ( GLOBE NEWSWIRE ) - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) will announce its financial results for the first quarter 2023 on Monday, May 8th, 2023. BioNTech invites investors and the general public to join a conference call and webcast with ...",PFE,0.12546,0.01085,Neutral
How Strong Is the Economy?,https://www.nytimes.com/2023/04/24/briefing/economy.html,2023-04-24 10:18:45,"My colleagues David Brooks and Paul Krugman have engaged in a running debate for much of their time as Times Opinion columnists, and I often find their exchanges illuminating. Their latest argument revolves around how strong the American economy really is.",PFE,0.024053,0.179619,Somewhat-Bullish
3 No-Brainer Stocks to Buy Right Now for Less than $100,https://www.fool.com/investing/2023/04/24/no-brainer-stocks-buy-right-now-less-than-100/,2023-04-24 09:50:00,Relatively low share prices. Really great long-term prospects.,PFE,0.361626,0.214478,Somewhat-Bullish
"These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge",https://www.fool.com/investing/2023/04/24/these-2-stocks-carry-risk-but-upside-is-huge/,2023-04-24 09:30:00,Novavax and Vaxart have each dropped more than 80% over the past year.,PFE,0.118647,0.04424,Neutral
Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?,https://www.fool.com/investing/2023/04/23/why-did-pfizer-offload-this-potential-mega-blockbu/,2023-04-23 20:45:00,"Pfizer's decision to offload a potential mega-blockbuster may seem counterintuitive, but the drugmaker appears to have solid reasons for doing so.",PFE,0.386377,0.136464,Neutral
"Amazon, McDonald's, Microsoft earnings and debt limit battle top week ahead",https://www.foxbusiness.com/markets/amazon-mcdonalds-microsoft-earnings-debt-limit-battle-top-week-ahead,2023-04-23 15:07:02,"It will be another busy week for investors with a plethora of blue chip and big tech earnings on tap, as well as first quarter GDP and the ongoing battle over the nation's debt limit. The stock market closed higher on Friday but ended the week with modest losses.",PFE,0.052685,-0.073657,Neutral
Cancer Immunotherapy Market Size Worth USD 388.25 Billion in 2030 - Emergen Research,https://markets.businessinsider.com/news/stocks/cancer-immunotherapy-market-size-worth-usd-388-25-billion-in-2030-%E2%80%93-emergen-research-1032251605,2023-04-23 13:22:00,"The global Cancer Immunotherapy Market size was USD 119.39 Billion in 2021 and is expected to register a revenue CAGR of 14.0% during the forecast period, according to latest analysis by Emergen Research Cancer immunotherapy, also known as immuno-oncology, is a fast expanding specialty in cancer ...",PFE,0.034282,-0.109525,Neutral
IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated Approval in First-Line Metastatic Uveal Melanoma,https://www.prnewswire.com/news-releases/ideaya-announces-positive-interim-phase-2-data-for-darovasertib-and-crizotinib-combination-and-successful-fda-type-c-meeting-on-registrational-trial-design-for-accelerated-approval-in-first-line-metastatic-uveal-melanoma-301804804.html,2023-04-23 13:00:00,IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib ... PR ...,PFE,0.015851,0.010043,Neutral
"Pharma Stock Roundup: JNJ Beats on Q1 Earnings, MRK to Buy RXDX & Other Updates",https://www.zacks.com/stock/news/2082821/pharma-stock-roundup-jnj-beats-on-q1-earnings-mrk-to-buy-rxdx-other-updates,2023-04-21 14:28:00,J&J (JNJ) beats earnings and sales estimates for the first quarter. Merck (MRK) offers to buy Prometheus Biosciences (RXDX).,PFE,0.110462,-0.187107,Somewhat-Bearish
LianBio Promotes Pascal Qian to Chief Commercial Officer,https://www.globenewswire.com/news-release/2023/04/21/2651900/0/en/LianBio-Promotes-Pascal-Qian-to-Chief-Commercial-Officer.html,2023-04-21 12:15:00,"SHANGHAI, China and PRINCETON, N.J., April 21, 2023 ( GLOBE NEWSWIRE ) -- LianBio ( Nasdaq: LIAN ) , a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced the promotion of Pascal Qian to the position of Chief ...",PFE,0.046724,-0.015856,Neutral
LianBio Promotes Pascal Qian to Chief Commercial Officer - LianBio  ( NASDAQ:LIAN ) ,https://www.benzinga.com/pressreleases/23/04/g31932948/lianbio-promotes-pascal-qian-to-chief-commercial-officer,2023-04-21 12:15:00,"SHANGHAI, China and PRINCETON, N.J., April 21, 2023 ( GLOBE NEWSWIRE ) -- LianBio LIAN, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced the promotion of Pascal Qian to the position of Chief Commercial Officer.",PFE,0.044386,-0.015781,Neutral
Biopharma Deals Are Hot. There's More to Come-and These Stocks Can Benefit.,https://www.barrons.com/articles/biotech-stocks-buy-mergers-acquisitions-f364e20b,2023-04-21 06:00:00,89Bio and Other Biotechs That Could Benefit While Biopharma Deals Are Hot ...,PFE,0.716023,0.097761,Neutral
Insiders Are Diving Into These 3 Stocks,https://www.zacks.com/stock/news/2093744/insiders-are-diving-into-these-3-stocks,2023-05-10 20:59:00,"When an insider buys, it can deliver a positive message to shareholders, indicating that they're confident in the long-term picture of the business.",PFE,0.546745,0.448793,Bullish
Is the Worst Over for Novavax?,https://www.fool.com/investing/2023/05/10/is-the-worst-over-for-novavax/,2023-05-10 17:30:00,Novavax shares climbed 26% in one trading session on the latest cost-cutting news.,PFE,0.054114,-0.053999,Neutral
FDA advisors recommend sale of birth control pill without a prescription,https://www.cnbc.com/2023/05/10/birth-control-fda-committee-vote-on-pill-without-prescription.html,2023-05-10 17:17:36,FDA scientists raised concerns about whether the general public will understand the drug label and use HRA Pharma's Opill in the right way.,PFE,0.034233,-0.086396,Neutral
Biotech ETFs Pop on M&A Resurgence,https://www.zacks.com/stock/news/2093665/biotech-etfs-pop-on-ma-resurgence,2023-05-10 16:33:00,2023 could be a year of heightened biotech dealmaking activity ...,PFE,0.295867,-0.173328,Somewhat-Bearish
Thermo Fisher  ( TMO )  Partners With Pfizer to Expand NGS Testing,https://www.zacks.com/stock/news/2093354/thermo-fisher-tmo-partners-with-pfizer-to-expand-ngs-testing,2023-05-10 13:23:00,Thermo Fisher's (TMO) latest collaboration with Pfizer is set to enhance localized access to NGS-based testing capabilities for breast and lung cancer across international markets.,PFE,0.219312,0.130053,Neutral
"Insiders Buying Pfizer And 2 Other Stocks - LendingClub  ( NYSE:LC ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/05/32312862/insiders-buying-pfizer-and-2-other-stocks,2023-05-10 11:53:22,"Although US stocks closed lower on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.",PFE,0.531326,0.072133,Neutral
Ireland wants to put its soaring corporate tax receipts into a new sovereign wealth fund,https://www.cnbc.com/2023/05/10/ireland-wants-to-put-soaring-corporate-taxes-into-a-new-sovereign-wealth-fund-.html,2023-05-10 07:01:19,"Multinationals in Ireland have paid record amounts of corporate tax in recent years, and the country estimates its budget surplus could hit 6.3% of GDP.",PFE,0.06515,0.082087,Neutral
How To Trade US CPI: The Top 5 Mega-Cap Gainers And Losers Following Last 3 Inflation Reports - Tesla  ( NASDAQ:TSLA ) ,https://www.benzinga.com/general/biotech/23/05/32295234/how-to-trade-us-cpi-the-top-5-mega-cap-gainers-and-losers-following-last-3-inflation-reports,2023-05-09 16:42:39,"Investors are eagerly awaiting the U.S. inflation statistics for April, which will be announced on Wednesday at 8.30 a.m. ET, before the start of trading on Wall Street. The CPI data is one of the most crucial market-moving events for stocks, as investors try to decipher the state of the economy ...",PFE,0.181137,0.0,Neutral
Covid vaccine maker Novavax plans to cut 25% jobs to slash expenses,https://www.business-standard.com/companies/news/covid-vaccine-maker-novavax-plans-to-cut-25-jobs-to-slash-expenses-123050901043_1.html,2023-05-09 15:50:17,"Novavax is cutting about a quarter of its workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said on Tuesday that it expects to trim next year's costs for research and development as well as selling, general and administrative ...",PFE,0.107495,0.103186,Neutral
FDA may allow birth control pill without prescription this summer as experts weigh data,https://www.cnbc.com/2023/05/09/fda-may-allow-birth-control-without-prescription-by-summer.html,2023-05-09 15:17:46,HRA Pharma asked the Food and Drug Administration to allow over-the-counter sales of Opill after the Supreme Court said there was no federal right to abortion.,PFE,0.04882,-0.087122,Neutral
Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance - Royalty Pharma  ( NASDAQ:RPRX ) ,https://www.benzinga.com/news/earnings/23/05/32286283/royalty-pharma-reaffirms-fy23-guidance-post-mixed-q1-performance,2023-05-09 15:15:05,"Royalty Pharma PLC RPRX reported Q1 2023 total income and other revenues increase of 22% Y/Y to $684 million, missing the consensus of $852.9 million. Adjusted EBITDA increased 88% Y/Y to $1.04 billion.",PFE,0.285526,0.428076,Bullish
Pharma ETFs Gain Post Q1 Earnings,https://www.zacks.com/stock/news/2092464/pharma-etfs-gain-post-q1-earnings,2023-05-09 15:15:00,"Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.",PFE,0.117678,0.037251,Neutral
Pharma Suppliers Are Nursing a Postpandemic Hangover,https://www.wsj.com/articles/pharma-suppliers-are-nursing-a-postpandemic-hangover-9e17572e,2023-05-09 14:06:00,Picks-and-shovel healthcare companies like Danaher and Repligen that supply drugmakers are seeing a slowdown.,PFE,0.524949,0.429419,Bullish
"Novavax Offers Upbeat Guide, But Scraps 25% Of Its Workforce",https://www.investors.com/news/technology/nvax-stock-novavax-earnings-q1-2023/,2023-05-09 14:04:00,NVAX Stock Rises On Upbeat Guidance As It Cuts Workforce Investor's Business Daily ...,PFE,0.101154,-0.042394,Neutral
"COVID-19 vaccine maker Novavax to chop workforce, expenses",https://apnews.com/article/novavax-covid-vaccine-b78ec71aa83eb7b4496b35a307787e09,2023-05-09 13:33:33,"Novavax is cutting about a quarter of its workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said Tuesday that it expects to trim next year's costs for research and development as well as selling, general and administrative ...",PFE,0.116348,0.1062,Neutral
Theravance's  ( TBPH )  Q1 Earnings and Revenues Miss Estimates,https://www.zacks.com/stock/news/2092291/theravances-tbph-q1-earnings-and-revenues-miss-estimates,2023-05-09 13:24:00,Thervance's (TBPH) first-quarter 2023 loss wider than expected. Revenues decline year over year and also miss estimates.,PFE,0.060541,-0.129011,Neutral
Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market,https://www.fool.com/investing/2023/05/09/moderna-plans-post-emergency-covid-vaccine-market/,2023-05-09 13:16:00,Its COVID-19 vaccine could remain a blockbuster for years.,PFE,0.05387,0.057922,Neutral
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets,https://investingnews.com/thermo-fisher-scientific-pfizer-partner-to-expand-localized-access-to-next-generation-sequencing-based-testing-for-cancer-patients-in-international-markets/,2023-05-09 12:47:13,"Pfizer and Thermo Fisher Scientific Inc. ( NYSE: TMO ) today announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing ( NGS ) -based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, ...",PFE,0.386306,0.148717,Neutral
"Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce",https://www.cnbc.com/2023/05/09/novavax-nvax-q1-earnings-report-2023.html,2023-05-09 12:14:13,Novavax still reported bleak first-quarter earnings and revenue that missed Wall Street's estimates.,PFE,0.20698,-0.035225,Neutral
"Tuberculosis rates rocket amid Ukraine, Sudan conflicts",https://www.aljazeera.com/news/2023/5/9/tuberculosis-rates-rocket-amid-ukraine-sudan-conflicts,2023-05-09 11:46:21,"Disease surges as health officials try to address the accessibility of treatments and trials for a new vaccine commence. The world must invest more to develop new vaccines and tackle a surge in tuberculosis ( TB ) fuelled by the impact of COVID-19 and conflicts including in Ukraine and Sudan, ...",PFE,0.056143,0.0,Neutral
"HilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of Directors - HilleVax  ( NASDAQ:HLVX ) ",https://www.benzinga.com/pressreleases/23/05/g32283010/hillevax-announces-appointment-of-nanette-cocero-ph-d-mba-to-its-board-of-directors,2023-05-09 11:00:00,"BOSTON, May 09, 2023 ( GLOBE NEWSWIRE ) -- HilleVax, Inc. HLVX, a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the appointment of Nanette Cocero, Ph.D., MBA, to its Board of Directors, effective May 8, 2023.",PFE,0.448316,0.231402,Somewhat-Bullish
23andMe Releases New Report Revealing Likelihood of Developing Lupus,https://www.globenewswire.com/news-release/2023/05/09/2664213/0/en/23andMe-Releases-New-Report-Revealing-Likelihood-of-Developing-Lupus.html,2023-05-09 11:00:00,23andMe+ members can now gain insights on the chronic autoimmune condition 23andMe+ members can now gain insights on the chronic autoimmune condition ...,PFE,0.034381,-0.064274,Neutral
"Voyager Therapeutics Announces Appointment of George Scangos, Ph.D., to Board of Directors - Voyager Therapeutics  ( NASDAQ:VYGR ) ",https://www.benzinga.com/pressreleases/23/05/g32282893/voyager-therapeutics-announces-appointment-of-george-scangos-ph-d-to-board-of-directors,2023-05-09 10:55:00,"CAMBRIDGE, Mass., May 09, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. VYGR, a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced the appointment of George Scangos, Ph.D., to its Board of Directors.",PFE,0.045054,0.036673,Neutral
"Voyager Therapeutics Announces Appointment of George Scangos, Ph.D., to Board of Directors",https://www.globenewswire.com/news-release/2023/05/09/2664203/36461/en/Voyager-Therapeutics-Announces-Appointment-of-George-Scangos-Ph-D-to-Board-of-Directors.html,2023-05-09 10:55:00,"CAMBRIDGE, Mass., May 09, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( NASDAQ: VYGR ) , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced the appointment of George Scangos, Ph.D., to its Board of Directors.",PFE,0.042496,0.037496,Neutral
"Macquarie gives 'outperform' rating to Mankind Pharma, sees 30% upside",https://www.moneycontrol.com/news/business/ipo/macquarie-gives-outperform-rating-to-mankind-pharma-sees-30-upside-10552291.html,2023-05-09 05:52:18,"Brokerage firm Macquarie Research has given Mankind Pharma Ltd an outperform rating with a target price of Rs 1400 per share, indicating a potential upside of 29.6% from its issue price of Rs 1068 per share.",PFE,0.081001,0.109765,Neutral
Evonik's pricing helps it beat profit estimates in tough first quarter,https://www.reuters.com/markets/commodities/evoniks-pricing-helps-it-beat-profit-estimates-tough-first-quarter-2023-05-09/,2023-05-09 05:23:00,"May 9 ( Reuters ) - German chemicals group Evonik Industries ( EVKn.DE ) reported a smaller than expected drop in first-quarter core profit on Tuesday, as higher prices offset some of the lost volumes in the quarter marked by muted economic activity and weak demand.",PFE,0.15347,-0.07325,Neutral
Maravai LifeSciences  ( MRVI )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/09/maravai-lifesciences-mrvi-q1-2023-earnings-call-tr/,2023-05-09 05:00:26,"MRVI earnings call for the period ending March 31, 2023.",PFE,0.010091,0.060488,Neutral
"Theravance Biopharma, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update",https://www.prnewswire.com/news-releases/theravance-biopharma-inc-reports-first-quarter-2023-financial-results-and-provides-business-update-301818591.html,2023-05-08 20:05:00,"Theravance Biopharma, Inc. Reports First Quarter 2023 Financial ... PR ...",PFE,0.017612,0.052949,Neutral
BioNTech Se  ( BNTX )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/08/biontech-se-bntx-q1-2023-earnings-call-transcript/,2023-05-08 20:00:21,"BNTX earnings call for the period ending March 31, 2023.",PFE,0.098121,0.081037,Neutral
Axsome Therapeutics  ( AXSM )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/08/axsome-therapeutics-axsm-q1-2023-earnings-call-tra/,2023-05-08 18:00:35,"AXSM earnings call for the period ending March 31, 2023.",PFE,0.006225,0.169026,Somewhat-Bullish
The Scientist Turned Biotech Empresario Who Changed How We Look At Gene Editing,https://www.forbes.com/sites/johncumbers/2023/05/08/the-scientist-turned-biotech-empresario-who-changed-how-we-look-at-gene-editing/,2023-05-08 17:09:27,"Discover the incredible potential of gene editing with Dr. David Liu, the Harvard inventor of base and prime editing. Learn about his groundbreaking work and visions for the future in my latest Forbes article.",PFE,0.036869,0.138028,Neutral
"5 Value Stocks In The Healthcare Sector - Innoviva  ( NASDAQ:INVA ) , AcelRx Pharmaceuticals  ( NASDAQ:ACRX ) , Intercure  ( NASDAQ:INCR ) , Assertio Holdings  ( NASDAQ:ASRT ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/05/32266483/5-value-stocks-in-the-healthcare-sector,2023-05-08 14:43:06,A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.,PFE,0.213048,0.29464,Somewhat-Bullish
Viatris reaffirms 2023 sales forecast on strong demand for newer drugs,https://www.reuters.com/business/healthcare-pharmaceuticals/viatris-reaffirms-2023-sales-forecast-strong-demand-newer-drugs-2023-05-08/,2023-05-08 14:04:00,"May 8 ( Reuters ) - Viatris Inc ( VTRS.O ) reaffirmed its full-year revenue forecast on Monday and said it was on track to achieve about $500 million in annual sales from its newly launched products, sending its shares up nearly 2% in early trading.",PFE,0.145145,0.074504,Neutral
"BioNTech Crushes Profit Views, But Guidance Assumes Declines",https://www.investors.com/news/technology/bntx-stock-biontech-earnings-q1-2023/,2023-05-08 13:18:00,"BNTX Stock Jumps As Covid Sales, Profit Beat. But Guidance ... Investor's Business Daily ...",PFE,0.377142,0.015844,Neutral
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2091438/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2023-05-08 13:00:11,"Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",PFE,0.491255,0.141394,Neutral
2 Top Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2023/05/08/2-top-healthcare-stocks-to-buy-right-now/,2023-05-08 12:45:00,Healthcare is a recession-resistant economic sector.,PFE,0.376005,0.171803,Somewhat-Bullish
eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference,https://www.globenewswire.com/news-release/2023/05/08/2663239/0/en/eFFECTOR-Therapeutics-to-Present-at-JMP-Securities-Life-Sciences-Conference.html,2023-05-08 12:00:00,"SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 08, 2023 ( GLOBE NEWSWIRE ) -- eFFECTOR Therapeutics, Inc. ( NASDAQ: EFTR ) , a leader in the development of selective translation regulator inhibitors ( ""STRIs"" ) for the treatment of cancer, today announced that the Company will present and ...",PFE,0.110462,-0.060753,Neutral
ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS,https://www.prnewswire.com/news-releases/endo-reports-first-quarter-2023-financial-results-301817825.html,2023-05-08 11:30:00,"DUBLIN, May 8, 2023 /PRNewswire/ -- Endo International plc ( OTC: ENDPQ ) today reported financial results for the first-quarter ended March 31, 2023. Adjusted Income from Continuing Operations ( 2 ) ( 3 ) Adjusted Diluted Weighted Average Shares ( 1 ) ( 2 )",PFE,0.021227,0.009935,Neutral
ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS,https://www.newswire.ca/news-releases/endo-reports-first-quarter-2023-financial-results-858369793.html,2023-05-08 11:30:00,"DUBLIN, May 8, 2023 /CNW/ -- Endo International plc ( OTC: ENDPQ ) today reported financial results for the first-quarter ended March 31, 2023. Total revenues were $515 million in first-quarter 2023, a decrease of 21% compared to $652 million in first-quarter 2022.",PFE,0.016427,0.0,Neutral
"Arvinas and Pfizer Announce Upcoming Vepdegestrant  ( ARV-471 )  Poster Presentations at the 2023 European Society for Medical Oncology  ( ESMO )  Breast Cancer Annual Congress - Arvinas  ( NASDAQ:ARVN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/05/g32260334/arvinas-and-pfizer-announce-upcoming-vepdegestrant-arv-471-poster-presentations-at-the-2023-europe,2023-05-08 11:00:36,"NEW HAVEN, Conn. and NEW YORK, May 08, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ARVN and Pfizer Inc. PFE today announced they will present updated data related to vepdegestrant ( ARV-471 ) at the 2023 European Society for Medical Oncology ( ESMO ) Breast Cancer Annual Congress.",PFE,0.423718,0.201766,Somewhat-Bullish
Arvinas and Pfizer Announce Upcoming Vepdegestrant  ( ARV-471 )  Poster Presentations at the 2023 European Society for Medical Oncology  ( ESMO )  Breast Cancer Annual Congress,https://www.globenewswire.com/news-release/2023/05/08/2663160/0/en/Arvinas-and-Pfizer-Announce-Upcoming-Vepdegestrant-ARV-471-Poster-Presentations-at-the-2023-European-Society-for-Medical-Oncology-ESMO-Breast-Cancer-Annual-Congress.html,2023-05-08 11:00:00,"NEW HAVEN, Conn. and NEW YORK, May 08, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ( Nasdaq: ARVN ) and Pfizer Inc. ( NYSE: PFE ) today announced they will present updated data related to vepdegestrant ( ARV-471 ) at the 2023 European Society for Medical Oncology ( ESMO ) Breast Cancer Annual ...",PFE,0.403226,0.197935,Somewhat-Bullish
"After weight loss, Alzheimer's may be next frontier for drugs like Ozempic",https://www.reuters.com/business/healthcare-pharmaceuticals/after-weight-loss-alzheimers-may-be-next-frontier-drugs-like-ozempic-2023-05-08/,2023-05-08 10:11:00,"After weight loss, Alzheimer's may be next frontier for drugs like ... ...",PFE,0.042421,0.0,Neutral
Is Moderna a Value Stock to Buy Right Now?,https://www.fool.com/investing/2023/05/07/is-moderna-a-value-stock-to-buy-right-now/,2023-05-07 19:13:00,The company has several potentially huge winners in its pipeline.,PFE,0.119235,0.194973,Somewhat-Bullish
3 Great Income Stocks That Retirees Should Love,https://www.fool.com/investing/2023/05/06/3-great-income-stocks-that-retirees-should-love/,2023-05-06 10:14:00,"If you're looking for additional retirement income, these three stocks should be right up your alley.",PFE,0.288408,0.299809,Somewhat-Bullish
Empowering Innovation to the Global Market with Acro Certify,https://www.prnewswire.com/news-releases/empowering-innovation-to-the-global-market-with-acro-certify-301817589.html,2023-05-06 02:18:00,"NEWARK, Del., May 5, 2023 /PRNewswire/ -- For many companies, entering the global market is a daunting challenge. These obstacles can come in various forms. Sometimes the problem is finding the right target customer base or establishing an appropriate quality management system and shipping ...",PFE,0.052918,0.126637,Neutral
Uber and Pfizer Update Their Investors About How Things Are Going,https://www.fool.com/investing/2023/05/05/uber-and-pfizer-update-their-investors/,2023-05-05 22:26:19,"We also chat about whether there is a ""new normal"" for start-ups and venture capital.",PFE,0.135031,0.05636,Neutral
FDA considering approval of first over-the-counter birth control pill,https://www.foxbusiness.com/healthcare/fda-considering-approval-first-over-counter-birth-control-pill,2023-05-05 20:50:55,Accessing birth control pills could soon become a lot easier in America. Advisers to the Food and Drug Administration ( FDA ) will meet next week to evaluate drugmaker HRA Pharma's application for its decades-old daily birth control pill Opill to be sold in the U.S. without requiring a ...,PFE,0.095138,0.0,Neutral
CDC Director Rochelle Walensky will resign in June,https://www.cnbc.com/2023/05/05/cdc-director-rochelle-walensky-will-resign-in-june-.html,2023-05-05 17:17:40,"Walensky did not provide a specific reason for her departure, but noted that the U.S. is transitioning out of the emergency of the Covid-19 response.",PFE,0.095517,-0.096621,Neutral
"Small Cell Lung Cancer Therapeutics Market Value to Exceed of USD 12.9 Bn by 2031, rising at a 11.9% CAGR: TMR Report",https://www.benzinga.com/pressreleases/23/05/g32243659/small-cell-lung-cancer-therapeutics-market-value-to-exceed-of-usd-12-9-bn-by-2031-rising-at-a-11-9,2023-05-05 16:30:00,"Wilmington, Delaware, United States, May 05, 2023 ( GLOBE NEWSWIRE ) -- The global small cell lung cancer therapeutics market was valued at USD 4.6 Bn in 2022 and is projected to expand at a CAGR of 11.9% from 2023 to 2031 to reach USD 12.9 Bn by 2031.",PFE,0.044801,-0.126061,Neutral
CDC will have less data to track Covid and new variants after public health emergency ends,https://www.cnbc.com/2023/05/05/covid-cdc-will-have-less-data-after-emergency-ends.html,2023-05-05 15:00:01,"The U.S. has a fragmented health-care system where the authority to decide what disease data gets reported largely rests with corporations, not the CDC.",PFE,0.034087,-0.086377,Neutral
"Which Is the Better Passive Income Stock, Eli Lilly or Bristol Myers Squibb?",https://www.fool.com/investing/2023/05/05/which-is-the-better-passive-income-stock-eli-lilly/,2023-05-05 14:15:00,"One offers more income today, and the other aims to offer more in the future.",PFE,0.04794,0.08094,Neutral
Should Income Investors Buy This Blue Chip Dividend Stock?,https://www.fool.com/investing/2023/05/05/should-income-investors-buy-this-blue-chip-stock/,2023-05-05 14:00:00,This pharmaceutical company has an exceptional drug portfolio and pipeline.,PFE,0.065866,0.146471,Neutral
US Perfume Giant Coty Weighs Paris Stock Listing,https://www.barrons.com/news/us-perfume-giant-coty-weighs-paris-stock-listing-963292d3,2023-05-05 13:26:30,"US perfume and beauty products giant Coty said Friday that it was looking at a second stock listing in Paris as part of its efforts to strengthen its presence in Europe. ""Paris is the historic home of beauty, and the industry still holds a special attraction for investors there,"" Coty board ...",PFE,0.137671,0.163512,Somewhat-Bullish
WHO declares end to Covid global public health emergency,https://www.cnbc.com/2023/05/05/who-declares-end-to-covid-global-public-health-emergency.html,2023-05-05 13:23:37,"The spread of Covid-19 is no longer a global public health emergency, the World Health Organization declared on Friday.",PFE,0.255641,-0.17745,Somewhat-Bearish
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update,https://www.globenewswire.com/news-release/2023/05/05/2662424/0/en/Arvinas-Reports-First-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html,2023-05-05 11:00:00,"-Multiple vepdegestrant ( ARV-471 ) studies enrolling globally, including Phase 1, 2, and ...",PFE,0.1589,0.052661,Neutral
Dexcom to build its first European factory in Ireland,https://www.reuters.com/business/healthcare-pharmaceuticals/dexcom-build-its-first-european-factory-ireland-2023-05-05/,2023-05-05 08:37:05,"DUBLIN, May 5 ( Reuters ) - U.S. medical device company Dexcom ( DXCM.O ) plans to invest 300 million euros ( $330.8 million ) over the next five years to build a manufacturing site in Ireland, creating up to 1,000 jobs, it said on Friday.",PFE,0.188193,0.19051,Somewhat-Bullish
J&J's Kenvue rallies out of the gate,https://www.axios.com/2023/05/04/kenvue-ipo,2023-05-04 22:25:53,"There was a giant IPO today. We haven't been able to write that since November 2021, when Rivian went public.",PFE,0.139265,-0.06272,Neutral
Curis Provides First Quarter 2023 Business Update,https://www.prnewswire.com/news-releases/curis-provides-first-quarter-2023-business-update-301816505.html,2023-05-04 20:01:00,"Company expects to discuss lifting of partial clinical hold on emavusertib with FDA in Q3 Curis strengthens executive team with appointment of industry veteran Jonathan Zung, Ph.D. as Chief Development Officer Strong balance sheet with $71.8 million in cash and investments; cash runway into 2025",PFE,0.019731,0.027452,Neutral
Moderna  ( MRNA )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/04/moderna-mrna-q1-2023-earnings-call-transcript/,2023-05-04 19:30:36,"MRNA earnings call for the period ending March 31, 2023.",PFE,0.007645,0.068621,Neutral
Protalix Clocks 40% Decline In Q1 Revenues Reflecting Lower Sales To Brazil - Protalix BioTherapeutics  ( AMEX:PLX ) ,https://www.benzinga.com/news/earnings/23/05/32212841/protalix-clocks-40-decline-in-q1-revenues-reflecting-lower-sales-to-brazil,2023-05-04 18:51:21,"Protalix BioTherapeutics, Inc. PLX reported first-quarter FY23 total revenue of $9.59 million, down 40.4% year over year, on lower sales in Brazil. The biopharmaceutical company registered an adjusted loss of $ ( 0.05 ) , which is flat Y/Y.",PFE,0.355588,-0.131803,Neutral
Vaccine Sales Are Falling. Should You Still Buy Pfizer?,https://www.fool.com/investing/2023/05/04/vaccine-sales-are-falling-should-you-still-buy-pfi/,2023-05-04 18:00:00,This is a transition year for Pfizer.,PFE,0.735845,0.267122,Somewhat-Bullish
OPKO Health  ( OPK )  Q1 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2090255/opko-health-opk-q1-earnings-and-revenues-top-estimates,2023-05-04 16:23:00,"Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall first-quarter results reflect soft performances.",PFE,0.070002,0.214404,Somewhat-Bullish
J&J Consumer-Health IPO Kenvue to Raise $3.8 Billion,https://www.barrons.com/articles/jnj-stock-ipo-kenvue-5cc1207d,2023-05-04 14:15:00,J&J Consumer-Health IPO Stock Kenvue to Raise $3.8 Billion ...,PFE,0.28664,-0.018759,Neutral
"Spot's Drugmaker Reports Mixed Earnings, But Keeps Guide",https://www.investors.com/news/technology/zts-stock-zoetis-earnings-q1-2023/,2023-05-04 13:27:00,ZTS Stock Tumbles As Spot's Drugmaker Reports Light Sales Investor's Business Daily ...,PFE,0.220809,0.178197,Somewhat-Bullish
Top-Rated Novo Skids As Obesity Sales Lag,https://www.investors.com/news/technology/novo-nordisk-stock-novo-nordisk-earnings-q1-2023/,2023-05-04 13:16:00,Novo Nordisk Stock Skids As Obesity Treatment Wegovy Misses ... Investor's Business Daily ...,PFE,0.162802,0.142808,Neutral
"The Next Evolution In Drugs? AI, According To One CEO",https://www.investors.com/news/technology/btai-stock-how-bioxcel-is-embracing-ai-in-the-next-drug-evolution/,2023-05-04 12:00:00,BTAI Stock: How BioXcel Is Embracing AI In The Next Drug ... Investor's Business Daily ...,PFE,0.074576,-0.081702,Neutral
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update,https://www.prnewswire.com/news-releases/insmed-reports-first-quarter-2023-financial-results-and-provides-business-update-301815538.html,2023-05-04 11:30:00,Insmed Reports First Quarter 2023 Financial Results and Provides ... PR ...,PFE,0.008868,0.06747,Neutral
"The daily business briefing: May 4, 2023",https://theweek.com/briefing/business-briefing/1023223/the-daily-business-briefing-may-4-2023,2023-05-04 11:24:58,The Federal Reserve on Wednesday raised interest rates a quarter of a percentage point and suggested it might pause its aggressive campaign to fight inflation to assess whether the damage from recent bank failures will get worse.,PFE,0.061003,0.00807,Neutral
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines,https://www.cnbc.com/2023/05/04/moderna-mrna-earnings-q1-2023.html,2023-05-04 10:58:12,"Moderna maintained its full-year guidance of around $5 billion in revenue from its Covid vaccine, its only marketable product.",PFE,0.089129,-0.089071,Neutral
"10 things you need to know today: May 4, 2023",https://theweek.com/briefing/daily-briefing/1023222/10-things-you-need-to-know-today-may-4-2023,2023-05-04 10:52:31,Russia claimed Wednesday that it foiled an attempt by Ukraine to assassinate Russian President Vladimir Putin with two drones that hit the Kremlin.,PFE,0.031907,0.007827,Neutral
Protalix BioTherapeutics Reports First Quarter 2023 Financial and Business Results,https://www.prnewswire.com/news-releases/protalix-biotherapeutics-reports-first-quarter-2023-financial-and-business-results-301815933.html,2023-05-04 10:50:00,Protalix BioTherapeutics Reports First Quarter 2023 Financial and ... PR ...,PFE,0.040044,0.029143,Neutral
Protalix BioTherapeutics Reports First Quarter 2023 Financial and Business Results,https://www.prnewswire.com/il/news-releases/protalix-biotherapeutics-reports-first-quarter-2023-financial-and-business-results-301815933.html,2023-05-04 10:50:00,Protalix BioTherapeutics Reports First Quarter 2023 Financial and ... PR ...,PFE,0.040044,0.029143,Neutral
Moderna beats COVID vaccine sales expectations as deferred revenue rolls in,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-beats-covid-vaccine-sales-expectations-deferred-revenue-rolls-2023-05-04/,2023-05-04 10:37:00,Moderna beats COVID vaccine sales expectations as deferred ... ...,PFE,0.086245,0.069224,Neutral
Novo Nordisk rivals see room to compete in $100 billion weight-loss drug market,https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-rivals-see-room-compete-100-bln-weight-loss-drug-market-2023-05-04/,2023-05-04 10:17:00,Novo Nordisk rivals see room to compete in $100 bln weight-loss ... ...,PFE,0.177802,0.124933,Neutral
"Deciphera  ( DCPH )  Q1 Earnings Match Estimates, Sales Miss",https://www.zacks.com/stock/news/2089709/deciphera-dcph-q1-earnings-match-estimates-sales-miss,2023-05-04 09:38:00,"Deciphera Pharmaceuticals (DCPH) reports mixed first-quarter 2023 results as its earnings are in line with the Zacks Consensus Estimate, while revenues miss the same.",PFE,0.182162,0.041888,Neutral
"Psychedelic Drug Industry Analysis: Forecast Market Size, Major Players And Their Strategies, And Key Segments - By The Business Research Company",https://www.prnewswire.com/news-releases/psychedelic-drug-industry-analysis-forecast-market-size-major-players-and-their-strategies-and-key-segments--by-the-business-research-company-301814512.html,2023-05-04 09:30:00,"Psychedelic Drug Industry Analysis: Forecast Market Size, Major ... PR ...",PFE,0.072,0.018172,Neutral
What's next with COVID-19 boosters,https://www.axios.com/2023/05/04/covid-boosters-omicron-moderna-pfizer-fda,2023-05-04 09:30:00,"Food and Drug Administration advisers have set their next meeting to decide how to make the next round of COVID-19 boosters available to the general public this fall, now that they're available for older adults and high-risk people.",PFE,0.392948,0.200936,Somewhat-Bullish
3 Top Healthcare Stocks to Buy in May,https://www.fool.com/investing/2023/05/04/3-top-healthcare-stocks-to-buy-in-may/,2023-05-04 09:30:00,You'll want to hold onto these innovative companies for the long term.,PFE,0.327366,0.245419,Somewhat-Bullish
Poland asks Pfizer to renegotiate COVID-19 vaccine deal,https://www.foxbusiness.com/economy/poland-asks-pfizer-renegotiate-covid-19-vaccine-deal,2023-05-04 07:34:36,"Poland sent a public letter to Pfizer shareholders calling on the U.S. pharmacy giant to renegotiate its COVID-19 vaccines contract with the EU, citing wasteful vaccines post pandemic.",PFE,0.504646,-0.114374,Neutral
João Marcelo Gomes Named President of Kemin Food Technologies - EMEA,https://www.prnewswire.com/news-releases/joao-marcelo-gomes-named-president-of-kemin-food-technologies--emea-301815580.html,2023-05-04 07:00:00,João Marcelo Gomes Named President of Kemin Food ... PR ...,PFE,0.054983,0.101827,Neutral
Valneva Reports First Quarter 2023 Financial Results and Provides Corporate Updates,https://www.globenewswire.com/news-release/2023/05/04/2661033/0/en/Valneva-Reports-First-Quarter-2023-Financial-Results-and-Provides-Corporate-Updates.html,2023-05-04 05:00:00,Product sales increased 98.6% to €32.1 million in the first quarter of 2023 compared to €16.2 million in the first quarter of ...,PFE,0.12007,0.064493,Neutral
US approves 1st vaccine for respiratory virus after decades of attempts,https://www.business-standard.com/world-news/us-approves-1st-vaccine-for-respiratory-virus-after-decades-of-attempts-123050301341_1.html,2023-05-04 02:03:27,"The US approved the first vaccine for RSV on Wednesday, shots to protect older adults against a respiratory virus that's most notorious for attacking babies but endangers their grandparents, too.",PFE,0.057767,0.153993,Somewhat-Bullish
Opko Health  ( OPK )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/03/opko-health-opk-q1-2023-earnings-call-transcript/,2023-05-04 02:00:28,"OPK earnings call for the period ending March 31, 2023.",PFE,0.059257,0.143025,Neutral
US Becomes First Country To Approve RSV Vaccine,https://www.barrons.com/news/us-issues-world-s-first-approval-of-rsv-vaccine-57bfdbdd,2023-05-03 20:16:26,US Issues World's First Approval Of RSV Vaccine ...,PFE,0.129866,0.0,Neutral
The Technical Balance of Power Hangs on the Fed,https://moneymorning.com/investing/the-technical-balance-of-power-hangs-on-the-fed/,2023-05-03 19:47:03,"The FOMC decision came this afternoon, but who are we kidding, it's been made for a while. And for what it's worth, the market has already priced in that decision - to raise rates another 0.25% and hold out for the ""data"" to give them a better view. Given that, I really don't care much for what ...",PFE,0.219312,-0.024338,Neutral
"A Shot of Success: GSK's Arexvy Wins FDA Approval, Pioneering RSV Prevention for Older Adults in Multi-Billion Dollar Market - GSK  ( NYSE:GSK ) ",https://www.benzinga.com/general/biotech/23/05/32194390/a-shot-of-success-gsks-arexvy-wins-fda-approval-pioneering-rsv-prevention-for-older-adults-in-mul,2023-05-03 19:38:02,The FDA has approved GSK Plc's GSK Arexvy ( respiratory syncytial virus vaccine for the prevention of lower respiratory tract disease ( LRTD ) caused by respiratory syncytial virus ( RSV ) in individuals 60 years of age and older. This is the first RSV vaccine for older adults to be ...,PFE,0.47379,0.468243,Bullish
America needs a jab in its corporate backside,https://www.economist.com/business/2023/05/03/america-needs-a-jab-in-its-corporate-backside,2023-05-03 19:32:19,Pfizer offers lessons in how to cope with paralysis over M&A and China ...,PFE,0.484308,0.031898,Neutral
FDA Approves First-Ever RSV Vaccine After Brutal 2022 Season,https://www.forbes.com/sites/mollybohannon/2023/05/03/fda-approves-first-ever-rsv-vaccine-after-brutal-2022-season/,2023-05-03 18:48:30,"Decades after the first attempt was made, an RSV vaccine has finally been approved by the FDA.",PFE,0.079392,-0.017664,Neutral
FDA approves United States' first-ever RSV vaccine,https://www.axios.com/2023/05/03/fda-approves-first-rsv-vaccine-gsk,2023-05-03 17:55:51,"The Food and Drug Administration on Wednesday approved GlaxoSmithKline's vaccine against the respiratory syncytial virus, making it the first authorized RSV shot in the U.S.",PFE,0.1331,0.190628,Somewhat-Bullish
"GSK Beats Pfizer, Moderna To RSV Finish Line - And Pops",https://www.investors.com/news/technology/gsk-stock-jumps-after-beating-pfizer-moderna-to-the-rsv-vaccine-finish-line/,2023-05-03 17:35:00,"GSK Stock Jumps After Beating Pfizer, Moderna To The RSV ... Investor's Business Daily ...",PFE,0.432291,0.376871,Bullish
US FDA approves first RSV vaccine from GSK,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-rsv-vaccine-gsk-2023-05-03/,2023-05-03 17:15:00,US FDA approves first RSV vaccine from ...,PFE,0.113597,0.087414,Neutral
R.S.V. Vaccine Approved for Older Adults,https://www.nytimes.com/2023/05/03/health/rsv-vaccine-fda-adults.html,2023-05-03 17:09:42,The shots would be the first vaccines available against a respiratory virus that kills thousands and leads to many more hospitalizations each year.,PFE,0.261818,0.149659,Neutral
"FDA approves GSK's RSV vaccine for older adults, world's first shot against virus",https://www.cnbc.com/2023/05/03/rsv-vaccine-fda-approves-gsk-shot-for-older-adults.html,2023-05-03 17:08:05,The FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that targets respiratory syncytial virus to the market.,PFE,0.122269,0.139034,Neutral
WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaphan to Emcee Melanoma Research Foundation's Miles for Melanoma 5K,https://www.benzinga.com/pressreleases/23/05/n32191762/wcvb-channel-5-chronicle-reporter-and-producer-nicole-estaphan-to-emcee-melanoma-research-foundati,2023-05-03 16:00:00,"BOSTON, May 3, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation ( MRF ) is thrilled to announce that WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaphan will be returning as the event emcee for the annual Miles for Melanoma New England 5K event on Saturday, May 13, 2023, at ...",PFE,0.070725,0.14788,Neutral
Here's Why You Should Retain Exact Sciences  ( EXAS )  Stock Now,https://www.zacks.com/stock/news/2089307/heres-why-you-should-retain-exact-sciences-exas-stock-now,2023-05-03 15:59:00,Investors are optimistic about Exact Sciences (EXAS) on continued strength across the Screening and Precision Oncology businesses.,PFE,0.046273,0.163993,Somewhat-Bullish
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/05/32191118/looking-at-pfizers-recent-unusual-options-activity,2023-05-03 15:32:52,"A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and ...",PFE,0.915019,0.334301,Somewhat-Bullish
"Is This Incredibly Cheap, High-Yield Dividend Stock a Screaming Buy After Q1 Earnings?",https://www.fool.com/investing/2023/05/03/is-this-incredibly-cheap-high-yield-dividend-stock/,2023-05-03 15:00:00,Pfizer's 4.2% dividend yield is among the highest within its peer group. The drugmaker's stock is also grossly undervalued based on a lesser-known but important valuation metric.,PFE,0.374624,-0.029457,Neutral
"Analgesic Infusion Pumps Market to Reach USD 1.72 Billion by 2032, Driven by Rising Prevalence of Chronic Pain and Surgical Procedures",https://markets.businessinsider.com/news/stocks/analgesic-infusion-pumps-market-to-reach-usd-1-72-billion-by-2032-driven-by-rising-prevalence-of-chronic-pain-and-surgical-procedures-1032286876,2023-05-03 14:25:02,"Analgesic Infusion Pumps Market By Product Type ( Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Disposable Infusion Pumps, Others ) , By Application ( Cancer Pain, Labor Pain, Postoperative Pain, Others ) , By Region Forecast to 2032",PFE,0.043818,0.037593,Neutral
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/05/03/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday-.html,2023-05-03 13:29:01,"The Federal Reserve is widely expected to raise interest rates by another 25 basis points, while a slate of Club holdings report quarterly results.",PFE,0.146916,0.073009,Neutral
Eli Lilly Surges After Alzheimer's Drug Cuts Cognitive Decline,https://www.investors.com/news/technology/eli-lilly-stock-surges-after-alzheimers-treatment-succeeds-in-final-phase-study/,2023-05-03 13:16:00,Eli Lilly Stock Surges After Alzheimer's Treatment Succeeds In Final ... Investor's Business Daily ...,PFE,0.197413,0.163765,Somewhat-Bullish
SunPower Stock Dims On Unexpectedly Steep Losses,https://www.investors.com/news/technology/spwr-stock-sunpower-earnings-q1-2023/,2023-05-03 12:55:00,SPWR Stock Dims On Unexpectedly Steep Losses Investor's Business Daily ...,PFE,0.279015,0.213105,Somewhat-Bullish
"Pharma Giant Pfizer To Start Selling Haleon Stake Within Months, CFO Says - Haleon  ( NYSE:HLN ) ",https://www.benzinga.com/news/earnings/23/05/32181530/pharma-giant-pfizer-to-start-selling-haleon-stake-within-months-cfo-says,2023-05-03 12:51:33,"Pfizer Inc PFE is reportedly looking to start selling its stake in Haleon plc HLN. In June last, the pharma giant announced its plans to exit the ownership interest in Haleon in a disciplined manner after the demerger.",PFE,0.538389,0.079035,Neutral
Only 2 Companies Are AAA Rated As U.S. Risks Being A Deadbeat,https://www.investors.com/etfs-and-funds/sectors/sp500-companies-cling-to-aaa-rating-as-u-s-risks-being-a-deadbeat/,2023-05-03 12:00:00,Lawmakers are playing chicken with the debt ceiling - and the U.S.' creditworthiness. Luckily there are still two U.S. S&P 500 companies left with perfect AAA credit ratings - a key asset with interest rates on the rise.,PFE,0.121343,0.159645,Somewhat-Bullish
TrendMiner Applauded by Frost & Sullivan for Global Product Leadership in the Category of Industrial Analytics,https://www.prnewswire.com/news-releases/trendminer-applauded-by-frost--sullivan-for-global-product-leadership-in-the-category-of-industrial-analytics-301814552.html,2023-05-03 11:34:00,TrendMiner Applauded by Frost & Sullivan for Global Product ... PR ...,PFE,0.051221,0.092457,Neutral
TrendMiner Applauded by Frost & Sullivan for Global Product Leadership in the Category of Industrial Analytics,https://www.newswire.ca/news-releases/trendminer-applauded-by-frost-amp-sullivan-for-global-product-leadership-in-the-category-of-industrial-analytics-831805001.html,2023-05-03 11:34:00,TrendMiner Applauded by Frost & Sullivan for Global Product ... Canada ...,PFE,0.051221,0.092457,Neutral
"AMD To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Wednesday - AmerisourceBergen  ( NYSE:ABC ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/news/23/05/32183589/amd-to-rally-around-32-here-are-10-other-analyst-forecasts-for-wednesday,2023-05-03 11:30:39,"Needham cut the price target for Zebra Technologies Corporation ZBRA from $385 to $340. Needham analyst James Ricchiuti maintained a Buy rating. Zebra Technologies shares fell 11.1% to close at $255.44 on Tuesday. Mizuho lowered the price target for Coinbase Global, Inc. COIN from $30 to $27.",PFE,0.29234,0.008763,Neutral
CVS beats on earnings and revenue but lowers profit outlook,https://www.cnbc.com/2023/05/03/cvs-earnings-q1-2023.html,2023-05-03 10:54:06,CVS lowered its earnings outlook due to costs associated with recent acquisitions.,PFE,0.162802,-0.127018,Neutral
Eli Lilly Alzheimer's treatment donanemab slowed disease progression in clinical trial,https://www.cnbc.com/2023/05/03/alzheimers-eli-lilly-treatment-donanemab-slowed-disease-progression.html,2023-05-03 10:00:01,"Donanemab, a monthly antibody infusion made by pharmaceutical company Eli Lilly, also significantly reduced brain plaque associated with Alzheimer's disease.",PFE,0.04028,-0.086933,Neutral
"Haleon is not losing ground to cheaper rivals, says CFO",https://www.reuters.com/business/healthcare-pharmaceuticals/haleon-is-not-losing-ground-private-label-competition-says-cfo-2023-05-03/,2023-05-03 09:57:19,"Haleon is not losing ground to private-label competition, says ...",PFE,0.112532,0.17721,Somewhat-Bullish
Why Pfizer Is Among the Best High-Yield Dividend Stocks on the Market Now,https://www.fool.com/investing/2023/05/03/pfizer-best-high-yield-dividend-stocks/,2023-05-03 09:52:00,Don't let the short-term headwinds the big pharma company faces fool you.,PFE,0.669232,0.258655,Somewhat-Bullish
Haleon quarterly profit squeezed by higher costs,https://www.reuters.com/business/healthcare-pharmaceuticals/haleon-q1-profit-misses-analyst-expectations-2023-05-03/,2023-05-03 06:20:00,"LONDON, May 3 ( Reuters ) - Haleon ( HLN.L ) , the world's biggest standalone consumer health business, on Wednesday reported first-quarter profit below analyst expectations. The company said it generated adjusted earnings per share of 4.2 pence on revenue of nearly 3 billion pounds.",PFE,0.220809,-0.049813,Neutral
Pfizer  ( PFE )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/02/pfizer-pfe-q1-2023-earnings-call-transcript/,2023-05-03 01:30:36,"PFE earnings call for the period ending March 31, 2023.",PFE,0.055347,0.138009,Neutral
Voyager Therapeutics Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting,https://www.globenewswire.com/news-release/2023/05/02/2659805/36461/en/Voyager-Therapeutics-Announces-Multiple-Data-Presentations-at-the-American-Society-of-Gene-and-Cell-Therapy-26th-Annual-Meeting.html,2023-05-02 20:30:00,"CAMBRIDGE, Mass., May 02, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( NASDAQ: VYGR ) , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced seven data presentations at the upcoming American Society of Gene and Cell Therapy ( ...",PFE,0.034381,0.036615,Neutral
Retail Pharmacies Add New Services As Specialty Drugs Take Greater Role,https://www.forbes.com/sites/brucejapsen/2023/05/02/retail-pharmacies-add-new-services-as-specialty-drugs-take-greater-role/,2023-05-02 20:03:41,"Retailers, grocers and drugstores are transforming with more pharmacy services - from infusion suites to state-of-the-art cold storage - to accommodate the increasing number of specialized drugs patients are prescribed.",PFE,0.046724,0.036483,Neutral
Gilead Sciences battles U.S. government in court over HIV prevention patent,https://www.cnbc.com/2023/05/02/gilead-government-trial-hiv-prevention-drug.html,2023-05-02 18:46:58,The U.S. claims Gilead's drugs Truvada and Descovy infringe on CDC patents.,PFE,0.102013,-0.098913,Neutral
"US Stocks Tumble As Banking Stress Persists Ahead Of High-Risk FOMC: Energy Collapses As Oil Dips 5% - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/05/32151628/stock-futures-signal-muted-open-as-fed-starts-2-day-meet-today-analyst-sees-good-chance-of-new-hi-1,2023-05-02 17:59:00,"Tuesday is a heavy risk-off day on the U.S. stock market, with losses recorded by all major indices and sectors, as tensions in the regional banking industry remain high ahead of a crucial Federal Open Market Committee meeting.",PFE,0.09402,-0.342802,Somewhat-Bearish
Pfizer first-quarter results beat expectations despite COVID-19 vaccine sales plunge,https://www.marketwatch.com/story/pfizer-stock-rallies-toward-4-day-win-streak-after-big-profit-and-revenue-beats-reiterated-outlook-c3ac1da7,2023-05-02 17:51:00,New product launches expected to accelerate non-COVID sales later this year ...,PFE,0.742397,0.262394,Somewhat-Bullish
"Pfizer  ( PFE )  Q1 Earnings Beat, COVID Jab Sales Down as Expected",https://www.zacks.com/stock/news/2088433/pfizer-pfe-q1-earnings-beat-covid-jab-sales-down-as-expected,2023-05-02 17:50:00,"Pfizer (PFE) beats estimates for Q1 earnings and sales. Revenues from its COVID-19 vaccine, Comirnaty declined, as expected.",PFE,0.423694,0.063717,Neutral
"Moore Kuehn Encourages ISEE, MDWT, CBOF, and SGEN Investors to Contact Law Firm - IVERIC bio  ( NASDAQ:ISEE ) , Cboa Finl  ( OTC:CBOF ) ",https://www.benzinga.com/pressreleases/23/05/g32168325/moore-kuehn-encourages-isee-mdwt-cbof-and-sgen-investors-to-contact-law-firm,2023-05-02 17:42:27,"NEW YORK, May 02, 2023 ( GLOBE NEWSWIRE ) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.",PFE,0.109956,0.212275,Somewhat-Bullish
Seasonality Hacked Away At Incyte's First-Quarter Sales,https://www.investors.com/news/technology/incyte-stock-crumbles-as-seasonality-hacks-at-first-quarter-sales/,2023-05-02 17:32:00,Incyte Stock Crumbles As Seasonality Hacks At First-Quarter Sales ... Investor's Business Daily ...,PFE,0.082963,0.104889,Neutral
"Fed Seen Hiking Again, But What's Its Next Step? Trading Could Be Subdued As FOMC Meeting Begins",https://www.benzinga.com/federal-reserve/23/05/32166433/fed-seen-hiking-again-but-whats-its-next-step-trading-could-be-subdued-as-fomc-meeting-begins,2023-05-02 16:27:29,( Tuesday market open ) Cue up the Jeopardy theme music as the entire market waits for tomorrow's Federal Open Market Committee ( FOMC ) rate decision.,PFE,0.060236,0.0,Neutral
StockNews.com Downgrades Eagle Pharmaceuticals Rating from 'Buy' to 'Hold': What Investors Need to Know,https://beststocks.com/stocknews-com-downgrades-eagle-pharmaceuticals-rat/,2023-05-02 15:37:22,StockNews.com Downgrades Eagle Pharmaceuticals Rating from ... Best Stocks ...,PFE,0.073098,0.027343,Neutral
Market Eagerly Awaits Outcome of Fed FOMC Meet,https://www.zacks.com/stock/news/2088281/market-eagerly-awaits-outcome-of-fed-fomc-meet,2023-05-02 15:11:00,"We closed down a tad on Monday afternoon in what is destined to be the busiest week of Q1 earnings season so far, and this morning it looks as if we're following suit. All four major indices are light in the red this morning, with the blue-chip Dow -0.23% at this hour and the small-cap Russell ...",PFE,0.137671,0.249897,Somewhat-Bullish
"JOLTS Data After the Bell, Q1 Reports for PFE, UBER & More",https://www.zacks.com/stock/news/2088251/jolts-data-after-the-bell-q1-reports-for-pfe-uber-more,2023-05-02 14:32:00,"The JOLTS report for March will be out today, making it the first of several employment-related releases out this week.",PFE,0.129866,0.073967,Neutral
Antacids Market Is Expected to Reach $9.1 Billion by 2032: Allied Market Research,https://www.benzinga.com/pressreleases/23/05/g32161276/antacids-market-is-expected-to-reach-9-1-billion-by-2032-allied-market-research,2023-05-02 13:55:08,"Portland, OR, May 02, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global antacids market generated $6.7 billion in 2022 and is estimated to reach $9.1 billion by 2032, witnessing a CAGR of 3.1% from 2023 to 2032.",PFE,0.038345,0.109189,Neutral
"No Surprises For Pfizer Earnings: Q1 Profit Beats Wall Street Estimates, Maintains Annual Guidance - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/05/32153517/no-surprises-for-pfizer-earnings-q1-profit-beats-wall-street-estimates-maintains-annual-guidance,2023-05-02 13:17:05,"Pfizer Inc PFE has reported a Q1 adjusted EPS of $1.23, down 24% Y/Y, beating the consensus of $0.98. It clocked revenues of $18.28 billion, down $28.76% year-over-year, surpassing the Wall Street estimate of $16.59 billion.",PFE,0.863608,0.249104,Somewhat-Bullish
"US STOCKS-Futures subdued on U.S. debt ceiling jitters, Fed meet in focus | The Financial Express",https://www.financialexpress.com/market/us-stocks-futures-subdued-on-u-s-debt-ceiling-jitters-fed-meet-in-focus/3071806/,2023-05-02 13:02:47,"US STOCKS-Futures subdued on U.S. debt ceiling jitters, Fed meet ... The Financial Express ...",PFE,0.085324,-0.011734,Neutral
Pfizer's Dramatic Sales Decline Wasn't As Bad As Expected,https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q1-2023/,2023-05-02 12:50:00,Pfizer Stock: Covid Revenues Plummet - But Not As Badly As ... Investor's Business Daily ...,PFE,0.90178,0.323282,Somewhat-Bullish
"Futures Fall Ahead Of Key Data, Fed Meeting",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-dip-ahead-of-key-economic-data-fed-meeting-tesla-hikes-prices/,2023-05-02 12:39:00,"Dow Jones futures slipped Tuesday morning ahead of key economic data, led by factory orders and the JOLTS jobs report. Meanwhile, the Federal Reserve's two-day policy meeting kicks off Tuesday. EV giant Tesla ( TSLA ) raised prices on its cars in Canada, China, Japan and the U.S.",PFE,0.072802,0.056003,Neutral
"Stocks making the biggest premarket moves: Uber, Pfizer, Chegg, Dell & more",https://www.cnbc.com/2023/05/02/stocks-making-the-biggest-premarket-moves.html,2023-05-02 12:13:09,These are the stocks posting the largest moves in the premarket.,PFE,0.060848,-0.016019,Neutral
Pfizer  ( PFE )  Tops Q1 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2087900/pfizer-pfe-tops-q1-earnings-and-revenue-estimates,2023-05-02 12:05:05,"Pfizer (PFE) delivered earnings and revenue surprises of 23% and 7.82%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.405651,0.146971,Neutral
Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models,https://www.benzinga.com/pressreleases/23/05/g32153627/ten63-therapeutics-raises-15-9-million-in-oversubscribed-series-a-financing-to-drug-the-undruggabl,2023-05-02 11:30:00,"Ten63's foundation is built on research developed by world-renowned computational scientists at Duke University Proprietary BEYOND platform searches over 100 trillion synthetically feasible molecules, enabling the development of first- and best-in-class therapeutics",PFE,0.033282,0.198152,Somewhat-Bullish
Pfizer beats profit estimates as new drugs offset Covid products slump,https://www.business-standard.com/companies/news/pfizer-beats-profit-estimates-as-new-drugs-offset-covid-products-slump-123050200784_1.html,2023-05-02 11:24:15,"Pfizer expects 2023 to be a ""transition year"" for its Covid products, before potential returning to growth in ...",PFE,0.432291,0.175001,Somewhat-Bullish
Pfizer Reports First-Quarter 2023 Results - Investing News Network,https://investingnews.com/pfizer-reports-first-quarter-2023-results/,2023-05-02 11:24:09,Pfizer Reports First-Quarter 2023 Results Investing News Network ...,PFE,0.269517,0.194835,Somewhat-Bullish
Pfizer tops Q1 forecasts; vaccine sales slide as expected,https://apnews.com/article/pfizer-comirnaty-paxlovid-quarter-d1b6a169bf3a0c24978d1d002fa4583a,2023-05-02 11:05:45,Pfizer tops Q1 forecasts. vaccine sales slide as expected The Associated Press ...,PFE,0.837089,-0.130095,Neutral
"Why US Stock Futures Indicate A Muted Open Today - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/05/32151628/stock-futures-signal-muted-open-as-fed-starts-2-day-meet-today-analyst-sees-good-chance-of-new-high,2023-05-02 11:00:20,Trading in the index futures suggests a nervous opening on Tuesday as Federal Reserve Chairman Jerome Powell and his team begin a two-day monetary policy meeting. This time around the market has to contend with more than the Fed move as the earnings season enters one of its busiest phases.,PFE,0.09495,0.0,Neutral
Voyager Therapeutics Announces First Quarter 2023 Conference Call and Webcast,https://www.globenewswire.com/news-release/2023/05/02/2658942/36461/en/Voyager-Therapeutics-Announces-First-Quarter-2023-Conference-Call-and-Webcast.html,2023-05-02 11:00:00,"CAMBRIDGE, Mass., May 02, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( Nasdaq: VYGR ) a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced it will report first quarter 2023 financial and operating results before the market opens ...",PFE,0.11983,0.043956,Neutral
Voyager Therapeutics Announces First Quarter 2023 Conference Call and Webcast - Voyager Therapeutics  ( NASDAQ:VYGR ) ,https://www.benzinga.com/pressreleases/23/05/g32152216/voyager-therapeutics-announces-first-quarter-2023-conference-call-and-webcast,2023-05-02 11:00:00,"CAMBRIDGE, Mass., May 02, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. VYGR a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced it will report first quarter 2023 financial and operating results before the market opens on Tuesday, ...",PFE,0.115232,0.04203,Neutral
Pfizer beats profit estimates as new drugs offset COVID products slump,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-beats-profit-estimates-strong-demand-new-drugs-2023-05-02/,2023-05-02 10:51:00,Pfizer beats profit estimates on strong demand for new drugs ...,PFE,0.38588,0.265884,Somewhat-Bullish
Pfizer earnings and revenue top expectations despite sales declines,https://www.cnbc.com/2023/05/02/pfizer-pfe-q1-earnings-report-2023.html,2023-05-02 10:49:51,"Pfizer topped analysts' expectations with its first-quarter earnings report, despite a sales decline driven by the lower demand for the company's Covid vaccine.",PFE,0.716023,-0.174509,Somewhat-Bearish
Futures slip ahead of Fed meet; U.S. debt ceiling jitters dent mood,https://www.reuters.com/markets/us/futures-slip-ahead-fed-meet-us-debt-ceiling-jitters-dent-mood-2023-05-02/,2023-05-02 10:23:00,Futures slip ahead of Fed meet. U.S. debt ceiling jitters dent mood ...,PFE,0.073773,0.0,Neutral
Are we in a recession? Elon Musk says the pile of failed banks proves it.,https://www.businessinsider.com/recession-forecast-elon-musk-tesla-larry-summers-treasury-markets-finance-2023-5,2023-05-02 10:15:00,Are We in a Recession? Elon Musk Says the Failed Banks Proves It. - Business Insider ...,PFE,0.046543,0.0,Neutral
"Morning Bid: Volatile news, not markets",https://www.reuters.com/markets/us/global-markets-view-usa-2023-05-02/,2023-05-02 10:04:19,May 2 ( Reuters ) - A look at the day ahead in U.S. and global markets from Mike Dolan A hail of potentially disruptive news developments makes for nervy start to May in world markets - but there's little sign of that in seismographs that capture pending price volatility.,PFE,0.053271,0.0,Neutral
"Pfizer, Ford And 3 Stocks To Watch Heading Into Tuesday - Ford Motor  ( NYSE:F ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/news/earnings/23/05/32147911/pfizer-ford-and-3-stocks-to-watch-heading-into-tuesday,2023-05-02 07:35:19,"With US stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Marriott International, Inc. MAR to post quarterly earnings at $1.84 per share on revenue of $5.41 billion before the opening bell.",PFE,0.524949,0.413283,Bullish
"Investor Optimism Improves Slightly Following JPMorgan's Purchase Of First Republic's Assets - Ford Motor  ( NYSE:F ) , First Republic Bank  ( NYSE:FRC ) ",https://www.benzinga.com/news/earnings/23/05/32146661/investor-optimism-improves-slightly-following-jpmorgans-purchase-of-first-republics-assets,2023-05-02 06:19:12,The CNN Money Fear and Greed index showed slight increase in overall sentiment among U.S. investors. U.S. stocks closed slightly lower after the FDIC confirmed First Republic Bank's FRC deposits and assets will be sold to JPMorgan Chase & Co. JPM.,PFE,0.371523,0.0,Neutral
Morning Bid: RBA shock hike starts huge week for central banks,https://www.reuters.com/markets/europe/global-markets-view-europe-2023-05-02/,2023-05-02 04:48:29,"A look at the day ahead in European and global markets from Asia markets correspondent Kevin Buckland. The Reserve Bank of Australia kicked off a string of major central bank meetings this week by surprising markets with a quarter-point rate hike, when most had been positioned for a pause.",PFE,0.088147,0.0,Neutral
"Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58% - Astellas Pharma  ( OTC:ALPMY ) , Astellas Pharma  ( OTC:ALPMF ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/05/32129041/pfizer-astellas-xtandi-combo-therapy-cuts-risk-of-metastasis-death-in-prostate-cancer-by-58,2023-05-01 18:32:12,Astellas Pharma Inc ALPMY and Pfizer Inc PFE announced detailed Phase 3 EMBARK trial data. The companies tested Xtandi plus leuprolide and Xtandi as a monotherapy against placebo plus leuprolide in men with non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence ( ...,PFE,0.462395,0.236045,Somewhat-Bullish
Novo Nordisk  ( NVO )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2087636/novo-nordisk-nvo-to-report-q1-earnings-whats-in-the-cards,2023-05-01 17:55:00,"Novo Nordisk's (NVO) Diabetes and Obesity Care products are expected to have increased sales in the first quarter of 2023, amid severe competition and pricing pressure in the United States.",PFE,0.234684,0.042758,Neutral
Will Pfizer  ( PFE )  Beat Expectations This Earnings Season?,https://www.zacks.com/stock/news/2087608/will-pfizer-pfe-beat-expectations-this-earnings-season,2023-05-01 16:40:00,"Higher alliance revenues from Eliquis, higher sales of Prevnar vaccines and drugs like Vyndaqel/Vyndamax are likely to have contributed to Pfizer's (PFE) sales growth in Q1.",PFE,0.488469,0.136923,Neutral
"Pivotal Week: FOMC Meeting Just One Highlight Among Many With Jobs Report, Apple Earnings Ahead - Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/markets/23/05/32124360/pivotal-week-fomc-meeting-just-one-highlight-among-many-with-jobs-report-apple-earnings-ahead,2023-05-01 15:31:44,"( Monday market open ) Investors have their pick of news this week, with Apple AAPL reporting on Thursday just a day after another interest rate decision by the Federal Open Market Committee ( FOMC ) and a day before the April jobs report.",PFE,0.083833,0.040983,Neutral
The Targeted Therapy Market Is Projected To Grow At An 8% Rate Through The Forecast Period As Per The Business Research Company's Targeted Therapy Global Market Report 2023,https://www.benzinga.com/pressreleases/23/05/g32124311/the-targeted-therapy-market-is-projected-to-grow-at-an-8-rate-through-the-forecast-period-as-per-t,2023-05-01 15:30:00,"LONDON, May 01, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the targeted therapy market forecasts that the market is expected to expand from $97.3 billion in 2022 to $106.7 billion in 2023, at a compound annual growth rate ( CAGR ) of more than 9%.The targeted therapy ...",PFE,0.066047,0.087133,Neutral
"Substance Abuse And Addiction Treatment Market Size, Share, Revenue, Trends And Drivers For 2023-2032 As Per The Business Research Company's Substance Abuse and Addiction Treatment Global Market Report for 2023",https://www.benzinga.com/pressreleases/23/05/g32124310/substance-abuse-and-addiction-treatment-market-size-share-revenue-trends-and-drivers-for-2023-2032,2023-05-01 15:30:00,"LONDON, May 01, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the substance abuse and addiction treatment market forecasts the market to experience significant growth, increasing from $9.8 billion in 2022 to $10.9 billion in 2023 at a CAGR of more than 11%.",PFE,0.05654,-0.094919,Neutral
Monday's Market Minute: The Waiting Is The Hardest Part,https://www.benzinga.com/markets/23/05/32124147/mondays-market-minute-the-waiting-is-the-hardest-part,2023-05-01 15:25:19,"This week's primary focus for investors and traders is the Fed announcement at 2 p.m. ET on Wednesday afternoon following the two-day policy meeting that begins Tuesday, and then the Non-Farm Payrolls report due on Friday.",PFE,0.200688,-0.007789,Neutral
Covid infection raised risk of facial paralysis more than vax: Report,https://www.business-standard.com/health/covid-infection-raised-risk-of-facial-paralysis-more-than-vax-report-123050100851_1.html,2023-05-01 15:00:33,"Covid infection significantly raises risk of rare Bell's palsy more than vaccination against the infectious disease, according to an international team of researchers from US and Iran. Bell's palsy is the sudden onset of one-sided facial paralysis.",PFE,0.101154,0.0,Neutral
Barbra Streisand Awarded Tenth Anniversary Genesis Prize,https://www.newswire.ca/news-releases/barbra-streisand-awarded-tenth-anniversary-genesis-prize-874257579.html,2023-05-01 14:00:00,"The ""Jewish Nobel"" will celebrate six decades of Streisand's contributions to cinema and music and her commitment to improving the world NEW YORK, May 1, 2023 /CNW/ -- Today, The Genesis Prize Foundation ( GPF ) announced iconic actor, singer, director, author, and activist Barbra Streisand as ...",PFE,0.046907,0.308817,Somewhat-Bullish
Barbra Streisand Awarded Tenth Anniversary Genesis Prize,https://www.benzinga.com/pressreleases/23/05/n32120829/barbra-streisand-awarded-tenth-anniversary-genesis-prize,2023-05-01 14:00:00,"The ""Jewish Nobel"" will celebrate six decades of Streisand's contributions to cinema and music and her commitment to improving the world NEW YORK, May 1, 2023 /PRNewswire/ -- Today, The Genesis Prize Foundation ( GPF ) announced iconic actor, singer, director, author, and activist Barbra ...",PFE,0.045743,0.308665,Somewhat-Bullish
Barbra Streisand Awarded Tenth Anniversary Genesis Prize,https://www.benzinga.com/pressreleases/23/05/n32120841/barbra-streisand-awarded-tenth-anniversary-genesis-prize,2023-05-01 14:00:00,"The ""Jewish Nobel"" will celebrate six decades of Streisand's contributions to cinema and music and her commitment to improving the world NEW YORK, May 1, 2023 /CNW/ -- Today, The Genesis Prize Foundation ( GPF ) announced iconic actor, singer, director, author, and activist Barbra Streisand as ...",PFE,0.04531,0.308597,Somewhat-Bullish
"European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/05/32115596/european-unions-amended-covid-19-vaccine-deal-with-pfizer-biontech-near-monopoly-status-potential,2023-05-01 12:43:32,"The European Union bloc is reportedly negotiating an amended deal with Pfizer Inc PFE and BioNTech SE BNTX for around 70 million COVID-19 vaccine doses, despite the European public prosecutor opening a criminal investigation into their original agreement.",PFE,0.600602,0.411256,Bullish
Futures Down As JPMorgan Buys First Republic Bank,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-jpmorgan-buys-failed-first-republic-bank-frc-stock-plunges-45/,2023-05-01 12:42:00,Dow Jones Futures Fall: JPMorgan Buys Failed First Republic Bank ... Investor's Business Daily ...,PFE,0.049732,0.0,Neutral
Will Pfizer Stock See Higher Levels Post Q1 Earnings?,https://www.forbes.com/sites/greatspeculations/2023/05/01/will-pfizer-stock-see-higher-levels-post-q1-earnings/,2023-05-01 12:00:00,"Not only do we expect Pfizer to post upbeat Q1 results, we find its stock undervalued, as discussed below Our interactive dashboard on Pfizer Earnings Preview has additional details.",PFE,0.638154,-0.003697,Neutral
Galera Expands Commercial Leadership Team,https://www.globenewswire.com/news-release/2023/05/01/2658164/0/en/Galera-Expands-Commercial-Leadership-Team.html,2023-05-01 11:00:00,"Company appoints leading sales, market access and operations executives with decades of experience successfully launching and commercializing new oncology products ...",PFE,0.057536,0.058,Neutral
Clinical Project Manager  ( CPM )  Beginner Training Course,https://www.prnewswire.com/news-releases/clinical-project-manager-cpm-beginner-training-course-301829578.html,2023-05-20 00:00:00,"DUBLIN, May 19, 2023 /PRNewswire/ -- The ""Clinical Project Manager ( CPM ) Beginner"" training has been added to ResearchAndMarkets.com's offering. If you are looking to enter the field of clinical research, this CPD-accredited is for you.",PFE,0.072655,0.033182,Neutral
Pfizer Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/05/32494902/pfizer-unusual-options-activity,2023-05-19 20:46:08,"A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer PFE we detected 14 strange trades. If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with bullish expectations and ...",PFE,0.803596,0.15581,Somewhat-Bullish
What Are Penny Stocks & Should You Buy Them In 2023?,https://pennystocks.com/featured/2023/05/19/what-are-penny-stocks-should-you-buy-them-2023/,2023-05-19 19:32:22,"In this article, we're going to go over some basics. We'll discuss the definition of penny stocks, the pros & cons, plus some extra details you should know before jumping into the market. A penny stock represents the stock of a company that trades for less than $5 per share.",PFE,0.052169,0.120545,Neutral
RDY: Dr. Reddy's Laboratories  ( RDY )  Is the Pharmaceutical Stock to Buy,https://stocknews.com/news/rdy-abbv-nvs-bmy-dr-reddys-laboratories-rdy-is-the-pharmaceutical-stock-to-buy/,2023-05-19 16:27:32,RDY: Dr. Reddy's Laboratories ( RDY ) Is the Pharmaceutical Stock to ... ...,PFE,0.035138,-0.050351,Neutral
NOT REAL NEWS: A look at what didn't happen this week,https://apnews.com/article/fact-check-misinformation-joe-biden-immigration-cdc-fc0109189d6d8ca9b4994e2822b9793b,2023-05-19 15:29:55,"A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts:",PFE,0.157741,0.001365,Neutral
"WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/05/32486404/who-recommends-new-covid-booster-shots-to-target-xbb-variants-despite-slower-uptake,2023-05-19 14:51:21,"An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the upcoming winter season. The shots currently used in the U.K. and U.S. target the original omicron strain, to which the XBB.1.5 or XBB.1.16 ...",PFE,0.338582,0.044044,Neutral
Pfizer's  ( PFE )  RSV Vaccine for Infants Gets FDA Panel Vote,https://www.zacks.com/stock/news/2097433/pfizers-pfe-rsv-vaccine-for-infants-gets-fda-panel-vote,2023-05-19 14:46:00,The FDA's decision on Pfizer's (PFE) BLA seeking approval for its RSV vaccine candidate in infants through maternal immunization is expected in August.,PFE,0.207571,0.261084,Somewhat-Bullish
"Global Pharma, Biotech and Diagnostics Co-development Partnering Deals Analysis Report 2023 with a Directory of Deals - Comprehensive Access to Actual Co-development Contracts",https://www.prnewswire.com/news-releases/global-pharma-biotech-and-diagnostics-co-development-partnering-deals-analysis-report-2023-with-a-directory-of-deals---comprehensive-access-to-actual-co-development-contracts-301829437.html,2023-05-19 14:15:00,"Global Pharma, Biotech and Diagnostics Co-development ... PR ...",PFE,0.035138,0.0,Neutral
1 Dirt Cheap Dividend Stock to Buy in May,https://www.fool.com/investing/2023/05/19/1-dirt-cheap-dividend-stock-to-buy-in-may/,2023-05-19 14:07:00,Don't wait too long before getting in on this excellent drugmaker.,PFE,0.062926,0.086378,Neutral
Pharma Stock Roundup: FDA Nod to ABBV's Rinvoq for New Indication & Other Updates,https://www.zacks.com/stock/news/2097319/pharma-stock-roundup-fda-nod-to-abbvs-rinvoq-for-new-indication-other-updates,2023-05-19 13:29:00,FDA panel votes in favor of Pfizer's (PFE) experimental maternal RSV vaccine. FDA approves AbbVie's (ABBV) Rinvoq for Crohn's Disease.,PFE,0.271777,0.098546,Neutral
Abbott's India arm posts 9.5% rise in fourth-quarter profit | The Financial Express,https://www.financialexpress.com/industry/abbotts-india-arm-posts-9-5-rise-in-fourth-quarter-profit/3094502/,2023-05-19 13:09:19,Abbott's India arm posts 9.5% rise in fourth-quarter profit The Financial Express ...,PFE,0.229149,0.098059,Neutral
FDA Votes In Favor Of Pfizer's Maternal RSV Vaccine To Prevent Disease In Infants - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/05/32483585/fda-votes-in-favor-of-pfizers-maternal-rsv-vaccine-to-prevent-disease-in-infants,2023-05-19 13:00:41,The U.S. Food and Drug Administration ( FDA ) voted that the available data support the efficacy and safety of Pfizer Inc's PFE unadjuvanted bivalent respiratory syncytial virus ( RSV ) prefusion F vaccine candidate RSVpreF or PF-06928316.,PFE,0.483434,0.243697,Somewhat-Bullish
Pfizer Inc.  ( PFE )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2097288/pfizer-inc-pfe-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-05-19 13:00:12,"Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",PFE,0.495015,0.160015,Somewhat-Bullish
Abbott's India arm posts 9.5% rise in fourth-quarter profit,https://www.reuters.com/business/healthcare-pharmaceuticals/abbotts-india-arm-posts-95-rise-fourth-quarter-profit-2023-05-19/,2023-05-19 11:32:00,"BENGALURU, May 19 ( Reuters ) - Abbott India Ltd ( ABOT.NS ) reported a 9.5% jump in fourth-quarter profit on Friday, helped by strong sales in its mainstay pharmaceuticals segment.",PFE,0.165031,0.071971,Neutral
It's the busiest week of the year for the bond market,https://www.axios.com/2023/05/19/bond-markets-us-debt-ceiling,2023-05-19 10:37:59,The looming risk of a U.S. debt default is showing up in the bond ... ...,PFE,0.16849,0.036008,Neutral
"Stocks to Watch today, Friday, May 19. 2023: ITC, Thomas Cook, Zomato, Nexus REIT, IndiGo",https://www.business-standard.com/markets/news/stocks-to-watch-today-may-19-itc-thomas-cook-zomato-nexus-reit-indigo-123051900123_1.html,2023-05-19 02:37:47,"Stocks to Watch on Friday: ITC Limited reported a 21.4 per cent YoY growth in standalone net profit at Rs 5,086.9 crore for the March quarter ...",PFE,0.072362,0.030155,Neutral
"Stocks To Watch: ITC, SBI, Zydus Lifesciences, Pfizer, PNB Housing Finance, GAIL  ( India ) , Jubilant FoodWorks | The Financial Express",https://www.financialexpress.com/market/stocks-to-watch-itc-sbi-zydus-lifesciences-pfizer-pnb-housing-finance-gail-india-jubilant-foodworks/3093312/,2023-05-19 02:04:18,"Stocks To Watch: ITC, SBI, Zydus Lifesciences, Pfizer, PNB Housing ... The Financial Express ...",PFE,0.085936,-0.160674,Somewhat-Bearish
"Buzzing Stocks: Pfizer, Rail Vikas Nigam, United Spirits, Bata, IndiGo & others in focus today",https://www.moneycontrol.com/news/photos/business/stocks/buzzing-stocks-pfizer-rail-vikas-nigam-united-spirits-bata-indigo-others-in-focus-today-10617531.html,2023-05-19 01:33:15,Stocks to Watch: Check out the companies making headlines before the opening bell today.,PFE,0.238133,-0.07088,Neutral
RSV Vaccine: FDA Advisors Recommend Pfizer Shot To Protect Infants From Infection-Here's What To Know,https://www.forbes.com/sites/roberthart/2023/05/18/rsv-vaccine-fda-advisors-recommend-pfizer-shot-to-protect-infants-from-infection-heres-what-to-know/,2023-05-18 23:46:50,The vaccine is given to pregnant people to protect infants from RSV in their first months of life.,PFE,0.125898,0.061808,Neutral
FDA advisers vote in favor of Pfizer's maternal RSV vaccine,https://www.marketwatch.com/story/fda-advisers-vote-in-favor-of-pfizer-maternal-rsv-vaccine-c90afdaf,2023-05-18 22:10:00,"If approved, vaccine would be the first in U.S. to protect babies against leading cause of hospitalization ...",PFE,0.391923,0.203046,Somewhat-Bullish
FDA advisers endorse maternal vaccine for RSV,https://www.axios.com/2023/05/18/fda-advisers-rsv-maternal-vaccine,2023-05-18 21:46:48,FDA advisers endorse maternal vaccine for ...,PFE,0.166743,0.100445,Neutral
FDA advisers back RSV vaccine for pregnant women that protects their newborns,https://apnews.com/article/rsv-vaccine-respiratory-syncytial-virus-pregnant-42330f5b3ce608f9c5b1f4d8ed91594f,2023-05-18 21:33:45,FDA advisers back RSV vaccine for pregnant women that protects ... The Associated Press ...,PFE,0.139064,0.014092,Neutral
F.D.A. Panel Recommends R.S.V. Vaccine to Protect Young Infants,https://www.nytimes.com/2023/05/18/health/rsv-vaccine-infants-fda.html,2023-05-18 21:17:55,"A committee of experts voted in favor of a new shot administered to pregnant women, one in a series of new ways to arm the very young against a life-threatening virus.",PFE,0.283167,-0.00857,Neutral
FDA advisors recommend Pfizer's RSV vaccine for infants but raise safety concerns,https://www.cnbc.com/2023/05/18/rsv-vaccine-fda-advisors-recommend-pfizers-shot-for-infants-.html,2023-05-18 20:52:12,The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus season in the fall.,PFE,0.07887,0.078135,Neutral
Pfizer Named Top Dividend Stock With Insider Buying And 4.46% Yield,https://www.forbes.com/sites/dividendchannel/2023/05/18/pfizer-named-top-dividend-stock-with-insider-buying-and-446-yield/,2023-05-18 19:15:48,"Back on May 8, Gottlieb invested $77,005.00 into 2,000 shares of PFE, for a cost per share of $38.50.",PFE,0.648164,0.512129,Bullish
WHO recommends new Covid-19 shots should target only XBB variants,https://www.business-standard.com/world-news/who-recommends-new-covid-19-shots-should-target-only-xbb-variants-123051900008_1.html,2023-05-18 18:37:46,WHO recommends new Covid-19 shots should target only XBB ... Business Standard ...,PFE,0.124164,0.027609,Neutral
Patent Infringement Case: Delhi HC relies on WayBack Machine evidence,https://www.business-standard.com/india-news/delhi-hc-relies-on-wayback-machine-evidence-in-patent-infringement-case-123051801126_1.html,2023-05-18 16:42:48,Delhi HC relies on WayBack Machine evidence in patent ... Business Standard ...,PFE,0.12165,-0.048786,Neutral
Neighbourhood Pharmacy Association of Canada Announces Dayle Acorn as Recipient of Len Marks Pharmacy Advancement Award and Jeff Watson as Recipient of Distinguished Associate of the Year Award,https://www.newswire.ca/news-releases/neighbourhood-pharmacy-association-of-canada-announces-dayle-acorn-as-recipient-of-len-marks-pharmacy-advancement-award-and-jeff-watson-as-recipient-of-distinguished-associate-of-the-year-award-829045470.html,2023-05-18 16:10:00,Neighbourhood Pharmacy Association of Canada Announces Dayle ... Canada ...,PFE,0.033144,0.055984,Neutral
Communicator Spotlight: Franz Paasche of PayPal,https://www.axios.com/2023/05/18/communicator-spotlight-franz-paasche-paypal,2023-05-18 15:59:00,Communicator Spotlight: Franz Paasche of ...,PFE,0.115232,0.271153,Somewhat-Bullish
WHO recommends new COVID shots should target only XBB variants,https://www.reuters.com/business/healthcare-pharmaceuticals/who-recommends-new-covid-shots-should-target-only-xbb-variants-2023-05-18/,2023-05-18 15:50:00,May 18 ( Reuters ) - A World Health Organization ( WHO ) advisory group on Thursday recommended that this year's COVID-19 booster shots be updated to target one of the currently dominant XBB variants.,PFE,0.115787,0.026671,Neutral
RSV vaccine for pregnant women protects their newborns but is it ready for US sale?,https://apnews.com/article/rsv-vaccine-respiratory-syncytial-virus-pregnant-42330f5b3ce608f9c5b1f4d8ed91594f,2023-05-18 14:26:27,RSV vaccine for pregnant women protects their newborns but is it ... The Associated Press ...,PFE,0.092927,-0.008605,Neutral
Thinking of Buying Novavax Stock? 3 Numbers You Should Look at First,https://www.fool.com/investing/2023/05/18/novavax-stock-3-numbers-you-should-look-at-first/,2023-05-18 13:53:00,Has the vaccine-focused biotech become a safer investment?,PFE,0.074001,0.087543,Neutral
A secretive annual meeting attended by the world's elite has A.I. top of the agenda,https://www.cnbc.com/2023/05/18/bilderberg-openai-microsoft-google-join-ai-talks-at-secretive-meeting.html,2023-05-18 13:32:39,"OpenAI CEO Sam Altman will join forces with key leadership from Microsoft, DeepMind and Google Thursday as the secretive Bilderberg meeting kickstarts in Lisbon.",PFE,0.062926,0.055011,Neutral
RSV Vaccine: Here's What To Know As FDA Advisors Consider Approving Pfizer's Shot,https://www.forbes.com/sites/roberthart/2023/05/18/rsv-vaccine-heres-what-to-know-as-fda-advisors-consider-approving-pfizers-shot/,2023-05-18 12:31:07,"FDA analysts have flagged concerns over the risk of preterm birth for the shot, which is given to pregnant people to protect infants from RSV in their first months of life.",PFE,0.124164,0.012019,Neutral
Pfizer suspends sale of three antibiotics in India over technical issues,https://www.business-standard.com/companies/news/pfizer-temporarily-suspends-sale-of-3-antibiotics-due-to-technical-issues-123051800856_1.html,2023-05-18 12:17:06,"Investigating matter with contract manufacturer Astral Steritech, says pharma firm ...",PFE,0.492659,-0.23716,Somewhat-Bearish
Corporate America Faces a Bankruptcy Boom,https://www.nytimes.com/2023/05/18/business/dealbook/corporate-bankruptcies-high-debt.html,2023-05-18 12:04:43,New data shows that 2023 is shaping up to be the biggest year for Chapter 11 filings in more than a decade.,PFE,0.019928,-0.033611,Neutral
"Pfizer suspends sale, use of some products in India over quality concerns",https://www.business-standard.com/companies/news/pfizer-suspends-sale-use-of-some-products-in-india-over-quality-concerns-123051800791_1.html,2023-05-18 11:52:24,"Stockists have been asked not to sell, distribute, or use the products until further notice from ...",PFE,0.940812,0.131686,Neutral
Charles Schwab raises $2.5 bln in bond offering amid surge in corporate bond deals,https://www.marketwatch.com/story/charles-schwab-raises-2-5-bln-in-bond-offering-49bf1961,2023-05-18 11:25:00,Charles Schwab Corp. on Thursday disclosed plans for a $2.5 billion bond offering as the corporate bond market continues to pick up steam.,PFE,0.320974,0.170688,Somewhat-Bullish
Google Ups the Ante in the Race for AI Dominance With 2 New Products -- Here's What Investors Should Know,https://www.fool.com/investing/2023/05/18/google-ups-the-ante-in-the-race-for-ai-dominance-w/,2023-05-18 11:05:00,Healthcare AI could become a big growth driver for Google Cloud.,PFE,0.183198,0.060057,Neutral
US FDA advisers to discuss Pfizer's maternal RSV vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-advisers-discuss-pfizers-maternal-rsv-vaccine-2023-05-18/,2023-05-18 11:05:00,May 18 ( Reuters ) - Advisers to the U.S. Food and Drug Administration on Thursday will discuss Pfizer Inc's ( PFE.N ) experimental respiratory syncytial virus ( RSV ) vaccine intended to protect infants through six months of age when given to expectant mothers.,PFE,0.17715,-0.011818,Neutral
How Charlotte Allerton Helped Win A Key Battle Against Covid-19,https://www.investors.com/news/management/leaders-and-success/charlotte-allerton-helped-win-a-key-battle-against-covid-19/,2023-05-18 11:00:00,"Charlotte Allerton was ready for action when the pandemic hit. She led a team of Pfizer scientists to develop Paxlovid as the first oral antiviral treatment for Covid-19. Allerton, Head of Medicine Design and Chief Scientific Officer of Anti-Infectives at Pfizer ( PFE ) , is no stranger to drug ...",PFE,0.362505,0.077463,Neutral
Protalix BioTherapeutics Announces $20 Million Milestone Payment from Chiesi Global Rare Diseases,https://www.prnewswire.com/il/news-releases/protalix-biotherapeutics-announces-20-million-milestone-payment-from-chiesi-global-rare-diseases-301828318.html,2023-05-18 10:50:00,Protalix BioTherapeutics Announces $20 Million Milestone Payment ... PR ...,PFE,0.038592,0.054134,Neutral
Protalix BioTherapeutics Announces $20 Million Milestone Payment from Chiesi Global Rare Diseases,https://www.prnewswire.com/news-releases/protalix-biotherapeutics-announces-20-million-milestone-payment-from-chiesi-global-rare-diseases-301828318.html,2023-05-18 10:50:00,Protalix BioTherapeutics Announces $20 Million Milestone Payment ... PR ...,PFE,0.038592,0.054134,Neutral
"Voyager Therapeutics Presents Robust, Multi-Species Results from Preclinical Studies of IV-Delivered, TRACER™-Generated Novel Capsids at the ASGCT 26th Annual Meeting",https://www.globenewswire.com/news-release/2023/05/18/2671676/36461/en/Voyager-Therapeutics-Presents-Robust-Multi-Species-Results-from-Preclinical-Studies-of-IV-Delivered-TRACER-Generated-Novel-Capsids-at-the-ASGCT-26th-Annual-Meeting.html,2023-05-18 10:00:00,"Oral presentation features further evaluation of second-generation capsids, demonstrating increased transduction in several brain areas across multiple non-human primate species Oral presentation features further evaluation of second-generation capsids, demonstrating increased transduction in ...",PFE,0.022579,0.034598,Neutral
Pharma major Pfizer asks doctors to stop using these life-saving antibiotics; Here's why | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/pharma-major-pfizer-asks-doctors-to-stop-using-these-life-saving-antibiotics-heres-why/3092611/,2023-05-18 09:53:00,Pharma major Pfizer asks doctors to stop using these life-saving ... The Financial Express ...,PFE,0.622414,0.173408,Somewhat-Bullish
"CEOs and other top execs are saving billions with 'top hat' retirement plans, study says",https://www.marketwatch.com/story/ceos-and-other-top-execs-are-saving-billions-with-top-hat-retirement-plans-study-says-e8472535,2023-05-18 04:01:00,There's a separate system for the most highly paid at some companies to defer unlimited amounts of compensation and pay the taxes later.,PFE,0.114682,0.037638,Neutral
Will Google Cloud's New AI Drug Development Tools Impact The Cannabis Industry? - Alphabet  ( NASDAQ:GOOG ) ,https://www.benzinga.com/general/biotech/23/05/32454856/will-google-clouds-new-ai-drug-development-tools-impact-the-cannabis-industry,2023-05-17 22:40:23,Alphabet Inc.'s GOOG Google Cloud introduced two new AI-powered tools that hold the potential to revolutionize the drug development process for biotech and pharmaceutical companies.,PFE,0.090474,0.0,Neutral
Claims misconstrue Pfizer grants received by NIH nominee's nonprofit,https://apnews.com/article/fact-check-NIH-Biden-pfizer-cancer-882296155977,2023-05-17 22:15:31,"CLAIM: A White House press release says that Dr. Monica Bertagnolli, President Joe Biden's pick to lead the National Institutes of Health, received tens of millions of dollars in research money from Pfizer. AP'S ASSESSMENT: False. The image circulating online has been manipulated.",PFE,0.510588,-0.089967,Neutral
Pfizer Unusual Options Activity For May 17 - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/05/32450867/pfizer-unusual-options-activity-for-may-17,2023-05-17 17:16:16,"A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer PFE we detected 20 strange trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and ...",PFE,0.807885,0.15612,Somewhat-Bullish
"Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows",https://www.cnbc.com/2023/05/17/pfizer-to-raise-31-billion-for-seagen-deal-in-debt-offering.html,2023-05-17 16:32:26,"The debt offering by Pfizer to buy cancer drug maker Seagen comes as Apple, Merck and T-Mobile tap the U.S. bond market ahead of the debt ceiling standoff.",PFE,0.466325,-0.07618,Neutral
Biden Says Confident In Reaching Deal To Avert Default,https://www.barrons.com/news/biden-says-confident-in-reaching-deal-to-avert-default-31c21529,2023-05-17 16:30:55,President Joe Biden said Wednesday he was confident about reaching a deal with Republican leaders to avert a potentially catastrophic US debt default as early as June 1.,PFE,0.087824,-0.071295,Neutral
The Turnaround For Weight Watchers Is Taking Shape - WW International  ( NASDAQ:WW ) ,https://www.benzinga.com/news/earnings/23/05/32441821/the-turnaround-for-weight-watchers-is-taking-shape,2023-05-17 14:35:54,Weight management meals and services provider WW International Inc. WW stock made a 52-week high of $10.02 after its Q1 2023 earnings release. Shares collapsed ( 26% ) as Artal Group S.A. sold its remaining 14.8 million share stake.,PFE,0.082535,0.048345,Neutral
"""Recession? Nah"" - Homebuilders, Probably - Cisco Systems  ( NASDAQ:CSCO ) , DLocal  ( NASDAQ:DLO ) ",https://www.benzinga.com/news/23/05/32445736/recession-nah-homebuilders-probably,2023-05-17 13:56:49,"The U.S. now spends more money on servicing its debt than national defense. US factory output bounced back in April. Industrial and manufacturing production both rose more than expected, increasing by 0.5% and 1%, respectively. The gains were driven by the largest jump in auto production since ...",PFE,0.041466,-0.246605,Somewhat-Bearish
Pfizer  ( PFE )  to Raise $31B in Debt to Fund Seagen  ( SGEN )  Deal,https://www.zacks.com/stock/news/2096263/pfizer-pfe-to-raise-31b-in-debt-to-fund-seagen-sgen-deal,2023-05-17 13:36:00,"Pfizer (PFE) offers bonds worth $31 billion to fund its pending acquisition of cancer drugmaker, Seagen (SGEN).",PFE,0.570165,0.075942,Neutral
Washington Confronts the Challenge of Policing A.I.,https://www.nytimes.com/2023/05/17/business/openai-altman-congress-ai-regulation.html,2023-05-17 12:42:36,"Lawmakers and Sam Altman, the chief executive of OpenAI, agreed that artificial intelligence should be regulated. How to do that remains an open question.",PFE,0.021659,-0.287058,Somewhat-Bearish
"FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/05/32440200/fda-signals-support-for-pfizers-maternal-rsv-shot-ahead-of-adcomm-pfizer-raises-31b-in-debt-to-fu,2023-05-17 12:17:34,"Pfizer Inc PFE plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc SGEN for $43 billion. The debt offering, which would be in eight tranches, is expected to close on May 19.",PFE,0.502207,0.207303,Somewhat-Bullish
Pfizer Canada Launches National Initiative to Propel Startup Solutions for Key Challenges in Healthcare,https://www.newswire.ca/news-releases/pfizer-canada-launches-national-initiative-to-propel-startup-solutions-for-key-challenges-in-healthcare-852006421.html,2023-05-17 12:00:00,Pfizer Canada Launches National Initiative to Propel Startup ... Canada ...,PFE,0.750038,0.684051,Bullish
Gluware to Demonstrate Ability to Accelerate Hyperautomation for the World's Most Complex Networks at ONUG Spring 2023,https://www.prnewswire.com/news-releases/gluware-to-demonstrate-ability-to-accelerate-hyperautomation-for-the-worlds-most-complex-networks-at-onug-spring-2023-301826868.html,2023-05-17 12:00:00,Gluware to Demonstrate Ability to Accelerate Hyperautomation for ... PR ...,PFE,0.035241,0.144124,Neutral
Western Alliance Bancorp deposit growth sparks rally in bank stocks,https://www.marketwatch.com/story/western-alliance-bancorp-stock-up-10-after-deposits-grow-regional-bank-stocks-climb-9cb20ec1,2023-05-17 12:00:00,Down-beaten bank stocks are having a positive day so far as Western Alliance's deposit growth triggers gains across the sector.,PFE,0.303175,0.059683,Neutral
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears,https://www.reuters.com/markets/deals/amgens-antitrust-woes-spur-wider-pharmaceutical-deal-fears-2023-05-17/,2023-05-17 10:07:30,"NEW YORK, May 17 ( Reuters ) - Investors are scrambling to assess the fallout of a U.S. regulatory challenge against Amgen Inc's ( AMGN.O ) proposed $27.8 billion acquisition of Horizon Therapeutics Plc ( HZNP.O ) , with some fearing a spillover to other big deals in the drug sector.",PFE,0.216376,0.092528,Neutral
Is This Dow Jones Stock a Buy for Income Investors?,https://www.fool.com/investing/2023/05/17/is-this-dow-jones-stock-a-buy-for-income-investors/,2023-05-17 09:06:00,This pharmaceutical company is dedicated to maintaining its track record of innovation.,PFE,0.118354,0.24216,Somewhat-Bullish
Race for RSV shots heats up with maternal vaccine,https://www.axios.com/2023/05/17/rsv-disease-vaccine-pfizer-gsk-sanofi,2023-05-17 07:15:55,"After decades of research and multiple failed attempts, Americans could find themselves with several respiratory syncytial virus vaccines to choose from by next winter.",PFE,0.248343,0.017128,Neutral
'What I Promised': Greek PM Touts Economy In Re-election Bid,https://www.barrons.com/news/what-i-promised-greek-pm-touts-economy-in-re-election-bid-b4d22d3,2023-05-17 05:30:54,"To build a successful company in Greece, the CEO of the popular ship tracking firm MarineTraffic says he does not ask much from the government. ""What we want from the government is, let us do our jobs, leave us alone,"" says Demitris Memos, whose platform was recently acquired by the prominent ...",PFE,0.053153,0.271872,Somewhat-Bullish
Pfizer borrows $31 billion in mega bond deal as debt issuance picks up ahead of debt-ceiling deadline,https://www.marketwatch.com/story/pfizer-borrows-31-billion-in-mega-bond-deal-as-debt-issuance-picks-up-ahead-of-debt-ceiling-deadline-a1a464b0,2023-05-16 23:54:00,"Pharmaceutical giant Pfizer secures $31 billion in financing on Tuesday, as companies pick up the borrowing pace ahead of a June U.S. debt-ceiling deadline.",PFE,0.417304,0.014432,Neutral
Pfizer plans $31 bln debt offering to fund Seagen takeover,https://www.reuters.com/markets/deals/pfizer-plans-raise-31-bln-debt-offering-finance-seagen-takeover-2023-05-16/,2023-05-16 23:35:41,May 16 ( Reuters ) - Pfizer Inc ( PFE.N ) said on Tuesday it plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc ( SGEN.O ) .,PFE,0.514619,-0.557467,Bearish
Is Novavax Finally Turning Things Around? - Novavax  ( NASDAQ:NVAX ) ,https://www.benzinga.com/news/earnings/23/05/32422604/is-novavax-finally-turning-things-around,2023-05-16 20:47:22,"Vaccine developer Novavax Inc. NVAX stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious diseases, including COVID-19, influenza, respiratory syncytial and Ebola. Its shares ran up to $331.68 on Feb. 9, 2021, on its COVID-19 vaccine, ...",PFE,0.147516,0.051038,Neutral
"Goldman Sachs' Solomon, Pfizer's Bourla, More CEOs Implore Biden, McCarthy To Avoid Disastrous Default - Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/government/23/05/32431273/goldman-sachs-solomon-pfizers-bourla-more-ceos-implore-biden-mccarthy-to-avoid-disastrous-default,2023-05-16 19:44:20,"More than 140 top executives of American corporations issued a letter urging the government to reach a solution to promptly lift the debt ceiling and avert the disastrous implications of a default, just a few hours ahead of the key Joe Biden-Kevin McCarthy meeting later Tuesday.",PFE,0.136888,0.0,Neutral
FTC May Reportedly Block Amgen's  ( AMGN )  $28B Horizon Buyout,https://www.zacks.com/stock/news/2096013/ftc-may-reportedly-block-amgens-amgn-28b-horizon-buyout,2023-05-16 19:16:00,Unconfirmed reports suggest that the FTC may challenge the $28-billion buyout of Horizon Therapeutics (HZNP) by Amgen.,PFE,0.400052,0.226511,Somewhat-Bullish
"FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A - Horizon Therapeutics  ( NASDAQ:HZNP ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/05/32428869/ftc-files-lawsuit-to-stop-amgen-buying-horizon-therapeutics-sending-shockwaves-through-biopharma-,2023-05-16 18:37:11,"In a rare move to block a large pharma deal, the U.S. Federal Trade Commission would sue to stop Amgen Inc's AMGN $28 billion takeover of Horizon Therapeutics PLC HZNP.",PFE,0.246582,0.087309,Neutral
Could Latecomer Moderna Match Big Pharma Rivals in RSV?,https://www.fool.com/investing/2023/05/16/could-latecomer-moderna-match-rivals-in-rsv/,2023-05-16 18:00:00,RSV is a key part of Moderna's respiratory vaccine business.,PFE,0.30928,0.405675,Bullish
FTC sues to block Amgen's acquisition of Horizon Therapeutics,https://www.marketwatch.com/story/ftc-sues-to-block-amgens-acquisition-of-horizon-therapeutics-39a5cd1,2023-05-16 17:44:00,"Deal could allow Amgen to ""entrench the monopoly positions"" of two Horizon medications, regulators say.",PFE,0.160099,0.128818,Neutral
"Stocks making the biggest moves midday: Horizon Therapeutics, Capital One, RH, Home Depot and more",https://www.cnbc.com/2023/05/16/stocks-making-the-biggest-moves-midday.html,2023-05-16 16:38:26,These are the stocks posting the largest moves midday.,PFE,0.054983,-0.023007,Neutral
"German study looked into COVID's impact on the brain, not vaccine effects",https://apnews.com/article/fact-check-study-covid-vaccines-infection-brain-damage-914340054420,2023-05-16 16:14:38,"German study looked into COVID's impact on the brain, not vaccine ... The Associated Press ...",PFE,0.092927,0.093879,Neutral
Lexicon Strategies strengthens nationwide and international coverage with two new partners,https://www.benzinga.com/pressreleases/23/05/g32426926/lexicon-strategies-strengthens-nationwide-and-international-coverage-with-two-new-partners,2023-05-16 16:02:32,"ATLANTA, May 16, 2023 ( GLOBE NEWSWIRE ) -- Two experienced international consultants, Sheryl Golub and Amelia Schaffner, have joined Lexicon Strategies as partners.",PFE,0.060694,0.20657,Somewhat-Bullish
FTC's Amgen Activism Will Spare These Biotechs,https://www.wsj.com/articles/ftcs-amgen-activism-will-spare-these-biotechs-310cc702,2023-05-16 15:47:00,Federal Trade Commission action to block Amgen-Horizon deal threatens the thesis driving biotech stocks higher.,PFE,0.395012,-0.140048,Neutral
FDA staff supports safety data for Pfizer's RSV vaccine to protect newborns,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-say-safety-data-favorable-pfizers-rsv-vaccine-protect-newborns-2023-05-16/,2023-05-16 15:46:00,FDA staff supports safety data for Pfizer's RSV vaccine to protect ... ...,PFE,0.214937,0.088887,Neutral
Abortion pill case heads back to federal appeals court: What's at stake,https://www.marketwatch.com/story/abortion-pill-case-heads-back-to-federal-appeals-court-whats-at-stake-b3155343,2023-05-16 15:23:00,"Case threatens to ""wreak havoc"" on drug development and approval, drugmakers say ...",PFE,0.098456,-0.118628,Neutral
"The Zacks Analyst Blog Highlights Visa, Pfizer, SAP SE, International Business Machines and The Boeing",https://www.zacks.com/stock/news/2095939/the-zacks-analyst-blog-highlights-visa-pfizer-sap-se-international-business-machines-and-the-boeing,2023-05-16 14:59:00,"Visa, Pfizer, SAP SE, International Business Machines and The Boeing are part of the Zacks top Analyst Blog.",PFE,0.724687,0.0,Neutral
Is Novo Nordisk Stock a Screaming Buy Right Now?,https://www.fool.com/investing/2023/05/16/is-novo-nordisk-stock-a-screaming-buy-right-now/,2023-05-16 14:45:00,The drugmaker's shares have crushed the broader markets over the past two years. Can it keep up this blistering momentum?,PFE,0.05833,0.145998,Neutral
"Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine",https://www.cnbc.com/2023/05/16/google-cloud-launches-ai-tools-to-accelerate-drug-discovery.html,2023-05-16 12:00:01,The solutions mark Google's latest advancements in the AI arms race and hope to address a long-standing issue facing biotech and pharmaceutical companies.,PFE,0.025487,0.044892,Neutral
Erasca Further Strengthens Business Leadership with Two Key Promotions - Erasca  ( NASDAQ:ERAS ) ,https://www.benzinga.com/pressreleases/23/05/g32418880/erasca-further-strengthens-business-leadership-with-two-key-promotions,2023-05-16 12:00:00,"David Chacko, M.D., previously Erasca's Chief Financial Officer, has been promoted to the dual position of Chief Financial Officer and Chief Business Officer Nik Chetwyn, Ph.D., previously Erasca's SVP of Operations, has been promoted to Chief Operating Officer",PFE,0.055236,0.035952,Neutral
Aspergillosis Treatment Market is to reach USD 3569.72 Mn by 2029 at a growth rate of 5.4 percent over the forecast period,https://www.benzinga.com/pressreleases/23/05/g32416515/aspergillosis-treatment-market-is-to-reach-usd-3569-72-mn-by-2029-at-a-growth-rate-of-5-4-percent-,2023-05-16 10:16:55,"Pune, May 16, 2023 ( GLOBE NEWSWIRE ) -- Maximize Market Research, a global Healthcare market research firm has published a competitive intelligence and market research report on the ""Aspergillosis Treatment Market"". The Aspergillosis Treatment Market size was valued at USD 2470.30 Mn in 2022.",PFE,0.031159,0.133497,Neutral
"Stocks to Watch today, May 16: RIL, Adani Ent, HDFC, Airtel, BoB, IOC",https://www.business-standard.com/markets/news/stocks-to-watch-today-may-16-ril-adani-ent-hdfc-airtel-bob-ioc-123051600117_1.html,2023-05-16 02:26:44,"Stocks to Watch on Tuesday: Multiplex firm PVR Inox Ltd, on Monday, reported a widening in consolidated net loss at Rs 333 crore for ...",PFE,0.108794,0.093208,Neutral
"Stocks To Watch: Pfizer, Vedanta, PVR Inox, GAIL, Oil India, ONGC, Indian Oil, Bharti Airtel | The Financial Express",https://www.financialexpress.com/market/stocks-to-watch-pfizer-vedanta-pvr-inox-gail-oil-india-ongc-indian-oil-bharti-airtel/3089131/,2023-05-16 02:04:12,"Stocks To Watch: Pfizer, Vedanta, PVR Inox, GAIL, Oil India, ONGC ... The Financial Express ...",PFE,0.101154,0.072377,Neutral
Vaccinex Reports First Quarter 2023 Financial Results and Provides Corporate Update,https://www.globenewswire.com/news-release/2023/05/15/2669378/34858/en/Vaccinex-Reports-First-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html,2023-05-15 20:45:00,Significant YTD Progress in Neurology and Oncology Programs ...,PFE,0.017145,0.0,Neutral
"Top Analyst Reports for Visa, Pfizer & SAP",https://www.zacks.com/research-daily/2095324/top-analyst-reports-for-visa-pfizer-sap,2023-05-15 20:15:00,"Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Pfizer Inc. (PFE) and SAP SE (SAP).",PFE,0.355588,0.244887,Somewhat-Bullish
Macron courts Tesla's Musk and others to 'Choose France',https://www.foxbusiness.com/markets/macron-courts-teslas-musk-others-choose-france,2023-05-15 19:01:46,"President Emmanuel Macron met Tesla's CEO Elon Musk, the boss of Pfizer and other business chiefs on Monday to urge them to pour money into France, and his office said the country was poised to win record foreign investment pledges.",PFE,0.176287,0.095416,Neutral
Are Psychedelics Cannabis 2.0? Takeaways From The Top Psychedelics Business Conference In The US,https://www.benzinga.com/markets/cannabis/23/05/31940312/are-psychedelics-cannabis-2-0-takeaways-from-the-top-psychedelics-business-conference-in-the-us,2023-05-15 18:27:18,This article was originally published on Cannabis.net and appears here with permission.,PFE,0.020686,0.133599,Neutral
"3 Top Penny Stocks To Watch As GSIT, OMH Stock Explode",https://pennystocks.com/featured/2023/05/15/3-top-penny-stocks-to-watch-gsit-omh-stock-explode/,2023-05-15 17:03:03,"Penny stocks are sought after for their potential to explode to extreme levels. Look at a company we discussed roughly one month ago, Ohmyhome Ltd ( NASDAQ: OMH ) . In the article 3 Hot Penny Stocks To Watch Today. Is It Time To Buy? OMH stock was discussed shortly after the company made its ...",PFE,0.116536,0.066961,Neutral
Pfizer's India unit posts 3% rise in Q4 profit,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizers-india-unit-posts-3-rise-q4-profit-2023-05-15/,2023-05-15 14:42:00,"BENGALURU, May 15 ( Reuters ) - Pfizer Ltd ( PFIZ.NS ) , the Indian unit of U.S. pharmaceutical group Pfizer Inc ( PFE.N ) , on Monday reported a 3.1% rise in fourth-quarter profit, helped by lower raw material expenses.",PFE,0.595343,0.483066,Bullish
Pfizer consolidated net profit rises 3% to Rs 130 crore in March quarter,https://www.business-standard.com/companies/results/pfizer-consolidated-net-profit-rises-3-to-rs-130-crore-in-march-quarter-123051500977_1.html,2023-05-15 14:17:04,The company said its board recommended a final dividend of Rs 35 per share of Rs 10 each ...,PFE,0.518022,0.354673,Bullish
Accumulus Synergy Announces the Appointment of New Leadership Team Members,https://www.benzinga.com/pressreleases/23/05/g32393385/accumulus-synergy-announces-the-appointment-of-new-leadership-team-members,2023-05-15 13:22:00,"BURLINGAME, Calif., May 15, 2023 ( GLOBE NEWSWIRE ) -- Accumulus Synergy ( ""Accumulus"" ) , a nonprofit trade association working to address the global need for digital transformation within the life sciences - health authority ecosystem, today announced the appointment of two new executive ...",PFE,0.070517,0.292523,Somewhat-Bullish
"Macron, Musk Meet In Paris On Investing In France",https://www.barrons.com/news/macron-musk-meet-in-paris-on-investing-in-france-cc790bb2,2023-05-15 13:00:17,"President Emmanuel Macron met billionaire businessman Elon Musk on Monday to discuss future investment projects, as the French leader hosts a conference aimed at persuading business leaders to put their money in France.",PFE,0.080188,0.0,Neutral
Musk Says Considering 'Significant Investments In France',https://www.barrons.com/news/macron-musk-meet-in-paris-on-investing-in-france-cc790bb2,2023-05-15 13:00:17,"Macron, Musk Meet In Paris On Investing In France ...",PFE,0.072217,0.0,Neutral
"Up 40% in 1 Day, Is Novavax Stock a Buy Now?",https://www.fool.com/investing/2023/05/15/up-40-in-1-day-is-novavax-stock-a-buy-now/,2023-05-15 13:00:00,The market is being a bit too exuberant about the struggling biotech's latest earnings report.,PFE,0.122581,-0.052956,Neutral
"Pfizer Q4FY23 profit up 3.1% at Rs 129.65 crore, revenue at Rs 572.64 crore; dividend declared | The Financial Express",https://www.financialexpress.com/industry/pfizer-q4fy23-profit-up-3-1-at-rs-12965-crore-revenue-at-rs-57264-crore-dividend-declared/3088790/,2023-05-15 12:55:00,"Pfizer Q4FY23 profit up 3.1% at Rs 129.65 crore, revenue at Rs ... The Financial Express ...",PFE,0.252987,0.209638,Somewhat-Bullish
Pfizer Announces Proposed Notes Offering - Investing News Network,https://investingnews.com/pfizer-announces-proposed-notes-offering/,2023-05-15 12:25:12,Pfizer Announces Proposed Notes Offering Investing News Network ...,PFE,0.520385,0.438818,Bullish
FCM Director Nominees Will Put MindMed Drug Development Process Back on Track - Mind Medicine  ( NASDAQ:MNMD ) ,https://www.benzinga.com/pressreleases/23/05/g32391165/fcm-director-nominees-will-put-mindmed-drug-development-process-back-on-track,2023-05-15 12:24:20,"FCM Believes MindMed Focused on Pursuing Misguided Clinical Path for MM-120 MindMed Executives, Advisors - Barrow, Karlin, and Liechti - Do Not Have Experience in Bringing Drugs to Market and Are Making Fundamental Errors in Approach MindMed Cash Expected to Run Out in 2024 and Dilution Set to Soar",PFE,0.028764,0.032934,Neutral
Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer - Fulcrum Therapeutics  ( NASDAQ:FULC ) ,https://www.benzinga.com/pressreleases/23/05/g32388014/fulcrum-therapeutics-appoints-alex-c-sapir-chief-executive-officer,2023-05-15 11:00:00,- Industry veteran brings more than 20 years of experience; will assume role effective July 1st - - During transition period Mr. Sapir will serve as special advisor to the interim CEO and president -,PFE,0.054483,0.008985,Neutral
Global Home Health Hub Market to Garner High Returns by 2029 - Brandessence Market Research,https://www.prnewswire.com/news-releases/global-home-health-hub-market-to-garner-high-returns-by-2029---brandessence-market-research-301824468.html,2023-05-15 10:48:00,Global Home Health Hub Market to Garner High Returns by 2029 ... PR ...,PFE,0.019879,0.108575,Neutral
Size of Microalgae Market to Grow at 4.5% CAGR and Reach $4996.8 Million by 2027: Brandessence Market Research,https://www.prnewswire.com/news-releases/size-of-microalgae-market-to-grow-at-4-5-cagr-and-reach-4996-8-million-by-2027-brandessence-market-research-301824453.html,2023-05-15 10:35:00,Size of Microalgae Market to Grow at 4.5% CAGR and Reach ... PR ...,PFE,0.022243,0.110124,Neutral
Digital Lending Market: How Digital Platforms are Democratizing Access to Finance | Brandessence Market Research,https://www.prnewswire.com/news-releases/digital-lending-market-how-digital-platforms-are-democratizing-access-to-finance--brandessence-market-research-301824432.html,2023-05-15 10:14:00,Digital Lending Market: How Digital Platforms are Democratizing ... PR ...,PFE,0.019846,0.114533,Neutral
Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research,https://www.prnewswire.com/news-releases/global-acute-repetitive-seizures-market-to-showcase-promising-growth-says-brandessence-market-research-301824427.html,2023-05-15 10:06:00,Global Acute Repetitive Seizures Market to Showcase Promising ... PR ...,PFE,0.036282,0.109896,Neutral
"Will Tesla's Next Hub Be In France? Musk-Macron Meeting Sparks Buzz - Tesla  ( NASDAQ:TSLA ) , Pfizer  ( NYSE:PFE ) , Walt Disney  ( NYSE:DIS ) ",https://www.benzinga.com/news/23/05/32386347/will-teslas-next-hub-be-in-france-musk-macron-meeting-sparks-buzz,2023-05-15 10:05:01,"French President Emmanuel Macron is set to meet with Tesla Inc TSLA CEO Elon Musk on Monday. What Happened: The meeting will take place during a gathering of global business leaders organized by Macron in Versailles to showcase France's appeal for foreign investment, Reuters reported, citing a ...",PFE,0.145145,0.076999,Neutral
Report Forecasts Promising Future for Alzheimer's Disease Market with New Therapeutic Approaches | Brandessence Market Research,https://www.prnewswire.com/news-releases/report-forecasts-promising-future-for-alzheimers-disease-market-with-new-therapeutic-approaches--brandessence-market-research-301824407.html,2023-05-15 09:32:00,Report Forecasts Promising Future for Alzheimer's Disease Market ... PR ...,PFE,0.017394,0.112745,Neutral
TILT Biotherapeutics Announces First Patient Dosed in Phase I Solid Tumors Trial Assessing Oncolytic Adenovirus TILT-123 in Combination with Checkpoint Inhibitor,https://www.benzinga.com/pressreleases/23/05/g32383073/tilt-biotherapeutics-announces-first-patient-dosed-in-phase-i-solid-tumors-trial-assessing-oncolyt,2023-05-15 06:00:00,"HELSINKI, Finland, May 15, 2023 ( GLOBE NEWSWIRE ) -- TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, today announced that the first patient has been dosed in a Phase I trial of the company's oncolytic adenovirus TILT-123.",PFE,0.114137,-0.01149,Neutral
'Biotech is the ultimate impact investment' - family offices can't get enough of it,https://www.ft.com/content/20d69b46-11fd-4904-8d6c-86927a3f4cd5,2023-05-15 04:00:03,Strong personal interest in healthcare among reasons for increase in flow of family office money into venture capital ...,PFE,0.017269,0.067736,Neutral
Macron eyes record 13 bln euros in investments at Versailles summit,https://www.reuters.com/markets/europe/macron-eyes-record-13-bln-euros-investments-versailles-summit-2023-05-14/,2023-05-14 19:10:00,"PARIS, May 14 ( Reuters ) - France is set to win record foreign investment pledges when President Emmanuel Macron rolls out the red carpet for global CEOs on Monday at the annual 'Choose France' summit in Versailles, his office said on Sunday.",PFE,0.25168,0.109285,Neutral
"Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too",https://www.fool.com/investing/2023/05/13/novavax-ceo-leads-vaccine-trial-success-layoffs/,2023-05-13 10:00:00,Is the biotech on the road to recovery?,PFE,0.056808,-0.143959,Neutral
Pfizer CEO Fires Back: US Drug Pricing Reforms - 'Negotiation with a Gun to Your Head' - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/05/32368106/pfizer-ceo-fires-back-us-drug-pricing-reforms-negotiation-with-a-gun-to-your-head,2023-05-12 17:28:26,"Pfizer Inc's PFE CEO Albert Bourla called U.S. plans to negotiate drug prices for its Medicare health program ""negotiation with a gun to your head."" Bristol Myers Squibb & Co's BMY Eliquis, Pfizer Inc's PFE Ibrance, and AbbVie Inc's ABBV Imbruvica are expected to be among the ten top-selling ...",PFE,0.660632,-0.011017,Neutral
"In China, the Police Came for the Consultants. Now the C.E.O.s Are Alarmed.",https://www.nytimes.com/2023/05/12/business/china-anti-espionage-law.html,2023-05-12 15:45:12,"Foreign businesses, a top Chinese official said in March, ""are not foreigners, but family."" Then came a crackdown on firms with foreign ties.",PFE,0.031822,-0.069205,Neutral
"GSK Trims Stake On Consumer Business Spin Off, Raises £804M - Haleon  ( NYSE:HLN ) , GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/05/32360529/gsk-trims-stake-on-consumer-business-spin-off-raises-804m,2023-05-12 13:47:00,GSK Plc GSK sold 240 million shares of its spun-out consumer healthcare group Haleon Plc HLN in a move that has raised £804 million for the firm. The offloaded shares are equivalent to up to 2.5% of Haleon's issued share capital.,PFE,0.528475,0.237555,Somewhat-Bullish
"Pharma Stock Roundup: BAYRY Mixed Q1 Results, AZN, RHHBY Regulatory/Pipeline Updates",https://www.zacks.com/stock/news/2094647/pharma-stock-roundup-bayry-mixed-q1-results-azn-rhhby-regulatorypipeline-updates,2023-05-12 13:12:00,Bayer (BAYRY) announces mixed Q1 results. AstraZeneca's (AZN) Ultomiris gets approval for a new rare disease indication in the EU.,PFE,0.108712,-0.131021,Neutral
Factbox: Drugmakers bulk up with bets on weight-loss treatments,https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-bulk-up-with-bets-weight-loss-treatments-2023-05-12/,2023-05-12 11:28:46,May 12 ( Reuters ) - Zealand Pharma ( ZELA.CO ) and partner Boehringer Ingelheim on Wednesday announced positive trial data for their weight-loss treatment and joined the race for a share of a global obesity drug market that is expected to touch $100 billion within a decade.,PFE,0.058759,0.096991,Neutral
Here's why Covid vaccines will still be free for uninsured Americans as public health emergency ends,https://www.cnbc.com/2023/05/12/covid-shots-free-for-uninsured-after-public-health-emergency.html,2023-05-12 11:00:01,The Biden administration and drugmakers Pfizer and Moderna have announced programs that aim to help uninsured Americans access Covid shots for free.,PFE,0.141935,0.144258,Neutral
3 Market Neutral Funds to Counter Market Volatility,https://www.zacks.com/stock/news/2094548/3-market-neutral-funds-to-counter-market-volatility,2023-05-12 10:05:00,"Below, we share with you three top-ranked market-neutral funds. Each has earned a Zacks Mutual Fund Rank #1.",PFE,0.16117,0.035971,Neutral
Sanofi Scores Big In RSV Race As It Faces Off With Pfizer,https://www.investors.com/news/technology/sanofi-stock-nears-record-high-here-is-how-it-could-rival-pfizer-in-rsv/,2023-05-12 08:50:00,Sanofi Stock Nears Record High: Here's How It Could Rival Pfizer In ... Investor's Business Daily ...,PFE,0.366061,0.261697,Somewhat-Bullish
"Covid vax, booster dose immunity to decline rapidly in obese people: Study",https://www.business-standard.com/world-news/covid-vax-booster-dose-immunity-to-decline-rapidly-in-obese-people-study-123051200314_1.html,2023-05-12 07:51:51,"Covid vax, booster dose immunity to decline rapidly in obese people ... Business Standard ...",PFE,0.085936,0.0,Neutral
Sosei Heptares Operational Highlights and Consolidated Results for the First Quarter 2023,https://www.globenewswire.com/news-release/2023/05/12/2667534/0/en/Sosei-Heptares-Operational-Highlights-and-Consolidated-Results-for-the-First-Quarter-2023.html,2023-05-12 06:30:00,"Tokyo, Japan and Cambridge, UK, 12 May 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2023. The full report can be found here.",PFE,0.030446,0.039664,Neutral
Pfizer CEO says Medicare will likely face legal action over drug price negotiations,https://www.cnbc.com/2023/05/11/pfizer-medicare-could-face-legal-action-over-drug-price-negotiations.html,2023-05-11 21:21:09,Pfizer CEO Albert Bourla argued the Biden administration's plan will cut profits and force Big Pharma companies to pull back on developing medicines.,PFE,0.290033,0.062222,Neutral
"The week's good news: May 11, 2023",https://theweek.com/briefing/it-wasnt-all-bad/1023408/the-weeks-good-news-may-11-2023,2023-05-11 19:10:04,"There's no building that can scare Marjy Stagmeier - show her a ramshackle apartment complex, and she sees the opportunity to provide hundreds of families with affordable housing.",PFE,0.052112,-0.036009,Neutral
Pfizer pouring windfall profits from Covid-19 vaccine into cancer battle,https://www.business-standard.com/companies/news/pfizer-pouring-windfall-profits-from-covid-19-vaccine-into-cancer-battle-123051101321_1.html,2023-05-11 18:03:13,"""Pfizer is giving all the profits that we made from COVID in '21 and '22 and what we will make in '23 to acquire technology and products that we believe will allow us to battle cancer,"" he said, calling the effort the drugmaker's ""next moonshot."" The COVID products drove Pfizer's revenue to ...",PFE,0.548633,0.084067,Neutral
"Pfizer pouring COVID profits into cancer battle, CEO Bourla says",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-pouring-covid-profits-into-cancer-battle-ceo-bourla-says-2023-05-11/,2023-05-11 17:02:58,"May 11 ( Reuters ) - Pfizer Inc ( PFE.N ) is pouring the windfall profits from its COVID-19 vaccine and treatment into developing products to battle cancer, most notably in its $43 billion purchase of Seagen Inc ( SGEN.O ) , Chief Executive Albert Bourla said at a Reuters newsmaker event on ...",PFE,0.521465,0.088284,Neutral
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/05/32345208/this-is-what-whales-are-betting-on-pfizer,2023-05-11 15:32:19,"Someone with a lot of money to spend has taken a bullish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.823771,0.318823,Somewhat-Bullish
"[INVNT GROUP]™ achieves record global growth, accelerating history-making brand campaigns, strategic partnerships, and humanitarian work.",https://www.benzinga.com/pressreleases/23/05/g32343113/invnt-group-achieves-record-global-growth-accelerating-history-making-brand-campaigns-strategic-pa,2023-05-11 14:25:55,"New York, NY, May 11, 2023 ( GLOBE NEWSWIRE ) -- [INVNT GROUP] THE GLOBAL BRANDSTORY PROJECT™ and leading agency portfolio of complementary brand storytelling disciplines, continues its explosive growth trajectory and worldwide expansion, reporting a top line revenue of $142 Million in 2022, up ...",PFE,0.017306,0.01606,Neutral
The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer,https://www.fool.com/investing/2023/05/11/fda-approved-rsv-vaccine-and-it-isnt-from-pfizer/,2023-05-11 14:23:00,RSV could be the next big battleground for big pharma -- but it could soon become crowded.,PFE,0.558244,0.102248,Neutral
Adomantra Digital ropes in Vikas Pandey as marketing and business head | The Financial Express,https://www.financialexpress.com/business/brandwagon-adomantra-digital-ropes-in-vikas-pandey-as-marketing-and-business-head-3083667/,2023-05-11 13:07:00,Adomantra Digital ropes in Vikas Pandey as marketing and ... The Financial Express ...,PFE,0.235823,0.086172,Neutral
Niklas Prager appointed new CEO of SmartCella,https://www.prnewswire.com/news-releases/niklas-prager-appointed-new-ceo-of-smartcella-301821861.html,2023-05-11 07:43:00,"STOCKHOLM, May 11, 2023 /PRNewswire/ -- SmartCella Holding AB today announces that Niklas Prager has been appointed as the new CEO. SmartCella is an innovative biotech and medtech company that combines targeted delivery of medical substances to organs and tumors through a unique device, and the ...",PFE,0.058903,0.033985,Neutral
Moderna's Revolutionary Cancer Vaccine Sets Investors Abuzz,https://www.forbes.com/sites/jonmarkman/2023/05/10/modernas-revolutionary-cancer-vaccine-sets-investors-abuzz/,2023-05-11 01:54:54,Investors should buy Moderna shares into any future weakness.,PFE,0.18343,0.050823,Neutral
Pfizer Unusual Options Activity For May 30 - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/05/32635184/pfizer-unusual-options-activity-for-may-30,2023-05-30 20:30:55,"Someone with a lot of money to spend has taken a bullish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.819522,0.450626,Bullish
"Joint Pain Injection Market to Surge at a CAGR of 7.8%, Reaching USD 9.8 Billion by 2031: TMR Analysis",https://www.benzinga.com/pressreleases/23/05/g32635140/joint-pain-injection-market-to-surge-at-a-cagr-of-7-8-reaching-usd-9-8-billion-by-2031-tmr-analysi,2023-05-30 20:30:00,"Wilmington, Delaware, United States, May 31, 2023 ( GLOBE NEWSWIRE ) -- The global joint pain injection market is projected to flourish at a CAGR of 7.8% from 2023 to 2031. As per the report published by TMR, the global joint pain injection market is expected to exceed a value of US$ 9.8 billion ...",PFE,0.042571,-0.102661,Neutral
Valneva  ( VALN )  Stock Down 53% in the Past Year: Here's Why,https://www.zacks.com/stock/news/2101435/valneva-valn-stock-down-53-in-the-past-year-heres-why,2023-05-30 13:26:00,The European Commission's revised advance purchase agreement jeopardizes Valneva's (VALN) COVID-19 vaccine program.,PFE,0.211191,0.03697,Neutral
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2101289/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2023-05-30 13:00:11,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.49407,0.108484,Neutral
Sequoia China-Backed AI Startup Xtalpi To Partner With Pharma Giant Eli Lilly In $250 Million Novel Drug Deal,https://www.forbes.com/sites/zinnialee/2023/05/30/sequoia-china-backed-ai-startup-xtalpi-to-partner-with-pharma-giant-eli-lilly-in-250-million-novel-drug-deal/,2023-05-30 12:00:12,Xtalpi said the drug candidates will target a disease that currently has no medicine available.,PFE,0.140076,0.098742,Neutral
Pfizer's hemophilia therapy reduces bleeding in late-stage study,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizers-hemophilia-therapy-reduces-bleeding-late-stage-study-2023-05-30/,2023-05-30 10:58:00,May 30 ( Reuters ) - U.S. drugmaker Pfizer Inc ( PFE.N ) said on Tuesday late-stage study data for its experimental hemophilia therapy showed superiority to the current standard of care treatment in reducing bleeding rates in patients.,PFE,0.499789,-0.20869,Somewhat-Bearish
Protalix BioTherapeutics Issues Letter to Stockholders,https://www.prnewswire.com/news-releases/protalix-biotherapeutics-issues-letter-to-stockholders-301837044.html,2023-05-30 10:50:00,"CARMIEL, Israel, May 30, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. ( NYSE American: PLX ) , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein ...",PFE,0.035345,0.064996,Neutral
Protalix BioTherapeutics Issues Letter to Stockholders,https://www.prnewswire.com/il/news-releases/protalix-biotherapeutics-issues-letter-to-stockholders-301837044.html,2023-05-30 10:50:00,"CARMIEL, Israel, May 30, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. ( NYSE American: PLX ) , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein ...",PFE,0.035345,0.064996,Neutral
Protalix BioTherapeutics Issues Letter to Stockholders - Protalix BioTherapeutics  ( AMEX:PLX ) ,https://www.benzinga.com/pressreleases/23/05/n32620406/protalix-biotherapeutics-issues-letter-to-stockholders,2023-05-30 10:50:00,"CARMIEL, Israel, May 30, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc.",PFE,0.035035,0.064916,Neutral
How Pfizer's First-Ever Approach To Hemophilia Just Paid Off,https://www.investors.com/news/technology/pfizer-stock-how-pfizer-first-ever-approach-to-hemophilia-treatment-just-paid-off/,2023-05-30 10:45:00,"Pfizer ( PFE ) stock could pop Tuesday after the company said its experimental hemophilia treatment cut down on bleeding episodes in a pivotal study. The drug is a under-the-skin injection administered once a week. It targets TFPI, an inhibitor in the body that prevents blood clots from forming.",PFE,0.682689,-0.019089,Neutral
Pfizer's Heading for a Patent Cliff. Is the Stock Still a Buy?,https://www.fool.com/investing/2023/05/30/pfizer-heading-for-patent-cliff-is-stock-a-buy/,2023-05-30 09:30:00,"Last year, Pfizer reported record revenue.",PFE,0.755086,0.138638,Neutral
Pain Relief Therapeutics Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/pain-relief-therapeutics-market-to-grow-significantly-by-2029--brandessence-market-research-301836608.html,2023-05-29 15:15:00,Pain Relief Therapeutics Market to Grow Significantly by 2029 ... PR ...,PFE,0.046953,0.130099,Neutral
Intraocular Lens  ( IOL )  Market to Grow Phenomenally by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/intraocular-lens-iol-market-to-grow-phenomenally-by-2029--brandessence-market-research-301836613.html,2023-05-29 15:00:00,Intraocular Lens ( IOL ) Market to Grow Phenomenally by 2029 ... PR ...,PFE,0.02241,0.122751,Neutral
Coronary Stents Market to Witness Phenomenal Gains by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/coronary-stents-market-to-witness-phenomenal-gains-by-2029--brandessence-market-research-301836605.html,2023-05-29 14:45:00,Coronary Stents Market to Witness Phenomenal Gains by 2029 ... PR ...,PFE,0.020615,0.121535,Neutral
"5 Value Stocks In The Healthcare Sector - Dynavax Technologies  ( NASDAQ:DVAX ) , Helius Medical Tech  ( NASDAQ:HSDT ) , Zymeworks  ( NASDAQ:ZYME ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/news/23/05/32614682/5-value-stocks-in-the-healthcare-sector,2023-05-29 14:43:15,"A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the ...",PFE,0.186738,0.208462,Somewhat-Bullish
Arthroscopy Market to Showcase Remarkable Growth by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/arthroscopy-market-to-showcase-remarkable-growth-by-2029--brandessence-market-research-301836603.html,2023-05-29 14:30:00,Arthroscopy Market to Showcase Remarkable Growth by 2029 ... PR ...,PFE,0.02105,0.121847,Neutral
EMA Panel Endorses Novavax's  ( NVAX )  COVID Jab for Full Approval,https://www.zacks.com/stock/news/2100940/ema-panel-endorses-novavaxs-nvax-covid-jab-for-full-approval,2023-05-29 13:48:00,Novavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization in COVID-19 patients from European Medicines Agency.,PFE,0.357293,0.269828,Somewhat-Bullish
The Top Healthcare Stocks to Buy With $100,https://www.fool.com/investing/2023/05/29/the-top-healthcare-stocks-to-buy-with-100/,2023-05-29 13:30:00,There's plenty of upside in this multitrillion-dollar industry.,PFE,0.29887,0.149717,Neutral
Lung Cancer Therapies Market to Amplify Significantly over 2022-2029 - Brandessence Market Research,https://www.prnewswire.com/news-releases/lung-cancer-therapies-market-to-amplify-significantly-over-2022-2029---brandessence-market-research-301836472.html,2023-05-29 10:26:00,Lung Cancer Therapies Market to Amplify Significantly over 2022 ... PR ...,PFE,0.070656,0.123983,Neutral
"Americans May Not Love Crypto, But These Top Brands Are Into It",https://decrypt.co/142698/americans-may-not-love-crypto-but-these-top-brands-are-into-it,2023-05-29 04:28:13,"Chick-Fil-A, Toyota, Pfizer and Samsung are among the Top 100 brands to explore the cryptocurrency space.",PFE,0.152983,0.044749,Neutral
Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend Income,https://www.fool.com/investing/2023/05/27/investing-43-in-this-stock-per-week-for-5-years-co/,2023-05-27 11:25:00,"The risk of a dividend cut is minimal, and the yield of this stock is favorable.",PFE,0.388879,0.128387,Neutral
3 No-Brainer Stocks to Buy for Under $100 Right Now,https://www.fool.com/investing/2023/05/27/3-no-brainer-stocks-to-buy-for-under-100-right-now/,2023-05-27 10:14:00,These stocks might not remain under $100 for too much longer.,PFE,0.47672,0.272798,Somewhat-Bullish
Global Recombinant DNA Technology Market Report 2023: Increasing Number of Chronic Diseases Drives Growth,https://www.prnewswire.com/news-releases/global-recombinant-dna-technology-market-report-2023-increasing-number-of-chronic-diseases-drives-growth-301835829.html,2023-05-27 01:45:00,Global Recombinant DNA Technology Market Report 2023 ... PR ...,PFE,0.033006,0.110153,Neutral
"The dark side of the weight-loss-drug craze: eating disorders, medication shortages, dangerous knockoffs",https://www.marketwatch.com/story/the-dark-side-of-the-weight-loss-drug-craze-eating-disorders-medication-shortages-dangerous-knock-offs-509ed96a,2023-05-26 18:46:00,"Teens and older adults at risk, say doctors and researchers, as Novo Nordisk's Wegovy and Ozempic are hyped heavily online.",PFE,0.039811,0.07352,Neutral
Eli Lilly Adds To The Obesity Fray With Its Own Piece Of Bullish News,https://www.investors.com/news/technology/eli-lilly-stock-the-battle-for-weight-loss-drugs-heats-up-with-lilly-news/,2023-05-26 16:17:00,Eli Lilly Stock: The Battle For Weight-Loss Drugs Heats Up With ... Investor's Business Daily ...,PFE,0.134968,0.012253,Neutral
Drugmakers Released a Ton of New Cancer Treatment Data. The Biggest Developments.,https://www.barrons.com/articles/pfizer-merck-effector-cancer-treatment-data-a1cfbbd8,2023-05-26 15:42:00,"Pfizer, Merck, eFFECTOR and Other Drugmakers Released New Cancer Treatment Data ...",PFE,0.296761,-0.135269,Neutral
Pfizer's  ( PFE )  COVID-19 Oral Treatment Gets FDA Nod in Adults,https://www.zacks.com/stock/news/2100448/pfizers-pfe-covid-19-oral-treatment-gets-fda-nod-in-adults,2023-05-26 15:08:00,"Per the FDA, Pfizer's (PFE) Paxlovid is the first oral antiviral pill approved in the United States to treat COVID-19 in adults. The drug was granted emergency use authorization by the FDA in 2021.",PFE,0.442522,0.029569,Neutral
eFFECTOR Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules,https://www.globenewswire.com/news-release/2023/05/26/2677133/0/en/eFFECTOR-Therapeutics-Announces-7-5-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html,2023-05-26 13:00:00,"SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 26, 2023 ( GLOBE NEWSWIRE ) -- eFFECTOR Therapeutics, Inc. ( NASDAQ: EFTR ) , a leader in the development of selective translation regulator inhibitors ( STRIs ) for the treatment of cancer, today announced that it has entered into a definitive ...",PFE,0.042048,-0.053417,Neutral
eFFECTOR Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - eFFECTOR Therapeutics  ( NASDAQ:EFTR ) ,https://www.benzinga.com/pressreleases/23/05/g32593767/effector-therapeutics-announces-7-5-million-registered-direct-offering-priced-at-the-market-under-,2023-05-26 13:00:00,"SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 26, 2023 ( GLOBE NEWSWIRE ) -- eFFECTOR Therapeutics, Inc.",PFE,0.041538,-0.052357,Neutral
"Top Stories Friday, May 26: Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial - AstraZeneca  ( NASDAQ:AZN ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/general/biotech/23/05/32592717/amazons-prime-video-trolls-netflixs-password-crackdown-tesla-data-leak-exposes-safety-nightmare-e,2023-05-26 12:42:48,"Amazon.com Inc's AMZN Prime Video boldly roasted Netflix Inc NFLX with a hilarious meme and a clever throwback, challenging the sanctity of shared passwords. Prime Video has unleashed a formidable response to Netflix's recent password-sharing crackdown with a witty meme and a nostalgic reminder ...",PFE,0.070621,0.073325,Neutral
"Amended European Deal For BioNTech-Pfizer's Covid-19 Vaccines Allows Reduced Purchases - Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/05/32591844/amended-european-deal-for-biontech-pfizers-covid-19-vaccines-allows-reduced-purchases,2023-05-26 11:53:33,"The European Commission ( EC ) had agreed with BioNTech SE BNTX and Pfizer Inc PFE on adapting the existing contract on vaccines against Covid-19, including a reduction in the quantity of doses purchased by EU countries under the contract and pushing the delivery deadline to 2026.",PFE,0.535653,0.108359,Neutral
"After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer - Merck & Co  ( NYSE:MRK ) ",https://www.benzinga.com/general/biotech/23/05/32590040/after-back-to-back-failure-for-keytruda-plus-lenvima-merck-touts-durable-clinical-benefit-for-the,2023-05-26 09:36:09,Merck & Co Inc MRK announced data from the final pre-specified overall survival ( OS ) analysis of the pivotal Phase 3 CLEAR ( Study 307 ) /KEYNOTE-581 trial investigating Keytruda ( pembrolizumab ) plus Eisai Co Ltd's ESALY Lenvima ( lenvatinib ) for the first-line treatment of advanced renal ...,PFE,0.305058,0.170737,Somewhat-Bullish
"EU, Pfizer/BioNTech announce amendment to COVID vaccine contract",https://www.reuters.com/business/healthcare-pharmaceuticals/eu-pfizerbiontech-amend-covid-vaccine-contract-source-2023-05-26/,2023-05-26 08:34:02,"Exclusive: EU, Pfizer/Biontech to amend COVID vaccine contract ... ...",PFE,0.31482,0.174379,Somewhat-Bullish
VIATRIS INC.  ( NASDAQ: VTRS )  SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Viatris Inc. - Viatris  ( NASDAQ:VTRS ) ,https://www.benzinga.com/pressreleases/23/05/g32589303/viatris-inc-nasdaq-vtrs-shareholder-class-action-alert-bernstein-liebhard-llp-announces-that-a-sec,2023-05-26 05:45:00,"Did you lose money on investments in Viatris? If so, please visit Viatris Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at ( 212 ) 951-2030 or pallocco@bernlieb.com to discuss your rights.",PFE,0.059341,-0.030016,Neutral
Covid pill Paxlovid gets full FDA approval after a year of emergency use,https://www.business-standard.com/world-news/covid-pill-paxlovid-gets-full-fda-approval-after-a-year-of-emergency-use-123052501253_1.html,2023-05-26 01:27:45,Covid pill Paxlovid gets full FDA approval after a year of emergency ... Business Standard ...,PFE,0.194242,-0.282809,Somewhat-Bearish
Why Pfizer Stock Slipped by 2% Today,https://www.fool.com/investing/2023/05/25/why-pfizer-stock-slipped-by-2-today/,2023-05-25 22:03:31,"The market wasn't impressed by the company's latest drug approval, plus an analyst cut her price target on the shares.",PFE,0.690822,0.31924,Somewhat-Bullish
Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meeting Abstract,https://www.newswire.ca/news-releases/oncolytics-biotech-r-announces-positive-randomized-phase-2-data-from-bracelet-1-metastatic-breast-cancer-trial-demonstrating-pelareorep-drives-50-improvements-in-orr-and-mpfs-in-an-asco-annual-meeting-abstract-855322006.html,2023-05-25 21:41:00,Oncolytics Biotech® Announces Positive Randomized Phase 2 Data ... Canada ...,PFE,0.047324,0.073959,Neutral
"Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech's Vengeance Over 2022's Rate-Hike-Induced Market Fall - iShares Core S&P U.S. Growth ETF  ( NASDAQ:IUSG ) , iShares Core S&P U.S. Value ETF  ( NASDAQ:IUSV ) ",https://www.benzinga.com/news/large-cap/23/05/32583715/value-stocks-hit-15-month-low-against-growth-as-ai-fuels-techs-vengeance-over-2022s-rate-hike-indu,2023-05-25 21:18:09,"Value stocks fell to a seven-month low in relation to growth stocks, already lagging by more than 20% year to date on the heels of an AI-related rally propelling equities in the technology sector.",PFE,0.178459,-0.075643,Neutral
eFFECTOR Therapeutics Reports Positive Data Updates from Phase 2 Expansion Cohorts Evaluating Zotatifin in Patients with ER+ Metastatic Breast Cancer at the ASCO 2023 Annual Meeting,https://www.globenewswire.com/news-release/2023/05/25/2676744/0/en/eFFECTOR-Therapeutics-Reports-Positive-Data-Updates-from-Phase-2-Expansion-Cohorts-Evaluating-Zotatifin-in-Patients-with-ER-Metastatic-Breast-Cancer-at-the-ASCO-2023-Annual-Meeting.html,2023-05-25 20:50:00,Partial responses observed in 5 of 19 ( 26% ) evaluable patients treated with zotatifin 0.07 mg/kg combined with fulvestrant and abemaciclib ( ZFA triplet ) in heavily pretreated populationPartial response observed in 1 of 3 ( 33% ) patients treated with zotatifin 0.1 mg/kg combined with ...,PFE,0.020615,-0.049126,Neutral
"Apexigen  ( APGN )  to Get Acquired by Pyxis Oncology, Stock Up",https://www.zacks.com/stock/news/2099939/apexigen-apgn-to-get-acquired-by-pyxis-oncology-stock-up,2023-05-25 19:25:00,Apexigen (APGN) surges as Pyxis Oncology offers to acquire it for approximately $16 million.,PFE,0.084127,0.03958,Neutral
"BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/05/32580784/biontechs-ready-to-use-single-dose-vaccine-the-perfect-counterattack-to-chinas-rising-xbb1-5-case,2023-05-25 18:10:23,"In an annual general meeting, BioNTech SE's BNTX CEO and co-founder Ugur Sahin told shareholders the company is working on COVID-19 vaccines targeting XBB.1.5 strains in line with recommendations by the World Health Organization.",PFE,0.282234,0.304562,Somewhat-Bullish
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?,https://www.fool.com/investing/2023/05/25/wall-street-expects-these-stocks-soar-100-percent/,2023-05-25 18:00:00,These companies haven't given up on the coronavirus vaccine market.,PFE,0.137671,0.114777,Neutral
FDA Nods to Pfizer's Paxlovid for COVID-19: A Potential $8 Billion Lifesaver in 2023 - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/05/32578521/fda-nods-to-pfizers-paxlovid-for-covid-19-a-potential-8-billion-lifesaver-in-2023,2023-05-25 17:02:46,"The FDA has approved Pfizer Inc's PFE Paxlovid ( nirmatrelvir and ritonavir ) for mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. The FDA approval is based on safety and efficacy data from the EPIC clinical ...",PFE,0.618922,-0.204632,Somewhat-Bearish
Can Pfizer Stock Double Your Money in 3 Years?,https://www.fool.com/investing/2023/05/25/can-pfizer-stock-double-your-money-in-3-years/,2023-05-25 17:00:00,Wall Street may be overlooking the potential of the drugmaker's GLP-1 pipeline assets.,PFE,0.563609,0.225026,Somewhat-Bullish
Scientists propose long Covid definition based on key symptoms in large study,https://www.cnbc.com/2023/05/25/long-covid-scientists-propose-definition-based-on-key-symptoms.html,2023-05-25 15:01:14,The proposed definition is based on 12 symptoms that most separate people with long Covid from people who didn't have the coronavirus.,PFE,0.090816,0.027612,Neutral
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults,https://www.cnbc.com/2023/05/25/paxlovid-fda-approves-pfizer-covid-drug-for-high-risk-adults-.html,2023-05-25 14:24:26,Pfizer and the FDA view Paxlovid as an important complementary tool to vaccination that can help high-risk Americans manage their Covid infections.,PFE,0.171282,0.077624,Neutral
US FDA approves Pfizer's COVID antiviral pill,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-covid-antiviral-pill-2023-05-25/,2023-05-25 14:23:00,"[1/2] Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration/File Photo May 25 ( Reuters ) - The U.S. Food and Drug Administration on Thursday granted full approval to Pfizer's ( PFE.N ) oral antiviral COVID-19 treatment, Paxlovid, for adults at high risk of ...",PFE,0.329551,0.16142,Somewhat-Bullish
Allison Transmission and Alico have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2099541/allison-transmission-and-alico-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-05-25 12:54:00,"Chicago, IL - May 25, 2023 - Zacks Equity Research shares Allison Transmission Holdings ( ALSN Quick QuoteALSN - ) as the Bull of the Day and Alico ( ALCO Quick QuoteALCO - ) as the Bear of the Day.",PFE,0.088799,0.054155,Neutral
BioNTech is proceeding with COVID-shot in line with WHO guidance,https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-is-proceeding-with-covid-shot-line-with-who-guidance-2023-05-25/,2023-05-25 12:47:00,"FRANKFURT, May 25 ( Reuters ) - Germany's BioNTech ( 22UAy.DE ) said it was on track to introduce a COVID-19 shot by the early fall in the northern hemisphere that is adapted to currently dominant virus variants in line with recommendations by the World Health Organization.",PFE,0.183895,0.233607,Somewhat-Bullish
Weight-Loss Programs Push for Meds on Top of Diet and Exercise,https://www.fool.com/investing/2023/05/24/weight-loss-programs-push-for-meds-on-top-of-diet/,2023-05-25 00:00:13,"Eat right, stay active, and tame your inner food demons -- but also inject this syringe deep into your stomach to keep the pounds off. Noom, the...",PFE,0.07031,-0.05661,Neutral
"Zura Bio's Veteran Leadership Eyes Repeat Success, Confident Analyst Sees 150% Upside - Zura Bio  ( NASDAQ:ZURA ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/05/32557437/zura-bios-veteran-leadership-eyes-repeat-success-confident-analyst-sees-150-upside,2023-05-24 18:42:38,Raymond James initiated coverage on Zura Bio Limited ZURA with a price target of $20 and a Strong Buy rating. Zura has three clinical-stage inflammation & immunology ( I&I ) drugs in development. All three assets were licensed from Pfizer Inc PFE or Eli Lilly And Co LLY on favorable economic ...,PFE,0.459624,0.244321,Somewhat-Bullish
GeoVax's Next-Gen Single Dose COVID-19 Vaccine Shows Promising Results - Geovax Labs  ( NASDAQ:GOVX ) ,https://www.benzinga.com/general/biotech/23/05/32555985/geovaxs-next-gen-single-dose-covid-19-vaccine-shows-promising-results,2023-05-24 18:32:30,"GeoVax Labs Inc GOVX announced the presentation of updates on developing its next-generation COVID-19 vaccine, GEO-CM04S1, including preliminary data from an ongoing Phase 2 trial. The data were presented at the Vaccines Summit Boston 2023 and the Congress for the International Society for the ...",PFE,0.285526,0.186357,Somewhat-Bullish
Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M - Pyxis Oncology  ( NASDAQ:PYXS ) ,https://www.benzinga.com/general/biotech/23/05/32554799/small-spac-biotech-apexigen-to-be-acquired-pyxis-oncology-for-16m,2023-05-24 18:28:48,Pyxis Oncology Inc PYXS agreed to acquire Apexigen Inc APGN in an all-stock transaction for an implied value of $0.64 per Apexigen share. Apexigen went public in a blank-check deal just last summer.,PFE,0.371523,0.254431,Somewhat-Bullish
Best Small-Cap Index Funds to Buy Now,https://www.fool.com/investing/how-to-invest/index-funds/small-cap-index-funds/,2023-05-24 17:35:36,Make small-cap investing easy.,PFE,0.085936,0.095928,Neutral
Hemostasis Diagnostics Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/hemostasis-diagnostics-market-to-grow-significantly-by-2029--brandessence-market-research-301833482.html,2023-05-24 14:20:00,Hemostasis Diagnostics Market to Grow Significantly by 2029 ... PR ...,PFE,0.019474,0.103792,Neutral
US Debt-Ceiling Crisis Looms: How Will It Impact Medical Stocks?,https://www.zacks.com/stock/news/2099057/us-debt-ceiling-crisis-looms-how-will-it-impact-medical-stocks,2023-05-24 13:56:00,The United States is on the brink of a debt-ceiling crisis that could have devastating consequences for the global economy. Will the looming fiscal showdown shake the world?,PFE,0.193465,0.094996,Neutral
"Why Novavax, Pfizer And BioNTech Shares Are Rising Today - Novavax  ( NASDAQ:NVAX ) ",https://www.benzinga.com/news/23/05/32550179/why-novavax-pfizer-and-biontech-shares-are-rising-today,2023-05-24 12:47:24,"Shares of vaccine makers Novavax Inc NVAX, Pfizer Inc PFE and BioNTech SE BNTX are moving higher Wednesday amid reports of a COVID-19 surge in China. What Happened: According to a Washington Post report, China is preparing for another wave of COVID-19 as cases of the new XBB variant are on the ...",PFE,0.657566,0.578052,Bullish
Hitachi Energy Q4 profit dips 1.68 pc to Rs 51 cr | The Financial Express,https://www.financialexpress.com/industry/hitachi-energy-q4-profit-dips-1-68-pc-to-rs-51-cr/3100383/,2023-05-24 11:56:03,Hitachi Energy Q4 profit dips 1.68 pc to Rs 51 cr The Financial Express ...,PFE,0.140076,0.095128,Neutral
Hitachi Energy net profit dips 1.68% to Rs 51 cr in March quarter,https://www.business-standard.com/companies/results/hitachi-energy-net-profit-dips-1-68-to-rs-51-cr-in-march-quarter-123052400676_1.html,2023-05-24 11:44:39,"Hitachi Energy on Wednesday said its net profit dipped 1.68 per cent to Rs 50.81 crore in March quarter 2022-23. The company reported a net profit of Rs 51.68 crore for the year-ago period, according to a BSE filing. Total income rose to Rs 1,336.30 crore from Rs 1,142.13 crore in the same period ...",PFE,0.13459,0.0,Neutral
Jnana Therapeutics Announces Milestone Achieved Under First Collaboration with Roche - Roche Holding  ( OTC:RHHBY ) ,https://www.benzinga.com/pressreleases/23/05/g32547493/jnana-therapeutics-announces-milestone-achieved-under-first-collaboration-with-roche,2023-05-24 11:00:00,"BOSTON, May 24, 2023 ( GLOBE NEWSWIRE ) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, announces the achievement of a milestone from its first collaboration agreement ...",PFE,0.075397,0.122934,Neutral
"Pyxis Oncology to Acquire Apexigen - Pyxis Oncology  ( NASDAQ:PYXS ) , Apexigen  ( NASDAQ:APGN ) ",https://www.benzinga.com/pressreleases/23/05/g32547139/pyxis-oncology-to-acquire-apexigen,2023-05-24 10:45:00,"Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate ( ADC ) development Commercially and clinically validated APXiMAB platform for antibody generation complements FACT ADC toolkit of linkers, payloads and conjugation chemistries previously obtained from Pfizer",PFE,0.0367,0.140027,Neutral
Pyxis Oncology to Acquire Apexigen,https://www.globenewswire.com/news-release/2023/05/24/2675054/0/en/Pyxis-Oncology-to-Acquire-Apexigen.html,2023-05-24 10:45:00,Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate ( ADC ) development ...,PFE,0.030216,0.127603,Neutral
Worried About a Recession? 2 Safe Stocks to Buy Now,https://www.fool.com/investing/2023/05/24/worried-about-a-recession-2-safe-stocks-to-buy/,2023-05-24 10:30:00,These stocks have what it takes to remain strong during tough economic times and beyond.,PFE,0.489807,0.27254,Somewhat-Bullish
"FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?",https://www.fool.com/investing/2023/05/24/ftc-block-amgen-horizon-deal-pfizer-seagen-risk/,2023-05-24 09:15:00,Should Pfizer and Seagen investors be worried?,PFE,0.582526,-0.031813,Neutral
Covid Vaccination Risk: Covid kills one person every four minutes as vaccination rates fall,https://www.business-standard.com/world-news/covid-kills-one-person-every-four-minutes-as-vaccination-rates-fall-123052400112_1.html,2023-05-24 01:22:40,"Covid is still a leading killer, the third-biggest in the US last year behind heart disease and cancer ...",PFE,0.03916,-0.0666,Neutral
Pfizer Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/05/32541207/pfizer-unusual-options-activity,2023-05-23 20:46:16,"Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.757528,0.251912,Somewhat-Bullish
"PFE: Buy, Sell, or Hold: Pfizer Inc.  ( PFE ) ",https://stocknews.com/news/pfe-sgen-nvs-nvo-irwd-buy-sell-or-hold-pfizer-inc-pfe/,2023-05-23 18:09:16,"PFE: Buy, Sell, or Hold: Pfizer Inc. ...",PFE,0.575814,0.260281,Somewhat-Bullish
Why Novo Nordisk Stock Is Falling Today,https://www.fool.com/investing/2023/05/23/why-novo-nordisk-stock-is-falling-today/,2023-05-23 18:06:13,Investors are worried that Novo's flagship medication may fail to live up to the hype.,PFE,0.275867,0.201161,Somewhat-Bullish
Novo Nordisk  ( NVO )  Announces Positive Obesity Program Data,https://www.zacks.com/stock/news/2098715/novo-nordisk-nvo-announces-positive-obesity-program-data,2023-05-23 17:29:00,Novo Nordisk's (NVO) late-stage study of once-daily oral semaglutide 25 mg and 50 mg in obesity shows superior weight loss at week 68 compared with placebo.,PFE,0.12013,0.074608,Neutral
New HIV infections decline in U.S. but most people at risk are not receiving prevention drugs,https://www.cnbc.com/2023/05/23/cdc-hiv-infections-decline-but-most-at-risk-people-dont-get-prep.html,2023-05-23 17:05:18,Just 11% of Black people and 21% of Hispanics who face a high risk from the virus received drugs to prevention HIV infection.,PFE,0.103331,0.028709,Neutral
"Harris Poll 100: Americans move on from ""defensive"" health",https://www.axios.com/2023/05/24/axios-harris-poll-100-defensive-health,2023-05-23 15:33:47,"Data: Axios Harris poll; Note: Positive refers to a reputation score of 5, 6 or 7 on a scale from 1-7; Chart: Axios Visuals Health care companies were less visible and less reputable for most Americans last year compared to earlier in the pandemic, according to new rankings from the annual Axios ...",PFE,0.186259,0.178128,Somewhat-Bullish
There's An Overlooked Caveat To Pfizer's Ozempic Rival,https://www.investors.com/news/technology/pfizer-stock-the-one-caveat-investors-missed-with-its-ozempic-rival/,2023-05-23 14:43:00,Pfizer Stock: The One Caveat Investors Missed With Its Ozempic Rival Investor's Business Daily ...,PFE,0.654522,0.218294,Somewhat-Bullish
"Pfizer's  ( PFE )  Oral Diabetes Drug Aids in Weight Loss, Stock Up",https://www.zacks.com/stock/news/2098553/pfizers-pfe-oral-diabetes-drug-aids-in-weight-loss-stock-up,2023-05-23 14:13:00,Data from a phase II study published in JAMA showed that Pfizer's (PFE) danuglipron reduces glycated hemoglobin and fasting plasma glucose (at all doses) and body weight (at the highest doses) at week 16.,PFE,0.124809,0.151746,Somewhat-Bullish
Is Moderna Stock a Buy Now?,https://www.fool.com/investing/2023/05/23/is-moderna-stock-a-buy-now/,2023-05-23 14:00:00,The company's post-pandemic plans are slowly taking shape.,PFE,0.057907,-0.027006,Neutral
"Company News for May 23, 2023",https://www.zacks.com/stock/news/2098449/company-news-for-may-23-2023,2023-05-23 13:23:00,"Companies in The News Are: GOOGL, PFE, NVO, CBRE, PG ...",PFE,0.644033,-0.007337,Neutral
"Harbinger Health Appoints May Orfali, M.D. as Chief Medical Officer",https://www.prnewswire.com/news-releases/harbinger-health-appoints-may-orfali-md-as-chief-medical-officer-301831298.html,2023-05-23 12:30:00,Dr. Orfali brings over 25 years of experience across biopharma clinical development and medical practice Appointment comes at period of rapid growth as Harbinger prepares to complete enrollment for the CORE-HH clinical trial and meet other clinical and business milestones by end of 2023,PFE,0.110717,0.029135,Neutral
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years,https://www.fool.com/investing/2023/05/23/2-undervalued-stocks-to-buy-for-potentially-massiv/,2023-05-23 12:20:00,Both are experiencing a bit of a hangover from declining COVID-19-related sales.,PFE,0.096283,0.089323,Neutral
"New weight-loss drug found to be effective in pill form, Wegovy maker says | The Financial Express",https://www.financialexpress.com/healthcare/pharma-healthcare/new-weight-loss-drug-found-to-be-effective-in-pill-form-wegovy-maker-says/3098398/,2023-05-23 06:35:00,"New weight-loss drug found to be effective in pill form, Wegovy ... The Financial Express ...",PFE,0.345674,0.16193,Somewhat-Bullish
Weight-loss drug pioneers aim to jump on Wegovy bandwagon,https://www.reuters.com/business/healthcare-pharmaceuticals/weight-loss-drug-pioneers-aim-jump-wegovy-bandwagon-2023-05-23/,2023-05-23 05:04:00,"DUBLIN, May 23 ( Reuters ) - Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing treatments are hoping the resulting demand will boost demand for their older, less effective but cheaper, drugs.",PFE,0.053271,0.0,Neutral
"TSLA, ZM, HEPA, PFE, ZIM: Top 5 Trending Stocks - Tesla  ( NASDAQ:TSLA ) , Zoom Video Comms  ( NASDAQ:ZM ) , Novo Nordisk  ( NYSE:NVO ) , Pfizer  ( NYSE:PFE ) , Hepion Pharmaceuticals  ( NASDAQ:HEPA ) , ZIM Integrated Shipping  ( NYSE:ZIM ) ",https://www.benzinga.com/markets/equities/23/05/32522239/tesla-zoom-hepion-pfizer-zim-why-these-5-stocks-are-drawing-investor-attention-today,2023-05-23 01:22:12,U.S. markets ended mixed on Monday as Wall Street's wait for a debt ceiling resolution continues with both sides unwilling to yield on spending cuts - the biggest bone of contention in the negotiations. President Joe Biden's administration and Republican lawmakers are yet to reach a decisive ...,PFE,0.227007,0.142264,Neutral
Disney's reputation hit by polarizing political drama,https://www.axios.com/2023/05/23/disneys-reputation-political-drama-polarization,2023-05-23 00:42:17,"The Walt Disney Company took a big hit in this year's Axios Harris Poll 100, dropping a dozen spots, to 77th, after tangling with Florida Gov. Ron DeSantis over students' LGBTQ+ rights.",PFE,0.056011,0.12991,Neutral
NCLA Challenges Government's Censorship of Support Groups for Victims of Covid Vaccine Injuries,https://www.benzinga.com/pressreleases/23/05/g32520947/ncla-challenges-governments-censorship-of-support-groups-for-victims-of-covid-vaccine-injuries,2023-05-22 21:39:09,"Washington, D.C., May 22, 2023 ( GLOBE NEWSWIRE ) -- Today, the New Civil Liberties Alliance, a nonpartisan, nonprofit civil rights group, filed a lawsuit challenging the federal government's ongoing efforts to work in concert with social media companies and the Stanford Internet Observatory's ...",PFE,0.050465,-0.139828,Neutral
Why Pfizer Stock Crushed the Market on Monday,https://www.fool.com/investing/2023/05/22/why-pfizer-stock-crushed-the-market-on-monday/,2023-05-22 21:31:00,The pharmaceuctical giant could have a potential blockbuster drug on its hands.,PFE,0.567144,0.459999,Bullish
Tesla Among S&P 500's Big Winners Monday,https://www.investors.com/news/sp-500-tesla-pfizer-among-stock-market-winners-monday-nike-micron-slide/,2023-05-22 20:35:00,"S&P 500: Tesla Among Stock Winners Monday. Nike, Micron Slide ... Investor's Business Daily ...",PFE,0.213517,0.043936,Neutral
Pfizer Stock Pops: Study Shows Company's Oral Weight Loss Drug Could Be As Effective As Novo Nordic's Ozempic Injection - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/23/05/32514964/pfizer-stock-pops-study-shows-companys-oral-weight-loss-drug-could-be-as-effective-as-novo-nordics-o,2023-05-22 18:22:59,Pfizer Inc PFE shares are trading higher Monday in the wake of a newly released study suggesting the company's oral weight loss drug may be as effective as Novo Nordisk's NVO Ozempic injection.,PFE,0.414559,0.336677,Somewhat-Bullish
Pfizer Next Blockbuster Act? It Might Be In Obesity,https://www.investors.com/news/technology/pfizer-stock-jumps-after-oral-drug-outperforms-novo-superstar-ozempic-in-weight-loss/,2023-05-22 16:58:00,Pfizer Stock Jumps After Oral Drug Outperforms Novo Superstar ... Investor's Business Daily ...,PFE,0.521961,0.062192,Neutral
"Stocks making the biggest moves midday: PacWest, DraftKings, Pfizer, Foot Locker and more",https://www.cnbc.com/2023/05/22/stocks-moving-big-midday-pacw-dkng-pfe-fl.html,2023-05-22 16:49:59,These are the stocks posting the largest moves in midday trading.,PFE,0.24289,0.158075,Somewhat-Bullish
Here's what Pfizer and Moderna say is next for their Covid vaccines,https://www.cnbc.com/2023/05/22/covid-vaccines-pfizer-moderna.html,2023-05-22 16:22:14,Pfizer and Moderna are ushering in a new era for their Covid shots that aims to simplify what people need to do to coexist with the virus.,PFE,0.251161,0.141204,Neutral
Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-diabetes-drug-reduces-weight-similar-novos-ozempic-2023-05-22/,2023-05-22 15:51:29,Pfizer's diabetes drug results in similar weight loss levels as Novo's ... ...,PFE,0.846873,-0.004084,Neutral
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News,https://www.fool.com/investing/2023/05/22/pfizer-took-out-31-billion-in-debt-why-good-news/,2023-05-22 15:25:07,The pharmaceutical giant wouldn't be borrowing if it didn't have plans for how to make a tidy return.,PFE,0.391486,0.071053,Neutral
"Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says",https://www.cnbc.com/2023/05/22/pfizer-weight-loss-drug-compares-to-ozempic-by-novo-nordisk.html,2023-05-22 15:00:47,"Danuglipron, made by Pfizer could offer an advantage as an oral treatment option for weight loss over a frequent injection of Ozempic, made by Novo Nordisk.",PFE,0.207571,0.140099,Neutral
"Sickle Cell Disease Market to Observe Impressive Growth, Predicts DelveInsight | Key Companies Active in the Domain - Sanofi, Novartis, Vertex, CRISPR, Vifor, Pfizer, GlaxoSmithKline, Alexion, Global Blood",https://www.prnewswire.com/news-releases/sickle-cell-disease-market-to-observe-impressive-growth-predicts-delveinsight--key-companies-active-in-the-domain---sanofi-novartis-vertex-crispr-vifor-pfizer-glaxosmithkline-alexion-global-blood-301830486.html,2023-05-22 15:00:00,"Sickle Cell Disease Market to Observe Impressive Growth, Predicts ... PR ...",PFE,0.058047,0.068992,Neutral
Global Biotechnology Market Size & Share to Surpass $2772.7 Billion by 2030 | Vantage Market Research,https://www.benzinga.com/pressreleases/23/05/g32509392/global-biotechnology-market-size-share-to-surpass-2772-7-billion-by-2030-vantage-market-research,2023-05-22 14:21:22,"WASHINGTON, May 22, 2023 ( GLOBE NEWSWIRE ) -- The Global Biotechnology Market is valued at USD 1094.6 Billion in 2022 and is projected to reach a value of USD 2772.7 Billion by 2030 at a CAGR ( Compound Annual Growth Rate ) of 14.2% over the forecast period 2023-2030.",PFE,0.025008,0.0,Neutral
Thermo Fisher  ( TMO )  Gets FDA Clearance for Its Immunoassays,https://www.zacks.com/stock/news/2097826/thermo-fisher-tmo-gets-fda-clearance-for-its-immunoassays,2023-05-22 12:01:00,Thermo Fisher (TMO) announces the FDA clearance of its blood-based biomarkers used in the determination of risk assessment and clinical management of preeclampsia with severe features.,PFE,0.059935,0.052234,Neutral
America's drug shortages reach new heights,https://www.axios.com/2023/05/22/americas-drug-shortages-reach-new-heights,2023-05-22 10:00:00,"Shortages of cancer drugs and other life-saving medications are reaching their worst point in a decade, forcing physicians to develop workarounds and the Biden administration to mount an all-of-government response.",PFE,0.039878,-0.04371,Neutral
Should Income Investors Buy This Big Pharma Stock?,https://www.fool.com/investing/2023/05/21/should-income-investors-buy-this-big-pharma-stock/,2023-05-21 16:42:07,This company is prepared to lead the pharmaceutical industry beyond the COVID-19 pandemic.,PFE,0.481177,-0.009329,Neutral
"Cathie Wood Is Buying This Biotech Stock Like Wildfire, But Should You?",https://www.fool.com/investing/2023/05/21/cathie-wood-is-buying-this-biotech-stock-like-wild/,2023-05-21 12:23:00,It's facing a few issues that are practically guaranteed to affect shareholder returns.,PFE,0.05257,0.257787,Somewhat-Bullish
TipRanks reveals the top 10 health care sector analysts of the past decade,https://www.cnbc.com/2023/05/21/tipranks-names-the-top-10-health-care-analysts-of-the-past-decade.html,2023-05-21 12:20:15,TipRanks' analyst ranking service ranks the top Wall Street firms of the past decade.,PFE,0.058472,0.114279,Neutral
Exclusive: US seeks new suppliers of highly used cancer drug methotrexate in short supply,https://www.reuters.com/business/healthcare-pharmaceuticals/us-seeks-new-suppliers-highly-used-cancer-drug-methotrexate-short-supply-2023-06-09/,2023-06-09 18:00:50,Exclusive: US seeks new suppliers of highly used cancer drug ... ...,PFE,0.090134,-0.071442,Neutral
The Top Healthcare Stocks to Buy With $100,https://www.fool.com/investing/2023/06/09/the-top-healthcare-stocks-to-buy-with-100/,2023-06-09 18:00:00,You don't need a fortune to start investing.,PFE,0.382088,0.3641,Bullish
"FDA Panel Endorses AstraZeneca  ( AZN ) , Sanofi's RSV Antibody",https://www.zacks.com/stock/news/2106607/fda-panel-endorses-astrazeneca-azn-sanofis-rsv-antibody,2023-06-09 17:43:00,The FDA's AMDAC unanimously recommends AstraZeneca (AZN)/Sanofi's (SNY) nirsevimab as full immunization against RSV disease for all infants.,PFE,0.210579,0.0522,Neutral
"1 Stock Down 83% That Could Triple, According to Wall Street",https://www.fool.com/investing/2023/06/09/1-stock-down-82-that-could-triple-according-to-wal/,2023-06-09 12:40:00,It would be quite the turnaround for the vaccine maker.,PFE,0.122894,0.143851,Neutral
"HDFC Bank, Reliance, ICICI Bank, Infosys: Top largecap holdings in life insurance equity portfolios | The Financial Express",https://www.financialexpress.com/market/hdfc-bank-reliance-icici-bank-infosys-top-largecap-holdings-in-life-insurance-equity-portfolios/3119327/,2023-06-09 06:32:26,"HDFC Bank, Reliance, ICICI Bank, Infosys: Top largecap holdings in ... The Financial Express ...",PFE,0.07157,0.059296,Neutral
Pfizer  ( PFE )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2106059/pfizer-pfe-gains-but-lags-market-what-you-should-know,2023-06-08 21:45:22,"Pfizer (PFE) closed at $39.09 in the latest trading session, marking a +0.51% move from the prior day.",PFE,0.556576,0.154896,Somewhat-Bullish
Is Frontline's 20% Dividend Too Good To Be True? - Frontline  ( NYSE:FRO ) ,https://www.benzinga.com/news/earnings/23/06/32759807/is-frontlines-20-dividend-too-good-to-be-true,2023-06-08 21:17:38,"The Cyprus-based tanker firm Frontline FRO, on May 31, posted stellar earnings of $0.90 per share and declared a $0.70 dividend. Given the company's stock price of $13.70, this makes for a mouth-watering annualized yield of over 20%. But the question arises, can this be sustained?",PFE,0.058047,-0.003004,Neutral
eFFECTOR Therapeutics Raises a Total of $16.2 Million in Gross Proceeds from Two Recent Registered Direct Offerings,https://www.globenewswire.com/news-release/2023/06/08/2685181/0/en/eFFECTOR-Therapeutics-Raises-a-Total-of-16-2-Million-in-Gross-Proceeds-from-Two-Recent-Registered-Direct-Offerings.html,2023-06-08 20:01:00,eFFECTOR Closes Second Registered Direct Offering Priced At-The-Market Under Nasdaq Rules eFFECTOR Closes Second Registered Direct Offering Priced At-The-Market Under Nasdaq Rules ...,PFE,0.042723,-0.053485,Neutral
"No, Pfizer wasn't caught 'funneling' millions to Anderson Cooper",https://apnews.com/article/fact-check-pfizer-funneled-millions-anderson-cooper-cnn-900999920182,2023-06-08 16:15:31,"CLAIM: Pfizer was caught ""funneling"" $12 million to CNN host Anderson Cooper to promote COVID-19 vaccines. AP'S ASSESSMENT: False. There is no evidence to support that claim, which is an outgrowth of comments made by anti-vaccine activist and presidential candidate Robert F.",PFE,0.635085,0.155482,Somewhat-Bullish
This Red-Hot Growth Stock Has Soared 885% in Just 12 Months,https://www.fool.com/investing/2023/06/08/this-red-hot-growth-stock-has-soared-885-in-just/,2023-06-08 14:07:00,Is it too late to buy shares of Viking Therapeutics?,PFE,0.05833,0.089057,Neutral
These 2 Dividend Stocks Yield 5% -- and They Aren't Risky Buys,https://www.fool.com/investing/2023/06/08/these-2-dividend-stocks-yield-5-and-they-arent-ris/,2023-06-08 12:08:00,These stocks are both down 20% in the past year. Now could be the time to load up on them.,PFE,0.061949,0.0,Neutral
Continued strong Cresemba®  ( isavuconazole )  sales by Pfizer trigger USD 26 million sales milestone payments to Basilea,https://www.globenewswire.com/news-release/2023/06/08/2684411/0/en/Continued-strong-Cresemba-isavuconazole-sales-by-Pfizer-trigger-USD-26-million-sales-milestone-payments-to-Basilea.html,2023-06-08 05:15:00,Ad hoc announcement pursuant to Art. 53 LR ...,PFE,0.127119,0.13902,Neutral
Merck  ( MRK )  Sues US Government to Halt Drug Price Negotiations,https://www.zacks.com/stock/news/2105340/merck-mrk-sues-us-government-to-halt-drug-price-negotiations,2023-06-07 18:01:00,Merck (MRK) files a lawsuit against claiming that the federal government is violating the Constitution by forcing drugmakers to negotiate prices at below market rates.,PFE,0.195814,-0.089661,Neutral
Bond Duration Basics For Individual Investors,https://www.forbes.com/sites/investor-hub/article/bond-duration-basics-for-individual-investors/,2023-06-07 17:34:14,"Bond duration is used to assess interest-rate risk, something very timely with the Fed expected to be at the end of its rate hiking cycle. Learn how to calculate bond duration and the risks involved with bond investments to make the most of your investments.",PFE,0.151349,0.101184,Neutral
"Organ Transplant Rejection Medication Market to Surpass USD 7.0 Billion by 2031, Propelled by Remarkable CAGR of 3.9% | Transparency Market Research",https://www.benzinga.com/pressreleases/23/06/g32764419/organ-transplant-rejection-medication-market-to-surpass-usd-7-0-billion-by-2031-propelled-by-remar,2023-06-07 17:30:00,"Wilmington, Delaware, United States, June 07, 2023 ( GLOBE NEWSWIRE ) -- The global organ transplant rejection medication market is estimated to flourish at a CAGR of 3.9% from 2023 to 2031.",PFE,0.03916,-0.115481,Neutral
GSK's RSV Vaccine Arexvy Gets EU Approval for Older Adults,https://www.zacks.com/stock/news/2105309/gsks-rsv-vaccine-arexvy-gets-eu-approval-for-older-adults,2023-06-07 17:22:00,The approval of GSK's RSV vaccine for older adults is based on positive data from the pivotal AReSVi-006 phase III study.,PFE,0.108712,0.053562,Neutral
Why Is Theravance Bio  ( TBPH )  Down 3.8% Since Last Earnings Report?,https://www.zacks.com/stock/news/2105174/why-is-theravance-bio-tbph-down-38-since-last-earnings-report,2023-06-07 15:30:41,Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PFE,0.06211,-0.126046,Neutral
PFE: Which Pharma Stock is a Pick for June: Pfizer  ( PFE )  or SNDL Inc.  ( SNDL ) ?,https://stocknews.com/news/pfe-sndl-which-pharma-stock-is-a-pick-for-june-pfizer-pfe/,2023-06-07 14:46:56,PFE: Which Pharma Stock is a Pick for June: Pfizer ( PFE ) or SNDL ... ...,PFE,0.664083,0.112197,Neutral
"Top Stories Wednesday, June 7: ChatGPT's Parent Has No IPO Plans, CNN CEO Chris Licht Out, Kim Kardashian's Bid To Dismiss EthereumMax Lawsuit Rejected - Alibaba Group Holding  ( NYSE:BABA ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/general/biotech/23/06/32757915/chatgpts-parent-has-no-ipo-plans-cnn-ceo-chris-licht-out-kim-kardashians-bid-to-dismiss-ethereumm,2023-06-07 13:28:53,"Chris Licht, the news giant CNN's controversial and embattled chairman and CEO, is stepping aside after a very short, turbulent time as CNN's top executive. Licht was appointed CEO a little over a year ago when Warner Bros. Discovery Inc WBD took control of the network.",PFE,0.072987,-0.10982,Neutral
"Another Patent Dispute Emerges: Small Biotech Firm Sues Moderna, Pfizer, and BioNTech Over COVID-19 Vaccine Tech - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/06/32755812/another-patent-dispute-emerges-small-biotech-firm-sues-moderna-pfizer-and-biontech-over-covid-19,2023-06-07 12:51:03,"Pfizer Inc PFE, BioNTech SE BNTX, and Moderna Inc MRNA were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA ( mRNA ) technology.",PFE,0.47672,-0.412575,Bearish
GSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults - GSK  ( NYSE:GSK ) ,https://www.benzinga.com/general/biotech/23/06/32753768/gsks-arexvy-gets-the-green-light-in-europe-first-ever-rsv-vaccine-in-europe-for-older-adults,2023-06-07 12:47:47,"The European Commission has approved GSK plc's GSK Arexvy ( respiratory syncytial virus vaccine, adjuvanted ) for active immunization for the prevention of lower respiratory tract disease ( LRTD ) caused by respiratory syncytial virus ( RSV ) in adults 60 years of age and older.",PFE,0.297661,0.175852,Somewhat-Bullish
2 Unstoppable Stocks to Buy Before the Bull Market,https://www.fool.com/investing/2023/06/07/2-unstoppable-stocks-to-buy-before-the-bull-market/,2023-06-07 11:15:00,Investors should expect both of these businesses to get even bigger in the years ahead.,PFE,0.405029,0.226325,Somewhat-Bullish
European Commission gives final nod to GSK's RSV vaccine | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/european-commission-gives-final-nod-to-gsks-rsv-vaccine/3116942/,2023-06-07 09:20:00,European Commission gives final nod to GSK's RSV vaccine The Financial Express ...,PFE,0.262522,0.149543,Neutral
EU Approves First Vaccine Against Common Respiratory Virus,https://www.barrons.com/news/eu-approves-first-vaccine-against-common-respiratory-virus-9ca1fae2,2023-06-07 08:06:28,"The European Commission has followed the United States in approving the world's first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday.",PFE,0.086556,0.0,Neutral
EU approves its first vaccine for common respiratory virus RSV,https://www.reuters.com/business/healthcare-pharmaceuticals/eu-authorises-gsks-rsv-vaccine-2023-06-07/,2023-06-07 07:12:22,EU approves its first vaccine for common respiratory virus ...,PFE,0.28664,0.036392,Neutral
Drug Maker Merck Sues US Gov. Over Inflation Reduction Act,https://www.fool.com/investing/2023/06/06/drug-maker-merck-sues-us-gov-over-inflation-reduct/,2023-06-07 01:00:13,The war on drug prices faces a counter-offensive. While many pharmaceutical companies have been moaning and groaning about the new regulations on...,PFE,0.075874,-0.064996,Neutral
"Moderna, Pfizer hit with new patent lawsuits over COVID vaccines",https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-pfizer-hit-with-new-patent-lawsuits-over-covid-vaccines-2023-06-06/,2023-06-06 21:17:00,"[1/2] Dr. Mayank Amin draws the Moderna coronavirus disease ( COVID-19 ) booster vaccine targeting BA.4 and BA.5 Omicron sub variants at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier",PFE,0.502693,-0.238312,Somewhat-Bearish
"Pharmaceutical Giant Merck Challenges Inflation Reduction Act over Medicare Drug Pricing, Calls It 'Extortion' - Merck & Co  ( NYSE:MRK ) ",https://www.benzinga.com/general/biotech/23/06/32743949/pharmaceutical-giant-merck-challenges-inflation-reduction-act-over-medicare-drug-pricing-calls-it,2023-06-06 19:03:23,Merck & Co Inc MRK has reportedly filed a lawsuit against the U.S. government to halt implementing the Medicare drug price negotiation program outlined in the Inflation Reduction Act ( IRA ) .,PFE,0.301315,-0.194432,Somewhat-Bearish
Posts misrepresent Israeli data on COVID-19 deaths in young people,https://apnews.com/article/fact-check-israel-covid-zero-healthy-young-died-387670068095,2023-06-06 18:43:03,"An Israeli paramedic from Magen David Adom medical services, administers a dose of the Pfizer-BioNtech COVID-19 vaccine to a woman at an Ikea store in Rishon Lezion, Israel, Monday, Feb. 22, 2021.",PFE,0.060848,-0.1231,Neutral
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/06/32743973/this-is-what-whales-are-betting-on-pfizer,2023-06-06 17:31:29,"Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.682689,0.162614,Somewhat-Bullish
"Moderna  ( MRNA ) , Merck's Cancer Jab Delays Melanoma Spreading",https://www.zacks.com/stock/news/2104573/moderna-mrna-mercks-cancer-jab-delays-melanoma-spreading,2023-06-06 14:42:00,Updated data from a mid-stage study showed that Moderna (MRNA)/Merck's personalized cancer vaccine combined with Keytruda reduces the skin cancer's spreading by 65% in melanoma patients.,PFE,0.054983,0.16403,Somewhat-Bullish
"Top Stories Tuesday, June 6: SEC Accuses Binance & Coinbase Of Acting As Unregistered Broker, Binance Takes Biggest Hit As $300M In Crypto Positions Liquidated In 24 Hours, JPMorgan Clarifies CEO Jamie Dimon Not Running For Presidency",https://www.benzinga.com/general/biotech/23/06/32737955/sec-accuses-binance-coinbase-of-acting-as-unregistered-broker-binance-takes-biggest-hit-as-300m-i,2023-06-06 13:44:10,"A day after the Securities and Exchange Commission accused Binance ( BNB/USD ) of deceptive tactics, conflicts of interest, and evasion of law, the regulatory watchdog sued Coinbase Global Inc COIN in federal court in New York on Tuesday, alleging that it broke securities rules in the United ...",PFE,0.090989,-0.053584,Neutral
Novavax's New Vaccine Approach Set to Tackle Rising COVID-19 Emerging Variants - Novavax  ( NASDAQ:NVAX ) ,https://www.benzinga.com/general/biotech/23/06/32735537/novavaxs-new-vaccine-approach-set-to-tackle-rising-covid-19-emerging-variants,2023-06-06 13:32:37,"Novavax Inc's NVAX R&D chief Filip Dubovsky expressed confidence that the company's updated COVID-19 vaccine, already in production, will offer protection against the rapidly emerging coronavirus variants prevalent in the U.S.",PFE,0.27432,-0.105352,Neutral
Merck sues Biden administration over Medicare drug price negotiations,https://www.cnbc.com/2023/06/06/merck-sues-biden-administration-over-medicare-drug-price-negotiations.html,2023-06-06 12:58:10,"In a scathing complaint filed in federal district court, Merck excoriated the Medicare price negotiation process as a ""sham"" and ""tantamount to extortion."" ...",PFE,0.11983,0.030484,Neutral
"Covid mRNA vax safe, has no serious side effects in infants: Study",https://www.business-standard.com/world-news/covid-mrna-vax-safe-has-no-serious-side-effects-in-infants-study-123060600330_1.html,2023-06-06 07:28:27,"Covid-19 mRNA vaccines given to young children ( most of them age 4 and younger ) are safe and showed no indications of serious side effects, according to a review of more than 245,000 doses. The study marks the first analysis looking for serious side effects from the mRNA vaccines in young ...",PFE,0.194242,0.058835,Neutral
Novavax exec says its new COVID shot should work against variants on the rise,https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-exec-says-its-new-covid-shot-should-work-against-variants-rise-2023-06-05/,2023-06-05 22:31:00,Novavax exec says its new COVID shot should work against variants ... ...,PFE,0.113597,0.0,Neutral
Over $5 million to accelerate cancer research and innovation in Quebec - Oncopole strengthens its leadership role in the oncology ecosystem with the support of numerous partners,https://www.newswire.ca/news-releases/over-5-million-to-accelerate-cancer-research-and-innovation-in-quebec-oncopole-strengthens-its-leadership-role-in-the-oncology-ecosystem-with-the-support-of-numerous-partners-810781317.html,2023-06-05 19:37:00,Over $5 million to accelerate cancer research and innovation in ... Canada ...,PFE,0.256796,0.316913,Somewhat-Bullish
Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.,https://www.marketwatch.com/story/biotech-stocks-could-soon-get-a-m-a-boost-here-are-3-likely-takeover-plays-206b79c3,2023-06-05 19:05:00,Big pharma will be looking to acquire companies with promsing new medicines.,PFE,0.064885,0.058044,Neutral
Moderna cancer vaccine used with Merck Keytruda reduces risk of deadly skin cancer spreading,https://www.cnbc.com/2023/06/05/moderna-cancer-vaccine-with-merck-keytruda-cuts-skin-cancer-spread.html,2023-06-05 13:17:53,"Melanoma is responsible for the large majority of skin cancer deaths, according to the American Cancer Society.",PFE,0.221819,0.045731,Neutral
Greek NGO leads 'crazy' bid to rid Mediterranean of plastic waste,https://www.aljazeera.com/features/2023/6/5/greek-ngo-leads-crazy-bid-to-rid-mediterranean-of-plastic-waste,2023-06-05 13:12:38,"A fifth-generation fisherman finds an innovative way to remove and recycle plastic waste from the Mediterranean Sea. Salamis, Greece - Three divers' heads bobbed in the sea. Then, two white balloons surfaced.",PFE,0.02506,0.0,Neutral
Novavax Partners With Gates Foundation Offshoot In Efforts To Develop Malaria And TB Shots,https://www.forbes.com/sites/roberthart/2023/06/05/novavax-partners-with-gates-foundation-offshoot-in-efforts-to-develop-malaria-and-tb-shots/,2023-06-05 12:32:54,"The Bill & Melinda Gates Medical Research Institute said it will use Matrix-M, the vaccine adjuvant used in Novavax's Covid shot, to advance its ""early-stage vaccine programs."" ...",PFE,0.051886,-0.005002,Neutral
NEW CERTIFICATION AIMS TO MITIGATE ANTIMICROBIAL RESISTANCE RISK IN ANTIBIOTIC MANUFACTURING,https://www.prnewswire.com/news-releases/new-certification-aims-to-mitigate-antimicrobial-resistance-risk-in-antibiotic-manufacturing-301840073.html,2023-06-05 12:10:00,NEW CERTIFICATION AIMS TO MITIGATE ANTIMICROBIAL ... PR ...,PFE,0.091046,0.090526,Neutral
Could Pfizer Have an Ozempic Killer on the Way?,https://www.fool.com/investing/2023/06/05/could-pfizer-have-an-ozempic-killer-on-the-way/,2023-06-05 09:55:00,Pfizer hopes to compete in what could be a $100 billion to $200 billion market.,PFE,0.516883,0.225866,Somewhat-Bullish
Dietary Supplements Market worth $239.4 billion by 2028 - Exclusive Report by MarketsandMarkets™,https://www.prnewswire.com/news-releases/dietary-supplements-market-worth-239-4-billion-by-2028--exclusive-report-by-marketsandmarkets-301842127.html,2023-06-05 09:45:00,Dietary Supplements Market worth $239.4 billion by 2028 ... PR ...,PFE,0.028558,0.025459,Neutral
Looking for Passive Income at a Decent Price? Buy These 2 Stocks,https://www.fool.com/investing/2023/06/05/looking-passive-income-decent-price-buy-stocks/,2023-06-05 09:05:00,"If you're willing to accept slower growth, there are great bargains awaiting.",PFE,0.146618,0.060102,Neutral
Fact checking Nikki Haley's town hall in Iowa | Politics,https://edition.cnn.com/2023/06/04/politics/fact-check-nikki-haley-cnn-townhall/index.html,2023-06-05 02:43:54,Fact checking Nikki Haley's CNN town hall in Iowa CNN International ...,PFE,0.023304,0.023727,Neutral
Fact checking Nikki Haley's town hall in Iowa | Politics,https://edition.cnn.com/2023/06/04/politics/fact-check-nikki-haley-cnn-townhall,2023-06-05 02:43:54,Fact checking Nikki Haley's CNN town hall in Iowa CNN International ...,PFE,0.023304,0.023727,Neutral
Fact checking Nikki Haley's town hall in Iowa | Politics,https://www.cnn.com/2023/06/04/politics/fact-check-nikki-haley-cnn-townhall,2023-06-05 02:43:54,Fact checking Nikki Haley's CNN town hall in Iowa ...,PFE,0.023304,0.023727,Neutral
Fact checking Nikki Haley's town hall in Iowa | Politics,https://us.cnn.com/2023/06/04/politics/fact-check-nikki-haley-cnn-townhall/index.html,2023-06-05 02:43:54,Fact checking Nikki Haley's CNN town hall in Iowa ...,PFE,0.023304,0.023727,Neutral
"Here Are All The Corporate CEOs Who Made A Beeline To China To Chase Huge Market Opportunities Amid The Country's Reopening - LVMH  ( OTC:LVMUY ) , NVIDIA  ( NASDAQ:NVDA ) , Apple  ( NASDAQ:AAPL ) , iShares MSCI China ETF  ( NASDAQ:MCHI ) , Tesla  ( NASDAQ:TSLA ) , Starbucks  ( NASDAQ:SBUX ) , General Motors  ( NYSE:GM ) , JPMorgan Chase  ( NYSE:JPM ) , LVMH  ( OTC:LVMHF ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/markets/asia/23/06/32706368/here-are-all-the-corporate-ceos-who-made-a-beeline-to-china-to-chase-huge-market-opportunities-amid,2023-06-04 15:46:41,"Nvidia Corp.'s NVDA CEO Jensen Huang is rumored to be visiting China on Tuesday for the first time in four years. Incidentally, a slew of corporate head honchos have been heading to the country.",PFE,0.124486,0.200936,Somewhat-Bullish
"Conservatives call out multinational corporations for supporting pride month in America, but not Middle East",https://www.foxbusiness.com/politics/conservatives-call-multinational-corporations-supporting-pride-month-america-not-middle-east,2023-06-03 22:53:59,"Conservatives on Twitter are calling out several multinational corporations for showing their support for pride month in America, but not in regions such as the Middle East.",PFE,0.247838,0.153701,Somewhat-Bullish
Postcards - Do This Whenever You See Buffett Buy OXY,https://moneymorning.com/2023/06/03/postcards-do-this-whenever-you-see-buffett-buy-oxy/,2023-06-03 17:25:12,"I always told myself I wouldn't be a ""helicopter parent"" - hovering over my child and making sure she didn't get scrapes or bruises. But this morning, until I finally caught myself, I told my daughter to slow down, not run down the trails, and hold my hand while slowly descending rocky trail steps.",PFE,0.079656,0.026685,Neutral
Where Will Veeva Systems Stock Be in 1 Year?,https://www.fool.com/investing/2023/06/03/where-will-veeva-systems-stock-be-in-1-year/,2023-06-03 11:55:00,The cloud software company's near-term headwinds are dissipating.,PFE,0.059194,0.147159,Neutral
3 Dividend Stocks You Can Buy Without Any Hesitation,https://www.fool.com/investing/2023/06/03/3-dividend-stocks-you-can-buy-without-hesitation/,2023-06-03 10:14:00,The choices are easy with these stocks.,PFE,0.305328,0.397549,Bullish
Autoinjectors Global Market Report 2023: Increasing Prevalence of Chronic Disease Drives Growth,https://www.prnewswire.com/news-releases/autoinjectors-global-market-report-2023-increasing-prevalence-of-chronic-disease-drives-growth-301841281.html,2023-06-03 01:00:00,Autoinjectors Global Market Report 2023: Increasing Prevalence of ... PR ...,PFE,0.03853,0.12297,Neutral
Pfizer  ( PFE )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2103461/pfizer-pfe-gains-but-lags-market-what-you-should-know,2023-06-02 21:45:12,"In the latest trading session, Pfizer (PFE) closed at $38.36, marking a +0.89% move from the previous day.",PFE,0.620664,0.302805,Somewhat-Bullish
Why Shares of BioNTech Rose Friday,https://www.fool.com/investing/2023/06/02/why-shares-of-biontech-rose-friday/,2023-06-02 20:37:07,The company released positive trial data for a non-small cell lung cancer therapy.,PFE,0.137671,0.044944,Neutral
FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage,https://www.cnbc.com/2023/06/02/cancer-drug-shortage-fda-allows-import-of-unapproved-china-chemo-med.html,2023-06-02 19:44:44,The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.,PFE,0.155451,0.035245,Neutral
"Navy Removes Pride Month Posts Amid Right-Wing Backlash- NASCAR, Major League Baseball Also Targeted",https://www.forbes.com/sites/conormurray/2023/06/02/navy-drops-pride-month-posts-as-right-wing-critics-target-even-mild-lgbtq-pride-support-from-nascar-major-league-baseball/,2023-06-02 19:35:14,Right-wing anger over companies celebrating Pride Month is already going viral on social media.,PFE,0.043264,0.045876,Neutral
Promontory Therapeutics Announces Preliminary Data from the National Cancer Institute Phase 2 Clinical Trial of PT-112 in Thymoma and Thymic Carcinoma at 2023 ASCO Annual Meeting,https://www.prnewswire.com/news-releases/promontory-therapeutics-announces-preliminary-data-from-the-national-cancer-institute-phase-2-clinical-trial-of-pt-112-in-thymoma-and-thymic-carcinoma-at-2023-asco-annual-meeting-301841509.html,2023-06-02 18:38:00,Promontory Therapeutics Announces Preliminary Data from the ... PR ...,PFE,0.055364,0.061026,Neutral
NOT REAL NEWS: A look at what didn't happen this week,https://apnews.com/article/fact-check-misinformation-elections-guns-vaccines-target-28eabeaeb9317ac2b6a030de36714d66,2023-06-02 17:46:53,"A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts:",PFE,0.018831,-0.005383,Neutral
Why The Biotech Buying Bonanza Will Likely Continue,https://www.investors.com/news/technology/biotech-stocks-are-in-blistering-ma-climate-ftc-could-change-that/,2023-06-02 17:17:00,Biotech Stocks Are In A 'Blistering' M&A Climate. The FTC Could ... Investor's Business Daily ...,PFE,0.172097,0.001427,Neutral
BioNTech Is Taking On Bristol In Cancer Treatment - Could It Win?,https://www.investors.com/news/technology/bntx-stock-pops-as-it-takes-on-bristol-in-hard-to-treat-cancer-treatment/,2023-06-02 15:11:00,BNTX Stock Pops As It Takes On Bristol In Hard-To-Treat Lung ... Investor's Business Daily ...,PFE,0.151539,-0.278688,Somewhat-Bearish
European Union didn't advise against COVID vaccines for pregnant women,https://apnews.com/article/fact-check-european-union-covid-vaccines-pregnancy-728944139341,2023-06-02 14:17:28,European Union didn't advise against COVID vaccines for pregnant ... The Associated Press ...,PFE,0.065685,0.015191,Neutral
"Pharma Stock Roundup: FDA Okays PFE RSV Jab for Elderly, AZN Ends Brazikumab Studies",https://www.zacks.com/stock/news/2103200/pharma-stock-roundup-fda-okays-pfe-rsv-jab-for-elderly-azn-ends-brazikumab-studies,2023-06-02 14:14:00,FDA approves Pfizer's (PFE) RSV vaccine for older adults and AstraZeneca (AZN) and Merck's (MRK) Lynparza for BRCA-mutated metastatic castration-resistant prostate cancer ...,PFE,0.092095,0.012641,Neutral
Why Biohaven Stock Caught Fire This Week,https://www.fool.com/investing/2023/06/02/why-biohaven-stock-caught-fire-this-week/,2023-06-02 13:11:34,Investors are excited about the company's recent progress.,PFE,0.143415,-0.04512,Neutral
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups,https://www.globenewswire.com/news-release/2023/06/02/2681096/0/en/Novartis-Kisqali-significantly-reduced-the-risk-of-recurrence-by-25-across-a-broad-population-of-patients-with-early-breast-cancer-clinically-meaningful-benefit-was-consistent-acro.html,2023-06-02 12:00:00,"Basel, June 2, 2023 - Novartis today presents positive primary endpoint data from the pivotal Phase III NATALEE trial at the 2023 American Society of Clinical Oncology ( ASCO ) Annual Meeting. Data showed that Kisqali® ( ribociclib ) plus endocrine therapy ( ET ) , compared to ET alone, lowered ...",PFE,0.013144,0.0,Neutral
BioNTech's OncoC4 partnership off to good start with mid-stage trial results,https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-says-drug-oncoc4-partnership-shows-promise-mid-stage-trial-2023-06-02/,2023-06-02 11:51:00,BioNTech's OncoC4 partnership off to good start with mid-stage trial ... ...,PFE,0.204072,0.123979,Neutral
F.D.A. Approves Pfizer's R.S.V. Vaccine for Older Adults,https://www.nytimes.com/2023/05/31/health/fda-rsv-vaccine-older-adults.html,2023-06-01 21:05:58,"Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.",PFE,0.364987,-0.039419,Neutral
Medicare details plan to cover Alzheimer's treatments,https://www.cnbc.com/2023/06/01/medicare-details-plan-to-cover-alzheimers-treatments-.html,2023-06-01 20:33:41,Patients will have to participate in registries that collect real-world data on how the drug works as a condition of coverage.,PFE,0.164468,0.03659,Neutral
Top 2% Biotech Comes 'Out Of Stealth Mode' On A Four-Day Sprint,https://www.investors.com/news/technology/bhvn-stock-runs-up-for-the-fourth-day-as-it-comes-out-of-stealth-mode/,2023-06-01 20:08:00,BHVN Stock Exits 'Stealth Mode' And Hits A Record High Investor's Business Daily ...,PFE,0.11894,0.162133,Somewhat-Bullish
Pfizer  ( PFE )  Down 1.1% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2102670/pfizer-pfe-down-11-since-last-earnings-report-can-it-rebound,2023-06-01 15:31:18,Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PFE,0.330654,0.152344,Somewhat-Bullish
Biohaven  ( BHVN )  Stock up 8% on Encouraging Pipeline Updates,https://www.zacks.com/stock/news/2102772/biohaven-bhvn-stock-up-8-on-encouraging-pipeline-updates,2023-06-01 15:29:00,"At its R&D Day, Biohaven (BHVN) provides updates on its pipeline. It also announced submission of a regulatory filing seeking approval for troriluzole in SCA3, an ultra-rare disorder.",PFE,0.248851,0.154205,Somewhat-Bullish
Pfizer says its experimental antibiotic combo can treat some superbug infections,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-says-its-experimental-antibiotic-combo-can-treat-some-superbug-infections-2023-06-01/,2023-06-01 15:11:04,Pfizer says its experimental antibiotic combo can treat some ... ...,PFE,0.414559,-0.133459,Neutral
US FDA approves Pfizer's RSV vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-rsv-vaccine-2023-05-31/,2023-05-31 22:38:00,"May 31 ( Reuters ) - The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's ( PFE.N ) respiratory syncytial virus ( RSV ) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors.",PFE,0.324139,0.10833,Neutral
Does Pfizer Have a Weight-Loss Pill That's Better Than Ozempic?,https://www.fool.com/investing/2023/05/31/does-pfizer-have-a-weight-loss-pill-thats-better/,2023-05-31 13:53:00,A highly lucrative weight-loss market could be the growth opportunity Pfizer needs to make the stock a better buy.,PFE,0.480056,0.177534,Somewhat-Bullish
5 Large Drug Stocks to Watch From a Thriving Industry,https://www.zacks.com/commentary/2101789/5-large-drug-stocks-to-watch-from-a-thriving-industry,2023-05-31 13:42:00,"Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Roche (RHHBY) and Novartis (NVS) are worth retaining in your portfolio.",PFE,0.025845,0.027075,Neutral
Pyxis  ( PYXS )  Up on Advancing Cancer Therapy Candidates,https://www.zacks.com/stock/news/2101934/pyxis-pyxs-up-on-advancing-cancer-therapy-candidates,2023-05-31 13:39:00,"Pyxis' (PYXS) shares rise as the company advances its phase I candidates, PYX-106 and PYX-201, for challenging cancer therapies.",PFE,0.258351,0.204503,Somewhat-Bullish
"Narrow Market Breadth: Not As Bad As You Think - Advance Auto Parts  ( NYSE:AAP ) , C3.ai  ( NYSE:AI ) ",https://www.benzinga.com/markets/cryptocurrency/23/05/32647812/narrow-market-breadth-not-as-bad-as-you-think,2023-05-31 13:32:53,"Credit card debt hit a record $1 trillion in America. The average household carries $10,000 on their card - another record It's nearly impossible to build wealth when you're paying 20% interest every month. Today, the House of Representatives will vote on the debt limit deal.",PFE,0.035502,0.3438,Somewhat-Bullish
Reassessing the Board Fight That Was Meant to Transform Exxon,https://www.nytimes.com/2023/05/31/business/dealbook/engine-no-1-exxon-mobil.html,2023-05-31 11:18:16,Reassessing Engine No. 1's Fight Against Exxon Mobil The New York Times ...,PFE,0.020421,0.057605,Neutral
"Jnana Therapeutics Reports Positive Topline Results from Phase 1a Clinical Study of JNT-517, a Potential First-in-Class Oral Treatment for PKU",https://www.benzinga.com/pressreleases/23/05/g32642999/jnana-therapeutics-reports-positive-topline-results-from-phase-1a-clinical-study-of-jnt-517-a-pote,2023-05-31 11:00:00,JNT-517 demonstrated proof of mechanism and was safe and well tolerated in healthy volunteers Results support advancement to Phase 1b study in individuals with PKU; study now open for enrollment,PFE,0.045054,0.123941,Neutral
China's commerce minister Wang Wentao meets Tesla CEO Musk | The Financial Express,https://www.financialexpress.com/world-news/chinas-commerce-minister-meets-teslas-musk-promises-support-to-foreign-companies/3109107/,2023-05-31 10:49:14,China's commerce minister Wang Wentao meets Tesla CEO Musk The Financial Express ...,PFE,0.103778,0.167001,Somewhat-Bullish
2 Ultra-Safe Dividend Stocks to Load Up On Right Now,https://www.fool.com/investing/2023/05/31/3-ultra-safe-dividend-stocks-to-load-up-on-right-n/,2023-05-31 10:45:00,These two beaten-down dividend stocks ought to shine over the long term.,PFE,0.334008,0.096127,Neutral
"China's commerce minister meets Tesla's Musk, promises support to foreign companies",https://apnews.com/article/china-musk-tesla-economy-foreign-investor-efa7c803c6efc8805e12f9f336ce3b2d,2023-05-31 07:30:00,"China's commerce minister meets Tesla's Musk, promises support to ... The Associated Press ...",PFE,0.089797,0.160972,Somewhat-Bullish
Tesla's Musk Hails China's 'Vitality' On Beijing Visit,https://www.barrons.com/news/musk-talks-new-energy-vehicles-with-industry-minister-during-china-visit-f0ad8968,2023-05-31 05:35:36,Musk Talks 'New Energy Vehicles' With Industry Minister During China Visit ...,PFE,0.072435,0.0,Neutral
RSV vaccines for older adults under the spotlight,https://www.axios.com/2023/05/31/rsv-vaccines-older-adults-pfizer-fda,2023-05-31 00:32:52,"After years of failed attempts at finding a vaccine against respiratory syncytial virus, researchers are getting closer to soon offering some sort of protection for older adults who are particularly susceptible to the disease.",PFE,0.239305,-0.071514,Neutral
Big Pharma Vs. Washington - An Opportunity To Buy Merck & Co.  ( MRK ) ,https://www.forbes.com/sites/johnbuckingham/2023/06/19/big-pharma-vs-washingtonan-opportunity-to-buy-merck--co-mrk/,2023-06-19 23:34:34,"Warren Buffett states, ""Uncertainty is the friend of the buyer of long-term values,"" and Washington represents a big question mark these days for the pharma sector.",PFE,0.051886,0.033,Neutral
"Alopecia Areata Market to Show Positive Growth at a CAGR of 26.3% During the Study Period  ( 2019-2032 ) , Estimates DelveInsight",https://www.prnewswire.com/news-releases/alopecia-areata-market-to-show-positive-growth-at-a-cagr-of-26-3-during-the-study-period-20192032-estimates-delveinsight-301853907.html,2023-06-19 20:00:00,"Alopecia Areata Market to Show Positive Growth at a CAGR of 26.3% During the Study Period ( 2019-2032 ) , Estimates ... PR ...",PFE,0.079304,0.080311,Neutral
Lilly's  ( LLY )  Migraine Drug Fails Vis-a-Vis Pfizer's Nurtec ODT,https://www.zacks.com/stock/news/2110200/lillys-lly-migraine-drug-fails-vis-a-vis-pfizers-nurtec-odt,2023-06-19 15:01:00,Results from a post-approval study show that treatment with Lilly's (LLY) Emgality failed to achieve statistical superiority over Pfizer's Nurtec ODT in preventing episodic migraine in adults.,PFE,0.17715,0.040938,Neutral
3 Secrets to a Healthy Portfolio,https://moneymorning.com/investing/3-secrets-to-a-healthy-portfolio/,2023-06-19 14:55:32,"""It's not how much money you make, but how much money you keep, how hard it works for you, and how many generations you keep it for."" - Robert Kiyosaki The markets are closed today in celebration of independence. In recognition of the dream of freedom achieved by millions.",PFE,0.158519,0.12471,Neutral
"Why Peter Hotez says he won't debate RFK Jr. after weekend of Rogan, Musk taunts",https://www.marketwatch.com/story/why-peter-hotez-says-he-wont-debate-rfk-jr-after-weekend-of-rogan-musk-taunts-fd02055d,2023-06-19 12:48:00,"Dr. Peter Hotez, the dean of the National School of Tropical Medicine at Baylor College of Medicine, explains why he won't debate presidential candidate Robert F. Kennedy Jr.",PFE,0.256989,0.035445,Neutral
"Over 40 Companies Commit to Provide Jobs & Training to More Than 250,000 Ukrainian and Other Refugees at Tent European Business Summit",https://www.prnewswire.com/news-releases/over-40-companies-commit-to-provide-jobs--training-to-more-than-250-000-ukrainian-and-other-refugees-at-tent-european-business-summit-301853757.html,2023-06-19 05:00:00,Over 40 Companies Commit to Provide Jobs & Training to More Than 250000 Ukrainian and Other Refugees at Tent ... PR ...,PFE,0.018173,0.032288,Neutral
"First on : Ahead of World Refugee Day, dozens of big companies pledge to hire and train over 250,000 refugees in Europe | Business",https://www.cnn.com/2023/06/19/success/refugees-europe-jobs-training/index.html,2023-06-19 04:07:00,"First on CNN: Ahead of World Refugee Day, dozens of big companies pledge to hire and train over 250,000 refugees in Europe ...",PFE,0.061315,0.081004,Neutral
"First on : Ahead of World Refugee Day, dozens of big companies pledge to hire and train over 250,000 refugees in Europe | Business",https://edition.cnn.com/2023/06/19/success/refugees-europe-jobs-training/index.html,2023-06-19 04:07:00,"First on CNN: Ahead of World Refugee Day, dozens of big companies pledge to hire and train over 250,000 refugees in Europe CNN International ...",PFE,0.061315,0.081004,Neutral
What Emma Lazarus Got Wrong About Immigration,https://www.theatlantic.com/ideas/archive/2023/06/immigration-job-creation-entrepreneurship/674443/,2023-06-18 11:00:00,Immigrants Create More Jobs Than They Take The Atlantic ...,PFE,0.032825,0.092261,Neutral
3 Bargain Stocks to Buy on the Dip,https://www.fool.com/investing/2023/06/17/3-bargain-stocks-to-buy-on-the-dip/,2023-06-17 10:10:00,These stocks should be poised to rebound.,PFE,0.29689,0.081348,Neutral
"Pomerantz Law Firm Announces the Filing of a Class Action Against Viatris, Inc. and Certain Officers - VTRS",https://www.prnewswire.com/news-releases/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-viatris-inc-and-certain-officers--vtrs-301853598.html,2023-06-17 03:46:00,"NEW YORK, June 16, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Viatris, Inc. ( ""Viatris"" or the ""Company"" ) ( NASDAQ: VTRS ) , and certain officers.",PFE,0.048621,0.0,Neutral
Bristol Myers sues US government over Medicare drug price negotiation plan,https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-sues-us-government-over-medicare-drug-price-negotiation-plan-2023-06-16/,2023-06-16 22:06:00,"June 16 ( Reuters ) - Bristol Myers Squibb Co ( BMY.N ) on Friday sued the U.S. government in an attempt to halt the Medicare drug price negotiation program that analysts believe will involve one of its top-selling medicines, saying it violates the Fifth and First Amendments to the U.S.",PFE,0.090134,0.077676,Neutral
Next round of COVID-19 shots in fall will target latest omicron strain,https://apnews.com/article/covid-vaccines-booster-shot-coronavirus-fall-21912cf8980ab8a0763625de37cc7704,2023-06-16 20:45:37,"NEW YORK ( AP ) - The next round of COVID-19 vaccines will target one of the latest versions of the coronavirus, the Food and Drug Administration said Friday. FDA's decision came one day after an agency panel of outside advisers supported the recipe change.",PFE,0.166169,0.102682,Neutral
"Paclitaxel Injection Market to Grow at a CAGR of -3.4% from 2023 to 2031, reaching US$ 484.5 million: As per TMR Study",https://www.benzinga.com/pressreleases/23/06/g32900916/paclitaxel-injection-market-to-grow-at-a-cagr-of-3-4-from-2023-to-2031-reaching-us-484-5-million-a,2023-06-16 20:30:00,"Wilmington, Delaware, United States, June 17, 2023 ( GLOBE NEWSWIRE ) -- The global paclitaxel injection market stood at US$ 811.0 million in 2022, and the global market is projected to reach US$ 484.5 million by 2031. The global industry is anticipated to record a CAGR of -3.4% between 2023 and ...",PFE,0.039224,0.02995,Neutral
US FDA advises COVID vaccine makers to develop shots aimed at XBB.1.5 variant,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-advises-covid-vaccine-makers-develop-shots-aimed-xbb15-variant-2023-06-16/,2023-06-16 19:28:00,June 16 ( Reuters ) - The U.S. Food and Drug Administration ( FDA ) said on Friday it has advised manufacturers that are updating their COVID-19 vaccines to develop monovalent shots to target the XBB.1.5 subvariant.,PFE,0.231332,0.195348,Somewhat-Bullish
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall,https://www.cnbc.com/2023/06/16/fda-covid-shots-should-target-omicron-subvariant-xbbpoint1point5-this-fall.html,2023-06-16 18:14:23,"The FDA's decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5.",PFE,0.327366,0.080242,Neutral
Eli Lilly's Migraine Candidate Flunks Head-To-Head Study With Pfizer's Newly Acquired Drug - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/23/06/32897316/eli-lillys-migraine-candidate-flunks-head-to-head-study-with-pfizers-newly-acquired-drug,2023-06-16 17:48:45,Eli Lilly And Co LLY announced the results of the CHALLENGE-MIG clinical trial of Emgality ( galcanezumab-gnlm ) and Nurtec ODT ( rimegepant orally disintegrating tablet ) .,PFE,0.331765,0.0,Neutral
Eli Lilly's migraine drug fails to meet main goal in post-approval study,https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lillys-migraine-drug-fails-meet-main-goal-post-approval-study-2023-06-16/,2023-06-16 16:28:00,June 16 ( Reuters ) - Eli Lilly ( LLY.N ) said on Friday its drug Emgality did not meet the primary goal of superiority to Pfizer Inc's ( PFE.N ) Nurtec ODT in prevention of episodic migraine in a post-approval study. This was the first-of-its-kind study comparing the two drugs.,PFE,0.366061,0.159422,Somewhat-Bullish
FDA advisors raise doubts about seasonal updates to Covid vaccines as with flu shots,https://www.cnbc.com/2023/06/16/covid-vaccines-fda-advisors-raise-doubts-about-seasonal-updates.html,2023-06-16 16:16:57,The panel's concerns push back against the FDA's proposed shift to annual Covid shots - an approach that vaccine makers like Pfizer are already preparing for.,PFE,0.145437,0.114336,Neutral
Steps To Strengthening Your Stock Portfolio And Why You Should Diversify,https://www.benzinga.com/23/06/32895940/steps-to-strengthening-your-stock-portfolio-and-why-you-should-diversify,2023-06-16 15:48:08,"We all know diversification is typically a good thing, but you rarely see anyone talk about the why behind it. What is the impact of it? How about we start here. Diversification is defined as the spreading of your investments both among and within different asset classes.",PFE,0.053271,0.054126,Neutral
FDA Panel Endorses Updating COVID Jab to Target XBB Strain,https://www.zacks.com/stock/news/2109553/fda-panel-endorses-updating-covid-jab-to-target-xbb-strain,2023-06-16 15:46:00,An FDA panel unanimously recommends updating COVID vaccines to target one of the currently dominating XBB strains of the virus.,PFE,0.455525,0.1303,Neutral
Dietary Supplements Market size to grow by USD 61.4 billion from 2023 to 2027: Increasing adoption of healthy eating habits to Boost the market growth - Technavio,https://www.prnewswire.com/news-releases/dietary-supplements-market-size-to-grow-by-usd-61-4-billion-from-2023-to-2027-increasing-adoption-of-healthy-eating-habits-to-boost-the-market-growth---technavio-301852668.html,2023-06-16 14:30:00,Dietary Supplements Market size to grow by USD 61.4 billion from 2023 to 2027: Increasing adoption of healthy eating ... PR ...,PFE,0.025761,0.00673,Neutral
"Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support - Moderna  ( NASDAQ:MRNA ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/06/32891359/pfizer-moderna-and-novavax-gear-up-for-xbb-1-5-strain-targeted-vaccines-as-fda-AdCom-Support,2023-06-16 12:52:21,"Thursday, the FDA's Vaccines and Related Biological Products Advisory Committee all 21 members voted ""Yes,"" recommending that updated monovalent COVID shots in the fall and winter targeting the XBB variants, which are now the dominant strains of the SARS-CoV-2 virus in the world.",PFE,0.256989,0.0,Neutral
Dietary Supplements Market Expected to Reach $239.4 Billion with Impressive 7.4% CAGR | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/06/g32891455/dietary-supplements-market-expected-to-reach-239-4-billion-with-impressive-7-4-cagr-marketsandmark,2023-06-16 12:30:00,"Chicago, June 16, 2023 ( GLOBE NEWSWIRE ) -- The dietary supplements market is poised for significant growth, with an estimated value of USD 167.5 billion in 2023, projected to reach USD 239.4 billion by 2028, exhibiting a robust CAGR of 7.4%.",PFE,0.035138,0.017859,Neutral
This Biotech Is Developing The Next Ozempic. Should You Buy It?,https://www.fool.com/investing/2023/06/16/this-biotech-is-developing-the-next-ozempic-should/,2023-06-16 12:00:00,"If it succeeds, it'll still face a battle for market share.",PFE,0.047465,0.109274,Neutral
AbbVie's  ( ABBV )  Skyrizi Meets Ulcerative Colitis Study Goals,https://www.zacks.com/stock/news/2109293/abbvies-abbv-skyrizi-meets-ulcerative-colitis-study-goals,2023-06-16 11:45:00,AbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical remission in a late-stage study as a maintenance treatment for ulcerative colitis.,PFE,0.052455,0.10259,Neutral
A Hotter World Should Light a Fire Under These Stocks,https://realmoney.thestreet.com/investing/stocks/a-hotter-world-should-light-a-fire-under-these-stocks-16126576,2023-06-16 11:00:00,"After a massive cloud of smoke from Canada's forest fires engulfed my home state of New York, I can't help but consider the effects of climate change. I often contemplate the potential ecological devastation ahead, the ways to mitigate atmospheric carbon, and investment opportunities.",PFE,0.095707,0.109306,Neutral
Pfizer alerts doctors to impending shortage of long-acting penicillin for kids,https://www.cnn.com/2023/06/15/health/pfizer-long-acting-penicillin-shortage/index.html,2023-06-15 23:44:00,"Pfizer alerts doctors to impending shortage of antibiotic for kids, will prioritize drug for pregnant adults ...",PFE,0.31282,-0.088649,Neutral
FDA advisers endorse targeting XBB variant in new COVID booster,https://www.axios.com/2023/06/15/covid-boosters-vaccine-fda-strain,2023-06-15 21:57:29,"An expert panel of the Food and Drug Administration today endorsed updating COVID boosters for the fall, unanimously recommending that they target an omicron strain known as XBB that's responsible for nearly every infection in the U.S.",PFE,0.295867,0.110629,Neutral
Pfizer  ( PFE )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2109070/pfizer-pfe-gains-but-lags-market-what-you-should-know,2023-06-15 21:45:22,"In the latest trading session, Pfizer (PFE) closed at $39.75, marking a +0.99% move from the previous day.",PFE,0.490323,0.198891,Somewhat-Bullish
F.D.A. Panel Advises Vaccine Makers to Aim at Only One Covid Variant,https://www.nytimes.com/2023/06/15/health/fda-covid-vaccine-boosters-xbb.html,2023-06-15 21:07:55,An F.D.A. advisory panel told manufacturers to aim the latest coronavirus vaccine for the fall at the dominant SARS-CoV-2 variant.,PFE,0.074926,0.081747,Neutral
FDA advisors recommend that new Covid vaccines target an omicron XBB variant this fall,https://www.cnbc.com/2023/06/15/covid-vaccines-this-fall-target-xbb-fda-advisors.html,2023-06-15 20:19:43,"The FDA advisory panel's recommendation is a win for Covid vaccine makers Pfizer, Moderna and Novavax, which will race to deliver updated shots for the fall.",PFE,0.216215,0.14198,Neutral
Why BridgeBio Pharma Stock Is Plunging Today,https://www.fool.com/investing/2023/06/15/why-bridgebio-pharma-stock-is-plunging-today/,2023-06-15 18:04:34,A cautionary note from JPMorgan is weighing on the biotech's shares today.,PFE,0.155451,0.102958,Neutral
The Gardner Syndrome Treatment Market Size Is Expected To Reach $21.6 Billion By 2027 As Per The Business Research Company's Gardner Syndrome Treatment Global Market Report 2023,https://www.benzinga.com/pressreleases/23/06/g32877754/the-gardner-syndrome-treatment-market-size-is-expected-to-reach-21-6-billion-by-2027-as-per-the-bu,2023-06-15 15:35:00,"LONDON, June 15, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Gardner Syndrome Treatment Market Report 2023, the market will grow from $17.6 billion in 2022 to $18.4 billion in 2023, at a compound annual growth rate ( CAGR ) of more than 4%.",PFE,0.059194,-0.22204,Somewhat-Bearish
PFE: 3 Pharma Stocks Every Investor Should Know,https://stocknews.com/news/pfe-sny-spro-3-pharma-stocks-every-investor-should-know/,2023-06-15 15:13:06,"The Pharmaceuticals market shows solid growth, primarily driven by innovative technology and an increasing demand for healthcare, especially in emerging countries. Moreover, as the industry enjoys inelastic demand, quality pharma stocks Pfizer Inc. ( PFE ) , Sanofi ( SNY ) , and Spero ...",PFE,0.373378,0.197338,Somewhat-Bullish
Earn Dividends EVERY Month With These 3 Stocks,https://www.fool.com/investing/2023/06/15/earn-dividends-every-month-with-these-3-stocks/,2023-06-15 15:03:00,These three blue chip dividend stocks will have you receiving a dividend paycheck every month.,PFE,0.807885,0.252854,Somewhat-Bullish
FDA advisers consider changing COVID vaccine to target latest omicron strain,https://apnews.com/article/covid19-vaccine-booster-shot-coronavirus-fall-72c0436ac9211f1a893fe8056106909d,2023-06-15 14:05:03,"The COVID-19 vaccines are on track for a big recipe change this fall. Today's vaccines still contain the original coronavirus strain, the one that started the pandemic - even though that was long ago supplanted by mutated versions as the virus rapidly evolves.",PFE,0.055881,0.06599,Neutral
CULT Food Science Announces Artificial Intelligence Partnership for Taste Optimization in Cultivated Foods,https://www.newswire.ca/news-releases/cult-food-science-announces-artificial-intelligence-partnership-for-taste-optimization-in-cultivated-foods-859585739.html,2023-06-15 11:00:00,New partnership with Alcheme Bio leverages artificial intelligence and machine learning to accelerate cellular agriculture products to market,PFE,0.049732,-0.000998,Neutral
Biomarkers Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/biomarkers-market-to-grow-significantly-by-2029--brandessence-market-research-301851886.html,2023-06-15 10:40:00,"LONDON, June 15, 2023 /PRNewswire/ -- Biomarkers are referred to as a type of measurable biological indicators or characteristics found in body tissues or fluids like blood.",PFE,0.023861,0.109009,Neutral
Anaemia Drugs Market to Grow Exponentially by 2029 Says Brandessence Market Research,https://www.prnewswire.com/news-releases/anaemia-drugs-market-to-grow-exponentially-by-2029-says-brandessence-market-research-301851868.html,2023-06-15 10:22:00,"LONDON, June 15, 2023 /PRNewswire/ -- Anaemia is a disorder occurrence by the deficiency of red blood cells or decreasing amount of haemoglobin in the blood. It often leads to extreme weakness, fatigue, pale skin and irregular heartbeat, among others.",PFE,0.057215,0.116057,Neutral
US FDA panel to weigh makeup of next COVID vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-weigh-makeup-next-covid-vaccine-2023-06-15/,2023-06-15 10:04:00,"[1/2] A woman receives a booster dose of Pfizer-BioNTech vaccine against the coronavirus disease ( COVID-19 ) , ahead of brace of an influx of Chinese tourists as COVID restriction are dismantled, at the Police hospital in Bangkok, Thailand, January 5, 2023. REUTERS/Athit Perawongmetha/File Photo",PFE,0.217508,0.063604,Neutral
IMAGIO consortium receives Innovative Health Initiative EUR 24 million grant to improve cancer treatments,https://www.globenewswire.com/news-release/2023/06/15/2688694/0/en/IMAGIO-consortium-receives-Innovative-Health-Initiative-EUR-24-million-grant-to-improve-cancer-treatments.html,2023-06-15 10:00:00,June ...,PFE,0.083107,0.041045,Neutral
2 Stocks Down 11% and 20% to Buy Right Now,https://www.fool.com/investing/2023/06/15/2-stocks-down-11-and-20-to-buy-right-now/,2023-06-15 10:00:00,These companies' long-term prospects look bright.,PFE,0.482406,0.277693,Somewhat-Bullish
Biosimilars Market worth $66.9 billion | MarketsandMarkets,https://www.prnewswire.com/news-releases/biosimilars-market-worth-66-9-billion--marketsandmarkets-301851755.html,2023-06-15 10:00:00,"CHICAGO, June 15, 2023 /PRNewswire/ -- The biosimilars industry is poised for significant growth and innovation in the near future.",PFE,0.026299,0.076496,Neutral
The strain COVID vaccines might target next,https://www.axios.com/2023/06/15/strain-covid-vaccines-might-target-next,2023-06-15 09:52:19,"Food and Drug Administration advisers on Thursday will vote on whether the next round of COVID-19 shots should target XBB, a subvariant of omicron that's driving the majority of new infections in the U.S.",PFE,0.069094,0.0,Neutral
McKinsey Says Artificial Intelligence  ( AI )  Could Add $4.4 Trillion to the Global Economy,https://www.fool.com/investing/2023/06/15/mckinsey-says-artificial-intelligence-ai-could-add/,2023-06-15 09:50:00,The full impact of generative AI could be even higher than McKinsey predicts.,PFE,0.129168,0.17959,Somewhat-Bullish
One Change Could Help U.S. Drugmakers Save 11 Million Trees a Year,https://www.wsj.com/articles/one-change-could-help-u-s-drugmakers-save-11-million-trees-a-year-74c077f2,2023-06-15 09:30:00,Paper and pharmaceutical lobbies are clashing over rules to digitize drug information leaflets which ensure up-to-date information while also cutting emissions and waste.,PFE,0.04161,0.083197,Neutral
The strain COVID vaccines might target next,https://www.axios.com/2023/06/15/strain-covid-vaccines-might-target-next,2023-06-15 05:56:20,"Food and Drug Administration advisers on Thursday will vote on whether the next round of COVID-19 shots should target XBB, a subvariant of omicron that's driving the majority of new infections in the U.S.",PFE,0.069094,0.0,Neutral
"Oracle hits record after 50% surge in 2023, defying tech struggles",https://www.cnbc.com/2023/06/14/oracle-hits-record-after-50percent-surge-in-2023-defying-tech-struggles.html,2023-06-14 20:25:43,"Oracle shares reached a record this week after analysts applauded an earnings beat, driven by accelerating growth in cloud infrastructure ...",PFE,0.035929,-0.137593,Neutral
"Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with 'Buy' Rating - Ambrx Biopharma  ( NASDAQ:AMAM ) ",https://www.benzinga.com/general/biotech/23/06/32861151/investor-opportunities-ahead-of-clinical-updates-says-analyst-initiating-coverage-on-ambrx-biopha,2023-06-14 19:05:23,"B Riley Securities has initiated Ambrx Biopharma Inc AMAM with a Buy rating and a price target of $26 per share. The analyst notes much excitement surrounding antibody-drug conjugates ( ADCs ) , as demonstrated by mega M&A and cross-border deals, most recently Seagen Inc SGEN being acquired by ...",PFE,0.391923,0.244147,Somewhat-Bullish
Comscore Ranks Latino Alternative TV  ( LATV )  as the Fifth Largest U.S. Hispanic Focused Digital Network - comScore  ( NASDAQ:SCOR ) ,https://www.benzinga.com/pressreleases/23/06/n32857619/comscore-ranks-latino-alternative-tv-latv-as-the-fifth-largest-u-s-hispanic-focused-digital-networ,2023-06-14 15:02:47,LATV's American Latino audience engagement and reach outranks Telemundo and Univision,PFE,0.077845,0.0,Neutral
"The Atlantic Festival Returns September 28 and 29, Announces First Headliners",https://www.theatlantic.com/press-releases/archive/2023/06/atlantic-festival-september-28-and-29-announces-headliners/674396/,2023-06-14 15:00:00,"The Atlantic Festival Returns to The Wharf in D.C., September 28 and 29, and Announces First Headliners Meet great minds who don't think alike. The Atlantic is releasing tickets and revealing the first slate of conversations that will take place at The Atlantic Festival, its annual live event on ...",PFE,0.095517,0.252494,Somewhat-Bullish
"Top Stories Wednesday, June 14: Deflation Pushes PPI To 28-Month Lows; Google's Dominance in Ad Tech Under European Scrutiny; Disney Delays Avatar, Marvel & Star Wars Release - Apple  ( NASDAQ:AAPL ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/news/23/06/32855678/deflation-pushes-ppi-to-28-month-lows-googles-dominance-in-ad-tech-under-european-scrutiny-disney-de,2023-06-14 13:47:34,"U.S. producers now face the reality of deflation, as the Producer Price Index ( PPI ) for final demand slumped 0.3% month-on-month in May, down from the previous 0.2% monthly increase and below the expected 0.1% fall, the U.S. Bureau of Labor Statistics reported Wednesday.",PFE,0.07157,-0.10865,Neutral
"Eli Lilly CEO Joins Other Pharma Execs, Raises Concern Over Medicare Price Negotiations Impacting Drug Development - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/06/32853565/eli-lilly-ceo-joins-other-pharma-execs-raises-concern-over-medicare-price-negotiations-impacting-,2023-06-14 12:46:23,"Eli Lilly And Co LLY CEO David Ricks voiced his concerns about the potential impact of Medicare price negotiations on drug development, which aim to reduce costs for older Americans. In an interview on CNBC's ""The Exchange,"" Ricks said, ""I'm really worried about the harm this will do to new cures ...",PFE,0.258351,-0.172067,Somewhat-Bearish
Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer,https://www.globenewswire.com/news-release/2023/06/14/2688043/0/en/Spero-Therapeutics-Appoints-Sath-Shukla-as-President-Chief-Executive-Officer.html,2023-06-14 12:05:00,"Sath Shukla, current Spero Chief Financial Officer, will bring more than 20 years of strategic and financial leadership to the role of CEO, to be effective August ...",PFE,0.106659,0.110037,Neutral
"Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/06/g32852871/spero-therapeutics-appoints-sath-shukla-as-president-chief-executive-officer,2023-06-14 12:05:00,"Sath Shukla, current Spero Chief Financial Officer, will bring more than 20 years of strategic and financial leadership to the role of CEO, to be effective August 1, 2023 Current President and Chief Executive Officer, Ankit Mahadevia, M.D to become Chairman of the Board of Directors",PFE,0.103442,0.107856,Neutral
Pfizer Warns of Potential Pediatric Antibiotic Shortage Amid Surge in Syphilis Infections - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/06/32852079/pfizer-warns-of-potential-pediatric-antibiotic-shortage-amid-surge-in-syphilis-infections,2023-06-14 12:03:20,"Pfizer Inc PFE cautions about potential supply shortages for pediatric Bicillin L-A, an antibiotic for syphilis treatment, by the end of June. The company has prioritized the production of adult versions due to a surge in syphilis infections in that population.",PFE,0.55533,-0.209489,Somewhat-Bearish
"Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight It - Altimmune  ( NASDAQ:ALT ) , BioRestorative Therapies  ( NASDAQ:BRTX ) ",https://www.benzinga.com/general/biotech/23/06/32851622/metabolic-syndrome-the-silent-epidemic-on-the-rise-and-how-biorestorative-therapies-inc-is-helpin,2023-06-14 11:00:58,"Once a lesser-known health condition, now a problem crippling millions of people around the world: metabolic syndrome is unfortunately on the rise.",PFE,0.130571,0.118869,Neutral
Covid vaccine maker Novavax sees a pathway to survival - but it won't be easy,https://www.cnbc.com/2023/06/14/why-novavax-path-to-survival-wont-be-easy-.html,2023-06-14 11:00:01,"Cash-strapped Covid vaccine Novavax still faces a nunber of challenges, chiefly competing with Pfizer and Moderna in the U.S. commercial market this fall.",PFE,0.097457,0.017212,Neutral
"[Research Report] Global Folate Market Size to Surpass USD 1113.4 Million by 2030, Growing at 14.30% CAGR: Zion Market Research",https://www.benzinga.com/pressreleases/23/06/g32851475/research-report-global-folate-market-size-to-surpass-usd-1113-4-million-by-2030-growing-at-14-30-c,2023-06-14 10:57:20,"NEW YORK, United States, June 14, 2023 ( GLOBE NEWSWIRE ) -- Zion Market Research has published a new research report titled ""Folate Market 2023 - 2030"" in its research database. According to the latest research study, the demand of global folate market size was worth at approximately USD 789.3 ...",PFE,0.042196,0.107492,Neutral
Pfizer expects to run out of antibiotic supply soon,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-expects-run-out-antibiotic-supply-soon-2023-06-13/,2023-06-13 18:09:00,June 13 ( Reuters ) - Pfizer ( PFE.N ) has warned that a drug used to treat syphilis and other bacterial infections in children could run out by the end of June as a spike in infections has put pressure on an already short supply of the antibiotic.,PFE,0.554365,-0.235407,Somewhat-Bearish
PFE: Should You Buy Into Pfizer  ( PFE )  Today?,https://stocknews.com/news/pfe-jnj-mrk-alpmy-should-you-buy-into-pfizer-pfe-today/,2023-06-13 13:57:17,"Pfizer Inc.'s ( PFE ) first-quarter results were in-line with the company's expectations, underlining its continued confidence in achieving 7% to 9% operational revenue growth for the fiscal year 2023.",PFE,0.643681,0.392641,Bullish
5 Biotech Stocks to Buy as Industry Prospects for 2H23 Look Good,https://www.zacks.com/commentary/2107444/5-biotech-stocks-to-buy-as-industry-prospects-for-2h23-look-good,2023-06-13 13:30:00,"New drug approvals and pipeline progress are likely to help maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and a solid pipeline progress position PCVX, PTGX, LGND, MESO and PBYI well amid volatility.",PFE,0.023191,0.069874,Neutral
Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer - Black Diamond Therapeutic  ( NASDAQ:BDTX ) ,https://www.benzinga.com/pressreleases/23/06/g32832558/black-diamond-therapeutics-announces-promotion-of-melanie-morrison-to-chief-development-officer,2023-06-13 12:00:00,"CAMBRIDGE, Mass. and NEW YORK, June 13, 2023 ( GLOBE NEWSWIRE ) -- Black Diamond Therapeutics, Inc.",PFE,0.058615,0.021003,Neutral
2 Bargain Stocks You Can Buy Today and Hold Forever,https://www.fool.com/investing/2023/06/13/2-bargain-stocks-you-can-buy-today-and-hold-foreve/,2023-06-13 09:52:00,These stocks could only be cheap for a season.,PFE,0.395903,0.195756,Somewhat-Bullish
"Arvinas, Inc.  ( ARVN )  Moves 17.5% Higher: Will This Strength Last?",https://www.zacks.com/stock/news/2107394/arvinas-inc-arvn-moves-175-higher-will-this-strength-last,2023-06-13 08:51:00,"Arvinas, Inc. (ARVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",PFE,0.09402,0.005336,Neutral
Pfizer and GSK to battle for share of new RSV vaccine market: Report,https://www.business-standard.com/companies/news/pfizer-and-gsk-to-battle-for-share-of-new-rsv-vaccine-market-report-123061300331_1.html,2023-06-13 08:02:29,"US drugmaker Pfizers and British pharma major GSK are likely to face significant competition in the respiratory syncytial virus ( RSV ) vaccine market, according to a report on Tuesday. GSK's novel vaccine, Arexvy, approved by the US FDA in May, becomes the first RSV vaccine authorised for use ...",PFE,0.077845,0.091329,Neutral
Novartis  ( NVS )  to Buy Chinook for $3.5B to Strengthen Pipeline,https://www.zacks.com/stock/news/2107225/novartis-nvs-to-buy-chinook-for-35b-to-strengthen-pipeline,2023-06-12 16:35:00,"Novartis (NVS) is looking to strengthen its renal pipeline with the acquisition of Chinook Therapeutics for $3.5 billion, which adds two late-stage medicines in development for rare, severe chronic kidney diseases.",PFE,0.21686,0.245804,Somewhat-Bullish
Negotiation or Coercion? Big Pharma and US Chamber of Commerce Tackle Government on Drug Prices - Merck & Co  ( NYSE:MRK ) ,https://www.benzinga.com/general/biotech/23/06/32818125/negotiation-or-coercion-big-pharma-and-us-chamber-of-commerce-tackle-government-on-drug-prices,2023-06-12 16:06:31,"The U.S. Chamber of Commerce has filed a lawsuit against the federal government, challenging a recent law that grants Medicare the authority to negotiate drug prices with pharmaceutical companies. In the complaint, the chamber argued that the pricing program violated the due process rights of ...",PFE,0.419153,-0.118472,Neutral
"Updated Covid vaccines need to target XBB omicron variants this fall, FDA staff says",https://www.cnbc.com/2023/06/12/new-covid-vaccines-in-fall-need-to-target-xbb-variant-fda-staff-says.html,2023-06-12 16:05:32,"Vaccine manufacturers Pfizer, Moderna and Novavax will be expected to update their shots according to the strain the FDA selects for the fall.",PFE,0.244109,0.09527,Neutral
"5 Value Stocks In The Healthcare Sector - Agile Therapeutics  ( NASDAQ:AGRX ) , Sensus Healthcare  ( NASDAQ:SRTS ) , Revelation Biosciences  ( NASDAQ:REVB ) , First Wave BioPharma  ( NASDAQ:FWBI ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/06/32817507/5-value-stocks-in-the-healthcare-sector,2023-06-12 14:44:11,A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.,PFE,0.207571,0.239399,Somewhat-Bullish
Actions Speak Louder Than Words: My Stock Model Portfolio,https://www.forbes.com/sites/johndorfman/2023/06/12/actions-speak-louder-than-words-my-stock-model-portfolio/,2023-06-12 14:39:32,"While I write about more than 200 stocks each year, I own far fewer. Here are 25 that are in my portfolio.",PFE,0.057628,-0.090962,Neutral
Updated COVID vaccines need to target XBB subvariants -U.S. FDA staff,https://www.reuters.com/business/healthcare-pharmaceuticals/updated-covid-vaccines-need-target-xbb-strains-us-fda-staff-2023-06-12/,2023-06-12 14:22:24,Updated COVID vaccines need to target XBB strains -U.S. FDA staff ...,PFE,0.224903,0.041212,Neutral
"Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape - Teva Pharmaceutical Indus  ( NYSE:TEVA ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/06/32816376/drug-shortages-in-focus-how-fdas-quest-for-new-methotrexate-suppliers-affects-the-cancer-treatmen,2023-06-12 14:16:55,"The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat various cancers and autoimmune diseases like rheumatoid arthritis, as stated by the National Cancer ...",PFE,0.294093,-0.109407,Neutral
"Immix Biopharma Subsidiary Nexcella Appoints Henry McKinnell, Jr., former Chairman & CEO of Pfizer Inc., to Board of Directors",https://www.globenewswire.com/news-release/2023/06/12/2686410/0/en/Immix-Biopharma-Subsidiary-Nexcella-Appoints-Henry-McKinnell-Jr-former-Chairman-CEO-of-Pfizer-Inc-to-Board-of-Directors.html,2023-06-12 13:49:00,"• Dr. McKinnell joins the Nexcella, Inc. Board of Directors with 35 years of experience at Pfizer, Inc., including 6 years as Chairman and Chief Executive Officer • Dr. McKinnell is a former independent director of ChemoCentryx, acquired by Amgen for $3.7 billion in 2022 and former Chairman/CEO ...",PFE,0.14028,0.025497,Neutral
Is Most-Watched Stock Pfizer Inc.  ( PFE )  Worth Betting on Now?,https://www.zacks.com/stock/news/2106919/is-most-watched-stock-pfizer-inc-pfe-worth-betting-on-now,2023-06-12 13:00:12,"Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",PFE,0.490323,0.11993,Neutral
"Delix Therapeutics Appoints Aaron Koenig, MD as Chief Medical Officer",https://www.prnewswire.com/news-releases/delix-therapeutics-appoints-aaron-koenig-md-as-chief-medical-officer-301846490.html,2023-06-12 12:00:00,"Delix Therapeutics Appoints Aaron Koenig, MD as Chief Medical ... PR ...",PFE,0.052918,0.161663,Somewhat-Bullish
POINT Biopharma Announces Appointment of Dr. Bridget Martell to its Board of Directors - POINT Biopharma Global  ( NASDAQ:PNT ) ,https://www.benzinga.com/pressreleases/23/06/g32813333/point-biopharma-announces-appointment-of-dr-bridget-martell-to-its-board-of-directors,2023-06-12 12:00:00,"INDIANAPOLIS, June 12, 2023 ( GLOBE NEWSWIRE ) -- POINT Biopharma Global Inc. PNT ( the ""Company"" or ""POINT"" ) , a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced the filling of its vacant board seat with the appointment of ...",PFE,0.044222,0.065947,Neutral
BioNTech faces several lawsuits in Germany over Covid vaccine side effects,https://www.business-standard.com/world-news/biontech-faces-several-lawsuits-in-germany-over-covid-vaccine-side-effects-123061200492_1.html,2023-06-12 10:11:36,BioNTech faces several lawsuits in Germany over Covid vaccine ... Business Standard ...,PFE,0.208464,-0.042555,Neutral
BC Platforms Expands Data Partner Network with Major Brazilian Cardiovascular Health Institution,https://www.benzinga.com/pressreleases/23/06/g32810675/bc-platforms-expands-data-partner-network-with-major-brazilian-cardiovascular-health-institution,2023-06-12 07:00:39,"ZURICH, Switzerland, June 12, 2023 ( GLOBE NEWSWIRE ) -- BC Platforms ( BCP ) , a global leader in healthcare data management and analytics, today announces the addition of one of Brazil's leading cardiology centres, Hospital do Coração ( HCor ) , to its Global Data Partner network, ...",PFE,0.037098,0.093124,Neutral
First Post-Covid Jab Claims Land In German Courts,https://www.barrons.com/news/first-post-covid-jab-claims-land-in-german-courts-bbb9d749,2023-06-12 06:25:49,"German courts will from Monday begin examining a series of claims over adverse effects suffered after coronavirus vaccinations, more than two years after one of the world's fastest and most extensive innoculation campaigns.",PFE,0.057767,0.0,Neutral
First Post-Covid Jab Claims Land In German Courts,https://www.barrons.com/news/first-post-covid-jab-claims-land-in-german-courts-43d71202,2023-06-12 06:25:49,"German courts will from Monday begin examining a series of claims over adverse effects suffered after coronavirus vaccinations, more than two years after one of the world's fastest and most extensive innoculation campaigns.",PFE,0.057767,0.0,Neutral
First Covid Vaccine Side-effect Claims Land In German Courts,https://www.barrons.com/news/first-post-covid-jab-claims-land-in-german-courts-43d71202,2023-06-12 06:25:49,First Post-Covid Jab Claims Land In German Courts ...,PFE,0.053992,0.065776,Neutral
BioNTech faces first German lawsuit over alleged COVID vaccine side effects | The Financial Express,https://www.financialexpress.com/healthcare/biontech-faces-first-german-lawsuit-over-alleged-covid-vaccine-side-effects/3121788/,2023-06-11 10:28:00,BioNTech faces first German lawsuit over alleged COVID vaccine ... The Financial Express ...,PFE,0.114409,0.017078,Neutral
BioNTech faces first German lawsuit over alleged COVID vaccine side effects,https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-faces-first-german-lawsuit-over-alleged-covid-vaccine-side-effects-2023-06-11/,2023-06-11 09:56:14,BioNTech faces first German lawsuit over alleged COVID vaccine ... ...,PFE,0.107255,0.016645,Neutral
3 No-Brainer Stocks to Buy in June,https://www.fool.com/investing/2023/06/10/3-no-brainer-stocks-to-buy-in-june/,2023-06-10 10:14:00,These biopharma stocks could be big winners.,PFE,0.345073,0.167966,Somewhat-Bullish
Does Moderna's Cancer Breakthrough Make It a Good Stock to Buy Now?,https://www.fool.com/investing/2023/06/10/does-modernas-cancer-breakthrough-make-it-a-good-s/,2023-06-10 09:39:00,"Cancer vaccines have been around a long time, but they usually don't produce such compelling results.",PFE,0.044386,0.11126,Neutral
'Home buyers have adjusted' to new normal of near-7% mortgage rates and more newlyweds are asking for this specific gift,https://www.marketwatch.com/story/home-buyers-have-adjusted-to-new-normal-of-near-7-mortgage-rates-and-more-newlyweds-are-asking-for-this-specific-gift-ddc1467c,2023-06-29 21:19:00,Thursday's top personal finance stories.,PFE,0.112008,-0.00348,Neutral
"Liver Cancer Market to Proliferate Positively, Assesses DelveInsight | Key Companies Active in the Domain - SOTIO, GlaxoSmithKline, Pfizer, Merck, Takeda, Genentech, Boehringer Ingelheim, DNAtrix, Celldex",https://www.prnewswire.com/news-releases/liver-cancer-market-to-proliferate-positively-assesses-delveinsight--key-companies-active-in-the-domain---sotio-glaxosmithkline-pfizer-merck-takeda-genentech-boehringer-ingelheim-dnatrix-celldex-301867060.html,2023-06-29 21:01:00,"Liver Cancer Market to Proliferate Positively, Assesses DelveInsight | Key Companies Active in the Domain - SOTIO ... PR ...",PFE,0.027828,-0.048986,Neutral
Why Shares of Opko Health Jumped on Thursday,https://www.fool.com/investing/2023/06/29/why-shares-of-opko-health-jumped-on-thursday/,2023-06-29 19:51:58,The FDA approved a growth therapy the company was collaborating on with Pfizer.,PFE,0.582526,0.438286,Bullish
"Ex-Pfizer employee, business partner charged with insider trading on COVID drug trial results",https://www.foxbusiness.com/lifestyle/ex-pfizer-employee-business-partner-charged-with-insider-trading-on-covid-drug-trial-results,2023-06-29 19:47:42,"A former Pfizer employee and his business associate are being charged with insider trading after allegedly gaining significant profits from trading on game-changing non-public drug trial results for a COVID-19 treatment, according to the Securities and Exchange Commission ( SEC ) .",PFE,0.679118,0.195365,Somewhat-Bullish
Former Pfizer employee charged with Covid drug insider trading | Business,https://www.cnn.com/2023/06/29/business/former-pfizer-employee-insider-trading/index.html,2023-06-29 18:45:00,Former Pfizer employee charged with Covid drug insider trading ...,PFE,0.660632,0.232286,Somewhat-Bullish
"Americans still say Disney is among the most patriotic brands, despite DeSantis feud",https://www.marketwatch.com/story/americans-still-say-disney-is-among-the-most-patriotic-brands-in-the-u-s-despite-desantis-feud-8926d7c5,2023-06-29 16:45:00,"Ahead of the Fourth of July, these are the top 50 companies that Americans call the most patriotic --- and OpenAI, the company behind ChatGPT, makes the list ...",PFE,0.131643,-0.097963,Neutral
Ex-Pfizer employee charged with illegal trading based on unreleased Covid pill trial data,https://www.cnbc.com/2023/06/29/ex-pfizer-employee-charged-over-trading-on-paxlovid-data.html,2023-06-29 15:49:34,"The DOJ said the former employee and his close friend sold their Pfizer call options at ""significant profits"" totaling more than $350,000.",PFE,0.614086,0.0,Neutral
OPKO Health's  ( OPK )  NGENLA Approved by FDA for GHD Treatment,https://www.zacks.com/stock/news/2114869/opko-healths-opk-ngenla-approved-by-fda-for-ghd-treatment,2023-06-29 15:23:00,"The latest approval for OPKO Health's (OPK) NGENLA is expected to reduce the treatment frequency from daily injections, thereby better serving the GHD patient pool.",PFE,0.31282,0.212503,Somewhat-Bullish
Why Every Investor Should Be Invested In Emerging Markets,https://www.forbes.com/sites/investor-hub/article/why-every-investor-should-be-invested-in-emerging-markets/,2023-06-29 15:03:06,"Emerging markets are countries experiencing rapid economic growth and development. They have historically offered investors higher rates of return than developed markets, but U.S. stimulus has dulled their shine. Here's why investors should reconsider.",PFE,0.015613,-0.066903,Neutral
Feds charge three with illegal trading ahead of Trump Media merger announcement,https://www.cnbc.com/2023/06/29/three-charged-with-illegal-trading-ahead-of-trump-media-merger.html,2023-06-29 14:57:32,"Michael Shvartsman, Gerald Shvartsman, and Bruce Garelick allegedly ""made more than $22 million dollars in illegal profits.",PFE,0.089129,-0.178961,Somewhat-Bearish
"3 charged in insider trading case related to taking Trump media firm public, accused of making $22M",https://apnews.com/article/trump-digital-world-insider-trading-f5da209f43e5e3fd03ea7ca2961ced95,2023-06-29 14:42:00,NEW YORK ( AP ) - Three Florida men were arrested Thursday and charged with illegally making more than $22 million by insider trading ahead of the public announcement that an acquisition firm was going to take a media company owned by former President Donald Trump public.,PFE,0.136113,-0.034556,Neutral
5 High-Yielding Dividend Stocks That Are Bargain Buys,https://www.fool.com/investing/2023/06/29/5-high-yielding-dividend-stocks-that-are-bargain/,2023-06-29 14:00:00,This is a good time for investors to load up on healthcare companies.,PFE,0.250816,0.232948,Somewhat-Bullish
"CDC recommends Pfizer, GSK vaccines for older adults",https://www.axios.com/2023/06/29/cdc-recommends-gsk-pfizer-rsv-vaccine,2023-06-29 13:50:17,"The Centers for Disease and Prevention on Thursday recommended adults aged 60 and older get one of two respiratory syncytial virus vaccines this fall, making them the first shots against the disease to be authorized in the U.S.",PFE,0.465196,-0.196874,Somewhat-Bearish
"10 things to watch in the stock market Thursday, including bank stress tests and a possible chip trough",https://www.cnbc.com/2023/06/29/10-things-to-watch-in-the-stock-market-thursday-including-bank-stress-tests.html,2023-06-29 13:07:43,"With two trading days left in June and the second quarter, the Dow, S&P 500 and Nasdaq are all sitting on solid gains.",PFE,0.151858,0.089758,Neutral
"Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday - Green Dot  ( NYSE:GDOT ) , Foghorn Therapeutics  ( NASDAQ:FHTX ) ",https://www.benzinga.com/news/23/06/33058152/schr-dinger-to-rally-around-14-here-are-10-other-analyst-forecasts-for-thursday,2023-06-29 12:53:03,"Keybanc boosted the price target for Micron Technology, Inc. MU from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market trading. Credit Suisse cut the price target for Pfizer Inc. PFE from $47 to $40.",PFE,0.274834,0.259031,Somewhat-Bullish
"CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older",https://www.cnbc.com/2023/06/29/rsv-vaccine-cdc-recommends-pfizer-gsk-shots-for-older-adults.html,2023-06-29 12:45:00,"The CDC said the shots from Pfizer and GSK are expected to be available this fall, when RSV - along with Covid and the flu - begins to spread at higher levels.",PFE,0.345674,0.131373,Neutral
"US CDC recommends use of new Pfizer, GSK vaccines for RSV in older adults",https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-recommends-use-new-pfizer-gsk-vaccines-rsv-older-adults-2023-06-29/,2023-06-29 12:34:00,"June 29 ( Reuters ) - The director of the U.S. Centers for Disease Control and Prevention ( CDC ) signed off on Thursday on the use of new vaccines from Pfizer ( PFE.N ) and GSK ( GSK.L ) to prevent severe respiratory syncytial virus ( RSV ) infections in older adults, the agency's spokesperson ...",PFE,0.222838,-0.246177,Somewhat-Bearish
Pfizer  ( PFE )  Gets FDA Nod for Growth Hormone Deficiency Drug,https://www.zacks.com/stock/news/2114713/pfizer-pfe-gets-fda-nod-for-growth-hormone-deficiency-drug,2023-06-29 12:10:00,The FDA approves Pfizer (PFE) and OPKO Health's (OPK) Ngenla to treat growth hormone deficiency in pediatric patients. The drug's commercial launch is expected this August.,PFE,0.544495,0.250296,Somewhat-Bullish
Blacklisted 'Woke' Companies Gain $832 Billion During Boycotts,https://www.investors.com/etfs-and-funds/etfs/sp500-blacklisted-woke-companies-gain-832-billion-during-boycotts/,2023-06-29 12:00:00,S&P 500: Blacklisted 'Woke' Companies Gain $832 Billion During ... Investor's Business Daily ...,PFE,0.184363,-0.113771,Neutral
"Older Americans can get RSV vaccine this fall after speaking with their doctor, CDC says",https://apnews.com/article/rsv-vaccine-adults-gsk-pfizer-cdc-virus-592dcd5ae36cdbec8c003511f5fd27f0,2023-06-29 11:00:00,"Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first, U.S. health officials recommended Thursday. The are expected to be ready in the fall, a time when flu shots and updated also will be available.",PFE,0.217834,0.08734,Neutral
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC,https://www.globenewswire.com/news-release/2023/06/29/2696837/0/en/BioNTech-and-OncoC4-Initiate-Pivotal-Phase-3-Trial-of-BNT316-ONC-392-Program-in-Metastatic-NSCLC.html,2023-06-29 10:45:00,"MAINZ, Germany, and ROCKVILLE, Maryland, USA, June 29, 2023 ( GLOBE NEWSWIRE ) - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" ) and OncoC4, Inc. ( ""OncoC4"" ) today announced that the first patient with non-small cell lung cancer ( NSCLC ) has been treated in a pivotal Phase 3 trial evaluating the ...",PFE,0.025706,0.007533,Neutral
This Sentiment Gauge Just Reached Its Most Optimistic Level Since Pre-Covid Days. Time to Buy Stocks?,https://www.fool.com/investing/2023/06/29/this-sentiment-gauge-just-reached-its-most-optimis/,2023-06-29 09:30:00,Many stocks are trading at reasonable levels after declines last year.,PFE,0.243498,-0.070626,Neutral
China's CSPC Pharma partners with Pfizer for COVID oral treatment,https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cspc-pharma-partners-with-pfizer-covid-oral-treatment-2023-06-29/,2023-06-29 08:51:00,"[1/2] Test tubes labelled ""COVID-19 Omicron variant test positive"" are seen in this illustration picture taken January 15, 2022. REUTERS/Dado Ruvic/Illustration/File photo",PFE,0.459624,0.0,Neutral
Qiming-Backed AI Drug Discovery Startup Insilico Medicine Files For Hong Kong IPO,https://www.forbes.com/sites/zinnialee/2023/06/29/qiming-backed-ai-drug-discovery-startup-insilico-medicine-files-for-hong-kong-ipo/,2023-06-29 07:45:07,"Insilico Medicine was valued at about $895 million after raising $95 million last July from the likes of leading Chinese healthcare-focused firm Qiming Venture Partners and billionaire Eduardo Saverin's B Capital, among others.",PFE,0.061003,-0.028,Neutral
Sanofi says it's back to the drawing board on mRNA flu vaccines,https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-says-its-back-drawing-board-mrna-flu-vaccines-2023-06-29/,2023-06-29 05:20:19,June 29 ( Reuters ) - Sanofi ( SASY.PA ) said that trials show the currently available mRNA technology behind the most successful COVID-19 shots will not be effective against influenza and it is already working on a next generation of shots.,PFE,0.194242,-0.126128,Neutral
2 Medical Stocks to Consider Buying in June,https://www.zacks.com/stock/news/2114516/2-medical-stocks-to-consider-buying-in-june,2023-06-29 00:08:00,"With solid top and bottom-line growth on the horizon for HealthEquity (HQY) and iRadimed (IRMD), they are starting to look like viable investments for 2023 and beyond.",PFE,0.275867,-0.120834,Neutral
Big Pharma Vs. Washington - An Opportunity To Buy Pfizer,https://www.forbes.com/sites/johnbuckingham/2023/06/28/big-pharma-vs-washingtonan-opportunity-to-buy-pfizer/,2023-06-28 23:32:50,"As I mentioned on my last Blog Post, blood clot drug Eliquis, sold by both Bristol Myers and Pfizer, is likely to face price controls under the Inflation Reduction Act.",PFE,0.580595,0.104784,Neutral
"After 'transformative' year, Roivant aims to challenge bigger rivals in inflammation and immunology",https://www.marketwatch.com/story/after-transformative-year-roivant-aims-to-challenge-bigger-rivals-in-inflammation-and-immunology-f254fc3a,2023-06-28 19:50:00,Roivant shares gain more than 10% after narrower-than-expected quarterly loss.,PFE,0.11894,0.086748,Neutral
Why Opko Health Stock Is Moving Today - OPKO Health  ( NASDAQ:OPK ) ,https://www.benzinga.com/news/23/06/33047584/why-opko-health-stock-is-moving-today,2023-06-28 17:43:19,"Opko Health, Inc. OPK shares are trading higher Wednesday after the FDA approved NGENLA treatment for pediatric growth hormone deficiency, produced in partnership with Pfizer PFE.",PFE,0.558244,0.539656,Bullish
"As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge",https://www.cnbc.com/2023/06/28/eli-lilly-pfizer-novo-nordisk-weight-loss-pills.html,2023-06-28 13:35:14,"For now, Eli Lilly's orforglipron appears to be the top contender in the weight loss pill space due to its strong efficacy data and ease of use.",PFE,0.210666,-0.020231,Neutral
FDA Accepts Pfizer's  ( PFE )  Hemophilia B Gene Therapy Filing,https://www.zacks.com/stock/news/2114257/fda-accepts-pfizers-pfe-hemophilia-b-gene-therapy-filing,2023-06-28 13:20:00,"A final decision on Pfizer's (PFE) BLA filing, seeking approval for hemophilia B gene therapy, treatment is expected by second-quarter 2024.",PFE,0.580245,0.24595,Somewhat-Bullish
InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer,https://www.globenewswire.com/news-release/2023/06/28/2696083/0/en/InflaRx-Appoints-Dr-Camilla-Chong-as-Chief-Medical-Officer.html,2023-06-28 11:30:00,"JENA, Germany, June 28, 2023 ( GLOBE NEWSWIRE ) -- InflaRx N.V. ( Nasdaq: IFRX ) , a clinical-stage biopharmaceutical company commercializing and developing anti-inflammatory therapeutics that target the complement system, today announced the appointment of Dr. Camilla Chong as Chief Medical ...",PFE,0.031949,0.024614,Neutral
InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer - InflaRx  ( NASDAQ:IFRX ) ,https://www.benzinga.com/pressreleases/23/06/g33039361/inflarx-appoints-dr-camilla-chong-as-chief-medical-officer,2023-06-28 11:30:00,"Camilla Chong, M.D., joins the team with 25 years of experience in the global pharmaceutical industry in drug development Dr. Chong to lead clinical development of InflaRx's portfolio of C5a/C5aR inhibitors JENA, Germany, June 28, 2023 ( GLOBE NEWSWIRE ) -- InflaRx N.V.",PFE,0.031159,0.023573,Neutral
US FDA approves Pfizer's drug for growth hormone deficiency,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-drug-growth-hormone-deficiency-2023-06-28/,2023-06-28 11:15:00,"June 28 ( Reuters ) - The U.S. Food and Drug Administration has approved Pfizer Inc ( PFE.N ) and partner OPKO Health Inc's ( OPK.O ) treatment for growth hormone deficiency in children, the companies said on Wednesday.",PFE,0.295867,0.151244,Somewhat-Bullish
Ophthalmology therapeutics market size to increase by USD 15.72 billion from 2022 to 2027; North America will account for 44% of market growth - Technavio,https://www.prnewswire.com/news-releases/ophthalmology-therapeutics-market-size-to-increase-by-usd-15-72-billion-from-2022-to-2027-north-america-will-account-for-44-of-market-growth---technavio-301864687.html,2023-06-28 01:15:00,Ophthalmology therapeutics market size to increase by USD 15.72 billion from 2022 to 2027. North America will ... PR ...,PFE,0.026013,0.191762,Somewhat-Bullish
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2113840/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-06-27 21:45:24,"Pfizer (PFE) closed the most recent trading day at $36.42, moving -1.27% from the previous trading session.",PFE,0.710888,0.285902,Somewhat-Bullish
Platelet-Rich Plasma Global Market to Grow Substantially at a CAGR of ~11% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/platelet-rich-plasma-global-market-to-grow-substantially-at-a-cagr-of-11-by-2028--delveinsight-301863904.html,2023-06-27 21:01:00,"Platelet-rich plasma ( PRP ) demand is being driven primarily by an increase in the number of patients suffering from orthopedic diseases, sports injuries, acute and chronic wounds, gynecological diseases, and urological diseases, among other conditions.",PFE,0.050679,0.049573,Neutral
Alation Launches Connected Sheets for Snowflake to Empower More Accurate Data-Driven Decision-Making Across the Enterprise,https://www.benzinga.com/pressreleases/23/06/g33032226/alation-launches-connected-sheets-for-snowflake-to-empower-more-accurate-data-driven-decision-maki,2023-06-27 19:00:00,"REDWOOD CITY, Calif., June 27, 2023 ( GLOBE NEWSWIRE ) -- Alation, Inc., the data intelligence company, today announced at Snowflake's annual user conference, Snowflake Summit 2023, the launch of Alation Connected Sheets for Snowflake.",PFE,0.058047,0.218103,Somewhat-Bullish
Alation Launches Open Data Quality Framework for Snowflake Data Cloud,https://www.benzinga.com/pressreleases/23/06/g33032221/alation-launches-open-data-quality-framework-for-snowflake-data-cloud,2023-06-27 19:00:00,"REDWOOD CITY, Calif., June 27, 2023 ( GLOBE NEWSWIRE ) -- Alation, Inc., the data intelligence company, today announced at Snowflake's annual user conference, Snowflake Summit 2023, the launch of the Open Data Quality Framework to bring best-of-breed data quality and data observability ...",PFE,0.048919,0.217536,Somewhat-Bullish
"Merck, Ridgeback Withdraw COVID-19 Pill European Application Amid Regulatory Hurdles - Merck & Co  ( NYSE:MRK ) ",https://www.benzinga.com/general/biotech/23/06/33029227/merck-ridgeback-withdraw-covid-19-pill-european-application-amid-regulatory-hurdles,2023-06-27 18:06:45,Merck & Co Inc MRK and Ridgeback Biotherapeutics have reportedly withdrawn their COVID-19 pill application in the European Union ( EU ) . The withdrawal came after the European Medicines Agency cited insufficient data for not backing the drug.,PFE,0.316846,0.36248,Bullish
"Top Stock Reports for Novo Nordisk, Home Depot & Walt Disney",https://www.zacks.com/research-daily/2113647/top-stock-reports-for-novo-nordisk-home-depot-walt-disney,2023-06-27 16:29:00,"Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), The Home Depot, Inc. (HD) and The Walt Disney Company (DIS).",PFE,0.059935,0.131276,Neutral
Pfizer  ( PFE )  Stock Down on Halting Development of Obesity Drug,https://www.zacks.com/stock/news/2113685/pfizer-pfe-stock-down-on-halting-development-of-obesity-drug,2023-06-27 14:25:00,Shares of Pfizer's (PFE) fell 3.7% on Monday after management's decision to terminate the development of an experimental obesity pill following concerns over liver safety.,PFE,0.449219,0.094777,Neutral
GeoVax Universal Coronavirus Vaccine Design & Development Approach Published in Vaccine Insights,https://www.globenewswire.com/news-release/2023/06/27/2695490/0/en/GeoVax-Universal-Coronavirus-Vaccine-Design-Development-Approach-Published-in-Vaccine-Insights.html,2023-06-27 14:15:00,"Spotlight Content on Pandemic Preparedness: Getting Ready for the Next ""Disease X"" ...",PFE,0.039289,0.133145,Neutral
"Company News for Jun 27, 2023",https://www.zacks.com/stock/news/2113550/company-news-for-jun-27-2023,2023-06-27 13:28:00,Companies in The News Are: ...,PFE,0.70749,-0.107897,Neutral
Eli Lilly Nears Record High After Setting A New Bar In Weight Loss,https://www.investors.com/news/technology/eli-lilly-stock-nears-record-high-after-setting-a-new-bar-for-weight-loss-drugs/,2023-06-27 13:24:00,"Eli Lilly ( LLY ) stock surged closer to a record high Tuesday after the company set a new bar among weight-loss drugs. Patients without diabetes who are obese or overweight lost an average 24.2% of their body weight after taking Lilly's next-generation anti-obesity drug, retatrutide, over 48 ...",PFE,0.155451,-0.1727,Somewhat-Bearish
Buck receives four IABC Gold Quill Awards for excellence in strategic employee communications,https://www.prnewswire.com/news-releases/buck-receives-four-iabc-gold-quill-awards-for-excellence-in-strategic-employee-communications-301864122.html,2023-06-27 13:00:00,"NEW YORK, June 27, 2023 /PRNewswire/ -- Buck, an integrated HR, pensions, and benefits consulting, technology, and administration services firm, and a Gallagher company, today announced that it won four Gold Quill Awards for its work with market leaders in the healthcare and entertainment ...",PFE,0.214462,0.499644,Bullish
"Analysis: Weight loss drug candidates multiply, spurring hopes of better outcomes, lower costs",https://www.reuters.com/business/healthcare-pharmaceuticals/weight-loss-drug-candidates-multiply-spurring-hopes-better-outcomes-lower-costs-2023-06-27/,2023-06-27 10:09:00,"SAN DIEGO, June 27 ( Reuters ) - New data on weight loss drugs that could compete with Novo Nordisk's Wegovy are raising expectations there will soon be more options, and possibly lower prices, in an estimated $100 billion marketplace, doctors and pharmaceutical executives say.",PFE,0.045655,-0.034996,Neutral
2 Growth Stocks With Major Incoming Catalysts,https://www.fool.com/investing/2023/06/27/3-biotech-stocks-with-major-incoming-catalysts/,2023-06-27 09:31:00,Binary events slated for July could quickly send these biotech stocks through the roof.,PFE,0.053749,0.004998,Neutral
Eli Lilly's 'triple G' anti-obesity drug leads to 24% weight loss in trial,https://www.business-standard.com/industry/news/eli-lilly-s-triple-g-anti-obesity-drug-leads-to-24-weight-loss-in-trial-123062700205_1.html,2023-06-27 05:22:29,"An experimental drug Retatrutide, also called ""triple G"", has helped patients with obesity lose an average of 24 per cent of body weight on the highest dosage over 48 weeks, a study showed. The drug is being developed by Indianapolis-based drug company Eli Lilly.",PFE,0.097062,-0.014133,Neutral
Why Viking Therapeutics Stock Is Crashing Today,https://www.fool.com/investing/2023/06/26/why-viking-therapeutics-stock-is-crashing-today/,2023-06-27 03:39:11,Investors seem concerned about the company's competitive positioning in weight loss.,PFE,0.2872,0.059924,Neutral
Obesity Pills: Race to develop weight-loss pills has some drugmakers falling behind,https://www.business-standard.com/health/race-to-develop-weight-loss-pills-has-some-drugmakers-falling-behind-123062700106_1.html,2023-06-27 02:57:12,Race to develop weight-loss pills has some drugmakers falling behind Business Standard ...,PFE,0.253426,0.001947,Neutral
Why Shares of Structure Therapeutics Rose Monday,https://www.fool.com/investing/2023/06/26/why-shares-of-structure-therapeutics-rose-monday/,2023-06-27 01:05:52,The company's lead diabetes and weight-loss therapy may benefit from a decision by Pfizer.,PFE,0.255641,0.247805,Somewhat-Bullish
"Wall Street slips as investors eye Russia, Fed hikes, quarter-end",https://www.moneycontrol.com/news/business/markets/wall-street-slips-as-investors-eye-russia-fed-hikes-quarter-end-10862041.html,2023-06-27 00:34:01,"The rebellion by Russian mercenaries raised questions about President Vladimir Putin's future. While Putin on Monday thanked mercenary fighters and commanders who had stood down to avoid bloodshed, the U.S. State Department said the situation in Russia remained dynamic.",PFE,0.057907,-0.087969,Neutral
Sosei Heptares Provides Update on Lotiglipron Development,https://www.globenewswire.com/news-release/2023/06/26/2694892/0/en/Sosei-Heptares-Provides-Update-on-Lotiglipron-Development.html,2023-06-26 22:40:00,"Tokyo, Japan and Cambridge, UK, 27 June 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) notes the decision by its partner Pfizer to prioritize the development of clinical-stage GLP-1 receptor agonist candidate danuglipron for the treatment of diabetes and obesity and as a result has ...",PFE,0.514619,0.232441,Somewhat-Bullish
"Next-generation drug from Eli Lilly boosts weight loss to 24%, highest yet seen in trials",https://www.cnn.com/2023/06/26/health/weight-loss-next-gen-triple-g-lilly/index.html,2023-06-26 21:05:00,"An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen yet in a new class of drugs that's revolutionizing the field.",PFE,0.058188,0.001,Neutral
Weight-loss drugs in development aim to replace injections with pills,https://www.marketwatch.com/story/weight-loss-drugs-in-development-aim-to-replace-injections-with-pills-b830168d,2023-06-26 19:21:00,"Promising results for weight-loss treatments that could compete with Ozempic and Wegovy, along with new screening recommendations for fatty-liver disease, emerge from diabetes conference.",PFE,0.227007,0.111843,Neutral
"Stocks making the biggest moves midday: Pfizer, Lucid, WSFS Financial and more",https://www.cnbc.com/2023/06/26/stocks-making-the-biggest-moves-midday-pfizer-lucid-wsfs-financial-and-more.html,2023-06-26 16:11:48,These are the stocks posting the largest moves in midday trading.,PFE,0.344074,-0.392473,Bearish
Why Pfizer Stock Is Tanking Today,https://www.fool.com/investing/2023/06/26/why-pfizer-stock-is-tanking-today/,2023-06-26 15:20:47,The pharma titan cut a high-profile obesity candidate today.,PFE,0.538389,0.263664,Somewhat-Bullish
U.S. Stocks Turning In Lackluster Performance After Last Week's Pullback,https://markets.businessinsider.com/news/stocks/u-s-stocks-turning-in-lackluster-performance-after-last-week-s-pullback-1032410116,2023-06-26 15:07:23,"( RTTNews ) - Stocks have shown a lack of direction over the course of the trading session on Monday, with the major averages bouncing back and forth across the unchanged line following the notable pullback seen during the previous week. Currently, the major averages are turning in a mixed ...",PFE,0.170878,-0.234521,Somewhat-Bearish
Stock Market Starts Slow; Cruise Stock Sinks,https://www.investors.com/market-trend/stock-market-today/stock-market-slow-to-start-last-week-of-quarter-cruise-line-stock-sinks-after-earnings/,2023-06-26 14:57:00,Stock Market Slow To Start Last Week Of Quarter. Cruise Line Stock ... Investor's Business Daily ...,PFE,0.063594,-0.003011,Neutral
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/06/33006824/looking-at-pfizers-recent-unusual-options-activity,2023-06-26 14:20:17,"Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.694349,0.163871,Somewhat-Bullish
"Top Stories Monday, June 26: Pfizer Pulls Plug On One Weight Loss Candidate, 23 Banks Expected To Show Resilience In Fed Stress Test, HSBC To Exit Iconic Canary Wharf HQ - Apollo Global Management  ( NYSE:APO ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/06/33006100/pfizer-pulls-plug-on-one-weight-loss-candidate-23-banks-expected-to-show-resilience-in-fed-stress-te,2023-06-26 13:54:34,The U.S. central bank will release stress test results assessing banks' capital resilience in severe economic downturn scenarios on Wednesday. Big U.S. banks are reportedly expected to demonstrate sufficient capital to withstand banking sector turmoil in Federal Reserve stress tests.,PFE,0.072217,0.0,Neutral
Why This Biotech Just Crashed 79% To A Record Low,https://www.investors.com/news/technology/fgen-stock-crashes-to-its-lowest-ever-point-on-a-second-failure-for-its-lead-drug/,2023-06-26 13:49:00,FGEN Stock Crashes To Its Lowest-Ever Point On A Second Failure ... Investor's Business Daily ...,PFE,0.192694,-0.199797,Somewhat-Bearish
Pfizer Stock Is Plunging Today - What's Going On - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/06/33005680/pfizer-stock-is-plunging-today-whats-going-on,2023-06-26 13:47:20,"Pfizer Inc PFE has decided to continue the clinical development of the oral late-stage glucagon-like peptide-1 receptor agonist ( GLP-1-RA ) candidate, danuglipron ( PF-06882961 ) , for adults with obesity and Type 2 diabetes mellitus.",PFE,0.364275,0.109475,Neutral
Why This Mutual Fund Darling And Top 1% Stock Nearly Doubled,https://www.investors.com/news/technology/biotech-stock-and-mutual-fund-darling-moonlake-nearly-doubles-here-is-why/,2023-06-26 13:39:00,Biotech Stock And Mutual Fund Darling MoonLake Nearly Doubles ... Investor's Business Daily ...,PFE,0.166169,-0.1802,Somewhat-Bearish
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss,https://www.cnbc.com/2023/06/26/novo-nordisk-says-high-dose-obesity-pill-leads-to-15percent-weight-loss.html,2023-06-26 13:33:54,"Novo Nordisk's pill is an oral version of semaglutide, the active ingredient in the Danish company's blockbuster weight loss injections Ozempic and Wegovy.",PFE,0.126119,-0.046413,Neutral
Pfizer Stock Tumbles On 'A Big Setback' In Obesity Treatment,https://www.investors.com/news/technology/pfizer-stock-tumbles-on-a-big-set-back-for-its-efforts-in-weight-loss-drugs/,2023-06-26 13:01:00,"Pfizer ( PFE ) stock toppled Monday after the company tossed out a potential diabetes and weight-loss drug that leads to elevated liver enzymes. That drug, dubbed lotiglipron, was a once-daily pill for patients with type 2 diabetes.",PFE,0.769861,0.007943,Neutral
Pfizer to end development of experimental obesity pill due to elevated liver enzymes,https://www.cnbc.com/2023/06/26/pfizer-to-end-development-of-experimental-obesity-pill-lotiglipron.html,2023-06-26 12:35:25,Pfizer's two pills are part of the same class of obesity drugs as Novo Nordisk's blockbuster weight loss injections Ozempic and Wegovy.,PFE,0.454714,0.0,Neutral
Pfizer's  ( PFE )  Litfulo Receives FDA Nod for Alopecia Areata,https://www.zacks.com/stock/news/2112988/pfizers-pfe-litfulo-receives-fda-nod-for-alopecia-areata,2023-06-26 12:21:00,"Pfizer's (PFE) Litfulo becomes the first kinase inhibitor approved for treating severe alopecia areata in adolescents, following FDA's approval.",PFE,0.511734,0.172622,Somewhat-Bullish
Pfizer's Litfulo Scores FDA Approval As First Alopecia Treatment For Adolescents - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/06/33001406/pfizers-litfulo-scores-fda-approval-as-first-alopecia-treatment-for-adolescents,2023-06-26 12:20:37,"The FDA approved Pfizer Inc's PFE Litfulo ( ritlecitinib ) , an oral treatment for severe alopecia areata in individuals 12 and older. Litfulo is the first and only FDA-approved treatment for adolescents ( 12+ ) with severe alopecia areata.",PFE,0.524949,0.172861,Somewhat-Bullish
"Stocks making the biggest premarket moves: Tesla, Moderna, Alphabet, PacWest and more",https://www.cnbc.com/2023/06/26/stocks-making-the-biggest-premarket-moves-.html,2023-06-26 11:56:31,These are the stocks posting the largest moves in the premarket.,PFE,0.135347,-0.061747,Neutral
Pfizer to discontinue development of obesity drug due to side effects,https://www.business-standard.com/world-news/pfizer-to-discontinue-development-of-obesity-drug-due-to-side-effects-123062600463_1.html,2023-06-26 11:24:54,"Pfizer Inc said on Monday it is discontinuing the development of an experimental obesity and diabetes drug, lotiglipron, due to elevated liver enzymes in patients in clinical studies. The company said it will instead focus on its other obesity drug danuglipron, the mid-stage trial of which is ...",PFE,0.524949,-0.061249,Neutral
uniQure Announces Leadership Addition to Support Advancement of Clinical Programs - uniQure  ( NASDAQ:QURE ) ,https://www.benzinga.com/pressreleases/23/06/g33002867/uniqure-announces-leadership-addition-to-support-advancement-of-clinical-programs,2023-06-26 11:11:42,"LEXINGTON, Mass. and AMSTERDAM, June 26, 2023 ( GLOBE NEWSWIRE ) -- uniQure N.V. QURE, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the appointment of Walid Abi-Saab, M.D., as Chief Medical Officer, effective immediately.",PFE,0.036091,0.024952,Neutral
uniQure Announces Leadership Addition to Support Advancement of Clinical Programs,https://www.globenewswire.com/news-release/2023/06/26/2694317/0/en/uniQure-Announces-Leadership-Addition-to-Support-Advancement-of-Clinical-Programs.html,2023-06-26 11:11:00,"~ Walid Abi-Saab, M.D., appointed Chief Medical Officer, will bring extensive track record in leading drug development and execution ~ ~ Walid Abi-Saab, M.D., appointed Chief Medical Officer, will bring extensive track record in leading drug development and execution ...",PFE,0.036532,0.025962,Neutral
Pfizer to discontinue development of obesity drug,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-discontinue-development-obesity-drug-2023-06-26/,2023-06-26 11:02:54,"June 26 ( Reuters ) - Pfizer Inc ( PFE.N ) said on Monday it is discontinuing the development of an experimental obesity and diabetes drug, lotiglipron, due to elevated liver enzymes in patients in clinical studies.",PFE,0.459624,-0.053339,Neutral
Element Nutritional Sciences Appoints Janice Day as Chief Sales Officer,https://www.newswire.ca/news-releases/element-nutritional-sciences-appoints-janice-day-as-chief-sales-officer-899132632.html,2023-06-26 10:00:00,"BURLINGTON, ON, June 26, 2023 /CNW/ - Element Nutritional Sciences Inc. ( CSE: ELMT ) ( OTC: ELNSF ) ( FRANKFURT: 93X ) ( the ""Company"" or ""Element"" ) , today announced that it has appointed Janice Day as its Chief Sales Officer.",PFE,0.04531,0.19003,Somewhat-Bullish
"U.S. Vaccine Program Now Flush With Cash, but Short on Key Details",https://www.nytimes.com/2023/06/26/health/covid-vaccines-nextgen.html,2023-06-26 09:00:53,"Efforts to develop the next generation of Covid vaccines are running up against bureaucratic hassles and regulatory uncertainty, scientists say, obstacles that could make it harder to curb the spread of the coronavirus and arm the United States against future pandemics.",PFE,0.067791,-0.067139,Neutral
Tesla dominates US single-stock leveraged and inverse ETFs,https://www.ft.com/content/6cae8992-b8ac-47da-afb5-e14769a9e82f,2023-06-26 04:00:05,"There are 29 leveraged and inverse US single-stock ETFs on the market with a combined $1.3bn in assets, but $1bn of those assets are in seven ETFs that target the performance of Tesla, according to data from FactSet.",PFE,0.151222,0.124967,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Viatris, Inc. of Class Action Lawsuit and Upcoming Deadline - VTRS - Viatris  ( NASDAQ:VTRS ) ",https://www.benzinga.com/pressreleases/23/06/g33000192/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-viatr,2023-06-26 02:21:55,"NEW YORK, June 25, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Viatris, Inc. ( ""Viatris"" or the ""Company"" ) VTRS, and certain officers.",PFE,0.048036,0.0,Neutral
No more needles? A daily pill may work as well as Wegovy shots to treat obesity,https://apnews.com/article/weight-loss-pill-obesity-ozempic-wegovy-2c0f852513994226af456166f65b5e82,2023-06-26 01:49:35,No more needles? A daily pill may work as well as Wegovy shots to treat obesity What if treating obesity could be as easy as popping an effective pill? That's a notion that has long fueled hope for many of the more than 40% of Americans who are considered obese - and fueled criticism by those ...,PFE,0.038969,0.0,Neutral
A Pill Form of Ozempic Is on the Horizon,https://www.nytimes.com/2023/06/25/well/ozempic-pill-weight-loss.html,2023-06-26 01:00:55,An Ozempic Pill Is On the Horizon: What to Know The New York Times ...,PFE,0.046006,0.0,Neutral
"Ozempic But Without The Needles? Pharma Giants Rush To Bring Weight Loss Drugs In Pill Form: WSJ - Eli Lilly  ( NYSE:LLY ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/06/32999008/ozempic-but-without-the-needles-pharma-giants-rush-to-bring-weight-loss-drugs-in-pill-form-wsj,2023-06-25 12:21:10,"Pharmaceutical giants are developing pill versions of popular injectable weight-loss drugs like Ozempic, aiming to appeal to needle-averse patients and potentially cost less, The Wall Street Journal reports. While injectable drugs such as Ozempic have gained popularity for their weight loss ...",PFE,0.258351,-0.114016,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Viatris, Inc. of Class Action Lawsuit and Upcoming Deadline - VTRS",https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-viatris-inc-of-class-action-lawsuit-and-upcoming-deadline--vtrs-301861367.html,2023-06-24 01:57:00,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Viatris, Inc. of ... PR ...",PFE,0.048621,0.0,Neutral
Big Pharma Vs. Washington-An Opportunity To Buy Bristol Myers,https://www.forbes.com/sites/johnbuckingham/2023/06/23/big-pharma-vs-washington-an-opportunity-to-buy-bristol-myers/,2023-06-23 22:27:12,"After all, news broke on Friday that Bristol Myers Squibb has sued Uncle Sam over a Medicare price renegotiation program in the Inflation Reduction Act (IRA) that was ...",PFE,0.087344,0.014494,Neutral
US FDA approves Pfizer's hair loss drug,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-hair-loss-drug-2023-06-23/,2023-06-23 22:19:00,"June 23 ( Reuters ) - The U.S. Food and Drug Administration has approved Pfizer Inc's ( PFE.N ) drug to treat hair loss caused by an autoimmune disease, the company said on Friday.",PFE,0.136888,0.115521,Neutral
"Daily pill from Eli Lilly leads to 15% weight loss in mid-stage study, rivaling Wegovy results without the shot",https://www.cnn.com/2023/06/23/health/eli-lilly-pill-orforglipron/index.html,2023-06-23 21:30:21,"Daily pill from Eli Lilly leads to 15% weight loss in midstage study, rivaling Wegovy results without the shot ...",PFE,0.103554,-0.004328,Neutral
Pfizer/BioNTech initiate application with EU regulator for updated COVID vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizerbiontech-initiate-application-with-eu-regulator-updated-covid-vaccine-2023-06-23/,2023-06-23 21:19:00,June 23 ( Reuters ) - Pfizer ( PFE.N ) and partner BioNTech ( 22UAy.DE ) said on Friday they have initiated an application to the European Medicines Agency ( EMA ) for authorization of updated COVID-19 vaccine targeting Omicron subvariant XBB.1.5.,PFE,0.439786,0.269267,Somewhat-Bullish
"Psoriatic Arthritis Therapeutics Market to Grow at a CAGR of 8.0% from 2022 to 2031, reaching USD 24.2 Billion: As per TMR Study",https://www.benzinga.com/pressreleases/23/06/g32992593/psoriatic-arthritis-therapeutics-market-to-grow-at-a-cagr-of-8-0-from-2022-to-2031-reaching-usd-24,2023-06-23 20:30:00,"Wilmington, Delaware, United States, June 24, 2023 ( GLOBE NEWSWIRE ) -- The global psoriatic arthritis therapeutics market stood at USD 10.8 billion in 2021, and the global market is projected to reach USD 24.2 billion by 2031. The global industry is anticipated to record a CAGR of 8.0% between ...",PFE,0.039353,0.125864,Neutral
"Mirati Therapeutics Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director",https://www.prnewswire.com/news-releases/mirati-therapeutics-appoints-industry-veteran-carol-gallagher-pharmd-as-new-independent-director-301861168.html,2023-06-23 20:00:00,"SAN DIEGO, June 23, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® ( NASDAQ: MRTX ) , a commercial stage biotechnology company, today announced its Board of Directors has appointed a new independent director, Dr. Carol Gallagher.",PFE,0.054483,0.016926,Neutral
Best Healthcare Stocks To Beat Inflation,https://www.forbes.com/sites/investor-hub/article/best-healthcare-stocks-to-beat-inflation/,2023-06-23 19:50:02,"When your investment portfolio faces inflation, one of the approaches you can take to minimize the impact is to have companies whose value can stand up. Here are 9 healthcare stocks to consider adding to your portfolio.",PFE,0.091422,0.208414,Somewhat-Bullish
Moderna  ( MRNA )  Seeks FDA Nod for Updated COVID-19 Vaccine,https://www.zacks.com/stock/news/2112566/moderna-mrna-seeks-fda-nod-for-updated-covid-19-vaccine,2023-06-23 16:33:00,"Moderna's (MRNA) updated COVID-19 vaccine is designed to target the XBB.1.5 sublineage. The company expects the vaccine to be available for the fall season, provided the FDA authorizes the same.",PFE,0.508593,0.144668,Neutral
Is Trending Stock Pfizer Inc.  ( PFE )  a Buy Now?,https://www.zacks.com/stock/news/2112296/is-trending-stock-pfizer-inc-pfe-a-buy-now,2023-06-23 13:00:13,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.486627,0.167311,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Pfizer, Philip Morris, American Tower, Boston Scientific and Northrop Grumman",https://www.zacks.com/stock/news/2112158/the-zacks-analyst-blog-highlights-pfizer-philip-morris-american-tower-boston-scientific-and-northrop-grumman,2023-06-23 09:00:00,"Pfizer, Philip Morris, American Tower, Boston Scientific and Northrop Grumman are included in this Analyst Blog.",PFE,0.699089,0.0,Neutral
Moderna files for FDA approval of updated Covid vaccine for fall,https://www.cnbc.com/2023/06/22/moderna-files-for-fda-approval-of-updated-covid-vaccine-for-fall.html,2023-06-22 21:09:21,Moderna said the submission is based on the FDA's recommendation that vaccine makers update their jabs to target omicron subvariant XBB.1.5.,PFE,0.328819,0.069898,Neutral
"Acrivon Therapeutics Announces the Appointment of Seasoned Biopharma Executive Charles Baum, M.D., Ph.D., a Recognized Leader in Clinical Precision Oncology, to its Board of Directors - Acrivon Therapeutics  ( NASDAQ:ACRV ) ",https://www.benzinga.com/pressreleases/23/06/g32975171/acrivon-therapeutics-announces-the-appointment-of-seasoned-biopharma-executive-charles-baum-m-d-ph,2023-06-22 20:00:00,"WATERTOWN, Mass., June 22, 2023 ( GLOBE NEWSWIRE ) -- Acrivon Therapeutics, Inc. ( ""Acrivon"" or ""Acrivon Therapeutics"" ) ACRV, a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each ...",PFE,0.149038,0.065536,Neutral
"Daily Dividend Report: Corning, Starbucks, Lockheed Martin, Kroger, Pfizer",https://www.forbes.com/sites/dividendchannel/2023/06/22/daily-dividend-report-corning-starbucks-lockheed-martin-kroger-pfizer/,2023-06-22 19:08:29,"Corning's Board of Directors today declared a quarterly dividend of $0.28 per share. The dividend will be payable on Sept. 28, 2023, to shareholders of record on Aug. 31, 2023. Starbucks today announced that its Board of Directors has approved a quarterly cash dividend of $0.53 per share of ...",PFE,0.353059,0.0,Neutral
First gene therapy for deadly form of muscular dystrophy gets FDA approval for young kids,https://apnews.com/article/fda-gene-therapy-duchenne-muscular-dystrophy-approval-82a82cfb67ef9fb6cf75cd3b5865c138,2023-06-22 19:02:51,WASHINGTON ( AP ) - The first gene therapy for a deadly form of muscular dystrophy received preliminary U.S. approval on Thursday despite concerns from some government scientists about the treatment's ability to help boys with the inherited disease.,PFE,0.046907,0.053148,Neutral
"Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says",https://www.cnbc.com/2023/06/22/pfizer-gsk-rsv-shots-may-prevent-thousands-of-hospitalizations.html,2023-06-22 18:06:46,The CDC analysis suggests the shots will reduce the burden of RSV on hospitals in the fall.,PFE,0.224903,-0.069689,Neutral
"Top Stock Reports for Pfizer, Philip Morris & American Tower",https://www.zacks.com/research-daily/2111844/top-stock-reports-for-pfizer-philip-morris-american-tower,2023-06-22 18:03:00,"Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Philip Morris International Inc. (PM) and American Tower Corporation (AMT).",PFE,0.40225,0.243199,Somewhat-Bullish
Is AstraZeneca a Top Stock to Buy Right Now?,https://www.fool.com/investing/2023/06/22/is-astrazeneca-a-top-stock-to-buy-right-now/,2023-06-22 18:00:00,The pharma specialist's top-shelf clinical pipeline and product portfolio should be tremendous growth drivers in the years ahead.,PFE,0.068306,0.032202,Neutral
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout,https://www.zacks.com/stock/news/2111997/biotech-etfs-in-focus-on-covid-vaccines-fall-rollout,2023-06-22 18:00:00,"The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.",PFE,0.633079,0.242756,Somewhat-Bullish
Why Dice Therapeutics Stock Bolted Higher This Week,https://www.fool.com/investing/2023/06/22/why-dice-therapeutics-stock-bolted-higher-this-wee/,2023-06-22 17:45:32,The small-cap drugmaker fetched a hefty premium in a buyout deal with Eli Lilly.,PFE,0.127456,0.112231,Neutral
Pfizer Unusual Options Activity For June 22 - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/06/32970613/pfizer-unusual-options-activity-for-june-22,2023-06-22 16:05:04,"Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.703874,0.164871,Somewhat-Bullish
"CDC Advisors Give Tepid Endorsement of GSK, Pfizer RSV Vaccines. What to Know.",https://www.barrons.com/articles/cdc-rsv-gsk-pfizer-vaccine-1512b9b9,2023-06-22 15:46:00,"In a surprising decision that could undermine the blockbuster sales expectations for Pfizer and GSK 's new respiratory syncytial virus vaccines, the Centers for Disease Control and Prevention's influential vaccines advisory committee gave only a lukewarm endorsement of the shots late Wednesday.",PFE,0.341699,0.202723,Somewhat-Bullish
Why Roivant Sciences Stock Is Perking Up Today,https://www.fool.com/investing/2023/06/22/why-roivant-sciences-stock-is-perking-up-today/,2023-06-22 15:41:01,Positive long-term data for a novel ulcerative colitis medication is fueling a double-digit rise in the drugmaker's stock.,PFE,0.275867,0.059688,Neutral
I'm Buying These 3 Resilient Stocks During a Bear Market,https://www.fool.com/investing/2023/06/22/im-buying-these-3-resilient-stocks-during-a-bear/,2023-06-22 14:23:00,Be ready for the next bear market with stocks that bounce back fast.,PFE,0.295867,0.095873,Neutral
"Immix Biopharma Subsidiary Nexcella Appoints Edward J. Borkowski, former Chief Financial Officer of Mylan N.V, to Board of Directors",https://www.globenewswire.com/news-release/2023/06/22/2693043/0/en/Immix-Biopharma-Subsidiary-Nexcella-Appoints-Edward-J-Borkowski-former-Chief-Financial-Officer-of-Mylan-N-V-to-Board-of-Directors.html,2023-06-22 13:53:00,"• Mr. Borkowski joins the Nexcella, Inc. Board of Directors with more than 30 years of experience in the pharmaceutical and healthcare industry, including 7 years as Chief Financial Officer of Mylan N.V. • Mr. Borkowski is also the former Chief Financial Officer of CareFusion, which was ...",PFE,0.035293,0.048254,Neutral
"Top Stories Thursday, June 22: Intel Voices Plans To Restructure Manufacturing Business, Bumble's BFF App, Spirit AeroSystems To Stop Work At Kansas Plant Amid Workers Strike - Apple  ( NASDAQ:AAPL ) , Accenture  ( NYSE:ACN ) ",https://www.benzinga.com/news/23/06/32966536/intel-voices-plans-to-restructure-manufacturing-business-bumbles-bff-app-spirit-aerosystems-to-stop,2023-06-22 13:30:16,"Intel Corp INTC has had an eventful week so far, enlightening investors with significant turnaround updates. On Wednesday, the company voiced plans to restructure its manufacturing business, likely to work like a separate unit and begin to generate a margin.",PFE,0.077719,0.074928,Neutral
Is Pfizer Stock a Buy Now?,https://www.fool.com/investing/2023/06/22/is-pfizer-stock-a-buy-now/,2023-06-22 13:30:00,Is the pharmaceutical giant a steal or a value trap?,PFE,0.638941,0.384181,Bullish
"RSV Vaccines from Pfizer and GSK Gain CDC Advisory Committee's Favor for Older Adults - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/06/32963743/rsv-vaccines-from-pfizer-and-gsk-gain-cdc-advisory-committees-favor-for-older-adults,2023-06-22 12:56:28,The US Centers for Disease Control and Prevention's ( CDC ) Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines from Pfizer Inc PFE and GSK plc GSK for older adults.,PFE,0.240489,0.132217,Neutral
"Pharmaceutical Lobbying Group Challenges Biden Administration Over Medicare Price Negotiations - Merck & Co  ( NYSE:MRK ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/06/32960230/pharmaceutical-lobbying-group-challenges-biden-administration-over-medicare-price-negotiations,2023-06-22 11:38:36,"The Pharmaceutical Research and Manufacturers of America ( PhRMA ) , the National Infusion Center Association, and the Global Colon Cancer Association have filed a lawsuit against the Biden administration over Medicare's new powers to reduce drug prices for seniors.",PFE,0.261117,-0.16597,Somewhat-Bearish
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement,https://www.globenewswire.com/news-release/2023/06/22/2692800/0/en/Talaris-Therapeutics-and-Tourmaline-Bio-Announce-Merger-Agreement.html,2023-06-22 11:30:00,"Merger to create Nasdaq-listed, late-stage clinical biotechnology company focused on developing Tourmaline's anti-IL-6 antibody ( TOUR006 ) in thyroid eye disease ( TED ) and atherosclerotic cardiovascular disease ...",PFE,0.030292,0.002896,Neutral
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement - Talaris Therapeutics  ( NASDAQ:TALS ) ,https://www.benzinga.com/pressreleases/23/06/g32963297/talaris-therapeutics-and-tourmaline-bio-announce-merger-agreement,2023-06-22 11:30:00,"Merger to create Nasdaq-listed, late-stage clinical biotechnology company focused on developing Tourmaline's anti-IL-6 antibody ( TOUR006 ) in thyroid eye disease ( TED ) and atherosclerotic cardiovascular disease ( ASCVD )",PFE,0.02949,0.002887,Neutral
CDC vaccine advisers' vote sets stage for first RSV shot for older adults this fall,https://www.cnn.com/2023/06/21/health/cdc-acip-rsv-shot-seniors/index.html,2023-06-21 23:24:00,"Adults 60 and older will be eligible to get a shot that could protect them from respiratory syncytial virus, or RSV, this fall if the US Centers for Disease Control and Prevention follows the advice of its independent vaccine advisory committee.",PFE,0.116161,-0.087454,Neutral
Pharma lobby group warns EU could lose edge with proposed law,https://www.reuters.com/business/healthcare-pharmaceuticals/pharma-lobby-group-warns-eu-could-lose-edge-with-proposed-law-2023-06-21/,2023-06-21 22:17:00,"BRUSSELS, June 21 ( Reuters ) - Europe's pharmaceutical sector could lose out to increased competition from emerging markets, China and the U.S. in terms of research and innovation if a proposed European Union health package is not amended, its key industry group said on Thursday.",PFE,0.122894,0.0,Neutral
CDC advisers endorse RSV vaccines for older adults,https://www.axios.com/2023/06/21/rsv-vaccine-cdc-endorse,2023-06-21 22:05:30,CDC advisers now recommend RSV vaccine for adults 60 and up ...,PFE,0.091162,0.001045,Neutral
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60,https://www.cnbc.com/2023/06/21/rsv-vaccine-cdc-panel-pfizer-gsk-shots-adults-over-60.html,2023-06-21 21:57:53,The CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.,PFE,0.357636,-0.172153,Somewhat-Bearish
Pfizer  ( PFE )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2111463/pfizer-pfe-dips-more-than-broader-markets-what-you-should-know,2023-06-21 21:45:22,"Pfizer (PFE) closed the most recent trading day at $38.90, moving -1.12% from the previous trading session.",PFE,0.571903,0.19274,Somewhat-Bullish
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations,https://www.cnbc.com/2023/06/21/phrma-sues-biden-administration-over-medicare-drug-negotiations-.html,2023-06-21 21:08:48,"PhRMA's lawsuit is the fourth legal challenge to the law after separate suits from Merck, Bristol Myers Squibb and the U.S. Chamber of Commerce.",PFE,0.096283,0.0,Neutral
"Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for - Pfizer, Sanofi, CSL Behring, Freeline, Genentech, Shire, Spark, Novo Nordisk, Sangamo, UBI, uniQure",https://www.prnewswire.com/news-releases/hemophilia-market-to-proliferate-immensly-predicts-delveinsight--key-companies-to-look-out-for---pfizer-sanofi-csl-behring-freeline-genentech-shire-spark-novo-nordisk-sangamo-ubi-uniqure-301856658.html,2023-06-21 21:01:00,"Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for - Pfizer, Sanofi, CSL ... PR ...",PFE,0.12546,0.05621,Neutral
"Pfizer's Elderly Vaccine Efficacy Drops Slightly After 18 Months, New Clinical Trials Reveal - CDC Advisory Panel Set To Vote Today On Recommended Use Of RSV Shots - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/06/32954338/pfizers-elderly-vaccine-efficacy-drops-slightly-after-18-months-new-clinical-trials-reveal-cdc-ad,2023-06-21 18:52:07,"Pfizer Inc's PFE vaccine for elderly 60 and above was slightly less effective after 18 months, according to the company's clinical trial results presented on Wednesday.",PFE,0.62523,0.117421,Neutral
FDA Expands Pfizer's  ( PFE )  Talzenna Label in Prostate Cancer,https://www.zacks.com/stock/news/2111428/fda-expands-pfizers-pfe-talzenna-label-in-prostate-cancer,2023-06-21 18:05:00,"Following FDA's label-expansion approval, Pfizer's (PFE) Talzenna is the first PARP inhibitor approved in combination with existing standard of care for treating HRR gene-mutated mCRPC.",PFE,0.498188,0.194683,Somewhat-Bullish
Valneva Announces Successful Outcome of its AGM and the Appointment of Pfizer's Former Vaccine R&D Head to its Supervisory Board,https://www.globenewswire.com/news-release/2023/06/21/2692360/0/en/Valneva-Announces-Successful-Outcome-of-its-AGM-and-the-Appointment-of-Pfizer-s-Former-Vaccine-R-D-Head-to-its-Supervisory-Board.html,2023-06-21 16:15:00,"Saint-Herblain ( France ) , June 21, 2023 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) , a specialty vaccine company, today announced that all the resolutions recommended by the Management Board were approved by the shareholders at its Annual General Meeting ( AGM ) held today in Lyon, ...",PFE,0.095138,0.02132,Neutral
GSK says RSV vaccine for older adults provides protection over two seasons,https://www.cnbc.com/2023/06/21/gsk-rsv-vaccine-for-older-adults-provides-long-term-protection.html,2023-06-21 14:38:36,GlaxoSmithKline's new clinical trial results suggest seniors may only need to take the pharmaceutical company's RSV shot every other year.,PFE,0.200688,0.04509,Neutral
15 Biotech Stocks Wall Street Analysts Say Are Too Cheap,https://www.barrons.com/articles/15-biotech-stocks-wall-street-analysts-cheap-9da65e89,2023-06-21 12:39:00,Biotech stocks have shown signs of life in recent months as investors begin to flirt with a sector that has been distinctly out of favor for more than two years. It's an opportunity to pick up shares that have been beaten down.,PFE,0.153961,0.207914,Somewhat-Bullish
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months,https://www.cnbc.com/2023/06/21/pfizer-adult-rsv-vaccine-efficacy-18-months.html,2023-06-21 12:35:01,"Pfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the shot should be administered in the U.S.",PFE,0.325637,0.085332,Neutral
"US CDC advisers weigh use of GSK, Pfizer RSV vaccines in older adults",https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-advisers-weigh-use-gsk-pfizer-rsv-vaccines-older-adults-2023-06-21/,2023-06-21 11:20:00,June 21 ( Reuters ) - A panel of advisers to the U.S. Centers for Disease Control and Prevention ( CDC ) on Wednesday will vote on whether to recommend the use of recently approved vaccines from Pfizer ( PFE.N ) and GSK ( GSK.L ) to prevent severe respiratory syncytial virus ( RSV ) infections in ...,PFE,0.3007,-0.044976,Neutral
Shapiro+Raj Strengthens and Expands Global Capabilities,https://www.prnewswire.com/news-releases/shapiroraj-strengthens-and-expands-global-capabilities-301856181.html,2023-06-21 11:08:00,"CHICAGO, June 21, 2023 /PRNewswire/ -- Shapiro+Raj, the largest minority-owned Insights company, is pleased to announce the addition of Herminder Bains as Vice President, Head of Global Client Services.",PFE,0.112008,0.147972,Neutral
Havas Launches Welltainment™: One Dose Entertainment and One Dose Education,https://www.prnewswire.com/news-releases/havas-launches-welltainment-one-dose-entertainment-and-one-dose-education-301856070.html,2023-06-21 11:00:00,A new form of creativity offers new solutions to close the global health equity gap,PFE,0.047092,0.342063,Somewhat-Bullish
Havas Launches Welltainment™: One Dose Entertainment and One Dose Education,https://www.benzinga.com/pressreleases/23/06/n32942832/havas-launches-welltainment-one-dose-entertainment-and-one-dose-education,2023-06-21 11:00:00,A new form of creativity offers new solutions to close the global health equity gap,PFE,0.04583,0.341714,Somewhat-Bullish
"Noema Pharma Appoints Ilise Lombardo, M.D., as Chief Executive Officer",https://www.benzinga.com/pressreleases/23/06/g32942769/noema-pharma-appoints-ilise-lombardo-m-d-as-chief-executive-officer,2023-06-21 11:00:00,"BASEL, Switzerland, June 21, 2023 ( GLOBE NEWSWIRE ) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system ( CNS ) disorders, today announced the appointment of Ilise Lombardo, M.D., as Chief Executive Officer of the Company.",PFE,0.045396,0.021511,Neutral
Voyager Therapeutics  ( VYGR )  Moves 7.9% Higher: Will This Strength Last?,https://www.zacks.com/stock/news/2110961/voyager-therapeutics-vygr-moves-79-higher-will-this-strength-last,2023-06-21 08:49:00,Voyager Therapeutics (VYGR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.,PFE,0.101582,0.209118,Somewhat-Bullish
Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo With ENHANZE® for Subcutaneous Use in Generalized Myasthenia Gravis,https://www.prnewswire.com/news-releases/halozyme-announces-argenx-receives-fda-approval-for-vyvgart-hytrulo-with-enhanze-for-subcutaneous-use-in-generalized-myasthenia-gravis-301855994.html,2023-06-20 22:30:00,Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo With ENHANZE® for Subcutaneous Use ... PR ...,PFE,0.087985,0.132075,Neutral
2 Biotech Stocks For Your June 2023 Watchlist,https://stockmarket.com/featured/2-biotech-stocks-for-your-june-2023-watchlist-2023-06-20,2023-06-20 15:22:42,"The biotechnology sector is an exciting and dynamic area within the broader healthcare industry. It primarily involves the application of biological systems, organisms, or derivatives to develop or manufacture novel products or technologies.",PFE,0.280615,-0.029158,Neutral
"After Blasting Off 881% in 1 Year, Is Viking Therapeutics Still a Good Buy?",https://www.fool.com/investing/2023/06/20/after-blasting-off-881-in-1-year-is-viking-still/,2023-06-20 14:15:00,"The risks are high, and the rewards are uncertain for new buyers.",PFE,0.052112,0.087863,Neutral
"Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start",https://www.cnbc.com/2023/06/20/covid-vaccines-pfizer-moderna-and-novavax-gear-up-for-fall-rollout.html,2023-06-20 13:07:05,"The FDA's strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the fall.",PFE,0.412619,0.053458,Neutral
Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2110460/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,2023-06-20 12:50:07,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,PFE,0.265378,0.272128,Somewhat-Bullish
2 Biopharma Stocks Making Big Moves Tuesday,https://www.fool.com/investing/2023/06/20/2-biopharma-stocks-making-big-moves-tuesday/,2023-06-20 12:41:13,"Markets looked poised for a pause, but these stocks didn't stand still.",PFE,0.064449,-0.055543,Neutral
Sanofi Stock Is Trading Higher Today - Here's Why - Sanofi  ( NASDAQ:SNY ) ,https://www.benzinga.com/general/biotech/23/06/32917283/sanofi-stock-is-trading-higher-today-heres-why,2023-06-20 11:47:46,Sanofi SA SNY announced that the tribunal dismissed Boehringer Ingelheim's indemnification claim against Sanofi in an International Chamber of Commerce dispute in cancer lawsuits linked to heartburn drug Zantac ( ranitidine ) in the United States.,PFE,0.290607,0.0,Neutral
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court,https://www.cnbc.com/2023/06/20/drug-prices-drugmakers-aim-to-fight-medicare-negotiations-at-scotus.html,2023-06-20 11:00:02,The lawsuits are the opening salvo in a historic and potentially decisive battle over Medicare's efforts to bring rising drug prices under control.,PFE,0.046633,-0.089185,Neutral
"CULT Food Science Announces Investment in ""AI for Taste Optimization"" Company, Alcheme Bio",https://www.newswire.ca/news-releases/cult-food-science-announces-investment-in-ai-for-taste-optimization-company-alcheme-bio-811555841.html,2023-06-20 11:00:00,CULT has also announced a partnership with Alcheme Bio to leverage artificial intelligence and machine learning to accelerate cellular agriculture products to market,PFE,0.045139,0.085847,Neutral
What Do Bears Know About Novavax That Bulls Don't?,https://www.fool.com/investing/2023/06/20/what-do-bears-know-about-novavax-that-bulls-dont/,2023-06-20 09:30:00,Novavax shares have dropped almost 80% over the past year.,PFE,0.306198,-0.02475,Neutral
Press Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim,https://www.benzinga.com/pressreleases/23/06/g32916368/press-release-sanofi-prevails-in-zantac-arbitration-initiated-by-boehringer-ingelheim,2023-06-20 05:30:00,"Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim Arbitral tribunal dismisses claim brought by Boehringer Ingelheim ( ""BI"" ) against Sanofi for indemnification of potential liabilities related to the ongoing Zantac litigation in the U.S. decision is final and cannot be ...",PFE,0.095517,0.031322,Neutral
Press Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim,https://www.globenewswire.com/news-release/2023/06/20/2690713/0/en/Press-Release-Sanofi-prevails-in-Zantac-arbitration-initiated-by-Boehringer-Ingelheim.html,2023-06-20 05:30:00,"• Arbitral tribunal dismisses claim brought by Boehringer Ingelheim ( ""BI"" ) against Sanofi for indemnification of potential liabilities related to the ongoing Zantac litigation in the U.S.",PFE,0.100588,0.032947,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Viatris, Inc. of Class Action Lawsuit and Upcoming Deadline - VTRS - Viatris  ( NASDAQ:VTRS ) ",https://www.benzinga.com/pressreleases/23/07/g33158707/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-viatr,2023-07-09 20:15:30,"NEW YORK, July 09, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Viatris, Inc. ( ""Viatris"" or the ""Company"" ) VTRS, and certain officers.",PFE,0.048036,0.0,Neutral
Streamlining financial reporting with AI-led automation | The Financial Express,https://www.financialexpress.com/business/blockchain-streamlining-financial-reporting-with-ai-led-automation-3161546/,2023-07-09 12:00:00,Streamlining financial reporting with AI-led automation The Financial Express ...,PFE,0.046543,0.085759,Neutral
Ashford  ( NYSE:AINC )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/09/ashford-nyseainc-research-coverage-started-at-stocknews-com-3.html,2023-07-09 07:58:47,"StockNews.com started coverage on shares of Ashford ( NYSE:AINC - Free Report ) in a research report released on Saturday. The firm issued a buy rating on the stock. Ashford ( NYSE:AINC - Free Report ) last posted its earnings results on Tuesday, May 2nd.",PFE,0.183895,0.13944,Neutral
Enservco  ( NYSE:ENSV )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/enservco-nyseensv-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-09 07:58:43,StockNews.com initiated coverage on shares of Enservco ( NYSE:ENSV - Free Report ) in a report released on Saturday morning. The brokerage issued a sell rating on the stock. Shares of NYSE:ENSV opened at $0.29 on Friday. Enservco ( NYSE:ENSV - Free Report ) last released its earnings results ...,PFE,0.186738,0.285402,Somewhat-Bullish
StockNews.com Initiates Coverage on American Shared Hospital Services  ( NYSE:AMS ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-initiates-coverage-on-american-shared-hospital-services-nyseams.html,2023-07-09 07:58:43,StockNews.com assumed coverage on shares of American Shared Hospital Services ( NYSE:AMS - Free Report ) in a report published on Saturday. The brokerage issued a hold rating on the stock. Shares of NYSE:AMS opened at $2.54 on Friday.,PFE,0.169676,0.214679,Somewhat-Bullish
Espey Mfg. & Electronics  ( NYSE:ESP )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/espey-mfg-electronics-nyseesp-receives-new-coverage-from-analysts-at-stocknews-com-2.html,2023-07-09 07:58:43,"StockNews.com assumed coverage on shares of Espey Mfg. & Electronics ( NYSE:ESP - Free Report ) in a report published on Saturday morning. The brokerage issued a strong-buy rating on the stock. Espey Mfg. & Electronics ( NYSE:ESP - Free Report ) last released its earnings results on Monday, May ...",PFE,0.146025,0.121286,Neutral
Ayala Pharmaceuticals  ( NASDAQ:ADXS )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/09/ayala-pharmaceuticals-nasdaqadxs-coverage-initiated-at-stocknews-com-2.html,2023-07-09 07:58:41,StockNews.com assumed coverage on shares of Ayala Pharmaceuticals ( NASDAQ:ADXS - Free Report ) in a research report report published on Saturday morning. The brokerage issued a sell rating on the stock.,PFE,0.21686,0.262482,Somewhat-Bullish
Ampio Pharmaceuticals  ( NYSE:AMPE )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/09/ampio-pharmaceuticals-nyseampe-now-covered-by-stocknews-com.html,2023-07-09 07:58:41,StockNews.com began coverage on shares of Ampio Pharmaceuticals ( NYSE:AMPE - Free Report ) in a research report sent to investors on Saturday. The firm issued a sell rating on the stock. Shares of Ampio Pharmaceuticals stock opened at $0.25 on Friday.,PFE,0.194242,0.082249,Neutral
StockNews.com Initiates Coverage on Chicago Rivet & Machine  ( NYSE:CVR ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-initiates-coverage-on-chicago-rivet-machine-nysecvr.html,2023-07-09 07:58:41,"StockNews.com assumed coverage on shares of Chicago Rivet & Machine ( NYSE:CVR - Free Report ) in a research note published on Saturday. The firm issued a sell rating on the stock. Chicago Rivet & Machine ( NYSE:CVR - Free Report ) last posted its quarterly earnings data on Monday, May 8th.",PFE,0.163909,0.102634,Neutral
Chesapeake Energy  ( NYSE:CHK )  Lifted to Hold at StockNews.com,https://www.defenseworld.net/2023/07/09/chesapeake-energy-nysechk-lifted-to-hold-at-stocknews-com.html,2023-07-09 07:58:41,StockNews.com upgraded shares of Chesapeake Energy ( NYSE:CHK - Free Report ) from a sell rating to a hold rating in a research note published on Saturday. Shares of CHK stock opened at $82.15 on Friday. Chesapeake Energy ( NYSE:CHK - Free Report ) last announced its quarterly earnings data on ...,PFE,0.160633,0.328486,Somewhat-Bullish
Aspira Women's Health  ( NYSE:AWH )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/09/aspira-womens-health-nyseawh-coverage-initiated-at-stocknews-com.html,2023-07-09 07:58:41,"StockNews.com started coverage on shares of Aspira Women's Health ( NYSE:AWH - Free Report ) in a research report report published on Saturday. The firm issued a sell rating on the stock. Aspira Women's Health ( NYSE:AWH - Free Report ) last announced its quarterly earnings data on Thursday, ...",PFE,0.160633,0.153974,Somewhat-Bullish
Bar Harbor Bankshares  ( NYSE:BHB )  Upgraded to Hold by StockNews.com,https://www.defenseworld.net/2023/07/09/bar-harbor-bankshares-nysebhb-upgraded-to-hold-by-stocknews-com-2.html,2023-07-09 07:58:41,StockNews.com upgraded shares of Bar Harbor Bankshares ( NYSE:BHB - Free Report ) from a sell rating to a hold rating in a research report sent to investors on Saturday. Shares of NYSE BHB opened at $24.37 on Friday.,PFE,0.157483,0.168669,Somewhat-Bullish
BlackBerry  ( NASDAQ:BB )  Raised to Hold at StockNews.com,https://www.defenseworld.net/2023/07/09/blackberry-nasdaqbb-raised-to-hold-at-stocknews-com.html,2023-07-09 07:54:41,StockNews.com upgraded shares of BlackBerry ( NASDAQ:BB - Free Report ) from a sell rating to a hold rating in a research report released on Saturday morning. Shares of BlackBerry stock opened at $4.76 on Friday. BlackBerry ( NASDAQ:BB - Free Report ) last announced its quarterly earnings data ...,PFE,0.172097,0.273255,Somewhat-Bullish
Argo Group International  ( NASDAQ:ARGO )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/argo-group-international-nasdaqargo-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-07-09 07:54:41,StockNews.com began coverage on shares of Argo Group International ( NASDAQ:ARGO - Free Report ) in a research note issued to investors on Saturday morning. The firm issued a hold rating on the stock. Shares of Argo Group International stock opened at $29.65 on Friday.,PFE,0.132368,-0.071015,Neutral
Creative Media & Community Trust Co.  ( NASDAQ:CMCT )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/creative-media-community-trust-co-nasdaqcmct-now-covered-by-analysts-at-stocknews-com.html,2023-07-09 07:52:41,StockNews.com initiated coverage on shares of Creative Media & Community Trust Co. ( NASDAQ:CMCT - Free Report ) in a report issued on Saturday morning. The brokerage issued a sell rating on the real estate investment trust's stock.,PFE,0.054732,0.185047,Somewhat-Bullish
BlackBerry  ( NYSE:BB )  Rating Increased to Hold at StockNews.com,https://www.defenseworld.net/2023/07/09/blackberry-nysebb-rating-increased-to-hold-at-stocknews-com.html,2023-07-09 06:30:42,"BlackBerry ( NYSE:BB - Free Report ) was upgraded by research analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a report issued on Friday. A number of other research firms have also recently commented on BB. Robert W.",PFE,0.06623,0.193557,Somewhat-Bullish
Argo Group International  ( NYSE:ARGO )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/09/argo-group-international-nyseargo-now-covered-by-stocknews-com.html,2023-07-09 06:30:42,"Research analysts at StockNews.com initiated coverage on shares of Argo Group International ( NYSE:ARGO - Free Report ) in a note issued to investors on Friday. The brokerage set a ""hold"" rating on the stock.",PFE,0.064973,-0.05689,Neutral
StockNews.com Initiates Coverage on Ayala Pharmaceuticals  ( OTCMKTS:ADXS ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-initiates-coverage-on-ayala-pharmaceuticals-otcmktsadxs.html,2023-07-09 05:54:41,"Research analysts at StockNews.com started coverage on shares of Ayala Pharmaceuticals ( OTCMKTS:ADXS - Free Report ) in a research report issued to clients and investors on Friday. The brokerage set a ""sell"" rating on the biotechnology company's stock.",PFE,0.15347,0.024815,Neutral
Biocept  ( NASDAQ:BIOC )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/biocept-nasdaqbioc-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-07-09 05:46:42,"Research analysts at StockNews.com initiated coverage on shares of Biocept ( NASDAQ:BIOC - Free Report ) in a report released on Sunday. The brokerage set a ""hold"" rating on the medical research company's stock.",PFE,0.109455,-0.037263,Neutral
uniQure  ( NASDAQ:QURE )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/07/09/uniqure-nasdaqqure-stock-rating-lowered-by-stocknews-com.html,2023-07-09 05:42:41,"uniQure ( NASDAQ:QURE - Free Report ) was downgraded by equities research analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a report released on Friday. Several other equities research analysts have also recently commented on the company.",PFE,0.049526,0.031989,Neutral
"StockNews.com Upgrades Seanergy Maritime  ( NASDAQ:SHIP )  to ""Hold""",https://www.defenseworld.net/2023/07/09/stocknews-com-upgrades-seanergy-maritime-nasdaqship-to-hold.html,2023-07-09 05:42:41,"Seanergy Maritime ( NASDAQ:SHIP - Free Report ) was upgraded by stock analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a report issued on Friday. Separately, TheStreet cut Seanergy Maritime from a ""c"" rating to a ""d+"" rating in a research report on Wednesday, March 15th.",PFE,0.108466,0.111477,Neutral
First Bank  ( NASDAQ:FRBA )  Rating Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/07/09/first-bank-nasdaqfrba-rating-lowered-to-sell-at-stocknews-com.html,2023-07-09 05:22:51,"First Bank ( NASDAQ:FRBA - Free Report ) was downgraded by equities research analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a research report issued to clients and investors on Friday. Shares of FRBA opened at $10.93 on Friday.",PFE,0.073098,0.140198,Neutral
StockNews.com Begins Coverage on Quotient Technology  ( NYSE:QUOT ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-begins-coverage-on-quotient-technology-nysequot.html,2023-07-09 05:16:41,"Investment analysts at StockNews.com began coverage on shares of Quotient Technology ( NYSE:QUOT - Free Report ) in a report released on Sunday. The brokerage set a ""hold"" rating on the technology company's stock. QUOT has been the topic of a number of other reports.",PFE,0.078099,0.095218,Neutral
"NewMarket  ( NYSE:NEU )  Downgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2023/07/09/newmarket-nyseneu-downgraded-by-stocknews-com-to-buy.html,2023-07-09 05:16:41,"NewMarket ( NYSE:NEU - Free Report ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a report issued on Sunday. Shares of NYSE NEU opened at $422.48 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.58 and ...",PFE,0.077343,0.062066,Neutral
Airgain  ( NASDAQ:AIRG )  Earns Buy Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/airgain-nasdaqairg-earns-buy-rating-from-analysts-at-stocknews-com.html,2023-07-09 05:16:41,"Investment analysts at StockNews.com initiated coverage on shares of Airgain ( NASDAQ:AIRG - Free Report ) in a research report issued to clients and investors on Sunday. The brokerage set a ""buy"" rating on the technology company's stock.",PFE,0.077094,0.160692,Somewhat-Bullish
Steel Partners  ( NYSE:SPLP )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/09/steel-partners-nysesplp-research-coverage-started-at-stocknews-com.html,2023-07-09 05:16:41,"Analysts at StockNews.com started coverage on shares of Steel Partners ( NYSE:SPLP - Free Report ) in a research report issued to clients and investors on Sunday. The brokerage set a ""strong-buy"" rating on the conglomerate's stock. NYSE SPLP opened at $47.00 on Friday.",PFE,0.053271,0.167005,Somewhat-Bullish
Marin Software  ( NYSE:MRIN )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/marin-software-nysemrin-coverage-initiated-by-analysts-at-stocknews-com-3.html,2023-07-09 05:16:41,"Stock analysts at StockNews.com initiated coverage on shares of Marin Software ( NYSE:MRIN - Free Report ) in a research note issued to investors on Sunday. The firm set a ""hold"" rating on the stock. Marin Software ( NYSE:MRIN - Free Report ) last posted its quarterly earnings data on Thursday, ...",PFE,0.173333,0.20624,Somewhat-Bullish
Aeterna Zentaris  ( NASDAQ:AEZS )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/09/aeterna-zentaris-nasdaqaezs-research-coverage-started-at-stocknews-com.html,2023-07-09 05:16:41,"Equities researchers at StockNews.com initiated coverage on shares of Aeterna Zentaris ( NASDAQ:AEZS - Free Report ) ( TSE:AEZ ) in a research report issued to clients and investors on Sunday. The brokerage set a ""sell"" rating on the biopharmaceutical company's stock.",PFE,0.135347,0.152929,Somewhat-Bullish
Blueprint Medicines  ( NASDAQ:BPMC )  Cut to Sell at StockNews.com,https://www.defenseworld.net/2023/07/09/blueprint-medicines-nasdaqbpmc-cut-to-sell-at-stocknews-com.html,2023-07-09 05:12:50,"Blueprint Medicines ( NASDAQ:BPMC - Free Report ) was downgraded by research analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a research note issued on Sunday. A number of other equities analysts have also recently weighed in on the company.",PFE,0.059636,0.075274,Neutral
Zynerba Pharmaceuticals  ( NASDAQ:ZYNE )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/09/zynerba-pharmaceuticals-nasdaqzyne-coverage-initiated-at-stocknews-com.html,2023-07-09 05:12:48,"Research analysts at StockNews.com started coverage on shares of Zynerba Pharmaceuticals ( NASDAQ:ZYNE - Free Report ) in a research report issued to clients and investors on Sunday. The brokerage set a ""sell"" rating on the stock.",PFE,0.086556,0.087701,Neutral
StockNews.com Lowers Celestica  ( NYSE:CLS )  to Buy,https://www.defenseworld.net/2023/07/09/stocknews-com-lowers-celestica-nysecls-to-buy.html,2023-07-09 05:12:48,"Celestica ( NYSE:CLS - Free Report ) ( TSE:CLS ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Sunday. Other analysts have also recently issued reports about the stock.",PFE,0.068112,0.111352,Neutral
Avalon  ( NYSE:AWX )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/09/avalon-nyseawx-research-coverage-started-at-stocknews-com.html,2023-07-09 05:12:48,"Research analysts at StockNews.com initiated coverage on shares of Avalon ( NYSE:AWX - Free Report ) in a research report issued on Sunday. The brokerage set a ""hold"" rating on the stock. Shares of NYSE AWX opened at $2.54 on Friday. Avalon has a one year low of $2.22 and a one year high of ...",PFE,0.136113,0.106835,Neutral
StockNews.com Begins Coverage on Rubicon Technology  ( NASDAQ:RBCN ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-begins-coverage-on-rubicon-technology-nasdaqrbcn.html,2023-07-09 05:12:47,"Equities research analysts at StockNews.com initiated coverage on shares of Rubicon Technology ( NASDAQ:RBCN - Free Report ) in a research note issued on Sunday. The brokerage set a ""sell"" rating on the semiconductor company's stock. Shares of NASDAQ RBCN opened at $1.48 on Friday.",PFE,0.115232,0.090824,Neutral
RedHill Biopharma  ( NASDAQ:RDHL )  Cut to Hold at StockNews.com,https://www.defenseworld.net/2023/07/09/redhill-biopharma-nasdaqrdhl-cut-to-hold-at-stocknews-com.html,2023-07-09 05:12:46,"RedHill Biopharma ( NASDAQ:RDHL - Free Report ) was downgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research note issued to investors on Sunday. NASDAQ RDHL opened at $1.21 on Friday. RedHill Biopharma has a 52-week low of $1.16 and a 52-week high of ...",PFE,0.092213,0.024955,Neutral
SVB Financial Group  ( NASDAQ:SIVB )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/svb-financial-group-nasdaqsivb-now-covered-by-analysts-at-stocknews-com.html,2023-07-09 05:12:46,"Stock analysts at StockNews.com assumed coverage on shares of SVB Financial Group ( NASDAQ:SIVB - Free Report ) in a research note issued to investors on Sunday. The firm set a ""sell"" rating on the bank's stock. Shares of SIVB stock opened at $0.53 on Friday.",PFE,0.077845,0.110538,Neutral
StockNews.com Initiates Coverage on Diebold Nixdorf  ( NYSE:DBD ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-initiates-coverage-on-diebold-nixdorf-nysedbd.html,2023-07-09 05:12:46,"Research analysts at StockNews.com assumed coverage on shares of Diebold Nixdorf ( NYSE:DBD - Free Report ) in a report released on Sunday. The brokerage set a ""sell"" rating on the technology company's stock.",PFE,0.076602,0.149008,Neutral
Fuel Tech  ( NASDAQ:FTEK )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/fuel-tech-nasdaqftek-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-07-09 05:12:46,"Stock analysts at StockNews.com started coverage on shares of Fuel Tech ( NASDAQ:FTEK - Free Report ) in a research note issued on Sunday. The brokerage set a ""hold"" rating on the industrial products company's stock. Separately, TheStreet upgraded Fuel Tech from a ""d"" rating to a ""c-"" rating in ...",PFE,0.075397,0.139372,Neutral
Globus Maritime  ( NASDAQ:GLBS )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/globus-maritime-nasdaqglbs-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-09 05:12:46,"StockNews.com assumed coverage on shares of Globus Maritime ( NASDAQ:GLBS - Free Report ) in a report released on Sunday. The brokerage set a ""hold"" rating on the shipping company's stock. Shares of NASDAQ GLBS opened at $0.89 on Friday.",PFE,0.127456,0.055901,Neutral
CSI Compressco  ( NASDAQ:CCLP )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/csi-compressco-nasdaqcclp-coverage-initiated-by-analysts-at-stocknews-com.html,2023-07-09 05:12:45,"Equities researchers at StockNews.com began coverage on shares of CSI Compressco ( NASDAQ:CCLP - Free Report ) in a note issued to investors on Sunday. The firm set a ""buy"" rating on the oil and gas company's stock. Shares of NASDAQ:CCLP opened at $1.12 on Friday.",PFE,0.093289,0.157533,Somewhat-Bullish
Flexsteel Industries  ( NASDAQ:FLXS )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/09/flexsteel-industries-nasdaqflxs-now-covered-by-stocknews-com-2.html,2023-07-09 05:12:45,"Equities research analysts at StockNews.com began coverage on shares of Flexsteel Industries ( NASDAQ:FLXS - Free Report ) in a note issued to investors on Sunday. The brokerage set a ""strong-buy"" rating on the stock.",PFE,0.07887,0.096314,Neutral
Signature Bank  ( NASDAQ:SBNY )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/09/signature-bank-nasdaqsbny-research-coverage-started-at-stocknews-com.html,2023-07-09 05:12:45,"StockNews.com began coverage on shares of Signature Bank ( NASDAQ:SBNY - Free Report ) in a research note issued on Sunday. The brokerage set a ""sell"" rating on the bank's stock.",PFE,0.076358,0.143582,Neutral
Infinity Pharmaceuticals  ( NASDAQ:INFI )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/infinity-pharmaceuticals-nasdaqinfi-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-09 05:12:45,"StockNews.com assumed coverage on shares of Infinity Pharmaceuticals ( NASDAQ:INFI - Free Report ) in a report issued on Sunday. The firm set a ""hold"" rating on the biotechnology company's stock. NASDAQ:INFI opened at $0.22 on Friday.",PFE,0.073546,-0.04765,Neutral
StockNews.com Initiates Coverage on LiqTech International  ( NYSE:LIQT ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-initiates-coverage-on-liqtech-international-nyseliqt-2.html,2023-07-09 05:12:45,"Analysts at StockNews.com began coverage on shares of LiqTech International ( NYSE:LIQT - Free Report ) in a research note issued on Sunday. The firm set a ""sell"" rating on the stock.",PFE,0.214937,0.222005,Somewhat-Bullish
Can-Fite BioPharma  ( NYSE:CANF )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/can-fite-biopharma-nysecanf-coverage-initiated-by-analysts-at-stocknews-com-2.html,2023-07-09 05:12:45,"Analysts at StockNews.com initiated coverage on shares of Can-Fite BioPharma ( NYSE:CANF - Free Report ) in a research note issued on Sunday. The firm set a ""hold"" rating on the stock.",PFE,0.115787,0.004748,Neutral
GasLog Partners  ( NYSE:GLOP )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/gaslog-partners-nyseglop-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-09 05:12:44,"Investment analysts at StockNews.com started coverage on shares of GasLog Partners ( NYSE:GLOP - Free Report ) in a note issued to investors on Sunday. The brokerage set a ""buy"" rating on the shipping company's stock. NYSE:GLOP opened at $8.63 on Friday.",PFE,0.075161,0.110181,Neutral
Energous  ( NASDAQ:WATT )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/09/energous-nasdaqwatt-coverage-initiated-at-stocknews-com-2.html,2023-07-09 05:12:44,"Equities researchers at StockNews.com assumed coverage on shares of Energous ( NASDAQ:WATT - Free Report ) in a research report issued on Sunday. The firm set a ""sell"" rating on the industrial products company's stock. WATT opened at $0.24 on Friday.",PFE,0.07423,0.094499,Neutral
HNI  ( NYSE:HNI )  Downgraded by StockNews.com,https://www.defenseworld.net/2023/07/09/hni-nysehni-downgraded-by-stocknews-com.html,2023-07-09 05:12:44,"HNI ( NYSE:HNI - Free Report ) was downgraded by analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research note issued on Sunday. HNI stock opened at $27.68 on Friday. The company has a quick ratio of 0.73, a current ratio of 1.27 and a debt-to-equity ratio of 0.35.",PFE,0.065866,0.106516,Neutral
ViewRay  ( NASDAQ:VRAY )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/viewray-nasdaqvray-coverage-initiated-by-analysts-at-stocknews-com.html,2023-07-09 05:12:44,"StockNews.com initiated coverage on shares of ViewRay ( NASDAQ:VRAY - Free Report ) in a research note issued on Sunday. The firm set a ""sell"" rating on the stock. A number of other brokerages have also commented on VRAY. Stifel Nicolaus decreased their price objective on ViewRay from $1.75 to ...",PFE,0.065506,0.07915,Neutral
FreightCar America  ( NASDAQ:RAIL )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/freightcar-america-nasdaqrail-coverage-initiated-by-analysts-at-stocknews-com.html,2023-07-09 05:12:44,"Analysts at StockNews.com initiated coverage on shares of FreightCar America ( NASDAQ:RAIL - Free Report ) in a report released on Sunday. The firm set a ""sell"" rating on the transportation company's stock. Other analysts also recently issued reports about the company.",PFE,0.051551,0.076905,Neutral
Intellicheck  ( NYSE:IDN )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/intellicheck-nyseidn-now-covered-by-analysts-at-stocknews-com.html,2023-07-09 05:12:43,"Equities research analysts at StockNews.com began coverage on shares of Intellicheck ( NYSE:IDN - Free Report ) in a note issued to investors on Sunday. The brokerage set a ""hold"" rating on the stock.",PFE,0.096283,0.02566,Neutral
Inuvo  ( NYSE:INUV )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/09/inuvo-nyseinuv-now-covered-by-stocknews-com.html,2023-07-09 05:12:42,"Equities research analysts at StockNews.com assumed coverage on shares of Inuvo ( NYSE:INUV - Free Report ) in a research report issued to clients and investors on Sunday. The brokerage set a ""sell"" rating on the stock.",PFE,0.091162,0.135187,Neutral
ReWalk Robotics  ( NASDAQ:RWLK )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/rewalk-robotics-nasdaqrwlk-now-covered-by-analysts-at-stocknews-com.html,2023-07-09 05:12:42,"Stock analysts at StockNews.com started coverage on shares of ReWalk Robotics ( NASDAQ:RWLK - Free Report ) in a research report issued to clients and investors on Sunday. The firm set a ""sell"" rating on the medical device company's stock. RWLK stock opened at $0.78 on Friday.",PFE,0.077845,0.087003,Neutral
StockNews.com Begins Coverage on Friedman Industries  ( NYSE:FRD ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-begins-coverage-on-friedman-industries-nysefrd.html,2023-07-09 05:12:42,"Investment analysts at StockNews.com began coverage on shares of Friedman Industries ( NYSE:FRD - Free Report ) in a report released on Sunday. The firm set a ""hold"" rating on the stock.",PFE,0.214937,0.16159,Somewhat-Bullish
Insignia Systems  ( NASDAQ:ISIG )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/insignia-systems-nasdaqisig-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-09 05:12:42,"Investment analysts at StockNews.com initiated coverage on shares of Insignia Systems ( NASDAQ:ISIG - Free Report ) in a research note issued on Sunday. The brokerage set a ""sell"" rating on the business services provider's stock. NASDAQ ISIG opened at $7.33 on Friday.",PFE,0.126784,0.198705,Somewhat-Bullish
StockNews.com Begins Coverage on Almaden Minerals  ( NYSE:AAU ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-begins-coverage-on-almaden-minerals-nyseaau.html,2023-07-09 05:12:42,"Analysts at StockNews.com began coverage on shares of Almaden Minerals ( NYSE:AAU - Free Report ) in a research note issued on Sunday. The brokerage set a ""sell"" rating on the stock. AAU stock opened at $0.13 on Friday. The company has a 50-day simple moving average of $0.12 and a 200 day ...",PFE,0.102449,0.191857,Somewhat-Bullish
StockNews.com Initiates Coverage on Calithera Biosciences  ( NASDAQ:CALA ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-initiates-coverage-on-calithera-biosciences-nasdaqcala.html,2023-07-09 05:12:41,"Analysts at StockNews.com began coverage on shares of Calithera Biosciences ( NASDAQ:CALA - Free Report ) in a report issued on Sunday. The firm set a ""hold"" rating on the biotechnology company's stock. CALA stock opened at $0.07 on Friday.",PFE,0.097854,0.147928,Neutral
InnSuites Hospitality Trust  ( NYSE:IHT )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/09/innsuites-hospitality-trust-nyseiht-now-covered-by-stocknews-com.html,2023-07-09 05:12:41,"Research analysts at StockNews.com initiated coverage on shares of InnSuites Hospitality Trust ( NYSE:IHT - Free Report ) in a research report issued on Sunday. The firm set a ""hold"" rating on the stock. Shares of IHT opened at $2.26 on Friday.",PFE,0.082677,0.161148,Somewhat-Bullish
StockNews.com Begins Coverage on CIRCOR International  ( NYSE:CIR ) ,https://www.defenseworld.net/2023/07/09/stocknews-com-begins-coverage-on-circor-international-nysecir.html,2023-07-09 05:12:41,"Stock analysts at StockNews.com initiated coverage on shares of CIRCOR International ( NYSE:CIR - Free Report ) in a research report issued on Sunday. The firm set a ""buy"" rating on the industrial products company's stock. Other equities analysts also recently issued research reports about the ...",PFE,0.077343,0.080156,Neutral
Credit Suisse Group  ( NYSE:CS )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/09/credit-suisse-group-nysecs-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-09 05:12:41,"Equities researchers at StockNews.com initiated coverage on shares of Credit Suisse Group ( NYSE:CS - Free Report ) in a report released on Sunday. The firm set a ""hold"" rating on the financial services provider's stock. NYSE CS opened at $0.89 on Friday.",PFE,0.072,0.161456,Somewhat-Bullish
Iovance Biotherapeutics  ( NASDAQ:IOVA )  Stock Rating Upgraded by StockNews.com,https://www.defenseworld.net/2023/07/09/iovance-biotherapeutics-nasdaqiova-stock-rating-upgraded-by-stocknews-com.html,2023-07-09 05:12:41,"Iovance Biotherapeutics ( NASDAQ:IOVA - Free Report ) was upgraded by research analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a research note issued on Sunday. Other equities analysts also recently issued reports about the stock.",PFE,0.0699,0.034834,Neutral
HIVE Blockchain Technologies  ( NYSE:HIVE )  Rating Increased to Sell at StockNews.com,https://www.defenseworld.net/2023/07/09/hive-blockchain-technologies-nysehive-rating-increased-to-sell-at-stocknews-com-2.html,2023-07-09 05:12:41,"HIVE Blockchain Technologies ( NYSE:HIVE - Free Report ) was upgraded by analysts at StockNews.com to a ""sell"" rating in a research report issued to clients and investors on Sunday. HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland.",PFE,0.213048,0.217047,Somewhat-Bullish
3 No-Brainer Stocks You Can Buy Right Now,https://www.fool.com/investing/2023/07/08/3-no-brainer-stocks-you-can-buy-right-now/,2023-07-08 10:14:00,Going with these stocks is an easy decision.,PFE,0.273661,0.122758,Neutral
Eversource Energy  ( NYSE:ES )  Downgraded by StockNews.com to Sell,https://www.defenseworld.net/2023/07/08/eversource-energy-nysees-downgraded-by-stocknews-com-to-sell.html,2023-07-08 09:07:13,StockNews.com cut shares of Eversource Energy ( NYSE:ES - Free Report ) from a hold rating to a sell rating in a research report sent to investors on Friday. Other equities research analysts have also issued research reports about the stock.,PFE,0.064797,0.161009,Somewhat-Bullish
American Equity Investment Life  ( NYSE:AEL )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/american-equity-investment-life-nyseael-now-covered-by-analysts-at-stocknews-com.html,2023-07-08 08:36:48,StockNews.com started coverage on shares of American Equity Investment Life ( NYSE:AEL - Free Report ) in a research note released on Friday morning. The firm issued a hold rating on the financial services provider's stock. A number of other analysts have also recently commented on the stock.,PFE,0.05749,0.106178,Neutral
"Allison Transmission  ( NYSE:ALSN )  Lowered to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/allison-transmission-nysealsn-lowered-to-buy-at-stocknews-com.html,2023-07-08 08:36:48,StockNews.com cut shares of Allison Transmission ( NYSE:ALSN - Free Report ) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning. Several other equities research analysts also recently weighed in on the stock.,PFE,0.054483,0.062099,Neutral
Materion  ( NYSE:MTRN )  Downgraded by StockNews.com to Hold,https://www.defenseworld.net/2023/07/08/materion-nysemtrn-downgraded-by-stocknews-com-to-hold.html,2023-07-08 08:35:03,StockNews.com cut shares of Materion ( NYSE:MTRN - Free Report ) from a buy rating to a hold rating in a research note published on Friday morning. Several other equities analysts have also recently issued reports on MTRN. Seaport Res Ptn reiterated a buy rating on shares of Materion in a ...,PFE,0.056275,0.157094,Somewhat-Bullish
"QUALCOMM  ( NASDAQ:QCOM )  Upgraded to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/qualcomm-nasdaqqcom-upgraded-to-buy-at-stocknews-com-2.html,2023-07-08 08:16:46,StockNews.com upgraded shares of QUALCOMM ( NASDAQ:QCOM - Free Report ) from a hold rating to a buy rating in a report published on Friday. Several other brokerages also recently commented on QCOM. Robert W. Baird lowered their price objective on QUALCOMM from $150.00 to $130.00 in a research ...,PFE,0.064276,0.098377,Neutral
Vale  ( NYSE:VALE )  Upgraded to Buy at StockNews.com,https://www.defenseworld.net/2023/07/08/vale-nysevale-upgraded-to-buy-at-stocknews-com.html,2023-07-08 08:16:46,StockNews.com upgraded shares of Vale ( NYSE:VALE - Free Report ) from a hold rating to a buy rating in a report published on Friday morning. Several other analysts have also issued reports on the company.,PFE,0.060694,0.11622,Neutral
Olympic Steel  ( NASDAQ:ZEUS )  Upgraded by StockNews.com to Buy,https://www.defenseworld.net/2023/07/08/olympic-steel-nasdaqzeus-upgraded-by-stocknews-com-to-buy.html,2023-07-08 08:16:45,"StockNews.com upgraded shares of Olympic Steel ( NASDAQ:ZEUS - Free Report ) from a hold rating to a buy rating in a research report released on Friday morning. Shares of NASDAQ ZEUS opened at $48.60 on Friday. The firm has a market cap of $540.92 million, a P/E ratio of 8.85 and a beta of 1.79.",PFE,0.062926,0.157572,Somewhat-Bullish
SecureWorks  ( NASDAQ:SCWX )  Upgraded by StockNews.com to Hold,https://www.defenseworld.net/2023/07/08/secureworks-nasdaqscwx-upgraded-by-stocknews-com-to-hold.html,2023-07-08 08:16:44,StockNews.com upgraded shares of SecureWorks ( NASDAQ:SCWX - Free Report ) from a sell rating to a hold rating in a research report released on Friday morning. SCWX has been the topic of several other reports.,PFE,0.069495,0.138299,Neutral
Viasat  ( NASDAQ:VSAT )  Upgraded to Hold by StockNews.com,https://www.defenseworld.net/2023/07/08/viasat-nasdaqvsat-upgraded-to-hold-by-stocknews-com.html,2023-07-08 08:16:44,StockNews.com upgraded shares of Viasat ( NASDAQ:VSAT - Free Report ) from a sell rating to a hold rating in a research report released on Friday morning. A number of other analysts have also recently issued reports on the company.,PFE,0.059049,0.11307,Neutral
Toro  ( NYSE:TTC )  Downgraded by StockNews.com to Hold,https://www.defenseworld.net/2023/07/08/toro-nysettc-downgraded-by-stocknews-com-to-hold.html,2023-07-08 08:16:44,"StockNews.com downgraded shares of Toro ( NYSE:TTC - Free Report ) from a buy rating to a hold rating in a report released on Friday. Several other equities research analysts have also commented on TTC. Northland Securities assumed coverage on shares of Toro in a research report on Monday, ...",PFE,0.047844,0.096549,Neutral
Teekay Tankers  ( NYSE:TNK )  Lowered to Buy at StockNews.com,https://www.defenseworld.net/2023/07/08/teekay-tankers-nysetnk-lowered-to-buy-at-stocknews-com.html,2023-07-08 08:16:43,StockNews.com lowered shares of Teekay Tankers ( NYSE:TNK - Free Report ) from a strong-buy rating to a buy rating in a research report released on Friday morning. Shares of Teekay Tankers stock opened at $39.14 on Friday.,PFE,0.086245,0.087555,Neutral
Spok  ( NASDAQ:SPOK )  Upgraded by StockNews.com to Strong-Buy,https://www.defenseworld.net/2023/07/08/spok-nasdaqspok-upgraded-by-stocknews-com-to-strong-buy.html,2023-07-08 08:16:43,"StockNews.com upgraded shares of Spok ( NASDAQ:SPOK - Free Report ) from a buy rating to a strong-buy rating in a research report report published on Friday. Separately, TheStreet raised shares of Spok from a c+ rating to a b- rating in a research note on Monday, April 10th.",PFE,0.08183,0.175149,Somewhat-Bullish
"Bancorp  ( NASDAQ:TBBK )  Downgraded by StockNews.com to ""Sell""",https://www.defenseworld.net/2023/07/08/bancorp-nasdaqtbbk-downgraded-by-stocknews-com-to-sell.html,2023-07-08 08:16:43,StockNews.com downgraded shares of Bancorp ( NASDAQ:TBBK - Free Report ) from a hold rating to a sell rating in a research report sent to investors on Friday morning.,PFE,0.058188,0.136141,Neutral
"Progress Software  ( NASDAQ:PRGS )  Upgraded to ""Strong-Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/progress-software-nasdaqprgs-upgraded-to-strong-buy-at-stocknews-com.html,2023-07-08 08:16:43,StockNews.com upgraded shares of Progress Software ( NASDAQ:PRGS - Free Report ) from a buy rating to a strong-buy rating in a research report report published on Friday morning. PRGS has been the topic of a number of other reports.,PFE,0.044634,0.070504,Neutral
"Toronto-Dominion Bank  ( NYSE:TD )  Downgraded to ""Sell"" at StockNews.com",https://www.defenseworld.net/2023/07/08/toronto-dominion-bank-nysetd-downgraded-to-sell-at-stocknews-com.html,2023-07-08 08:16:42,StockNews.com downgraded shares of Toronto-Dominion Bank ( NYSE:TD - Free Report ) ( TSE:TD ) from a hold rating to a sell rating in a research note published on Friday. TD has been the topic of several other reports.,PFE,0.061159,0.101171,Neutral
Primo Water  ( NASDAQ:PRMW )  Lowered to Buy at StockNews.com,https://www.defenseworld.net/2023/07/08/primo-water-nasdaqprmw-lowered-to-buy-at-stocknews-com-2.html,2023-07-08 08:16:42,StockNews.com downgraded shares of Primo Water ( NASDAQ:PRMW - Free Report ) from a strong-buy rating to a buy rating in a research report released on Friday. Primo Water stock opened at $13.10 on Friday. Primo Water has a 12 month low of $12.15 and a 12 month high of $16.47.,PFE,0.124164,0.126398,Neutral
Seanergy Maritime  ( NASDAQ:SHIP )  Upgraded to Hold by StockNews.com,https://www.defenseworld.net/2023/07/08/seanergy-maritime-nasdaqship-upgraded-to-hold-by-stocknews-com.html,2023-07-08 08:16:41,"StockNews.com upgraded shares of Seanergy Maritime ( NASDAQ:SHIP - Free Report ) from a sell rating to a hold rating in a report published on Friday. Separately, TheStreet downgraded shares of Seanergy Maritime from a c rating to a d+ rating in a research report on Wednesday, March 15th.",PFE,0.090134,0.105376,Neutral
OPKO Health  ( NASDAQ:OPK )  Downgraded to Sell at StockNews.com,https://www.defenseworld.net/2023/07/08/opko-health-nasdaqopk-downgraded-to-sell-at-stocknews-com.html,2023-07-08 08:16:41,StockNews.com lowered shares of OPKO Health ( NASDAQ:OPK - Free Report ) from a hold rating to a sell rating in a report released on Friday. OPK has been the subject of a number of other reports. HC Wainwright restated a buy rating and issued a $3.00 target price on shares of OPKO Health in a ...,PFE,0.060694,0.065232,Neutral
uniQure  ( NASDAQ:QURE )  Downgraded to Sell at StockNews.com,https://www.defenseworld.net/2023/07/08/uniqure-nasdaqqure-downgraded-to-sell-at-stocknews-com.html,2023-07-08 08:16:41,StockNews.com lowered shares of uniQure ( NASDAQ:QURE - Free Report ) from a hold rating to a sell rating in a report published on Friday. A number of other equities research analysts have also recently commented on QURE. Guggenheim dropped their target price on uniQure from $53.00 to $46.00 in ...,PFE,0.044801,0.031872,Neutral
StockNews.com Begins Coverage on Universal Security Instruments  ( NYSE:UUU ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-begins-coverage-on-universal-security-instruments-nyseuuu.html,2023-07-08 08:14:42,"Analysts at StockNews.com started coverage on shares of Universal Security Instruments ( NYSE:UUU - Free Report ) in a research report issued on Saturday. The brokerage set a ""hold"" rating on the stock.",PFE,0.172097,0.004604,Neutral
StockNews.com Begins Coverage on WidePoint  ( NYSE:WYY ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-begins-coverage-on-widepoint-nysewyy.html,2023-07-08 08:14:41,"Equities research analysts at StockNews.com began coverage on shares of WidePoint ( NYSE:WYY - Free Report ) in a research report issued on Saturday. The firm set a ""sell"" rating on the stock.",PFE,0.202366,0.279571,Somewhat-Bullish
"American Axle & Manufacturing  ( NYSE:AXL )  Downgraded by StockNews.com to ""Hold""",https://www.defenseworld.net/2023/07/08/american-axle-manufacturing-nyseaxl-downgraded-by-stocknews-com-to-hold.html,2023-07-08 08:02:48,"StockNews.com cut shares of American Axle & Manufacturing ( NYSE:AXL - Free Report ) from a buy rating to a hold rating in a research note released on Friday morning. Separately, Citigroup reduced their price objective on American Axle & Manufacturing from $9.00 to $8.00 in a research note on ...",PFE,0.072217,0.082989,Neutral
"Barnes Group  ( NYSE:B )  Upgraded to ""Strong-Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/barnes-group-nyseb-upgraded-to-strong-buy-at-stocknews-com.html,2023-07-08 08:02:48,"StockNews.com upgraded shares of Barnes Group ( NYSE:B - Free Report ) from a buy rating to a strong-buy rating in a research note released on Friday. Separately, Truist Financial cut their target price on Barnes Group from $40.00 to $37.00 in a research report on Monday, April 24th.",PFE,0.068306,0.142352,Neutral
"Belden  ( NYSE:BDC )  Upgraded to ""Strong-Buy"" by StockNews.com",https://www.defenseworld.net/2023/07/08/belden-nysebdc-upgraded-to-strong-buy-by-stocknews-com.html,2023-07-08 08:02:48,StockNews.com upgraded shares of Belden ( NYSE:BDC - Free Report ) from a buy rating to a strong-buy rating in a research note released on Friday. NYSE:BDC opened at $95.62 on Friday. The stock's 50-day moving average is $89.08 and its two-hundred day moving average is $83.99.,PFE,0.055236,0.134003,Neutral
Bar Harbor Bankshares  ( NYSE:BHB )  Upgraded to Hold by StockNews.com,https://www.defenseworld.net/2023/07/08/bar-harbor-bankshares-nysebhb-upgraded-to-hold-by-stocknews-com.html,2023-07-08 08:02:48,StockNews.com upgraded shares of Bar Harbor Bankshares ( NYSE:BHB - Free Report ) from a sell rating to a hold rating in a research note issued to investors on Friday. Bar Harbor Bankshares stock opened at $24.37 on Friday. Bar Harbor Bankshares has a 52-week low of $19.55 and a 52-week high of ...,PFE,0.151539,0.164621,Somewhat-Bullish
"Banco Santander-Chile  ( NYSE:BSAC )  Lowered to ""Sell"" at StockNews.com",https://www.defenseworld.net/2023/07/08/banco-santander-chile-nysebsac-lowered-to-sell-at-stocknews-com.html,2023-07-08 08:02:47,StockNews.com cut shares of Banco Santander-Chile ( NYSE:BSAC - Free Report ) from a hold rating to a sell rating in a research report sent to investors on Friday. Shares of NYSE BSAC opened at $18.68 on Friday. The company has a 50-day simple moving average of $18.83 and a 200-day simple ...,PFE,0.068306,0.131064,Neutral
"Chesapeake Energy  ( NYSE:CHK )  Upgraded to ""Hold"" by StockNews.com",https://www.defenseworld.net/2023/07/08/chesapeake-energy-nysechk-upgraded-to-hold-by-stocknews-com.html,2023-07-08 08:02:47,StockNews.com upgraded shares of Chesapeake Energy ( NYSE:CHK - Free Report ) from a sell rating to a hold rating in a research report report published on Friday morning. NYSE CHK opened at $82.15 on Friday. Chesapeake Energy has a 12 month low of $69.68 and a 12 month high of $107.31.,PFE,0.15347,0.319695,Somewhat-Bullish
Cherry Hill Mortgage Investment  ( NYSE:CHMI )  Upgraded to Sell at StockNews.com,https://www.defenseworld.net/2023/07/08/cherry-hill-mortgage-investment-nysechmi-upgraded-to-sell-at-stocknews-com.html,2023-07-08 08:02:46,StockNews.com upgraded shares of Cherry Hill Mortgage Investment ( NYSE:CHMI - Free Report ) to a sell rating in a research report report published on Friday. A number of other equities analysts have also recently commented on the company.,PFE,0.06515,0.166195,Somewhat-Bullish
"Euronav  ( NYSE:EURN )  Upgraded to ""Buy"" by StockNews.com",https://www.defenseworld.net/2023/07/08/euronav-nyseeurn-upgraded-to-buy-by-stocknews-com.html,2023-07-08 08:02:45,StockNews.com upgraded shares of Euronav ( NYSE:EURN - Free Report ) from a hold rating to a buy rating in a research note published on Friday. A number of other analysts have also recently commented on the company.,PFE,0.069094,0.063967,Neutral
Donaldson  ( NYSE:DCI )  Lowered to Buy at StockNews.com,https://www.defenseworld.net/2023/07/08/donaldson-nysedci-lowered-to-buy-at-stocknews-com.html,2023-07-08 08:02:45,"StockNews.com lowered shares of Donaldson ( NYSE:DCI - Free Report ) from a strong-buy rating to a buy rating in a report issued on Friday morning. Other analysts have also recently issued research reports about the company. Citigroup began coverage on Donaldson in a report on Tuesday, June ...",PFE,0.053749,0.053001,Neutral
Enservco  ( NYSE:ENSV )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/enservco-nyseensv-coverage-initiated-by-analysts-at-stocknews-com-3.html,2023-07-08 08:02:45,StockNews.com initiated coverage on shares of Enservco ( NYSE:ENSV - Free Report ) in a report released on Friday morning. The firm issued a sell rating on the stock. Shares of NYSE:ENSV opened at $0.29 on Friday. Enservco has a 12 month low of $0.29 and a 12 month high of $3.22.,PFE,0.183895,0.282392,Somewhat-Bullish
"Saratoga Investment  ( NYSE:SAR )  Lowered to ""Hold"" at StockNews.com",https://www.defenseworld.net/2023/07/08/saratoga-investment-nysesar-lowered-to-hold-at-stocknews-com.html,2023-07-08 08:02:44,StockNews.com lowered shares of Saratoga Investment ( NYSE:SAR - Free Report ) from a buy rating to a hold rating in a report issued on Friday. Other equities analysts have also issued research reports about the company.,PFE,0.065685,0.026476,Neutral
Gildan Activewear  ( NYSE:GIL )  Upgraded to Hold at StockNews.com,https://www.defenseworld.net/2023/07/08/gildan-activewear-nysegil-upgraded-to-hold-at-stocknews-com.html,2023-07-08 08:02:44,StockNews.com upgraded shares of Gildan Activewear ( NYSE:GIL - Free Report ) ( TSE:GIL ) from a sell rating to a hold rating in a report published on Friday morning. GIL has been the topic of several other reports. Stifel Nicolaus began coverage on shares of Gildan Activewear in a research ...,PFE,0.060085,0.152335,Somewhat-Bullish
"Exelon  ( NYSE:EXC )  Upgraded by StockNews.com to ""Hold""",https://www.defenseworld.net/2023/07/08/exelon-nyseexc-upgraded-by-stocknews-com-to-hold.html,2023-07-08 08:02:44,StockNews.com upgraded shares of Exelon ( NYSE:EXC - Free Report ) from a sell rating to a hold rating in a research note released on Friday. Shares of EXC opened at $40.96 on Friday. Exelon has a fifty-two week low of $35.19 and a fifty-two week high of $47.23.,PFE,0.169676,0.24852,Somewhat-Bullish
LiqTech International  ( NYSE:LIQT )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/liqtech-international-nyseliqt-now-covered-by-analysts-at-stocknews-com.html,2023-07-08 08:02:44,StockNews.com initiated coverage on shares of LiqTech International ( NYSE:LIQT - Free Report ) in a research report sent to investors on Friday morning. The brokerage issued a sell rating on the stock. Shares of LIQT opened at $3.21 on Friday.,PFE,0.167322,0.185347,Somewhat-Bullish
Friedman Industries  ( NYSE:FRD )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/friedman-industries-nysefrd-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 08:02:44,StockNews.com started coverage on shares of Friedman Industries ( NYSE:FRD - Free Report ) in a research report sent to investors on Friday morning. The brokerage issued a hold rating on the stock. Shares of NYSE FRD opened at $12.69 on Friday.,PFE,0.163909,0.132658,Neutral
"ITT  ( NYSE:ITT )  Upgraded to ""Strong-Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/itt-nyseitt-upgraded-to-strong-buy-at-stocknews-com.html,2023-07-08 08:02:43,StockNews.com upgraded shares of ITT ( NYSE:ITT - Free Report ) from a buy rating to a strong-buy rating in a research report report published on Friday morning. Other research analysts have also issued research reports about the company. Robert W.,PFE,0.073321,0.07251,Neutral
Mueller Industries  ( NYSE:MLI )  Upgraded to Buy at StockNews.com,https://www.defenseworld.net/2023/07/08/mueller-industries-nysemli-upgraded-to-buy-at-stocknews-com.html,2023-07-08 08:02:43,"StockNews.com upgraded shares of Mueller Industries ( NYSE:MLI - Free Report ) from a hold rating to a buy rating in a research report report published on Friday. NYSE MLI opened at $84.45 on Friday. The stock has a market cap of $4.81 billion, a P/E ratio of 7.08 and a beta of 1.12.",PFE,0.053992,0.135,Neutral
Ingersoll Rand  ( NYSE:IR )  Upgraded by StockNews.com to Buy,https://www.defenseworld.net/2023/07/08/ingersoll-rand-nyseir-upgraded-by-stocknews-com-to-buy.html,2023-07-08 08:02:43,StockNews.com upgraded shares of Ingersoll Rand ( NYSE:IR - Free Report ) from a hold rating to a buy rating in a report released on Friday morning. Other research analysts have also issued reports about the stock. Robert W.,PFE,0.045569,0.129477,Neutral
OncoCyte  ( NYSE:OCX )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/oncocyte-nyseocx-now-covered-by-analysts-at-stocknews-com.html,2023-07-08 08:02:43,StockNews.com initiated coverage on shares of OncoCyte ( NYSE:OCX - Free Report ) in a research note issued to investors on Friday. The brokerage issued a sell rating on the stock. Shares of OCX stock opened at $0.23 on Friday. OncoCyte has a 52-week low of $0.20 and a 52-week high of $1.10.,PFE,0.169676,0.040139,Neutral
"JinkoSolar  ( NYSE:JKS )  Upgraded to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/jinkosolar-nysejks-upgraded-to-buy-at-stocknews-com.html,2023-07-08 08:02:42,"StockNews.com upgraded shares of JinkoSolar ( NYSE:JKS - Free Report ) from a hold rating to a buy rating in a report published on Friday. Separately, HSBC upped their price objective on shares of JinkoSolar from $77.00 to $78.00 in a research report on Thursday, May 4th.",PFE,0.078354,0.101494,Neutral
"Moody's  ( NYSE:MCO )  Upgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2023/07/08/moodys-nysemco-upgraded-by-stocknews-com-to-buy.html,2023-07-08 08:02:42,StockNews.com upgraded shares of Moody's ( NYSE:MCO - Free Report ) from a hold rating to a buy rating in a report issued on Friday morning.,PFE,0.055364,0.067127,Neutral
Marin Software  ( NYSE:MRIN )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/marin-software-nysemrin-coverage-initiated-by-analysts-at-stocknews-com-2.html,2023-07-08 08:02:42,StockNews.com began coverage on shares of Marin Software ( NYSE:MRIN - Free Report ) in a research report report published on Friday. The firm issued a hold rating on the stock. MRIN opened at $0.66 on Friday. Marin Software has a 1 year low of $0.56 and a 1 year high of $2.38.,PFE,0.165031,0.198037,Somewhat-Bullish
"HIVE Blockchain Technologies  ( NYSE:HIVE )  Upgraded by StockNews.com to ""Sell""",https://www.defenseworld.net/2023/07/08/hive-blockchain-technologies-nysehive-upgraded-by-stocknews-com-to-sell-2.html,2023-07-08 08:02:42,StockNews.com upgraded shares of HIVE Blockchain Technologies ( NYSE:HIVE - Free Report ) to a sell rating in a report released on Friday morning. Shares of NYSE HIVE opened at $5.53 on Friday. HIVE Blockchain Technologies has a twelve month low of $1.36 and a twelve month high of $7.53.,PFE,0.154455,0.173174,Somewhat-Bullish
New Gold  ( NYSE:NGD )  Downgraded to Hold at StockNews.com,https://www.defenseworld.net/2023/07/08/new-gold-nysengd-downgraded-to-hold-at-stocknews-com-2.html,2023-07-08 08:02:42,StockNews.com downgraded shares of New Gold ( NYSE:NGD - Free Report ) from a buy rating to a hold rating in a research report report published on Friday morning. NYSE NGD opened at $1.04 on Friday. New Gold has a fifty-two week low of $0.61 and a fifty-two week high of $1.48.,PFE,0.149656,0.21077,Somewhat-Bullish
Prudential  ( NYSE:PUK )  Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/07/08/prudential-nysepuk-lowered-to-sell-at-stocknews-com.html,2023-07-08 08:02:41,StockNews.com downgraded shares of Prudential ( NYSE:PUK - Free Report ) from a hold rating to a sell rating in a report published on Friday morning. Several other analysts also recently commented on the company.,PFE,0.07031,0.099389,Neutral
"Seabridge Gold  ( NYSE:SA )  Upgraded by StockNews.com to ""Sell""",https://www.defenseworld.net/2023/07/08/seabridge-gold-nysesa-upgraded-by-stocknews-com-to-sell.html,2023-07-08 08:02:41,StockNews.com upgraded shares of Seabridge Gold ( NYSE:SA - Free Report ) ( TSE:SEA ) to a sell rating in a report issued on Friday. NYSE SA opened at $11.90 on Friday. Seabridge Gold has a one year low of $10.03 and a one year high of $16.18.,PFE,0.0699,0.151631,Somewhat-Bullish
"Smith & Nephew  ( NYSE:SNN )  Lowered to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/smith-nephew-nysesnn-lowered-to-buy-at-stocknews-com.html,2023-07-08 08:02:41,StockNews.com lowered shares of Smith & Nephew ( NYSE:SNN - Free Report ) from a strong-buy rating to a buy rating in a research note released on Friday morning.,PFE,0.063763,0.035343,Neutral
Marathon Petroleum  ( NYSE:MPC )  Upgraded to Buy by StockNews.com,https://www.defenseworld.net/2023/07/08/marathon-petroleum-nysempc-upgraded-to-buy-by-stocknews-com.html,2023-07-08 08:02:41,StockNews.com upgraded shares of Marathon Petroleum ( NYSE:MPC - Free Report ) from a hold rating to a buy rating in a research report released on Friday morning.,PFE,0.046273,0.151741,Somewhat-Bullish
Oragenics  ( NYSE:OGEN )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/oragenics-nyseogen-now-covered-by-analysts-at-stocknews-com.html,2023-07-08 08:02:41,StockNews.com started coverage on shares of Oragenics ( NYSE:OGEN - Free Report ) in a research report released on Friday. The brokerage issued a sell rating on the stock. Shares of OGEN stock opened at $3.27 on Friday. Oragenics has a 52-week low of $2.60 and a 52-week high of $24.00.,PFE,0.182506,0.177604,Somewhat-Bullish
Micron Technology  ( NASDAQ:MU )  Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/07/08/micron-technology-nasdaqmu-lowered-to-sell-at-stocknews-com.html,2023-07-08 07:44:41,StockNews.com lowered shares of Micron Technology ( NASDAQ:MU - Free Report ) from a hold rating to a sell rating in a report released on Friday.,PFE,0.046907,0.069776,Neutral
"MiMedx Group  ( NASDAQ:MDXG )  Lowered to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/mimedx-group-nasdaqmdxg-lowered-to-buy-at-stocknews-com.html,2023-07-08 07:42:49,"StockNews.com lowered shares of MiMedx Group ( NASDAQ:MDXG - Free Report ) from a strong-buy rating to a buy rating in a report released on Friday. Separately, HC Wainwright cut their target price on MiMedx Group from $9.50 to $8.00 in a research note on Wednesday, June 21st.",PFE,0.068698,0.066852,Neutral
Logitech International  ( NASDAQ:LOGI )  Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/07/08/logitech-international-nasdaqlogi-lowered-to-hold-at-stocknews-com.html,2023-07-08 07:42:49,StockNews.com lowered shares of Logitech International ( NASDAQ:LOGI - Free Report ) from a buy rating to a hold rating in a report released on Friday morning. A number of other research analysts also recently commented on the stock.,PFE,0.053629,0.125,Neutral
Merrimack Pharmaceuticals  ( NASDAQ:MACK )  Downgraded by StockNews.com to Sell,https://www.defenseworld.net/2023/07/08/merrimack-pharmaceuticals-nasdaqmack-downgraded-by-stocknews-com-to-sell.html,2023-07-08 07:42:49,"StockNews.com lowered shares of Merrimack Pharmaceuticals ( NASDAQ:MACK - Free Report ) from a hold rating to a sell rating in a report released on Friday morning. Shares of MACK stock opened at $11.80 on Friday. The firm has a market cap of $168.27 million, a PE ratio of -98.33 and a beta of ...",PFE,0.101582,0.120839,Neutral
Ideal Power  ( NASDAQ:IPWR )  Upgraded by StockNews.com to Sell,https://www.defenseworld.net/2023/07/08/ideal-power-nasdaqipwr-upgraded-by-stocknews-com-to-sell.html,2023-07-08 07:42:47,"StockNews.com upgraded shares of Ideal Power ( NASDAQ:IPWR - Free Report ) to a sell rating in a research note published on Friday. Separately, Benchmark reiterated a buy rating and set a $18.00 target price on shares of Ideal Power in a research report on Thursday, March 9th.",PFE,0.078611,0.060749,Neutral
"Horizon Technology Finance  ( NASDAQ:HRZN )  Lowered to ""Sell"" at StockNews.com",https://www.defenseworld.net/2023/07/08/horizon-technology-finance-nasdaqhrzn-lowered-to-sell-at-stocknews-com.html,2023-07-08 07:42:47,StockNews.com downgraded shares of Horizon Technology Finance ( NASDAQ:HRZN - Free Report ) from a hold rating to a sell rating in a research note published on Friday morning. HRZN has been the topic of several other reports.,PFE,0.070517,0.121043,Neutral
"Horizon Bancorp  ( NASDAQ:HBNC )  Downgraded by StockNews.com to ""Sell""",https://www.defenseworld.net/2023/07/08/horizon-bancorp-nasdaqhbnc-downgraded-by-stocknews-com-to-sell.html,2023-07-08 07:42:46,StockNews.com downgraded shares of Horizon Bancorp ( NASDAQ:HBNC - Free Report ) from a hold rating to a sell rating in a research report released on Friday. Several other equities analysts also recently weighed in on HBNC. TheStreet downgraded shares of Horizon Bancorp from a b- rating to a c+ ...,PFE,0.068502,0.124435,Neutral
"Aqua Metals  ( NASDAQ:AQMS )  Upgraded by StockNews.com to ""Sell""",https://www.defenseworld.net/2023/07/08/aqua-metals-nasdaqaqms-upgraded-by-stocknews-com-to-sell.html,2023-07-08 07:42:44,"StockNews.com upgraded shares of Aqua Metals ( NASDAQ:AQMS - Free Report ) to a sell rating in a report released on Friday. NASDAQ AQMS opened at $1.20 on Friday. The company has a market cap of $99.77 million, a PE ratio of -6.00 and a beta of 1.26.",PFE,0.092213,0.158964,Somewhat-Bullish
"Gencor Industries  ( NASDAQ:GENC )  Downgraded by StockNews.com to ""Hold""",https://www.defenseworld.net/2023/07/08/gencor-industries-nasdaqgenc-downgraded-by-stocknews-com-to-hold.html,2023-07-08 07:42:44,StockNews.com cut shares of Gencor Industries ( NASDAQ:GENC - Free Report ) from a buy rating to a hold rating in a research note published on Friday. Shares of NASDAQ:GENC opened at $15.76 on Friday. Gencor Industries has a 1 year low of $8.38 and a 1 year high of $15.81.,PFE,0.088147,0.056662,Neutral
First Bank  ( NASDAQ:FRBA )  Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/07/08/first-bank-nasdaqfrba-lowered-to-sell-at-stocknews-com.html,2023-07-08 07:42:44,StockNews.com downgraded shares of First Bank ( NASDAQ:FRBA - Free Report ) from a hold rating to a sell rating in a research note issued to investors on Friday morning. FRBA stock opened at $10.93 on Friday. The firm has a 50 day moving average of $10.38 and a 200-day moving average of $11.69.,PFE,0.077845,0.141561,Neutral
"Pathward Financial  ( NASDAQ:CASH )  Lowered to ""Sell"" at StockNews.com",https://www.defenseworld.net/2023/07/08/pathward-financial-nasdaqcash-lowered-to-sell-at-stocknews-com.html,2023-07-08 07:42:44,StockNews.com lowered shares of Pathward Financial ( NASDAQ:CASH - Free Report ) from a hold rating to a sell rating in a research report sent to investors on Friday. CASH has been the subject of several other reports.,PFE,0.064104,0.126845,Neutral
"Chesapeake Energy  ( NASDAQ:CHK )  Upgraded to ""Hold"" at StockNews.com",https://www.defenseworld.net/2023/07/08/chesapeake-energy-nasdaqchk-upgraded-to-hold-at-stocknews-com.html,2023-07-08 07:42:44,StockNews.com upgraded shares of Chesapeake Energy ( NASDAQ:CHK - Free Report ) from a sell rating to a hold rating in a research note released on Friday. Other equities analysts have also recently issued reports about the stock.,PFE,0.05654,0.243214,Somewhat-Bullish
Amgen  ( NASDAQ:AMGN )  Downgraded by StockNews.com to Buy,https://www.defenseworld.net/2023/07/08/amgen-nasdaqamgn-downgraded-by-stocknews-com-to-buy-2.html,2023-07-08 07:42:43,StockNews.com cut shares of Amgen ( NASDAQ:AMGN - Free Report ) from a strong-buy rating to a buy rating in a research note released on Friday morning.,PFE,0.056674,0.041132,Neutral
"Five Below  ( NASDAQ:FIVE )  Upgraded to ""Hold"" at StockNews.com",https://www.defenseworld.net/2023/07/08/five-below-nasdaqfive-upgraded-to-hold-at-stocknews-com-2.html,2023-07-08 07:42:43,StockNews.com upgraded shares of Five Below ( NASDAQ:FIVE - Free Report ) from a sell rating to a hold rating in a research report report published on Friday. FIVE has been the topic of several other research reports.,PFE,0.045396,0.194478,Somewhat-Bullish
Athersys  ( NASDAQ:ATHX )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/athersys-nasdaqathx-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 07:42:42,StockNews.com initiated coverage on shares of Athersys ( NASDAQ:ATHX - Free Report ) in a report issued on Friday. The firm issued a hold rating on the biopharmaceutical company's stock. Shares of NASDAQ:ATHX opened at $0.85 on Friday.,PFE,0.097457,0.110132,Neutral
"Applied Optoelectronics  ( NASDAQ:AAOI )  Downgraded to ""Sell"" at StockNews.com",https://www.defenseworld.net/2023/07/08/applied-optoelectronics-nasdaqaaoi-downgraded-to-sell-at-stocknews-com.html,2023-07-08 07:42:42,"StockNews.com downgraded shares of Applied Optoelectronics ( NASDAQ:AAOI - Free Report ) from a hold rating to a sell rating in a research note published on Friday. Separately, Northland Securities raised their price objective on Applied Optoelectronics from $5.00 to $7.00 in a report on ...",PFE,0.095899,0.09612,Neutral
BCB Bancorp  ( NASDAQ:BCBP )  Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/07/08/bcb-bancorp-nasdaqbcbp-lowered-to-sell-at-stocknews-com.html,2023-07-08 07:42:42,"StockNews.com downgraded shares of BCB Bancorp ( NASDAQ:BCBP - Free Report ) from a hold rating to a sell rating in a report published on Friday. Separately, Keefe, Bruyette & Woods decreased their target price on shares of BCB Bancorp from $17.50 to $16.50 and set a market perform rating on ...",PFE,0.05234,0.126,Neutral
Westwood Holdings Group  ( NYSE:WHG )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/westwood-holdings-group-nysewhg-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 07:36:44,StockNews.com started coverage on shares of Westwood Holdings Group ( NYSE:WHG - Free Report ) in a report published on Friday morning. The brokerage issued a buy rating on the asset manager's stock.,PFE,0.074692,0.14054,Neutral
"Bar Harbor Bankshares  ( NYSEAMERICAN:BHB )  Upgraded to ""Hold"" by StockNews.com",https://www.defenseworld.net/2023/07/08/bar-harbor-bankshares-nyseamericanbhb-upgraded-to-hold-by-stocknews-com.html,2023-07-08 07:36:41,"StockNews.com upgraded shares of Bar Harbor Bankshares ( NYSEAMERICAN:BHB - Free Report ) from a sell rating to a hold rating in a research report released on Friday. Shares of NYSEAMERICAN BHB opened at $24.37 on Friday. The company has a debt-to-equity ratio of 0.98, a quick ratio of 0.98 and ...",PFE,0.077593,0.12687,Neutral
"Vermilion Energy  ( NYSE:VET )  Upgraded to ""Buy"" by StockNews.com",https://www.defenseworld.net/2023/07/08/vermilion-energy-nysevet-upgraded-to-buy-by-stocknews-com.html,2023-07-08 07:36:41,StockNews.com upgraded shares of Vermilion Energy ( NYSE:VET - Free Report ) ( TSE:VET ) from a hold rating to a buy rating in a research report report published on Friday. Several other equities research analysts have also recently commented on the stock.,PFE,0.059341,0.198185,Somewhat-Bullish
Navios Maritime  ( NYSE:NM )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/08/navios-maritime-nysenm-now-covered-by-stocknews-com.html,2023-07-08 05:20:47,"Investment analysts at StockNews.com started coverage on shares of Navios Maritime ( NYSE:NM - Free Report ) in a note issued to investors on Saturday. The brokerage set a ""buy"" rating on the shipping company's stock. Shares of NM stock opened at $1.64 on Friday.",PFE,0.084722,0.082,Neutral
Life Storage  ( NYSE:LSI )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/08/life-storage-nyselsi-research-coverage-started-at-stocknews-com.html,2023-07-08 05:20:46,"Research analysts at StockNews.com initiated coverage on shares of Life Storage ( NYSE:LSI - Free Report ) in a research report issued to clients and investors on Saturday. The brokerage set a ""hold"" rating on the real estate investment trust's stock.",PFE,0.052455,0.073968,Neutral
Navidea Biopharmaceuticals  ( NYSE:NAVB )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/navidea-biopharmaceuticals-nysenavb-now-covered-by-analysts-at-stocknews-com.html,2023-07-08 05:20:46,"Equities research analysts at StockNews.com began coverage on shares of Navidea Biopharmaceuticals ( NYSE:NAVB - Free Report ) in a report issued on Saturday. The brokerage set a ""sell"" rating on the stock. Shares of NAVB stock opened at $0.10 on Friday.",PFE,0.131643,0.090329,Neutral
Empire State Realty OP  ( NYSE:ESBA )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/08/empire-state-realty-op-nyseesba-coverage-initiated-at-stocknews-com.html,2023-07-08 05:20:46,"StockNews.com assumed coverage on shares of Empire State Realty OP ( NYSE:ESBA - Free Report ) in a research note issued on Saturday. The firm set a ""buy"" rating on the stock. Shares of ESBA stock opened at $7.67 on Friday. Empire State Realty OP has a one year low of $5.08 and a one year high ...",PFE,0.103331,0.128421,Neutral
Desktop Metal  ( NYSE:DM )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/desktop-metal-nysedm-earns-sell-rating-from-analysts-at-stocknews-com.html,2023-07-08 05:20:45,"Equities researchers at StockNews.com started coverage on shares of Desktop Metal ( NYSE:DM - Free Report ) in a note issued to investors on Saturday. The firm set a ""sell"" rating on the pipeline company's stock. Shares of NYSE:DM opened at $1.73 on Friday.",PFE,0.102888,0.119638,Neutral
Aerojet Rocketdyne  ( NYSE:AJRD )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/08/aerojet-rocketdyne-nyseajrd-coverage-initiated-at-stocknews-com.html,2023-07-08 05:20:44,"StockNews.com initiated coverage on shares of Aerojet Rocketdyne ( NYSE:AJRD - Free Report ) in a report released on Saturday. The brokerage set a ""hold"" rating on the aerospace company's stock. Shares of AJRD stock opened at $55.17 on Friday.",PFE,0.073773,0.193383,Somewhat-Bullish
Laboratory Co. of America  ( NYSE:LH )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/laboratory-co-of-america-nyselh-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 05:20:44,"Research analysts at StockNews.com assumed coverage on shares of Laboratory Co. of America ( NYSE:LH - Free Report ) in a research note issued to investors on Saturday. The firm set a ""buy"" rating on the medical research company's stock.",PFE,0.045655,0.180506,Somewhat-Bullish
StockNews.com Initiates Coverage on Espey Mfg. & Electronics  ( NYSEAMERICAN:ESP ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-initiates-coverage-on-espey-mfg-electronics-nyseamericanesp.html,2023-07-08 05:20:43,"Equities research analysts at StockNews.com started coverage on shares of Espey Mfg. & Electronics ( NYSEAMERICAN:ESP - Free Report ) in a report released on Saturday. The brokerage set a ""strong-buy"" rating on the stock. NYSEAMERICAN:ESP opened at $16.32 on Friday.",PFE,0.081276,0.097626,Neutral
StockNews.com Initiates Coverage on Orion Group  ( NYSE:ORN ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-initiates-coverage-on-orion-group-nyseorn-2.html,2023-07-08 05:20:43,"Investment analysts at StockNews.com began coverage on shares of Orion Group ( NYSE:ORN - Free Report ) in a report released on Saturday. The brokerage set a ""hold"" rating on the construction company's stock. Separately, Noble Financial started coverage on Orion Group in a report on Wednesday, ...",PFE,0.080188,0.096548,Neutral
"EnPro Industries  ( NYSE:NPO )  Raised to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/enpro-industries-nysenpo-raised-to-buy-at-stocknews-com.html,2023-07-08 05:20:43,"EnPro Industries ( NYSE:NPO - Free Report ) was upgraded by StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued to investors on Saturday. Several other analysts also recently weighed in on the stock.",PFE,0.078611,0.082791,Neutral
Gold Fields  ( NYSE:GFI )  Rating Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/07/08/gold-fields-nysegfi-rating-lowered-to-hold-at-stocknews-com.html,2023-07-08 05:20:43,"Gold Fields ( NYSE:GFI - Free Report ) was downgraded by research analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research report issued to clients and investors on Saturday. A number of other equities analysts have also recently commented on the stock.",PFE,0.073546,0.124402,Neutral
"ABM Industries  ( NYSE:ABM )  Downgraded to ""Hold"" at StockNews.com",https://www.defenseworld.net/2023/07/08/abm-industries-nyseabm-downgraded-to-hold-at-stocknews-com.html,2023-07-08 05:20:41,"ABM Industries ( NYSE:ABM - Free Report ) was downgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research note issued on Saturday. Separately, UBS Group began coverage on ABM Industries in a research report on Wednesday, May 31st.",PFE,0.076115,0.187483,Somewhat-Bullish
Issuer Direct  ( NYSE:ISDR )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/issuer-direct-nyseisdr-coverage-initiated-by-analysts-at-stocknews-com.html,2023-07-08 05:20:41,"Stock analysts at StockNews.com assumed coverage on shares of Issuer Direct ( NYSE:ISDR - Free Report ) in a report issued on Saturday. The brokerage set a ""strong-buy"" rating on the stock. ISDR has been the topic of a number of other reports.",PFE,0.070105,0.141401,Neutral
Haemonetics  ( NYSE:HAE )  Downgraded to Buy at StockNews.com,https://www.defenseworld.net/2023/07/08/haemonetics-nysehae-downgraded-to-buy-at-stocknews-com.html,2023-07-08 05:20:41,"Haemonetics ( NYSE:HAE - Free Report ) was downgraded by analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Saturday. HAE has been the topic of several other reports.",PFE,0.060085,0.170306,Somewhat-Bullish
"Primerica  ( NYSE:PRI )  Raised to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/07/08/primerica-nysepri-raised-to-buy-at-stocknews-com.html,2023-07-08 05:20:41,"Primerica ( NYSE:PRI - Free Report ) was upgraded by investment analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued to investors on Saturday. Several other equities research analysts also recently commented on the stock.",PFE,0.058047,0.119102,Neutral
Aeglea BioTherapeutics  ( NASDAQ:AGLE )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/08/aeglea-biotherapeutics-nasdaqagle-research-coverage-started-at-stocknews-com.html,2023-07-08 05:08:43,"Analysts at StockNews.com started coverage on shares of Aeglea BioTherapeutics ( NASDAQ:AGLE - Free Report ) in a research note issued on Saturday. The brokerage set a ""hold"" rating on the biotechnology company's stock.",PFE,0.070725,0.138569,Neutral
Creative Media & Community Trust Co.  ( NASDAQ:CMCT )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/08/creative-media-community-trust-co-nasdaqcmct-coverage-initiated-at-stocknews-com.html,2023-07-08 05:08:43,"Equities researchers at StockNews.com began coverage on shares of Creative Media & Community Trust Co. ( NASDAQ:CMCT - Free Report ) in a note issued to investors on Saturday. The firm set a ""sell"" rating on the real estate investment trust's stock.",PFE,0.052801,0.185002,Somewhat-Bullish
StockNews.com Initiates Coverage on Moatable  ( NYSE:RENN ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-initiates-coverage-on-moatable-nyserenn.html,2023-07-08 05:08:42,"Stock analysts at StockNews.com started coverage on shares of Moatable ( NYSE:RENN - Free Report ) in a research note issued on Saturday. The firm set a ""hold"" rating on the technology company's stock. Moatable has a 12 month low of $0.87 and a 12 month high of $33.91.",PFE,0.087185,0.185048,Somewhat-Bullish
CASI Pharmaceuticals  ( NASDAQ:CASI )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/08/casi-pharmaceuticals-nasdaqcasi-research-coverage-started-at-stocknews-com-2.html,2023-07-08 05:08:42,"Research analysts at StockNews.com initiated coverage on shares of CASI Pharmaceuticals ( NASDAQ:CASI - Free Report ) in a research report issued on Saturday. The brokerage set a ""hold"" rating on the biotechnology company's stock. CASI opened at $2.62 on Friday.",PFE,0.085936,0.104152,Neutral
Applied DNA Sciences  ( NASDAQ:APDN )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/applied-dna-sciences-nasdaqapdn-coverage-initiated-by-analysts-at-stocknews-com.html,2023-07-08 05:08:42,"Research analysts at StockNews.com began coverage on shares of Applied DNA Sciences ( NASDAQ:APDN - Free Report ) in a research note issued on Saturday. The firm set a ""hold"" rating on the technology company's stock.",PFE,0.085936,0.086494,Neutral
CSP  ( NASDAQ:CSPI )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/csp-nasdaqcspi-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 05:08:42,"Analysts at StockNews.com initiated coverage on shares of CSP ( NASDAQ:CSPI - Free Report ) in a report issued on Saturday. The firm set a ""hold"" rating on the information technology services provider's stock. Separately, TheStreet cut CSP from a ""b-"" rating to a ""c"" rating in a report on ...",PFE,0.070935,0.114552,Neutral
VMware  ( NYSE:VMW )  Upgraded to Strong-Buy by StockNews.com,https://www.defenseworld.net/2023/07/08/vmware-nysevmw-upgraded-to-strong-buy-by-stocknews-com.html,2023-07-08 05:08:42,"VMware ( NYSE:VMW - Free Report ) was upgraded by StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a note issued to investors on Saturday. A number of other research firms also recently commented on VMW. Mizuho lifted their target price on VMware from $135.00 to $138.00 in a report ...",PFE,0.057767,0.069265,Neutral
Superior Industries International  ( NYSE:SUP )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/08/superior-industries-international-nysesup-research-coverage-started-at-stocknews-com.html,2023-07-08 05:08:42,"Equities researchers at StockNews.com assumed coverage on shares of Superior Industries International ( NYSE:SUP - Free Report ) in a research note issued to investors on Saturday. The brokerage set a ""strong-buy"" rating on the auto parts company's stock.",PFE,0.057352,0.098049,Neutral
StockNews.com Initiates Coverage on Eagle Bancorp Montana  ( NASDAQ:EBMT ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-initiates-coverage-on-eagle-bancorp-montana-nasdaqebmt.html,2023-07-08 05:08:42,"Analysts at StockNews.com started coverage on shares of Eagle Bancorp Montana ( NASDAQ:EBMT - Free Report ) in a research note issued to investors on Saturday. The firm set a ""hold"" rating on the bank's stock. Shares of NASDAQ EBMT opened at $12.89 on Friday.",PFE,0.052455,0.154997,Somewhat-Bullish
Bridgeline Digital  ( NASDAQ:BLIN )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/08/bridgeline-digital-nasdaqblin-research-coverage-started-at-stocknews-com.html,2023-07-08 05:08:42,"Equities research analysts at StockNews.com began coverage on shares of Bridgeline Digital ( NASDAQ:BLIN - Free Report ) in a research report issued to clients and investors on Saturday. The brokerage set a ""hold"" rating on the software maker's stock. Shares of BLIN stock opened at $1.23 on ...",PFE,0.114682,0.184205,Somewhat-Bullish
Carver Bancorp  ( NASDAQ:CARV )  Downgraded by StockNews.com,https://www.defenseworld.net/2023/07/08/carver-bancorp-nasdaqcarv-downgraded-by-stocknews-com.html,2023-07-08 05:08:41,"Carver Bancorp ( NASDAQ:CARV - Free Report ) was downgraded by investment analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a note issued to investors on Saturday. Shares of NASDAQ CARV opened at $2.57 on Friday.",PFE,0.092569,0.119214,Neutral
AcelRx Pharmaceuticals  ( NASDAQ:ACRX )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/08/acelrx-pharmaceuticals-nasdaqacrx-coverage-initiated-at-stocknews-com.html,2023-07-08 05:08:41,"Stock analysts at StockNews.com initiated coverage on shares of AcelRx Pharmaceuticals ( NASDAQ:ACRX - Free Report ) in a research report issued to clients and investors on Saturday. The brokerage set a ""sell"" rating on the specialty pharmaceutical company's stock.",PFE,0.087185,-0.046939,Neutral
StockNews.com Downgrades FS Bancorp  ( NASDAQ:FSBW )  to Hold,https://www.defenseworld.net/2023/07/08/stocknews-com-downgrades-fs-bancorp-nasdaqfsbw-to-hold.html,2023-07-08 05:08:41,"FS Bancorp ( NASDAQ:FSBW - Free Report ) was downgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a note issued to investors on Saturday. Shares of NASDAQ:FSBW opened at $30.91 on Friday.",PFE,0.079392,0.09024,Neutral
Horizon Therapeutics Public  ( NASDAQ:HZNP )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/horizon-therapeutics-public-nasdaqhznp-coverage-initiated-by-analysts-at-stocknews-com.html,2023-07-08 05:08:41,"Analysts at StockNews.com initiated coverage on shares of Horizon Therapeutics Public ( NASDAQ:HZNP - Free Report ) in a report issued on Saturday. The brokerage set a ""buy"" rating on the biopharmaceutical company's stock.",PFE,0.07446,-0.010348,Neutral
Cellectis  ( NASDAQ:CLLS )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/cellectis-nasdaqclls-coverage-initiated-by-analysts-at-stocknews-com.html,2023-07-08 05:08:41,"Stock analysts at StockNews.com began coverage on shares of Cellectis ( NASDAQ:CLLS - Free Report ) in a research note issued to investors on Saturday. The firm set a ""hold"" rating on the biotechnology company's stock. Other analysts have also issued research reports about the company.",PFE,0.063594,0.052326,Neutral
Broadway Financial  ( NASDAQ:BYFC )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/08/broadway-financial-nasdaqbyfc-coverage-initiated-at-stocknews-com-2.html,2023-07-08 05:08:41,"Research analysts at StockNews.com began coverage on shares of Broadway Financial ( NASDAQ:BYFC - Free Report ) in a note issued to investors on Saturday. The firm set a ""sell"" rating on the savings and loans company's stock. BYFC stock opened at $0.97 on Friday.",PFE,0.136113,0.211841,Somewhat-Bullish
StockNews.com Initiates Coverage on Diffusion Pharmaceuticals  ( NASDAQ:DFFN ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-initiates-coverage-on-diffusion-pharmaceuticals-nasdaqdffn.html,2023-07-08 05:08:41,"StockNews.com started coverage on shares of Diffusion Pharmaceuticals ( NASDAQ:DFFN - Free Report ) in a research report issued on Saturday. The firm set a ""hold"" rating on the stock. Shares of NASDAQ:DFFN opened at $2.86 on Friday. The company has a market cap of $5.83 million, a P/E ratio of ...",PFE,0.124809,0.248498,Somewhat-Bullish
Onconova Therapeutics  ( NASDAQ:ONTX )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/08/onconova-therapeutics-nasdaqontx-coverage-initiated-at-stocknews-com.html,2023-07-08 05:06:44,"Equities researchers at StockNews.com began coverage on shares of Onconova Therapeutics ( NASDAQ:ONTX - Free Report ) in a note issued to investors on Saturday. The brokerage set a ""hold"" rating on the biopharmaceutical company's stock.",PFE,0.082677,0.089162,Neutral
Ruth's Hospitality Group  ( NASDAQ:RUTH )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/ruths-hospitality-group-nasdaqruth-now-covered-by-analysts-at-stocknews-com-3.html,2023-07-08 05:06:44,"Research analysts at StockNews.com started coverage on shares of Ruth's Hospitality Group ( NASDAQ:RUTH - Free Report ) in a research note issued on Saturday. The firm set a ""buy"" rating on the restaurant operator's stock. RUTH has been the subject of several other reports.",PFE,0.075397,0.152284,Somewhat-Bullish
Orthofix Medical  ( NASDAQ:OFIX )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/08/orthofix-medical-nasdaqofix-coverage-initiated-at-stocknews-com.html,2023-07-08 05:06:44,"Analysts at StockNews.com started coverage on shares of Orthofix Medical ( NASDAQ:OFIX - Free Report ) in a report issued on Saturday. The firm set a ""buy"" rating on the medical device company's stock. OFIX stock opened at $17.84 on Friday.",PFE,0.050148,0.161727,Somewhat-Bullish
StockNews.com Begins Coverage on Moleculin Biotech  ( NASDAQ:MBRX ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-begins-coverage-on-moleculin-biotech-nasdaqmbrx.html,2023-07-08 05:06:43,"Investment analysts at StockNews.com started coverage on shares of Moleculin Biotech ( NASDAQ:MBRX - Free Report ) in a research report issued to clients and investors on Saturday. The firm set a ""sell"" rating on the stock.",PFE,0.096671,0.147103,Neutral
Sorrento Therapeutics  ( NASDAQ:SRNE )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/sorrento-therapeutics-nasdaqsrne-now-covered-by-analysts-at-stocknews-com.html,2023-07-08 05:06:43,"Investment analysts at StockNews.com started coverage on shares of Sorrento Therapeutics ( NASDAQ:SRNE - Free Report ) in a report issued on Saturday. The brokerage set a ""hold"" rating on the biopharmaceutical company's stock. Shares of Sorrento Therapeutics stock opened at $0.38 on Friday.",PFE,0.095517,0.073538,Neutral
StockNews.com Initiates Coverage on Pieris Pharmaceuticals  ( NASDAQ:PIRS ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-initiates-coverage-on-pieris-pharmaceuticals-nasdaqpirs.html,2023-07-08 05:06:43,"Equities research analysts at StockNews.com started coverage on shares of Pieris Pharmaceuticals ( NASDAQ:PIRS - Free Report ) in a note issued to investors on Saturday. The firm set a ""hold"" rating on the biotechnology company's stock.",PFE,0.085629,0.066011,Neutral
Mitek Systems  ( NASDAQ:MITK )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/mitek-systems-nasdaqmitk-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 05:06:43,"Investment analysts at StockNews.com initiated coverage on shares of Mitek Systems ( NASDAQ:MITK - Free Report ) in a report issued on Saturday. The brokerage set a ""buy"" rating on the software maker's stock. Shares of NASDAQ:MITK opened at $10.98 on Friday.",PFE,0.083541,0.168444,Somewhat-Bullish
Malvern Bancorp  ( NASDAQ:MLVF )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/malvern-bancorp-nasdaqmlvf-coverage-initiated-by-analysts-at-stocknews-com.html,2023-07-08 05:06:43,"StockNews.com started coverage on shares of Malvern Bancorp ( NASDAQ:MLVF - Free Report ) in a research note issued to investors on Saturday. The firm set a ""hold"" rating on the savings and loans company's stock. MLVF opened at $16.04 on Friday.",PFE,0.082111,0.151732,Somewhat-Bullish
Jaguar Health  ( NASDAQ:JAGX )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/08/jaguar-health-nasdaqjagx-research-coverage-started-at-stocknews-com.html,2023-07-08 05:06:43,"Equities research analysts at StockNews.com initiated coverage on shares of Jaguar Health ( NASDAQ:JAGX - Free Report ) in a note issued to investors on Saturday. The firm set a ""hold"" rating on the biotechnology company's stock. JAGX opened at $0.54 on Friday.",PFE,0.080188,0.029323,Neutral
Inovio Pharmaceuticals  ( NASDAQ:INO )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/inovio-pharmaceuticals-nasdaqino-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 05:06:43,"Equities research analysts at StockNews.com initiated coverage on shares of Inovio Pharmaceuticals ( NASDAQ:INO - Free Report ) in a research report issued on Saturday. The brokerage set a ""sell"" rating on the biopharmaceutical company's stock. Shares of NASDAQ:INO opened at $0.49 on Friday.",PFE,0.069495,0.145329,Neutral
Paratek Pharmaceuticals  ( NASDAQ:PRTK )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/paratek-pharmaceuticals-nasdaqprtk-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 05:06:43,"Stock analysts at StockNews.com started coverage on shares of Paratek Pharmaceuticals ( NASDAQ:PRTK - Free Report ) in a research note issued on Saturday. The firm set a ""hold"" rating on the specialty pharmaceutical company's stock. PRTK has been the topic of a number of other reports.",PFE,0.06697,-0.040569,Neutral
National Instruments  ( NASDAQ:NATI )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/08/national-instruments-nasdaqnati-research-coverage-started-at-stocknews-com-2.html,2023-07-08 05:06:43,"Equities researchers at StockNews.com initiated coverage on shares of National Instruments ( NASDAQ:NATI - Free Report ) in a report issued on Saturday. The brokerage set a ""buy"" rating on the technology company's stock. Other research analysts have also issued research reports about the stock.",PFE,0.052112,0.088958,Neutral
SuperCom  ( NASDAQ:SPCB )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/supercom-nasdaqspcb-earns-sell-rating-from-analysts-at-stocknews-com.html,2023-07-08 05:06:43,"Research analysts at StockNews.com assumed coverage on shares of SuperCom ( NASDAQ:SPCB - Free Report ) in a research report issued to clients and investors on Saturday. The brokerage set a ""sell"" rating on the industrial products company's stock. Shares of SPCB opened at $0.97 on Friday.",PFE,0.128822,0.100454,Neutral
NuVasive  ( NASDAQ:NUVA )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/08/nuvasive-nasdaqnuva-now-covered-by-stocknews-com.html,2023-07-08 05:06:42,"StockNews.com started coverage on shares of NuVasive ( NASDAQ:NUVA - Free Report ) in a research note issued to investors on Saturday. The brokerage set a ""hold"" rating on the medical device company's stock. Other research analysts have also recently issued research reports about the company.",PFE,0.07446,0.127566,Neutral
Community Financial  ( NASDAQ:TCFC )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/08/community-financial-nasdaqtcfc-research-coverage-started-at-stocknews-com-3.html,2023-07-08 05:06:42,"Equities research analysts at StockNews.com started coverage on shares of Community Financial ( NASDAQ:TCFC - Free Report ) in a research note issued to investors on Saturday. The firm set a ""buy"" rating on the financial services provider's stock.",PFE,0.072655,0.124225,Neutral
Salisbury Bancorp  ( NASDAQ:SAL )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/08/salisbury-bancorp-nasdaqsal-coverage-initiated-at-stocknews-com-3.html,2023-07-08 05:06:42,"Equities research analysts at StockNews.com began coverage on shares of Salisbury Bancorp ( NASDAQ:SAL - Free Report ) in a research report issued on Saturday. The firm set a ""hold"" rating on the bank's stock. Shares of Salisbury Bancorp stock opened at $23.21 on Friday.",PFE,0.066598,0.163036,Somewhat-Bullish
Spectrum Pharmaceuticals  ( NASDAQ:SPPI )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/spectrum-pharmaceuticals-nasdaqsppi-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-07-08 05:06:42,"Equities researchers at StockNews.com assumed coverage on shares of Spectrum Pharmaceuticals ( NASDAQ:SPPI - Free Report ) in a note issued to investors on Saturday. The brokerage set a ""hold"" rating on the biotechnology company's stock.",PFE,0.059935,0.052453,Neutral
Vascular Biogenics  ( NASDAQ:VBLT )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/vascular-biogenics-nasdaqvblt-earns-sell-rating-from-analysts-at-stocknews-com.html,2023-07-08 05:06:41,"Equities research analysts at StockNews.com began coverage on shares of Vascular Biogenics ( NASDAQ:VBLT - Free Report ) in a research note issued to investors on Saturday. The brokerage set a ""sell"" rating on the biopharmaceutical company's stock. Shares of Vascular Biogenics stock opened at ...",PFE,0.092213,0.040218,Neutral
SigmaTron International  ( NASDAQ:SGMA )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/sigmatron-international-nasdaqsgma-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 05:06:41,"Equities research analysts at StockNews.com assumed coverage on shares of SigmaTron International ( NASDAQ:SGMA - Free Report ) in a note issued to investors on Saturday. The firm set a ""sell"" rating on the technology company's stock. NASDAQ:SGMA opened at $3.07 on Friday.",PFE,0.081276,0.11426,Neutral
MediciNova  ( NASDAQ:MNOV )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/medicinova-nasdaqmnov-now-covered-by-analysts-at-stocknews-com.html,2023-07-08 05:06:41,"Investment analysts at StockNews.com started coverage on shares of MediciNova ( NASDAQ:MNOV - Free Report ) in a note issued to investors on Saturday. The brokerage set a ""hold"" rating on the biopharmaceutical company's stock. NASDAQ:MNOV opened at $2.40 on Friday.",PFE,0.080458,0.113358,Neutral
LightPath Technologies  ( NASDAQ:LPTH )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/lightpath-technologies-nasdaqlpth-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-08 05:06:41,"StockNews.com assumed coverage on shares of LightPath Technologies ( NASDAQ:LPTH - Free Report ) in a report released on Saturday. The firm set a ""hold"" rating on the technology company's stock.",PFE,0.077593,0.063713,Neutral
Strattec Security  ( NASDAQ:STRT )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/08/strattec-security-nasdaqstrt-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-07-08 05:06:41,"Stock analysts at StockNews.com started coverage on shares of Strattec Security ( NASDAQ:STRT - Free Report ) in a research note issued on Saturday. The firm set a ""hold"" rating on the auto parts company's stock.",PFE,0.075161,0.120147,Neutral
StockNews.com Begins Coverage on Northern Technologies International  ( NASDAQ:NTIC ) ,https://www.defenseworld.net/2023/07/08/stocknews-com-begins-coverage-on-northern-technologies-international-nasdaqntic.html,2023-07-08 05:06:41,"Stock analysts at StockNews.com began coverage on shares of Northern Technologies International ( NASDAQ:NTIC - Free Report ) in a research report issued to clients and investors on Saturday. The firm set a ""hold"" rating on the specialty chemicals company's stock.",PFE,0.0699,-0.036946,Neutral
"From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs - Astellas Pharma  ( OTC:ALPMY ) , BELLUS Health  ( NASDAQ:BLU ) ",https://www.benzinga.com/general/biotech/23/07/33150126/from-ai-to-obesity-drugs-global-pharma-has-700b-for-m-a-and-investments-goldman-sachs,2023-07-07 17:18:25,Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as patents for some of the industry's blockbuster drugs are on the expiration cliff.,PFE,0.19661,0.071598,Neutral
Novavax's  ( NVAX )  COVID Jab Gets Full Approval in Europe,https://www.zacks.com/stock/news/2118223/novavaxs-nvax-covid-jab-gets-full-approval-in-europe,2023-07-07 16:02:00,"Novavax's (NVAX) protein-based COVID-19 vaccine, Nuvaxovid, gets full marketing authorization for COVID patients in Europe.",PFE,0.420483,0.207592,Somewhat-Bullish
Global 2000 List 2023: The Top 200,https://www.forbes.com/sites/forbesstaff/2023/07/07/forbes-global-2000-list-2023-the-top-200/,2023-07-07 15:45:31,"Two years after the start of the pandemic, Covid casualties like airlines and oil producers have reclaimed top spots among the largest companies in the world.",PFE,0.010247,0.0,Neutral
Antibiotic Shortage Could Worsen Syphilis Epidemic,https://www.nytimes.com/2023/07/07/health/syphilis-epidemic-antibiotic-shortage-pfizer.html,2023-07-07 14:30:09,"The primary drug used to treat the sexually transmitted infection could be scarce into next year, Pfizer warns.",PFE,0.199859,-0.025816,Neutral
"How To Earn $500 A Month From Pfizer Stock - JPMorgan Chase  ( NYSE:JPM ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/large-cap/23/07/33147824/how-to-earn-500-a-month-from-pfizer-stock,2023-07-07 13:54:14,"Shares of Pfizer Inc PFE are trading at 52-week lows as investors adjust to the company's pursuit of a candidate for a weight loss pill, marking its entry into the competitive obesity drug market. The Street responded critically. JPMorgan Chase & Co JPM analysts called the news a setback for the ...",PFE,0.373378,0.083922,Neutral
Look at the Stocks Leading the Market Now,https://www.nytimes.com/2023/07/07/business/cruise-lines-stock-market.html,2023-07-07 13:00:16,"Devastated at the height of the pandemic, cruise lines have become top performers.",PFE,0.035821,-0.029984,Neutral
Caribou Biosciences  ( CRBU )  Soars on $25M Investment by Pfizer,https://www.zacks.com/stock/news/2118022/caribou-biosciences-crbu-soars-on-25m-investment-by-pfizer,2023-07-07 12:14:00,"Caribou Biosciences (CRBU) gets a major boost with a $25 million equity investment by Pfizer, which will accelerate the development of its allogeneic CAR-T cell therapy pipeline.",PFE,0.263231,0.285168,Somewhat-Bullish
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial,https://www.globenewswire.com/news-release/2023/07/07/2701007/25359/en/CytoSorbents-Completes-Enrollment-of-the-STAR-T-Pivotal-Trial.html,2023-07-07 11:07:00,"PRINCETON, N.J., July 07, 2023 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation ( NASDAQ: CTSO ) , a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that it has ...",PFE,0.028056,0.047159,Neutral
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial - CytoSorbents  ( NASDAQ:CTSO ) ,https://www.benzinga.com/pressreleases/23/07/g33145457/cytosorbents-completes-enrollment-of-the-star-t-pivotal-trial,2023-07-07 11:07:00,"PRINCETON, N.J., July 07, 2023 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation CTSO, a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that it has completed ...",PFE,0.027288,0.046015,Neutral
2 High-Yield Dividend Stocks That Billionaires Are Buying Hand Over Fist,https://www.fool.com/investing/2023/07/07/2-high-yield-dividend-stocks-that-billionaires-are/,2023-07-07 09:12:00,Some of the world's best investors can't get enough of these high-yield dividend stocks.,PFE,0.270973,0.353518,Bullish
Biotech firms target weight-loss drugs without Wegovy's side-effects,https://www.reuters.com/business/healthcare-pharmaceuticals/biotech-firms-target-weight-loss-drugs-without-wegovys-side-effects-2023-07-07/,2023-07-07 05:00:11,Biotech firms target weight-loss drugs without ...,PFE,0.03319,0.147961,Neutral
"Caribou Biosciences, Inc.  ( CRBU )  Surges 45.6%: Is This an Indication of Further Gains?",https://www.zacks.com/stock/news/2118021/caribou-biosciences-inc-crbu-surges-456-is-this-an-indication-of-further-gains,2023-07-07 03:03:00,"Caribou Biosciences, Inc. (CRBU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.",PFE,0.106541,0.167302,Somewhat-Bullish
Biologics CDMO Market to grow by USD 13.26 billion from 2022 to 2027 | Research and development pipeline of biologics therapeutics to boost the market - Technavio,https://www.prnewswire.com/news-releases/biologics-cdmo-market-to-grow-by-usd-13-26-billion-from-2022-to-2027--research-and-development-pipeline-of-biologics-therapeutics-to-boost-the-market---technavio-301870322.html,2023-07-06 23:45:00,Biologics CDMO Market to grow by USD 13.26 billion from 2022 to 2027 | Research and development pipeline of ... PR ...,PFE,0.031738,0.020383,Neutral
"FDA approves Alzheimer's drug Leqembi, paving way for broader Medicare coverage",https://www.cnbc.com/2023/07/06/fda-approves-alzheimers-drug-leqembi-from-eisai-biogen.html,2023-07-06 20:44:19,"Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding.",PFE,0.027134,0.136509,Neutral
Top Penny Stocks To Buy? 3 To Watch Before Next Week,https://pennystocks.com/featured/2023/07/06/top-penny-stocks-to-buy-3-to-watch-before-next-week/,2023-07-06 19:42:08,"With the uptick of volatility in the stock market today, there's no question as to why penny stocks are red hot. Whether the broader markets are risk-on or risk-off, the stock market is crashing or rallying, or if there's a significant global catalyst, cheap stocks are usually a topic of ...",PFE,0.122269,0.199399,Somewhat-Bullish
Check Out What Whales Are Doing With PFE - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/07/33138639/check-out-what-whales-are-doing-with-pfe,2023-07-06 19:17:06,"Someone with a lot of money to spend has taken a bullish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.684999,0.342164,Somewhat-Bullish
"Nasdaq Drops Over 100 Points; Genius Sports Shares Spike Higher - ASLAN Pharma  ( NASDAQ:ASLN ) , Caribou Biosciences  ( NASDAQ:CRBU ) ",https://www.benzinga.com/news/earnings/23/07/33138035/nasdaq-drops-over-100-points-genius-sports-shares-spike-higher,2023-07-06 18:30:21,"U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday. The Dow traded down 1.09% to 33,913.56 while the NASDAQ fell 0.96% to 13,659.77. The S&P 500, also fell, dropping, 0.87% to 4,408.14. Consumer staples shares fell by just 0.3% on ...",PFE,0.061473,0.109017,Neutral
"Crude Oil Moves Lower; ISM Services PMI Surges In June - ASLAN Pharma  ( NASDAQ:ASLN ) , Borqs Technologies  ( NASDAQ:BRQS ) ",https://www.benzinga.com/news/earnings/23/07/33136045/crude-oil-moves-lower-ism-services-pmi-surges-in-june,2023-07-06 16:04:38,"U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Thursday. The Dow traded down 1.38% to 33,814.23 while the NASDAQ fell 1.37% to 13,602.19. The S&P 500, also fell, dropping, 1.29% to 4,389.59. Consumer staples shares fell by just 0.5% on Thursday.",PFE,0.061315,0.109014,Neutral
Why Shares of Caribou Biosciences Are Skyrocketing Today,https://www.fool.com/investing/2023/07/06/why-shares-of-caribou-biosciences-are-skyrocketing/,2023-07-06 15:54:56,The company's shares spiked after Pfizer bought $25 million of Caribou stock.,PFE,0.597963,0.431284,Bullish
Pfizer makes equity investment in Caribou Biosciences,https://www.reuters.com/markets/deals/pfizer-makes-equity-investment-caribou-biosciences-2023-07-06/,2023-07-06 14:52:00,"July 6 ( Reuters ) - Pfizer ( PFE.N ) has invested $25 million to buy a minority stake in Caribou Biosciences ( CRBU.O ) , making it the latest small biotechnology firm to attract the pharmaceutical giant's interest. The news lifted shares of Caribou more than 61% in early trade.",PFE,0.461699,0.247079,Somewhat-Bullish
Moderna  ( MRNA )  Initiates Rolling BLA Filing for RSV Vaccine,https://www.zacks.com/stock/news/2117581/moderna-mrna-initiates-rolling-bla-filing-for-rsv-vaccine,2023-07-06 14:38:00,"Alongside the FDA filing, Moderna (MRNA) submits similar filings in Europe and Australia, seeking approval for using its RSV vaccine in older adults aged 60 years and above.",PFE,0.266246,0.124531,Neutral
Pfizer Is Driving Caribou Biosciences Stock Higher Today: What's Going On? - Caribou Biosciences  ( NASDAQ:CRBU ) ,https://www.benzinga.com/news/23/07/33133702/pfizer-is-driving-caribou-biosciences-stock-higher-today-whats-going-on,2023-07-06 14:12:33,"Caribou Biosciences, Inc. CRBU shares are racing higher on Thursday after the company announced a $25 million equity investment from Pfizer PFE. According to the terms of a Securities Purchase Agreement dated June 29, Pfizer purchased 4,690,431 of Caribou common shares at a price of $5.33 per ...",PFE,0.566143,0.597439,Bullish
"Dow Tumbles Over 300 Points; US Jobless Claims Increase More Than Projected - ASLAN Pharma  ( NASDAQ:ASLN ) , Allarity Therapeutics  ( NASDAQ:ALLR ) ",https://www.benzinga.com/news/earnings/23/07/33133314/dow-tumbles-over-300-points-us-jobless-claims-increase-more-than-projected,2023-07-06 13:52:15,"U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday. Following the market opening Thursday, the Dow traded down 0.96% to 33,958.13 while the NASDAQ fell 1.06% to 13,645.10. The S&P 500, also fell, dropping, 0.97% to 4,403.76.",PFE,0.06515,0.109145,Neutral
Caribou Gains In Pre-market After Getting $25 Mln Equity Investment From Pfizer,https://markets.businessinsider.com/news/stocks/caribou-gains-in-pre-market-after-getting-25-mln-equity-investment-from-pfizer-1032430250,2023-07-06 13:44:51,Caribou Gains In Pre-market After Getting $25 Mln Equity Investment From ...,PFE,0.908087,0.273169,Somewhat-Bullish
"A Big Test Is Looming for Pfizer, Moderna, and Novavax",https://www.fool.com/investing/2023/07/06/big-test-is-looming-for-pfizer-moderna-and-novavax/,2023-07-06 13:00:00,Investors in these companies should brace for some potentially underwhelming results this year.,PFE,0.272181,-0.035443,Neutral
ABBV: AbbVie  ( ABBV )  vs. Pfizer  ( PFE )  - Which Pharma Stock Comes out on Top?,https://stocknews.com/news/abbv-pfe-abbvie-abbv-vs-pfizer-pfe-which-pharma-stock-comes/,2023-07-06 12:53:53,"Pharmaceutical companies are known to maintain their profit margins even during economic downturns due to inelastic demand for their products. In this piece, I evaluated two pharma stocks, AbbVie Inc. ( ABBV ) and Pfizer Inc. ( PFE ) , to determine which comes out on top.",PFE,0.37982,0.126453,Neutral
"Caribou Biosciences Announces $25 Million Equity Investment from Pfizer - Caribou Biosciences  ( NASDAQ:CRBU ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/07/g33130684/caribou-biosciences-announces-25-million-equity-investment-from-pfizer,2023-07-06 12:00:00,"-- Pfizer purchases $25 million of Caribou common shares -- -- Sriram Krishnaswami, PhD, vice president and development head, multiple myeloma, Pfizer Global Product Development, has joined Caribou's Scientific Advisory Board -- BERKELEY, Calif., July 06, 2023 ( GLOBE NEWSWIRE ) -- Caribou ...",PFE,0.233236,0.187076,Somewhat-Bullish
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer,https://www.globenewswire.com/news-release/2023/07/06/2700252/0/en/Caribou-Biosciences-Announces-25-Million-Equity-Investment-from-Pfizer.html,2023-07-06 12:00:00,"-- Pfizer purchases $25 million of Caribou common shares -- -- Sriram Krishnaswami, PhD, vice president and development head, multiple myeloma, Pfizer Global Product Development, has joined Caribou's Scientific Advisory Board ...",PFE,0.139104,0.163233,Somewhat-Bullish
The plan to dodge another tripledemic,https://www.axios.com/2023/07/06/tripledemic-covid-vaccines,2023-07-06 09:53:48,The plan to dodge another ...,PFE,0.137278,-0.021339,Neutral
China says it told the U.S. and Europe about the export controls in advance,https://www.cnbc.com/2023/07/06/china-says-it-told-us-europe-about-chip-metals-export-controls-in-advance.html,2023-07-06 08:34:43,China's Ministry of Commerce said Thursday the country told the U.S. and Europe about this week's export controls in advance.,PFE,0.193465,-0.04961,Neutral
Moderna inks deal to make mRNA medicines in China | Business,https://www.cnn.com/2023/07/06/business/china-moderna-investment-mrna-hnk-intl/index.html,2023-07-06 06:32:00,Moderna inks deal to make mRNA medicines in China ...,PFE,0.155451,0.0,Neutral
5 biggest mergers and acquisitions in the US: These deal values dwarf anything ever seen in India | The Financial Express,https://www.financialexpress.com/market/5-biggest-mergers-and-acquisitions-in-the-us-these-deal-values-dwarf-anything-ever-seen-in-india/3158254/,2023-07-06 04:49:46,5 biggest mergers and acquisitions in the US: These deal values dwarf anything ever seen in India The Financial Express ...,PFE,0.199037,0.055315,Neutral
Should investors stay and fight for green change - or divest?,https://www.ft.com/content/54750a26-1f3e-4714-9d28-b9a5e677d454,2023-07-06 03:30:38,"Socially conscious investors, employees and consumers are increasingly pushing funds to divest certain shareholdings, to address the big social problems of our time. But we have conducted research that suggests, in most cases, they would do better to retain their stakes and engage with management ...",PFE,0.043979,0.163634,Somewhat-Bullish
Moderna To Develop mRNA Vaccines in China,https://www.thedailyupside.com/moderna-to-develop-mrna-vaccines-in-china/,2023-07-05 23:12:51,"The US and China may be taking jabs at one another over trade and other stuff, but that isn't stopping Beijing from inviting an American company...",PFE,0.236972,0.093531,Neutral
Pfizer  ( PFE )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2117181/pfizer-pfe-dips-more-than-broader-markets-what-you-should-know,2023-07-05 21:45:24,"Pfizer (PFE) closed the most recent trading day at $36.46, moving -0.52% from the previous trading session.",PFE,0.617188,0.181474,Somewhat-Bullish
Prostate Cancer Global Market to Witness Upsurge in Growth at a CAGR of ~5% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/prostate-cancer-global-market-to-witness-upsurge-in-growth-at-a-cagr-of-5-by-2028--delveinsight-301869890.html,2023-07-05 21:01:00,"The prostate cancer market is anticipated to propel owing to the increasing incidence of prostate cancer around the world, the rising number of risk factors for prostate cancer, growing technological advancements in prostate cancer diagnostics, government, and non-government awareness ...",PFE,0.135347,-0.131624,Neutral
Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday,https://www.fool.com/investing/2023/07/05/why-shares-of-amneal-pharmaceuticals-are-plunging/,2023-07-05 17:23:58,The company received a complete response letter from the FDA regarding a Parkinson's disease generic therapy.,PFE,0.113062,-0.013659,Neutral
Coke Or Pepsi? Most Of Coke's Shareholders Don't Care,https://www.forbes.com/sites/sarahkeohanewilliamson/2023/07/05/coke-or-pepsi-most-of-cokes-shareholders-dont-care/,2023-07-05 14:51:56,"It would be a fair assumption that Coca-Cola shareholders also want the company to succeed in beating Pepsi - they own the stock, after all. But this assumption is wrong.",PFE,0.05339,0.161718,Somewhat-Bullish
Three Vaccines for Fall: What You Need to Know,https://www.nytimes.com/2023/07/05/health/flu-covid-rsv-vaccines.html,2023-07-05 14:10:41,"Most Americans have had one or more shots of the flu and Covid vaccines. New this year are the first shots to protect older adults from respiratory syncytial virus, a lesser-known threat whose toll in hospitalizations and deaths may rival that of flu.",PFE,0.039878,-0.036149,Neutral
Federal Officials Hatch a Three-Pronged Defense Against Another 'Tripledemic',https://www.nytimes.com/2023/07/05/health/vaccines-rsv-covid-flu.html,2023-07-05 14:08:36,"This fall, Americans will be urged to get shots against the flu, Covid and, if they're older, R.S.V.",PFE,0.180172,0.046559,Neutral
Can Eli Lilly's  ( LLY )  Continue its Ride on Obesity Drug Wave?,https://www.zacks.com/stock/news/2117034/can-eli-lillys-lly-continue-its-ride-on-obesity-drug-wave,2023-07-05 13:51:00,Lilly (LLY) continues to raise the bar on obesity drugs as latest data show that participants treated with these experimental drugs achieved mean weight reduction of up to 24%.,PFE,0.230892,0.028244,Neutral
"Top Stories Wednesday, July 5: Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry - Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/news/23/07/33114860/apple-loses-appeal-over-4g-patent-infringement-in-london-court-ai-can-drive-tsmcs-revenue-rebound-al,2023-07-05 13:23:56,"Apple Inc AAPL overstepped two telecommunications patents used in devices, including iPhones and iPads, London's Court of Appeal ruled on Tuesday, dismissing the iPhonemaker's appeal in a long-running dispute.",PFE,0.109123,0.094933,Neutral
Moderna strikes deal to develop mRNA drugs in China,https://www.cnbc.com/2023/07/05/moderna-strikes-deal-to-develop-mrna-drugs-in-china-.html,2023-07-05 13:05:53,The deal is the biotech company's first agreement with China after the Asian nation repeatedly refused to accept mRNA vaccines from U.S.-based manufacturers.,PFE,0.178459,0.023263,Neutral
Here is What to Know Beyond Why Pfizer Inc.  ( PFE )  is a Trending Stock,https://www.zacks.com/stock/news/2116867/here-is-what-to-know-beyond-why-pfizer-inc-pfe-is-a-trending-stock,2023-07-05 13:00:12,"Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",PFE,0.489394,0.147156,Neutral
Pfizer and South Korea's Samsung Biologics Ink $900M Partnership for Biosimilar Production: Details - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/07/33113476/pfizer-and-south-koreas-samsung-biologics-ink-900m-partnership-for-biosimilar-production-details,2023-07-05 12:24:54,"South Korean contract development and manufacturing organization Samsung Biologics and Pfizer Inc PFE have signed two agreements for the long-term manufacturing of Pfizer's multiproduct biosimilar portfolio, worth $897 million.",PFE,0.673107,0.247705,Somewhat-Bullish
Pfizer and Soth Korea's Samsung Biologics Ink $900M Partnership for Biosimilar Production: Details - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/07/33113476/pfizer-and-soth-koreas-samsung-biologics-ink-900m-partnership-for-biosimilar-production-details,2023-07-05 12:24:54,"South Korean contract development and manufacturing organization Samsung Biologics and Pfizer Inc PFE have signed two agreements for the long-term manufacturing of Pfizer's multiproduct biosimilar portfolio, worth $897 million.",PFE,0.673107,0.247705,Somewhat-Bullish
"NanoViricides Inc.  ( NYSE American: NNVC )  Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment - Nanoviricides  ( AMEX:NNVC ) ",https://www.benzinga.com/general/biotech/23/07/33113617/nanoviricides-inc-nyse-american-nnvc-begins-long-awaited-clinical-trials-for-its-anti-viral-nanom,2023-07-05 11:50:51,"NanoViricides NNVC is a drug development company working on a novel nanomedical treatment. It recently updated the world on the status of its long-awaited and now active trials into its lead drug candidate, NV-CoV-2.",PFE,0.137671,0.027658,Neutral
Moderna starts application process for RSV vaccine approval in older adults,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-starts-application-process-rsv-vaccine-approval-older-adults-2023-07-05/,2023-07-05 11:30:12,"July 5 ( Reuters ) - Moderna Inc ( MRNA.O ) said on Wednesday it had started the application process for its respiratory syncytial virus ( RSV ) vaccine, seeking approval to be used in older adults, with various regulators, including the United States and Europe.",PFE,0.285526,0.147751,Neutral
Small Pharma Announces Management Team Change,https://www.globenewswire.com/news-release/2023/07/05/2699421/0/en/Small-Pharma-Announces-Management-Team-Change.html,2023-07-05 11:25:00,"LONDON, July 05, 2023 ( GLOBE NEWSWIRE ) -- Small Pharma Inc. ( TSXV: DMT ) ( OTCQB: DMTTF ) ( the ""Company"" or ""Small Pharma"" ) , a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that Mr. Peter Rands, co-founder, Chief ...",PFE,0.05749,0.184998,Somewhat-Bullish
Small Pharma Announces Management Team Change - Small Pharma  ( OTC:DMTTF ) ,https://www.benzinga.com/pressreleases/23/07/g33113309/small-pharma-announces-management-team-change,2023-07-05 11:25:00,"LONDON, July 05, 2023 ( GLOBE NEWSWIRE ) -- Small Pharma Inc.",PFE,0.054732,0.184876,Somewhat-Bullish
China extends squeezed-out foreign pharmaceuticals firms an olive branch,https://www.reuters.com/business/healthcare-pharmaceuticals/china-extends-squeezed-out-foreign-pharmaceuticals-firms-an-olive-branch-2023-07-05/,2023-07-05 10:35:00,"BEIJING, July 5 ( Reuters ) - China's Commerce Minister told foreign pharmaceuticals firms they can expect ""more development opportunities"" during a roundtable on Wednesday, his ministry said, as drugmakers bemoan government procurement policies pricing them out of the market.",PFE,0.110462,0.0,Neutral
Is Moderna Heading for a Critical Moment?,https://www.fool.com/investing/2023/07/05/is-moderna-heading-for-a-critical-moment/,2023-07-05 09:30:00,Moderna predicts the coronavirus vaccine market will follow that of the flu shot.,PFE,0.12165,0.101179,Neutral
Global Nanoparticle Formulation Market 2023 to 2035: Lipid Nanoparticle Formulation is Driving Partnership Activity,https://www.prnewswire.com/news-releases/global-nanoparticle-formulation-market-2023-to-2035-lipid-nanoparticle-formulation-is-driving-partnership-activity-301869650.html,2023-07-05 01:15:00,"DUBLIN, July 4, 2023 /PRNewswire/ -- The ""Nanoparticle Formulation Market 2023-2035"" report has been added to ResearchAndMarkets.com's offering. The global nanoparticle formulation market was estimated to be worth USD 5.1 billion in 2023 and is expected to grow at compounded annual growth rate ( ...",PFE,0.04497,0.158964,Somewhat-Bullish
"A Sriracha shortage has boosted the cost of a single bottle to $70. It's cheaper to buy a share of Coca-Cola, PayPal, or Pfizer.",https://africa.businessinsider.com/markets/a-sriracha-shortage-has-boosted-the-cost-of-a-single-bottle-to-dollar70-its-cheaper/2e4z8qp,2023-07-04 11:53:02,Online prices of the popular sauce surged in recent months due to a production crunch. Huy Fong Foods - the company behind one of America's favorite condiments - has been facing a chili pepper shortage over the past year due to extreme weather conditions.,PFE,0.47379,0.370705,Bullish
"A Sriracha shortage has boosted the cost of a single bottle to $70. It's cheaper to buy a share of Coca-Cola, PayPal, or Pfizer.",https://markets.businessinsider.com/news/stocks/sriracha-sauce-shortage-cheaper-invest-sp-500-companies-2023-7,2023-07-04 11:53:00,It's Cheaper to Buy S&P 500 Stocks Than Buy a Bottle of Sriracha Sauce - Markets Insider ...,PFE,0.512596,0.398736,Bullish
Samsung Biologics unveils $920 mln manufacturing deals for Pfizer,https://www.reuters.com/business/healthcare-pharmaceuticals/samsung-biologics-unveils-920-mln-manufacturing-deals-pfizer-2023-07-04/,2023-07-04 04:03:00,Samsung Biologics unveils $920 mln manufacturing deals for ...,PFE,0.428632,0.264784,Somewhat-Bullish
Worst Stocks Of 2023's First Half: Battered Banks And Vaccine Makers,https://www.forbes.com/sites/dereksaul/2023/07/03/worst-stocks-of-2023s-first-half-battered-banks-and-vaccine-makers/,2023-07-04 00:07:46,The well's run dry for the sector thus far this year as energy prices stabilized.,PFE,0.164468,-0.034474,Neutral
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,https://www.prnewswire.com/news-releases/bispecific-antibody-clinical-trial-pipeline-appears-robust-with-250-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-301868673.html,2023-07-03 21:01:00,Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the ... PR ...,PFE,0.020404,-0.005463,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Viatris, Inc. of Class Action Lawsuit and Upcoming Deadline - VTRS",https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-viatris-inc-of-class-action-lawsuit-and-upcoming-deadline--vtrs-301869126.html,2023-07-03 19:40:00,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Viatris, Inc. of ... PR ...",PFE,0.048621,0.0,Neutral
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/07/33099551/looking-at-pfizers-recent-unusual-options-activity,2023-07-03 17:02:57,"Someone with a lot of money to spend has taken a bullish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.678102,0.340669,Somewhat-Bullish
Moderna  ( MRNA )  Submits Filing in EU for Updated COVID-19 Jab,https://www.zacks.com/stock/news/2116029/moderna-mrna-submits-filing-in-eu-for-updated-covid-19-jab,2023-07-03 13:39:00,"Moderna's (MRNA) updated COVID-19 vaccine is designed to target the XBB.1.5 sublineage. If the filing is approved in the EU, the vaccine will be made available for the fall season.",PFE,0.406526,0.236541,Somewhat-Bullish
"First US Trial Over Zantac's Alleged Cancer-Causing Properties Set For November In California - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) , Sanofi  ( NASDAQ:SNY ) ",https://www.benzinga.com/general/biotech/23/07/33093960/first-u-s-trial-over-zantacs-alleged-cancer-causing-properties-set-for-november-in-california,2023-07-03 12:50:19,"The initial U.S. court trial concerning the antacid medication Zantac is slated to commence on November 13 in a state court in California, as stated by a lawyer representing the plaintiffs. The lawsuit alleges that Zantac is responsible for causing nine different forms of cancer, including ...",PFE,0.340915,-0.165116,Somewhat-Bearish
"Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster - Fortrea Holdings Inc. - Common Stock  ( NASDAQ:FTRE ) , Laboratory Corp  ( NYSE:LH ) ",https://www.benzinga.com/pressreleases/23/07/g33094737/fortrea-launches-as-leading-global-contract-research-organization-positioned-to-bring-life-changin,2023-07-03 11:05:44,"Company completes spin-off from Labcorp and begins trading on Nasdaq under ticker ""FTRE"" Independent company positioned to capitalize on growth opportunities in phases I-IV clinical trials and patient access, and to extend leading positions in oncology, clinical pharmacology and partnership models",PFE,0.039811,0.0,Neutral
"Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster",https://www.globenewswire.com/news-release/2023/07/03/2698448/0/en/Fortrea-Launches-as-Leading-Global-Contract-Research-Organization-Positioned-to-Bring-Life-Changing-Therapies-to-Patients-Faster.html,2023-07-03 11:05:00,Company completes spin-off from Labcorp and begins trading on Nasdaq under ticker ...,PFE,0.041682,-0.001966,Neutral
Here's the AI Stock Wall Street Appears to Be Most Bullish About Right Now  ( Hint: It's Not Nvidia ) ,https://www.fool.com/investing/2023/07/03/heres-the-ai-stock-wall-street-is-most-bullish-abo/,2023-07-03 09:52:00,"Move over, Nvidia. Analysts could have a new favorite AI stock.",PFE,0.065685,0.015077,Neutral
"Sosei Heptares Doses First Subject in Phase I Trial with HTL0048149, a First-in-Class GPR52 Agonist for Schizophrenia",https://www.globenewswire.com/news-release/2023/07/03/2698249/0/en/Sosei-Heptares-Doses-First-Subject-in-Phase-I-Trial-with-HTL0048149-a-First-in-Class-GPR52-Agonist-for-Schizophrenia.html,2023-07-03 00:23:00,"Tokyo, Japan and Cambridge, UK, 3 July 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , the world leader in G protein-coupled receptor ( GPCR ) focused structure-based drug design ( SBDD ) and development, announces it has dosed the first subject in a Phase I trial evaluating ...",PFE,0.048919,0.060323,Neutral
10 Stocks You Can Buy Right Now With Dividend Yields of Over 4%,https://www.fool.com/investing/2023/07/02/10-stocks-you-can-buy-right-now-with-dividend-yiel/,2023-07-02 09:50:00,Income investors could love these high-yield stocks.,PFE,0.105836,0.144586,Neutral
Musk puts temporary reading limits on Twitter to stop data scrapping,https://www.business-standard.com/world-news/musk-puts-temporary-reading-limits-on-twitter-to-stop-data-scrapping-123070200077_1.html,2023-07-02 01:23:52,"Tesla chief Elon Musk threatens to sue Microsoft for using data 'illegally' Twitter removes legacy blue ticks for thousands; all you need to know Who's Linda Yaccarino, the executive likely to replace Musk as Twitter CEO? Twitter gets new DM feature; voice and video chat to be added soon: Musk",PFE,0.340915,-0.325999,Somewhat-Bearish
Bad boys: Four dumb ways people just got caught allegedly engaging in insider trading,https://www.marketwatch.com/story/bad-boys-four-dumb-ways-people-just-got-caught-allegedly-engaging-in-insider-trading-d43a4f23,2023-07-01 19:56:00,"A Pfizer exec tipping a COVID drug's success, a cop, a man breaking into a girlfriend's laptop and investors in Trump's media group deal all are charged.",PFE,0.202028,0.265213,Somewhat-Bullish
Why Veeva Systems Is a Top Pick for Investors in 2023,https://www.fool.com/investing/2023/07/01/why-veeva-systems-is-a-top-pick-for-investors-2023/,2023-07-01 17:30:00,This leading provider of cloud-based software solutions is well-positioned to benefit from the life sciences industry's steady growth.,PFE,0.04161,0.259707,Somewhat-Bullish
US: 2 Indian-origin men charged with insider trading with Pfizer Covid meds,https://www.business-standard.com/world-news/us-2-indian-origin-men-charged-with-insider-trading-with-pfizer-covid-meds-123070100614_1.html,2023-07-01 16:35:29,"Two Indian-origin people, including a former Pfizer employee, have been charged with insider trading by federal authorities for their scheme to reap illicit profits by trading on information about the results of a COVID-19 medicine's clinical trials by the pharmaceutical giant.",PFE,0.272788,-0.006281,Neutral
1 Green Flag and 1 Red Flag for Pfizer,https://www.fool.com/investing/2023/07/01/1-green-flag-and-1-red-flag-for-pfizer/,2023-07-01 13:15:00,"Pfizer's long-term potential shows promise, but concerns exist.",PFE,0.559145,0.055118,Neutral
Pfizer Just Canned One of Its Ozempic Killers. What's Next?,https://www.fool.com/investing/2023/07/01/pfizer-just-canned-one-of-its-ozempic-killers-what/,2023-07-01 11:55:00,It's going to have quite the hard time getting a foothold in the market now.,PFE,0.261117,0.070557,Neutral
Sandoz launches rival version of AbbVie's arthritis drug Humira,https://www.reuters.com/business/healthcare-pharmaceuticals/sandoz-launches-rival-version-abbvies-arthritis-drug-humira-2023-07-01/,2023-07-01 04:20:00,Sandoz launches rival version of AbbVie's arthritis drug ...,PFE,0.141726,0.141368,Neutral
"Pfizer, European Pharma Firms Collaborate With European Commission For Future Health Emergency Preparedness - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/06/33080675/pfizer-european-pharma-firms-collaborate-with-european-commission-for-future-health-emergency-pre,2023-06-30 18:06:15,The European Commission has reportedly made arrangements with Pfizer Inc PFE and various European pharmaceutical companies to secure the capacity to produce up to 325 million vaccines annually for potential future global health crises.,PFE,0.459624,0.285208,Somewhat-Bullish
Market Rally Roars Back Toward Highs: Weekly Review,https://www.investors.com/news/stock-market-rally-roars-back-toward-highs-carnival-delta-micron-nvidia-in-focus/,2023-06-30 17:48:00,"The stock market rally ran toward 2023 highs again with broad-based gains, as many of the major indexes rebound from or near their 21-day moving averages. A number of stocks flashed buy signals, either from traditional breakouts or from pullbacks or early entries.",PFE,0.1081,0.042,Neutral
"EU secures vaccine deals with Pfizer, and others for future pandemic",https://www.business-standard.com/world-news/eu-secures-vaccine-deals-with-pfizer-and-others-for-future-pandemic-123063000972_1.html,2023-06-30 17:02:21,"The European Commission has secured deals with Pfizer and several European drugmakers to reserve capacity to make up to 325 million vaccines per year in case of a future global health emergency, it said on Friday.",PFE,0.439786,0.070827,Neutral
BioMarin  ( BMRN )  Gets FDA Nod for Hemophilia A Gene Therapy,https://www.zacks.com/stock/news/2115478/biomarin-bmrn-gets-fda-nod-for-hemophilia-a-gene-therapy,2023-06-30 14:57:00,"Following FDA's approval, BioMarin's (BMRN) Roctavian becomes the first gene therapy for treating severe hemophilia A.",PFE,0.437512,0.186412,Somewhat-Bullish
Andreas Halvorsen's Firm Curbs Roivant Sciences Stake,https://www.forbes.com/sites/gurufocus/2023/06/30/andreas-halvorsens-firm-curbs-roivant-sciences-stake/,2023-06-30 14:23:34,Viking Global reduces holding of biotech company ...,PFE,0.095327,0.176923,Somewhat-Bullish
Will Eli Lilly Stock Continue To Rise After 40% Gains In The Ongoing Inflation Shock?,https://www.forbes.com/sites/greatspeculations/2023/06/30/will-eli-lilly-stock-continue-to-rise-after-40-gains-in-the-ongoing-inflation-shock/,2023-06-30 12:00:16,"Eli Lilly stock (NYSE: LLY) currently trades at $459 per share, roughly 150% above its level in March 2021..",PFE,0.090645,0.032582,Neutral
Being Honest And Staying Humble To Win Trust,https://www.investors.com/news/management/leaders-and-success/being-honest-and-stay-humble-to-win-trust/,2023-06-30 12:00:00,Being honest and humble is a winning combination. But pulling both off can be tougher than it seems. Truth and honesty are always important.,PFE,0.233556,0.28684,Somewhat-Bullish
3 American Mutual Funds Worth Buying for Long-Term Investing,https://www.zacks.com/stock/news/2115217/3-american-mutual-funds-worth-buying-for-long-term-investing,2023-06-30 11:22:00,"Given the prevailing market conditions, it would be wise for investors to consider allocating their investments to renowned American mutual funds such as RMFEX, WSHFX and FIFAX.",PFE,0.046907,0.049196,Neutral
Analysis: New Humira rivals likely to hit US market with small discounts in July,https://www.reuters.com/business/healthcare-pharmaceuticals/new-humira-rivals-likely-hit-us-market-with-small-discounts-july-2023-06-30/,2023-06-30 10:02:24,"[1/2] Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo",PFE,0.055364,0.109856,Neutral
"Exclusive: EU to announce deal with Pfizer, others to reserve vaccines for future pandemic -source",https://www.reuters.com/business/healthcare-pharmaceuticals/eu-announce-deal-with-pfizer-others-reserve-vaccines-future-pandemic-source-2023-06-30/,2023-06-30 09:38:00,"Exclusive: EU to announce deal with Pfizer, others to reserve vaccines for future pandemic ...",PFE,0.60415,0.028378,Neutral
Pharma stares down another term without a friend in the White House,https://www.axios.com/2023/06/30/pharma-another-term-without-friend-white-house,2023-06-30 09:30:00,"Regardless of how the next year and a half shakes out, it seems increasingly likely that the pharmaceutical industry is going to have an adversary in the White House come 2025.",PFE,0.103331,0.001112,Neutral
"Insider trading bust: Covid corruption, snooping on an investment bank assistant's laptop, Trump Spac and a cop",https://www.fnlondon.com/articles/insider-trading-bust-covid-corruption-snooping-on-an-investment-bank-assistants-laptop-trump-spac-and-a-cop-20230630,2023-06-30 07:41:09,"A Pfizer exec tipping a COVID drug's success, a cop, a man breaking into a girlfriend's laptop and investors in Trump's media group deal are charged. Insider trading may seem like an easy bet to some, but it's a dumb way to lose if you get caught.",PFE,0.192694,0.219033,Somewhat-Bullish
Former Pfizer employee charged with insider trading over Paxlovid - .com,https://www.upi.com/Top_News/US/2023/06/29/pfizer-employee-charged-insider-trading-paxlovid-covid-19/5311688083757/,2023-06-30 00:22:35,Former Pfizer employee charged with insider trading over Paxlovid UPI News ...,PFE,0.428632,0.092787,Neutral
Pharmaceutical Industry Overview: Top Regions  ( Updated 2023 ) ,https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/top-pharmaceutical-regions/,2023-07-19 21:15:00,"The pharmaceutical industry has a global presence, but the world's biggest markets are the US and Europe. Regions such as China and India have seen growth in recent years, but when it comes to the life science space - particularly the pharma industry - the US and Europe remain on top for ...",PFE,0.043499,0.117759,Neutral
"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio",https://www.prnewswire.com/news-releases/hypertension-market-to-accelerate-positively-estimates-delveinsight--key-companies-active-in-the-market---novartis-bayer-merck-insmed-acceleron-abbvie-alnylam--apnimed-astrazeneca-gossamer-bio-301880558.html,2023-07-19 21:01:00,"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis ... PR ...",PFE,0.024801,0.042885,Neutral
Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results,https://www.cnbc.com/2023/07/19/pfizer-group-b-strep-vaccine-for-infants-returns-strong-trial-results.html,2023-07-19 21:00:01,"Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.",PFE,0.319488,0.052722,Neutral
"Pfizer reports North Carolina pharmaceutical plant damaged by tornado, no serious injuries",https://apnews.com/article/heat-wave-arizona-flooding-climate-change-b7377765a8a0c2b1fd46107261e79e9d,2023-07-19 18:55:00,"RALEIGH, N.C. ( AP ) - A tornado heavily damaged a major Pfizer pharmaceutical plant in North Carolina on Wednesday, the latest in a string of extreme weather events plaguing the U.S. on a day when floods deluged communities in Kentucky and scorching heat smothered Phoenix and Miami.",PFE,0.176373,-0.103482,Neutral
Better Pharma Buy: Viatris vs. Pfizer,https://www.fool.com/investing/2023/07/19/better-pharma-buy-viatris-vs-pfizer/,2023-07-19 18:00:00,Both stocks look cheap today.,PFE,0.635488,0.27244,Somewhat-Bullish
Is Moderna Stock A Buy As It Eyes The Massive RSV Market?,https://www.investors.com/news/technology/mrna-stock-buy-now/,2023-07-19 17:32:00,"Moderna ( MRNA ) is making progress in its efforts to rival Pfizer ( PFE ) and GSK ( GSK ) with a respiratory syncytial virus vaccine this fall, but Moderna stock remains far off its 2021 peak.",PFE,0.199037,-0.10249,Neutral
Insider-Trading Horror Stories: The Covid-19 Files,https://www.forbes.com/sites/brucebrumberg/2023/07/19/insider-trading-horror-stories-the-covid-19-files/,2023-07-19 16:40:52,Recent SEC actions and federal criminal indictments for alleged insider trading during the pandemic offer jolting lessons in securities law for us all.,PFE,0.177584,0.106619,Neutral
"Jnana Therapeutics Appoints George Vratsanos, M.D., as Chief Medical Officer and Head of R&D",https://www.benzinga.com/pressreleases/23/07/g33281406/jnana-therapeutics-appoints-george-vratsanos-m-d-as-chief-medical-officer-and-head-of-r-d,2023-07-19 11:00:00,"BOSTON, July 19, 2023 ( GLOBE NEWSWIRE ) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced the appointment of George Vratsanos, M.D., F.A.C.R., to chief ...",PFE,0.065685,0.121503,Neutral
5 Beaten-Down Healthcare Stocks With Potential for a Rebound,https://www.barrons.com/articles/bargain-healthcare-stocks-rebound-f2c744a9,2023-07-19 07:31:00,"Investors have fled healthcare stocks this year, ducking out of a trade that seemed a smart defensive play last year, as market conditions have changed. Fear of a recession has eased and interest rates have climbed, making the pull of big pharma's steady dividends less potent.",PFE,0.304114,0.124079,Neutral
"Pfizer, Flagship Pioneering Invest $100M In New Pipeline Of Innovative Drugs - What's On The Cards? - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/markets/equities/23/07/33268063/pfizer-flagship-pioneering-invest-100m-in-new-pipeline-of-innovative-drugs-whats-on-the-cards,2023-07-18 15:43:36,"Pfizer, Inc. PFE inked a pact with life sciences venture capital firm Flagship Pioneering to invest $100 million in developing ten single-asset programs targeting diseases with limited treatment options.",PFE,0.737032,0.334405,Somewhat-Bullish
"Sanofi  ( SNY ) , AstraZeneca's RSV Antibody Gets FDA Nod in Infants",https://www.zacks.com/stock/news/2123163/sanofi-sny-astrazenecas-rsv-antibody-gets-fda-nod-in-infants,2023-07-18 15:24:00,"Following FDA approval, Sanofi (SNY)/AstraZeneca's (AZN) Beyfortus is the first RSV antibody approved to protect all infants. The companies plan to make it available ahead of the upcoming RSV season.",PFE,0.187705,0.047751,Neutral
What's in Store for Thermo Fisher  ( TMO )  in Q2 Earnings?,https://www.zacks.com/stock/news/2123161/whats-in-store-for-thermo-fisher-tmo-in-q2-earnings,2023-07-18 15:23:00,"Thermo Fisher (TMO) is likely to have generated growth in the second quarter, driven by a favorable business mix and new launches.",PFE,0.037622,0.113424,Neutral
"Meet the $1 billion water-recycling startup helping the likes of Coca-Cola, BMW, and TSMC curb their usage and clamp down on pollution",https://www.businessinsider.com/gradiant-water-startup-helps-businesses-recycle-water-2023-7,2023-07-18 13:30:51,Gradiant: $1 billion startup helping corporate giants curb water usage - Business Insider ...,PFE,0.037155,0.0,Neutral
Stagwell's  ( STGW )  Constellation Network Acquires Fast-Growing Tinsel Experiential Design,https://www.prnewswire.com/news-releases/stagwells-stgw-constellation-network-acquires-fast-growing-tinsel-experiential-design-301879703.html,2023-07-18 12:30:00,"Women and Minority-Led Business Grew Tenfold in the Last Three Years NEW YORK, July 18, 2023 /PRNewswire/ -- Stagwell ( NASDAQ: STGW ) , the challenger network built to transform marketing, has acquired Tinsel Experiential Design ( Tinsel ) , a marketing and design studio focused on immersive ...",PFE,0.057767,0.158994,Somewhat-Bullish
"SARS-CoV-2 Is Not Done Yet - Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19? - Merck & Co  ( NYSE:MRK ) , Gilead Sciences  ( NASDAQ:GILD ) ",https://www.benzinga.com/general/biotech/23/07/33264588/sars-cov-2-is-not-done-yet-could-this-new-drug-in-clinical-trials-be-the-safest-option-for-treati,2023-07-18 12:07:40,"SARS-CoV-2 is not done yet - Although it is not grabbing as many headlines, the number of deaths arestill greater than even a pandemic influenza year at last count.",PFE,0.106541,0.042105,Neutral
Tactile Medical Appoints Sherri Ferstler as Senior Vice President of Sales,https://www.globenewswire.com/news-release/2023/07/18/2706337/0/en/Tactile-Medical-Appoints-Sherri-Ferstler-as-Senior-Vice-President-of-Sales.html,2023-07-18 12:00:00,"MINNEAPOLIS, July 18, 2023 ( GLOBE NEWSWIRE ) -- Tactile Systems Technology, Inc. ( ""Tactile Medical"" ) ( Nasdaq: TCMD ) , a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Sherri Ferstler to the position of Senior Vice ...",PFE,0.049221,0.068304,Neutral
"Pfizer, Flagship Pioneering to invest $100 mln for drug discovery",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-flagship-pioneering-invest-100-mln-drug-discovery-2023-07-18/,2023-07-18 11:06:00,July 18 ( Reuters ) - U.S. drugmaker Pfizer ( PFE.N ) and venture capital firm Flagship Pioneering on Tuesday agreed to invest $100 million to discover and develop 10 new potential drugs targeting diseases with few or no treatment options.,PFE,0.586747,0.253704,Somewhat-Bullish
"ACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer",https://www.globenewswire.com/news-release/2023/07/18/2706277/0/en/ACELYRIN-INC-Appoints-Ken-Lock-as-Chief-Commercial-Officer.html,2023-07-18 11:00:00,Accomplished global leader brings 20 years of immunology sales and marketing expertise.,PFE,0.048919,0.090139,Neutral
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2122390/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-07-17 21:45:22,"Pfizer (PFE) closed at $35.86 in the latest trading session, marking a -1.27% move from the prior day.",PFE,0.629492,0.329455,Somewhat-Bullish
2 Stocks I'm Buying on the Dip This Week,https://www.fool.com/investing/2023/07/17/2-stocks-im-buying-on-the-dip-this-week/,2023-07-17 21:03:00,Caribou Biosciences and AT&T screen as incredible bargains for patient investors.,PFE,0.067536,0.079366,Neutral
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/07/33255039/this-is-what-whales-are-betting-on-pfizer,2023-07-17 19:01:18,"A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer PFE we detected 15 strange trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and ...",PFE,0.661658,0.055482,Neutral
F.D.A. Approves R.S.V. Shot for Infants,https://www.nytimes.com/2023/07/17/health/rsv-infants-fda.html,2023-07-17 18:07:34,The respiratory virus is a global killer of babies and young children.,PFE,0.351807,0.022848,Neutral
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season,https://apnews.com/article/rsv-babies-drug-fda-19fd0b16d0ff078b9ec50e0f2a1d041b,2023-07-17 17:08:00,WASHINGTON ( AP ) - U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.,PFE,0.175221,0.027679,Neutral
Pfizer Canada and the Skin Spectrum Summit announce a new scholarship to improve dermatological care for racialized Canadians,https://www.newswire.ca/news-releases/pfizer-canada-and-the-skin-spectrum-summit-announce-a-new-scholarship-to-improve-dermatological-care-for-racialized-canadians-837855067.html,2023-07-17 16:00:00,Pfizer Canada and the Skin Spectrum Summit announce a new scholarship to improve dermatological care for ... Canada ...,PFE,0.334762,0.472749,Bullish
Investors Heavily Search Pfizer Inc.  ( PFE ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2121999/investors-heavily-search-pfizer-inc-pfe-here-is-what-you-need-to-know,2023-07-17 13:00:10,"Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",PFE,0.491255,0.120088,Neutral
BridgeBio Pharma Shares Are Shooting Higher Today - Here's Why - BridgeBio Pharma  ( NASDAQ:BBIO ) ,https://www.benzinga.com/general/biotech/23/07/33245855/bridgebio-pharma-shares-are-shooting-higher-today-heres-why,2023-07-17 12:31:35,"BridgeBio Pharma Inc BBIO released results from ATTRibute-CM Phase 3 study of acoramidis in transthyretin amyloid cardiomyopathy, or ATTR-CM.",PFE,0.318897,0.380546,Bullish
Positive Topline Data Reported from argenx's ADHERE Study of VYVGART® Hytrulo with Halozyme's ENHANZE® Drug Delivery Technology in Patients with Chronic Inflammatory Demyelinating Polyneuropathy,https://www.prnewswire.com/news-releases/positive-topline-data-reported-from-argenxs-adhere-study-of-vyvgart-hytrulo-with-halozymes-enhanze-drug-delivery-technology-in-patients-with-chronic-inflammatory-demyelinating-polyneuropathy-301878178.html,2023-07-17 05:15:00,Positive Topline Data Reported from argenx's ADHERE Study of VYVGART® Hytrulo with Halozyme's ENHANZE ... PR ...,PFE,0.07423,0.128286,Neutral
2 Nasdaq Stocks That Could Soar This Week,https://www.fool.com/investing/2023/07/16/2-nasdaq-stocks-that-could-soar-this-week/,2023-07-17 00:00:00,BridgeBio Pharma and Roivant Sciences could make big moves this week.,PFE,0.257668,0.080301,Neutral
3 Dividend Growth Stocks to Buy and Hold,https://www.fool.com/investing/2023/07/16/3-dividend-growth-stocks-to-buy-and-hold/,2023-07-16 10:15:00,Where these dividends are going is even more important than where they've been.,PFE,0.308407,0.378318,Bullish
2 Supercharged Growth Stocks That Could Make You Richer,https://www.fool.com/investing/2023/07/15/2-supercharged-growth-stocks-that-could-make-you-r/,2023-07-15 19:45:00,These two companies could disrupt healthcare on a global scale.,PFE,0.060848,-0.081075,Neutral
"""Rule Breaker Investing"" Market Cap Game Show: A Battle of Wits",https://www.fool.com/investing/2023/07/15/rule-breaker-investing-market-cap-game-show-a-batt/,2023-07-15 13:30:00,"Sometimes you know the market cap, sometimes you're just guessing.",PFE,0.013027,0.130407,Neutral
"Weight Loss Supplement Market to grow by USD 2,066.13 million from 2022 to 2027 | Abbott Laboratories, Ajinomoto Co. Inc., Amway Corp., and more to emerge as key players- Technavio",https://www.prnewswire.com/news-releases/weight-loss-supplement-market-to-grow-by-usd-2-066-13-million-from-2022-to-2027--abbott-laboratories-ajinomoto-co-inc-amway-corp-and-more-to-emerge-as-key-players--technavio-301876882.html,2023-07-14 23:45:00,"Weight Loss Supplement Market to grow by USD 2,066.13 million from 2022 to 2027 | Abbott Laboratories, Ajinomoto ... PR ...",PFE,0.054175,0.104854,Neutral
US FTC seeks additional info on Pfizer's proposed takeover of Seagen,https://www.reuters.com/markets/deals/us-ftc-seeks-additional-info-pfizers-proposed-takeover-seagen-2023-07-14/,2023-07-14 21:37:18,US FTC seeks additional info on Pfizer's proposed takeover of ...,PFE,0.729067,-0.353382,Bearish
Pfizer's COVID-19 Pill Paxlovid Underutilized in Nursing Homes Despite Proven Efficacy - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/07/33233861/pfizers-covid-19-pill-paxlovid-underutilized-in-nursing-homes-despite-proven-efficacy,2023-07-14 18:40:22,"Elderly and frail nursing home residents, who could have significantly benefited from antiviral treatments for COVID-19, received inadequate amounts of the medication following their coronavirus infections, even when Pfizer Inc's PFE Paxlovid pill was readily available.",PFE,0.327366,-0.063471,Neutral
Why Eli Lilly Stock Is Rising Today,https://www.fool.com/investing/2023/07/14/why-eli-lilly-stock-is-rising-today/,2023-07-14 16:43:36,An acquisition in the lucrative weight loss market is sparking a rally in the drugmaker's shares today.,PFE,0.131643,-0.004769,Neutral
Roivant  ( ROIV )  Up on Reports of Colitis Drug Sale to Roche,https://www.zacks.com/stock/news/2121419/roivant-roiv-up-on-reports-of-colitis-drug-sale-to-roche,2023-07-14 15:02:00,"Roivant's (ROIV) RVT-3101, a once-monthly subcutaneously administered anti-TL1A antibody, is being developed for ulcerative colitis and Crohn's disease ...",PFE,0.359014,0.191006,Somewhat-Bullish
Roche Could Pay $7 Billion For One Drug. Its Owner Just Surged.,https://www.investors.com/news/technology/roiv-stock-surges-as-roche-reportedly-mulls-a-deal/,2023-07-14 13:57:00,ROIV Stock Surges As Roche Reportedly Mulls A $7 Billion Deal Investor's Business Daily ...,PFE,0.456884,0.015009,Neutral
Roche Could Take A Page Out Of Merck's Playbook. Why Another Stock Surged.,https://www.investors.com/roiv-stock-surges-as-roche-reportedly-mulls-a-deal/,2023-07-14 13:57:00,ROIV Stock Surges As Roche Reportedly Mulls A $7 Billion Deal Investor's Business Daily ...,PFE,0.279813,0.107115,Neutral
Caribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested $25M - Caribou Biosciences  ( NASDAQ:CRBU ) ,https://www.benzinga.com/general/biotech/23/07/33228917/caribou-biosciences-raises-125m-via-equity-just-one-week-after-pfizer-invested-25m,2023-07-14 13:27:59,"Caribou Biosciences Inc CRBU reported long-term follow-up data from the dose escalation portion of the ongoing ANTLER Phase 1 trial of CB-010, an allogeneic anti-CD19 CAR-T cell therapy for relapsed or refractory B cell non-Hodgkin lymphoma ( r/r B-NHL ) .",PFE,0.228073,0.0,Neutral
Caribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested $25M,https://markets.businessinsider.com/news/stocks/caribou-biosciences-raises-125m-via-equity-just-one-week-after-pfizer-invested-25m-1032447513,2023-07-14 13:27:59,Caribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested ...,PFE,0.120431,0.0,Neutral
"Republican Presidential Candidate Vivek Ramaswamy Founded Roivant In Discussions With Roche For $7B Stomach Disease ( s )  Drug Deal - Roche Holding  ( OTC:RHHBF ) , Roche Holding  ( OTC:RHHVF ) , Roche Holding  ( OTC:RHHBY ) , Roivant Sciences  ( NASDAQ:ROIV ) ",https://www.benzinga.com/general/biotech/23/07/33227551/republican-presidential-candidate-vivek-ramaswamy-founded-roivant-in-discussions-with-roche-for-7,2023-07-14 12:55:28,"Roivant Sciences Ltd ROIV, a biotech company founded by Vivek Ramaswamy, a Republican presidential candidate, is reportedly in discussions with Roche Holdings AG RHHBY regarding the potential sale of an experimental drug for a debilitating stomach disease.",PFE,0.312158,-0.059608,Neutral
2 Best Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/07/14/2-best-biotech-stocks-to-buy-right-now/,2023-07-14 12:50:00,These two pharmaceutical titans look like convincing buys for income investors.,PFE,0.314017,0.212918,Somewhat-Bullish
"3 Reasons to Buy Viatris Stock, and 1 Reason to Sell",https://www.fool.com/investing/2023/07/14/3-reasons-to-buy-viatris-and-1-reason-to-sell/,2023-07-14 11:45:00,This drugmaker could be a great stock to own over the coming years.,PFE,0.050359,0.039832,Neutral
"Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio",https://www.prnewswire.com/news-releases/vaccine-research-market-to-grow-at-a-cagr-of-9-88-from-2022-to-2027--abbott-laboratories-astellas-pharma-inc-astrazeneca-plc-more-to-emerge-as-key-players--technavio-301876877.html,2023-07-14 11:01:00,"Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc ... PR ...",PFE,0.068112,0.088244,Neutral
This Emerging Market Could Be the Next Big Thing in Biotech,https://www.fool.com/investing/2023/07/14/this-emerging-market-could-be-the-next-big-thing-i/,2023-07-14 10:55:00,Medicines to treat the many symptoms of long COVID are in high demand already.,PFE,0.050465,0.326679,Somewhat-Bullish
Caribou's cell therapy shows promise in early-stage cancer study,https://www.reuters.com/business/healthcare-pharmaceuticals/caribous-cell-therapy-shows-promise-early-stage-cancer-study-2023-07-13/,2023-07-13 20:11:00,"July 13 ( Reuters ) - Caribou Biosciences Inc ( CRBU.O ) said on Thursday its experimental CAR T-cell therapy helped clear all signs or decrease tumor size in 94% of patients being treated for a type of cancer in the lymph nodes in a small, early-stage trial.",PFE,0.135347,0.011324,Neutral
Biden administration to provide free Covid vaccines to uninsured Americans this fall through end of 2024,https://www.cnbc.com/2023/07/13/biden-hhs-to-provide-free-covid-vaccines-for-uninsured-through-2024.html,2023-07-13 18:35:49,The HHS program aims to maintain broad access to Covid shots and treatments after the federal government shifts those products to the commercial market.,PFE,0.142565,0.0,Neutral
Get Ready For A Slew Of New Weight-Loss Drugs,https://www.investors.com/news/technology/weight-loss-drugs-to-watch-rivals-ramp-up-to-unseat-the-undisputed-leaders/,2023-07-13 17:37:00,Weight Loss Drugs To Watch: New Rivals Are Ramping Up To Unseat The Undisputed Leaders Investor's Business Daily ...,PFE,0.094125,0.044119,Neutral
FDA approves first over-the-counter birth-control pill,https://www.marketwatch.com/story/perrigos-stock-soars-6-after-fda-approves-its-over-the-counter-daily-oral-contraceptive-ba9ff947,2023-07-13 16:55:00,"Pill will be available at retail stores across the country early next year, but affordability and insurance coverage are still in question.",PFE,0.053629,0.141725,Neutral
"Biden administration asks Pfizer, Moderna and Novavax for 'reasonable' prices on updated Covid vaccines",https://www.cnbc.com/2023/07/13/updated-covid-vaccines-should-have-reasonable-prices-hhs.html,2023-07-13 16:43:37,"Pfizer, Moderna and Novavax have not disclosed the exact pricing of their new vaccines, which will target the circulating omicron subvariant XBB.1.5.",PFE,0.339745,0.214718,Somewhat-Bullish
Undervalued And Unsexy: 6 Bargain Stocks In Industrials And Healthcare,https://www.forbes.com/sites/jessicanix/2023/07/13/undervalued-and-unsexy-6-bargain-stocks-in-industrials-and-healthcare/,2023-07-13 15:23:38,Tech companies like Apple and Meta are crushing it on Wall Street. But the next wave of strong returns may come from stocks like Deere and Cigna.,PFE,0.07887,-0.028813,Neutral
Looking Into Pfizer's Recent Short Interest - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/short-sellers/23/07/33217124/looking-into-pfizers-recent-short-interest,2023-07-13 14:30:37,"Pfizer's PFE short percent of float has risen 7.14% since its last report. The company recently reported that it has 59.51 million shares sold short, which is 1.05% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.85 days to cover their ...",PFE,0.224903,0.158881,Somewhat-Bullish
US health department asks for 'reasonable' prices on updated COVID shots,https://www.reuters.com/business/healthcare-pharmaceuticals/us-health-department-asks-reasonable-prices-updated-covid-shots-2023-07-13/,2023-07-13 13:42:00,"July 13 ( Reuters ) - Updated COVID-19 shots expected to enter the market this fall should be priced at a reasonable rate, the U.S. Department of Health and Human Services ( HHS ) said on Thursday, in a letter addressed to COVID vaccine manufacturers.",PFE,0.255641,0.041717,Neutral
2 Magnificient Growth Stocks to Buy in July,https://www.fool.com/investing/2023/07/13/2-magnificient-growth-stocks-to-buy-in-july/,2023-07-13 13:30:00,These two growth stocks might be incredibly undervalued right now.,PFE,0.066784,0.02115,Neutral
"Biotech Stock Roundup: BIIB, Eisai's Drug Update, NVAX Gains on Deal Amendment",https://www.zacks.com/stock/news/2120702/biotech-stock-roundup-biib-eisais-drug-update-nvax-gains-on-deal-amendment,2023-07-13 13:22:00,Regulatory and key pipeline updates from Biogen (BIIB) and Novavax (NVAX) are in focus in the biotech sector.,PFE,0.15347,0.153248,Somewhat-Bullish
3 Healthcare Stocks With Healthy Dividends,https://www.fool.com/investing/2023/07/13/3-healthcare-stocks-with-healthy-dividends/,2023-07-13 13:05:00,These pharmaceutical companies all combine relatively high dividends with safe payout ratios.,PFE,0.384233,0.018722,Neutral
Chamber of Commerce asks judge to block Medicare drug price negotiations before October 1,https://www.cnbc.com/2023/07/12/chamber-of-commerce-asks-judge-to-block-medicare-drug-negotiations.html,2023-07-12 21:10:11,The U.S. Chamber of Commerce asked a judge to block the landmark ability of Medicare to negotiate drug prices.,PFE,0.303175,0.311275,Somewhat-Bullish
Novo Nordisk  ( NVO )  Falls on EMA Safety Review of Obesity Drugs,https://www.zacks.com/stock/news/2119748/novo-nordisk-nvo-falls-on-ema-safety-review-of-obesity-drugs,2023-07-12 11:57:00,Novo Nordisk's (NVO) important diabetes care and obesity drugs are under review by the EMA's safety committee for the risk of suicidal behavior with its use. The stock falls 3%.,PFE,0.221212,0.288341,Somewhat-Bullish
"Billionaire Ken Fisher Says Today's ""Doom and Gloom"" Is a Bullish Sign. Here Are the Stocks He's Betting On.",https://www.fool.com/investing/2023/07/12/billionaire-ken-fisher-says-todays-doom-and-gloom/,2023-07-12 09:30:00,"The rally may be far from over, Fisher says.",PFE,0.172507,0.079201,Neutral
"European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) , Amgen  ( NASDAQ:AMGN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/07/33192661/european-regulator-expands-ozempic-probe-to-include-other-weight-loss-drugs-over-suicide-risks,2023-07-12 02:33:47,"On Tuesday, the European Union's drug regulator expanded its investigation into the risk of suicidal thoughts and self-injury among patients taking weight loss and diabetes medications, including those produced by Novo Nordisk NVO.",PFE,0.210274,0.0,Neutral
Free Slurpee NFTs Served Up by 7-Eleven,https://decrypt.co/148232/7-eleven-slurpee-vibe-nft-solana,2023-07-12 02:08:22,The 'Find Your Slurpee Vibe' Polygon collectible represents the latest snack food brand to enter Web3.,PFE,0.099066,0.136962,Neutral
Pfizer  ( PFE )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2119497/pfizer-pfe-outpaces-stock-market-gains-what-you-should-know,2023-07-11 21:45:21,"In the latest trading session, Pfizer (PFE) closed at $36.02, marking a +0.95% move from the previous day.",PFE,0.558244,0.320573,Somewhat-Bullish
Sickle Cell Disease Clinical Trial Pipeline Accelerates as 40+ Pharma Companies Rigorously Developing Drugs for the Market Entry,https://www.prnewswire.com/news-releases/sickle-cell-disease-clinical-trial-pipeline-accelerates-as-40-pharma-companies-rigorously-developing-drugs-for-the-market-entry-301873885.html,2023-07-11 21:01:00,Sickle Cell Disease Clinical Trial Pipeline Accelerates as 40+ Pharma Companies Rigorously Developing Drugs for the ... PR ...,PFE,0.088964,0.053975,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Viatris, Inc. of Class Action Lawsuit and Upcoming Deadline - VTRS",https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-viatris-inc-of-class-action-lawsuit-and-upcoming-deadline--vtrs-301874653.html,2023-07-11 20:46:00,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Viatris, Inc. of ... PR ...",PFE,0.048621,0.0,Neutral
"EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs",https://www.cnbc.com/2023/07/11/weight-loss-drugs-eu-expands-ozempic-probe-over-suicide-risks.html,2023-07-11 20:13:20,"The European Medicines Agency didn't specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli Lilly's Mounjaro.",PFE,0.067727,0.06414,Neutral
Is This a Good Sign for Novavax?,https://www.fool.com/investing/2023/07/11/is-this-a-good-sign-for-novavax/,2023-07-11 18:30:00,The stock soared 30% in one trading session this week.,PFE,0.057628,0.094207,Neutral
EU regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harm,https://www.marketwatch.com/story/eu-medicines-regulator-is-reviewing-weight-loss-drugs-ozempic-and-wegovy-for-risk-of-suicidal-thoughts-and-self-harm-e24036e3,2023-07-11 18:20:00,The European Medicines Agency is reviewing data on the popular new class of drugs used for weight loss and Type 2 diabetes.,PFE,0.187463,0.216357,Somewhat-Bullish
Activision Stock Jumps As U.S. Judge Clears Hurdle To Microsoft Buyout,https://www.investors.com/news/technology/activision-stock-jumps-as-judge-clears-hurdle-to-microsoft-buyout/,2023-07-11 17:43:00,Activision Blizzard ( ATVI ) shares rocketed Tuesday after a federal court allowed Microsoft ( MSFT ) to proceed with its $69 billion acquisition of the video game publisher. Activision stock surged to a two-year high on the news. U.S.,PFE,0.151539,0.067473,Neutral
Why Are NanoViricides Shares Gaining Today - Nanoviricides  ( AMEX:NNVC ) ,https://www.benzinga.com/general/biotech/23/07/33188392/why-are-nanoviricides-shares-gaining-today,2023-07-11 16:51:10,NanoViricides Inc NNVC shares are trading higher after the company reported preclinical data from an antiviral clinical drug candidate for Respiratory Syncytial Virus ( RSV ) .,PFE,0.338582,-0.137041,Neutral
The Damaging Report That Sent The Weight-Loss Kingpins Into A Dive,https://www.investors.com/news/technology/eli-lilly-stock-and-its-key-rival-skid-on-a-damaging-report-for-weight-loss-drugs/,2023-07-11 16:22:00,Eli Lilly Stock And Its Key Rival Skid On A Damaging Report For Weight Loss Drugs Investor's Business Daily ...,PFE,0.063425,-0.133108,Neutral
Few patients continue weight loss drugs like Wegovy after a year - but health costs soar for all,https://www.cnbc.com/2023/07/11/weight-loss-drugs-few-patients-continue-wegovy-after-a-year.html,2023-07-11 16:12:58,"The analysis from Prime Therapeutics highlights the hefty price tag of Wegovy and other weight loss and diabetes medicines, which are also known as GLP-1s.",PFE,0.065506,-0.073083,Neutral
"Unemployment Data, Social Media Happenings, and Stocks to Watch",https://www.fool.com/investing/2023/07/10/unemployment-data-social-media-happenings-and-stoc/,2023-07-10 19:18:00,Vesta Real Estate and Topgolf Callaway are worth a look.,PFE,0.005561,0.046943,Neutral
PFE: Should Value Investors Watch Pfizer  ( PFE ) ?,https://stocknews.com/news/pfe-crbu-abbv-nvs-nvo-should-value-investors-watch-pfizer-pfe/,2023-07-10 17:00:01,"Major pharmaceutical corporation Pfizer Inc. ( PFE ) recently channeled $25 million into acquiring a minority interest in Caribou Biosciences, Inc. ( CRBU ) . This move aligns with previous strategies PFE has pursued over recent years, utilizing the substantial cash flow it generated from its ...",PFE,0.379147,0.100614,Neutral
What's Going On With Novavax  ( NVAX )  Stock? - Novavax  ( NASDAQ:NVAX ) ,https://www.benzinga.com/news/23/07/33168342/whats-going-on-with-novavax-nvax-stock,2023-07-10 15:42:30,"Novavax, Inc. NVAX shares are trading higher on Monday after the company announced an amendment to its Canada supply agreement, under which the Government of Canada will pay Novavax $349.6 million for forfeiting certain doses of its COVID vaccine.",PFE,0.244109,0.237502,Somewhat-Bullish
Novavax stock spikes 20% after company snags $350 million from Canada for unused Covid shots,https://www.cnbc.com/2023/07/10/novavax-stock-jumps-after-canada-agrees-to-pay-for-unused-covid-shots.html,2023-07-10 15:18:55,Canada's Covid shot settlement is a sign of hope for investors after Novavax raised doubts about its ability to stay in business earlier this year.,PFE,0.130217,0.196883,Somewhat-Bullish
GSK's RSV Vaccine Scores Approval In UK For Older Adults - GSK  ( NYSE:GSK ) ,https://www.benzinga.com/general/biotech/23/07/33163968/gsks-rsv-vaccine-scores-approval-in-uk-for-older-adults,2023-07-10 13:26:27,The U.K. Medicines and Healthcare Products Regulatory Agency ( MHRA ) has approved GSK Plc's GSK Arexvy ( respiratory syncytial virus vaccine ) for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus ( RSV ) in adults 60 years of age and ...,PFE,0.288893,0.149144,Neutral
"Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials - What Other Viruses Could This COVID Treatment Target? - Merck & Co  ( NYSE:MRK ) , Gilead Sciences  ( NASDAQ:GILD ) ",https://www.benzinga.com/general/biotech/23/07/33166416/novel-nanomedicine-platform-with-pipeline-of-antivirals-goes-to-human-trials-what-other-viruses-c,2023-07-10 13:13:14,"NanoViricides NNVC has begun trials for its new drug candidate, NV-CoV-2 - an exciting development for the biotech company, as it starts its first human trials with drug sponsor Karveer Meditech Pvt. Ltd. India, the company's licensee and co-developer in India.",PFE,0.099271,-0.045466,Neutral
Major business group slams disclosure rules as House Republicans probe ESG investing,https://www.cnbc.com/2023/07/10/national-association-of-manufacturers-esg-disclosures.html,2023-07-10 13:00:01,"House Republicans scheduled several hearings this month to probe ESG investing, which has become a big target on the right.",PFE,0.063763,-0.09406,Neutral
'Radical Reinvention' - Fearless Realignment in a Post-Covid Complex World,https://www.prnewswire.com/news-releases/radical-reinvention--fearless-realignment-in-a-post-covid-complex-world-301872300.html,2023-07-10 12:05:00,"- Former Fashion, Beauty and Health Editor of Vogue and Harper's Bazaar, Maureen Lippe, Shares Her Most Personal Journey and One-of-a-Kind Formula for Success in Debut Book - All Proceeds to Benefit Non-Profit, Step Up Women's Network",PFE,0.048327,0.097008,Neutral
Voyager Therapeutics Announces Appointment of Jacquelyn Fahey Sandell as Chief Legal Officer,https://www.globenewswire.com/news-release/2023/07/10/2701709/36461/en/Voyager-Therapeutics-Announces-Appointment-of-Jacquelyn-Fahey-Sandell-as-Chief-Legal-Officer.html,2023-07-10 12:00:00,"CAMBRIDGE, Mass., July 10, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( NASDAQ: VYGR ) , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced the appointment of Jacquelyn Fahey Sandell as Chief Legal Officer ( CLO ) .",PFE,0.046452,0.037767,Neutral
Should You Buy the First Half's Worst-Performing Sector?,https://www.fool.com/investing/2023/07/10/should-you-buy-the-worst-performing-sector/,2023-07-10 09:30:00,Healthcare stocks may not lead gains in the next bull market.,PFE,0.180685,-0.135143,Neutral
3 Beaten-Down Dividend Stocks That Look Like Bargains Right Now,https://www.fool.com/investing/2023/07/10/3-beaten-down-dividend-stocks-that-look-like-barga/,2023-07-10 09:12:00,These stocks have fallen so far over the past six months that they look like bargains that income-seeking investors don't want to pass up.,PFE,0.04794,0.165766,Somewhat-Bullish
HIVE Blockchain Technologies  ( NYSE:HIVE )  Lifted to Sell at StockNews.com,https://www.defenseworld.net/2023/07/10/hive-blockchain-technologies-nysehive-lifted-to-sell-at-stocknews-com.html,2023-07-10 08:20:43,"HIVE Blockchain Technologies ( NYSE:HIVE - Free Report ) was upgraded by equities research analysts at StockNews.com to a ""sell"" rating in a report released on Monday. HIVE stock opened at $5.53 on Monday.",PFE,0.195814,0.125789,Neutral
Espey Mfg. & Electronics  ( NYSE:ESP )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/espey-mfg-electronics-nyseesp-receives-new-coverage-from-analysts-at-stocknews-com-3.html,2023-07-10 08:20:43,"Equities researchers at StockNews.com assumed coverage on shares of Espey Mfg. & Electronics ( NYSE:ESP - Free Report ) in a report issued on Monday. The firm set a ""strong-buy"" rating on the stock. Shares of NYSE ESP opened at $16.32 on Monday.",PFE,0.154455,0.127727,Neutral
Friedman Industries  ( NYSE:FRD )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/friedman-industries-nysefrd-now-covered-by-analysts-at-stocknews-com.html,2023-07-10 08:20:42,"StockNews.com started coverage on shares of Friedman Industries ( NYSE:FRD - Free Report ) in a research note issued to investors on Monday. The brokerage set a ""hold"" rating on the stock. Shares of NYSE FRD opened at $12.69 on Monday.",PFE,0.195814,0.160913,Somewhat-Bullish
Marin Software  ( NYSE:MRIN )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/marin-software-nysemrin-receives-new-coverage-from-analysts-at-stocknews-com-5.html,2023-07-10 08:20:42,"StockNews.com started coverage on shares of Marin Software ( NYSE:MRIN - Free Report ) in a research note issued on Monday. The brokerage set a ""hold"" rating on the stock. Shares of Marin Software stock opened at $0.66 on Monday.",PFE,0.18967,0.157168,Somewhat-Bullish
"StockNews.com Upgrades Exelon  ( NYSE:EXC )  to ""Hold""",https://www.defenseworld.net/2023/07/10/stocknews-com-upgrades-exelon-nyseexc-to-hold.html,2023-07-10 08:20:41,"Exelon ( NYSE:EXC - Free Report ) was upgraded by StockNews.com from a ""sell"" rating to a ""hold"" rating in a research report issued to clients and investors on Monday. NYSE EXC opened at $40.96 on Monday.",PFE,0.21686,0.135975,Neutral
Enservco  ( NYSE:ENSV )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/10/enservco-nyseensv-now-covered-by-stocknews-com.html,2023-07-10 08:20:41,"Investment analysts at StockNews.com started coverage on shares of Enservco ( NYSE:ENSV - Free Report ) in a note issued to investors on Monday. The brokerage set a ""sell"" rating on the stock. Shares of NYSE:ENSV opened at $0.29 on Monday.",PFE,0.207571,0.171558,Somewhat-Bullish
LiqTech International  ( NYSE:LIQT )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/liqtech-international-nyseliqt-coverage-initiated-by-analysts-at-stocknews-com-2.html,2023-07-10 08:20:41,"Equities researchers at StockNews.com assumed coverage on shares of LiqTech International ( NYSE:LIQT - Free Report ) in a report released on Monday. The brokerage set a ""sell"" rating on the stock. LiqTech International stock opened at $3.21 on Monday.",PFE,0.195814,0.127492,Neutral
StockNews.com Begins Coverage on Ayala Pharmaceuticals  ( NASDAQ:ADXS ) ,https://www.defenseworld.net/2023/07/10/stocknews-com-begins-coverage-on-ayala-pharmaceuticals-nasdaqadxs.html,2023-07-10 07:54:46,StockNews.com started coverage on shares of Ayala Pharmaceuticals ( NASDAQ:ADXS - Free Report ) in a research report sent to investors on Sunday. The brokerage issued a sell rating on the stock. Shares of ADXS stock opened at $0.95 on Friday.,PFE,0.205807,0.163496,Somewhat-Bullish
StockNews.com Upgrades BlackBerry  ( NASDAQ:BB )  to Hold,https://www.defenseworld.net/2023/07/10/stocknews-com-upgrades-blackberry-nasdaqbb-to-hold.html,2023-07-10 07:54:46,StockNews.com upgraded shares of BlackBerry ( NASDAQ:BB - Free Report ) from a sell rating to a hold rating in a research report sent to investors on Sunday. BB stock opened at $4.76 on Friday. BlackBerry has a twelve month low of $3.17 and a twelve month high of $7.20.,PFE,0.165031,0.265891,Somewhat-Bullish
Chesapeake Energy  ( NYSE:CHK )  Lifted to Hold at StockNews.com,https://www.defenseworld.net/2023/07/10/chesapeake-energy-nysechk-lifted-to-hold-at-stocknews-com-2.html,2023-07-10 07:54:46,StockNews.com upgraded shares of Chesapeake Energy ( NYSE:CHK - Free Report ) from a sell rating to a hold rating in a research note released on Sunday. Shares of NYSE:CHK opened at $82.15 on Friday. Chesapeake Energy has a 1-year low of $69.68 and a 1-year high of $107.31.,PFE,0.155451,0.322108,Somewhat-Bullish
Argo Group International  ( NASDAQ:ARGO )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/argo-group-international-nasdaqargo-receives-new-coverage-from-analysts-at-stocknews-com-2.html,2023-07-10 07:54:46,StockNews.com started coverage on shares of Argo Group International ( NASDAQ:ARGO - Free Report ) in a research note published on Sunday. The brokerage issued a hold rating on the stock. Shares of ARGO stock opened at $29.65 on Friday.,PFE,0.127456,-0.069579,Neutral
Aspira Women's Health  ( NYSE:AWH )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/aspira-womens-health-nyseawh-earns-sell-rating-from-analysts-at-stocknews-com.html,2023-07-10 07:54:45,StockNews.com began coverage on shares of Aspira Women's Health ( NYSE:AWH - Free Report ) in a report published on Sunday. The brokerage issued a sell rating on the stock. NYSE:AWH opened at $3.20 on Friday. Aspira Women's Health has a 12-month low of $2.65 and a 12-month high of $16.50.,PFE,0.151539,0.148395,Neutral
Chicago Rivet & Machine  ( NYSE:CVR )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/10/chicago-rivet-machine-nysecvr-coverage-initiated-at-stocknews-com-2.html,2023-07-10 07:54:45,StockNews.com initiated coverage on shares of Chicago Rivet & Machine ( NYSE:CVR - Free Report ) in a report released on Sunday morning. The firm issued a sell rating on the stock. Shares of CVR opened at $25.00 on Friday. Chicago Rivet & Machine has a twelve month low of $23.65 and a twelve ...,PFE,0.151539,0.097552,Neutral
Oragenics  ( NYSE:OGEN )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/oragenics-nyseogen-now-covered-by-analysts-at-stocknews-com-3.html,2023-07-10 07:54:44,StockNews.com started coverage on shares of Oragenics ( NYSE:OGEN - Free Report ) in a research report released on Sunday. The firm issued a sell rating on the stock. NYSE:OGEN opened at $3.27 on Friday. Oragenics has a 12 month low of $2.60 and a 12 month high of $24.00.,PFE,0.188193,0.181573,Somewhat-Bullish
Ampio Pharmaceuticals  ( NYSE:AMPE )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/ampio-pharmaceuticals-nyseampe-earns-sell-rating-from-analysts-at-stocknews-com.html,2023-07-10 07:54:44,StockNews.com started coverage on shares of Ampio Pharmaceuticals ( NYSE:AMPE - Free Report ) in a research note released on Sunday. The brokerage issued a sell rating on the stock. AMPE stock opened at $0.25 on Friday. Ampio Pharmaceuticals has a 12-month low of $0.18 and a 12-month high of ...,PFE,0.185306,0.079417,Neutral
American Shared Hospital Services  ( NYSE:AMS )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/10/american-shared-hospital-services-nyseams-now-covered-by-stocknews-com.html,2023-07-10 07:54:44,StockNews.com initiated coverage on shares of American Shared Hospital Services ( NYSE:AMS - Free Report ) in a research report sent to investors on Sunday. The firm issued a hold rating on the stock. Shares of NYSE AMS opened at $2.54 on Friday.,PFE,0.158519,0.205266,Somewhat-Bullish
Bar Harbor Bankshares  ( NYSE:BHB )  Rating Increased to Hold at StockNews.com,https://www.defenseworld.net/2023/07/10/bar-harbor-bankshares-nysebhb-rating-increased-to-hold-at-stocknews-com.html,2023-07-10 07:54:44,StockNews.com upgraded shares of Bar Harbor Bankshares ( NYSE:BHB - Free Report ) from a sell rating to a hold rating in a research note published on Sunday. Bar Harbor Bankshares stock opened at $24.37 on Friday. Bar Harbor Bankshares has a 1-year low of $19.55 and a 1-year high of $33.11.,PFE,0.150592,0.163984,Somewhat-Bullish
International Tower Hill Mines  ( NYSE:THM )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/international-tower-hill-mines-nysethm-coverage-initiated-by-analysts-at-stocknews-com-2.html,2023-07-10 07:54:43,StockNews.com assumed coverage on shares of International Tower Hill Mines ( NYSE:THM - Free Report ) in a research note released on Sunday. The firm issued a sell rating on the stock. NYSE THM opened at $0.43 on Friday.,PFE,0.19117,0.113609,Neutral
Ashford  ( NYSE:AINC )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/10/ashford-nyseainc-coverage-initiated-at-stocknews-com.html,2023-07-10 07:54:43,StockNews.com began coverage on shares of Ashford ( NYSE:AINC - Free Report ) in a research report released on Sunday morning. The firm issued a buy rating on the stock. Ashford stock opened at $9.67 on Friday. Ashford has a 1-year low of $9.20 and a 1-year high of $19.70.,PFE,0.172097,0.133033,Neutral
OncoCyte  ( NYSE:OCX )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/10/oncocyte-nyseocx-now-covered-by-stocknews-com.html,2023-07-10 07:54:41,StockNews.com initiated coverage on shares of OncoCyte ( NYSE:OCX - Free Report ) in a research note published on Sunday. The brokerage issued a sell rating on the stock. OncoCyte stock opened at $0.23 on Friday. OncoCyte has a 1 year low of $0.20 and a 1 year high of $1.10.,PFE,0.170878,0.040339,Neutral
WidePoint  ( NYSE:WYY )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/widepoint-nysewyy-coverage-initiated-by-analysts-at-stocknews-com-3.html,2023-07-10 07:54:41,StockNews.com started coverage on shares of WidePoint ( NYSE:WYY - Free Report ) in a research note issued to investors on Sunday morning. The brokerage issued a sell rating on the stock. Shares of NYSE WYY opened at $1.85 on Friday. WidePoint has a 52-week low of $1.70 and a 52-week high of ...,PFE,0.160633,0.238611,Somewhat-Bullish
Universal Security Instruments  ( NYSE:UUU )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/universal-security-instruments-nyseuuu-now-covered-by-analysts-at-stocknews-com-5.html,2023-07-10 07:54:41,StockNews.com initiated coverage on shares of Universal Security Instruments ( NYSE:UUU - Free Report ) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the stock. NYSE:UUU opened at $2.47 on Friday.,PFE,0.158519,0.103935,Neutral
Primo Water  ( NASDAQ:PRMW )  Downgraded to Buy at StockNews.com,https://www.defenseworld.net/2023/07/10/primo-water-nasdaqprmw-downgraded-to-buy-at-stocknews-com-2.html,2023-07-10 07:54:41,StockNews.com cut shares of Primo Water ( NASDAQ:PRMW - Free Report ) from a strong-buy rating to a buy rating in a research note issued to investors on Sunday morning. Shares of NASDAQ PRMW opened at $13.10 on Friday. Primo Water has a 1 year low of $12.15 and a 1 year high of $16.47.,PFE,0.123526,0.126096,Neutral
StockNews.com Begins Coverage on Ashford  ( NYSEAMERICAN:AINC ) ,https://www.defenseworld.net/2023/07/10/stocknews-com-begins-coverage-on-ashford-nyseamericanainc.html,2023-07-10 07:26:41,"StockNews.com started coverage on shares of Ashford ( NYSEAMERICAN:AINC - Free Report ) in a report issued on Friday. The brokerage issued a buy rating on the financial services provider's stock. Separately, B. Riley cut their price objective on shares of Ashford from $15.00 to $10.00 in a ...",PFE,0.119235,0.107649,Neutral
CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr. Lara Sullivan,https://www.benzinga.com/pressreleases/23/07/g33159728/cancervax-ceo-ryan-davies-discusses-biotech-entrepreneurship-with-pyxis-oncology-ceo-dr-lara-sulli,2023-07-10 07:01:00,"LEHI, Utah, July 10, 2023 ( GLOBE NEWSWIRE ) -- CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that uses the body's immune system to fight cancer, today announced that in a recent Company podcast its CEO, Ryan Davies, and Pyxis Oncology President & CEO, Dr. Lara Sullivan, ...",PFE,0.328819,0.118708,Neutral
Comstock Resources  ( NYSE:CRK )  Upgraded to Hold by StockNews.com,https://www.defenseworld.net/2023/07/10/comstock-resources-nysecrk-upgraded-to-hold-by-stocknews-com.html,2023-07-10 05:52:41,"Comstock Resources ( NYSE:CRK - Free Report ) was upgraded by stock analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a research note issued to investors on Monday.",PFE,0.07446,0.190936,Somewhat-Bullish
StockNews.com Initiates Coverage on NeuroMetrix  ( NASDAQ:NURO ) ,https://www.defenseworld.net/2023/07/10/stocknews-com-initiates-coverage-on-neurometrix-nasdaqnuro.html,2023-07-10 05:20:49,"StockNews.com initiated coverage on shares of NeuroMetrix ( NASDAQ:NURO - Free Report ) in a research note issued to investors on Monday. The firm set a ""sell"" rating on the medical device company's stock. Shares of NURO opened at $0.92 on Monday.",PFE,0.084722,0.09866,Neutral
StockNews.com Initiates Coverage on Oncternal Therapeutics  ( NASDAQ:ONCT ) ,https://www.defenseworld.net/2023/07/10/stocknews-com-initiates-coverage-on-oncternal-therapeutics-nasdaqonct.html,2023-07-10 05:20:49,"Research analysts at StockNews.com initiated coverage on shares of Oncternal Therapeutics ( NASDAQ:ONCT - Free Report ) in a report issued on Monday. The brokerage set a ""sell"" rating on the stock.",PFE,0.056943,0.02405,Neutral
Lipocine  ( NASDAQ:LPCN )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/lipocine-nasdaqlpcn-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-10 05:20:48,"Stock analysts at StockNews.com assumed coverage on shares of Lipocine ( NASDAQ:LPCN - Free Report ) in a research note issued to investors on Monday. The brokerage set a ""buy"" rating on the specialty pharmaceutical company's stock. NASDAQ LPCN opened at $4.42 on Monday.",PFE,0.095517,0.109021,Neutral
Heska  ( NASDAQ:HSKA )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/heska-nasdaqhska-now-covered-by-analysts-at-stocknews-com.html,2023-07-10 05:20:48,"StockNews.com started coverage on shares of Heska ( NASDAQ:HSKA - Free Report ) in a research report issued on Monday. The brokerage set a ""hold"" rating on the medical research company's stock. Other equities analysts have also recently issued research reports about the stock.",PFE,0.062761,0.081153,Neutral
StockNews.com Initiates Coverage on Galectin Therapeutics  ( NASDAQ:GALT ) ,https://www.defenseworld.net/2023/07/10/stocknews-com-initiates-coverage-on-galectin-therapeutics-nasdaqgalt.html,2023-07-10 05:20:47,"Stock analysts at StockNews.com initiated coverage on shares of Galectin Therapeutics ( NASDAQ:GALT - Free Report ) in a report issued on Monday. The firm set a ""hold"" rating on the stock. Shares of NASDAQ GALT opened at $1.46 on Monday. Galectin Therapeutics has a 12 month low of $1.02 and a ...",PFE,0.088147,0.057541,Neutral
Gaia  ( NASDAQ:GAIA )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/10/gaia-nasdaqgaia-research-coverage-started-at-stocknews-com-2.html,2023-07-10 05:20:47,"Research analysts at StockNews.com began coverage on shares of Gaia ( NASDAQ:GAIA - Free Report ) in a note issued to investors on Monday. The brokerage set a ""buy"" rating on the stock. Gaia stock opened at $2.16 on Monday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.60 ...",PFE,0.081552,0.129131,Neutral
Fiserv  ( NASDAQ:FISV )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/fiserv-nasdaqfisv-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-07-10 05:20:46,"Equities research analysts at StockNews.com assumed coverage on shares of Fiserv ( NASDAQ:FISV - Free Report ) in a research note issued on Monday. The firm set a ""buy"" rating on the stock. NASDAQ:FISV opened at $114.23 on Monday. Fiserv has a one year low of $87.03 and a one year high of ...",PFE,0.093653,0.124553,Neutral
Diversified Healthcare Trust  ( NASDAQ:DHC )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/diversified-healthcare-trust-nasdaqdhc-coverage-initiated-by-analysts-at-stocknews-com.html,2023-07-10 05:20:45,"Equities researchers at StockNews.com initiated coverage on shares of Diversified Healthcare Trust ( NASDAQ:DHC - Free Report ) in a research note issued to investors on Monday. The firm set a ""sell"" rating on the real estate investment trust's stock.",PFE,0.060541,0.206658,Somewhat-Bullish
BorgWarner  ( NYSE:BWA )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/10/borgwarner-nysebwa-research-coverage-started-at-stocknews-com.html,2023-07-10 05:20:44,"Equities researchers at StockNews.com started coverage on shares of BorgWarner ( NYSE:BWA - Free Report ) in a report released on Monday. The brokerage set a ""strong-buy"" rating on the auto parts company's stock. Other equities analysts also recently issued reports about the stock. Robert W.",PFE,0.049732,0.121889,Neutral
New Concept Energy  ( NYSE:GBR )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/new-concept-energy-nysegbr-receives-new-coverage-from-analysts-at-stocknews-com-2.html,2023-07-10 05:20:44,"Research analysts at StockNews.com initiated coverage on shares of New Concept Energy ( NYSE:GBR - Free Report ) in a research note issued on Monday. The brokerage set a ""sell"" rating on the stock.",PFE,0.109455,0.150754,Somewhat-Bullish
StockNews.com Initiates Coverage on Milestone Scientific  ( NYSE:MLSS ) ,https://www.defenseworld.net/2023/07/10/stocknews-com-initiates-coverage-on-milestone-scientific-nysemlss.html,2023-07-10 05:20:42,"StockNews.com initiated coverage on shares of Milestone Scientific ( NYSE:MLSS - Free Report ) in a report released on Monday. The firm set a ""sell"" rating on the stock. Milestone Scientific stock opened at $0.96 on Monday. The company has a market capitalization of $67.27 million, a PE ratio ...",PFE,0.090134,0.111704,Neutral
NanoViricides  ( NYSE:NNVC )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/10/nanoviricides-nysennvc-research-coverage-started-at-stocknews-com.html,2023-07-10 05:20:42,"Stock analysts at StockNews.com initiated coverage on shares of NanoViricides ( NYSE:NNVC - Free Report ) in a research report issued to clients and investors on Monday. The firm set a ""sell"" rating on the stock. NYSE NNVC opened at $1.20 on Monday.",PFE,0.085629,0.0,Neutral
Mercury General  ( NYSE:MCY )  Rating Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/07/10/mercury-general-nysemcy-rating-lowered-to-hold-at-stocknews-com.html,2023-07-10 05:20:42,"Mercury General ( NYSE:MCY - Free Report ) was downgraded by equities researchers at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research report issued on Monday.",PFE,0.07887,0.023359,Neutral
World Wrestling Entertainment  ( NYSE:WWE )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/10/world-wrestling-entertainment-nysewwe-coverage-initiated-at-stocknews-com-2.html,2023-07-10 05:20:42,"Equities research analysts at StockNews.com started coverage on shares of World Wrestling Entertainment ( NYSE:WWE - Free Report ) in a note issued to investors on Monday. The brokerage set a ""hold"" rating on the stock. Several other equities analysts have also issued reports on the stock.",PFE,0.06179,0.1475,Neutral
StockNews.com Initiates Coverage on CPS Technologies  ( NASDAQ:CPSH ) ,https://www.defenseworld.net/2023/07/10/stocknews-com-initiates-coverage-on-cps-technologies-nasdaqcpsh.html,2023-07-10 05:20:41,"Research analysts at StockNews.com began coverage on shares of CPS Technologies ( NASDAQ:CPSH - Free Report ) in a research note issued on Monday. The brokerage set a ""hold"" rating on the electronics maker's stock. CPSH stock opened at $2.78 on Monday.",PFE,0.077845,0.106165,Neutral
DCP Midstream  ( NYSE:DCP )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/10/dcp-midstream-nysedcp-now-covered-by-stocknews-com.html,2023-07-10 05:20:41,"Equities researchers at StockNews.com started coverage on shares of DCP Midstream ( NYSE:DCP - Free Report ) in a research note issued to investors on Monday. The firm set a ""hold"" rating on the pipeline company's stock. DCP Midstream stock opened at $41.69 on Monday.",PFE,0.072435,0.1839,Somewhat-Bullish
voxeljet  ( NYSE:VJET )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/voxeljet-nysevjet-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-07-10 05:20:41,"Stock analysts at StockNews.com initiated coverage on shares of voxeljet ( NYSE:VJET - Free Report ) in a report released on Monday. The brokerage set a ""hold"" rating on the stock. Separately, Alliance Global Partners dropped their price objective on shares of voxeljet from $6.00 to $4.00 in a ...",PFE,0.156461,0.111466,Neutral
StockNews.com Initiates Coverage on LGL Group  ( NYSE:LGL ) ,https://www.defenseworld.net/2023/07/10/stocknews-com-initiates-coverage-on-lgl-group-nyselgl.html,2023-07-10 05:20:41,"Research analysts at StockNews.com started coverage on shares of LGL Group ( NYSE:LGL - Free Report ) in a research report issued on Monday. The firm set a ""hold"" rating on the stock. LGL stock opened at $4.67 on Monday. LGL Group has a 12 month low of $3.88 and a 12 month high of $15.15.",PFE,0.155451,0.168692,Somewhat-Bullish
BSQUARE  ( NASDAQ:BSQR )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/07/10/bsquare-nasdaqbsqr-earns-sell-rating-from-analysts-at-stocknews-com.html,2023-07-10 05:20:41,"Research analysts at StockNews.com began coverage on shares of BSQUARE ( NASDAQ:BSQR - Free Report ) in a research report issued to clients and investors on Monday. The brokerage set a ""sell"" rating on the software maker's stock. Shares of NASDAQ:BSQR opened at $1.26 on Monday.",PFE,0.107978,0.157116,Somewhat-Bullish
Titan Pharmaceuticals  ( NASDAQ:TTNP )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/07/10/titan-pharmaceuticals-nasdaqttnp-now-covered-by-stocknews-com.html,2023-07-10 05:18:46,"Analysts at StockNews.com assumed coverage on shares of Titan Pharmaceuticals ( NASDAQ:TTNP - Free Report ) in a research note issued on Monday. The brokerage set a ""sell"" rating on the specialty pharmaceutical company's stock. NASDAQ:TTNP opened at $0.62 on Monday.",PFE,0.09439,0.064196,Neutral
S&W Seed  ( NASDAQ:SANW )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/07/10/sw-seed-nasdaqsanw-research-coverage-started-at-stocknews-com.html,2023-07-10 05:18:46,"Equities research analysts at StockNews.com began coverage on shares of S&W Seed ( NASDAQ:SANW - Free Report ) in a research note issued on Monday. The brokerage set a ""sell"" rating on the stock. Separately, Lake Street Capital lowered their target price on shares of S&W Seed from $4.00 to ...",PFE,0.092213,0.096942,Neutral
T2 Biosystems  ( NASDAQ:TTOO )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/10/t2-biosystems-nasdaqttoo-coverage-initiated-at-stocknews-com.html,2023-07-10 05:18:43,"Research analysts at StockNews.com started coverage on shares of T2 Biosystems ( NASDAQ:TTOO - Free Report ) in a research report issued on Monday. The firm set a ""sell"" rating on the medical equipment provider's stock. Shares of TTOO opened at $0.12 on Monday.",PFE,0.149656,0.169843,Somewhat-Bullish
TRACON Pharmaceuticals  ( NASDAQ:TCON )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/07/10/tracon-pharmaceuticals-nasdaqtcon-coverage-initiated-at-stocknews-com.html,2023-07-10 05:18:41,"Equities research analysts at StockNews.com began coverage on shares of TRACON Pharmaceuticals ( NASDAQ:TCON - Free Report ) in a report issued on Monday. The firm set a ""hold"" rating on the biopharmaceutical company's stock. A number of other analysts have also issued reports on TCON. Robert W.",PFE,0.089797,0.039856,Neutral
"'Miracle' Weight Loss Drug Ozempic Linked To Thyroid Cancer, Regulator Warns",https://www.benzinga.com/news/23/07/33159345/miracle-weight-loss-drug-ozempic-linked-to-thyroid-cancer-regulator-warns,2023-07-10 04:39:59,"In a recent revelation, the weight loss drug Ozempic has been linked to an increased risk of thyroid cancers, The Vaccine Reaction reports.",PFE,0.119235,0.020742,Neutral
"New Covid vaccines are coming to the U.S. this fall, but uptake may be low - Here's why",https://www.cnbc.com/2023/07/29/covid-vaccine-what-uptake-of-new-shots-could-look-like.html,2023-07-29 13:00:01,"Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September.",PFE,0.124036,-0.001185,Neutral
3 Stocks Retirees Should Absolutely Love,https://www.fool.com/investing/2023/07/29/3-stocks-retirees-should-absolutely-love/,2023-07-29 10:14:00,These stocks offer solid income plus more.,PFE,0.342093,0.290083,Somewhat-Bullish
"Investing Action Plan: Apple, Amazon And An Upturn In Optimism",https://www.investors.com/research/investing-action-plan/stock-market-action-plan-apple-amazon-and-an-upturn-in-optimism/,2023-07-28 22:25:00,"A good week for optimism left the stock market in strong standing as it heads into early August. Chips showed strength, riding the rising trend in AI computing. Department stores also soared as markets begin to look toward the back-to-school and holiday shopping seasons.",PFE,0.04346,0.0,Neutral
"The Dow Breaks 13-Day Winning Streak, Fed Raises Interest Rates To 2001 Levels And AI Is The Buzzword For Big Tech Earnings: The Week In The Markets - PacWest Banc  ( NASDAQ:PACW ) , CVS Health  ( NYSE:CVS ) , JPMorgan Chase  ( NYSE:JPM ) , Merck & Co  ( NYSE:MRK ) , Amgen  ( NASDAQ:AMGN ) , Pfizer  ( NYSE:PFE ) , Peoples Trust Company  ( OTC:PPAL ) , Anheuser-Busch InBev  ( NYSE:BUD ) , Microsoft  ( NASDAQ:MSFT ) , Shopify  ( NYSE:SHOP ) , Starbucks  ( NASDAQ:SBUX ) , Qualcomm  ( NASDAQ:QCOM ) , Advanced Micro Devices  ( NASDAQ:AMD ) , Alibaba Gr Holding  ( NYSE:BABA ) , PayPal Holdings  ( NASDAQ:PYPL ) , Alphabet  ( NASDAQ:GOOG ) , Meta Platforms  ( NASDAQ:META ) , Bank of America  ( NYSE:BAC ) , ConocoPhillips  ( NYSE:COP ) , Banc of California  ( NYSE:BANC ) , HSBC Holdings  ( NYSE:HSBC ) , Intel  ( NASDAQ:INTC ) , Caterpillar  ( NYSE:CAT ) , Toyota Motor  ( NYSE:TM ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/equities/23/07/33449979/the-dow-breaks-13-day-winning-streak-fed-raises-interest-rates-to-2001-levels-and-ai-is-the-buzz,2023-07-28 20:06:47,"The S&P 500 and other major indexes slid on Thursday but recovered on Friday to wrap up the week to the upside. The Dow Jones broke a 13-day winning streak Thursday, its best since 1987, and was up 0.65% on a weekly basis Friday. The Nasdaq Composite posted a weekly gain of 1.67%.",PFE,0.114956,0.0,Neutral
These Stocks Hit 2023 Highs As Dow Heads For Best 2-Month Stretch Since November,https://www.forbes.com/sites/dereksaul/2023/07/28/these-stocks-hit-2023-highs-as-dow-heads-for-best-2-month-stretch-since-november/,2023-07-28 19:52:11,"A slew of strong economic and earnings data points this week ""could be the catalyst to send the market to new highs,"" according to one strategist.",PFE,0.108958,-0.018242,Neutral
AstraZeneca Plc  ( AZN )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/07/28/astrazeneca-plc-azn-q2-2023-earnings-call-transcri/,2023-07-28 19:00:27,"AZN earnings call for the period ending June 30, 2023.",PFE,0.013648,0.113498,Neutral
United States Steel  ( X )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/07/28/united-states-steel-x-q2-2023-earnings-call-transc/,2023-07-28 18:00:28,"X earnings call for the period ending June 30, 2023.",PFE,0.004758,0.017136,Neutral
"AstraZeneca  ( AZN )  Q2 Earnings & Sales Beat, Nil COVID Sales",https://www.zacks.com/stock/news/2129619/astrazeneca-azn-q2-earnings-sales-beat-nil-covid-sales,2023-07-28 15:57:00,AstraZeneca (AZN) beats second-quarter estimates for earnings and sales. The company did not generate any revenues from COVID-19 medications. Management reaffirms its 2023 guidance.,PFE,0.106541,0.094176,Neutral
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated - Biogen  ( NASDAQ:BIIB ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33444357/reatas-acquisition-fits-biogens-strategy-despite-high-cost-analyst-says-high-level-,2023-07-28 15:56:17,"Earlier today, Biogen Inc BIIB agreed to acquire Reata Pharmaceuticals Inc RETA for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion.",PFE,0.280615,0.0,Neutral
"Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III",https://www.zacks.com/stock/news/2129541/pharma-stock-roundup-azn-sny-abbv-q2-results-mrk-mrna-cancer-jab-in-phase-iii,2023-07-28 15:32:00,"AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results.",PFE,0.054794,-0.070823,Neutral
"Price Pressure Eased In June, Fueling Early Wall Street Gains, But BoJ Rate Policy Move Rattles Market - Ford Motor  ( NYSE:F ) , Intel  ( NASDAQ:INTC ) ",https://www.benzinga.com/markets/23/07/33445247/price-pressure-eased-in-june-fueling-early-wall-street-gains-but-boj-rate-policy-move-rattles-market,2023-07-28 15:27:33,"( Friday market open ) Welcome signs of easing U.S. inflation propelled Wall Street to early gains Friday, but the market remains rattled following a policy tweak earlier from the Bank of Japan ( BoJ ) and worries about the Federal Reserve potentially tightening further.",PFE,0.039128,0.0,Neutral
AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies,https://www.marketwatch.com/story/astrazeneca-strikes-1-billion-deal-for-pfizer-rare-disease-gene-therapies-705d2fc5,2023-07-28 15:00:00,Stock gains 5% after AstraZeneca's second-quarter results top analyst expectations.,PFE,0.199037,-0.113923,Neutral
"Top Stories Friday, July 28: iPhone US Shipments Take A Hit, Does Social Media Algorithm Impact Political Beliefs? Research Reveals Answer, Disney Joins Netflix To Crack Down Password Sharing In India - Apple  ( NASDAQ:AAPL ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/23/07/33443528/iphone-us-shipments-take-a-hit-does-social-media-algorithm-impact-political-beliefs-research-reveals,2023-07-28 14:24:31,DoorDash Inc DASH has leveraged an artificial intelligence-based chatbot to speed up ordering and help customers find food options. The Uber Technologies Inc UBER rival is working on a system called DashAI that it's testing in a limited capacity.,PFE,0.078354,0.072964,Neutral
"AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots Up - AstraZeneca  ( NASDAQ:AZN ) , AstraZeneca  ( OTC:AZNCF ) ",https://www.benzinga.com/general/biotech/23/07/33438234/astrazeneca-q2-earnings-beat-consensus-despite-zero-covid-19-vaccine-sales-stock-shoots-up,2023-07-28 12:46:39,"AstraZeneca Plc's AZN unit Alexion has agreed to buy Pfizer Inc's PFE preclinical gene therapy programs and enabling technologies for up to $1 billion, plus royalties on sales. AstraZeneca bought Alexion in 2021. It focuses on rare diseases, AstraZeneca said. It plans to close the deal in the ...",PFE,0.250386,0.132905,Neutral
"As syphilis cases rise and supply of a key treatment runs short, federal health officials are forming a task force to address the threat",https://www.marketwatch.com/story/as-syphilis-cases-rise-and-supply-of-a-key-treatment-runs-short-federal-health-officials-are-forming-a-task-force-to-address-the-threat-31870d28,2023-07-28 12:37:00,Shortages of injectable penicillin made by Pfizer raise alarms as syphilis cases hit a 70-year high.,PFE,0.398148,-0.049901,Neutral
"Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more",https://www.cnbc.com/2023/07/28/stocks-making-the-biggest-moves-premarket-intc-roku-pg-.html,2023-07-28 11:56:16,These are the stocks posting the largest moves in premarket trading.,PFE,0.049322,0.062355,Neutral
Dietary supplements market to grow by 61.4 billion from 2022 to 2027 |The growing number of healthy eating habits to ... - PR Newswire,https://www.prnewswire.com/news-releases/dietary-supplements-market-to-grow-by-61-4-billion-from-2022-to-2027-the-growing-number-of-healthy-eating-habits-to-boost-the-market-growth---technavio-301886583.html,2023-07-28 04:15:00,Dietary supplements market to grow by 61.4 billion from 2022 to 2027 |The growing number of healthy eating habits to ... PR ...,PFE,0.051441,0.096806,Neutral
AstraZeneca Q2 results beat estimates; COVID vaccine sales evaporate,https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-second-quarter-profit-beats-expectations-2023-07-28/,2023-07-28 03:55:55,AstraZeneca Q2 results beat estimates. COVID vaccine sales evaporate ...,PFE,0.084423,-0.119865,Neutral
A Look Into Pfizer Inc's Price Over Earnings - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/23/07/33429554/a-look-into-pfizer-incs-price-over-earnings,2023-07-27 20:00:23,"In the current market session, Pfizer Inc. PFE share price is at $36.26, after a 1.47% decrease. Over the past month, the stock spiked by 0.23%, but over the past year, it actually decreased by 28.20%.",PFE,0.340915,-0.024467,Neutral
"Bristol-Myers  ( BMY )  Q2 Earnings, Sales Miss, '23 View Lowered",https://www.zacks.com/stock/news/2129009/bristol-myers-bmy-q2-earnings-sales-miss-23-view-lowered,2023-07-27 17:55:00,Bristol-Myers' (BMY) second-quarter 2023 earnings and sales miss estimates due to generic erosion for the oncology drug Revlimid. The company also cuts its forecast for 2023.,PFE,0.139804,0.194442,Somewhat-Bullish
"Stocks Begin Day With Strength, Propelled By Solid Earnings And Economic Data Including GDP - Bank of America  ( NYSE:BAC ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/markets/23/07/33427159/stocks-begin-day-with-strength-propelled-by-solid-earnings-and-economic-data-including-gdp,2023-07-27 17:51:26,"( Thursday market open ) Major indexes turned green in premarket trading on Thursday following solid earnings from Meta Platforms META and McDonald's MCD, accompanied by a host of price target increases from Wall Street analysts.",PFE,0.042685,0.0,Neutral
"Beneath France's revolts, hidden success",https://www.economist.com/europe/2023/07/27/beneath-frances-revolts-hidden-success,2023-07-27 15:12:47,"S year the French have done a fine job portraying their country as broken. Twice they have spread mayhem, and derailed a state visit, with street rebellions. The first, over a rise in the retirement age, underlined people's refusal to face up to the financing needs of the state pension system.",PFE,0.030254,0.055056,Neutral
Fast Company Announces 9th Annual Innovation Festival,https://www.prnewswire.com/news-releases/fast-company-announces-9th-annual-innovation-festival-301887178.html,2023-07-27 14:01:00,"The event of the year unfolds in New York City, celebrating thousands of innovators, change-makers, and visionaries from across the globe NEW YORK, July 27, 2023 /PRNewswire/ -- Fast Company announces its 9th annual Fast Company Innovation Festival, taking place September 18-21 in New York City.",PFE,0.055236,0.150877,Somewhat-Bullish
Fast Company Announces 9th Annual Innovation Festival,https://www.benzinga.com/pressreleases/23/07/n33421246/fast-company-announces-9th-annual-innovation-festival,2023-07-27 14:01:00,"NEW YORK, July 27, 2023 /PRNewswire/ -- Fast Company announces its 9th annual Fast Company Innovation Festival, taking place September 18-21 in New York City. The 2023 Innovation Festival will bring together an extraordinary range of leaders, thinkers, and entrepreneurs who are shaping our future.",PFE,0.050254,0.15025,Somewhat-Bullish
Does Pfizer's Latest Biotech Move Make It a Buy?,https://www.fool.com/investing/2023/07/27/does-pfizers-latest-biotech-move-make-it-a-buy/,2023-07-27 13:53:00,Pfizer is teaming up with one of the most important venture capital firms in biotech.,PFE,0.450496,0.304674,Somewhat-Bullish
2 Dirt Cheap Dividend Stocks to Buy Right Now,https://www.fool.com/investing/2023/07/27/2-dirt-cheap-dividend-stocks-to-buy-right-now/,2023-07-27 13:37:00,Business never sleeps for these companies.,PFE,0.42503,0.387612,Bullish
Alphabet CEO Sundar Pichai Says AI Start-Ups Are Choosing Google Cloud -- Time to Buy the Stock?,https://www.fool.com/investing/2023/07/27/sundar-pichai-says-ai-startups-prefer-google-cloud/,2023-07-27 13:13:00,Google stock could be a great way to safely bet on generative AI hype.,PFE,0.051663,0.112945,Neutral
"Bristol Myers sales fall, cuts 2023 forecast as drugs face competition",https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-sales-fall-cuts-2023-forecast-drugs-face-competition-2023-07-27/,2023-07-27 13:09:00,"July 27 ( Reuters ) - Drugmaker Bristol Myers Squibb ( BMY.N ) on Thursday said its second-quarter sales fell more than expected and cut its full-year forecast as two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, face generic competition.",PFE,0.091509,-0.032787,Neutral
AbbVie  ( ABBV )  Beats Q2 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2128680/abbvie-abbv-beats-q2-earnings-and-revenue-estimates,2023-07-27 12:55:04,"AbbVie (ABBV) delivered earnings and revenue surprises of 4.30% and 2.54%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.140485,0.0,Neutral
"Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform - Insights From The Discussion - Abbott Laboratories  ( NYSE:ABT ) , BioRestorative Therapies  ( NASDAQ:BRTX ) ",https://www.benzinga.com/general/biotech/23/07/33417469/chronic-pain-specialist-speaks-at-panel-on-stem-cell-based-therapies-and-the-need-for-spinal-care,2023-07-27 12:05:32,"Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to the National Institute of Neurological Disorders and Stroke, approximately 80% of adults will experience back pain at some point. BioRestorative Therapies Inc.",PFE,0.142565,-0.322125,Somewhat-Bearish
Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast - Voyager Therapeutics  ( NASDAQ:VYGR ) ,https://www.benzinga.com/pressreleases/23/07/g33414844/voyager-therapeutics-announces-second-quarter-2023-conference-call-and-webcast,2023-07-27 11:00:00,"CAMBRIDGE, Mass., July 27, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. VYGR a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced it will report second quarter 2023 financial and operating results before the market opens on ...",PFE,0.110973,0.024721,Neutral
"Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and Company, Janssen, Merck, BioVie, Biogen, Vivoryon, Sage, Alnylam, BioXcel, EIP, Otsuka, Alector, Transposon",https://www.prnewswire.com/news-releases/dementia-market-to-grow-rapidly-estimates-delveinsight--key-companies-active-in-the-market---pfizer-eli-lilly-and-company-janssen-merck-biovie-biogen-vivoryon-sage-alnylam-bioxcel-eip-otsuka-alector-transposon-301885979.html,2023-07-26 21:01:00,"Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and ... PR ...",PFE,0.047607,0.083205,Neutral
"Drama Lacking: Fed Seen Hiking Rates Later Today As Investors Digest Microsoft, Alphabet Results - Apple  ( NASDAQ:AAPL ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/markets/23/07/33400341/drama-lacking-fed-seen-hiking-rates-later-today-as-investors-digest-microsoft-alphabet-results,2023-07-26 18:29:02,"( Wednesday market open ) The Federal Reserve wraps up its July meeting today, and the market widely expects a quarter-point rate increase-and wonders what's next. There's debate about whether this is the final hike or if the economy's summer sizzle might warrant another.",PFE,0.038468,0.0,Neutral
Thermo Fisher Scientific  ( TMO )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/07/26/thermo-fisher-scientific-tmo-q2-2023-earnings-call/,2023-07-26 18:00:22,"TMO earnings call for the period ending June 30, 2023.",PFE,0.00933,0.118713,Neutral
Here's Why Vaccines Probably Didn't Cause Bronny James' Cardiac Arrest-Despite Musk's Claims,https://www.forbes.com/sites/darreonnadavis/2023/07/26/heres-why-vaccines-probably-didnt-cause-bronny-james-cardiac-arrest-despite-musks-claims/,2023-07-26 17:27:23,"Research shows that myocarditis from the Covid-19 vaccine is rare, but a basketball player going into sudden cardiac arrest is not unheard-of.",PFE,0.048133,0.01493,Neutral
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/07/33398757/this-is-what-whales-are-betting-on-pfizer,2023-07-26 17:01:01,"Someone with a lot of money to spend has taken a bullish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.749418,0.281679,Somewhat-Bullish
These 7 momentum stocks ignited the market. Look out when they start to fall.,https://www.marketwatch.com/story/the-algos-are-the-enemy-machines-created-this-stock-market-rally-eventually-they-will-end-it-9bd77277,2023-07-26 15:22:00,TheoTrade's Jeffrey Bierman on algorithmic trading: 'Nothing matters except what the algos can chase higher.' Beware the 'Magnificent Seven' stocks.,PFE,0.058976,0.169204,Somewhat-Bullish
2 No-Brainer Cathie Wood Stocks to Buy Right Now,https://www.fool.com/investing/2023/07/26/2-no-brainer-cathie-wood-stocks-to-buy-right-now/,2023-07-26 15:15:00,Vertex Pharmaceuticals and Pfizer should be stellar long-term buys.,PFE,0.372448,0.340228,Somewhat-Bullish
Argenx Rides 'Megabuster' Drug Excitement To 40% Gain Before Q2 Earnings,https://www.investors.com/news/technology/argenx-stock-rides-megabuster-drug-excitement-to-40-percent-gain-before-earnings/,2023-07-26 12:01:00,"Argenx ( ARGX ) is set to announce second-quarter financials early Thursday as analysts expect another quarterly loss for the biotechnology company, even as its stock is hitting all time highs, thanks to its Vyvgart drug.",PFE,0.132368,0.0,Neutral
The Smartest Dividend Stocks to Buy With $400 Right Now,https://www.fool.com/investing/2023/07/26/smartest-dividend-stocks-to-buy-with-400-right-now/,2023-07-26 09:53:00,A modest amount of money can go a long way with these stocks.,PFE,0.344712,0.253433,Somewhat-Bullish
Alphabet  ( GOOGL )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/07/25/alphabet-googl-q2-2023-earnings-call-transcript/,2023-07-26 01:00:26,"GOOGL earnings call for the period ending June 30, 2023.",PFE,0.00491,0.201486,Somewhat-Bullish
Tornado at Pfizer Warehouse Likely to Worsen Shortage of Surgical Drugs,https://www.nytimes.com/2023/07/25/health/pfizer-warehouse-tornado-drug-shortages.html,2023-07-25 20:01:56,"A tornado that ripped apart a vast Pfizer drug warehouse in North Carolina last week will probably lead to disrupted supplies of crucial drugs used in surgery and critical care, according to estimates made by an independent nonprofit.",PFE,0.267559,0.043214,Neutral
Is Eli Lilly Stock Still a Top-Growth Play?,https://www.fool.com/investing/2023/07/25/is-eli-lilly-stock-still-a-top-growth-play/,2023-07-25 18:40:00,The drugmaker may be running out of steam.,PFE,0.072,-0.047465,Neutral
Pfizer advises hospitals on products with limited inventory after tornado damages manufacturing facility,https://www.cnn.com/2023/07/25/health/pfizer-limited-inventory-tornado-damage/index.html,2023-07-25 17:46:01,"Drug giant Pfizer is informing hospitals that dozens of its products could face ""continued or new supply disruptions in the near-term"" after an EF-3 tornado last week severely damaged its plant in Rocky Mount, North Carolina.",PFE,0.559547,0.023995,Neutral
"Double Dipping: Microsoft, Alphabet Earnings Both Due After Close as Fed Meeting Begins - Alaska Air Gr  ( NYSE:ALK ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/23/07/33375056/double-dipping-microsoft-alphabet-earnings-both-due-after-close-as-fed-meeting-begins,2023-07-25 17:21:24,"( Tuesday market open ) This afternoon serves up a double-feature, and it's not ""Barbenheimer."" Microsoft MSFT and Alphabet GOOGL accelerate the mega-cap earnings season by reporting today after the close, followed by Meta Platforms META tomorrow.",PFE,0.038437,0.0,Neutral
"It's Rare, But It Happens: What Bronny James' Health Teaches Us About Cardiac Arrest In Young Athletes",https://www.forbes.com/sites/maryroeloffs/2023/07/25/its-rare-but-it-happens-what-bronny-james-health-teaches-us-about-cardiac-arrest-in-young-athletes/,2023-07-25 17:19:33,"Bronny James, a USC basketball player and son of LeBron James, is in stable condition after collapsing on the court Monday.",PFE,0.050254,-0.062862,Neutral
ABBV: Is AbbVie  ( ABBV )  a Better Stock to Buy Than Pfizer  ( PFE ) ?,https://stocknews.com/news/abbv-pfe-opk-gmab-is-abbvie-abbv-a-better-stock-to-buy-than-pfizer/,2023-07-25 14:28:01,"In this article, I have evaluated leading medical stocks AbbVie Inc. ( ABBV ) and Pfizer Inc. ( PFE ) to analyze which stock is the better buy. After thoroughly evaluating these stocks, I think ABBV might be the right pick for the reasons discussed in this article.",PFE,0.445419,0.363829,Bullish
Earnings Preview: Pfizer  ( PFE )  Q2 Earnings Expected to Decline,https://www.zacks.com/stock/news/2126966/earnings-preview-pfizer-pfe-q2-earnings-expected-to-decline,2023-07-25 14:01:33,Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PFE,0.262052,-0.016089,Neutral
"October: Largest Spatial Computing, Metaverse, XR Event for Enterprise Comes to Houston; Hear Real Users, Discover Immersive Solutions for Business & Industry",https://www.prnewswire.com/news-releases/october-largest-spatial-computing-metaverse-xr-event-for-enterprise-comes-to-houston-hear-real-users-discover-immersive-solutions-for-business--industry-301884220.html,2023-07-25 14:00:00,"October: Largest Spatial Computing, Metaverse, XR Event for Enterprise Comes to Houston. Hear Real Users, Discover ... PR ...",PFE,0.097062,0.153377,Somewhat-Bullish
"October: Largest Spatial Computing, Metaverse, XR Event for Enterprise Comes to Houston; Hear Real Users, Discover Immersive Solutions for Business & Industry",https://www.benzinga.com/pressreleases/23/07/n33369808/october-largest-spatial-computing-metaverse-xr-event-for-enterprise-comes-to-houston-hear-real-use,2023-07-25 14:00:00,"Technology leaders from the world's biggest companies, including Airbus, BP, Coca-Cola, Delta Air Lines, FedEx, The Hershey Company, Mercedes-Benz, Pfizer, TD Bank and Walmart, will share how they're using augmented, virtual, and mixed reality to enable remote/hybrid work, improve collaboration, ...",PFE,0.088472,0.149825,Neutral
Pfizer  ( PFE )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2126448/pfizer-pfe-gains-but-lags-market-what-you-should-know,2023-07-24 21:45:21,"In the latest trading session, Pfizer (PFE) closed at $37.51, marking a +0.29% move from the previous day.",PFE,0.672055,0.268028,Somewhat-Bullish
Pfizer says supply of some drugs may be disrupted after NC tornado,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-says-supply-some-drugs-may-be-disrupted-after-nc-tornado-2023-07-24/,2023-07-24 20:54:00,"NEW YORK, July 24 ( Reuters ) - Drugmaker Pfizer Inc ( PFE.N ) said over 30 drugs, including injections of painkiller fentanyl and anesthetic lidocaine, may see supply disruption after a tornado destroyed a warehouse at its Rocky Mount, North Carolina, plant last week.",PFE,0.524949,-0.48749,Bearish
"Russia Is Seizing European Company Assets - What US Businesses Are Still At Risk? - Deere  ( NYSE:DE ) , United Airlines Holdings  ( NASDAQ:UAL ) , Ford Motor  ( NYSE:F ) , Danone  ( OTC:DANOY ) , Johnson & Johnson  ( NYSE:JNJ ) , Merck & Co  ( NYSE:MRK ) , HP  ( NYSE:HPQ ) , Kellogg  ( NYSE:K ) , Pfizer  ( NYSE:PFE ) , Abbott Laboratories  ( NYSE:ABT ) , Starbucks  ( NASDAQ:SBUX ) , IBM  ( NYSE:IBM ) , Qualcomm  ( NASDAQ:QCOM ) , Carlsberg  ( OTC:CABGY ) , Eli Lilly  ( NYSE:LLY ) , United Parcel Service  ( NYSE:UPS ) , FedEx  ( NYSE:FDX ) , Uber Technologies  ( NYSE:UBER ) , Dell Technologies  ( NYSE:DELL ) , General Electric  ( NYSE:GE ) , Netflix  ( NASDAQ:NFLX ) , Whirlpool  ( NYSE:WHR ) , Kimberly-Clark  ( NYSE:KMB ) , NVIDIA  ( NASDAQ:NVDA ) , Coca-Cola  ( NYSE:KO ) , Micron Technology  ( NASDAQ:MU ) , Colgate-Palmolive  ( NYSE:CL ) , Nike  ( NYSE:NKE ) , Delta Air Lines  ( NYSE:DAL ) , Tupperware Brands  ( NYSE:TUP ) , McDonald's  ( NYSE:MCD ) , Restaurant Brands Intl  ( NYSE:QSR ) , Intel  ( NASDAQ:INTC ) , Procter & Gamble  ( NYSE:PG ) , PepsiCo  ( NASDAQ:PEP ) , Cloudflare  ( NYSE:NET ) , Philip Morris Intl  ( NYSE:PM ) ",https://www.benzinga.com/markets/asia/23/07/33354641/russia-is-seizing-european-company-assets-what-us-businesses-are-still-at-risk,2023-07-24 20:45:18,"In recent months, Russia began seizing assets from companies based in Western countries. The most recent development came last week, when the Russian government seized the local operations of two of the world's largest consumer packaged goods manufacturers.",PFE,0.09186,-0.187684,Somewhat-Bearish
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition - Arcturus Therapeutics  ( NASDAQ:ARCT ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33350154/analyst-initiates-arcturus-sees-attractive-growth-trajectory-with-vaccine-franchise,2023-07-24 17:17:15,William Blair analyst Myles Minter has initiated coverage of Arcturus Therapeutics Holdings Inc ARCT with an Outperform rating and a fair value estimate of $71. The analyst notes the company's established partnership with vaccine producer CSL Seqirus ( $200 million upfront.,PFE,0.304428,0.227696,Somewhat-Bullish
Pfizer  ( PFE )  to Report Q2 Earnings: Here's What to Expect,https://www.zacks.com/stock/news/2126285/pfizer-pfe-to-report-q2-earnings-heres-what-to-expect,2023-07-24 15:58:00,"Higher alliance revenues from Eliquis, higher sales of Prevnar vaccines and drugs like Vyndaqel/Vyndamax are likely to have contributed to Pfizer's (PFE) sales growth in Q2.",PFE,0.323684,0.144013,Neutral
"AI in Genomics Market Size/Share Value Envisaged to Reach USD 16,757.95 Million By 2032, With 42.5% CAGR Growth: Polaris Market Research",https://www.prnewswire.com/news-releases/ai-in-genomics-market-sizeshare-value-envisaged-to-reach-usd-16-757-95-million-by-2032--with-42-5-cagr-growth-polaris-market-research-301884001.html,2023-07-24 14:30:00,"AI in Genomics Market Size/Share Value Envisaged to Reach USD 16,757.95 Million By 2032, With 42.5% CAGR ... PR ...",PFE,0.025272,0.162084,Somewhat-Bullish
"Top Stories Monday, July 24: Tesla's India Move, Adidas Receives Orders For Massive Unsold Yeezy Inventory, Spotify Raises Subscription Prices - Apple  ( NASDAQ:AAPL ) , adidas  ( OTC:ADDYY ) ",https://www.benzinga.com/news/23/07/33346371/teslas-india-move-adidas-receives-orders-for-massive-unsold-yeezy-inventory-spotify-raises-subscript,2023-07-24 14:07:08,AT&T Inc T and Verizon Communications Inc VZ struggled with toxic lead in their telephone lines and heavy debt loads as they reported their quarterly earnings. The issue of toxic lead in their networks emerged after a report triggered uncertainty among investors about potential environmental ...,PFE,0.081138,0.0,Neutral
Cadrenal Therapeutics Announces Appointment of Robert Lisicki to Board of Directors,https://www.prnewswire.com/news-releases/cadrenal-therapeutics-announces-appointment-of-robert-lisicki-to-board-of-directors-301883700.html,2023-07-24 13:00:00,"PONTE VEDRA, Fla., July 24, 2023 /PRNewswire/ -- Cadrenal Therapeutics, Inc., ( ""Cadrenal"" or the ""Company"" ) ( Nasdaq: CVKD ) , a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant ( blood thinner ) for certain rare medical conditions, today ...",PFE,0.054483,0.100788,Neutral
"GSK-Pfizer Backed HIV-Focused Unit ViiV Healthcare's Cabotegravir Injected Drug, Tablets Secure European Backing For Approval - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/07/33343691/gsk-pfizer-backed-hiv-focused-unit-viiv-healthcares-cabotegravir-injected-drug-tablets-secure-eur,2023-07-24 12:56:04,"ViiV Healthcare received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use, recommending marketing authorization for cabotegravir long-acting ( LA ) injectable and tablets for HIV prevention.",PFE,0.465196,0.322909,Somewhat-Bullish
Pfizer To Terminate Development Pact With Syros Pharmaceuticals For Novel Therapies For Two Blood Disorders - Syros Pharmaceuticals  ( NASDAQ:SYRS ) ,https://www.benzinga.com/general/biotech/23/07/33341964/pfizer-to-terminate-development-pact-with-syros-pharmaceuticals-for-novel-therapies-for-two-blood,2023-07-24 12:48:40,"Syros Pharmaceuticals Inc received notice from Pfizer Inc PFE, as successor to Global Blood Therapeutics Inc, exercising its right to terminate the License and Collaboration Agreement dated December 17, 2019, related to the discovery, development, and commercialization of novel therapies for ...",PFE,0.397098,0.318633,Somewhat-Bullish
"Johnson & Johnson Bankruptcy Talk: Q2 Earnings Soar, But Litigation Looms On Horizon",https://www.forbes.com/sites/qai/2023/07/24/johnson--johnson-bankruptcy-talk-q2-earnings-soar-but-litigation-looms-on-horizon/,2023-07-24 12:36:48,The company has proposed a $8.9 billion settlement to end tens of thousands of cases and stop new ones from coming through ...,PFE,0.064104,-0.034382,Neutral
"BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023",https://www.globenewswire.com/news-release/2023/07/24/2709374/0/en/BioNTech-to-Report-Second-Quarter-2023-Financial-Results-and-Operational-Update-on-August-7-2023.html,2023-07-24 10:45:00,"MAINZ, Germany, July 24, 2023 ( GLOBE NEWSWIRE ) - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) will announce its financial results for the second quarter 2023 on Monday, August 7th, 2023. BioNTech invites investors and the general public to join a conference call and webcast with ...",PFE,0.123526,0.009561,Neutral
Biotech wins fail to move stock indicators ahead of earnings,https://www.financialexpress.com/healthcare/news-healthcare/biotech-wins-fail-to-move-stock-indicators-ahead-of-earnings/3184760/,2023-07-24 10:35:25,Biotech has had a pretty good year between a flurry of deals and approvals of new drugs for vexing diseases such as Alzheimer's. Yet that isn't showing up in stock performance. Two closely watched indicators lag far behind the overall market.,PFE,0.114137,-0.003412,Neutral
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives,https://www.globenewswire.com/news-release/2023/07/24/2709344/0/en/Allarity-Therapeutics-Strengthens-Board-of-Directors-with-Appointment-of-Three-Accomplished-Biotechnology-Executives.html,2023-07-24 10:00:00,• New appointments bring therapeutic development expertise and proven leadership to support continued progress of Allarity's multiple oncology clinical programs,PFE,0.022264,0.028324,Neutral
Digestive Health Supplements to grow by USD 7.86 billion from 2022 to 2027|Growing awareness about digestive ... - PR Newswire,https://www.prnewswire.com/news-releases/digestive-health-supplements-to-grow-by-usd-7-86-billion-from-2022-to-2027growing-awareness-about-digestive-health-drives-the-market---technavio-301883088.html,2023-07-24 09:00:00,Digestive Health Supplements to grow by USD 7.86 billion from 2022 to 2027|Growing awareness about digestive ... PR ...,PFE,0.041394,0.0,Neutral
Big Pharma Bets Big on China,https://www.wsj.com/articles/big-pharma-bets-big-on-china-2383e6ec,2023-07-23 11:00:00,China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere.,PFE,0.622414,0.0,Neutral
"Tornado damage to North Carolina Pfizer plant unlikely to cause significant drug supply impacts, FDA says",https://www.foxbusiness.com/markets/tornado-damage-north-carolina-pfizer-plant-unlikely-cause-significant-drug-supply-impacts-fda,2023-07-22 17:18:43,The commissioner of the U.S. Food and Drug Administration said Friday that the agency does not expect any immediate significant impacts on supply following damage from a tornado to a large Pfizer facility in North Carolina on Wednesday.,PFE,0.541766,-0.020248,Neutral
Bavarian Nordic ends RSV vaccine programme after poor trial results,https://www.reuters.com/business/healthcare-pharmaceuticals/bavarian-nordic-discontinue-rsv-vaccine-programme-2023-07-22/,2023-07-22 17:00:07,July 22 ( Reuters ) - Denmark-based Bavarian Nordic ( BAVA.CO ) said on Saturday it was ending its respiratory syncytial virus ( RSV ) vaccine programme as its Phase 3 clinical trial did not meet all the primary goals of preventing lower respiratory tract disease.,PFE,0.159569,0.111998,Neutral
The Steep Cost of Ron DeSantis's Vaccine Turnabout,https://www.nytimes.com/2023/07/22/us/politics/ron-desantis-covid.html,2023-07-22 16:52:32,"On a Saturday in September 2020, with Covid-19 killing more than 600 Americans daily and hundreds of thousands of deaths still to come, Dr. Deborah L. Birx, a member of the White House coronavirus task force, heard her cellphone ring. It was Dr. Scott Rivkees, the Florida surgeon general.",PFE,0.011317,0.208046,Somewhat-Bullish
FDA Moves to Soothe Fears of Drug Shortages After Tornado Hits Pfizer Plant,https://www.barrons.com/articles/pfizer-plant-tornado-fda-fbe063d7,2023-07-22 15:06:00,"The Food and Drug Administration is moving to soothe worries that Wednesday's tornado strike on a Pfizer plant in North Carolina could lead to widespread drug shortages, saying that that there are enough supplies currently on hand at hospitals and in the distribution system to forestall a crisis.",PFE,0.716023,-0.02405,Neutral
CLIMATE GLIMPSE: Here's what you need to see and know today,https://apnews.com/article/climate-glimpse-heat-storms-floods-26bae988f31c0cbc3026b4bacca2635f,2023-07-22 12:54:00,"As Greece swelters in another heat wave, children are finding some cool respite - and fun - in a fountain near a cultural center in Athens.",PFE,0.090816,-0.163445,Somewhat-Bearish
Viatris Stock: Bull vs. Bear,https://www.fool.com/investing/2023/07/22/viatris-stock-bull-vs-bear/,2023-07-22 10:00:00,Viatris shares have declined in the double digits over the past few years.,PFE,0.053035,0.03095,Neutral
"Tornado Damages Pfizer Plant In North Carolina, Conspiracy Theories Swirl",https://www.forbes.com/sites/brucelee/2023/07/21/tornado-damages-pfizer-plant-in-north-carolina-conspiracy-theories-swirl/,2023-07-22 02:09:56,"Since this facility produces around 25% of Pfizer's sterile injectable products for U.S. hospitals, this may mean yet more product shortages in this country.",PFE,0.302553,-0.108054,Neutral
"Tornado damage to Pfizer plant unlikely to cause major drug supply shortages, FDA says",https://apnews.com/article/pfizer-tornado-north-carolina-02a55c07471cb20abad9c22c8a93415b,2023-07-22 00:38:00,"RALEIGH, N.C. ( AP ) - Most of the that tore through eastern North Carolina Wednesday and struck a large Pfizer pharmaceutical plant affected its storage facility, rather than its medicine production areas, the company said Friday.",PFE,0.427184,-0.124884,Neutral
"Pfizer says most tornado damage to North Carolina plant was to warehouse facility, not manufacturing lines",https://www.cnn.com/2023/07/21/health/pfizer-north-carolina-tornado-damage/index.html,2023-07-21 23:19:00,"Most of the damage from Wednesday's tornado to a major Pfizer plant in North Carolina was to a warehouse facility, rather than areas that produce medicines, the drug giant said Friday.",PFE,0.412017,0.016913,Neutral
FDA Provides Update Regarding Storm Damage at Pfizer Facility in North Carolina,https://www.prnewswire.com/news-releases/fda-provides-update-regarding-storm-damage-at-pfizer-facility-in-north-carolina-301883400.html,2023-07-21 23:10:00,"The following is attributed to FDA Commissioner Robert M. Califf, M.D. SILVER SPRING, Md., July 21, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration is working closely with Pfizer to assess the impact of the damage at Pfizer's Rocky Mount, North Carolina, facility.",PFE,0.350564,0.180079,Somewhat-Bullish
FDA Provides Update Regarding Storm Damage at Pfizer Facility in North Carolina,https://markets.businessinsider.com/news/stocks/fda-provides-update-regarding-storm-damage-at-pfizer-facility-in-north-carolina-1032466997,2023-07-21 23:10:00,"The following is attributed to FDA Commissioner Robert M. Califf, M.D. SILVER SPRING, Md., July 21, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration is working closely with Pfizer to assess the impact of the damage at Pfizer's Rocky Mount, North Carolina, facility.",PFE,0.350564,0.180079,Somewhat-Bullish
Pfizer to end license deal with Syros for blood disorder therapies,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-end-license-deal-with-syros-blood-disorder-therapies-2023-07-21/,2023-07-21 21:46:00,July 21 ( Reuters ) - Syros Pharmaceuticals ( SYRS.O ) said on Friday Pfizer ( PFE.N ) will terminate a license deal between the companies related to the development of novel therapies for two blood disorders. Shares of Syros were down 5.7% in trading after the bell.,PFE,0.504646,0.121485,Neutral
Pfizer says no major tornado damage to drug manufacturing areas of North Carolina facility,https://www.cnbc.com/2023/07/21/pfizer-no-major-tornado-damage-to-drug-manufacturing-in-nc-facility.html,2023-07-21 21:05:29,The pharmaceutical company did not say whether it expected the tornado damage to lead to new drug shortages for sterile injectables.,PFE,0.744646,-0.003918,Neutral
Pfizer says tornado significantly damaged warehouse storing drugs and raw materials,https://www.marketwatch.com/story/pfizer-says-most-tornado-damage-to-rocky-mount-facility-was-in-warehouse-32dd3b18,2023-07-21 20:35:00,"Key production facility for injectable medicines remains closed while damage is assessed, pharmaceutical giant says ...",PFE,0.655626,0.097272,Neutral
"Dow Jones Leads Weekly Gains As Tesla, Netflix Sell-Offs Dent Nasdaq; Big Banks Show Resilience To Volatility - Apple  ( NASDAQ:AAPL ) , Chevron  ( NYSE:CVX ) , Verizon Communications  ( NYSE:VZ ) , Pfizer  ( NYSE:PFE ) , Microsoft  ( NASDAQ:MSFT ) , Tesla  ( NASDAQ:TSLA ) , Mastercard  ( NYSE:MA ) , AT&T  ( NYSE:T ) , Union Pacific  ( NYSE:UNP ) , Visa  ( NYSE:V ) , Unilever  ( NYSE:UL ) , Shell  ( NYSE:SHEL ) , Netflix  ( NASDAQ:NFLX ) , Alphabet  ( NASDAQ:GOOG ) , Meta Platforms  ( NASDAQ:META ) , Bank of America  ( NYSE:BAC ) , Coca-Cola  ( NYSE:KO ) , General Motors  ( NYSE:GM ) , Morgan Stanley  ( NYSE:MS ) , Colgate-Palmolive  ( NYSE:CL ) , 3M  ( NYSE:MMM ) , McDonald's  ( NYSE:MCD ) , Comcast  ( NASDAQ:CMCSA ) , AstraZeneca  ( NASDAQ:AZN ) , Intel  ( NASDAQ:INTC ) , Procter & Gamble  ( NYSE:PG ) , Exxon Mobil  ( NYSE:XOM ) , Charles Schwab  ( NYSE:SCHW ) , Amazon.com  ( NASDAQ:AMZN ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/markets/equities/23/07/33329067/dow-jones-leads-weekly-gains-as-tesla-netflix-sell-offs-dent-nasdaq-big-banks-show-resilience-to,2023-07-21 20:12:23,"The star of the week is the blue-chip Dow Jones, which marked a winning streak of 10 consecutive sessions through Friday, riding high on positive quarterly results from many high-profile defensive stocks. The industrial average is up 2.1% on a weekly basis.",PFE,0.099271,-0.380761,Bearish
"Pharma Stock Roundup: JNJ, NVS Upbeat Q2 Results, FDA Nod to SNY & AZN RSV Antibody",https://www.zacks.com/stock/news/2125478/pharma-stock-roundup-jnj-nvs-upbeat-q2-results-fda-nod-to-sny-azn-rsv-antibody,2023-07-21 15:21:00,"FDA approves AstraZeneca (AZN) and Sanofi's (SNY) RSV antibody, Beyfortus. J&J (JNJ) and Novartis (NVS) announce strong second-quarter results.",PFE,0.041975,-0.117304,Neutral
NOT REAL NEWS: A look at what didn't happen this week,https://apnews.com/article/fact-check-misinformation-pfizer-mosquitoes-covid19-human-trafficking-a64fd180732aa3405691681f3d6c80e7,2023-07-21 14:53:00,"A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts:",PFE,0.107303,-0.074265,Neutral
Why Shares of BridgeBio Pharma Skyrocketed This Week,https://www.fool.com/investing/2023/07/21/why-shares-of-bridgebio-pharma-skyrocketed-this-we/,2023-07-21 14:44:42,The biotech company saw strong results in a phase 3 trial.,PFE,0.119235,0.286209,Somewhat-Bullish
Biomanufacturing Viral Detection and Quantification Market worth $981.41 Million by 2031 - Exclusive Report by InsightAce Analytic,https://www.prnewswire.com/news-releases/biomanufacturing-viral-detection-and-quantification-market-worth-981-41-million-by-2031---exclusive-report-by-insightace-analytic-301883033.html,2023-07-21 14:05:00,Biomanufacturing Viral Detection and Quantification Market worth $981.41 Million by 2031 - Exclusive Report by ... PR ...,PFE,0.03468,0.141011,Neutral
"EU regulator backs Pfizer's RSV vaccine for infants, older adults",https://www.reuters.com/business/healthcare-pharmaceuticals/eu-health-regulator-backs-pfizers-rsv-vaccine-infants-older-adults-2023-07-21/,2023-07-21 13:09:00,[1/2] View of Pfizer's new respiratory syncytial virus ( RSV ) vaccine Abrysvo during its manufacture in this undated handout picture. Pfizer/Handout via REUTERS/File Photo,PFE,0.230235,0.100885,Neutral
Cadence Design and Ligand have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2125288/cadence-design-and-ligand-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-07-21 13:04:00,"Chicago, IL - July 21, 2023 - Zacks Equity Research shares Cadence Design Systems ( CDNS Quick QuoteCDNS - ) as the Bull of the Day and Ligand Pharmaceuticals ( LGND Quick QuoteLGND - ) as the Bear of the Day.",PFE,0.016227,0.198649,Somewhat-Bullish
"The daily business briefing: July 21, 2023",https://theweek.com/briefing/business-briefing/1025197/the-daily-business-briefing-july-21-2023,2023-07-21 12:00:57,FTX lawyers on Thursday filed a lawsuit in Delaware bankruptcy court accusing company co-founder Sam Bankman-Fried and three members of his leadership team of stealing more than $1 billion shortly before the failed cryptocurrency exchange collapsed last year.,PFE,0.127456,-0.051283,Neutral
Bear of the Day: Ligand Pharmaceuticals  ( LGND ) ,https://www.zacks.com/commentary/2124960/bear-of-the-day-ligand-pharmaceuticals-lgnd,2023-07-21 10:20:00,"Ligand is an innovative Bio-Pharma M&A royalty-generator, but the model is volatile ...",PFE,0.118064,0.251012,Somewhat-Bullish
"As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion",https://www.marketwatch.com/story/as-ozempic-wegovy-frenzy-continues-morgan-stanley-lifts-forecasts-for-weight-loss-drugs-to-77-billion-8d3d8c31,2023-07-21 09:05:00,"Morgan Stanley on Friday lifted its forecast for weight-loss drugs to $77 billion, as patient demand for the medicines has outstripped supply and been fueled by a social-media frenzy.",PFE,0.181819,0.016289,Neutral
"North Carolina tornado that damaged Pfizer plant and shut down I-95 was an EF-3, NWS says",https://www.cnn.com/2023/07/19/weather/north-carolina-tornado-pfizer-climate/index.html,2023-07-20 23:19:00,"A tornado in North Carolina severely damaged a Pfizer plant, damaged several other structures, shut down a major interstate and injured at least 16 people Wednesday afternoon. The tornado was on the ground for 16.5 miles, lasting about 30 minutes, and produced peak winds of 150 mph, an EF-3 ...",PFE,0.18967,-0.185669,Somewhat-Bearish
"Tornado damage at Pfizer facility threatens to make critical drug-supply shortages even worse, experts say",https://www.marketwatch.com/story/tornado-damage-at-pfizer-facility-threatens-to-make-critical-drug-supply-shortages-even-worse-experts-say-db2a6ec3,2023-07-20 22:06:00,"Natural disaster highlights need for longer-term policies to support generic availability, researchers say ...",PFE,0.63573,-0.286884,Somewhat-Bearish
This Heat Wave Has Become Dangerous for the Elderly,https://www.nytimes.com/2023/07/20/briefing/heat-wave-elderly-womens-world-cup.html,2023-07-20 21:50:16,"An onslaught of heat waves - across the Southern U.S., as well as much of Europe and the Middle East - have elevated average global temperatures to historic highs. Extended exposure to the sweltering heat can be a potential health risk for anyone, particularly those who do outdoor work.",PFE,0.031612,-0.334886,Somewhat-Bearish
"Tornado Tears Through Pfizer's N.C. Site, Threatening Crucial Drug Supplies",https://www.nytimes.com/2023/07/20/health/tornado-pfizer-drug-shortage.html,2023-07-20 21:14:28,"Extensive damage occurred at the company's property in Rocky Mount, and many products used by hospitals appeared to have been affected. This could further exacerbate shortages.",PFE,0.396574,-0.257064,Somewhat-Bearish
Diabetic Peripheral Neuropathy Market Growing at a CAGR of ~6% by 2032 | DelveInsight,https://www.prnewswire.com/news-releases/diabetic-peripheral-neuropathy-market-growing-at-a-cagr-of-6-by-2032--delveinsight-301881945.html,2023-07-20 21:01:00,The dynamics of the diabetic peripheral neuropathy market are anticipated to change as companies across the globe are thoroughly working toward the development of new drug therapy options to treat this disease,PFE,0.047797,0.032496,Neutral
"Tornado damage to North Carolina Pfizer plant will create long-term shortages of certain drugs, experts fear",https://www.foxbusiness.com/lifestyle/tornado-damage-north-carolina-pfizer-plant-will-create-long-term-shortages-certain-drugs-experts,2023-07-20 20:37:09,"Experts fear that the tornado damage to Pfizer's plant in Rocky Mount, North Carolina, will create long-term shortages of already-strained drug supplies.",PFE,0.346884,-0.301675,Somewhat-Bearish
"Contrary to claims, Pfizer plant damaged by tornado didn't hold COVID vaccines",https://apnews.com/article/fact-check-pfizer-north-carolina-tornado-covid-vaccines-604985909374,2023-07-20 17:25:00,"CLAIM: A Pfizer warehouse in North Carolina damaged by a tornado was stocked with the company's COVID-19 vaccine. AP'S ASSESSMENT: False. Pfizer does not manufacture or store its COVID-19 vaccine or treatment for the disease at the facility, a company representative told The Associated Press.",PFE,0.56296,-0.162489,Somewhat-Bearish
CLIMATE GLIMPSE: Here's what you need to see and know today,https://apnews.com/article/climate-heat-rain-flooding-summer-wildfires-37ccee0eb88b18b619b321263ec52c98,2023-07-20 17:15:00,"A triggered by torrential rains in India's western Maharashtra state killed at least 10 people, with many others feared trapped under piles of debris, officials said Thursday.",PFE,0.085629,-0.162645,Somewhat-Bearish
Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need,https://apnews.com/article/pfizer-factory-tornado-drugs-north-carolina-3ce4b4ee0be984f751e0173091a3cdd7,2023-07-20 16:40:00,"The fallout from a Pfizer factory being damaged by a tornado could put even more pressure on already-strained drug supplies at U.S. hospitals, experts say.",PFE,0.446546,-0.158901,Somewhat-Bearish
Malaria Vaccines Are Finally Here: The Top Shots And What's On The Horizon Next,https://www.forbes.com/sites/roberthart/2023/07/20/malaria-vaccines-are-finally-here-the-top-shots-and-whats-on-the-horizon-next/,2023-07-20 15:57:54,"There are now two shots authorized for use against the mosquito-borne scourge, though companies like BioNTech and Moderna are hoping to compete using the same mRNA technology behind their successful Covid vaccines.",PFE,0.038345,0.133878,Neutral
"2 Growth Stocks That Could Rocket 81% to 233% Higher, According to Wall Street",https://www.fool.com/investing/2023/07/20/3-growth-stocks-that-could-rocket-to-higher-accord/,2023-07-20 15:35:00,The investment bank analysts who follow these stocks think they could deliver enormous gains in the not-so-distant future.,PFE,0.058759,0.164001,Somewhat-Bullish
"Top Stories Thursday, July 20: Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/23/07/33304679/tesla-recalls-over-17k-evs-over-camera-seat-belt-issues-university-research-uncovers-unexpected-fluc,2023-07-20 14:09:21,"Tesla Inc TSLA has issued a recall for over 1,300 Model S, X, and Y vehicles made in 2023, citing an issue with the forward-facing front camera, and over 15,000 Model S and X vehicles for problems related to front-row seat belts.",PFE,0.137671,-0.214822,Somewhat-Bearish
Is Novavax Stock a Buy Now?,https://www.fool.com/investing/2023/07/20/is-novavax-stock-a-buy-now/,2023-07-20 14:07:00,It might be a little too late to invest in this biotech.,PFE,0.168099,-0.058546,Neutral
Pfizer's North Carolina Plant Severely Damaged By Tornado: Report - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/equities/23/07/33301244/pfizers-north-carolina-plant-severely-damaged-by-tornado-report,2023-07-20 12:58:13,"Pfizer, Inc.'s PFE plant in Rocky Mount, North Carolina, has reportedly suffered heavy damage from a tornado. The company was assessing the situation to determine the impact on production, Reuters reported, citing an email statement from a company spokesperson.",PFE,0.617765,-0.475466,Bearish
"Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner' - Airbnb  ( NASDAQ:ABNB ) , Akoya Biosciences  ( NASDAQ:AKYA ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/07/33296828/jim-cramer-says-this-major-automotive-stock-is-just-too-cheap-thats-wrong-i-think-youve-,2023-07-20 12:45:13,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Tripadvisor, Inc. TRIP is not good enough, and he prefers Booking Holdings Inc. BKNG. ""I think that Brian Chesky is putting together amazing numbers, as we said when it was at 90, for Airbnb, Inc. ABNB."" When asked about Shockwave Medical, ...",PFE,0.463792,0.388259,Bullish
Pfizer's GBS6 Vaccine Candidate Showcases Promising Protection for Infants Against Invasive GBS Disease: Phase 2 Study Reveals - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/07/33300083/pfizers-gbs6-vaccine-candidate-showcases-promising-protection-for-infants-against-invasive-gbs-di,2023-07-20 12:27:43,"Pfizer Inc PFE announced data from a Phase 2 study investigating its hexavalent capsular polysaccharide ( CPS ) conjugate Group B Streptococcus ( GBS ) vaccine candidate, GBS6, being developed for maternal administration to protect infants against invasive GBS disease.",PFE,0.595343,0.080432,Neutral
Johnson & Johnson  ( JNJ )  Tops Q2 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2124299/johnson-johnson-jnj-tops-q2-earnings-and-revenue-estimates,2023-07-20 11:35:02,"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 7.28% and 3.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.136499,0.0,Neutral
"5 things to know for July 20: New Zealand shooting, Trump, Tornado, UPS, Netflix",https://edition.cnn.com/2023/07/20/us/5-things-to-know-for-july-20-auckland-shooting-trump-tornado-ups-netflix/index.html,2023-07-20 11:26:00,"Many people in the German capital of Berlin woke up to some bizarre news this morning. A suspected lioness is on the loose in the southwestern part of the city, German police warned, adding people in the area should remain indoors until they capture the dangerous wild animal.",PFE,0.034984,-0.104782,Neutral
"5 things to know for July 20: New Zealand shooting, Trump, Tornado, UPS, Netflix",https://www.cnn.com/2023/07/20/us/5-things-to-know-for-july-20-auckland-shooting-trump-tornado-ups-netflix/index.html,2023-07-20 11:26:00,"5 things to know for July 20: New Zealand shooting, Trump, Tornado, UPS, ...",PFE,0.034984,-0.104782,Neutral
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs,https://www.benzinga.com/pressreleases/23/07/n33299743/viva-biotechs-portfolio-company-riparian-pharmaceuticals-announces-exclusive-license-agreement-and,2023-07-20 11:00:00,"WATERTOWN, Mass., July 20, 2023 /PRNewswire/ -- Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases. Riparian today announced it has entered into an exclusive license agreement and research ...",PFE,0.296582,0.427538,Bullish
"Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory",https://www.reuters.com/business/healthcare-pharmaceuticals/shares-pfizer-rivals-hikma-fresenius-rally-after-tornado-hits-factory-2023-07-20/,2023-07-20 09:10:00,"LONDON, July 20 ( Reuters ) - Shares in UK pharmaceutical company Hikma ( HIK.L ) rose by the most in 10 months on Thursday, hitting an 18-month high, following news of tornado damage to a U.S. facility owned by competitor Pfizer, which boosted other drugmakers' stock.",PFE,0.685927,0.060823,Neutral
Sosei Heptares - Investor and Press Conference on Today's Announcement Regarding the Acquisition and License Transaction with Idorsia,https://www.globenewswire.com/news-release/2023/07/20/2707903/0/en/Sosei-Heptares-Investor-and-Press-Conference-on-Today-s-Announcement-Regarding-the-Acquisition-and-License-Transaction-with-Idorsia.html,2023-07-20 06:31:00,"Tokyo, Japan and Cambridge, UK, 20 July 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , will hold an investor and press conference on today's announcement. ""Sosei Heptares Acquires Idorsia's Pharmaceuticals Business in Japan and APAC ( ex-China ) , Accelerating its Transformation ...",PFE,0.070517,0.0,Neutral
Sosei Heptares - Investor and Press Conference on Today's Announcement Regarding the Acquisition and License Transaction with Idorsia,https://www.benzinga.com/pressreleases/23/07/g33296902/sosei-heptares-investor-and-press-conference-on-todays-announcement-regarding-the-acquisition-and-,2023-07-20 06:31:00,"Tokyo, Japan and Cambridge, UK, 20 July 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) , will hold an investor and press conference on today's announcement.",PFE,0.066784,0.0,Neutral
Idorsia sells its Asia Pacific  ( ex-China )  operations - including select license rights to products - to Sosei Heptares for a total consideration of CHF 400 million,https://www.globenewswire.com/news-release/2023/07/20/2707902/0/en/Idorsia-sells-its-Asia-Pacific-ex-China-operations-including-select-license-rights-to-products-to-Sosei-Heptares-for-a-total-consideration-of-CHF-400-million.html,2023-07-20 06:30:00,Ad hoc announcement pursuant to Art. 53 LR ...,PFE,0.038969,0.0,Neutral
"Sosei Heptares Acquires Idorsia's Pharmaceuticals Business in Japan and APAC  ( ex-China ) , Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company",https://www.benzinga.com/pressreleases/23/07/g33296896/sosei-heptares-acquires-idorsias-pharmaceuticals-business-in-japan-and-apac-ex-china-accelerating-,2023-07-20 06:30:00,"PIVLAZ® ( clazosentan; commercially available in Japan for cerebral vasospasm; NHI sales of ~JPY7.5 billion in FY22A launch year, with ~76% year-on-year growth expected for FY23E ) , and Daridorexant ( Japan filing expected 2H 2023 for insomnia, marketed in US/Europe as QUVIVIQ® )",PFE,0.012584,0.0,Neutral
"Sosei Heptares Acquires Idorsia's Pharmaceuticals Business in Japan and APAC  ( ex-China ) , Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company",https://www.globenewswire.com/news-release/2023/07/20/2707901/0/en/Sosei-Heptares-Acquires-Idorsia-s-Pharmaceuticals-Business-in-Japan-and-APAC-ex-China-Accelerating-its-Transformation-into-a-Fully-Integrated-Biopharmaceutical-Company.html,2023-07-20 06:30:00,"Tokyo, Japan and Cambridge, UK, 20 July 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) announces that it has resolved, at a meeting of the Board of Directors held on 20 July 2023, to acquire from Idorsia Ltd and Idorsia Pharmaceutical Ltd ( together ""Idorsia"" ) all shares of Idorsia ...",PFE,0.012095,0.0,Neutral
"Pfizer, Gilead, GSK to capture 62% of $150 billion infectious diseases market | The Financial Express",https://www.financialexpress.com/healthcare/pharma-healthcare/pfizer-gilead-gsk-to-capture-62-of-150-billion-infectious-diseases-market/3178455/,2023-07-20 04:30:00,"Pfizer, Gilead, GSK to capture 62% of $150 billion infectious diseases market The Financial Express ...",PFE,0.339745,0.264231,Somewhat-Bullish
"Hikma, Fresenius shares rally after tornado hits rival Pfizer's U.S. plant",https://www.reuters.com/business/healthcare-pharmaceuticals/hikma-fresenius-shares-rally-after-tornado-hits-rival-pfizers-us-plant-2023-07-20/,2023-07-20 00:57:36,"LONDON, July 20 ( Reuters ) - Shares in UK pharmaceutical company Hikma ( HIK.L ) rose by the most in 10 months on Thursday after tornado damage to a U.S. facility owned by competitor Pfizer boosted other drugmakers' stock.",PFE,0.473208,0.049721,Neutral
China Dietary Supplements Market to Grow at a CAGR 8.3% from 2023 to 2028,https://www.benzinga.com/pressreleases/23/08/g33648404/china-dietary-supplements-market-to-grow-at-a-cagr-8-3-from-2023-to-2028,2023-08-08 23:00:00,"Chicago, Aug. 08, 2023 ( GLOBE NEWSWIRE ) -- According to a research report ""China Dietary Supplements Market by Type ( Botanicals, Vitamins, Minerals, Amino Acids, Enzymes, Probiotics ) , Function, Mode of Application, Target Consumer, Distribution Channel ( Pharmacy, Supermarket/Hypermarket, ...",PFE,0.078354,0.0,Neutral
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Voyager Therapeutics  ( NASDAQ:VYGR ) ,https://www.benzinga.com/pressreleases/23/08/g33642517/voyager-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4,2023-08-08 20:01:00,"CAMBRIDGE, Mass., Aug. 08, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc.",PFE,0.078611,0.021526,Neutral
HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS,https://www.prnewswire.com/news-releases/halozyme-reports-second-quarter-2023-financial-and-operating-results-301896108.html,2023-08-08 20:01:00,Revenue Increased 45% YOY to $221.0 million; GAAP Diluted EPS of $0.56 and Non-GAAP Diluted EPS of $0.741 Royalty Revenue Increased 31% YOY to Record $111.7 million Raised 2023 Non-GAAP Diluted EPS Guidance to $2.65-$2.75,PFE,0.021937,0.077737,Neutral
"Warren Buffett Stocks: GOOGL, LULU And More Test Buy Zones",https://www.investors.com/research/warren-buffett-stocks-investing-strategy-stock-screen/,2023-08-08 18:56:00,"Alphabet ( GOOGL ) , Lattice Semiconductor ( LSCC ) , Lululemon Athletica ( LULU ) , Pfizer ( PFE ) and STMicroelectronics ( STM ) are among 34 stocks on this screen emulating Warren Buffett stocks based on the investing strategy of the Berkshire Hathaway CEO. Steel Dynamics ( STLD ) , D.R.",PFE,0.087185,0.0,Neutral
"COVID-19 hospitalizations in the US are on the rise again, but not like before",https://apnews.com/article/covid-cases-hospitalizations-increasing-9a831de37210c53c1ee48a30ad2ee611,2023-08-08 18:55:00,"Here we go again: COVID-19 hospital admissions have inched upward in the United States since early July in a small-scale echo of the three previous summers. With an updated vaccine still months away , this summer bump in new hospitalizations might be concerning, but the number of patients is far ...",PFE,0.059636,-0.019064,Neutral
Britain doubles down on the life-sciences industry,https://www.economist.com/britain/2023/08/08/britain-doubles-down-on-the-life-sciences-industry,2023-08-08 18:24:19,"M hope that success in one industry may beget success in another. Take Aberdeen, which grew rich from oil exploitation in the North Sea. By a decade ago, the Granite City laid claim to more multimillionaires per head of population than anywhere else in Britain.",PFE,0.024597,0.047923,Neutral
What's Happening With BioNTech  ( BNTX )  Stock? - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/news/23/08/33640270/whats-happening-with-biontech-bntx-stock,2023-08-08 18:18:55,BioNTech SE - ADR BNTX shares are trading higher by 3.28% to $101.73 Tuesday afternoon as the stock rebounds after falling on Monday. Traders and investors are likely weighing the company's second-quarter report from Monday's pre-market session.,PFE,0.282234,0.279486,Somewhat-Bullish
PFE: 3 Pharma Stocks Investors Are Chasing for Value,https://stocknews.com/news/pfe-sny-gsk-opk-blu-3-pharma-stocks-investors-are-chasing-for-value/,2023-08-08 17:44:57,"The growing desire for personalized treatments coupled with an aging population across numerous countries and rising chronic conditions are generating higher healthcare requirements, consequently leading to an elevated demand for pharmaceutical products and services.",PFE,0.211652,0.175862,Somewhat-Bullish
Ohio voters flock to the polls with abortion rights at stake in GOP-backed rules change,https://www.cnbc.com/2023/08/08/ohio-voters-flock-to-the-polls-with-abortion-rights-at-stake.html,2023-08-08 17:40:49,A GOP-backed effort to make it more difficult to amend the constitution comes ahead of a fall referendum to enshrine abortion rights in Ohio.,PFE,0.059341,-0.176011,Somewhat-Bearish
Eli Lilly  ( LLY )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/08/eli-lilly-lly-q2-2023-earnings-call-transcript/,2023-08-08 17:30:24,"LLY earnings call for the period ending June 30, 2023.",PFE,0.003595,0.113982,Neutral
"The Bond Market Has the Blues, Oil Breaks to the Upside and Moderna to the Downside",https://www.investorideas.com/news/2023/energy/08081Oil.asp,2023-08-08 16:49:00,"August 8, 2023 ( Investorideas.com Newswire ) The long end of the bond market is starting to price in sticky inflation, and Ron Struthers of Struthers' Stock Reports expects interest rates to rise further. Higher energy prices will start adding to inflation again, adding to the problem.",PFE,0.01455,0.006999,Neutral
Alation Expands Global Footprint with Launch of New Data Center in Japan,https://www.benzinga.com/pressreleases/23/08/g33627970/alation-expands-global-footprint-with-launch-of-new-data-center-in-japan,2023-08-08 13:00:00,"REDWOOD CITY, Calif., Aug. 08, 2023 ( GLOBE NEWSWIRE ) -- Alation, Inc., the data intelligence company, today announced the launch of its new data center. Located in Tokyo, Japan, Alation Cloud Service customers can now process and store data locally to meet data residency requirements.",PFE,0.077845,0.222687,Somewhat-Bullish
"Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Alteryx  ( NYSE:AYX ) , Biophytis  ( NASDAQ:BPTS ) ",https://www.benzinga.com/news/23/08/33626233/why-hims-hers-health-shares-are-trading-higher-by-17-here-are-20-stocks-moving-premarket,2023-08-08 12:20:19,"Infinity Pharmaceuticals, Inc. INFI shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the company's headcount by 78%. Biophytis S.A.",PFE,0.076602,-0.006264,Neutral
TMF Corporation Exec Joins Xeriant to Head Up New Manufacturing Subsidiary for Green Building Materials,https://www.globenewswire.com/news-release/2023/08/08/2720605/0/en/TMF-Corporation-Exec-Joins-Xeriant-to-Head-Up-New-Manufacturing-Subsidiary-for-Green-Building-Materials.html,2023-08-08 12:05:00,"Tom Fitzgerald, Jr. to become VP of Composites Manufacturing Tom Fitzgerald, Jr. to become VP of Composites Manufacturing ...",PFE,0.040145,0.156109,Somewhat-Bullish
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS,https://www.newswire.ca/news-releases/endo-reports-second-quarter-2023-financial-results-885986302.html,2023-08-08 11:45:00,"DUBLIN, Aug. 8, 2023 /CNW/ -- Endo International plc ( OTC: ENDPQ ) today reported financial results for the second-quarter ended June 30, 2023. Reported Income ( Loss ) from Continuing Operations Adjusted Income from ContinuingOperations ( 2 ) ( 3 )",PFE,0.02013,0.019629,Neutral
Novo Nordisk's Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults,https://www.marketwatch.com/story/novo-nordisk-says-wegovy-reduced-risk-of-adverse-cardiovascular-events-by-20-in-adults-with-obesity-in-trial-8f7e6661,2023-08-08 11:29:00,Obesity drug shows positive results in tackling some of the other illnesses caused by being overweight.,PFE,0.111747,0.156736,Somewhat-Bullish
Lyme disease: A doctor explains what it is,https://www.cnn.com/2023/08/08/health/lyme-diagnosis-disease-tick-prevention-wellness/index.html,2023-08-08 11:27:00,"Bella Hadid shares her health issues, including Lyme disease. A doctor explains what it is ...",PFE,0.036476,0.082238,Neutral
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update,https://www.globenewswire.com/news-release/2023/08/08/2720463/0/en/Arvinas-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html,2023-08-08 11:00:00,"- Enrollment continues globally in multiple clinical studies of vepdegestrant ( ARV-471 ) , including VERITAC-2 2L Phase 3 trial and study lead-in for the VERITAC-3 1L Phase 3 trial, both in ER+/HER2- metastatic breast cancer ...",PFE,0.182276,0.08863,Neutral
Novavax posts quarterly profit on COVID vaccine sales,https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-posts-unexpected-q2-profit-earlier-covid-revenue-2023-08-08/,2023-08-08 10:56:00,"Aug 8 ( Reuters ) - Novavax ( NVAX.O ) reported a second-quarter profit on Tuesday, helped by strong revenue from its COVID-19 vaccines, but still trimmed its full-year forecast for sales of the shot.",PFE,0.129516,0.012646,Neutral
2 High-Yield Dividend Stocks to Buy on the Dip,https://www.fool.com/investing/2023/08/08/2-high-yield-dividend-stocks-to-buy-on-the-dip/,2023-08-08 09:26:00,The market may have been a bit too harsh on these stocks.,PFE,0.346278,0.33192,Somewhat-Bullish
Is This Blue Chip Dividend Stock a Buy for Growth Investors?,https://www.fool.com/investing/2023/08/08/is-this-blue-chip-dividend-stock-a-buy-for-growth/,2023-08-08 09:20:00,The British drugmaker has been a winner for shareholders in recent years.,PFE,0.062761,0.204235,Somewhat-Bullish
Maravai LifeSciences  ( MRVI )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/08/maravai-lifesciences-mrvi-q2-2023-earnings-call-tr/,2023-08-08 05:30:19,"MRVI earnings call for the period ending June 30, 2023.",PFE,0.009732,0.021207,Neutral
"Bladder Cancer Market Likely to Exhibit Substantial Growth, Assesses DelveInsight | Leading Companies - CicloMed, Bristol-Myers Squibb, CG Oncology, Merck, Eli Lilly and Company, UroGen, Ferring",https://www.prnewswire.com/news-releases/bladder-cancer-market-likely-to-exhibit-substantial-growth-assesses-delveinsight--leading-companies---ciclomed-bristol-myers-squibb-cg-oncology-merck-eli-lilly-and-company-urogen-ferring-301894332.html,2023-08-07 21:01:00,"Bladder Cancer Market Likely to Exhibit Substantial Growth, Assesses DelveInsight | Leading Companies - CicloMed ... PR ...",PFE,0.045439,-0.031842,Neutral
BioNTech Se  ( BNTX )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/07/biontech-se-bntx-q2-2023-earnings-call-transcript/,2023-08-07 20:30:33,"BNTX earnings call for the period ending June 30, 2023.",PFE,0.072559,0.055503,Neutral
Covid Vaccine Makers' Stocks Crash To Multiyear Lows Monday As Sales Keep Sliding,https://www.forbes.com/sites/dereksaul/2023/08/07/covid-vaccine-makers-stocks-crash-to-multiyear-lows-monday-as-sales-keep-sliding/,2023-08-07 20:18:39,Moderna has now wiped out nearly $160 billion worth of early pandemic stock gains.,PFE,0.25168,-0.148197,Neutral
Why BioNTech Stock Was Sinking Today,https://www.fool.com/investing/2023/08/07/why-biontech-stock-was-sinking-today/,2023-08-07 19:46:15,"While the waning of the COVID pandemic is a positive development for the world, it's left the German biotech struggling.",PFE,0.148731,-0.082729,Neutral
OPKO Health  ( OPK )  Q2 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2133267/opko-health-opk-q2-earnings-and-revenues-top-estimates,2023-08-07 17:21:00,"Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall second-quarter results reflect soft performances.",PFE,0.077218,0.184518,Somewhat-Bullish
Red Cross ends blood donation restrictions that singled out gay and bisexual men,https://www.cnbc.com/2023/08/07/red-cross-ends-blood-donation-rules-singling-out-gay-and-bisexual-men.html,2023-08-07 17:02:14,The FDA in May dropped a nearly 40-year policy that had singled out men who have sex with men.,PFE,0.075635,-0.178207,Somewhat-Bearish
Bella Hadid Says She's 'Finally Healthy' After 10-Year Battle With Lyme-What To Know About The Increasingly Common Disease,https://www.forbes.com/sites/maryroeloffs/2023/08/07/bella-hadid-says-shes-finally-healthy-after-10-year-battle-with-lyme-what-to-know-about-the-increasingly-common-disease/,2023-08-07 16:34:15,"Lyme disease has become increasingly common in the United States, and the only vaccine approved to treat it was pulled from the market two decades ago.",PFE,0.061315,-0.024118,Neutral
"New Data May Push Insurers to Cover Novo, Lilly Obesity Drugs",https://www.barrons.com/amp/articles/novo-nordisk-wegovy-study-prevent-heart-attack-ae09e586,2023-08-07 15:55:00,Does Novo's Weight Loss Drug Prevent Heart Attacks? Investors Will Soon Know. ...,PFE,0.044885,0.0,Neutral
"Top Stories Monday, Aug 7: PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories - Apple  ( NASDAQ:AAPL ) , Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/markets/cryptocurrency/23/08/33602277/paypal-unveils-usd-backed-stablecoin-trucking-firm-yellow-corp-files-for-bankruptcy-fda-ap,2023-08-07 14:34:22,"In a significant move to bolster the adoption of digital tokens for transactions, PayPal Holdings Inc PYPL announced Monday the launch of a new U.S. dollar-denominated stablecoin. The digital coin, issued by Paxos Trust Co., is underpinned by U.S. dollar deposits, short-term Treasuries, and other ...",PFE,0.042876,0.08893,Neutral
Pharma Earnings Reports Are Moving The Markets And AI Shakes Up The Emerging Tech Space - AI Newsletter August 5th,https://www.forbes.com/sites/qai/2023/08/07/pharma-earnings-reports-are-moving-the-markets-and-ai-shakes-up-the-emerging-tech-spaceforbes-ai-newsletter-august-5th/,2023-08-07 14:16:24,"Subscribe to the Forbes AI newsletter to stay in the loop and get AI-backed investing insights, the latest news and more delivered directly to your inbox every weekend.",PFE,0.043579,0.007952,Neutral
Why BioNTech  ( BNTX )  Shares Are Trading Lower Today - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/general/biotech/23/08/33597934/biontech-slips-into-quarterly-loss-as-q2-revenue-evaporates-cuts-r-d-spending-for-fy23,2023-08-07 13:55:32,"BioNTech SE BNTX has reported Q2 revenues of €167.7 million, sharply down from €3.2 billion a year ago. For the six months ended June 30, 2023, total revenues were €1.44 billion, compared to €9.6 billion for the comparative prior year period.",PFE,0.416844,0.177687,Somewhat-Bullish
"Viatris beats second-quarter revenue estimates, says divestiture plans on track",https://www.reuters.com/business/healthcare-pharmaceuticals/viatris-beats-second-quarter-revenue-estimates-says-divestiture-plans-track-2023-08-07/,2023-08-07 12:29:00,"Aug 7 ( Reuters ) - Viatris Inc ( VTRS.O ) beat Wall Street estimates for second-quarter revenue on Monday, on the strength of its branded drug portfolio, sending its shares up 2% in premarket trading.",PFE,0.136888,-0.08301,Neutral
Lupin Pharmaceuticals Just Recalled Two Birth Control Pills - Did It Affect The Stock?,https://www.forbes.com/sites/qai/2023/08/07/lupin-pharmaceuticals-just-recalled-two-birth-control-pillsdid-it-affect-the-stock/,2023-08-07 12:19:59,"Despite the news, Lupin's share price rose 4% on earnings results and has increased 47% in ...",PFE,0.033562,-0.077014,Neutral
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer,https://www.prnewswire.com/news-releases/ligandal-inc-appoints-tushar-nuwal-as-chief-operating-officer-and-chief-business-officer-301894154.html,2023-08-07 11:55:00,"NEW YORK, Aug. 7, 2023 /PRNewswire/ -- Ligandal Inc., an early-stage genetic medicine biotechnology company, announces the appointment of Tushar Nuwal as Chief Operating Officer and Chief Business Officer. Mr. Nuwal brings 20 years of biopharmaceutical experience, including roles at small and ...",PFE,0.094762,0.253067,Somewhat-Bullish
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer,https://www.newswire.ca/news-releases/ligandal-inc-appoints-tushar-nuwal-as-chief-operating-officer-and-chief-business-officer-809902364.html,2023-08-07 11:55:00,"NEW YORK, Aug. 7, 2023 /CNW/ -- Ligandal Inc., an early-stage genetic medicine biotechnology company, announces the appointment of Tushar Nuwal as Chief Operating Officer and Chief Business Officer. Mr. Nuwal brings 20 years of biopharmaceutical experience, including roles at small and large ...",PFE,0.094762,0.253067,Somewhat-Bullish
"Viracta Therapeutics Appoints Darrel P. Cohen, M.D., Ph.D. as Chief Medical Officer - Viracta Therapeutics  ( NASDAQ:VIRX ) ",https://www.benzinga.com/pressreleases/23/08/g33597560/viracta-therapeutics-appoints-darrel-p-cohen-m-d-ph-d-as-chief-medical-officer,2023-08-07 11:30:00,"SAN DIEGO, Aug. 07, 2023 ( GLOBE NEWSWIRE ) -- Viracta Therapeutics, Inc. VIRX, a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced the appointment of Darrel P.",PFE,0.091335,0.00315,Neutral
Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1],https://www.prnewswire.com/news-releases/viatris-reports-strong-financial-and-operational-results-for-second-quarter-2023-and-reaffirms-full-year-2023-guidance-ranges1-301894251.html,2023-08-07 10:59:00,Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 ... PR ...,PFE,0.007882,0.073014,Neutral
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results,https://www.prnewswire.com/news-releases/protalix-biotherapeutics-reports-second-quarter-2023-financial-and-business-results-301894457.html,2023-08-07 10:50:00,Company to host conference call and webcast today at 8:30 a.m. EDT,PFE,0.075794,-0.01448,Neutral
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results,https://www.prnewswire.com/il/news-releases/protalix-biotherapeutics-reports-second-quarter-2023-financial-and-business-results-301894457.html,2023-08-07 10:50:00,Company to host conference call and webcast today at 8:30 a.m. EDT,PFE,0.075794,-0.01448,Neutral
BioNTech reduces drug development spend as COVID vaccine sales plunge,https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-reduces-drug-development-spend-covid-shot-sales-plunge-2023-08-07/,2023-08-07 10:19:00,BioNTech reduces drug development spend as COVID shot sales plunge ...,PFE,0.12546,0.268029,Somewhat-Bullish
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update,https://www.globenewswire.com/news-release/2023/08/07/2719502/0/en/BioNTech-Announces-Second-Quarter-2023-Financial-Results-and-Corporate-Update.html,2023-08-07 10:00:00,"Conference call and webcast scheduled for August 7, 2023, at 8:00 am EDT ( 2:00 pm CEST ...",PFE,0.098456,0.110349,Neutral
DualityBio Expands Global Strategic Partnership with BioNTech to Accelerate Development of a Third Antibody-Drug Conjugate Therapeutics for Solid Tumors,https://www.prnewswire.com/news-releases/dualitybio-expands-global-strategic-partnership-with-biontech-to-accelerate-development-of-a-third-antibody-drug-conjugate-therapeutics-for-solid-tumors-301894397.html,2023-08-07 10:00:00,DualityBio Expands Global Strategic Partnership with BioNTech to Accelerate Development of a Third Antibody-Drug ... PR ...,PFE,0.072435,-0.007133,Neutral
"AstraZeneca, Sanofi RSV Drug for infants wins CDC backing",https://www.financialexpress.com/healthcare/pharma-healthcare/astrazeneca-sanofi-rsv-drug-for-infants-wins-cdc-backing/3201773/,2023-08-07 03:30:00,"A drug from AstraZeneca Plc and Sanofi to protect infants against a potentially fatal respiratory illness won backing Thursday from US public health advisers, moving it closer to being administered alongside other childhood immunizations.",PFE,0.158,0.020741,Neutral
"Want $5,000 of Super-Safe Annual Income? Invest $91,400 in These 3 High-Yield Dividend Stocks",https://www.fool.com/investing/2023/08/06/want-5000-of-super-safe-annual-income-invest-91400/,2023-08-06 09:52:00,These dividends are dependable.,PFE,0.427597,0.358481,Bullish
Get Some Sleep Before the Week Ahead,https://moneymorning.com/2023/08/05/get-some-sleep-before-the-week-ahead/,2023-08-05 23:41:01,"An independent and profitable state of mind. They don't ask about stress or exercise. Instead, they write scripts and offer pills to get you back to seven hours of sleep. My doctor started with the ""sleep aid"" Ambien. What an adventure. My dreams - a mishmash of frantic clichés.",PFE,0.057284,-0.001001,Neutral
CDC recommends RSV shots to protect babies from illness,https://www.foxbusiness.com/lifestyle/cdc-recommends-rsv-shots-protect-babies-illness,2023-08-05 13:31:40,The Centers for Disease Control and Prevention said Thursday that it is recommending a new immunization this fall to protect infants under eight months and some older babies at increased risk of severe illness from respiratory syncytial virus.,PFE,0.167322,0.063666,Neutral
Alphabet Stock Looks Unbeatable. Here's Why,https://www.fool.com/investing/2023/08/05/alphabet-stock-looks-unbeatable-heres-why/,2023-08-05 13:31:00,"From cloud growth to enhancements in AI, Alphabet's Q2 earnings had it all.",PFE,0.046363,0.051747,Neutral
"As a summer wave of Covid-19 hits the US, questions about vaccines, quarantine and testing are back",https://www.cnn.com/2023/08/04/health/questions-about-covid-vaccines-quarantine-and-testing-are-back/index.html,2023-08-04 18:52:32,"Covid-19 is on the rise again as the world approaches the fourth virus season since the coronavirus arrived on the scene. US Centers for Disease Control and Prevention data show a slight increase in hospital admissions, emergency department visits, and positive Covid-19 tests - although not ...",PFE,0.065866,0.09254,Neutral
Women's Health Global Marketplace 2023-2030: Endometriosis Applications Poised for Remarkable Expansion with Relugoliz and Linzagolix Set to Lead the Way,https://www.prnewswire.com/news-releases/womens-health-global-marketplace-2023-2030-endometriosis-applications-poised-for-remarkable-expansion-with-relugoliz-and-linzagolix-set-to-lead-the-way-301893558.html,2023-08-04 18:30:00,Women's Health Global Marketplace 2023-2030: Endometriosis Applications Poised for Remarkable Expansion with ... PR ...,PFE,0.065866,0.160209,Somewhat-Bullish
Three Shots for Fall: What You Need to Know,https://www.nytimes.com/article/flu-covid-rsv-vaccines.html,2023-08-04 18:09:13,"Most Americans have had one or more shots of the flu and Covid vaccines. New this year are the first shots to protect older adults and infants from respiratory syncytial virus, a lesser-known threat whose toll in hospitalizations and deaths may rival that of flu.",PFE,0.037504,-0.033886,Neutral
Pfizer limits distribution of some drugs from North Carolina plant damaged by tornado,https://www.cnbc.com/2023/08/04/pfizer-limits-distribution-of-some-drugs-from-nc-plant-damaged-by-tornado.html,2023-08-04 17:41:17,"Pfizer's Rocky Mount facility supplies 8% of all sterile injectable medicines used in U.S. hospitals, including anesthesia, analgesia and anti-infectives.",PFE,0.400052,-0.184261,Somewhat-Bearish
"Will AI Take Our Jobs? Pew Research Shines Light On Exposure, Workers At These Corporates Are Vulnerable - Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) , Tesla  ( NASDAQ:TSLA ) , IBM  ( NYSE:IBM ) , Ford Motor  ( NYSE:F ) , JPMorgan Chase  ( NYSE:JPM ) , Amazon.com  ( NASDAQ:AMZN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/08/33578554/will-ai-going-take-our-jobs-pew-research-shines-light-on-exposure-workers-at-these-corporates-are-vu,2023-08-04 16:47:30,"A recent study by the Pew Research Center shed some light on the exposure of American workers to artificial intelligence ( AI ) at their jobs. The report disclosed intriguing information regarding the influence of AI on different sectors, demographic groups, and job categories.",PFE,0.12546,0.110311,Neutral
ABBV: Are Pfizer  ( PFE )  and AbbVie  ( ABBV )  Good Value Buys for August?,https://stocknews.com/news/abbv-pfe-opk-are-pfizer-pfe-and-abbvie-abbv-good-value-buys-for/,2023-08-04 15:18:59,"Demand for new and innovative drugs and widespread adoption of precision medicines is expected to boost the pharma industry. As the industry shows solid potential, quality pharma stock AbbVie Inc. ( ABBV ) might be a good value buy for August.",PFE,0.35106,0.370214,Bullish
Bioprocess Validation Market to grow at a CAGR of 11.39% from 2022 to 2027|Increasing demand for ... - PR Newswire,https://www.prnewswire.com/news-releases/bioprocess-validation-market-to-grow-at-a-cagr-of-11-39-from-2022-to-2027increasing-demand-for-biopharmaceuticals-to-boost-market-growth---technavio-301892736.html,2023-08-04 15:15:00,Bioprocess Validation Market to grow at a CAGR of 11.39% from 2022 to 2027|Increasing demand for ... PR ...,PFE,0.093168,0.12168,Neutral
"Acute Lymphoblastic Leukemia Market Size to Surpass USD 4.5 billion by 2031, globally, expanding at a CAGR of 7.6%: TMR Report",https://www.benzinga.com/pressreleases/23/08/g33574927/acute-lymphoblastic-leukemia-market-size-to-surpass-usd-4-5-billion-by-2031-globally-expanding-at-,2023-08-04 14:00:00,"Wilmington, Delaware, United States, Aug. 04, 2023 ( GLOBE NEWSWIRE ) -- The global acute lymphoblastic leukemia market is projected to flourish at a CAGR of 7.6% from 2022 to 2031. As per the report published by TMR, a valuation of more than US$ 4.5 billion is anticipated for the market in 2031.",PFE,0.080188,0.112944,Neutral
4 Biotech Stocks Set to Outpace Q2 Earnings Estimates,https://www.zacks.com/stock/news/2132745/4-biotech-stocks-set-to-outpace-q2-earnings-estimates,2023-08-04 13:21:00,"Let us look at some biotech stocks, ARCT, AXSM, EBS and NVAX, which are poised to beat on second-quarter earnings.",PFE,0.051886,-0.030014,Neutral
The Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027|The advancement ... - PR Newswire,https://www.prnewswire.com/news-releases/the-pulmonary-embolism-therapeutics-market-size-to-grow-at-a-cagr-of-9-52-from-2022-to-2027the-advancement-in-the-healthcare-and-medical-sector-is-a-major-trend-technavio-301892623.html,2023-08-04 09:30:00,The Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027|The advancement ... PR ...,PFE,0.045569,0.139204,Neutral
Sosei Heptares Operational Highlights and Consolidated Results for the Second Quarter and First Half of 2023,https://www.globenewswire.com/news-release/2023/08/04/2718743/0/en/Sosei-Heptares-Operational-Highlights-and-Consolidated-Results-for-the-Second-Quarter-and-First-Half-of-2023.html,2023-08-04 06:37:00,"Tokyo, Japan and Cambridge, UK, 4 August 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2023. The full report can be found by clicking here.",PFE,0.105604,0.122329,Neutral
Opko Health  ( OPK )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/04/opko-health-opk-q2-2023-earnings-call-transcript/,2023-08-04 05:00:22,"OPK earnings call for the period ending June 30, 2023.",PFE,0.081301,0.126125,Neutral
"Babies should get recently approved drug for RSV, CDC says",https://apnews.com/article/rsv-babies-drug-cdc-astrazeneca-sanofi-shot-c03b72aaa51e59176cfa3feb3ceac06c,2023-08-03 22:32:00,"Babies should get new drug that prevents RSV, CDC says The Associated Press ...",PFE,0.105141,0.124157,Neutral
"Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors - Structure Therapeutics  ( NASDAQ:GPCR ) ",https://www.benzinga.com/pressreleases/23/08/g33562525/structure-therapeutics-appoints-ted-w-love-m-d-to-board-of-directors,2023-08-03 21:32:00,"SAN FRANCISCO, Aug. 03, 2023 ( GLOBE NEWSWIRE ) -- Structure Therapeutics Inc. GPCR, a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases, today announced that it has appointed Ted W. Love, M.D., to its Board of ...",PFE,0.074001,0.139298,Neutral
"Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors",https://www.globenewswire.com/news-release/2023/08/03/2718677/0/en/Structure-Therapeutics-Appoints-Ted-W-Love-M-D-to-Board-of-Directors.html,2023-08-03 21:32:00,"SAN FRANCISCO, Aug. 03, 2023 ( GLOBE NEWSWIRE ) -- Structure Therapeutics Inc. ( NASDAQ: GPCR ) , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases, today announced that it has appointed Ted W.",PFE,0.044222,0.141804,Neutral
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,2023-08-03 21:01:00,"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight ... PR ...",PFE,0.041466,0.0,Neutral
"Buy Zone Adjacent Med Stock Beats Sales Views, But There's A Caveat",https://www.investors.com/news/technology/txg-stock-buy-zone-adjacent-beats-sales-views-but-there-is-a-caveat/,2023-08-03 20:46:00,"Life science company 10x Genomics ( TXG ) beat Wall Street's second-quarter sales forecasts Thursday, though losses came in steeper than expected. TXG stock, which has been on a 10-month run, skidded in late action. Chief Executive Serge Saxonov credited the strong launch of Xenium, a platform ...",PFE,0.067727,-0.118348,Neutral
Pfizer taking additional steps to manage inventory at Rocky Mount Plant,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-taking-additional-steps-manage-inventory-rocky-mount-plant-2023-08-03/,2023-08-03 18:45:00,"The roof of a Pfizer facility shows heavy damage after a tornado passed the area in Rocky Mount, North Carolina, U.S. July 19, 2023. ABC Affiliate WTVD via REUTERS/File Photo",PFE,0.690822,-0.373206,Bearish
"Infant RSV shot wins backing of CDC advisors, paving way for fall availability",https://www.cnbc.com/2023/08/03/infant-rsv-shot-faces-final-hurdle-at-cdc-could-be-available-by-fall.html,2023-08-03 18:39:29,Sanofi has said the companies are prepared to roll the shot out before RSV season this fall and do not foresee any challenges meeting demand.,PFE,0.058472,-0.176001,Somewhat-Bearish
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/08/33553273/looking-at-pfizers-recent-unusual-options-activity,2023-08-03 15:46:14,"A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 61% of the investors opened trades with bullish expectations and ...",PFE,0.835133,0.233923,Somewhat-Bullish
Here's What Vaccines Your Child Will Need Before School Starts,https://www.forbes.com/sites/willskipworth/2023/08/03/heres-what-vaccines-your-child-will-need-before-school-starts/,2023-08-03 15:09:30,"Each state has different school vaccinations requirements, but many vaccines are required across the country.",PFE,0.129516,-0.192826,Somewhat-Bearish
Moderna  ( MRNA )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/03/moderna-mrna-q2-2023-earnings-call-transcript/,2023-08-03 15:00:24,"MRNA earnings call for the period ending June 30, 2023.",PFE,0.005501,0.049535,Neutral
"DNA and Gene Cloning Services Market likely to surpass USD 9 billion, expected to expand at a 13.7% CAGR from 2022 to 2031: TMR Report",https://www.benzinga.com/pressreleases/23/08/g33551152/dna-and-gene-cloning-services-market-likely-to-surpass-usd-9-billion-expected-to-expand-at-a-13-7-,2023-08-03 14:30:00,"Wilmington, Delaware, United States, Aug. 03, 2023 ( GLOBE NEWSWIRE ) -- The global market for DNA and gene cloning services was estimated to have garnered a global market valuation around US$ 2.5 billion in 2022.",PFE,0.079392,0.136274,Neutral
Is Pfizer Stock A Buy Or A Sell With Covid Revenue In The Rearview?,https://www.investors.com/news/technology/pfizer-stock-buy-now/,2023-08-03 12:00:00,"Pfizer ( PFE ) stock has tumbled this year as demand for Covid products wanes and amid a fresh challenge in the obesity treatment space. During the second quarter, Pfizer's sales plummeted by half and missed forecasts. Adjusted earnings also tumbled, but beat forecasts by a penny.",PFE,0.647462,0.0,Neutral
"Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Likely Won't Work.",https://www.investors.com/news/technology/pfizer-stock-why-covid-boosters-likely-will-not-be-its-saving-grace/,2023-08-03 12:00:00,Pfizer Stock: Why Covid Boosters Likely Won't Be Its Saving Grace Investor's Business Daily ...,PFE,0.554365,-0.13168,Neutral
Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales,https://www.cnbc.com/2023/08/03/moderna-mrna-q2-earnings-report-2023.html,2023-08-03 11:09:56,Moderna and its rivals Pfizer and Novavax have all seen a steep drop in sales of Covid vaccines and treatments as the world moves on from the pandemic.,PFE,0.066414,-0.090377,Neutral
Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors - Cara Therapeutics  ( NASDAQ:CARA ) ,https://www.benzinga.com/pressreleases/23/08/g33543386/cara-therapeutics-appoints-helen-m-boudreau-to-board-of-directors,2023-08-03 11:00:00,"STAMFORD, Conn., Aug. 03, 2023 ( GLOBE NEWSWIRE ) -- Cara Therapeutics, Inc. CARA, a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the appointment of Helen M. Boudreau to its Board of Directors.",PFE,0.061159,0.0,Neutral
Fulcrum Therapeutics Appoints Chief Financial Officer,https://www.globenewswire.com/news-release/2023/08/03/2717802/0/en/Fulcrum-Therapeutics-Appoints-Chief-Financial-Officer.html,2023-08-03 10:55:00,"- Alan A. Musso appointed as CFO effective August 7, 2023 - - Alan A. Musso appointed as CFO effective August ...",PFE,0.075397,0.080771,Neutral
Fulcrum Therapeutics Appoints Chief Financial Officer - Fulcrum Therapeutics  ( NASDAQ:FULC ) ,https://www.benzinga.com/pressreleases/23/08/g33543240/fulcrum-therapeutics-appoints-chief-financial-officer,2023-08-03 10:55:00,"CAMBRIDGE, Mass., Aug. 03, 2023 ( GLOBE NEWSWIRE ) -- Fulcrum Therapeutics, Inc.® FULC, a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the appointment of Alan A.",PFE,0.072987,0.07954,Neutral
Moderna sees up to $8 bln in 2023 COVID vaccine sales on private market hopes,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-sees-up-8-bln-2023-covid-vaccine-sales-private-market-hopes-2023-08-03/,2023-08-03 10:49:00,"Moderna logo and stock graph are seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration/File photo",PFE,0.233556,-0.045315,Neutral
Big Pharma rakes in $215 billion a year in America - yet pays almost no taxes,https://www.businessinsider.com/big-pharma-companies-taxes-american-billion-dollar-profits-drugs-healthcare-2023-8,2023-08-03 09:28:00,Trick that helps Big Pharma companies avoid paying billons in US taxes - Business Insider ...,PFE,0.045482,0.094311,Neutral
Here's Why Investors Should Buy These 2 Medical Stocks After Earnings,https://www.zacks.com/stock/news/2131624/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings,2023-08-03 05:31:00,Following their favorable Q2 reports now looks like a good time to buy Encompass Health (EHC) and Vertex Pharmaceuticals (VRTX) stock.,PFE,0.213048,-0.010426,Neutral
"Atherosclerosis Market to Witness Growth by 2032, Estimates DelveInsight | Leading Companies - CSL Behring, Novartis, Merck, Amgen, Ionis , BioMarin, AstraZeneca",https://www.prnewswire.com/news-releases/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight--leading-companies---csl-behring-novartis-merck-amgen-ionis--biomarin-astrazeneca-301891245.html,2023-08-02 21:01:00,"Atherosclerosis Market to Witness Growth by 2032, Estimates DelveInsight | Leading Companies - CSL Behring ... PR ...",PFE,0.028868,0.037471,Neutral
"FDA warns some Tydemy birth control pills may not be effective, could result in unexpected pregnancy",https://www.cnbc.com/2023/08/02/tydemy-birth-control-pill-may-not-be-effective-fda-warns.html,2023-08-02 19:40:37,"The pills tested low for ascorbic acid, which could reduce their effectiveness and result in unwanted pregnancy, the FDA said.",PFE,0.144275,-0.218898,Somewhat-Bearish
Pfizer Sued By GSK Over Alleged Patent Infringement For Its RSV Vaccine,https://www.forbes.com/sites/willskipworth/2023/08/02/pfizer-sued-by-gsk-over-alleged-patent-infringement-for-its-rsv-vaccine/,2023-08-02 18:02:59,British drugmaker GlaxoSmithKline is accusing Pfizer of infringing on four of its patents in its RSV vaccine.,PFE,0.512933,0.052422,Neutral
"GSK, Pfizer Lock Horns Over Patent Fight Related To Respiratory Syncytial Virus Vaccine - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/08/33523594/gsk-pfizer-lock-horns-over-patent-fight-related-to-respiratory-syncytial-virus-vaccine,2023-08-02 15:18:41,"GSK Plc GSK has sued Pfizer Inc PFE in Delaware court, alleging that Pfizer's respiratory syncytial virus ( RSV ) vaccine Abrysvo violates GSK's four patent rights in its RSV shot Arexvy. The FDA approved both vaccines in May for use in adults over the age of 60.",PFE,0.866386,-0.083273,Neutral
2 Magnificient Growth Stocks I'm Buying in August,https://www.fool.com/investing/2023/08/02/2-magnificient-growth-stocks-im-buying-in-august/,2023-08-02 15:15:00,These biotech stocks could markedly outperform the broader market.,PFE,0.065327,0.132219,Neutral
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine,https://www.cnbc.com/2023/08/02/gsk-sues-pfizer-for-patent-infringement-over-rsv-vaccines.html,2023-08-02 14:59:29,Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.,PFE,0.56217,-0.032019,Neutral
Teva Surges Within Striking Distance Of A Key Line After Beat And Raise,https://www.investors.com/news/technology/teva-stock-teva-earnings-q2-2023/,2023-08-02 13:00:00,Teva Stock Flirts With 200-Day Line After Beat And Raise Investor's Business Daily ...,PFE,0.197413,-0.508899,Bearish
4 Vanguard Mutual Funds to Invest in for 2023 and Beyond,https://www.zacks.com/stock/news/2131101/4-vanguard-mutual-funds-to-invest-in-for-2023-and-beyond,2023-08-02 12:47:00,"Invest in Vanguard mutual funds like VEXPX, VASVX, VSTCX and VWNDX that have given impressive returns so far this year and are expected to do the same in 2023 and beyond.",PFE,0.050044,0.050511,Neutral
Voyager Therapeutics to Present at the Canaccord Genuity Growth Conference,https://www.globenewswire.com/news-release/2023/08/02/2716671/36461/en/Voyager-Therapeutics-to-Present-at-the-Canaccord-Genuity-Growth-Conference.html,2023-08-02 11:00:00,"CAMBRIDGE, Mass., Aug. 02, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( Nasdaq: VYGR ) , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that Chief Scientific Officer Todd Carter, Ph.D., and Chief Financial Officer Peter ...",PFE,0.136113,0.028497,Neutral
Voyager Therapeutics to Present at the Canaccord Genuity Growth Conference - Voyager Therapeutics  ( NASDAQ:VYGR ) ,https://www.benzinga.com/pressreleases/23/08/g33516871/voyager-therapeutics-to-present-at-the-canaccord-genuity-growth-conference,2023-08-02 11:00:00,"CAMBRIDGE, Mass., Aug. 02, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc.",PFE,0.130217,0.026583,Neutral
CVS beats on earnings and revenue as the company slashes costs,https://www.cnbc.com/2023/08/02/cvs-health-cvs-q2-2023-earnings.html,2023-08-02 10:39:16,CVS is cutting costs as it pushes deeper into healthcare services after its acquisitions of Signify Health and Oak Street Health.,PFE,0.154455,-0.227721,Somewhat-Bearish
Haleon Upgrades Full-Year Sales Forecasts As Recent Trading Impresses,https://www.forbes.com/sites/roystonwild/2023/08/02/haleon-upgrades-full-year-sales-forecasts-as-recent-trading-impresses/,2023-08-02 09:36:56,"The FTSE 100 healthcare firm said that revenues increased 10.6% in the first half, while pre-tax profit increased 11.1% year on year.",PFE,0.076358,0.111351,Neutral
"Fear & Greed Index Moves To 'Greed' Zone After S&P 500 Settles Lower - McKesson  ( NYSE:MCK ) , Merck & Co  ( NYSE:MRK ) ",https://www.benzinga.com/news/earnings/23/08/33513689/fear-greed-index-moves-to-greed-zone-after-s-p-500-settles-lower,2023-08-02 07:47:13,"U.S. stocks closed mixed on Tuesday, as investors digested recent earnings reports and a fresh batch of economic data. Merck & Co Inc MRK posted a narrower-than-expected quarterly loss, while sales topped estimates. Pfizer Inc PFE reported a second-quarter adjusted EPS of $0.67, down 67% Y/Y, but ...",PFE,0.325208,-0.383508,Bearish
Pfizer  ( PFE )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/01/pfizer-pfe-q2-2023-earnings-call-transcript/,2023-08-02 02:30:26,"PFE earnings call for the period ending June 30, 2023.",PFE,0.066405,0.098787,Neutral
"US stocks mixed as traders mull earnings, await jobs data",https://www.moneycontrol.com/news/business/markets/us-stocks-mixed-as-traders-mull-earnings-await-jobs-data-11077241.html,2023-08-02 00:42:53,"US manufacturing activity contracted for a ninth straight month in July, according to the Institute for Supply Management, as the impact of higher interest rates rippled through the world's largest economy.",PFE,0.303175,-0.335853,Somewhat-Bearish
"MicroStrategy Adds To Its Bitcoin Stash In Q2, Crypto Aids Results",https://www.forbes.com/sites/emilymason/2023/08/01/microstrategy-adds-to-its-bitcoin-stash-in-q2-crypto-aids-results/,2023-08-01 23:21:39,Earnings beat estimates as impairment charges dissipate. Potential ETF challengers offer rewards then risks.,PFE,0.075397,0.178149,Somewhat-Bullish
Vaccines for flu and RSV now available ahead of fall virus season,https://www.cnn.com/2023/08/01/health/vaccine-appointments-ahead-of-the-fall-virus-season/index.html,2023-08-01 21:14:00,"With the fall respiratory virus season just around the corner, major US pharmacy chains have begun rolling out flu and RSV vaccine appointments. Walgreens is now offering both kinds of shots, the company said Tuesday. Anyone 3 or older can get a flu shot, and adults 60 and older are eligible for ...",PFE,0.141726,0.091982,Neutral
Pfizer Expects Signoff For New Covid Boosters As Soon As This Month. Here's What To Know-And Why They're Needed,https://www.forbes.com/sites/willskipworth/2023/08/01/pfizer-expects-signoff-for-new-covid-boosters-as-soon-as-this-month-heres-what-to-know-and-why-theyre-needed/,2023-08-01 20:48:52,Pfizer and BioNTech expect to release a new Covid-19 booster shot designed to protect against the XXB.1.5 and XXB.1.6 variants.,PFE,0.218817,0.081552,Neutral
This Cathie Wood's Darling Just Came Up With A Sixth Big Sales Quarter,https://www.investors.com/news/technology/exas-stock-cologuard-sales-surge-as-exact-sciences-run-continues/,2023-08-01 20:27:00,EXAS Stock: Cologuard Sales Surge As Exact Sciences' Run Continues Investor's Business Daily ...,PFE,0.212115,-0.248074,Somewhat-Bearish
This Tech Giant And Cash Machine Just Beat Expectations,https://www.investors.com/news/technology/vrtx-stock-vertex-earnings-q2-2023/,2023-08-01 20:15:00,"VRTX Stock: Tech Leader Beats And Raises, But Shares Dip Investor's Business Daily ...",PFE,0.202366,-0.516542,Bearish
"Mixed Brew: Pfizer, Merck Earnings Head Opposite Ways, But Uber And Caterpillar Slug Line Drives - Alaska Air Gr  ( NYSE:ALK ) , Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/markets/23/08/33501240/mixed-brew-pfizer-merck-earnings-head-opposite-ways-but-uber-and-caterpillar-slug-line-drives,2023-08-01 17:36:23,"( Tuesday market open ) The new month starts with stocks tinted red, but this week's main events are just getting underway. A rise in Treasury yields might have investors nervous early Tuesday as the 10-year yield popped back above 4% ahead of key U.S. economic data.",PFE,0.077156,-0.033955,Neutral
Walgreens is now offering RSV vaccines for older adults,https://www.cnbc.com/2023/08/01/walgreens-is-now-offering-rsv-vaccines-for-older-adults.html,2023-08-01 16:48:30,This is the first RSV season in which older adults have the option to get vaccinated against the virus.,PFE,0.334762,-0.01697,Neutral
"Pfizer's  ( PFE )  Q2 Earnings Beat, Sales Miss, Stock Declines",https://www.zacks.com/stock/news/2130528/pfizers-pfe-q2-earnings-beat-sales-miss-stock-declines,2023-08-01 15:15:00,Pfizer (PFE) beats estimates for second-quarter earnings but misses the same for sales. It trims the upper end of its revenue guidance range for 2023. Stock falls.,PFE,0.481177,0.106627,Neutral
Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences,https://www.marketwatch.com/story/merck-posts-narrower-than-expected-loss-and-sales-top-estimates-42c4e417,2023-08-01 15:15:00,Merck's earnings were also hit by lower sales of its COVID antiviral Lagevrio.,PFE,0.254307,-0.313311,Somewhat-Bearish
Market Awaits JOLTS Report,https://www.zacks.com/stock/news/2130519/market-awaits-jolts-report,2023-08-01 15:03:00,"Although the month of August is generally one of the lightest for the stock market, in terms of trading volume, etc., in the early part of the month we're in the thick of Q2 earnings season.",PFE,0.131284,0.146514,Neutral
The Atlantic Festival Announces Full Agenda and Evening Programming,https://www.theatlantic.com/press-releases/archive/2023/08/atlantic-festival-full-agenda/674873/,2023-08-01 15:00:00,Atlantic Festival Full Agenda The Atlantic ...,PFE,0.063091,0.238392,Somewhat-Bullish
"Uber, Pfizer, JetBlue Beat Q2 Earnings, Miss Sales",https://www.zacks.com/stock/news/2130483/uber-pfizer-jetblue-beat-q2-earnings-miss-sales,2023-08-01 14:24:00,"After today's close, Advanced Micro Devices (AMD) will be the latest important tech stock reporting, and will join Starbucks (SBUX).",PFE,0.129168,0.14536,Neutral
US Stocks Mixed; Pfizer Earnings Beat Views,https://markets.businessinsider.com/news/stocks/us-stocks-mixed-pfizer-earnings-beat-views-1032501209,2023-08-01 13:51:40,US Stocks Mixed. Pfizer Earnings Beat Views ...,PFE,0.128822,0.130212,Neutral
US Stocks Mixed; Pfizer Earnings Beat Views - American Superconductor  ( NASDAQ:AMSC ) ,https://www.benzinga.com/news/earnings/23/08/33495105/us-stocks-mixed-pfizer-earnings-beat-views,2023-08-01 13:41:54,"U.S. stocks were mixed this morning, with the Dow Jones trading slightly higher on Tuesday. Following the market opening Tuesday, the Dow traded up 0.03% to 35,568.68 while the NASDAQ fell 0.57% to 14,264.52. The S&P 500, also fell, dropping, 0.32% to 4,574.50. Pfizer Inc.",PFE,0.195287,0.177424,Somewhat-Bullish
"Pfizer Takes Over 50% Hit In Q2 Sales As COVID-19 Related Revenues Dwindle, Tightens Annual Outlook - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/08/33492574/pfizer-takes-over-50-hit-in-q2-sales-as-covid-19-related-revenues-dwindle-tightens-annual-outlook,2023-08-01 13:33:58,"Pfizer Inc PFE has reported a Q2 adjusted EPS of $0.67, down 67% Y/Y, but beating the consensus of $0.57. The company reported sales of $12.73 billion, down 54% Y/Y, missing the consensus of $13.17 billion, primarily due to decreased sales from Paxlovid and Comirnaty.",PFE,0.745397,0.21098,Somewhat-Bullish
Jim Cramer's top 10 things to watch in the stock market Tuesday,https://www.cnbc.com/2023/08/01/jim-cramers-top-10-things-to-watch-in-the-stock-market-tuesday.html,2023-08-01 13:02:13,The S&P 500 and Nasdaq closed out July on five-month winning streaks.,PFE,0.111488,-0.001175,Neutral
Pfizer Dips As Waning Covid Products Demand Slams Sales,https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q2-2023/,2023-08-01 12:47:00,"Pfizer ( PFE ) stock fell Tuesday morning after the pharma giant reported adjusted earnings of 67 cents per share on $12.73 billion in second-quarter sales. On average, analysts polled by FactSet expected Pfizer to earn 57 cents per share on $13.36 billion in sales.",PFE,0.969608,0.332738,Somewhat-Bullish
Pfizer's stock drops as earnings fall sharply amid lower sales for its COVID products,https://www.marketwatch.com/story/pfizers-stock-falls-premarket-as-earnings-fall-sharply-amid-lower-sales-for-its-covid-vaccine-and-antiviral-a4fcffb1,2023-08-01 12:37:00,Pfizer's stock was down premarket as earnings hit by lower demand for its COVID products.,PFE,0.255641,-0.164754,Somewhat-Bearish
"Stocks making the biggest moves premarket: Uber, Gap, Caterpillar & more",https://www.cnbc.com/2023/08/01/stocks-making-the-biggest-moves-premarket-uber-gap-cat.html,2023-08-01 12:11:06,"Despite missing Wall Street's revenue expectations, shares of Uber rose more than 4% after the ride-hailing giant offered rosy guidance for the third quarter.",PFE,0.124164,-0.204185,Somewhat-Bearish
Pfizer  ( PFE )  Surpasses Q2 Earnings Estimates,https://www.zacks.com/stock/news/2130274/pfizer-pfe-surpasses-q2-earnings-estimates,2023-08-01 12:05:06,"Pfizer (PFE) delivered earnings and revenue surprises of 19.64% and 2.03%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.401331,0.122327,Neutral
Auron Establishes Premier Scientific Advisory Board to Support the Advancement of its AI-Powered Platform and Pipeline Targeting Cellular Plasticity in Cancer,https://www.benzinga.com/pressreleases/23/08/g33489909/auron-establishes-premier-scientific-advisory-board-to-support-the-advancement-of-its-ai-powered-p,2023-08-01 11:30:00,"NEWTON, Mass., Aug. 01, 2023 ( GLOBE NEWSWIRE ) -- Auron Therapeutics, a platform-based, product-driven biotechnology company focused on developing novel cancer therapies that target cellular plasticity, today announced the members of its scientific advisory board ( SAB ) , comprised of ...",PFE,0.0226,-0.003551,Neutral
uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress,https://www.globenewswire.com/news-release/2023/08/01/2715661/0/en/uniQure-Announces-Second-Quarter-2023-Financial-Results-and-Highlights-Recent-Company-Progress.html,2023-08-01 11:05:00,~ Announced encouraging interim analysis data from ongoing Phase I/II clinical trial of AMT-130 in Huntington's disease showing preservation of function compared to baseline and clinical benefits relative to natural history. both dose cohorts of AMT-130 continue to be generally ...,PFE,0.016304,0.049953,Neutral
"Pfizer beats on earnings, but revenue misses as Covid product sales plummet",https://www.cnbc.com/2023/08/01/pfizer-pfe-q2-earnings-report-2023.html,2023-08-01 10:54:56,Pfizer is in a transition period as it pivots away from its blockbuster Covid vaccine and drug Paxlovid while the world emerges from the pandemic.,PFE,0.749619,0.086632,Neutral
Pfizer misses revenue estimates as COVID product sales decline,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-misses-quarterly-revenue-estimates-covid-product-sales-decline-2023-08-01/,2023-08-01 10:54:00,"Aug 1 ( Reuters ) - Pfizer Inc ( PFE.N ) on Tuesday fell short of Wall Street estimates for quarterly revenue, hit by declining sales of its COVID-19 products. The U.S. drugmaker has said it expects 2023 to be a low point for COVID product sales following strong demand at the peak of the ...",PFE,0.318897,-0.4559,Bearish
"Nasdaq, S&P 500 Futures Pullback After Strong July; Why This Analyst Recommends Staying Fully Invested - MicroStrategy  ( NASDAQ:MSTR ) , Arista Networks  ( NYSE:ANET ) , JetBlue Airways  ( NASDAQ:JBLU ) , Merck & Co  ( NYSE:MRK ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) , Sirius XM Holdings  ( NASDAQ:SIRI ) , Pfizer  ( NYSE:PFE ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Starbucks  ( NASDAQ:SBUX ) , Caterpillar  ( NYSE:CAT ) , Advanced Micro Devices  ( NASDAQ:AMD ) , Electronic Arts  ( NASDAQ:EA ) , SPDR S&P 500  ( ARCA:SPY ) , Uber Technologies  ( NYSE:UBER ) ",https://www.benzinga.com/news/earnings/23/08/33488777/nasdaq-s-p-500-futures-pullback-after-strong-july-why-this-analyst-recommends-staying-fully-investe,2023-08-01 10:49:33,"U.S. stocks could reverse course on Tuesday as traders prepare to receive a barrage of earnings reports and the JOLTS report, which gives information regarding the health of the labor market. Two separate manufacturing activity readings due for the session are widely expected to show that the ...",PFE,0.112008,0.063755,Neutral
"Manufacturing stalled in the first half. But now the stage is set for a recovery, says JPMorgan.",https://www.marketwatch.com/story/manufacturing-stalled-in-the-first-half-why-jpmorgan-says-the-stage-is-set-for-a-recovery-cbcbbffe,2023-08-01 10:39:00,Factory output basically contributed nothing to the world economy. That may be out to change.,PFE,0.13873,0.103408,Neutral
"Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal",https://www.cnbc.com/2023/08/01/merck-mrk-q2-earnings-report-2023.html,2023-08-01 10:32:40,"Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.",PFE,0.056407,-0.07102,Neutral
"Merck Outplays Covid Declines, But Reports Losses After Key Buyout",https://www.investors.com/news/technology/merck-stock-merck-earnings-q2-2023/,2023-08-01 10:30:00,"Merck Stock: Sales Outplays Covid Decline, But Comes In With Per-Share Losses Investor's Business Daily ...",PFE,0.101582,-0.213441,Somewhat-Bearish
"Futures slip on caution ahead of factory, jobs data",https://www.reuters.com/markets/us/futures-slip-caution-ahead-factory-jobs-data-2023-08-01/,2023-08-01 10:11:00,"Aug 1 ( Reuters ) - Wall Street futures edged lower on Tuesday ahead of more economic data that could clear the air on a soft landing for the U.S. economy, while investors also awaited earnings from some major pharma firms.",PFE,0.093653,0.075167,Neutral
Morning Bid: August cools Wall St stocks,https://www.reuters.com/markets/us/global-markets-view-usa-2023-08-01/,2023-08-01 10:02:00,"A look at the day ahead in U.S. and global markets from Mike Dolan After notching a fifth straight month of gains for July ( .SPX ) , Wall St stocks looked set to step back on Tuesday as a deluge of corporate earnings hit this week and poor manufacturing soundings from around the world set a more ...",PFE,0.127795,0.035148,Neutral
U.S. stock futures start August on the back foot after five-month winning streak,https://www.marketwatch.com/story/u-s-stock-futures-start-august-on-the-back-foot-after-five-month-winning-streak-72397fa6,2023-08-01 08:48:00,U.S. stock futures pulled back from 16-month highs as caution prevailed after a five month winning streak.,PFE,0.19661,0.190636,Somewhat-Bullish
"Markets Remain Bullish After S&P 500 Rises For Fifth Consecutive Month - Caterpillar  ( NYSE:CAT ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/news/earnings/23/08/33484770/markets-remain-bullish-after-s-p-500-rises-for-fifth-consecutive-month,2023-08-01 06:42:35,"The CNN Money Fear and Greed index remained in the ""Extreme Greed"" zone on Monday. U.S. stocks closed higher on Monday, recording gains for the month of July. The S&P 500 gained 3.1% to record its fifth straight positive month, while the blue-chip Dow Jones rose about 3.4%.",PFE,0.345674,0.0,Neutral
Morning Bid: Testing the 'Goldilocks' view of the global economy,https://www.reuters.com/markets/global-markets-view-europe-2023-08-01/,2023-08-01 04:51:00,"A look at the day ahead in European and global markets from Kevin Buckland. The 'Goldilocks' view that equity investors are taking of the global economy continued into August, as a benchmark of Asian stocks hovered around Monday's 16-month highs.",PFE,0.108958,0.0,Neutral
Alphabet Stock  ( NASDAQ:GOOGL ) : Explosive Q2 Performance Strengthens Bull Case,https://markets.businessinsider.com/news/stocks/alphabet-stock-nasdaq-googl-explosive-q2-performance-strengthens-bull-case-1032497319,2023-08-01 02:25:50,Alphabet Stock (NASDAQ:GOOGL): Explosive Q2 Performance Strengthens Bull Case - Markets Insider ...,PFE,0.039483,0.105705,Neutral
"Japan's Daiichi Sankyo gets approval for COVID vaccine, first for country",https://www.reuters.com/business/healthcare-pharmaceuticals/japans-daiichi-sankyo-gets-approval-covid-vaccine-first-country-2023-08-01/,2023-08-01 02:07:00,"TOKYO, Aug 1 ( Reuters ) - A Japanese health ministry panel recommended approval for Daiichi Sankyo's ( 4568.T ) mRNA-based COVID-19 vaccine in what would be the nation's first home-grown shot for the coronavirus.",PFE,0.29234,0.0,Neutral
Why Novavax Stock Zoomed 13% Higher on Monday,https://www.fool.com/investing/2023/07/31/why-novavax-stock-zoomed-13-higher-on-monday/,2023-07-31 22:24:41,A renewed fight against COVID-19 might be coming.,PFE,0.141726,-0.004999,Neutral
Dow Jones Closes Higher; Tesla Rival Surges On New EV Truck Deal,https://www.investors.com:443/market-trend/stock-market-today/dow-jones-holds-gains-apple-software-stocks-rise-as-ipo-stock-breaks-out-branch/,2023-07-31 20:30:34,Investor's Business Daily ...,PFE,0.21686,0.232892,Somewhat-Bullish
"Arvinas and Pfizer Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway Steering Group for Vepdegestrant, an Investigational PROTAC® ER degrader being developed in ER+/HER2- Breast Cancer - Arvinas  ( NASDAQ:ARVN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/07/g33479497/arvinas-and-pfizer-awarded-innovation-passport-designation-by-the-u-k-innovative-licensing-and-acc,2023-07-31 20:30:14,"NEW HAVEN, Conn. and NEW YORK, July 31, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ARVN and Pfizer Inc. PFE today announced that the U.K.",PFE,0.443948,0.230521,Somewhat-Bullish
"Arvinas and Pfizer Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway Steering Group for Vepdegestrant, an Investigational PROTAC® ER degrader being developed in ER+/HER2- Breast Cancer",https://www.globenewswire.com/news-release/2023/07/31/2715330/0/en/Arvinas-and-Pfizer-Awarded-Innovation-Passport-Designation-by-the-U-K-Innovative-Licensing-and-Access-Pathway-Steering-Group-for-Vepdegestrant-an-Investigational-PROTAC-ER-degrader.html,2023-07-31 20:30:00,Designation indicates entry into the U.K.'s Innovative Licensing and Access Pathway ( ILAP ) Designation indicates entry into the U.K.'s Innovative Licensing and Access Pathway ...,PFE,0.40225,0.218852,Somewhat-Bullish
"Dow Jones Holds Gains: Apple, Software Stocks Rise As IPO Stock Breaks Out",https://www.investors.com/market-trend/stock-market-today/dow-jones-holds-gains-apple-software-stocks-rise-as-ipo-stock-breaks-out/,2023-07-31 18:01:00,"Major indexes traded sideways on Monday at 1:30 p.m. ET. The Dow Jones Industrial Average rose by less than 0.5%, holding a gain of over 3% for the month after June's hefty 4.6% gain. The S&P 500 declined less than 0.1%. The Nasdaq was also down less than 0.1% in early afternoon trading.",PFE,0.267804,0.300056,Somewhat-Bullish
"Earnings Extravaganza: Another One-Third of S&P 500 Companies Report this Week, Including Amazon, Apple - Apple  ( NASDAQ:AAPL ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/news/earnings/23/07/33474441/earnings-extravaganza-another-one-third-of-s-p-500-companies-report-this-week-including-amazon-appl,2023-07-31 16:13:15,"( Monday market open ) It's ""tech week"" on Wall Street. No, wait, it's ""pharma week."" Or is it ""employment week?"" How about all three?",PFE,0.17237,-0.07387,Neutral
"US NIH launches long-COVID trials of Pfizer's Paxlovid, other therapies",https://www.reuters.com/business/healthcare-pharmaceuticals/us-nih-launches-long-covid-trials-pfizers-paxlovid-other-therapies-2023-07-31/,2023-07-31 16:08:00,"[1/5] Pfizer's coronavirus disease ( COVID-19 ) pill Paxlovid is manufactured in Ringaskiddy, Ireland in this undated image obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS/File Photo July 31 ( Reuters ) - The U.S.",PFE,0.15347,0.0,Neutral
How Will Pfizer's  ( PFE )  Key Drugs Perform in Q2 Earnings?,https://www.zacks.com/stock/news/2129944/how-will-pfizers-pfe-key-drugs-perform-in-q2-earnings,2023-07-31 14:51:00,"Higher alliance revenues from Eliquis, higher sales of Prevnar vaccines and drugs like Vyndaqel/Vyndamax are likely to have contributed to Pfizer's (PFE) sales growth in Q2.",PFE,0.382925,0.235087,Somewhat-Bullish
Software-Maker New Relic Catapults On $6.5 Billion Takeover,https://www.investors.com/news/technology/new-relic-stock-catapults-on-takeover/,2023-07-31 14:44:00,New Relic Stock Catapults On $6.5 Billion Takeover Investor's Business Daily ...,PFE,0.194242,0.137587,Neutral
Week Heavy on Labor Data Commences,https://www.zacks.com/stock/news/2129936/week-heavy-on-labor-data-commences,2023-07-31 14:36:00,"We have an eventful week lined up for market participants, reaching a new level of Q2 earnings reports being released - which, by Friday morning, will put us on the back half of earnings season - as well as key economic prints, especially in the labor market.",PFE,0.148273,0.061553,Neutral
"Topical Corticosteroids Market size to grow by USD 1,089.66 million from 2022 to 2027|Advancements in drug delivery ... - PR Newswire",https://www.prnewswire.com/news-releases/topical-corticosteroids-market-size-to-grow-by-usd-1-089-66-million-from-2022-to-2027advancements-in-drug-delivery-systems-to-boost-market-growth---technavio-301888372.html,2023-07-31 14:15:00,"Topical Corticosteroids Market size to grow by USD 1,089.66 million from 2022 to 2027|Advancements in drug delivery ... PR ...",PFE,0.034984,0.103998,Neutral
"SOFI, ON Beat in Q2, Ahead of Jobs Week",https://www.zacks.com/stock/news/2129911/sofi-on-beat-in-q2-ahead-of-jobs-week,2023-07-31 14:07:00,"Pre-market levels are up modestly at this hour, staying in the green much the way we ended last week after taking a breather with last Thursday's selloff.",PFE,0.143843,0.06048,Neutral
"Drug, Biotech Stocks' Q2 Earnings Due on Aug 1: PFE, MRK & More",https://www.zacks.com/stock/news/2129900/drug-biotech-stocks-q2-earnings-due-on-aug-1-pfe-mrk-more,2023-07-31 13:58:00,"Let's look at five big biotech, pharma companies, PFE, MRK, VRTX, EXEL and INCY, slated to release quarterly results on Aug 1.",PFE,0.298437,0.100076,Neutral
"More Weight-Loss Drugs, Like Ozempic, are in the Works: Kiplinger Economic Forecasts",https://www.kiplinger.com/personal-finance/health-insurance/weight-loss-drugs-like-ozempic-are-in-the-works-kiplinger-economic-forecasts,2023-07-31 12:00:14,"More Weight-Loss Drugs, Like Ozempic, are in the Works Kiplinger's Personal Finance ...",PFE,0.056011,0.07908,Neutral
Op-ed: A.I. may take on doctors' roles sooner than later,https://www.cnbc.com/2023/07/31/op-ed-ai-may-take-on-doctors-roles-sooner-than-later.html,2023-07-31 11:54:50,"To grasp the potential of these tools to revolutionize the practice of medicine, it pays to start with a taxonomy of the different technologies and how they're being used in medical care.",PFE,0.038717,0.059585,Neutral
"Every Dividend Stock Cathie Wood Owns, Ranked From Highest to Lowest Yield",https://www.fool.com/investing/2023/07/31/every-dividend-stock-cathie-wood-owns-ranked-from/,2023-07-31 09:51:00,Cathie Wood and dividend stocks? It might seem to be an odd combination.,PFE,0.307924,0.28225,Somewhat-Bullish
"Urothelial Carcinoma Market is Expected to Showcase a Significant Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - MedPacto, AstraZeneca, EMD Serono, Bayer, Merck, Bristol-Myers Squibb, Inovio, Seagen, Incyte",https://www.prnewswire.com/news-releases/urothelial-carcinoma-market-is-expected-to-showcase-a-significant-growth-by-2032-assesses-delveinsight--key-companies-to-look-out---medpacto-astrazeneca-emd-serono-bayer-merck-bristol-myers-squibb-inovio-seagen-incyte-301889003.html,2023-07-31 09:01:00,"Urothelial Carcinoma Market is Expected to Showcase a Significant Growth by 2032, Assesses DelveInsight | Key ... PR ...",PFE,0.024053,0.069063,Neutral
Amazon and Apple to bat cleanup for Q2 earnings this week,https://www.marketwatch.com/story/amazon-and-apple-to-bat-cleanup-for-q2-earnings-this-week-2e5f0021,2023-07-30 14:01:00,"When Amazon.com Inc. and Apple Inc. report quarterly results on Thursday, we'll get a look at two big companies, with big expectations.",PFE,0.08282,-0.028057,Neutral
The case for a soft landing is slowly but surely building | Business,https://www.cnn.com/2023/07/30/business/stocks-week-ahead-fed-jobs-data/index.html,2023-07-30 11:30:00,The case for a soft landing is slowly but surely building ...,PFE,0.050465,0.0,Neutral
GDP Report Makes A Case For Earnings Bottoming,https://www.forbes.com/sites/bill_stone/2023/07/30/gdp-report-makes-a-case-for-the-earnings-bottoming/,2023-07-30 11:00:00,The busiest week of earnings season should continue to trend of outperforming estimates. The solid U.S. GDP report increases the probability that earnings growth should trough this quarter. The July jobs report on Friday should be closely watched with implications for future Fed actions.,PFE,0.098054,0.007469,Neutral
4 Top Stocks and 3 Top Cryptocurrencies for August,https://www.fool.com/investing/2023/07/30/4-top-stocks-and-3-top-cryptocurrencies-for-august/,2023-07-30 10:45:00,Investors looking for a portfolio checkup have come to the right place.,PFE,0.166599,0.069147,Neutral
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/08/33925211/this-is-what-whales-are-betting-on-pfizer,2023-08-18 20:45:44,"Someone with a lot of money to spend has taken a bullish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.874457,0.388618,Bullish
"As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant",https://www.marketwatch.com/story/moderna-says-updated-covid-vaccine-effective-against-widely-circulating-eris-variant-d6b63c46,2023-08-18 19:45:00,Free shots for people without health insurance may not be available at retail pharmacies until mid-October.,PFE,0.285526,0.147751,Neutral
Moderna  ( MRNA )  Updated COVID Jab Effective Against Eris Variant,https://www.zacks.com/stock/news/2138325/moderna-mrna-updated-covid-jab-effective-against-eris-variant,2023-08-18 17:30:00,Moderna's (MRNA) updated monovalent COVID-19 vaccine generates a robust immune response against the dominating Eris variant and another rapidly spreading virus strain in a clinical study.,PFE,0.437261,0.288802,Somewhat-Bullish
NOT REAL NEWS: A look at what didn't happen this week,https://apnews.com/article/fact-check-misinformation-trump-maui-wildfires-1f4d017e161a17d7deff2366daa93e70,2023-08-18 16:06:00,"A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: No, Georgia officials didn't err in releasing Trump indictment with ...",PFE,0.059686,-0.084152,Neutral
"Pharma Stock Roundup: FDA Okays PFE & JNJ Drugs, EU Approves ABBV's Migraine Drug",https://www.zacks.com/stock/news/2138154/pharma-stock-roundup-fda-okays-pfe-jnj-drugs-eu-approves-abbvs-migraine-drug,2023-08-18 15:38:00,"FDA approves Pfizer's (PFE) Elrexfio (elranatamab) for RRMM and J&J's (JNJ) oral combination tablet, Akeega to treat BRCA-positive mCRPC. European Commission approves AbbVie's (ABBV) Aquipta for migraine.",PFE,0.110209,0.036988,Neutral
"New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant",https://www.cnbc.com/2023/08/18/covid-new-vaccines-will-likely-protect-against-eris-variant.html,2023-08-18 14:32:30,"The drugmakers designed their updated coronavirus shots to target the omicron subvariant XBB.1.5, which is slowly declining nationwide.",PFE,0.127007,-0.003592,Neutral
"SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories - Buckle  ( NYSE:BKE ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/08/33914724/spacex-on-par-with-intel-disney-us-weight-loss-drugs-pricier-moderna-pfizers-shot-effective-against,2023-08-18 14:20:51,Moderna Inc MRNA announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies against EG.5 and FL.1.5.1 variants.,PFE,0.079656,0.0,Neutral
Covid Vaccine Makers Take On Something They've Never Seen,https://www.investors.com/news/technology/pfizer-stock-covid-rally-reverses-as-vaccine-makers-take-on-a-new-variant/,2023-08-18 14:17:00,Pfizer Stock: Covid Rally Reverses As Vaccine Makers Take On A ... Investor's Business Daily ...,PFE,0.386477,0.221987,Somewhat-Bullish
Fox News Wants Trump On The Debate Stage To Boost Interest,https://www.forbes.com/sites/bradadgate/2023/08/18/fox-news-wants-trump-on-the-debate-stage-to-boost-interest/,2023-08-18 12:37:52,Fox is hopeful Donald Trump will participate in the first GOP presidential debate on August 23. At this time his appearance is doubtful.,PFE,0.028254,0.132918,Neutral
"Obesity Crisis Costs US $200B Annually, But Arrival Of Treatments Signal Declining Surgery Demands - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/08/33912796/obesity-crisis-costs-us-200b-annually-but-arrival-of-treatments-signal-declining-surgery-demands,2023-08-18 12:04:14,"With an annual toll of $200 billion due to health complications like diabetes and heart disease, the surging obesity crisis has adversely impacted Americans regarding health and the economy.",PFE,0.167322,0.246186,Somewhat-Bullish
"Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/08/33912067/moderna-pfizers-updated-covid-shot-shows-effectiveness-against-eris-variant-in-early-human-precli,2023-08-18 11:59:26,Moderna Inc MRNA announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies against EG.5 and FL.1.5.1 variants.,PFE,0.274834,0.099596,Neutral
"Acute Migraine Treatment Market Predicted to Reach USD 7 billion by 2031, Recording Over a 15% CAGR Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/08/g33911444/acute-migraine-treatment-market-predicted-to-reach-usd-7-billion-by-2031-recording-over-a-15-cagr-,2023-08-18 10:30:00,"Wilmington, Delaware, United States, Aug. 18, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global market for acute migraine treatment was estimated to be worth a market valuation of around US$ 2.1 billion in 2021.",PFE,0.042571,0.059382,Neutral
"Moderna's Covid-19 vaccine protects against new variants, finds early study",https://www.business-standard.com/world-news/moderna-s-covid-19-vaccine-protects-against-new-variants-in-early-study-123081800078_1.html,2023-08-18 01:53:39,"Moderna Inc.'s updated Covid-19 shot provides some protection against two variants of the virus that are among those most widely circulating in the US, according to early results from a company study.",PFE,0.366061,0.054046,Neutral
"S&P 500, Dow gain on boost from Cisco",https://www.moneycontrol.com/news/business/markets/sp-500-dow-gain-on-boost-from-cisco-11212851.html,2023-08-18 00:43:05,"Weighing heavily on the SP 500, CVS Health ( CVS.N ) tumbled 8% on news that Blue Shield of California plans to cut its reliance on the company as its pharmacy benefit manager ( PBM ) and work with others including Amazon.com ( AMZN.O ) .",PFE,0.063258,0.06402,Neutral
Americans' Appetite for Weight-Loss Drugs is Feeding Denmark's Economy,https://www.thedailyupside.com/americans-appetite-for-weight-loss-drugs-is-feeding-denmarks-economy/,2023-08-17 23:00:57,"America's loss is Denmark's gain. Weight loss, that is. The US obsession with skinny-down pills Ozempic and Wegovy has turned Danish drugmaker...",PFE,0.111488,0.093442,Neutral
Dietary Supplements Market to grow by USD 61.4 billion from 2022 to 2027; Growing popularity of healthy eating habits ... - PR Newswire,https://www.prnewswire.com/news-releases/dietary-supplements-market-to-grow-by-usd-61-4-billion-from-2022-to-2027-growing-popularity-of-healthy-eating-habits-boosts-the-market---technavio-301903490.html,2023-08-17 22:15:00,Dietary Supplements Market to grow by USD 61.4 billion from 2022 to 2027. Growing popularity of healthy eating habits ... PR ...,PFE,0.035138,0.0,Neutral
Moderna's updated COVID vaccine effective against 'Eris' variant in humans,https://www.reuters.com/business/healthcare-pharmaceuticals/modernas-updated-covid-vaccine-effective-against-eris-variant-humans-2023-08-17/,2023-08-17 22:03:00,"Vials of the Moderna COVID-19 vaccine are seen at Apotex pharmaceutical company as Humber River Hospital's mobile vaccine clinic vaccinate employees as part of the coronavirus disease ( COVID-19 ) vaccination campaign, in Toronto, Ontario, Canada April 13, 2021.",PFE,0.266828,0.077778,Neutral
Moderna says new Covid vaccine was effective against Eris variant in early trial,https://www.cnbc.com/2023/08/17/moderna-covid-vaccine-effective-against-eris-fornax-variants.html,2023-08-17 21:35:20,"Moderna's vaccine and new shots from Pfizer and Novavax are slated to roll out within weeks, pending potential approvals from the Food and Drug Administration.",PFE,0.17715,0.0,Neutral
Pfizer's updated COVID shot effective against 'Eris' variant in mice study,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizers-updated-covid-shot-effective-against-eris-variant-mice-study-2023-08-17/,2023-08-17 18:56:51,"Aug 17 ( Reuters ) - Pfizer Inc ( PFE.N ) said on Thursday its updated COVID-19 shot, which is being tested against emerging variants, showed neutralizing activity against the ""Eris"" subvariant in a study conducted on mice.",PFE,0.380012,0.163866,Somewhat-Bullish
MRK: Looking for a Value Investment? Check out These 3 Pharma Stocks,https://stocknews.com/news/mrk-pfe-lpcn-looking-for-a-value-investment-check-out-these-3-pharma/,2023-08-17 18:06:21,MRK: Looking for a Value Investment? Check out These 3 Pharma ... ...,PFE,0.240489,0.267898,Somewhat-Bullish
AbbVie  ( ABBV )  Gets EU Approval for Migraine Prevention Drug,https://www.zacks.com/stock/news/2137725/abbvie-abbv-gets-eu-approval-for-migraine-prevention-drug,2023-08-17 15:43:00,"Following the approval, AbbVie's (ABBV) Aquipta is the first and the only oral CGRP receptor antagonist approved in the EU to prevent episodic and chronic migraines.",PFE,0.172097,0.169365,Somewhat-Bullish
Planview eyes India's digital transformation may reach $85 bn by 2026,https://www.business-standard.com/companies/news/planview-eyes-india-s-digital-transformation-may-reach-85-bn-by-2026-123081700777_1.html,2023-08-17 15:34:08,"Planview, the U.S.-based work management software company, is set to expand its operations in India, reflecting the surge in technology adoption by businesses and government organisations within the country.",PFE,0.068306,0.08926,Neutral
"Macular Degeneration Treatment Market to Expand USD 21.1 Bn by 2031, Registering at a CAGR of 8.8% | Exclusive Report by Transparency Market Research",https://www.benzinga.com/pressreleases/23/08/g33892714/macular-degeneration-treatment-market-to-expand-usd-21-1-bn-by-2031-registering-at-a-cagr-of-8-8-e,2023-08-17 11:30:00,"Wilmington, Delaware, United States, Aug. 17, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global macular degeneration treatment market is projected to exceed US$ 21.1 Bn by 2031, up from US$ 9.0 Bn in 2021.",PFE,0.042048,-0.026846,Neutral
"The Zacks Analyst Blog Highlights Broadcom, Pfizer, Advanced Micro Devices, Charles Schwab, Canadian National Railway and D.R. Horton",https://www.zacks.com/stock/news/2137275/the-zacks-analyst-blog-highlights-broadcom-pfizer-advanced-micro-devices-charles-schwab-canadian-national-railway-and-dr-horton,2023-08-17 08:50:00,"Broadcom, Pfizer, Advanced Micro Devices, Charles Schwab, Canadian National Railway and D.R. Horton are included in this Analyst Blog.",PFE,0.437261,0.12864,Neutral
"Anticoagulants Market to Exceed USD 56.6 billion by 2031, Expanding at a CAGR of 6.2%: TMR Report",https://www.benzinga.com/pressreleases/23/08/g33890025/anticoagulants-market-to-exceed-usd-56-6-billion-by-2031-expanding-at-a-cagr-of-6-2-tmr-report,2023-08-17 08:35:08,"Wilmington, Delaware, United States, Aug. 17, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global anticoagulants market is projected to flourish at a CAGR of 6.2% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 56.6 billion is anticipated for the ...",PFE,0.041901,0.0,Neutral
France Dietary Supplements Market to Grow at a CAGR 6.1% from 2023 to 2028,https://www.benzinga.com/pressreleases/23/08/g33889755/france-dietary-supplements-market-to-grow-at-a-cagr-6-1-from-2023-to-2028,2023-08-17 08:00:00,"Chicago, Aug. 17, 2023 ( GLOBE NEWSWIRE ) -- According to a research report ""France Dietary Supplements Market by Type ( Botanicals, Vitamins, Minerals, Amino Acids, Enzymes, Probiotics ) , Function, Mode of Application, Target Consumer, Distribution Channel ( Pharmacy, Supermarket/Hypermarket, ...",PFE,0.086245,0.0,Neutral
"Top Analyst Reports for Broadcom, Pfizer & AMD",https://www.zacks.com/research-daily/2136986/top-analyst-reports-for-broadcom-pfizer-amd,2023-08-16 19:24:00,"Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Pfizer Inc. (PFE) and Advanced Micro Devices, Inc. (AMD).",PFE,0.281153,0.129825,Neutral
"Federal Court Rules To Prohibit Access To Abortion Pill: Supreme Court To Weigh In - Johnson & Johnson  ( NYSE:JNJ ) , Merck & Co  ( NYSE:MRK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/08/33881514/federal-court-rules-to-prohibit-access-to-abortion-pill-supreme-court-to-weigh-in,2023-08-16 19:23:07,"The 5th Circuit Court of Appeals ruled Wednesday to prohibit access to mifepristone, the drug known as the abortion pill, in a case filed against the Food and Drug Administration. The ruling will not take effect until the Supreme Court weighs in, which may not occur until next year, according to ...",PFE,0.295867,-0.08874,Neutral
Seagen's Positive Trial Outcomes: Analyst Says The Update Might Double Tukysa's Current Market - Seagen  ( NASDAQ:SGEN ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33879639/seagens-positive-trial-outcomes-analyst-says-the-update-might-double-tukysas-curren,2023-08-16 18:12:16,"Earlier today, Seagen Inc SGEN announced that the Phase 3 HER2CLIMB-02 clinical trial of Tukysa ( tucatinib ) in combination with the antibody-drug conjugate ado-trastuzumab emtansine ( Kadcyla ) met its primary endpoint of progression-free survival ( PFS ) .",PFE,0.498188,0.377609,Bullish
Pfizer's CEO has not been arrested by the US Marine Corps,https://apnews.com/article/fact-check-pfizer-ceo-albert-bourla-arrested-marines-045573165189,2023-08-16 16:34:00,"CLAIM: The U.S. Marine Corps arrested Pfizer CEO Albert Bourla and killed his bodyguards. AP'S ASSESSMENT: False. Bourla has not been arrested, Pfizer confirmed to The Associated Press. The claim was made in a post by a website that says it publishes ""humor, parody, and satire"" and has previously ...",PFE,0.407844,-0.175442,Somewhat-Bearish
Win For Pfizer? Seagen's Cancer Combo Therapy Hits Primary Goal In Late-Stage Breast Cancer Study - Seagen  ( NASDAQ:SGEN ) ,https://www.benzinga.com/general/biotech/23/08/33876753/win-for-pfizer-seagens-cancer-combo-therapy-hits-primary-goal-in-late-stage-breast-cancer-study,2023-08-16 16:32:36,Seagen Inc SGEN announced that the Phase 3 HER2CLIMB-02 clinical trial of Tukysa ( tucatinib ) in combination with the antibody-drug conjugate ado-trastuzumab emtansine ( Kadcyla ) met its primary endpoint of progression-free survival ( PFS ) .,PFE,0.371523,0.110303,Neutral
"Nicotine Replacement Therapy Market Revenue to Cross USD 52.1 billion by 2031, Expanding at a CAGR of 7.7% | Exclusive Report by Transparency Market Research",https://www.benzinga.com/pressreleases/23/08/g33877743/nicotine-replacement-therapy-market-revenue-to-cross-usd-52-1-billion-by-2031-expanding-at-a-cagr-,2023-08-16 15:19:26,"Wilmington, Delaware, United States, Aug. 16, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global nicotine replacement therapy market is projected to flourish at a CAGR of 7.7% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 52.1 billion is ...",PFE,0.04303,0.017827,Neutral
"U.S. retailers lose their appetite for SlimFast, owner says",https://www.reuters.com/business/retail-consumer/us-retailers-lose-their-appetite-slimfast-owner-says-2023-08-16/,2023-08-16 13:23:00,"DUBLIN, Aug 16 ( Reuters ) - Sales of SlimFast plunged further in the three months to mid-July, prompting key U.S. retailers to stock fewer of the meal replacement shakes, the brand's owner said on Wednesday as weight-loss drugs shake up the diet market.",PFE,0.108466,0.205766,Somewhat-Bullish
Pfizer's  ( PFE )  New Multiple Myeloma Drug Elrexfio Gets FDA Nod,https://www.zacks.com/stock/news/2136916/pfizers-pfe-new-multiple-myeloma-drug-elrexfio-gets-fda-nod,2023-08-16 13:18:00,The FDA's accelerated approval of Pfizer's (PFE) new multiple myeloma drug Elrexfio/elranatamab is based on data from the pivotal phase II MagnetisMM-3 study.,PFE,0.544869,0.230079,Somewhat-Bullish
Seagen's breast cancer therapy meets main goal in late-stage study,https://www.reuters.com/business/healthcare-pharmaceuticals/seagens-breast-cancer-therapy-meets-main-goal-late-stage-study-2023-08-16/,2023-08-16 12:33:00,"Seagen logo and test tubes are seen in this illustration taken June 27, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",PFE,0.250386,0.086685,Neutral
"The Zacks Analyst Blog Highlights Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive",https://www.zacks.com/stock/news/2136821/the-zacks-analyst-blog-highlights-visa-novo-nordisk-medtronic-shopify-and-colgate-palmolive,2023-08-16 11:39:00,"Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive are included in this Analyst Blog.",PFE,0.079921,0.009428,Neutral
Elrexfio Gets Accelerated FDA Approval For Refractory Multiple Myeloma,https://www.benzinga.com/pressreleases/23/08/g33873434/elrexfio-gets-accelerated-fda-approval-for-refractory-multiple-myeloma,2023-08-16 11:36:49,"Delhi, Aug. 16, 2023 ( GLOBE NEWSWIRE ) -- US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 Report Highlights: US Bispecific Antibodies Market Opportunity: > USD 15 Billion By 2028 FDA Approved Bispecific Antibodies: 11 Antibodies Approved Bispecific Antibodies Dosage, Price ...",PFE,0.049526,0.169118,Somewhat-Bullish
"If You Invested $1000 in Novo Nordisk 10 Years Ago, This Is How Much You'd Have Now",https://www.zacks.com/stock/news/2136596/if-you-invested-1000-in-novo-nordisk-10-years-ago-this-is-how-much-youd-have-now,2023-08-15 18:27:29,"Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",PFE,0.052112,0.131995,Neutral
"Top Stock Reports for Visa, Novo Nordisk & Medtronic",https://www.zacks.com/research-daily/2136154/top-stock-reports-for-visa-novo-nordisk-medtronic,2023-08-15 17:54:00,"Today's Research Daily features new research reports on 12 major stocks, including Visa Inc. (V), Novo Nordisk A/S (NVO) and Medtronic plc (MDT).",PFE,0.105604,0.010239,Neutral
"Top Stories Tuesday, Aug 15: First Solar's Internal Audit Reveals Instances Of Forced Labor, Philips Recalls Faulty Ventilators, Home Depot's Q2 Performance - Cardinal Health  ( NYSE:CAH ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/08/33859346/first-solars-internal-audit-reveals-instances-of-forced-labor-philips-recalls-faulty-ventilators-hom,2023-08-15 13:59:35,"Home improvement retailer Home Depot Inc HD reported a second-quarter FY23 sales decline of 2% year-on-year to $42.92 billion, beating the analyst consensus of $42.25 billion. EPS of $4.65 beat the analyst consensus of $4.46.",PFE,0.107736,0.145969,Neutral
Novo Nordisk  ( NVO )  Rides on Ozempic & Wegovy Amid Rivalry,https://www.zacks.com/stock/news/2136457/novo-nordisk-nvo-rides-on-ozempic-wegovy-amid-rivalry,2023-08-15 13:40:00,"Novo Nordisk (NVO) continues to witness increasing demand for its diabetes and obesity care products like Ozempic, Wegovy and Rybelsus amid rising competition from other pharma bigwigs.",PFE,0.213988,0.016849,Neutral
Can Moderna  ( MRNA )  Diversify Beyond Its COVID-19 Jab Sales?,https://www.zacks.com/stock/news/2136458/can-moderna-mrna-diversify-beyond-its-covid-19-jab-sales,2023-08-15 13:39:00,"With COVID-19 vaccine sales declining, Moderna (MRNA) is accelerating the development of its non-COVID pipeline. It is gearing up for potential product launches over the next three years.",PFE,0.282886,0.178919,Somewhat-Bullish
Pfizer  ( PFE )  Seems Well-Poised for Long-Term Growth: Here's How,https://www.zacks.com/stock/news/2136436/pfizer-pfe-seems-well-poised-for-long-term-growth-heres-how,2023-08-15 13:15:00,"Though Pfizer's (PFE) revenues from COVID products are declining sharply, it is set to launch some key non-COVID products in 2023, which can drive long-term sales and profit growth.",PFE,0.764396,0.268666,Somewhat-Bullish
FDA Approves Pfizer's Blood Cancer Therapy For Heavily Pretreated Patients - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/08/33852876/fda-approves-pfizers-blood-cancer-therapy-for-heavily-pretreated-patients,2023-08-15 12:56:12,The FDA granted accelerated approval to Pfizer Inc's PFE Elrexfio ( elranatamab-bcmm ) for adult patients with relapsed or refractory multiple myeloma ( RRMM ) who have received at least four prior lines of therapy.,PFE,0.585687,0.333353,Somewhat-Bullish
Here's Why Pfizer's High-Yield Dividend Could Be Even Safer Than You Might Think,https://www.fool.com/investing/2023/08/15/heres-why-pfizers-high-yield-dividend-could-be-eve/,2023-08-15 09:50:00,"The drugmaker faces some uncertainties, but its dividend appears to be in good shape.",PFE,0.631445,0.20385,Somewhat-Bullish
Germany Dietary Supplements Market to Grow at a CAGR 5.8% from 2023 to 2028,https://www.benzinga.com/pressreleases/23/08/g33852354/germany-dietary-supplements-market-to-grow-at-a-cagr-5-8-from-2023-to-2028,2023-08-15 08:00:00,"Chicago, Aug. 15, 2023 ( GLOBE NEWSWIRE ) -- According to a research report ""Germany Dietary Supplements Market by Type ( Botanicals, Vitamins, Minerals, Amino Acids, Enzymes, Probiotics ) , Function, Mode of Application, Target Consumer, Distribution Channel ( Pharmacy, Supermarket/Hypermarket, ...",PFE,0.106541,0.0,Neutral
"As the new Eris Covid variant spreads across the world, here's what we know so far",https://www.cnbc.com/2023/08/15/covid-eris-new-variant-spreads-across-world-heres-what-we-know-so-far.html,2023-08-15 07:40:40,"EG.5 or ""Eris,"" now the dominant variant in the United States, is currently thought to have the same risk level as existing variants.",PFE,0.109455,-0.101623,Neutral
US FDA approves Pfizer's blood cancer therapy,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-blood-cancer-therapy-2023-08-14/,2023-08-14 18:18:00,"A compagny logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Aug 14 ( Reuters ) - The U.S. Food and Drug Administration on Monday granted accelerated approval to Pfizer's ( PFE.N ) therapy for treating patients with a type of blood cancer that ...",PFE,0.443626,0.0,Neutral
"Biotechnology Market to Worth Around USD 3,995.22 Billion by 2032",https://www.benzinga.com/pressreleases/23/08/g33835844/biotechnology-market-to-worth-around-usd-3-995-22-billion-by-2032,2023-08-14 15:00:00,"Ottawa, Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- The global biotechnology market size accounted for USD 1,224.31 billion in 2022, a study published by Towards Healthcare a sister firm of Precedence Research.",PFE,0.013202,0.172021,Somewhat-Bullish
Pfizer Rocky Mount Turns to SteraMist for Post-Tornado Decontamination,https://www.globenewswire.com/news-release/2023/08/14/2724581/34752/en/Pfizer-Rocky-Mount-Turns-to-SteraMist-for-Post-Tornado-Decontamination.html,2023-08-14 13:05:00,"FREDERICK, Md., Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- TOMI Environmental Solutions, Inc.® ( ""TOMI"" ) ( NASDAQ: TOMZ ) , a global company specializing in disinfection and decontamination solutions, announces that Pfizer Rocky Mount has engaged TOMI's iHP Corporate Service to conduct emergency ...",PFE,0.373611,0.090834,Neutral
Pfizer Rocky Mount Turns to SteraMist for Post-Tornado Decontamination - TOMI Environmental Solns  ( NASDAQ:TOMZ ) ,https://www.benzinga.com/pressreleases/23/08/g33831937/pfizer-rocky-mount-turns-to-steramist-for-post-tornado-decontamination,2023-08-14 13:05:00,"FREDERICK, Md., Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- TOMI Environmental Solutions, Inc.® ( ""TOMI"" ) TOMZ, a global company specializing in disinfection and decontamination solutions, announces that Pfizer Rocky Mount has engaged TOMI's iHP Corporate Service to conduct emergency decontamination ...",PFE,0.368773,0.08991,Neutral
Vaccinex Reports Second Quarter 2023 Financial Results and Provides Corporate Update,https://www.globenewswire.com/news-release/2023/08/14/2724371/34858/en/Vaccinex-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html,2023-08-14 12:10:00,Phase 1/2a SIGNAL-AD Study of Pepinemab in Alzheimer's Disease Achieves Full Accrual ...,PFE,0.01706,0.0,Neutral
"Vivek Ramaswamy-Founded Biotech Reports Steep Losses, Light Sales",https://www.investors.com/news/technology/roiv-stock-roivant-earnings-q2-2023/,2023-08-14 11:00:00,"ROIV Stock, A Top Biotech Stock, Misses On Both Sales And Losses Investor's Business Daily ...",PFE,0.140896,-0.103977,Neutral
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer,https://www.globenewswire.com/news-release/2023/08/14/2724220/0/en/BioNTech-Expands-Management-Board-by-Appointing-James-Ryan-as-Chief-Legal-Officer.html,2023-08-14 10:45:00,"MAINZ, Germany, August 14, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) announced that the Supervisory Board has appointed James Ryan, Ph.D., to the Management Board as Chief Legal Officer ( CLO ) , effective September 1, 2023.",PFE,0.071357,0.05569,Neutral
New Covid vaccines are on the way as 'Eris' variant rises,https://www.reuters.com/business/healthcare-pharmaceuticals/new-covid-vaccines-are-way-eris-variant-rises-2023-08-14/,2023-08-14 10:06:00,"A vial labelled ""VACCINE Coronavirus COVID-19"" is seen in front of a stock graph in this illustration taken on January 17, 2022. REUTERS/Dado Ruvic/Illustration/File Photo",PFE,0.144275,-0.141646,Neutral
Choice of arm for 2nd Covid jab could influence immune response: Research,https://www.business-standard.com/world-news/choice-of-arm-for-2nd-covid-jab-could-influence-immune-response-research-123081200366_1.html,2023-08-12 12:39:30,"Getting the second Covid jab on the same arm as the first one or on the opposite arm could influence the body's immune response generated against the SARS-CoV-2 virus, new research from Germany says.",PFE,0.102449,0.041589,Neutral
2 High-Yield Dividend Stocks That Could Be Incredible Bargains,https://www.fool.com/investing/2023/08/12/2-high-yield-dividend-stocks-that-could-be-incredi/,2023-08-12 12:00:00,Pfizer and AT&T both sport mouth-watering valuations and dividend yields.,PFE,0.449106,0.418473,Bullish
"Insiders Buy the Dip in These 2 Beaten-Down Stocks, Analysts Say They Could Be Ready to Bounce Back - Here's Why You Should Pay Attention",https://markets.businessinsider.com/news/stocks/insiders-buy-the-dip-in-these-2-beaten-down-stocks-analysts-say-they-could-be-ready-to-bounce-back-%E2%80%94-here-s-why-you-should-pay-attention-1032547754,2023-08-12 04:47:31,"Insiders Buy the Dip in These 2 Beaten-Down Stocks, Analysts Say They Could Be Ready to Bounce Back - Here's ... - Markets Insider ...",PFE,0.028422,-0.063801,Neutral
"Pfizer Collaboration Offers Potential Milestone Windfalls For TBIO, Despite Financial Hurdles: Analyst - Telesis Bio  ( NASDAQ:TBIO ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33757156/pfizer-collaboration-offers-potential-milestone-windfalls-for-tbio-despite-financia,2023-08-11 19:09:35,"KeyBanc Capital Markets analyst Paul Knight downgraded Telesis Bio, Inc. TBIO to Sector Weight from Overweight. TBIO slightly exceeded consensus in 2Q23 results, with Pfizer, Inc. PFE milestone payment showing progress in its technical collaboration.",PFE,0.419153,0.221418,Somewhat-Bullish
"Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots - Novavax  ( NASDAQ:NVAX ) , Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/08/33755215/meet-eris-the-covid-variant-behind-a-summer-resurgence-in-cases-3-drugmakers-prep-fall-booster-sh,2023-08-11 16:30:22,"In the midst of a seemingly constant hum of summer activity, something from the past is looming large again: COVID-19. What Happened: New data from the Centers for Disease Control and Prevention ( CDC ) showed hospitalizations shot up by 12.5% between July 23 and July 29.",PFE,0.1789,0.062498,Neutral
Pharma ETFs in Focus Post Q2 Earnings,https://www.zacks.com/stock/news/2135877/pharma-etfs-in-focus-post-q2-earnings,2023-08-11 16:15:00,Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.,PFE,0.076847,0.045476,Neutral
Does Pfizer Stock Belong in a Dividend Portfolio?,https://www.fool.com/investing/2023/08/11/does-pfizer-stock-belong-in-a-dividend-portfolio/,2023-08-11 14:07:00,Pfizer is a well-known name in the pharmaceutical industry.,PFE,0.390904,0.185196,Somewhat-Bullish
2 Beaten-Down Dividend Stocks to Buy,https://www.fool.com/investing/2023/08/11/2-beaten-down-dividend-stocks-to-buy/,2023-08-11 14:00:00,These two stocks look like bargains right now for income investors.,PFE,0.051999,0.04271,Neutral
"Pharma Stock Roundup: LLY, BAYRY Post Q2 Results, NVO's Wegovy Cuts Heart Attack Risk",https://www.zacks.com/stock/news/2135700/pharma-stock-roundup-lly-bayry-post-q2-results-nvos-wegovy-cuts-heart-attack-risk,2023-08-11 13:48:00,"Eli Lilly (LLY), Bayer (BAYRY) and Novo Nordisk (NVO) announce second-quarter results.",PFE,0.038592,-0.116146,Neutral
Up 45% This Year What's Driving The Growth For Eli Lilly Stock?,https://www.forbes.com/sites/greatspeculations/2023/08/11/up-45-this-year-whats-driving-the-growth-for-eli-lilly-stock/,2023-08-11 13:00:59,"The stock has been on a strong run for the last few years, primarily due to its pipeline potential.",PFE,0.177584,0.017294,Neutral
Pfizer Inc.  ( PFE )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2135587/pfizer-inc-pfe-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-08-11 13:00:10,"Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",PFE,0.486627,0.143592,Neutral
"If You'd Invested $25,000 in Viatris in 2020, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/08/11/if-youd-invested-25000-in-viatris-in-2020-this-is/,2023-08-11 12:25:00,Would you have been better off investing in the S&P 500?,PFE,0.065866,0.075292,Neutral
IO Biotech Appoints Heidi Hunter to its Board of Directors,https://www.globenewswire.com/news-release/2023/08/11/2723515/0/en/IO-Biotech-Appoints-Heidi-Hunter-to-its-Board-of-Directors.html,2023-08-11 12:05:00,"NEW YORK, Aug. 11, 2023 ( GLOBE NEWSWIRE ) -- IO Biotech ( Nasdaq: IOBT ) , a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced the appointment of Heidi Hunter to its board of directors.",PFE,0.046452,0.045197,Neutral
IO Biotech Appoints Heidi Hunter to its Board of Directors - IO Biotech  ( NASDAQ:IOBT ) ,https://www.benzinga.com/pressreleases/23/08/g33746404/io-biotech-appoints-heidi-hunter-to-its-board-of-directors,2023-08-11 12:05:00,"NEW YORK, Aug. 11, 2023 ( GLOBE NEWSWIRE ) -- IO Biotech IOBT, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced the appointment of Heidi Hunter to its board of directors.",PFE,0.045139,0.044061,Neutral
Pfizer Unusual Options Activity For August 10 - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/08/33721975/pfizer-unusual-options-activity-for-august-10,2023-08-10 19:32:13,"A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 80% of the investors opened trades with bullish expectations and ...",PFE,0.885652,0.366293,Bullish
These 10 medications are likely targets for Medicare price negotiations this fall,https://www.cnbc.com/2023/08/10/10-drugs-that-are-likely-targets-for-fall-medicare-price-negotiations.html,2023-08-10 17:21:52,"It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.",PFE,0.046999,-0.121821,Neutral
WHO names Eris a COVID variant of interest. Here's what you need to know.,https://www.marketwatch.com/story/who-names-eg-5-covid-strain-a-variant-of-interest-as-it-continues-to-spread-around-the-world-5505235d,2023-08-10 17:02:00,The World Health Organization has upgraded COVID-19 variant EG.5 to a variant of interest from a variant under monitoring as it continues to spread.,PFE,0.13347,0.135876,Neutral
"Deciphera  ( DCPH )  Q2 Earnings Beat, Qinlock Drives Revenues",https://www.zacks.com/stock/news/2134934/deciphera-dcph-q2-earnings-beat-qinlock-drives-revenues,2023-08-10 12:13:00,Deciphera (DCPH) reports narrower-than-expected loss for the second quarter of 2023. Qinlock drives year-over-year sales.,PFE,0.203215,0.047248,Neutral
Aprea Therapeutics Reports Second Quarter 2023 Financial Results and Provides Update on Business Operations,https://www.globenewswire.com/news-release/2023/08/10/2722554/0/en/Aprea-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Update-on-Business-Operations.html,2023-08-10 11:30:00,"DOYLESTOWN, Pa., Aug. 10, 2023 ( GLOBE NEWSWIRE ) -- Aprea Therapeutics, Inc. ( Nasdaq: APRE ) ( ""Aprea"", or the ""Company"" ) , a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality, today reported financial results for the three and six months ended ...",PFE,0.030759,0.046924,Neutral
"Pfizer's Pneumococcal 20-Valent Conjugate Vaccine is Now Available in Hong Kong, For Adults Aged 18 Years or Older[1]",https://www.prnewswire.com/apac/news-releases/pfizers-pneumococcal-20-valent-conjugate-vaccine-is-now-available-in-hong-kong-for-adults-aged-18-years-or-older1-301897593.html,2023-08-10 06:15:00,"Pfizer's Pneumococcal 20-Valent Conjugate Vaccine is Now Available in Hong Kong, For Adults Aged 18 Years or ... PR ...",PFE,0.214123,0.163641,Somewhat-Bullish
Germany's Evonik second-quarter core profit slumps 38%,https://www.reuters.com/business/evonik-posts-q2-core-profit-down-38-2023-08-10/,2023-08-10 03:45:05,Germany's Evonik second-quarter core profit slumps ...,PFE,0.135347,0.094545,Neutral
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update,https://www.prnewswire.com/news-releases/cardiff-oncology-reports-second-quarter-2023-results-and-provides-business-update-301897225.html,2023-08-09 20:05:00,"- New lead program in first-line RAS-mutated metastatic colorectal cancer ( mCRC ) and expanded Pfizer relationship; interim topline data expected in mid-2024 - - Advance to first-line mCRC follows strong signal from new clinical and preclinical findings and guidance from FDA, and represents an ...",PFE,0.24117,0.11067,Neutral
Abortion rights keep winning on the ballot in conservative states - Florida and Arizona could be next,https://www.cnbc.com/2023/08/09/abortion-rights-keep-winning-on-the-ballot-in-conservative-states.html,2023-08-09 19:52:40,Ohio is the latest in a string of conservative states to reject GOP-backed campaigns to make constitutional changes targeting abortion rights.,PFE,0.048036,-0.17479,Somewhat-Bearish
"Is Novavax A Buy Or A Sell After Beating Forecasts, But Trimming Its Outlook?",https://www.investors.com/news/technology/nvax-stock-buy-now/,2023-08-09 17:13:00,"Novavax ( NVAX ) beat second-quarter sales expectations and unexpectedly reported a profit, but NVAX stock remains under pressure after the company cut its 2023 outlook. For the year, Novavax now expects $1.3 billion to $1.5 billion in sales, a decrease of $100 million from the company's ...",PFE,0.09036,-0.036761,Neutral
PFE: Should Value Investors Go After Pfizer  ( PFE ) ?,https://stocknews.com/news/pfe-nvo-nvs-snphy-should-value-investors-go-after-pfizer-pfe/,2023-08-09 16:58:51,"In its second-quarter release, Pfizer Inc. ( PFE ) reported substantial strides in realizing its objective of introducing 19 novel products and indications within 18 months, with eleven launches already accomplished. Throughout 2023, PFE expects to maintain its momentum, achieving pivotal ...",PFE,0.537677,0.158307,Somewhat-Bullish
"Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data",https://www.cnbc.com/2023/08/09/wegovy-heart-health-data-insurance-hurdles-costs.html,2023-08-09 16:19:23,"There is likely a long way to go before the U.S. sees increased insurance coverage of obesity drugs, but Novo Nordisk's new data is a meaningful start.",PFE,0.028288,-0.007618,Neutral
"With Eris on the rise, US CDC sees no major shift in COVID variants",https://www.reuters.com/business/healthcare-pharmaceuticals/with-eris-rise-us-cdc-sees-no-major-shift-covid-variants-2023-08-09/,2023-08-09 16:07:32,"Aug 9 ( Reuters ) - Currently spreading COVID-19 variants such as EG.5, or Eris, do not represent a major shift and updated vaccines in September will offer protection, the director of the U.S. Centers for Disease Control and Prevention said on Wednesday.",PFE,0.120431,0.115699,Neutral
65% Profit On Eli Lilly - 20% Reduction In Heart Attacks And Strokes With Weight Loss Drug - Raising The Target - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/23/08/33670747/65-profit-on-eli-lilly-20-reduction-in-heart-attacks-and-strokes-with-weight-loss-drug-raising-the-t,2023-08-09 15:09:56,Signal Limited is a Signal ( s ) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.,PFE,0.110209,0.117806,Neutral
PAN-TB Collaboration Announces the Start of a Phase 2 Clinical Trial to Evaluate Two Novel Tuberculosis Treatment Regimens,https://www.prnewswire.com/news-releases/pan-tb-collaboration-announces-the-start-of-a-phase-2-clinical-trial-to-evaluate-two-novel-tuberculosis-treatment-regimens-301896161.html,2023-08-09 14:00:00,PAN-TB Collaboration Announces the Start of a Phase 2 Clinical Trial to Evaluate Two Novel Tuberculosis Treatment ... PR ...,PFE,0.01429,0.139091,Neutral
Pfizer's Profits Plunge 77%: Is the Dividend Still Safe?,https://www.fool.com/investing/2023/08/09/pfizers-profits-plunge-77-is-dividend-still-safe/,2023-08-09 13:45:00,Is this still a good dividend stock to own?,PFE,0.597724,0.166363,Somewhat-Bullish
Is Viatris Stock Good for Dividend Income?,https://www.fool.com/investing/2023/08/09/is-viatris-stock-good-for-dividend-income/,2023-08-09 13:37:00,"If you keep your expectations in check, it could be a great pick.",PFE,0.052112,0.146543,Neutral
World 50 Group Announces Dates for 2024 Inclusion & Diversity Impact Awards,https://www.prnewswire.com/news-releases/world-50-group-announces-dates-for-2024-inclusion--diversity-impact-awards-301896513.html,2023-08-09 13:00:00,"Global community of business leaders calls for entries by October 6 for second annual showcase of DEI progress and best practices Finalists and winners to be celebrated in Miami on March 27, 2024",PFE,0.04111,0.28759,Somewhat-Bullish
Eli Lilly Has Tentpoles In Weight Loss And Alzheimer's; But Is It A Buy?,https://www.investors.com/news/technology/eli-lilly-stock-buy-now/,2023-08-09 12:00:00,Eli Lilly Has Tentpoles In Weight Loss And Alzheimer's. But Is It A Buy? Investor's Business Daily ...,PFE,0.026474,0.155279,Somewhat-Bullish
"Novavax Earnings Call Reveals Surprise Profit, But Stocks Still Slide",https://www.forbes.com/sites/qai/2023/08/09/novavax-earnings-call-reveals-surprise-profit-but-stocks-still-slide/,2023-08-09 11:14:56,"It's not the only vaccine producer struggling to get by, but Novavax looked terminal earlier this year by its own admission.",PFE,0.067347,-0.052593,Neutral
Jnana Therapeutics Announces Dosing of First Participant in Phase 1b Clinical Trial of JNT-517 in Individuals with PKU,https://www.benzinga.com/pressreleases/23/08/g33658838/jnana-therapeutics-announces-dosing-of-first-participant-in-phase-1b-clinical-trial-of-jnt-517-in-,2023-08-09 11:00:00,JNT-517 is a Potential First-in-Class Oral Treatment for PKU; Phase 1b Study Follows Positive Clinical Proof of Mechanism Data in Healthy Individuals Upcoming Oral Presentation of Phase 1a Study Results at the Society for the Study of Inborn Errors of Metabolism ( SSIEM ) Annual Symposium 2023,PFE,0.044469,0.123821,Neutral
Why Novavax Stock Was So Healthy on Monday,https://www.fool.com/investing/2023/08/28/why-novavax-stock-was-so-healthy-on-monday/,2023-08-28 22:16:03,"As the coronavirus threat rises, so too does the vaccine maker's value to investors.",PFE,0.150592,0.010687,Neutral
2 Supercharged Growth Stocks Billionaires Can't Stop Buying,https://www.fool.com/investing/2023/08/28/2-supercharged-growth-stocks-billionaires-cant-sto/,2023-08-28 22:00:00,A top hedge fund has been steadily buying these two growth stocks in 2023.,PFE,0.151222,0.104375,Neutral
Fertility Supplement Global Market to Exhibit Growth at a CAGR of ~8% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/fertility-supplement-global-market-to-exhibit-growth-at-a-cagr-of-8-by-2028--delveinsight-301911682.html,2023-08-28 21:32:00,"The demand for fertility supplements is being driven primarily by key factors such as an increase in the number of cases of infertility, an increase in risk factors associated with causing infertility, growing reproductive health awareness, and an increase in product launches, all of which are ...",PFE,0.057079,0.015993,Neutral
Why BioNTech Shares Are Rising During Monday's Session - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/news/23/08/34074649/why-biontech-shares-are-rising-during-mondays-session,2023-08-28 17:46:44,"BioNTech SE - ADR BNTX shares are trading higher by some 2.25% to $120.26 Monday. The stock is gaining today amid rising COVID-19 cases in the U.S. Rising COVID-19 cases could result in increased demand for vaccines, including BioNTech's jointly developed Pfizer-BioNTech COVID-19 vaccine.",PFE,0.17715,0.047716,Neutral
"Viridian Chart Of The Week: How Capital Intensive Is Cannabis? - Brown Forman Inc Class B Common Stock  ( NYSE:BF/B ) , Ambev  ( NYSE:ABEV ) ",https://www.benzinga.com/markets/cannabis/23/08/34073822/viridian-chart-of-the-week-how-capital-intensive-is-cannabis,2023-08-28 17:10:39,"The chart explores the capital intensity of cannabis compared to four other industries thought to be likely suitors for cannabis companies upon federal legalization: Tobacco, Alcoholic Beverages, Pharmaceuticals, and Consumer Products. In the chart, the cannabis group comprises the nine MSOs with ...",PFE,0.11123,0.0,Neutral
Pfizer to restart production at tornado-hit plant by Q4,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-expects-restart-production-rocky-mount-plant-by-q4-2023-08-28/,2023-08-28 16:12:00,Pfizer expects to restart production at Rocky Mount plant by ...,PFE,0.885652,-0.164294,Somewhat-Bearish
Reasons to Retain OPKO Health  ( OPK )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2141454/reasons-to-retain-opko-health-opk-stock-in-your-portfolio,2023-08-28 15:56:00,OPKO Health's (OPK) potential in RAYALDEE raises optimism about the stock.,PFE,0.056407,0.277003,Somewhat-Bullish
"COVID is evolving quickly in white-tailed deer, study finds",https://www.marketwatch.com/story/covid-is-evolving-quickly-in-white-tailed-deer-study-finds-a7027d3b,2023-08-28 15:53:00,"Mutated virus can jump from animals back to humans, researchers say.",PFE,0.144275,0.185227,Somewhat-Bullish
Pfizer Was First In This Heart Disease. Why BridgeBio Could Be Better.,https://www.investors.com/news/technology/bbio-stock-pfizer-was-first-in-this-heart-disease-why-bridgebio-could-be-better/,2023-08-28 14:00:00,"BridgeBio Pharma ( BBIO ) stands a chance of taking on Pfizer ( PFE ) in treating a genetic heart disease, an analyst said Monday. But BBIO stock reversed a strong premarket gain while Pfizer stock was up marginally. On Sunday, BridgeBio spelled out its Phase 3 win in treating transthyretin ...",PFE,0.396574,0.602051,Bullish
Is It Time to Take Some Gains in Novo Nordisk Stock? Not So Fast.,https://www.fool.com/investing/2023/08/28/is-it-time-to-take-some-gains-in-novo-nordisk/,2023-08-28 12:00:00,"Novo Nordisk stock has been on a tear, but the company's latest financial report suggests it may just be getting started.",PFE,0.043186,0.075567,Neutral
Wall Street Week Ahead-Historically stormy month of September may test US stock rally,https://www.financialexpress.com/market/wall-street-week-ahead-historically-stormy-month-of-september-may-test-us-stock-rally-3224334/,2023-08-27 13:23:11,"U.S. stock investors are bracing for a potentially volatile September as the market faces key economic data reports, a Federal Reserve meeting and worries over a possible government shutdown during a month of historically muted equity performance.In Septembers since 1945, the S&P 500 has ...",PFE,0.064276,-0.004018,Neutral
COVID Is Making a Comeback: Should You Buy These 2 Stocks?,https://www.fool.com/investing/2023/08/27/covid-is-making-a-comeback-should-you-buy-these-2/,2023-08-27 10:10:00,Can these companies keep up their recent momentum?,PFE,0.223659,0.06077,Neutral
"3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street",https://www.fool.com/investing/2023/08/26/3-cathie-wood-stocks-with-parabolic-growth-potenti/,2023-08-26 11:50:00,These cutting-edge biotech stocks could deliver life-changing gains for early shareholders.,PFE,0.056275,0.0,Neutral
3 Surprisingly Underrated Stocks to Buy Right Now,https://www.fool.com/investing/2023/08/26/3-surprisingly-underrated-stocks-to-buy-right-now/,2023-08-26 10:55:00,These stocks deserve more respect than they're getting.,PFE,0.320279,0.086734,Neutral
Joe Biden says he will request more funding for a new coronavirus vaccine,https://www.business-standard.com/world-news/joe-biden-says-he-will-request-more-funding-for-a-new-coronavirus-vaccine-123082600057_1.html,2023-08-26 01:23:12,"President Joe Biden said Friday that he is planning to request more money from Congress to develop another new coronavirus vaccine, as scientists track new waves and hospitalizations rise, though not like before.",PFE,0.115787,-0.020719,Neutral
Multiple sclerosis market in the US to Grow by USD 3.95 billion from 2021 to 2026 | Rising prevalence of multiple ... - PR Newswire,https://www.prnewswire.com/news-releases/multiple-sclerosis-market-in-the-us-to-grow-by-usd-3-95-billion-from-2021-to-2026--rising-prevalence-of-multiple-sclerosis-will-drive-growth---technavio-301909378.html,2023-08-26 00:30:00,Multiple sclerosis market in the US to Grow by USD 3.95 billion from 2021 to 2026 | Rising prevalence of multiple ... PR ...,PFE,0.059785,0.185027,Somewhat-Bullish
Wall St Week Ahead Historically stormy month of September may test US stock rally,https://www.reuters.com/markets/us/wall-st-week-ahead-historically-stormy-month-september-may-test-us-stock-rally-2023-08-25/,2023-08-25 21:42:00,"The Wall Street entrance to the New York Stock Exchange ( NYSE ) is seen in New York City, U.S., November 15, 2022. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",PFE,0.059194,-0.047008,Neutral
President Joe Biden says he will request more funding for a new coronavirus vaccine,https://apnews.com/article/covid-biden-pandemic-79d8b3004009a1560744dfc116c4af0a,2023-08-25 21:37:00,"SOUTH LAKE TAHOE, California ( AP ) - President Joe Biden said Friday that he is planning to request more money from Congress to develop another new coronavirus vaccine, as scientists track new waves and hospitalizations rise, though not like before.",PFE,0.116348,-0.020762,Neutral
Some Older Adults Are Being Charged Over $300 for the New R.S.V. Vaccine,https://www.nytimes.com/2023/08/25/well/live/rsv-vaccines-health-insurance-medicare.html,2023-08-25 19:55:21,New RSV Vaccines Aren't Covered by Some Health Insurance Plans The New York Times ...,PFE,0.051999,-0.015026,Neutral
Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government - AstraZeneca  ( NASDAQ:AZN ) ,https://www.benzinga.com/general/biotech/23/08/34045861/pharma-giants-unite-against-drug-price-negotiation-astrazeneca-latest-to-challenge-the-government,2023-08-25 17:49:45,AstraZeneca Plc AZN announced its legal challenge against the U.S. government's Inflation Reduction Act ( IRA ) that allows the Medicare health insurance system to negotiate more competitive drug prices.,PFE,0.233556,0.0,Neutral
Novo Nordisk's  ( NVO )  Shares Jump 17% in a Month: Here's Why,https://www.zacks.com/stock/news/2140987/novo-nordisks-nvo-shares-jump-17-in-a-month-heres-why,2023-08-25 15:41:00,"Novo Nordisk's (NVO) commercial and pipeline progress with its popular obesity drug, Wegovy, continues to drive the share price momentum.",PFE,0.376329,0.002604,Neutral
US CDC advisers set to vote on updated COVID vaccines next month,https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-advisers-set-vote-updated-covid-vaccines-next-month-2023-08-25/,2023-08-25 14:59:00,"[1/2] A vial labelled ""VACCINE Coronavirus COVID-19"" is seen in front of a stock graph in this illustration taken on January 17, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",PFE,0.231332,-0.059775,Neutral
"As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit - even if their drugs aren't on the list",https://www.marketwatch.com/story/as-medicare-picks-10-drugs-for-price-negotiations-50-million-people-stand-to-benefit-even-if-their-drugs-arent-on-the-list-aceec7e,2023-08-25 14:54:00,Government negotiations with drugmakers are set to launch amid a growing number of legal challenges.,PFE,0.062843,-0.034042,Neutral
"Analysis of the Global AI in Clinical Trials Industry, 2023 to 2035 - Product/Technology Utilization and Integration Agreements Lead the Way in Partnerships",https://www.prnewswire.com/news-releases/analysis-of-the-global-ai-in-clinical-trials-industry-2023-to-2035---producttechnology-utilization-and-integration-agreements-lead-the-way-in-partnerships-301909941.html,2023-08-25 14:15:00,"Analysis of the Global AI in Clinical Trials Industry, 2023 to 2035 - Product/Technology Utilization and Integration ... PR ...",PFE,0.034655,0.16248,Somewhat-Bullish
Pfizer's  ( PFE )  RSV Vaccine Abrysvo Gets Approval in EU,https://www.zacks.com/stock/news/2140757/pfizers-pfe-rsv-vaccine-abrysvo-gets-approval-in-eu,2023-08-25 13:43:00,"Pfizer's (PFE) RSV vaccine, Abrysvo, gets approval in Europe to protect infants through maternal immunization as well as for older adults.",PFE,0.390904,0.312051,Somewhat-Bullish
"Pharma Stock Roundup: PFE Gets Nod for RSV Vaccine, J&J Finalizes Kenvue Separation",https://www.zacks.com/stock/news/2140722/pharma-stock-roundup-pfe-gets-nod-for-rsv-vaccine-jj-finalizes-kenvue-separation,2023-08-25 13:24:00,"FDA and EU approve Pfizer's (PFE) RSV vaccine, Abrysvo for maternal immunization. J&J (JNJ) finalizes separation of its Consumer Health company, Kenvue.",PFE,0.145804,0.084383,Neutral
Code and Theory Debuts 'Beyond Words' Inclusive Language Guide and Certification Program,https://www.prnewswire.com/news-releases/code-and-theory-debuts-beyond-words-inclusive-language-guide-and-certification-program-301910090.html,2023-08-25 12:30:00,"'Beyond Words: A Guide to Inclusive Language,' a new foundational resource for brands, will serve as the basis of the all-staff certification program for Code and Theory employees with plans to offer training network-wide across Stagwell ( STGW ) and throughout the industry.",PFE,0.043738,0.088829,Neutral
"Updated Covid-19 vaccines are coming mid-September, officials say",https://www.cnn.com/2023/08/25/health/covid-vaccine-release/index.html,2023-08-25 12:25:00,"Covid-19 vaccines that have been tweaked to teach the body how to fend off the current crop of circulating variants are now expected to land in drugstores and clinics in mid-September, CDC and FDA officials said.",PFE,0.092569,0.008502,Neutral
3 Dividend Stocks to Buy on Sale,https://www.fool.com/investing/2023/08/25/3-dividend-stocks-to-buy-on-sale/,2023-08-25 09:35:00,Long-term investors can profit from the market's overreaction to short-term challenges.,PFE,0.157483,0.045796,Neutral
"CDC expects new Covid vaccines from Pfizer, Moderna and Novavax to be available in mid-September",https://www.cnbc.com/2023/08/25/covid-vaccines-cdc-expects-new-shots-to-be-available-in-mid-september.html,2023-08-25 09:06:02,"The updated Covid vaccines from Pfizer, Moderna and Novavax still need green lights from the FDA and the CDC before they roll out to the public.",PFE,0.158519,-0.00816,Neutral
Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?,https://www.marketwatch.com/story/stock-buybacks-spur-wealth-inequality-and-stifle-innovation-but-should-they-be-banned-13e963c0,2023-08-24 21:56:00,"Stock buybacks have become a major source of wealth inequality and have stifled innovation in the U.S., according to this academic.",PFE,0.105295,-0.05102,Neutral
Bullish on Nvidia? This single-stock ETF could offer 1.5 times leverage on the chip maker stock - but be careful what you wish for,https://www.marketwatch.com/story/bullish-on-nvidia-this-single-stock-etf-could-offer-1-5-times-leverage-on-the-chip-maker-stock-but-be-careful-what-you-wish-for-c9966f8f,2023-08-24 20:23:00,"While Nvidia's blow out earnings reignite the artificial-intelligence trade in the U.S. stock market, some risk-seeking investors are looking for ways to gain more exposure to the clear leader in the chip manufacturing industry.",PFE,0.057767,0.023027,Neutral
eFFECTOR Stock To Rally Over 500%? Analyst Predict Blockbuster Status For Cancer Candidates - eFFECTOR Therapeutics  ( NASDAQ:EFTR ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/08/34029173/effector-stock-to-rally-over-500-analyst-predict-blockbuster-status-for-cancer-cand,2023-08-24 18:18:35,HC Wainwright has initiated coverage on eFFECTOR Therapeutics Inc EFTR with a Buy rating and a price target of $5.,PFE,0.301315,0.0,Neutral
EU approves Pfizer's RSV vaccine to protect infants and older adults,https://www.reuters.com/business/healthcare-pharmaceuticals/eu-approves-pfizers-rsv-vaccine-protect-infants-older-adults-2023-08-24/,2023-08-24 16:17:00,"[1/2] A company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights Aug 24 ( Reuters ) - The European Commission on Thursday approved Pfizer's ( PFE.N ) vaccine for respiratory syncytial virus ( RSV ) for use in babies and ...",PFE,0.546745,0.0,Neutral
"Michigan Teen Who Died 3 Days After Covid Vaccination Actually Killed By Bacterial Infection, CDC Reportedly Finds",https://www.forbes.com/sites/maryroeloffs/2023/08/24/michigan-teen-who-died-3-days-after-covid-vaccination-actually-killed-by-bacterial-infection-cdc-reportedly-finds/,2023-08-24 15:01:21,"A CDC report says Jacob Clynick did not die of vaccine-related causes, the Detroit Free Press reported Thursday, but the medical examiner who performed his autopsy stands by his findings.",PFE,0.095327,-0.072826,Neutral
Kansas City University Recognized for 'Groundbreaking' Pancreatic Cancer Research,https://markets.businessinsider.com/news/stocks/kansas-city-university-recognized-for-groundbreaking-pancreatic-cancer-research-1032579834,2023-08-24 13:49:55,"KANSAS CITY, Mo., Aug. 24, 2023 /PRNewswire/ -- Kansas City University ( KCU ) Associate professor Ehab Sarsour, MSc, PhD, and student-researchers have discovered a new and promising avenue for treating pancreatic cancer by treating the tumor microenvironment by repurposing a drug designed for ...",PFE,0.057079,0.028126,Neutral
PM360 Announces 2023 Trailblazer Award Finalists,https://www.prnewswire.com/news-releases/pm360-announces-2023-trailblazer-award-finalists-301907769.html,2023-08-24 13:00:00,"Top Companies, Marketers, CEOs, Products, and Initiatives to be Honored During Gala on October 3rd NEW YORK, Aug. 24, 2023 /PRNewswire/ -- PM360 has announced the finalists for its 15th annual Trailblazer Awards.",PFE,0.04161,0.075016,Neutral
Stock Market Sell-Off: Where to Invest $500 Right Now,https://www.fool.com/investing/2023/08/24/stock-market-sell-off-where-to-invest-500-right-no/,2023-08-24 11:05:00,"Down more than 10% through August, Apple's pullback may be the time to begin investing.",PFE,0.058759,0.031043,Neutral
"Page 4 of Cipla News: Cipla Latest News, Cipla Today news, Cipla Breaking News",https://www.financialexpress.com/about/cipla/news/page/4/,2023-08-24 06:14:15,Cipla share price falls 5% after warning letter from US Food and Drug Administration he USFDA had conducted an inspection at Cipla's Goa facility in September last year. Cipla share price was down at… Drug firm Cipla today said its board has approved appointment of Kedar Upadhye as the company's ...,PFE,0.159569,-0.150395,Somewhat-Bearish
Contraceptives Global Market Exhibit Growth at a CAGR of ~5% by 2027 | DelveInsight,https://www.prnewswire.com/news-releases/contraceptives-global-market-exhibit-growth-at-a-cagr-of-5-by-2027--delveinsight-301907623.html,2023-08-23 21:01:00,"The contraceptives market is experiencing positive growth as a result of increased awareness about sexually transmitted diseases, an increase in government initiatives for population control, an increase in unintended pregnancies, and technological innovations leading to effective contraception, ...",PFE,0.100308,0.012835,Neutral
Is Sarepta Therapeutics Stock a Top Growth Vehicle?,https://www.fool.com/investing/2023/08/23/is-sarepta-therapeutics-stock-a-top-growth-vehicle/,2023-08-23 17:00:00,An upcoming data readout could fuel another rally in the biotech's shares.,PFE,0.068896,0.092374,Neutral
Travel Leaders' International Network of Independent Travel Agencies Appoints New Regional Sales Manager for Latin ... - PR Newswire,https://www.prnewswire.com/news-releases/travel-leaders-international-network-of-independent-travel-agencies-appoints-new-regional-sales-manager-for-latin-america-301908208.html,2023-08-23 15:15:00,Travel Leaders' International Network of Independent Travel Agencies Appoints New Regional Sales Manager for Latin ... PR ...,PFE,0.07031,0.194848,Somewhat-Bullish
TEVA: Pfizer Inc.  ( PFE )  vs. Teva Pharmaceutical Industries  ( TEVA ) : Which Stock is the Better Growth AND Value Buy?,https://stocknews.com/news/teva-pfe-pfizer-inc-pfe-vs-teva-pharmaceutical-industries-teva-which-stock/,2023-08-23 14:46:51,TEVA: Pfizer Inc. ( PFE ) vs. Teva Pharmaceutical Industries ( TEVA ... ...,PFE,0.480832,0.232611,Somewhat-Bullish
Novavax  ( NVAX )  Updated COVID Jab Effective Against Eris Variant,https://www.zacks.com/stock/news/2139757/novavax-nvax-updated-covid-jab-effective-against-eris-variant,2023-08-23 14:32:00,"In studies on small animals and primates, Novavax's (NVAX) updated monovalent COVID-19 vaccine generates a robust immune response against the currently dominating Eris variant.",PFE,0.293741,0.245961,Somewhat-Bullish
How Is The Market Feeling About Pfizer? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/short-sellers/23/08/34005355/how-is-the-market-feeling-about-pfizer,2023-08-23 14:15:28,"Pfizer's PFE short percent of float has fallen 12.9% since its last report. The company recently reported that it has 45.86 million shares sold short, which is 0.81% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their ...",PFE,0.224903,0.085754,Neutral
Pyxis Oncology Successfully Completes Acquisition of Apexigen,https://www.globenewswire.com/news-release/2023/08/23/2730427/0/en/Pyxis-Oncology-Successfully-Completes-Acquisition-of-Apexigen.html,2023-08-23 12:35:00,"Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream ...",PFE,0.030524,0.186808,Somewhat-Bullish
Pyxis Oncology Successfully Completes Acquisition of Apexigen - Pyxis Oncology  ( NASDAQ:PYXS ) ,https://www.benzinga.com/pressreleases/23/08/g34002489/pyxis-oncology-successfully-completes-acquisition-of-apexigen,2023-08-23 12:35:00,"Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream Company positioned as a leader in next-generation, end-to-end Antibody-Drug Conjugate ( ""ADC"" ) creation with clinically and commercially validated platform capabilities",PFE,0.029472,0.198825,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Moderna, BioNTech, Novavax and Pfizer",https://www.zacks.com/stock/news/2139470/the-zacks-analyst-blog-highlights-moderna-biontech-novavax-and-pfizer,2023-08-23 09:00:00,"Moderna, BioNTech, Novavax and Pfizer are included in this Analyst Blog.",PFE,0.333557,0.15439,Somewhat-Bullish
Ireland's wild data is leaving economists stumped,https://www.ft.com/content/bfd666f3-9e2c-442b-9fe0-0a33d020241d,2023-08-23 04:00:42,Eurozone statistics have been seriously distorted by US tech and pharma groups that found a home in Dublin ...,PFE,0.154125,0.054658,Neutral
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2139377/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2023-08-22 21:53:16,"Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",PFE,0.490323,0.141226,Neutral
Sleep Aid Global Market to Surpass USD 50 Billion Mark by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/sleep-aid-global-market-to-surpass-usd-50-billion-mark-by-2028--delveinsight-301906368.html,2023-08-22 21:01:00,"The global sleep aid market is predicted to surge owing to the growing prevalence of sleep disorders such as insomnia, obstructive sleep apnea ( OSA ) , and narcolepsy, among others.",PFE,0.03443,0.111992,Neutral
"Top Stories Tuesday, Aug 22: S&P Slashes Ratings Of Five US Banks, SEC Fines Fintech Adviser Titan For Misleading Crypto Claims, Microsoft Modifies Activision Blizzard Purchase",https://www.benzinga.com/markets/cryptocurrency/23/08/33986057/s-p-slashes-ratings-of-five-us-banks-sec-fines-fintech-adviser-titan-for-misleading-crypto,2023-08-22 14:51:47,"S&P Global Ratings has cast a spotlight on the challenges faced by several U.S. regional banks, resulting in a series of downgrades that have reverberated through the financial sector.",PFE,0.063425,0.010096,Neutral
U.S. Govt to Urge Citizens to Get New COVID-19 Shots,https://www.zacks.com/stock/news/2139137/us-govt-to-urge-citizens-to-get-new-covid-19-shots,2023-08-22 14:25:00,Shares of COVID-19 vaccine makers soared after reports suggest that the Biden administration will start a campaign urging citizens to vaccinate themselves with updated shots vaccine in the upcoming fall.,PFE,0.295867,0.252918,Somewhat-Bullish
Novavax says new Covid vaccine was effective against Eris variant in animal trials,https://www.cnbc.com/2023/08/22/covid-novavax-vaccine-eris-variant.html,2023-08-22 14:22:42,"Novavax's vaccine and new shots from Pfizer and Moderna are expected to roll out in the U.S. within weeks, pending potential approvals from the FDA.",PFE,0.262522,0.067147,Neutral
FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/08/33983722/fda-greenlights-pfizers-rsv-vaccine-moms-can-now-protect-babies-before-birth,2023-08-22 13:28:41,"Monday, the FDA approved Pfizer Inc's PFE Abrysvo ( Respiratory Syncytial Virus Vaccine ) , the company's bivalent RSV prefusion F ( RSVpreF ) vaccine, to prevent the infection in infants from birth up to six months of age by active immunization of pregnant individuals at 32 through 36 weeks ...",PFE,0.47452,-0.103016,Neutral
"Gold Rush In Weight Loss Industry Impacts Retailers With Pharmacy Businesses - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/08/33980022/gold-rush-in-weight-loss-industry-impacts-retailers-with-pharmacy-businesses,2023-08-22 13:21:43,"Retailers with pharmacy businesses, including major players like Walmart Inc WMT, Kroger Company KR, and Rite Aid Corp RAD, are also seeing a boost in sales due to increased demand for prescription weight loss drugs.",PFE,0.230235,0.432791,Bullish
Pfizer's  ( PFE )  RSV Vaccine Gets FDA Nod for Pregnant Women,https://www.zacks.com/stock/news/2139030/pfizers-pfe-rsv-vaccine-gets-fda-nod-for-pregnant-women,2023-08-22 13:08:00,"The FDA approves Pfizer's (PFE) RSV vaccine, Abrysvo, for the prevention of lower respiratory tract disease in infants through administration to pregnant women.",PFE,0.401331,0.130188,Neutral
Paradox Named to Third Consecutive Inc. 5000 List -- Growing by More than 720% Since 2020,https://www.prnewswire.com/news-releases/paradox-named-to-third-consecutive-inc-5000-list--growing-by-more-than-720-since-2020-301906174.html,2023-08-22 12:04:00,"No. 1 among recruiting technology companies, the Scottsdale-based business is helping large global companies automate everyday hiring work to dramatically improve efficiency, save time and deliver experiences people love.",PFE,0.051003,0.311715,Somewhat-Bullish
"Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca",https://www.zacks.com/stock/news/2139000/zacks-industry-outlook-highlights-eli-lilly-jj-novo-nordisk-novartis-and-astrazeneca,2023-08-22 11:38:00,"Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca are part of the Zacks Industry Outlook article ...",PFE,0.047092,0.095788,Neutral
Down 25% In A Year Will Pfizer Stock Rebound To Its Pre-Inflation Shock Level?,https://www.forbes.com/sites/greatspeculations/2023/08/22/down-25-in-a-year-will-pfizer-stock-rebound-to-its-pre-inflation-shock-level/,2023-08-22 11:00:22,"Returning to the pre-inflation shock level of over $60 means that PFE stock will have to gain more than 65% from here, and we don't think this will materialize anytime...",PFE,0.640349,0.066338,Neutral
"5 things to know for Aug. 22: Trump, Storms, RSV, Ukraine, Radioactive water",https://www.cnn.com/2023/08/22/us/5-things-to-know-for-aug-22-trump-storms-rsv-ukraine-radioactive-water/index.html,2023-08-22 10:56:57,"The record-breaking film ""Barbie"" has been unseated from the top of the US box office, but many stores will be awash in pink for the rest of the year. Brands and retailers plan to stretch the ""Barbie"" excitement through the fall season, with an influx of themed products timed to release ahead of ...",PFE,0.033006,-0.069525,Neutral
What to Know About the Latest Covid Wave in New York City,https://www.nytimes.com/2023/08/22/nyregion/covid-nyc-explainer.html,2023-08-22 07:00:13,Do you know a friend or co-worker who has recently come down with Covid? Do you have a sore throat or sniffles yourself? Figuring out whether Covid is rising in the city - and whether you might have come down with it - has become trickier lately as the pandemic response winds down.,PFE,0.050465,0.044588,Neutral
US Approves Maternal Vaccine To Prevent RSV In Infants,https://www.barrons.com/news/us-approves-maternal-vaccine-to-prevent-rsv-in-infants-69135749,2023-08-21 23:05:00,The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus ( RSV ) in their babies.,PFE,0.153961,0.065652,Neutral
US Approves Vaccine For Pregnant Women To Prevent RSV In Infants,https://www.barrons.com/news/us-approves-vaccine-for-pregnant-women-to-prevent-rsv-in-infants-3d387fee,2023-08-21 22:09:00,The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus ( RSV ) in their babies.,PFE,0.524949,0.366248,Bullish
FDA Approves First RSV Vaccine For Kids-Given To Pregnant Moms-Here's What To Know,https://www.forbes.com/sites/roberthart/2023/08/21/fda-approves-first-rsv-vaccine-for-kids-given-to-pregnant-moms-heres-what-to-know/,2023-08-21 21:57:10,"RSV infects nearly every child by the time they reach 2 and can cause serious, potentially fatal, illness.",PFE,0.140621,0.024689,Neutral
FDA approves RSV vaccine for moms-to-be to guard their newborns,https://apnews.com/article/rsv-vaccine-pregnant-women-babies-a0f9dfec9930b55a134fe493c73fc389,2023-08-21 21:56:00,WASHINGTON ( AP ) - U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is notorious for filling hospitals with wheezing babies every fall and winter.,PFE,0.164282,-0.060847,Neutral
Pfizer maternal RSV vaccine gets FDA approval,https://www.marketwatch.com/story/pfizer-maternal-rsv-vaccine-gets-fda-approval-aaa7ccef,2023-08-21 21:54:00,New shot designed to protect babies against leading cause of hospitalization is expected to be available this fall.,PFE,0.387541,0.040542,Neutral
US FDA approves Pfizer's maternal RSV vaccine to protect infants,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-maternal-rsv-vaccine-protect-infants-2023-08-21/,2023-08-21 21:48:00,"[1/2] A company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights Aug 21 ( Reuters ) - The U.S.",PFE,0.320974,-0.047848,Neutral
FDA approves Pfizer maternal RSV vaccine for infants,https://www.cnbc.com/2023/08/21/rsv-fda-approves-pfizer-maternal-vaccine-for-infants-.html,2023-08-21 21:43:22,Pfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.,PFE,0.211652,0.089629,Neutral
FDA approves first vaccine to protect newborns from RSV,https://www.cnn.com/2023/08/21/health/rsv-vaccine-infants-pfizer-fda/index.html,2023-08-21 21:41:11,FDA approves first vaccine to protect newborns from ...,PFE,0.193207,0.162288,Somewhat-Bullish
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/medical-second-opinion-global-market-to-register-stunning-growth-at-a-cagr-of-17-by-2028--delveinsight-301905294.html,2023-08-21 21:01:00,"The medical second opinion market is expanding rapidly due to the increasing frequency of malignancies, infectious diseases, genetic diseases, cardiovascular diseases, hematological diseases, orthopedic diseases, and other diseases around the world.",PFE,0.048671,-0.012897,Neutral
"Why Moderna, BioNTech SE, and Novavax Surged Today",https://www.fool.com/investing/2023/08/21/why-moderna-biontech-se-and-novavax-surged-today/,2023-08-21 20:50:53,"The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign.",PFE,0.2035,0.130081,Neutral
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/08/33972665/looking-at-pfizers-recent-unusual-options-activity,2023-08-21 20:45:51,"Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.809819,0.224186,Somewhat-Bullish
Covid vaccine stocks jump as new variants emerge ahead of fall shot rollout,https://www.cnbc.com/2023/08/21/covid-vaccine-stocks-jump-as-new-variants-emerge.html,2023-08-21 16:44:37,"Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.",PFE,0.244109,0.185946,Somewhat-Bullish
"Weight loss drugs boost sales at retail pharmacies, but they may not help profits much",https://www.cnbc.com/2023/08/21/weight-loss-drugs-boost-retail-pharmacy-sales.html,2023-08-21 15:36:40,Analysts said blockbuster weight loss drugs like Wegovy are minimally profitable for retailers like Walmart - and may even come with slight margin headwinds.,PFE,0.03642,0.070736,Neutral
"5 Value Stocks To Watch In The Healthcare Sector - Kiniksa Pharmaceuticals  ( NASDAQ:KNSA ) , Akerna  ( NASDAQ:KERN ) , Acorda Therapeutics  ( NASDAQ:ACOR ) , Pfizer  ( NYSE:PFE ) , Spok Holdings  ( NASDAQ:SPOK ) ",https://www.benzinga.com/news/23/08/33964875/5-value-stocks-to-watch-in-the-healthcare-sector,2023-08-21 14:44:23,"A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the ...",PFE,0.175859,0.199868,Somewhat-Bullish
"Lung Cancer Treatment Market Revenue to Cross USD 102 billion by 2031, Expanding at a CAGR of 9.8% Says, Transparency Market Research Inc.",https://www.benzinga.com/pressreleases/23/08/g33964549/lung-cancer-treatment-market-revenue-to-cross-usd-102-billion-by-2031-expanding-at-a-cagr-of-9-8-s,2023-08-21 14:30:00,"Wilmington, Delaware, United States, Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global lung cancer treatment market is projected to flourish at a CAGR of 9.8% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 102 billion is anticipated for ...",PFE,0.041323,0.052319,Neutral
5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace,https://www.zacks.com/commentary/2138567/5-large-drug-stocks-to-watch-as-new-drug-approvals-ma-gain-pace,2023-08-21 13:51:00,"Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Novartis (NVS) and AstraZeneca (AZN) are worth retaining in your portfolio.",PFE,0.048278,0.068994,Neutral
"'The sharks are still there.' Stock market's decline is just beginning, this top fund manager says",https://www.marketwatch.com/story/the-sharks-are-still-there-stock-markets-decline-is-just-beginning-this-top-fund-manager-says-12cb6ad3,2023-08-21 11:33:00,Neuberger Berman's Eli Salzmann is positioning his portfolio for a U.S. recession. Here's his investment strategy and what he's buying now.,PFE,0.083638,0.099239,Neutral
"Clinton Global Initiative will return to New York with Jose Andres, Orlando Bloom, and Matt Damon",https://apnews.com/article/clinton-global-initiative-matt-damon-jose-andres-365b3d3572cff6e8a110b6442ccf525e,2023-08-21 10:12:00,"NEW YORK ( AP ) - The Clinton Global Initiative 2023 will convene ""leaders, innovators and dreamers"" - ranging from World Bank President Ajay Banga and The Bahamas' Prime Minister Philip E.",PFE,0.066047,0.11722,Neutral
What to Know About the New R.S.V. Immunizations,https://www.nytimes.com/article/rsv-vaccine.html,2023-08-21 09:00:31,"RSV Vaccines: What to Know For Babies, Pregnant Women and Older Adults The New York Times ...",PFE,0.126617,0.008485,Neutral
Why startups are investing millions to make drugs and semiconductors in space,https://www.cnbc.com/2023/08/20/startups-investing-millions-to-make-drugs-and-semiconductors-in-space-.html,2023-08-20 13:00:02,"The market for materials manufactured in space could reach $10 billion by 2030, according to an estimate from a McKinsey analyst.",PFE,0.051551,0.060594,Neutral
3 Fantastic Stocks to Buy in a New Bull Market,https://www.fool.com/investing/2023/08/20/3-fantastic-stocks-to-buy-in-a-new-bull-market/,2023-08-20 10:54:00,These stocks could be just the ticket if a sustained new bull market is beginning.,PFE,0.311829,0.310757,Somewhat-Bullish
3 Green Flags for Biotech Stocks in 2023 and Beyond,https://www.fool.com/investing/2023/08/19/3-green-flags-for-biotech-stocks-in-2023-and-beyon/,2023-08-19 13:45:00,"The industry is changing rapidly, and for the better.",PFE,0.051999,0.083568,Neutral
"Explainer: Eris, BA.2.86: Do I need to worry about COVID again?",https://www.reuters.com/business/healthcare-pharmaceuticals/eris-ba286-do-i-need-worry-about-covid-again-2023-08-19/,2023-08-19 12:10:00,"[1/3] A nurse fills up syringes with the coronavirus disease ( COVID-19 ) vaccines for residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin/File Photo Acquire Licensing ...",PFE,0.063763,0.0,Neutral
Pain Management Devices Market size to grow by USD 2.70 billion from 2022 to 2027 | Technological advances in ... - PR Newswire,https://www.prnewswire.com/news-releases/pain-management-devices-market-size-to-grow-by-usd-2-70-billion-from-2022-to-2027--technological-advances-in-ablation-devices-are-major-trends---technavio-301904152.html,2023-08-19 04:15:00,Pain Management Devices Market size to grow by USD 2.70 billion from 2022 to 2027 | Technological advances in ... PR ...,PFE,0.048425,-0.103848,Neutral
"T-Mobile's Dividend Debut Boosts Stock, $19 Billion Shareholder Return Announced - T-Mobile US  ( NASDAQ:TMUS ) ",https://www.benzinga.com/news/large-cap/23/09/34326677/t-mobiles-dividend-debut-boosts-stock-19-billion-shareholder-return-announced,2023-09-07 18:18:00,Shares of telecom titan T-Mobile Us Inc TMUS are trading higher during Thursday's trading session after the company announced the initiation of a dividend growth model. This also came on the heels of the company's recent announcement of a $19 billion shareholder return program.,PFE,0.112532,0.12372,Neutral
"FTC Settles Suit, Potentially Averting Further Hurdles",https://www.investorideas.com/news/2023/biotech/09072FTC-Settles-Suit.asp,2023-09-07 17:38:23,"Last week, the U.S. Federal Trade Commission ( FTC ) suspended its legal challenge to Amgen Inc. ( AMGN:NASDAQ ) 's proposed acquisition of Horizon Therapeutics Plc ( HZNP:NASDAQ ) , 2022's largest deal announcement in the biopharma space.",PFE,0.359014,0.315656,Somewhat-Bullish
The Atlantic Announces Hillary Rodham Clinton and New Speakers for the 15th Annual Atlantic Festival,https://www.theatlantic.com/press-releases/archive/2023/09/atlantic-festival-announces-hillary-rodham-clinton/675247/,2023-09-07 17:30:07,Atlantic Festival announces Hillary Rodham Clinton The Atlantic ...,PFE,0.040969,0.230351,Somewhat-Bullish
Don't Get Your Next Covid Booster Quite Yet,https://www.nytimes.com/article/covid-booster-fall.html,2023-09-07 16:15:59,"Should You Get Another Covid Booster Now, or Wait Until the Fall? The New York Times ...",PFE,0.063258,0.103056,Neutral
Exact Sciences  ( EXAS )  Gains From New Buyouts Amid Rising Costs,https://www.zacks.com/stock/news/2146155/exact-sciences-exas-gains-from-new-buyouts-amid-rising-costs,2023-09-07 15:50:00,Exact Sciences (EXAS) is improving customer experience by making it simpler to order Cologuard electronically and continue re-screening of patients every three years.,PFE,0.049526,0.126035,Neutral
Moderna  ( MRNA )  Updated COVID Jab Effective Against Pirola Variant,https://www.zacks.com/stock/news/2146191/moderna-mrna-updated-covid-jab-effective-against-pirola-variant,2023-09-07 15:20:00,"Clinical study data shows Moderna's (MRNA) updated COVID-19 vaccine generates a robust immune response against newer circulating variants, including Pirola and Eris.",PFE,0.317254,0.070961,Neutral
Could Pfizer Stock Help You Become A Millionaire?,https://www.fool.com/investing/2023/09/07/could-pfizer-stock-help-you-become-a-millionaire/,2023-09-07 13:15:00,"The stock's track record hasn't been great in recent years, but could that change?",PFE,0.41608,0.281142,Somewhat-Bullish
3 Dividend Stocks That Could Be Ideal Buys for Retirees in September,https://www.fool.com/investing/2023/09/07/3-dividend-stocks-that-could-ideal-buys-for-retire/,2023-09-07 11:53:00,"These companies all have stable and safe businesses, which can make them suitable options for retirees.",PFE,0.169279,0.070525,Neutral
Explainer: Do I need to worry about COVID again?,https://www.reuters.com/business/healthcare-pharmaceuticals/do-i-need-worry-about-covid-again-2023-09-07/,2023-09-07 10:10:00,"[1/3] A nurse fills up syringes with the coronavirus disease ( COVID-19 ) vaccines for residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin/File Photo Acquire Licensing ...",PFE,0.120431,-0.078938,Neutral
"Pfizer, Valneva say 'positive' result for Lyme disease vaccine candidate booster",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-valneva-announce-positive-results-lyme-disease-vaccine-candidate-booster-2023-09-07/,2023-09-07 05:37:30,"Sept 7 ( Reuters ) - Pfizer ( PFE.N ) and French pharmaceutical peer Valneva ( VLS.PA ) announced on Thursday that a phase 2 study for its VLA15 Lyme disease vaccine candidate showed a ""strong immune response"" in both children and adolescents a month after a booster shoot.",PFE,0.518022,0.296579,Somewhat-Bullish
Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate,https://www.globenewswire.com/news-release/2023/09/07/2738966/0/en/Valneva-and-Pfizer-Report-Positive-Pediatric-and-Adolescent-Phase-2-Booster-Results-for-Lyme-Disease-Vaccine-Candidate.html,2023-09-07 05:00:00,"Saint-Herblain ( France ) & New York, September 7, 2023 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) and Pfizer Inc. ( NYSE: PFE ) announced today positive pediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate, VLA15, when given as a booster.",PFE,0.281153,0.183728,Somewhat-Bullish
Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate,https://www.benzinga.com/pressreleases/23/09/g34301684/valneva-and-pfizer-report-positive-pediatric-and-adolescent-phase-2-booster-results-for-lyme-disea,2023-09-07 05:00:00,Strong immune response shown in both children and adolescents one month after booster dose ( month 19 ) in VLA15-221 study Previously observed high anamnestic antibody response in adults confirmed VLA15 well-tolerated in all age groups following booster dose,PFE,0.225063,0.196797,Somewhat-Bullish
Astellas withdraws lawsuit challenging Medicare drug price negotiation plans,https://www.reuters.com/business/healthcare-pharmaceuticals/astellas-withdraws-lawsuit-challenging-medicare-drug-price-negotiation-plans-2023-09-06/,2023-09-07 02:11:00,"Astellas Pharma's logo is pictured at its headquarters in Tokyo, Japan, December 3, 2019. REUTERS/Kim Kyung-Hoon Acquire Licensing Rights",PFE,0.150592,-0.034067,Neutral
"GME, AAPL, PFE, TSLA, AMC: Top 5 Trending Stocks Today - Tesla  ( NASDAQ:TSLA ) , GameStop  ( NYSE:GME ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/markets/equities/23/09/34298480/gamestop-apple-pfizer-tesla-amc-why-these-5-stocks-are-trending-today,2023-09-07 01:45:22,"U.S. stocks experienced a downward trend midway through trading, with the Dow Jones declining approximately 200 points on Wednesday. The Dow ended Wednesday lower by 0.57% to 34,443.19, while the NASDAQ saw a decrease of 1.06% to 13,872.47. Similarly, the S&P 500 also witnessed a drop, falling ...",PFE,0.155954,0.052884,Neutral
How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/09/34293430/how-to-earn-500-from-pfizer-stock-with-shares-trading-at-52-week-low,2023-09-06 22:37:26,"President Joe Biden's Inflation Reduction Act, which allows Medicare to negotiate the price of some prescription drugs, remains the talk of the town as investors sell off shares in pharmaceutical companies such as Pfizer Inc. PFE because drugs associated with the companies are on the negotiation ...",PFE,0.709611,0.057208,Neutral
Battery parts maker Entek breaks ground on $1.5B manufacturing campus in western Indiana,https://apnews.com/article/entek-battery-parts-plant-indiana-36f96a939eaeab161b926c55333a5718,2023-09-06 21:33:00,"Larry Keith, CEO of ENTEK, points out one of the features in the artist's rendering of the new lithium battery separators plant to Gov. Eric Holcomb during the groundbreaking ceremony for the plant on Wednesday, Sept. 6, 2023 in Vigo County Industrial Park II near Terre Haute, Ind. ( Joseph C.",PFE,0.069094,0.063225,Neutral
"Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period  ( 2023-2032 ) , Examines DelveInsight | Key Companies to Watch - Roche, AbbVie, AstraZeneca, BeiGene, GlaxoSmithKline, Genentech, Eli Lilly, Novartis",https://www.prnewswire.com/news-releases/triple-negative-breast-cancer-market-to-accelerate-substantially-during-the-forecast-period-20232032-examines-delveinsight--key-companies-to-watch---roche-abbvie-astrazeneca-beigene-glaxosmithkline-genentech-eli-lilly--301918858.html,2023-09-06 21:01:00,"Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period ( 2023-2032 ) , Examines ... PR ...",PFE,0.022494,-0.053504,Neutral
Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/small-cap/23/09/34294328/non-disappearing-covid-creates-another-chapter-for-the-pharmaceutical-industry,2023-09-06 20:39:39,"On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc PFE and its German partner BioNTech BNTX that targets only the Omicron XBB.1.5 subvariant.",PFE,0.526707,-0.026244,Neutral
"Covid hospitalizations spike with new variant as school returns, U.S. readies vaccines",https://www.cnbc.com/2023/09/06/covid-hospitalizations-spike-with-new-variant-as-us-readies-vaccines.html,2023-09-06 20:30:23,The late summer Covid spike comes after a quiet year in which hospitalizations and deaths had declined week after week since January.,PFE,0.046095,-0.193273,Somewhat-Bearish
"Dow Slides 200 Points As Disney, Pfizer, Walgreens Stocks Sink To 52-Week Lows",https://www.forbes.com/sites/dereksaul/2023/09/06/dow-slides-200-points-as-disney-pfizer-walgreens-stocks-sink-to-52-week-lows/,2023-09-06 20:02:10,Also weighing on stocks Wednesday was a roughly $240 billion wipeout in market capitalization for the Apple-led coalition of seven large tech companies who have buoyed 2023's gains.,PFE,0.119235,-0.098155,Neutral
Pfizer says updated COVID shot generated strong reaction vs new variant in mice,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-says-updated-covid-shot-generated-strong-reaction-vs-new-variant-mice-2023-09-06/,2023-09-06 18:10:00,"Vials with a sticker reading, ""COVID-19 / Coronavirus vaccine / Injection only"" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/File Photo Acquire Licensing Rights",PFE,0.693563,0.048776,Neutral
Stocks on the Mend: A Mean Reversion Duo,https://www.zacks.com/commentary/2145594/stocks-on-the-mend-a-mean-reversion-duo,2023-09-06 17:16:00,"September is starting in classic, historically weak form. However, if the market finds it's footing, two stocks have explosive, reversion to the mean potential.",PFE,0.185306,0.054842,Neutral
How Moderna Stacks Up Against Highly Mutated 'Pirola' Variant,https://www.investors.com/news/technology/moderna-stock-new-vaccine-takes-on-highly-mutated-covid-virus-and-wins/,2023-09-06 14:24:00,Moderna Stock: New Vaccine Takes On Highly Mutated Covid Virus ... Investor's Business Daily ...,PFE,0.166743,-0.012818,Neutral
Alphabet Is Primed for Strong Revenue Growth Thanks to These Businesses,https://www.fool.com/investing/2023/09/06/alphabets-primed-for-strong-revenue-growth-thanks/,2023-09-06 13:00:00,The tech titan owns two massive businesses in growing industries.,PFE,0.056407,0.301298,Somewhat-Bullish
"South Africa 'held to ransom' by big pharma, overcharged for COVID vaccines",https://www.aljazeera.com/news/2023/9/6/south-africa-held-to-ransom-by-big-pharma-overcharged-for-covid-vaccines,2023-09-06 12:27:10,"Johannesburg, South Africa - Big pharmaceutical companies ""bullied"" South Africa into signing unfair agreements that forced the country to overpay for COVID-19 vaccines compared with Western nations, according to a nonprofit that lobbied for the details to be released.",PFE,0.239305,-0.21999,Somewhat-Bearish
Moderna says updated COVID vaccine is effective against newer variant,https://www.financialexpress.com/healthcare/covid-19/moderna-says-updated-covid-vaccine-is-effective-against-newer-variant/3235157/,2023-09-06 11:38:12,Moderna on Wednesday said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus that has raised fears of a resurgence of infections.,PFE,0.321673,0.058081,Neutral
Moderna says updated COVID vaccine is effective against newer variant,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-says-updated-covid-vaccine-is-effective-against-newer-variant-2023-09-06/,2023-09-06 11:13:00,"[1/2] A vial and sryinge are seen in front of a displayed Moderna logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",PFE,0.293506,0.054031,Neutral
Moderna says updated Covid vaccine was effective against highly mutated BA.2.86 variant in trial,https://www.cnbc.com/2023/09/06/moderna-says-new-covid-vaccine-effective-against-bapoint2point86-variant.html,2023-09-06 11:02:01,"Moderna, Pfizer and Novavax are slated to roll out new vaccines targeting XBB.1.5 within weeks, pending approvals from the FDA.",PFE,0.098659,-0.024251,Neutral
"This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock?",https://www.fool.com/investing/2023/09/06/this-down-on-its-luck-biotech-could-surge-150-wall/,2023-09-06 09:30:00,"Today, Novavax is getting ready to compete in the fall vaccine market -- one that's in transition.",PFE,0.159218,0.025676,Neutral
Why Novavax Stock Rocketed 10% Higher Today,https://www.fool.com/investing/2023/09/05/why-novavax-stock-rocketed-10-higher-today/,2023-09-06 00:59:44,The COVID vaccine maker benefits on a day when worries about a surge intensify with a new case at the White House.,PFE,0.156461,-0.054914,Neutral
Nestlé Health Science CEO Don Kerrigan Talks Acquisition Of Vital Proteins And The Company's Future Growth,https://www.forbes.com/sites/douglasyu/2023/09/05/nestl-health-science-ceo-don-kerrigan-talks-acquisition-of-vital-proteins-and-the-companys-future-growth/,2023-09-05 21:38:22,"Launched over a decade ago, Nestle Health Science has emerged as a leading force in pioneering nutritional solutions with a diverse portfolio of brands.",PFE,0.066414,0.196621,Somewhat-Bullish
New Covid Variant Might Not Be That Bad,https://www.barrons.com/articles/new-covid-19-variant-boosters-2e77dd0,2023-09-05 20:30:00,New Covid-19 Variant Might Not Be That Bad. More Boosters Are Coming Soon. ...,PFE,0.245339,0.097341,Neutral
3 Forever Stocks to Buy With $100,https://www.fool.com/investing/2023/09/05/3-forever-stocks-to-buy-with-100/,2023-09-05 18:00:00,"With $100 or less, you can buy at least one share of one of these top stocks.",PFE,0.37552,0.227436,Somewhat-Bullish
Novo Nordisk  ( NVO )  Launches Wegovy in UK Amid Supply Issues,https://www.zacks.com/stock/news/2145039/novo-nordisk-nvo-launches-wegovy-in-uk-amid-supply-issues,2023-09-05 17:52:00,Novo Nordisk (NVO) announces the controlled and limited launch of Wegovy in the U.K. amid rising demand for weight loss treatment and supply constraints.,PFE,0.17879,0.076714,Neutral
The FTC cleared Amgen's $27.8 billion Horizon buyout - here's what it means for other massive pharma deals,https://www.cnbc.com/2023/09/05/ftc-clears-amgen-horizon-buyout-what-it-means-for-other-pharma-deals.html,2023-09-05 16:56:42,Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.,PFE,0.055236,0.0,Neutral
Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst - Pyxis Oncology  ( NASDAQ:PYXS ) ,https://www.benzinga.com/general/biotech/23/09/34244004/pyxis-oncology-m-a-spotlight-signals-potential-growth-amidst-competitive-adc-landscape-analyst,2023-09-05 16:43:14,"RBC Capital Markets has initiated coverage on Pyxis Oncology Inc PYXS with an Outperform rating and a price target of $7. Last month, Pyxis Oncology acquired Apexigen Inc., focused on discovering and developing antibody therapeutics for oncology, in an all-stock transaction valued at ...",PFE,0.405651,0.524373,Bullish
Novavax  ( NVAX )  Stock Increases 9% in a Month: Here's Why,https://www.zacks.com/stock/news/2145017/novavax-nvax-stock-increases-9-in-a-month-heres-why,2023-09-05 16:10:00,This growth in Novavax (NVAX) is likely due to the rising COVID-19 infection cases in the United States. Management claims its updated vaccine is effective against the newly emerged virus variants.,PFE,0.314017,0.210562,Somewhat-Bullish
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/penny-stocks/23/09/34242725/cancer-remains-pharmas-biggest-challenge-and-mainz-biomed-has-the-tool-to-help-win-the-battl,2023-09-05 16:06:10,"Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc PFE and BioNTech SE BNTX to be used in EU countries' vaccination campaigns this autumn to combat yet another Covid-19 variant.",PFE,0.221819,-0.094989,Neutral
Pfizer Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/09/34242571/pfizer-unusual-options-activity,2023-09-05 16:00:49,"Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.779232,0.284296,Somewhat-Bullish
Viatris  ( VTRS )  Gets Tentative Approval for HIV Regimen for Kids,https://www.zacks.com/stock/news/2144908/viatris-vtrs-gets-tentative-approval-for-hiv-regimen-for-kids,2023-09-05 14:36:00,"Viatris (VTRS) obtains tentative approval from the FDA for a pediatric formulation of abacavir/dolutegravir/lamivudine, a once-daily treatment for children living with HIV.",PFE,0.06697,0.0,Neutral
UK regulator approves updated Pfizer-BioNTech COVID vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/uk-regulator-approves-updated-pfizer-biontech-covid-vaccine-2023-09-05/,2023-09-05 14:07:00,"[1/2] Pfizer company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights",PFE,0.769861,-0.007894,Neutral
"Find Therapeutics Appoints Robert L. Glanzman, M.D., as Chief Medical Officer",https://www.newswire.ca/news-releases/find-therapeutics-appoints-robert-l-glanzman-m-d-as-chief-medical-officer-883730338.html,2023-09-05 12:00:00,"MONTREAL, Sept. 5, 2023 /CNW/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced the appointment of Robert L. Glanzman, M.D. FAAN, as Chief Medical Officer.",PFE,0.087185,0.066074,Neutral
Analysis: US healthcare stocks roiled by investor tug of war over economy,https://www.reuters.com/business/healthcare-pharmaceuticals/us-healthcare-stocks-roiled-by-investor-tug-war-over-economy-2023-09-05/,2023-09-05 10:48:00,"Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., July 26, 2023. REUTERS/Brendan McDermid Acquire Licensing Rights",PFE,0.095707,0.014795,Neutral
Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?,https://www.fool.com/investing/2023/09/05/coronavirus-rising-should-you-buy-vaccine-stocks/,2023-09-05 09:30:00,Investors have worried about vaccine revenue in a post-pandemic world.,PFE,0.444487,0.083107,Neutral
"Genmab, Seagen say Tivdak cervical cancer trial met overall survival endpoint",https://www.reuters.com/business/healthcare-pharmaceuticals/genmab-seagen-say-tivdak-cervical-cancer-trial-met-overall-survival-endpoint-2023-09-04/,2023-09-04 21:32:00,"Sept 4 ( Reuters ) - Genmab A/S ( GMAB.CO ) , and Seagen Inc ( SGEN.O ) on Monday said that the Phase III trial of Tivdak in recurrent or metastatic cervical cancer patients on or after front-line therapy met its primary endpoint of overall survival.",PFE,0.179788,0.0,Neutral
"Decoding the Global Vasectomy Market 2023: Trends, Strategies, and Regulatory Insights",https://www.prnewswire.com/news-releases/decoding-the-global-vasectomy-market-2023-trends-strategies-and-regulatory-insights-301916835.html,2023-09-04 16:00:00,"DUBLIN, Sept. 4, 2023 /PRNewswire/ -- The ""Global Vasectomy Market ( 2023-2028 ) by Drug, Type, Patients, End Users, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis"" report has been added to ResearchAndMarkets.com's offering.",PFE,0.088147,0.211476,Somewhat-Bullish
Pfizer Inc.  ( PFE )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2144199/pfizer-inc-pfe-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-09-04 13:00:10,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.485711,0.155113,Somewhat-Bullish
Wildly Bullish Sign: 4.5% Dividend Rallies On Bad News,https://www.forbes.com/sites/brettowens/2023/09/04/wildly-bullish-sign-45-dividend-rallies-on-bad-news/,2023-09-04 12:09:00,"The blue-chip pharma stock trades for less than 10-times earnings. It yields 4.5%, which beats the 10-year Treasury. PFE goes on sale like this once in a blue moon.",PFE,0.766141,0.312888,Somewhat-Bullish
3 Reasons to Buy Pfizer Stock,https://www.fool.com/investing/2023/09/03/3-reasons-to-buy-pfizer-stock/,2023-09-03 12:30:00,The market is undervaluing this stock. Don't make the same mistake.,PFE,0.793187,0.370813,Bullish
Is It Too Late to Buy Veeva Systems Stock?,https://www.fool.com/investing/2023/09/03/is-it-too-late-to-buy-veeva-systems-stock/,2023-09-03 11:40:00,This niche cloud software company's growth is accelerating again.,PFE,0.067347,0.089204,Neutral
From Art Squat To Berlin Gentrification Lightning Rod,https://www.barrons.com/news/from-art-squat-to-berlin-gentrification-lightning-rod-c2de8628,2023-09-03 03:03:00,"Berlin's Tacheles art squat, a symbol of the anything-goes vibe of the city after the fall of the Wall, is completing a disputed transformation into offices, shops and luxury flats.",PFE,0.059785,0.060056,Neutral
From Art Squat To Berlin Gentrification Lightning Rod,https://www.barrons.com/news/from-art-squat-to-berlin-gentrification-lightning-rod-5bc4174d,2023-09-03 03:03:00,"Berlin's Tacheles art squat, a symbol of the anything-goes vibe of the city after the fall of the Wall, is completing a disputed transformation into offices, shops and luxury flats.",PFE,0.059785,0.060056,Neutral
Federal appeals court revives lawsuit saying FDA overstepped on anti-ivermectin messaging,https://www.foxbusiness.com/healthcare/federal-appeals-court-revives-lawsuit-fda-overstepped-anti-ivermectin-messaging,2023-09-02 20:37:59,A federal appeals court is reviving a lawsuit against the Food and Drug Administration for discouraging ivermectin use during the COVID-19 pandemic. The three doctors behind the suit are claiming the agency overstepped its bounds by aggressively messaging against the medication ivermectin for the ...,PFE,0.141726,-0.246165,Somewhat-Bearish
Will Covid Mask Mandates Return? Here's Where They're Making A Comeback,https://www.forbes.com/sites/brianbushard/2023/09/02/will-covid-mask-mandates-return-heres-where-theyre-making-a-comeback/,2023-09-02 15:58:10,A rise in Covid-19 cases over the past month has prompted several colleges and hospitals to reimplement mask mandates.,PFE,0.057767,0.021024,Neutral
"Sen. Tommy Tuberville is worth at least $4.5 million, according to his financial disclosures",https://www.businessinsider.com/tommy-tuberville-net-worth-financial-disclosures-2023-8,2023-09-02 15:00:00,Tommy Tuberville net worth is at least $4.5 million: disclosures - Business Insider ...,PFE,0.056275,0.0,Neutral
8 Pharma Stocks Affected by New Drug Price Negotiation Rules,https://www.fool.com/investing/2023/09/02/8-pharma-stocks-affected-by-new-drug-price-negotia/,2023-09-02 10:51:00,Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?,PFE,0.141726,0.109774,Neutral
Global Vitiligo Treatment Market 2023 - 2028: Ongoing Research and Advocacy Drive Progress,https://www.prnewswire.com/news-releases/global-vitiligo-treatment-market-2023---2028-ongoing-research-and-advocacy-drive-progress-301915850.html,2023-09-01 23:15:00,"DUBLIN, Sept. 1, 2023 /PRNewswire/ -- The ""Vitiligo Treatment Market, Size, Share, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis"" report has been added to ResearchAndMarkets.com's offering.",PFE,0.058615,0.0,Neutral
"When to wear masks as Covid cases rise, new variants emerge in the U.S.",https://www.cnbc.com/2023/09/01/covid-when-to-wear-masks-as-cases-rise-new-variants-emerge-in-us-.html,2023-09-01 16:13:34,"The decision to mask depends on a few things: you personal risk level, Covid rates in your region and who you might make contact with, experts say.",PFE,0.040011,0.157174,Somewhat-Bullish
Why Is Seattle Genetics  ( SGEN )  Up 6.5% Since Last Earnings Report?,https://www.zacks.com/stock/news/2143765/why-is-seattle-genetics-sgen-up-65-since-last-earnings-report,2023-09-01 15:31:46,Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PFE,0.124164,0.127968,Neutral
"Jeff Bezos Vs. Elon Musk Space Contract Lawsuit, Novo Nordisk's Famed Drug Ozempic Could Be Next Contender For Medicare Negotiations, Tesla Rival XPeng's August Deliveries Zooms 43% - Booking Holdings  ( NASDAQ:BKNG ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/09/34172689/jeff-bezos-vs-elon-musk-space-contract-lawsuit-novo-nordisks-famed-drug-ozempic-could-be-next-conten,2023-09-01 14:05:51,"An institutional investor prosecuted Amazon.Com Inc AMZN and its board, including Jeff Bezos, over launch contracts awarded to Bezos' space company, Blue Origin.",PFE,0.083833,0.181682,Somewhat-Bullish
"Europe Approves Pfizer/BioNTech's Adapted COVID-19 Vaccine For Upcoming Autumn Vaccination Campaigns - Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/09/34171885/europe-approves-pfizerbiontechs-adapted-covid-19-vaccine-for-upcoming-autumn-vaccination-campaign,2023-09-01 13:57:39,"The European Commission has approved Comirnaty XBB.1.5-adapted COVID-19 vaccine, developed by BioNTech SE BNTX-Pfizer Inc PFE. It is the third adaptation of this vaccine to respond to new COVID-19 variants. The vaccine is authorized for adults, children, and infants above six months.",PFE,0.7887,0.031899,Neutral
"Pharma Stock Roundup: J&J's New '23 View After Kenvue Separation, Regulatory Updates",https://www.zacks.com/stock/news/2143569/pharma-stock-roundup-jjs-new-23-view-after-kenvue-separation-regulatory-updates,2023-09-01 13:39:00,"J&J (JNJ) updates its financial guidance for 2023 after the final separation of Kenvue. Pfizer, BioNTech, Merck and AbbVie announce regulatory developments.",PFE,0.292776,-0.013198,Neutral
New York Businesses: Give Immigrant Work Permits To Asylum Seekers,https://www.forbes.com/sites/stuartanderson/2023/09/01/new-york-businesses-give-immigrant-work-permits-to-asylum-seekers/,2023-09-01 12:52:12,Business leaders argue providing humane pathways and timely work permits also will help the places to which migrants flee.,PFE,0.03792,-0.073938,Neutral
Should Franklin U.S. Low Volatility High Dividend Index ETF  ( LVHD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2143387/should-franklin-us-low-volatility-high-dividend-index-etf-lvhd-be-on-your-investing-radar,2023-09-01 10:20:06,Style Box ETF report for ...,PFE,0.118354,0.067379,Neutral
Here's Why the Next 4 Months May Be Critical for Pfizer,https://www.fool.com/investing/2023/09/01/why-next-4-months-may-be-critical-for-pfizer/,2023-09-01 09:30:00,The pharmaceutical giant's stock has dropped by around 30% year to date.,PFE,0.615462,-0.095743,Neutral
EU authorises use of adapted Pfizer/BioNtech vaccine for COVID-19 variant,https://www.reuters.com/business/healthcare-pharmaceuticals/eu-authorises-use-adapted-pfizerbiontech-vaccine-covid-19-variant-2023-09-01/,2023-09-01 07:51:00,"A compagny logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights",PFE,0.656549,-0.166178,Somewhat-Bearish
"Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet",https://www.globenewswire.com/news-release/2023/09/01/2735772/0/en/Ipsen-announces-change-in-R-D-leadership-Howard-Mayer-to-retire-succeeded-by-Christelle-Huguet.html,2023-09-01 05:00:00,"PARIS, FRANCE, 1 September 2023 - Ipsen ( Euronext: IPN. ADR: IPSEY ) , a global specialty-driven biopharmaceutical company, announced today the appointment of Christelle Huguet as Executive Vice President, Head of Research and Development.",PFE,0.028868,0.018448,Neutral
"Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet - Ipsen  ( OTC:IPSEY ) ",https://www.benzinga.com/pressreleases/23/09/g34163064/ipsen-announces-change-in-r-d-leadership-howard-mayer-to-retire-succeeded-by-christelle-huguet,2023-09-01 05:00:00,"PARIS, FRANCE, 1 September 2023 - Ipsen ( IPNIPSEY, a global specialty-driven biopharmaceutical company, announced today the appointment of Christelle Huguet as Executive Vice President, Head of Research and Development.",PFE,0.028592,0.01842,Neutral
Valneva to Participate in Investor Conferences in the United States and Europe in September 2023,https://www.globenewswire.com/news-release/2023/08/31/2735615/0/en/Valneva-to-Participate-in-Investor-Conferences-in-the-United-States-and-Europe-in-September-2023.html,2023-08-31 17:00:00,"Saint-Herblain ( France ) , August 31, 2023 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) , a specialty vaccine company, today announced that members of its senior leadership team are scheduled to participate in 1-on-1 meetings with institutional investors at the following investor ...",PFE,0.060388,0.076061,Neutral
Why Is Pfizer  ( PFE )  Up 1.6% Since Last Earnings Report?,https://www.zacks.com/stock/news/2143115/why-is-pfizer-pfe-up-16-since-last-earnings-report,2023-08-31 15:31:27,Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PFE,0.43645,0.150436,Somewhat-Bullish
Should You Buy Novavax's Stock Before the FDA Approves Its New COVID Shot?,https://www.fool.com/investing/2023/08/31/should-you-buy-novavaxs-stock-before-the-fda/,2023-08-31 14:07:00,The vaccine's approval could come within weeks.,PFE,0.067158,0.088406,Neutral
Pfizer  ( PFE )  & BioNTech Get CHMP Nod for Updated Covid-19 Jab,https://www.zacks.com/stock/news/2143047/pfizer-pfe-biontech-get-chmp-nod-for-updated-covid-19-jab,2023-08-31 13:27:00,Pfizer (PFE) and partner BioNTech receive a positive recommendation from the CHMP for its Omicron XBB.1.5-adapted Covid-19 vaccine.,PFE,0.448316,0.24081,Somewhat-Bullish
"Biomea Fusion Announces Appointment of Juan Pablo Frías, M.D. as Chief Medical Officer",https://www.globenewswire.com/news-release/2023/08/31/2735267/0/en/Biomea-Fusion-Announces-Appointment-of-Juan-Pablo-Fr%C3%ADas-M-D-as-Chief-Medical-Officer.html,2023-08-31 12:30:00,"REDWOOD CITY, Calif., Aug. 31, 2023 ( GLOBE NEWSWIRE ) -- Biomea Fusion, Inc. ( ""Biomea"" ) ( Nasdaq: BMEA ) , a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined ...",PFE,0.025624,0.079697,Neutral
Jnana Therapeutics Presents Additional Data from Phase 1a Clinical Study of JNT-517 at SSIEM Annual Symposium,https://www.benzinga.com/pressreleases/23/08/g34138755/jnana-therapeutics-presents-additional-data-from-phase-1a-clinical-study-of-jnt-517-at-ssiem-annua,2023-08-31 11:00:03,"JNT-517 demonstrated sustained, dose-dependent pharmacodynamic effects and was safe and well tolerated in healthy volunteers Phase 1b study is ongoing in individuals with PKU",PFE,0.040829,0.122925,Neutral
J&J's Akeega FDA approval to heat up PARP battle with dual-action treatment for prostate cancer,https://www.financialexpress.com/healthcare/pharma-healthcare/jjs-akeega-fda-approval-to-heat-up-parp-battle-with-dual-action-treatment-for-prostate-cancer/3228202/,2023-08-31 05:21:44,"The FDA recently granted approval for Johnson & Johnson's ( J&J ) Akeega, a novel first-in-class combination tablet treatment for adults with breast cancer gene ( BRCA ) -positive, metastatic castration-resistant prostate cancer ( mCRPC ) .",PFE,0.069294,-0.076261,Neutral
Check Out What Whales Are Doing With PFE - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/08/34125695/check-out-what-whales-are-doing-with-pfe,2023-08-30 20:45:58,"A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer PFE we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 10% of the investors opened trades with bullish expectations and ...",PFE,0.814341,0.163579,Somewhat-Bullish
Medicare drug price negotiations may have a muted impact on drugmakers in the near term,https://www.cnbc.com/2023/08/30/medicare-drug-price-negotiations-may-have-muted-impact-on-drugmakers.html,2023-08-30 17:48:18,Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives.,PFE,0.069697,0.019232,Neutral
DNA Tech Co. Launches MRNA Platform and Files Two Patents,https://www.investorideas.com/news/2023/biotech/08302Applied-DNA-Sciences.asp,2023-08-30 15:55:27,"August 30, 2023 ( Investorideas.com Newswire ) This company has announced the general availability of its Linea IVT platform evaluation kits and the first kit shipment to an existing Linea IVT Template customer.",PFE,0.031446,0.144016,Neutral
Why Medicare Is Right To Negotiate Drug Prices,https://www.forbes.com/sites/howardgleckman/2023/08/30/why-medicare-is-right-to-negotiate-drug-prices/,2023-08-30 15:46:04,"When it comes to drugs, the Department of Health and Human Services is a consumer. It is by far the biggest purchaser of prescription drugs on the planet.",PFE,0.044634,0.093559,Neutral
3 High Dividend Stocks To Watch Before September 2023,https://stockmarket.com/featured/3-high-dividend-stocks-to-watch-before-september-2023-2023-08-30,2023-08-30 14:29:37,"Dividends serve as an attractive feature for investors looking to generate consistent income alongside capital gains. Essentially, they are a portion of a company's earnings paid out to shareholders, typically on a quarterly basis.",PFE,0.350564,0.143428,Neutral
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union,https://www.globenewswire.com/news-release/2023/08/30/2734517/0/en/Pfizer-and-BioNTech-Receive-Positive-CHMP-Opinion-for-Omicron-XBB-1-5-adapted-COVID-19-Vaccine-in-the-European-Union.html,2023-08-30 14:00:00,"NEW YORK and MAINZ, Germany, August 30, 2023 - Pfizer Inc. ( NYSE: PFE, ""Pfizer"" ) and BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" ) today announced that the Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) has recommended marketing authorization for ...",PFE,0.143064,0.064099,Neutral
EU regulator backs Pfizer's updated COVID vaccine for XBB.1.5 variant,https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-backs-authorizing-pfizers-vaccine-coronavirus-variant-xbb15-2023-08-30/,2023-08-30 12:38:00,"FILE PHOTO-The exterior of EMA, European Medicines Agency is seen in Amsterdam, Netherlands December 18, 2020. REUTERS/Piroschka van de Wouw/File Photo Acquire Licensing Rights",PFE,0.197413,0.0,Neutral
Voyager Therapeutics to Participate in Upcoming Investor Conferences,https://www.globenewswire.com/news-release/2023/08/30/2734183/36461/en/Voyager-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html,2023-08-30 11:00:00,"CAMBRIDGE, Mass., Aug. 30, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( Nasdaq: VYGR ) , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that management will participate in the following investor conferences: ...",PFE,0.152499,0.029134,Neutral
US to negotiate price of 10 prescription drugs: What you need to know,https://www.aljazeera.com/news/2023/8/30/us-negotiating-price-of-10-prescription-drugs-what-you-need-to-know,2023-08-30 09:38:53,"Under President Joe Biden's Inflation Reduction Act, the government will negotiate the prices of select medicines. The United States government on Tuesday released a list of 10 prescription medicines that will be subject to the first-ever price negotiations by the Medicare health program that ...",PFE,0.073546,0.091703,Neutral
"Morning Bid: US jobs data and China bring cheer, for now",https://www.reuters.com/markets/europe/global-markets-view-europe-2023-08-30/,2023-08-30 04:07:30,"EUROPE US jobs data and China bring cheer, for now ...",PFE,0.072217,0.0,Neutral
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?,https://www.fool.com/investing/2023/08/29/medicare-price-negotiations-big-pharma-stocks/,2023-08-29 21:00:00,Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.,PFE,0.157483,0.158342,Somewhat-Bullish
How This Manufacturer Turned Big Pharma's Commercialization Model Upside Down,https://www.forbes.com/sites/chasefeiger/2023/08/29/how-this-manufacturer-turned-big-pharmas-commercialization-model-upside-down/,2023-08-29 20:59:21,"When Pfizer﻿ acquired Biohaven for $11.6 billion, many big Pharma executives began to question their own beliefs and commercial tactics.",PFE,0.097062,0.039415,Neutral
"Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This? - Colgate-Palmolive  ( NYSE:CL ) , Diageo  ( NYSE:DEO ) ",https://www.benzinga.com/markets/cannabis/23/08/34100550/cannabis-industrys-capital-crunch-why-it-needs-more-funds-than-other-industries-will-fed-legaliz,2023-08-29 19:46:58,Recent research conducted by Viridian Capital Advisors reveals that the cannabis sector requires more capital as compared to other similar industries.,PFE,0.125789,0.0,Neutral
Here are the three most used drugs on the Medicare price negotiation list,https://www.cnbc.com/2023/08/29/most-used-drugs-on-medicare-price-negotiation-list-see-the-top-three.html,2023-08-29 17:52:25,The Biden administration unveiled the much-awaited list officially kicking off a process that aims to control rising drug costs in the U.S.,PFE,0.114137,-0.066384,Neutral
Wall Street CEOs demand Biden and Congress fix NYC migrant crisis,https://www.foxbusiness.com/politics/wall-street-ceos-demand-biden-congress-fix-nyc-migrant-crisis,2023-08-29 15:49:19,Top business leaders in New York City demanded Monday that President Biden and Congress provide relief to cities and states overburdened by illegal immigration. More than 100 Wall Street CEOs signed an open letter in support of New York Gov.,PFE,0.043108,0.078148,Neutral
PFE: 3 Pharma Stocks to Watch for Value in September,https://stocknews.com/news/pfe-cprx-knsa-opk-3-pharma-stocks-to-watch-for-value-in-september/,2023-08-29 15:02:50,"The pharma industry is expected to experience substantial growth in the coming years with expanding global medical needs. Also, the demand for innovative and personalized medicine is driving the expansion of the pharma industry.",PFE,0.293653,0.198832,Somewhat-Bullish
Biden admin names first 10 drugs subject to Medicare price negotiation,https://www.foxbusiness.com/economy/biden-administration-names-first-10-drugs-subject-medicare-price-negotiation,2023-08-29 14:53:52,"The Biden administration on Tuesday released a list of the first 10 prescription medications that will be subject to price negotiations with Medicare, in an effort to lower the cost of pharmaceutical drugs for older Americans.",PFE,0.105604,0.067305,Neutral
"AbbVie, Merck, Lilly Highlight Biden List For Price Cuts",https://www.investors.com/news/technology/pharmaceutical-stocks-biden-administration-unveils-10-drugs-subject-to-price-cuts/,2023-08-29 13:28:00,Pharmaceutical Stocks: Biden Administration Unveils 10 Drugs ... Investor's Business Daily ...,PFE,0.147818,0.03379,Neutral
Explainer: Why the US is negotiating the price of 10 drugs,https://www.reuters.com/business/healthcare-pharmaceuticals/why-us-is-negotiating-price-10-drugs-2023-08-29/,2023-08-29 12:08:00,"[1/2] U.S. President Joe Biden convenes the fourth virtual leader-level meeting of the Major Economies Forum ( MEF ) on Energy and Climate at the White House in Washington, U.S., April 20, 2023. REUTERS/Kevin Lamarque/File Photo Acquire Licensing Rights",PFE,0.069697,0.083321,Neutral
"Fast Company Innovation Festival Announces Additional Headliners Gabrielle Union, Dwyane Wade, and Tracee Ellis Ross",https://www.prnewswire.com/news-releases/fast-company-innovation-festival-announces-additional-headliners-gabrielle-union-dwyane-wade-and-tracee-ellis-ross-301912086.html,2023-08-29 12:03:00,"Fast Company Innovation Festival Announces Additional Headliners Gabrielle Union, Dwyane Wade, and Tracee Ellis ... PR ...",PFE,0.067347,0.206831,Somewhat-Bullish
"Fast Company Innovation Festival Announces Additional Headliners Gabrielle Union, Dwyane Wade, and Tracee Ellis Ross",https://www.benzinga.com/pressreleases/23/08/n34086433/fast-company-innovation-festival-announces-additional-headliners-gabrielle-union-dwyane-wade-and-t,2023-08-29 12:03:00,"NEW YORK, Aug. 29, 2023 /PRNewswire/ -- The Fast Company Innovation Festival is announcing additional speakers including Gabrielle Union, Dwyane Wade, Christy Turlington, Tracee Ellis Ross, and top executives from Ikea, Gap, Clare V, and the hotly anticipated AI startup Humane.",PFE,0.058759,0.206014,Somewhat-Bullish
U.S. Announces First Drugs Picked for Medicare Price Negotiations,https://www.nytimes.com/2023/08/29/us/politics/medicare-drug-pricing-negotiations.html,2023-08-29 11:39:43,"The Biden administration's announcement was an important moment for Democrats, who have campaigned on a promise to lower the cost of prescription drugs.",PFE,0.054236,-0.09077,Neutral
US to name first 10 drugs for Medicare price negotiation,https://www.reuters.com/business/healthcare-pharmaceuticals/us-name-first-10-drugs-medicare-price-negotiation-2023-08-29/,2023-08-29 10:20:00,"[1/3] U.S. President Joe Biden delivers remarks on Social Security and Medicare at the University of Tampa in Tampa, Florida, U.S. February 9, 2023. REUTERS/Jonathan Ernst Acquire Licensing Rights",PFE,0.068306,0.069181,Neutral
3 Market Neutral Funds to Counter Market Volatility,https://www.zacks.com/stock/news/2141659/3-market-neutral-funds-to-counter-market-volatility,2023-08-29 08:53:00,"Below, we share with you three top-ranked market-neutral mutual funds. Each has earned a Zacks Mutual Fund Rank #1.",PFE,0.154951,0.035055,Neutral
Halozyme Announces Approval of Roche's Tecentriq® Subcutaneous  ( SC )  with ENHANZE® in Great Britain,https://www.prnewswire.com/news-releases/halozyme-announces-approval-of-roches-tecentriq-subcutaneous-sc-with-enhanze-in-great-britain-301911904.html,2023-08-29 08:50:00,First subcutaneous anti-PD- ( L ) 1 cancer immunotherapy available to patients in Great Britain Tecentriq® subcutaneous formulation with ENHANZE® reduces treatment time to seven minutes compared to 30-60 minutes for standard intravenous infusion,PFE,0.029618,0.080493,Neutral
"Chewy, Pfizer, Raytheon, Toro Make New 52-Week Lows List",https://www.forbes.com/sites/johnnavin/2023/09/16/chewy-pfizer-raytheon-toro-make-new-52-week-lows-list/,2023-09-16 17:34:36,It's the heaviness of the selling volume in these big market capitalization stocks that stands out.,PFE,0.167322,0.092348,Neutral
Activist Elliott makes inroads at Catalent to build value. Here's what could happen next,https://www.cnbc.com/2023/09/16/activist-elliott-makes-inroads-at-catalent-to-build-value-heres-what-could-happen-next.html,2023-09-16 12:35:55,Elliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the pharmaceutical company.,PFE,0.036812,0.089875,Neutral
How Covid death demographics have changed,https://theweek.com/news/science-health/953923/how-covid-death-demographics-have-changed,2023-09-16 06:42:33,A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek. You will receive a verification email shortly. There was a problem. Please refresh the page and try again.,PFE,0.082111,-0.01154,Neutral
SAGALIAM ACQUISITION CORP. ANNOUNCES EXECUTION OF DEFINITIVE BUSINESS COMBINATION AGREEMENT AND RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER,https://www.globenewswire.com/news-release/2023/09/15/2744256/0/en/SAGALIAM-ACQUISITION-CORP-ANNOUNCES-EXECUTION-OF-DEFINITIVE-BUSINESS-COMBINATION-AGREEMENT-AND-RECEIPT-OF-NASDAQ-LISTING-DELINQUENCY-LETTER.html,2023-09-15 20:47:00,"New York, NY, Sept. 15, 2023 ( GLOBE NEWSWIRE ) -- Sagaliam Acquisition Corp. ( NASDAQ: ""SAGAU"", ""SAGA"", ""SAGAR"" ) ( ""we"", ""us"", ""our"", or the ""Company"" ) announced today that it received a delinquency notification letter ( ""Notice"" ) from the Listing Qualifications staff of the Nasdaq Stock ...",PFE,0.037098,-0.142066,Neutral
"Financial Crime Weekly: Pfizer Statistician's $214,000 Trade Leads To Charges - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/markets/equities/23/09/34628089/financial-crime-weekly-pfizer-statisticians-214-000-trade-leads-to-charges,2023-09-15 20:31:25,"Amit Dagar, once a trusted statistician for pharmaceutical behemoth Pfizer Inc PFE, and Atul Bhiwapurkar, his close business ally, now find themselves mired in allegations that could see their financial futures irreparably tarnished.",PFE,0.443626,-0.130564,Neutral
"More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone - Moderna  ( NASDAQ:MRNA ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/news/23/09/34628137/more-than-half-of-americans-want-new-covid-19-booster-but-ron-desantis-will-fight-virus-with-his-cha,2023-09-15 20:19:15,New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get boosters.,PFE,0.148273,0.197008,Somewhat-Bullish
EU antitrust regulators set Oct. 19 deadline for Pfizer's Seagen deal,https://www.reuters.com/markets/deals/eu-antitrust-regulators-set-oct-19-deadline-pfizers-seagen-deal-2023-09-15/,2023-09-15 19:01:00,"Test tubes are seen in front of Seagen logo in this illustration taken June 27, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights BRUSSELS, Sept 15 ( Reuters ) - Pfizer's ( PFE.N ) $43 billion bid for Seagen ( SGEN.O ) will be decided by EU antitrust regulators by Oct. 19, ...",PFE,0.31482,-0.187216,Somewhat-Bearish
Florida Defies CDC - Telling Under-65s To Skip Covid Boosters - Though The State Leads In Covid Deaths Nationwide,https://www.forbes.com/sites/conormurray/2023/09/15/florida-defies-cdc---telling-under-65s-to-skip-covid-boosters---though-the-state-leads-in-covid-deaths-nationwide/,2023-09-15 16:12:03,"The Centers for Disease Control and Prevention slammed Florida's decision as ""dangerous."" ...",PFE,0.050359,-0.011984,Neutral
NOT REAL NEWS: A look at what didn't happen this week,https://apnews.com/article/misinformation-fact-check-covid19-vaccines-ukraine-climate-change-c286b4f164c3582fdbdf7820e07a229d,2023-09-15 16:12:00,"A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: There is no connection between rising COVID cases and elections, ...",PFE,0.022079,0.010878,Neutral
Moderna  ( MRNA )  Receives CHMP Nod for Updated COVID Vaccine,https://www.zacks.com/stock/news/2149481/moderna-mrna-receives-chmp-nod-for-updated-covid-vaccine,2023-09-15 13:35:00,"Clinical data from studies on Moderna's (MRNA) updated COVID vaccine shows improved antibody responses against multiple circulating variants, including BA.2.86, EG.5 and FL.1.5.1 variants.",PFE,0.285526,0.160024,Somewhat-Bullish
"Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More",https://www.zacks.com/stock/news/2149445/pharma-stock-roundup-fda-nod-to-updated-pfe-mrna-covid-jabs-more,2023-09-15 13:33:00,The FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo Nordisk (NVO) conducts a two-for-one split of its shares and ADRs.,PFE,0.364529,0.081749,Neutral
Biotech Stock Crashes 29% On European Rejection,https://www.investors.com/news/technology/ptc-stock-crashes-after-european-regulators-reject-its-muscular-dystrophy-drug/,2023-09-15 13:28:00,PTC Stock Crashes After European Regulators Reject Its Muscular ... Investor's Business Daily ...,PFE,0.160633,0.26885,Somewhat-Bullish
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2149392/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2023-09-15 13:00:12,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.486627,0.14662,Neutral
We should all support Biden's war on Big Pharma,https://www.aljazeera.com/opinions/2023/9/15/we-should-all-support-bidens-war-on-big-pharma,2023-09-15 12:33:29,"If we want cutting-edge medicines at a price we can afford, the US president will need to stand his ground. ""This time, we beat Big Pharma"", United States President Joe Biden tweeted, after finally giving his government the power to negotiate the price of 10 prescription drugs, including ...",PFE,0.034087,-0.175942,Somewhat-Bearish
Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices,https://apnews.com/article/johnson-investigation-south-africa-pharmaceutical-eb8525424c07f6c8e6645fa036cdf284,2023-09-15 12:26:00,"CAPE TOWN, South Africa ( AP ) - U.S.-based pharmaceuticals company is being investigated in South Africa for allegedly charging ""excessive"" prices for a key tuberculosis drug, the country's antitrust regulator said Friday.",PFE,0.288044,0.100977,Neutral
"Covid, RSV and flu vaccines are now available - here's how to decide whether to get them together",https://www.cnbc.com/2023/09/15/covid-rsv-flu-vaccines-how-to-decide-whether-to-get-them-together.html,2023-09-15 11:07:24,"Public health officials are urging eligible Americans to take all three shots so the nation can avoid another ""tripledemic"" of Covid, flu and RSV.",PFE,0.110124,0.037493,Neutral
Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off - Novartis  ( NYSE:NVS ) ,https://www.benzinga.com/markets/equities/23/09/34609083/sandoz-pushes-product-launch-plans-as-novartis-shareholders-approve-the-spin-off,2023-09-15 10:54:54,"At an Extraordinary General Meeting, Novartis AG's NVS shareholders approved the proposed 100% spin-off of Sandoz. Novartis shareholders and Novartis ADR holders will receive one Sandoz share for every five Novartis shares and one Sandoz ADR for every five Novartis ADRs.",PFE,0.22595,0.0,Neutral
Meet the Black students who were instrumental in developing the first Covid-19 shots,https://www.cnn.com/2023/09/15/health/covid-vaccines-black-student-scientists/index.html,2023-09-15 10:31:00,"It was a meeting that changed their lives forever. The year was 2020, and reports had emerged from China that a never-before-seen coronavirus was spreading quickly, sickening hundreds of people and turning deadly.",PFE,0.026357,0.083048,Neutral
UK regulator approves Moderna's updated COVID vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/uk-regulator-approves-modernas-updated-covid-vaccine-2023-09-15/,2023-09-15 10:24:06,"A vial labelled ""Moderna COVID-19 Vaccine"" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration Acquire Licensing Rights",PFE,0.218817,0.167276,Somewhat-Bullish
Novartis shareholders vote in favour of Sandoz spin-off,https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-shareholders-vote-favour-sandoz-spin-off-2023-09-15/,2023-09-15 09:42:00,Novartis shareholders vote in favour of Sandoz ...,PFE,0.205807,0.0,Neutral
This 1 Number May Completely Change Your Opinion About Moderna,https://www.fool.com/investing/2023/09/15/this-1-number-may-change-your-opinion-of-moderna/,2023-09-15 09:30:00,Moderna shares look dirt cheap considering the company's prospects.,PFE,0.062761,-0.039079,Neutral
Sandoz dials up product launch plans ahead of market debut,https://www.reuters.com/business/healthcare-pharmaceuticals/sandoz-dials-up-product-launch-plans-ahead-market-debut-2023-09-15/,2023-09-15 06:10:30,"A sign marks the Novartis Institutes for BioMedical Research facility in Cambridge, Massachusetts, U.S., June 16, 2021. REUTERS/Brian Snyder/File Photo Acquire Licensing Rights",PFE,0.069697,0.0,Neutral
Ireland's Latest Fiscal Headache: What to Do With 10 Billion Euros,https://www.nytimes.com/2023/09/15/business/ireland-fiscal-budget-surplus.html,2023-09-15 04:00:18,"The government in Dublin has a big budget surplus, thanks to its low tax rate for multinationals. Build more housing? Or a subway? Sock it away? Whatever the case, someone will be unhappy.",PFE,0.029399,0.115128,Neutral
Quiz of The Week: 28 November - 4 December,https://theweek.com/quiz-of-the-week/108865/quiz-of-the-week-pfizer-vaccine-coronavirus,2023-09-14 23:31:34,A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek. You will receive a verification email shortly. There was a problem. Please refresh the page and try again.,PFE,0.211191,0.01022,Neutral
DeSantis rips Trump for claiming not to know who gave Fauci presidential commendation: 'Is this the immaculate commendation?' | Politics,https://www.cnn.com/2023/09/14/politics/desantis-trump-fauci-commendation-covid/index.html,2023-09-14 22:13:00,DeSantis rips Trump for claiming not to know who gave Fauci presidential commendation: 'Is this the immaculate commendation?' ...,PFE,0.078099,-0.011322,Neutral
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/09/34594209/looking-at-pfizers-recent-unusual-options-activity,2023-09-14 20:32:55,"Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.684999,0.162866,Somewhat-Bullish
NRx Pharmaceuticals Announces Agreement with LifeSci Associates to Provide Financial Services and Support,https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-announces-agreement-with-lifesci-associates-to-provide-financial-services-and-support-301928458.html,2023-09-14 20:01:00,"RADNOR, Pa., Sept. 14, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. ( Nasdaq: NRXP ) ( ""NRx Pharmaceuticals"" or the ""Company"" ) , a clinical-stage biopharmaceutical company, today announced that it has entered into an agreement ( the ""Agreement"" ) with LS Associates, a division of LifeSci ...",PFE,0.038284,0.039218,Neutral
NRx Pharmaceuticals Announces Agreement with LifeSci Associates to Provide Financial Services and Support - NRX Pharmaceuticals  ( NASDAQ:NRXP ) ,https://www.benzinga.com/pressreleases/23/09/n34593206/nrx-pharmaceuticals-announces-agreement-with-lifesci-associates-to-provide-financial-services-and-,2023-09-14 20:01:00,"Industry veteran Richard Narido joins the NRx Pharmaceuticals management team RADNOR, Pa., Sept. 14, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc.",PFE,0.036983,0.03901,Neutral
A new study doesn't show Pfizer's COVID vaccine causes 'VAIDS',https://apnews.com/article/fact-check-australia-study-vaccine-immunodeficiency-vaids-188567674141,2023-09-14 19:05:00,"CLAIM: A new study by Australian researchers shows that Pfizer's COVID-19 vaccine caused vaccine acquired immunodeficiency syndrome, or ""VAIDS."" AP'S ASSESSMENT: False. VAIDS is not a real condition, experts say.",PFE,0.062597,0.059009,Neutral
Planned Parenthood will resume abortions in Wisconsin after court rules against 1849 ban,https://www.cnbc.com/2023/09/14/planned-parenthood-resumes-abortions-in-wisconsin.html,2023-09-14 18:00:02,"A state judge ruled in July that the law does not prohibit consensual medical abortions, but instead targets anyone who kills a fetus by attacking the mother.",PFE,0.100729,-0.188138,Somewhat-Bearish
Questex's Fierce Pharma Announces the 2023 Fierce Pharma Marketing Awards Winners,https://www.benzinga.com/pressreleases/23/09/g34588495/questexs-fierce-pharma-announces-the-2023-fierce-pharma-marketing-awards-winners,2023-09-14 17:00:58,"NEW YORK, Sept. 14, 2023 ( GLOBE NEWSWIRE ) -- Last night at an awards gala, Questex's Fierce Pharma announced the winners of the 2023 Fierce Pharma Marketing Awards, an annual awards program presented by honoring leadership, vision, innovation and strategic accomplishments within the pharma ...",PFE,0.055236,0.0,Neutral
Novo Nordisk  ( NVO )  Announces Stock Split to Enhance Liquidity,https://www.zacks.com/stock/news/2149069/novo-nordisk-nvo-announces-stock-split-to-enhance-liquidity,2023-09-14 15:28:00,"Novo Nordisk (NVO) conducts a two-for-one stock split. While this is already in effect at the stock exchange in Denmark, the ADRs listed on the NYSE will be split in the same ratio by next week.",PFE,0.314017,0.041002,Neutral
Next month: Enterprises discuss use of XR / spatial computing / metaverse and try out the latest AR/VR hardware/software for work,https://www.prnewswire.com/news-releases/next-month-enterprises-discuss-use-of-xr--spatial-computing--metaverse-and-try-out-the-latest-arvr-hardwaresoftware-for-work-301926895.html,2023-09-14 14:00:00,Next month: Enterprises discuss use of XR / spatial computing / metaverse and try out the latest AR/VR hardware ... PR ...,PFE,0.101154,0.135612,Neutral
Why COVID Vaccine Demand Might Not Be That Strong,https://www.fool.com/investing/2023/09/14/why-covid-vaccine-demand-might-not-be-that-strong/,2023-09-14 13:37:00,"COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago.",PFE,0.060848,0.013029,Neutral
"COVID-19 Vaccine Market Predicted to Reach USD 9.9 billion by 2031, Garnering -13.6% CAGR: TMR Report",https://www.benzinga.com/pressreleases/23/09/g34581796/covid-19-vaccine-market-predicted-to-reach-usd-9-9-billion-by-2031-garnering-13-6-cagr-tmr-report,2023-09-14 13:30:00,"Wilmington, Delaware, United States, Sept. 14, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The COVID-19 vaccine market was estimated to have acquired US$ 92.6 billion in 2021. It is anticipated to register a negative 13.6% CAGR from 2022 to 2031 and by 2031, the market is ...",PFE,0.041901,0.0,Neutral
This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now,https://www.fool.com/investing/2023/09/14/this-market-could-be-worth-10-billion-by-2030/,2023-09-14 11:45:00,This market is currently in its infancy.,PFE,0.42503,0.471183,Bullish
"Despite FDA Doubts, Adcomm Backs Alnylam's Gene Silencing Therapy For Expanded Use Into Rare Heart Disease - Alnylam Pharmaceuticals  ( NASDAQ:ALNY ) ",https://www.benzinga.com/general/biotech/23/09/34571780/despite-fda-doubts-adcomm-backs-alnylams-gene-silencing-therapy-for-expanded-use-into-rare-heart-,2023-09-14 11:26:46,"On Wednesday, an FDA advisory committee voted 9-3 in favor of Alnylam Pharmaceuticals Inc's ALNY patisiran. It has a favorable benefit-risk profile in cardiomyopathy of transthyretin-mediated ( ATTR ) amyloidosis.",PFE,0.25168,0.319614,Somewhat-Bullish
"Novavax Is a Step Behind, Again. Should You Be Worried?",https://www.fool.com/investing/2023/09/14/novavax-is-a-step-behind-should-you-be-worried/,2023-09-14 09:00:00,The FDA still is reviewing Novavax's updated vaccine candidate.,PFE,0.395012,-0.131364,Neutral
DeSantis warns against Covid-19 boosters for people under 65 contradicting CDC guidance | Politics,https://www.cnn.com/2023/09/13/politics/desantis-covid-booster-florida-2024/index.html,2023-09-14 03:25:00,DeSantis warns against Covid-19 boosters for people under 65 contradicting CDC guidance ...,PFE,0.087503,-0.00943,Neutral
UK's Covid timeline: key dates in the pandemic,https://theweek.com/uk-news/107044/uk-coronavirus-timeline,2023-09-14 03:16:57,"Coronavirus cases in the UK are increasing once again, with 1.7 million people across the country estimated to be infected. Europe's winter twindemic of flu and Covid How accurate is the UK's official coronavirus death toll? Are lockdown effects 'killing more people than Covid'?",PFE,0.017256,0.105358,Neutral
Moderna poised to seek flu shot approval after trial results,https://www.financialexpress.com/healthcare/news-healthcare/moderna-poised-to-seek-flu-shot-approval-after-trial-results/3242674/,2023-09-14 02:30:00,Moderna Inc. said a reformulated version of its messenger-RNA based flu shot met its primary goals in a final-stage trial - a result that could pave the way for the company to seek regulatory approval for the influenza vaccine.,PFE,0.056808,0.0,Neutral
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2148576/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-09-13 21:45:20,"In the latest trading session, Pfizer (PFE) closed at $34.08, marking a -0.2% move from the previous day.",PFE,0.679118,0.258669,Somewhat-Bullish
"Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen",https://www.prnewswire.com/news-releases/acute-lymphocytic-leukemia-market-to-accelerate-substantially-by-2032-assesses-delveinsight--key-companies-in-the-market---beam-pfizer-genentech-abbvie-fate-roche-ascentage-janssen-jazz-adc-kymera-syndax-immunogen-301925772.html,2023-09-13 21:01:00,"Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in ... PR ...",PFE,0.021897,0.047845,Neutral
5 things to know about the new COVID-19 vaccine,https://www.marketwatch.com/story/five-things-to-know-about-the-new-covid-19-vaccine-96557794,2023-09-13 20:42:00,The booster will be available starting later this week.,PFE,0.137278,-0.072244,Neutral
OPKO Health  ( OPK )  Ties Up for Oral Peptide Tablet Formulations,https://www.zacks.com/stock/news/2148530/opko-health-opk-ties-up-for-oral-peptide-tablet-formulations,2023-09-13 17:18:00,OPKO Health's (OPK) latest Research Collaboration Agreement is likely to enable it to expand its pipeline to develop orally administered tablet presentations of long-acting peptides.,PFE,0.110462,0.140308,Neutral
"Stocks making the biggest moves midday: Citigroup, Adobe, Corteva and more",https://www.cnbc.com/2023/09/13/stocks-making-the-biggest-moves-midday-c-adbe-ctva-and-more.html,2023-09-13 16:53:29,These are the stocks posting the largest moves in midday trading.,PFE,0.092569,0.061397,Neutral
"The latest Covid-19 vaccine is here. Here's where and when to get it - and RSV and flu shots, too",https://www.cnn.com/2023/09/13/health/updated-covid-vaccine-where-when-flu-rsv-wellness/index.html,2023-09-13 16:38:00,"Now that the US Food and Drug Administration and Centers for Disease Control and Prevention have signed off, you won't have to wait long to get your updated Covid-19 shot. Major pharmacy chains have already started rolling out vaccine appointments.",PFE,0.054114,0.085893,Neutral
Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention - Mainz Biomed  ( NASDAQ:MYNZ ) ,https://www.benzinga.com/markets/penny-stocks/23/09/34543332/mainz-biomed-paves-the-way-for-early-colorectal-cancer-diagnosis-and-even-prevention,2023-09-13 16:31:52,"By the words of Dr. Ruediger Dahlke, cancer is a caricature of today's modern society as it reflects the dark side 'growth'. Our civilization is clearly more on the dark side of growth with technology advancing but not with our wellbeing in mind as everything seems to be thriving, besides our ...",PFE,0.245835,-0.008092,Neutral
US pharmacy chains gear up to administer updated COVID shots,https://www.reuters.com/business/healthcare-pharmaceuticals/us-pharmacy-chains-gear-up-administer-updated-covid-shots-2023-09-13/,2023-09-13 16:05:00,"Walgreens healthcare professional Luis S. Solano prepares a dose of the Pfizer-BioNTec vaccine against coronavirus disease ( COVID-19 ) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski/File Photo Acquire Licensing Rights",PFE,0.227007,0.046958,Neutral
"Top Stories Wednesday, Sep 13: Europe Set To Launch Anti-Subsidy Probe Into Chinese EVs, American Airlines and Spirit Lower Profit Outlook, Manchester United's New Shirt Sponsor - Apple  ( NASDAQ:AAPL ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/23/09/34537719/europe-set-to-launch-anti-subsidy-probe-into-chinese-evs-american-airlines-and-spirit-lower-profit-o,2023-09-13 14:15:20,"Chinese electric vehicle company stocks, including XPeng Inc XPEV, NIO Inc NIO, and Li Auto Inc LI, are trading lower Wednesday after Brussels shared plans to launch an anti-subsidy investigation into Chinese EVs that are ""distorting"" the EU market.",PFE,0.061081,0.069001,Neutral
New Covid vaccines could reach Americans as soon as Thursday - here's what you need to know,https://www.cnbc.com/2023/09/13/new-covid-vaccines-from-pfizer-and-moderna-what-you-need-to-know.html,2023-09-13 13:03:14,"Updated Covid vaccines from Pfizer and Moderna will soon be administered at pharmacies, and many other locations across the U.S.",PFE,0.112638,0.033408,Neutral
"Stocks making the biggest moves premarket: Moderna, American, Spirit Air, Ford and more",https://www.cnbc.com/2023/09/13/stocks-making-biggest-premarket-moves-moderna-american-air-and-more.html,2023-09-13 12:23:32,These are some of the stocks posting the largest moves in premarket trading.,PFE,0.124809,0.187214,Somewhat-Bullish
"Moderna says flu vaccine showed promising results in phase three trial, paving path to approval",https://www.cnbc.com/2023/09/13/moderna-flu-vaccine-shows-promising-phase-three-trial-results.html,2023-09-13 12:19:00,"Moderna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix.",PFE,0.088472,-0.004192,Neutral
"Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/09/34527706/say-goodbye-to-free-covid-19-shots-cdc-approves-priced-boosters-for-omicron-subvariants,2023-09-13 11:52:40,"The Centers for Disease Control and Prevention ( CDC ) has officially endorsed COVID-19 booster shots for individuals six months and older as we approach the fall season. Monday, the FDA cleared updated booster shots from Pfizer Inc PFE and Moderna Inc MRNA for individuals aged six months and ...",PFE,0.585052,0.53463,Bullish
ICON to partner with US govt agency to test COVID vaccine candidates,https://www.reuters.com/business/healthcare-pharmaceuticals/icon-partner-with-us-govt-agency-test-covid-19-vaccine-candidates-2023-09-13/,2023-09-13 11:39:19,ICON to partner with US govt agency to test COVID-19 vaccine candidates ...,PFE,0.200688,-0.193573,Somewhat-Bearish
Altimmune  ( ALT )  Rises 7% on Completing Dosing in Obesity Study,https://www.zacks.com/stock/news/2148179/altimmune-alt-rises-7-on-completing-dosing-in-obesity-study,2023-09-13 11:30:00,Altimmune (ALT) completes the dosing of all patients in the mid-stage obesity study of pemvidutide. The company remains on track to announce top-line results in fourth-quarter 2023. The stock rises 7%.,PFE,0.234006,0.129318,Neutral
Moderna aims to prove it's 'more than a COVID company',https://www.marketwatch.com/story/moderna-aims-to-prove-its-more-than-a-covid-company-8681c064,2023-09-13 10:32:00,"As COVID vaccine sales fall, Moderna releases positive results from mRNA flu vaccine, adds new development programs ...",PFE,0.101797,0.078452,Neutral
Why A Moderna Exec Says Its Growth Story Is 'Misunderstood',https://www.investors.com/news/technology/moderna-stock-why-moderna-executives-say-the-growth-story-is-misunderstood/,2023-09-13 10:30:00,Moderna Stock: Why Moderna Executives Say The Growth Story Is ... Investor's Business Daily ...,PFE,0.095138,-0.048123,Neutral
"COVID-19 Diagnostics Market Revenue to Cross USD 45.8 billion by 2031, Registering a Negative 7.9% CAGR Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/09/g34527619/covid-19-diagnostics-market-revenue-to-cross-usd-45-8-billion-by-2031-registering-a-negative-7-9-c,2023-09-13 10:20:24,"Wilmington, Delaware, United States, Sept. 13, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The COVID-19 diagnostics market was estimated to have acquired US$ 79.8 billion in 2021. It is anticipated to register a -7.9% CAGR from 2022 to 2031 and by 2031 the market is likely to ...",PFE,0.040622,0.130392,Neutral
"The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna and Novavax",https://www.zacks.com/stock/news/2148101/the-zacks-analyst-blog-highlights-pfizer-biontech-moderna-and-novavax,2023-09-13 08:51:00,"Pfizer, BioNTech, Moderna and Novavax are included in this Analyst Blog.",PFE,0.48182,0.03761,Neutral
You can now get a new Covid booster shot. Should you?,https://theweek.com/health/you-can-now-get-a-new-covid-booster-shot-should-you,2023-09-13 05:21:05,Covid-19 booster shots are now available. Should you get one? The Week ...,PFE,0.10607,0.138324,Neutral
CDC Head Gives Final Approval For New Covid Boosters For Most Americans,https://www.forbes.com/sites/willskipworth/2023/09/12/cdc-head-gives-final-approval-for-new-covid-boosters-for-most-americans/,2023-09-12 22:59:20,Vaccines are expected to be delivered to pharmacies and providers soon.,PFE,0.08183,0.069955,Neutral
Here's how much the new COVID vaccines will cost,https://www.foxbusiness.com/healthcare/heres-how-much-new-covid-vaccines-will-cost,2023-09-12 22:03:31,"The updated COVID vaccine will be priced between $120 and $130 per dose, the vaccine manufacturers announced on Tuesday, Sept. 12. Speaking at an advisory panel meeting at the Centers for Disease Control and Prevention ( CDC ) , executives from Pfizer, BioNTech, Moderna and Novavax laid out the ...",PFE,0.358152,0.0,Neutral
"NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years - Compass Pathways  ( NASDAQ:CMPS ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ",https://www.benzinga.com/markets/cannabis/23/09/34503645/ny-consulting-firm-predicts-psychedelic-drugs-market-will-generate-over-12b-in-next-12-years,2023-09-12 20:35:44,"NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035. Top players featured include known names such as COMPASS Pathways CMPS, Silo Pharma SILO, Numinus Wellness NUMIF, Cybin CYBN, Mind Medicine ( MindMed ) MNMD, ...",PFE,0.128822,0.118095,Neutral
CDC panel recommends updated COVID vaccines. Shots could be ready this week,https://apnews.com/article/covid-vaccines-shots-cdc-5bc4db844557120bcc50dc0838c0e044,2023-09-12 20:26:00,Americans may soon be able to get an updated COVID-19 vaccine. Advisers to the Centers for Disease Control and Prevention on Tuesday endorsed the new shots for everyone 6 months of age and older. The agency's director is expected to sign off on the panel's recommendation.,PFE,0.149038,0.118804,Neutral
CDC Panel Recommends New Covid Boosters For Most Americans,https://www.forbes.com/sites/willskipworth/2023/09/12/cdc-panel-recommends-new-covid-boosters-for-most-americans/,2023-09-12 20:20:38,"Now, the vaccines will need signoff from the CDC director.",PFE,0.07423,0.046711,Neutral
US CDC panel recommends broad use of updated COVID-19 vaccines,https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-panel-recommends-broad-use-updated-covid-19-vaccines-2023-09-12/,2023-09-12 20:03:00,"The word ""COVID-19"" is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights Sept 12 ( Reuters ) - A U.S.",PFE,0.240489,0.052874,Neutral
CDC advisors recommend updated Covid vaccines for all Americans ages 6 months and up,https://www.cnbc.com/2023/09/12/new-covid-vaccines-cdc-advisors-recommend-pfizer-and-moderna-shots.html,2023-09-12 20:00:57,CDC Director Mandy Cohen still has to sign off on the panel's recommendation before the new Pfizer and Moderna Covid vaccines become available nationwide.,PFE,0.236281,0.082187,Neutral
CDC advisers recommend updated COVID shots for people 6 months of age and older,https://www.marketwatch.com/story/cdc-advisers-recommend-updated-covid-shots-for-people-6-months-of-age-and-older-2a90e1b3,2023-09-12 19:59:00,Newly approved Pfizer and Moderna vaccines to hit pharmacies for fall vaccination season.,PFE,0.176502,0.081583,Neutral
CDC advisers recommend updated Covid-19 vaccines,https://www.cnn.com/2023/09/12/health/cdc-covid-19-vaccines/index.html,2023-09-12 19:59:00,"The US Centers for Disease Control and Prevention's independent vaccine advisers voted 13-1 on Tuesday to recommend updated Covid-19 vaccines for all Americans 6 months of age and older. The Advisory Committee on Immunization Practices, or ACIP, is a panel of experts that advises the CDC on its ...",PFE,0.112182,0.083277,Neutral
COVID vaccine manufacturers set list price between $120-$130 per dose,https://www.reuters.com/business/healthcare-pharmaceuticals/covid-vaccine-manufacturers-set-list-price-between-120-130-per-dose-2023-09-12/,2023-09-12 18:05:00,"A patient receives their coronavirus disease ( COVID-19 ) vaccine booster during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, U.S., September 29, 2021. REUTERS/Emily Elconin/File photo Acquire Licensing Rights Sept 12 ( Reuters ) - U.S.",PFE,0.570165,0.307379,Somewhat-Bullish
Will A Jump To An 8-Month High Erase This Biotech's Recent Setbacks?,https://www.investors.com/news/technology/nbix-stock-why-neurocrine-shares-surged-within-striking-distance-of-a-breakout/,2023-09-12 16:12:00,NBIX Stock: Why Neurocrine Shares Surged Within Striking ... Investor's Business Daily ...,PFE,0.091162,-0.174067,Somewhat-Bearish
"Top Stories Tuesday, Sep 12: DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/09/34490786/draftkings-apologizes-for-911-never-forget-parlay-promotion-apple-set-for-selling-made-in-india-ipho,2023-09-12 14:32:57,"DraftKings Inc DKNG has apologized for a parlay that the app featured on Sunday night. DraftKings shares featured parlays on its app, such as the current offerings of the ""Shay Shay Parlay,"" which includes three betting picks from Shannon Sharpe, or the ""Hard Knocks"" parlay, which includes four ...",PFE,0.083833,0.097902,Neutral
FDA Approves Pfizer & Moderna's New COVID Booster Vaccines,https://www.zacks.com/stock/news/2147828/fda-approves-pfizer-modernas-new-covid-booster-vaccines,2023-09-12 14:26:00,"Pfizer (PFE)/ BioNTech (BNTX), and Moderna's (MRNA) updated mRNA vaccines are now approved for individuals 12 years of age and older and are authorized under emergency use for individuals 6 months through 11 years of age.",PFE,0.459624,0.045984,Neutral
FBI warns cash machine global cyber-attack imminent,https://theweek.com/95804/fbi-warns-cash-machine-global-cyber-attack-imminent,2023-09-12 14:23:14,A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek. You will receive a verification email shortly. There was a problem. Please refresh the page and try again.,PFE,0.056011,0.0,Neutral
What to Know About the New Covid Booster Shots,https://www.nytimes.com/2023/09/11/well/live/covid-vaccine-booster-fall.html,2023-09-12 13:47:00,"Two new Covid shots have received the green light from the Food and Drug Administration. The Centers for Disease Control and Prevention is expected to follow up with guidance on eligibility as soon as Tuesday, making the new vaccines from Pfizer-BioNTech and Moderna available as Covid cases ...",PFE,0.144853,0.112765,Neutral
The Surprising News That Sent One Biotech Up 19% And Another Down 59%,https://www.investors.com/news/technology/mltx-stock-flirts-with-new-record-on-unexpected-setback-for-rival-acelyrin/,2023-09-12 13:37:00,MLTX Stock Flirts With New Record On Unexpected Setback For ... Investor's Business Daily ...,PFE,0.140896,-0.204993,Somewhat-Bearish
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes,https://www.globenewswire.com/news-release/2023/09/12/2741673/0/en/Entera-Bio-Announces-Collaboration-with-OPKO-Biologics-to-Develop-Oral-Peptide-Tablet-Formulations-for-Obesity-and-Intestinal-Malabsorption-Syndromes.html,2023-09-12 12:30:00,"JERUSALEM, Sept. 12, 2023 ( GLOBE NEWSWIRE ) -- Entera Bio Ltd. ( NASDAQ: ENTX, ""Entera"" ) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. ( NASDAQ: OPK, ""OPKO"" ) have entered into a Research Collaboration Agreement. Under the terms of the Agreement, OPKO will supply its proprietary ...",PFE,0.030369,0.169473,Somewhat-Bullish
"10 things you need to know today: September 12, 2023",https://theweek.com/digest/round-up/10-things-you-need-to-know-today-september-12-2023,2023-09-12 12:14:50,1. US to release $6 billion to Iran under prisoner swap 2. Kim arrives in Russia for talks with Putin 4. Morocco earthquake death toll rises as frantic rescue efforts continue 5. UK says Russia attacked civilian cargo ship in Black Sea port,PFE,0.02241,-0.017796,Neutral
The New Stakes in Pay-TV Battles to Come,https://www.nytimes.com/2023/09/12/business/dealbook/disney-charter-pay-tv.html,2023-09-12 12:13:40,"Disney's deal with Charter will give it more streaming customers, but it also reflects concessions that other content providers will have to make in the future.",PFE,0.021124,-0.014921,Neutral
Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration,https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-acquires-vertical-bio-and-its-innovative-targeted-therapy-candidate-for-patients-suffering-from-non-small-cell-lung-cancer-with-met-alteration-301921818.html,2023-09-12 12:00:00,Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering ... PR ...,PFE,0.057352,0.078949,Neutral
Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration,https://www.newswire.ca/news-releases/pierre-fabre-laboratories-acquires-vertical-bio-and-its-innovative-targeted-therapy-candidate-for-patients-suffering-from-non-small-cell-lung-cancer-with-met-alteration-834013692.html,2023-09-12 12:00:00,Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering ... Canada ...,PFE,0.057352,0.078949,Neutral
The Other Naomi,https://www.theatlantic.com/magazine/archive/2023/10/naomi-wolf-klein-doppelganger-book/675120/,2023-09-12 11:00:00,"In 2019, a mnemonic began to circulate on the internet: ""If the Naomi be Klein / you're doing just fine / If the Naomi be Wolf / Oh, buddy.",PFE,0.019132,0.014912,Neutral
US CDC contemplates who should get the new COVID shots,https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-contemplates-who-should-get-new-covid-shots-2023-09-12/,2023-09-12 10:06:00,"Syringes ready to be administrated to residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots of the coronavirus disease ( COVID-19 ) vaccines are seen in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin/File Photo Acquire ...",PFE,0.116631,0.114184,Neutral
"What to know about the updated Pfizer, Moderna COVID vaccines",https://www.aljazeera.com/news/2023/9/12/fda-approves-updated-pfizer-moderna-covid-vaccines-here-is-what-to-know,2023-09-12 09:29:48,"FDA approves updated Pfizer, Moderna COVID vaccines: Here is what to know Al Jazeera English ...",PFE,0.164468,0.147968,Neutral
Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.,https://www.fool.com/investing/2023/09/12/wall-street-has-next-high-flying-stock-split-stock/,2023-09-12 09:06:00,"Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage have all split their shares since July 2021. Next week, another industry leader will join this exclusive club.",PFE,0.064276,0.142446,Neutral
"The Zacks Analyst Blog Highlights Microsoft, Novo Nordisk, Booking Holdings, Sony and EOG",https://www.zacks.com/stock/news/2147534/the-zacks-analyst-blog-highlights-microsoft-novo-nordisk-booking-holdings-sony-and-eog,2023-09-12 09:05:00,"Microsoft, Novo Nordisk, Booking Holdings, Sony and EOG are included in this Analyst Blog.",PFE,0.065327,-0.017232,Neutral
C.D.C. Advisers to Decide Who Should Receive New Covid Vaccines,https://www.nytimes.com/2023/09/12/health/covid-cdc-vaccines.html,2023-09-12 09:02:07,"Americans may be able to receive the next Covid shots as early as Wednesday, the last of a trifecta of vaccines intended to prevent respiratory infections this fall and winter. On Monday, the Food and Drug Administration authorized updated Covid vaccines by Pfizer and Moderna.",PFE,0.072876,0.046276,Neutral
2024 GOP contenders clash over Covid-19 records as they warn against future mandates | Politics,https://edition.cnn.com/2023/09/12/politics/covid-republican-president-candidates-warning/index.html,2023-09-12 09:01:00,2024 GOP contenders clash over Covid-19 records as they warn against future mandates CNN International ...,PFE,0.041039,0.060071,Neutral
2024 GOP contenders clash over Covid-19 records as they warn against future mandates | Politics,https://www.cnn.com/2023/09/12/politics/covid-republican-president-candidates-warning/index.html,2023-09-12 09:01:00,2024 GOP contenders clash over Covid-19 records as they warn against future mandates ...,PFE,0.041039,0.060071,Neutral
"TSLA, ORCL, NVAX, DKNG, PFE: Top 5 Trending Stocks - DraftKings  ( NASDAQ:DKNG ) , Tesla  ( NASDAQ:TSLA ) , Oracle  ( NYSE:ORCL ) , Novavax  ( NASDAQ:NVAX ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/markets/equities/23/09/34466205/tesla-oracle-novavax-draftkings-pfizer-why-these-five-stocks-are-tending-today,2023-09-12 02:26:51,"U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday. The tech-heavy index closed at 13,917.89 for the day. The Dow Jones Industrial Average also reflected an upward trend, increasing by ...",PFE,0.173333,-0.029058,Neutral
The F.D.A. Approved New Covid Shots,https://www.nytimes.com/2023/09/11/briefing/fda-covid-shots-elon-musk-book.html,2023-09-11 21:42:19,"The F.D.A. gave the green light today to a new round of Covid boosters, the first to be approved since the public health emergency ended in May. The move comes as the Biden administration is preparing a campaign to convince Americans to get immunized, and as Covid cases tick up.",PFE,0.032602,0.0,Neutral
"Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits - Novavax  ( NASDAQ:NVAX ) , Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/09/34457751/moderna-pfizer-get-fda-nod-for-omicron-covid-boosters-while-novavax-waits,2023-09-11 20:57:35,"The U.S. Food and Drug Administration on Monday approved and authorized updated COVID-19 vaccines by Moderna Inc MRNA and partners Pfizer Inc PFE and BioNTech SE BNTX aimed at better countering circulating viral strains, including the omicron variant XBB.1.5.",PFE,0.52759,0.159456,Somewhat-Bullish
Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a/1b Clinical Trial with AB-101; Cash Runway Extended - Arbutus Biopharma  ( NASDAQ:ABUS ) ,https://www.benzinga.com/pressreleases/23/09/g34456832/arbutus-announces-pipeline-updates-and-dosing-of-the-first-subject-in-the-phase-1a1b-clinical-tria,2023-09-11 20:15:00,"WARMINSTER, Pa., Sept. 11, 2023 ( GLOBE NEWSWIRE ) -- Arbutus Biopharma Corporation ABUS ( ""Arbutus"" or the ""Company"" ) , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced ...",PFE,0.087583,0.049805,Neutral
Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a/1b Clinical Trial with AB-101; Cash Runway Extended,https://www.globenewswire.com/news-release/2023/09/11/2741168/14025/en/Arbutus-Announces-Pipeline-Updates-and-Dosing-of-the-First-Subject-in-the-Phase-1a-1b-Clinical-Trial-with-AB-101-Cash-Runway-Extended.html,2023-09-11 20:15:00,"Progressing development of hepatitis B virus ( HBV ) compounds imdusiran ( AB-729 ) and AB-101, an oral PD-L1 inhibitor ...",PFE,0.087027,0.049728,Neutral
US Approves Updated Covid Vaccines For Fall,https://www.barrons.com/news/us-approves-updated-covid-vaccines-for-fall-3ceceedc,2023-09-11 19:37:00,"The United States on Monday approved Covid vaccines with formulations that more closely target currently circulating variants, as infections are once more on the rise. The new approvals relate to updated vaccines produced by Moderna and Pfizer that correspond to an Omicron sublineage.",PFE,0.152983,-0.006775,Neutral
"Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters",https://www.investors.com/news/technology/novavax-stock-dives-as-pfizer-moderna-win-first-fda-ok-for-covid-boosters/,2023-09-11 19:10:00,"Novavax Dives As Pfizer, Moderna Snag First Nods For Covid ... Investor's Business Daily ...",PFE,0.587278,0.135554,Neutral
Explainer: Who should get a COVID vaccine this year?,https://www.reuters.com/business/healthcare-pharmaceuticals/who-should-get-covid-vaccine-this-year-2023-09-11/,2023-09-11 19:04:03,"A nurse fills up syringes with the coronavirus disease ( COVID-19 ) vaccines for residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin/File Photo Acquire Licensing Rights",PFE,0.11123,0.024564,Neutral
New Pfizer and Moderna COVID shots approved by FDA,https://www.marketwatch.com/story/pfizer-and-moderna-updated-covid-vaccines-approved-by-fda-449108b,2023-09-11 19:01:00,"CDC is set to vote on the new shots Tuesday, but questions remain about costs for uninsured people.",PFE,0.433877,0.175596,Somewhat-Bullish
FDA Approves New Covid Vaccines To Target Latest Strains,https://www.forbes.com/sites/willskipworth/2023/09/11/fda-approves-new-covid-vaccines-to-target-latest-strains/,2023-09-11 18:33:27,The updated booster shots arrive as new coronavirus variants circulate.,PFE,0.375016,0.031565,Neutral
US approves updated COVID vaccines to rev up protection this fall,https://apnews.com/article/covid-vaccines-coronavirus-234f27c74438fb4812a014dbd98ddbde,2023-09-11 18:05:00,"WASHINGTON ( AP ) - The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter.",PFE,0.098659,-0.039894,Neutral
US FDA authorizes updated COVID vaccines,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-authorizes-updated-covid-vaccines-2023-09-11/,2023-09-11 17:55:00,"Sept 11 ( Reuters ) - The U.S. health regulator on Monday authorized updated COVID-19 vaccines that closely match the Omicron variants that are circulating, starting the process to deploy the shots this month.",PFE,0.595343,0.0,Neutral
FDA signs off on updated Covid-19 vaccines to target circulating variants,https://www.cnn.com/2023/09/11/health/fda-signs-off-on-updated-covid-19-vaccines/index.html,2023-09-11 17:50:05,FDA signs off on updated Covid-19 vaccines that target circulating variants ...,PFE,0.188193,0.050965,Neutral
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise,https://www.cnbc.com/2023/09/11/covid-vaccines-fda-approves-new-shots-from-pfizer-moderna.html,2023-09-11 17:49:48,The Biden administration said it expects the new Pfizer and Moderna vaccines targeting the omicron variant XBB.1.5 to be available in mid-September.,PFE,0.342487,0.216679,Somewhat-Bullish
AI Integration In Biotech & Pharma: Companies Positioned To Benefit - Recursion Pharmaceuticals  ( NASDAQ:RXRX ) ,https://www.benzinga.com/markets/penny-stocks/23/09/34451218/ai-integration-in-biotech-pharma-companies-positioned-to-benefit,2023-09-11 17:27:31,The convergence of artificial intelligence ( AI ) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care.,PFE,0.166169,0.173764,Somewhat-Bullish
"Top Stock Reports for Microsoft, Novo Nordisk & Booking Holdings",https://www.zacks.com/research-daily/2147209/top-stock-reports-for-microsoft-novo-nordisk-booking-holdings,2023-09-11 16:32:00,"Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Novo Nordisk A/S (NVO) and Booking Holdings Inc. (BKNG).",PFE,0.088147,-0.01815,Neutral
Nurix  ( NRIX )  Stock Increases 9% in a Month: Here's Why,https://www.zacks.com/stock/news/2147375/nurix-nrix-stock-increases-9-in-a-month-heres-why,2023-09-11 16:10:00,The upside in Nurix's (NRIX) shares can be attributed to the company's recently signed collaboration with Seagen (SGEN) to develop a new class of medicines for cancer.,PFE,0.245959,0.231238,Somewhat-Bullish
The Prostate Cancer Drugs Market Is Expected To Reach A Value Of $23 Billion By 2027 At A CAGR Of More Than 5 % As Per The Business Research Company's Prostate Cancer Drugs Global Market Report 2023,https://www.benzinga.com/pressreleases/23/09/g34446203/the-prostate-cancer-drugs-market-is-expected-to-reach-a-value-of-23-billion-by-2027-at-a-cagr-of-m,2023-09-11 15:30:00,"LONDON, Sept. 11, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Prostate Cancer Drugs Global Market Report 2023, the global prostate cancer drugs market is making strides worth noting.",PFE,0.059341,0.012045,Neutral
"5 Value Stocks In The Healthcare Sector - Kiniksa Pharmaceuticals  ( NASDAQ:KNSA ) , POINT Biopharma Global  ( NASDAQ:PNT ) , Ocuphire Pharma  ( NASDAQ:OCUP ) , Palisade Bio  ( NASDAQ:PALI ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/09/34444452/5-value-stocks-in-the-healthcare-sector,2023-09-11 14:44:17,"A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the ...",PFE,0.179788,0.268115,Somewhat-Bullish
How Is The Market Feeling About Pfizer? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/short-sellers/23/09/34440997/how-is-the-market-feeling-about-pfizer,2023-09-11 13:30:29,"Pfizer's PFE short percent of float has risen 14.81% since its last report. The company recently reported that it has 52.39 million shares sold short, which is 0.93% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.08 days to cover their ...",PFE,0.224903,0.158881,Somewhat-Bullish
Covid vaccine rollout begins early in the UK with new variant under watch,https://www.cnbc.com/2023/09/11/uk-begins-covid-vaccine-rollout-early-with-new-variant-under-watch.html,2023-09-11 11:38:26,"The National Health Service wants to avoid another ""twindemic"" of Covid and flu putting strain on hospitals.",PFE,0.070517,0.0,Neutral
2 Dirt Cheap Stocks to Buy With $100,https://www.fool.com/investing/2023/09/11/2-dirt-cheap-stocks-to-buy-with-100/,2023-09-11 10:00:00,These players offer a great buying opportunity today for long-term investors.,PFE,0.458446,0.238442,Somewhat-Bullish
Covid Vaccines May Roll Out Within Days,https://www.nytimes.com/2023/09/11/health/covid-vaccines-may-roll-out-within-days.html,2023-09-11 09:02:35,The F.D.A. is expected to approve a new round of shots by Pfizer and Moderna as early as Monday to prepare Americans for the fall and winter season when infections usually tick upward.,PFE,0.123526,0.004639,Neutral
Covid Vaccines May Roll Out Within Days,https://www.nytimes.com/2023/09/11/health/covid-vaccine-boosters-fda-pfizer-moderna.html,2023-09-11 09:02:35,The F.D.A. is expected to approve a new round of shots by Pfizer and Moderna as early as Monday to prepare Americans for the fall and winter season when infections usually tick upward.,PFE,0.123526,0.004639,Neutral
Female Sexual Dysfunction Treatment Market to grow by USD 7.76 billion from 2022-2027; North America to account ... - PR Newswire,https://www.prnewswire.com/news-releases/female-sexual-dysfunction-treatment-market-to-grow-by-usd-7-76-billion-from-2022-2027-north-america-to-account-for-61-of-market-growth---technavio-301922154.html,2023-09-11 07:35:00,Female Sexual Dysfunction Treatment Market to grow by USD 7.76 billion from 2022-2027. North America to account ... PR ...,PFE,0.097854,0.023502,Neutral
Will Mask Mandates Return? Fauci Doesn't Expect More Federal Mandates As Covid Deaths Rise,https://www.forbes.com/sites/mollybohannon/2023/09/10/will-mask-mandates-return-fauci-doesnt-expect-more-federal-mandates-as-covid-deaths-rise/,2023-09-10 16:57:24,"The former chief medical advisor to the White House said he'd be ""extremely surprised"" to see another federal mask mandate.",PFE,0.138066,0.130221,Neutral
"Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion",https://www.cnbc.com/2023/09/09/big-pharma-blockbuster-obesity-drug-battle-is-headed-for-100-billion.html,2023-09-09 13:19:42,"As Novo Nordisk and Eli Lilly duke it out in the weight-loss drug market with Ozempic, Wegovy and Mounjaro, drug company competitors plan to join the fray.",PFE,0.060388,-0.023001,Neutral
3 Top Healthcare Stocks to Buy for September,https://www.fool.com/investing/2023/09/09/3-top-healthcare-stocks-to-buy-for-september/,2023-09-09 13:15:00,These blue-chip healthcare stocks are trading at attractive valuations today.,PFE,0.199037,0.288213,Somewhat-Bullish
Big Pharma's Battle With the Biden Administration Could Have Legs,https://www.wsj.com/health/pharma/big-pharmas-battle-with-the-biden-administration-could-have-legs-a0524692,2023-09-09 12:00:00,Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act.,PFE,0.546745,0.577545,Bullish
Big Pharma's Battle With the Biden Administration Could Have Legs,https://www.wsj.com/health/pharma/big-pharmas-battle-with-the-biden-administration-could-have-legs-a0524692,2023-09-09 12:00:00,Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act.,PFE,0.535653,0.551775,Bullish
3 Pharmaceutical Stocks That Are Too Cheap to Ignore,https://www.fool.com/investing/2023/09/09/pharmaceutical-stocks-that-are-too-cheap-to-ignore/,2023-09-09 11:20:00,"Viatris, GSK, and Organon are all trading at less than 7 times earnings.",PFE,0.049424,0.06038,Neutral
"Updated Covid-19 shots are coming soon, to be part of trio of vaccines",https://www.business-standard.com/india-news/updated-covid-19-shots-are-coming-soon-to-be-part-of-trio-of-vaccines-123090900529_1.html,2023-09-09 10:08:51,"Updated COVID-19 vaccines are coming soon, just in time to pair them with flu shots. And this fall, the first vaccines for another scary virus called RSV are rolling out to older adults and pregnant women.",PFE,0.091162,0.072647,Neutral
Updated COVID shots are coming. They're part of a trio of vaccines to block fall viruses,https://apnews.com/article/covid-flu-rsv-vaccines-tripledemic-2a55728638c1c0879ce58deeeb0196bf,2023-09-09 04:29:00,"WASHINGTON ( AP ) - Updated COVID-19 are coming soon, just in time to pair them with flu shots. And this fall, the first vaccines for another scary virus called RSV are rolling out to and .",PFE,0.090474,0.072535,Neutral
Pharma Stock Roundup: J&J to End Hypertension Study & Other Regulatory Updates,https://www.zacks.com/stock/news/2146892/pharma-stock-roundup-jj-to-end-hypertension-study-other-regulatory-updates,2023-09-08 22:54:00,J&J (JNJ) to end a late-stage study on macitentan for CTEPH. Merck's (MRK) Ebola vaccine gets approval in Europe for use in kids.,PFE,0.11894,-0.135549,Neutral
Danco Laboratories asks Supreme Court to decide abortion pill case,https://www.cnbc.com/2023/09/08/drug-company-asks-supreme-court-to-decide-abortion-pill-case.html,2023-09-08 18:08:22,"Danco asked the court to reverse a lower court ruling that would impose restrictions, saying the case is of ""indisputable importance"" to women's health.",PFE,0.075874,-0.178266,Somewhat-Bearish
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/09/34366927/this-is-what-whales-are-betting-on-pfizer,2023-09-08 17:00:58,"A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer PFE we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and ...",PFE,0.713164,0.057426,Neutral
3 Large-Cap Value Mutual Funds to Counter New Inflation Worries,https://www.zacks.com/stock/news/2146516/3-large-cap-value-mutual-funds-to-counter-new-inflation-worries,2023-09-08 12:24:00,"Invest in large-cap value funds like DRGVX, ACSDX and VWNDX to preserve your capital and earn returns amid fresh inflation worries.",PFE,0.052112,0.04869,Neutral
This Cathie Wood Stock Is Down 40% in 2023. Here's Why She's Still Buying It.,https://www.fool.com/investing/2023/09/08/this-cathie-wood-stock-is-down-40-in-2023-heres-wh/,2023-09-08 12:20:00,"The decline of Beam's stock says little about its long-term potential, according to Wood.",PFE,0.149966,0.141755,Neutral
3 AI Stocks You Might Want to Own Before the Next Bull Market,https://www.fool.com/investing/2023/09/08/three-ai-stocks-you-might-want-to-own-before-the-n/,2023-09-08 09:52:00,"While growth stocks may be getting the most attention, investors have several reasons to keep an eye on Big Tech.",PFE,0.03642,-0.021669,Neutral
3 Must-Know Tricks for Investing in Big Pharma Stocks,https://www.fool.com/investing/2023/09/08/must-know-tricks-investing-in-big-pharma-stocks/,2023-09-08 09:46:00,Using these tricks will help you appreciate where and when to invest.,PFE,0.179788,0.081938,Neutral
Investing In Value Stocks - Prudent Speculator Picks: PFE & PYPL,https://www.forbes.com/sites/johnbuckingham/2023/09/08/investing-in-value-stocksprudent-speculator-picks-pfe--pypl/,2023-09-08 05:55:03,"The Prudent Speculator, the value-oriented investment newsletter I have edited for more than three decades, has been guided-through thick and thin-by three core tenets: ...",PFE,0.160277,0.084393,Neutral
"Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold - Nuvalent  ( NASDAQ:NUVL ) ",https://www.benzinga.com/general/biotech/23/09/34956007/challenging-road-ahead-for-cancer-drugs-nuvalent-seeks-to-break-the-mold,2023-09-27 18:44:52,"Stifel initiated coverage on Nuvalent Inc NUVL, recognizing that adopting a bullish stance in anticipation of Phase 1 cancer drug data, mainly when derived from heavily pretreated patients, has proven unprofitable for approximately two years. The analyst keeps the price target of $65, with a Buy ...",PFE,0.213988,0.032817,Neutral
Why Pfizer Stock Hit A New 52-Week Low Today - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/23/09/34955410/why-pfizer-stock-hit-a-new-52-week-low-today,2023-09-27 17:22:41,"Pfizer, Inc. PFE shares are trading lower Wednesday. The stock hit a new 52-week low and has fallen more than 24% over the last year. Pfizer faces some challenges including the flawed commerical roll-out of the updated COVID-19 vaccines which has seen some patients being denied vaccination due to ...",PFE,0.98466,-0.156846,Somewhat-Bearish
What's Going On Pfizer's Subsidiary Biohaven Stock? - Biohaven  ( NYSE:BHVN ) ,https://www.benzinga.com/general/biotech/23/09/34955283/whats-going-on-pfizers-subsidiary-biohaven-stock,2023-09-27 17:05:21,"Pfizer Inc's PFE subsidiary Biohaven Ltd BHVN released an updated investor presentation with additional data on the company's BHV-1300 program, a potential competitor to FcRn-targeting therapeutics such as argenx's SE ARGX Vyvgart, Immunovant Inc's IMVT IMVT-1402, and Janssen's JNJ nipocalimab.",PFE,0.206685,0.0,Neutral
Why Ginkgo Bioworks Stock Is Surging Higher Today,https://www.fool.com/investing/2023/09/27/why-ginkgo-bioworks-stock-is-surging-higher-today/,2023-09-27 16:03:14,A new collaboration with Pfizer is fueling a rally in the company's shares today.,PFE,0.38489,0.375927,Bullish
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/penny-stocks/23/09/34953715/mainz-biomed-to-present-the-power-of-mrna-that-promises-to-revolutionize-medicine,2023-09-27 15:43:00,"Pharma companies across the globe, including Pfizer Inc PFE and Moderna Inc MRNA, are harnessing the potential of mRNA which is creating plenty of space for scientific improvement in the fight against pathogens. The world learned about messenger RNA molecules and their flexibility, speed and ...",PFE,0.231884,-0.074778,Neutral
"As Covid Infections Rise, Nursing Homes Are Still Waiting for Vaccines",https://www.nytimes.com/2023/09/27/health/nursing-homes-covid-vaccines.html,2023-09-27 14:30:10,"Now that the U.S. government has stepped back from issuing vaccines, long-term care operators have yet to start administering shots to protect one of the most vulnerable populations.",PFE,0.023304,-0.060542,Neutral
"MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday - Biohaven  ( NYSE:BHVN ) , Peabody Energy  ( NYSE:BTU ) ",https://www.benzinga.com/news/23/09/34951000/millerknoll-hayward-holdings-ginkgo-bioworks-and-other-big-stocks-moving-higher-on-wednesday,2023-09-27 14:28:13,"U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Here are some big stocks recording gains in today's session. MillerKnoll, Inc. MLKN surged 27% to $24.31 after the company announced better-than-expected first-quarter financial results and issued ...",PFE,0.131643,0.244357,Somewhat-Bullish
These 2 Stocks Are Getting Smart Investors' Attention Wednesday,https://www.fool.com/investing/2023/09/27/these-2-stocks-are-getting-smart-investors-attenti/,2023-09-27 13:49:32,Big movers in either direction can give hints about broader market sentiment.,PFE,0.402403,0.340575,Somewhat-Bullish
"Top Stories Wednesday, Sep 27: Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds - Alibaba Gr Holding  ( NYSE:BABA ) ",https://www.benzinga.com/news/23/09/34949379/apple-defends-its-19b-google-search-deal-hollywoods-writers-secure-credit-for-ai-training-chinas-amb,2023-09-27 13:47:47,Alibaba Group Holding Limited BABA stock is trading higher Wednesday as the company's logistics arm Cainiao Smart Logistics Network Ltd filed for its Hong Kong initial public offering on Tuesday. The first-time share sale could fetch a minimum of $1 billion.,PFE,0.07423,0.0,Neutral
Pfizer Is Sending Ginkgo Bioworks  ( DNA )  Stock Higher: Here's Why - Ginkgo Bioworks Holdings  ( NYSE:DNA ) ,https://www.benzinga.com/news/23/09/34949327/pfizer-is-sending-ginkgo-bioworks-dna-stock-higher-heres-why,2023-09-27 13:45:51,"Ginkgo Bioworks Holdings Inc DNA shares are trading higher Wednesday after the company announced a collaboration with Pfizer Inc PFE focused on the discovery of RNA-based drug candidates. What To Know: Under the collaboration, Pfizer will use Ginkgo's RNA technology to advance novel RNA molecule ...",PFE,0.773597,0.793,Bullish
"Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields - Gilead Sciences  ( NASDAQ:GILD ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/09/34947896/wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-4-dividend-yields,2023-09-27 13:03:32,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",PFE,0.103778,0.079384,Neutral
Pharma lobby says EU ban on 'forever chemicals' would halt drug production,https://www.reuters.com/business/healthcare-pharmaceuticals/pharma-lobby-says-eu-ban-forever-chemicals-would-halt-drug-production-2023-09-27/,2023-09-27 13:01:00,"FRANKFURT, Sept 27 ( Reuters ) - European drugmakers warned that a proposed complete ban on substances known as PFAS or ""forever chemicals"" would render medicine production in the region impossible, part of a high-stakes wrangle between manufacturers and environmental regulators.",PFE,0.08687,-0.064628,Neutral
Here is What to Know Beyond Why Pfizer Inc.  ( PFE )  is a Trending Stock,https://www.zacks.com/stock/news/2156079/here-is-what-to-know-beyond-why-pfizer-inc-pfe-is-a-trending-stock,2023-09-27 13:00:11,"Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",PFE,0.484798,0.122128,Neutral
Uncertainty Looms Over Pfizer's Oral COVID-19 Antiviral Pill - Doubts Over Commercial Approval - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/09/34946686/uncertainty-looms-over-pfizers-oral-covid-19-antiviral-pill-doubts-over-commercial-approval,2023-09-27 12:54:10,"Pfizer Inc's PFE CEO Albert Bourla provided an update on the status of the company's oral antiviral COVID-19 treatment, Paxlovid, during his speech at the Cantor Fitzgerald Annual Healthcare Conference.",PFE,0.595343,0.138981,Neutral
2 Magnificent Growth Stocks to Buy On the Dip,https://www.fool.com/investing/2023/09/27/2-magnificent-growth-stocks-to-buy-on-the-dip/,2023-09-27 12:30:00,It might be time to catch these falling knives.,PFE,0.0699,0.196196,Somewhat-Bullish
Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer - PR Newswire,https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-multi-target-rna-discovery-collaboration-with-pfizer-301939570.html,2023-09-27 11:01:00,Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer PR ...,PFE,0.463545,0.437932,Bullish
"Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer - Ginkgo Bioworks Holdings  ( NYSE:DNA ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/09/n34943067/ginkgo-bioworks-announces-multi-target-rna-discovery-collaboration-with-pfizer,2023-09-27 11:01:00,"BOSTON, Sept. 27, 2023 /PRNewswire/ -- Ginkgo Bioworks DNA today announced a collaboration with Pfizer PFE focused on the discovery of RNA-based drug candidates. In the collaboration, Pfizer will leverage Ginkgo's proprietary RNA technology to advance the discovery and development of novel RNA ...",PFE,0.462067,0.429713,Bullish
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry - CytoSorbents  ( NASDAQ:CTSO ) ,https://www.benzinga.com/pressreleases/23/09/g34942966/cytosorbents-highlights-upcoming-presentations-at-eacts-2023-focus-on-antithrombotic-removal-inclu,2023-09-27 11:00:00,"PRINCETON, N.J., Sept. 27, 2023 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation CTSO, a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the upcoming original ...",PFE,0.018995,0.043822,Neutral
Why Travis Kelce's Love Story With Taylor Swift Will Make Him An Even Bigger Marketing Star,https://www.forbes.com/sites/justinbirnbaum/2023/09/27/why-travis-kelces-love-story-with-taylor-swift-will-make-him-a-bigger-marketing-star/,2023-09-27 10:00:00,The Kansas City Chiefs tight end was already scoring big with sponsors. Then he went on a date in Arrowhead Stadium. Now advertisers-and millions of Swifties-see him as quite the catch.,PFE,0.038407,0.098443,Neutral
"About 250,000 courses of COVID pill Paxlovid being administered per week - Pfizer CEO",https://www.reuters.com/business/healthcare-pharmaceuticals/about-250000-courses-covid-pill-paxlovid-being-administered-per-week-pfizer-ceo-2023-09-26/,2023-09-26 23:20:00,About 250000 courses of COVID pill Paxlovid being administered per week - Pfizer CEO ...,PFE,0.379051,0.201249,Somewhat-Bullish
Mum's the bad word: Most big Menendez donors won't say if they will keep backing New Jersey senator,https://www.cnbc.com/2023/09/26/sen-bob-menendez-donors-keep-backing-new-jersey-lawmaker.html,2023-09-26 18:53:39,Sen. Bob Menendez faces a federal bribery indictment and calls by fellow Democrats to step resign as he seeks re-election in 2024.,PFE,0.105836,0.07987,Neutral
Pfizer Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/09/34920929/pfizer-unusual-options-activity,2023-09-26 17:45:42,"Benzinga's options scanner just detected over 16 options trades for Pfizer PFE summing a total amount of $536,080. At the same time, our algo caught 8 for a total amount of 326,565.",PFE,0.666827,0.254199,Somewhat-Bullish
Moderna Talks Offer Hope for Enhanced COVID-19 Vaccine Availability In Europe - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/general/biotech/23/09/34909329/moderna-talks-offer-hope-for-enhanced-covid-19-vaccine-availability-in-europe,2023-09-26 16:31:43,European countries are actively negotiating a fresh COVID-19 vaccine procurement agreement with Moderna Inc MRNA as concerns mount within EU health authorities regarding a surge in coronavirus infections.,PFE,0.31482,0.029786,Neutral
Alation Named a Leader in 2023 Data Governance Solutions Report by Independent Global Research Firm,https://www.benzinga.com/pressreleases/23/09/g34915070/alation-named-a-leader-in-2023-data-governance-solutions-report-by-independent-global-research-fir,2023-09-26 15:28:55,"REDWOOD CITY, Calif., Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- Alation, Inc., the data intelligence company, today announced it has been named a Leader in The Forrester Wave™: Data Governance Solutions, Q3 2023 report.",PFE,0.072876,0.22093,Somewhat-Bullish
Medical Stock Catapults Almost 400% On Obesity Treatment Win,https://www.investors.com/news/technology/slno-stock-catapults-after-its-pill-controls-hunger-in-obesity-causing-disease/,2023-09-26 13:23:00,SLNO Stock Catapults Almost 400% After Its Pill Controls Hunger In ... Investor's Business Daily ...,PFE,0.138464,0.0,Neutral
"Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant - AstraZeneca  ( NASDAQ:AZN ) , GSK  ( NYSE:GSK ) ",https://www.benzinga.com/general/biotech/23/09/34905240/multi-billion-dollar-treatment-market-for-lung-infection-that-causes-over-200-000-hospitalization,2023-09-26 12:45:12,"The CDC recently issued a warning that Respiratory Syncytial Virus ( RSV ) , a common and highly contagious lung infection that can cause bronchitis and pneumonia, is on the rise in the Southeastern United States - and the very young and the elderly are the most at risk of developing severe ...",PFE,0.110717,-0.049793,Neutral
EU in talks with Moderna over new deal for COVID vaccines - FT,https://www.reuters.com/business/healthcare-pharmaceuticals/eu-talks-with-moderna-over-new-covid-vaccine-deal-ft-2023-09-26/,2023-09-26 12:33:00,EU in talks with Moderna over new COVID vaccine deal - FT ...,PFE,0.249106,-0.058677,Neutral
FDA Accepts Sanofi's  ( SNY )  sBLA for Dupixent in Pediatric EoE,https://www.zacks.com/stock/news/2155380/fda-accepts-sanofis-sny-sbla-for-dupixent-in-pediatric-eoe,2023-09-26 12:11:00,"If this filing is approved, Sanofi (SNY)/Regeneron's (REGN) Dupixent will be the first FDA-approved treatment for eosinophilic esophagitis in children aged 1 to 11. A final decision is expected in January.",PFE,0.270523,0.083242,Neutral
"Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation - Avalo Therapeutics  ( NASDAQ:AVTX ) , Horizon Tech Finance  ( NASDAQ:HRZN ) ",https://www.benzinga.com/pressreleases/23/09/g34899423/avalo-therapeutics-successfully-eliminates-35-million-debt-paving-the-way-for-future-growth-and-in,2023-09-26 11:00:00,"WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- In a major achievement, Avalo Therapeutics AVTX proudly announces the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance Corporation HRZN. This significant milestone not only signifies the ...",PFE,0.037387,0.119603,Neutral
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation,https://www.globenewswire.com/news-release/2023/09/26/2749320/0/en/Avalo-Therapeutics-Successfully-Eliminates-35-Million-Debt-Paving-the-Way-for-Future-Growth-and-Innovation.html,2023-09-26 11:00:00,"WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- In a major achievement, Avalo Therapeutics ( Nasdaq: AVTX ) proudly announces the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance Corporation ( Nasdaq: HRZN ) .",PFE,0.028695,0.115436,Neutral
"Coty shares fall after announcing offering, and other movers early Tuesday",https://www.marketwatch.com/story/coty-shares-fall-after-announcing-offering-and-other-movers-early-tuesday-8e2e696c,2023-09-26 09:09:00,"Shoe Carnival Inc.'s stock rose 2% after the retailer said it has a new CFO, effectively immediately.",PFE,0.895116,0.410794,Bullish
What to Know About Paxlovid Rebound,https://www.nytimes.com/2023/09/26/well/live/covid-paxlovid-rebound.html,2023-09-26 09:01:48,What to Know About Covid Rebound After Paxlovid Treatment The New York Times ...,PFE,0.103109,-0.011824,Neutral
"Revolutionizing Genetic Disease Research: DLI's Vital Role in Meeting Unmet Needs, Pipeline Assessment, Disease Intelligence, Pricing, Market Access Data, and Analysis for Pharma Companies | Disease Landscape Insights",https://www.prnewswire.com/news-releases/revolutionizing-genetic-disease-research-dlis-vital-role-in-meeting-unmet-needs-pipeline-assessment-disease-intelligence-pricing-market-access-data-and-analysis-for-pharma-companies--disease-landscape-insights-301938533.html,2023-09-26 08:02:00,"Revolutionizing Genetic Disease Research: DLI's Vital Role in Meeting Unmet Needs, Pipeline Assessment, Disease ... PR ...",PFE,0.029618,0.0,Neutral
Pfizer  ( PFE )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2155093/pfizer-pfe-outpaces-stock-market-gains-what-you-should-know,2023-09-25 21:45:19,"In the latest trading session, Pfizer (PFE) closed at $32.98, marking a +0.89% move from the previous day.",PFE,0.493442,0.306683,Somewhat-Bullish
"Pfizer restarts production at tornado-damaged facility, but some supply is still affected",https://www.marketwatch.com/story/pfizer-restarts-production-at-tornado-damaged-facility-but-some-supply-is-still-affected-1d5eadf1,2023-09-25 21:23:00,"Pfizer resumes production at its North Carolina site damaged by a tornado in July, but says that some medications may not be back in 'full supply' until next year.",PFE,0.661658,-0.155507,Somewhat-Bearish
"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html,2023-09-25 21:01:00,"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key ... PR ...",PFE,0.037504,0.028556,Neutral
Travis Kelce's Ads For Pfizer And Bud Light Draw Right-Wing Anger,https://www.forbes.com/sites/conormurray/2023/09/25/travis-kelces-ads-for-pfizer-and-bud-light-draw-right-wing-anger/,2023-09-25 20:52:47,Kelce has already been making headlines for his rumored relationship with Taylor Swift.,PFE,0.427024,-0.172613,Somewhat-Bearish
"Pfizer restarts production at tornado-hit North Carolina plant, but drug supply will still be affected",https://www.cnbc.com/2023/09/25/pfizer-restarts-production-at-tornado-damaged-plant-in-north-carolina.html,2023-09-25 20:16:40,"Pfizer expects operations to fully resume by the end of the year, but it warned that supply of some medicines would be affected until at least mid-2024.",PFE,0.587597,-0.246067,Somewhat-Bearish
Conspiracy theories about FEMA's Oct. 4 emergency alert test spread online,https://apnews.com/article/fact-check-fema-test-graphene-oxide-covid-vaccine-517946413392,2023-09-25 18:47:00,CLAIM: An emergency broadcast system test on Oct. 4 will send a signal to cell phones nationwide in order to activate nanoparticles such as graphene oxide that have been introduced into people's bodies. AP'S ASSESSMENT: False.,PFE,0.042876,0.0,Neutral
Pfizer restarts production at tornado-hit North Carolina plant,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-restarts-production-tornado-hit-north-carolina-plant-2023-09-25/,2023-09-25 18:23:00,"Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",PFE,0.736438,-0.357132,Bearish
18 top public-relations experts CEOs scramble to hire in a crisis,https://www.businessinsider.com/meet-the-top-pr-people-in-crisis-communications-2023-9,2023-09-25 18:13:00,Meet the Top PR People in Crisis Communications - Business Insider ...,PFE,0.022431,0.074731,Neutral
Tornado-damaged Pfizer plant in North Carolina restarts production,https://apnews.com/article/tornado-pfizer-plant-medicine-rocky-mount-cf75a1b731559699c27cfb848d58c99b,2023-09-25 17:12:00,"ROCKY MOUNT, N.C. ( AP ) - A major Pfizer pharmaceutical plant in North Carolina that makes critical supplies for U.S. hospitals has restarted production about 10 weeks after it was by a tornado, the company announced Monday.",PFE,0.737032,-0.13527,Neutral
The Surprise That Prompted This Stock To Dump 52% Over Two Days,https://www.investors.com/news/technology/morf-stock-collapses-over-two-days-as-takeda-rivalry-slams-ulcerative-colitis-drug/,2023-09-25 16:45:00,MORF Stock Collapses 52% Over Two Days As Takeda Rivalry ... Investor's Business Daily ...,PFE,0.085324,0.0,Neutral
CDC Recommends Pfizer's  ( PFE )  RSV Jab to Protect Newborns,https://www.zacks.com/stock/news/2154937/cdc-recommends-pfizers-pfe-rsv-jab-to-protect-newborns,2023-09-25 13:38:00,"Pfizer's (PFE) Abrysvo has been recommended by the CDC for preventing RSV in infants by immunizing pregnant women, during weeks 32-36 of pregnancy.",PFE,0.373751,0.073507,Neutral
"The Zacks Analyst Blog Highlights Pfizer, Merck and AstraZeneca",https://www.zacks.com/stock/news/2154894/the-zacks-analyst-blog-highlights-pfizer-merck-and-astrazeneca,2023-09-25 12:55:00,"Pfizer, Merck and AstraZeneca are part of the Zacks top Analyst Blog.",PFE,0.257805,0.044915,Neutral
Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference,https://www.globenewswire.com/news-release/2023/09/25/2748498/36461/en/Voyager-Therapeutics-to-Present-at-the-Chardan-Genetic-Medicines-Conference.html,2023-09-25 11:00:00,"CAMBRIDGE, Mass., Sept. 25, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( Nasdaq: VYGR ) , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that Chief Executive Officer Alfred W.",PFE,0.136888,0.027325,Neutral
Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference - Voyager Therapeutics  ( NASDAQ:VYGR ) ,https://www.benzinga.com/pressreleases/23/09/g34857476/voyager-therapeutics-to-present-at-the-chardan-genetic-medicines-conference,2023-09-25 11:00:00,"CAMBRIDGE, Mass., Sept. 25, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. VYGR, a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that Chief Executive Officer Alfred W.",PFE,0.130926,0.026641,Neutral
"Greece, Battered a Decade Ago, Is Booming",https://www.nytimes.com/2023/09/25/business/greece-economy-eurozone.html,2023-09-25 04:01:25,"Paris Skouros pointed toward the sky outside his office in Athens on a recent weekday. In the past six months, four high-rises had sprung up, built by Greek and international builders to be sold for use as tourist rentals, foreign real estate investments and company offices.",PFE,0.057837,-0.047001,Neutral
The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories ... - PR Newswire,https://www.prnewswire.com/news-releases/the-thyroid-gland-disorder-treatment-market-to-grow-by-usd-868-87-million-from-2022-to-2027--abbott-laboratories-abbvie-inc-alvogen-iceland-ehf-and-more-among-key-companies--technavio-301936306.html,2023-09-25 02:15:00,The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories ... PR ...,PFE,0.077845,0.027652,Neutral
Goldman Sachs Remains a Buy on Pfizer  ( PFE ) ,https://markets.businessinsider.com/news/stocks/goldman-sachs-remains-a-buy-on-pfizer-pfe-1032651303,2023-09-24 20:55:57,Goldman Sachs Remains a Buy on ...,PFE,0.791876,0.192745,Somewhat-Bullish
"Consumer Healthcare Market to grow by USD 189.13 billion from 2022 to 2027, North America to account for 33% of ... - PR Newswire",https://www.prnewswire.com/news-releases/consumer-healthcare-market-to-grow-by-usd-189-13-billion-from-2022-to-2027--north-america-to-account-for-33-of-market-growth--technavio-301935802.html,2023-09-24 20:35:00,"Consumer Healthcare Market to grow by USD 189.13 billion from 2022 to 2027, North America to account for 33% of ... PR ...",PFE,0.052918,0.0,Neutral
"Safety Sectors For 2024: Yields Up To 6% In Healthcare, Staples",https://www.forbes.com/sites/brettowens/2023/09/24/safety-sectors-for-2024-yields-up-to-6-in-healthcare-staples/,2023-09-24 13:51:00,Worried that the Federal Reserve is driving our economy off a cliff? I've got two words for you: Drugs 'n diapers.,PFE,0.291297,0.162256,Somewhat-Bullish
"Dietary Supplements Market to grow by USD 61.4 billion between 2022 to 2027, Increasing adoption of healthy eating ... - PR Newswire",https://www.prnewswire.com/news-releases/dietary-supplements-market-to-grow-by-usd-61-4-billion-between-2022-to-2027--increasing-adoption-of-healthy-eating-habits-is-notably-driving-the-dietary-supplements-market---technavio-301935773.html,2023-09-24 01:30:00,"Dietary Supplements Market to grow by USD 61.4 billion between 2022 to 2027, Increasing adoption of healthy eating ... PR ...",PFE,0.05654,0.015,Neutral
Is lockdown or vaccination behind the drop in Covid deaths?,https://theweek.com/952540/is-lockdown-or-vaccination-behind-drop-in-covid-deaths,2023-09-23 01:40:39,A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek. You will receive a verification email shortly. There was a problem. Please refresh the page and try again.,PFE,0.065957,-0.029173,Neutral
Innovative Gelatin Capsules Transforming Pharmaceutical Industry: A Look into the Future,https://www.prnewswire.com/news-releases/innovative-gelatin-capsules-transforming-pharmaceutical-industry-a-look-into-the-future-301936082.html,2023-09-22 21:45:00,"DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The ""Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Source, By Function, By End Use, By Regions, Segment Forecast, 2023-2032"" report has been added to ResearchAndMarkets.com's offering.",PFE,0.060236,-0.055999,Neutral
"As Covid-19 hospitalizations climb, rates among seniors and children raise concern",https://edition.cnn.com/2023/09/22/health/covid-hospitalizations-seniors-kids-vaccines/index.html,2023-09-22 21:34:00,"Covid-19 hospitalizations have been on the rise in the United States for months, with weekly admissions now more than triple what they were two months ago. Seniors have the highest rates of Covid hospitalizations by far, but hospitalizations among children - especially among those younger than 5 ...",PFE,0.030759,0.065068,Neutral
"As Covid-19 hospitalizations climb, rates among seniors and children raise concern",https://www.cnn.com/2023/09/22/health/covid-hospitalizations-seniors-kids-vaccines/index.html,2023-09-22 21:34:00,"Covid-19 hospitalizations have been on the rise in the United States for months, with weekly admissions now more than triple what they were two months ago. Seniors have the highest rates of Covid hospitalizations by far, but hospitalizations among children - especially among those younger than 5 ...",PFE,0.030759,0.065068,Neutral
"Global Dermatology Drugs Market Set to Skyrocket, Anticipated Valuation of $50.47 Billion by 2032",https://www.prnewswire.com/news-releases/global-dermatology-drugs-market-set-to-skyrocket-anticipated-valuation-of-50-47-billion-by-2032--301936081.html,2023-09-22 21:30:00,"DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The ""Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area, By Drug Class, By Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2023-2032"" report has been added to ResearchAndMarkets.com's ...",PFE,0.060541,-0.056,Neutral
"WW International Shares Jump On BCBS Michigan's Revised Authorization For Wegovy, Other Weight Loss Drugs - WW International  ( NASDAQ:WW ) , Novo Nordisk  ( NYSE:NVO ) ",https://www.benzinga.com/general/biotech/23/09/34832242/ww-international-shares-jump-on-bcbs-michigans-revised-authorization-for-wegovy-other-weight-loss,2023-09-22 20:25:54,Shares of WW International Inc WW spiked as much as 15% on Friday after Blue Cross Blue Shield of Michigan and Blue Care Network announced changes to the prior authorization coverage criteria for certain brand-name weight loss medications.,PFE,0.07887,0.065377,Neutral
"More than 75,000 Kaiser Permanente workers threaten strike if labor agreement not reached",https://www.cnbc.com/2023/09/22/kaiser-permanente-workers-threaten-strike.html,2023-09-22 20:07:50,Kaiser Permanente is the largest nonprofit health-care organization in the U.S. serving nearly 13 million patients.,PFE,0.088147,-0.182261,Somewhat-Bearish
CDC Panel Recommends RSV Vaccine For Some Expectant Mothers,https://www.forbes.com/sites/anafaguy/2023/09/22/cdc-panel-recommend-rsv-vaccine-for-some-expectant-mothers/,2023-09-22 20:07:25,"RSV is one of the leading causes of hospitalizations among infants in the U.S., according to the CDC.",PFE,0.234684,0.303724,Somewhat-Bullish
Pfizer maternal RSV vaccine recommended by CDC advisers,https://www.marketwatch.com/story/pfizer-maternal-rsv-vaccine-recommended-by-cdc-advisors-25d7e6ad,2023-09-22 20:02:00,New shot aims to protect babies from a leading cause of hospitalization.,PFE,0.465901,0.365773,Bullish
CDC vaccine advisers vote to recommend first maternal vaccine to protect newborns from RSV,https://www.cnn.com/2023/09/22/health/rsv-vaccine-infants-pfizer-cdc/index.html,2023-09-22 19:29:00,CDC vaccine advisers vote to recommend first maternal vaccine to protect newborns from ...,PFE,0.145672,0.028002,Neutral
US CDC panel backs Pfizer's maternal RSV vaccine to protect infants,https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-panel-weighs-use-pfizers-maternal-rsv-vaccine-protect-infants-2023-09-22/,2023-09-22 19:05:00,"[1/3] A child suffering from an RSV infection at the pediatric intensive care unit at the Asklepios Clinic in Sankt Augustin, Germany, December, 6, 2022. REUTERS/Benjamin Westhoff/File Photo Acquire Licensing Rights Sept 22 ( Reuters ) - Advisers to the U.S.",PFE,0.067347,0.0,Neutral
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants,https://www.cnbc.com/2023/09/22/rsv-vaccine-cdc-advisors-recommend-pfizer-maternal-shot-for-infants-.html,2023-09-22 18:57:01,CDC Director Mandy Cohen still needs to sign off on that recommendation before mothers can receive Pfizer's shot to protect their infants from RSV.,PFE,0.203729,0.022611,Neutral
New Covid Vaccine Rollout Is Slowed by Insurance and Supply Snags,https://www.nytimes.com/2023/09/22/well/covid-vaccine-booster-insurance.html,2023-09-22 17:49:31,New Covid Vaccines Hit Insurance Snags: What to Do if Yours Gets Denied The New York Times ...,PFE,0.047371,0.147645,Neutral
PFE: Pfizer Inc.  ( PFE )  - Buy or Hold Analysis on This Pharma Stock,https://stocknews.com/news/pfe-nvs-nvo-snphy-pfizer-inc-pfe-buy-or-hold-analysis-on-this/,2023-09-22 16:57:19,"Pfizer Inc. ( PFE ) has reported a decline in revenue this year, as sales of its COVID-related products have started to fall.",PFE,0.520971,0.127195,Neutral
Explainer: What you need to know about RSV and the new vaccines,https://www.reuters.com/business/healthcare-pharmaceuticals/what-you-need-know-about-rsv-new-vaccines-2023-09-22/,2023-09-22 16:29:00,Sept 22 ( Reuters ) - Advisers to the U.S. Centers for Disease Control and Prevention ( CDC ) are meeting on Friday to discuss recommendations for use of the first vaccine for respiratory syncytial virus ( RSV ) approved for pregnant women to protect their babies.,PFE,0.06623,0.153206,Somewhat-Bullish
We Can Finally Do Something About the Third 'Tripledemic' Virus,https://www.theatlantic.com/health/archive/2023/09/tripledemic-virus-rsv-vaccine/675417/,2023-09-22 16:11:08,"Every fall, when the air turns chilly and the leaves red, pediatric ICUs begin preparing for the onslaught of the virus known as RSV. Not flu, not COVID, but RSV, or respiratory syncytial virus, is the No. 1 reason babies are hospitalized, year after year.",PFE,0.084622,0.027121,Neutral
Biopharma Co. Adds CTO to Team,https://www.investorideas.com/news/2023/biotech/09221DiaMedica-Therapeutics.asp,2023-09-22 15:48:58,"September 22, 2023 ( Investorideas.com Newswire ) This newest member brings with him extensive experience in protein development and manufacturing, noted an Oppenheimer report.",PFE,0.102449,0.140431,Neutral
Summer's Over: Here Are The Stock Market's Most Notable Winners And Losers,https://www.forbes.com/sites/dereksaul/2023/09/22/summers-over-here-are-the-stock-markets-most-notable-winners-and-losers/,2023-09-22 14:42:59,"The ""magnificent seven"" big tech stocks including Apple and Nvidia lost $13 in market value this summer.",PFE,0.089797,0.0376,Neutral
Seagen Pops After Scoring A 'Must-Win' For Its $43 Billion Pfizer Takeover,https://www.investors.com/news/technology/sgen-stock-pops-after-scoring-a-must-win-for-its-pfizer-takeover/,2023-09-22 13:30:00,Seagen Pops After Scoring A 'Must-Win' For Its $43 Billion Pfizer ... Investor's Business Daily ...,PFE,0.401331,0.011197,Neutral
"Pharma Stock Roundup: EU Nod to PFE's Litfulo, FDA Priority Tag to MRK Applications",https://www.zacks.com/stock/news/2154134/pharma-stock-roundup-eu-nod-to-pfes-litfulo-fda-priority-tag-to-mrk-applications,2023-09-22 13:21:00,The European Commission approves Pfizer's (PFE) Litfulo for severe alopecia areata. FDA gives priority tag to Merck's (MRK) supplemental applications for Welireg and Keytruda.,PFE,0.162802,0.043157,Neutral
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination,https://www.globenewswire.com/news-release/2023/09/22/2747998/0/en/Conduit-Pharmaceuticals-and-Murphy-Canyon-Acquisition-Corp-Announce-Completion-of-Business-Combination.html,2023-09-22 13:01:00,"SAN DIEGO, Sept. 22, 2023 ( GLOBE NEWSWIRE ) -- Conduit Pharmaceuticals Limited ( ""Conduit Pharmaceuticals"" ) , a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., a special purpose ...",PFE,0.033515,0.031801,Neutral
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination - Murphy Canyon Acquisition  ( NASDAQ:MURF ) ,https://www.benzinga.com/pressreleases/23/09/g34822750/conduit-pharmaceuticals-and-murphy-canyon-acquisition-corp-announce-completion-of-business-combina,2023-09-22 13:01:00,"SAN DIEGO, Sept. 22, 2023 ( GLOBE NEWSWIRE ) -- Conduit Pharmaceuticals Limited ( ""Conduit Pharmaceuticals"" ) , a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., a special purpose ...",PFE,0.032736,0.031677,Neutral
Glioma Treatment Market worth $8.29 Billion by 2030 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/09/g34822634/glioma-treatment-market-worth-8-29-billion-by-2030-exclusive-report-by-the-insight-partners,2023-09-22 12:54:42,"Pune, India, Sept. 22, 2023 ( GLOBE NEWSWIRE ) -- Glioma is a condition that covers a broad category of brain and spinal cord tumors that concern the glial cells in the brain function and can be fatal depending on the location and severity of the tumor.",PFE,0.023418,0.087173,Neutral
Moderna Is Expecting Massive Growth Over the Next Decade. Is the Stock a No-Brainer Buy?,https://www.fool.com/investing/2023/09/22/moderna-is-expecting-massive-growth-over-the-next/,2023-09-22 12:45:00,"The stock has been struggling this year, but could things soon be getting brighter for Moderna?",PFE,0.056143,0.020025,Neutral
"FISH Imaging Systems Market - 7.3% CAGR for Fluorescence In-Situ Hybridization Imaging Systems Industry worth $1.9Bn, Globally, by 2030 - The Insight Partners",https://www.benzinga.com/pressreleases/23/09/g34821672/fish-imaging-systems-market-7-3-cagr-for-fluorescence-in-situ-hybridization-imaging-systems-indust,2023-09-22 12:36:17,"Pune, India, Sept. 22, 2023 ( GLOBE NEWSWIRE ) -- According to our recent research study on ""Fluorescence In-Situ Hybridization ( FISH ) Imaging Systems Market Size and Forecasts ( 2020 - 2030 ) , Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product ( ...",PFE,0.028388,0.123399,Neutral
Providers struggle to get latest Covid shots into arms amid early supply issues,https://www.cnbc.com/2023/09/21/covid-vaccine-boosters-some-appointments-canceled-amid-supply-issues.html,2023-09-21 21:39:11,"Some Americans are having Covid vaccine appointments canceled or finding a pharmacy doesn't have a shot for them, as the U.S. tries an unprecedented rollout.",PFE,0.083251,0.180448,Somewhat-Bullish
"Chronic Lower Back Pain Market to Showcase Tremendous Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - Eli Lilly, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG",https://www.prnewswire.com/news-releases/chronic-lower-back-pain-market-to-showcase-tremendous-growth-by-2032-predicts-delveinsight--key-companies-to-look-out---eli-lilly-camurus-braeburn-inc-scilex-holding-mesoblast-limited-anges-mg-301934365.html,2023-09-21 21:01:00,"Chronic Lower Back Pain Market to Showcase Tremendous Growth by 2032, Predicts DelveInsight | Key Companies to ... PR ...",PFE,0.02275,0.014186,Neutral
FTC sues Texas anesthesiology provider to bust monopoly,https://www.cnbc.com/2023/09/21/ftc-sues-texas-anesthesiology-provider-to-bust-monopoly.html,2023-09-21 20:12:39,"The Federal Trade Commission sued U.S. Anesthesia Partners, alleging the company has established monopoly power in key Texas health-care markets.",PFE,0.099476,-0.187479,Somewhat-Bearish
Booking a COVID-19 vaccine? Some are reporting canceled appointments or insurance issues,https://apnews.com/article/covid-vaccine-delays-cdc-moderna-pfizer-ba66d06cbcc31ba4b22d60e93d3d5024,2023-09-21 20:07:00,"MILWAUKEE ( AP ) - Some people seeking the newest COVID-19 vaccine are running into high demand, insurance headaches and supply delays coast to coast. Millions of the have shipped out since the Centers for Disease Control and Prevention signed off on them last week for ages 6 months and up.",PFE,0.224903,0.03613,Neutral
Covid Drug Paxlovid Now Less Effective Than In Early Trials-But It's Still Great At Preventing Death,https://www.forbes.com/sites/willskipworth/2023/09/21/covid-drug-paxlovid-now-less-effective-than-in-early-trials-but-its-still-great-at-preventing-death/,2023-09-21 18:33:14,"The study found Paxlovid is now less effective at keeping patients out of the hospital, but still remains highly effective at stopping death.",PFE,0.109956,-0.009486,Neutral
3 Bargain Stocks to Buy in a Market That's Priced for Perfection,https://www.fool.com/investing/2023/09/21/3-bargain-stocks-to-buy-in-a-market-thats-priced-f/,2023-09-21 17:54:00,Many stocks have nosebleed valuations. But not these.,PFE,0.362065,0.068748,Neutral
"Biotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down",https://www.zacks.com/stock/news/2153765/biotech-stock-roundup-gsks-drug-approval-mrnas-vaccine-news-ptct-spry-down,2023-09-21 14:43:00,Regulatory updates from GSK and Moderna (MRNA) are in focus in the biotech sector.,PFE,0.04882,0.0,Neutral
2 Dividend Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/09/21/2-dividend-growth-stocks-to-buy-right-now/,2023-09-21 13:37:00,"A wise man once said, be greedy when others are fearful.",PFE,0.225321,0.010819,Neutral
Big pharma can't get enough of one class of cancer drugs,https://www.economist.com/business/2023/09/21/big-pharma-cant-get-enough-of-one-class-of-cancer-drugs,2023-09-21 12:51:46,A spate of dealmaking suggests high expectations for antibody-drug conjugates ...,PFE,0.0699,-0.026247,Neutral
"You can get more free Covid-19 tests mailed to your door, starting Monday-here's how",https://www.cnbc.com/2023/09/21/how-to-get-more-free-covid-19-tests-mailed-to-your-door.html,2023-09-21 12:00:01,"With Covid-19 cases rising again, the federal government is brining back one tool to help mitigate the spread of illness.",PFE,0.100729,0.021698,Neutral
Valneva's half-year loss narrows on strong travel vaccine demand,https://www.reuters.com/markets/europe/valnevas-half-year-loss-narrows-strong-travel-vaccine-demand-2023-09-21/,2023-09-21 05:47:54,"Valneva logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights Sept 21 ( Reuters ) - French vaccine maker Valneva ( VLS.PA ) on Thursday reported a smaller half-year loss, as a rebound in global tourism boosted sales of ...",PFE,0.157483,0.0,Neutral
Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates,https://www.globenewswire.com/news-release/2023/09/21/2746950/0/en/Valneva-Reports-Half-Year-2023-Financial-Results-and-Provides-Corporate-Updates.html,2023-09-21 05:00:00,Product sales more than doubled in the first half of 2023 to €69.7 million compared to ...,PFE,0.100413,0.092483,Neutral
DeSantis says he won't support Covid vaccine funding if elected president | Politics,https://www.cnn.com/2023/09/20/politics/desantis-covid-vaccine-funding/index.html,2023-09-21 03:04:00,DeSantis says he won't support Covid vaccine funding if elected president ...,PFE,0.053992,-0.003,Neutral
"Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means? - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/09/34769704/updated-covid-vaccine-us-rollout-hit-by-insurance-coverage-delays-what-it-means,2023-09-20 18:15:25,"As the U.S. launches a fresh round of updated COVID-19 vaccines, some patients encounter hurdles in obtaining prompt health insurance coverage for their shots. Under the recommendation of U.S. regulators, Pfizer Inc PFE/ BioNTech SE BNTX and Moderna Inc's MRNA new vaccine doses have become ...",PFE,0.2872,0.271426,Somewhat-Bullish
Check Out What Whales Are Doing With PFE - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/09/34769392/check-out-what-whales-are-doing-with-pfe,2023-09-20 17:17:14,"A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 80% of the investors opened trades with bullish expectations and ...",PFE,0.696319,0.302684,Somewhat-Bullish
Meet the top FT 20 in-house legal leaders,https://www.ft.com/content/4487451a-3934-4386-887c-5a5fa1e8c899,2023-09-20 17:00:32,"In the past few months the Business Legal Leaders series has addressed various challenges facing in-house lawyers. Among them, geopolitical uncertainty, protecting their businesses from potential cyber attacks, and navigating evolving environmental, social and governance-related regulations.",PFE,0.014171,0.117474,Neutral
World Leaders in Proteomics and Genomics to Convene at the 2nd International Top-Down Proteomics Symposium,https://www.benzinga.com/pressreleases/23/09/g34766426/world-leaders-in-proteomics-and-genomics-to-convene-at-the-2nd-international-top-down-proteomics-s,2023-09-20 15:11:48,"Building the bridge from genotype to phenotype, the Symposium will feature scientific leaders creating cutting edge technologies and approaches that are ushering in the era of proteoform systems biology & medicine and paving the way for the Human Proteoform Project.",PFE,0.087503,0.16848,Somewhat-Bullish
Fall Covid shot rollout gets off to a bumpy start as some patients see insurance delays,https://www.cnbc.com/2023/09/20/covid-vaccine-rollout-some-patients-see-insurance-coverage-delays.html,2023-09-20 14:56:26,The reports are fueling confusion among insured patients about whether they can still access Covid shots for free - just as cases tick up across the country.,PFE,0.13347,0.096259,Neutral
"With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?",https://www.fool.com/investing/2023/09/20/with-new-covid-19-boosters-in-tow-which-is-the-bet/,2023-09-20 11:45:00,All three companies should benefit from increased COVID-19 booster sales.,PFE,0.29485,0.221283,Somewhat-Bullish
"IV Bags Market Predicted to Reach USD 1.5 billion by 2032, Expanding at a CAGR of 5.8%: TMR Report",https://www.benzinga.com/pressreleases/23/09/g34754339/iv-bags-market-predicted-to-reach-usd-1-5-billion-by-2032-expanding-at-a-cagr-of-5-8-tmr-report,2023-09-20 09:24:27,"Wilmington, Delaware, United States, Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global IV bags market is projected to flourish at a CAGR of 5.8% from 2022 to 2032. As per the report published by TMR, a valuation of US$ 1.5 billion is anticipated for the market in ...",PFE,0.039614,-0.065615,Neutral
Pfizer  ( PFE )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2152742/pfizer-pfe-gains-as-market-dips-what-you-should-know,2023-09-19 21:45:21,"Pfizer (PFE) closed the most recent trading day at $33.99, moving +1.04% from the previous trading session.",PFE,0.556576,0.178949,Somewhat-Bullish
"Most Ukrainian companies are fully operational after 18 months of war, Kyiv-based American Chamber of Commerce",https://www.marketwatch.com/story/most-ukrainian-companies-are-fully-operational-after-18-months-of-war-kyiv-based-american-chamber-of-commerce-98f17821,2023-09-19 15:51:00,"Demining, IT and digital solutions, infrastructure and logistics, financial services, manufacturing and construction are attracting investment ...",PFE,0.127795,0.0,Neutral
Uninsured Americans can still get free Covid boosters - here's how to find them,https://www.cnbc.com/2023/09/19/covid-vaccine-boosters-uninsured-americans-can-find-free-moderna-pfizer-shots.html,2023-09-19 15:19:53,The new Covid vaccines from Pfizer and Moderna began to roll out last week after the CDC recommended them to all Americans ages six months and up.,PFE,0.158519,0.039436,Neutral
Pfizer Stock: Bear vs. Bull,https://www.fool.com/investing/2023/09/19/pfizer-stock-bear-vs-bull/,2023-09-19 14:07:00,The pharma giant's future financial performance is a matter of debate.,PFE,0.334008,0.343354,Somewhat-Bullish
"Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/09/34730567/amazon-poaches-microsofts-product-chief-google-and-dod-team-up-for-ai-powered-microscope-to-identify,2023-09-19 14:01:51,"After Microsoft Corp MSFT Chief Product Officer Panos Panay confirmed that he is leaving the software giant, a report said he is shifting base to Amazon Inc AMZN. Panay said in a post on X, formerly Twitter, ""After 19 incredible years at Microsoft, I've decided to turn the page and write the next ...",PFE,0.079921,0.0,Neutral
Pfizer's  ( PFE )  Alopecia Areata Drug Litfulo Receives EU Nod,https://www.zacks.com/stock/news/2152472/pfizers-pfe-alopecia-areata-drug-litfulo-receives-eu-nod,2023-09-19 13:37:00,Pfizer (PFE) gets marketing authorization in the EU for Litfulo to treat adults and adolescent patients aged 12 years and older with severe alopecia areata.,PFE,0.510144,0.384596,Bullish
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss,https://www.fool.com/investing/2023/09/19/2-cutting-edge-gene-editing-stocks-that-you-dont/,2023-09-19 13:37:00,"The gene-editing market is moving fast, and it pays to get to know some of these companies.",PFE,0.050254,0.079631,Neutral
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100 - Maravai LifeSciences  ( NASDAQ:MRVI ) ,https://www.benzinga.com/pressreleases/23/09/g34729414/maravai-lifesciences-chief-innovation-officer-kate-broderick-named-to-2023-pharmavoice-100,2023-09-19 13:31:08,"SAN DIEGO, Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- Maravai LifeSciences, Inc. MRVI, a global provider of life science reagents and services to researchers and biotech innovators, today announced that Chief Innovation Officer Kate Broderick, PhD, has been named to the 2023 PharmaVoice 100 list, which ...",PFE,0.085324,0.155137,Somewhat-Bullish
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100,https://www.globenewswire.com/news-release/2023/09/19/2745757/0/en/Maravai-LifeSciences-Chief-Innovation-Officer-Kate-Broderick-Named-to-2023-PharmaVoice-100.html,2023-09-19 13:31:00,"SAN DIEGO, Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- Maravai LifeSciences, Inc. ( NASDAQ: MRVI ) , a global provider of life science reagents and services to researchers and biotech innovators, today announced that Chief Innovation Officer Kate Broderick, PhD, has been named to the 2023 PharmaVoice ...",PFE,0.087824,0.157084,Somewhat-Bullish
"European Commission Approves GSK/Pfizer-Backed HIV Infection Prevention Drug - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/09/34727088/european-commission-approves-gskpfizer-backed-hiv-infection-prevention-drug,2023-09-19 13:20:36,The European Commission has approved ViiV Healthcare's Apretude ( cabotegravir long-acting ( LA ) injectable and tablets ) for HIV prevention.,PFE,0.269776,0.0,Neutral
"Cramer Says 'I Can't Tell You To Sell It Here,' As Massive Pharma Stock Falls 34% So Far This Year: 'It's Just A Very Good Company' - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/09/34718626/cramer-says-i-cant-tell-you-to-sell-it-here-as-massive-pharma-stock-falls-34-so-far-this,2023-09-19 12:25:23,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Paycom Software, Inc. PAYC is ""one of those fintech companies. The fintechs are going out of fashion.""",PFE,0.497391,-0.05529,Neutral
Torrent in talks with Apollo to borrow up to $1 billion for Cipla bid: Report,https://www.financialexpress.com/healthcare/news-healthcare/torrent-in-talks-with-apollo-to-borrow-up-to-1-billion-for-cipla-bid/3248460/,2023-09-19 09:37:14,"Pharma major Torrent Pharmaceutical is in preliminary talks with Apollo Global Management to secure a loan of up to $1 billion. Reportedly, this loan will help to fund a planned bid for Cipla.",PFE,0.086245,0.057481,Neutral
"You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10",https://www.fool.com/investing/2023/09/19/high-risk-high-reward-stocks-for-10-dollars/,2023-09-19 09:30:00,These stocks look cheap right now -- if the companies can meet their goals.,PFE,0.050894,-0.061,Neutral
Pfizer expects 24 percent of Americans will get new Covid boosters,https://www.financialexpress.com/healthcare/covid-19/pfizer-expects-24-percent-of-americans-will-get-new-covid-boosters/3248414/,2023-09-19 09:11:30,"Pfizer Inc. is forecasting 24 percent of the US population recommended to take newly approved Covid-19 vaccinations will decide to roll up their sleeves, representing a slight increase in takeup from the previous round of boosters.",PFE,0.491878,0.333503,Somewhat-Bullish
Moderna faces tougher competition in its next chapter: Lisa Jarvis,https://www.financialexpress.com/healthcare/pharma-healthcare/moderna-faces-tougher-competition-in-its-next-chapter-lisa-jarvis/3248401/,2023-09-19 08:59:03,"Moderna Inc. made a pitch to investors this week at its annual R&D day that the unprecedented success of its Covid vaccine wasn't a one-off, and the company is well on the way to becoming a big biotech contender.",PFE,0.083833,0.053688,Neutral
Torrent in talks with Apollo to borrow up to $1 bn for Cipla bid: Reports,https://www.business-standard.com/companies/news/torrent-in-talks-with-apollo-to-borrow-up-to-1-bn-for-cipla-bid-reports-123091900427_1.html,2023-09-19 08:13:15,"India's Torrent Pharmaceutical is in preliminary talks with Apollo Global Management to secure a loan of up to $1 billion to help fund a planned bid for Cipla, two people briefed on the discussions said. Torrent is hoping to secure roughly $3 billion to $4 billion in financing for the bid for its ...",PFE,0.089129,0.057821,Neutral
"India's Torrent in talks with Apollo to borrow up to $1 bln for Cipla bid, sources say",https://www.reuters.com/markets/deals/indias-torrent-talks-with-apollo-borrow-up-1-bln-cipla-bid-sources-say-2023-09-19/,2023-09-19 07:50:00,"Employees and security staff work at the reception area of Cipla at its headquarters in Mumbai, India June 17, 2015. REUTERS/Danish Siddiqui/File Photo Acquire Licensing Rights",PFE,0.061949,0.054003,Neutral
2 Stocks That Sank Hard on Monday,https://www.fool.com/investing/2023/09/18/2-stocks-that-sank-hard-on-monday/,2023-09-18 22:49:00,"Investors were generally in wait-and-see mode, but not with certain individual stocks.",PFE,0.146025,0.052411,Neutral
TIME MAGAZINE NAMED GRUPO BIMBO AS THE BEST MEXICAN COMPANY IN THE WORLD - PR Newswire,https://www.prnewswire.com/news-releases/time-magazine-named-grupo-bimbo-as-the-best-mexican-company-in-the-world-301931166.html,2023-09-18 22:26:00,TIME MAGAZINE NAMED GRUPO BIMBO AS THE BEST MEXICAN COMPANY IN THE WORLD PR ...,PFE,0.150592,0.224322,Somewhat-Bullish
TIME MAGAZINE NAMED GRUPO BIMBO AS THE BEST MEXICAN COMPANY IN THE WORLD - Canada NewsWire,https://www.newswire.ca/news-releases/time-magazine-named-grupo-bimbo-as-the-best-mexican-company-in-the-world-831520347.html,2023-09-18 22:26:00,TIME MAGAZINE NAMED GRUPO BIMBO AS THE BEST MEXICAN COMPANY IN THE WORLD Canada ...,PFE,0.144275,0.218898,Somewhat-Bullish
"Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte",https://www.prnewswire.com/news-releases/head-and-neck-squamous-cell-carcinoma-market-to-witness-upsurge-in-growth-by-2032-assesses-delveinsight--key-companies-in-the-market---pfizer-merck-eisai-astrazeneca-innate-roche-glaxosmithkline-beigene-io-biotech-incyt-301930322.html,2023-09-18 21:01:00,"Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key ... PR ...",PFE,0.023146,0.04357,Neutral
Why Moderna Stock Is Sinking Today - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/news/23/09/34700390/why-moderna-stock-is-sinking-today,2023-09-18 19:29:48,"Moderna, Inc. MRNA shares are trading lower Monday alongside other vaccine stocks amid a selloff after the sector gained amid rising cases. Weakness comes after Pfizer said it expects a 24% vaccination rate this year.",PFE,0.252987,-0.152432,Somewhat-Bearish
"Stocks making the biggest moves midday: Marathon Petroleum, Tesla, Moderna and more",https://www.cnbc.com/2023/09/18/stocks-making-biggest-midday-moves-marathon-tesla-moderna-and-more.html,2023-09-18 16:19:52,These are the stocks posting the largest moves in midday trading.,PFE,0.051551,0.058855,Neutral
Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now? - Takeda Pharmaceutical  ( NYSE:TAK ) ,https://www.benzinga.com/news/small-cap/23/09/34696172/is-this-250-year-old-japanese-big-pharma-giant-selling-for-half-price-right-now,2023-09-18 15:31:30,"When it comes to Big Pharma, Japan's Takeda Pharmaceutical Co Ltd TAK is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to dominate in treating niche illnesses.",PFE,0.083251,0.157318,Somewhat-Bullish
"First Human Clinical Trials Of A Potentially ""Game-Changing Broad Spectrum Antiviral"" Are Progressing Successfully - Drug Could Treat COVID, RSV And Many Other Respiratory Viruses - Nanoviricides  ( AMEX:NNVC ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/09/34688641/first-human-clinical-trials-of-a-potentially-game-changing-broad-spectrum-antiviral-are-progressi,2023-09-18 12:50:10,"As COVID cases begin to rise again, heralding the beginning of another COVID wave, new variants have appeared leading this wave. EG.5 ( ""Eris"" ) is currently in the majority in the U.S.A, but a very different variant, BA.2.86 ( ""Pirola"" ) is already rising in the number of cases.",PFE,0.118354,-0.069282,Neutral
"The Zacks Analyst Blog Highlights Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley",https://www.zacks.com/stock/news/2151790/the-zacks-analyst-blog-highlights-meta-platforms-walmart-johnson-johnson-pfizer-and-morgan-stanley,2023-09-18 12:03:00,"Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley are part of the Zacks top Analyst Blog.",PFE,0.147366,0.039994,Neutral
Germany kicks off autumn COVID vaccine campaign targeting high-risk groups,https://www.reuters.com/business/healthcare-pharmaceuticals/germany-kicks-off-autumn-covid-vaccine-campaign-targeting-high-risk-groups-2023-09-18/,2023-09-18 11:42:00,"[1/4] German Health Minister Karl Lauterbach gives a statement following his coronavirus disease ( COVID-19 ) booster vaccination at the military hospital in Berlin, Germany, September 18, 2023. REUTERS/Lisi Niesner Acquire Licensing Rights",PFE,0.126784,0.192073,Somewhat-Bullish
Pfizer expects 24% uptake of COVID vaccines in US - CFO,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-expects-24-uptake-covid-vaccines-us-cfo-2023-09-18/,2023-09-18 11:04:00,Pfizer expects 24% uptake of COVID vaccines in US ...,PFE,0.546745,0.156508,Somewhat-Bullish
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI's 100 Days Mission,https://www.globenewswire.com/news-release/2023/09/18/2744601/0/en/BioNTech-and-CEPI-Announce-Partnership-to-Advance-mRNA-Mpox-Vaccine-Development-and-Support-CEPI-s-100-Days-Mission.html,2023-09-18 10:45:00,"MAINZ, Germany, and OSLO, Norway, September 18, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"", ""the Company"" ) and the Coalition for Epidemic Preparedness Innovations ( CEPI ) today announced a strategic partnership to advance mRNA-based vaccine candidates with the development of BNT166 for the ...",PFE,0.018285,0.018942,Neutral
Is Franklin U.S. Low Volatility High Dividend Index ETF  ( LVHD )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2151659/is-franklin-us-low-volatility-high-dividend-index-etf-lvhd-a-strong-etf-right-now,2023-09-18 10:20:05,Smart Beta ETF report for ...,PFE,0.113329,0.059598,Neutral
Here Are 15 New Reasons to Be Bullish About Moderna Stock,https://www.fool.com/investing/2023/09/18/15-new-reasons-bullish-about-moderna-stock/,2023-09-18 09:15:00,"With its first big successes drawing to a close, new products are on the horizon.",PFE,0.060541,-0.043235,Neutral
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,2023-09-18 09:15:00,"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... PR ...",PFE,0.043108,0.0,Neutral
"India's Torrent Pharma in talks with CVC, Bain Capital for Cipla bid- sources",https://www.reuters.com/markets/deals/indias-torrent-pharma-talks-with-cvc-bain-capital-cipla-bid-sources-2023-09-18/,2023-09-18 09:04:00,"DELHI/MUMBAI, Sept 18 ( Reuters ) - India's Torrent Pharmaceuticals ( TORP.NS ) is in talks with private equity funds CVC Capital Partners and Bain Capital to raise up to $1.5 billion to bid for India's Cipla ( CIPL.NS ) , according to three sources with direct knowledge of the matter.",PFE,0.06697,-0.072675,Neutral
Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for ... - PR Newswire,https://www.prnewswire.com/news-releases/large-molecule-injectable-drugs-market-to-grow-by-usd-191-45-billion-from-2022-2027--north-america-to-account-for-45-of-market-growth---technavio-301929312.html,2023-09-18 08:35:00,Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for ... PR ...,PFE,0.052685,0.0,Neutral
Brigade Enterprises gains on picking up over 5 acres in Bengaluru for Rs 123 crore,https://www.moneycontrol.com/news/business/stocks/brigade-enterprises-gains-on-picking-up-over-5-acres-in-bengaluru-for-rs-123-crore-11383951.html,2023-09-18 04:10:20,The company will be developing a residential project on the land parcel with an overall development of nearly one million square feet with an overall revenue potential of around Rs 800 crore.,PFE,0.160633,-0.046151,Neutral
"Novavax's updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall",https://www.cnbc.com/2023/10/07/novavax-covid-vaccine-can-still-catch-up-to-pfizer-moderna-shots.html,2023-10-07 12:00:02,Novavax's Covid shot is arriving nearly three weeks after new jabs from Pfizer and Moderna reached Americans - but analysts aren't worried about that delay.,PFE,0.199584,0.008055,Neutral
This Could be Novavax's Big Opportunity,https://www.fool.com/investing/2023/10/07/this-could-be-novavaxs-big-opportunity/,2023-10-07 09:30:00,Novavax has lagged behind bigger rivals in the vaccine market.,PFE,0.361626,0.224074,Somewhat-Bullish
Kansas City Chiefs' Travis Kelce laughs off Aaron Rodgers' 'Mr. Pfizer' quip,https://www.cnn.com/2023/10/06/sport/travis-kelce-aaron-rodgers-nickname-swift-spt-intl/index.html,2023-10-06 21:58:00,"Travis Kelce has laughed off Aaron Rodgers' new nickname for the Kansas City Chiefs tight end after the injured New York Jets quarterback called him ""Mr. Pfizer"" during his weekly appearance on ESPN's ""The Pat McAfee Show.""",PFE,0.485711,0.38099,Bullish
Chiefs' Kelce: 'Just got to keep living' as relationship with Taylor Swift consumes spotlight,https://apnews.com/article/chiefs-kansas-city-kelce-e97f370dc8931de37cc0875dd53cf46d,2023-10-06 19:41:00,"KANSAS CITY, Mo. ( AP ) - Travis Kelce has long prided himself on his ability to compartmentalize and his professional life. That ability has been the past few weeks.",PFE,0.055621,0.037992,Neutral
Kaiser Permanente health workers threaten more strikes if demands not met,https://www.cnbc.com/2023/10/06/kaiser-permanente-health-workers-threaten-more-strikes-.html,2023-10-06 18:47:09,"More than 75,000 workers are currently on strike in California, Colorado, Washington and Oregon.",PFE,0.136113,-0.212177,Somewhat-Bearish
HAVAS HEALTH & YOU'S NETWORK OF AGENCIES TOOK HOME RECORD NUMBER OF WINS AT 2023 MM+M ... - PR Newswire,https://www.prnewswire.com/news-releases/havas-health--yous-network-of-agencies-took-home-record-number-of-wins-at-2023-mmm-awards-including-titanium-best-in-show-and-agency-entrepreneur-of-the-year-301949697.html,2023-10-06 15:34:00,HAVAS HEALTH & YOU'S NETWORK OF AGENCIES TOOK HOME RECORD NUMBER OF WINS AT 2023 MM+M ... PR ...,PFE,0.070935,0.207452,Somewhat-Bullish
ETFs in Focus on Exxon-Pioneer Deal Talks,https://www.zacks.com/stock/news/2161608/etfs-in-focus-on-exxon-pioneer-deal-talks,2023-10-06 14:35:00,"Exxon Mobil (XOM) is in talks to acquire Pioneer Natural (PXD). The acquisition, if successful, could be valued at approximately $60 billion, marking Exxon's biggest acquisition since its merger with Mobil Corp. in 1999.",PFE,0.045139,0.134109,Neutral
Better Growth Stock: Novo Nordisk vs. Pfizer,https://www.fool.com/investing/2023/10/06/better-growth-stock-novo-nordisk-vs-pfizer/,2023-10-06 13:45:00,Which of these two pharmaceutical giants should you add to your portfolio?,PFE,0.477827,0.373981,Bullish
Pharma Stock Roundup: LLY Offers to Buy POINT Biopharma & Other Updates,https://www.zacks.com/stock/news/2161488/pharma-stock-roundup-lly-offers-to-buy-point-biopharma-other-updates,2023-10-06 13:30:00,Eli Lilly (LLY) offers to buy POINT Biopharma for approximately $1.4 billion. Sanofi (SNY) partners with Teva for co-developing immunology candidate.,PFE,0.063763,-0.122104,Neutral
"What's Going On With Haleon  ( HLN )  Stock Today - Haleon  ( NYSE:HLN ) , GSK  ( NYSE:GSK ) ",https://www.benzinga.com/news/large-cap/23/10/35124638/gsk-cuts-stake-in-consumer-healthcare-business-haleon-raises-around-1b,2023-10-06 13:12:15,"GSK Plc GSK said it raised £885.6 million ( around $1.08 billion ) from selling some of its shares in Haleon Plc HLN, reducing its stake in the consumer-healthcare business to around 7.4%.",PFE,0.451494,0.062792,Neutral
Who are the 2023 Nobel Prize winners so far?,https://www.aljazeera.com/news/2023/10/6/who-are-the-2023-nobel-prize-winners-so-far,2023-10-06 11:41:05,"This year's laureates have opened doors for disease control, technological advancements and subversive literature. This week marks the announcement of Nobel Prizes for 2023. The six prizes recognise individuals and groups for their contributions to particular fields.",PFE,0.09402,0.056373,Neutral
3 Top Vanguard Mutual Funds to Buy Amid Market Uncertainty,https://www.zacks.com/stock/news/2161370/3-top-vanguard-mutual-funds-to-buy-amid-market-uncertainty,2023-10-06 11:35:00,"Invest in Vanguard mutual funds like VASVX, VWNDX and VSTCX to hedge your portfolio amid rising market volatility.",PFE,0.057767,0.052961,Neutral
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?,https://www.fool.com/investing/2023/10/06/did-moderna-just-jump-ahead-of-rivals/,2023-10-06 10:00:00,"Moderna, Pfizer, and Novavax all are working on combined vaccine candidates.",PFE,0.381255,0.183085,Somewhat-Bullish
"2 Nasdaq 100 Stocks That Are Surefire Buys in October, and 1 to Avoid Like the Plague",https://www.fool.com/investing/2023/10/06/2-nasdaq-100-stocks-buy-and-1-to-avoid-like-plague/,2023-10-06 09:21:00,"Two Nasdaq 100 components stand out as plain-as-day values, while another widely owned Nasdaq 100 stock may find it impossible to meet investors' lofty growth expectations.",PFE,0.029292,0.133784,Neutral
GSK raises $1.1 billion from Haleon stake sale,https://www.reuters.com/markets/deals/gsk-raises-886-mln-pounds-haleon-stake-sale-2023-10-06/,2023-10-06 08:04:42,"GSK ( GlaxoSmithKline ) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration Acquire Licensing Rights",PFE,0.252987,0.06669,Neutral
"Diffuse Cutaneous Systemic Sclerosis Market to Proliferate at a Considerable Growth Rate by 2032, Estimates DelveInsight | Leading Companies in the Market - Kyowa Kirin Acceleron, Cumberland, Horizon, CSL Behring, Seagen, Janssen",https://www.prnewswire.com/news-releases/diffuse-cutaneous-systemic-sclerosis-market-to-proliferate-at-a-considerable-growth-rate-by-2032-estimates-delveinsight--leading-companies-in-the-market---kyowa-kirin-acceleron-cumberland-horizon-csl-behring-seagen-janssen-301947923.html,2023-10-05 21:01:00,"Diffuse Cutaneous Systemic Sclerosis Market to Proliferate at a Considerable Growth Rate by 2032, Estimates ... PR ...",PFE,0.05133,0.016846,Neutral
"Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/10/35114073/small-biotech-promosome-drops-lawsuit-against-pfizer-biontech-in-covid-19-vaccine-patent-dispute,2023-10-05 19:04:32,"Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc PFE and BioNTech SE BNTX, of patent infringement related to messenger RNA technology. However, the financial terms of the agreement were not disclosed.",PFE,0.841282,-0.210998,Somewhat-Bearish
NVS: 3 Pharma Stocks With Potential to Outperform Pfizer Inc.  ( PFE )  in October,https://stocknews.com/news/nvs-pfe-zts-hznp-3-pharma-stocks-with-potential-to-outperform-pfizer-inc-pfe/,2023-10-05 18:14:10,NVS: 3 Pharma Stocks With Potential to Outperform Pfizer Inc. ( PFE ... ...,PFE,0.139426,0.125623,Neutral
Kaiser Permanente workers strike for second day after negotiations fail to reach labor contract,https://www.cnbc.com/2023/10/05/kaiser-permanente-workers-strike-continues-for-second-day.html,2023-10-05 16:35:49,The union coalition has described the work stoppage at Kaiser as the largest health-care worker strike in U.S. history.,PFE,0.126784,-0.204954,Somewhat-Bearish
LLY: Which Pharma Stock Has More Potential Gains This Month: Pfizer  ( PFE )  or Eli Lilly & Co.  ( LLY ) ?,https://stocknews.com/news/lly-pfe-dna-which-pharma-stock-has-more-potential-gains-this-month-pfizer/,2023-10-05 16:06:24,LLY: Which Pharma Stock Has More Potential Gains This Month ... ...,PFE,0.47672,0.330028,Somewhat-Bullish
Comparative Study: BioNTech And Industry Competitors In Biotechnology Industry - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/news/23/10/35112343/comparative-study-biontech-and-industry-competitors-in-biotechnology-industry,2023-10-05 16:00:47,"In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and industry followers. In this article, we will carry out an in-depth industry comparison, assessing BioNTech BNTX alongside its primary competitors in ...",PFE,0.067347,-0.004025,Neutral
What should Ireland's government do with a huge budget surplus?,https://www.economist.com/europe/2023/10/05/what-should-irelands-government-do-with-a-huge-budget-surplus,2023-10-05 12:47:55,"B offshore profits of global corporations, the Irish economy has long been prone to manic mood swings.",PFE,0.077593,-0.001041,Neutral
Fighting The Fed? Brace For Next Stock And Bond Battle,https://www.investors.com/etfs-and-funds/personal-finance/stock-market-investors-fighting-the-fed-brace-for-next-battle/,2023-10-05 11:00:00,"September lived up to its reputation as being the worst month for the stock market. Stocks tumbled for a second straight month, accelerating a downturn that is chipping away at fund investors' 2023 gains. Investors can only hope October turns around the selling.",PFE,0.06515,0.304148,Somewhat-Bullish
Can Moderna Achieve Its Most Ambitious Goal Yet?,https://www.fool.com/investing/2023/10/05/can-moderna-achieve-its-most-ambitious-goal-yet/,2023-10-05 09:30:00,Even the best of news has failed to boost Moderna shares in recent times.,PFE,0.054483,0.044999,Neutral
Why Novavax Stock Fell Today - Novavax  ( NASDAQ:NVAX ) ,https://www.benzinga.com/news/23/10/35095052/why-novavax-stock-fell-today,2023-10-04 23:22:24,"Novavax, Inc. NVAX shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated protein-based COVID-19 vaccine for people 12 and older.",PFE,0.439786,-0.152461,Somewhat-Bearish
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,2023-10-04 21:01:00,"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period ( 2019-2032 ) , Assesses ... PR ...",PFE,0.021778,-0.092267,Neutral
"Moderna's flu-Covid combo vaccine elicits 'strong' immune response in Phase 1/2 study, company says",https://www.cnn.com/2023/10/04/health/moderna-flu-covid-vaccine-trial-results/index.html,2023-10-04 16:53:42,"In a Phase 1/2 clinical trial, Moderna's combination vaccine appeared to elicit ""strong"" immune responses against both influenza and Covid-19 and was found to be safe, the company announced Wednesday.",PFE,0.066414,-0.019143,Neutral
"Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe - Pfizer, Inc. Common Stock  ( NYSE:PFE ) ",https://www.benzinga.com/markets/penny-stocks/23/10/35093169/mainz-biomed-continues-to-transform-early-cancer-detection-across-the-globe,2023-10-04 16:10:21,"While Pfizer Inc PFE and Moderna Inc MRNA are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated.",PFE,0.526707,-0.251526,Somewhat-Bearish
BNTX: 3 Biotech Stocks Offering Great Potential for Gains in October,https://stocknews.com/news/bntx-pbyi-plx-3-biotech-stocks-offering-great-potential-for-gains-in-october/,2023-10-04 15:29:22,"The biotechnology industry is flourishing due to accelerated progress in drug formulation, technological advancements, and solid governmental backing.",PFE,0.025596,0.106097,Neutral
Novavax  ( NVAX )  Up 8% on FDA Nod for Updated COVID Booster Jab,https://www.zacks.com/stock/news/2160224/novavax-nvax-up-8-on-fda-nod-for-updated-covid-booster-jab,2023-10-04 15:19:00,Novavax's (NVAX) updated COVID vaccine is authorized under emergency use for individuals aged 12 years and older. It is currently the only non-mRNA COVID vaccine available in the country.,PFE,0.350564,0.114288,Neutral
2 High-Yield Dividend Stocks to Buy in October,https://www.fool.com/investing/2023/10/04/2-high-yield-dividend-stocks-to-buy-in-october/,2023-10-04 15:00:00,These two high-yield dividend stocks are too cheap to ignore.,PFE,0.367865,0.278079,Somewhat-Bullish
Teva Hooks Immunology Powerhouse Sanofi In $1.5 Billion Deal,https://www.investors.com/news/technology/teva-stock-dives-after-inking-deal-for-inflammation-drug/,2023-10-04 14:47:00,Teva Stock Dives After Inking $1.5 Billion Deal For Inflammation Drug Investor's Business Daily ...,PFE,0.148426,0.0,Neutral
Moderna reports positive results for combination flu and COVID vaccine,https://www.marketwatch.com/story/moderna-reports-positive-results-for-combination-flu-and-covid-vaccine-de6cb204,2023-10-04 14:31:00,Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine against COVID-19 and flu on Wednesday.,PFE,0.264897,0.215505,Somewhat-Bullish
"Pfizer's Diversity Program Faces Legal Heat, Advocacy Group Revives Discrimination Case - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/large-cap/23/10/35087542/pfizers-diversity-program-faces-legal-heat-advocacy-group-revives-discrimination-case,2023-10-04 14:25:59,"Advocacy group Do No Harm has made a case before the New York-based 2nd U.S. Circuit Court of Appeals to resurrect its lawsuit against pharmaceutical giant Pfizer Inc PFE, claiming that Pfizer's fellowship program, designed to enhance diversity within the company, discriminates against white and ...",PFE,0.514619,0.225333,Somewhat-Bullish
Emerson Forms Life Sciences Executive Board to Advance One-Click Technology Transfer Initiative - PR Newswire,https://www.prnewswire.com/news-releases/emerson-forms-life-sciences-executive-board-to-advance-one-click-technology-transfer-initiative-301945784.html,2023-10-04 14:00:00,Emerson Forms Life Sciences Executive Board to Advance One-Click Technology Transfer Initiative PR ...,PFE,0.129284,0.193358,Somewhat-Bullish
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares - Novartis  ( NYSE:NVS ) ,https://www.benzinga.com/markets/penny-stocks/23/10/35089590/cancer-drug-maker-3d-medicines-inc-trading-higher-after-company-announces-it-will-repurchase,2023-10-04 13:49:03,"3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock. 3D Pharma said in a statement that it would buy back up to 25,605,700 shares over the next 12 months.",PFE,0.220809,0.0,Neutral
2 Magnificent Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/10/04/2-magnificent-growth-stocks-to-buy-right-now/,2023-10-04 13:25:00,These two biotech stocks could be big winners for patient investors.,PFE,0.058615,0.041001,Neutral
"Wall Street Says Ginkgo Bioworks Stock Will Soar 132%, and Cathie Wood's Buying It. Should You?",https://www.fool.com/investing/2023/10/04/wall-street-says-ginkgo-bioworks-stock-will-soar/,2023-10-04 13:00:00,"It's not a stock for the faint of heart, but its ambitious vision might pay off.",PFE,0.057628,0.157051,Somewhat-Bullish
"More than 75,000 workers to strike at hundreds of Kaiser Permanente health facilities across U.S.",https://www.cnbc.com/2023/10/04/health-care-workers-strike-at-kaiser-permanente.html,2023-10-04 12:07:38,The Coalition of Kaiser Permanente Unions has described the work stoppage as the largest strike of health-care workers in U.S. history.,PFE,0.057215,-0.17599,Somewhat-Bearish
PM360 Announces 2023 Trailblazer Award Winners,https://www.prnewswire.com/news-releases/pm360-announces-2023-trailblazer-award-winners-301943290.html,2023-10-04 12:00:00,"Top Companies, Marketers, CEOs, Products, and Initiatives Were Honored During Gala on October 3rd NEW YORK, Oct. 4, 2023 /PRNewswire/ -- Last night at a gala event held at Gotham Hall in New York City, PM360 announced the winners of its 15th annual Trailblazer Awards.",PFE,0.020615,0.305846,Somewhat-Bullish
"Moderna combination Covid, flu vaccine moves to final stage trial after positive data",https://www.cnbc.com/2023/10/04/moderna-combination-covid-flu-vaccine-shows-positive-data.html,2023-10-04 11:00:01,"Moderna and other vaccine makers like Pfizer believe combination shots will simplify what people can do to protect themselves against Covid, RSV and the flu.",PFE,0.235823,0.046774,Neutral
"Breast Cancer Therapeutics Market to Hit $63.96 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35082720/breast-cancer-therapeutics-market-to-hit-63-96-billion-globally-by-2030-exclusive-report-by-the-in,2023-10-04 09:57:03,"Pune, India, Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Breast cancer is one of the most common types of cancer and has a sizable market for therapies. According to the Centers for Disease Control and Prevention, in 2020, in the US, 239,612 new cases of breast cancer were reported among women, of which ...",PFE,0.036643,-0.119027,Neutral
"You Can't Control Recessions, but You Can Control What You Do About Them",https://www.fool.com/investing/2023/10/04/you-cant-control-recessions-but-you-can-control-wh/,2023-10-04 09:32:00,These strategies can help you weather the storms to come ... and they will come.,PFE,0.057079,0.160979,Somewhat-Bullish
Global South should learn from Big Pharma's bullying of South Africa,https://www.aljazeera.com/opinions/2023/10/4/global-south-should-learn-from-big-pharmas-bullying-of-south-africa,2023-10-04 08:42:41,The extortionate vaccine contracts Pretoria signed during the pandemic demonstrate why achieving pharmaceutical sovereignty should be a priority for all developing nations.,PFE,0.075874,-0.004109,Neutral
"'Traylor' Effect? Pfizer, Campbell's Soup, Other Brands Are Basking In Travis Kelce-Taylor Swift Romance Rumors - Campbell Soup  ( NYSE:CPB ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/entertainment/23/10/35080389/traylor-effect-pfizer-campbells-soup-other-brands-are-basking-in-travis-kelce-taylor-swift-,2023-10-04 06:33:18,"Brands associated with NFL player Travis Kelce, including Pfizer Inc. PFE and Campbell Soup Company CPB, have seen an uptick in engagement. The surge is reportedly due to rumors of a possible romantic relationship between Kelce and pop star Taylor Swift.",PFE,0.384397,0.236246,Somewhat-Bullish
"Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today? - Tesla  ( NASDAQ:TSLA ) , Digital World Acq  ( NASDAQ:DWAC ) , Novavax  ( NASDAQ:NVAX ) , Palantir Technologies  ( NYSE:PLTR ) ",https://www.benzinga.com/markets/equities/23/10/35077102/trumps-spac-partner-digital-world-novavax-palantir-and-tesla-why-these-stocks-are-trending-today,2023-10-04 01:47:50,"U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%, echoing the performance of the Dow and the NASDAQ, which declined by 1.3% and 1.9% respectively.",PFE,0.119235,-0.036585,Neutral
Pfizer  ( PFE )  Stock Moves -0.12%: What You Should Know,https://www.zacks.com/stock/news/2159574/pfizer-pfe-stock-moves--012-what-you-should-know,2023-10-03 21:45:21,"Pfizer (PFE) closed at $33.90 in the latest trading session, marking a -0.12% move from the prior day.",PFE,0.490323,0.078618,Neutral
Researcher Demoted By University Of Pennsylvania Wins Nobel Prize For mRNA Discoveries-And Some Academics Urge Penn To Apologize,https://www.forbes.com/sites/conormurray/2023/10/03/researcher-demoted-by-university-of-pennsylvania-wins-nobel-prize-for-mrna-discoveries-and-some-academics-urge-penn-to-apologize/,2023-10-03 20:46:21,Katalin Karikó's research laid the foundation for both the Pfizer/BioNTech and Moderna Covid-19 vaccines.,PFE,0.082535,0.036569,Neutral
Novavax Surges After FDA Signs Off On Its Updated Covid Shot,https://www.investors.com/news/technology/nvax-stock-surges-after-fda-signs-off-on-its-updated-covid-shot/,2023-10-03 20:36:00,"The Food and Drug Administration signed off on Novavax's ( NVAX ) updated Covid booster late Tuesday, and NVAX stock surged just before the close. Novavax expects doses to be available ""at thousands of locations"" in the coming days. Specifically, the agency signed off on Novavax's shot for ...",PFE,0.421485,0.256592,Somewhat-Bullish
US adds another option for fall COVID vaccination with updated Novavax shots,https://apnews.com/article/covid19-vaccine-novavax-ffba40058fe64d6a6a32cfdb760e2043,2023-10-03 20:01:00,"WASHINGTON ( AP ) - U.S. regulators on Tuesday authorized another option for fall COVID-19 vaccination, updated shots made by Novavax. began rolling out last month, intended for adults and children as young as age 6 months.",PFE,0.140896,-0.287248,Somewhat-Bearish
Novavax updated COVID vaccine gets FDA approval,https://www.marketwatch.com/story/novavax-updated-covid-vaccine-gets-fda-approval-68b4c1b5,2023-10-03 19:32:00,Stock jumps 12% on regulatory approval of new shot ...,PFE,0.498188,0.352971,Bullish
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? - Novavax  ( NASDAQ:NVAX ) ,https://www.benzinga.com/news/23/10/35071468/novavax-stock-soars-on-fda-clearance-for-updated-covid-19-shot-whats-going-on,2023-10-03 19:17:37,"Novavax Inc NVAX shares are surging Tuesday afternoon after the U.S. Food and Drug Administration ( FDA ) granted Emergency Use Authorization for the company's Covid-19 vaccine, Adjuvanted ( 2023-2024 Formula ) to prevent Covid in individuals aged 12 and older.",PFE,0.363388,0.140284,Neutral
FDA signs off on updated protein-based Covid-19 vaccine from Novavax,https://www.cnn.com/2023/10/03/health/novavax-covid-vaccine/index.html,2023-10-03 19:11:00,FDA signs off on updated protein-based Covid-19 vaccine from ...,PFE,0.163909,0.178503,Somewhat-Bullish
US FDA authorizes Novavax's updated COVID shot,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-authorizes-novavaxs-updated-covid-shot-2023-10-03/,2023-10-03 18:47:00,"A vial labelled ""Novavax COVID-19 Vaccine"" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights Oct 3 ( Reuters ) - The U.S.",PFE,0.279015,0.0,Neutral
"FDA authorizes updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.",https://www.cnbc.com/2023/10/03/fda-approves-novavax-updated-covid-vaccine.html,2023-10-03 18:44:49,Health officials see Novavax's protein-based vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna.,PFE,0.216376,-0.025415,Neutral
"Brands endorsed by Travis Kelce, like Pfizer and Campbell's Soup, are also benefitting from Taylor Swift's halo",https://www.businessinsider.com/travis-kelces-brand-partnerships-boosted-by-taylor-swift-rumors-2023-10,2023-10-03 18:37:00,Travis Kelce's Brand Partnerships Boosted by Taylor Swift Rumors - Business Insider ...,PFE,0.469457,0.411519,Bullish
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/10/35070630/this-is-what-whales-are-betting-on-pfizer,2023-10-03 18:31:00,"Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PFE,0.678102,0.162111,Somewhat-Bullish
Walgreens resolves COVID-19 vaccine supply after appointment challenges,https://www.foxbusiness.com/lifestyle/walgreens-covid-19-vaccine-supply-appointment-availability-challenges,2023-10-03 15:50:44,"Walgreens is adjusting its COVID-19 vaccine availability in response to ongoing appointment disruptions, a company spokesperson told Fox News Digital. Customers on social media have reported numerous vaccine appointment cancellations at Walgreens locations.",PFE,0.157483,0.079654,Neutral
Dividend Paying Stocks To Buy In October 2023? 2 In Focus,https://stockmarket.com/featured/dividend-paying-stocks-to-buy-in-october-2023-2-in-focus-2023-10-03,2023-10-03 14:22:40,"Dividends are like small bonuses companies give to people who own their stock. When a company makes money, it can either use that profit to grow the business or share a bit of it with its stockholders.",PFE,0.369685,0.219276,Somewhat-Bullish
3 Healthcare Stocks to Keep an Eye On,https://www.fool.com/investing/2023/10/03/3-healthcare-stocks-to-keep-an-eye-on/,2023-10-03 13:45:00,These three lesser-known healthcare companies have strong growth potential.,PFE,0.040078,0.02641,Neutral
AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug - AstraZeneca  ( NASDAQ:AZN ) ,https://www.benzinga.com/general/biotech/23/10/35052662/astrazeneca-settles-heartburn-treatment-lawsuit-for-one-of-biggest-selling-drug,2023-10-03 12:18:54,"AstraZeneca Plc AZN has agreed to pay $425 million to settle U.S. lawsuits related to heartburn and stomach acid treatments Nexium and Prilosec. The heartburn treatments have been under litigation, as some users said they caused kidney damage.",PFE,0.323078,-0.126928,Neutral
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?,https://www.fool.com/investing/2023/10/03/cathie-wood-is-buying-this-stock-hand-over-fist-la/,2023-10-03 10:27:00,The Internet's most famous innovation-focused investor is excited about this company's innovative approach to editing the human genome.,PFE,0.056275,0.145936,Neutral
Is Pfizer Stock a Buy Now?,https://www.fool.com/investing/2023/10/03/is-pfizer-stock-a-buy-now/,2023-10-03 10:00:00,Pfizer shares have dropped 35% this year.,PFE,0.770793,0.115427,Neutral
"[INVNT GROUP]™, the leading independent agency portfolio, advances global growth, launching virtual storytelling technology platform, and driving best-in-class strategic partnerships",https://www.benzinga.com/pressreleases/23/10/g35048785/invnt-group-the-leading-independent-agency-portfolio-advances-global-growth-launching-virtual-stor,2023-10-03 07:00:00,"New York, NY, Oct. 03, 2023 ( GLOBE NEWSWIRE ) -- [INVNT GROUP] THE GLOBAL BRANDSTORY PROJECT™ continues expanding its service offerings, growing its global team, and leveraging strategic business partnerships to redefine brand storytelling and audience engagement in the innovation-first ...",PFE,0.042876,0.176207,Somewhat-Bullish
Bill Gates Applauds Nobel Laureates Katalin Kariko And Drew Weissman Behind Revolutionary mRNA COVID-19 Vaccines,https://www.benzinga.com/general/biotech/23/10/35044448/bill-gates-applauds-nobel-laureates-katalin-kariko-and-drew-weissman-behind-revolutionary-mrna-co,2023-10-03 03:17:43,"Tech visionary Bill Gates commended the groundbreaking work of Nobel Prize laureates Katalin Kariko and Drew Weissman, whose research on mRNA has revolutionized vaccine development against COVID-19. What Happened: Gates took to X, formerly Twitter, to acknowledge the work of scientists Kariko and ...",PFE,0.132368,0.141415,Neutral
"The NFL  ( And Travis Kelce )  Is Benefitting From ""The Taylor Swift Effect""",https://www.forbes.com/sites/bradadgate/2023/10/02/the-nfl-and-travis-kelce-is-benefitting-from-the-taylor-swift-effect/,2023-10-02 22:13:25,"As popular as the NFL is, Taylor Swift dating Kansas City Chief tight end Travis Kelce may bring in new fans.",PFE,0.030998,0.059485,Neutral
"Parkinson's Disease Psychosis Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Key Companies Working to Develop Therapies - Vanda, Kyowa Kirin, Sage, Athira, Aptinyx, CogState, AgeneBio",https://www.prnewswire.com/news-releases/parkinsons-disease-psychosis-market-is-likely-to-increase-at-a-steady-growth-rate-by-2032-estimates-delveinsight--key-companies-working-to-develop-therapies---vanda-kyowa-kirin-sage-athira-aptinyx-cogstate-agenebio-301941331.html,2023-10-02 21:01:00,"Parkinson's Disease Psychosis Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight ... PR ...",PFE,0.027508,0.032597,Neutral
Drugmakers sign on to negotiate Medicare prices under protest,https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-sign-negotiate-medicare-prices-under-protest-2023-10-02/,2023-10-02 17:12:00,"U.S. President Joe Biden delivers remarks on Social Security and Medicare at the University of Tampa in Tampa, Florida, U.S. February 9, 2023. REUTERS/Jonathan Ernst/File Photo Acquire Licensing Rights",PFE,0.085022,0.033017,Neutral
Kaiser Permanente union workers poised to strike after contract expires,https://www.cnbc.com/2023/10/02/kaiser-permanente-union-workers-poised-to-strike-health-provider.html,2023-10-02 16:40:30,The workers' contract with Kaiser Permanente expired Saturday with disagreements still simmering over staffing levels.,PFE,0.097457,-0.18645,Somewhat-Bearish
What is the Nobel Prize and what to expect this year?,https://www.aljazeera.com/news/2023/10/2/what-is-the-nobel-prize-and-what-to-expect-this-year,2023-10-02 14:00:50,There are 351 nominees for the Nobel Peace Prize this year. The Nobel Prizes are slated to be announced this week with the first award in medicine or physiology won by Hungary's Katalin Kariko and Drew Weissman of the United States on Monday.,PFE,0.065685,0.091406,Neutral
3 Top Stocks to Buy in October and Hold Forever,https://www.fool.com/investing/2023/10/02/3-top-stocks-to-buy-in-october-and-hold-forever/,2023-10-02 13:40:13,Check out these three blue chip buys playing crucial roles in America's $6 trillion healthcare opportunity.,PFE,0.216376,0.238453,Somewhat-Bullish
Baudax's  ( BXRX )  Hemophilia A Drug Gets FDA's Orphan Drug Tag,https://www.zacks.com/stock/news/2158642/baudaxs-bxrx-hemophilia-a-drug-gets-fdas-orphan-drug-tag,2023-10-02 13:15:00,"FDA grants the Orphan Drug designation to Baudax (BXRX) for its lead pipeline candidate, TI-168, to treat Hemophilia A patients with inhibitors.",PFE,0.288893,-0.036372,Neutral
"Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19 - Moderna  ( NASDAQ:MRNA ) , Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/10/35030546/nobel-prize-honors-scientists-behind-mrna-vaccines-against-covid-19,2023-10-02 12:55:51,The Nobel Assembly has awarded two scientists with the Nobel Prize in medicine for their pioneering work in the development of messenger-RNA ( mRNA ) vaccines against Covid-19. The research of Katalin Kariko and Drew Weissman paved the way for companies like Moderna Inc. MRNA and the Pfizer ...,PFE,0.291182,0.167754,Somewhat-Bullish
"Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant - AstraZeneca  ( NASDAQ:AZN ) , GSK  ( NYSE:GSK ) ",https://www.benzinga.com/general/biotech/23/10/35030457/multi-billion-dollar-treatment-market-for-lung-infection-that-causes-over-200-000-hospitalization,2023-10-02 12:50:10,"The CDC recently issued a warning that Respiratory Syncytial Virus ( RSV ) , a common and highly contagious lung infection that can cause bronchitis and pneumonia, is on the rise in the Southeastern United States - and the very young and the elderly are the most at risk of developing severe ...",PFE,0.110717,-0.049793,Neutral
ACM Research and Advance Auto Parts have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2158590/acm-research-and-advance-auto-parts-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-10-02 12:25:00,"Chicago, IL - October 2, 2023 - Zacks Equity Research shares ACM Research ( ACMR Quick QuoteACMR - ) as the Bull of the Day and Advance Auto Parts ( AAP Quick QuoteAAP - ) as the Bear of the Day.",PFE,0.105064,0.040069,Neutral
"Katalin Kariko, Scientific Maverick Who Paved Way For MRNA Vaccines",https://www.barrons.com/news/katalin-kariko-scientific-maverick-who-paved-way-for-mrna-vaccines-bfd9daaa,2023-10-02 10:46:00,"Hungarian-born scientist Katalin Kariko's obsession with researching a substance called mRNA to fight disease once cost her a faculty position at a prestigious US university, which dismissed the idea as a dead end.",PFE,0.128135,0.143825,Neutral
"The Zacks Analyst Blog Highlights AbbVie, Lilly, Sanofi, Merck and J&J",https://www.zacks.com/stock/news/2158561/the-zacks-analyst-blog-highlights-abbvie-lilly-sanofi-merck-and-jj,2023-10-02 10:31:00,"AbbVie, Lilly, Sanofi, Merck and J&J are included in this Analyst Blog.",PFE,0.037504,-0.11573,Neutral
Nobel Prize Given To Researchers Behind mRNA Tech In Covid Vaccines,https://www.forbes.com/sites/siladityaray/2023/10/02/nobel-prize-given-to-researchers-behind-mrna-tech-in-covid-vaccines/,2023-10-02 10:18:28,The mRNA technology was used to rapidly develop and deploy two effective vaccines that offered protection against the Covid-19 pandemic.,PFE,0.345674,0.416413,Bullish
Nobel Prize Goes To MRNA Covid Vaccine Researchers,https://www.barrons.com/news/nobel-prize-goes-to-mrna-covid-vaccine-researchers-c65535aa,2023-10-02 10:13:00,Katalin Kariko and Drew Weissman won the Nobel Medicine Prize on Monday for work on messenger RNA ( mRNA ) technology that paved the way for groundbreaking Covid-19 vaccines.,PFE,0.12645,0.11007,Neutral
"Katalin Kariko, Drew Weissman win Nobel Prize in medicine",https://www.aljazeera.com/news/2023/10/2/katalin-kariko-drew-weissman-win-nobel-prize-in-medicine,2023-10-02 09:52:14,The duo win the prestigious prize for the research that led directly to the first mRNA vaccines to fight COVID-19.,PFE,0.570165,0.55758,Bullish
Nobel Prize in medicine goes to Katalin Karikó and Drew Weissman for work on mRNA Covid-19 vaccines,https://www.cnn.com/2023/10/02/europe/nobel-prize-medicine-mrna-covid-vaccines-2023-intl-scn/index.html,2023-10-02 09:48:23,"This year's Nobel Prize in physiology or medicine has been awarded to Katalin Karikó and Drew Weissman for their work on mRNA vaccines, which were crucial in curtailing the spread of Covid-19.",PFE,0.096671,0.088414,Neutral
"Narcolepsy, Cancer Tipped As Medicine Prize Opens Nobel Week",https://www.barrons.com/news/narcolepsy-cancer-tipped-as-medicine-prize-opens-nobel-week-f8055e7,2023-10-02 03:03:00,"Narcolepsy, cancer or mRNA vaccine research could win the Nobel Medicine Prize on Monday when a week of announcements kick off, but experts see no clear frontrunner for the Peace Prize.",PFE,0.051221,0.057999,Neutral
3 No-Brainer Growth Stocks to Buy in October,https://www.fool.com/investing/2023/10/01/3-no-brainer-growth-stocks-to-buy-in-october/,2023-10-01 12:30:00,These three top mid-cap stocks could be poised for a long-tailed growth spurt.,PFE,0.045655,0.133776,Neutral
"3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street",https://www.fool.com/investing/2023/10/01/3-stocks-to-buy-in-october-that-could-soar-more-th/,2023-10-01 09:52:00,Analysts like these stocks for very good reasons.,PFE,0.125789,-0.076478,Neutral
Could Viatris Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/09/30/could-viatris-stock-help-you-become-a-millionaire/,2023-09-30 11:58:00,Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?,PFE,0.055881,0.146915,Neutral
Moderna's Shares Could Take Off if These 2 Things Happen,https://www.fool.com/investing/2023/09/30/moderna-could-rise-if-these-2-things-happen/,2023-09-30 10:00:00,Moderna stock soared early in the pandemic.,PFE,0.160633,0.173537,Somewhat-Bullish
"Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine",https://www.fool.com/investing/2023/09/30/heres-why-you-should-consider-moderna-stock-and-no/,2023-09-30 09:30:00,"The COVID-19 vaccine put Moderna on the map, but its pipeline is going to be what keeps it there.",PFE,0.06515,0.114691,Neutral
Pro-vaccination Ad Leaves NFL's Kelce In Misinformation Crosshairs,https://www.barrons.com/news/pro-vaccination-ad-leaves-nfl-s-kelce-in-misinformation-crosshairs-d54214e6,2023-09-30 02:02:00,"Vaccine skeptics are attacking Travis Kelce for participating in a Pfizer advertisement, recycling conspiracy theories about Covid-19 shots as the NFL star is getting attention for his rumored romance with pop icon Taylor Swift.",PFE,0.118647,-0.023881,Neutral
Pro-vaccination Ad Leaves NFL's Kelce In Misinformation Crosshairs,https://www.barrons.com/news/pro-vaccination-ad-leaves-nfl-s-kelce-in-misinformation-crosshairs-72bef15d,2023-09-30 02:02:00,"Vaccine skeptics are attacking Travis Kelce for participating in a Pfizer advertisement, recycling conspiracy theories about Covid-19 shots as the NFL star is getting attention for his rumored romance with pop icon Taylor Swift.",PFE,0.118647,-0.023881,Neutral
From Managing Chronic Diseases to Monitoring Nutrition: Patient-Centric Apps are the Next Big Thing in Healthcare,https://www.prnewswire.com/news-releases/from-managing-chronic-diseases-to-monitoring-nutrition-patient-centric-apps-are-the-next-big-thing-in-healthcare-301943201.html,2023-09-29 23:15:00,"DUBLIN, Sept. 29, 2023 /PRNewswire/ -- The ""Patient Centric Healthcare App Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028"" report has been added to ResearchAndMarkets.com's offering.",PFE,0.073098,0.099734,Neutral
Why Pfizer and BioNTech Stocks Zoomed Higher Today,https://www.fool.com/investing/2023/09/29/why-pfizer-and-biontech-stocks-zoomed-higher-today/,2023-09-29 23:03:00,"The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.",PFE,0.514619,-0.055374,Neutral
Around 1.8 mln Americans received COVID shots last week -IQVIA,https://www.reuters.com/business/healthcare-pharmaceuticals/around-18-mln-americans-received-covid-shots-last-week-iqvia-2023-09-29/,2023-09-29 19:58:21,Around 1.8 mln Americans received COVID shots last ...,PFE,0.137671,-0.056619,Neutral
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data,https://www.cnbc.com/2023/09/29/obesity-pill-data-boosts-structure-therapeutics-shares.html,2023-09-29 16:02:36,Structure's pill is part of the same class of drugs as Novo Nordisk's blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy.,PFE,0.128135,0.144874,Neutral
3 Top Undervalued Stocks To Watch: October 2023,https://www.forbes.com/sites/investor-hub/article/3-top-undervalued-stocks-to-watch-october-2023/,2023-09-29 14:53:07,"We are in what is historically considered the slow season of the investing world, but there are still opportunities for value-minded investors willing to turn over a rock or two. Here are three undervalued stocks to consider.",PFE,0.085203,0.152136,Somewhat-Bullish
"'s 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet - Biohaven  ( NYSE:BHVN ) , MillerKnoll  ( NASDAQ:MLKN ) ",https://www.benzinga.com/news/23/09/35002281/benzingas-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-about-yet,2023-09-29 13:59:00,"Investors are constantly on the hunt for undervalued, under-followed, and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance to uncover new information.",PFE,0.148731,0.17224,Somewhat-Bullish
3 Stocks to Focus on as Demand for Obesity Drugs Booms,https://www.zacks.com/stock/news/2157743/3-stocks-to-focus-on-as-demand-for-obesity-drugs-booms,2023-09-29 13:35:00,"With the obesity market gaining popularity, analysts are expecting sales to increase. Pharma companies are rushing to enter the market ...",PFE,0.215702,0.061785,Neutral
"Pharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs",https://www.zacks.com/stock/news/2157714/pharma-stock-roundup-fda-and-ema-regulatory-updates-for-abbv-lly-sny-mrks-drugs,2023-09-29 13:28:00,The European Commission approves AbbVie's (ABBV) Tepkinly (epcoritamab) for DLBCL. FDA approves Lilly's (LLY) Jardiance for chronic kidney disease.,PFE,0.038969,-0.116285,Neutral
Artwork Management Software Market worth $1.12 Billion by 2030 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/09/g35002288/artwork-management-software-market-worth-1-12-billion-by-2030-exclusive-report-by-the-insight-part,2023-09-29 13:26:58,"Pune, India., Sept. 29, 2023 ( GLOBE NEWSWIRE ) -- According to a new report on ""Artwork Management Software Market Size and Forecasts ( 2020 - 2030 ) , Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Deployment ( Cloud and On-Premise ) , Application ( Life ...",PFE,0.031822,0.171305,Somewhat-Bullish
Where Will Pfizer Be in 5 Years?,https://www.fool.com/investing/2023/09/29/where-will-pfizer-be-in-5-years/,2023-09-29 13:15:00,Investors should expect to see big changes from the company as it addresses concerns about its growth prospects.,PFE,0.651499,-0.052449,Neutral
Why CureVac Stock Plunged Today,https://www.fool.com/investing/2023/09/29/why-curevac-nv-stock-plunged-today/,2023-09-29 13:07:43,A German court temporarily suspended proceedings in CureVac's IP lawsuit against BioNTech.,PFE,0.136113,0.099751,Neutral
"Volatility, gold and stocks to avoid: Citi delivers its shutdown playbook",https://www.marketwatch.com/story/volatility-gold-and-stocks-to-avoid-citi-delivers-its-shutdown-playbook-fc0ca947,2023-09-29 10:42:00,It's likely October will start with a U.S. government shutdown. What will that mean for markets? Citi looks at history as a guide.,PFE,0.068896,0.04211,Neutral
"Rimegepant is Now Available in Hong Kong, the First Market in Asia, for Migraine Management",https://www.prnewswire.com/apac/news-releases/rimegepant-is-now-available-in-hong-kong-the-first-market-in-asia-for-migraine-management-301942766.html,2023-09-29 09:03:00,"HONG KONG, Sept. 29, 2023 /PRNewswire/ -- Pfizer announced the availability of Rimegepant in Hong Kong, the first market in Asia, a calcitonin gene-related peptide ( CGRP ) receptor antagonist for migraine management.[1],[2] There are approximately 12.5% of people living with migraine in Hong ...",PFE,0.221145,0.272475,Somewhat-Bullish
"Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?",https://www.zacks.com/stock/news/2157418/is-it-time-to-buy-pfizer-moderna-or-astrazenecas-stock,2023-09-29 02:13:00,Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings potential.,PFE,0.268589,0.024587,Neutral
"What to know as fall vaccinations against COVID, flu and RSV get underway",https://apnews.com/article/vaccines-flu-covid19-rsv-viruses-fall-8ffa6bf0c2c0da1a8842db524aad5006,2023-09-28 21:02:00,WASHINGTON ( AP ) - Updated may be getting a little easier for adults to find but they're still frustratingly scarce for young children. Health officials said Thursday the kid shots have started shipping - and reminded most everyone to get a fall flu shot too.,PFE,0.072655,-0.002031,Neutral
"Neuroblastoma Market to Grow at a Substantial Growth Rate During the Forecast Period  ( 2023-2032 ) , Examines DelveInsight | Key Companies to Watch - Y-mAbs, Exelixis, Clarity, Eli Lilly, Innervate Radiopharmaceuticals, Adaptimmune",https://www.prnewswire.com/news-releases/neuroblastoma-market-to-grow-at-a-substantial-growth-rate-during-the-forecast-period-20232032-examines-delveinsight--key-companies-to-watch---y-mabs-exelixis-clarity-eli-lilly-innervate-radiopharmaceuticals-adaptimmune-301941281.html,2023-09-28 21:01:00,"Neuroblastoma Market to Grow at a Substantial Growth Rate During the Forecast Period ( 2023-2032 ) , Examines ... PR ...",PFE,0.029508,0.053418,Neutral
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer,https://www.globenewswire.com/news-release/2023/09/28/2751637/0/en/Molecular-Templates-Announces-the-Appointment-of-Dr-Maurizio-Voi-to-the-Role-of-Chief-Medical-Officer.html,2023-09-28 20:11:00,"AUSTIN, Texas, Sept. 28, 2023 ( GLOBE NEWSWIRE ) -- Molecular Templates, Inc. ( Nasdaq: MTEM, ""Molecular Templates,"" or ""MTEM"" ) , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action, today announced the ...",PFE,0.04823,0.03378,Neutral
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer - Molecular Templates  ( NASDAQ:MTEM ) ,https://www.benzinga.com/pressreleases/23/09/g34986881/molecular-templates-announces-the-appointment-of-dr-maurizio-voi-to-the-role-of-chief-medical-offi,2023-09-28 20:11:00,"AUSTIN, Texas, Sept. 28, 2023 ( GLOBE NEWSWIRE ) -- Molecular Templates, Inc. MTEM ""Molecular Templates, "" or ""MTEM"" ) ) ) , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action, today announced the appointment of ...",PFE,0.047465,0.03374,Neutral
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine,https://www.newswire.ca/news-releases/pfizer-and-biontech-receive-health-canada-authorization-for-xbb-1-5-adapted-monovalent-covid-19-vaccine-813191203.html,2023-09-28 18:34:00,"KIRKLAND, QC and MAINZ, Germany, Sept. 28, 2023 /CNW/ - Pfizer Canada ULC and BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" ) announced today that Health Canada has authorized the companies' Omicron XBB.1.5-adapted monovalent COVID-19 vaccine ( COMIRNATY® Omicron XBB.1.5 ) for ages 6 months and older.",PFE,0.312158,0.138185,Neutral
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine,https://www.globenewswire.com/news-release/2023/09/28/2751493/0/en/Pfizer-and-BioNTech-Receive-Health-Canada-Authorization-for-XBB-1-5-Adapted-Monovalent-COVID-19-Vaccine.html,2023-09-28 16:24:00,"KIRKLAND, QUEBEC and MAINZ, GERMANY, September 28, 2023 - Pfizer Canada ULC and BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" ) announced today that Health Canada has authorized the companies' Omicron XBB.1.5-adapted monovalent COVID-19 vaccine ( COMIRNATY® Omicron XBB.1.5 ) for ages 6 months and older.",PFE,0.258625,0.127383,Neutral
"Covid-19 Vaccine Uptake Could Beat Expectations, Poll Indicates",https://www.barrons.com/articles/covid-19-vaccine-uptake-moderna-pfizer-ffc99e30,2023-09-28 15:23:00,"Nearly half of U.S. adults say they plan to get a Covid-19 shot this year, according to a poll from the healthcare policy research group KFF, suggesting more demand than expected.",PFE,0.293214,0.052112,Neutral
GSK lifts growth target for HIV business on demand for long-acting drug,https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-lifts-growth-ambitions-hiv-business-long-acting-drug-2023-09-28/,2023-09-28 15:10:00,"GSK ( GlaxoSmithKline ) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File photo Acquire Licensing Rights",PFE,0.093653,0.155531,Somewhat-Bullish
The Anti-obesity Drug Market Is About to Get More Crowded,https://www.thedailyupside.com/industries/the-anti-obesity-drug-market-is-about-to-get-more-crowded/,2023-09-28 14:31:33,"Obesity is an epidemic that affects more than 40% of all American adults, and it's creating a feeding frenzy for investors. With the rise of...",PFE,0.181137,-0.109422,Neutral
Pharma's big push for a new generation of obesity drugs,https://www.economist.com/business/2023/09/28/pharmas-big-push-for-a-new-generation-of-obesity-drugs,2023-09-28 14:10:08,"F ago Novo Nordisk was a boring Danish drugmaker whose diabetes medications were reliably profitable. The only time the company made headlines was when it was caught up in complaints about the high cost of insulin. Then in 2021 a trial of its diabetes drug, Ozempic ( semaglutide ) , showed that ...",PFE,0.05234,0.072857,Neutral
"Alation Announces revAlation 2023 Conference Series in London, Chicago, and Sydney",https://www.benzinga.com/pressreleases/23/09/g34974974/alation-announces-revalation-2023-conference-series-in-london-chicago-and-sydney,2023-09-28 13:09:00,"REDWOOD CITY, Calif., Sept. 28, 2023 ( GLOBE NEWSWIRE ) -- Alation, Inc., the data intelligence company, today announced the details of its annual global conference series, revAlation. The 2023 series encompasses three conferences in London ( Oct. 10-12 ) , Chicago ( Oct. 23-24 ) , and Sydney ( ...",PFE,0.065685,0.21909,Somewhat-Bullish
Grain Management Welcomes Franklin Raines as Senior Advisor,https://www.prnewswire.com/news-releases/grain-management-welcomes-franklin-raines-as-senior-advisor-301941557.html,2023-09-28 13:00:00,"WASHINGTON, Sept. 28, 2023 /PRNewswire/ -- Grain Management, LLC ( ""Grain"" ) , investment firm and solutions provider to the global broadband industry, announced today that Franklin Raines has joined its board as a Senior Advisor.",PFE,0.09402,0.094128,Neutral
Jasper Welcomes Former Dropbox President Timothy Young as CEO,https://www.prnewswire.com/news-releases/jasper-welcomes-former-dropbox-president-timothy-young-as-ceo-301941452.html,2023-09-28 13:00:00,"Young will provide vision and leadership through the company's next chapter of growth, with a focus on becoming the AI-powered marketing copilot of choice for global enterprises",PFE,0.060541,0.14602,Neutral
German court suspends mRNA patent trial against BioNTech,https://www.reuters.com/business/healthcare-pharmaceuticals/german-court-suspends-mrna-patent-trial-against-biontech-2023-09-28/,2023-09-28 08:51:00,German court suspends mRNA patent trial against ...,PFE,0.29234,-0.165083,Somewhat-Bearish
"Travis Kelce could earn millions more thanks to the Taylor Swift effect, as experts say he could double or triple endorsement paydays",https://www.businessinsider.com/travis-kelce-earn-millions-taylor-swift-endorsements-merch-sales-2023-9,2023-09-28 08:45:00,Travis Kelce could earn millions more thanks to Taylor Swift - Business Insider ...,PFE,0.03878,0.0,Neutral
Why Pfizer Stock Slipped Today,https://www.fool.com/investing/2023/10/17/why-pfizer-stock-slipped-today/,2023-10-17 22:10:00,The company continues to be somewhat out of favor after reducing its guidance late last week.,PFE,0.627119,0.01492,Neutral
Pfizer  ( PFE )  Suffers a Larger Drop Than the General Market: Key Insights,https://www.zacks.com/stock/news/2167519/pfizer-pfe-suffers-a-larger-drop-than-the-general-market-key-insights,2023-10-17 21:45:19,"Pfizer (PFE) concluded the recent trading session at $32.75, signifying a -1.56% move from its prior day's close.",PFE,0.691734,0.179256,Somewhat-Bullish
Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/23/10/35294426/johnson-johnson-was-saved-by-its-focus-on-medtech-and-innovative-medicine,2023-10-17 17:16:16,Johnson & Johnson JNJ reported its third quarter results that topped Wall Street's expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical and medical devices businesses.,PFE,0.21803,-0.077784,Neutral
How One Stock's 18% Dive Dragged Down An Entire Industry,https://www.investors.com/news/technology/ntct-stock-plummets-and-drags-down-an-entire-industry-on-its-preannouncement/,2023-10-17 16:15:00,NTCT Stock Plummets On Disappointing Preannouncement Investor's Business Daily ...,PFE,0.138464,0.016936,Neutral
Moderna  ( MRNA )  Down Despite Maintaining COVID Jab Sales View,https://www.zacks.com/stock/news/2167338/moderna-mrna-down-despite-maintaining-covid-jab-sales-view,2023-10-17 14:17:00,"Though Moderna (MRNA) reiterated its sales guidance for COVID vaccine, it warned investors that it could not predict exact demand yet.",PFE,0.577838,0.007022,Neutral
What's Going On With Moderna Stock? - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/news/23/10/35288500/whats-going-on-with-moderna-stock,2023-10-17 13:52:19,Moderna Inc MRNA shares are continuing to trade lower Tuesday following Pfizer Inc's PFE warning about reduced Covid-19 product demand. What Happened: Moderna shares closed Monday down 6.47% at $91.94 after Pfizer slashed its full-year 2023 sales outlook from a range of $67 billion to $70 billion ...,PFE,0.716023,-0.08523,Neutral
J&J Raises Outlook As Health Bellwether Tries To Reinvent Itself,https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q3-2023/,2023-10-17 13:05:00,JNJ Stock: Health Care Bellwether Boosts Outlook As It Refocuses ... Investor's Business Daily ...,PFE,0.154455,0.018124,Neutral
Nu Holdings and Tyson Foods have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2166987/nu-holdings-and-tyson-foods-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-10-17 12:44:00,"Chicago, IL - October 17, 2023 - Zacks Equity Research shares Nu Holdings Ltd. ( NU Quick QuoteNU - ) as the Bull of the Day and Tyson Foods ( TSN Quick QuoteTSN - ) as the Bear of the Day.",PFE,0.379253,0.181838,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Q3 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2166934/johnson-johnson-jnj-q3-earnings-and-revenues-surpass-estimates,2023-10-17 11:40:02,"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.56% and 1.67%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.136888,0.0,Neutral
Pfizer Looks for a Covid Bottom,https://www.wsj.com/health/pharma/pfizer-looks-for-a-covid-bottom-f9b551fa,2023-10-17 10:00:00,"The pharma giant has had to slash projections, but investors welcome its plans to cut costs.",PFE,0.7887,-0.183703,Somewhat-Bearish
Do These 5 Words From Pfizer Mean Trouble for Novavax?,https://www.fool.com/investing/2023/10/17/does-this-pfizer-comment-mean-trouble-for-novavax/,2023-10-17 10:00:00,Coronavirus vaccine sales could represent recurrent annual revenue for Novavax and rivals.,PFE,0.439364,0.089844,Neutral
"Markets Pop on Bargain Hunting, Stronger Economy",https://www.zacks.com/stock/news/2166817/markets-pop-on-bargain-hunting-stronger-economy,2023-10-16 22:42:00,"The small-cap Russell 2000, still under water over the past month, led the way higher today.",PFE,0.174587,0.101763,Neutral
"Price of lifesaving Covid-19 antiviral Paxlovid expected to rise next year, raising concerns about access",https://www.cnn.com/2023/10/16/health/paxlovid-price-expected-to-rise/index.html,2023-10-16 21:34:00,"The price of the lifesaving Covid-19 medication Paxlovid is likely to rise next year for most patients as the United States continues to transition out of the emergency phase of the pandemic, sparking concerns among doctors that it will become less accessible.",PFE,0.188486,0.09113,Neutral
Novavax positive on updated COVID vaccine availability in US,https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-positive-updated-covid-vaccine-availability-us-2023-10-16/,2023-10-16 20:05:00,"A vial labelled ""Novavax V COVID-19 Vaccine"" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",PFE,0.468029,-0.255789,Somewhat-Bearish
"Dow Rises 300 Points-But Big Losses Will Dash Earnings Season Cheer, Morgan Stanley Warns",https://www.forbes.com/sites/dereksaul/2023/10/16/dow-rises-300-points-but-big-losses-will-dash-earnings-season-cheer-morgan-stanley-warns/,2023-10-16 20:02:59,The Dow rose to its highest level of the month thanks to big banks bashing earnings.,PFE,0.083833,0.030164,Neutral
Moderna's stock slides to three-year low as co-founder sells more shares,https://www.marketwatch.com/story/modernas-stock-slides-to-three-year-low-as-co-founder-sells-more-shares-ab48a02a,2023-10-16 18:55:00,"Moderna's stock slid toward a fourth straight loss Monday. The company's co-founder and chair, Noubar Afeyan, has sold $3 million worth of shares in October.",PFE,0.436009,0.056316,Neutral
"Dow Rises 320 Points-But Big Losses Will Dash Earnings Season Cheer, Morgan Stanley Warns",https://www.forbes.com/sites/dereksaul/2023/10/16/dow-rises-320-points-but-big-losses-will-dash-earnings-season-cheer-morgan-stanley-warns/,2023-10-16 18:26:18,"Earnings season seemingly got off to a hot start, but Morgan Stanley says stocks will slide without material changes to profit forecasts.",PFE,0.082677,0.030082,Neutral
"Analysts Divided Over Pfizer's Outlook, Some See Positives Amid Negative Sentiment - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35271640/analysts-divided-over-pfizers-outlook-some-see-positives-amid-negative-sentiment,2023-10-16 17:56:29,"Friday, Pfizer Inc PFE slashed its full-year earnings and revenue guidance, citing decreasing demand for its COVID-19 products. The company now expects 2023 sales of $58 billion-$61 billion, down from its previous guidance of $67 billion-$70 billion versus consensus of $66.0 billion.",PFE,0.651499,0.257552,Somewhat-Bullish
"Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Aldeyra Therapeutics  ( NASDAQ:ALDX ) , Alignment Healthcare  ( NASDAQ:ALHC ) ",https://www.benzinga.com/news/23/10/35272489/why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in,2023-10-16 17:09:53,"MingZhu Logistics Holdings Limited YGMZ shares gained 64% to $0.7798 after gaining more than 10% on Friday. PCTEL, Inc. PCTI climbed 47.3% to $6.86. On Friday, Amphenol Corp APH inked a deal to acquire PCTEL for around $139.7 million. Almacenes Éxito S.A. EXTO shares rose 32.6% to $6.66.",PFE,0.076236,-0.175071,Somewhat-Bearish
"Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants - Pfizer  ( NYSE:PFE ) , Sanofi  ( NASDAQ:SNY ) ",https://www.benzinga.com/general/biotech/23/10/35269447/pfizer-sanofis-respiratory-syncytial-virus-products-faces-insurance-and-logistical-hurdles-to-pro,2023-10-16 16:16:55,"As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's PFE vaccine, Abrysvo, to pregnant patients and Sanofi SA's SNY monoclonal antibody, Beyfortus, to protect against respiratory syncytial virus ( RSV ) complications in infants.",PFE,0.478939,0.216145,Somewhat-Bullish
Pfizer confronts 'peak of anti-vaccination rhetoric' as shares rebound,https://www.marketwatch.com/story/pfizer-confronts-peak-of-anti-vaccination-rhetoric-as-shares-rebound-54c5ef89,2023-10-16 15:05:00,"Cost-saving program ""will touch all parts of the business"" but won't affect Seagen acquisition, Pfizer says.",PFE,0.727604,0.162829,Somewhat-Bullish
Stock Market Starts The Week With A Bang; Lululemon Stock Rallies,https://www.investors.com/market-trend/stock-market-today/stock-market-starts-week-with-a-bang-lululemon-rallies-on-sp-addition/,2023-10-16 14:52:00,Stock Market Starts The Week With A Bang. Lululemon Stock Rallies Investor's Business Daily ...,PFE,0.344712,0.035346,Neutral
"Top Stories Monday, Oct 16: Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo",https://www.benzinga.com/markets/cryptocurrency/23/10/35268834/bitcoins-etf-approval-rumor-pfizer-slashes-annual-outlook-activist-shareholder-shakes-up-n,2023-10-16 14:35:10,"Bitcoin ( BTC/USD ) , the ace cryptocurrency, spiked on unverified reports of the approval of an iShares Bitcoin ETF. BlackRock said the information is false, according to Fox Business journalist Eleanor Terrett. The company's Bitcoin ETF application is still under review, BlackRock, which ...",PFE,0.12003,-0.181602,Somewhat-Bearish
"Moderna, BioNTech Leads Covid Sell-Off After Pfizer Slashes Outlook",https://www.investors.com/news/technology/moderna-stock-biontech-stock-lead-covid-sell-off-after-pfizer-slashes-guidance/,2023-10-16 14:18:00,Moderna ( MRNA ) stock and BioNTech ( BNTX ) led a sell-off Monday among Covid vaccine makers after Pfizer ( PFE ) slashed about $9 billion from its full-year guidance. Pfizer said it wrote off about $5.5 billion in inventory during the third quarter due to lower-than-expected demand for ...,PFE,0.651499,0.118694,Neutral
Pfizer's  ( PFE )  Ulcerative Colitis Pill Etrasimod Gets FDA Nod,https://www.zacks.com/stock/news/2166456/pfizers-pfe-ulcerative-colitis-pill-etrasimod-gets-fda-nod,2023-10-16 13:46:00,"The approval for Pfizer's (PFE) Velsipity (etrasimod) is based on data from two pivotal phase III studies, ELEVATE UC 52 and ELEVATE 12.",PFE,0.699089,0.083713,Neutral
Moderna confirms COVID sales guidance as shares sink on Pfizer news,https://www.marketwatch.com/story/moderna-confirms-covid-sales-guidance-as-shares-sink-on-pfizer-news-fdde463b,2023-10-16 13:37:00,Company sees full-year COVID sales of $6 billion to $8 billion but says size of U.S. market is still uncertain ...,PFE,0.574235,0.077691,Neutral
Pfizer  ( PFE )  Cuts 2023 Outlook as COVID Products' Demand Falls,https://www.zacks.com/stock/news/2166403/pfizer-pfe-cuts-2023-outlook-as-covid-products-demand-falls,2023-10-16 13:29:00,"Pfizer (PFE) lowers its total revenue guidance for 2023 by $9 billion as sales from its COVID products, Comirnaty vaccine and Paxlovid pill decline.",PFE,0.782378,0.185029,Somewhat-Bullish
"JPMorgan To Rally Over 29%? Here Are 10 Other Analyst Forecasts For Monday - Apple  ( NASDAQ:AAPL ) , Check Point Software  ( NASDAQ:CHKP ) ",https://www.benzinga.com/news/23/10/35267375/jpmorgan-to-rally-over-29-here-are-10-other-analyst-forecasts-for-monday,2023-10-16 13:27:19,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Morgan Stanley raised JPMorgan Chase & Co. JPM price target from $187 to $191.",PFE,0.242084,-0.137997,Neutral
"The Zacks Analyst Blog Highlights Pfizer, Allogene Therapeutics and Corcept Therapeutics",https://www.zacks.com/stock/news/2166381/the-zacks-analyst-blog-highlights-pfizer-allogene-therapeutics-and-corcept-therapeutics,2023-10-16 13:26:00,"Pfizer, Allogene Therapeutics and Corcept Therapeutics are included in this Analyst Blog.",PFE,0.497126,0.233195,Somewhat-Bullish
Moderna reaffirms annual COVID vaccine sales forecast,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-reaffirms-annual-covid-vaccine-sales-forecast-2023-10-16/,2023-10-16 13:17:00,"Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",PFE,0.421485,-0.303389,Somewhat-Bearish
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket,https://markets.businessinsider.com/news/stocks/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket-1032708380,2023-10-16 13:15:35,Why ContraFect Shares Are Trading Higher By Around 30%. Here Are 20 Stocks Moving Premarket - Markets Insider ...,PFE,0.105604,-0.240048,Somewhat-Bearish
2 Big-Name Stocks Making Monday Morning Moves,https://www.fool.com/investing/2023/10/16/2-big-name-stocks-making-monday-morning-moves/,2023-10-16 13:11:05,Investors are watching these two companies closely as the week kicks off.,PFE,0.582526,0.26768,Somewhat-Bullish
The Investing Club's top 10 things to watch in the stock market Monday,https://www.cnbc.com/2023/10/16/the-investing-clubs-top-10-things-to-watch-in-the-stock-market-monday.html,2023-10-16 13:09:53,Stocks edge up in premarket trading Monday ahead of a busy week of third-quarter corporate earnings.,PFE,0.171688,0.015856,Neutral
"The Middle East, Economic Data And Earnings",https://www.forbes.com/sites/jjkinahan/2023/10/16/the-middle-east-economic-data-and-earnings/,2023-10-16 13:06:44,"As we kick off this week, there are any number of potential pockets of turbulence from the geopolitical situation. domestic politics, where we still have no Speaker of...",PFE,0.119235,-0.210194,Somewhat-Bearish
Pfizer CEO expects 17% of Americans will get new COVID shots,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-expects-17-americans-will-get-new-covid-shots-2023-10-16/,2023-10-16 12:57:00,"A company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights Oct 16 ( Reuters ) - Pfizer ( PFE.N ) CEO Albert Bourla said on Monday that he expects about 17% of the U.S. population to get updated COVID-19 vaccines during ...",PFE,0.817578,0.0,Neutral
"Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket - Ambrx Biopharma  ( NASDAQ:AMAM ) , Amphenol  ( NYSE:APH ) ",https://www.benzinga.com/news/23/10/35266067/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket,2023-10-16 12:47:12,"LQR House Inc. LQR shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey's presence on store shelves. Processa Pharmaceuticals, Inc. PCSA shares rose 84.4% to $0.8853 in pre-market trading after jumping 45% on Friday.",PFE,0.097854,-0.225147,Somewhat-Bearish
"Tesla, Netflix Grab Earnings Spotlight This Week, Apple Rumored To Launch New iPads - Top Headlines Today While US Was Sleeping",https://www.benzinga.com/news/23/10/35265264/tesla-netflix-grab-earnings-spotlight-this-week-apple-rumored-to-launch-new-ipads-top-headlines-toda,2023-10-16 12:41:18,"Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar? Pfizer, Charles Schwab And 3 Stocks To Watch Heading Into Monday Why The Fear Level Among US Investors Is Growing Americans Face Historic Lack Of Affordability In Housing ...",PFE,0.063763,0.0,Neutral
"Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine",https://markets.businessinsider.com/news/stocks/novavax-faces-setback-european-authority-delays-decision-on-variant-tailored-covid-19-vaccine-1032708167,2023-10-16 12:31:24,"Novavax Inc ( NASDAQ:NVAX ) faces a setback as the European Medicines Agency ( EMA ) delays a decision on its variant-tailored COVID-19 vaccine. This delay comes at a challenging time for the US-listed biotech, grappling with declining demand for COVID-19 vaccines.",PFE,0.16171,0.123483,Neutral
Allogene Therapeutics Appoints Geoffrey Parker as Chief Financial Officer - Allogene Therapeutics  ( NASDAQ:ALLO ) ,https://www.benzinga.com/pressreleases/23/10/g35265639/allogene-therapeutics-appoints-geoffrey-parker-as-chief-financial-officer,2023-10-16 12:30:00,"SOUTH SAN FRANCISCO, Calif., Oct. 16, 2023 ( GLOBE NEWSWIRE ) -- Allogene Therapeutics, Inc. ALLO, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T ( AlloCAR T™ ) products for cancer, has appointed Geoffrey Parker as Executive Vice President, Chief Financial ...",PFE,0.04583,0.063322,Neutral
Pfizer cuts full-year outlook due to declining sales of Covid-19-related products,https://apnews.com/article/pfizer-vaccine-covid-comirnaty-paxlovid-3f3d5291232c08c21fe3a11f143f76ff,2023-10-16 12:21:00,Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are in less than expected and cut revenue expectations for the year by $9 billion.,PFE,0.644033,0.04743,Neutral
"Futures Rise As Netflix, Tesla Earnings Loom",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-netflix-tesla-earnings-loom-lululemon-surges-on-sp-news/,2023-10-16 12:17:00,"Dow Jones futures rose Monday ahead of a big week of earning reports, headlined by Netflix ( NFLX ) and Tesla ( TSLA ) . Meanwhile, Lululemon Athletica ( LULU ) jumped on news that the company will join the S&P 500 index this week.",PFE,0.070207,-0.312709,Somewhat-Bearish
"The daily business briefing: October 16, 2023",https://theweek.com/business/the-daily-business-briefing-october-16-2023,2023-10-16 12:09:57,"2. Taylor Swift's concert movie breaks records 3. Dow, S&P edge higher ahead of wave of earnings 5. Pfizer cuts forecast for Covid vaccine, therapy sales A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek.",PFE,0.099614,-0.026246,Neutral
Novavax  ( NVAX )  Stock Is Falling Today - Here's Why - Novavax  ( NASDAQ:NVAX ) ,https://www.benzinga.com/general/biotech/23/10/35262408/novavax-faces-setback-european-authority-delays-decision-on-variant-tailored-covid-19-vaccine,2023-10-16 12:04:44,"Novavax Inc NVAX faces a setback as the European Medicines Agency ( EMA ) delays a decision on its variant-tailored COVID-19 vaccine. This delay comes at a challenging time for the US-listed biotech, grappling with declining demand for COVID-19 vaccines.",PFE,0.299478,0.188578,Somewhat-Bullish
"Ten Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA",https://www.investors.com/news/tesla-stock-10-most-shorted-stocks-include-3-ev-rivals-but-not-tsla/,2023-10-16 12:01:00,"Tesla ( TSLA ) has a large number of shares sold short, but it's relatively low as share of the float. But three EV makers are among the most-shorted stocks: VinFast Auto ( VFS ) , Fisker ( FSR ) and Faraday Future Intelligent Electric ( FFIE ) .",PFE,0.078226,-0.142144,Neutral
Halozyme Announces Positive Clinical Data of its High-Volume Auto-Injector Demonstrating Successful Rapid Subcutaneous Drug Delivery,https://www.prnewswire.com/news-releases/halozyme-announces-positive-clinical-data-of-its-high-volume-auto-injector-demonstrating-successful-rapid-subcutaneous-drug-delivery-301957079.html,2023-10-16 12:00:00,Halozyme Announces Positive Clinical Data of its High-Volume Auto-Injector Demonstrating Successful Rapid ... PR ...,PFE,0.075754,0.126564,Neutral
"Pfizer Canada Invests in Canadian Innovation, Announcing Winners of Open Call for Healthcare Solutions",https://www.newswire.ca/news-releases/pfizer-canada-invests-in-canadian-innovation-announcing-winners-of-open-call-for-healthcare-solutions-813722249.html,2023-10-16 12:00:00,"With support from Pfizer Canada's Healthcare Hub, selected startups will further develop innovations to foster more patient-centred care at this critical time in healthcare",PFE,0.674163,0.710937,Bullish
"What's Going On With Pfizer  ( PFE )  And BioNTech  ( BNTX )  Stock Today? - Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/10/35260356/pfizer-cuts-annual-revenue-guidance-by-9b-amid-covid-19-vaccine-sales-slump-biontech-warns-900m-w,2023-10-16 11:58:32,"Friday, Pfizer Inc PFE slashed its full-year earnings and revenue guidance, citing decreasing demand for its COVID-19 products. The privatized COVID-19 vaccine distribution system has led to upfront payment requests, which the government previously covered during the public health emergency ...",PFE,0.744646,-0.070653,Neutral
Dietary supplements Market Size to Cross $319.09Bn Globally by 2028 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/10/g35263932/dietary-supplements-market-size-to-cross-319-09bn-globally-by-2028-exclusive-report-by-the-insight,2023-10-16 11:36:40,"Pune, India, Oct. 16, 2023 ( GLOBE NEWSWIRE ) -- According to our latest study on ""Dietary supplements Market Size Report, Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Form, Distribution Channel, and Geography,"" the dietary supplements market is expected to grow from $214.17 ...",PFE,0.03448,0.119329,Neutral
"BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Elbit Systems  ( NASDAQ:ESLT ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/news/23/10/35263882/biontech-moderna-and-other-big-stocks-moving-lower-in-mondays-pre-market-session,2023-10-16 11:33:35,U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today's pre-market trading session. Manchester United plc MANU fell 11.8% to $17.62 in pre-market trading .,PFE,0.443626,-0.160671,Somewhat-Bearish
"Vaccine Stocks-Including Pfizer, Moderna, BioNTech And Novavax-Slide Amid Plummeting Demand",https://www.forbes.com/sites/roberthart/2023/10/16/vaccine-stocks-including-pfizer-moderna-biontech-and-novavax-slide-amid-plummeting-demand/,2023-10-16 11:18:14,Pfizer slashed its revenue forecasts on Friday amid falling demand for its Covid vaccine and antiviral drug Paxlovid.,PFE,0.616842,0.065191,Neutral
It's earnings season. Why Netflix and Nvidia have been crossed off this firm's list for quality stocks.,https://www.marketwatch.com/story/its-earnings-season-why-netflix-and-nvidia-have-been-crossed-off-this-firms-list-for-quality-stocks-51264c43,2023-10-16 10:53:00,A storied investment firm says investors shouldn't pay too much attention to earnings news.,PFE,0.076971,-0.200544,Somewhat-Bearish
Is Novavax Stock a Buy Now?,https://www.fool.com/investing/2023/10/16/is-novavax-stock-a-buy-now/,2023-10-16 10:34:00,Is this company just a pandemic stock?,PFE,0.05234,-0.026996,Neutral
"Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move",https://www.marketwatch.com/story/pfizer-shares-fall-on-guidance-cut-weighing-on-biontech-and-moderna-stocks-and-other-shares-on-the-move-8f868658,2023-10-16 10:09:00,"Shares in Pfizer, BioNTech, Moderna, Manchester United, and Lululemon Atheltica were all active in premarket trading ...",PFE,0.504646,-0.349854,Somewhat-Bearish
"Futures up ahead of earnings and data, Middle East tensions weigh",https://www.reuters.com/markets/us/futures-up-ahead-earnings-data-middle-east-tensions-weigh-2023-10-16/,2023-10-16 09:56:00,"Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., September 28, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",PFE,0.085324,-0.295459,Somewhat-Bearish
Slowing Vaccine Demand To Weigh On BioNTech Profits,https://www.barrons.com/news/slowing-vaccine-demand-to-weigh-on-biontech-profits-f8d82a78,2023-10-16 09:39:00,"German vaccine-maker BioNTech said Monday its earnings would take a hit as demand for its coronavirus jab slowed. BioNTech, which developed and marketed the first coronavirus vaccine together with the US pharma company Pfizer, said in a statement it would likely write off up to 900 million euros ...",PFE,0.538389,0.036792,Neutral
BioNTech will likely take 900 mln eur write-off on Pfizer-partnered vaccines,https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-will-likely-take-900-mln-eur-write-off-pfizer-partnered-vaccines-2023-10-16/,2023-10-16 07:59:00,"A vial of Biontech-Pfizer's Comirnaty vaccine against COVID-19 and syringes are seen during vaccination at the Institute for Health and Food Safety of Zenica, Bosnia and Herzegovina, December 16, 2021. REUTERS/Dado Ruvic/File photo Acquire Licensing Rights",PFE,0.504646,-0.111086,Neutral
European shares rise on mining boost; investors eye Middle East conflict,https://www.reuters.com/markets/europe/european-shares-rise-mining-boost-investors-eye-middle-east-conflict-2023-10-16/,2023-10-16 07:33:00,European shares rise on mining boost. investors eye Middle East conflict ...,PFE,0.185306,-0.211741,Somewhat-Bearish
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023,https://www.globenewswire.com/news-release/2023/10/16/2760330/0/en/BioNTech-to-Present-Multiple-Program-Updates-Across-Modalities-at-ESMO-Congress-2023.html,2023-10-16 07:30:00,"MAINZ, Germany, October 16, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) will present data across its oncology pipeline, covering multiple solid tumor types and novel mechanisms of action, at the European Society for Molecular Oncology ( ""ESMO"" ) Congress 2023 in Madrid, ...",PFE,0.024421,0.018678,Neutral
Update Regarding Pfizer's Statement on COMIRNATY-Related Write-Offs,https://www.globenewswire.com/news-release/2023/10/16/2760318/0/en/Update-Regarding-Pfizer-s-Statement-on-COMIRNATY-Related-Write-Offs.html,2023-10-16 07:00:00,"MAINZ, Germany, October 16, 2023 ( GLOBE NEWSWIRE ) -- On October 13, 2023, Pfizer Inc. ( NYSE: PFE, ""Pfizer"" ) , a collaboration partner of BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) , announced a non-cash charge for inventory write-offs and other charges related to COMIRNATY of ...",PFE,0.291471,0.080228,Neutral
"Pfizer, Charles Schwab And 3 Stocks To Watch Heading Into Monday - HDFC Bank  ( NYSE:HDB ) , FB Financial  ( NYSE:FBK ) ",https://www.benzinga.com/news/earnings/23/10/35258125/pfizer-charles-schwab-and-3-stocks-to-watch-heading-into-monday,2023-10-16 05:36:06,"With U.S. stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects The Charles Schwab Corporation SCHW to report quarterly earnings at 75 cents per share on revenue of $4.66 billion before the opening ...",PFE,0.507932,-0.39174,Bearish
Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023,https://www.prnewswire.com/news-releases/astellas-to-share-new-data-across-hard-to-treat-cancers-during-esmo-congress-2023-301956897.html,2023-10-15 22:37:00,"Data include three late-breaking abstracts, underscoring Astellas' efforts to potentially redefine expectations for patients across its oncology portfolio",PFE,0.132611,0.184301,Somewhat-Bullish
"Arvinas and Pfizer Announce Upcoming Vepdegestrant  ( ARV-471 )  Poster Presentation at ESMO Congress 2023 - Arvinas  ( NASDAQ:ARVN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/10/g35257417/arvinas-and-pfizer-announce-upcoming-vepdegestrant-arv-471-poster-presentation-at-esmo-congress-20,2023-10-15 22:05:45,"NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ARVN and Pfizer Inc. PFE today announced they will present updated Phase 1/2 data for vepdegestrant ( ARV-471 ) at the 2023 European Society for Medical Oncology ( ESMO ) Annual Congress.",PFE,0.519985,0.269304,Somewhat-Bullish
Arvinas and Pfizer Announce Upcoming Vepdegestrant  ( ARV-471 )  Poster Presentation at ESMO Congress 2023,https://www.globenewswire.com/news-release/2023/10/15/2760265/0/en/Arvinas-and-Pfizer-Announce-Upcoming-Vepdegestrant-ARV-471-Poster-Presentation-at-ESMO-Congress-2023.html,2023-10-15 22:05:00,"NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ( Nasdaq: ARVN ) and Pfizer Inc. ( NYSE: PFE ) today announced they will present updated Phase 1/2 data for vepdegestrant ( ARV-471 ) at the 2023 European Society for Medical Oncology ( ESMO ) Annual Congress.",PFE,0.494517,0.267746,Somewhat-Bullish
Why You Should Invest In Healthcare Stocks,https://www.kiplinger.com/investing/healthcare-stocks/why-you-should-invest-in-healthcare-stocks,2023-10-15 14:00:59,"Healthcare stocks have had a rough few years. So why invest in them? First, I'm a contrarian. I like what's down. Second, healthcare is a booming industry, accounting for 18% of gross domestic product ( GDP ) in 2021, up from 12% in 1991. Third, the sector adds stability to any portfolio.",PFE,0.099752,-0.01214,Neutral
2 Dirt Cheap High-Yield Dividend Stocks to Buy Right Now,https://www.fool.com/investing/2023/10/15/2-dirt-cheap-high-yield-dividend-stocks-to-buy/,2023-10-15 14:00:00,These companies aren't getting the respect they deserve.,PFE,0.522854,0.36755,Bullish
"The Real Meaning Of ""Integrity"" In Financial Planning",https://www.forbes.com/sites/timmaurer/2023/10/15/the-real-meaning-of-integrity-in-financial-planning/,2023-10-15 11:00:00,"Some words get overused so that their true meaning is obscured. But ""integrity"" is worth a revisit because its essence is powerful and directive in our financial planning ...",PFE,0.052918,0.0,Neutral
"1 Big Risk Facing Ozempic, Wegovy, and Other GLP-1 Weight-Loss Drugs",https://www.fool.com/investing/2023/10/14/1-big-risk-facing-ozempic-wegovy-and-other-glp-1/,2023-10-14 14:23:00,Can concerns about side effects derail the growth of these incredibly popular drugs?,PFE,0.066047,0.10158,Neutral
Pfizer Launches $3.5 Billion Cost-Cutting Program Amid Declining Covid Vaccine Sales,https://www.forbes.com/sites/antoniopequenoiv/2023/10/13/pfizer-launches-35-billion-cost-cutting-program-amid-declining-covid-vaccine-sales/,2023-10-13 23:43:56,The pharmaceutical company warned in January it expected revenue for its Covid vaccine and Paxlovid pill to drop sharply.,PFE,0.572601,0.075535,Neutral
"Pfizer's stock sinks after company slashes $9 billion from outlook, foreshadows layoffs",https://www.marketwatch.com/story/pfizers-stock-sinks-after-company-cuts-outlook-on-lower-demand-for-covid-products-c84f7c93,2023-10-13 21:53:00,Pfizer and biotech drug maker shares fell after Pfizer slashed its full-year earnings outlook due to a drop in demand for COVID pills and more.,PFE,0.86509,0.016694,Neutral
"Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump",https://www.cnbc.com/2023/10/13/pfizer-cuts-earnings-revenue-guidance-as-covid-sales-slump.html,2023-10-13 21:47:18,Pfizer said it anticipates sales of its Covid treatment Paxlovid and its vaccine will be $9 billion less than it had expected.,PFE,0.666827,-0.30013,Somewhat-Bearish
"Pfizer lowers full-year revenue forecast, shares fall",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-lowers-full-year-revenue-forecast-shares-fall-2023-10-13/,2023-10-13 20:48:00,"A company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights Oct 13 ( Reuters ) - Pfizer Inc ( PFE.N ) on Friday cut forecast for 2023 revenue to between $58 billion and $61 billion, from $67 billion to $70 billion ...",PFE,0.879272,-0.12214,Neutral
FDA Approves Pfizer's  ( PFE )  Braftovi + Mektovi for Lung Cancer,https://www.zacks.com/stock/news/2165823/fda-approves-pfizers-pfe-braftovi-mektovi-for-lung-cancer,2023-10-13 16:30:00,Pfizer's (PFE) Braftovi + Mektovi drug combo gets label expansion for BRAF V600E-mutant non-small cell lung cancer.,PFE,0.434142,0.245377,Somewhat-Bullish
"FDA OKs Pfizer's New Bowel Disease Drug, Analysts Predict Peak Sales Of $3B A Year - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/10/35243580/fda-oks-pfizers-new-bowel-disease-drug-analysts-predict-peak-sales-of-3b-a-year,2023-10-13 16:26:56,"The Food and Drug Administration ( FDA ) approved Pfizer Inc's PFE Velsipity ( etrasimod ) , an oral, once-daily, selective sphingosine-1-phosphate ( S1P ) receptor modulator for adults with moderately to severely active ulcerative colitis ( UC ) .",PFE,0.573213,0.359332,Bullish
"New RSV protections for infants hit cost, insurance hurdles in U.S. rollout",https://www.cnbc.com/2023/10/13/new-rsv-shots-for-infants-abrysvo-and-beyfortus-face-hurdles-in-us.html,2023-10-13 16:22:28,"Pfizer's maternal vaccine, Abrysvo, and Sanofi's monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this year.",PFE,0.102449,0.07366,Neutral
Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics,https://www.prnewswire.com/news-releases/growing-geriatric-population-fuels-ankylosing-spondylitis-market-management-of-pain-and-mobility-gains-importance-in-aging-demographics-301956060.html,2023-10-13 15:45:00,Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance ... PR ...,PFE,0.073209,0.08925,Neutral
Novavax says new COVID shot now available in many U.S. pharmacies,https://www.reuters.com/business/healthcare-pharmaceuticals/novavaxs-updated-covid-19-vaccines-available-us-pharmacies-2023-10-13/,2023-10-13 13:48:00,"Syringes with needles are seen in front of a displayed Novavax logo in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",PFE,0.229149,-0.056397,Neutral
"Pharma Stock Roundup: LLY Meets IBD Study Goal, PFE, MRK Give Cancer Pipeline Updates",https://www.zacks.com/stock/news/2165526/pharma-stock-roundup-lly-meets-ibd-study-goal-pfe-mrk-give-cancer-pipeline-updates,2023-10-13 13:41:00,"Eli Lilly's (LLY) mirikizumab meets the main goals in a Crohn's disease study. PFE, MRK and JNJ provide updates on cancer drugs in their pipeline.",PFE,0.119235,-0.11971,Neutral
U.S. FDA approves Pfizer's inflammatory bowel disease drug,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-inflammatory-bowel-disease-drug-2023-10-13/,2023-10-13 13:11:51,"A company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights Oct 13 ( Reuters ) - Pfizer said on Friday that the U.S. Food and Drug Administration has approved its drug to treat adults with moderate-to-severe inflammatory ...",PFE,0.82082,0.211734,Somewhat-Bullish
First on : HHS awards more than $500 million to study Covid-19 vaccine nasal sprays and more,https://www.cnn.com/2023/10/13/health/hhs-project-nextgen-covid/index.html,2023-10-13 12:00:00,First on CNN: HHS awards more than $500 million to study Covid-19 vaccine nasal sprays and more ...,PFE,0.042876,-0.02284,Neutral
Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team,https://www.globenewswire.com/news-release/2023/10/13/2759874/0/en/Fortrea-Appoints-Life-Science-Executive-Dr-John-Doyle-to-Lead-Consulting-Team.html,2023-10-13 11:00:00,"Industry veteran brings more than three decades of experience spanning R&D, commercialization, and market access Industry veteran brings more than three decades of experience spanning R&D, commercialization, and market access ...",PFE,0.060541,0.143068,Neutral
"5 things to know for Oct. 13: Israel, House speaker, Covid-19, Medicare, TikTok",https://www.cnn.com/2023/10/13/us/5-things-to-know-for-oct-13-israel-house-speaker-covid-19-medicare-tiktok/index.html,2023-10-13 10:41:00,"5 things to know for Oct. 13: Israel, House speaker, Covid-19, Medicare, ...",PFE,0.033144,0.08015,Neutral
"'Pat McAfee Show' Has Paid Aaron Rodgers Over $1 Million For Appearances, Report Says",https://www.forbes.com/sites/dereksaul/2023/10/12/pat-mcafee-show-has-paid-aaron-rodgers-over-1-million-for-appearances-report-says/,2023-10-12 19:10:16,"Rodgers ""deserves more"" than that, Pat McAfee told the New York Post.",PFE,0.083833,-0.021859,Neutral
"Despite rocky rollout, more than 7 million Americans have received updated Covid-19 vaccines, HHS says",https://www.cnn.com/2023/10/12/health/hhs-covid-vaccine/index.html,2023-10-12 18:58:00,"This year's uptake of the updated Covid-19 vaccine appears to be somewhat slower than last year's, according to data from the US Department of Health and Human Services and the US Centers for Disease Control and Prevention. More than 7 million Americans have received a dose of the latest ...",PFE,0.056943,0.105942,Neutral
ETFs to Benefit From the Historic Exxon-Pioneer Oil Merger,https://www.zacks.com/stock/news/2164926/etfs-to-benefit-from-the-historic-exxon-pioneer-oil-merger,2023-10-12 14:05:00,"The largest U.S. oil producer, Exxon Mobil Corp. (XOM) has agreed to acquire Pioneer Natural Resources (PXD) in an all-stock deal valued at $59.5 billion or $253 per share.",PFE,0.082393,0.038707,Neutral
VitaDAO Community Approves Launch and Financing of Its First Biotech Company,https://www.prnewswire.com/news-releases/vitadao-community-approves-launch-and-financing-of-its-first-biotech-company-301955044.html,2023-10-12 14:00:00,"ROCHESTER, N.Y., Oct. 12, 2023 /PRNewswire/ -- VitaDAO, the global online community driving early-stage longevity research through innovative funding collaborations announced today the launch of its very first biotech company, Matrix Biosciences.",PFE,0.064104,0.212404,Somewhat-Bullish
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations - Cardiol Therapeutics  ( NASDAQ:CRDL ) ,https://www.benzinga.com/general/biotech/23/10/35220787/cardiol-therapeutics-fights-heart-inflammation-with-novel-formulations,2023-10-12 13:53:19,"697,000 people die from heart disease every year in the United States - that is one in every five deaths. In fact, cardiovascular disease is the number one killer for most Americans per the CDC. Everyday life choices play an essential role in heart health, and sometimes unfortunate accidents can ...",PFE,0.033328,-0.056748,Neutral
"Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields - Pfizer  ( NYSE:PFE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/news/23/10/35219939/wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-4-dividend-yields,2023-10-12 13:19:23,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",PFE,0.104228,0.159619,Somewhat-Bullish
"The Zacks Analyst Blog UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer",https://www.zacks.com/stock/news/2164828/the-zacks-analyst-blog-unitedhealth-chevron-astrazeneca-adobe-and-pfizer,2023-10-12 12:31:00,"UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer are part of the Zacks Analyst Blog.",PFE,0.152983,0.040903,Neutral
The Fall Vaccination Season Is Here. Is Novavax a Buy?,https://www.fool.com/investing/2023/10/12/fall-vaccine-season-is-here-is-novavax-a-buy/,2023-10-12 10:00:00,Novavax shares have declined 28% this year.,PFE,0.20537,0.088114,Neutral
FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot- Care Access,https://www.reuters.com/business/healthcare-pharmaceuticals/fda-finds-no-misconduct-trial-sites-pfizers-lyme-disease-shot-care-access-2023-10-11/,2023-10-11 17:21:00,"Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights",PFE,0.426225,-0.059689,Neutral
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/10/35199124/looking-at-pfizers-recent-unusual-options-activity,2023-10-11 17:01:23,"A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 15 strange trades. If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish expectations and ...",PFE,0.733479,0.25927,Somewhat-Bullish
Ventyx  ( VTYX )  Down Despite Positive Ulcerative Colitis Study Data,https://www.zacks.com/stock/news/2164407/ventyx-vtyx-down-despite-positive-ulcerative-colitis-study-data,2023-10-11 15:37:00,"Ventyx Biosciences (VTYX) announces positive top-line data from a phase II study evaluating its pipeline candidate, VTX002, for treating moderate-to-severely active ulcerative colitis. Stock down.",PFE,0.193207,0.12783,Neutral
Petrie joins Wall Street powerhouses on Exxon-Pioneer megadeal,https://www.reuters.com/markets/deals/petrie-joins-wall-street-powerhouses-exxon-pioneer-megadeal-2023-10-11/,2023-10-11 13:41:00,Petrie joins Wall Street powerhouses on ...,PFE,0.095138,0.039744,Neutral
"Alation Announces ALLIE AI as a Co-Pilot for AI Engineers, Data Analysts, and Data Stewards to Accelerate Time-To-Value",https://www.benzinga.com/pressreleases/23/10/g35192311/alation-announces-allie-ai-as-a-co-pilot-for-ai-engineers-data-analysts-and-data-stewards-to-accel,2023-10-11 13:02:00,"REDWOOD CITY, Calif., Oct. 11, 2023 ( GLOBE NEWSWIRE ) -- Alation, Inc., the data intelligence company, today announced ALLIE AI, a co-pilot to increase the productivity of AI engineers, data analysts, and data stewards.",PFE,0.049629,0.217643,Somewhat-Bullish
Alation Introduces Alation Analytics Cloud to Help Organizations Measure the Business Value of Their Data Initiatives,https://www.benzinga.com/pressreleases/23/10/g35192309/alation-introduces-alation-analytics-cloud-to-help-organizations-measure-the-business-value-of-the,2023-10-11 13:02:00,"REDWOOD CITY, Calif., Oct. 11, 2023 ( GLOBE NEWSWIRE ) -- Alation, Inc., the data intelligence company, today announced Alation Analytics Cloud1, a unified reporting platform.",PFE,0.047371,0.214248,Somewhat-Bullish
GSK Settles Zantac Cases After Claims Popular Heartburn Drug Causes Cancer,https://www.forbes.com/sites/roberthart/2023/10/11/gsk-settles-zantac-cases-after-claims-popular-heartburn-drug-causes-cancer/,2023-10-11 12:30:39,"The pharma giant settled four cases in California for an undisclosed amount to avoid the ""distraction"" of a trial.",PFE,0.082111,-0.050678,Neutral
"The Zacks Analyst Blog Highlights Bristol Myers Squibb, Mirati Therapeutics, Eli Lilly, POINT Biopharma and Pfizer",https://www.zacks.com/stock/news/2164151/the-zacks-analyst-blog-highlights-bristol-myers-squibb-mirati-therapeutics-eli-lilly-point-biopharma-and-pfizer,2023-10-11 11:56:00,"Bristol Myers Squibb, Mirati Therapeutics, Eli Lilly, POINT Biopharma and Pfizer are part of the Zacks top Analyst Blog.",PFE,0.234684,0.048244,Neutral
"Veterinary Diagnostics Market $7.27 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35189513/veterinary-diagnostics-market-7-27-billion-globally-by-2030-exclusive-report-by-the-insight-partne,2023-10-11 11:47:06,"Pune, India, Oct. 11, 2023 ( GLOBE NEWSWIRE ) -- According to our new research study on ""Veterinary Diagnostics Market Size and Forecast ( 2020-2030 ) , Global and Regional Share, Trend, and Growth Opportunity Analysis Coverage: Product ( Instruments and Consumables ) , Technology ( ...",PFE,0.018787,-0.001782,Neutral
24 Leading Companies Join New U.S. Initiative to Help Hispanic Refugees Advance Their Careers,https://www.prnewswire.com/news-releases/24-leading-companies-join-new-us-initiative-to-help-hispanic-refugees-advance-their-careers-301952947.html,2023-10-11 11:00:00,"Businesses including Bank of America, Diageo North America, Google, Hilton, Marriott International, and TelevisaUnivision join the Tent Partnership for Refugees' new Hispanic Refugee Mentorship Program",PFE,0.041901,0.1004,Neutral
2 Exciting Biotech Stocks to Buy With Less Than $10,https://www.fool.com/investing/2023/10/11/2-exciting-biotech-stocks-to-buy-with-less-than-10/,2023-10-11 10:00:00,You can pick up these stocks for a song right now.,PFE,0.281153,0.227989,Somewhat-Bullish
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?,https://www.fool.com/investing/2023/10/11/vaccine-market-is-changing-shoud-you-invest/,2023-10-11 09:30:00,Vaccine revenue may have slipped but could still represent billions of dollars for these companies.,PFE,0.211652,0.008524,Neutral
Get to know the 2023 Nobel Prize winners,https://theweek.com/science/get-to-know-the-2023-nobel-prize-winners,2023-10-11 08:45:38,Meet this year's Nobel Prize winners The Week ...,PFE,0.023885,0.07818,Neutral
"Antihypertensive Drugs Market to Exceed USD 40 billion by 2031, Evolving at a CAGR of 3% - Exclusive Report by Transparency Market Research",https://www.benzinga.com/pressreleases/23/10/g35183313/antihypertensive-drugs-market-to-exceed-usd-40-billion-by-2031-evolving-at-a-cagr-of-3-exclusive-r,2023-10-11 07:16:41,"Wilmington, Delaware, United States, Oct. 11, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global antihypertensive drugs market is expected to develop at a CAGR of 3.0% from 2021 to 2031. The market is likely to exceed US$ 40 billion by the end of 2031.",PFE,0.087344,-0.08712,Neutral
Aaron Rodgers Challenges Travis Kelce To Debate Vaccine Safety With RFK Jr. And Fauci,https://www.forbes.com/sites/anafaguy/2023/10/10/aaron-rodgers-challenges-travis-kelce-to-debate-vaccine-safety-with-rfk-jr-and-fauci/,2023-10-10 21:12:53,"Last week, Rodgers made fun of Kelce for his appearance in a Pfizer advertisement, dubbing him ""Mr. ...",PFE,0.271576,-0.010313,Neutral
Big Pharma Could Transform Into BioTech Pharma - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/penny-stocks/23/10/35168562/big-pharma-could-transform-into-biotech-pharma,2023-10-10 17:53:42,"As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall health of the planet that is only our home.",PFE,0.293038,-0.002182,Neutral
Why Shares of Ventyx Biosciences Are Dropping Tuesday,https://www.fool.com/investing/2023/10/10/why-shares-of-ventyx-biosciences-are-dropping-tues/,2023-10-10 16:55:00,Investors were unimpressed by the company's trial results for an ulcerative colitis therapy.,PFE,0.258351,0.212131,Somewhat-Bullish
"Mana.bio Advances AI-Based Lipid Nanoparticle  ( LNP )  Platform to Accelerate ""Programmable Drug Delivery"" for RNA and Gene Therapies",https://www.prnewswire.com/news-releases/manabio-advances-ai-based-lipid-nanoparticle-lnp-platform-to-accelerate-programmable-drug-delivery-for-rna-and-gene-therapies-301952340.html,2023-10-10 16:30:00,"Mana.bio Advances AI-Based Lipid Nanoparticle ( LNP ) Platform to Accelerate ""Programmable Drug Delivery"" for RNA ... PR ...",PFE,0.03443,0.083694,Neutral
Novavax  ( NVAX )  Focuses on Diversifying Vaccines Portfolio,https://www.zacks.com/stock/news/2163659/novavax-nvax-focuses-on-diversifying-vaccines-portfolio,2023-10-10 16:04:00,"Owing to the slow uptake of Novavax's (NVAX) COVID-19 vaccine, the company is trying to develop other vaccine candidates targeting different indications.",PFE,0.366061,-0.012901,Neutral
Cancer Biotechs Pique Buyout Interest: Recent Deals in Focus,https://www.zacks.com/stock/news/2163363/cancer-biotechs-pique-buyout-interest-recent-deals-in-focus,2023-10-10 15:37:00,The M&A trend of 2023 shows that there is an increasing interest in biotech companies making innovative cancer treatments.,PFE,0.195287,0.059242,Neutral
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company,https://www.cnbc.com/2023/10/10/ozempic-wegovy-novo-nordisk.html,2023-10-10 15:00:01,"Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history - thanks to its newfound success with two products: Ozempic and Wegovy. The drugs are once-weekly injectables of a medication called semaglutide, prescribed for Type 2 diabetes and weight loss.",PFE,0.104228,-0.004395,Neutral
BEAM Focuses on Developing Gene Drug for Growth,https://www.zacks.com/stock/news/2163582/beam-focuses-on-developing-gene-drug-for-growth,2023-10-10 14:06:00,"While BEAM's pipeline candidates are in early-stage clinical studies, their development is progressing well. Collaborations are a primary source of revenues in the absence of a marketed product.",PFE,0.237358,0.293729,Somewhat-Bullish
"IBN Announces Latest Episode of The Bell2Bell Podcast featuring Rob Etherington, CEO of Clene Inc.",https://www.benzinga.com/pressreleases/23/10/g35160236/ibn-announces-latest-episode-of-the-bell2bell-podcast-featuring-rob-etherington-ceo-of-clene-inc,2023-10-10 12:17:00,"LOS ANGELES, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to ...",PFE,0.028695,0.182241,Somewhat-Bullish
"Fibrin Sealants Market Size to Hit USD 2 billion in 2031, to Expand at a CAGR of 6.7% - Exclusive Report by Transparency Market Research",https://www.benzinga.com/pressreleases/23/10/g35158953/fibrin-sealants-market-size-to-hit-usd-2-billion-in-2031-to-expand-at-a-cagr-of-6-7-exclusive-repo,2023-10-10 11:30:00,"Wilmington, Delaware, United States, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global fibrin sealants market stood at US$ 1.04 billion in 2021, and the global market is projected to reach US$ 2 billion in 2031.",PFE,0.041828,0.0,Neutral
"Shake it off: Travis Kelce hip to Taylor Swift's lyrics as he slips free from injury, Rodgers insult",https://apnews.com/article/behind-call-kelce-rodgers-2f0725e098511f88ba36a25faa760503,2023-10-10 10:00:00,"Need another sign that Travis Kelce and Taylor Swift are simply meant to be together or ""Tayvis"" or besties or whatever it is they are? How about this: the Kansas City Chiefs star tight end just spent Week 5 dealing with both a gnarly-looking sprained ankle and a needless dig from Aaron Rodgers ...",PFE,0.296463,0.167273,Somewhat-Bullish
Pfizer  ( PFE )  Rises Yet Lags Behind Market: Some Facts Worth Knowing,https://www.zacks.com/stock/news/2162957/pfizer-pfe-rises-yet-lags-behind-market-some-facts-worth-knowing,2023-10-09 21:45:18,"Pfizer (PFE) concluded the recent trading session at $33.20, signifying a +0.21% move from its prior day's close.",PFE,0.538782,0.276462,Somewhat-Bullish
"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight",https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-factor-based-bleeding-disorders-hemophilia-a-hemophilia-b-and-von-willebrand-disease--key-analysis-by-delveinsight-301950491.html,2023-10-09 21:01:00,"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand ... PR ...",PFE,0.036338,0.034129,Neutral
Penny Stocks To Buy This Week? Analysts Like These 3,https://pennystocks.com/featured/2023/10/09/penny-stocks-to-buy-this-week-analysts-like-these-3/,2023-10-09 20:06:08,"Penny Stocks: Using Analyst Sentiment and Research for Smart Trading Penny stocks are shares of small companies priced under $5 per share. While the potential returns can be alluring, penny stocks carry high risk. Thorough research is essential before trading.",PFE,0.031446,-0.001896,Neutral
Gates Foundation donates $40M to enhance accessibility to mRNA vaccines - .com,https://www.upi.com/Top_News/World-News/2023/10/09/bill-melinda-gates-mrna-research/7601696879247/,2023-10-09 19:59:43,Gates Foundation donates $40M to enhance accessibility to mRNA vaccines UPI News ...,PFE,0.112008,0.070819,Neutral
"Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand - Novavax  ( NASDAQ:NVAX ) ",https://www.benzinga.com/general/biotech/23/10/35149072/timing-favors-novavaxs-delayed-approval-arrival-ahead-of-peak-covid-vaccine-demand,2023-10-09 18:23:27,"Last week, Novavax Inc NVAX received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in individuals aged 12 and older. Wall Street analysts are optimistic about Novavax's prospects despite its vaccine's release delay compared to Pfizer Inc PFE and ...",PFE,0.570165,0.253677,Somewhat-Bullish
"Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand",https://markets.businessinsider.com/news/stocks/timing-favors-novavax-s-delayed-approval-arrival-ahead-of-peak-covid-vaccine-demand-1032689900,2023-10-09 18:23:27,"Last week, Novavax Inc ( NASDAQ:NVAX ) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in individuals aged 12 and older.",PFE,0.470894,0.230886,Somewhat-Bullish
"Privatized Vaccine Distribution Sparks Confusion, Payment Challenges - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/10/35147852/privatized-vaccine-distribution-sparks-confusion-payment-challenges,2023-10-09 16:40:19,"As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.",PFE,0.423251,0.0,Neutral
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/general/biotech/23/10/35142181/weight-loss-drug-boom-has-another-ripple-effect-rapid-growth-expected-in-fill-finish-market,2023-10-09 15:21:29,Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's NVO Wegovy.,PFE,0.272788,0.091076,Neutral
Investors Heavily Search Pfizer Inc.  ( PFE ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2162511/investors-heavily-search-pfizer-inc-pfe-here-is-what-you-need-to-know,2023-10-09 13:00:12,"Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",PFE,0.489394,0.13199,Neutral
Dyadic Appoints Doug Pace to Its Executive Leadership Team,https://www.globenewswire.com/news-release/2023/10/09/2756672/0/en/Dyadic-Appoints-Doug-Pace-to-Its-Executive-Leadership-Team.html,2023-10-09 12:30:00,"JUPITER, Fla., Oct. 09, 2023 ( GLOBE NEWSWIRE ) -- Dyadic International, Inc. ( ""Dyadic"", ""we"", ""us"", ""our"", or the ""Company"" ) ( NASDAQ: DYAI ) , a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and ...",PFE,0.043979,0.02262,Neutral
Dyadic Appoints Doug Pace to Its Executive Leadership Team - Dyadic International  ( NASDAQ:DYAI ) ,https://www.benzinga.com/pressreleases/23/10/g35144167/dyadic-appoints-doug-pace-to-its-executive-leadership-team,2023-10-09 12:30:00,"JUPITER, Fla., Oct. 09, 2023 ( GLOBE NEWSWIRE ) -- Dyadic International, Inc. ( ""Dyadic"", ""we"", ""us"", ""our"", or the ""Company"" ) DYAI, a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet needs ...",PFE,0.0428,0.022552,Neutral
"Antibody Drug Conjugates Market Revenue to Hit $29.6 Billion, Globally, by 2030 - Exclusive Study by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35143608/antibody-drug-conjugates-market-revenue-to-hit-29-6-billion-globally-by-2030-exclusive-study-by-th,2023-10-09 12:04:10,"Pune, India, Oct. 09, 2023 ( GLOBE NEWSWIRE ) -- Antibody drug conjugates ( ADC ) are one of the fastest growing anticancer drugs. It is typically composed of a monoclonal antibody ( mAbs ) covalently attached to a cytotoxic drug via a chemical linker.",PFE,0.04406,0.092172,Neutral
Gates Foundation funding $40 mn to help develop mRNA vaccines in Africa,https://www.business-standard.com/world-news/gates-foundation-funding-40-mn-to-help-develop-mrna-vaccines-in-africa-123100900749_1.html,2023-10-09 11:51:40,"A $ 40 million investment will help several African manufacturers produce new messenger RNA vaccines on the continent where people were last in line to receive jabs during the COVID-19 pandemic, the Bill and Melinda Gates Foundation announced Monday.",PFE,0.064623,0.0,Neutral
Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel,https://www.prnewswire.com/news-releases/protalix-biotherapeutics-issues-statement-regarding-security-situation-in-israel-301950666.html,2023-10-09 10:50:00,"CARMIEL, Israel, Oct. 9, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. ( NYSE American:PLX ) , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein ...",PFE,0.06179,0.078044,Neutral
Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming years,https://apnews.com/article/bill-gates-foundation-africa-vaccines-mrna-institut-pasteur-biovac-fa28c0502925a4152df1709cc8f228fe,2023-10-09 10:46:00,"DAKAR, Senegal ( AP ) - A $40 million investment will help several African manufacturers produce new messenger RNA vaccines on the continent where people were last in line to receive jabs during the COVID-19 pandemic, the Bill & Melinda Gates Foundation announced Monday.",PFE,0.066047,-0.021093,Neutral
VitaDAO Launches Biotech Firm to Fight Aging With Naked Mole-Rats,https://decrypt.co/200643/vitadao-matrix-biosciences-longevity-aging,2023-10-09 07:01:02,The decentralized collective and a noted biologist launched Matrix Biosciences to research longevity.,PFE,0.088147,0.0,Neutral
Pfizer  ( NYSE:PFE )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/10/09/pfizer-nysepfe-research-coverage-started-at-stocknews-com.html,2023-10-09 05:30:44,StockNews.com assumed coverage on shares of Pfizer ( NYSE:PFE - Free Report ) in a report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company's stock. PFE has been the topic of a number of other research reports.,PFE,0.883048,0.419739,Bullish
Weight-loss drugs fuel boom for firms that fill syringes,https://www.reuters.com/business/healthcare-pharmaceuticals/weight-loss-drugs-fuel-boom-firms-that-fill-syringes-2023-10-09/,2023-10-09 05:15:08,"A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration//File Photo Acquire Licensing Rights",PFE,0.042346,0.047605,Neutral
Nobel Prize winner Katalin Karikó raised a two-time Olympic gold medalist: Here's her No. 1 piece of parenting advice,https://www.cnbc.com/2023/10/08/nobel-prize-winner-raised-a-two-time-olympic-gold-medalist-.html,2023-10-08 15:00:02,"Karikó's persistence and confidence didn't just make her a good scientist, she says. Those qualities also made her a good parent.",PFE,0.069495,0.289155,Somewhat-Bullish
New COVID shots still hard to find for some Americans,https://www.reuters.com/business/healthcare-pharmaceuticals/new-covid-shots-still-hard-find-some-americans-2023-10-08/,2023-10-08 12:05:00,"The word ""COVID-19"" is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",PFE,0.125898,0.020693,Neutral
"Apple, Fed Meeting, Caterpillar, Jobs Report; Investing Action Plan",https://www.investors.com/research/investing-action-plan/apple-fed-meeting-caterpillar-jobs-report-investing-action-plan/,2023-10-27 21:53:00,"Apple, Fed Meeting, Caterpillar, Jobs Report. Investing Action Plan Investor's Business Daily ...",PFE,0.069951,0.019329,Neutral
COVID-19 treatments to enter the market with a hefty price tag,https://apnews.com/article/covid19-paxlovid-treatment-coronavirus-drugs-5ea6124208e915382c40303bd6d749ef,2023-10-27 21:41:00,"WASHINGTON ( AP ) - The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag. Pharmaceutical giant Pfizer is setting the price for a at $1,390, but Americans can still access the pills at no cost ...",PFE,0.366061,0.305941,Somewhat-Bullish
"Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets - CVS Health  ( NYSE:CVS ) , Enphase Energy  ( NASDAQ:ENPH ) , Alphabet  ( NASDAQ:GOOGL ) , Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/news/earnings/23/10/35474151/bears-roam-wall-street-as-middle-east-conflict-earnings-outlook-raise-concerns-despite-strong-q3-us,2023-10-27 20:33:57,"It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S. corporations.",PFE,0.09347,0.0,Neutral
"Top Research Reports for Costco, Pfizer & IBM",https://www.zacks.com/research-daily/2173509/top-research-reports-for-costco-pfizer-ibm,2023-10-27 20:28:00,"Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp. (COST), Pfizer Inc. (PFE) and IBM Corp. (IBM).",PFE,0.338582,0.369036,Bullish
US shifting COVID antivirals to commercial market on Nov. 1,https://www.reuters.com/business/healthcare-pharmaceuticals/us-shifting-covid-antivirals-commercial-market-nov-1-2023-10-27/,2023-10-27 19:43:00,US shifting COVID antivirals to commercial market on Nov. ...,PFE,0.224903,0.185402,Somewhat-Bullish
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX,https://www.benzinga.com/pressreleases/23/10/g35470462/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-biontech-se-bnt,2023-10-27 17:48:50,"NEW YORK, Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE ( ""BioNTech"" or the ""Company"" ) BNTX. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",PFE,0.393462,-0.061662,Neutral
"FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/10/35465199/fda-gives-nod-to-eli-lillys-first-treatment-for-type-of-inflammatory-bowel-disease-to-compete-wit,2023-10-27 14:28:19,"The FDA approved Eli Lilly And Co's LLY Omvoh ( mirikizumab-mrkz ) for moderately to severely active ulcerative colitis ( UC ) in adults, marking Lilly's first approved treatment for a type of inflammatory bowel disease.",PFE,0.2872,0.447515,Bullish
Sanofi loses $21 bn in market value after dropping 2025 profit target,https://www.business-standard.com/companies/news/sanofi-loses-21-bn-in-market-value-after-dropping-2025-profit-target-123102701074_1.html,2023-10-27 14:18:23,"Sanofi stock plunged on Friday, wiping 20 billion euros ( $21 billion ) off its market value, after it abandoned its 2025 profit target under a plan to list its consumer healthcare business to focus on its core innovative drugs business.",PFE,0.049526,0.001999,Neutral
"Pharma Stock Roundup: SNY, MRK, NVS Report Q3 Earnings, FDA Okays PFE, LLY Products",https://www.zacks.com/stock/news/2173795/pharma-stock-roundup-sny-mrk-nvs-report-q3-earnings-fda-okays-pfe-lly-products,2023-10-27 14:05:00,"Merck (MRK), Sanofi (SNY) and Novartis (NVS) report third-quarter results. FDA approves Pfizer's (PFE) Penbraya and Eli ...",PFE,0.294093,0.163231,Somewhat-Bullish
Weight-Loss Beating Continues For Devices Makers; Why It's Overdone,https://www.investors.com/news/technology/weight-loss-drugs-spook-medical-device-stocks-an-overreaction/,2023-10-27 13:00:00,Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors ... Investor's Business Daily ...,PFE,0.034907,0.0,Neutral
AbbVie  ( ABBV )  Q3 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2173589/abbvie-abbv-q3-earnings-and-revenues-beat-estimates,2023-10-27 12:50:04,"AbbVie (ABBV) delivered earnings and revenue surprises of 3.15% and 1.65%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.140485,0.0,Neutral
"The Zacks Analyst Blog Highlights Microsoft, Novo Nordisk A/S and Lowe's",https://www.zacks.com/stock/news/2173468/the-zacks-analyst-blog-highlights-microsoft-novo-nordisk-as-and-lowes,2023-10-27 10:50:00,"Microsoft, Novo Nordisk A/S and Lowe's are included in this Analyst Blog.",PFE,0.071145,0.019439,Neutral
3 Top-Ranked Market Neutral Funds to Hedge Your Risk,https://www.zacks.com/stock/news/2173422/3-top-ranked-market-neutral-funds-to-hedge-your-risk,2023-10-27 08:10:00,"Below, we share with you three market-neutral mutual funds, viz. ADANX, HSGFX and CVSIX. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy).",PFE,0.149192,0.034226,Neutral
"Sanofi shares plunge after 2025 target dropped, consumer unit marked for spin-off",https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-considering-consumer-unit-listing-late-next-year-2023-10-27/,2023-10-27 08:00:00,"Sanofi shares plunge after 2025 target dropped, consumer unit marked for ...",PFE,0.056943,0.002002,Neutral
Sanofi takes page from rivals' separation playbook,https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-takes-page-rivals-separation-playbook-2023-10-27/,2023-10-27 07:36:00,"FILE PHTOO: The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File photo Acquire Licensing Rights",PFE,0.100729,-0.018451,Neutral
Take Five: Central bank trick or treat,https://www.reuters.com/business/take-five/global-markets-themes-graphic-2023-10-27/,2023-10-27 07:25:00,"Oct 27 ( Reuters ) - Central bankers will keep investors on alert in the coming days, with the Bank of Japan, the U.S. Federal Reserve and the Bank of England all due to meet, while Apple tops the bill for earnings on both sides of the Atlantic.",PFE,0.051999,0.0,Neutral
"Pompe Disease Market to Exhibit Significant Growth by 2032, Predicts DelveInsight | Leading Companies - Asklepios Biopharmaceutical, Inc., Astellas Pharma Inc., Amicus Therapeutics, Sanofi, Spark Therapeutics",https://www.prnewswire.com/news-releases/pompe-disease-market-to-exhibit-significant-growth-by-2032-predicts-delveinsight--leading-companies---asklepios-biopharmaceutical-inc-astellas-pharma-inc-amicus-therapeutics-sanofi-spark-therapeutics-301968793.html,2023-10-26 21:01:00,"Pompe Disease Market to Exhibit Significant Growth by 2032, Predicts DelveInsight | Leading Companies - Asklepios ... PR ...",PFE,0.054983,0.021951,Neutral
Neoantigen Cancer Vaccine Market Size is Projected to Reach $1.38 billion by 2030: Straits Research,https://www.benzinga.com/pressreleases/23/10/g35449061/neoantigen-cancer-vaccine-market-size-is-projected-to-reach-1-38-billion-by-2030-straits-research,2023-10-26 19:00:00,"New York, United States, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- Neoantigens that arise from cancer-specific mutations are an additional class of antigens that are desirable for therapeutic cancer vaccines.",PFE,0.04823,-0.002986,Neutral
Q3 Earnings Season Scorecard - Earnings Growth Turns Positive,https://www.zacks.com/research-daily/2172539/q3-earnings-season-scorecard---earnings-growth-turns-positive,2023-10-26 18:36:00,"Today's Research Daily features real-time scorecard of the Q3 earnings season in addition to Microsoft (MSFT), Novo Nordisk (NVO), Lowe's (LOW) and others.",PFE,0.055492,0.019047,Neutral
"Bristol-Myers  ( BMY )  Q3 Earnings & Sales Beat, Opdivo Sales Grow",https://www.zacks.com/stock/news/2173090/bristol-myers-bmy-q3-earnings-sales-beat-opdivo-sales-grow,2023-10-26 16:13:00,Bristol-Myers' (BMY) third-quarter 2023 earnings and sales beat estimates as Opdivo and new products offset losses due to oncology drug Revlimid's generic erosion.,PFE,0.076971,0.175884,Somewhat-Bullish
JNJ: 3 Pharma Stocks on the Rise - Buy Now,https://stocknews.com/news/jnj-azn-sny-3-pharma-stocks-on-the-rise-buy-now/,2023-10-26 15:48:43,"The pharmaceutical industry is set to grow in the coming years thanks to an aging population, chronic diseases, and new technologies. In this article, we'll look at the fundamentals of three pharma stocks, Sanofi ( SNY ) , Johnson & Johnson ( JNJ ) and AstraZeneca PLC ( AZN ) , which can boost ...",PFE,0.068209,0.068173,Neutral
"Scleroderma Market Outlook 2023-2027: Expected Market Size, Growth Drivers, And Key Trends As Per The Business Research Company's Scleroderma Global Market Report 2023",https://www.benzinga.com/pressreleases/23/10/g35444019/scleroderma-market-outlook-2023-2027-expected-market-size-growth-drivers-and-key-trends-as-per-the,2023-10-26 15:30:00,"LONDON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Scleroderma Global Market Report 2023, the global scleroderma market is on an upward trajectory, with expectations of reaching $2.15 billion in 2023, signifying a compound annual growth rate ( CAGR ) of 7.5%.",PFE,0.068698,0.071658,Neutral
"Fatty Liver Treatment Market Is Set To Grow At A CAGR Of 6%, Driven By Rise In Alcohol Consumption As Per The Business Research Company's Fatty Liver Treatment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/10/g35444012/fatty-liver-treatment-market-is-set-to-grow-at-a-cagr-of-6-driven-by-rise-in-alcohol-consumption-a,2023-10-26 15:30:00,"LONDON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Fatty Liver Treatment Global Market Report 2023, the global fatty liver treatment market is gearing up for substantial growth, expected to rise from $20.83 billion in 2022 to $22.17 billion in 2023, with a ...",PFE,0.05749,0.06602,Neutral
Earnings Preview: Eli Lilly  ( LLY )  Q3 Earnings Expected to Decline,https://www.zacks.com/stock/news/2172796/earnings-preview-eli-lilly-lly-q3-earnings-expected-to-decline,2023-10-26 14:02:25,Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PFE,0.175539,-0.025752,Neutral
Jim Cramer's top 10 things to watch in the stock market Thursday,https://www.cnbc.com/2023/10/26/jim-cramers-top-10-things-to-watch-in-the-stock-market-thursday.html,2023-10-26 13:10:18,Stocks are set to open lower as the Street prepares for another busy day of earnings.,PFE,0.101797,-0.029064,Neutral
"Covid shots may slightly increase risk of stroke in older adults, particularly when administered with certain flu vaccines",https://www.cnn.com/2023/10/25/health/covid-flu-vaccine-stroke-risk-study/index.html,2023-10-26 12:24:00,"Vaccines for Covid-19 and influenza may slightly increase the risk of strokes caused by blood clots in the brains of seniors, particularly when the two vaccines are given at the same time and when they are given to adults who are age 85 and older, according to a new study.",PFE,0.068404,-0.018071,Neutral
"Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive data",https://www.cnbc.com/2023/10/26/pfizer-combination-covid-flu-vaccine-shows-positive-trial-data.html,2023-10-26 12:10:45,"Pfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.",PFE,0.634282,0.36164,Bullish
2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive Income,https://www.fool.com/investing/2023/10/26/2-magnifient-dividend-stocks-that-could-deliver-a/,2023-10-26 11:45:00,These two healthcare stocks are proven passive income vehicles.,PFE,0.38489,0.328703,Somewhat-Bullish
"Pfizer, BioNtech say flu-COVID shot generates strong immune response in trial",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-biontech-say-flu-covid-shot-generates-immune-response-2023-10-26/,2023-10-26 11:20:00,"[1/3] A woman receives a booster dose of Pfizer-BioNTech vaccine against the coronavirus disease ( COVID-19 ) in Bangkok, Thailand, January 5, 2023. REUTERS/Athit Perawongmetha/File Photo Acquire Licensing Rights",PFE,0.447528,0.077658,Neutral
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition,https://www.cnbc.com/2023/10/26/bristol-myers-squibb-bmy-q3-earnings-report-2023.html,2023-10-26 11:05:39,"Bristol Myers Squibb's revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.",PFE,0.071357,0.091497,Neutral
A 'new turning point': Patients could soon have a new shot to protect them from deadly meningitis,https://www.cnn.com/2023/10/25/health/meningitis-vaccine-changes/index.html,2023-10-26 10:48:00,"Patti Wukovits still thinks about how she had to bury her daughter in her prom dress. In June 2012, 17-year-old Kimberly Coffey had a fever and body aches. She told her mom it felt like her ankles were bleeding. When Wukovits looked, she noticed a purple rash.",PFE,0.029728,0.326248,Somewhat-Bullish
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19,https://www.globenewswire.com/news-release/2023/10/26/2767318/0/en/Pfizer-and-BioNTech-Announce-Positive-Topline-Data-for-mRNA-based-Combination-Vaccine-Program-Against-Influenza-and-COVID-19.html,2023-10-26 10:45:00,"NEW YORK and MAINZ, GERMANY, October 26, 2023 - Pfizer Inc. ( NYSE: PFE ) and BioNTech SE ( Nasdaq: BNTX ) today announced positive topline results from a Phase 1/2 study ( NCT05596734 ) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for ...",PFE,0.269392,0.043404,Neutral
"Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth",https://www.cnbc.com/2023/10/26/merck-mrk-q3-earnings-report-2023.html,2023-10-26 10:37:36,"Merck's revenue and earnings beat expectations, and it hiked its sales forecast while lowering its profit outlook.",PFE,0.067727,0.074172,Neutral
"A new study flags a link between Covid-19 and influenza vaccines and stroke in older adults, but experts say vaccination is still your best bet",https://www.cnn.com/2023/10/25/health/a-new-study-flags-a-link-between-covid-19-and-influenza-vaccines-and-stroke-in-older-adults-but-experts-say-vaccination-is-still-your-best-bet/index.html,2023-10-25 23:54:35,"Covid shots may slightly increase risk of stroke in older adults, particularly when administered with certain flu vaccines ...",PFE,0.069495,-0.018088,Neutral
America May Be Missing Out on a Better COVID Treatment,https://www.theatlantic.com/health/archive/2023/10/xocova-ensitrelvir-covid-antiviral/675768/,2023-10-25 18:25:39,"Japan is home to an untold number of conveniences and delights that American consumers regularly go without: Faster public transit! Better sunscreen! Lychee KitKats! But as we head into sick season, one Japanese invention would be especially welcome on the U.S. market: an antiviral pill that ...",PFE,0.084821,0.004177,Neutral
Thermo Fisher Scientific  ( TMO )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/10/25/thermo-fisher-scientific-tmo-q3-2023-earnings-call/,2023-10-25 18:00:23,"TMO earnings call for the period ending September 30, 2023.",PFE,0.004951,0.029349,Neutral
"Insiders question WPP CEO Mark Read's bounceback plan after chaotic period of mergers, account losses, and a stock market slump",https://www.businessinsider.com/insiders-question-ad-giant-wpp-ceo-mark-reads-bounceback-plan-2023-10,2023-10-25 17:40:00,Insiders Question Ad Giant WPP CEO Mark Read's Bounceback Plan - Business Insider ...,PFE,0.023079,0.010712,Neutral
Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment,https://www.benzinga.com/pressreleases/23/10/g35420396/valneva-submits-chikungunya-vaccine-marketing-application-to-ema-and-announces-chmp-accelerated-as,2023-10-25 16:15:00,"Saint-Herblain ( France ) , October 25, 2023 - Valneva SE VALNVLA, a specialty vaccine company, today announces the submission of a marketing application with the European Medicines Agency ( EMA ) for approval of the Company's single-shot chikungunya vaccine candidate, VLA1553.",PFE,0.032425,0.086477,Neutral
Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment,https://www.globenewswire.com/news-release/2023/10/25/2766798/0/en/Valneva-Submits-Chikungunya-Vaccine-Marketing-Application-to-EMA-and-Announces-CHMP-Accelerated-Assessment.html,2023-10-25 16:15:00,"Saint-Herblain ( France ) , October 25, 2023 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) , a specialty vaccine company, today announces the submission of a marketing application with the European Medicines Agency ( EMA ) for approval of the Company's single-shot chikungunya vaccine ...",PFE,0.027635,-0.004851,Neutral
Pfizer Unusual Options Activity For October 25 - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/10/35418521/pfizer-unusual-options-activity-for-october-25,2023-10-25 15:16:54,"A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 80% of the investors opened trades with bullish expectations and ...",PFE,0.889109,0.319076,Somewhat-Bullish
Pfizer's Dividend Yield Is Now 5%. Is the Stock a No-Brainer Buy for Income Investors?,https://www.fool.com/investing/2023/10/25/pfizers-divdiend-yield-is-now-5-is-the-stock-a-no/,2023-10-25 13:37:00,The company's strong financials suggest the dividend may still be safe even with a big drop in revenue.,PFE,0.535653,0.053967,Neutral
"Physiological Saline Market Share Worth Nearly $11 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35415543/physiological-saline-market-share-worth-nearly-11-billion-globally-by-2030-exclusive-report-by-the,2023-10-25 13:24:57,"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Physiological saline is also known as normal saline. An isotonic crystalloid solution known as normal saline has a tonicity comparable to that of plasma. An intravenous infusion of normal saline is a sterile solution.",PFE,0.028868,-0.018603,Neutral
RSV vaccine from GSK shows potential to protect adults 50 to 59,https://www.cnbc.com/2023/10/25/gsk-rsv-vaccine-shows-potential-to-protect-adults-50-to-59.html,2023-10-25 12:42:32,"The results suggest that GSK's shot could help protect a wider population from RSV, which causes thousands of hospitalizations and deaths each year.",PFE,0.256538,0.047018,Neutral
Is BioNTech Stock a Buy Now?,https://www.fool.com/investing/2023/10/25/is-biontech-stock-a-buy-now/,2023-10-25 11:00:00,Or is it too late to get in on the company after its coronavirus-related success?,PFE,0.331024,0.002433,Neutral
"Dietary supplements market size to grow by USD 61.4 billion from 2022 to 2027 | Abbott Laboratories, Amway Corp ... - PR Newswire",https://www.prnewswire.com/news-releases/dietary-supplements-market-size-to-grow-by-usd-61-4-billion-from-2022-to-2027--abbott-laboratories-amway-corp-archer-daniels-midland-co-arkopharma-laboratories-and-more-among-the-key-companies-in-the-market---technavio-301966560.html,2023-10-25 03:00:00,"Dietary supplements market size to grow by USD 61.4 billion from 2022 to 2027 | Abbott Laboratories, Amway Corp ... PR ...",PFE,0.076602,0.0,Neutral
"Stocks to watch: Reliance Industries, Tech Mahindra, ONGC, Lupin",https://www.financialexpress.com/market/stocks-to-watch-reliance-industries-tech-mahindra-ongc-lupin-3285598/,2023-10-25 01:52:43,"Stocks in Focus: GIFT Nifty traded down 14.5 points, or 0.08%, at 19,309.5, indicating a tepid opening for domestic indices NSE Nifty 50 and BSE Sensex on Wednesday. Previously on Monday, the NSE Nifty 50 tanked 260.90 points or 1.34% to settle at 19,281.75, while the BSE Sensex shed as much as ...",PFE,0.076115,0.081856,Neutral
A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free,https://markets.businessinsider.com/news/stocks/vivek-ramaswamy-biotech-firm-tl1a-drug-pfizer-treatment-roivant-roche-2023-10,2023-10-24 19:19:00,Vivek Ramaswamy's Biotech Firm Flipped $15 Million Asset Into $5 Billion - Markets Insider ...,PFE,0.777664,0.337524,Somewhat-Bullish
"Alopecia Areata Market Overview 2023-2027: Projected Market Size, Major Driver And Lucrative Segments As Per The Business Research Company's Alopecia Areata Global Market Report 2023",https://www.benzinga.com/pressreleases/23/10/g35397742/alopecia-areata-market-overview-2023-2027-projected-market-size-major-driver-and-lucrative-segment,2023-10-24 15:30:00,"LONDON, Oct. 24, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Alopecia Areata Global Market Report 2023, the global alopecia areata market is on a steady growth trajectory, with expectations to increase from $3.08 billion in 2022 to $3.31 billion in 2023, marking a ...",PFE,0.111747,0.163424,Somewhat-Bullish
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma,https://www.prnewswire.com/apac/news-releases/cyrus-k-mirsaidi-named-global-ceo-to-bridgewest-perth-pharma-301965005.html,2023-10-24 15:17:00,"--Industry veteran to lead growth for company's CDMO and pharmaceutical supply divisions, NovaCina and LumaCina-- MIAMI and PERTH, Australia, Oct. 25, 2023 /PRNewswire/ -- Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, announced today that Cyrus K.",PFE,0.071145,0.009055,Neutral
Earnings Preview: Pfizer  ( PFE )  Q3 Earnings Expected to Decline,https://www.zacks.com/stock/news/2170863/earnings-preview-pfizer-pfe-q3-earnings-expected-to-decline,2023-10-24 14:00:48,Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PFE,0.262522,-0.005986,Neutral
"GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities - Geovax Labs  ( NASDAQ:GOVXW ) , Geovax Labs  ( NASDAQ:GOVX ) ",https://www.benzinga.com/pressreleases/23/10/g35392979/geovax-update-clinical-and-operational-progress-toward-transformative-opportunities,2023-10-24 13:00:00,"ATLANTA, GA, Oct. 24, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire - GeoVax Labs, Inc. GOVX, a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced an update on key strategic initiatives.",PFE,0.034185,0.047062,Neutral
Moderna Stock Hasn't Been This Cheap Since 2020: Is Now the Time to Buy?,https://www.fool.com/investing/2023/10/24/moderna-stock-hasnt-been-this-cheap-since-2020-is/,2023-10-24 12:48:00,Pfizer recently slashed its guidance and that could be a big warning for Moderna investors as well.,PFE,0.151858,-0.070184,Neutral
"It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy",https://www.fool.com/investing/2023/10/24/its-hard-to-be-a-biotech-bull-in-this-market-but-t/,2023-10-24 12:45:00,The market's dour reaction to Roivant Sciences' latest deal doesn't add up.,PFE,0.218817,0.043518,Neutral
This $5 Billion Biotech Home Run Took Less Than a Year,https://www.wsj.com/health/pharma/this-5-billion-biotech-home-run-took-less-than-a-year-94e1c0df,2023-10-24 12:00:00,"In a deal that now feels like a biotech version of ""Moneyball,"" Roivant announced it was selling an asset that only 11 months ago it got for free from Pfizer.",PFE,0.558244,0.249637,Somewhat-Bullish
Daily: Chevron Continues Big Oil's Big Rush,https://www.forbes.com/sites/daniellechemtob/2023/10/24/forbes-daily-chevron-continues-big-oils-big-rush/,2023-10-24 11:54:02,"This is a published version of the Forbes Daily newsletter, you can sign-up to get Forbes Daily in your inbox here. Your best friend can now play matchmaker for you, thanks to a new feature on Tinder. Tinder Matchmaker allows the friends and family of users to view and recommend matches, even if ...",PFE,0.022903,-0.052765,Neutral
Pfizer  ( PFE )  to Report Q3 Earnings: Here's What to Expect,https://www.zacks.com/stock/news/2170681/pfizer-pfe-to-report-q3-earnings-heres-what-to-expect,2023-10-24 11:39:00,"Pfizer (PFE) expects better non-COVID operational revenue growth sequentially in the third quarter, driven by its key products, new launches as well as newly acquired products.",PFE,0.489057,0.065703,Neutral
IIM Rohtak organises the Management Conclave 2023 on the theme of leadership and sustainability,https://www.financialexpress.com/jobs-career/education-nbspiim-rohtak-organises-the-management-conclave-2023-on-the-theme-of-leadership-and-sustainability-3285020/,2023-10-24 05:23:01,"The Indian Institute of Management Rohtak organised Prabandh: Management Conclave, under the theme ""Empowering Success: Strategic Integration of Leadership and Sustainability"", according to the press release.",PFE,0.111488,0.051537,Neutral
Pfizer  ( PFE )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2170447/pfizer-pfe-gains-as-market-dips-what-you-should-know,2023-10-23 21:45:19,"Pfizer (PFE) closed the most recent trading day at $30.84, moving +0.62% from the previous trading session.",PFE,0.600271,0.163627,Somewhat-Bullish
Moderna's stock suffering record losing streak as 'investor caution remains high' over COVID vaccine sales,https://www.marketwatch.com/story/modernas-stock-suffering-record-losing-streak-as-investor-caution-remains-high-over-covid-vaccine-sales-2663eafa,2023-10-23 16:58:00,Moderna's stock was in danger of breaking its record for consecutive losses as investors expressed increasing caution over slowing sales of COVID vaccines.,PFE,0.201523,0.0066,Neutral
Pfizer Canada and the Skin Spectrum Summit reveal recipients of new scholarship to improve dermatological care for ... - Canada NewsWire,https://www.newswire.ca/news-releases/pfizer-canada-and-the-skin-spectrum-summit-reveal-recipients-of-new-scholarship-to-improve-dermatological-care-for-racialized-canadians-864514867.html,2023-10-23 16:00:00,Pfizer Canada and the Skin Spectrum Summit reveal recipients of new scholarship to improve dermatological care for ... Canada ...,PFE,0.337427,0.478422,Bullish
Stock Market Trims Losses As Benchmark Yield Backs Off From 5%; Investors Face These Risks,https://www.investors.com/market-trend/stock-market-today/stock-market-trims-losses-as-benchmark-yield-backs-off-from-5-investors-face-these-risks/,2023-10-23 14:47:00,Stock Market Trims Losses As Benchmark Yield Backs Off From 5 ... Investor's Business Daily ...,PFE,0.131643,0.122916,Neutral
Charles River  ( CRL )  Offers Access to Preclinical Cancer Research,https://www.zacks.com/stock/news/2170290/charles-river-crl-offers-access-to-preclinical-cancer-research,2023-10-23 14:10:00,Charles River (CRL) contributes to 84 percent of the FDA-approved cancer medicines and provides partners with 16 oncology prospects.,PFE,0.172097,0.121222,Neutral
This Drug Space Is So Hot 3 Big Pharmas Have Spent $19.4 Billion On It,https://www.investors.com/news/technology/roiv-stock-surges-as-roche-spends-to-get-into-a-new-immunology-space/,2023-10-23 13:28:00,ROIV Stock Surges On $7.1 Billion Roche Acquisition Deal Investor's Business Daily ...,PFE,0.405651,0.115291,Neutral
Debunking claims that a 'cartel' of asset managers controls major U.S. corporations,https://www.cnbc.com/2023/10/23/vanguard-blackrock-state-street-dont-own-major-us-corporations.html,2023-10-23 13:00:01,The so-called Big Three asset managers have been called a 'cartel' that controls U.S. corporations. Here's the truth.,PFE,0.064018,0.097073,Neutral
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal - Roche Holding  ( OTC:RHHBY ) ,https://www.benzinga.com/markets/equities/23/10/35368282/roche-buys-pfizer-roivant-sciences-televant-in-7-1b-deal,2023-10-23 12:55:05,"Roche Holding AG RHHBY inked a deal to acquire Telavant Holdings, Inc. for $7.1 billion. As per the terms, Roche will pay a purchase price upfront, along with a near-term milestone payment of $150 million.",PFE,0.443626,0.0,Neutral
3 Stocks Cathie Wood Is Buying That Should Be on Your List Too,https://www.fool.com/investing/2023/10/23/3-stocks-cathie-wood-is-buying-that-should-be-on/,2023-10-23 12:45:00,The three companies are positioned to benefit from red-hot trends.,PFE,0.093289,0.037481,Neutral
"Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President of Market Access, Strengthening Commercial Leadership in Buildup to Launch",https://www.benzinga.com/pressreleases/23/10/g35372500/elevar-therapeutics-names-brian-cunningham-vice-president-of-sales-and-kenneth-rankin-vice-preside,2023-10-23 12:45:00,"FORT LEE, N.J., Oct. 23, 2023 ( GLOBE NEWSWIRE ) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, ...",PFE,0.04882,0.110043,Neutral
Unveiling the Integration: Sphere and Safe Software's Spatial Collaboration Tool with Key Enterprise Applications at Augmented Enterprise Summit 2023,https://www.benzinga.com/pressreleases/23/10/g35369492/unveiling-the-integration-sphere-and-safe-softwares-spatial-collaboration-tool-with-key-enterprise,2023-10-23 11:00:00,"San Jose, California, Oct. 23, 2023 ( GLOBE NEWSWIRE ) -- Sphere, the spatial collaboration software for modern professionals, and Safe Software, the creators of FME, the only enterprise integration platform with comprehensive support for spatial data, are proud to announce the exciting ...",PFE,0.065327,0.204518,Somewhat-Bullish
"Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer - Eledon Pharma  ( NASDAQ:ELDN ) ",https://www.benzinga.com/pressreleases/23/10/g35369495/eledon-pharmaceuticals-strengthens-leadership-team-with-appointment-of-eliezer-katz-m-d-facs-as-ch,2023-10-23 11:00:00,"IRVINE, Calif., Oct. 23, 2023 ( GLOBE NEWSWIRE ) -- Eledon Pharmaceuticals, Inc. ( ""Eledon"" ) ELDN today announced the appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer with responsibility for leading the company's clinical development programs.",PFE,0.137278,0.022131,Neutral
"Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion",https://www.wsj.com/health/pharma/roche-to-buy-telavant-from-roivant-sciences-and-pfizer-in-7-25-bln-deal-638ccc3c,2023-10-23 10:55:00,The deal is the latest example of a big pharma company turning to the deal table to bolster its pipeline of autoimmune drugs.,PFE,0.395012,0.158095,Somewhat-Bullish
"BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023",https://www.globenewswire.com/news-release/2023/10/23/2764554/0/en/BioNTech-to-Report-Third-Quarter-Financial-Results-and-Corporate-Update-on-November-6-2023-And-to-Host-Innovation-Series-Day-on-November-7-2023.html,2023-10-23 10:45:00,"MAINZ, Germany, October 23, 2023 ( GLOBE NEWSWIRE ) - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) will announce its financial results for the third quarter 2023 on Monday, November 6th, 2023. BioNTech invites investors and the general public to join a conference call and webcast ...",PFE,0.09402,0.008604,Neutral
Respiratory virus season threatens to be a challenge again. Getting vaccinated now can help,https://www.cnn.com/2023/10/23/health/respiratory-virus-season-vaccination/index.html,2023-10-23 10:29:00,"The first signs of respiratory virus season are just starting to show in the United States, but experts stress the importance of getting vaccinated now to stay healthy through the winter and reduce strain on the health care system.",PFE,0.042876,0.0,Neutral
3 No-Brainer Stocks to Buy Right Now for Less than $100,https://www.fool.com/investing/2023/10/23/3-no-brainer-stocks-to-buy-right-now-for-less-than/,2023-10-23 09:30:00,You can start with a small investment and win big over time.,PFE,0.054983,-0.179134,Somewhat-Bearish
Futures fall as risk of wider Middle East conflict lingers; Big Tech results in focus,https://www.reuters.com/markets/us/futures-fall-risk-wider-middle-east-conflict-lingers-big-tech-results-focus-2023-10-23/,2023-10-23 09:12:00,Futures fall as risk of wider Middle East conflict lingers. Big Tech results in focus ...,PFE,0.073773,-0.081627,Neutral
Aurobindo Pharma's arm gets FDA nod for hypogonadism drug,https://www.moneycontrol.com/news/business/stocks/aurobindo-pharmas-arm-gets-fda-nod-for-hypogonadism-drug-11586431.html,2023-10-23 07:52:53,"Testosterone Cypionate Injection USP is indicated replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone, Primary hypogonadism ( congenital or acquired ) and Hypogonadotropic hypogonadism ( congenital or acquired ) .",PFE,0.186738,0.079182,Neutral
"Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? - Alphabet  ( NASDAQ:GOOGL ) , Logitech International  ( NASDAQ:LOGI ) , Archer-Daniels Midland  ( NYSE:ADM ) , Novartis  ( NYSE:NVS ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35367409/amazon-alphabet-meta-intel-q3-earnings-this-week-will-mega-caps-shatter-forecasts-a,2023-10-23 07:15:17,"After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-declining trend.",PFE,0.104228,-0.100479,Neutral
Roche To Pay $7.1 Bn For Telavant Holdings,https://www.barrons.com/news/roche-to-pay-7-1-bn-for-telavant-holdings-7f6c91d8,2023-10-23 06:02:00,"Swiss pharmaceutical group Roche said Monday it will pay $7.1 billion to buy Telavant Holdings, a group developing new treatments for inflammatory bowel diseases. The company is currently owned by British laboratory Roivant and American pharma giant Pfizer.",PFE,0.395012,0.081936,Neutral
Roche buys Telavant Holdings for $7.1 billion,https://www.reuters.com/markets/deals/roche-buys-telavant-holdings-71-billion-2023-10-23/,2023-10-23 05:00:37,"The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann Acquire Licensing Rights",PFE,0.170878,0.0,Neutral
[Ad hoc announcement pursuant to Art. 53 LR] Roche enters into a definitive agreement to acquire Telavant including rights to novel TL1A directed antibody  ( RVT-3101 )  for the treatment of inflammatory bowel disease from Roivant,https://www.globenewswire.com/news-release/2023/10/23/2764368/0/en/Ad-hoc-announcement-pursuant-to-Art-53-LR-Roche-enters-into-a-definitive-agreement-to-acquire-Telavant-including-rights-to-novel-TL1A-directed-antibody-RVT-3101-for-the-treatment-o.html,2023-10-23 05:00:00,"Basel, 23 October 2023 - Roche ( SIX: RO, ROG. OTCQX: RHHBY ) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. ( Telavant ) , a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc..",PFE,0.172919,0.057746,Neutral
Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody  ( RVT-3101 )  for the Treatment of Inflammatory Bowel Disease From Roivant,https://www.globenewswire.com/news-release/2023/10/23/2764359/34323/en/Roche-Enters-Into-a-Definitive-Agreement-to-Acquire-Telavant-Including-Rights-to-Novel-TL1A-Directed-Antibody-RVT-3101-for-the-Treatment-of-Inflammatory-Bowel-Disease-From-Roivant.html,2023-10-23 05:00:00,"BASEL, Switzerland and LONDON and NEW YORK, Oct. 23, 2023 ( GLOBE NEWSWIRE ) -- Roivant ( Nasdaq: ROIV ) announced today the entry into a definitive agreement with Roche ( SIX: RO, ROG. OTCQX: RHHBY ) to acquire Telavant Holdings, Inc. ( Telavant ) , a Roivant company, owned by Roivant Sciences ...",PFE,0.155451,0.136083,Neutral
"Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody  ( RVT-3101 )  for the Treatment of Inflammatory Bowel Disease From Roivant - Roche Holding  ( OTC:RHHBY ) , Roivant Sciences  ( NASDAQ:ROIV ) ",https://www.benzinga.com/pressreleases/23/10/g35366843/roche-enters-into-a-definitive-agreement-to-acquire-telavant-including-rights-to-novel-tl1a-direct,2023-10-23 05:00:00,"Roche will gain the rights to develop, manufacture and commercialize RVT-3101 in the US and Japan for the treatment of inflammatory bowel disease and potentially multiple other diseases",PFE,0.155326,0.132045,Neutral
"Voicing Opinions On Israel-Hamas Conflict: A Double-edged Sword For Businesses - Alphabet  ( NASDAQ:GOOGL ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/news/large-cap/23/10/35365716/voicing-opinions-on-israel-hamas-conflict-a-double-edged-sword-for-businesses,2023-10-22 17:55:16,"According to an Associated Press report, the Israel-Hamas conflict has stirred up controversy within the global business sector. High-ranking executives and ordinary workers alike are grappling with the repercussions of voicing their opinions on the issue. The CEO of Pfizer Inc.",PFE,0.280615,-0.383338,Bearish
How This Merck-Seagen Regimen Could 'Rewrite Textbooks' In Cancer,https://www.investors.com/news/technology/merck-stock-how-a-new-combo-could-rewrite-textbooks-in-bladder-cancer-treatment/,2023-10-22 14:30:00,Merck Stock: How A New Combo Could 'Rewrite Textbooks' In ... Investor's Business Daily ...,PFE,0.158173,0.066672,Neutral
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks This Year?,https://www.fool.com/investing/2023/10/22/is-it-time-to-buy-the-sp-500s-3-worst-performing-s/,2023-10-22 14:13:00,Venture beyond the headlines on a journey among 2023's least celebrated S&P 500 stocks. A roadmap to informed investment decisions awaits.,PFE,0.088309,-0.112646,Neutral
Hidden Gems: 3 Stealthy AI Stocks Quietly Conquering the 2023 Market,https://www.fool.com/investing/2023/10/22/hidden-gems-3-stealthy-ai-stocks/,2023-10-22 11:19:00,"Twilio, UiPath, and Ginkgo Bioworks are all massively underrated opportunities in artificial intelligence.",PFE,0.033375,0.137295,Neutral
65 Million People Suffer From Long Covid. Our Experts Say New Vaccines Are The Best Defense,https://www.forbes.com/sites/melissadelaney/2023/10/20/covid-19-vaccines/,2023-10-22 10:00:00,"New Covid vaccines based on Nobel prize-winning mRNA technology provide updated protection - especially important heading into the winter, when Covid-19, flu and RSV infections spike. eart palpitations. Anxiety. Fatigue. Dizziness. Difficulty breathing.",PFE,0.068698,0.036169,Neutral
Pfizer Just Announced Layoffs. Should You Still Buy the Stock?,https://www.fool.com/investing/2023/10/21/pfizer-just-announced-layoffs-should-you-still-buy/,2023-10-21 13:45:00,There's nothing to suggest its workforce is contracting permanently.,PFE,0.175433,0.026199,Neutral
Beam Therapeutics Stock: Bear vs. Bull,https://www.fool.com/investing/2023/10/21/beam-therapeutics-stock-bear-vs-bull/,2023-10-21 12:45:00,"This biotech has a few factors in its corner, but it also faces a difficult path.",PFE,0.090474,0.18322,Somewhat-Bullish
Company bosses and workers grapple with the fallout of speaking up about the Israel-Hamas war,https://apnews.com/article/israel-hamas-war-palestinians-companies-harvard-daecf3a387a689339dc41f35b773e063,2023-10-21 11:19:00,NEW YORK ( AP ) - Starbucks accused a union representing thousands of its baristas of damaging the brand and endangering co-workers with a pro-Palestinian tweet. The CEO of a prominent tech conference is facing boycotts after he publicly suggested Israel was committing war crimes.,PFE,0.072108,-0.034876,Neutral
Cathie Wood Just Doubled Down on This Biotech Stock. Should You Follow Her Lead?,https://www.fool.com/investing/2023/10/21/cathie-wood-just-doubled-down-on-this-biotech-stoc/,2023-10-21 10:45:00,Cathie Wood has bought over 5 million shares in Ginkgo Bioworks so far this month.,PFE,0.080055,0.131308,Neutral
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?,https://www.fool.com/investing/2023/10/21/which-is-the-better-long-term-hold-for-investors-p/,2023-10-21 10:00:00,The venerable pharmaceutical companies' shares have slumped this year.,PFE,0.364987,0.052006,Neutral
Is Pfizer a Bad News Buy Right Now?,https://www.fool.com/investing/2023/10/21/is-pfizer-a-bad-news-buy-right-now/,2023-10-21 09:15:00,Can Pfizer still win without record-breaking vaccine sales?,PFE,0.753715,-0.011892,Neutral
Sollers To Cancel $3.4M In Student Loan Debt Amid Deceptive Practice Charges,https://www.kiplinger.com/personal-finance/student-loans/sollers-to-cancel-dollar34m-in-student-loan-debt-amid-deceptive-practice-charges,2023-10-20 22:19:57,Sollers to Cancel $3.4M In Student Loan Debt to Settle Suit Kiplinger's Personal Finance ...,PFE,0.069294,-0.007084,Neutral
Pfizer Secures FDA Approval For Penbraya,https://markets.businessinsider.com/news/stocks/pfizer-secures-fda-approval-for-penbraya-1032725214,2023-10-20 20:48:30,"( RTTNews ) - On Friday, Pfizer Inc. ( PFE ) announced that the FDA had approved its vaccine Penbraya, the first and only pentavalent vaccine that provides the broadest serogroup coverage of any meningococcal vaccine in individuals 10 through 25 years of age.",PFE,0.495015,0.134601,Neutral
Pfizer gets FDA green light for new shot that can streamline teenagers' vaccinations,https://www.marketwatch.com/story/pfizer-gets-fda-green-light-for-new-shot-that-can-streamline-teenagers-vaccinations-d0c1f542,2023-10-20 19:57:00,"Combination meningococcal vaccine may boost uptake among adolescents, researchers say.",PFE,0.644856,0.107252,Neutral
US FDA approves Pfizer's vaccine for meningococcal disease,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-vaccine-meningococcal-diseases-2023-10-20/,2023-10-20 19:45:00,"Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights Oct 20 ( Reuters ) - The U.S.",PFE,0.18967,-0.006303,Neutral
ABBV: 3 High-Performing Pharma Stocks to Boost Your Portfolio,https://stocknews.com/news/abbv-azn-taro-pfe-3-high-performing-pharma-stocks-to-boost-your-portfolio/,2023-10-20 16:39:40,"The pharmaceutical industry is set to grow in the coming years, thanks to an aging population, heightened toll of chronic diseases, and new technologies.",PFE,0.063425,0.068026,Neutral
"Pharma Stock Roundup: JNJ Posts Upbeat Q3 Earnings, PFE, NVO Revise 2023 View",https://www.zacks.com/stock/news/2169495/pharma-stock-roundup-jnj-posts-upbeat-q3-earnings-pfe-nvo-revise-2023-view,2023-10-20 13:02:00,J&J (JNJ) reports strong third-quarter results. Merck's (MRK) new deal with Japan's Daiichi Sankyo to jointly develop the latter's three DXd ADC candidates.,PFE,0.253316,-0.128908,Neutral
Pfizer Inc.  ( PFE )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2169498/pfizer-inc-pfe-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-10-20 13:00:11,"Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",PFE,0.484798,0.095323,Neutral
Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable,https://www.marketwatch.com/story/biotech-stocks-are-in-a-post-pandemic-slump-and-recovery-in-2024-is-questionable-344e8e9f,2023-10-20 11:10:00,"Once buoyed by demand for COVID-19 vaccines and treatments, the biotech industry is experiencing a sobering leveling out ...",PFE,0.172919,0.153656,Somewhat-Bullish
Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer,https://www.globenewswire.com/news-release/2023/10/20/2763906/0/en/Novartis-Kisqali-NATALEE-analysis-reinforces-consistent-reduction-in-risk-of-recurrence-across-key-subgroups-of-patients-with-early-breast-cancer.html,2023-10-20 10:00:00,"Basel, October 20, 2023 - Novartis will present late-breaking results from a prespecified exploratory subgroup analysis of invasive disease-free survival ( iDFS ) from the pivotal Phase III NATALEE trial at the European Society for Medical Oncology ( ESMO ) Congress 2023.",PFE,0.013217,0.0,Neutral
2 Top Growth Stocks to Buy Right Now Without Hesitation,https://www.fool.com/investing/2023/10/20/2-top-growth-stocks-to-buy-without-hesitation/,2023-10-20 09:00:00,These stocks are dirt cheap right now.,PFE,0.111488,0.236932,Somewhat-Bullish
Why Moderna Stock Is Sinking This Week,https://www.fool.com/investing/2023/10/19/why-moderna-stock-is-sinking-this-week/,2023-10-19 21:14:59,Investors appear to believe that bad news for Pfizer could mean bad news for Moderna.,PFE,0.371523,-0.133229,Neutral
Robotic Surgery Giant Tumbles On Light Third-Quarter Sales,https://www.investors.com/news/technology/isrg-stock-intuitive-surgical-earnings-q3-2023/,2023-10-19 20:14:00,ISRG Stock Dives As Robotic Surgery Behemoth Lags Sales ... Investor's Business Daily ...,PFE,0.205807,0.0,Neutral
"Anti-obesity drugs are an investable ""fountain of youth"" for baby boomers",https://www.investorideas.com/news/2023/biotech/10191RichardMills-Anti-Obesity-Drugs.asp,2023-10-19 18:23:25,"Anti-obesity drugs are an investable ""fountain of youth"" for baby ... ...",PFE,0.013409,-0.034385,Neutral
Pfizer to more than double price of its COVID antiviral once drug moves to commercial market,https://www.marketwatch.com/story/pfizer-to-more-than-double-price-of-its-covid-antiviral-once-drug-moves-to-commercial-market-a104a03a,2023-10-19 17:24:00,The listing price for Paxlovid is more than double what Pfizer charged the federal government during the COVID-19 pandemic.,PFE,0.593484,-0.053045,Neutral
Global Atherosclerosis Drugs Market Is Projected To Reach $54.8 Billion In 2027 With A CAGR Of 3% As Per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023,https://www.benzinga.com/pressreleases/23/10/g35333824/global-atherosclerosis-drugs-market-is-projected-to-reach-54-8-billion-in-2027-with-a-cagr-of-3-as,2023-10-19 15:45:00,"LONDON, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023, the global atherosclerosis drugs market is poised for significant growth in 2023, with a projected value of $48.72 billion, marking a steady Compound Annual Growth ...",PFE,0.062271,0.072345,Neutral
"Pfizer Reportedly Doubles Paxlovid Price To $1,390 In The U.S.",https://www.investors.com/news/technology/pfizer-stock-slips-as-covid-drugmaker-hikes-paxlovid-price/,2023-10-19 15:06:00,"Pfizer Stock Slips As Covid Drugmaker Hikes Paxlovid Price To $1,390 Investor's Business Daily ...",PFE,0.835459,0.0,Neutral
Pfizer wins unconditional EU antitrust okay for $43 bln Seagen buy,https://www.reuters.com/markets/deals/pfizer-wins-unconditional-eu-antitrust-okay-43-bln-seagen-buy-2023-10-19/,2023-10-19 14:54:15,"A company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights BRUSSELS, Oct 19 ( Reuters ) - U.S. pharmaceutical company Pfizer ( PFE.N ) gained unconditional EU antitrust approval on Thursday for its proposed $43 billion ...",PFE,0.416844,0.342058,Somewhat-Bullish
EU Clears Pfizer's $43 Bn Takeover Of Biotech Firm Seagen,https://www.barrons.com/news/eu-clears-pfizer-s-43-bn-takeover-of-biotech-firm-seagen-2022a254,2023-10-19 14:45:00,EU Clears Pfizer's $43 Bn Takeover Of Biotech Firm ...,PFE,0.186738,-0.048524,Neutral
"Pfizer Decides To Raise COVID-19 Treatment Pill Price, Defends Itself Amid Criticism for Cost Increase - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/10/35323628/pfizer-decides-to-raise-covid-19-treatment-pill-price-defends-itself-amid-criticism-for-cost-incr,2023-10-19 12:45:10,"Pfizer Inc PFE is reportedly gearing up to price its Covid-19 drug Paxlovid at $1,390 for a five-day course, more than double what the U.S. government initially paid for it, at $529. Pfizer's decision to raise the price has garnered criticism from doctors and patient advocates who fear limited ...",PFE,0.827318,0.222289,Somewhat-Bullish
Business | Oct 21st 2023 Edition,https://www.economist.com/the-world-this-week/2023/10/19/business,2023-10-19 12:32:02,"Tesla issued a downbeat earnings report. Net profit fell by 44% in the third quarter, year on year. its operating margin, a closely tracked measure of the difference between its income and expenses, plunged to 7.6%.",PFE,0.149038,-0.10342,Neutral
BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial with mRNA-based Individualized Neoantigen Specific Immunotherapy in New Cancer Indication,https://www.globenewswire.com/news-release/2023/10/19/2763018/0/en/BioNTech-Expands-Late-Stage-Clinical-Oncology-Portfolio-with-Initiation-of-further-Phase-2-Trial-with-mRNA-based-Individualized-Neoantigen-Specific-Immunotherapy-in-New-Cancer-Indi.html,2023-10-19 10:45:00,"MAINZ, Germany, October 19, 2023 ( GLOBE NEWSWIRE ) - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) today announced that the first patient has been treated in a Phase 2 clinical trial evaluating the mRNA-based individualized neoantigen-specific immunotherapy ( iNeST ) candidate ...",PFE,0.019271,0.018142,Neutral
"5 things to know for Oct. 19: Israel, House speaker, Covid-19, Pollution, UFOs",https://www.cnn.com/2023/10/19/us/5-things-to-know-for-oct-19-israel-house-speaker-covid-19-pollution-ufos/index.html,2023-10-19 10:39:00,"An artificial intelligence innovation recently deciphered one word from the famously indiscernible 2,000-year-old Herculaneum scrolls. The documents, which were burned in the eruption of Mount Vesuvius in 79 AD, would crumble if anyone attempted to unroll them and were considered to be nearly ...",PFE,0.070935,0.072339,Neutral
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point,https://www.fool.com/investing/2023/10/19/pfizer-moderna-dont-agree-on-1-point/,2023-10-19 09:00:00,The coronavirus vaccine leaders recently made different decisions.,PFE,0.577979,0.072286,Neutral
Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director - Bicycle Therapeutics  ( NASDAQ:BCYC ) ,https://www.benzinga.com/pressreleases/23/10/g35323423/macomics-announces-the-appointment-of-kevin-lee-as-independent-non-executive-director,2023-10-19 08:00:00,"EDINBURGH and CAMBRIDGE, United Kingdom, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- Macomics Ltd, a leader in macrophage drug discovery, announces that it has appointed Kevin Lee Ph.D., MBA as Independent Non-Executive Director.",PFE,0.097062,0.105113,Neutral
"Pfizer Will Charge Up To $1,400 For Covid Drug Paxlovid",https://www.forbes.com/sites/antoniopequenoiv/2023/10/18/pfizer-will-charge-up-to-1400-for-covid-drug-paxlovid/,2023-10-19 00:48:44,The pill is designed to treat Covid-19 in adults and pediatric patients with a high risk for developing severe symptoms.,PFE,0.7414,-0.015613,Neutral
Pfizer more than doubles price of lifesaving Covid-19 medication Paxlovid as US transitions out of pandemic phase,https://www.cnn.com/2023/10/18/health/pfizer-paxlovid-price/index.html,2023-10-19 00:07:00,"The price of the lifesaving Covid-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic, drugmaker Pfizer said Wednesday. The list price, before insurance, will be $1,390 for a five-day course, Pfizer said in a statement.",PFE,0.415927,0.231453,Somewhat-Bullish
"With education funding cut and trouble tracking doses, experts see scattered Covid-19 vaccine rollout ahead of winter season",https://www.cnn.com/2023/10/18/health/covid-vaccine-awareness-campaigns/index.html,2023-10-18 22:30:00,"With education funding cut and trouble tracking doses, experts see scattered Covid-19 vaccine rollout ahead of winter ... ...",PFE,0.046452,0.082141,Neutral
"Pfizer to price Covid drug Paxlovid at $1,390 per course",https://www.cnbc.com/2023/10/18/pfizer-to-price-covid-drug-paxlovid-at-1390-per-course-.html,2023-10-18 21:51:25,Paxlovid will transition to the private market in November as demand for Covid vaccines and treatments slumps nationwide.,PFE,0.519739,-0.003257,Neutral
"Pfizer to price COVID treatment Paxlovid at $1,390 per course",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-price-covid-19-drug-paxlovid-1400-five-day-course-wsj-2023-10-18/,2023-10-18 21:07:00,Pfizer to price COVID-19 drug Paxlovid at $1400 for five-day course ...,PFE,0.618922,0.04636,Neutral
"HTR Recognizes RXNT as a ""True Trailblazer"" Among Top 100 Health Tech Companies of 2023",https://www.prnewswire.com/news-releases/htr-recognizes-rxnt-as-a-true-trailblazer-among-top-100-health-tech-companies-of-2023-301961225.html,2023-10-18 20:18:00,"ANNAPOLIS, Md., Oct. 18, 2023 /PRNewswire/ -- , an enduring pioneer in the ambulatory healthcare technology space, today announced that it has been recognized as one of the ""Top 100 Healthcare Technology Companies of 2023"" by the .",PFE,0.090816,0.142504,Neutral
Nestle To Close Ireland Facilities With 542 Job Losses,https://www.barrons.com/news/nestle-to-close-ireland-facilities-with-542-job-losses-feceed50,2023-10-18 18:55:00,"Swiss giant Nestle said Wednesday it plans to close a baby food factory, and an adjacent research and development ( R&D ) facility in southwest Ireland with the expected loss of around 542 jobs.",PFE,0.179788,-0.032644,Neutral
Mainz Biomed's Groundbreaking Study Results Mark A Big Advancement In The Battle Against Colorectal Cancer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/penny-stocks/23/10/35311158/mainz-biomeds-groundbreaking-study-results-mark-a-big-advancement-in-the-battle-against-colo,2023-10-18 15:03:08,"Mainz Biomed N.V. MYNZ, a molecular genetics diagnostic company specializing in the early detection of cancer, was scheduled to present the groundbreaking results from its CRC study at the 4th International Conference on Gastroenterology in Paris, but the event was postponed from October to ...",PFE,0.230017,-0.147987,Neutral
Biotech Stumbles As It Aims For A First-Ever In CRISPR Gene Editing,https://www.investors.com/news/technology/ntla-stock-stumbles-as-intellia-aims-for-a-first-ever-in-crispr-gene-editing/,2023-10-18 14:38:00,"The Food and Drug Administration gave Intellia Therapeutics ( NTLA ) the go-ahead to begin a pivotal study of its gene-editing treatment for a deadly heart disease, but NTLA stock reversed lower at the open.",PFE,0.192694,0.359459,Bullish
EvolveImmune Therapeutics to Present New Preclinical and Translational Data Highlighting Precision Medicine Potential of its Novel Costimulatory T Cell Engager Platform at 38th Annual Meeting of the Society for Immunotherapy of Cancer  ( SITC ) ,https://www.benzinga.com/pressreleases/23/10/g35304683/evolveimmune-therapeutics-to-present-new-preclinical-and-translational-data-highlighting-precision,2023-10-18 11:00:19,EVOLVE Platform Integrates Differentiated T Cell Costimulation Approach with Unique Insights into Solid Tumor Features to Optimize Discovery and Clinical Development of Differentiated Precision Immunotherapies,PFE,0.04912,0.063324,Neutral
"This Cathie Wood Stock Could Soar 140%, Wall Street Says. Is That Too Optimistic?",https://www.fool.com/investing/2023/10/18/is-wall-street-too-optimistic-on-cathie-wood-stock/,2023-10-18 10:00:00,Some of the world's biggest pharma companies are partnering with Ginkgo.,PFE,0.056674,0.078922,Neutral
BioNTech Se  ( BNTX )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/11/06/biontech-se-bntx-q3-2023-earnings-call-transcript/,2023-11-06 21:30:53,"BNTX earnings call for the period ending September 30, 2023.",PFE,0.127432,0.092428,Neutral
ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS,https://www.newswire.ca/news-releases/endo-reports-third-quarter-2023-financial-results-817017937.html,2023-11-06 21:05:00,"DUBLIN, Nov. 6, 2023 /CNW/ -- Endo International plc ( OTC: ENDPQ ) today reported financial results for the third-quarter ended September 30, 2023. Share from Continuing Operations ( 2 ) ( 3 )",PFE,0.021857,0.023354,Neutral
HALOZYME REPORTS THIRD QUARTER 2023 FINANCIAL AND OPERATING RESULTS,https://www.prnewswire.com/news-releases/halozyme-reports-third-quarter-2023-financial-and-operating-results-301979106.html,2023-11-06 21:01:00,Royalty Revenue Increased 15% YOY to Record $114.4 million Announces Acceleration into 2023 of Remaining $250M Share Repurchase through ASR GAAP Diluted EPS of $0.61 and Non-GAAP Diluted EPS of $0.751 Maintained Revenue Guidance and Raised 2023 EBITDA Guidance to $430-$445 million and Non-GAAP ...,PFE,0.020526,0.076156,Neutral
4 big takeaways from earnings season as Wall Street digests surprisingly resilient corporate results,https://markets.businessinsider.com/news/stocks/us-economy-3q-earnings-sp500-corporate-profits-consumer-growth-bofa-2023-11,2023-11-06 20:39:00,What Strong 3Q Earnings Say About the US Economy: BofA - Markets Insider ...,PFE,0.061003,-0.105008,Neutral
"The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman - and Martin Shkreli",https://www.marketwatch.com/story/the-doctor-lowering-drug-prices-for-1-million-patients-with-help-from-mark-cuban-sam-altman-and-martin-shkreli-5e72d77a,2023-11-06 20:32:00,Kristopher Koeller relies on two daily medications to keep his blood pressure under control. They're both generics that have been on the market for decades-the kind of drugs that should be cheap.,PFE,0.027941,0.024774,Neutral
Peering Into Pfizer's Recent Short Interest - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/short-sellers/23/11/35628957/peering-into-pfizers-recent-short-interest,2023-11-06 20:30:12,"Pfizer's PFE short percent of float has risen 7.78% since its last report. The company recently reported that it has 54.57 million shares sold short, which is 0.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.1 days to cover their ...",PFE,0.224903,0.158881,Somewhat-Bullish
Eli Lilly chief scientific officer 'extremely optimistic' that major new Alzheimer's breakthrough is coming,https://www.marketwatch.com/story/eli-lilly-chief-scientific-officer-extremely-optimistic-that-major-new-alzheimers-breakthrough-is-coming-79003fcc,2023-11-06 16:05:00,"Dr. Daniel Skovronsky believes a big leap in Alzheimer's disease treatment may be just around the corner-and that an overlooked class of medicines could become the GLP-1 drugs of the future. If he's right, Eli Lilly & Co.'s LLY, remarkable winning streak won't fizzle any time soon.",PFE,0.113418,0.152012,Somewhat-Bullish
Stock Market Slow To Start Week; Warren Buffett's Stock Reacts After Its Results,https://www.investors.com/market-trend/stock-market-today/stock-market-slow-to-start-week-warren-buffetts-stock-reacts-after-its-results/,2023-11-06 15:57:00,Stock Market Slow To Start Week. Warren Buffett's Stock Reacts ... Investor's Business Daily ...,PFE,0.105604,0.151556,Somewhat-Bullish
Crohn's and Colitis Canada and Pfizer Canada Announce 2023 Women in IBD Award Recipients,https://www.newswire.ca/news-releases/crohn-s-and-colitis-canada-and-pfizer-canada-announce-2023-women-in-ibd-award-recipients-884916969.html,2023-11-06 15:03:00,"For the fourth year, these awards recognize outstanding contributions of female leaders and emerging talent in the field of inflammatory bowel disease ( IBD ) research",PFE,0.27535,0.390671,Bullish
"What's Going On With BioNTech  ( BNTX )  Stock Today? - Pfizer  ( NYSE:PFE ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/11/35620073/like-moderna-biontech-cuts-annual-sales-forecast-by-20-as-pandemic-fades,2023-11-06 15:01:34,"BioNTech SE BNTX has reported Q3 revenues of €895.3 million ( $974.49 million ) , sharply down from €3.461 billion a year ago. Analysts estimated $1.06 billion in sales. For the nine months, total revenues were €2.34 billion, compared to €13.03 billion for the comparative prior year period.",PFE,0.461283,-0.024398,Neutral
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2179074/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2023-11-06 14:00:12,"Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",PFE,0.491255,0.105367,Neutral
BioNTech slashes Covid vaccine forecast as pandemic fades,https://www.financialexpress.com/healthcare/covid-19/biontech-slashes-covid-vaccine-forecast-as-pandemic-fades/3298817/,2023-11-06 12:42:43,"BioNTech SE cut its forecast for this year's COVID-19 vaccine sales by 20%, the latest among drugmakers forced to adjust as the world moves on from the pandemic. Vaccine sales will probably reach about €4 billion ( $4.3 billion ) , compared with an initial prediction of €5 billion, the German ...",PFE,0.48268,0.189263,Somewhat-Bullish
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates,https://www.globenewswire.com/news-release/2023/11/06/2773958/0/en/Zentalis-Pharmaceuticals-Reports-Third-Quarter-2023-Financial-Results-and-Operational-Updates.html,2023-11-06 12:18:00,Updated data from azenosertib monotherapy study with longer follow up shows 37% ORR and mPFS of 6.5 months in heavily pretreated ovarian and uterine serous carcinoma patients ...,PFE,0.01645,0.052853,Neutral
BioNTech's stock rallies after it posts surprise Q3 profit and revenue that tops estimates,https://www.marketwatch.com/story/biontechs-stock-rallies-after-it-posts-surprise-q3-profit-and-revenue-that-tops-estimates-fb493aae,2023-11-06 11:59:00,"BioNTech SE beat estimates, despite lower COVID-19 vaccine revenue.",PFE,0.485711,-0.097232,Neutral
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results,https://www.prnewswire.com/il/news-releases/protalix-biotherapeutics-reports-third-quarter-2023-financial-and-business-results-301978381.html,2023-11-06 11:50:00,Company to host conference call and webcast today at 8:30 a.m. EST,PFE,0.063036,-0.022228,Neutral
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results,https://www.prnewswire.com/news-releases/protalix-biotherapeutics-reports-third-quarter-2023-financial-and-business-results-301978381.html,2023-11-06 11:50:00,Company to host conference call and webcast today at 8:30 a.m. EST,PFE,0.063036,-0.022228,Neutral
BioNTech cuts 2023 revenue target on reduced prospects for vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-cuts-2023-revenue-target-reduced-prospects-vaccine-2023-11-06/,2023-11-06 11:48:00,"The logo of BioNTech is pictured at Biontech's research laboratory for individualised vaccines against cancer in Mainz, Germany, July 27, 2023. REUTERS/Wolfgang Rattay/File Photo Acquire Licensing Rights",PFE,0.308246,0.006871,Neutral
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update,https://www.globenewswire.com/news-release/2023/11/06/2773898/0/en/BioNTech-Announces-Third-Quarter-2023-Financial-Results-and-Corporate-Update.html,2023-11-06 11:45:00,"Conference call and webcast scheduled for November 6, 2023, at 8:00 am ET ( 2:00 pm ...",PFE,0.102651,0.068473,Neutral
"Cryogenic Control Valve Market Size to Hit $3.11 Billion, Globally, by 2028 | Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/11/g35615598/cryogenic-control-valve-market-size-to-hit-3-11-billion-globally-by-2028-exclusive-report-by-the-i,2023-11-06 11:42:27,"Pune, India, Nov. 06, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Cryogenic Control Valve Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type ( Globe Control Valves, Ball Control Valves, Butterfly Control Valves, Others ).",PFE,0.032602,0.123525,Neutral
Active Pharmaceutical Ingredients Market Set to Surge USD 363.68 Billion by 2032 | Precedence Research,https://www.prnewswire.com/news-releases/active-pharmaceutical-ingredients-market-set-to-surge-usd-363-68-billion-by-2032--precedence-research-301978434.html,2023-11-06 11:38:00,"OTAWA,ON, Nov. 6, 2023 /PRNewswire/ -- The active pharmaceutical ingredients ( API ) market size was valued at USD 204.04 billion in 2023 and likely to hit around USD 363.68 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032. An active pharmaceutical ingredient ( API ) is a drug's ...",PFE,0.018554,0.078226,Neutral
"Sosei Heptares' Partner, Pfizer, Progresses Its GLP-1 Receptor Agonist PF-06954522 into a Phase 1 Trial",https://www.globenewswire.com/news-release/2023/11/05/2773680/0/en/Sosei-Heptares-Partner-Pfizer-Progresses-Its-GLP-1-Receptor-Agonist-PF-06954522-into-a-Phase-1-Trial.html,2023-11-05 23:35:00,"Tokyo, Japan and Cambridge, UK, 06 November 2023 - Sosei Group Corporation ( ""Sosei Heptares"" or ""the Company"". TSE: 4565 ) has been notified by Pfizer that it has entered a new oral small molecule GLP-1 receptor agonist into a Phase 1 clinical trial.",PFE,0.550532,0.318637,Somewhat-Bullish
"Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest - CVS Health  ( NYSE:CVS ) , SPDR Select Sector Fund - Health Care  ( ARCA:XLV ) , Johnson & Johnson  ( NYSE:JNJ ) , Walgreens Boots Alliance  ( NASDAQ:WBA ) ",https://www.benzinga.com/news/23/11/35610842/pharmacy-workers-strike-at-cvs-and-walgreens-echoing-wider-pharma-sector-unrest,2023-11-05 20:48:48,"In a recent surge of labor unrest, pharmacy employees from CVS Health Corporation CVS and Walgreens Boots Alliance, Inc. WBA raised their voices by calling out sick or walking out entirely last week.",PFE,0.14131,-0.093063,Neutral
3 Spectacular High-Yield Dividend Stocks to Buy in November,https://www.fool.com/investing/2023/11/05/3-spectacular-high-yield-dividend-stocks-to-buy-in/,2023-11-05 15:00:00,Income investors should find plenty to like with these stocks.,PFE,0.286002,0.010988,Neutral
Down 84% From Its Peak. Is It Finally Time to Buy Moderna?,https://www.fool.com/investing/2023/11/05/down-84-from-its-peak-is-it-finally-time-to-buy-mo/,2023-11-05 11:18:00,The vaccine developer's huge profits have turned into heavy losses.,PFE,0.051221,0.04604,Neutral
Morimatsu International Adapts to the Changing World by Upholding Technological Innovation in Global Expansion,https://www.prnewswire.com/news-releases/morimatsu-international-adapts-to-the-changing-world-by-upholding-technological-innovation-in-global-expansion-301977827.html,2023-11-05 06:50:00,"SHANGHAI, Nov. 3, 2023 /PRNewswire/ -- The World Bank recently released its updated ""Global Economic Outlook"" report, projecting a 2.1% global economic growth for 2023.",PFE,0.022794,0.10909,Neutral
Moderna May Be Facing Its Toughest Moment Ever. Time to Sell?,https://www.fool.com/investing/2023/11/04/moderna-facing-tough-moment-should-you-sell/,2023-11-04 09:00:00,Moderna still has big ambitions -- beyond the coronavirus vaccine -- that could pay off in a few years.,PFE,0.09989,0.08017,Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX,https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-biontech-se---bntx-301977548.html,2023-11-03 22:27:00,"NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE ( ""BioNTech"" or the ""Company"" ) ( NASDAQ: BNTX ) . Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.",PFE,0.41627,-0.064175,Neutral
"From IRFC to Polycab India, eight stocks move up the ladder to largecap",https://www.business-standard.com/markets/stock-market-news/from-irfc-to-polycab-india-8-stocks-see-moving-from-mid-to-large-cap-123110300833_1.html,2023-11-03 17:46:02,"Eight stocks including Indian Railway Finance Corporation ( IRFC ) , Polycab India, Macrotech Developers ( Lodha ) are seen migrating from midcap to largecap universe. Meanwhile, 13 stocks will graduate from smallcap universe to midcap universe during the semi-annual rebalancing due next month.",PFE,0.114682,0.0,Neutral
PFE: Is Pfizer  ( PFE )  a Stock to Buy Following Its Q3 Earnings?,https://stocknews.com/news/pfe-abbv-taro-nvs-is-pfizer-pfe-a-stock-to-buy-following-its-q3/,2023-11-03 16:58:30,Drug and vaccine manufacturing giant Pfizer Inc. ( PFE ) is facing losses due to the company's charges due to its difficulty concerning COVID antiviral treatment Paxlovid and COVID vaccine.,PFE,0.560692,0.034256,Neutral
Market Rally Back In Force As Yields Plunge: Weekly Review,https://www.investors.com/news/stock-market-rally-back-in-force-as-treasury-yields-plunge-arista-palantir-are-winners/,2023-11-03 16:55:59,"The stock market rally took off this past week as Treasury yields plunged on generally weak economic data and soothing words from Fed Chief Jerome Powell Nasdaq staged a follow-through day to confirm the market rally on Wednesday, with the S&P 500 and Dow Jones following through on Thursday.",PFE,0.035476,-0.352867,Bearish
Which Corporations Pay The Most Federal Income Tax?,https://www.forbes.com/sites/taxnotes/2023/11/03/which-corporations-pay-the-most-federal-income-tax/,2023-11-03 14:31:05,"Corporations report their total cash payments of income tax - federal, state, and foreign combined - but they don't identify, nor does the IRS reveal, how much federal income tax they pay. We believe, however, that we can make reasonable estimates from information reported by publicly traded ...",PFE,0.0367,0.04961,Neutral
This Stock Just Dropped By 15%: Is It a Buy?,https://www.fool.com/investing/2023/11/03/this-stock-just-dropped-by-15-is-it-a-buy/,2023-11-03 14:07:00,Now could be a great opportunity to buy low.,PFE,0.061315,0.047,Neutral
Eli Lilly Just Added Another Potential Billion-Dollar Product: Is It a Buy?,https://www.fool.com/investing/2023/11/03/eli-lilly-just-added-another-potential-billion/,2023-11-03 13:45:00,The answer is relatively clear.,PFE,0.072,0.111724,Neutral
Should You Pick Pfizer Stock At $30?,https://www.forbes.com/sites/greatspeculations/2023/11/03/should-you-pick-pfizer-stock-at-30/,2023-11-03 13:00:50,"Pfizer ( NYSE: PFE ) reported its Q3 results earlier this week, with revenues missing but earnings beating the street estimates, and we believe that PFE stock has ample room for growth, as discussed below.",PFE,0.751437,0.039546,Neutral
Actinium Appoints Lynn Bodarky as Chief Business Officer,https://www.prnewswire.com/news-releases/actinium-appoints-lynn-bodarky-as-chief-business-officer-301976722.html,2023-11-03 11:30:00,- Senior leader with proven track record of executing business development and licensing transactions totaling $5 billion at multinational pharmaceutical and biotechnology companies,PFE,0.097854,0.058113,Neutral
"Billionaires Bill Gross, Steve Cohen, and Leon Cooperman Predict a Recession Is Coming. Here's What Investors Should Do If They're Right.",https://www.fool.com/investing/2023/11/03/billionaires-bill-gross-steve-cohen-leon-cooperman/,2023-11-03 09:50:00,There are two things investors can do regardless of whether or not an economic downturn is around the corner.,PFE,0.050254,0.136971,Neutral
There's a Silver Lining in Pfizer's Dark Cloud. Should You Buy the Stock?,https://www.fool.com/investing/2023/11/03/theres-a-silver-lining-in-pfizers-dark-cloud/,2023-11-03 09:30:00,It's important to look at Pfizer through a long-term lens.,PFE,0.637818,0.215341,Somewhat-Bullish
Moderna reports $3.6 billion loss on covid supply writedowns,https://www.financialexpress.com/healthcare/pharma-healthcare/moderna-reports-3-6-billion-loss-on-covid-supply-writedowns/3295412/,2023-11-03 03:30:00,Moderna Inc. reported a larger-than-expected loss in the third quarter after registering a $3.1 billion charge to write down excess Covid shots and reduce its manufacturing footprint as the vaccine maker prepares for a post-pandemic era.,PFE,0.205225,-0.173867,Somewhat-Bearish
Moderna Takes $1.3 Billion Hit From Sluggish Covid Vaccine Uptake,https://www.thedailyupside.com/industries/healthcare/moderna-takes-1-3-billion-hit-from-sluggish-covid-vaccine-uptake/,2023-11-02 21:35:53,"When vaccines go bad, so does your bottom line. Moderna posted a quarterly loss of $3.63 billion on Thursday, half of which was accounted for by...",PFE,0.298264,0.033557,Neutral
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update,https://www.prnewswire.com/news-releases/cardiff-oncology-reports-third-quarter-2023-results-and-provides-business-update-301976372.html,2023-11-02 20:05:00,- Advance to first-line RAS-mutated metastatic colorectal cancer ( mCRC ) for lead program based on positive clinical and preclinical data and guidance from FDA -,PFE,0.063763,0.060239,Neutral
Moderna  ( MRNA )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/11/02/moderna-mrna-q3-2023-earnings-call-transcript/,2023-11-02 17:00:22,"MRNA earnings call for the period ending September 30, 2023.",PFE,0.033019,0.095575,Neutral
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.,https://www.cnbc.com/2023/11/02/eli-lilly-diabetes-drug-mounjaro-supply-improves-in-us.html,2023-11-02 16:00:56,The remarks suggest that Eli Lilly's initial efforts to expand manufacturing capacity for Mounjaro are paying off as demand for the diabetes treatment soars.,PFE,0.082677,-0.010364,Neutral
This High-Yield Dividend Stock Is a Proven Wealth Creator,https://www.fool.com/investing/2023/11/02/this-high-yield-dividend-stock-is-a-proven-wealth/,2023-11-02 14:00:00,This heavily sold-off pharma stock is a bargain.,PFE,0.356438,0.126413,Neutral
"Down 75% From Its High, Has Novavax Stock Become Too Cheap to Pass Up?",https://www.fool.com/investing/2023/11/02/down-75-from-its-high-has-novavax-stock-become-too/,2023-11-02 14:00:00,"It won't be easy for this company to win back investors, as the business faces some big challenges.",PFE,0.24289,-0.098512,Neutral
Lion TCR clinched the prestigious T-Up Excellence Awards in Singapore - PR Newswire,https://www.prnewswire.com/apac/news-releases/lion-tcr-clinched-the-prestigious-t-up-excellence-awards-in-singapore-301975866.html,2023-11-02 12:52:14,Lion TCR clinched the prestigious T-Up Excellence Awards in Singapore PR ...,PFE,0.038345,0.200141,Somewhat-Bullish
"vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer - vTv Therapeutics  ( NASDAQ:VTVT ) ",https://www.benzinga.com/pressreleases/23/11/g35560732/vtv-therapeutics-appoints-thomas-strack-m-d-as-chief-medical-officer,2023-11-02 12:00:54,"HIGH POINT, N.C., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- vTv Therapeutics Inc. VTVT, a clinical stage biopharmaceutical company focused on the development of cadisegliatin ( TTP399 ) as an adjunctive therapy to insulin for the treatment of type 1 diabetes ( ""T1D"" ) , today announced the appointment ...",PFE,0.073546,0.011092,Neutral
"vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer",https://www.globenewswire.com/news-release/2023/11/02/2772267/0/en/vTv-Therapeutics-Appoints-Thomas-Strack-M-D-as-Chief-Medical-Officer.html,2023-11-02 12:00:00,"HIGH POINT, N.C., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- vTv Therapeutics Inc. ( Nasdaq: VTVT ) , a clinical stage biopharmaceutical company focused on the development of cadisegliatin ( TTP399 ) as an adjunctive therapy to insulin for the treatment of type 1 diabetes ( ""T1D"" ) , today announced ...",PFE,0.045918,0.010822,Neutral
1 Supercharged Growth Stock That Could Make You a Millionaire in 10 Years,https://www.fool.com/investing/2023/11/02/1-supercharged-growth-stock-that-could-make-you-a/,2023-11-02 10:45:00,"Biotech may be in a slump, but this innovator holds enormous promise as a potential wealth escalator.",PFE,0.129516,-0.007223,Neutral
European Medicines Agency validates Pierre Fabre Laboratories' marketing authorisation application for combination BRAFTOVI®  ( encorafenib )  and MEKTOVI®  ( binimetinib )  for patients with BRAFV600-mutant advanced non-small cell lung cancer  ( NSCLC ) ,https://www.newswire.ca/news-releases/european-medicines-agency-validates-pierre-fabre-laboratories-marketing-authorisation-application-for-combination-braftovi-r-encorafenib-and-mektovi-r-binimetinib-for-patients-with-brafv600-mutant-advanced-non-small-cell-lung-cancer-nsclc--852410087.html,2023-11-02 10:41:00,European Medicines Agency validates Pierre Fabre Laboratories' marketing authorisation application for combination ... Canada ...,PFE,0.054421,0.105783,Neutral
Moderna posts quarterly loss as company takes $1.3 billion write-down on unused Covid shots,https://www.cnbc.com/2023/11/02/moderna-mrna-q3-earnings-report-2023.html,2023-11-02 10:33:26,Moderna's total revenue for the third quarter still topped Wall Street's expectations despite plummeting demand for its Covid-19 shot.,PFE,0.057215,0.049946,Neutral
"Moderna Beats Sales Views, But Light Outlook Could Rattle Shares",https://www.investors.com/news/technology/moderna-stock-will-light-guidance-rattle-shares-despite-a-massive-sales-beat/,2023-11-02 10:30:25,Moderna Stock: Will Light Guidance Rattle Shares Despite A ... Investor's Business Daily ...,PFE,0.178021,-0.129621,Neutral
Should You Buy Physicians Realty Trust Before It Merges With Healthpeak?,https://www.fool.com/investing/2023/11/02/should-you-buy-physicians-realty-trust-before-it-m/,2023-11-02 10:23:00,"The merger will create a healthcare giant, but that doesn't necessarily make it a great stock to buy.",PFE,0.06211,0.031176,Neutral
"3 Beaten-Down, High-Yield Dividend Stocks That Wall Street Predicts Could Soar More Than 25% Over the Next 12 Months",https://www.fool.com/investing/2023/11/02/3-beaten-down-high-yield-dividend-stocks-that-wall/,2023-11-02 09:50:00,Analysts view these dividend stocks as great rebound candidates.,PFE,0.393462,0.252496,Somewhat-Bullish
"Pfizer trades highers, sells Thane land parcel to Zoetis Pharma for Rs 264 crore",https://www.moneycontrol.com/news/business/stocks/pfizer-trades-highers-sells-thane-land-parcel-to-zoetis-pharma-for-rs-264-crore-11645791.html,2023-11-02 04:19:14,"The share touched a 52-week high of Rs 4,662.35 on December 2, 2022 and a 52-week low of Rs 3,406.95 on March 28, 2023.",PFE,0.566143,0.138625,Neutral
Rule Breaker Investing: 9 Foolish Truths,https://www.fool.com/investing/2023/11/01/rule-breaker-investing-9-foolish-truths/,2023-11-02 02:47:00,What are the eternal verities in the world of money?,PFE,0.019158,0.018462,Neutral
Pfizer Analysts Cut Their Forecasts Following Q3 Results - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/earnings/23/11/35546084/pfizer-analysts-cut-their-forecasts-following-q3-results,2023-11-01 18:29:17,"Pfizer Inc PFE reported a loss for the third quarter on Tuesday. Pfizer reported a quarterly adjusted EPS loss of 17 cents versus a consensus loss of 32 cents, down from an EPS income of 67 cents in Q2 and $1.78 a year ago.",PFE,0.969608,-0.280536,Somewhat-Bearish
Exclusive: Novo hires FUJIFILM unit to help make Wegovy weight-loss drug - source,https://www.reuters.com/business/healthcare-pharmaceuticals/novo-hires-fujifilm-unit-help-make-wegovy-weight-loss-drug-source-2023-11-01/,2023-11-01 17:14:00,"A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights",PFE,0.112008,0.053828,Neutral
"Atlanta Leader Renee Mathewson selected as one of the 2023 ""30 Black Stars"" Corporate Achievers",https://www.globenewswire.com/news-release/2023/11/01/2771532/0/en/Atlanta-Leader-Renee-Mathewson-selected-as-one-of-the-2023-30-Black-Stars-Corporate-Achievers.html,2023-11-01 16:22:00,"The Sage Vice President will be honored at the Black Stars Awards Gala on Friday, November 3, in NYC The Sage Vice President will be honored at the Black Stars Awards Gala on Friday, November 3, in ...",PFE,0.053271,0.175984,Somewhat-Bullish
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/11/35542116/looking-at-pfizers-recent-unusual-options-activity,2023-11-01 16:01:12,"A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer PFE we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and ...",PFE,0.853983,0.240695,Somewhat-Bullish
GSK Hikes Its Outlook After Clocking Strong RSV Vaccine Sales,https://www.investors.com/news/technology/gsk-stock-gsk-earnings-q3-2023/,2023-11-01 13:09:25,GSK Stock Slips Despite Hiking Guidance On The Back Of Its Strong ... Investor's Business Daily ...,PFE,0.268294,-0.091804,Neutral
"Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors",https://www.globenewswire.com/news-release/2023/11/01/2771173/0/en/Eterna-Therapeutics-Appoints-James-Bristol-Ph-D-Pharmaceutical-Research-and-Drug-Discovery-Veteran-to-Board-of-Directors.html,2023-11-01 12:30:00,"CAMBRIDGE, Mass., Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- Eterna Therapeutics Inc. ( Nasdaq: ERNA ) ( ""Eterna"" or the ""Company"" ) , a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the ...",PFE,0.095327,0.036939,Neutral
Dietary Supplements Market is Expected to Grow $239.4 Billion,https://www.benzinga.com/pressreleases/23/11/g35535268/dietary-supplements-market-is-expected-to-grow-239-4-billion,2023-11-01 12:30:00,"Chicago, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- MarketsandMarkets, a premier market research firm, has published an in-depth analysis of the global dietary supplements market, forecasting significant expansion the global dietary supplements market size is expected to grow from USD 167.5 billion in ...",PFE,0.058759,0.0,Neutral
How To Earn $500 A Month From Pfizer Stock After Q3 Results - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/earnings/23/11/35530435/how-to-earn-500-a-month-from-pfizer-stock-after-q3-results,2023-11-01 11:56:33,"Pfizer Inc PFE reported a loss for the third quarter on Tuesday. Pfizer reported a quarterly adjusted EPS loss of 17 cents versus a consensus loss of 32 cents, down from an EPS income of 67 cents in Q2 and $1.78 a year ago.",PFE,0.754041,-0.114101,Neutral
UK regulator approves Pfizer's hair loss drug,https://www.reuters.com/business/healthcare-pharmaceuticals/uk-regulator-approves-pfizers-hair-loss-drug-2023-11-01/,2023-11-01 11:39:00,"A man walks past a Pfizer logo during the Convention on Pharmaceutical Ingredients ( CPHI ) , in Barcelona, Spain, October 24, 2023. REUTERS/ Albert Gea Acquire Licensing Rights Nov 1 ( Reuters ) - Britain's medicines regulator on Wednesday approved Pfizer Inc's ( PFE.N ) drug to treat hair loss ...",PFE,0.576289,0.201004,Somewhat-Bullish
"Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say",https://www.reuters.com/business/healthcare-pharmaceuticals/unlike-pfizer-moderna-can-meet-2023-covid-forecast-analysts-say-2023-11-01/,2023-11-01 10:20:00,"Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",PFE,0.320974,-0.075093,Neutral
Pfizer Posted a Steep Loss. Is It Time to Sell?,https://www.fool.com/investing/2023/11/01/pfizer-posted-a-steep-loss-is-it-time-to-sell/,2023-11-01 10:19:00,"A $5.6 billion inventory write-down isn't what investors wanted to see, but this company is made of many moving pieces.",PFE,0.596532,-0.025234,Neutral
Pfizer Layoffs Confirmed As Vaccine Manufacturer Drives For Cost Savings,https://www.forbes.com/sites/qai/2023/11/01/pfizer-layoffs-confirmed-as-vaccine-manufacturer-drives-for-cost-savings/,2023-11-01 09:26:04,"• Pfizer is laying off an undisclosed amount of employees after confirming it's shutting down its New Jersey facility • Two other facilities are closing in North Carolina, with other layoffs in Illinois and Colorado • Pfizer's share price was flat as the company reported a narrower-than-expected ...",PFE,0.624172,-0.047063,Neutral
Lupin shares gain after Mandideep facility gets US FDA clean chit,https://www.moneycontrol.com/news/business/stocks/lupin-shares-gain-after-mandideep-facility-gets-us-fda-clean-chit-11636311.html,2023-11-01 04:01:06,"The share touched a 52-week high of Rs 1,215.20 and a 52-week low of Rs 628.10 on 17 October, 2023 and 31 March, 2023, respectively.",PFE,0.128822,0.041313,Neutral
Pfizer quarterly sales fall short as covid continues to haunt,https://www.financialexpress.com/healthcare/pharma-healthcare/pfizer-quarterly-sales-fall-short-as-covid-continues-to-haunt/3292988/,2023-11-01 02:30:00,Pfizer Inc.'s sales missed expectations for the quarter as its Covid-19 shot and pill continued to create instability for the drugmaker's efforts to transition out of the pandemic.,PFE,0.440549,-0.174065,Somewhat-Bearish
Pfizer quarterly results hit by soft demand for COVID-19 products,https://www.foxbusiness.com/markets/pfizer-quarterly-results-soft-demand-covid-19-products,2023-11-01 00:14:13,Pfizer on Tuesday reported its first quarterly loss since 2019 as demand for its COVID products dwindled. Sales of the company's coronavirus vaccine Comirnaty dropped 70% during the third quarter compared with the same period a year earlier.,PFE,0.749166,0.306934,Somewhat-Bullish
Pfizer  ( PFE )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/10/31/pfizer-pfe-q3-2023-earnings-call-transcript/,2023-10-31 20:00:25,"PFE earnings call for the period ending September 30, 2023.",PFE,0.082993,0.111405,Neutral
"Dressed Up For Data: Halloween Dawns With Head Spinning Amounts Of Numbers, Stocks On Pace For Monthly Loss - Apple  ( NASDAQ:AAPL ) , Bank of America  ( NYSE:BAC ) ",https://www.benzinga.com/markets/23/10/35522024/dressed-up-for-data-halloween-dawns-with-head-spinning-amounts-of-numbers-stocks-on-pace-for-monthly,2023-10-31 18:18:50,( Tuesday market open ) A scary October for stocks skids to the finish line today with major U.S. indexes on pace to post their third straight monthly loss for the first time since early 2020 despite emerging from correction territory.,PFE,0.039614,0.055828,Neutral
"Never Mind Covid, Investors Want a Pfizer Obesity Pill",https://www.wsj.com/health/pharma/nevermind-covid-investors-want-a-pfizer-obesity-pill-18f6a9e5,2023-10-31 16:35:00,The pharmaceutical company's silence on its oral obesity drug worries investors.,PFE,0.633079,0.390329,Bullish
"Pfizer's  ( PFE )  Q3 Loss Narrows, Sales Miss on COVID Slump",https://www.zacks.com/stock/news/2175660/pfizers-pfe-q3-loss-narrows-sales-miss-on-covid-slump,2023-10-31 15:23:00,Pfizer (PFE) reports mixed third-quarter 2023 results. It re-affirms its 2023 sales and earnings guidance provided earlier this month.,PFE,0.467602,0.135202,Neutral
Markets Wait for Fed's FOMC Meeting Decisions,https://www.zacks.com/stock/news/2175633/markets-wait-for-feds-fomc-meeting-decisions,2023-10-31 14:52:00,"The Fed kicks off its two-day policy meeting, the Federal Open Market Committee ( FOMC ) today, where they will release their decision on interest rates tomorrow at 2pm ET, followed by a press conference by Fed Chair Jay Powell.",PFE,0.088799,0.069206,Neutral
"UAW Wins; CAT & PFE Beat, Fall in Pre-Market",https://www.zacks.com/stock/news/2175610/uaw-wins-cat-pfe-beat-fall-in-pre-market,2023-10-31 14:32:00,"This morning, a muted version of yesterday's bull market continues: the Dow is +2 points, and the S&P 500 and the Nasdaq are +6.",PFE,0.085324,0.063086,Neutral
Pfizer's Coming for AbbVie's Market Share. Here's What It Means for Investors,https://www.fool.com/investing/2023/10/31/pfizers-coming-for-abbvies-market-share-heres-what/,2023-10-31 14:07:00,"AbbVie has a head start, but that might not be enough to save its top line.",PFE,0.392362,0.306023,Somewhat-Bullish
"US Stocks Fall; Pfizer Swings To Q3 Loss - Avalo Therapeutics  ( NASDAQ:AVTX ) , Cardio Diagnostics Hldgs  ( NASDAQ:CDIO ) ",https://www.benzinga.com/news/earnings/23/10/35514600/us-stocks-fall-pfizer-swings-to-q3-loss,2023-10-31 13:52:10,"U.S. stocks traded lower this morning, following the release of economic reports. Following the market opening Tuesday, the Dow traded down 0.25% to 32,845.12 while the NASDAQ fell 0.50% to 12,726.17. The S&P 500 also fell, dropping, 0.14% to 4,161.09. Communication services shares jumped by ...",PFE,0.174587,-0.202404,Somewhat-Bearish
A continuing decline in sales of COVID-19 products clips revenue at Pfizer,https://apnews.com/article/pfizer-covid19-earnings-pharmaceutical-6cdf517cb52b38865d7e0b899a2d9056,2023-10-31 13:46:00,"Pfizer lost more than $2 billion in the third quarter as an expected COVID-19 product sales decline clipped revenue. Sales of the drugmaker's COVID treatment Paxlovid and the vaccine Comirnaty slid 97% and 70%, respectively, as Pfizer, like its competitors, switched to selling on the commercial ...",PFE,0.630514,-0.220168,Somewhat-Bearish
"Pfizer Skids As Covid Products Drive 41% Sales Decline, Losses",https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q3-2023/,2023-10-31 13:02:44,"Early Tuesday, Pfizer ( PFE ) stock dipped after the pharma mammoth reported an adjusted loss of 17 cents per share on $13.23 billion in third-quarter sales. On average, analysts polled by FactSet expected Pfizer to lose 8 cents a share and report $13.34 billion in sales.",PFE,0.922387,0.19257,Somewhat-Bullish
JANUARY DIGITAL APPOINTS BRIAN SIMMONS AS HEAD OF GROWTH - PR Newswire,https://www.prnewswire.com/news-releases/january-digital-appoints-brian-simmons-as-head-of-growth-301972076.html,2023-10-31 13:00:00,JANUARY DIGITAL APPOINTS BRIAN SIMMONS AS HEAD OF GROWTH PR ...,PFE,0.081552,0.214872,Somewhat-Bullish
Pfizer swings to wider-than-expected loss but keeps full-year outlook intact,https://www.marketwatch.com/story/pfizer-stock-inches-up-after-wider-than-expected-loss-but-full-year-outlook-kept-intact-7efc0039,2023-10-31 12:49:00,Drugmaker looks to flurry of new products to drive growth as COVID sales drop.,PFE,0.616842,0.01084,Neutral
"Pfizer Q3 Earnings: Swings To Quarterly Loss On COVID-19 Products' Write-Offs, Sales Fall 42% - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/10/35511459/pfizer-q3-earnings-swings-to-quarterly-loss-on-covid-19-products-write-offs-sales-fall-42,2023-10-31 12:41:26,"Pfizer Inc PFE has reported a Q3 adjusted EPS loss of $ ( 0.17 ) versus a consensus loss of $ ( 0.32 ) , down from EPS income of $0.67 in Q2 and $1.78 a year ago. The company reported a 42% slump in Q3 sales to $13.23 billion, down from $22.64 billion a year ago, beating the consensus of ...",PFE,0.628066,0.11481,Neutral
Futures Rise Ahead Of Key Housing Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-key-housing-data-tesla-stock-continues-to-slide/,2023-10-31 12:22:57,"Dow Jones futures rose Tuesday morning, as Wall Street braces for the start of the Federal Reserve's two-day meeting. Meanwhile, Tesla stock continued to fall Tuesday, with solid losses, after Monday's dive below the 200 price level.",PFE,0.067536,0.0,Neutral
Pfizer swings to quarterly loss as COVID product demand slump sparks charges,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-swings-quarterly-loss-due-paxlovid-write-off-2023-10-31/,2023-10-31 12:08:00,"Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease ( COVID-19 ) , is displayed in this picture illustration taken October 7, 2022. REUTERS/Wolfgang Rattay/Illustration/File Photo Acquire Licensing Rights",PFE,0.457977,-0.103891,Neutral
"Pfizer  ( PFE )  Reports Q3 Loss, Lags Revenue Estimates",https://www.zacks.com/stock/news/2175168/pfizer-pfe-reports-q3-loss-lags-revenue-estimates,2023-10-31 12:05:08,"Pfizer (PFE) delivered earnings and revenue surprises of 46.88% and 3.93%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.40348,0.074066,Neutral
Pfizer Reports Loss As Covid-19 Revenues Shrink,https://www.barrons.com/news/pfizer-reports-loss-as-covid-19-revenues-shrink-fa1ac729,2023-10-31 11:58:00,"Pfizer reported Tuesday a loss following a sharp fall in the sales of its Covid-19 vaccine and therapeutic from pandemic peaks. The drugmaker reported a third-quarter loss of $2.4 billion, compared with $8.6 billion in profits in the year-ago period.",PFE,0.762438,-0.163397,Somewhat-Bearish
Pfizer Reports Loss As Covid-19 Revenues Shrink,https://www.barrons.com/news/pfizer-reports-loss-as-covid-19-revenues-shrink-618c8bff,2023-10-31 11:58:00,"Pfizer reported Tuesday a loss following a sharp fall in the sales of its Covid-19 vaccine and therapeutic from pandemic peaks. The drugmaker reported a third-quarter loss of $2.4 billion, compared with $8.6 billion in profits in the year-ago period.",PFE,0.762438,-0.163397,Somewhat-Bearish
"U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive - Meritage Homes  ( NYSE:MTH ) , Arista Networks  ( NYSE:ANET ) , JetBlue Airways  ( NASDAQ:JBLU ) , Chesapeake Energy  ( NASDAQ:CHK ) ",https://www.benzinga.com/news/earnings/23/10/35510696/u-s-stocks-poised-to-extend-gains-as-fed-meeting-gets-underway-why-this-analyst-expects-young-bull-,2023-10-31 11:44:44,"Early indications suggest U.S. stock could strive to retain the winning momentum intact, although key catalysts scheduled for the next couple of sessions could leave investors cautious. Some of the Smid-cap earnings have come in better than expected, triggering a strong upward move in the ...",PFE,0.084423,0.0,Neutral
Deciphera  ( DCPH )  Stock Gains 17% on Q3 Earnings & Sales Beat,https://www.zacks.com/stock/news/2175198/deciphera-dcph-stock-gains-17-on-q3-earnings-sales-beat,2023-10-31 11:25:00,"Deciphera (DCPH) reports better-than-expected third-quarter 2023 results, wherein earnings and revenues beat estimates, driven by increased Qinlock sales. The stock rises 17%.",PFE,0.172404,0.087358,Neutral
"Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs",https://www.cnbc.com/2023/10/31/pfizer-pfe-q3-earnings-report-2023.html,2023-10-31 11:03:02,The results come two weeks after Pfizer slashed its full-year adjusted earnings and revenue guidance and launched a sweeping $3.5 billion cost-cutting plan.,PFE,0.697809,0.01151,Neutral
"Charlie Munger says not much 'low-hanging fruit left' as he discusses Apple, Costco vs. Walmart and EVs.",https://www.marketwatch.com/story/charlie-munger-says-not-much-low-hanging-fruit-left-as-he-discusses-apple-costco-vs-walmart-and-evs-105a3ff0,2023-10-31 10:04:00,"Our call of the day comes from a podcast interview with the legendary Charlie Munger, who discusses a range of investing topics.",PFE,0.059268,-0.040454,Neutral
Morning Bid: Refunding relief stokes bond-led bounce,https://www.reuters.com/markets/global-markets-view-usa-2023-10-31/,2023-10-31 10:01:00,"Traders work on the floor at the New York Stock Exchange ( NYSE ) in New York City, U.S., October 23, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights A look at the day ahead in U.S. and global markets from Mike Dolan",PFE,0.054114,0.202848,Somewhat-Bullish
3 No-Brainer Stocks to Buy With $50 Right Now,https://www.fool.com/investing/2023/10/31/3-no-brainer-stocks-to-buy-with-50-right-now/,2023-10-31 09:00:00,These stocks have declined in the double digits over the past few months.,PFE,0.053271,0.040793,Neutral
S&P 500 futures steady as lower Treasury yields support sentiment,https://www.marketwatch.com/story/s-p-500-futures-steady-as-lower-treasury-yields-support-sentiment-7e463e27,2023-10-31 07:49:00,"U.S. stock futures were mildly mixed early Tuesday, holding most of the previous day's rally as Treasury yields moved lower.",PFE,0.195814,0.0,Neutral
"Investor Fear Eases Ahead Of Fed's Decision; Dow Notches Best Day Since June - Caterpillar  ( NYSE:CAT ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/news/earnings/23/10/35505998/investor-fear-eases-ahead-of-feds-decision-dow-notches-best-day-since-june,2023-10-31 06:16:56,"The CNN Money Fear and Greed index showed easing in the overall fear level, with the index moving to the ""Fear"" zone on Monday. U.S. stocks closed sharply higher on Monday, with the Dow Jones recording its best session since June 2 ahead of Federal Reserve's interest rate decision and jobs ...",PFE,0.239305,0.0,Neutral
"Pfizer, AMD And 3 Stocks To Watch Heading Into Tuesday - Caterpillar  ( NYSE:CAT ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/news/earnings/23/10/35505778/pfizer-amd-and-3-stocks-to-watch-heading-into-tuesday,2023-10-31 06:16:44,"With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Caterpillar Inc. CAT to report quarterly earnings at $4.79 per share on revenue of $16.59 billion before the opening bell.",PFE,0.470894,0.372727,Bullish
Dow closes up more than 510 points to kick off a busy week for the US economy | Business,https://edition.cnn.com/2023/10/30/markets/markets-stocks-fed/index.html,2023-10-30 19:40:06,Dow closes up more than 510 points to kick off a busy week for the US economy CNN International ...,PFE,0.07423,0.0,Neutral
Dow soars more than 580 points to kick off a busy week for the US economy | Business,https://www.cnn.com/2023/10/30/markets/markets-stocks-fed/index.html,2023-10-30 19:40:00,Dow soars more than 560 points to kick off a busy week for the US economy ...,PFE,0.076602,0.0,Neutral
"Cram Session: Week Ahead Packed with Earnings, Fed Meeting, Jobs Data as Markets Attempt Rebound - Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/markets/23/10/35497918/cram-session-week-ahead-packed-with-earnings-fed-meeting-jobs-data-as-markets-attempt-rebound,2023-10-30 18:25:25,"( Monday market open ) This week offers something for everyone as Wall Street licks its wounds after Friday's plunge to fresh five-month lows. Major indexes bounced in premarket trading early Monday, helped by technical buying and a drop in crude oil prices, but remain squarely in correction mode ...",PFE,0.089378,0.024916,Neutral
"Monday's Market Minute: Fed In Focus This Week, But Plenty Of Earnings & Data As Well - Apple  ( NASDAQ:AAPL ) , Airbnb  ( NASDAQ:ABNB ) ",https://www.benzinga.com/markets/23/10/35497791/mondays-market-minute-fed-in-focus-this-week-but-plenty-of-earnings-data-as-well,2023-10-30 18:20:03,"While the primary focus this week will be on the Federal Reserve's policy announcement on Wednesday, it never hurts to take a market minute to look at a few of the other focal points for investors and traders. We begin with earnings - and how! - with more than 150 S&P 500 companies reporting this ...",PFE,0.235823,0.049193,Neutral
Dow Jones: Have the rules of the game changed in the American stock market?,https://www.investorideas.com/news/2023/main/10304MarketAnalyst-Dow-Jones.asp,2023-10-30 18:18:06,Dow Jones: Have the rules of the game changed in the American ... ...,PFE,0.054607,0.047003,Neutral
"GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/10/35492470/gsks-competitive-edge-surpasses-pfizer-in-respiratory-syncytial-virus-vaccine-sales,2023-10-30 15:48:02,"GSK GSK has reportedly taken an early lead in the race for respiratory syncytial virus ( RSV ) vaccine dominance, surpassing Pfizer Inc PFE, which previously dominated the COVID-19 vaccine market.",PFE,0.275867,0.170557,Somewhat-Bullish
"Drug, Biotech Stocks' Q3 Earnings Due on Oct 31: AMGN, PFE, INCY",https://www.zacks.com/stock/news/2174650/drug-biotech-stocks-q3-earnings-due-on-oct-31-amgn-pfe-incy,2023-10-30 15:37:00,"Let's take a look at three biotech/drug companies, AMGN, PFE and INCY, slated to release quarterly results on Oct 31.",PFE,0.474958,0.283441,Somewhat-Bullish
Pre-Markets in Green to Start a Crucial Week of Events,https://www.zacks.com/stock/news/2174622/pre-markets-in-green-to-start-a-crucial-week-of-events,2023-10-30 15:06:00,"It's the start of the busiest week of Q3 earnings season, and pre-market futures are up. Perhaps this is a sign of optimism for expected earnings, or perhaps it's looking favorably on a parade of economic reports out this week.",PFE,0.173333,0.0,Neutral
"Busy Week for Earnings, Fed, Reports; MCD, ON Beat in Q3",https://www.zacks.com/stock/news/2174606/busy-week-for-earnings-fed-reports-mcd-on-beat-in-q3,2023-10-30 14:35:00,Mid-October near-term highs have given way to lower trading levels for the most part in the past couple weeks.,PFE,0.167322,0.0,Neutral
"The Zacks Analyst Blog Highlights Costco Wholesale, Pfizer, IBM, NextEra Energy and HCA Healthcare",https://www.zacks.com/stock/news/2174599/the-zacks-analyst-blog-highlights-costco-wholesale-pfizer-ibm-nextera-energy-and-hca-healthcare,2023-10-30 13:23:00,"Costco Wholesale, Pfizer, IBM, NextEra Energy and HCA Healthcare are part of the Zacks top Analyst Blog.",PFE,0.523451,0.311446,Somewhat-Bullish
Pfizer's  ( PFE )  Key Drugs to Drive Q3 Earnings Amid COVID Decline?,https://www.zacks.com/stock/news/2174310/pfizers-pfe-key-drugs-to-drive-q3-earnings-amid-covid-decline,2023-10-30 12:49:00,"Pfizer (PFE) expects better non-COVID operational revenue growth sequentially in the third quarter, driven by its key products, new launches as well as newly acquired products.",PFE,0.363388,0.203159,Somewhat-Bullish
Futures Rise Ahead Of Fed Meeting; Apple Earnings Loom,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-fed-meeting-apple-earnings-jobs-report-loom/,2023-10-30 12:11:51,Futures Rise Ahead Of Fed Meeting. Apple Earnings Loom Investor's Business Daily ...,PFE,0.070207,0.0,Neutral
Aquinnah Pharmaceuticals Advances Oral Small Molecule Program Targeting Alzheimer's and Other Tauopathy Diseases,https://www.newswire.ca/news-releases/aquinnah-pharmaceuticals-advances-oral-small-molecule-program-targeting-alzheimer-s-and-other-tauopathy-diseases-873057095.html,2023-10-30 11:00:00,Aquinnah Pharmaceuticals Advances Oral Small Molecule Program Targeting Alzheimer's and Other Tauopathy ... Canada ...,PFE,0.051774,0.162508,Somewhat-Bullish
Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast,https://www.globenewswire.com/news-release/2023/10/30/2769027/36461/en/Voyager-Therapeutics-Announces-Third-Quarter-2023-Conference-Call-and-Webcast.html,2023-10-30 11:00:00,"CAMBRIDGE, Mass., Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( Nasdaq: VYGR ) a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced it will report third quarter 2023 financial and operating results after market close on ...",PFE,0.114682,0.025068,Neutral
Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast - Voyager Therapeutics  ( NASDAQ:VYGR ) ,https://www.benzinga.com/pressreleases/23/10/g35486476/voyager-therapeutics-announces-third-quarter-2023-conference-call-and-webcast,2023-10-30 11:00:00,"CAMBRIDGE, Mass., Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. VYGR a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced it will report third quarter 2023 financial and operating results after market close on Monday, ...",PFE,0.110462,0.024663,Neutral
Pfizer RSV vaccine lags GSK's as head-to-head competition underway,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-rsv-vaccine-lags-gsks-head-to-head-competition-underway-2023-10-30/,2023-10-30 10:35:00,[1/3] View of Pfizer's new respiratory syncytial virus ( RSV ) vaccine Abrysvo during its manufacture in this undated handout picture. Pfizer/Handout via REUTERS/File photo Acquire Licensing Rights,PFE,0.309539,0.013732,Neutral
Futures jump as investors await Fed rate verdict; Middle East tensions eyed,https://www.reuters.com/markets/us/futures-jump-investors-await-fed-rate-verdict-middle-east-tensions-eyed-2023-10-30/,2023-10-30 09:57:00,Futures jump as investors await Fed rate verdict. Middle East tensions eyed ...,PFE,0.07913,0.10562,Neutral
"The market's in a funk. Why now is an attractive entry point for long-term investors, says JPMorgan strategist.",https://www.marketwatch.com/story/the-markets-in-a-funk-why-now-is-an-attractive-entry-point-for-long-term-investors-says-jpmorgan-strategist-67dd989a,2023-10-30 09:29:00,"If you can overlook the danger, it's looking like a good entry point for long-term investors, says a private bank strategist.",PFE,0.09239,0.0,Neutral
Pfizer Holds MERA Vaccines Summit to Discuss the Impact of Vaccines on Controlling Diseases in the Region,https://www.prnewswire.com/news-releases/pfizer-holds-mera-vaccines-summit-to-discuss-the-impact-of-vaccines-on-controlling-diseases-in-the-region-301970718.html,2023-10-30 06:00:00,"• The MERA Vaccines Summit brought together more than 100 physicians and healthcare professionals to to discuss a range of communicable diseases. • The summit educated healthcare professionals with the latest literature on vaccines, and its impact to the region's population. • Vaccines are ...",PFE,0.461699,0.516042,Bullish
"Pfizer may open lower as Q2 revenue, profit take a hit",https://www.moneycontrol.com/news/business/markets/pfizer-may-open-lower-as-q2-revenue-profit-take-a-hit-11621941.html,2023-10-30 02:49:40,Pfizer's profit fell over 50 percent year-on-year as the lower topline and high base in the previous fiscal impacted earnings ...,PFE,0.343279,0.137758,Neutral
"Stocks to Watch Today: Reliance, Ultratech Cement, AU SFB, NTPC, Gujarat Gas, MGL",https://www.business-standard.com/markets/news/stocks-to-watch-today-reliance-ultratech-cement-au-sfb-ntpc-gujarat-gas-mgl-q2-results-123103000099_1.html,2023-10-30 02:29:29,"Stocks to Watch: Reliance, Ultratech Cement, AU SFB, NTPC, Gujarat Gas, MGL Business Standard ...",PFE,0.07446,-0.088269,Neutral
The 7 Most Undervalued Long-Term Stocks to Buy: October 2023,https://markets.businessinsider.com/news/stocks/undervalued-long-term-stocks-7-to-buy-in-october-2023-1032751361,2023-10-29 20:21:08,The 7 Most Undervalued Long-Term Stocks to Buy: October ...,PFE,0.135653,0.106577,Neutral
"Apple earnings, Fed decision and jobs data top Wall Street week ahead",https://www.foxbusiness.com/markets/apple-earnings-fed-decision-and-jobs-data-top-wall-street-week-ahead,2023-10-29 16:38:03,"Investors are gearing up for another busy week of earnings and economic data, including the jobs report for October. Meanwhile, on Wall Street, stocks ended mixed Friday leaving both the S&P 500 and the Nasdaq Composite in correction territory. As of Friday, the S&P 500 is now 10% from its most ...",PFE,0.07031,0.080345,Neutral
How the Fed is using its multi-trillion-dollar balance sheet to fight inflation | Business,https://www.cnn.com/2023/10/29/economy/stocks-week-ahead-fed-balance-sheet/index.html,2023-10-29 11:30:00,How the Fed is using its multi-trillion-dollar balance sheet to fight inflation ...,PFE,0.027195,-0.009436,Neutral
"Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More - Target  ( NYSE:TGT ) , CVS Health  ( NYSE:CVS ) , Rite Aid  ( OTC:RADCQ ) , Novartis  ( NYSE:NVS ) ",https://www.benzinga.com/markets/equities/23/10/35478496/are-your-eyes-at-grave-risk-fda-issues-dangerous-warning-over-popular-drops-from-cvs-target-card,2023-10-28 16:49:12,"The U.S. Food and Drug Administration has recently issued a stern warning to the public, advising against the purchase and use of multiple specific over-the-counter eye drop products from prominent brands.",PFE,0.216215,0.0,Neutral
"Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?",https://www.fool.com/investing/2023/10/28/roche-lilly-or-pfizer-whos-the-winner-in-ibd-wars/,2023-10-28 12:45:00,The three companies are spending big on IBD therapies.,PFE,0.353059,0.078417,Neutral
Intellia Therapeutics Will Soon Make Biotech History. Is the Stock a Buy?,https://www.fool.com/investing/2023/10/28/intellia-therapeutics-will-soon-make-biotech-histo/,2023-10-28 11:30:00,There's more to being a good investment than doing groundbreaking science.,PFE,0.045054,0.040691,Neutral
"Pfizer Q2 results: Net profit declines 52% at Rs 149 cr, revenue slips 9.8%",https://www.business-standard.com/companies/results/pfizer-q2-results-net-profit-declines-52-at-rs-149-cr-revenue-slips-9-8-123102800550_1.html,2023-10-28 11:20:14,"Drug firm Pfizer Ltd on Saturday reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023. The company had logged a net profit of Rs 311.07 crore in July-September period a year ago, according to a regulatory filing by Pfizer.",PFE,0.674691,0.189329,Somewhat-Bullish
3 No-Brainer Stocks to Buy for Under $100 Right Now,https://www.fool.com/investing/2023/10/28/3-no-brainer-stocks-to-buy-for-under-100-right-now/,2023-10-28 10:50:00,A couple of these stocks might not be available for under $100 for too much longer.,PFE,0.142284,0.018418,Neutral
"Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight",https://www.prnewswire.com/news-releases/unraveling-the-shifting-rare-eye-diseases-market-landscape-analysis-of-retinoblastoma-market-retinitis-pigmentosa-market-limbal-stem-cell-deficiency-market-leber-hereditary-optic-neuropathy-market-and-stargardt-disease-market-301991311.html,2023-11-16 22:01:00,"Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis ... PR ...",PFE,0.01645,0.006093,Neutral
3 Top Penny Stocks To Watch Before Next Week,https://pennystocks.com/featured/2023/11/16/3-top-penny-stocks-to-watch-before-next-week-november-2023/,2023-11-16 19:12:36,"Have you ever thought about diving into penny stocks? These are the stocks that won't break the bank, typically trading for less than $5. They're a bit like roller coasters - full of ups and downs. But guess what? There's a way to ride these ups and downs smartly. And it's all about keeping an ...",PFE,0.033144,0.036542,Neutral
"New York feds arrest 2, confiscate $1.03B in counterfeit goods - .com",https://www.upi.com/Top_News/US/2023/11/16/counterfeit-items-arrests-Homeland-Security/4921700148246/,2023-11-16 15:51:11,"New York feds arrest 2, confiscate $1.03B in counterfeit goods UPI News ...",PFE,0.103778,-0.269479,Somewhat-Bearish
Pfizer's  ( PFE )  New Products May Drive Long-Term Sales Growth,https://www.zacks.com/stock/news/2185206/pfizers-pfe-new-products-may-drive-long-term-sales-growth,2023-11-16 13:39:00,"Though Pfizer's (PFE) revenues from COVID products are declining sharply, the launch of some key non-COVID products in 2023 is expected to drive long-term sales and profit growth.",PFE,0.739097,0.170875,Somewhat-Bullish
"Tim Cook, Elon Musk, Steve Schwarzman spotted at Xi Jinping dinner with U.S. CEOs",https://www.cnbc.com/2023/11/16/xi-dinner-with-us-ceos-tim-cook-elon-musk-steve-schwarzman-spotted.html,2023-11-16 13:12:33,"The Xi dinner was a hot ticket for CEOs of America's most prominent companies, and a chance to rub elbows with high-ranking Chinese government ministers.",PFE,0.069294,0.070234,Neutral
AbbVie and Pfizer Have 1 Thing in Common: Their Biggest Products Are on the Decline. Time to Sell?,https://www.fool.com/investing/2023/11/16/abbvie-and-pfizer-have-1-thing-in-common-their-big/,2023-11-16 10:00:00,Both companies' share prices have slipped recently.,PFE,0.454174,0.048243,Neutral
China Ready To Be 'Partner And Friend' Of US: Xi,https://www.barrons.com/news/china-ready-to-be-partner-and-friend-of-us-xi-ec12d188,2023-11-16 07:01:00,"China is ""ready to be a partner and friend of the United States,"" President Xi Jinping told US business leaders on Wednesday, as concerns mount over the country's slowing economy.",PFE,0.062926,0.0,Neutral
Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.,https://www.barrons.com/articles/eli-lilly-pfizer-astrazeneca-drug-pharma-stocks-de1d4c9d,2023-11-16 07:00:00,"Most drug stocks have been out of favor in 2023. Pfizer was down 43.4% as of the market close Monday, while Johnson & Johnson is down 16.4%. Despite Eli Lilly's monster 66.8% gain on the year, amid investor frenzy over its weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.",PFE,0.716023,0.410039,Bullish
InnovationRx: A New Blood Thinner On The Horizon,https://www.forbes.com/sites/alexknapp/2023/11/15/innovationrx-a-new-blood-thinner-on-the-horizon/,2023-11-15 22:10:51,"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. The number of Americans with irregular heartbeats, known as atrial fibrillation, is expected to top 12 million people by the end of the decade.",PFE,0.047654,0.013998,Neutral
"Eli Lilly's Olumiant and Pfizer's Litfulo Strengthen Alopecia Areata Arsenal, Yet Resounding Opportunity for JAK Expansion and New Assets in Development Remain",https://www.benzinga.com/pressreleases/23/11/g35809150/eli-lillys-olumiant-and-pfizers-litfulo-strengthen-alopecia-areata-arsenal-yet-resounding-opportun,2023-11-15 16:22:30,"Exton, Pennsylvania, Nov. 15, 2023 ( GLOBE NEWSWIRE ) -- Spherix Global Insights has been monitoring the alopecia areata ( AA ) market for the past four years and has found that the entry of JAK inhibitors has had a notable impact on the overall unmet need for those suffering from severe AA. ...",PFE,0.085629,0.103252,Neutral
"The Zacks Analyst Blog Highlights Meta Platforms, Walmart, Pfizer, Intel and Ecolab",https://www.zacks.com/stock/news/2184501/the-zacks-analyst-blog-highlights-meta-platforms-walmart-pfizer-intel-and-ecolab,2023-11-15 13:52:00,"The Zacks Analyst Blog Highlights Meta Platforms, Walmart, Pfizer, Intel and ...",PFE,0.48457,0.193191,Somewhat-Bullish
Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology - CureVac  ( NASDAQ:CVAC ) ,https://www.benzinga.com/general/biotech/23/11/35799395/acuitas-challenges-curevac-in-legal-tussle-over-covid-19-vaccine-technology,2023-11-15 13:15:24,"Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE CVAC, accusing it of failing to credit Acuitas on patents related to COVID-19 vaccines. Acuitas is developing lipid nanoparticle ( LNP ) technology used in mRNA vaccines and other ...",PFE,0.350564,-0.488643,Bearish
"PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors - PepGen  ( NASDAQ:PEPG ) ",https://www.benzinga.com/pressreleases/23/11/g35802158/pepgen-announces-appointment-of-howard-mayer-m-d-to-board-of-directors,2023-11-15 13:00:00,"BOSTON, Nov. 15, 2023 ( GLOBE NEWSWIRE ) -- PepGen Inc. PEPG, a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of Howard ...",PFE,0.052455,-0.060901,Neutral
Could a Short Squeeze Be Coming for These 3 Heavily Shorted Stocks?,https://www.fool.com/investing/2023/11/15/could-short-squeeze-coming-heavily-shorted-stocks/,2023-11-15 10:20:00,Should investors expect any of these stocks to turn their fortunes around next year?,PFE,0.042421,-0.106586,Neutral
Airfinity gives decision makers big picture on health,https://www.ft.com/content/f7b3f9ff-b57a-4fcd-8dd7-83301b1908b9,2023-11-15 05:00:14,"Covid may have abated, but emerging diseases and new drug categories are keeping the analytics firm busy ...",PFE,0.041682,0.031358,Neutral
Investors increase holdings of weight-loss drug makers' shares in Q3 -filings,https://www.reuters.com/business/healthcare-pharmaceuticals/investors-increase-holdings-weight-loss-drug-makers-shares-q3-filings-2023-11-14/,2023-11-14 23:45:00,Investors increase holdings of weight-loss drug makers' shares in ...,PFE,0.084722,0.205813,Somewhat-Bullish
Homology Medicines Reports Third Quarter 2023 Financial Results,https://www.globenewswire.com/news-release/2023/11/14/2780577/0/en/Homology-Medicines-Reports-Third-Quarter-2023-Financial-Results.html,2023-11-14 21:33:00,"- Continuing to Evaluate Strategic Options for the Company and the Pipeline of Genetic Medicines, including ...",PFE,0.057079,0.024006,Neutral
Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame.,https://www.wsj.com/finance/stocks/earnings-estimates-are-falling-these-two-companies-are-shouldering-the-blame-4bcb68f1,2023-11-14 21:19:00,"Investors appear to be taking the shifting picture in stride, partly because much of the responsibility appears to fall on Pfizer and Merck.",PFE,0.443626,-0.211056,Somewhat-Bearish
"Employer coverage of GLP-1 drugs for weight loss lags far behind diabetes coverage, survey finds",https://www.marketwatch.com/story/employer-coverage-of-glp-1-drugs-for-weight-loss-lags-far-behind-diabetes-coverage-survey-finds-aa9f8936,2023-11-14 20:34:00,Many employers hold off on coverage of Wegovy and similar drugs amid cost concerns and the prospect of cheaper options down the road ...,PFE,0.125134,0.251447,Somewhat-Bullish
What's Going On With Pfizer Stock Today? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/11/35782291/pfizers-cost-cutting-measures-500-job-cuts-in-kent-facility-higher-than-anticipated,2023-11-14 17:15:12,"Pfizer Inc PFE is reportedly discontinuing its pharmaceutical sciences small molecule ( PSSM ) operations at Sandwich in Kent to streamline operations and enhance efficiency. The decision will result in significant job cuts, with plans to eliminate 500 out of 940 positions.",PFE,0.70749,0.362197,Bullish
"Top Analyst Reports for Meta Platforms, Walmart & Pfizer",https://www.zacks.com/research-daily/2183837/top-analyst-reports-for-meta-platforms-walmart-pfizer,2023-11-14 16:33:00,"Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Walmart Inc. (WMT) and Pfizer Inc. (PFE).",PFE,0.414559,0.244326,Somewhat-Bullish
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/11/35780187/this-is-what-whales-are-betting-on-pfizer,2023-11-14 15:45:48,"Financial giants have made a conspicuous bullish move on Pfizer. Our analysis of options history for Pfizer PFE revealed 16 unusual trades. Delving into the details, we found 56% of traders were bullish, while 43% showed bearish tendencies.",PFE,0.830322,0.173214,Somewhat-Bullish
Pfizer to cut 500 jobs at Kent site - Sky News,https://www.reuters.com/business/pfizer-cut-500-jobs-kent-site-sky-news-2023-11-14/,2023-11-14 15:27:00,"A person walks past the Pfizer Headquarters building in the Manhattan borough of New York City, New York, U.S., November 9, 2020. REUTERS/Carlo Allegri/File Photo Acquire Licensing Rights",PFE,0.856646,-0.10099,Neutral
Better Growth Stock: Pfizer vs. Novo Nordisk,https://www.fool.com/investing/2023/11/14/better-growth-stock-pfizer-vs-novo-nordisk/,2023-11-14 14:45:00,"One is growing now, and the other will grow soon.",PFE,0.395792,0.255422,Somewhat-Bullish
Dr. Alan Kivitz to Chair XBiotech's Natrunix Program in Rheumatoid Arthritis - XBiotech  ( NASDAQ:XBIT ) ,https://www.benzinga.com/pressreleases/23/11/g35776284/dr-alan-kivitz-to-chair-xbiotechs-natrunix-program-in-rheumatoid-arthritis,2023-11-14 14:00:00,"AUSTIN, Texas, Nov. 14, 2023 ( GLOBE NEWSWIRE ) -- XBiotech XBIT today announced that Alan Kivitz M.D. is now Lead Investigator & Study Chairman for its clinical research program for Natrunix in Rheumatoid Arthritis. XBiotech believes Natrunix will be a breakthrough therapy for ...",PFE,0.039614,0.037048,Neutral
"Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, J&J and AbbVie",https://www.zacks.com/stock/news/2183791/zacks-industry-outlook-highlights-eli-lilly-novo-nordisk-jj-and-abbvie,2023-11-14 12:42:00,"Eli Lilly, Novo Nordisk, J&J and AbbVie are part of the Zacks Industry Outlook article.",PFE,0.023556,0.11584,Neutral
Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame.,https://www.wsj.com/finance/stocks/earnings-estimates-are-falling-these-two-companies-are-shouldering-the-blame-4bcb68f1,2023-11-14 10:30:00,"Investors appear to be taking the shifting picture in stride, partly because much of the responsibility appears to fall on Pfizer and Merck.",PFE,0.443626,-0.211056,Somewhat-Bearish
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX,https://www.benzinga.com/pressreleases/23/11/g35767100/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-biontech-se-bnt,2023-11-13 23:45:34,"NEW YORK, Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE ( ""BioNTech"" or the ""Company"" ) BNTX. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",PFE,0.393462,-0.061662,Neutral
Pfizer Stock Hits 3-Year Low-Down 50% From 2021 Peak,https://www.forbes.com/sites/dereksaul/2023/11/13/pfizer-stock-hits-3-year-low-down-50-from-2021-peak/,2023-11-13 21:08:53,"Pfizer shares tumbled again Monday, continuing the pharmaceutical giant's struggles tied to declining demand for its Covid-19 products and essentially wiping out the entirety of the firm's peak pandemic gains. Pfizer stock slipped 1.6% to $28.96, closing at its lowest share price since March 26, ...",PFE,0.733479,-0.031645,Neutral
"What Are Pfizer's Prospects In Obesity Pill Market? Analysts Say Optimism, Cautiousness Surround With Data Awaited Next Year - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/11/35757948/what-are-pfizers-prospects-in-obesity-pill-market-analysts-say-optimism-cautiousness-surround-wit,2023-11-13 19:04:21,"Pfizer Inc PFE is turning its focus to the weight loss drug market, aiming to capture a $10 billion segment with its experimental obesity pill, danuglipron.",PFE,0.677342,-0.136366,Neutral
Stock Market Indexes Stumble As Moody's Cuts U.S. Rating; Boeing Soars On Deal News,https://www.investors.com/market-trend/stock-market-today/stock-market-indexes-stumble-as-moodys-cuts-us-rating/,2023-11-13 15:53:00,Stock Market Indexes Stumble As Moody's Cuts U.S. Rating. Boeing ... Investor's Business Daily ...,PFE,0.140348,0.047442,Neutral
4 Large Drug Stocks Likely to Sail Through Industry Woes,https://www.zacks.com/commentary/2183148/4-large-drug-stocks-likely-to-sail-through-industry-woes,2023-11-13 15:03:00,"Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), J&J (JNJ) and AbbVie (ABBV) are worth retaining in your portfolio.",PFE,0.024546,0.067704,Neutral
Pfizer wants in on the weight loss drug market - and upcoming data will be crucial for its success,https://www.cnbc.com/2023/11/13/pfizer-enters-weight-loss-drug-market-with-novo-nordisk-eli-lilly.html,2023-11-13 13:00:01,"Analysts said upcoming data on Pfizer's obesity pill, danuglipron, will be crucial to how competitive the company can be against Eli Lilly and Novo Nordisk.",PFE,0.278222,0.10843,Neutral
Better Buy Now: Novo Nordisk vs. Eli Lilly,https://www.fool.com/investing/2023/11/13/better-buy-now-novo-nordisk-vs-eli-lilly/,2023-11-13 11:17:00,"Both of these companies are reporting positive news for their competing weight-loss drugs, but which is the better stock to buy now?",PFE,0.045743,0.029926,Neutral
3 Cathie Wood Bargain Buys That Should Be on Your List Too,https://www.fool.com/investing/2023/11/13/3-cathie-wood-buys-that-should-be-on-your-list/,2023-11-13 10:00:00,Wood just picked up shares of these companies recently.,PFE,0.057215,0.079944,Neutral
Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss,https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-shares-rise-wegovy-shows-heart-benefits-beyond-weight-loss-2023-11-13/,2023-11-13 09:54:00,"LONDON, Nov 13 ( Reuters ) - Novo Nordisk ( NOVOb.CO ) shares rose 3% on Monday as the market reacted to data the drugmaker presented over the weekend showing that the heart protective benefits of its popular obesity drug Wegovy are not solely due to weight loss.",PFE,0.098659,0.229931,Somewhat-Bullish
"Basilea announces acquisition of fosmanogepix, a phase-3-ready broad-spectrum antifungal",https://www.globenewswire.com/news-release/2023/11/13/2778685/0/en/Basilea-announces-acquisition-of-fosmanogepix-a-phase-3-ready-broad-spectrum-antifungal.html,2023-11-13 06:15:00,Ad hoc announcement pursuant to Art. 53 LR ...,PFE,0.059341,0.115089,Neutral
Valneva Reports Positive Pivotal Phase 3 Immunogenicity Data in Adolescents for its Single-Shot Chikungunya Vaccine Candidate,https://www.globenewswire.com/news-release/2023/11/13/2778680/0/en/Valneva-Reports-Positive-Pivotal-Phase-3-Immunogenicity-Data-in-Adolescents-for-its-Single-Shot-Chikungunya-Vaccine-Candidate.html,2023-11-13 06:00:00,"Saint-Herblain ( France ) , November 13, 2023 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) , a specialty vaccine company, today reported positive pivotal Phase 3 immunogenicity data in adolescents for its single-dose chikungunya virus ( CHIKV ) vaccine candidate VLA1553.",PFE,0.020352,-0.004704,Neutral
Valneva Reports Positive Pivotal Phase 3 Immunogenicity Data in Adolescents for its Single-Shot Chikungunya Vaccine Candidate,https://www.benzinga.com/pressreleases/23/11/g35742025/valneva-reports-positive-pivotal-phase-3-immunogenicity-data-in-adolescents-for-its-single-shot-ch,2023-11-13 06:00:00,"Saint-Herblain ( France ) , November 13, 2023 - Valneva SE VALNVLA, a specialty vaccine company, today reported positive pivotal Phase 3 immunogenicity data in adolescents for its single-dose chikungunya virus ( CHIKV ) vaccine candidate VLA1553.",PFE,0.019928,-0.004694,Neutral
3 Stocks That Can Benefit from a Santa Claus Rally,https://www.fool.com/investing/2023/11/12/3-stocks-that-can-benefit-from-a-santa-claus-rally/,2023-11-12 10:30:00,'Tis the season to hope for a strong stock market.,PFE,0.204647,0.098492,Neutral
Where Will Novavax Be in 3 Years?,https://www.fool.com/investing/2023/11/11/where-will-novavax-be-in-3-years/,2023-11-11 10:30:00,Novavax shares have plunged from early pandemic highs.,PFE,0.154125,0.07966,Neutral
Wegovy Maker Novo Nordisk Pumps $6 Billion To Boost Production As Obesity Drug Rival Zepbound Is Approved,https://www.forbes.com/sites/roberthart/2023/11/10/wegovy-maker-novo-nordisk-pumps-6-billion-to-boost-production-as-obesity-drug-rival-zepbound-is-approved/,2023-11-10 15:10:52,"Danish pharma giant Novo Nordisk on Friday announced plans to spend $6 billion to boost manufacturing capacity, amid booming demand for its wildly popular weight loss and diabetes drugs Ozempic and Wegovy and as new competitors reach the market.",PFE,0.051111,0.029996,Neutral
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research,https://www.prnewswire.com/news-releases/oncology-drugs-market-worth-520-billion-by-2033---exclusive-report-by-we-market-research-301984776.html,2023-11-10 15:01:00,"CHICAGO, Nov. 10, 2023 /PRNewswire/ -- According to the latest findings from We Market Research, the oncology drug market is on track to achieve a value of USD 205 billion by the year 2023.",PFE,0.081138,0.046543,Neutral
"Novavax  ( NVAX )  Beats on Q3 Earnings & Sales, Cuts Sales View",https://www.zacks.com/stock/news/2182275/novavax-nvax-beats-on-q3-earnings-sales-cuts-sales-view,2023-11-10 14:06:00,"Novavax (NVAX) reports better-than-expected third-quarter results, with earnings and revenues beating estimates. It lowers product sales guidance for 2023.",PFE,0.037329,0.109888,Neutral
WHO's new COVID guidelines see fewer patients requiring hospitalization,https://www.marketwatch.com/story/whos-new-covid-guidelines-see-fewer-patients-requiring-hospitalization-f4703057,2023-11-10 13:43:00,Groups previously deemed high-risk are now at moderate risk of getting severe disease or dying.,PFE,0.265859,0.121675,Neutral
AstraZeneca  ( AZN )  Buys Global Rights to Oral Obesity Candidate,https://www.zacks.com/stock/news/2182200/astrazeneca-azn-buys-global-rights-to-oral-obesity-candidate,2023-11-10 13:11:00,"To cash in on the rising demand for obesity drugs, AstraZeneca (AZN) in-licenses exclusive rights to ECC5004, a novel oral GLP-1RA therapy, from private Chinese biotech Eccogene.",PFE,0.266101,0.097013,Neutral
"Got $5,000? Get the Most Bang for Your Buck With These 4%-Plus Dividend Yield Stocks",https://www.fool.com/investing/2023/11/10/got-5000-get-most-bang-for-your-buck-with-these/,2023-11-10 12:45:00,These stocks provide good values and pay high dividends.,PFE,0.375016,0.024267,Neutral
The Stock-Split Stock Behind Ozempic and Wegovy Could Be Yours for Just $100,https://www.fool.com/investing/2023/11/10/the-stock-split-stock-behind-ozempic-and-wegovy-co/,2023-11-10 11:54:00,Novo Nordisk just reported financial and operating results through the first nine months of the year. One thing is clear: Demand is not an issue.,PFE,0.068209,0.076597,Neutral
"Look Out, Ozempic and Wegovy: Eli Lilly Has a New Weight-Loss Drug in Town",https://www.fool.com/investing/2023/11/10/look-out-ozempic-and-wegovy-eli-lilly-has-a-new-we/,2023-11-10 10:49:00,"Analysts predict Lilly's tirzepatide, marketed under the Mounjaro and Zepbound brands, could achieve peak annual sales of more than $50 billion.",PFE,0.251032,0.135461,Neutral
Sosei Heptares Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2023,https://www.globenewswire.com/news-release/2023/11/10/2778048/0/en/Sosei-Heptares-Operational-Highlights-and-Consolidated-Results-for-the-Third-Quarter-and-First-Nine-Months-of-2023.html,2023-11-10 06:30:00,"Tokyo, Japan and Cambridge, UK, 10 November 2023 - Sosei Group Corporation ( ""Sosei Heptares"" or ""the Company"". TSE: 4565 ) provides an update on operational activities and reports its consolidated results for the third quarter and nine months ended 30 September 2023.",PFE,0.066722,0.116794,Neutral
"Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ®",https://www.globenewswire.com/news-release/2023/11/10/2778039/0/en/Valneva-Announces-U-S-FDA-Approval-of-World-s-First-Chikungunya-Vaccine-IXCHIQ.html,2023-11-10 06:00:00,"Saint-Herblain ( France ) , November 10, 2023 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) , a specialty vaccine company, today announced that the U.S. Food and Drug Administration ( FDA ) has approved IXCHIQ®, Valneva's single-dose, live-attenuated vaccine indicated for the prevention of ...",PFE,0.016541,-0.004609,Neutral
"Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ®",https://www.benzinga.com/pressreleases/23/11/g35720301/valneva-announces-u-s-fda-approval-of-worlds-first-chikungunya-vaccine-ixchiq,2023-11-10 06:00:00,"Saint-Herblain ( France ) , November 10, 2023 - Valneva SE VALNVLA, a specialty vaccine company, today announced that the U.S.",PFE,0.016129,-0.004598,Neutral
DoubleVerify  ( DV )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/11/09/doubleverify-dv-q3-2023-earnings-call-transcript/,2023-11-10 02:30:15,"DV earnings call for the period ending September 30, 2023.",PFE,0.004533,0.100425,Neutral
Why Ginkgo Bioworks Stock Was Plummeting on Thursday,https://www.fool.com/investing/2023/11/09/why-ginkgo-bioworks-stock-was-plummeting-on-thursd/,2023-11-09 20:22:19,"The market reacted very negatively to the company's earnings release. However, there were several positive developments contained within it.",PFE,0.131643,-0.003731,Neutral
Novavax plans to slash costs by another $300 mn amid sagging demand,https://www.business-standard.com/companies/news/novavax-plans-to-slash-costs-by-another-300-mn-amid-sagging-demand-123111000010_1.html,2023-11-09 18:45:39,Covid-19 vaccine maker Novavax Inc slashed its sales forecast and said it's ready to cut at least another $300 million in costs next year amid sagging demand for its shots.,PFE,0.091162,0.178626,Somewhat-Bullish
Novavax shares rise as third-quarter results top expectations,https://www.marketwatch.com/story/novavax-shares-rise-as-third-quarter-results-top-expectations-a422bdca,2023-11-09 13:50:00,"Vaccine maker reins in full-year sales outlook, looks to expand cost-cutting program ...",PFE,0.312158,0.103064,Neutral
"Zacks Earnings Trends Highlights: Pfizer, Eli Lilly, General Motors and Tesla",https://www.zacks.com/stock/news/2181525/zacks-earnings-trends-highlights-pfizer-eli-lilly-general-motors-and-tesla,2023-11-09 13:50:00,"Pfizer, Eli Lilly, General Motors and Tesla have been highlighted in this Earnings Trends article.",PFE,0.188193,-0.028304,Neutral
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.,https://www.fool.com/investing/2023/11/09/modernas-stock-just-tumbled-12-heres-why-its-still/,2023-11-09 13:45:00,It's gearing up for its next growth spurt.,PFE,0.057628,0.009028,Neutral
"Novavax posts higher-than-expected revenue, says prepared to further cut costs",https://www.reuters.com/business/healthcare-pharmaceuticals/covid-vaccine-maker-novavax-reports-better-than-expected-revenue-2023-11-09/,2023-11-09 13:01:00,"A vial labelled ""Novavax V COVID-19 Vaccine"" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration Acquire Licensing Rights",PFE,0.092569,0.04888,Neutral
Vera Therapeutics Provides Business Update and Reports Third Quarter Financial Results,https://www.globenewswire.com/news-release/2023/11/09/2777266/0/en/Vera-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-Financial-Results.html,2023-11-09 13:00:00,"BRISBANE, Calif., Nov. 09, 2023 ( GLOBE NEWSWIRE ) -- Vera Therapeutics, Inc. ( Nasdaq: VERA ) , a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today reported its business highlights ...",PFE,0.030102,-0.055885,Neutral
"Dr. Tom Frieden: Covid-19 is still around, and so are these misconceptions",https://www.cnn.com/2023/11/09/health/tom-frieden-covid-19-misconceptions/index.html,2023-11-09 11:14:00,"Editor's note: Dr. Tom Frieden was director of the US Centers for Disease Control and Prevention from 2009 to 2017, where he oversaw responses to the H1N1 influenza, Ebola and Zika epidemics. He is president and CEO of Resolve to Save Lives and Senior Fellow for Global Health at the Council on ...",PFE,0.027257,0.063364,Neutral
Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights,https://www.globenewswire.com/news-release/2023/11/09/2777099/0/en/Shattuck-Labs-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Business-Highlights.html,2023-11-09 11:00:00,- Positive interim data from Phase 1B clinical trial of SL-172154 in combination with pegylated liposomal doxorubicin ( PLD ) in platinum-resistant ovarian cancer ( PROC ) demonstrated an acceptable safety profile and encouraging anti-tumor activity that compares favorably to PLD as a monotherapy.,PFE,0.016427,0.024328,Neutral
Earnings Estimates Come Under Pressure,https://www.zacks.com/commentary/2181217/earnings-estimates-come-under-pressure,2023-11-08 23:22:00,"While Q3 results have been better than expected, there is a notable acceleration in negative estimate revisions over the last few weeks, contrasting the largely favorable revisions trend of the preceding six months.",PFE,0.195287,-0.029102,Neutral
Earnings Estimates Come Under Pressure,https://www.zacks.com/commentary/2181196/earnings-estimates-come-under-pressure,2023-11-08 23:20:00,"While Q3 results have been better than expected, there is a notable acceleration in negative estimate revisions over the last few weeks, contrasting the largely favorable revisions trend of the preceding six months.",PFE,0.195287,-0.029102,Neutral
Ginkgo Bioworks Reports Third Quarter 2023 Financial Results,https://www.prnewswire.com/news-releases/ginkgo-bioworks-reports-third-quarter-2023-financial-results-301982398.html,2023-11-08 22:01:00,Ginkgo added 21 new Cell Programs to the Foundry platform in Q3 2023 Entered into strategic cloud and AI partnership with Google Cloud; first milestone recently achieved,PFE,0.056011,0.05206,Neutral
Solid Biosciences Provides Third Quarter Business Update and Financial Results,https://www.globenewswire.com/news-release/2023/11/08/2776751/0/en/Solid-Biosciences-Provides-Third-Quarter-Business-Update-and-Financial-Results.html,2023-11-08 21:17:00,- IND submission for SGT-003 for patients with Duchenne muscular dystrophy in ...,PFE,0.070725,0.053401,Neutral
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/11/35681769/looking-at-pfizers-recent-unusual-options-activity,2023-11-08 19:02:46,"A financial giant has made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer PFE revealed 10 unusual trades. Delving into the details, we found 30% of traders were bullish, while 70% showed bearish tendencies.",PFE,0.831658,0.126581,Neutral
Biopharma Has No Choice But To Comply With Price Controls,https://www.forbes.com/sites/johnlamattina/2023/11/08/biopharma-has-no-choice-but-to-comply-with-price-controls/,2023-11-08 17:46:19,"There is no doubt that the American people endorse the concept of the U.S. government controlling the prices of drugs. With the passage of the Inflation Reduction Act ( IRA ) , this is now reality for the biopharma industry.",PFE,0.290607,0.047667,Neutral
Pharma ETFs in Focus Post Q3 Earnings,https://www.zacks.com/stock/news/2180987/pharma-etfs-in-focus-post-q3-earnings,2023-11-08 16:10:00,"Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.",PFE,0.075516,-0.043588,Neutral
ABBV: Can Pfizer  ( PFE )  and AbbVie  ( ABBV )  Cure Your Portfolio's Ailments?,https://stocknews.com/news/abbv-pfe-can-pfizer-pfe-and-abbvie-abbv-cure-your-portfolios-ailments/,2023-11-08 15:54:19,ABBV: Can Pfizer ( PFE ) and AbbVie ( ABBV ) Cure Your Portfolio's ... ...,PFE,0.289462,0.263121,Somewhat-Bullish
Pfizer's Weight Loss Pill Is a Do-Or-Die Milestone,https://www.barrons.com/articles/pfizer-stock-price-weight-loss-pill-data-danuglipron-848227ad,2023-11-08 14:21:00,Data on Pfizer's New Weight Loss Pill Is Coming. Why it's Crucial for the Stock. ...,PFE,0.947069,0.436252,Bullish
Pfizer's Weight Loss Pill Is a Do-Or-Die Milestone,https://www.barrons.com/articles/data-on-pfizers-new-weight-loss-pill-is-coming-why-its-crucial-for-the-stock-848227ad,2023-11-08 06:45:00,Data on Pfizer's New Weight Loss Pill Is Coming. Why it's Crucial for ... ...,PFE,0.947069,0.436252,Bullish
Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints - Lumos Pharma  ( NASDAQ:LUMO ) ,https://www.benzinga.com/pressreleases/23/11/g35657731/lumos-pharma-announces-topline-data-from-phase-2-oragrowth210-and-oragrowth212-trials-of-lum-201-i,2023-11-07 21:01:00,"OraGrowtH210 Results Show LUM-201 Dose of 1.6 mg/kg Achieves Annualized Height Velocities ( AHV ) of 8.2 cm/yr at 6 Months and 8.0 cm/yr at 12 Months, Comparable to Growth Rates for Moderate PGHD Population",PFE,0.014904,0.039168,Neutral
Syphilis cases in US newborns skyrocketed in 2022. Health officials suggest more testing,https://apnews.com/article/syphilis-newborns-cdc-std-testing-25df6e6352508fce37fb20ac10770124,2023-11-07 18:45:00,"NEW YORK ( AP ) - Alarmed by yet another jump in , U.S. health officials are calling for stepped-up prevention measures, including encouraging millions of women of childbearing age and their partners to get tested for the sexually transmitted disease.",PFE,0.083687,-0.075742,Neutral
"Syphilis cases among newborns are skyrocketing, CDC says",https://www.marketwatch.com/story/syphilis-cases-among-newborns-are-skyrocketing-cdc-says-52f123c5,2023-11-07 18:16:00,"Pfizer works to speed production of key penicillin as officials see ""unacceptable American crisis,"" underscoring need for rapid testing and treatment.",PFE,0.362254,0.074792,Neutral
"OPKO Health  ( OPK )  Q3 Earnings Lag Estimates, Revenues Top",https://www.zacks.com/stock/news/2180185/opko-health-opk-q3-earnings-lag-estimates-revenues-top,2023-11-07 15:29:00,"Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall third-quarter results reflect soft performances.",PFE,0.076358,0.122029,Neutral
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Arbutus Biopharma  ( NASDAQ:ABUS ) ,https://www.benzinga.com/pressreleases/23/11/g35641107/arbutus-reports-third-quarter-2023-financial-results-and-provides-corporate-update,2023-11-07 12:30:00,"WARMINSTER, Pa., Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- Arbutus Biopharma Corporation ABUS ( ""Arbutus"" or the ""Company"" ) , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a cure for people with chronic hepatitis B virus ( cHBV ) infection, today ...",PFE,0.063008,0.060307,Neutral
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update,https://www.globenewswire.com/news-release/2023/11/07/2774965/14025/en/Arbutus-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html,2023-11-07 12:30:00,"Multiple data presentations upcoming at AASLD - The Liver Meeting®, including preliminary data from Phase 2a clinical trial combining imdusiran, our RNAi therapeutic, with VTP-300, an HBV antigen-specific immunotherapy ...",PFE,0.061552,0.06023,Neutral
Arbor Biotechnologies Appoints Industry Veteran R. Nolan Townsend to Board of Directors,https://www.benzinga.com/pressreleases/23/11/g35640147/arbor-biotechnologies-appoints-industry-veteran-r-nolan-townsend-to-board-of-directors,2023-11-07 12:00:00,"CAMBRIDGE, Mass., Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of R. Nolan Townsend to the Company's Board of Directors.",PFE,0.256989,0.094297,Neutral
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update,https://www.globenewswire.com/news-release/2023/11/07/2774938/0/en/Arvinas-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html,2023-11-07 12:00:00,- Enrollment continues in the 2L Phase 3 VERITAC-2 trial and study lead-in for the VERITAC-3 1L Phase 3 trial with vepdegestrant. Top-line data readout for VERITAC-2 remains on-track for ...,PFE,0.141541,0.05331,Neutral
"IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update",https://www.prnewswire.com/news-releases/ideaya-biosciences-inc-reports-third-quarter-2023-financial-results-and-provides-business-update-301979207.html,2023-11-07 11:00:00,"SOUTH SAN FRANCISCO, Calif., Nov. 7, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. ( Nasdaq: IDYA ) , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the third quarter ended ...",PFE,0.029581,0.092063,Neutral
Anti-Infective Drugs Market to Hit USD 177.9 billion by 2031 | Transparency Market Research Inc.,https://www.benzinga.com/pressreleases/23/11/g35637643/anti-infective-drugs-market-to-hit-usd-177-9-billion-by-2031-transparency-market-research-inc,2023-11-07 10:30:00,"Wilmington, Delaware, United States, Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global anti-infective drugs market is projected to flourish at a CAGR of 4.0% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 117.9 billion is anticipated for ...",PFE,0.043658,0.0,Neutral
Cathie Wood Just Bought This Struggling Stock After Its Billion-Dollar Quarterly Loss. Should You?,https://www.fool.com/investing/2023/11/07/cathie-wood-just-bought-this-struggling-stock/,2023-11-07 10:00:00,This particular stock has dropped more than 50% this year.,PFE,0.05133,-0.041003,Neutral
Kynexis Launched to Advance Precision Therapeutics for Brain Diseases,https://www.benzinga.com/pressreleases/23/11/g35637279/kynexis-launched-to-advance-precision-therapeutics-for-brain-diseases,2023-11-07 10:00:00,"- Lead Candidate KYN-5356, a First-In-Class Small Molecule KAT-II Inhibitor, Advancing Toward the Clinic for Cognitive Impairment Associated With Schizophrenia - Kees Been Joins as Chief Executive Officer and Jens Wendland, M.D., as Chief Medical Officer.",PFE,0.04406,0.132807,Neutral
Roche sells $5.5 billion of bonds to fund Telavant buyout,https://www.financialexpress.com/healthcare/news-healthcare/roche-sells-5-5-billion-of-bonds-to-fund-telavant-buyout/3299577/,2023-11-07 08:30:25,Roche Holding AG sold investment-grade debt in the US corporate bond market on Monday to help fund its acquisition of Telavant Holdings Inc.,PFE,0.12165,0.001183,Neutral
CIIE to share China's enormous market with world - PR Newswire,https://www.prnewswire.com/apac/news-releases/ciie-to-share-chinas-enormous-market-with-world-301979539.html,2023-11-07 07:13:44,CIIE to share China's enormous market with world PR ...,PFE,0.079392,0.054775,Neutral
Opko Health  ( OPK )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/11/07/opko-health-opk-q3-2023-earnings-call-transcript/,2023-11-07 06:00:15,"OPK earnings call for the period ending September 30, 2023.",PFE,0.072,0.08781,Neutral
Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference,https://www.benzinga.com/pressreleases/23/11/g35635791/valneva-to-present-and-hold-investor-meetings-at-the-jefferies-london-healthcare-conference,2023-11-07 06:00:00,"Saint-Herblain ( France ) , November 7, 2023 - Valneva SE VALNVLA, a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at the Jefferies London Healthcare Conference, to take place November 14-16, ...",PFE,0.328819,0.038084,Neutral
"Evonik's cost savings, animal feed demand drive Q3 profit beat",https://www.reuters.com/business/evoniks-cost-savings-animal-feed-demand-drive-q3-profit-beat-2023-11-07/,2023-11-07 00:07:03,"The logo of German specialty chemical company Evonik Industries AG is pictured at their plant in Bitterfeld, Germany, February 29, 2016. REUTERS/Fabrizio Bensch/File Photo Acquire Licensing Rights",PFE,0.116348,0.210845,Somewhat-Bullish
2 Biotech Stocks That Could Soar in December,https://www.fool.com/investing/2023/11/26/2-biotech-stocks-that-could-soar-in-december/,2023-11-26 21:44:00,These two biotechs have important catalysts coming up in December.,PFE,0.154951,0.140006,Neutral
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?,https://www.fool.com/investing/2023/11/26/is-pfizer-stock-a-buy-ahead-of-this-highly-anticip/,2023-11-26 19:00:00,An upcoming mid-stage readout may not spark a trend reversal in the big pharma's shares.,PFE,0.325637,-0.112992,Neutral
"AWS Reinvent Preview With Matt Wood, Who's Been At AWS From The Start",https://www.forbes.com/sites/patrickmoorhead/2023/11/25/aws-reinvent-preview-with-matt-wood-whos-been-at-aws-from-the-start/,2023-11-25 18:11:26,"This Sunday, November 27, is the beginning of the annual AWS Reinvent conference-one of my favorite events, and one that I've attended eight different years. ( The company styles it ""re:Invent,"" but I'm going to use ""Reinvent"" for simplicity and to adhere to the Forbes style guide. ) In my ...",PFE,0.019666,0.229533,Somewhat-Bullish
NOT REAL NEWS: A look at what didn't happen this week,https://apnews.com/article/fact-check-misinformation-f3c1d54f2d059de0532360d638335e99,2023-11-24 15:26:00,"A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: No evidence that DNA sequence used in Pfizer shot leads to cancer ...",PFE,0.109956,-0.094959,Neutral
Novo Nordisk  ( NVO )  to Expand Manufacturing Site in France,https://www.zacks.com/stock/news/2189006/novo-nordisk-nvo-to-expand-manufacturing-site-in-france,2023-11-24 14:30:00,"Novo Nordisk (NVO) announces that it is initiating plans to expand its existing manufacturing facility in Chartres, France, for the current and future product portfolio within serious chronic diseases.",PFE,0.208017,0.087543,Neutral
"Pharma Stock Roundup: NVO & LLY to Expand Manufacturing Capacity in Europe, & More",https://www.zacks.com/stock/news/2188971/pharma-stock-roundup-nvo-lly-to-expand-manufacturing-capacity-in-europe-more,2023-11-24 14:15:00,Eli Lilly (LLY) plans to build a $2.5 billion manufacturing plant in Germany. Novo Nordisk (NVO) plans to invest $2.3 billion to expand an existing production site in France.,PFE,0.058188,-0.119988,Neutral
"You can get Covid-19 and flu vaccines at the same time, but should you? What the science says",https://www.cnn.com/2023/11/24/health/covid-19-flu-vaccines-same-time/index.html,2023-11-24 13:06:00,"With holiday season underway, you may be realizing that you forgot to get your Covid-19 and flu vaccines, and now you'll be sitting across the table from your elderly relatives. The good news is that it's not too late to get your shots, but what about knocking them both out at the same time?",PFE,0.046006,0.005977,Neutral
Is Pfizer Stock a Buy Now?,https://www.fool.com/investing/2023/11/24/is-pfizer-stock-a-buy-now/,2023-11-24 13:00:00,The company keeps falling out of favor with the market.,PFE,0.780411,0.415314,Bullish
Where Will Ginkgo Bioworks Be in 5 Years?,https://www.fool.com/investing/2023/11/24/where-will-ginkgo-bioworks-be-in-5-years/,2023-11-24 12:45:00,"Ginkgo Bioworks has been securing deals with many top companies, but will they pay off for the business?",PFE,0.05654,0.14695,Neutral
Nutraceuticals Market to grow by USD 223.56 billion from 2022 to 2027 | The increasing cost of medical treatment to ... - PR Newswire,https://www.prnewswire.com/news-releases/nutraceuticals-market-to-grow-by-usd-223-56-billion-from-2022-to-2027--the-increasing-cost-of-medical-treatment-to-drive-market-growth---technavio-301996928.html,2023-11-24 09:15:00,Nutraceuticals Market to grow by USD 223.56 billion from 2022 to 2027 | The increasing cost of medical treatment to ... PR ...,PFE,0.05654,0.073002,Neutral
"Underdeveloped nations fighting drugmakers over access to TB, HIV drugs",https://www.business-standard.com/world-news/underdeveloped-nations-fighting-drugmakers-over-access-to-tb-hiv-drugs-123112400284_1.html,2023-11-24 07:25:01,"South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.",PFE,0.035241,0.0,Neutral
"South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs",https://apnews.com/article/bedaquiline-dolutegravir-tuberculosis-hiv-south-africa-0f6de15ea57279b699c147c015b23c02,2023-11-24 05:07:00,"CAPE TOWN, South Africa ( AP ) - South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.",PFE,0.035661,0.0,Neutral
"Spasticity Market Likely to Exhibit Substantial Growth by 2032, Predicts DelveInsight | Key Pharma Companies - Saol, Jazz, Supernus, Solstice Neurosciences, Ipsen, Merz, Motric Bio, SwanBio",https://www.prnewswire.com/news-releases/spasticity-market-likely-to-exhibit-substantial-growth-by-2032-predicts-delveinsight--key-pharma-companies----saol-jazz-supernus-solstice-neurosciences-ipsen-merz-motric-bio-swanbio-301996647.html,2023-11-23 22:01:00,"Spasticity Market Likely to Exhibit Substantial Growth by 2032, Predicts DelveInsight | Key Pharma Companies - Saol ... PR ...",PFE,0.027476,0.020748,Neutral
Novo Nordisk Spends Big In France To Expand Obesity Drug Capacity,https://www.barrons.com/news/novo-nordisk-spends-big-in-france-to-expand-obesity-drug-capacity-ab3f2e01,2023-11-23 13:38:00,"Danish pharmaceutical giant Novo Nordisk will announce Thursday a major investment in a French production site to expand capacity for a blockbuster anti-obesity drug, the French presidency said.",PFE,0.09402,0.0,Neutral
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,2023-11-22 22:01:00,"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic ... PR ...",PFE,0.013173,0.026023,Neutral
"The Zacks Analyst Blog Highlights Novo Nordisk Bank of America, Netflix, Johnson & Johnson and TotalEnergies",https://www.zacks.com/stock/news/2187835/the-zacks-analyst-blog-highlights-novo-nordisk-bank-of-america-netflix-johnson-johnson-and-totalenergies,2023-11-22 14:43:00,"Novo Nordisk, Bank of America, Netflix, Johnson & Johnson and TotalEnergies are part of the Zacks top Analyst Blog.",PFE,0.066047,-0.018282,Neutral
Need a path to your dream profession? Rutgers Business School offers a roadmap to success,https://www.prnewswire.com/news-releases/need-a-path-to-your-dream-profession-rutgers-business-school-offers-a-roadmap-to-success-301995139.html,2023-11-22 14:15:00,"NEW BRUNSWICK, N.J., Nov. 22, 2023 /PRNewswire/ -- For Eric Yao, a high school student in Rockville, Maryland, Rutgers Business School offered proximity to New York City ( ""the capital of the world,"" as he put it ) , an extremely large alumni network and the opportunity to study at a tier-one ...",PFE,0.021013,0.135909,Neutral
3 Top Vanguard Mutual Funds to Buy for Long-Term Gains,https://www.zacks.com/stock/news/2187780/3-top-vanguard-mutual-funds-to-buy-for-long-term-gains,2023-11-22 14:01:00,"Invest in Vanguard mutual funds like VASVX, VWNDX and VEVFX that have given positive returns amid uncertain market conditions and are expected to perform well in the future.",PFE,0.056674,0.050928,Neutral
Here's How Much You'd Have If You Invested $1000 in Novo Nordisk a Decade Ago,https://www.zacks.com/stock/news/2187730/heres-how-much-youd-have-if-you-invested-1000-in-novo-nordisk-a-decade-ago,2023-11-22 13:30:06,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",PFE,0.051774,0.139918,Neutral
A Customer Service Expert's Top Business Books Of 2023,https://www.forbes.com/sites/shephyken/2023/11/22/a-customer-service-experts-top-business-books-of-2023/,2023-11-22 12:00:00,"Just in time for Black Friday, Cyber Monday and the gift-giving holidays, I want to share with you my favorite business books from 40-plus that I read this year. While I typically stay in the customer service and experience lanes, this year you'll also find books on marketing and sales.",PFE,0.041538,0.088591,Neutral
2 Stocks You'll Be Grateful You Bought at These Bargain Prices,https://www.fool.com/investing/2023/11/22/2-stocks-youll-be-grateful-you-bought-at-bargain/,2023-11-22 10:00:00,These companies are leaders in their industries.,PFE,0.388126,-0.02442,Neutral
Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period  ( 2019-2032 )  | DelveInsight,https://www.prnewswire.com/news-releases/colorectal-cancer-treatment-drug-market-to-show-immense-growth-during-the-study-period-20192032--delveinsight-301994315.html,2023-11-21 22:01:00,"Apart from the already existing players such as Pfizer, Sanofi, Taiho Pharma, Ono Pharma, along with others, there are several emerging key players, that are expected to change the dynamics of the metastatic colorectal cancer market in the coming years owing to the positive outcomes of the ...",PFE,0.092213,-0.055925,Neutral
4 out of 5 Mexicans who got a flu shot this year turned down Cuban and Russian COVID-19 vaccines,https://apnews.com/article/mexico-vaccines-covid-influenza-sputnik-faeef82d7806cb2e5511beb5e1319221,2023-11-21 21:28:00,"MEXICO CITY ( AP ) - Four out of five people in Mexico who got influenza shots so far this year turned down the government's recommendation that they get Russian or at the same time, officials said Tuesday.",PFE,0.126784,0.191954,Somewhat-Bullish
"Top Analyst Reports for Novo Nordisk, Bank of America & Netflix",https://www.zacks.com/research-daily/2187288/top-analyst-reports-for-novo-nordisk-bank-of-america-netflix,2023-11-21 19:07:00,"Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Bank of America Corporation (BAC) and Netflix, Inc. (NFLX).",PFE,0.090134,-0.019369,Neutral
Why Is COVID-19 Vaccine Maker Moderna  ( MRNA )  Stock Trading Lower Today? - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/general/biotech/23/11/35900447/why-is-covid-19-vaccine-maker-moderna-stock-trading-lower-today,2023-11-21 16:59:07,"Moderna Inc MRNA shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is invalid, marking a victory for Pfizer Inc PFE / BioNTech SE BNTX in a patent dispute between the biggest coronavirus vaccine makers.",PFE,0.772973,-0.408661,Bearish
"Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF? - Harvest Oil & Gas  ( OTC:HRST ) , Tema Oncology ETF  ( NASDAQ:CANC ) ",https://www.benzinga.com/general/biotech/23/11/35894597/can-weight-loss-drug-ozempic-tip-the-scales-for-temas-new-healthcare-etf,2023-11-21 13:55:13,"Tema, the exchange-traded fund platform, has launched a healthcare ETF focused on companies that research and treat cardiovascular disease and conditions associated with obesity and diabetes, including Novo Nordisk, maker of the blockbuster diet drug Ozempic.",PFE,0.177802,0.050661,Neutral
"Texas AG sues Pfizer for allegedly selling medicine it knew was ineffective, manipulated quality-test results",https://www.foxbusiness.com/politics/texas-ag-sues-pfizer-allegedly-selling-medicine-knew-ineffective-manipulated-quality-test-results,2023-11-21 13:06:00,Texas Attorney General Ken Paxton has sued Pfizer and its drug manufacturer for allegedly providing medicine it knew to be ineffective.,PFE,0.670305,-0.340483,Somewhat-Bearish
Jnana Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference,https://www.benzinga.com/pressreleases/23/11/g35892337/jnana-therapeutics-to-present-at-the-piper-sandler-35th-annual-healthcare-conference,2023-11-21 13:00:12,"BOSTON, Nov. 21, 2023 ( GLOBE NEWSWIRE ) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, will present a ...",PFE,0.157483,0.206879,Somewhat-Bullish
Fortune Debuts Power List of 50 AI Innovators,https://www.prnewswire.com/news-releases/fortune-debuts-power-list-of-50-ai-innovators-301994270.html,2023-11-21 12:00:00,"Fortune editors name the companies leading the way in the AI boom An essential guide to the companies every executive needs to know in the sector attracting one out of every four startup investment dollars Inaugural Fortune 50 AI Innovators includes established players: OpenAI, Anthropic, Google ...",PFE,0.044718,-0.002943,Neutral
BioNTech says European Patent Office has declared Moderna patent invalid,https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-says-european-patent-office-has-declared-moderna-patent-invalid-2023-11-21/,2023-11-21 10:52:00,"The logo of BioNTech is pictured at Biontech's research laboratory for individualised vaccines against cancer in Mainz, Germany, July 27, 2023. REUTERS/Wolfgang Rattay/ File photo Acquire Licensing Rights",PFE,0.285526,-0.341672,Somewhat-Bearish
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now,https://www.fool.com/investing/2023/11/21/ignore-eli-lilly-these-2-stocks-are-better-buys/,2023-11-21 10:30:00,Investors have favored an exciting billion-dollar opportunity at Eli Lilly.,PFE,0.428632,0.15879,Somewhat-Bullish
No evidence that DNA sequence used in Pfizer shot leads to cancer and other health issues,https://apnews.com/article/fact-check-covid-vaccine-pfizer-sv40-dna-853343189368,2023-11-20 23:06:00,"CLAIM: Pfizer's COVID-19 vaccine contains a DNA sequence called Simian Virus 40 that can cause health problems, including cancer. AP'S ASSESSMENT: False.",PFE,0.201105,-0.047137,Neutral
SAGALIAM ACQUISITION CORP. ANNOUNCES A TEMPORARY RESTRAINING ORDER ON ITS EXTENSION PROXY SHAREHOLDER MEETING,https://www.globenewswire.com/news-release/2023/11/20/2783640/0/en/SAGALIAM-ACQUISITION-CORP-ANNOUNCES-A-TEMPORARY-RESTRAINING-ORDER-ON-ITS-EXTENSION-PROXY-SHAREHOLDER-MEETING.html,2023-11-20 22:15:00,"New York, NY, Nov. 20, 2023 ( GLOBE NEWSWIRE ) -- Sagaliam Acquisition Corp. ( NASDAQ: ""SAGAU"", ""SAGA"", ""SAGAR"" ) ( ""we"", ""us"", ""our"", or the ""Company"" ) announced today that it received a Temporary Restraining Order on its extension proxy shareholder meeting.",PFE,0.033894,-0.140497,Neutral
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence - Bristol-Myers Squibb  ( NYSE:BMY ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/11/35878620/analyst-assess-implications-of-bristol-myers-investigational-blood-thinner-post-bay,2023-11-20 19:58:20,"Monday, Bayer AG BAYRY BAYZF stopped the OCEANIC-AF Phase 3 study early after asundexian showed inferiority to Bristol-Myers Squibb Company BMY and Pfizer Inc's PFE apixaban ( Eliquis ) .",PFE,0.245339,-0.257856,Somewhat-Bearish
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details - Bayer  ( OTC:BAYRY ) ,https://www.benzinga.com/general/biotech/23/11/35878286/bayers-blood-thinner-study-stopped-early-due-to-lack-of-efficacy-details,2023-11-20 18:34:49,Bayer AG BAYRY BAYZF stopped the OCEANIC-AF Phase 3 study investigating asundexian compared to apixaban ( a direct oral anticoagulant ) in patients with atrial fibrillation at risk for stroke.,PFE,0.285526,0.0,Neutral
Behind the Scenes of Pfizer's Latest Options Trends - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/11/35879032/behind-the-scenes-of-pfizers-latest-options-trends,2023-11-20 18:01:31,"Investors with a lot of money to spend have taken a bearish stance on Pfizer PFE. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",PFE,0.754476,0.070004,Neutral
Lilly  ( LLY )  to Build $2.5B Plant to Meet Increased Drug Demand,https://www.zacks.com/stock/news/2186768/lilly-lly-to-build-25b-plant-to-meet-increased-drug-demand,2023-11-20 16:31:00,"Through this expansion, Eli Lilly (LLY) intends to expand its global manufacturing footprint to support the rising demand for its diabetes and obesity portfolio.",PFE,0.265378,0.198716,Somewhat-Bullish
What's different about this stock-market rally after 63 post-correction advances,https://www.marketwatch.com/story/thestock-market-has-rallied-63-times-after-a-correction-why-this-time-is-different-says-deutsche-bank-472ac19f,2023-11-20 11:50:00,"What makes this recovery after a stock-market correction different than the rest, according to Deutsche Bank.",PFE,0.443626,0.667654,Bullish
Continued strong Cresemba®  ( isavuconazole )  sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this year,https://www.globenewswire.com/news-release/2023/11/20/2782909/0/en/Continued-strong-Cresemba-isavuconazole-sales-performance-in-Asia-Pacific-and-China-triggers-third-sales-milestone-payment-for-the-region-from-Pfizer-this-year.html,2023-11-20 06:15:00,"Allschwil, Switzerland, November ...",PFE,0.243498,0.149768,Neutral
Wegovy craze was all the rage on Q3 earnings calls,https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-craze-was-all-rage-q3-earnings-calls-2023-11-20/,2023-11-20 06:00:39,"[1/2] Boxes of Ozempic and Mounjaro, semaglutide and tirzepatide injection drugs used for treating type 2 diabetes and made by Novo Nordisk and Lilly, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey Acquire Licensing Rights",PFE,0.054359,0.059809,Neutral
Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?,https://www.fool.com/investing/2023/11/19/eli-lilly-just-got-one-step-closer-to-dethroning-o/,2023-11-19 11:05:00,"Eli Lilly just received FDA approval for its obesity medication Zepbound, the sister treatment to its blockbuster drug Mounjaro.",PFE,0.033328,0.105236,Neutral
Is Beam Therapeutics Stock a Buy Now?,https://www.fool.com/investing/2023/11/18/is-beam-therapeutics-stock-a-buy-now/,2023-11-18 12:15:00,"It has plenty of money, but it'll be facing plenty of competition, too.",PFE,0.102668,0.073621,Neutral
"Lawmaker, USCIRF slam US cos for showing up for Chinese president's events",https://www.business-standard.com/india-news/lawmaker-uscirf-slam-us-cos-for-showing-up-for-chinese-president-s-events-123111800191_1.html,2023-11-18 06:34:35,"An Influential US lawmaker has slammed top American firms for showing up for events which Xi Jinping held on the sidelines of the APEC Summit here, saying corporate toasting of the Chinese president contradicts America's commitment to human rights and the rule of law.",PFE,0.058759,-0.050982,Neutral
"What's Going On With Penny Stock AgeX Therapeutics  ( AGE ) ? - Pfizer  ( NYSE:PFE ) , AgeX Therapeutics  ( AMEX:AGE ) ",https://www.benzinga.com/general/biotech/23/11/35852819/whats-going-on-with-penny-stock-agex-therapeutics,2023-11-17 18:10:30,"Serina Therapeutics Inc, a privately held, clinical-stage biotechnology company, entered into a License Agreement under which Pfizer Inc PFE will license, on a non-exclusive basis, Serina's POZ polymer technology.",PFE,0.468029,0.398049,Bullish
Is Trending Stock Pfizer Inc.  ( PFE )  a Buy Now?,https://www.zacks.com/stock/news/2185892/is-trending-stock-pfizer-inc-pfe-a-buy-now,2023-11-17 14:00:10,"Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",PFE,0.491255,0.065343,Neutral
3 Key Trends to Consider in Ginkgo Bioworks' Q3 Earnings Report,https://www.fool.com/investing/2023/11/17/3-key-trends-to-consider-in-ginkgo-bioworks-q3-ear/,2023-11-17 13:35:00,"Favorable trends are continuing, but there are new headwinds too.",PFE,0.171282,0.203907,Somewhat-Bullish
The War In Alzheimer's Treatment Is Just Beginning,https://www.investors.com/news/technology/biotech-stocks-the-war-in-alzheimers-treatment-is-just-beginning-why-there-is-still-hope/,2023-11-17 13:15:00,Biotech Stocks: The Race For An Alzheimer's Cure Takes Off Investor's Business Daily ...,PFE,0.033966,-0.088133,Neutral
Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use,https://www.zacks.com/stock/news/2185842/pharma-stock-roundup-fda-okays-azns-capivasertib-mrks-keytruda-expanded-use,2023-11-17 13:14:00,"FDA approves AstraZeneca's (AZN) new breast cancer drug, Truqap, and the expanded use of Merck's (MRK) Keytruda in a gastric cancer indication ...",PFE,0.113597,0.002274,Neutral
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting,https://www.prnewswire.com/news-releases/pfizer-and-astellas-xtandi-approved-by-us-fda-in-earlier-prostate-cancer-treatment-setting-301991574.html,2023-11-17 03:33:00,XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy* in nonmetastatic castration-sensitive prostate cancer,PFE,0.118647,-0.008207,Neutral
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/japan-buy-14-mln-doses-daiichi-sankyo-covid-vaccine-2023-11-17/,2023-11-17 02:04:35,"Daiichi Sankyo's company logo is pictured at its headquarters in Tokyo, Japan, October 20, 2023. REUTERS/Kim Kyung-Hoon/ File Photo Acquire Licensing Rights TOKYO, Nov 17 ( Reuters ) - Japan's health ministry said on Friday it agreed to buy 1.4 million doses of Daiichi Sankyo's ( 4568.T ) updated ...",PFE,0.327366,0.0,Neutral
Pfizer  ( PFE )  Declines More Than Market: Some Information for Investors,https://www.zacks.com/stock/news/2194469/pfizer-pfe-declines-more-than-market-some-information-for-investors,2023-12-06 22:45:17,"In the most recent trading session, Pfizer (PFE) closed at $28.79, indicating a -1.03% shift from the previous trading day.",PFE,0.598621,0.12561,Neutral
Why Is OPKO Health  ( OPK )  Up 18.7% Since Last Earnings Report?,https://www.zacks.com/stock/news/2194313/why-is-opko-health-opk-up-187-since-last-earnings-report,2023-12-06 16:30:39,OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PFE,0.051663,-0.013971,Neutral
"JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/12/36114393/jnj-ceo-signals-no-rush-into-weight-loss-drug-realm-emphasizes-different-priorities,2023-12-06 16:23:36,"Johnson & Johnson JNJ has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer Joaquin Duato highlighted. During the firm's investor day on Tuesday, Duato emphasized that the company's priorities lie in extensive expansion, ...",PFE,0.27432,-0.148264,Neutral
"Pfizer  ( PFE ) , Arvinas Post Upbeat Data From Breast Cancer Study",https://www.zacks.com/stock/news/2194285/pfizer-pfe-arvinas-post-upbeat-data-from-breast-cancer-study,2023-12-06 16:18:00,Interim data from an early-stage study shows that treatment with Pfizer (PFE)/Arvinas' (ARVN) breast cancer combination therapy demonstrates encouraging clinical activity in heavily pre-treated patients.,PFE,0.318897,0.002365,Neutral
"THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday - Applied Optoelectronics  ( NASDAQ:AAOI ) , Arvinas  ( NASDAQ:ARVN ) ",https://www.benzinga.com/news/23/12/36115321/thor-industries-reports-upbeat-earnings-joins-dave-busters-entertainment-campbell-soup-and-other-big,2023-12-06 15:48:22,"U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday. Shares of THOR Industries, Inc. THO shares moved higher during Wednesday's session following better-than-expected quarterly results.",PFE,0.078099,0.0,Neutral
"2024's Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains - Angi  ( NASDAQ:ANGI ) , Aptiv  ( NYSE:APTV ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36113326/2024s-potential-stock-surprises-goldman-sachs-unveils-s-p-500-laggards-for-major-ga,2023-12-06 14:26:56,"Investors are always on the lookout for untapped opportunities, especially in stocks that have been heavily discounted and now present promising opportunities for those prepared to wager on a recovery. As the new year looms, a seasoned strategy, known as the ""Laggards"" trade, is witnessing a ...",PFE,0.114409,0.0,Neutral
"Arvinas, Pfizer Plan To Broaden Development Of Breast Cancer Candidate - Arvinas  ( NASDAQ:ARVN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/12/36111136/arvinas-pfizer-plan-to-broaden-development-of-breast-cancer-candidate,2023-12-06 13:50:32,Arvinas Inc ARVN and Pfizer Inc PFE released clinical data for vepdegestrant ( ARV-471 ) in combination with palbociclib ( IBRANCE ) .,PFE,0.56415,0.134384,Neutral
Jnana Therapeutics to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference,https://www.benzinga.com/pressreleases/23/12/g36110550/jnana-therapeutics-to-present-at-the-rbc-capital-markets-healthcare-private-company-virtual-confer,2023-12-06 13:00:13,"BOSTON, Dec. 06, 2023 ( GLOBE NEWSWIRE ) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, will participate ...",PFE,0.154455,0.201841,Somewhat-Bullish
"Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant  ( ARV-471 )  Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program - Arvinas  ( NASDAQ:ARVN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/12/g36106128/arvinas-to-host-conference-call-and-webcast-to-discuss-vepdegestrant-arv-471-data-presented-at-202,2023-12-06 03:52:59,"NEW HAVEN, Conn., Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ARVN, a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that a conference call and webcast will be held with executives from Arvinas and Pfizer Inc.",PFE,0.377855,0.142213,Neutral
Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant  ( ARV-471 )  Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program,https://www.globenewswire.com/news-release/2023/12/06/2791437/0/en/Arvinas-to-Host-Conference-Call-and-Webcast-to-Discuss-Vepdegestrant-ARV-471-Data-Presented-at-2023-San-Antonio-Breast-Cancer-Symposium-and-Plans-to-Expand-Vepdegestrant-Developmen.html,2023-12-06 03:52:00,"NEW HAVEN, Conn., Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ( Nasdaq: ARVN ) , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that a conference call and webcast will be held with executives from Arvinas and ...",PFE,0.393462,0.149111,Neutral
"Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen ... - PR Newswire",https://www.prnewswire.com/news-releases/fallopian-tube-cancer-therapeutics-market-size-to-grow-by-usd-832-01-million-from-2023-2028-abbvie-inc-amgen-inc-arrien-pharmaceuticals-llc-and-more-among-the-key-companies-in-the-market---technavio-302006567.html,2023-12-05 22:15:00,"Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen ... PR ...",PFE,0.057628,-0.003,Neutral
"Altimmune open to partnerships, deals with drugmakers, says CEO",https://www.reuters.com/business/healthcare-pharmaceuticals/altimmune-open-partnerships-deals-with-drugmakers-says-ceo-2023-12-05/,2023-12-05 18:22:00,"Dec 5 ( Reuters ) - Weight-loss drug developer Altimmune ( ALT.O ) is open to deals and collaborations with large drugmakers as it actively looks for partners to launch and develop its experimental obesity drug, CEO Vipin Garg told Reuters on Tuesday.",PFE,0.096671,-0.085243,Neutral
Changes In Tax Policy Come Before SCOTUS,https://www.forbes.com/sites/meganpoinski/2023/12/05/changes-in-tax-policy-come-before-scotus/,2023-12-05 17:57:57,"This is the published version of Forbes' CFO newsletter, which offers the latest news for chief finance officers and other leaders focused on the budget. Sign up here to get it delivered to your inbox every Tuesday.",PFE,0.059292,-0.085091,Neutral
"While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/markets/penny-stocks/23/12/36097032/while-pfizer-faced-a-setback-altimmune-roche-and-mainz-biomed-advanced-in-the-battle-against,2023-12-05 17:06:02,"Obesity has been linked to development of a range of diseases and unfortunately, cancer. More specifically, the National Cancer Institute estimated that colorectal cancer is 1.3 times more likely in obese individuals. Therefore, this is a highly lucrative segment for pharmaceutical companies.",PFE,0.485711,-0.022515,Neutral
"Global Drug Discovery Market Size is Expected to Reach USD 120,809 million by 2030: Straits Research",https://www.benzinga.com/pressreleases/23/12/g36094187/global-drug-discovery-market-size-is-expected-to-reach-usd-120-809-million-by-2030-straits-researc,2023-12-05 15:10:00,"New York, United States, Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- Drug discovery is the process of examining potential novel treatments, and it takes place in the domains of pharmacology, biotechnology, and medicine.",PFE,0.03853,0.0,Neutral
Alation Releases The State of Data Culture Maturity Research Report,https://www.benzinga.com/pressreleases/23/12/g36091190/alation-releases-the-state-of-data-culture-maturity-research-report,2023-12-05 14:04:00,"REDWOOD CITY, Calif., Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- Alation, Inc., the data intelligence company, today released The State of Data Culture Maturity: Research Report.",PFE,0.049221,0.217584,Somewhat-Bullish
Opinion | Why Europe is falling behind US and China in global innovation race,https://www.scmp.com/comment/opinion/article/3243821/why-europe-falling-behind-us-and-china-global-innovation-race,2023-12-05 11:30:14,"Europe's innovation lag comes from complacency rooted in the belief that scientific achievements will inevitably translate into innovation and foster economic growth, but science alone is not enough to promote deep tech innovation.",PFE,0.038969,0.10843,Neutral
Practice of law: best examples in legal work,https://www.ft.com/content/06e08baa-6229-4189-9bb3-0807bfb7a218,2023-12-05 05:00:59,Featuring the most innovative services that lawyers have developed for clients ...,PFE,0.01938,0.130882,Neutral
Standout examples of in-house lawyers' work,https://www.ft.com/content/e7abfd36-600a-481c-ab21-5e970a34670a,2023-12-05 05:00:59,Case studies in best practice among general counsel and company legal teams in North America ...,PFE,0.014239,0.104647,Neutral
Cramer on Monday's market action: Some investors are headed for a 'nasty hangover',https://www.cnbc.com/2023/12/04/jim-cramer-says-some-investors-are-headed-for-a-nasty-hangover.html,2023-12-05 00:08:55,CNBC's Jim Cramer said many investors may not be buying with a clear head.,PFE,0.098255,-0.108974,Neutral
"Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market - Tema Cardiovascular and Metabolic ETF  ( NASDAQ:HRTS ) , Altimmune  ( NASDAQ:ALT ) ",https://www.benzinga.com/markets/equities/23/12/36079945/roche-pfizer-race-to-find-next-ozempic-as-pharma-giants-hustle-to-join-obesity-treatment-market,2023-12-04 21:20:12,"How important it is to have the latest blockbuster in your product portfolio. The pharmaceuticals industry has displayed this over and again in recent years - getting a Covid vaccine to market during the pandemic, and now tackling the obesity epidemic.",PFE,0.318897,-0.004677,Neutral
"Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15",https://www.benzinga.com/pressreleases/23/12/g36079828/pfizer-and-valneva-complete-recruitment-for-phase-3-valor-trial-for-lyme-disease-vaccine-candidate,2023-12-04 21:20:00,"9,437* participants enrolled at sites across the U.S., Europe and Canada in areas where Lyme disease is endemic Trial conclusion expected by year-end 2025 Pfizer aims to submit regulatory filings in the U.S. and Europe in 2026 New York, NY, and Saint-Herblain ( France ) , December 4, 2023 - ...",PFE,0.278169,0.223653,Somewhat-Bullish
"Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15",https://www.globenewswire.com/news-release/2023/12/04/2790478/0/en/Pfizer-and-Valneva-Complete-Recruitment-for-Phase-3-VALOR-Trial-for-Lyme-Disease-Vaccine-Candidate-VLA15.html,2023-12-04 21:20:00,"Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, ...",PFE,0.273935,0.168929,Somewhat-Bullish
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX,https://www.benzinga.com/pressreleases/23/12/g36079301/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-biontech-se-bnt,2023-12-04 21:19:11,"NEW YORK, Dec. 04, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE ( ""BioNTech"" or the ""Company"" ) BNTX. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",PFE,0.393462,-0.061662,Neutral
Roche  ( RHHBY )  to Acquire Obesity Drug Maker Carmot for $2.7B,https://www.zacks.com/stock/news/2193099/roche-rhhby-to-acquire-obesity-drug-maker-carmot-for-27b,2023-12-04 16:52:00,"Roche (RHHBY) aims to enter the promising and much-in-demand obesity drug market with the acquisition of Carmot Therapeutics, Inc. for $2.7 billion.",PFE,0.212425,-0.135965,Neutral
Altimmune  ( ALT )  Rises 83% on Successful Phase II Obesity Study,https://www.zacks.com/stock/news/2193078/altimmune-alt-rises-83-on-successful-phase-ii-obesity-study,2023-12-04 16:37:00,"Altimmune (ALT) reports positive top-line data from its 48-week phase II MOMENTUM study of obesity drug candidate, pemvidutide. The stock gains 83%.",PFE,0.177802,0.03385,Neutral
"LITFULO™ Receives Health Canada Approval, Becoming the First Approved Treatment for Severe Alopecia Areata in Canada.",https://www.newswire.ca/news-releases/litfulo-tm-receives-health-canada-approval-becoming-the-first-approved-treatment-for-severe-alopecia-areata-in-canada--820730634.html,2023-12-04 16:00:00,"LITFULO™ Receives Health Canada Approval, Becoming the First Approved Treatment for Severe Alopecia Areata in ... Canada ...",PFE,0.413587,0.18031,Somewhat-Bullish
This Is What Whales Are Betting On Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/12/36071139/this-is-what-whales-are-betting-on-pfizer,2023-12-04 15:15:41,"Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",PFE,0.737032,0.19908,Somewhat-Bullish
Roche enters obesity market with Carmot takeover but drugs may not be available until 2030,https://www.cnbc.com/2023/12/04/roche-enters-obesity-market-with-carmot-takeover.html,2023-12-04 14:37:13,"Roche is to acquire anti obesity drug developer Carmot Therapeutics, becoming the latest pharma company to enter the global weight-loss drugs market.",PFE,0.076115,0.0,Neutral
"Daily: Market Rallies On As Bitcoin, S&P Hit 2023 Highs",https://www.forbes.com/sites/daniellechemtob/2023/12/04/forbes-daily-market-rallies-on-as-bitcoin-sp-hit-2023-highs/,2023-12-04 13:13:55,"This is a published version of the Forbes Daily newsletter, you can sign-up to get Forbes Daily in your inbox here. The original smartwatch doesn't track your steps, your heart rate or your sleep, but it also doesn't have to be reset for another 77 years.",PFE,0.023933,-0.094531,Neutral
Thermo Fisher  ( TMO )  Advances Health Equity via New Partnership,https://www.zacks.com/stock/news/2192709/thermo-fisher-tmo-advances-health-equity-via-new-partnership,2023-12-04 11:15:00,Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.,PFE,0.045482,-0.117717,Neutral
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics in race to rival Novo Nordisk's Ozempic,https://www.marketwatch.com/story/roche-strikes-3-1-billion-deal-to-buy-obesity-drug-maker-carmot-therapeutics-billion-in-race-to-rival-novo-nordisks-ozempic-6b88b8c9,2023-12-04 10:40:00,The race for weight-loss drugs stepped up Monday after Roche said it would buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion.,PFE,0.232996,-0.013105,Neutral
Pfizer  ( PFE )  Stock Down 5% as Obesity Drug Fails in Phase II,https://www.zacks.com/stock/news/2192689/pfizer-pfe-stock-down-5-as-obesity-drug-fails-in-phase-ii,2023-12-04 10:32:00,The failure of the phase IIb study on danuglipron is a significant blow to Pfizer's (PFE) efforts to take a share of the growing market of GLP-1 drugs for treating obesity.,PFE,0.333257,-0.002375,Neutral
Valneva Reports Positive 24-Month Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®,https://www.globenewswire.com/news-release/2023/12/04/2789696/0/en/Valneva-Reports-Positive-24-Month-Antibody-Persistence-Data-for-its-Single-Shot-Chikungunya-Vaccine-IXCHIQ.html,2023-12-04 06:00:00,Valneva Reports Positive 24-Month Antibody Persistence Data for its Single-Shot Chikungunya Vaccine ...,PFE,0.020976,-0.004719,Neutral
Valneva Reports Positive 24-Month Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®,https://www.benzinga.com/pressreleases/23/12/g36063204/valneva-reports-positive-24-month-antibody-persistence-data-for-its-single-shot-chikungunya-vaccin,2023-12-04 06:00:00,Valneva Reports Positive 24-Month Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® Primary endpoint met with 97% seroresponse rate 24 months after a single vaccination,PFE,0.020335,-0.004704,Neutral
The New Generation Of Weight-loss Drugs,https://www.barrons.com/news/the-new-generation-of-weight-loss-drugs-a6057612,2023-12-04 03:22:00,"Wegovy, Mounjaro, Ozempic... These new drugs drawing such intense attention have raised the hopes of millions around the world suffering from diabetes or obesity. But what are they, how are they used and who makes them?",PFE,0.12165,-0.017836,Neutral
Largest 'Long Vax' Study To Date On Post-Covid-19 Vaccination Syndrome,https://www.forbes.com/sites/brucelee/2023/12/03/largest-long-vax-study-to-date-on-post-covid-19-vaccination-syndrome/,2023-12-03 15:59:46,"Since the Covid-19 vaccines first reached the market in late 2020, lots of unsubstantiated vaccination side effect claims have emerged such as assertions that Covid-19 vaccines can turn you into a gigantic magnet.",PFE,0.036532,-0.048632,Neutral
Is Pfizer Stock a Buy Now?,https://www.fool.com/investing/2023/12/03/is-pfizer-stock-a-buy-now/,2023-12-03 10:00:00,Pfizer shares have fallen by double digits this year.,PFE,0.802808,0.265691,Somewhat-Bullish
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes,https://www.fool.com/investing/2023/12/02/why-im-considering-selling-pfizer-for-tax-loss-har/,2023-12-02 19:00:00,"For growth investors, it may be time to sell this pharma stock for tax-loss harvesting purposes.",PFE,0.636698,0.04398,Neutral
Everyone Is Talking About This Stock. Is It a Good Long-Term Option?,https://www.fool.com/investing/2023/12/02/everyone-is-talking-about-this-stock-is-it-a-good/,2023-12-02 14:30:00,This company famously helps manage a prevalent chronic illness.,PFE,0.055751,0.142026,Neutral
An Important History Lesson for Gene-Editing Investors,https://www.fool.com/investing/2023/12/02/an-important-history-lesson-for-gene-editing-inves/,2023-12-02 13:30:00,Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.,PFE,0.12165,-0.003598,Neutral
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops,https://www.cnbc.com/2023/12/02/pfizer-weight-loss-pill-joins-list-of-obesity-drug-flops.html,2023-12-02 13:00:01,"Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.",PFE,0.100518,-0.015533,Neutral
5 Top Stocks to Buy Before 2024,https://www.fool.com/investing/2023/12/02/5-top-stocks-to-buy-before-2024/,2023-12-02 10:00:00,These stocks have room to run -- next year and over the long term.,PFE,0.259529,0.252343,Somewhat-Bullish
"Animal Biotechnology Market size to grow by USD 3.65 billion from 2023-2028, North America to account for 47% of ... - PR Newswire",https://www.prnewswire.com/news-releases/animal-biotechnology-market-size-to-grow-by-usd-3-65-billion-from-2023-2028--north-america-to-account-for-47-of-market-growth---technavio-302002797.html,2023-12-02 00:35:00,"Animal Biotechnology Market size to grow by USD 3.65 billion from 2023-2028, North America to account for 47% of ... PR ...",PFE,0.057767,0.0,Neutral
Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd ... - PR Newswire,https://www.prnewswire.com/news-releases/laryngeal-cancer-therapeutics-market-size-to-grow-by-usd-575-25-million-from-2022-2027-accord-healthcare-ltd-amgen-inc-astrazeneca-plc-athenex-inc-and-more-among-the-major-companies-in-the-market--technavio-302002789.html,2023-12-01 22:35:00,Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd ... PR ...,PFE,0.066414,-0.02104,Neutral
Business Highlights: Fed's Powell notes easing inflation; Walmart ditches Musk's X,https://apnews.com/article/musk-x-walmart-fed-powell-inflation-a9561b9c75b24dd027a0b642bb99cb3d,2023-12-01 21:54:26,Business Highlights: Fed's Powell notes easing inflation. Walmart ditches Musk's X The Associated Press ...,PFE,0.106857,0.042287,Neutral
Dow Jones Bucks Hawkish Powell As Yields Plunge; Tesla Falls On Huge 'Product Problem',https://www.investors.com/market-trend/stock-market-today/dow-jones-bucks-hawkish-powell-yields-plunge-tesla-falls/,2023-12-01 21:30:00,Dow Jones Bucks Hawkish Powell As Yields Plunge. Tesla Falls On ... Investor's Business Daily ...,PFE,0.108712,-0.140089,Neutral
Is Novavax Stock a Buy Now?,https://www.fool.com/investing/2023/12/01/is-novavax-stock-a-buy-now/,2023-12-01 21:00:00,"The company's shares may look cheap on the surface, but don't be too quick to jump in.",PFE,0.064449,0.02208,Neutral
JNJ: 3 Pharma Stocks Navigating Future Investments - Buy Now,https://stocknews.com/news/jnj-zts-wve-3-pharma-stocks-navigating-future-investments-buy-now/,2023-12-01 19:00:39,"The surge in investment and spending in global medicine is fueling the pharma industry. Therefore, investors could consider investing in quality pharma stocks Zoetis Inc. ( ZTS ) , Wave Life Sciences Ltd. ( WVE ) , and Johnson & Johnson ( JNJ ) .",PFE,0.032736,-0.042965,Neutral
"Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023",https://apnews.com/article/financial-markets-stocks-wall-street-8ec0ba5f237d4f528f102417e7bbdc7c,2023-12-01 18:57:00,"Dell, Marvell Technology fall. Ulta Beauty, UiPath rise, Friday, 12/1/2023 The Associated Press ...",PFE,0.582526,0.0,Neutral
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive ... - PR Newswire,https://www.prnewswire.com/news-releases/neuromuscular-disease-therapeutics-market-size-to-grow-by-usd-65-13-billion-from-2022-2027-aquestive-therapeutics-inc-bausch-health-companies-inc-biogen-inc-and-more-among-the-major-companies-in-the-market--technavio-302002042.html,2023-12-01 18:30:00,Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive ... PR ...,PFE,0.059636,0.014995,Neutral
Pfizer scraps twice-daily weight loss pill danuglipron after study shows 'high rates' of adverse side effects,https://www.foxbusiness.com/lifestyle/pfizer-scraps-twice-daily-weight-loss-pill-danuglipron-study-shows-high-rates-adverse-side-effects,2023-12-01 17:10:00,"Pfizer announced Friday that it is discontinuing development of its twice-daily weight loss pill danuglipron after a clinical trial showed ""high rates"" of adverse side effects among users.",PFE,0.5633,0.101987,Neutral
Why Pfizer Stock Is Sinking Today,https://www.fool.com/investing/2023/12/01/why-pfizer-stock-is-sinking-today/,2023-12-01 16:51:03,The big drugmaker delivered bad news for its top pipeline program.,PFE,0.902573,-0.004269,Neutral
Why Is Seattle Genetics  ( SGEN )  Down 0.7% Since Last Earnings Report?,https://www.zacks.com/stock/news/2192355/why-is-seattle-genetics-sgen-down-07-since-last-earnings-report,2023-12-01 16:32:02,Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PFE,0.124593,0.131819,Neutral
Why investors should stick with Eli Lilly,https://www.cnbc.com/2023/12/01/why-investors-should-stick-with-eli-lilly-.html,2023-12-01 16:26:56,The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.,PFE,0.173333,0.160996,Somewhat-Bullish
Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous,https://apnews.com/article/pfizer-obesity-treatment-47fc1b189e3b38e4f1a7233a28f48dd7,2023-12-01 16:16:43,"Pfizer shares sank Friday when the drugmaker said it would abandon a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it. The pharmaceutical company said it will focus instead on a once-daily version of the pill, danuglipron, instead of starting a ...",PFE,0.749166,0.213229,Somewhat-Bullish
Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/12/36041571/texas-attorney-general-alleges-pfizer-misled-public-on-covid-19-vaccine-efficacy,2023-12-01 15:59:03,"Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc PFE, alleging the pharmaceutical giant misrepresented the efficacy of its widely-administered COVID-19 vaccine. Paxton argued that Pfizer's claim of 95% effectiveness was misleading, based on limited clinical trial data ...",PFE,0.83383,-0.25894,Somewhat-Bearish
PFE Stock Slides After Pfizer's Latest Setback For Weight-Loss Drug,https://www.investors.com/news/technology/pfe-stock-slides-after-pfizers-latest-setback-for-weight-loss-drug/,2023-12-01 15:42:00,"Pfizer ( PFE ) said Friday it would not advance development of a twice-daily oral weight-loss drug because of its side effects. PFE stock fell in early trading, as the company said it would focus on a once-daily version of the drug.",PFE,0.898236,-0.075898,Neutral
Dow Hits 2023 High; Cybertruck Deliveries Begin: Weekly Review,https://www.investors.com/news/dow-jones-hits-2023-high-nasdaq-slips-tesla-cybertruck-salesforce-in-focus-weekly-review/,2023-12-01 15:33:00,"Dow Hits '23 High, Nasdaq Slips. Cybertruck Debuts: Weekly Review Investor's Business Daily ...",PFE,0.043698,-0.158559,Somewhat-Bearish
Stock Market Lower Ahead Of Powell Remarks As Small Caps Lead; This AI Stock Soars 35%,https://www.investors.com/market-trend/stock-market-today/stock-market-lower-ahead-of-powell-remarks-as-small-caps-lead-this-ai-stock-soars-35/,2023-12-01 15:23:00,Stock Market Lower Ahead Of Powell Remarks As Small Caps Lead ... Investor's Business Daily ...,PFE,0.115787,-0.234425,Somewhat-Bearish
"S&P, Nasdaq slip as caution prevails ahead of Powell comments",https://www.reuters.com/markets/us/futures-muted-traders-gear-up-powells-remarks-2023-12-01/,2023-12-01 15:10:00,"Traders work on the floor at the New York Stock Exchange ( NYSE ) in New York City, U.S., October 27, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",PFE,0.070935,-0.099521,Neutral
Pfizer Pulls Experimental Twice-Daily Weight Loss Drug-Shares Slide 6% To Multiyear Low,https://www.forbes.com/sites/dereksaul/2023/12/01/pfizer-pulls-experimental-twice-daily-weight-loss-drug-shares-slide-6-to-multiyear-low/,2023-12-01 14:43:38,"Pfizer announced Friday it won't move forward with trials for a twice-daily regimen of its weight-loss pill intended to compete with Ozempic and other booming drugs in the class, sending Pfizer's stock toward a fresh multiyear low as its shares continue to vastly underperform its pharmaceutical ...",PFE,0.320279,-0.125841,Neutral
"Tale Of Two Investigational Obesity Drugs: Altimmune Stock Jumps, While Pfizer Trades Lower - Altimmune  ( NASDAQ:ALT ) ",https://www.benzinga.com/general/biotech/23/12/36042805/tale-of-two-investigational-obesity-drugs-altimmune-stock-jumps-while-pfizer-trades-lower,2023-12-01 14:06:40,"Altimmune Inc ALT announced topline results from its 48-week MOMENTUM Phase 2 obesity trial of pemvidutide with 391 subjects. Friday, Pfizer Inc PFE reported topline data from the Phase 2b trial of danuglipron.",PFE,0.268294,-0.014658,Neutral
Why Is Pfizer Stock Trading Lower Today After Dropping Obesity Candidate Data? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/12/36041804/this-twice-daily-weight-loss-drug-has-adverse-side-effects-and-pfizer-wants-to-discontinue-it,2023-12-01 13:15:37,"Pfizer Inc PFE reported topline data from the Phase 2b trial investigating its oral weight loss drug Glucagon-like peptide-1 receptor agonist ( GLP-1RA ) candidate, danuglipron ( PF-06882961 ) , in adults with obesity and without type 2 diabetes.",PFE,0.636698,0.101025,Neutral
"Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More",https://www.zacks.com/stock/news/2192051/pharma-stock-roundup-abbv-to-buy-immunogen-nvs-ups-mid-term-sales-view-more,2023-12-01 13:13:00,AbbVie (ABBV) offers to acquire cancer biotech Immunogen for $10.1 billion. Novartis (NVS) raises its mid-term sales growth outlook by 1%.,PFE,0.0378,-0.115845,Neutral
"Vaccines Market to Hit USD 99.3 billion by 2031, at a CAGR 4.2% | Says Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/23/12/g36041488/vaccines-market-to-hit-usd-99-3-billion-by-2031-at-a-cagr-4-2-says-transparency-market-research-in,2023-12-01 12:30:00,"Wilmington, Delaware, United States, Dec. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global vaccines market was estimated at a value of US$ 119.1 billion in 2022. It is anticipated to register a 4.2% CAGR from 2022 to 2031 and by 2031, the market is likely to attain ...",PFE,0.042647,-0.04279,Neutral
"India, US to boost cooperation in pharma, critical minerals & emerging tech",https://www.business-standard.com/india-news/india-us-to-boost-cooperation-in-pharma-critical-minerals-emerging-tech-123120100715_1.html,2023-12-01 12:10:49,"India and the US have agreed to strengthen cooperation in sectors like pharmaceuticals, semiconductors, critical minerals and emerging technologies, an official statement said on Friday. The two countries also discussed collaborative opportunities in green and clean technologies.",PFE,0.110462,0.0,Neutral
Pfizer's stock falls 4% after halting trial of obesity drug due to side effects,https://www.marketwatch.com/story/pfizers-stock-falls-4-after-saying-it-will-not-move-to-phase-3-trial-of-weight-loss-drug-as-twice-daily-formation-3813e092,2023-12-01 11:58:00,Pfizer's drug helped patients lose weight but also caused nausea and diarrhea.,PFE,0.44622,0.136681,Neutral
Pfizer drops plan to study twice-daily obesity pill in late-stage studies,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-drops-plan-study-twice-daily-obesity-pill-late-stage-studies-2023-12-01/,2023-12-01 11:46:46,"A person walks past the Pfizer Headquarters building in the Manhattan borough of New York City, New York, U.S., November 9, 2020. REUTERS/Carlo Allegri Acquire Licensing Rights",PFE,0.586747,-0.126428,Neutral
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects,https://www.cnbc.com/2023/12/01/pfizer-to-discontinue-twice-daily-version-of-weight-loss-pill.html,2023-12-01 11:45:17,"Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024.",PFE,0.295867,-0.067778,Neutral
AbbVie  ( ABBV )  to Acquire ImmunoGen  ( IMGN )  for $10.1 Billion,https://www.zacks.com/stock/news/2191954/abbvie-abbv-to-acquire-immunogen-imgn-for-101-billion,2023-12-01 10:55:00,"AbbVie (ABBV) offers to buy ImmunoGen (IMGN) for approximately $10.1 billion, which will diversify its oncology pipeline across solid tumors and hematologic malignancies.",PFE,0.069294,-0.106663,Neutral
Bond yields continue to ease after biggest monthly drop in four years,https://www.marketwatch.com/story/bond-yields-continue-to-ease-after-biggest-monthly-drop-in-four-years-680fc295,2023-12-01 10:30:00,"Bond yields fell Friday, following the biggest one-month slide in long-term yields in more than four years.",PFE,0.194242,0.175371,Somewhat-Bullish
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist,https://www.fool.com/investing/2023/12/01/looking-for-growth-2-top-stocks-to-buy/,2023-12-01 10:15:00,These stocks offer enormous long-term growth potential.,PFE,0.055236,0.074848,Neutral
Tencent-Backed AI Drug Discovery Startup Xtalpi Files For Hong Kong IPO,https://www.forbes.com/sites/zinnialee/2023/12/01/tencent-backed-ai-drug-discovery-startup-xtalpi-files-for-hong-kong-ipo/,2023-12-01 10:05:07,"Xtalpi, a Shenzhen-based company which uses artificial intelligence to find chemical compounds that could be developed into new drugs, has filed for an initial public offering in Hong Kong. Xtalpi did not disclose details of its IPO in its filing to the Hong Kong stock exchange on Thursday ...",PFE,0.074692,-0.00707,Neutral
"Zacks Market Edge Highlights: SHOP, TWLO, PYPL, PFE and PINS",https://www.zacks.com/stock/news/2191924/zacks-market-edge-highlights-shop-twlo-pypl-pfe-and-pins,2023-12-01 09:11:00,"SHOP, TWLO, PYPL, PFE and PINS have been highlighted in this Market Edge article.",PFE,0.535653,-0.099627,Neutral
Texas AG Sues Pfizer Over Covid Vaccine Effectiveness,https://www.forbes.com/sites/mollybohannon/2023/11/30/texas-ag-sues-pfizer-over-covid-vaccine-effectiveness/,2023-11-30 22:39:33,"Texas Attorney General Ken Paxton announced Thursday he sued pharmaceutical company Pfizer for misleading Texans about the efficacy of its Covid-19 vaccine and ""attempting to censor public discussion""-despite the vaccine continuing to be effective and recommended by leading health agencies.",PFE,0.488007,-0.092263,Neutral
"Texas Attorney General Ken Paxton sues Pfizer, alleges pharma giant lied about COVID vaccine efficacy",https://www.foxbusiness.com/politics/texas-attorney-general-ken-paxton-sues-pfizer-alleges-pharma-giant-lied-about-covid-vaccine-efficacy,2023-11-30 19:36:00,"Texas Attorney General Ken Paxton is suing Pfizer, alleging that the pharmaceutical giant lied about the effectiveness of its COVID-19 vaccine.",PFE,0.879272,-0.409376,Bearish
Competition and Optimism: GSK's CEO Walmsley Foresees Growth Despite Competition In RSV Vaccine Market - GSK  ( NYSE:GSK ) ,https://www.benzinga.com/general/biotech/23/11/36028926/competition-and-optimism-gsks-ceo-walmsley-foresees-growth-despite-competition-in-rsv-vaccine-mar,2023-11-30 19:15:36,"Emma Walmsley, the Chief Executive Officer of GSK plc GSK, expressed confidence in its respiratory syncytial virus ( RSV ) vaccine, Arexvy, anticipating sales to surpass £1 billion ( $1.26 billion ) in its debut year.",PFE,0.151539,0.249417,Somewhat-Bullish
"Nasdaq Falls Over 100 Points; Cracker Barrel Shares Slide After Q1 Results - Cracker Barrel Old  ( NASDAQ:CBRL ) , Immunogen  ( NASDAQ:IMGN ) ",https://www.benzinga.com/news/earnings/23/11/36031052/nasdaq-falls-over-100-points-cracker-barrel-shares-slide-after-q1-results,2023-11-30 19:12:52,"U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.88% to 35,742.35 while the NASDAQ fell 0.79% to 14,145.17. The S&P 500 also fell, dropping, 0.15% to 4,543.88. Health care shares rose by 0.8% on Thursday.",PFE,0.054983,0.0,Neutral
GraniteShares plans to boost leverage levels on US single-stock ETFs,https://www.reuters.com/business/finance/graniteshares-plans-boost-leverage-levels-us-single-stock-etfs-2023-11-30/,2023-11-30 17:45:00,GraniteShares plans to boost leverage levels on US ...,PFE,0.085629,0.004142,Neutral
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion,https://www.cnbc.com/2023/11/30/biotech-stocks-jump-on-abbvie-deal-to-buy-cancer-drugmaker-immunogen.html,2023-11-30 17:28:25,"Shares of other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of the buyout.",PFE,0.119235,0.164167,Somewhat-Bullish
"Crude Oil Falls Sharply; Kroger Posts Upbeat Earnings - Kroger  ( NYSE:KR ) , Immunogen  ( NASDAQ:IMGN ) ",https://www.benzinga.com/news/earnings/23/11/36028629/crude-oil-falls-sharply-kroger-posts-upbeat-earnings,2023-11-30 17:16:25,"U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded up 0.85% to 35,729.88 while the NASDAQ fell 0.71% to 14,156.60. The S&P 500 also fell, dropping, 0.13% to 4,544.50. Health care shares rose by 0.9% on Thursday.",PFE,0.057628,0.0,Neutral
Why Is Pfizer  ( PFE )  Down 1.4% Since Last Earnings Report?,https://www.zacks.com/stock/news/2191647/why-is-pfizer-pfe-down-14-since-last-earnings-report,2023-11-30 16:30:51,Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PFE,0.382925,-0.005434,Neutral
Turkey launches investigation into 19 pharma companies,https://www.reuters.com/business/healthcare-pharmaceuticals/turkey-launches-investigation-into-19-pharma-companies-2023-11-30/,2023-11-30 16:19:00,"ANKARA, Nov 30 ( Reuters ) - Turkey's competition authority said on Thursday it had launched an investigation into 19 pharmaceutical companies to determine whether they had violated competition law.",PFE,0.407844,-0.090206,Neutral
Elevating Workplace Inclusion: Leading Companies Embrace myGwork Academy's Award-Winning Allyship Course,https://www.prnewswire.com/news-releases/elevating-workplace-inclusion-leading-companies-embrace-mygwork-academys-award-winning-allyship-course-302002289.html,2023-11-30 15:56:00,"LONDON, Nov. 30, 2023 /PRNewswire/ -- In an era where workplace inclusivity and allyship are pivotal for organisational success, the myGwork Academy's award-winning e-learning course on allyship is providing much-needed training for companies to foster more inclusive environments.",PFE,0.048327,0.10796,Neutral
"The Zacks Analyst Blog Highlights AbbVie, J&J, Eli Lilly, Pfizer",https://www.zacks.com/stock/news/2191547/the-zacks-analyst-blog-highlights-abbvie-jj-eli-lilly-pfizer,2023-11-30 15:08:00,"AbbVie, J&J, Eli Lilly, Pfizer are included in this Analyst Blog.",PFE,0.210823,0.152176,Somewhat-Bullish
"Dow Jumps Around 200 Points; US Core PCE Inflation Slows In October - AgriFORCE Growing Systems  ( NASDAQ:AGRI ) , Immunogen  ( NASDAQ:IMGN ) ",https://www.benzinga.com/news/earnings/23/11/36024059/dow-jumps-around-200-points-us-core-pce-inflation-slows-in-october,2023-11-30 14:42:50,"U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.56% to 35,630.09 while the NASDAQ fell 0.11% to 14,242.75. The S&P 500 also rose, gaining, 0.06% to 4,553.49.",PFE,0.063594,0.0,Neutral
Covid vaccine rates in the U.S. are slumping - and it will be a challenge to boost them,https://www.cnbc.com/2023/11/30/us-covid-shot-rates-are-low-and-it-will-be-a-challenge-to-boost-them.html,2023-11-30 14:23:33,"The one thing that experts, along with vaccine makers, can agree on is that low vaccination rates put people at risk of getting severe Covid infections.",PFE,0.113597,0.072545,Neutral
How To Make $500 A Month With Pfizer Stock - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/earnings/23/11/36016689/how-to-make-500-a-month-with-pfizer-stock,2023-11-30 13:52:08,"Pfizer Inc. PFE shares closed higher on Wednesday. The company is reportedly discontinuing its pharmaceutical sciences small molecule ( PSSM ) operations at Sandwich in Kent, UK to streamline operations and enhance efficiency.",PFE,0.77688,0.238469,Somewhat-Bullish
AbbVie signs $10 bln deal to buy cancer drugmaker ImmunoGen,https://www.reuters.com/markets/deals/abbvie-buy-immunogen-101-billion-boost-cancer-drug-portfolio-2023-11-30/,2023-11-30 13:34:00,"A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo Acquire Licensing Rights",PFE,0.140896,0.182816,Somewhat-Bullish
"Levicept Appoints Eliot Forster as CEO - Immunocore Hldgs  ( NASDAQ:IMCR ) , Immatics  ( NASDAQ:IMTX ) ",https://www.benzinga.com/pressreleases/23/11/g36017480/levicept-appoints-eliot-forster-as-ceo,2023-11-30 09:00:00,"SANDWICH, United Kingdom, Nov. 30, 2023 ( GLOBE NEWSWIRE ) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for chronic pain indications, today announces the appointment of Eliot Forster as CEO. Founder and inventor of LEVI-04, Simon ...",PFE,0.178021,0.089825,Neutral
Our Opportunity to Cure Cancer Has Never Been Greater,https://www.theatlantic.com/sponsored/pfizer-2023/pfizer-2023-qa/3847/,2023-11-30 02:32:33,"C ancer is one of the biggest health challenges of our lifetime. It touches all of us, regardless of age, race, ethnicity or where you live, and remains a leading cause of death around the world.",PFE,0.19677,0.154357,Somewhat-Bullish
"Loser Stocks: Buy More, Hold or Sell?",https://www.zacks.com/stock/news/2191164/loser-stocks-buy-more-hold-or-sell,2023-11-29 23:43:00,Did you buy at the pandemic highs and now your stock is in the red? What to do now.,PFE,0.578355,-0.103976,Neutral
InnovationRx: The 30 Under 30 Healthcare List,https://www.forbes.com/sites/alexknapp/2023/11/29/innovationrx-the-30-under-30-healthcare-list/,2023-11-29 21:26:23,"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Reid Waldman, 29, a Connecticut-based dermatologist believes there's a way to make wart removal less painful. His company Veradermics is testing a microneedle patch - basically a high-tech Band-Aid - ...",PFE,0.047749,0.056645,Neutral
"Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Chief Scientific Officer - Dianthus Therapeutics  ( NASDAQ:DNTH ) ",https://www.benzinga.com/pressreleases/23/11/g36011541/dianthus-therapeutics-enhances-leadership-team-with-appointment-of-jeffrey-stavenhagen-ph-d-as-chi,2023-11-29 21:05:00,"Dr. Stavenhagen brings over 20 years of experience in leading drug discovery initiatives, with a focus on monoclonal antibodies targeting neuro diseases Jennifer Davis Ruff also named Vice President, Head of Investor Relations & Corporate Affairs with over 20 years of experience at leading public ...",PFE,0.032691,-0.053857,Neutral
Novavax's  ( NVAX )  Updated COVID Jab Gets WHO Nod for Emergency Use,https://www.zacks.com/stock/news/2191042/novavaxs-nvax-updated-covid-jab-gets-who-nod-for-emergency-use,2023-11-29 16:53:00,"Following this authorization, Novavax's (NVAX) updated COVID-19 vaccine is available as an option to all 194 WHO member states.",PFE,0.311829,0.10663,Neutral
Occupational Medicines Global Market Report 2023 Highlights Robust Growth: Market Size To Reach $6.2 Billion By 2027 As Per The Business Research Company's Occupational Medicines Global Market Report 2023,https://www.benzinga.com/pressreleases/23/11/g36005663/occupational-medicines-global-market-report-2023-highlights-robust-growth-market-size-to-reach-6-2,2023-11-29 16:30:00,"LONDON, Nov. 29, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Occupational Medicines Global Market Report 2023, the global occupational medicines market is poised for significant expansion, projecting a rise from $4.52 billion in 2022 to $4.86 billion in 2023, demonstrating ...",PFE,0.064623,0.242625,Somewhat-Bullish
4 Large Drug Stocks to Watch as IBD Market Gains Traction,https://www.zacks.com/stock/news/2190845/4-large-drug-stocks-to-watch-as-ibd-market-gains-traction,2023-11-29 14:39:00,"As demand for novel IBD treatments rises, investment in this dynamic sector could be rewarding. Some of the key players in the market are AbbVie (ABBV), J&J (JNJ), Lilly (LLY) and Pfizer (PFE).",PFE,0.179788,0.167822,Somewhat-Bullish
co:collective announces Derek Newberry as Head of Organization and Culture Design Practice and Noah Salzman ... - PR Newswire,https://www.prnewswire.com/news-releases/cocollective-announces-derek-newberry-as-head-of-organization-and-culture-design-practice-and-noah-salzman-elevated-to-senior-strategy-director-to-grow-internal-transformation-practice-302000727.html,2023-11-29 14:30:00,co:collective announces Derek Newberry as Head of Organization and Culture Design Practice and Noah Salzman ... PR ...,PFE,0.057352,0.27302,Somewhat-Bullish
Merck's  ( MRK )  Pneumococcal Jab Shows Upbeat Responses in Study,https://www.zacks.com/stock/news/2190739/mercks-mrk-pneumococcal-jab-shows-upbeat-responses-in-study,2023-11-29 13:26:00,"Positive data from Merck's (MRK) phase III study on V116, an investigational, 21-valent pneumococcal conjugate vaccine, supports the immunogenicity of V116 compared to standard of care.",PFE,0.233556,0.132633,Neutral
"Amazon launches workplace chatbot Q in race against Microsoft, OpenAI",https://www.scmp.com/tech/big-tech/article/3243172/amazon-launches-q-ai-chatbot-corporate-clients-and-competitor-services-microsoft-openai,2023-11-29 02:48:32,"The company also released new versions of its home-grown chips, including one designed for AI applications, and deepened its relationship with Nvidia.",PFE,0.045482,0.064796,Neutral
"Arvinas and Pfizer Announce Updated Vepdegestrant  ( ARV-471 )  Data to be Presented at the 2023 San Antonio Breast Cancer Symposium - Arvinas  ( NASDAQ:ARVN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/11/g35991076/arvinas-and-pfizer-announce-updated-vepdegestrant-arv-471-data-to-be-presented-at-the-2023-san-ant,2023-11-28 22:05:13,"-- Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination with palbociclib ( IBRANCE® ) -- NEW HAVEN, Conn. and NEW YORK, Nov. 28, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ARVN and Pfizer Inc.",PFE,0.331977,0.19372,Somewhat-Bullish
Arvinas and Pfizer Announce Updated Vepdegestrant  ( ARV-471 )  Data to be Presented at the 2023 San Antonio Breast Cancer Symposium,https://www.globenewswire.com/news-release/2023/11/28/2787397/0/en/Arvinas-and-Pfizer-Announce-Updated-Vepdegestrant-ARV-471-Data-to-be-Presented-at-the-2023-San-Antonio-Breast-Cancer-Symposium.html,2023-11-28 22:05:00,"-- Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination with palbociclib ( IBRANCE® ) -- NEW HAVEN, Conn. and NEW YORK, Nov. 28, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ( Nasdaq: ARVN ) and Pfizer Inc. ( NYSE: PFE ) today announced ...",PFE,0.306963,0.187193,Somewhat-Bullish
What To Know About Rapidly Spreading 'Pirola' Covid Variant BA.2.86-And If Vaccines Offer Protection,https://www.forbes.com/sites/ariannajohnson/2023/11/28/what-to-know-about-rapidly-spreading-pirola-covid-variant-ba286-and-if-vaccines-offer-protection/,2023-11-28 20:57:59,"Pirola, or BA.2.86, is the third most prevalent Covid strain in the U.S., and although there may be concerns the new monovalent vaccines-which protect against the XBB lineage that Pirola isn't a part of-don't offer protection against Pirola and its subvariants, drugmakers and the CDC are sure ...",PFE,0.068502,0.074419,Neutral
"Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's - Merck & Co  ( NYSE:MRK ) ",https://www.benzinga.com/general/biotech/23/11/35981646/merck-highlights-data-on-new-vaccine-compares-tolerability-and-safety-to-pfizers,2023-11-28 17:03:10,"Merck & Co Inc MRK released results from the STRIDE-3 Phase 3 trial evaluating V116, the company's investigational 21-valent pneumococcal conjugate vaccine. The trial evaluated the immunogenicity, tolerability, and safety of V116 compared to Pfizer Inc's PFE Prevnar 20 ( PCV20 ) in adults who had ...",PFE,0.294093,0.184553,Somewhat-Bullish
Tofacitinib Market Poised for Strong Growth: Driven by Rising Cases of Arthritis As Per The Business Research Company's Tofacitinib Global Market Report 2023,https://www.benzinga.com/pressreleases/23/11/g35983488/tofacitinib-market-poised-for-strong-growth-driven-by-rising-cases-of-arthritis-as-per-the-busines,2023-11-28 16:30:00,"LONDON, Nov. 28, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's research on the tofacitinib market, the global tofacitinib market is anticipated to experience robust growth, with the market size expected to increase from $2.43 billion in 2022 to $2.76 billion in 2023, ...",PFE,0.067347,0.095454,Neutral
What's Going On With Biodexa Pharmaceuticals Stock  ( BDRX )  Today? - Biodexa Pharmaceuticals  ( NASDAQ:BDRX ) ,https://www.benzinga.com/news/23/11/35978102/whats-going-on-with-biodexa-pharmaceuticals-stock-bdrx-today,2023-11-28 14:11:29,"Biodexa Pharmaceuticals PLC-ADR BDRX shares are trading lower by 6.8% to $4.76 Tuesday morning after the company announced an offering of 1,397,849 Class A Units at an assumed public offering price of $2.79 per Class A Unit in a preliminary prospectus.",PFE,0.199037,0.0,Neutral
Here is What to Know Beyond Why Pfizer Inc.  ( PFE )  is a Trending Stock,https://www.zacks.com/stock/news/2190234/here-is-what-to-know-beyond-why-pfizer-inc-pfe-is-a-trending-stock,2023-11-28 14:00:11,"Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",PFE,0.490323,0.132569,Neutral
"7 Companies Will Propel Profit More Than 100% Next Year, Analysts",https://www.investors.com/etfs-and-funds/sectors/sp500-companies-already-aim-to-propel-profit-at-least-100-percent-next-year/,2023-11-28 13:00:00,It's only November - but if you're like most investors - 2024 is what matters now. And some S&P 500 companies already look primed to put up big numbers.,PFE,0.067536,0.22459,Somewhat-Bullish
WHO authorizes emergency use of Novavax's updated COVID vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/who-authorizes-emergency-use-novavaxs-updated-covid-vaccine-2023-11-28/,2023-11-28 11:28:00,"Vials labelled ""VACCINE Coronavirus COVID-19"" and a syringe are seen in front of a displayed Novavax logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration Acquire Licensing Rights",PFE,0.24289,0.0,Neutral
How Is The Market Feeling About Pfizer? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/short-sellers/23/11/35966323/how-is-the-market-feeling-about-pfizer,2023-11-27 19:15:13,"Pfizer's PFE short percent of float has fallen 13.4% since its last report. The company recently reported that it has 47.18 million shares sold short, which is 0.84% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.34 days to cover their ...",PFE,0.224903,0.085754,Neutral
Olema Pharmaceuticals  ( OLMA )  Skyrockets 471% YTD: Here's Why,https://www.zacks.com/stock/news/2189936/olema-pharmaceuticals-olma-skyrockets-471-ytd-heres-why,2023-11-27 17:54:00,Olema's (OLMA) shares surge on the successful development of its lead candidate in metastatic breast cancer indication.,PFE,0.106541,0.005572,Neutral
Global Advanced Drug Delivery Systems Market To Witness Significant Growth In The Forecast Period - Projected CAGR Of 6% From 2023 To 2027 As Per The Business Research Company's Advanced Drug Delivery Systems Global Market Report 2023,https://www.benzinga.com/pressreleases/23/11/g35962849/global-advanced-drug-delivery-systems-market-to-witness-significant-growth-in-the-forecast-period-,2023-11-27 16:30:00,"LONDON, Nov. 27, 2023 ( GLOBE NEWSWIRE ) -- The latest market report from The Business Research Company reveals promising prospects for the global advanced drug delivery systems market.",PFE,0.051999,0.178561,Somewhat-Bullish
Page 251 of,https://www.financialexpress.com/about-videos/page/251/,2023-11-27 15:33:08,An eruption of incandescent fragments from Costa Rica's Turrialba volcano is caught on infrared camera. Rough cut ( no reporter narration ) . Russia tops the bookmakers' list of favourites in the Eurovision Song Contest hosted this year by Sweden. Paul Chapman reports.,PFE,0.266828,-0.722634,Bearish
Why Biodexa Pharmaceuticals Stock  ( BDRX )  Is Skyrocketing - Biodexa Pharmaceuticals  ( NASDAQ:BDRX ) ,https://www.benzinga.com/news/23/11/35958666/why-biodexa-pharmaceuticals-stock-bdrx-is-skyrocketing,2023-11-27 14:23:46,"Biodexa Pharmaceuticals PLC-ADR BDRX shares are trading higher by 60% to $4.48 Monday morning after the company announced it has acquired the rights to tolimidone, an experimental drug initially developed by Pfizer Inc. for gastric ulcers.",PFE,0.162802,0.085325,Neutral
GSK Key Drugs & Vaccines Help Stock Outperform Industry YTD,https://www.zacks.com/stock/news/2189596/gsk-key-drugs-vaccines-help-stock-outperform-industry-ytd,2023-11-27 13:46:00,"Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates are expected drive the stock in the future quarters.",PFE,0.116725,0.002242,Neutral
"Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields - Pfizer  ( NYSE:PFE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/news/23/11/35957603/wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-4-dividend-yields,2023-11-27 13:37:26,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",PFE,0.10607,-0.104773,Neutral
"Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD",https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-announces-name-change-to-spyre-therapeutics-appoints-ceo-and-additional-directors-and-expands-leadership-team-to-develop-next-generation-therapeutic-combinations-for-the-treatment-of-ibd-301996712.html,2023-11-27 13:30:00,"Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and ... PR ...",PFE,0.036869,0.138028,Neutral
Arvinas Announces Oversubscribed $350 Million Private Placement - Arvinas  ( NASDAQ:ARVN ) ,https://www.benzinga.com/pressreleases/23/11/g35955560/arvinas-announces-oversubscribed-350-million-private-placement,2023-11-27 12:00:10,"NEW HAVEN, Conn., Nov. 27, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc.",PFE,0.138663,0.116992,Neutral
Arvinas Announces Oversubscribed $350 Million Private Placement,https://www.globenewswire.com/news-release/2023/11/27/2786028/0/en/Arvinas-Announces-Oversubscribed-350-Million-Private-Placement.html,2023-11-27 12:00:00,"NEW HAVEN, Conn., Nov. 27, 2023 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ( Nasdaq: ARVN ) , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that it has entered into a securities purchase agreement with a select group of ...",PFE,0.141102,0.119384,Neutral
3 Top-Ranked Market Neutral Funds to Hedge Risk,https://www.zacks.com/stock/news/2189508/3-top-ranked-market-neutral-funds-to-hedge-risk,2023-11-27 11:42:00,"Below, we share with you three market-neutral mutual funds, viz. HSGFX, ADANX, and CVSIX. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy).",PFE,0.148273,0.034096,Neutral
EMA Accepts Valneva's Chikungunya Vaccine Marketing Authorization Application for Accelerated Assessment,https://www.globenewswire.com/news-release/2023/11/27/2785831/0/en/EMA-Accepts-Valneva-s-Chikungunya-Vaccine-Marketing-Authorization-Application-for-Accelerated-Assessment.html,2023-11-27 06:00:00,"Saint-Herblain ( France ) , November 27, 2023 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) , a specialty vaccine company, today announced that the European Medicines Agency ( EMA ) has performed a technical validation of the Marketing Authorization Application ( MAA ) for Valneva's ...",PFE,0.025845,-0.004819,Neutral
EMA Accepts Valneva's Chikungunya Vaccine Marketing Authorization Application for Accelerated Assessment,https://www.benzinga.com/pressreleases/23/11/g35953221/ema-accepts-valnevas-chikungunya-vaccine-marketing-authorization-application-for-accelerated-asses,2023-11-27 06:00:00,"Saint-Herblain ( France ) , November 27, 2023 - Valneva SE VALNVLA, a specialty vaccine company, today announced that the European Medicines Agency ( EMA ) has performed a technical validation of the Marketing Authorization Application ( MAA ) for Valneva's single-shot chikungunya vaccine ...",PFE,0.025272,-0.004809,Neutral
Could Pfizer Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/12/16/could-pfizer-stock-help-you-become-a-millionaire/,2023-12-16 14:30:00,"Everyone has been talking about this stock, but that alone doesn't make it a good buy.",PFE,0.677342,0.301188,Somewhat-Bullish
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally,https://www.fool.com/investing/2023/12/16/3-fantastic-stocks-that-could-enjoy-a-santa-claus/,2023-12-16 11:55:00,These stocks could bring investors more than just a lump of coal for Christmas.,PFE,0.239698,0.073491,Neutral
5 Beaten-Down Stocks That Could Soar in 2024,https://www.fool.com/investing/2023/12/16/5-beaten-down-stocks-that-could-soar-in-2024/,2023-12-16 10:00:00,"These players may offer your portfolio a lift as early as next year. But most importantly, they could excel over time.",PFE,0.039614,0.127352,Neutral
PADCEV®  ( enfortumab vedotin-ejfv )  with KEYTRUDA®  ( pembrolizumab )  Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer,https://www.prnewswire.com/news-releases/padcev-enfortumab-vedotin-ejfv-with-keytruda-pembrolizumab-approved-by-fda-as-the-first-and-only-adc-plus-pd-1-to-treat-advanced-bladder-cancer-302017114.html,2023-12-15 22:00:00,PADCEV® ( enfortumab vedotin-ejfv ) with KEYTRUDA® ( pembrolizumab ) Approved by FDA as the First and Only ADC ... PR ...,PFE,0.07751,0.033114,Neutral
What's Going On With Pfizer Stock? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/23/12/36262162/whats-going-on-with-pfizer-stock,2023-12-15 18:31:50,"Pfizer, Inc. PFE shares are trading higher Friday. The stock remains down by more than 11% over the past five days and down by more than 47% year-to-date. Pfizer shares are climbing on heavy trading volume Friday after the company announced that its board of directors declared an increase in the ...",PFE,0.968984,0.32907,Somewhat-Bullish
"32 managers and agents helping athletes forge careers in media and entertainment, from launching podcasts and production companies to building influencer businesses",https://www.businessinsider.com/athlete-agents-managers-in-sports-landing-media-content-deals-2023-12,2023-12-15 16:28:00,"32 Athlete Agents and Managers Landing Media, Content Deals in 2023 - Business Insider ...",PFE,0.008813,0.068568,Neutral
Market Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review,https://www.investors.com/news/stock-market-rally-surges-to-2023-highs-as-fed-pivots-toward-rate-cuts-weekly-review/,2023-12-15 15:54:00,"The stock market rally raced higher in a powerful, broad advance as the Federal Reserve signaled it could cut rates three times in 2024. The Dow Jones hit a record high while the S&P 500, Nasdaq composite, S&P MidCap 400 and small-cap Russell 2023 all set 2023 bests. Treasury yields plunged.",PFE,0.059935,-0.441897,Bearish
SEC Green Lights Public Listing Of Texas Cannabis Co. That Will Use AI In Clinical Trials - Cannabis Bioscience  ( OTC:CBIH ) ,https://www.benzinga.com/markets/cannabis/23/12/36258856/sec-green-lights-public-listing-of-texas-cannabis-co-that-will-use-ai-in-clinical-trials,2023-12-15 15:09:38,"Cannabis Bioscience International Holdings CBIH announced on Friday that its registration statement on Form S-1, filed under the Securities Act of 1933, was declared effective by the United States Securities and Exchange Commission ( SEC ) on Dec. 5.",PFE,0.07913,0.106639,Neutral
The Pain Continues For Bedraggled Pharma Heavyweight Pfizer,https://www.investors.com/news/technology/pfizer-stock-suffers-another-price-target-cut-as-the-pain-continues/,2023-12-15 14:40:00,Pfizer Stock Suffers Another Price Target Cut As The Pain Continues Investor's Business Daily ...,PFE,0.827318,-0.310448,Somewhat-Bearish
"BONK, Dogecoin Rival, Surges 75% - Analyst Predicts 20x Gain, Trump Leads Biden In All 7 Swing States - Top Headlines Today While US Was Sleeping",https://www.benzinga.com/news/23/12/36255248/bonk-dogecoin-rival-surges-75-analyst-predicts-20x-gain-trump-leads-biden-in-all-7-swing-states-top,2023-12-15 13:50:06,"Scholastic Posts Downbeat Earnings, Joins Lennar And Other Big Stocks Moving Lower In Friday's Pre-Market Session Fear & Greed Index Remains In 'Greed' Zone Following Economic Reports; Dow Records New High EXCLUSIVE: EQI Bank's Eli Taranto Talks Bitcoin Spot ETF Optimism, Reflects On Cathie ...",PFE,0.054983,0.369015,Bullish
"Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More",https://www.zacks.com/stock/news/2198513/pharma-stock-roundup-pfe-issues-weak-2024-view-azn-to-buy-icosavax-more,2023-12-15 13:34:00,"Pfizer (PFE) issues a disappointing outlook for 2024. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax.",PFE,0.344606,0.047034,Neutral
SNL's New Kings of Bizarro Buddy Comedy,https://www.theatlantic.com/magazine/archive/2024/01/please-dont-destroy-snl-foggy-mountain-movie/676144/,2023-12-15 12:00:00,The Bizarro Buddy Comedy of SNL's Please Don't Destroy The Atlantic ...,PFE,0.029184,0.005883,Neutral
3 No-Brainer Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2023/12/15/3-no-brainer-healthcare-stocks-to-buy-right-now/,2023-12-15 10:00:00,These players have what it takes to boost your portfolio over time.,PFE,0.399506,0.205006,Somewhat-Bullish
Bill Ackman's antisemitism crusade has earned him a new fan - Elon Musk,https://www.businessinsider.com/bill-ackman-antisemitism-crusade-earned-new-fan-elon-musk-2023-12,2023-12-15 08:54:00,Bill Ackman's antisemitism crusade has earned him a new fan: Elon Musk - Business Insider ...,PFE,0.057079,-0.123958,Neutral
"Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate  ( ADC ) ",https://www.benzinga.com/pressreleases/23/12/n36249773/nona-biosciences-enters-into-a-global-license-agreement-with-pfizer-for-hbm9033-an-msln-targeted-a,2023-12-14 23:30:00,"Nona Biosciences will receive a total of up to $53 Million in upfront and near-term payments, with the potential for milestones of up to $1.05 billion plus royalties. Pfizer partnership expands Nona's global network of collaborations, reinforcing its commitment to providing cutting-edge ...",PFE,0.277433,0.314119,Somewhat-Bullish
Are You Sure You Want an Ozempic Pill?,https://www.theatlantic.com/health/archive/2023/12/obesity-drugs-ozempic-pills-injections/676359/,2023-12-14 22:44:00,Obesity-Drugs Are Becoming Pills. Is That Really Better? The Atlantic ...,PFE,0.082017,0.00624,Neutral
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,2023-12-14 22:15:00,"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... PR ...",PFE,0.078099,0.0,Neutral
Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted' - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/news/23/12/36246521/moderna-ceo-highlights-promising-cancer-vaccine-data-think-about-the-number-of-lives-that-can-be-imp,2023-12-14 21:03:25,"Moderna, Inc. MRNA CEO Stéphane Bancel appeared on CNBC's ""Squawk Box"" Thursday to discuss the company's promising new cancer vaccine developed in partnership with Merck & Company, Inc. MRK.",PFE,0.269776,-0.187431,Somewhat-Bearish
10 Best Stocks For 2024,https://www.forbes.com/sites/investor-hub/article/best-stocks-for-2024/,2023-12-14 20:47:02,"Pundits are divided on their economic and financial market predictions for 2024. Some see lingering high interest rates prompting recession, while others see growth as the Fed starts to implement rate cuts. Amid this uncertainty, picking the best stocks for the year ahead can be stressful.",PFE,0.017432,0.0,Neutral
"Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast - Seagen  ( NASDAQ:SGEN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36242182/pfizers-2030-vision-bolstered-by-seagen-deal-analyst-cuts-price-target-amid-conserv,2023-12-14 18:34:24,"Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on Pfizer, Inc. PFE, lowering the price target to $36 from $42. While PFE provided lower-than-expected 2024 guidance, primarily driven by the management's conservative $8 billion COVID-19 product forecast, the analyst sees ...",PFE,0.908493,0.380124,Bullish
LACROIX and AIAC enter into exclusive negotiations for the sale/acquisition of the Road Signs Business Unit.,https://www.globenewswire.com/news-release/2023/12/14/2796545/0/en/LACROIX-and-AIAC-enter-into-exclusive-negotiations-for-the-sale-acquisition-of-the-Road-Signs-Business-Unit.html,2023-12-14 17:11:00,...,PFE,0.064104,0.02901,Neutral
These Stocks Have Gained The Most During Stock Market's Record Rally,https://www.forbes.com/sites/dereksaul/2023/12/14/these-stocks-have-gained-the-most-during-stock-markets-record-rally/,2023-12-14 15:34:40,"The stock market's nearly two-month-long rally culminated this week with the Dow Jones Industrial Average hitting an all-time high, officially erasing all the losses associated with the spike in interest rates, with gains spread across a diverse group of stocks.",PFE,0.085324,-0.096319,Neutral
"Company News for Dec 14, 2023",https://www.zacks.com/stock/news/2197972/company-news-for-dec-14-2023,2023-12-14 14:36:00,Companies in The News Are: ...,PFE,0.644033,-0.200807,Somewhat-Bearish
Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?,https://www.fool.com/investing/2023/12/14/are-these-3-cheap-dividend-stocks-with-high-yields/,2023-12-14 13:45:00,The highest-yielding stock on this list pays 7.7%.,PFE,0.246582,-0.099357,Neutral
"Moderna's Cancer Vaccine Cuts Risk Of Relapse, Death By 49%",https://www.investors.com/news/technology/moderna-stock-cancer-vaccine-cuts-risk-of-relapse-death/,2023-12-14 13:40:00,"Moderna's ( MRK ) Merck ( MRK ) -partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients, the companies said Thursday. The update fueled big gains for Moderna stock, which has been hamstrung recently on Covid news.",PFE,0.148731,-0.151083,Somewhat-Bearish
Pfizer  ( PFE )  Stock Sinks on Weak 2024 View as COVID Sales Fall,https://www.zacks.com/stock/news/2197825/pfizer-pfe-stock-sinks-on-weak-2024-view-as-covid-sales-fall,2023-12-14 13:13:00,"Pfizer's (PFE) shares decline almost 7% in response to the muted guidance for 2024. Revenues are expected to be in the range of $58.5 to $61.5 billion, while adjusted EPS is expected in the range of $2.05 to $2.25.",PFE,0.748033,0.175994,Somewhat-Bullish
"Daily: As Federal Reserve Holds Steady, Markets Rally",https://www.forbes.com/sites/forbesdaily/2023/12/14/forbes-daily-as-federal-reserve-holds-steady-markets-rally/,2023-12-14 13:12:42,"This is a published version of the Forbes Daily newsletter, you can sign-up to get Forbes Daily in your inbox here. Taylor Swift and Beyoncé may have dominated the headlines, but the blockbuster year for women extended across numerous fields.",PFE,0.047324,0.045001,Neutral
"Harmonic To Rally Over 80%? Here Are 10 Top Analyst Forecasts For Thursday - Deckers Outdoor  ( NYSE:DECK ) , Alector  ( NASDAQ:ALEC ) ",https://www.benzinga.com/news/23/12/36234624/harmonic-to-rally-over-80-here-are-10-top-analyst-forecasts-for-thursday,2023-12-14 12:57:43,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JP Morgan increased Whirlpool Corporation WHR price target from $104 to $120.",PFE,0.244518,-0.131369,Neutral
"The daily business briefing: December 14, 2023",https://theweek.com/business/the-daily-business-briefing-december-14-2023,2023-12-14 12:46:01,1. Fed signals interest rate cuts in 2024 4. Pfizer shares plunge as Covid vaccine demand drops 5. Gas prices drop to lowest level of 2023 The Federal Reserve ended its last policy meeting of 2023 on Wednesday by keeping interest rates unchanged and projecting three rate cuts next year.,PFE,0.105759,-0.067588,Neutral
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board,https://www.globenewswire.com/news-release/2023/12/14/2796170/0/en/Tourmaline-Bio-Appoints-Dr-Clay-Siegall-as-Chairman-of-the-Board.html,2023-12-14 12:30:00,"NEW YORK, Dec. 14, 2023 ( GLOBE NEWSWIRE ) -- Tourmaline Bio, Inc. ( ""Tourmaline"" ) ( NASDAQ: TRML ) , a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, announced ...",PFE,0.046095,-0.007981,Neutral
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board - Tourmaline Bio  ( NASDAQ:TRML ) ,https://www.benzinga.com/pressreleases/23/12/g36234063/tourmaline-bio-appoints-dr-clay-siegall-as-chairman-of-the-board,2023-12-14 12:30:00,"NEW YORK, Dec. 14, 2023 ( GLOBE NEWSWIRE ) -- Tourmaline Bio, Inc. ( ""Tourmaline"" ) TRML, a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, announced today that Clay ...",PFE,0.045396,-0.007975,Neutral
"Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?",https://www.fool.com/investing/2023/12/14/pfizers-2024-outlook-wall-street-buy-sell-hold/,2023-12-14 10:34:00,Pfizer recently outlined expectations for 2024 results in light of an upcoming $43 billion acquisition of Seagen.,PFE,0.560379,0.149731,Neutral
"Apple, Adobe, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today - Apple  ( NASDAQ:AAPL ) , Adobe  ( NASDAQ:ADBE ) ",https://www.benzinga.com/markets/equities/23/12/36229359/apple-adobe-pfizer-alibaba-tesla-why-these-5-stocks-are-on-investors-radars-today,2023-12-14 02:46:09,"Major U.S. indices were in the green on Wednesday with the Dow Jones rising 1.4% to 37,090.24, the S&P 500 gaining 1.37% to 4,707.09 and the tech-heavy Nasdaq appreciating 1.38% to 14,733.96. On the same day, Federal Reserve Chair Jerome Powell signaled a peak in interest rates and foresaw cuts ...",PFE,0.095899,-0.119248,Neutral
Dow ends at record high as Fed signals lower borrowing costs in 2024,https://www.moneycontrol.com/news/business/markets/dow-ends-at-record-high-as-fed-signals-lower-borrowing-costs-in-2024-11901511.html,2023-12-14 00:44:51,"In its policy statement, the Fed also left interest rates steady, as expected, and a near-unanimous 17 of 19 Fed officials projected that the policy rate will be lower by the end of 2024.",PFE,0.073546,0.109889,Neutral
InnovationRx: Tough Road Ahead For Bluebird's Gene Therapy,https://www.forbes.com/sites/alexknapp/2023/12/13/innovationrx-tough-road-ahead-for-bluebirds-gene-therapy/,2023-12-13 23:33:29,"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Last Friday marked a biotech milestone as the Food and Drug Administration approved two Cripsr-based gene therapies for the treatment of sickle cell disease.",PFE,0.034933,-0.125168,Neutral
"Company Rundown: Chewy, Lululemon, Smucker, and More",https://www.fool.com/investing/2023/12/13/company-rundown-chewy-lululemon-smucker/,2023-12-13 21:55:00,"Author Bethany McLean also stops by to chat about her latest book, ""What the Pandemic Revealed About Who America Protects and Who It Leaves Behind."" ...",PFE,0.00598,0.041441,Neutral
Stock Market Today: Dow Closes at New High After Fed Signals Rate Cuts,https://www.kiplinger.com/investing/stocks/stock-market-today-dow-closes-at-new-high-after-fed-signals-rate-cuts,2023-12-13 21:14:45,Stocks traded in a tight range in the lead up to this afternoon's policy announcement from the Federal Reserve as investors took in another mixed inflation reading.,PFE,0.143843,-0.029458,Neutral
Dow reaches new record high as markets celebrate Fed decision | Business,https://www.cnn.com/2023/12/13/investing/dow-reaches-new-high/index.html,2023-12-13 21:11:00,Dow reaches record high as Fed pivots toward rate cuts ...,PFE,0.092927,-0.07375,Neutral
What's Going On With Novavax Hitting A New 52-Week Low? - Novavax  ( NASDAQ:NVAX ) ,https://www.benzinga.com/news/23/12/36222672/whats-going-on-with-novavax-hitting-a-new-52-week-low,2023-12-13 19:15:07,Novavax Inc NVAX shares are trading lower by 4.4% to $5.08 Wednesday afternoon. Shares of several COVID vaccine stocks are trading lower after Pfizer Inc. provided FY24 guidance. Pfizer's guidance might hint at a saturation point in the COVID vaccine market.,PFE,0.443626,0.249858,Somewhat-Bullish
What's Going On With Moderna  ( MRNA )  Stock? - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/news/23/12/36221374/whats-going-on-with-moderna-mrna-stock,2023-12-13 18:30:49,Moderna Inc MRNA shares are trading lower by 4.5% to $74.50 during Wednesday's session. Shares of several COVID vaccine stocks are trading lower after Pfizer Inc. provided FY24 guidance. Investors might have been expecting higher performance across the board from COVID vaccine manufacturers.,PFE,0.613172,0.28355,Somewhat-Bullish
What's Going On With BioNTech  ( BNTX )  Shares? - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/news/23/12/36221052/whats-going-on-with-biontech-bntx-shares,2023-12-13 17:46:03,BioNTech SE - ADR BNTX shares are trading lower by 5.6% to $93.10 Wednesday afternoon. Shares of several COVID vaccine stocks are trading lower after Pfizer Inc. PFE provided FY24 guidance. BioNTech's revenue relies on its collaboration with Pfizer for the COVID-19 vaccine.,PFE,0.839046,0.147501,Neutral
"Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday? - SPDR Dow Jones Industrial Average ETF  ( ARCA:DIA ) ",https://www.benzinga.com/markets/equities/23/12/36221173/stocks-hold-steady-yields-decline-as-fed-meeting-looms-whats-driving-markets-wednesday,2023-12-13 17:45:07,"Midway through the trading day on Wall Street, calm reigns supreme as investors eagerly await the Federal Reserve's decision on interest rates. The Federal Open Market Committee ( FOMC ) is scheduled to publish its policy statement at 2 p.m. ET, followed by Chair Jerome Powell's address at 2:30 ...",PFE,0.163354,-0.468248,Bearish
"Eli Lilly will be the first trillion-dollar drug company in history, billionaire investor Ken Langone says",https://markets.businessinsider.com/news/stocks/eli-lilly-stock-diabetes-ozempic-wegovy-weight-loss-drug-pharma-2023-12,2023-12-13 17:40:00,Eli Lilly Will Be the First Trillion-Dollar Drug Company: Ken Langone - Markets Insider ...,PFE,0.124809,-0.142072,Neutral
Pfizer shares sink after it resets 2024 COVID expectations,https://www.foxbusiness.com/markets/pfizer-shares-sink-resets-2024-covid-expectations,2023-12-13 17:34:00,"Pfizer on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, a move top executives said provided a more reliable view of its COVID-19 business than it had this year, driving shares down 9% to a 10-year low.",PFE,0.532556,0.026888,Neutral
Why Pfizer Stock Is Sinking Today,https://www.fool.com/investing/2023/12/13/why-pfizer-stock-is-sinking-today/,2023-12-13 17:14:09,The big drugmaker's 2024 guidance disappointed investors.,PFE,0.893234,0.174556,Somewhat-Bullish
Pfizer Becomes Oversold,https://www.forbes.com/sites/dividendchannel/2023/12/13/pfizer-becomes-oversold/,2023-12-13 16:32:20,"The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics - strong fundamentals and a valuation that looks inexpensive.",PFE,0.565345,0.417858,Bullish
"Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday - JetBlue Airways  ( NASDAQ:JBLU ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/news/23/12/36218848/pfizer-issues-fy24-forecast-joins-target-hospitality-southwest-airlines-and-other-big-stocks-moving,2023-12-13 16:03:10,"U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Shares of Pfizer Inc. PFE shares fell sharply during Wednesday's session after the company provided FY24 guidance.",PFE,0.423843,0.056296,Neutral
Pfizer Crashes 9% As Seagen Guidance Update Disappoints,https://www.investors.com/news/technology/pfizer-stock-tumble-steepens-as-seagen-guidance-update-disappoints/,2023-12-13 15:04:00,Pfizer Stock Crashes 9% On Disappointing Outlook As Seagen Takeover Looms Investor's Business Daily ...,PFE,0.740604,-0.467006,Bearish
2 Big-Name Stocks Are Falling Wednesday -- Here's Why,https://www.fool.com/investing/2023/12/13/2-big-name-stocks-are-falling-wednesday-heres-why/,2023-12-13 14:54:59,"Even as market participants wait for the latest from the Federal Reserve, some companies are having issues of their own.",PFE,0.496201,0.079567,Neutral
Pfizer's stock down 8% as 2024 profit and revenue guidance falls short of expectations,https://www.marketwatch.com/story/pfizers-stock-down-7-as-2024-guidance-for-profit-and-revenue-lags-consensus-aabe0e57,2023-12-13 14:45:00,Drugmaker expands cost-cutting program as it wraps up Seagen acquisition.,PFE,0.887556,0.037621,Neutral
Pfizer shares fall as 2024 revenue and profit forecast disappoints,https://www.cnbc.com/2023/12/13/pfizer-forecasts-2024-revenue-below-wall-street-expectations.html,2023-12-13 14:40:18,"After raking in billions from Covid products, Pfizer has struggled to navigate a world beyond the pandemic and reassure investors about its growth potential.",PFE,0.682689,-0.120742,Neutral
Pfizer Stock Sinks To 10-Year Low-Why Investors Have Soured On Covid-Era Giant,https://www.forbes.com/sites/dereksaul/2023/12/13/pfizer-stock-sinks-to-10-year-low-why-investors-have-soured-on-covid-era-giant/,2023-12-13 14:38:23,"Pfizer stock's struggles continued Wednesday, as shares of the healthcare titan dropped to their lowest level since before the Covid-19 pandemic, the latest dubious milestone for the battered stock that has failed to convert its vaccine boom into long-term sales growth.",PFE,0.66906,0.003816,Neutral
"The Zacks Analyst Blog Highlights The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment",https://www.zacks.com/stock/news/2197286/the-zacks-analyst-blog-highlights-the-home-depot-advanced-micro-devices-pfizer-the-cigna-group-and-live-nation-entertainment,2023-12-13 14:15:00,"The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment are part of the Zacks top Analyst Blog.",PFE,0.29234,-0.021497,Neutral
"Pfizer, Humana, Shake Shack And More On CNBC's 'Final Trades' - Humana  ( NYSE:HUM ) , Cigna Group  ( NYSE:CI ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/12/36210700/pfizers-dividend-yield-is-5-7-plus-humana-and-shake-shack-on-cnbcs-final-trades,2023-12-13 13:21:58,"On CNBC's ""Halftime Report Final Trades,"" Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc SHAK as his final trade. Shake Shack CEO Randy Garutti recently informed the board of his intention to retire in 2024 after the selection of a successor.",PFE,0.558244,-0.294027,Somewhat-Bearish
Pfizer's Tumble Steepens As Seagen Guidance Update Disappoints,https://www.investors.com/news/pfizer-stock-tumble-steepens-as-seagen-guidance-update-disappoints/,2023-12-13 13:03:00,Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints Investor's Business Daily ...,PFE,0.757528,-0.220962,Somewhat-Bearish
Why Is US Pharma Giant Pfizer Stock Trading Lower Today? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/12/36213638/why-is-us-pharma-giant-pfizer-stock-trading-lower-today,2023-12-13 12:50:12,"Pfizer Inc PFE provided its full-year 2024 guidance, which includes the expected financial impact from the Seagen Inc SGEN transaction. On Tuesday, Pfizer said it received all regulatory approvals to close the deal on Thursday, about nine months after announcing the acquisition.",PFE,0.751437,0.297781,Somewhat-Bullish
Pfizer shares sink after weak 2024 forecasts,https://www.reuters.com/business/healthcare-pharmaceuticals/pfizers-2024-revenue-forecast-below-wall-street-estimate-2023-12-13/,2023-12-13 12:48:00,"Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights Dec 13 ( Reuters ) - Pfizer ( PFE.N ) on Wednesday forecast 2024 revenue and profit below Wall Street expectations, sending its shares down 7% in premarket trading even ...",PFE,0.507107,0.019558,Neutral
EvolveImmune Therapeutics Provides Corporate and Program Update Highlighted by Closing of $37 Million Financing,https://www.benzinga.com/pressreleases/23/12/g36213164/evolveimmune-therapeutics-provides-corporate-and-program-update-highlighted-by-closing-of-37-milli,2023-12-13 12:00:02,"Fundraising Includes Strategic Investment by Bristol Myers Squibb Coupled with Support from Existing Investors EvolveImmune Initiates Chemistry, Manufacturing, and Control ( CMC ) Activities for Lead Multi-Functional T-cell Engager Program, EV-104, Following Presentation of Latest Preclinical ...",PFE,0.110209,0.02336,Neutral
3 Dirt-Cheap Stocks to Buy Hand Over Fist Before the End of the Year,https://www.fool.com/investing/2023/12/13/3-dirt-cheap-stocks-to-buy-before-2024/,2023-12-13 10:00:00,These players could lift your portfolio when they rebound and over the long term.,PFE,0.055751,0.189947,Somewhat-Bullish
"China's 'walking' pneumonia outbreak exposes stark global threat of superbugs, drug resistance",https://www.financialexpress.com/healthcare/news-healthcare/chinas-walking-pneumonia-outbreak-exposes-stark-global-threat-of-superbugs-drug-resistance-bkg/3337521/,2023-12-13 08:45:42,"Even as China battles the latest outbreak of respiratory diseases among kids, experts are observing an alarming trend. A Bloomberg report says that medical practitioners are seeing an evident impact of antibiotic resistance in crowded pediatric hospitals across China.",PFE,0.033894,-0.0919,Neutral
"China's 'walking' pneumonia outbreak exposes stark global threat of superbugs, drug resistance",https://www.financialexpress.com/healthcare/news-healthcare/chinas-walking-pneumonia-outbreak-exposes-starknbsp-global-threat-of-superbugs-drug-resistance-bkg/3337521/,2023-12-13 08:45:42,"Even as China battles the latest outbreak of respiratory diseases among kids, experts are observing an alarming trend. A Bloomberg report says that medical practitioners are seeing an evident impact of antibiotic resistance in crowded pediatric hospitals across China.",PFE,0.033894,-0.0919,Neutral
"China's 'walking' pneumonia outbreak exposes stark global threat of superbugs, drug resistance",https://www.financialexpress.com/healthcare/news-healthcare/chinas-walking-pneumonia-outbreak-exposes-stark-global-threat-of-superbugs-drug-resistance-bkg/3337521/lite/,2023-12-13 08:45:42,"Even as China battles the latest outbreak of respiratory diseases among kids, experts are observing an alarming trend. A Bloomberg report says that medical practitioners are seeing an evident impact of antibiotic resistance in crowded pediatric hospitals across China.",PFE,0.033894,-0.0919,Neutral
Bristol to pay SystImmune up to $8.4 billion in cancer-drug deal,https://www.financialexpress.com/healthcare/news-healthcare/bristol-to-pay-systimmune-up-to-8-4-billion-in-cancer-drug-deal/3336763/,2023-12-13 03:30:00,"Bristol Myers Squibb Co. will pay SystImmune Inc. up to $8.4 billion for rights to co-develop and sell an experimental drug for lung and breast cancers, the latest in a string of large deals for a potent new class of oncology treatments.",PFE,0.163909,0.094593,Neutral
Update: Annual Changes to the Nasdaq-100® Index,https://www.globenewswire.com/news-release/2023/12/12/2795166/6948/en/Update-Annual-Changes-to-the-Nasdaq-100-Index.html,2023-12-12 23:00:00,"NEW YORK, Dec. 12, 2023 ( GLOBE NEWSWIRE ) -- Nasdaq ( Nasdaq: NDAQ ) today announced an update to the annual reconstitution of the Nasdaq-100 Index® ( Nasdaq: NDX ) . Per the announcement by Pfizer Inc. ( NYSE: PFE ) , the pending acquisition of Seagen, Inc. ( Nasdaq: SGEN ) is expected to close ...",PFE,0.167322,0.048775,Neutral
"Update: Annual Changes to the Nasdaq-100® Index - Nasdaq  ( NASDAQ:NDAQ ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/12/g36208441/update-annual-changes-to-the-nasdaq-100-index,2023-12-12 23:00:00,"NEW YORK, Dec. 12, 2023 ( GLOBE NEWSWIRE ) -- Nasdaq NDAQ today announced an update to the annual reconstitution of the Nasdaq-100 Index® NDX. Per the announcement by Pfizer Inc. PFE, the pending acquisition of Seagen, Inc. SGEN is expected to close on December 14, 2023.",PFE,0.165598,0.048436,Neutral
Pfizer  ( PFE )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2197043/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,2023-12-12 22:45:17,"Pfizer (PFE) concluded the recent trading session at $28.58, signifying a -0.21% move from its prior day's close.",PFE,0.540358,0.341485,Somewhat-Bullish
Dow Jones Rises As Fed Decision Looms; Google Nicked By Jury Verdict,https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-as-fed-decision-looms-google-slammed-by-antitrust-verdict/,2023-12-12 22:15:00,Dow Jones Rises As Fed Decision Looms. Google Slammed By Jury Verdict Investor's Business Daily ...,PFE,0.12645,0.156762,Somewhat-Bullish
Here's why our favorite way to invest in the clean energy transition jumped out of nowhere,https://www.cnbc.com/2023/12/12/linde-shares-can-go-higher-if-the-club-stock-is-added-to-the-nasdaq.html,2023-12-12 19:56:56,The Investing Club releases the Homestretch weekday audio feature in time for the last hour of trading on Wall Street.,PFE,0.095899,0.069873,Neutral
Airline Mergers Give Us Something to Talk About,https://www.fool.com/investing/2023/12/12/airline-mergers-give-us-something-to-talk-about/,2023-12-12 18:49:00,A proposed merger between Alaska Airlines and Hawaiian Airlines could help Alaska take market share over time.,PFE,0.008144,0.057733,Neutral
What's Going On With Moderna Stock Today? - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/general/biotech/23/12/36199743/whats-going-on-with-moderna-stock-today,2023-12-12 18:38:33,"Moderna Inc MRNA announced changes to its operating model to bring focus to its short- and long-term business goals. The company is focused on driving continued sales of its COVID-19 vaccine and launching its Respiratory syncytial virus ( RSV ) vaccine in 2024, while also preparing to launch ...",PFE,0.259727,-0.138012,Neutral
"Why Seagen  ( SGEN )  Shares Are Gaining Today - Seagen  ( NASDAQ:SGEN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/12/36198526/pfizer-clears-required-regulatory-hurdles-to-complete-43b-seagen-acquisition,2023-12-12 18:03:58,Pfizer Inc PFE agreed to donate the rights of royalties from sales of cancer drug Bavencio ( avelumab ) to the American Association for Cancer Research to address U.S. Federal Trade Commission concerns related to its $43-billion deal to buy Seagen Inc SGEN.,PFE,0.972931,0.155149,Somewhat-Bullish
"Top Stock Reports for Home Depot, Advanced Micro Devices & Pfizer",https://www.zacks.com/research-daily/2196642/top-stock-reports-for-home-depot-advanced-micro-devices-pfizer,2023-12-12 17:57:00,"Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Advanced Micro Devices, Inc. (AMD) and Pfizer Inc. (PFE).",PFE,0.130926,-0.026085,Neutral
"Pediatric Health Care Products and Services Market Set to Surge at 6.9% CAGR, to Reach USD 173.5 billion by 2031| Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/23/12/g36201229/pediatric-health-care-products-and-services-market-set-to-surge-at-6-9-cagr-to-reach-usd-173-5-bil,2023-12-12 16:30:00,"Wilmington, Delaware, United States, Dec. 12, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The market for pediatric health care products and services is projected to thrive with an anticipated CAGR of 6.9% between 2023 and 2031.",PFE,0.067064,0.146108,Neutral
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors,https://www.fool.com/investing/2023/12/12/abbvie-just-followed-pfizers-big-move-heres-what/,2023-12-12 15:15:00,It's making a major acquisition to beef up a key area of its pipeline.,PFE,0.051551,0.002992,Neutral
Fortune and Accenture to Launch New Global AI Conference Series Starting in 2024,https://www.prnewswire.com/apac/news-releases/fortune-and-accenture-to-launch-new-global-ai-conference-series-starting-in-2024-302012619.html,2023-12-12 15:00:00,"Fortune and Accenture team up for ""Brainstorm AI 2024: The New Race for AI,"" a series of conferences taking place in London, Singapore, and San Francisco",PFE,0.045655,0.064824,Neutral
Pfizer's  ( PFE )  Hemophilia Candidate BLA Gets FDA Acceptance,https://www.zacks.com/stock/news/2196706/pfizers-pfe-hemophilia-candidate-bla-gets-fda-acceptance,2023-12-12 14:14:00,"The FDA decision on Pfizer's (PFE) BLA for marstacimab for hemophilia A and B is expected in the fourth quarter of 2024, while the European Commission's decision is expected in 2025.",PFE,0.378777,0.097796,Neutral
Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal - Bristol-Myers Squibb  ( NYSE:BMY ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36195740/bristol-myers-squibb-further-diversifies-oncology-portfolio-with-mega-8-4b-deal,2023-12-12 14:00:05,"SystImmune and Bristol Myers Squibb & Co BMY announced an exclusive license and collaboration agreement for SystImmune's BL-B01D1, a potentially first-in-class EGFRxHER3 bispecific antibody-drug conjugate ( ADC ) .",PFE,0.369685,0.130707,Neutral
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?,https://www.fool.com/investing/2023/12/12/better-growth-stock-viking-therapeutics-or-iovance/,2023-12-12 13:45:00,Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.,PFE,0.060388,0.17028,Somewhat-Bullish
CD&R Announces New Partners,https://www.prnewswire.com/news-releases/cdr-announces-new-partners-302012429.html,2023-12-12 12:00:00,"NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Clayton, Dubilier & Rice ( ""CD&R"" or the ""Firm"" ) announced today the appointment of three new Partners - Sid Jhaver, Jon Selib and Bill Berutti.",PFE,0.065685,0.068283,Neutral
"BioNTech to Inaugurate First African Site on December 18, 2023",https://www.globenewswire.com/news-release/2023/12/12/2794577/0/en/BioNTech-to-Inaugurate-First-African-Site-on-December-18-2023.html,2023-12-12 11:45:00,"MAINZ, Germany, December 12, 2023 ( GLOBE NEWSWIRE ) - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) will inaugurate its first African site in Kigali, Rwanda, on Monday, December 18th, 2023. The inauguration takes place on the occasion of the set-up of the containers for the first ...",PFE,0.122269,0.023714,Neutral
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 billion deal,https://www.financialexpress.com/healthcare/pharma-healthcare/astrazeneca-buys-respiratory-vaccine-developer-icosavax-in-1-1-billion-deal/3336616/,2023-12-12 10:57:37,Pharma major AstraZeneca on Tuesday announced that it had agreed to buy respiratory syncytial virus ( RSV ) vaccine developer Icosavax in a deal valued at up to $1.1 billion. Icosavax is developing a combination vaccine candidate targeting RSV and human metapneumovirus ( hMPV ) .,PFE,0.098659,0.237441,Somewhat-Bullish
3 Dirt Cheap Stocks That Make Terrific Buys Before the End of the Year,https://www.fool.com/investing/2023/12/12/3-dirt-cheap-stocks-that-make-terrific-buys-now/,2023-12-12 10:00:00,"These stocks have missed out on the 2023 rally, but they could climb at any moment.",PFE,0.342939,0.162519,Somewhat-Bullish
"Nutricosmetics Market Size to be Worth USD 9.81 billion by 2031, with Notable CAGR of 7.7 %| Says Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/23/12/g36190621/nutricosmetics-market-size-to-be-worth-usd-9-81-billion-by-2031-with-notable-cagr-of-7-7-says-tran,2023-12-12 08:15:30,"Wilmington, Delaware, United States, Dec. 12, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global nutricosmetics market is estimated to flourish at a CAGR of 7.7% from 2022 to 2031.",PFE,0.067727,0.309069,Somewhat-Bullish
Larry Summers says the ongoing turmoil about antisemitism at Harvard is as serious a reckoning as the Vietnam War,https://africa.businessinsider.com/politics/larry-summers-says-the-ongoing-turmoil-about-antisemitism-at-harvard-is-as-serious-a/227cj39,2023-12-12 08:15:19,"""This is as difficult a moment for elite higher education as any moment since the Vietnam War. Perhaps more difficult,"" former treasury secretary Lawrence H. Summers told Bloomberg in a story published on Monday.",PFE,0.104683,0.093651,Neutral
Larry Summers says the ongoing turmoil about antisemitism at Harvard is as serious a reckoning as the Vietnam War,https://www.businessinsider.com/harvard-antisemitism-row-as-serious-as-vietnam-war-larry-summers-2023-12,2023-12-12 08:15:00,Harvard antisemitism row is as serious as Vietnam War: Larry Summers - Business Insider ...,PFE,0.076358,0.087962,Neutral
China's children battling pneumonia shows dangers of drug resistance,https://www.business-standard.com/world-news/china-s-children-battling-pneumonia-shows-dangers-of-drug-resistance-123121200078_1.html,2023-12-12 01:37:33,"The harm caused by antibiotic drug resistance was clear to see in China's packed pediatric hospitals. An outbreak of walking pneumonia, normally a mild infection, struck millions of children in the second half of 2023, creating Covid flashbacks and raising fears about another novel pathogen.",PFE,0.038223,-0.085696,Neutral
SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ DELISTING LETTER - UPDATED,https://www.globenewswire.com/news-release/2023/12/12/2794337/0/en/SAGALIAM-ACQUISITION-CORP-ANNOUNCES-RECEIPT-OF-NASDAQ-DELISTING-LETTER-UPDATED.html,2023-12-12 01:05:00,"New York, NY, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- Sagaliam Acquisition Corp. ( NASDAQ: ""SAGAU"", ""SAGA"", SAGAR"" ) ( the ""Company"" ) received a delisting notification letter ( ""Notice"" ) from the Listing Qualifications staff of the Nasdaq Stock Market LLC ( ""Nasdaq"" ) on December 5, 2023.",PFE,0.020045,-0.131406,Neutral
SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ DELISTING LETTER,https://www.globenewswire.com/news-release/2023/12/11/2794302/0/en/SAGALIAM-ACQUISITION-CORP-ANNOUNCES-RECEIPT-OF-NASDAQ-DELISTING-LETTER.html,2023-12-11 22:16:00,"New York, NY, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- Sagaliam Acquisition Corp. ( NASDAQ: ""SAGAU"", ""SAGA"", SAGAR"" ) ( the ""Company"" ) received a delisting notification letter ( ""Notice"" ) from the Listing Qualifications staff of the Nasdaq Stock Market LLC ( ""Nasdaq"" ) on December 8, 2023.",PFE,0.020045,-0.131406,Neutral
DNA Contamination of COVID Vaccines Explored in Journal of American Physicians and Surgeons,https://www.benzinga.com/pressreleases/23/12/g36182443/dna-contamination-of-covid-vaccines-explored-in-journal-of-american-physicians-and-surgeons,2023-12-11 18:36:05,"TUCSON, Ariz., Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- The current controversy over the alleged DNA contamination of COVID-19 vaccines involves complex issues, and also shows the difficulties in arriving at truth in today's polarized and politicized atmosphere, writes Jane Orient, M.D., in the ...",PFE,0.090474,-0.034134,Neutral
Pfizer's  ( PFE )  Multiple Myeloma Drug Elrexfio Gets Nod in EU,https://www.zacks.com/stock/news/2196346/pfizers-pfe-multiple-myeloma-drug-elrexfio-gets-nod-in-eu,2023-12-11 17:00:00,"Pfizer's (PFE) targeted immunotherapy, Elrexfio, for treating heavily pretreated adults with relapsed/refractory multiple myeloma gets EC's conditional marketing authorization.",PFE,0.290607,0.109243,Neutral
Neurology Focused Pasithea Therapeutics Stock Soars Over 150% Today - Here's Why - Pasithea Therapeutics  ( NASDAQ:KTTA ) ,https://www.benzinga.com/general/biotech/23/12/36175794/neurology-focused-pasithea-therapeutics-stock-soars-over-150-today-heres-why,2023-12-11 14:05:35,"Pasithea Therapeutics Corp KTTA announced preclinical results from two in vivo studies evaluating the antitumor efficacy of PAS-004 in NRAS mutation cancer xenograft models. In the first study, PAS-004 exhibited dose-dependent antitumor efficacy in the lung cancer NCI-H1299 cell-line-derived ...",PFE,0.340915,0.232118,Somewhat-Bullish
Investors Heavily Search Pfizer Inc.  ( PFE ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2196068/investors-heavily-search-pfizer-inc-pfe-here-is-what-you-need-to-know,2023-12-11 14:00:12,"Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",PFE,0.491255,0.080652,Neutral
BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs - BioXcel Therapeutics  ( NASDAQ:BTAI ) ,https://www.benzinga.com/pressreleases/23/12/g36173480/bioxcel-therapeutics-strengthens-clinical-development-leadership-to-advance-late-stage-programs,2023-12-11 12:00:00,"Vincent J. O'Neill, M.D., promoted to Executive Vice President, Chief of Product Development and Medical Officer Rajiv Patni, M.D., appointed Strategic Clinical Advisor to CEO and Board of Directors NEW HAVEN, Conn., Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- BioXcel Therapeutics, Inc.",PFE,0.025761,0.072552,Neutral
Studies Highlight Impacts of Applying New Technologies in Everyday Care,https://www.prnewswire.com/news-releases/studies-highlight-impacts-of-applying-new-technologies-in-everyday-care-302010724.html,2023-12-10 01:10:00,"SAN DIEGO, Dec. 9, 2023 /PRNewswire/ -- Researchers report striking progress in the application of cutting-edge tools and treatments to address longstanding challenges in blood disorders and related health conditions in four studies presented during the 65th American Society of Hematology ( ASH ...",PFE,0.035415,0.115406,Neutral
New Hybrid Treatment Forces Cancer Cells to Starve,https://www.prnewswire.com/news-releases/new-hybrid-treatment-forces-cancer-cells-to-starve-302010705.html,2023-12-09 20:01:00,"NEW YORK, Dec. 9, 2023 /PRNewswire/ -- The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows. The work addressed multiple myeloma, a cancer that forms in blood cells that normally fight infections by making proteins that remove germs.",PFE,0.045743,0.119346,Neutral
3 Dividend Stocks Trading at 52-Week Lows,https://www.fool.com/investing/2023/12/09/3-dividend-stocks-trading-at-52-week-lows/,2023-12-09 14:40:00,All three of these companies have seen brighter days.,PFE,0.699089,-0.368202,Bearish
Is Pfizer Stock a Buy Now?,https://www.fool.com/investing/2023/12/09/is-pfizer-stock-a-buy-now/,2023-12-09 12:15:00,Pfizer's stock recently hit a new 52-week low as the bad news continues for the pharma giant.,PFE,0.676525,0.068596,Neutral
"Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them' - Novo Nordisk  ( NYSE:NVO ) ",https://www.benzinga.com/general/biotech/23/12/36161067/bernie-sanders-to-take-on-ozempic-wegovy-weight-loss-drugs-could-be-helpful-but-theyre-not-going-,2023-12-08 21:07:41,"Congressman Bernie Sanders ( I-Vt. ) has been known to tussle with public companies over their high prices or anticompetitive behavior, including pharmaceutical companies and their high costs. In his newest battle, Sanders is taking on the growing popularity of weight-loss drugs and diabetes ...",PFE,0.144275,0.027719,Neutral
"Business leaders slam Harvard, Penn, and MIT leadership following congressional hearing",https://www.businessinsider.com/business-leaders-slam-harvard-penn-mit-after-congressional-testimony-antisemitism-2023-12,2023-12-08 19:37:00,"Business Leaders Slam Harvard, Penn, MIT After Antisemitism Hearing - Business Insider ...",PFE,0.063258,-0.278607,Somewhat-Bearish
"'s 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Johnson & Johnson  ( NYSE:JNJ ) , Altimmune  ( NASDAQ:ALT ) ",https://www.benzinga.com/top-stories/23/12/36157420/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet,2023-12-08 17:50:15,"Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks.",PFE,0.129866,0.029265,Neutral
"Torrid Reports Upbeat Results, Joins MBIA, Virco Mfg. And Other Big Stocks Moving Higher On Friday - Applied Optoelectronics  ( NASDAQ:AAOI ) , ALX Oncology Holdings  ( NASDAQ:ALXO ) ",https://www.benzinga.com/news/23/12/36154924/torrid-reports-upbeat-results-joins-mbia-virco-mfg-and-other-big-stocks-moving-higher-on-friday,2023-12-08 15:40:52,"U.S. stocks traded mostly higher, with the Dow Jones index gaining more than 40 points on Friday. Shares of Torrid Holdings Inc. CURV shares rose sharply during Friday's session after the company reported better-than-expected third-quarter financial results and issued FY23 revenue guidance above ...",PFE,0.087503,0.105169,Neutral
How a 75-year-old Indian-American tech entrepreneur is betting $1 billion of his own fortune on AI's future,https://www.cnbc.com/2023/12/08/75-year-old-tech-mogul-betting-1-billion-of-his-fortune-on-ai-future.html,2023-12-08 15:14:26,Romesh Wadhwani made a fortune in tech and now he is betting $1 billion of his money on three enterprise AI software technologies.,PFE,0.023673,0.048888,Neutral
"Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights  ( CMI ) ",https://www.prnewswire.com/news-releases/active-pharmaceutical-ingredients-market-to-surpass-372-4-billion-globally-by-2030-at-6-8-cagr-coherent-market-insights-cmi-302010044.html,2023-12-08 15:01:00,"Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market ... PR ...",PFE,0.043342,-0.088711,Neutral
"Novo, Lilly rivals explore booming weight-loss drug market entry",https://www.reuters.com/business/healthcare-pharmaceuticals/novo-lilly-rivals-explore-booming-weight-loss-drug-market-entry-2023-12-08/,2023-12-08 14:58:00,"[1/2] An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar Acquire Licensing Rights",PFE,0.067347,-0.05009,Neutral
Pfizer's Latest Ozempic Competitor Just Flopped  ( Again ) . Is the Stock Still a Buy?,https://www.fool.com/investing/2023/12/08/pfizers-latest-ozempic-competitor-flopped-again/,2023-12-08 14:30:00,It's already planning to get back on the horse and make another attempt.,PFE,0.344074,0.168193,Somewhat-Bullish
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions,https://www.globenewswire.com/news-release/2023/12/08/2793232/0/en/Latest-Novartis-Kisqali-NATALEE-analysis-reinforces-25-reduction-in-risk-of-recurrence-across-broad-population-of-patients-with-early-breast-cancer-supports-regulatory-submissions.html,2023-12-08 14:15:00,"Basel, December 8, 2023 - Novartis today announced results from an updated invasive disease-free survival ( iDFS ) analysis of the pivotal Phase III NATALEE trial, with a median follow-up of 33.3 months and following Kisqali® ( ribociclib ) treatment completion by 78.3% of patients.",PFE,0.013402,0.0,Neutral
eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in ER+ Metastatic Breast Cancer Patients,https://www.globenewswire.com/news-release/2023/12/08/2793183/0/en/eFFECTOR-Therapeutics-Announces-New-Positive-Interim-Data-from-Dose-Escalation-and-Phase-2-Expansion-Cohorts-of-Zotatifin-in-ER-Metastatic-Breast-Cancer-Patients.html,2023-12-08 13:15:00,Median progression free survival ( mPFS ) of 7.4 months in the ZFA expansion cohort evaluating zotatifin in combination with fulvestrant and abemaciclib in heavily pretreated patients ...,PFE,0.030369,-0.051576,Neutral
eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in ER+ Metastatic Breast Cancer Patients - eFFECTOR Therapeutics  ( NASDAQ:EFTR ) ,https://www.benzinga.com/pressreleases/23/12/g36152119/effector-therapeutics-announces-new-positive-interim-data-from-dose-escalation-and-phase-2-expansi,2023-12-08 13:15:00,Median progression free survival ( mPFS ) of 7.4 months in the ZFA expansion cohort evaluating zotatifin in combination with fulvestrant and abemaciclib in heavily pretreated patients Zotatifin generally well tolerated as dose escalation continues.,PFE,0.030026,-0.050515,Neutral
"Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod",https://www.zacks.com/stock/news/2195315/pharma-stock-roundup-abbv-to-buy-cere-jnjs-2024-view-lly-nvs-get-fda-nod,2023-12-08 13:12:00,AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.,PFE,0.205807,0.0,Neutral
"The 6 Worst, Career-Crushing, Mistakes Any Leader Can Make",https://www.forbes.com/sites/toddnordstrom/2023/12/08/the-6-biggest-career-crushing-mistakes-any-leader-can-make/,2023-12-08 12:30:00,"His words became baked in my memory, ""The worst thing in medicine is a diagnosis-because that's when everyone stops thinking."" I was a young man when I first heard those words. Actually, I was writing a book with a heart surgeon. And I knew absolutely nothing about medicine, but those words have ...",PFE,0.038592,0.110403,Neutral
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?,https://www.fool.com/investing/2023/12/08/abbvies-on-an-acquisition-binge-could-your-favorit/,2023-12-08 10:38:00,Here's what's attracting lucrative buyout offers from big pharmaceutical companies these days.,PFE,0.051551,-0.011015,Neutral
"Zacks Market Edge Highlights: SAIC, ANET, LLY, PFE and SIG",https://www.zacks.com/stock/news/2195206/zacks-market-edge-highlights-saic-anet-lly-pfe-and-sig,2023-12-08 08:35:00,"SAIC, ANET, LLY, PFE and SIG have been highlighted in this Market Edge article.",PFE,0.446966,-0.275549,Somewhat-Bearish
"Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights",https://www.prnewswire.com/news-releases/red-biotechnology-market-to-reach-1-513-22-billion-globally-by-2030-at-10-7-cagr-coherent-market-insights-302009313.html,2023-12-08 07:14:00,"BURLINGAME, Calif., Dec. 8, 2023 /PRNewswire/ -- According to Coherent Market Insights, The global red biotechnology market was valued at US$ 742.80 Billion in 2023 and is forecast to reach a value of US$ 1,513.22 Billion by 2030 at a CAGR of 10.7% between 2023 and 2030.",PFE,0.028833,0.001897,Neutral
"Vaccine Player Vaxcyte Can Potentially Disrupt Pfizer's 20-Plus-Year Near Monopoly, Says Analyst - Vaxcyte  ( NASDAQ:PCVX ) ",https://www.benzinga.com/general/biotech/23/12/36139094/vaccine-player-vaxcyte-can-potentially-disrupt-pfizers-20-plus-year-near-monopoly-says-analyst,2023-12-07 20:27:45,"Mizuho Securities initiated coverage on Vaxcyte Inc PCVX, a vaccine company targeting bacterial infectious diseases ( primarily for disease prevention ) . Lead asset VAX-24 is set to enter the Phase 3 stage of development in 2024 for pneumococcal disease.",PFE,0.327366,-0.139625,Neutral
Altimmune's stock pops as analysts see obesity-drug partnership potential,https://www.marketwatch.com/story/altimmune-shares-pop-as-analysts-see-obesity-drug-partnership-potential-524ea4f4,2023-12-07 17:33:00,Altimmune shares have jumped this week as analysts see potential for the company to find a partner for its experimental weight-loss drug.,PFE,0.187463,0.023005,Neutral
Will There Be a Recession in 2024?,https://www.zacks.com/stock/news/2195010/will-there-be-a-recession-in-2024,2023-12-07 16:58:00,Tracey Ryniec and John Blank examine whether a recession is looming and how to invest in the new year.,PFE,0.487021,-0.290289,Somewhat-Bearish
Here's Why You Should Retain OPKO Health  ( OPK )  Stock for Now,https://www.zacks.com/stock/news/2194846/heres-why-you-should-retain-opko-health-opk-stock-for-now,2023-12-07 15:20:00,OPKO Health's (OPK) potential in Rayaldee raises optimism about the stock.,PFE,0.056674,0.303021,Somewhat-Bullish
US sets policy to seize government-funded drug patents if price deemed too high,https://www.reuters.com/business/healthcare-pharmaceuticals/us-sets-policy-seize-government-funded-drug-patents-if-price-deemed-too-high-2023-12-07/,2023-12-07 14:03:00,Dec 7 ( Reuters ) - The Biden Administration on Thursday announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.,PFE,0.100729,-0.302498,Somewhat-Bearish
Biden administration asserts power to seize drug patents in move to slash high prices,https://www.cnbc.com/2023/12/07/biden-administration-asserts-power-to-seize-drug-patents.html,2023-12-07 14:00:03,The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining whether to use march-in rights.,PFE,0.107978,-0.163652,Somewhat-Bearish
White House asserts authority to break patents of certain high-cost drugs,https://www.marketwatch.com/story/white-house-asserts-authority-to-break-patents-of-certain-high-cost-drugs-56532507,2023-12-07 14:00:00,The Biden administration announced steps to rein in the cost of prescription drugs developed with taxpayer money and examine private equity's role in the healthcare industry ...,PFE,0.088472,-0.164521,Somewhat-Bearish
"How are Harvard, Penn presidents responding to campus anti-Semitism row?",https://www.aljazeera.com/news/2023/12/7/how-are-harvard-penn-presidents-responding-to-campus-anti-semitism-row,2023-12-07 12:38:24,The presidents of Harvard University and the University of Pennsylvania ( Penn ) are responding to a backlash against their testimonies on campus anti-Semitism at the United States Congress.,PFE,0.043499,-0.099943,Neutral
"5 things to know for Dec. 7: Presidential debate, Las Vegas shooting, Israel, Foreign aid, Cigarettes",https://www.cnn.com/2023/12/07/us/5-things-to-know-for-dec-7-presidential-debate-las-vegas-shooting-israel-foreign-aid-cigarettes/index.html,2023-12-07 11:40:00,"One of the key sticking points at the global climate summit underway in Dubai is fossil fuels, the main driver of the climate crisis. The big question is whether countries will agree to a phase-out of oil, gas and coal, a phase-down - or neither.",PFE,0.035661,-0.144333,Neutral
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.,https://www.fool.com/investing/2023/12/07/for-dividend-growth-3-stocks-to-buy/,2023-12-07 10:00:00,These particular players look cheap right now.,PFE,0.444487,0.288734,Somewhat-Bullish
"Pfizer CEO slams Harvard, MIT, and UPenn's presidents: 'One of the most despicable moments in the history of US academia'",https://www.businessinsider.com/pfizer-ceo-slams-harvard-mit-and-upenn-presidents-2023-12,2023-12-07 07:13:00,"Pfizer CEO slams Harvard, MIT and UPenn's presidents - Business Insider ...",PFE,0.083833,-0.093113,Neutral
S&P 500 Notches Fresh 2-Year High: How 2023's Rally Compares To Recent Years,https://www.forbes.com/sites/dereksaul/2023/12/26/sp-500-notches-fresh-2-year-high-how-2023s-rally-compares-to-recent-years/,2023-12-26 21:17:55,"Major stock indexes gained again Tuesday, marching toward a strong, but far from historic, year for investors. as the Dow Jones Industrial Average registered its highest closing price ever and the S&P 500 and Nasdaq Composite closed at their highest prices since January 2022.",PFE,0.080458,-0.016847,Neutral
Investors Lose $426 Billion On These 8 Giant Losers This Year,https://www.investors.com/etfs-and-funds/sectors/sp500-investors-lose-billions-on-these-giant-losers-this-year-2023/,2023-12-26 13:00:00,"Investors scored big-time on the biggest S&P 500 stocks this year. But those who picked the wrong stocks suffered mightily. Investors lost $462 billion holding just eight stocks dropping the most market value this year, including ailing vaccine maker Pfizer ( PFE ) , struggling oil giant Chevron ...",PFE,0.346642,0.121081,Neutral
Protalix BioTherapeutics Issues 2024 Letter to Stockholders,https://www.prnewswire.com/news-releases/protalix-biotherapeutics-issues-2024-letter-to-stockholders-302022312.html,2023-12-26 11:50:00,"CARMIEL, Israel, Dec. 26, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. ( NYSE American: PLX ) , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell based protein ...",PFE,0.067473,-0.022375,Neutral
"Recap 2023: From postpartum depression to Alzheimer's disease, here are some crucial USFDA approvals this year",https://www.financialexpress.com/healthcare/pharma-healthcare/recap-2023-from-postpartum-depression-to-alzheimers-disease-here-are-some-crucial-usfda-approvals-this-year/3347615/,2023-12-26 08:11:11,"The United States Food and Drug Administration ( FDA ) approves a wide range of innovative drugs and products that play a crucial role in improved patient outcomes. Based on the science used to create new products, testing and manufacturing procedures, and the diseases and conditions that new ...",PFE,0.080188,0.168534,Somewhat-Bullish
The Nine Breakthroughs of the Year,https://www.theatlantic.com/ideas/archive/2023/12/scientific-breakthroughs-2023-list/676952/,2023-12-25 11:00:00,"This is Work in Progress, a newsletter about work, technology, and how to solve some of America's biggest problems. Sign up here. The theme of my second-annual Breakthroughs of the Year is the long road of progress. My top breakthrough is Casgevy, a gene-editing treatment for sickle-cell anemia.",PFE,0.013379,0.087075,Neutral
Should You Buy This Year's Worst-Performing S&P 500 Stocks for 2024?,https://www.fool.com/investing/2023/12/25/should-you-buy-this-years-worst-performing-sp-500/,2023-12-25 10:52:00,Some of this year's underperformers could have brighter futures.,PFE,0.245959,-0.074275,Neutral
Could Ginkgo Bioworks Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/12/24/could-ginkgo-bioworks-stock-help-you-become-a-mill/,2023-12-24 13:10:00,"It's easy to see a way for this to be a huge business in the future, but the path ahead of it is by no means a smooth one.",PFE,0.064797,0.086356,Neutral
The Paid Leave Paradox: Two Leaders Creating Change With Transparency,https://www.forbes.com/sites/gemmaallen/2023/12/23/a-paid-leave-paradox-two-leaders-creating-change-through-transparency/,2023-12-23 18:39:34,"2023 has been another challenging year in the battle for gender equality in the United States. In a year where we marked 100 years of the Equal Rights Amendment, we slipped to 43rd position on the World Economic Forum Global Gender Gap Report, down 16 places year on year.",PFE,0.032164,0.096847,Neutral
Adding Marine Products: December 23 - FDI Weekly Review,https://www.forbes.com/newsletters/forbes-dividend-investor/2023/12/23/adding-marine-products-december-23fdi-weekly-review/,2023-12-23 15:56:15,"Positive stock market momentum persisted for another week, with all major indices posting gains. Utilities, down 1.2%, were the only sector in the red.",PFE,0.080865,0.018853,Neutral
Are Investors Overreacting to Pfizer's Underwhelming Forecast for 2024?,https://www.fool.com/investing/2023/12/23/are-investors-overreacting-to-pfizer-underwhelming/,2023-12-23 13:15:00,Is Pfizer stock a bargain buy?,PFE,0.693563,-0.057574,Neutral
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?,https://www.fool.com/investing/2023/12/23/invivyd-stock-more-than-doubled-last-week-is/,2023-12-23 10:29:00,The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.,PFE,0.13459,0.021767,Neutral
"Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion, boosting neuroscience portfolio",https://apnews.com/article/bristol-myers-squibb-acquires-karuna-therapeutics-bbd1c1e1b4c219fdb822c6755fc1dd79,2023-12-22 19:53:00,"NEW YORK ( AP ) - Drugmaker Bristol Myers Squibb is acquiring Karuna Therapeutics, a biopharmaceutical company that has developed a new antipsychotic, in a $14 billion deal. Bristol Myers Squibb and Karuna announced their merger agreement on Friday.",PFE,0.099066,-0.045472,Neutral
"2023, the year of layoffs",https://www.aljazeera.com/news/2023/12/22/2023-the-year-of-layoffs,2023-12-22 18:56:25,"Despite widespread layoffs few CEOs took meaningful pay cuts and could actually get raises in the year ahead. Carlin Putman of Houston, Texas worked at AIG for more than two decades. Earlier this year, she lost her job. She was devastated. But the writing was on the wall for months as the ...",PFE,0.029078,0.0,Neutral
"HBM gets health boost from drug licensing deals - BeiGene  ( NASDAQ:BGNE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/23/12/36367426/hbm-gets-health-boost-from-drug-licensing-deals,2023-12-22 18:11:47,"Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion HBM Holdings boosted its revenue by 48% in the first half of this year through licensing-out partnerships and ...",PFE,0.145804,0.183487,Somewhat-Bullish
"Biotech stocks set for a rebound in 2024, analysts say",https://www.marketwatch.com/story/biotech-stocks-set-for-a-rebound-in-2024-analysts-say-24df6236,2023-12-22 16:06:00,"A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting up biotech for a brighter 2024, analysts say.",PFE,0.089129,-0.009465,Neutral
13 stocks that are down for 2023 but may bounce back in 2024 or beyond,https://www.marketwatch.com/story/13-stocks-that-are-down-for-2023-but-may-bounce-back-in-2024-or-beyond-1970f980,2023-12-22 15:55:00,John Buckingham of the Prudent Speculator takes a hard look at opportunities brought about by the stock market's focus on short-term developments ...,PFE,0.261918,0.140026,Neutral
"Pharma Stock Roundup: FDA Nod to AZN's Eplontersen, CRL to MRK's Cough Candidate",https://www.zacks.com/stock/news/2201507/pharma-stock-roundup-fda-nod-to-azns-eplontersen-crl-to-mrks-cough-candidate,2023-12-22 14:21:00,"FDA approves AstraZeneca (AZN) and Ionis' (IONS) Wainua (eplontersen) for ATTRv-PN and gives CRL to Merck's chronic cough candidate, gefapixant.",PFE,0.170878,-0.179093,Somewhat-Bearish
Here are the big health sector themes to watch next year,https://www.cnbc.com/2023/12/22/health-sector-themes-to-watch-in-2024.html,2023-12-22 13:41:09,"The health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have positive momentum in 2024.",PFE,0.025352,-0.087163,Neutral
Bristol Myers to buy Karuna Therapeutics for $14B,https://www.foxbusiness.com/markets/bristol-myers-buy-karuna-therapeutics-14-billion,2023-12-22 13:35:00,"Under the terms, Bristol would pay $330 a share in cash for Karuna and its experimental schizophrenia drug now up for U.S. government approval. Bristol expects the deal, which includes $1.3 billion in cash that Karuna has on hand, would close in the first half of next year.",PFE,0.064104,0.084454,Neutral
Pharma stocks rally up to 8% to 52-week highs amid rise in fresh Covid cases,https://www.moneycontrol.com/news/business/markets/pharma-stocks-rally-up-to-8-to-52-week-highs-amid-rise-in-fresh-covid-cases-11943551.html,2023-12-22 08:34:45,"The pharma industry is one of the few defensive industries and investor interest in it is also rising, as concerns about COVID-19 gain momentum, said Aamar Deo Singh, Senior Vice President, Research, Angel One.",PFE,0.097854,0.211238,Somewhat-Bullish
What to Know About the New Fast-Spreading Covid-19 Strain,https://www.barrons.com/amp/articles/what-know-about-jn-1-new-covid-strain-342dab5b,2023-12-21 17:09:00,"What to Know About JN.1, the New Fast-Spreading Covid-19 Strain ...",PFE,0.267413,0.065433,Neutral
Unpacking the Latest Options Trading Trends in Pfizer - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/12/36345395/unpacking-the-latest-options-trading-trends-in-pfizer,2023-12-21 15:18:07,"Investors with a lot of money to spend have taken a bearish stance on Pfizer PFE. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",PFE,0.7887,0.130187,Neutral
The Top Healthcare Stocks to Buy With $100,https://www.fool.com/investing/2023/12/21/the-top-healthcare-stocks-to-buy-with-100/,2023-12-21 15:07:00,These stocks haven't been popular with investors lately.,PFE,0.504646,0.170111,Somewhat-Bullish
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry,https://www.fool.com/investing/2023/12/21/weighing-their-chances-5-leading-healthcare-compan/,2023-12-21 14:45:00,Which weight-loss stocks are good buys today?,PFE,0.243864,0.100877,Neutral
BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer,https://www.globenewswire.com/news-release/2023/12/21/2799939/0/en/BioNTech-and-DualityBio-Receive-FDA-Breakthrough-Therapy-Designation-for-Antibody-Drug-Conjugate-Candidate-BNT323-DB-1303-in-Endometrial-Cancer.html,2023-12-21 13:00:00,"MAINZ, Germany and SHANGHAI, China, December 21, 2023 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" ) and Duality Biologics ( Suzhou ) Co. Ltd. ( ""DualityBio"" ) today announced that the U.S. Food and Drug Administration ( ""FDA"" ) granted Breakthrough Therapy designation for BNT323/DB-1303 for the ...",PFE,0.02135,0.018368,Neutral
Better Bull Market Buy: CRISPR Therapeutics vs. Pfizer Stock,https://www.fool.com/investing/2023/12/21/better-bull-market-buy-crispr-vs-pfizer-stock/,2023-12-21 10:51:00,"These stocks are currently going in different directions, but both could go up in a new bull market.",PFE,0.560201,0.332942,Somewhat-Bullish
Why global health partnerships can tackle infectious disease,https://gsk.ft.com/article/why-global-health-partnerships-tackle-infectious-disease,2023-12-21 08:14:39,"Most concerning are the zero-dose children, meaning those who have received no vaccines at all. Reaching these children is complicated. They often live in remote places or conflict zones, may not have parents and are likely to suffer from other problems such as malnourishment.",PFE,0.05833,0.087015,Neutral
InnovationRx: Obamacare Enrollment Is Hitting New Highs,https://www.forbes.com/sites/alexknapp/2023/12/20/innovationrx-obamacare-enrollment-is-hitting-new-highs/,2023-12-20 22:29:54,"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.",PFE,0.056674,-0.096824,Neutral
BioMarin Announces Governance Enhancements and Value Creation Initiatives,https://www.prnewswire.com/news-releases/biomarin-announces-governance-enhancements-and-value-creation-initiatives-302020453.html,2023-12-20 21:05:00,Board Approves Appointment of Three New Independent Directors Company Establishes Strategic and Operating Review Committee of the Board BioMarin Enters into Cooperation and Information Sharing Agreements with Elliott,PFE,0.024546,0.02129,Neutral
Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors,https://www.globenewswire.com/news-release/2023/12/20/2799505/0/en/Valneva-Shareholders-Approve-EGM-Resolutions-Including-the-Transition-to-a-Board-of-Directors.html,2023-12-20 16:45:00,Anne-Marie Graffin is appointed as Chair of the Board of Directors ...,PFE,0.043421,-0.004999,Neutral
FDA Accepts Merck's  ( MRK )  BLA for 21-Valent Pneumococcal Jab,https://www.zacks.com/stock/news/2200645/fda-accepts-mercks-mrk-bla-for-21-valent-pneumococcal-jab,2023-12-20 16:39:00,The FDA grants priority review to Merck's (MRK) filing seeking approval for its 21-valent pneumococcal conjugate vaccine in adults. A final decision is expected in June 2024.,PFE,0.303926,0.170888,Somewhat-Bullish
Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk?,https://www.marketwatch.com/story/five-obesity-drug-trends-to-watch-in-2024-who-can-compete-with-eli-lilly-and-novo-nordisk-1dc62a7d,2023-12-20 16:17:00,"The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient access in the year ahead, analysts say.",PFE,0.065625,-0.017049,Neutral
Understanding BioNTech's Position In Biotechnology Industry Compared To Competitors - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/news/23/12/36327936/understanding-biontechs-position-in-biotechnology-industry-compared-to-competitors,2023-12-20 16:00:25,"In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and industry followers. In this article, we will carry out an in-depth industry comparison, assessing BioNTech BNTX alongside its primary competitors in ...",PFE,0.065685,-0.003015,Neutral
"For gen AI like Microsoft Copilot, it's looking like 2024 will be a big corporate spending year",https://www.cnbc.com/2023/12/20/for-microsoft-copilot-it-looks-like-2024-will-be-a-big-spending-year.html,2023-12-20 15:07:16,It's more than just AI hype. A majority of top tech officers across the economy say their companies are accelerating spend on software like Microsoft Copilot.,PFE,0.028321,0.0,Neutral
Better Dividend Stock: Pfizer or British American Tobacco?,https://www.fool.com/investing/2023/12/20/better-dividend-stock-pfizer-or-british-american-t/,2023-12-20 13:45:00,Both blue chip dividend stocks are prized for their rich payouts.,PFE,0.437082,0.322443,Somewhat-Bullish
"Single-stock ETFs tap into the market's 'gambling mindset,' expert says. What investors need to know",https://www.cnbc.com/2023/12/20/what-investors-need-to-know-about-single-stock-etfs.html,2023-12-20 13:00:01,"With the bull market raging and big-tech stocks soaring, single-stock ETFs blew up in a good way this year, and the leveraged markets bet seems here to stay.",PFE,0.039224,-0.000983,Neutral
"Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma",https://www.cnbc.com/2023/12/20/weight-loss-drugs-covid-downturn-pharma-had-a-year-full-of-firsts.html,2023-12-20 12:00:01,"Wall Street turned its focus to a handful of newer treatments in different disease areas in 2023, including weight loss medications and a new Alzheimer's drug.",PFE,0.08091,0.132047,Neutral
"Insiders Buying Pfizer And 3 Other Stocks - First Merchants  ( NASDAQ:FRME ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/12/36321546/insiders-buying-pfizer-and-3-other-stocks,2023-12-20 11:39:55,"Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.",PFE,0.417304,0.169173,Somewhat-Bullish
"Want $1,500 in Dividend Income in 2024? Invest $25,000 in These 3 Top Income Stocks",https://www.fool.com/investing/2023/12/20/want-1500-in-dividend-income-in-2024-invest-25000/,2023-12-20 11:38:00,These stocks are relatively safe buys with strong positions in their respective industries.,PFE,0.274012,0.077246,Neutral
3 Stocks Near Multiyear Lows That Could Bounce Back in 2024,https://www.fool.com/investing/2023/12/20/3-stocks-near-multiyear-lows-that-could-bounce-bac/,2023-12-20 10:45:00,"If you're a contrarian investor, these are stocks you'll want to consider adding to your portfolio.",PFE,0.222838,0.016349,Neutral
"Hello, Goodbye: Incentives Draw A Battery Maker, Sweeten A Steel Sale",https://www.forbes.com/sites/cfo/2023/12/19/hello-goodbye-incentives-draw-a-battery-maker-sweeten-a-steel-sale/,2023-12-19 17:23:30,"This is the published version of Forbes' CFO newsletter, which offers the latest news for chief finance officers and other leaders focused on the budget. Sign up here to get it delivered to your inbox every Tuesday.",PFE,0.045482,-0.004988,Neutral
Leading Hub Services Provider COPILOT Appoints Valerie Sullivan as Chief Commercial Officer,https://www.benzinga.com/pressreleases/23/12/g36308484/leading-hub-services-provider-copilot-appoints-valerie-sullivan-as-chief-commercial-officer,2023-12-19 16:35:31,"MAITLAND, Fla., Dec. 19, 2023 ( GLOBE NEWSWIRE ) -- COPILOT Provider Support Services, a leading HUB Services Provider, announces Valerie Sullivan as Chief Commercial Officer. In this newly created role, Sullivan's appointment represents the company's evolution following significant growth in new ...",PFE,0.067919,0.230656,Somewhat-Bullish
The Migraine Market Size Is Expected To Reach $2.15 Billion By 2028 At A CAGR Of 2.8% As Per The Business Research Company's Migraine Global Market Report 2024,https://www.benzinga.com/pressreleases/23/12/g36308373/the-migraine-market-size-is-expected-to-reach-2-15-billion-by-2028-at-a-cagr-of-2-8-as-per-the-bus,2023-12-19 16:30:00,"LONDON, Dec. 19, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Migraine Global Market Report 2024, the migraine market has demonstrated a steady growth trajectory, marking an increase from $1.87 billion in 2023 to an estimated $1.93 billion in 2024.",PFE,0.063763,-0.006038,Neutral
Why Pfizer Stock Is Bouncing Back,https://www.fool.com/investing/2023/12/19/why-pfizer-stock-is-bouncing-back/,2023-12-19 16:23:15,I think Pfizer stock looks kinda cheap.,PFE,0.971202,0.371613,Bullish
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?,https://markets.businessinsider.com/news/stocks/why-is-covid-19-vaccine-player-curevac-stock-plummeting-today-1032913221,2023-12-19 15:31:11,"A German court has invalidated a patent central to CureVac N.V's ( NASDAQ:CVAC ) lawsuit against BioNTech SE ( NASDAQ:BNTX ) related to seeking fair compensation for infringement of a portfolio of CureVac's intellectual property rights utilized in Comirnaty, BioNTech, and Pfizer Inc's ( NYSE:PFE ...",PFE,0.357293,0.117515,Neutral
"Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today? - CureVac  ( NASDAQ:CVAC ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/general/biotech/23/12/36305189/why-is-covid-19-vaccine-player-curevac-stock-plummeting-today,2023-12-19 15:31:10,"A German court has invalidated a patent central to CureVac N.V's CVAC lawsuit against BioNTech SE BNTX related to seeking fair compensation for infringement of a portfolio of CureVac's intellectual property rights utilized in Comirnaty, BioNTech, and Pfizer Inc's PFE mRNA COVID-19 vaccine.",PFE,0.445569,0.136906,Neutral
Pfizer  ( PFE )  Stock Rises on FDA Nod for Expanded Use of Padcev,https://www.zacks.com/stock/news/2200049/pfizer-pfe-stock-rises-on-fda-nod-for-expanded-use-of-padcev,2023-12-19 15:28:00,The FDA approves Pfizer's (PFE) Padcev in combination with Merck's (MRK) Keytruda for adult patients with advanced bladder cancer. Stock rises 1.6%.,PFE,0.374312,-0.069602,Neutral
"Related Sciences Adds 8 New Senior Advisors Including Former CEOs and Heads of R&D from Genentech, Novartis, Seagen, Pfizer, Celgene, and AstraZeneca",https://www.benzinga.com/pressreleases/23/12/g36305665/related-sciences-adds-8-new-senior-advisors-including-former-ceos-and-heads-of-r-d-from-genentech-,2023-12-19 15:00:00,"DENVER, Dec. 19, 2023 ( GLOBE NEWSWIRE ) -- Related Sciences ( RS ) , a leading data science-driven drug discovery firm, today announced the appointment of 8 leading biopharma executives as senior advisors to support its growing portfolio of drug programs, data science capabilities, and R&D ...",PFE,0.070105,0.0,Neutral
5 of the Safest High-Yield Dividend Stocks to Buy for 2024,https://www.fool.com/investing/2023/12/19/5-safest-high-yield-dividend-stocks-to-buy-in-2024/,2023-12-19 10:06:00,"These supercharged dividend stocks, with yields ranging from 5.4% to 10.5%, offer highly favorable risk-versus-reward profiles for income seekers in the new year.",PFE,0.163909,0.083738,Neutral
Why Pfizer Stock Was a Winner on Monday,https://www.fool.com/investing/2023/12/18/why-pfizer-stock-was-a-winner-on-monday/,2023-12-18 23:08:21,The company received its latest U.S. regulatory green light.,PFE,0.692465,0.292878,Somewhat-Bullish
Pfizer  ( PFE )  Beats Stock Market Upswing: What Investors Need to Know,https://www.zacks.com/stock/news/2199617/pfizer-pfe-beats-stock-market-upswing-what-investors-need-to-know,2023-12-18 22:45:20,"The latest trading day saw Pfizer (PFE) settling at $27.06, representing a +1.61% change from its previous close.",PFE,0.642187,0.238794,Somewhat-Bullish
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda,https://www.globenewswire.com/news-release/2023/12/18/2798070/0/en/BioNTech-Achieves-Milestone-at-mRNA-based-Vaccine-Manufacturing-Site-in-Rwanda.html,2023-12-18 18:15:00,"KIGALI, Rwanda, December 18, 2023 ( GLOBE NEWSWIRE ) - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) has reached the next milestone in the establishment of mRNA vaccine manufacturing capacities in Africa with the inauguration of the Company's site in Kigali, Rwanda.",PFE,0.03072,0.015992,Neutral
"Schizophrenia Future Outlook 2024-2028: Forecasted Market Rate, Growth Factors, And Leading Segments As Per The Business Research Company's Schizophrenia Global Market Report 2024",https://www.benzinga.com/pressreleases/23/12/g36286286/schizophrenia-future-outlook-2024-2028-forecasted-market-rate-growth-factors-and-leading-segments-,2023-12-18 16:30:00,"LONDON, Dec. 18, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Schizophrenia Global Market Report 2024, the schizophrenia market has exhibited robust growth, surging from $5.48 billion in 2023 to $5.82 billion in 2024, reflecting a notable compound annual growth rate ( CAGR ) ...",PFE,0.059488,0.153093,Somewhat-Bullish
"Pfizer Slashed Its Guidance, but Is It Still a Smart Long-Term Buy?",https://www.fool.com/investing/2023/12/18/pfizer-slashed-its-guidance-but-is-it-still-a-buy/,2023-12-18 14:30:00,It's no secret that the next couple of years will be slow.,PFE,0.38716,0.226689,Somewhat-Bullish
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?,https://www.fool.com/investing/2023/12/18/these-are-the-3-hottest-biopharma-trends-of-2024/,2023-12-18 14:15:00,2024 is going to be a sizzler in the biopharma sector.,PFE,0.098659,0.04645,Neutral
"As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist? - Ginkgo Bioworks Holdings  ( NYSE:DNA ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/12/36281714/as-2023-comes-to-a-close-and-updates-are-expected-from-many-companies-are-these-three-unique-biot,2023-12-18 13:45:42,"Biotech stocks have had a tough run in 2023 so far. As of early November, the iShares Biotechnology ETF ( IBB ) was down 7.5% while the S&P 500 was up more than 14%. But that doesn't mean investors should count them out.",PFE,0.098456,0.214798,Somewhat-Bullish
"2 High-Yield Dividend Stocks That Could Climb 29% and 24% in 2024, According to Wall Street.",https://www.fool.com/investing/2023/12/18/2-high-yield-dividend-stocks-that-could-climb-and/,2023-12-18 12:19:00,These dividend payers offer attention-getting yields and a chance for significant growth of your principal investment.,PFE,0.309539,0.12419,Neutral
"Muckle Wells Syndrome Market to Reach US$ 335.9 Million by 2030, Rising at a CAGR of 12.6% | Report by CoherentMI",https://www.prnewswire.com/news-releases/muckle-wells-syndrome-market-to-reach-us-335-9-million-by-2030--rising-at-a-cagr-of-12-6--report-by-coherentmi-302017763.html,2023-12-18 11:54:00,"BURLINGAME, Calif., Dec. 18, 2023 /PRNewswire/ -- CoherentMI published a report, titled, Muckle Wells Syndrome Market is estimated to value at US$ 146.4 Million in the year 2023 and is anticipated to reach US$ 335.9 Million by 2030, at a CAGR of 12.6% during forecast period 2023-2030.",PFE,0.030331,0.083206,Neutral
Enterome Appoints Industry Veteran Dr. Peter Hirth to its Board of Directors,https://www.benzinga.com/pressreleases/23/12/g36277895/enterome-appoints-industry-veteran-dr-peter-hirth-to-its-board-of-directors,2023-12-18 11:00:00,"PARIS, Dec. 18, 2023 ( GLOBE NEWSWIRE ) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry platform, today announced the appointment of Dr. K.",PFE,0.051999,0.040983,Neutral
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024,https://www.fool.com/investing/2023/12/18/stocks-down-wall-street-expects-skyrocket-2024/,2023-12-18 10:50:00,Analysts think these beaten-down stocks could rebound strongly in the new year.,PFE,0.056943,-0.137961,Neutral
EMA Recommends Arpraziquantel for Treatment of Schistosomiasis in Preschool-Aged Children - PR Newswire,https://www.prnewswire.com/news-releases/ema-recommends-arpraziquantel-for-treatment-of-schistosomiasis-in-preschool-aged-children-302017407.html,2023-12-17 23:35:00,EMA Recommends Arpraziquantel for Treatment of Schistosomiasis in Preschool-Aged Children PR ...,PFE,0.05986,0.0,Neutral
2 Cathie Wood Stocks That Might Be Smart Buys Right Now,https://www.fool.com/investing/2023/12/17/2-cathie-wood-stocks-that-might-be-smart-buys-righ/,2023-12-17 16:30:00,These two biotech stocks hold enormous potential.,PFE,0.058188,0.061971,Neutral
The weight loss drug boom isn't over yet - here's what to expect in the year ahead,https://www.cnbc.com/2023/12/17/weight-loss-drugs-2024-expectations-for-wegovy-ozempic-zepbound.html,2023-12-17 13:00:01,"2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance coverage and unpleasant side effects.",PFE,0.082677,0.014482,Neutral
Should You Worry About the Latest Wave of Bad News from Pfizer?,https://www.fool.com/investing/2023/12/17/should-you-worry-about-pfizer-latest-bad-news/,2023-12-17 11:00:00,"In response to the news, Pfizer shares fell to a 10-year low.",PFE,0.741869,0.055436,Neutral
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference,https://www.cnbc.com/2024/01/05/cramers-week-ahead-follow-ceos-at-the-jpmorgan-healthcare-conference.html,2024-01-05 23:44:43,CNBC's Jim Cramer told investors to pay attention next week to the JPMorgan Healthcare Conference.,PFE,0.08183,0.034838,Neutral
Covid Hospitalizations And Deaths See Double-Digit Spike After Holiday - Amid Surge In Respiratory Illnesses,https://www.forbes.com/sites/ariannajohnson/2024/01/05/covid-hospitalizations-and-deaths-see-double-digit-spike-after-holiday---amid-surge-in-respiratory-illnesses/,2024-01-05 22:37:06,"Hospitalizations for Covid spiked 20% in the week after Christmas, according to new data from Centers for Disease Control and Prevention, along with an increase in Covid deaths, and flu hospitalizations and deaths, solidifying what experts predicted to be a ""severe"" season for respiratory ...",PFE,0.064623,0.056276,Neutral
"Active Pharmaceutical Ingredients Market is to grow by USD 86.47 billion from 2023 to 2028, Asia to account for 52% of ... - PR Newswire",https://www.prnewswire.com/news-releases/active-pharmaceutical-ingredients-market-is-to-grow-by-usd-86-47-billion-from-2023-to-2028--asia-to-account-for-52-of-market-growth---technavio-302026179.html,2024-01-05 22:01:00,"Active Pharmaceutical Ingredients Market is to grow by USD 86.47 billion from 2023 to 2028, Asia to account for 52% of ... PR ...",PFE,0.06623,0.0,Neutral
IBD Stock Of The Day: The Buying Opportunity In Weight Loss,https://www.investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-lingers-in-a-buy-zone-after-snagging-two-obesity-deals/,2024-01-05 18:01:00,Novo Nordisk Stock Lingers In Buy Zone After Snagging Two Obesity Deals Investor's Business Daily ...,PFE,0.120431,0.032569,Neutral
"Dry January Investing: Trading Pints For Portfolio Growth - Merck & Co  ( NYSE:MRK ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/markets/equities/24/01/36513620/dry-january-investing-trading-pints-for-portfolio-growth,2024-01-05 17:20:22,"Around 15% of Americans said they were planning to participate this year in Dry January - a month of abstinence from alcohol - according to a survey by Morning Consult. Most cite the health benefits from taking a break from the bottle, but it has its financial benefits too.",PFE,0.143843,0.115142,Neutral
"Pharma Stock Roundup: LLY's New Digital Pharmacy, NVO & ABBV's Fresh R&D Deals",https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-llys-new-digital-pharmacy-nvo-abbvs-fresh-rd-deals,2024-01-05 15:25:00,Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases.,PFE,0.050465,-0.119302,Neutral
"Short Sellers' Nightmare: $195B Evaporates In 2023's Market Surge - Apple  ( NASDAQ:AAPL ) , Coinbase Glb  ( NASDAQ:COIN ) ",https://www.benzinga.com/markets/equities/24/01/36510120/short-sellers-nightmare-195b-evaporates-in-2023s-market-surge,2024-01-05 14:25:22,"In a year when equity markets rallied strongly, short sellers - traders who position for losses on assets - had an extremely tough time in 2023. Data published on Friday by S3 Partners showed that short sellers in the U.S. and Canada were down $194.9 billion in 2023 - down 20.4% on an average ...",PFE,0.188193,-0.042676,Neutral
Cancer Antibodies Combination Therapies Clinical Research Market Size Insight,https://www.benzinga.com/pressreleases/24/01/g36507666/cancer-antibodies-combination-therapies-clinical-research-market-size-insight,2024-01-05 12:09:51,"Delhi, Jan. 05, 2024 ( GLOBE NEWSWIRE ) -- Global Cancer Antibody Combinations Market Opportunity & Clinical Trials Insight 2028 Report Findings & Highlights: Global Cancer Antibody Combinations Market Opportunity: > USD 40 Billion By 2028",PFE,0.042048,0.061243,Neutral
"EXCLUSIVE: Buy The Dip - There's A Lot More Upside To Come, Says Marc Chaikin - Boise Cascade  ( NYSE:BCC ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36497683/exclusive-buy-the-dip-theres-a-lot-more-upside-to-come-says-marc-chaikin,2024-01-04 19:29:33,"Stocks have experienced a shaky beginning in 2024, with initial losses followed by slight gains on Thursday. However, Marc Chaikin, founder and CEO of Chaikin Analytics, believes that this does not signify an end to the rally that began in late October.",PFE,0.137671,0.167166,Somewhat-Bullish
Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum,https://www.benzinga.com/pressreleases/24/01/g36494454/valneva-to-conduct-investor-meetings-during-the-j-p-morgan-healthcare-conference-and-oddo-bhf-foru,2024-01-04 16:45:00,"Saint-Herblain ( France ) , January 4, 2024 - Valneva SE VALNVLA, a specialty vaccine company, today announces that members of its management team including Thomas Lingelbach, CEO and Peter Bühler, CFO will hold investor meetings during the 42nd Annual J.P.",PFE,0.110462,0.038857,Neutral
Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum,https://www.globenewswire.com/news-release/2024/01/04/2804202/0/en/Valneva-to-Conduct-Investor-Meetings-during-the-J-P-Morgan-Healthcare-Conference-and-Oddo-BHF-Forum.html,2024-01-04 16:45:00,"Saint-Herblain ( France ) , January 4, 2024 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) , a specialty vaccine company, today announces that members of its management team including Thomas Lingelbach, CEO and Peter Bühler, CFO will hold investor meetings during the 42nd Annual J.P.",PFE,0.109705,0.038761,Neutral
2 Biotech Stocks For Your January 2024 Watchlist,https://stockmarket.com/featured/2-biotech-stocks-for-your-january-2024-watchlist-2024-01-04,2024-01-04 14:41:43,"The biotechnology sector is an innovative and dynamic area of the stock market, primarily focused on using biological systems and organisms to develop new products and technologies. Companies in this sector engage in a wide range of activities.",PFE,0.399204,0.272594,Somewhat-Bullish
Jnana Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference,https://www.benzinga.com/pressreleases/24/01/g36488133/jnana-therapeutics-to-present-at-42nd-annual-j-p-morgan-healthcare-conference,2024-01-04 13:00:45,"BOSTON, Jan. 04, 2024 ( GLOBE NEWSWIRE ) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, ...",PFE,0.154455,0.200545,Somewhat-Bullish
Health Canada Approves Pfizer's Bivalent Respiratory Syncytial Virus  ( RSV )  Vaccine for Older Adults and Infants Through Maternal Immunization,https://www.newswire.ca/news-releases/health-canada-approves-pfizer-s-bivalent-respiratory-syncytial-virus-rsv-vaccine-for-older-adults-and-infants-through-maternal-immunization-840002238.html,2024-01-04 13:00:00,Health Canada Approves Pfizer's Bivalent Respiratory Syncytial Virus ( RSV ) Vaccine for Older Adults and Infants ... Canada ...,PFE,0.295358,0.238669,Somewhat-Bullish
ESPN remains silent after Aaron Rodgers' ugly attack on Jimmy Kimmel | Business,https://www.cnn.com/2024/01/04/media/espn-pat-mcafee-aaron-rodgers-jimmy-kimmel,2024-01-04 12:41:00,ESPN remains silent after Aaron Rodgers' ugly attack on Jimmy Kimmel ...,PFE,0.058759,-0.09409,Neutral
ESPN remains silent after Aaron Rodgers' ugly attack on Jimmy Kimmel | Business,https://www.cnn.com/2024/01/04/media/espn-pat-mcafee-aaron-rodgers-jimmy-kimmel/index.html,2024-01-04 12:41:00,ESPN remains silent after Aaron Rodgers' ugly attack on Jimmy Kimmel ...,PFE,0.058759,-0.09409,Neutral
"Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024",https://www.newswire.ca/news-releases/oncolytics-biotech-r-recaps-2023-accomplishments-provides-outlook-for-2024-818179929.html,2024-01-04 12:00:00,"SAN DIEGO, CA and CALGARY, AB, Jan. 4, 2024 /CNW/ -- Oncolytics Biotech® Inc. ( NASDAQ: ONCY ) ( TSX: ONC ) , a clinical-stage immunotherapeutics company focused on oncology, reported on significant 2023 accomplishments and announced corporate priorities and anticipated clinical development ...",PFE,0.021087,0.141789,Neutral
American stocks loiter near an all-time high,https://www.economist.com/finance-and-economics/2024/01/04/american-stocks-loiter-near-an-all-time-high,2024-01-04 10:42:10,Their performance this year will depend on the real economy ...,PFE,0.054483,0.039017,Neutral
America's stocks loiter near an all-time high,https://www.economist.com/finance-and-economics/2024/01/04/americas-stocks-loiter-near-an-all-time-high,2024-01-04 10:42:10,"I first trading day of the year. The stockmarket opens a whisker away from an all-time high. American equities have soared over the past 12 months, up by around 25%, with a handful of technology giants leading the charge.",PFE,0.054483,0.039017,Neutral
"AMFI classification: Jio Financial makes it to largecap list, Tata Tech, IREDA midcaps",https://www.moneycontrol.com/news/business/markets/amfi-classification-jio-financial-makes-it-to-largecap-list-tata-tech-ireda-midcaps-11996161.html,2024-01-04 04:18:51,"As per AMFI's definition, largecaps are the 1-100 companies based on full market cap, midcaps are 101-250 and smallcaps are 251 onwards ...",PFE,0.085324,0.052246,Neutral
Pfizer  ( PFE )  Flat As Market Sinks: What You Should Know,https://www.zacks.com/stock/news/2205278/pfizer-pfe-flat-as-market-sinks-what-you-should-know,2024-01-03 22:45:18,"Pfizer (PFE) closed the most recent trading day at $29.73, making no change from the previous trading session.",PFE,0.548363,0.173289,Somewhat-Bullish
Looking At Pfizer's Recent Unusual Options Activity - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/24/01/36477410/looking-at-pfizers-recent-unusual-options-activity,2024-01-03 20:15:40,"Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer PFE revealed 33 unusual trades. Delving into the details, we found 39% of traders were bullish, while 60% showed bearish tendencies.",PFE,0.817578,0.044455,Neutral
Pharmaceutical Drug Delivery Market Set For Robust Growth: Market Size To Reach $2337 Billion By 2028 As Per The Business Research Company's Pharmaceutical Drug Delivery Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36473207/pharmaceutical-drug-delivery-market-set-for-robust-growth-market-size-to-reach-2337-billion-by-202,2024-01-03 16:30:00,"LONDON, Jan. 03, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's pharmaceutical drug delivery global market report 2024, the global pharmaceutical drug delivery market has exhibited robust growth, expanding from $1711.47 billion in 2023 to an estimated $1816.05 billion in 2024, ...",PFE,0.04882,0.091119,Neutral
Comparative Study: BioNTech And Industry Competitors In Biotechnology Industry - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/news/24/01/36472511/comparative-study-biontech-and-industry-competitors-in-biotechnology-industry,2024-01-03 16:00:21,"In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry comparison, evaluating BioNTech BNTX in relation to its major competitors in the ...",PFE,0.066598,-0.003017,Neutral
EF Hutton Appoints David Sans as Head of Healthcare,https://www.globenewswire.com/news-release/2024/01/03/2803431/0/en/EF-Hutton-Appoints-David-Sans-as-Head-of-Healthcare.html,2024-01-03 15:00:00,Accomplished healthcare and finance leader brings strategic experience and vision to Healthcare & Life Sciences Investment Banking Team ...,PFE,0.072655,-0.011055,Neutral
EF Hutton Appoints David Sans as Head of Healthcare,https://www.benzinga.com/pressreleases/24/01/g36471001/ef-hutton-appoints-david-sans-as-head-of-healthcare,2024-01-03 15:00:00,Accomplished healthcare and finance leader brings strategic experience and vision to Healthcare & Life Sciences Investment Banking Team,PFE,0.067727,-0.010015,Neutral
Looking Into Pfizer's Recent Short Interest - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/short-sellers/24/01/36468828/looking-into-pfizers-recent-short-interest,2024-01-03 13:45:22,"Pfizer's PFE short percent of float has risen 8.91% since its last report. The company recently reported that it has 61.89 million shares sold short, which is 1.1% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their ...",PFE,0.224903,0.158881,Somewhat-Bullish
HEALTH CANADA APPROVES PFIZER CANADA'S GENE THERAPY IN HEMOPHILIA B,https://www.newswire.ca/news-releases/health-canada-approves-pfizer-canada-s-gene-therapy-in-hemophilia-b-841249479.html,2024-01-03 13:00:00,"KIRKLAND, QC, Jan. 3, 2024 /CNW/ - Pfizer Canada ULC announced that Health Canada approved BEQVEZ ( fidanacogene elaparvovec ) , an adeno-associated viral ( AAV ) vector-based gene therapy for the treatment of adults ( aged 18 years or older ) with moderately severe to severe hemophilia B ( ...",PFE,0.400531,0.182923,Somewhat-Bullish
Expiring Pfizer covid drug doses to cost Europe $2.2 billion,https://www.financialexpress.com/healthcare/covid-19/expiring-pfizer-covid-drug-doses-to-cost-europe-2-2-billion/3354261/,2024-01-03 10:07:44,"Stockpiles of Pfizer Inc.'s Paxlovid in Europe and the UK worth $2.2 billion are set to expire by the end of next month as demand for the Covid-19 treatment plummets. The outdated supply includes $1.1 billion worth of doses that had already expired as of November, according to the London-based ...",PFE,0.262052,0.152517,Somewhat-Bullish
Value Stocks Shine in Year's First Trading Day in Big Reversal From 2023,https://www.barrons.com/amp/articles/value-stocks-rise-6d8b367b,2024-01-02 21:22:00,Value Stock Shine in Year's First Trading Day in Big Reversal From ...,PFE,0.206685,0.245021,Somewhat-Bullish
Drugmakers to Hike Prices on 500 Drugs Soon - Report,https://www.kiplinger.com/retirement/medicare/drugmakers-to-hike-prices-on-500-drugs-soon-report,2024-01-02 18:08:14,"Big pharma companies including Pfizer are planning to raise prices on more than 500 drugs this month, according to a recent Reuters report. Using data from healthcare research firm 3 Axis Advisors, the report noted that prices will rise for 140 brands of drugs.",PFE,0.195025,0.127373,Neutral
Travel Updates: Gatwick Hikes Drop-Off Fee,https://www.forbes.com/uk/advisor/travel-insurance/2024/01/02/travel-latest-news/,2024-01-02 18:01:48,"2 January: Minimum Charge To Rise 20% To £6 For 10 Minutes Gatwick Airport is increasing its minimum drop-off charge by 20% from 5 January, when it will increase from £5 to £6. The minimum charge covers the first 10 minutes and must be paid by midnight the day after the visit.",PFE,0.004506,0.034618,Neutral
What's Going On With Pfizer Stock? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/24/01/36456287/whats-going-on-with-pfizer-stock,2024-01-02 17:48:05,"Pfizer, Inc. PFE shares are trading higher on the first trading day of 2024 after the stock lost more than 40% in 2023. Here's a look at what's going on. Pfizer shares may be moving in sympathy with fellow drug-maker, Moderna, Inc. MRNA which is up nearly 15% Tuesday.",PFE,0.927326,0.631211,Bullish
Moderna's stock soars after Oppenheimer upgrades to buy,https://www.marketwatch.com/story/modernas-stock-soars-10-to-lead-s-p-500-gainers-as-oppenheimer-upgrades-to-buy-f822bb42,2024-01-02 15:46:00,Moderna's stock started the year with a bang thanks to an analyst upgrade.,PFE,0.191929,0.118352,Neutral
How To Earn $500 A Month From Pfizer Stock - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/trading-ideas/long-ideas/24/01/36446319/how-to-earn-500-a-month-from-pfizer-stock,2024-01-02 12:59:52,"Pfizer Inc. PFE shares closed almost flat on Friday, but lost around 44% during 2023. Pfizer recently announced the completion of its acquisition of Seagen Inc SGEN for $229 per share at a total value of approximately $43 billion.",PFE,0.742397,0.359551,Bullish
"Pharma giants are hiking prices on over 500 drugs for 2024, report says",https://www.businessinsider.com/big-pharma-hiking-prices-on-500-drugs-in-2024-report-2024-1,2024-01-02 11:38:00,Big pharma hiking prices on 500 drugs in 2024: report - Business Insider ...,PFE,0.202366,0.0,Neutral
"Got $5,000? Buy and Hold These 3 Value Stocks for Years",https://www.fool.com/investing/2023/12/30/got-5000-buy-and-hold-these-3-value-stocks-for-yea/,2023-12-30 11:40:00,"Sometimes it pays for investors to take a step back and look at the (much) bigger, longer-term picture.",PFE,0.182782,0.065776,Neutral
Valneva Provides Updated 2023 Financial Guidance,https://www.globenewswire.com/news-release/2023/12/29/2802174/0/en/Valneva-Provides-Updated-2023-Financial-Guidance.html,2023-12-29 21:30:00,"Saint-Herblain ( France ) , December 29, 2023 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) , a specialty vaccine company, today announced that the Company is modifying its financial guidance for 2023. Product sales guidance remains unchanged, as do anticipated R&D expenses.",PFE,0.043898,-0.004999,Neutral
Valneva Provides Updated 2023 Financial Guidance,https://www.benzinga.com/pressreleases/23/12/g36434532/valneva-provides-updated-2023-financial-guidance,2023-12-29 21:30:00,"Saint-Herblain ( France ) , December 29, 2023 - Valneva SE VALNVLA, a specialty vaccine company, today announced that the Company is modifying its financial guidance for 2023. Product sales guidance remains unchanged, as do anticipated R&D expenses.",PFE,0.043264,-0.004998,Neutral
2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer - AstraZeneca  ( NASDAQ:AZN ) ,https://www.benzinga.com/markets/penny-stocks/23/12/36431167/2023-will-go-down-as-the-year-pharma-showed-its-determination-to-beat-cancer,2023-12-29 17:48:58,"During the last week of 2023, AstraZeneca PLC AZN agreed to acquire Chinese cancer therapy developer Gracell Biotechnologies Inc. as it continues its efforts to tap pharma innovations from China's biotech industry.",PFE,0.572194,-0.069952,Neutral
"Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/12/36427615/expensive-drugs-for-americans-in-2024-drugmakers-including-pfizer-sanofi-mull-price-increase-in-j,2023-12-29 15:31:50,"Just as large pharma companies prepare a showdown with Medicare's newfound power to negotiate down drug prices, several major drug companies are reportedly gearing up to implement price increases on more than 500 drugs in the U.S. in early January.",PFE,0.238133,0.047811,Neutral
Stocks are going out with a bang: The market is on pace for a record. The Nasdaq is having its best year since '03 | Business,https://www.cnn.com/2023/12/29/investing/stock-market-record-winners-and-losers-2023/index.html,2023-12-29 14:35:00,Stocks are going out with a bang: The market is on pace for a record. The Nasdaq is having its best year since ...,PFE,0.096283,-0.170334,Somewhat-Bearish
Stocks are sliding on final trading day of 2023. But the Nasdaq is still on pace for its best year since '03 | Business,https://www.cnn.com/2023/12/29/investing/stock-market-record-winners-and-losers-2023,2023-12-29 14:35:00,Stocks are going out with a bang: The market is on pace for a record. The Nasdaq is having its best year since ...,PFE,0.090645,-0.167479,Somewhat-Bearish
"Tax-loss selling makes these stocks in cannabis, pharma, energy and industrials worth buying",https://www.marketwatch.com/story/tax-loss-selling-makes-these-stocks-in-cannabis-pharma-energy-and-industrials-worth-buying-3c437466,2023-12-29 12:18:00,Investors have been dumping losers to offset 2023's outsized capital gains.,PFE,0.262679,-0.205836,Somewhat-Bearish
"Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 - Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/23/12/36394374/upward-trajectory-for-biotechpharma-m-a-sector-trends-towards-pre-pandemic-levels-forecasts-posit,2023-12-29 12:04:52,"According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023. Deal volume fell 9% from 242 deals in Q2 2023 to 221 M&A deals in Q3 2023. PricewaterhouseCoopers wrote in its Pharmaceutical and Life Sciences: ...",PFE,0.16171,0.0,Neutral
Forever Cheer picks Hong Kong as gateway for global launch of pain management drugs,https://www.scmp.com/business/companies/article/3246499/forever-cheer-picks-hong-kong-gateway-global-launch-pain-management-drugs-eye-us882-billion-market,2023-12-29 00:00:15,Forever Cheer Holding picks Hong Kong as the gateway for worldwide expansion with an eye on the US$88.2 billion global chronic pain management market whose size is seen near doubling by 2033.,PFE,0.07031,0.114564,Neutral
Why Is Blood Purification Focused CytoSorbents  ( CTSO )  Trading Lower Today? - CytoSorbents  ( NASDAQ:CTSO ) ,https://www.benzinga.com/markets/equities/23/12/36410011/why-is-blood-purification-focused-cytosorbents-trading-lower-today,2023-12-28 14:01:41,CytoSorbents Corporation CTSO released an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board for the pivotal U.S. and Canadian STAR-T trial.,PFE,0.221819,0.139011,Neutral
This Artificial Intelligence Stock Could Be Like Buying Amazon in 1997,https://www.fool.com/investing/2023/12/28/this-artificial-intelligence-stock-could-be-like-b/,2023-12-28 13:30:00,Ginkgo Bioworks has frequently been compared to Amazon in the media.,PFE,0.055364,0.286998,Somewhat-Bullish
"Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.",https://www.fool.com/investing/2023/12/28/interested-in-the-weight-loss-market-heres-1-stock/,2023-12-28 13:30:00,"While Novo Nordisk dominates the weight-loss market, there are two other stocks to consider as well.",PFE,0.454714,0.146467,Neutral
"Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky",https://www.marketwatch.com/story/heres-a-solid-contrarian-idea-for-2024-according-to-btigs-krinsky-32a86261,2023-12-28 11:34:00,Investors should consider this list of healthcare stocks for ...,PFE,0.121856,-0.174814,Somewhat-Bearish
"Operation Warp Speed, but for Everything Government Does",https://www.theatlantic.com/ideas/archive/2023/12/operation-warp-speed-trump-lessons/676913/,2023-12-28 11:00:00,"The U.S. government can achieve great things quickly when it has to. In November 2020, the Food and Drug Administration granted emergency-use authorization to the Pfizer-BioNTech vaccine for COVID-19. Seven days later, a competing vaccine from Moderna was approved.",PFE,0.021659,0.118938,Neutral
"Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge?",https://www.fool.com/investing/2023/12/28/could-pfizer-be-a-no-brainer-stock-to-buy-right-no/,2023-12-28 10:50:00,COVID-19 products Comirnaty and Paxlovid are no longer Pfizer's crown jewels. But that's OK.,PFE,0.754476,0.202336,Somewhat-Bullish
Pfizer  ( PFE )  Surpasses Market Returns: Some Facts Worth Knowing,https://www.zacks.com/stock/news/2202857/pfizer-pfe-surpasses-market-returns-some-facts-worth-knowing,2023-12-27 22:45:18,"In the most recent trading session, Pfizer (PFE) closed at $28.61, indicating a +0.7% shift from the previous trading day.",PFE,0.469457,0.277299,Somewhat-Bullish
Severe Acute Respiratory-Syndrome Treatment Market Set for Unprecedented Growth: Forecast Predicts $6.12 Billion by 2028 As Per The Business Research Company's Severe Acute Respiratory-Syndrome Treatment Global Market Report 2024,https://www.benzinga.com/pressreleases/23/12/g36400046/severe-acute-respiratory-syndrome-treatment-market-set-for-unprecedented-growth-forecast-predicts-,2023-12-27 16:30:00,"LONDON, Dec. 27, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's severe acute respiratory-syndrome treatment global market report 2024, the Severe Acute Respiratory-Syndrome ( SARS ) treatment market has witnessed remarkable growth in recent years, with the market size expanding from ...",PFE,0.053749,0.145,Neutral
Market Whales and Their Recent Bets on PFE Options - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/23/12/36399386/market-whales-and-their-recent-bets-on-pfe-options,2023-12-27 16:02:07,"High-rolling investors have positioned themselves bullish on Pfizer PFE, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.",PFE,0.746491,0.233576,Somewhat-Bullish
THE SKIN OF COLOR SOCIETY  ( SOCS )  REPORTS A BANNER YEAR OF PROGRESS TOWARD GREATER DIVERSITY & INCLUSION IN DERMATOLOGY AND HEALTH EQUITY FOR PATIENTS OF COLOR,https://markets.businessinsider.com/news/stocks/the-skin-of-color-society-socs-reports-a-banner-year-of-progress-toward-greater-diversity-inclusion-in-dermatology-and-health-equity-for-patients-of-color-1032928334,2023-12-27 15:10:00,THE SKIN OF COLOR SOCIETY (SOCS) REPORTS A BANNER YEAR OF PROGRESS TOWARD GREATER DIVERSITY & INCLUSION IN DERMATOLOGY AND HEALTH EQUITY FOR PATIENTS OF COLOR ...,PFE,0.052226,0.122732,Neutral
"Analysts flag Fusion Pharma as takeover candidate, as stock climbs",https://www.marketwatch.com/story/fusion-pharma-climbs-as-analyst-flags-radiopharmaceutical-company-as-potential-merger-target-e50a6cfa,2023-12-27 14:28:00,Targeted-oncology specialist draws upgrade at Raymond James after big premium paid is for Rayze Bio.,PFE,0.272788,0.042803,Neutral
Pfizer Inc.  ( PFE )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2202549/pfizer-inc-pfe-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-12-27 14:00:13,"Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",PFE,0.485711,0.149512,Neutral
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split,https://www.globenewswire.com/news-release/2023/12/27/2801310/0/en/Avalo-Therapeutics-Announces-1-for-240-Reverse-Stock-Split.html,2023-12-27 12:00:00,"WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 ( GLOBE NEWSWIRE ) -- Avalo Therapeutics, Inc. ( Nasdaq: AVTX ) today announced a 1-for-240 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on December 28, 2023.",PFE,0.039811,0.120526,Neutral
"Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight",https://www.prnewswire.com/news-releases/heart-failure-treatment-drug-market-to-accelerate-immensely-by-2032-predicts-delveinsight-302034593.html,2024-01-15 22:05:00,"The dynamics of the heart failure market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, and incremental healthcare spending across the world.",PFE,0.023441,0.03228,Neutral
"Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies - Pfizer, ModernaTX, Tarsus Pharmaceuticals, Valneva, Cortene",https://www.prnewswire.com/news-releases/lyme-disease-treatment-market-is-expected-to-showcase-significant-growth-by-2032-assesses-delveinsight--key-companies---pfizer-modernatx-tarsus-pharmaceuticals-valneva-cortene-302034340.html,2024-01-15 22:01:00,"Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key ... PR ...",PFE,0.027257,0.114623,Neutral
4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry,https://www.cnbc.com/2024/01/15/jim-cramer-4-health-stock-ideas-from-jpmorgan-health-care-conference.html,2024-01-15 21:36:12,"Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech.",PFE,0.182506,0.192005,Somewhat-Bullish
"BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36629555/bntx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-biontech-se-investors-with-subst,2024-01-15 14:07:07,"NEW YORK, Jan. 15, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BioNTech SE ( ""BioNTech"" or ""the Company"" ) BNTX and certain of its officers.",PFE,0.270523,-0.130104,Neutral
My Top Underrated Dow Dividend Stock to Buy in January,https://www.fool.com/investing/2024/01/15/my-top-underrated-dow-dividend-stock-buy-january/,2024-01-15 12:37:00,Honeywell has explosive potential once it truly capitalizes on the industrial internet of things.,PFE,0.035189,0.013524,Neutral
I'm Passing on Pfizer Stock in 2024. Here's Why.,https://www.fool.com/investing/2024/01/15/im-passing-on-pfizer-stock-in-2024-heres-why/,2024-01-15 12:25:00,Pfizer's best days might be behind it as demand for its COVID-19 products hits a wall.,PFE,0.746902,0.229002,Somewhat-Bullish
Aaron Rodgers Is Making It Hard to Root for Him,https://www.theatlantic.com/ideas/archive/2024/01/aaron-rodgers-making-it-hard-root-him/677128/,2024-01-14 19:20:44,"One of Aaron Rodgers's biggest strengths as a Hall of Fame-caliber player is his awareness. At his best, the New York Jets quarterback can anticipate the movements of aggressive defenders and use his legs to create breathtaking plays down the field.",PFE,0.031654,-0.038061,Neutral
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth,https://www.cnbc.com/2024/01/14/cancer-drugs-renewed-interest-in-adcs-will-continue-in-2024.html,2024-01-14 13:12:40,The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer drugs.,PFE,0.2258,0.05974,Neutral
DEI opponents are using a 1866 Civil Rights law to challenge equity policies in the workplace,https://apnews.com/article/dei-corporate-diversity-supreme-court-affirmative-action-a4ddf354423feee9697310366248f646,2024-01-14 13:01:39,Opponents of workplace diversity programs are increasingly banking on a section of the Civil Rights Act of 1866 to challenge equity policies as well as funding to minority-owned businesses. Section 1981 of the act was originally meant to protect formerly enslaved people - or Black people ...,PFE,0.075161,0.054726,Neutral
"As legal challenges mount, some companies retool diversity and inclusion programs",https://apnews.com/article/dei-diversity-corporations-affirmative-action-309864f08e6ec63a45d18ca5f25d7540,2024-01-14 13:01:39,NEW YORK ( AP ) - Sophia Danner-Okotie's has ambitious plans for her Nigerian-inspired clothing line but a sense of dread has punctured her optimism as she watches a legal battle being waged against a small venture capital firm that has provided funding instrumental to her boutique brand's ...,PFE,0.070242,0.005136,Neutral
Is Pfizer Stock a Buy in 2024?,https://www.fool.com/investing/2024/01/14/is-pfizer-stock-a-buy-in-2024/,2024-01-14 13:00:00,"The drugmaker appears to be a top value play, but execution will be key.",PFE,0.592455,0.282377,Somewhat-Bullish
7 Incredible Reasons to Buy Pfizer Stock Right Now,https://www.fool.com/investing/2024/01/13/7-reasons-to-buy-pfizer-stock/,2024-01-13 15:00:00,The company's work should pay off eventually.,PFE,0.750138,0.248368,Somewhat-Bullish
2 Red Flags That Could Sink Pfizer in 2024,https://www.fool.com/investing/2024/01/13/2-red-flags-that-could-sink-pfizer-in-2024/,2024-01-13 10:05:00,Pfizer shares dropped more than 40% last year.,PFE,0.767901,0.068293,Neutral
"Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight",https://www.prnewswire.com/news-releases/gene-therapy-global-market-is-projected-to-grow-at-a-cagr-of-19-by-2028-predicts-delveinsight-302033381.html,2024-01-12 22:01:00,"LAS VEGAS, Jan. 12, 2024 /PRNewswire/ -- DelveInsight's Gene Therapy Market Insights report provides the current and forecast market analysis, individual leading gene therapy companies' market shares, challenges, gene therapy market drivers, barriers, trends, and key market gene therapy ...",PFE,0.090931,0.00954,Neutral
Stakes On A Plane: Is It Insider Trading To Sell Boeing Stock While Inside Its Damaged Airliner?,https://www.forbes.com/sites/brucebrumberg/2024/01/12/stakes-on-a-plane-is-it-insider-trading-to-trade-boeing-stock-while-inside-a-damaged-boeing-airliner/,2024-01-12 18:53:18,"As a financial educator who is a lawyer by training, I'm always looking for attention-grabbing scenarios that provide teachable moments on technical topics. An unusual example comes from the recent incident, widely reported in the news, in which a door panel blew off a Boeing 737 Max 9 in mid-air.",PFE,0.033236,0.084042,Neutral
Billionaires spending a fortune to lure scientists away from universities,https://www.business-standard.com/world-news/billionaires-spending-a-fortune-to-lure-scientists-away-from-universities-124011201095_1.html,2024-01-12 17:32:35,"In an unmarked laboratory stationed between the campuses of Harvard and the Massachusetts Institute of Technology, a splinter group of scientists is hunting for the next billion-dollar drug.",PFE,0.057907,0.025061,Neutral
"Pharma Stock Roundup: MRK to Buy Harpoon, JNJ to Acquire Ambrx Biopharma & More",https://www.zacks.com/stock/news/2209354/pharma-stock-roundup-mrk-to-buy-harpoon-jnj-to-acquire-ambrx-biopharma-more,2024-01-12 12:48:00,Merck (MRK) offers to acquire Harpoon for $680 million. J&J (JNJ) is set to acquire Ambrx Biopharma for approximately $2.0 billion ...,PFE,0.325208,0.242886,Somewhat-Bullish
Antibiotic Resistance Market Projected to Hit US$ 17.8 Billion by 2033 with a CAGR of 5.3% | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36606656/antibiotic-resistance-market-projected-to-hit-us-17-8-billion-by-2033-with-a-cagr-of-5-3-persisten,2024-01-12 09:08:35,"New York, Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- The growing demand for new antibiotic therapies to combat antibiotic resistance is a prominent driver in the global market. In a July 2023 Science Daily article, the World Health Organization ( WHO ) recognized antibiotic-resistant bacteria as a major ...",PFE,0.036365,-0.083171,Neutral
Equities rally takes FT stock pickers by surprise,https://www.ft.com/content/eb0062eb-08e6-4409-8e45-aafe6dee1c57,2024-01-12 05:00:21,"People ""have had enough of experts"", said Michael Gove, now UK housing secretary, during the Brexit campaign in 2016. In 2023 the stock market agreed. Professional investors were wrongfooted by the unexpected strength of the US economy.",PFE,0.020668,0.063078,Neutral
"Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar",https://www.prnewswire.com/news-releases/gastroenteropancreatic-neuroendocrine-tumors-market-to-showcase-a-significant-growth-by-2032-evaluates-delveinsight--key-players---eli-lilly-and-company-phanes-therapeutics-camurus-ab-advanced-accelerator-applications-pharma-302032286.html,2024-01-11 22:01:00,"Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates ... PR ...",PFE,0.075318,0.02929,Neutral
"Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/24/01/36594746/large-drugmakers-show-enthusiasm-to-embrace-100b-obesity-market-despite-novo-and-lillys-dominance,2024-01-11 16:40:37,"Pharmaceutical companies, including Amgen Inc AMGN and Pfizer Inc PFE, are strategically positioning themselves to tap into the burgeoning obesity market. The pursuit involves developing innovative drugs or engaging in strategic acquisitions to compete with established players such as Novo ...",PFE,0.43789,0.185632,Somewhat-Bullish
FDA Allows Importing Unapproved But Essential Syphilis Treatment Amid Shortage Of Pfizer's Antibiotic - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/24/01/36594393/fda-allows-importing-unapproved-but-essential-syphilis-treatment-amid-shortage-of-pfizers-antibio,2024-01-11 14:24:02,"The FDA is working with a French drugmaker, Laboratoires Delbert, to temporarily allow the import of syphilis treatment amid an ongoing shortage. In a letter on Wednesday, Delbert said that it's working with the FDA to temporarily import 3.5 million units of Extencilline, which is not approved in ...",PFE,0.509589,0.006362,Neutral
What's the best way to invest in the S&P 500?,https://www.marketwatch.com/story/whats-the-best-way-to-invest-in-the-s-p-500-632ad25b,2024-01-11 11:05:00,The merits of an equal-weight S&P 500 fund compared to a cap-weighted fund ...,PFE,0.083687,0.009439,Neutral
A Bull Market Is Coming: 2 Magnificent Stocks Down More Than 50% to Buy Right Now,https://www.fool.com/investing/2024/01/11/a-bull-market-is-coming-2-magnificent-stocks-down/,2024-01-11 10:00:00,These market leaders offer great long-term prospects.,PFE,0.302642,0.004546,Neutral
From Sam Altman to Emmanuel Macron: Who's going to Davos 2024?,https://www.cnbc.com/2024/01/11/wef-2024-whos-speaking-at-davos-from-sam-altman-to-macron.html,2024-01-11 09:42:57,China's second-in-command Li Qiang and the French president will both give special addresses.,PFE,0.080458,0.170312,Somewhat-Bullish
FDA allows imports of syphilis drug alternate during shortage,https://www.financialexpress.com/healthcare/pharma-healthcare/fda-allows-imports-of-syphilis-drug-alternate-during-shortage/3361656/,2024-01-11 06:35:12,US regulators gave temporary permission for importation of a form of penicillin used to treat syphilis amid a national shortage of Pfizer Inc.'s version of the drug along with a dramatic increase in cases.,PFE,0.330286,-0.109502,Neutral
"Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics",https://www.prnewswire.com/news-releases/focal-segmental-glomerulosclerosis-market-to-observe-impressive-growth-by-2032-predicts-delveinsight--leading-companies---acelyrin-genentech-chemocentryx-travere-therapeutics-boehringer-ingelheim-chinook-therapeutics-302030785.html,2024-01-10 22:01:00,"Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading ... PR ...",PFE,0.028321,0.038274,Neutral
"Accenture  ( ACN )  to Snap Up Work & Co, Boost Digital Capabilities",https://www.zacks.com/stock/news/2208359/accenture-acn-to-snap-up-work-co-boost-digital-capabilities,2024-01-10 15:39:00,Accenture (ACN) maintains a disciplined acquisition strategy focused on channelizing its business in high-growth areas.,PFE,0.105141,0.140463,Neutral
Decoding Pfizer's Options Activity: What's the Big Picture? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/options/24/01/36578328/decoding-pfizers-options-activity-whats-the-big-picture,2024-01-10 15:31:12,"Financial giants have made a conspicuous bullish move on Pfizer. Our analysis of options history for Pfizer PFE revealed 11 unusual trades. Delving into the details, we found 63% of traders were bullish, while 36% showed bearish tendencies.",PFE,0.768168,0.106348,Neutral
Only 1 Week Into 2024 and the S&P 500 and Dow Are Crushing the Nasdaq. Here's Why It Could Continue,https://www.fool.com/investing/2024/01/10/1-week-into-2024-sp-500-dow-beating-nasdaq/,2024-01-10 13:55:00,The Nasdaq's valuation is a cause for concern.,PFE,0.034185,0.079554,Neutral
HEALTH CANADA GRANTS PRIORITY REVIEW STATUS OF ViiV HEALTHCARE'S NEW DRUG SUBMISSION FOR CABOTEGRAVIR LONG-ACTING INJECTABLE AND TABLETS FOR PREVENTION OF HIV,https://www.newswire.ca/news-releases/health-canada-grants-priority-review-status-of-viiv-healthcare-s-new-drug-submission-for-cabotegravir-long-acting-injectable-and-tablets-for-prevention-of-hiv-865831802.html,2024-01-10 13:01:00,HEALTH CANADA GRANTS PRIORITY REVIEW STATUS OF ViiV HEALTHCARE'S NEW DRUG SUBMISSION FOR ... Canada ...,PFE,0.104379,0.14183,Neutral
Ginkgo Bioworks Provides Business Updates at J.P. Morgan Healthcare Conference,https://www.prnewswire.com/news-releases/ginkgo-bioworks-provides-business-updates-at-jp-morgan-healthcare-conference-302031259.html,2024-01-10 12:35:00,"Expects to meet 2023 new program and revenue guidance ranges Ended the year with nearly $950 million in cash and cash equivalents, a strong balance sheet providing multi-year runway as Ginkgo sees operational efficiencies in the business",PFE,0.05492,0.142845,Neutral
Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine,https://www.globenewswire.com/news-release/2024/01/10/2806803/0/en/Valneva-Vaccinates-First-Participant-in-Pediatric-Trial-of-Single-Shot-Chikungunya-Vaccine.html,2024-01-10 06:00:00,"Saint-Herblain ( France ) , January 10, 2024 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) today announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and Immunogenicity in children of two different dose levels of Valneva's single-shot ...",PFE,0.027763,-0.004853,Neutral
Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine,https://www.benzinga.com/pressreleases/24/01/g36570682/valneva-vaccinates-first-participant-in-pediatric-trial-of-single-shot-chikungunya-vaccine,2024-01-10 06:00:00,"Saint-Herblain ( France ) , January 10, 2024 - Valneva SE VALNVLA today announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and Immunogenicity in children of two different dose levels of Valneva's single-shot chikungunya vaccine.",PFE,0.027413,-0.004847,Neutral
Here's Why Pfizer  ( PFE )  Fell More Than Broader Market,https://www.zacks.com/stock/news/2207776/heres-why-pfizer-pfe-fell-more-than-broader-market,2024-01-09 22:45:19,"Pfizer (PFE) closed the most recent trading day at $29.40, moving -0.61% from the previous trading session.",PFE,0.5633,0.0,Neutral
"Achondroplasia Treatment Drug Market to Register Positive Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Ascendis Pharma, QED Therapeutics  ( BridgeBio ) , Novartis, Sanofi, RIBOMIC",https://www.prnewswire.com/news-releases/achondroplasia-treatment-drug-market-to-register-positive-growth-by-2032-assesses-delveinsight--key-companies-in-the-market---ascendis-pharma-qed-therapeutics-bridgebio-novartis-sanofi-ribomic-302029269.html,2024-01-09 22:01:00,"Achondroplasia Treatment Drug Market to Register Positive Growth by 2032, Assesses DelveInsight | Key Companies ... PR ...",PFE,0.053271,0.131762,Neutral
Why Is BioNTech Stock Trading Lower Today? - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/general/biotech/24/01/36562028/biontech-prepares-to-be-commercial-ready-by-2025-revenue-growth-expected-to-return-in-2025,2024-01-09 19:11:48,"On Tuesday, BioNTech SE BNTX outlined priorities at the Annual J.P. Morgan Healthcare Conference and said it expects to grow its topline again in 2025. In the outer years, the company projects revenues from oncology and respiratory combination vaccine launches, subject to successful development ...",PFE,0.308891,0.0,Neutral
2024 Marks a New Era Of Pharmaceutical Innovation - Moderna  ( NASDAQ:MRNA ) ,https://www.benzinga.com/markets/penny-stocks/24/01/36563119/2024-marks-a-new-era-of-pharmaceutical-innovation,2024-01-09 18:40:50,"With Covid-19 finally fading into history, the Covid-19 heroes, namely Moderna Inc MRNA and Pfizer Inc PFE were forced to redefine their business focus last year, and so, they turned to fighting cancer, the one battle that pharma never seems to win.",PFE,0.17813,-0.241466,Somewhat-Bearish
Ambrx  ( AMAM )  Skyrockets 102% on $2B Buyout Offer From J&J,https://www.zacks.com/stock/news/2207649/ambrx-amam-skyrockets-102-on-2b-buyout-offer-from-jj,2024-01-09 18:04:00,J&J (JNJ) is set to acquire Ambrx Biopharma (AMAM) in an all-cash transaction for $2.0 billion. The transaction will likely close in first-half 2024.,PFE,0.234684,0.122646,Neutral
Doctors Aren't Prescribing Paxlovid Often Enough. Here's Why,https://www.forbes.com/sites/judystone/2024/01/09/doctors-arent-prescribing-paxlovid-often-enough-heres-why/,2024-01-09 17:00:00,"Covid-19 infections and deaths have been steadily increasing in recent weeks, now reaching 1,500 deaths per week. There are antiviral drugs that still protect against severe infection and death, yet practitioners prescribe them infrequently. Why?",PFE,0.040969,0.0147,Neutral
MercadoLibre and Pfizer have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2207448/mercadolibre-and-pfizer-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2024-01-09 14:21:00,MercadoLibre and Pfizer are part of the Zacks Bull and Bear of the Day article.,PFE,0.181819,-0.046903,Neutral
Artificial Intelligence: OurCrowd's 20 Verticals For Investors To Watch - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/emerging-markets/24/01/36555269/artificial-intelligence-ourcrowds-20-verticals-for-investors-to-watch,2024-01-09 13:32:24,"AI seems to be the world's fastest-growing investment sector. The rush of interest in ChatGPT and similar generative AI platforms has triggered a global wave of funding for the new technology. ""Artificial intelligence may be one of the biggest technological leaps in history.",PFE,0.071075,0.120694,Neutral
"eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024",https://www.globenewswire.com/news-release/2024/01/09/2806253/0/en/eFFECTOR-Therapeutics-to-Host-Virtual-Investor-R-D-Day-on-January-24-2024.html,2024-01-09 13:05:00,- Summary of development progress for tomivosertib and zotatifin and a preview of anticipated ...,PFE,0.044801,-0.053668,Neutral
eFFECTOR Therapeutics Announces Reverse Stock Split - eFFECTOR Therapeutics  ( NASDAQ:EFTR ) ,https://www.benzinga.com/pressreleases/24/01/g36553934/effector-therapeutics-announces-reverse-stock-split,2024-01-09 13:00:00,"SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- eFFECTOR Therapeutics, Inc.",PFE,0.044304,-0.052622,Neutral
Better Growth Investment: Ginkgo Bioworks vs. Shiba Inu,https://www.fool.com/investing/2024/01/09/better-growth-investment-ginkgo-bioworks-vs-shiba/,2024-01-09 12:57:00,Both of these investments need to prove that they can actually grow.,PFE,0.050572,0.076428,Neutral
Pfizer's Aggressive Stance In Obesity Drugs: CEO Albert Bourla Confirms Bold Bet Despite Prior Drug Hurdles - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/24/01/36552329/pfizers-aggressive-stance-in-obesity-drugs-ceo-albert-bourla-confirms-bold-bet-despite-prior-drug,2024-01-09 12:42:31,"Monday, at the JP Morgan Healthcare Conference, Pfizer Inc PFE CEO Albert Bourla expressed that the company is determined to move forward in the burgeoning obesity market despite setbacks involving a terminated weight-loss drug candidate due to severe side effects.",PFE,0.500753,0.056545,Neutral
Is Pfizer Stock a Buy Now?,https://www.fool.com/investing/2024/01/09/is-pfizer-stock-a-buy-now/,2024-01-09 12:01:00,The shareholders have little to show for the company's billion-dollar COVID-19 vaccine windfall.,PFE,0.499789,0.361588,Bullish
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors,https://www.prnewswire.com/news-releases/oncolytics-biotech-appoints-patricia-s-andrews-to-its-board-of-directors-302029215.html,2024-01-09 12:00:00,"SAN DIEGO and CALGARY, AB, Jan. 9, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. ( NASDAQ: ONCY ) ( TSX: ONC ) , a clinical-stage immunotherapeutics company focused on oncology, today announced the appointment of Patricia S. Andrews to its Board of Directors ( the ""Board"" ) .",PFE,0.039096,0.001991,Neutral
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors,https://www.newswire.ca/news-releases/oncolytics-biotech-r-appoints-patricia-s-andrews-to-its-board-of-directors-818628389.html,2024-01-09 12:00:00,"SAN DIEGO and CALGARY, AB, Jan. 9, 2024 /CNW/ -- Oncolytics Biotech® Inc. ( NASDAQ: ONCY ) ( TSX: ONC ) , a clinical-stage immunotherapeutics company focused on oncology, today announced the appointment of Patricia S. Andrews to its Board of Directors ( the ""Board"" ) .",PFE,0.039096,0.001991,Neutral
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference,https://www.globenewswire.com/news-release/2024/01/09/2806101/0/en/BioNTech-Outlines-2024-Strategic-Priorities-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html,2024-01-09 11:45:00,"Mainz, Germany, January 9, 2024 ( GLOBE NEWSWIRE ) -- BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" or ""the Company"" ) provided its full year 2024 revenue guidance as part of its outlined 2024 strategic priorities today at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.",PFE,0.082223,0.081613,Neutral
TIVDAK®  ( tisotumab vedotin-tftv )  Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer,https://www.globenewswire.com/news-release/2024/01/09/2806100/0/en/TIVDAK-tisotumab-vedotin-tftv-Supplemental-Biologics-License-Application-Accepted-for-Priority-Review-by-U-S-Food-and-Drug-Administration-for-Patients-with-Recurrent-or-Metastatic-.html,2024-01-09 11:45:00,Media Release ...,PFE,0.260719,0.138108,Neutral
Will Pfizer's Stock Bounce Back in 2024?,https://www.fool.com/investing/2024/01/09/will-pfizer-stock-bounce-back-in-2024/,2024-01-09 10:35:00,"The stock looks cheap, but it does come with risks.",PFE,0.607283,0.09998,Neutral
"3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts",https://www.fool.com/investing/2024/01/09/3-turnaround-stocks-with-151-to-600-upside-in-2024/,2024-01-09 10:21:00,High-water price targets from select analysts imply triple-digit gains in the new year for three former highfliers.,PFE,0.035086,0.057443,Neutral
Bear of the Day: Pfizer  ( PFE ) ,https://www.zacks.com/commentary/2207279/bear-of-the-day-pfizer-pfe,2024-01-09 10:00:00,Negative earnings estimate revisions from analysts and weakening sales post-pandemic paint a challenging picture for the company's shares in the near term.,PFE,0.620083,-0.194616,Somewhat-Bearish
"Healthcare BPO Market size to grow by USD 12.90 billion from 2022 to 2027, Growth Driven by the presence of skilled ... - PR Newswire",https://www.prnewswire.com/news-releases/healthcare-bpo-market-size-to-grow-by-usd-12-90-billion-from-2022-to-2027--growth-driven-by-the-presence-of-skilled-professionals---technavio-302027967.html,2024-01-09 04:35:00,"Healthcare BPO Market size to grow by USD 12.90 billion from 2022 to 2027, Growth Driven by the presence of skilled ... PR ...",PFE,0.040969,0.2564,Somewhat-Bullish
Moderna sales beat estimates at $6.7 bn last year on rising vaccine share,https://www.business-standard.com/companies/news/moderna-sales-beat-estimates-at-6-7-bn-last-year-on-rising-vaccine-share-124010900007_1.html,2024-01-08 18:40:21,"Moderna Inc.'s sales for 2023 modestly beat analyst estimates as it eked out a bigger US market share for Covid shots, though the biotech giant reiterated a downbeat outlook for the year ahead.",PFE,0.140076,-0.118495,Neutral
"Saudi Arabia's New HQ Mandate Lures Global Tech Giants, Amazon, Microsoft, Google To Follow - Microsoft  ( NASDAQ:MSFT ) , Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/government/24/01/36531473/saudi-arabias-new-hq-mandate-lures-global-tech-giants-amazon-microsoft-google-to-follow,2024-01-08 15:05:05,"Global tech giants Amazon.Com Inc AMZN, Alphabet Inc GOOG GOOGL Google, and Microsoft Corp MSFT are expanding their presence in Saudi Arabia, driven by the government's mandate requiring companies to establish regional headquarters in the country for state contract eligibility.",PFE,0.178459,0.0,Neutral
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion,https://www.cnbc.com/2024/01/08/jj-to-acquire-ambrx-biopharma-a-cancer-drug-developer.html,2024-01-08 14:09:31,"The deal, which was announced on the first day of the annual JPMorgan Healthcare Conference, makes J&J the latest drugmaker to bet on ADCs.",PFE,0.154455,0.0,Neutral
Pfizer Inc.  ( PFE )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2206880/pfizer-inc-pfe-is-attracting-investor-attention-here-is-what-you-should-know,2024-01-08 14:00:11,"Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",PFE,0.490323,0.10843,Neutral
"Regenerative Medicine Market Set to Hit USD 194.9 Billion by 2032, Driven by Robust CAGR of 19.4%",https://www.benzinga.com/pressreleases/24/01/g36531197/regenerative-medicine-market-set-to-hit-usd-194-9-billion-by-2032-driven-by-robust-cagr-of-19-4,2024-01-08 12:35:33,"New York, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- According to the market.us, the anticipated value of the Global Regenerative Medicine Market is projected to reach approximately USD 194.9 billion by the year 2032, showing a significant increase from USD 41.3 billion recorded in 2023.",PFE,0.040314,0.108883,Neutral
Ginkgo Bioworks Announces Inaugural Members of New Biopharma Advisory Board - PR Newswire,https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-inaugural-members-of-new-biopharma-advisory-board-302027954.html,2024-01-08 12:00:00,Ginkgo Bioworks Announces Inaugural Members of New Biopharma Advisory Board PR ...,PFE,0.032916,0.090614,Neutral
Beam Therapeutics Highlights Progress Across Base Editing Portfolio and Outlines 2024 Anticipated Milestones,https://www.globenewswire.com/news-release/2024/01/08/2805214/0/en/Beam-Therapeutics-Highlights-Progress-Across-Base-Editing-Portfolio-and-Outlines-2024-Anticipated-Milestones.html,2024-01-08 11:30:00,First Patient Dosed and Successfully Engrafted in BEACON Phase 1/2 Trial of BEAM-101 in Patients with Severe Sickle Cell Disease; Significant Enrollment Progress Supports First Expected Clinical Data Readout in Second Half of 2024 European Clinical Trial Application ( CTA ) Submitted for BEAM-302.,PFE,0.019666,0.059306,Neutral
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report,https://www.prnewswire.com/news-releases/clarivate-identifies-thirteen-potential-blockbuster-drugs-and-gamechangers-in-annual-drugs-to-watch-report-302027294.html,2024-01-08 08:00:00,"Therapeutic advancements for sickle cell disease, RSV, breast cancer, Crohn's and other ailments poised to advance patient health despite urgent challenges facing life science companies",PFE,0.020266,0.0,Neutral
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report,https://www.newswire.ca/news-releases/clarivate-identifies-thirteen-potential-blockbuster-drugs-and-gamechangers-in-annual-drugs-to-watch-report-802561925.html,2024-01-08 08:00:00,"Therapeutic advancements for sickle cell disease, RSV, breast cancer, Crohn's and other ailments poised to advance patient health despite urgent challenges facing life science companies",PFE,0.020266,0.0,Neutral
"Epinephrine Autoinjector Market size to grow by USD 2.44 billion from 2023 to 2028, North America to account for 46 ... - PR Newswire",https://www.prnewswire.com/news-releases/epinephrine-autoinjector-market-size-to-grow-by-usd-2-44-billion-from-2023-to-2028--north-america-to-account-for-46-of-market-growth--technavio-302027156.html,2024-01-07 22:15:00,"Epinephrine Autoinjector Market size to grow by USD 2.44 billion from 2023 to 2028, North America to account for 46 ... PR ...",PFE,0.051999,0.0,Neutral
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024 - Caribou Biosciences  ( NASDAQ:CRBU ) ,https://www.benzinga.com/pressreleases/24/01/g36525999/caribou-biosciences-appoints-tim-kelly-as-chief-technology-officer-and-highlights-multiple-clinica,2024-01-07 16:00:00,-- Tim Kelly to lead Caribou's technical operations strategy and execution -- -- CB-010 ANTLER Phase 1 trial initial dose expansion data and RP2D to be disclosed Q2 2024; Caribou plans to initiate pivotal Phase 3 trial in 2L LBCL by YE 2024 -- -- CB-011 CaMMouflage Phase 1 trial enrolling ...,PFE,0.045139,0.113397,Neutral
24 Top Dividend Stocks to Buy and Hold in 2024,https://www.fool.com/investing/2024/01/07/24-top-dividend-stocks-to-buy-and-hold-in-2024/,2024-01-07 10:50:00,These stocks could deliver positive gains in the new year -- but the real money-making opportunities are over the next decade and beyond.,PFE,0.126119,-0.031661,Neutral
Investing Trends to Follow in 2024,https://www.fool.com/investing/2024/01/06/investing-trends-to-follow-in-2024/,2024-01-06 13:00:00,We've also got Motley Fool co-founder Tom Gardner sharing an investing lesson from last year and a stock for this one.,PFE,0.005937,0.013661,Neutral
3 Magnificent High-Yield Dividend Stocks to Buy in 2024,https://www.fool.com/investing/2024/01/06/3-high-yield-dividend-stocks-to-buy-in-2024/,2024-01-06 12:50:00,There's more than meets the eye with all three of these dividend stocks.,PFE,0.366061,0.246757,Somewhat-Bullish
5 Innovative Stocks That Could Score a Win for Your Portfolio in 2024,https://www.fool.com/investing/2024/01/06/5-innovative-stocks-that-could-score-win-in-2024/,2024-01-06 10:00:00,You'll find exciting innovators across industries.,PFE,0.042421,0.091772,Neutral
Can Moderna's  ( MRNA )  Launches Reduce COVID Sales Dependency?,https://www.zacks.com/stock/news/2216082/can-modernas-mrna-launches-reduce-covid-sales-dependency,2024-01-25 18:37:00,"With COVID-19 vaccine sales declining, Moderna (MRNA) is accelerating the development of its non-COVID pipeline. It is gearing up for potential product launches over the next five years.",PFE,0.251032,0.120427,Neutral
SHAREHOLDER ALERT: Levi & Korsinsky Notifies BioNTech SE  ( BNTX )  Investors of a Class Action Lawsuit and Upcoming Deadline - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/pressreleases/24/01/g36786502/shareholder-alert-levi-korsinsky-notifies-biontech-se-bntx-investors-of-a-class-action-lawsuit-and,2024-01-25 18:04:00,"NEW YORK, Jan. 25, 2024 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in BioNTech SE ( ""BioNTech"" or the ""Company"" ) BNTX of a class action securities lawsuit.",PFE,0.18967,-0.143037,Neutral
Merck  ( MRK )  Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release,https://www.zacks.com/stock/news/2215849/merck-mrk-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q4-release,2024-01-25 15:00:57,Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PFE,0.17618,-0.056009,Neutral
What's Going On With Pfizer Stock Today? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/24/01/36780854/whats-going-on-with-pfizer-stock-today,2024-01-25 14:26:07,"Pfizer Inc PFE is set to announce its fourth quarter 2023 earnings next week on 30th January. The analysts expect the US pharma giant to report an EPS loss of $ ( 0.22 ) and revenues of $14.25 billion, according to data from Benzinga Pro. Last week, Daiichi Sankyo Co Ltd DSKYF DSNKY announced ...",PFE,0.59972,-0.199256,Somewhat-Bearish
"Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX",https://www.zacks.com/stock/news/2215726/pharma-stock-roundup-jnj-reports-q4-earnings-sny-inks-ma-deal-with-inbx,2024-01-25 14:26:00,"J&J (JNJ) beats estimates for fourth-quarter earnings and sales. Sanofi (SNY) is set to acquire Inhibrx's (INBX) rare disease pipeline candidate, INBRX-101.",PFE,0.119235,-0.07664,Neutral
Curious about Pfizer  ( PFE )  Q4 Performance? Explore Wall Street Estimates for Key Metrics,https://www.zacks.com/stock/news/2215714/curious-about-pfizer-pfe-q4-performance-explore-wall-street-estimates-for-key-metrics,2024-01-25 14:15:21,"Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Pfizer (PFE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.",PFE,0.450354,0.07121,Neutral
eFFECTOR Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - eFFECTOR Therapeutics  ( NASDAQ:EFTR ) ,https://www.benzinga.com/pressreleases/24/01/g36778011/effector-therapeutics-announces-15-million-registered-direct-offering-priced-at-the-market-under-n,2024-01-25 13:00:00,"SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 25, 2024 ( GLOBE NEWSWIRE ) -- eFFECTOR Therapeutics, Inc.",PFE,0.058759,-0.052062,Neutral
How Does Pfizer Fit Into a Well-Diversified Portfolio?,https://www.fool.com/investing/2024/01/25/how-does-pfizer-fit-into-a-well-diversified-portfo/,2024-01-25 11:00:00,This tier 1 pharma stock is best-suited for one particular role in a broadly diversified portfolio.,PFE,0.741707,0.583291,Bullish
These 2 Growth Stocks Down 37% and 47% Are Screaming Buys for 2024,https://www.fool.com/investing/2024/01/25/these-2-growth-stocks-down-37-and-47-are-screaming/,2024-01-25 06:59:00,These beaten-down stocks should still be on your watch list.,PFE,0.281153,0.080891,Neutral
"Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight",https://www.prnewswire.com/news-releases/drug-eluting-balloons-global-market-is-expected-to-expand-at-a-healthy-growth-rate-of-8-by-2028-predicts-delveinsight-302042856.html,2024-01-24 22:01:00,"Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts ... PR ...",PFE,0.025985,0.033663,Neutral
Pfizer Options Trading: A Deep Dive into Market Sentiment - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/insights/options/24/01/36766295/pfizer-options-trading-a-deep-dive-into-market-sentiment,2024-01-24 19:45:40,"Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",PFE,0.659949,0.203956,Somewhat-Bullish
2 of the Best Stocks to Buy on a Dip in 2024,https://www.fool.com/investing/2024/01/24/2-of-the-best-stocks-to-buy-on-a-dip-in-2024/,2024-01-24 15:15:00,These stocks are down but don't count them out.,PFE,0.282234,0.149131,Neutral
WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit,https://www.newswire.ca/news-releases/westgene-spearheads-oncology-breakthroughs-at-the-3rd-mrna-based-therapeutics-summit-859935454.html,2024-01-24 13:32:00,"CHENGDU, China, Jan. 24, 2024 /CNW/ -- Kicking off the New Year with remarkable achievements, Chengdu-based WestGene made a significant impact at the 3rd mRNA-Based Therapeutics Summit in Berlin, Germany.",PFE,0.084127,0.168356,Somewhat-Bullish
Multivitamin Gummies Market is Projected to Exceed US$7.3 Billion by 2034 with an 6.5% CAGR | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36756690/multivitamin-gummies-market-is-projected-to-exceed-us-7-3-billion-by-2034-with-an-6-5-cagr-persist,2024-01-24 13:15:35,"New York, Jan. 24, 2024 ( GLOBE NEWSWIRE ) -- Multivitamin Gummies Market Overview: The multivitamin gummies market has witnessed significant growth in recent years, driven by increasing consumer awareness of the importance of maintaining a healthy lifestyle and the convenience offered by ...",PFE,0.014022,0.166941,Somewhat-Bullish
3 Growth Stocks Under $100 to Buy and Hold for Years,https://www.fool.com/investing/2024/01/24/3-growth-stocks-under-100-to-buy-and-hold-for-year/,2024-01-24 13:00:00,These stocks are trading at significantly reduced prices compared to where they were a few years ago.,PFE,0.362505,0.187374,Somewhat-Bullish
Pfizer  ( PFE )  to Report Q4 Earnings: Here's What to Expect,https://www.zacks.com/stock/news/2214745/pfizer-pfe-to-report-q4-earnings-heres-what-to-expect,2024-01-24 11:38:00,Pfizer's (PFE) revenues are expected to have declined in the fourth quarter of 2023 due to a steep decline in sales of its COVID-19 products on lower demand.,PFE,0.362725,0.106621,Neutral
"Immunotherapy Drugs Market Size Anticipated to Surge to USD 237.4 billion at 7.1% CAGR by 2031 - Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36754138/immunotherapy-drugs-market-size-anticipated-to-surge-to-usd-237-4-billion-at-7-1-cagr-by-2031-tran,2024-01-24 11:14:00,"Wilmington, Delaware, United States, Jan. 24, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global immunotherapy drugs market is estimated to flourish at a CAGR of 7.1% from 2023 to 2031.",PFE,0.067919,0.248511,Somewhat-Bullish
Why Pfizer Is a Much Better Stock Than You Might Think,https://www.fool.com/investing/2024/01/24/why-pfizer-is-a-much-better-stock-than-you-might-t/,2024-01-24 10:50:00,Don't write off this big pharma stock because of its current woes.,PFE,0.508878,-0.081123,Neutral
Could Pfizer Stock Help You Retire A Millionaire?,https://www.fool.com/investing/2024/01/24/could-pfizer-stock-help-you-retire-a-millionaire/,2024-01-24 10:00:00,Pfizer shares have slipped in the double digits over the past year.,PFE,0.792937,0.171071,Somewhat-Bullish
"Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight",https://www.prnewswire.com/news-releases/implantable-drug-delivery-devices-global-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2028-assesses-delveinsight-302041477.html,2024-01-23 22:31:00,Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028 ... PR ...,PFE,0.027103,0.025235,Neutral
"Lice Treatment Market Analysis 2024-2028: Expected Market Size, Major Drivers And Leading Segments As Per The Business Research Company's Lice Treatment Global Market Report 2024",https://www.benzinga.com/pressreleases/24/01/g36741497/lice-treatment-market-analysis-2024-2028-expected-market-size-major-drivers-and-leading-segments-a,2024-01-23 16:30:00,"LONDON, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Lice Treatment Global Market Report 2024, the global lice treatment market has demonstrated robust growth, reaching $1.05 billion in 2024 with an impressive compound annual growth rate ( CAGR ) of 7.7%.",PFE,0.064623,0.175309,Somewhat-Bullish
"Bristol Myers, Exelixis Reveal 4-Year Follow-Up Results From Cancer Treatment Study - Exelixis  ( NASDAQ:EXEL ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/24/01/36741223/bristol-myers-exelixis-reveal-4-year-follow-up-results-from-cancer-treatment-study,2024-01-23 16:11:15,Bristol Myers Squibb & Co BMY and Exelixis Inc EXEL revealed four-year follow-up results from a cancer study that compared one treatment with another from Pfizer Inc PFE.,PFE,0.160633,-0.21343,Somewhat-Bearish
Earnings Preview: Pfizer  ( PFE )  Q4 Earnings Expected to Decline,https://www.zacks.com/stock/news/2214264/earnings-preview-pfizer-pfe-q4-earnings-expected-to-decline,2024-01-23 15:00:28,Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PFE,0.301315,-0.07627,Neutral
"Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?",https://www.fool.com/investing/2024/01/23/novavax-may-soar-379-wall-street-says/,2024-01-23 14:13:00,Novavax faces a couple of key issues that could be crucial for the stock price.,PFE,0.113866,0.0642,Neutral
Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors,https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-nomination-of-pharmaceutical-executive-robert-j-smith-to-its-board-of-directors-302041672.html,2024-01-23 13:30:00,Independent Director nominee expected to be elected at Annual Shareholders' Meeting in March 2024,PFE,0.087717,0.169456,Somewhat-Bullish
Bristol Myers Squibb's Combo Therapy Shows Sustained Benefits Over Pfizer's Cancer Drug In Kidney Cancer Patients After 8 Years Of Followup - Bristol-Myers Squibb  ( NYSE:BMY ) ,https://www.benzinga.com/general/biotech/24/01/36736105/bristol-myers-squibbs-combo-therapy-shows-sustained-benefits-over-pfizers-cancer-drug-in-kidney-c,2024-01-23 13:23:15,Bristol Myers Squibb & Co BMY announced that Opdivo ( nivolumab ) plus Yervoy ( ipilimumab ) combination continued to demonstrate long-term survival results in the Phase 3 CheckMate -214 trial.,PFE,0.195025,-0.19332,Somewhat-Bearish
Expectorant Drugs Market Poised to Reach US$22.9 Billion by 2030 with a Steady 4.5% CAGR | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36732382/expectorant-drugs-market-poised-to-reach-us-22-9-billion-by-2030-with-a-steady-4-5-cagr-persistenc,2024-01-23 09:30:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global expectorant drugs market is projected to grow at a robust CAGR of 4.5%, surging from US$16.8 billion in 2023 to reach US$22.9 billion by the conclusion of 2030.",PFE,0.015226,0.119248,Neutral
"Myasthenia Gravis Treatment Market Will Experience Growth, Reaching US$4.1 Billion by the End of 2030, Predicts Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36731428/myasthenia-gravis-treatment-market-will-experience-growth-reaching-us-4-1-billion-by-the-end-of-20,2024-01-23 06:45:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Myasthenia Gravis Treatment Market Poised for Steady Growth, driven by Innovation and Rising Awareness",PFE,0.017108,0.256932,Somewhat-Bullish
"Buzzing Stocks: Tata Motors, ICICI Bank, Zee, TCS, Colgate-Palmolive, SAIL, others in news",https://www.moneycontrol.com/news/photos/business/stocks/buzzing-stocks-tata-motors-icici-bank-zee-tcs-colgate-palmolive-sail-others-in-news-12104931.html,2024-01-23 01:17:02,"Stocks to watch: Check out the companies making headlines before the opening bell today, on January 23, 2024.",PFE,0.059194,0.0,Neutral
BioNTech SE  ( BNTX )  Investor Alert: Robbins LLP Reminds Shareholders of Class Action Against BioNTech SE - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/pressreleases/24/01/g36728057/biontech-se-bntx-investor-alert-robbins-llp-reminds-shareholders-of-class-action-against-biontech-,2024-01-22 23:02:00,"SAN DIEGO, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioNTech SE BNTX between March 30, 2022 and October 13, 2023.",PFE,0.280615,-0.133058,Neutral
Pfizer  ( PFE )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2213769/pfizer-pfe-gains-but-lags-market-what-you-should-know,2024-01-22 22:45:18,"In the latest trading session, Pfizer (PFE) closed at $28.31, marking a +0.11% move from the previous day.",PFE,0.617188,0.201367,Somewhat-Bullish
"Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer",https://www.prnewswire.com/news-releases/non-alcoholic-fatty-liver-disease-market-to-observe-impressive-growth-by-2032-evaluates-delveinsight--key-companies---medicinova-eli-lilly-and-company-astrazeneca-madrigal-pharmaceuticals-biomarin-pharmaceutical-glaxosmithk-302040349.html,2024-01-22 22:01:00,"Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key ... PR ...",PFE,0.086634,0.066999,Neutral
Highlights From the 2024 JPMorgan Health Care Conference,https://www.fool.com/investing/2024/01/22/highlights-from-the-2024-jpmorgan-health-care-conf/,2024-01-22 18:39:00,"Weight loss drugs are taking center spotlight, but other developing treatments could change how we live.",PFE,0.019772,0.091155,Neutral
SHAREHOLDER ALERT: Levi & Korsinsky Notifies BioNTech SE  ( BNTX )  Investors of a Class Action Lawsuit and Upcoming Deadline - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/pressreleases/24/01/g36721162/shareholder-alert-levi-korsinsky-notifies-biontech-se-bntx-investors-of-a-class-action-lawsuit-and,2024-01-22 18:05:00,"NEW YORK, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in BioNTech SE ( ""BioNTech"" or the ""Company"" ) BNTX of a class action securities lawsuit.",PFE,0.18967,-0.143037,Neutral
Competitor Analysis: Evaluating Pfizer And Competitors In Pharmaceuticals Industry - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/insights/news/24/01/36718688/competitor-analysis-evaluating-pfizer-and-competitors-in-pharmaceuticals-industry,2024-01-22 16:01:06,"In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry comparison, evaluating Pfizer PFE in relation to its major competitors in the ...",PFE,0.449219,0.203776,Somewhat-Bullish
Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024,https://www.globenewswire.com/news-release/2024/01/22/2813041/0/en/Biodexa-CEO-Issues-Shareholder-Letter-Highlighting-Progress-in-2023-and-Expected-Milestones-in-2024.html,2024-01-22 13:30:00,"Biodexa Pharmaceuticals PLC ( ""Biodexa"" or the ""Company"" ...",PFE,0.026621,0.068876,Neutral
Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024,https://markets.businessinsider.com/news/stocks/biodexa-ceo-issues-shareholder-letter-highlighting-progress-in-2023-and-expected-milestones-in-2024-1032983534,2024-01-22 13:30:00,Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in ...,PFE,0.026621,0.068876,Neutral
3 Top-Ranked Market Neutral Funds to Sail Through Volatility,https://www.zacks.com/stock/news/2213311/3-top-ranked-market-neutral-funds-to-sail-through-volatility,2024-01-22 13:05:00,"Below, we share with you three market-neutral mutual funds, viz. CVSIX, ADANX and HSGFX. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy).",PFE,0.148273,0.034096,Neutral
"SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer",https://www.globenewswire.com/news-release/2024/01/22/2812935/9738/en/SIGA-Announces-Appointment-of-Diem-Nguyen-Ph-D-MBA-as-New-Chief-Executive-Officer.html,2024-01-22 12:30:00,"NEW YORK, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- SIGA Technologies, Inc. ( SIGA ) ( NASDAQ: SIGA ) , a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem Nguyen, Ph.D., will join the Company as chief executive officer ( CEO ) , effective January ...",PFE,0.051496,-0.006997,Neutral
"SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer - SIGA Technologies  ( NASDAQ:SIGA ) ",https://www.benzinga.com/pressreleases/24/01/g36713753/siga-announces-appointment-of-diem-nguyen-ph-d-mba-as-new-chief-executive-officer,2024-01-22 12:30:00,"NEW YORK, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- SIGA Technologies, Inc. ( SIGA ) SIGA, a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem Nguyen, Ph.D., will join the Company as chief executive officer ( CEO ) , effective January 27, 2024, ...",PFE,0.050625,-0.006994,Neutral
"Apnimed Announces New Leadership Appointments as the Company Builds Its Commercial and Human Resource Capabilities in Support of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea",https://www.benzinga.com/pressreleases/24/01/g36712976/apnimed-announces-new-leadership-appointments-as-the-company-builds-its-commercial-and-human-resou,2024-01-22 12:00:00,"CAMBRIDGE, Mass., Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea ( OSA ) and related disorders, today announced Graham Goodrich has joined the company as ...",PFE,0.067727,0.148504,Neutral
BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer,https://www.globenewswire.com/news-release/2024/01/22/2812878/0/en/BioNTech-and-DualityBio-Initiate-Pivotal-Phase-3-Trial-Of-Antibody-Drug-Conjugate-Candidate-BNT323-DB-1303-in-Metastatic-Breast-Cancer.html,2024-01-22 11:45:00,"MAINZ, Germany and SHANGHAI, China, January 22, 2024 - BioNTech SE ( Nasdaq: BNTX, ""BioNTech"" ) and Duality Biologics ( Suzhou ) Co., Ltd. ( ""DualityBio"" ) today announced that the first patient with metastatic breast cancer has been treated in a pivotal Phase 3 trial evaluating the efficacy and ...",PFE,0.017769,0.018879,Neutral
BIONTECH SE  ( NASDAQ: BNTX )  DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/pressreleases/24/01/g36712282/biontech-se-nasdaq-bntx-deadline-alert-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to,2024-01-22 11:00:00,"NEW YORK, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP: Do you, or did you, own shares of BioNTech SE BNTX? Did you purchase your shares between March 30, 2022 and October 13, 2023, inclusive? Did you lose money in your investment in BioNTech SE?",PFE,0.315493,-0.072894,Neutral
3 Ultra-High-Yield Dividend Stocks That Are Simply Too Cheap to Ignore,https://www.fool.com/investing/2024/01/22/3-ultra-high-yield-dividend-stocks-that-are-simply/,2024-01-22 10:51:00,These stocks check off all the boxes for income and value investors.,PFE,0.20997,0.137722,Neutral
2 Incredible Growth Stocks That Are Screaming Buys for 2024,https://www.fool.com/investing/2024/01/22/2-incredible-growth-stocks-that-are-screaming-buys/,2024-01-22 10:16:00,These healthcare businesses are compelling buys for very different reasons.,PFE,0.441059,0.079226,Neutral
"BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36711528/bntx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-biontech-se-investors-with-subst,2024-01-22 09:00:00,"NEW YORK, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BioNTech SE ( ""BioNTech"" or ""the Company"" ) BNTX and certain of its officers.",PFE,0.270523,-0.130104,Neutral
"USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and ... - PR Newswire",https://www.prnewswire.com/news-releases/usd-10-40-billion-growth-in-vascular-endothelial-market-between-2022-and-2027--the-strategic-alliances-and-collaborations-are-notably-driving-market-growth-17-000-technavio-research-reports-302039609.html,2024-01-22 04:35:00,"USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and ... PR ...",PFE,0.049939,0.083583,Neutral
Little-Known Biotech Company Shows How Hard It Is To Ride The Ozempic Wave,https://www.forbes.com/sites/johnkang/2024/01/21/little-known-biotech-company-shows-how-hard-it-is-to-ride-the-ozempic-wave/,2024-01-22 03:00:41,Shares of Korea-listed Caregen surged on hope its diabetes-weight loss supplement could give the little-known biotech company an Ozempic-like boost. But then the stock crashed.,PFE,0.024126,0.187772,Somewhat-Bullish
"ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36710297/rosen-leading-trial-attorneys-encourages-biontech-se-investors-with-losses-to-secure-counsel-befor,2024-01-22 01:15:00,"NEW YORK, Jan. 21, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of BioNTech SE BNTX between March 30, 2022 and October 13, 2023, both dates inclusive ( the ""Class Period"" ) .",PFE,0.063763,-0.155634,Somewhat-Bearish
"EQS-News: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX",https://markets.businessinsider.com/news/stocks/eqs-news-rosen-top-ranked-global-counsel-encourages-biontech-se-investors-with-losses-to-secure-counsel-before-important-deadline-in-securities-class-action-bntx-1032981591,2024-01-21 14:53:30,"EQS-News: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors with Losses to Secure ... - Markets Insider ...",PFE,0.057907,-0.154649,Somewhat-Bearish
1 Stock Down 43% to Buy and Hold for 10 Years,https://www.fool.com/investing/2024/01/21/1-stock-down-43-to-buy-and-hold-for-10-years/,2024-01-21 13:53:00,This biotech isn't just a pandemic stock.,PFE,0.062434,0.076197,Neutral
"4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either",https://www.fool.com/investing/2024/01/20/4-magnificent-stocks-im-done-waiting-on-a-dip-for/,2024-01-20 14:02:00,These stocks never seem to go on sale. Here's why I'm buying them anyway.,PFE,0.039878,0.094995,Neutral
Better Bull Market Buy: Pfizer vs. Moderna,https://www.fool.com/investing/2024/01/20/better-bull-market-buy-pfizer-vs-moderna/,2024-01-20 11:49:00,There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks.,PFE,0.701054,0.186767,Somewhat-Bullish
"Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against BioNTech SE  ( BNTX )  - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36704291/kessler-topaz-meltzer-check-llp-announces-a-securities-fraud-class-action-lawsuit-filed-against-bi,2024-01-20 00:38:01,"RADNOR, Pa., Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against BioNTech SE ( ""BioNTech"" ...",PFE,0.177671,-0.042807,Neutral
"Ex-Pfizer Employee Netted $270,000 In Covid-Tied Insider Trading",https://www.investors.com/news/technology/pfizer-stock-ex-employee-found-guilty-in-paxlovid-tied-insider-trading-scheme/,2024-01-19 15:04:00,Pfizer Stock: Ex Employee Found Guilty In Paxlovid-Tied Insider Trading Scheme Investor's Business Daily ...,PFE,0.616842,0.175249,Somewhat-Bullish
Is Trending Stock Pfizer Inc.  ( PFE )  a Buy Now?,https://www.zacks.com/stock/news/2212716/is-trending-stock-pfizer-inc-pfe-a-buy-now,2024-01-19 14:00:11,"Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",PFE,0.491255,0.114642,Neutral
Sizing Up Barron's Stock Picks of 2023. Why We Trailed the Market.,https://www.barrons.com/articles/stock-picks-performance-tesla-pfizer-walmart-chevron-1f573340,2024-01-19 13:59:45,Barron's Stock Picks 2023: How They Performed ...,PFE,0.115787,-0.016624,Neutral
"Pfizer, Autodesk, AbbVie And More: CNBC's 'Final Trades' - Autodesk  ( NASDAQ:ADSK ) , AbbVie  ( NYSE:ABBV ) ",https://www.benzinga.com/trading-ideas/long-ideas/24/01/36691104/pfizer-autodesk-abbvie-and-more-cnbcs-final-trades,2024-01-19 13:57:08,"On CNBC's ""Halftime Report Final Trades,"" Liz Young of BNY Mellon Investment Management named Health Care Select Sector SPDR Fund XLV as her final trade. Joshua Brown of Ritholtz Wealth Management picked Pfizer Inc. PFE, which bottomed in the middle of December.",PFE,0.541149,0.104432,Neutral
Pfizer Insider Trading: Former Employee Found Guilty Of Trading On Successful COVID-19 Paxlovid Trial News - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/24/01/36693531/pfizer-insider-trading-former-employee-found-guilty-of-trading-on-successful-covid-19-paxlovid-trial,2024-01-19 12:43:24,"Amit Dagar, a former senior statistical program lead at Pfizer Inc PFE, has been found guilty of securities fraud by a federal jury in Manhattan. In October, Pfizer slashed its full-year earnings and revenue guidance, citing decreasing demand for its COVID-19 products.",PFE,0.706282,0.023304,Neutral
4 Large-Cap Value Mutual Funds to Build a Solid Portfolio,https://www.zacks.com/stock/news/2212630/4-large-cap-value-mutual-funds-to-build-a-solid-portfolio,2024-01-19 12:42:00,"Invest in large-cap value funds like DAGVX, TGIGX, VWNDX and PEYAX to preserve your capital and generate future returns.",PFE,0.041394,0.043563,Neutral
3 No-Brainer Stocks to Buy Right Now for Less than $50,https://www.fool.com/investing/2024/01/19/3-no-brainer-stocks-to-buy-right-now-for-less-than/,2024-01-19 10:50:00,A little upfront money can go a long way with these three stocks.,PFE,0.387875,0.142437,Neutral
Harbour BioMed Announces Positive Profit Alert,https://www.prnewswire.com/news-releases/harbour-biomed-announces-positive-profit-alert-302039159.html,2024-01-19 04:52:00,"CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Jan. 18, 2024 /PRNewswire/ -- Harbour BioMed ( the ""Company"".",PFE,0.07157,0.086911,Neutral
"Inflation-Busting Price Hikes For Ozempic, Mounjaro And Others: Are Drugmakers Profiteering? - Eli Lilly  ( NYSE:LLY ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/markets/equities/24/01/36682926/inflation-busting-price-hikes-for-ozempic-mounjaro-and-others-are-drugmakers-profiteering,2024-01-18 17:48:42,"Diabetes treatments such as Ozempic and Mounjaro became the blockbuster drugs of 2023 thanks to their popularity as weight-loss remedies. Prices for a month's supply of these drugs were high then, and in 2024 their manufacturers have raised them higher still.",PFE,0.196877,0.190828,Somewhat-Bullish
Nivolumab Market Overview 2024-2028: Global Expansion Driven By Immunotherapy Advancements And Rising Cancer Incidence As Per The Business Research Company's Nivolumab Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36681451/nivolumab-market-overview-2024-2028-global-expansion-driven-by-immunotherapy-advancements-and-risi,2024-01-18 16:30:00,"LONDON, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Nivolumab Global Market Report 2024, nivolumab market has experienced remarkable growth in recent years and is set to continue its upward trajectory, with the market size projected to reach $1.69 billion in 2024, ...",PFE,0.061315,0.115659,Neutral
Otic Drugs Market To Surge At A CAGR Of 7.0%: Global Growth Driven By Rising Prevalence Of Ear Infections And Innovations In Drug Formulations As Per The Business Research Company's Otic Drugs Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36681448/otic-drugs-market-to-surge-at-a-cagr-of-7-0-global-growth-driven-by-rising-prevalence-of-ear-infec,2024-01-18 16:30:00,"LONDON, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Otic Drugs Global Market Report 2024, the otic drugs market has witnessed robust growth in recent years and is poised to continue its upward trajectory, with the market size projected to reach $1.71 billion in ...",PFE,0.057079,0.097064,Neutral
Inactivated Vaccines Market Set to Reach $7.3 Billion in 2028 - Global Growth Driven by Immunization Initiatives and Advancements in Biomanufacturing As Per The Business Research Company's Inactivated Vaccines Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36681454/inactivated-vaccines-market-set-to-reach-7-3-billion-in-2028-global-growth-driven-by-immunization-,2024-01-18 16:30:00,"LONDON, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Inactivated Vaccines Global Market Report 2024, the inactivated vaccines market has exhibited consistent growth, with the market size reaching $5.95 billion in 2023 and expected to climb to $6.19 billion in 2024, ...",PFE,0.056808,0.180983,Somewhat-Bullish
Check Out What Whales Are Doing With PFE - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/insights/options/24/01/36680634/check-out-what-whales-are-doing-with-pfe,2024-01-18 16:00:50,"Whales with a lot of money to spend have taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer PFE we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with ...",PFE,0.634884,0.14297,Neutral
Is Novo Nordisk Stock a Buy Now?,https://www.fool.com/investing/2024/01/18/is-novo-nordisk-stock-a-buy-now/,2024-01-18 14:30:00,"The biotech is on a roll, and that won't end soon.",PFE,0.061949,0.081064,Neutral
2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter,https://www.kiplinger.com/business/a-good-year-for-the-pharma-industry-the-kiplinger-letter,2024-01-18 13:30:15,2024: The Pharma Industry's Good Year Kiplinger's Personal Finance ...,PFE,0.291182,0.032821,Neutral
Catheter Associated Urinary Tract Infections Treatment Market Surges with a Promising CAGR of 4.0% through 2033 | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36673659/catheter-associated-urinary-tract-infections-treatment-market-surges-with-a-promising-cagr-of-4-0-,2024-01-18 10:15:00,"New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global market for treating catheter-associated urinary tract infections ( CAUTIs ) is projected to grow at a compound annual growth rate ( CAGR ) of 4.0%.",PFE,0.059121,0.096069,Neutral
3 Things That Could Help 2023 Loser-Stock Moderna Roar Higher in 2024,https://www.fool.com/investing/2024/01/18/3-things-that-could-help-2023-loser-stock-moderna/,2024-01-18 10:00:00,Moderna may be heading for a new era of growth.,PFE,0.059636,0.13532,Neutral
Sephora and Zoetis Recognized by Catalyst for Improving Gender Representation and Advancing Women,https://www.prnewswire.com/news-releases/sephora-and-zoetis-recognized-by-catalyst-for-improving-gender-representation-and-advancing-women-302037782.html,2024-01-18 05:01:00,"2024 Catalyst Award Winners to be Honored at Annual Gender Equity Conference and Dinner NEW YORK, Jan. 18, 2024 /PRNewswire/ -- Sephora and Zoetis have demonstrated the value of diversity, equity, and inclusion efforts to create workplaces that work for women - and for everyone - and will be ...",PFE,0.02692,0.133496,Neutral
"BIONTECH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioNTech SE and Encourages Investors to Contact the Firm - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36671838/biontech-alert-bragar-eagel-squire-p-c-announces-that-a-class-action-lawsuit-has-been-filed-agains,2024-01-18 02:00:00,"NEW YORK, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against BioNTech SE ( ""BioNTech"" or the ""Company"" ) BNTX in the United States District Court for the Central ...",PFE,0.100729,-0.155482,Somewhat-Bearish
"ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36669794/rosen-recognized-investor-counsel-encourages-biontech-se-investors-with-losses-to-secure-counsel-b,2024-01-17 22:32:15,"NEW YORK, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of BioNTech SE BNTX between March 30, 2022 and October 13, 2023, both dates inclusive ( the ""Class Period"" ) .",PFE,0.063763,-0.155634,Somewhat-Bearish
The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space,https://www.cnbc.com/2024/01/17/weight-loss-drugs-boehringer-ingelheim-terns-viking-may-join-market.html,2024-01-17 20:40:55,"Wall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss drug market, such as Pfizer, Roche and Amgen.",PFE,0.042122,-0.193871,Somewhat-Bearish
Pfizer Dividend Yield Pushes Past 6%,https://www.forbes.com/sites/dividendchannel/2024/01/17/pfizer-dividend-yield-pushes-past-6/,2024-01-17 20:33:52,"In trading on Wednesday, shares of Pfizer were yielding above the 6% mark based on its quarterly dividend ( annualized to $1.68 ) , with the stock changing hands as low as $27.93 on the day.",PFE,0.598621,0.467496,Bullish
"Anthropic's Claude Chatbot Gets an Upgrade with Image Analysis, Challenging Google and OpenAI - Alphabet  ( NASDAQ:GOOG ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/24/01/36666335/anthropics-claude-chatbot-gets-an-upgrade-with-image-analysis-challenging-google-and-openai,2024-01-17 19:21:29,"Artificial intelligence startup Anthropic is developing a new feature for its chatbot, Claude, enabling it to analyze images.",PFE,0.288893,0.371114,Bullish
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against BioNTech SE  ( BNTX )  - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/pressreleases/24/01/g36663065/gainey-mckenna-egleston-announces-a-class-action-lawsuit-has-been-filed-against-biontech-se-bntx,2024-01-17 16:11:08,"NEW YORK, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of all persons or entities who purchased or otherwise acquired BioNTech SE ...",PFE,0.100308,-0.162742,Somewhat-Bearish
"GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M - GSK  ( NYSE:GSK ) ",https://www.benzinga.com/general/biotech/24/01/36658404/gsk-cuts-more-stake-in-its-spun-off-consumer-healthcare-business-haleon-raises-over-900m,2024-01-17 13:14:21,"Tuesday, GSK plc GSK announced to sell 300 million ordinary shares in Haleon plc HLN at 326 pence per share, raising gross proceeds of approximately £978 million. Following the settlement of the Placing, GSK will hold approximately 385 million ordinary shares in Haleon, representing approximately ...",PFE,0.470894,-0.015397,Neutral
Council Post: How AI Is Reshaping Five Manufacturing Industries,https://www.forbes.com/sites/forbestechcouncil/2024/01/17/how-ai-is-reshaping-five-manufacturing-industries/,2024-01-17 12:00:00,How AI Is Reshaping Five Manufacturing Industries Forbes ...,PFE,0.035608,0.0,Neutral
"Alzheimer's Disease Diagnostics & Treatment Market Revenues to Reach US$11.9 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36655498/alzheimers-disease-diagnostics-treatment-market-revenues-to-reach-us-11-9-billion-by-2030-market-s,2024-01-17 10:00:00,"New York, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global market for Alzheimer's disease diagnostics and treatment is projected to experience a compound annual growth rate ( CAGR ) of 8.9%, reaching a value of US$11.9 billion by the end of 2030, up from US$6.5 billion ...",PFE,0.042073,0.148051,Neutral
Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/equities/24/01/36653786/cathie-woods-ark-invest-liquidates-15-8m-worth-of-proshares-bitcoin-strategy-etf-units,2024-01-17 03:39:39,"On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling $15.84 million worth of ProShares Bitcoin Strategy ETF BITO units. This trade comes amidst a dynamic period in the cryptocurrency market, reflecting Ark Invest's strategic adjustments in response to evolving market ...",PFE,0.224903,0.439433,Bullish
Pfizer  ( PFE )  Sees a More Significant Dip Than Broader Market: Some Facts to Know,https://www.zacks.com/stock/news/2211059/pfizer-pfe-sees-a-more-significant-dip-than-broader-market-some-facts-to-know,2024-01-16 22:45:21,"In the closing of the recent trading day, Pfizer (PFE) stood at $28.32, denoting a -1.32% change from the preceding trading day.",PFE,0.624172,0.100845,Neutral
Infosys Stock Shows Market Leadership; Shares Jumped Recently,https://www.investors.com/news/technology/stocks-showing-improving-market-leadership-infosys-adr-earns-81-rs-rating/,2024-01-16 22:34:00,Infosys Stock Shows Market Leadership. Shares Jumped Recently Investor's Business Daily ...,PFE,0.160633,0.318501,Somewhat-Bullish
Arvinas Appoints Jared Freedberg as General Counsel,https://www.globenewswire.com/news-release/2024/01/16/2810361/0/en/Arvinas-Appoints-Jared-Freedberg-as-General-Counsel.html,2024-01-16 22:01:00,Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635 ( c ) ( 4 ) Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635 ( c ...,PFE,0.171485,0.114385,Neutral
Top 5 Life Science ETFs,https://investingnews.com/daily/life-science-investing/biotech-investing/top-performing-life-science-etfs/,2024-01-16 21:15:00,"Taking a position in a life science exchange-traded fund ( ETF ) provides exposure to a basket of stocks focused on the healthcare sector, while mitigating the risks of holding shares in a single company.",PFE,0.060085,0.02205,Neutral
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against BioNTech SE  ( BNTX )  - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/pressreleases/24/01/g36649363/investor-notice-robbins-llp-informs-investors-of-class-action-filed-against-biontech-se-bntx,2024-01-16 20:27:12,"SAN DIEGO, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioNTech SE BNTX between March 30, 2022 and October 13, 2023.",PFE,0.280615,-0.133058,Neutral
"BIONTECH SE SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against BioNTech SE  ( NASDAQ: BNTX )  - Assertio Holdings  ( NASDAQ:ASRT ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36647549/biontech-se-shareholder-alert-bernstein-liebhard-llp-announces-that-a-securities-class-action-laws,2024-01-16 18:30:00,"NEW YORK, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP: Do you, or did you, own shares of BioNTech SE BNTX? Did you purchase your shares between March 30, 2022 and October 13, 2023, inclusive? Did you lose money in your investment in BioNTech SE?",PFE,0.323785,-0.074353,Neutral
Basal Cell Carcinoma Treatment Market To Reach $10.7 Billion In 2028 At A CAGR Of More Than 9% As Per The Business Research Company's Basal Cell Carcinoma Treatment Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36645145/basal-cell-carcinoma-treatment-market-to-reach-10-7-billion-in-2028-at-a-cagr-of-more-than-9-as-pe,2024-01-16 16:30:00,"LONDON, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Basal Cell Carcinoma Treatment Global Market Report 2024, the basal cell carcinoma treatment market is set to witness robust growth, expanding from $6.69 billion in 2023 to an estimated $7.42 billion in 2024, ...",PFE,0.05339,0.27599,Somewhat-Bullish
"Financial Relief For Medicare Patients: Part D Overhaul Caps Out-of-Pocket Drug Cost Limits - Pfizer  ( NYSE:PFE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/24/01/36641146/financial-relief-for-medicare-patients-part-d-overhaul-caps-out-of-pocket-drug-cost-limits,2024-01-16 13:54:55,Medicare Part D beneficiaries facing rising drug costs received welcome news as changes brought about by the 2022 Inflation Reduction Act cap their out-of-pocket expenses in 2024.,PFE,0.218817,-0.117393,Neutral
"Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD - Renovaro Biosciences  ( NASDAQ:RENB ) ",https://www.benzinga.com/pressreleases/24/01/g36638414/message-from-renovaro-bioscience-inc-s-ceo-the-hon-mark-dybul-md,2024-01-16 13:00:00,"LOS ANGELES, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Renovaro Biosciences Inc. RENB",PFE,0.015522,0.014824,Neutral
"David Werner Real Estate Investments Secures Long-term Lease Extension with Dow at Collegeville, Pennsylvania Life Sciences Campus - Rithm Capital  ( NYSE:RITM ) ",https://www.benzinga.com/pressreleases/24/01/n36638351/david-werner-real-estate-investments-secures-long-term-lease-extension-with-dow-at-collegeville-pe,2024-01-16 13:00:00,Long-Term Commitment Coincides with Planned Repositioning into World Class Life Sciences Facility,PFE,0.13347,0.166492,Somewhat-Bullish
"Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board",https://www.globenewswire.com/news-release/2024/01/16/2809773/0/en/Ocugen-Inc-Announces-Bob-Smith-Joins-Business-Advisory-Board.html,2024-01-16 12:30:00,"MALVERN, Pa., Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Ocugen, Inc. ( Ocugen or the Company ) ( NASDAQ: OCGN ) , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that Bob Smith, former Senior Vice ...",PFE,0.117486,0.178361,Somewhat-Bullish
"Hospital Acquired Infection Control Market Expected to be Valued US$ 10.1 Billion by the end of 2033, By Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36635941/hospital-acquired-infection-control-market-expected-to-be-valued-us-10-1-billion-by-the-end-of-203,2024-01-16 10:45:00,"New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Hospital Acquired Infection Control Market: A Comprehensive Report Hospital Acquired Infections ( HAIs ) are infections acquired by patients during their stay in healthcare facilities.",PFE,0.030582,0.027029,Neutral
Halozyme Announces Roche Receives European Commission Approval of Tecentriq® SC with ENHANZE® Representing the EU's First Subcutaneous PD- ( L ) 1 Cancer Immunotherapy for Multiple Cancer Types,https://www.prnewswire.com/news-releases/halozyme-announces-roche-receives-european-commission-approval-of-tecentriq-sc-with-enhanze-representing-the-eus-first-subcutaneous-pd-l1-cancer-immunotherapy-for-multiple-cancer-types-302035190.html,2024-01-16 06:15:00,Halozyme Announces Roche Receives European Commission Approval of Tecentriq® SC with ENHANZE ... PR ...,PFE,0.034984,0.080944,Neutral
How To Be A Big Brand In 2024: Travis Kelce's Publicity Playbook,https://www.forbes.com/sites/mollymcpherson/2024/02/04/how-to-be-a-big-brand-in-2024-travis-kelces-publicity-playbook/,2024-02-04 20:30:29,Travis Kelce may not be the best player heading into Super Bowl LVIII but he is arguably the most buzzworthy. The tight end for the Kansas City Chiefs has surpassed even quarterbacks in endorsement deals and commercial screen time this season. This proves that his star power extends far beyond ...,PFE,0.032294,0.027863,Neutral
"The Bull Market Left These 3 Stocks Behind, but They're Buys Right Now",https://www.fool.com/investing/2024/02/04/the-bull-market-left-these-3-stocks-behind-but-the/,2024-02-04 19:45:00,"Sometimes, undervalued market laggards have what it takes to catch up over the long haul.",PFE,0.232439,0.080374,Neutral
"Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for BioNTech SE Investors in Securities Fraud Class Action Lawsuit - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/02/g36925338/kessler-topaz-meltzer-check-llp-important-deadline-reminder-for-biontech-se-investors-in-securitie,2024-02-04 16:08:00,"RADNOR, Pa. , Feb. 04, 2024 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against BioNTech SE ( ...",PFE,0.177671,-0.042807,Neutral
Hold That Spinoff Stock: Selling Could Cost You Big,https://www.forbes.com/sites/jimosman/2024/02/04/hold-that-spinoff-stock-selling-could-cost-you-big/,2024-02-04 16:00:00,"The legendary investor Peter Lynch once said, ""Invest in what you know."" Lynch emphasized the importance of understanding the companies or investments you're involved in, suggesting that investors will make better decisions if they invest in industries or companies they're familiar with or have ...",PFE,0.01978,0.069379,Neutral
"1 Beaten-Down Dividend Stock to Avoid in 2024, and 1 to Consider Buying and Holding Forever",https://www.fool.com/investing/2024/02/04/1-beaten-down-dividend-stock-to-avoid-in-2024-and/,2024-02-04 14:15:00,These two companies have dramatically different futures in store.,PFE,0.223866,0.070421,Neutral
3 Fabulous Dividend Stocks to Buy in February,https://www.fool.com/investing/2024/02/04/3-fabulous-dividend-stocks-to-buy-in-february/,2024-02-04 10:50:00,These stocks offer great dividends and more.,PFE,0.344473,0.205286,Somewhat-Bullish
10 Tax Forms Retirees Receive and What They Mean,https://www.kiplinger.com/retirement/tax-forms-retirees-receive-and-what-they-mean,2024-02-04 10:30:23,"I'm an IRS enrolled agent, which sounds ( sort of ) cool and scary. What it actually means is that I am licensed by the IRS to prepare taxes and represent taxpayers, which is not cool or scary. The reality of the situation is that I have the same feelings of unhappiness and annoyance you do every ...",PFE,0.090645,-0.142447,Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines - BNTX - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/pressreleases/24/02/g36923335/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-biont,2024-02-03 16:53:00,"NEW YORK, Feb. 03, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against BioNTech SE ( ""BioNTech"" or the ""Company"" ) BNTX. The class action, filed in the United States District Court for the Central District of California, and docketed under ...",PFE,0.316846,-0.085641,Neutral
Better Recovery Story Buy: Novavax vs. Teladoc,https://www.fool.com/investing/2024/02/03/better-recovery-story-buy-novavax-vs-teladoc/,2024-02-03 10:35:00,Both stocks have fallen more than 90% from their peak.,PFE,0.102013,0.089319,Neutral
First Private Covid-19 Vaccines Announced In U.K.,https://www.forbes.com/sites/katherinehignett/2024/02/03/first-private-covid-19-vaccines-announced-in-uk/,2024-02-03 08:30:19,"People in Britain will be able to buy Covid-19 vaccines for the first time this year, with a pharmacy service company announcing it will offer the shots in England and Scotland no later than April.",PFE,0.069094,0.0,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mercury Systems, Onsemi, BioNTech, and BioVie and Encourages Investors to Contact the Firm - BioVie  ( NASDAQ:BIVI ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/02/g36921282/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-mercu,2024-02-03 02:00:00,"NEW YORK, Feb. 02, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Mercury Systems, Inc. MRCY, ON Semiconductor Corporation ON, BioNTech SE BNTX, and ...",PFE,0.021312,-0.132607,Neutral
Tech execs are telling investors they have to spend money to make money on AI,https://www.cnbc.com/2024/02/02/techs-new-ai-game-plan-spend-money-to-make-money.html,2024-02-02 21:35:54,"On this week's earnings calls, tech executives highlighted the need in AI to build infrastructure and the opportunities to make money with agents.",PFE,0.025139,-0.034928,Neutral
"Bristol-Myers  ( BMY )  Q4 Earnings & Sales Beat, Stock Gains",https://www.zacks.com/stock/news/2220491/bristol-myers-bmy-q4-earnings-sales-beat-stock-gains,2024-02-02 17:40:00,Bristol-Myers' (BMY) fourth-quarter 2023 earnings and sales surpass estimates as Reblozyl and Revlimid outperform. Shares rise on the same.,PFE,0.104988,0.170629,Somewhat-Bullish
"Stocks Handle Huge Earnings, Fed, Jobs Report: Weekly Review",https://www.investors.com/news/stock-market-handles-huge-earnings-week-fed-powell-jobs-report-weekly-review/,2024-02-02 17:15:00,"Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review Investor's Business Daily ...",PFE,0.049835,-0.136008,Neutral
BIONTECH SHAREHOLDER ACTION REMINDER - PR Newswire,https://www.prnewswire.com/news-releases/biontech-shareholder-action-reminder-302051523.html,2024-02-02 16:45:00,BIONTECH SHAREHOLDER ACTION REMINDER PR ...,PFE,0.230235,-0.119296,Neutral
Market Whales and Their Recent Bets on BNTX Options - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/insights/options/24/02/36912886/market-whales-and-their-recent-bets-on-bntx-options,2024-02-02 16:31:46,"High-rolling investors have positioned themselves bearish on BioNTech BNTX, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.",PFE,0.087185,-0.003127,Neutral
"Maison Solutions, Dada Nexus, and BioNtech Class Action Update: Johnson Fistel Alerts Shareholders of Ongoing Legal Proceedings - Dada Nexus  ( NASDAQ:DADA ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/02/g36910571/maison-solutions-dada-nexus-and-biontech-class-action-update-johnson-fistel-alerts-shareholders-of,2024-02-02 14:52:50,"SAN DIEGO, Feb. 02, 2024 ( GLOBE NEWSWIRE ) -- Johnson Fistel, LLP, a law firm specializing in shareholder rights, has announced the initiation of class action lawsuits on behalf of investors of the following companies. Investors are encouraged to review the deadlines listed and submit their ...",PFE,0.156461,-0.173667,Somewhat-Bearish
"Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates",https://www.zacks.com/stock/news/2220214/pharma-stock-roundup-pfe-mrk-nvo-snys-q4-earnings-fda-updates,2024-02-02 14:21:00,"Pfizer (PFE), Merck (MRK), Novartis (NVS), Novo Nordisk (NVO) and Sanofi (SNY) announce fourth-quarter and full-year 2023 results.",PFE,0.121241,0.03563,Neutral
4 Large Drug Stocks Trying to Survive the Industry Challenges,https://www.zacks.com/commentary/2220023/4-large-drug-stocks-trying-to-survive-the-industry-challenges,2024-02-02 13:47:00,"Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), AbbVie (ABBV) and Novartis (NVS) are worth retaining in one's portfolio.",PFE,0.023885,0.065458,Neutral
Bristol Myers Shares Rise On Fourth-Quarter Earnings Beat,https://www.investors.com/news/technology/bmy-stock-bristol-myers-squibb-earnings-q4-2023/,2024-02-02 13:03:00,BMY Stock Gains On Fourth-Quarter Earnings Beat Investor's Business Daily ...,PFE,0.275867,0.114163,Neutral
4 Top Vanguard Mutual Funds to Buy for 2024 & Beyond,https://www.zacks.com/stock/news/2220044/4-top-vanguard-mutual-funds-to-buy-for-2024-beyond,2024-02-02 12:28:00,"Invest in Vanguard mutual funds like VGENX, VASVX, VWNDX and VSEQX, which have given impressive returns in the past and are expected to do the same in 2024 and beyond.",PFE,0.043499,0.043856,Neutral
Bristol Myers Squibb results top estimates as new drugs post strong sales growth,https://www.cnbc.com/2024/02/02/bristol-myers-squibb-bmy-q4-earnings-report-2023.html,2024-02-02 11:59:57,"Bristol Myers Squibb also issued its full-year 2024 forecast, which was generally in line with expectations.",PFE,0.077845,0.051613,Neutral
Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer,https://www.globenewswire.com/news-release/2024/02/02/2822739/0/en/Tisotumab-Vedotin-Marketing-Authorization-Application-Validated-by-European-Medicines-Agency-for-Treatment-of-Recurrent-or-Metastatic-Cervical-Cancer.html,2024-02-02 11:45:00,"Media ReleaseCOPENHAGEN, Denmark. February ...",PFE,0.25374,0.067162,Neutral
"ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/02/g36903634/rosen-recognized-investor-counsel-encourages-biontech-se-investors-to-secure-counsel-before-import,2024-02-02 03:04:00,"NEW YORK, Feb. 01, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE BNTX between March 30, 2022 and October 13, 2023, both dates inclusive ( the ""Class Period"" ) , of the important March 12, 2024 lead plaintiff ...",PFE,0.063425,-0.155566,Somewhat-Bearish
"BIONTECH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/02/g36903510/biontech-investor-deadline-approaching-faruqi-faruqi-securities-litigation-partner-james-josh-wils,2024-02-02 02:30:00,"If you suffered losses exceeding $100,000 investing in BioNTech stock or options between March 30, 2022 and October 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ( Ext. 1310 ) .",PFE,0.238523,-0.122696,Neutral
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/markets/penny-stocks/24/02/36896319/pfizer-surprises-with-profit-but-revolutionizing-cancer-treatment-is-its-best-chance-of-gett,2024-02-01 19:17:02,"On Tuesday, Pfizer Inc PFE reported mixed results for its fourth quarter. Last year, Pfizer has responded to concerns related to its COVID-19 products being the rearview mirror with a cost-cutting program, internal restructuring and by getting deeper into oncology with its purchase of cancer ...",PFE,0.565858,-0.09083,Neutral
Merck  ( MRK )  Q4 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2024/02/01/merck-mrk-q4-2023-earnings-call-transcript/,2024-02-01 19:00:23,"MRK earnings call for the period ending December 31, 2023.",PFE,0.009699,0.110045,Neutral
SHAREHOLDER ALERT: Levi & Korsinsky Notifies BioNTech SE  ( BNTX )  Investors of a Class Action Lawsuit and Upcoming Deadline - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/pressreleases/24/02/g36894639/shareholder-alert-levi-korsinsky-notifies-biontech-se-bntx-investors-of-a-class-action-lawsuit-and,2024-02-01 18:01:00,"NEW YORK, Feb. 01, 2024 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in BioNTech SE ( ""BioNTech"" or the ""Company"" ) BNTX of a class action securities lawsuit.",PFE,0.18967,-0.143037,Neutral
Why you can count on the Dow making changes in February,https://www.marketwatch.com/story/why-you-can-count-on-the-dow-making-changes-in-february-6334fda9,2024-02-01 16:49:00,"Investors can count on the Dow Jones Industrial Average changing its members next month, for the first time in nearly four years, for several reasons. The question is, who's out and who's in?",PFE,0.075995,0.0,Neutral
What's Going On With Pfizer Stock Today? - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/24/02/36889139/whats-going-on-with-pfizer-stock-today,2024-02-01 14:21:19,"Pfizer Inc PFE shares have a session volume of 1.218 million, with an average volume ( 100 day ) of 44.467 million. Tuesday, Pfizer reported a Q4 adjusted EPS of $0.10 versus a consensus loss of $ ( 0.22 ) .",PFE,0.554916,0.245348,Somewhat-Bullish
"Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales",https://www.cnbc.com/2024/02/01/merck-mrk-q4-earnings-report-2023.html,2024-02-01 11:31:22,Merck still posted a quarterly loss due to previously announced charges associated with its cancer drug collaboration deal with Daiichi Sankyo.,PFE,0.049732,-0.184822,Somewhat-Bearish
Could Novavax Stock Help You Become a Millionaire?,https://www.fool.com/investing/2024/02/01/could-novavax-stock-help-you-become-a-millionaire/,2024-02-01 10:04:00,"Novavax aims to win with its coronavirus/flu vaccine candidate, now in clinical trials.",PFE,0.107736,0.068618,Neutral
Is the Worst Over for Pfizer?,https://www.fool.com/investing/2024/02/01/is-the-worst-over-for-pfizer/,2024-02-01 10:00:00,Pfizer shares sank 43% last year.,PFE,0.799321,0.145257,Neutral
Volumes soar at Pfizer Ltd counter,https://www.business-standard.com/markets/capital-market-news/volumes-soar-at-pfizer-ltd-counter-124020101000_1.html,2024-02-01 09:00:00,"Pfizer Ltd recorded volume of 2.03 lakh shares by 14:14 IST on NSE, a 12.3 times surge over two-week average daily volume of 16518 shares India Cements Ltd, Indus Towers Ltd, Westlife Foodworld Ltd, Motherson Sumi Wiring India Ltd are among the other stocks to see a surge in volumes on NSE today, ...",PFE,0.265378,0.354076,Bullish
"Stocks to watch on Budget day: Paytm, Godrej Consumer, Infra, rail, PSUs",https://www.business-standard.com/markets/news/stocks-to-watch-on-budget-day-paytm-godej-consumer-infra-rail-psus-124020100080_1.html,2024-02-01 01:55:16,"Equity benchmark indices Sensex and Nifty are looking to start near the flatline on Thursday ahead of the interim budget for 2024-25. The tepid sentiment follows losses across Asian markets, which fell this morning as the US Fed pushed against near-term rate cuts.",PFE,0.067919,0.003042,Neutral
"Buzzing Stocks on budget day: Paytm, Titan, Thomas Cook, Religare, GCPL, others in news",https://www.moneycontrol.com/news/photos/business/stocks/buzzing-stocks-on-budget-day-paytm-titan-thomas-cook-religare-gcpl-others-in-news-12165301.html,2024-01-31 23:57:10,"Stocks to watch: Check out the companies making headlines before the opening bell today, on February 1, 2024.",PFE,0.112269,0.050565,Neutral
Taylor Swift + Super Bowl = conspiracy theories. The claims are baseless,https://apnews.com/article/super-bowl-taylor-swift-travis-kelce-conspiracy-theories-838ce3087c795cb45468d08ebbb27059,2024-01-31 23:02:56,The budding love story featuring music superstar Taylor Swift and Kansas City Chiefs' tight end Travis Kelce took an unexpected turn into the world of political conspiracy theories this week after the team .,PFE,0.04823,-0.025955,Neutral
"DEADLINE ALERT for MSS, ASRT, DADA, BNTX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Assertio Holdings  ( NASDAQ:ASRT ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36872957/deadline-alert-for-mss-asrt-dada-bntx-law-offices-of-howard-g-smith-reminds-investors-of-class-act,2024-01-31 18:24:44,"BENSALEM, Pa., Jan. 31, 2024 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",PFE,0.056808,-0.071415,Neutral
"Global Life Science Analytics Market Size is Estimated to Reach USD 19,610.13 Million by 2031, Growing at a CAGR of 8.41%: Straits Research",https://www.benzinga.com/pressreleases/24/01/g36868896/global-life-science-analytics-market-size-is-estimated-to-reach-usd-19-610-13-million-by-2031-grow,2024-01-31 15:25:00,"New York, United States, Jan. 31, 2024 ( GLOBE NEWSWIRE ) -- Life sciences analytics refers to any analytical tool used in clinical research organizations, pharmaceutical and medical device companies, and various departments like research, supply chain, marketing, and pharmacovigilance.",PFE,0.034087,0.13962,Neutral
"GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost",https://www.cnbc.com/2024/01/31/gsk-posts-blowout-rsv-vaccine-sales-raises-outlook.html,2024-01-31 14:47:47,"The RSV shot, called Abrysvo, booked £1.2 billion, or $1.5 billion, in sales after only being on the market for roughly half a year.",PFE,0.28636,0.170102,Somewhat-Bullish
"Glenmark, Pfizer launch Abrocitinib in India for Atopic Dermatitis",https://www.business-standard.com/companies/news/glenmark-pfizer-launch-abrocitinib-in-india-for-atopic-dermatitis-124013100941_1.html,2024-01-31 14:12:14,"Abrocitinib is available in over 35 markets globally, including the US, Japan, and China Glenmark Pharmaceuticals and Pfizer announced on Wednesday that they have collaborated to launch Abrocitinib, an oral treatment for moderate-to-severe atopic dermatitis ( AD ) , in India.",PFE,0.483888,0.204836,Somewhat-Bullish
"Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares - AstraZeneca  ( NASDAQ:AZN ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36866023/take-your-ozempic-why-late-entry-of-rival-weight-loss-drugs-wont-floor-novo-eli-sha,2024-01-31 13:49:44,"Eli Lilly LLY reports its fourth quarter earnings next week and, as Novo Nordisk NVO did on Wednesday, is expected to wow investors with earnings and revenue beats thanks, in large part, to the overwhelming success of its diabetes treatments that have become popular weight-loss solutions.",PFE,0.211191,0.092059,Neutral
Here's the real reason why right-wing media figures are targeting Taylor Swift and Travis Kelce | Business,https://www.cnn.com/2024/01/31/media/taylor-swift-travis-kelce-right-wing-media,2024-01-31 12:42:00,Here's the real reason why right-wing media figures are targeting Taylor Swift and Travis ...,PFE,0.042271,0.189039,Somewhat-Bullish
Here's the real reason why right-wing media figures are targeting Taylor Swift and Travis Kelce | Business,https://www.cnn.com/2024/01/31/media/taylor-swift-travis-kelce-right-wing-media/index.html,2024-01-31 12:42:00,Here's the real reason why right-wing media figures are targeting Taylor Swift and Travis ...,PFE,0.042271,0.189039,Somewhat-Bullish
Sumitomo Pharma and Pfizer Canada Announce Availability of MYFEMBREE® in Canada - Canada NewsWire,https://www.newswire.ca/news-releases/sumitomo-pharma-and-pfizer-canada-announce-availability-of-myfembree-r-in-canada-800678647.html,2024-01-31 12:30:00,Sumitomo Pharma and Pfizer Canada Announce Availability of MYFEMBREE® in Canada Canada ...,PFE,0.289652,0.017325,Neutral
Glenmark partners with Pfizer to launch oral drug for atopic dermatitis in India,https://www.financialexpress.com/healthcare/pharma-healthcare/glenmark-partners-with-pfizer-to-launch-oral-drug-for-atopic-dermatitis-in-india/3380243/,2024-01-31 12:01:44,"Pfizer and Glenmark Pharmaceuticals Ltd. have partnered to launch abrocitinib, an oral advanced systemic treatment for moderate‐to‐severe atopic dermatitis ( AD ) , in India.",PFE,0.414559,0.378477,Bullish
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305,https://www.globenewswire.com/news-release/2024/01/31/2820922/0/en/BioNTech-and-DualityBio-Receive-FDA-Fast-Track-Designation-for-Next-Generation-Antibody-Drug-Conjugate-Candidate-BNT325-DB-1305.html,2024-01-31 11:45:00,"• Designation is based on preliminary safety and efficacy data from an ongoing Phase 1/2 trial in patients with platinum-resistant ovarian epithelial cancer, fallopian tube, or primary peritoneal cancer1 • Fast Track designation can facilitate the development and expedite the regulatory review ...",PFE,0.020526,0.019203,Neutral
Microsoft  ( MSFT )  Q2 2024 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2024/01/31/microsoft-msft-q2-2024-earnings-call-transcript/,2024-01-31 05:00:17,"MSFT earnings call for the period ending December 31, 2023.",PFE,0.004424,0.13913,Neutral
Alphabet  ( GOOGL )  Q4 2024 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2024/01/30/alphabet-googl-q4-2024-earnings-call-transcript/,2024-01-31 01:45:18,"GOOGL earnings call for the period ending December 31, 2023.",PFE,0.004924,0.22669,Somewhat-Bullish
Pfizer  ( PFE )  Q4 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2024/01/30/pfizer-pfe-q4-2023-earnings-call-transcript/,2024-01-30 21:45:23,"PFE earnings call for the period ending December 31, 2023.",PFE,0.079154,0.141052,Neutral
"Why Pfizer Stock Was Jumping Today, but Then Gave Up Its Gains",https://www.fool.com/investing/2024/01/30/why-pfizer-stock-was-jumping-today-but-gave-up-its/,2024-01-30 17:15:37,"The drugmaker's Q4 results were better than many expected, but still not good enough to spark a sustained rally.",PFE,0.696714,0.352654,Bullish
"Stocks Fall Amid Economic Data; Alphabet, Microsoft, Apple To Report",https://www.investors.com/market-trend/stock-market-today/dow-jones-stocks-fall-amid-economic-data-nvidia-rises-with-alphabet-microsoft-apple-to-report/,2024-01-30 16:15:00,"Stocks Fall Amid Economic Data. Alphabet, Microsoft, Apple To Report Investor's Business Daily ...",PFE,0.11894,-0.217723,Somewhat-Bearish
Home Prices Decreased in November,https://www.zacks.com/stock/news/2218065/home-prices-decreased-in-november,2024-01-30 15:56:00,"Pre-market futures are giving back some of the gains we've seen in the past few days of trading - ones which have pumped the Dow and S&P 500 to fresh all-time highs. At this hour, the Dow is -70 points, the S&P is -10 and the tech-heavy Nasdaq is -30 points.",PFE,0.12546,0.086319,Neutral
"Pfizer  ( PFE )  Q4 Earnings Top, Revenues Miss on COVID Sales Slump",https://www.zacks.com/stock/news/2218064/pfizer-pfe-q4-earnings-top-revenues-miss-on-covid-sales-slump,2024-01-30 15:53:00,Pfizer (PFE) reports mixed fourth-quarter 2023 results. It re-affirms its 2024 sales and earnings guidance provided in December 2023.,PFE,0.348452,0.185884,Somewhat-Bullish
"Pfizer posts surprise 4th quarter profit, but key products miss on sales",https://www.business-standard.com/companies/results/pfizer-posts-surprise-4th-quarter-profit-but-key-products-miss-on-sales-124013001010_1.html,2024-01-30 15:48:46,"Pfizer reported a surprise quarterly profit on Tuesday, helped by cost cuts and fewer returns of its COVID treatment Paxlovid by the U.S. government than it had expected, but sales of some high profile products fell short of Wall Street estimates.",PFE,0.399204,-0.058175,Neutral
"GM Up on Q4 Beat & Raise; UPS, Pfizer Mixed",https://www.zacks.com/stock/news/2218048/gm-up-on-q4-beat-raise-ups-pfizer-mixed,2024-01-30 15:22:00,"Aside from a cavalcade of earnings, Case-Shiller came in lower month over month and JOLTS are out after the open.",PFE,0.122269,0.085031,Neutral
"US Stocks Edge Lower; Pfizer Reports Surprise Profit - Agrify  ( NASDAQ:AGFY ) , Agape ATP  ( NASDAQ:ATPC ) ",https://www.benzinga.com/news/earnings/24/01/36846621/us-stocks-edge-lower-pfizer-reports-surprise-profit,2024-01-30 14:44:51,"U.S. stocks traded slightly lower this morning on Tuesday. Following the market opening Tuesday, the Dow traded down 0.04% to 38,316.43 while the NASDAQ fell 0.12% to 15,608.59. The S&P 500 also fell, dropping, 0.03% to 4,926.32. Health care shares rose by 0.2% on Tuesday.",PFE,0.152983,0.42423,Bullish
"Taylor Swift At The Super Bowl: The Conspiracy Theory, Explained",https://www.forbes.com/sites/danidiplacido/2024/01/30/the-taylor-swift-super-bowl-conspiracy-explained/,2024-01-30 14:44:01,"Taylor Swift Super Bowl Conspiracy, Explained Forbes ...",PFE,0.06697,-0.217848,Somewhat-Bearish
"Stock Market News for Jan 30, 2024",https://www.zacks.com/stock/news/2217895/stock-market-news-for-jan-30-2024,2024-01-30 14:30:00,U.S. stocks closed sharply higher on Monday as investors looked forward to earnings reports from a slew of big tech companies and the Federal Reserve's monetary policy meeting later this week.,PFE,0.155954,0.0,Neutral
Pfizer Ekes Out Surprise Fourth-Quarter Profit Despite Covid Collapse,https://www.investors.com/news/technology/pfizer-stock-inches-higher-on-unexpected-fourth-quarter-profit-but-covid-downfall-continues/,2024-01-30 13:51:00,"Pfizer Stock Inches Higher On Unexpected Fourth-Quarter Profit, But Covid Downfall Continues Investor's Business Daily ...",PFE,0.804025,-0.377633,Bearish
"Pfizer Surprises With Q4 Profit Despite Muted COVID Products Demand, Sticks To 2024 Guidance - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/24/01/36844732/pfizer-surprises-with-q4-profit-despite-muted-covid-products-demand-sticks-to-2024-guidance,2024-01-30 13:48:10,"Tuesday, Pfizer Inc PFE reported a Q4 adjusted EPS of $0.10 versus a consensus loss of $ ( 0.22 ) . The company reported fiscal year 2023 adjusted EPS of $1.84, down 72% year-on-year, significantly impacted by one-time events.",PFE,0.648995,0.361881,Bullish
AION Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery,https://www.prnewswire.com/news-releases/aion-labs-launches-new-startup-leveraging-machine-learning-for-molecular-glue-discovery-302047708.html,2024-01-30 13:30:00,"TenAces Formed by Israel-Based Venture Studio Comprising AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund, Amiti Ventures and Amazon Web Services ( AWS ) , powered by BioMed X",PFE,0.053749,0.065759,Neutral
Futures Fall Ahead Of Key Economic Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-key-economic-data-alphabet-amd-microsoft-to-report-earnings/,2024-01-30 13:23:00,"Dow Jones futures fell slightly Tuesday morning, as Wall Street prepared for key economic data, with the early release of two housing reports, consumer confidence numbers and job openings.",PFE,0.035929,0.222658,Somewhat-Bullish
"Jnana Therapeutics Announces Positive Clinical Proof of Concept Achieved with JNT-517, a Potential First-in-Class Oral Treatment for PKU",https://www.benzinga.com/pressreleases/24/01/g36842900/jnana-therapeutics-announces-positive-clinical-proof-of-concept-achieved-with-jnt-517-a-potential-,2024-01-30 13:15:57,Treatment with JNT-517 demonstrated a statistically significant mean blood phenylalanine reduction of 51% versus baseline Jnana has adapted the ongoing trial to accelerate the program and aims to advance JNT-517 directly into a pivotal study in early 2025,PFE,0.035293,0.149058,Neutral
Analysis: Some blue chip stocks are crumbling: Here's why | Business,https://edition.cnn.com/2024/01/30/investing/premarket-stocks-trading/index.html,2024-01-30 13:08:00,Some blue chip stocks are crumbling. Here's why CNN International ...,PFE,0.03463,0.0,Neutral
Analysis: Some blue chip stocks are crumbling: Here's why | Business,https://www.cnn.com/2024/01/30/investing/premarket-stocks-trading/index.html,2024-01-30 13:08:00,Some blue chip stocks are crumbling. Here's why ...,PFE,0.03463,0.0,Neutral
Pfizer  ( PFE )  Surpasses Q4 Earnings Estimates,https://www.zacks.com/stock/news/2217695/pfizer-pfe-surpasses-q4-earnings-estimates,2024-01-30 12:55:03,"Pfizer (PFE) delivered earnings and revenue surprises of 152.63% and 0.80%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",PFE,0.40348,0.019489,Neutral
"US Stocks Hold Steady Ahead Of Microsoft, Alphabet Earnings: Analyst Warns Of 'Big Air Pocket' In Pivotal Trading Week - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/01/36841675/us-stocks-hold-steady-ahead-of-microsoft-alphabet-earnings-analyst-warns-of-big-air-pocket-in-pivot,2024-01-30 12:25:51,"The sentiment on Wall Street turned extremely cautious on Tuesday as investors awaited key earnings releases from companies like Microsoft Corp. MSFT, Alphabet, Inc. GOOGL, and Advanced Micro Devices, Inc. AMD.",PFE,0.105836,0.0,Neutral
"Pfizer's stock rises as earnings beat expectations, company seeks 'clean slate' in 2024",https://www.marketwatch.com/story/pfizers-stock-rises-as-earnings-beat-expectations-company-seeks-clean-slate-in-2024-a259d7c9,2024-01-30 12:23:00,Pfizer stock rose early Tuesday as the drugmaker beat analysts' earnings expectations and reaffirmed full-year 2024 guidance.,PFE,0.743214,-0.098215,Neutral
Pfizer beats earnings estimates as declining Covid business performs better than expected,https://www.cnbc.com/2024/01/30/pfizer-pfe-q4-earnings-report-2023.html,2024-01-30 12:16:11,"Pfizer reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug, Paxlovid, from the U.S. government.",PFE,0.661191,0.01129,Neutral
Right-wing media figures target Taylor Swift with absurd conspiracy theory ahead of the Super Bowl | Business,https://www.cnn.com/2024/01/30/media/taylor-swift-super-bowl-right-wing-conspiracy/index.html,2024-01-30 12:16:00,Right-wing media figures target Taylor Swift with absurd conspiracy theory ahead of the Super Bowl ...,PFE,0.09347,0.07658,Neutral
COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha Wave Ventures,https://www.benzinga.com/pressreleases/24/01/g36839828/cour-pharmaceuticals-secures-105-million-in-series-a-financing-co-led-by-lumira-ventures-and-alpha,2024-01-30 11:00:00,"Funds will be used to support the advancement of COUR's Myasthenia Gravis ( MG ) and Type 1 Diabetes ( T1D ) product candidates into Phase 2a clinical trials Participating investors include Roche Venture Fund, Pfizer, Bristol Myers Squibb, Angelini Ventures, and JDRF T1D Fund",PFE,0.158519,0.149767,Neutral
S&P 500 futures hold near highs as Microsoft results loom,https://www.marketwatch.com/story/s-p-500-futures-hold-near-highs-as-microsoft-results-loom-5311f018,2024-01-30 09:51:00,U.S. stock futures held near record highs early Tuesday ahead of crucial earnings from market darling Microsoft.,PFE,0.166743,0.0,Neutral
"Microsoft, UPS, GM, Pfizer, Super Micro Computer, Calix, Sanmina, and More Stock Market Movers",https://www.barrons.com/amp/articles/stock-market-movers-67acb5bd,2024-01-30 09:25:00,"Microsoft, Alphabet, Super Micro Computer, Calix, Sanmina, and More Market Movers ...",PFE,0.075635,0.128423,Neutral
"Investor Optimism Improves Slightly Ahead Of Big Earnings, Fed's Policy Decision - General Motors  ( NYSE:GM ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/earnings/24/01/36838488/investor-optimism-improves-slightly-ahead-of-big-earnings-feds-policy-decision,2024-01-30 08:03:45,"The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the ""Extreme Greed"" zone on Monday. U.S. stocks closed higher on Monday, with the S&P 500 rising to a new record ahead of various mega-cap tech earnings reports and the Fed's ...",PFE,0.250386,0.0,Neutral
"Antibody drug conjugates focus draws global pharma giants attention to China, says GlobalData",https://www.financialexpress.com/healthcare/pharma-healthcare/antibody-drug-conjugates-focus-draws-global-pharma-giants-attention-to-china-says-globaldata/3377889/,2024-01-30 02:30:00,"Antibody-drug conjugates ( ADCs ) represent a significant breakthrough in targeted cancer therapy. By blending the specificity of monoclonal antibodies with the potency of cytotoxic drugs, ADCs offer a targeted approach to cancer treatment, minimizing the damage to healthy cells.",PFE,0.097854,0.031578,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mercury Systems, Onsemi, BioNTech, and BioVie and Encourages Investors to Contact the Firm - BioVie  ( NASDAQ:BIVI ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36837516/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-mercu,2024-01-30 02:00:00,"NEW YORK, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Mercury Systems, Inc. MRCY, ON Semiconductor Corporation ON, BioNTech SE BNTX, and ...",PFE,0.021312,-0.132607,Neutral
"Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc ... - PR Newswire",https://www.prnewswire.com/news-releases/renal-anemia-therapeutics-market-to-record-growth-of-usd-2-08-billion-from-2023-to-2028--akebia-therapeutics-inc-and-amgen-inc-to-emerge-as-some-of-the-key-companies---technavio-302045440.html,2024-01-29 23:30:00,"Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc ... PR ...",PFE,0.050572,0.10634,Neutral
"Markets Stroll Higher Ahead of Key Data; SMCI, FFIV, WHR Beat",https://www.zacks.com/stock/news/2217484/markets-stroll-higher-ahead-of-key-data-smci-ffiv-whr-beat,2024-01-29 23:06:00,A sixth record closing high for the S&P 500 just this month/year alone ought to give a good impression of where the market's collective head is at presently.,PFE,0.146025,0.071009,Neutral
Pfizer Kicks Off Big Pharma Earnings. Cost-Cutting Will Be Key.,https://www.barrons.com/amp/articles/pfizer-earnings-stock-price-0afaf198,2024-01-29 22:30:00,Pfizer Earnings Are Coming Tuesday. What to Expect. ...,PFE,0.636698,0.086971,Neutral
eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules,https://www.globenewswire.com/news-release/2024/01/29/2819427/0/en/eFFECTOR-Therapeutics-Announces-Closing-of-15-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html,2024-01-29 21:05:00,"SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- eFFECTOR Therapeutics, Inc. ( NASDAQ: EFTR ) ( the ""Company"" ) , a leader in the development of selective translation regulator inhibitors ( ""STRIs"" ) for the treatment of cancer, today announced that it has ...",PFE,0.04823,-0.053882,Neutral
Jürgen Klopp and the importance of energy,https://www.economist.com/bartleby/2024/01/29/jurgen-klopp-and-the-importance-of-energy,2024-01-29 19:06:57,"J is a football manager. That means there is a limit to how much he can teach corporate bosses about how to do their jobs. Managers in firms tend not to be parent substitutes to their charges, envelop people in bear hugs after a successful meeting or use the gegenpressing technique against rivals.",PFE,0.051999,-0.046964,Neutral
Jürgen Klopp and the importance of energy,https://www.economist.com/business/2024/01/29/jurgen-klopp-and-the-importance-of-energy,2024-01-29 19:06:57,The resignation of a football manager is a reminder of a CEO superpower ...,PFE,0.051999,-0.046964,Neutral
"Pfizer's COVID-19 Treatment Paxlovid Will No Longer Be Available For Emergency Use After This Date, FDA Revises Label - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/24/01/36829826/pfizers-covid-19-treatment-paxlovid-will-no-longer-be-available-for-emergency-use-after-this-date,2024-01-29 17:39:45,"The FDA has updated the emergency use authorization ( EUA ) for Pfizer Inc's PFE Paxlovid, impacting its distribution and use in treating mild-to-moderate COVID-19.",PFE,0.337811,-0.021798,Neutral
Pfizer Gears Up For Q4 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/earnings/24/01/36827166/pfizer-gears-up-for-q4-print-heres-a-look-at-recent-price-target-changes-by-the-most-accurate-analy,2024-01-29 16:00:21,"Pfizer Inc. PFE is expected to release earnings results for its fourth quarter, before the opening bell on Jan. 30, 2024. Analysts expect the company to report a quarterly loss at 22 cents per share, versus year-ago earnings of $1.14 per share.",PFE,0.414559,-0.23117,Somewhat-Bearish
Big Earnings Week Ahead,https://www.zacks.com/stock/news/2217255/big-earnings-week-ahead,2024-01-29 15:31:00,"Who says January's a long month? This week starts slow, but we'll end it with a full-fledged Jobs Week for February.",PFE,0.16171,0.079619,Neutral
"At 3.7% CAGR, Global Carboprost Tromethamine Market Size Value to be Worth USD 2,100.63 Million By 2032: Polaris Market Research",https://www.prnewswire.com/news-releases/at-3-7-cagr-global-carboprost-tromethamine-market-size-value-to-be-worth-usd-2-100-63-million-by-2032-polaris-market-research-302046762.html,2024-01-29 15:30:00,"At 3.7% CAGR, Global Carboprost Tromethamine Market Size Value to be Worth USD 2,100.63 Million By 2032 ... PR ...",PFE,0.027319,0.094772,Neutral
"It's Jobs Week Already? Plus Q4 Reports from MSFT, GOOGL, AAPL, AMZN",https://www.zacks.com/stock/news/2217145/its-jobs-week-already-plus-q4-reports-from-msft-googl-aapl-amzn,2024-01-29 14:45:00,"This week starts slow, but we'll end it with a full-fledged Jobs Week for February. Plus more than half the Magnificent 7 reports earnings.",PFE,0.158519,0.079916,Neutral
"Nvidia, Microsoft, Alphabet, Meta Platforms and Amazon are part of Zacks Earnings Preview",https://www.zacks.com/stock/news/2216939/nvidia-microsoft-alphabet-meta-platforms-and-amazon-are-part-of-zacks-earnings-preview,2024-01-29 13:45:00,"Nvidia, Microsoft, Alphabet, Meta Platforms and Amazon are highlights of Zacks Earnings Preview article.",PFE,0.042271,0.0,Neutral
Will New Drugs Drive Pfizer  ( PFE )  Sales in Q4 Earnings?,https://www.zacks.com/stock/news/2216911/will-new-drugs-drive-pfizer-pfe-sales-in-q4-earnings,2024-01-29 13:22:00,"Investor focus is likely to be on the sales numbers of Pfizer's (PFE) several newly launched drugs like Abrysvo, Velsipity, Penbraya as well as newly acquired products like Nurtec and Oxbryta on the fourth-quarter earnings call.",PFE,0.3038,-0.042372,Neutral
"1 Reason to Buy Novavax Stock, and 3  ( Better )  Reasons to Sell",https://www.fool.com/investing/2024/01/29/1-reason-to-buy-novavax-stock-and-3-better-reasons/,2024-01-29 13:15:00,"This biotech isn't at the end of the road just yet, but don't bet on a revival.",PFE,0.051999,0.116525,Neutral
A Bull Market Is Here: 2 Cheap Stocks to Buy Right Now,https://www.fool.com/investing/2024/01/29/a-bull-market-is-here-2-cheap-stocks-to-buy-right/,2024-01-29 13:00:00,The past few years have been a roller-coaster ride for these stocks.,PFE,0.287537,0.404014,Bullish
"Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? - SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/01/36820476/tech-titans-microsoft-apple-lead-magnificent-seven-earnings-wave-this-week-can-mega-caps-ignite-mar,2024-01-29 10:51:00,"The past week's earnings were bordering on the negative, impacting trader sentiment, and the focus now shifts to the unfolding week that would see the release of a slew of tech earnings reports. The Week That Was: Tesla, Inc. TSLA, Intel, Inc. INTC, and Texas Instruments, Inc.",PFE,0.086713,0.0,Neutral
"SoFi, iRobot, Tesla, Archer Daniels, McGrath RentCorp, ZoomInfo, and More Stock Market Movers",https://www.barrons.com/amp/articles/stock-market-movers-149f2d69,2024-01-29 09:24:00,"Boeing, Evergrande, SoFi, Microsoft, Apple, and More Stock Market Movers ...",PFE,0.06211,0.0,Neutral
"BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36819702/bntx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-biontech-se-investors-with-subst,2024-01-29 09:00:00,"NEW YORK, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BioNTech SE ( ""BioNTech"" or ""the Company"" ) BNTX and certain of its officers.",PFE,0.270523,-0.130104,Neutral
"Big Tech, Boeing, and More Stocks to Watch",https://www.barrons.com/amp/articles/stocks-to-watch-apple-meta-microsoft-fed-meeting-jobs-report-8313983c,2024-01-28 19:00:00,"Apple, Meta, Amazon, Microsoft, Boeing, and More Stocks to Watch This Week ...",PFE,0.06697,0.0,Neutral
"20 ""Tech"" Stocks Make Up Over 35% of the S&P 500. Here's What That Means for Your Portfolio.",https://www.fool.com/investing/2024/01/28/20-tech-stocks-sp-500-buy-2024-invest/,2024-01-28 15:20:00,The stock market isn't what it used to be.,PFE,0.043579,0.0,Neutral
The busiest and most crucial week for fourth-quarter earnings is here.,https://www.marketwatch.com/story/the-busiest-and-most-crucial-week-for-fourth-quarter-earnings-is-here-these-five-companies-will-do-the-heavy-lifting-74ca1666,2024-01-28 15:01:00,"The heaviest stretch of the fourth-quarter earnings storm hits this week, with 106 companies set to report results.",PFE,0.09347,-0.117172,Neutral
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell,https://www.fool.com/investing/2024/01/28/1-reason-to-buy-novavax-stock-hand-over-fist-and-1/,2024-01-28 12:25:00,"The stock is high risk, but rewards could be great if all works out well for Novavax.",PFE,0.118064,0.06509,Neutral
The Economy Outperforms And Earnings Improve,https://www.forbes.com/sites/bill_stone/2024/01/28/the-economy-outperforms-and-earnings-improve/,2024-01-28 12:00:00,"The earnings season kicked into gear last week, with 74 S&P 500 companies reporting. The S&P 500 rose 1.1% for the week and closed slightly lower than the all-time high set on Thursday. The 10-year Treasury yield was fractionally changed at 4.1%.",PFE,0.116631,0.0,Neutral
5 Magnificent Stocks to Buy That Are Dirt Cheap,https://www.fool.com/investing/2024/01/28/5-magnificent-stocks-to-buy-that-are-dirt-cheap/,2024-01-28 10:51:00,Attractive valuations plus solid underlying businesses qualify these stocks as magnificent picks right now.,PFE,0.310843,0.171577,Somewhat-Bullish
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week,https://www.fool.com/investing/2024/01/28/cathie-wood-bargain-hunts-3-stocks-she-bought/,2024-01-28 10:10:00,Wood added to her existing positions in these three exciting companies.,PFE,0.09186,0.088233,Neutral
Where Will Pfizer Be in 10 Years?,https://www.fool.com/investing/2024/01/28/where-will-pfizer-be-in-10-years/,2024-01-28 10:05:00,Pfizer stock has dropped about 50% from its peak.,PFE,0.653656,0.263818,Somewhat-Bullish
Is It Too Late to Buy Novavax Stock?,https://www.fool.com/investing/2024/01/28/is-it-too-late-to-buy-novavax-stock/,2024-01-28 08:15:00,The biotech could fade into irrelevance soon.,PFE,0.058047,0.081203,Neutral
"BNTX CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against BioNTech SE  ( BNTX )  - BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36815734/bntx-class-action-announcement-kessler-topaz-meltzer-check-llp-announces-securities-class-action-l,2024-01-27 21:52:00,"RADNOR, Pa., Jan. 27, 2024 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against BioNTech SE ( ""BioNTech"" ...",PFE,0.177671,-0.042807,Neutral
"2 Growth Stocks That Could Rocket 144% and 202% Higher This Year, According to Wall Street",https://www.fool.com/investing/2024/01/27/2-growth-stocks-that-could-rocket-144-and-202-high/,2024-01-27 18:25:00,"Expectations for these stocks are sky-high, but so are the risks.",PFE,0.045224,0.034834,Neutral
How Does Berkshire Hathaway Stock Fit Into a Diversified Portfolio?,https://www.fool.com/investing/2024/01/27/how-does-berkshire-hathaway-stock-fit-into-a-diver/,2024-01-27 17:00:00,Berkshire Hathaway stock offers a compelling mix of capital appreciation and safety.,PFE,0.120733,-0.126699,Neutral
Where Will Novavax Be in 5 Years?,https://www.fool.com/investing/2024/01/27/where-will-novavax-be-in-5-years/,2024-01-27 13:45:00,Can the beaten-down stock turn things around?,PFE,0.066784,0.059606,Neutral
2 Ultra-High-Yield Dividend Stocks Down 47% or More to Buy Hand Over Fist Right Now,https://www.fool.com/investing/2024/01/27/2-ultra-high-yield-dividend-stocks-down-47-or-more/,2024-01-27 10:52:00,These stocks could be poised to rebound in a big way.,PFE,0.325924,0.060911,Neutral
"Cramer's week ahead: Fed meeting, labor report, Big Tech earnings",https://www.cnbc.com/2024/01/26/cramers-week-ahead-fed-meeting-labor-report-big-tech-earnings.html,2024-01-26 23:39:36,"Tuesday features earnings reports from Pfizer, General Motors, Microsoft, Alphabet, Starbucks and AMD while Apple, Amazon and Meta report Thursday.",PFE,0.082393,0.142431,Neutral
Big Tech Earnings Loom: What Can Investors Expect?,https://www.zacks.com/commentary/2216675/big-tech-earnings-loom-what-can-investors-expect,2024-01-26 23:13:00,A big part of Tech's improved earnings outlook has been a function of more effective cost controls that have helped stabilize margins. What will the Q4 results show?,PFE,0.03545,0.0,Neutral
"Apple, Boeing, Microsoft, Alphabet And A Fed Meeting, For Starters: Investing Action Plan",https://www.investors.com/research/investing-action-plan/apple-boeing-microsoft-alphabet-and-a-fed-meeting-for-starters-investing-action-plan/,2024-01-26 22:32:00,"As the stock market pushes its rally toward the end of a third straight month, some of its biggest names line up for earnings releases in the coming week. Apple ( AAPL ) , Alphabet ( GOOGL ) , Microsoft ( MSFT ) and Meta Platforms ( META ) are part of the picture.",PFE,0.107335,-0.013276,Neutral
"Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results - Colgate-Palmolive  ( NYSE:CL ) , AppFolio  ( NASDAQ:APPF ) ",https://www.benzinga.com/news/earnings/24/01/36807767/nasdaq-down-over-50-points-colgate-palmolive-posts-upbeat-results,2024-01-26 19:32:18,"U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling over 50 points on Friday The Dow traded up 0.05% to 38,069.66 while the NASDAQ fell 0.4% to 15,447.78. The S&P 500 also fell, dropping, 0.15% to 4,886.79. Health care shares rose by 0.5% on Friday.",PFE,0.065327,0.0,Neutral
"Crude Oil Down 1%; American Express Shares Rise After Q4 Results - American Express  ( NYSE:AXP ) , AppFolio  ( NASDAQ:APPF ) ",https://www.benzinga.com/news/earnings/24/01/36805309/crude-oil-down-1-american-express-shares-rise-after-q4-results,2024-01-26 17:00:26,"U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Friday. The Dow traded up 0.32% to 38,170.95 while the NASDAQ rose 0.10% to 15,525.24. The S&P 500 also rose, gaining, 0.19% to 4,903.28. Health care shares rose by 0.5% on Friday.",PFE,0.067347,0.0,Neutral
European Medicines Agency Validates Type II Variation Application for PADCEV™  ( enfortumab vedotin )  with KEYTRUDA® ( pembrolizumab )  for First-Line Treatment of Advanced Bladder Cancer,https://www.prnewswire.com/news-releases/european-medicines-agency-validates-type-ii-variation-application-for-padcev-enfortumab-vedotin-with-keytrudapembrolizumab-for-first-line-treatment-of-advanced-bladder-cancer-302045751.html,2024-01-26 17:00:00,European Medicines Agency Validates Type II Variation Application for PADCEV™ ( enfortumab vedotin ) with ... PR ...,PFE,0.080518,0.028066,Neutral
These Analysts Revise Their Forecasts On Levi Strauss Following Q4 Results - Levi Strauss  ( NYSE:LEVI ) ,https://www.benzinga.com/news/earnings/24/01/36805247/these-analysts-revise-their-forecasts-on-levi-strauss-following-q4-results,2024-01-26 16:58:54,"Levi Strauss & Co LEVI reported upbeat earnings for its fourth quarter on Thursday. Levi said fourth-quarter revenue increased 3% year-over-year to $1.64 billion, which missed the consensus estimate of $1.66 billion, according to Benzinga Pro.",PFE,0.142565,0.0,Neutral
These Analysts Revise Their Forecasts On Union Pacific After Q4 Results - Union Pacific  ( NYSE:UNP ) ,https://www.benzinga.com/news/earnings/24/01/36805074/these-analysts-revise-their-forecasts-on-union-pacific-after-q4-results,2024-01-26 16:52:07,"Union Pacific Corporation UNP reported better-than-expected fourth-quarter financial results on Thursday. Union Pacific reported a fourth-quarter FY23 operating revenue of $6.159 billion, beating the consensus of $6.05 billion. EPS was $2.71 ( +1% Y/Y ) , beating the consensus of $2.57, according ...",PFE,0.122894,0.0,Neutral
"Medicare patients with highest COVID risks were less likely to get treatment, study finds",https://www.marketwatch.com/story/medicare-patients-with-highest-covid-risks-were-less-likely-to-get-treatment-study-finds-831ae6ed,2024-01-26 16:00:00,"Medicare patients who were at the highest risk of severe COVID-19 infections were less likely to get Paxlovid or other treatments, according to new research.",PFE,0.13459,0.009906,Neutral
"Maison Solutions, Dada Nexus, and BioNTech Class Action Update: Johnson Fistel Alerts Shareholders of Ongoing Legal Proceedings - Dada Nexus  ( NASDAQ:DADA ) , BioNTech  ( NASDAQ:BNTX ) ",https://www.benzinga.com/pressreleases/24/01/g36802663/maison-solutions-dada-nexus-and-biontech-class-action-update-johnson-fistel-alerts-shareholders-of,2024-01-26 15:13:57,"SAN DIEGO, Jan. 26, 2024 ( GLOBE NEWSWIRE ) -- Johnson Fistel, LLP, a law firm specializing in shareholder rights, has announced the initiation of class action lawsuits on behalf of investors of the following companies. Investors are encouraged to review the deadlines listed and submit their ...",PFE,0.156461,-0.173667,Somewhat-Bearish
"US Stocks Mixed; Core PCE Prices Rise In December - Corbus Pharmaceuticals  ( NASDAQ:CRBP ) , Aclarion  ( NASDAQ:ACON ) ",https://www.benzinga.com/news/earnings/24/01/36802315/us-stocks-mixed-core-pce-prices-rise-in-december,2024-01-26 15:02:01,"U.S. stocks traded mixed this morning, following the release of PCE price inflation data. Following the market opening Friday, the Dow traded up 0.12% to 38,096.06 while the NASDAQ fell 0.19% to 15,481.44. The S&P 500 also fell, dropping, 0.05% to 4,891.94. Health care shares rose by 0.5% on ...",PFE,0.082393,0.0,Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines - BNTX - BioNTech  ( NASDAQ:BNTX ) ,https://www.benzinga.com/pressreleases/24/01/g36801828/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-biont,2024-01-26 14:34:00,"NEW YORK, Jan. 26, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against BioNTech SE ( ""BioNTech"" or the ""Company"" ) BNTX. The class action, filed in the United States District Court for the Central District of California, and docketed under ...",PFE,0.316846,-0.085641,Neutral
How To Earn $500 A Month From Pfizer Stock Ahead Of Q4 Earnings Print - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/news/earnings/24/01/36796404/how-to-earn-500-a-month-from-pfizer-stock-ahead-of-q4-earnings-print,2024-01-26 13:41:45,"Pfizer Inc. PFE is expected to release earnings results for its fourth quarter, before the opening bell on Jan. 30, 2024. Analysts expect the New York-based pharma giant to report quarterly earnings at 22 cents per share, versus year-ago earnings of $1.14 per share.",PFE,0.674691,0.183122,Somewhat-Bullish
"1 Growth Stock Down 79% That's a Screaming Buy Right Now, According to Several Wall Street Analysts",https://www.fool.com/investing/2024/01/26/1-growth-stock-down-79-thats-a-screaming-buy-right/,2024-01-26 10:50:00,This biotech's prospects go well beyond COVID-19.,PFE,0.062761,0.224228,Somewhat-Bullish
"SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioNTech SE of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2024 -  ( NASDAQ: BNTX ) ",https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-biontech-se-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-march-12-2024--nasdaq-bntx-302045309.html,2024-01-26 10:45:00,SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioNTech SE of a Class Action Lawsuit and a ... PR ...,PFE,0.219809,-0.237025,Somewhat-Bearish
China confirms the 2022 conviction of a British businessperson on espionage charges,https://apnews.com/article/china-ian-stones-national-security-espionage-d1699d20ed7aeb1600a78f425466d667,2024-01-26 10:38:15,BEIJING ( AP ) - Beijing confirmed Friday that a longtime British businessperson in China was sentenced to five years in prison in 2022 on an espionage charge. Ian J.,PFE,0.09989,0.0,Neutral
"Urinary Tract Infections  ( UTI )  Treatment Market Projection US$ 13.7 Billion by 2030 with a 5.5% CAGR, Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36796399/urinary-tract-infections-uti-treatment-market-projection-us-13-7-billion-by-2030-with-a-5-5-cagr-p,2024-01-26 08:31:44,"New York, Jan. 26, 2024 ( GLOBE NEWSWIRE ) -- The effective management of Urinary Tract Infections ( UTIs ) is crucial in healthcare, targeting bacterial infections affecting the entire urinary system, including the bladder, kidneys, ureters, and urethra.",PFE,0.029691,0.157375,Somewhat-Bullish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mercury Systems, Onsemi, and BioNTech and Encourages Investors to Contact the Firm - BioNTech  ( NASDAQ:BNTX ) , Mercury Sys  ( NASDAQ:MRCY ) ",https://www.benzinga.com/pressreleases/24/01/g36794821/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-mercu,2024-01-26 02:00:00,"NEW YORK, Jan. 25, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Mercury Systems, Inc.",PFE,0.02692,-0.135615,Neutral
